<SEC-DOCUMENT>0001564590-23-002309.txt : 20230223
<SEC-HEADER>0001564590-23-002309.hdr.sgml : 20230223
<ACCEPTANCE-DATETIME>20230223161149
ACCESSION NUMBER:		0001564590-23-002309
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		140
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230223
DATE AS OF CHANGE:		20230223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		23659751

	BUSINESS ADDRESS:	
		STREET 1:		1 CASPER STREET
		CITY:			DANBURY
		STATE:			CT
		ZIP:			06810
		BUSINESS PHONE:		818-661-5000

	MAIL ADDRESS:	
		STREET 1:		1 CASPER STREET
		CITY:			DANBURY
		STATE:			CT
		ZIP:			06810
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mnkd-10k_20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T17:49:03.1659210+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mnkd="http://www.mannkindcorp.com/20221231" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
mnkd-10k_20221231.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000899460_20220101_20221231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0000899460_20220101_20221231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0000899460_20220101_20221231">0000899460</ix:nonNumeric>
			<ix:nonNumeric id="F_000008" name="dei:CurrentFiscalYearEndDate" contextRef="C_0000899460_20220101_20221231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_001438" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108">P4Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001440" name="us-gaap:LesseeOperatingSubleaseExistenceOfOptionToExtend" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">true</ix:nonNumeric>
			<ix:nonNumeric id="F_000622" name="us-gaap:AssetAcquisitionDateOfAcquisitionAgreement" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">2022-05-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000660" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231">2020-12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_001143" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001235" name="us-gaap:SaleOfStockTransactionDate" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180201_20180228">2018-02-28</ix:nonNumeric>
			<ix:nonNumeric id="F_001475" name="mnkd:LongtermPurchaseCommitmentRenewalTimePeriod" contextRef="C_0000899460_20220101_20221231">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_001424" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231">P2Y2M19D</ix:nonNumeric>
			<ix:nonNumeric id="F_001423" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231">P2Y29D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000107" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0000899460_20221231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000108" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0000899460_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000109" name="us-gaap:PreferredStockValue" contextRef="C_0000899460_20221231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000110" name="us-gaap:PreferredStockValue" contextRef="C_0000899460_20211231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000188" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000189" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000190" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20200101_20201231" decimals="2" sign="-">0.26</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlishares" id="F_000194" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20220101_20221231" decimals="-3">257092000</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlishares" id="F_000195" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20210101_20211231" decimals="-3">249244000</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlishares" id="F_000196" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20200101_20201231" decimals="-3">222585000</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000658" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000659" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction>
			<ix:nonNumeric id="F_000802" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">P39Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000804" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000806" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000808" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">P5Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000810" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20220101_20221231">P3Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000803" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">P40Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000805" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">P40Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000807" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">P15Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000809" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000831" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20220101_20221231">P15Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000883" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20221231" decimals="INF">0.0625</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000879" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231" decimals="-5">18400000</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000880" name="mnkd:AccruedPaidInKindInterest" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231" decimals="-5">400000</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000881" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="INF">0.0250</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000882" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231" decimals="INF">0.0250</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000884" name="mnkd:DebtInstrumentFloorRate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231" decimals="2">0.01</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000885" name="mnkd:DebtInstrumentCapInterestRate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231" decimals="4">0.0825</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001283" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001284" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001285" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0000899460_20200101_20201231" decimals="2" sign="-">0.26</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001364" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0000899460_20200101_20201231" decimals="4">0.0263</ix:nonFraction>
			<ix:nonNumeric id="F_001366" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20200101_20201231">P5Y10M24D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001368" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0000899460_20200101_20201231" decimals="4">0.9268</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001365" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0000899460_20200101_20201231" decimals="4">0.0311</ix:nonFraction>
			<ix:nonNumeric id="F_001367" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231">P7Y2M8D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_001369" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0000899460_20200101_20201231" decimals="4">0.9362</ix:nonFraction>
			<ix:nonNumeric id="F_001382" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0000899460_20210101_20211231">P5Y5M26D</ix:nonNumeric>
			<ix:nonNumeric id="F_001383" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0000899460_20220101_20221231">P5Y1M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001384" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0000899460_20220101_20221231">P5Y1M24D</ix:nonNumeric>
			<ix:nonNumeric id="F_001452" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0000899460_20221231">P18Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001453" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0000899460_20211231">P19Y9M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_001504" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0000899460_20221231">P4Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001505" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0000899460_20211231">P2Y7M6D</ix:nonNumeric>
			<ix:nonNumeric id="F_001492" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20221231">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric>
			<ix:nonNumeric id="F_001493" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20211231">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric>
			<ix:nonNumeric id="F_001496" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20221231">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric>
			<ix:nonNumeric id="F_001497" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20211231">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</ix:nonNumeric>
			<ix:nonNumeric id="F_001500" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20221231">http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent</ix:nonNumeric>
			<ix:nonNumeric id="F_001501" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_0000899460_20211231">http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="mnkd-20221231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000899460_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_20230210">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2023-02-10</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_20220630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_mnkdSegment">
				<xbrli:measure>mnkd:Segment</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMinimumMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMaximumMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210601_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-06-01</xbrli:startDate>
					<xbrli:endDate>2021-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20220101_20220101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-01-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_us-gaapLongLivedAssetsHeldForSaleByAssetTypeAxis_mnkdCommitmentAssetMember_20200401_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongLivedAssetsHeldForSaleByAssetTypeAxis">mnkd:CommitmentAssetMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_mnkdContract">
				<xbrli:measure>mnkd:Contract</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-31</xbrli:startDate>
					<xbrli:endDate>2022-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-31</xbrli:startDate>
					<xbrli:endDate>2022-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-05-31</xbrli:startDate>
					<xbrli:endDate>2022-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_mnkdYear">
				<xbrli:measure>mnkd:Year</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputEntityCreditRiskMember_20220531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEntityCreditRiskMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201201_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201201_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">mnkd:DueInOneYearOrLessMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">mnkd:DueInOneYearOrLessMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_mnkdDistributor">
				<xbrli:measure>mnkd:Distributor</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:PreLaunchInventoryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:PreLaunchInventoryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdAgreementWithRetailPharmacyMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:AgreementWithRetailPharmacyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-11-08</xbrli:startDate>
					<xbrli:endDate>2021-11-08</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210401_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_20210401_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToFirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210401_20210430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToFirstAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-01</xbrli:startDate>
					<xbrli:endDate>2021-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-08-01</xbrli:startDate>
					<xbrli:endDate>2022-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210315">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-15</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrD">
				<xbrli:measure>utr:D</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-04</xbrli:startDate>
					<xbrli:endDate>2021-03-04</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-04</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-04-22</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-22</xbrli:startDate>
					<xbrli:endDate>2021-04-22</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-22</xbrli:startDate>
					<xbrli:endDate>2021-04-22</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_mnkdInstallment">
				<xbrli:measure>mnkd:Installment</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodOneMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodThreeMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190806_20190806">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-06</xbrli:startDate>
					<xbrli:endDate>2019-08-06</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertibleNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210422">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-04-22</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20210422_20210422">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-04-22</xbrli:startDate>
					<xbrli:endDate>2021-04-22</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-01</xbrli:startDate>
					<xbrli:endDate>2019-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-10-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-10-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-04-01</xbrli:startDate>
					<xbrli:endDate>2020-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:BaringsGlobalMilestoneRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:BaringsGlobalMilestoneRightsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:OtherAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:OtherAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:ReceptorLifeScienceIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:ReceptorLifeScienceIncMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdResearchAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ResearchAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdRoyaltiesArrangementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:RoyaltiesArrangementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20181031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20190401_20201130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-04-01</xbrli:startDate>
					<xbrli:endDate>2020-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:PreCommercialServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:FacilityExpansionServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:PreCommercialServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:FacilityExpansionServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20211031_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-31</xbrli:startDate>
					<xbrli:endDate>2021-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-08-12</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-12</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-12</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-08-12</xbrli:startDate>
					<xbrli:endDate>2021-08-12</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-16</xbrli:startDate>
					<xbrli:endDate>2021-10-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-16</xbrli:startDate>
					<xbrli:endDate>2021-10-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-16</xbrli:startDate>
					<xbrli:endDate>2021-10-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-10-16</xbrli:startDate>
					<xbrli:endDate>2021-10-16</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:CommercializationAndContinuousImprovementActivitiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-04-01</xbrli:startDate>
					<xbrli:endDate>2022-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-04-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221201_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-12-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:CommercializationAndContinuousImprovementActivitiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-12-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-12-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdAmendmentToCoPromotionAgreementMember_20210701_20210701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AmendmentToCoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-07-01</xbrli:startDate>
					<xbrli:endDate>2021-07-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180501_20180531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-05-01</xbrli:startDate>
					<xbrli:endDate>2018-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
						<xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
							<us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2018-06-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
						</xbrldi:typedMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20211130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20211130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-02-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20220201_20220228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-02-01</xbrli:startDate>
					<xbrli:endDate>2022-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180201_20180228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-02-01</xbrli:startDate>
					<xbrli:endDate>2018-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdJuneTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200624_20200624">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:JuneTwoThousandTwentyNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-24</xbrli:startDate>
					<xbrli:endDate>2020-06-24</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdDecemberTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201009_20201009">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:DecemberTwoThousandTwentyNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-10-09</xbrli:startDate>
					<xbrli:endDate>2020-10-09</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:UnderwritingAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:UnderwritingAgreementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdMidCapCreditFacilityMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-01</xbrli:startDate>
					<xbrli:endDate>2021-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:SeniorConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:SeniorConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdWarrantsAssociatedWithMidcapCreditFacilityMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:WarrantsAssociatedWithMidcapCreditFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdConvertibleNotesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20180531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-05-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20180516">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-05-16</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-05-17</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-17</xbrli:startDate>
					<xbrli:endDate>2021-05-17</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFiveMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFiveMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdTwoThousandFourEquityIncentivePlanMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMinimumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockOptionsAndPerformanceBasedOptionsMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockOptionsAndPerformanceBasedOptionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20130701">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2013-07-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211101_20211130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-11-01</xbrli:startDate>
					<xbrli:endDate>2021-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-11-08</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_srtRangeAxis_srtMinimumMember_20211108">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-11-08</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217EUR">
				<xbrli:measure>iso4217:EUR</xbrli:measure>
			</xbrli:unit>
			<xbrli:unit id="U_mnkdVehicle">
				<xbrli:measure>mnkd:Vehicle</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:MasterLeaseAgreementWithEnterpriseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-05-01</xbrli:startDate>
					<xbrli:endDate>2017-05-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-11-01</xbrli:startDate>
					<xbrli:endDate>2017-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:MarlboroughLeaseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-06-01</xbrli:startDate>
					<xbrli:endDate>2022-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20220601_20220630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-06-01</xbrli:startDate>
					<xbrli:endDate>2022-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeAndVehicleMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtRangeAxis_srtMaximumMember_20210101_20211231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtStatementScenarioAxis_mnkdOneYearServiceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:OneYearServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:TwoYearServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:TwoYearServiceMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20040831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2004-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_20040801_20040831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2004-08-01</xbrli:startDate>
					<xbrli:endDate>2004-08-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapNewJerseyDivisionOfTaxationMember_20220101_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-01-01</xbrli:startDate>
					<xbrli:endDate>2022-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdConnecticutTaxAuthorityMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnkd:ConnecticutTaxAuthorityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdCaliforniaDivisionOfTaxationMember_20221231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000899460</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnkd:CaliforniaDivisionOfTaxationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2022-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000013" fromRefs="F_001087 F_001090 F_001092"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000000" fromRefs="F_000687 F_000688 F_000693 F_000694"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000003" fromRefs="F_000882 F_000888"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000021" fromRefs="F_001105"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000002" fromRefs="F_000875 F_000878 F_000883 F_000884 F_000885 F_000887"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000004" fromRefs="F_001028 F_001029"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000005" fromRefs="F_001030 F_001031 F_001032"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000006" fromRefs="F_001059"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000007" fromRefs="F_001070"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000008" fromRefs="F_001073 F_001074 F_001075 F_001076 F_001087 F_001088 F_001089 F_001099 F_001100 F_001119 F_001120 F_001132 F_001133"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000010" fromRefs="F_001080 F_001092"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000011" fromRefs="F_001081 F_001082"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000009" fromRefs="F_001076 F_001083"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000012" fromRefs="F_001083"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000014" fromRefs="F_001093 F_001104 F_001124 F_001137"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000015" fromRefs="F_001094"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000016" fromRefs="F_001098 F_001118 F_001131"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000019" fromRefs="F_001101 F_001103 F_001121 F_001123 F_001134 F_001136"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000020" fromRefs="F_001103 F_001123 F_001136"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000017" fromRefs="F_001099 F_001102 F_001104 F_001119 F_001122 F_001124 F_001132 F_001135 F_001137"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000018" fromRefs="F_001100 F_001105"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000001" fromRefs="F_000866 F_000867"></ix:relationship>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="Background-color:#auto;margin-bottom:0pt;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:2pt;">&#160;</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000899460_20220101_20221231">10-K</ix:nonNumeric></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:DocumentAnnualReport" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p></td>
<td valign="top">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></table></div>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000899460_20220101_20221231" format="ixt:datemonthdayyearen">December 31, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0000899460_20220101_20221231">2022</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">or</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000027" name="dei:DocumentTransitionReport" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p></td>
<td valign="top">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:8pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td></tr></table></div>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the transition period from&#160; <span style="text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span> to <span style="text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission file number: <ix:nonNumeric id="F_000016" name="dei:EntityFileNumber" contextRef="C_0000899460_20220101_20221231">000-50865</ix:nonNumeric></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0000899460_20220101_20221231">MannKind Corporation</ix:nonNumeric></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:49.91%;"></td>
<td style="width:2.2%;"></td>
<td style="width:47.88%;"></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000028" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000899460_20220101_20221231">13-3607736</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:3pt;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:3pt;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:3pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:EntityAddressAddressLine1" contextRef="C_0000899460_20220101_20221231">1 Casper Street</ix:nonNumeric><span style="font-size:10pt;font-weight:normal;">&#160;</span></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:EntityAddressCityOrTown" contextRef="C_0000899460_20220101_20221231">Danbury</ix:nonNumeric>, <ix:nonNumeric id="F_000020" name="dei:EntityAddressStateOrProvince" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:stateprovnameen">Connecticut</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:EntityAddressPostalZipCode" contextRef="C_0000899460_20220101_20221231">06810</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:CityAreaCode" contextRef="C_0000899460_20220101_20221231">(818)</ix:nonNumeric> <ix:nonNumeric id="F_000023" name="dei:LocalPhoneNumber" contextRef="C_0000899460_20220101_20221231">661-5000</ix:nonNumeric></p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of Each Class</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of Each Exchange on Which Registered</p></td>
</tr>
<tr>
<td valign="top" style="width:34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000029" name="dei:Security12bTitle" contextRef="C_0000899460_20220101_20221231">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td valign="top" style="width:1%;">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:32%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0000899460_20220101_20221231">MNKD</ix:nonNumeric></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:32%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000030" name="dei:SecurityExchangeName" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act:</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">None</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Title of Class)</p>
<p style="text-align:right;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000009" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0000899460_20220101_20221231">Yes</ix:nonNumeric>&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span>&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000011" name="dei:EntityVoluntaryFilers" contextRef="C_0000899460_20220101_20221231">No</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span> </p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000010" name="dei:EntityCurrentReportingStatus" contextRef="C_0000899460_20220101_20221231">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;No&#160;&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> </p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T <span style="color:#000000;">(&#167; 232.405 of this chapter)</span><span style="font-weight:bold;color:#000000;"> </span>during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric id="F_000031" name="dei:EntityInteractiveDataCurrent" contextRef="C_0000899460_20220101_20221231">Yes</ix:nonNumeric>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> </p>
<p style="margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:20.36%;"></td>
<td style="width:1.15%;"></td>
<td style="width:51.79%;"></td>
<td style="width:1.93%;"></td>
<td style="width:22.14%;"></td>
<td style="width:1.14%;"></td>
<td style="width:1.49%;"></td>
</tr>
<tr>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityFilerCategory" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:entityfilercategoryen">Large&#160;accelerated&#160;filer</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated filer</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;<span style="font-family:Times New Roman;">&#160;&#160;</span></p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntitySmallBusiness" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth&#160;company</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000032" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If<span style="color:#231F20;letter-spacing:0.9pt;"> </span><span style="color:#231F20;">securities are</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">registered pursuant to</span><span style="color:#231F20;letter-spacing:0.95pt;"> </span><span style="color:#231F20;">Section 12(b)</span><span style="color:#231F20;letter-spacing:2.4pt;"> </span><span style="color:#231F20;">of</span><span style="color:#231F20;letter-spacing:1.1pt;"> </span><span style="color:#231F20;">the</span><span style="color:#231F20;letter-spacing:0.75pt;"> </span><span style="color:#231F20;">Act,</span><span style="color:#231F20;letter-spacing:1.75pt;"> </span><span style="color:#231F20;">indicate by</span><span style="color:#231F20;letter-spacing:1.25pt;"> </span><span style="color:#231F20;">check</span><span style="color:#231F20;letter-spacing:2.35pt;"> </span><span style="color:#231F20;">mark</span><span style="color:#231F20;letter-spacing:2.1pt;"> </span><span style="color:#231F20;">whether the</span><span style="color:#231F20;letter-spacing:1.3pt;"> </span><span style="color:#231F20;">financial statements of</span><span style="color:#231F20;letter-spacing:1.1pt;"> </span><span style="color:#231F20;">the</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">registrant included in</span><span style="color:#231F20;letter-spacing:0.95pt;"> </span><span style="color:#231F20;">the</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">filing</span><span style="color:#231F20;letter-spacing:1.65pt;"> </span><span style="color:#231F20;">reflect</span><span style="color:#231F20;letter-spacing:2pt;"> </span><span style="color:#231F20;">the</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">correction of</span><span style="color:#231F20;letter-spacing:1.1pt;"> </span><span style="color:#231F20;">an</span><span style="color:#231F20;letter-spacing:1.1pt;"> </span><span style="color:#231F20;">error</span><span style="color:#231F20;letter-spacing:2pt;"> </span><span style="color:#231F20;">to</span><span style="color:#231F20;letter-spacing:0.95pt;"> </span><span style="color:#231F20;">previously issued financial statements.&#160;</span><span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate<span style="color:#231F20;"> by</span><span style="color:#231F20;letter-spacing:0.75pt;"> </span><span style="color:#231F20;">check</span><span style="color:#231F20;letter-spacing:1.9pt;"> </span><span style="color:#231F20;">mark</span><span style="color:#231F20;letter-spacing:1.65pt;"> </span><span style="color:#231F20;">whether any</span><span style="color:#231F20;letter-spacing:1.05pt;"> </span><span style="color:#231F20;">of</span><span style="color:#231F20;letter-spacing:0.6pt;"> </span><span style="color:#231F20;">those</span><span style="color:#231F20;letter-spacing:1.65pt;"> </span><span style="color:#231F20;">error</span><span style="color:#231F20;letter-spacing:1.5pt;"> </span><span style="color:#231F20;">corrections</span><span style="color:#231F20;letter-spacing:-0.4pt;"> </span><span style="color:#231F20;">are</span><span style="color:#231F20;letter-spacing:0.9pt;"> </span><span style="color:#231F20;">restatements</span><span style="color:#231F20;letter-spacing:-0.4pt;"> </span><span style="color:#231F20;">that</span><span style="color:#231F20;letter-spacing:1.15pt;"> </span><span style="color:#231F20;">required a</span><span style="color:#231F20;letter-spacing:0.15pt;"> </span><span style="color:#231F20;">recovery</span><span style="color:#231F20;letter-spacing:-0.4pt;"> </span><span style="color:#231F20;">analysis of</span><span style="color:#231F20;letter-spacing:0.6pt;"> </span><span style="color:#231F20;">incentive-based compensation received by</span><span style="color:#231F20;letter-spacing:1.25pt;"> </span><span style="color:#231F20;">any</span><span style="color:#231F20;letter-spacing:1.55pt;"> </span><span style="color:#231F20;">of</span><span style="color:#231F20;letter-spacing:1.1pt;"> </span><span style="color:#231F20;">the</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">registrant</span><span style="color:#231F20;letter-spacing:-0.65pt;">&#8217;</span><span style="color:#231F20;">s</span><span style="color:#231F20;letter-spacing:0.1pt;"> </span><span style="color:#231F20;">executive </span><span style="color:#231F20;letter-spacing:-0.05pt;">o</span><span style="color:#231F20;">&#64259;cers during the</span><span style="color:#231F20;letter-spacing:1.35pt;"> </span><span style="color:#231F20;">relevant recovery period pursuant to</span><span style="color:#231F20;letter-spacing:0.95pt;"> </span><span style="color:#231F20;">&#167;240.10D-1(b).&#160;</span><span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000015" name="dei:EntityShellCompany" contextRef="C_0000899460_20220101_20221231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;No&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June&#160;30, 2022, the aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the last sale price of such stock as of such date on the Nasdaq Global Market, was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000025" name="dei:EntityPublicFloat" contextRef="C_0000899460_20220630" decimals="0" format="ixt:numdotdecimal">910,286,410</ix:nonFraction>.</p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of February 10, 2023, there were <ix:nonFraction unitRef="U_xbrlishares" id="F_000024" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0000899460_20230210" decimals="INF" format="ixt:numdotdecimal">263,923,726</ix:nonFraction> shares of the registrant&#8217;s Common Stock outstanding.</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:3pt;border-bottom:Solid 0.75pt;padding-bottom:2pt;margin-top:0pt;margin-left:37.5%;margin-right:37.5%;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p><ix:nonNumeric id="F_000488" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Portions of the registrant&#8217;s definitive Proxy Statement (the &#8220;Proxy Statement&#8221;) for the 2023 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than May 1, 2023 are incorporated by reference into Part III of this Annual Report on Form 10-K.</p></ix:nonNumeric>
<p style="Background-color:#auto;margin-bottom:0pt;border-bottom:Double 2.25pt;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual Report on Form 10-K</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Fiscal Year Ended December 31, 2022</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td colspan="5" valign="top" style="width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART I</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:none;">Business</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#Item_1A_RISK_FACTORS"><span style="text-decoration:none;">Risk Factors</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:none;">Unresolved Staff Comments</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:none;">Properties</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 3.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_LEGAL_PROCEEDINGS_UPDATE_"><span style="text-decoration:none;">Legal Proceedings</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 4.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:none;">Mine Safety Disclosures</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td colspan="5" valign="top" style="width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART II</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 5.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:none;">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 6.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_6_RESERVED"><span style="text-decoration:none;">[Reserved]</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 7.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:none;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS"><span style="text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 8.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR"><span style="text-decoration:none;">Financial Statements and Supplementary Data</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:none;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:none;">Controls and Procedures</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OR_INFORMATION"><span style="text-decoration:none;">Other Information</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9C.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9C_DISCLOSURE_REGARDING_FOREIGN_JUR"><span style="text-decoration:none;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p></td>
</tr>
<tr>
<td colspan="5" valign="top" style="width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART III</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 10.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO"><span style="text-decoration:none;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 11.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11_EXECUTIVE_COMPENSATION"><span style="text-decoration:none;">Executive Compensation</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 12.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF"><span style="text-decoration:none;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 13.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR"><span style="text-decoration:none;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 14.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC"><span style="text-decoration:none;">Principal Accounting Fees and Services</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
</tr>
<tr>
<td colspan="5" valign="top" style="width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART IV</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:none;">Exhibits. Financial Statement Schedules</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p></td>
</tr>
<tr>
<td valign="top" style="width:12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 16. </p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16_FORM_10K_SUMMARY"><span style="text-decoration:none;">Form 10-K Summary</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="width:93%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:none;">Signatures</span></a></p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statements in this report that are not strictly historical in nature are &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions intended to identify forward-looking statements, though not all forward-looking statements contain these identifying words. These statements may include, but are not limited to, statements regarding: our ability to successfully market, commercialize and achieve market acceptance for Afrezza&#174;, V-Go&#174; or other product candidates or therapies that we may develop or acquire&#59; our ability to manufacture sufficient quantities of Afrezza and obtain insulin supply as needed&#59; our ability to manufacturing sufficient quantities of Tyvaso DPI&#174; to meet demand&#59; our expectation to receive FDA approval of a new source of FDKP in 2024&#59; our expectations regarding our contract manufacturer&#8217;s ability to meet our current and expected near-term demand for V-Go&#59; our ability to successfully commercialize our Technosphere drug delivery platform&#59; our estimates for future performance&#59; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing&#59; the progress or success of our research, development and clinical programs, including the application for and receipt of regulatory clearances and approvals&#59; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others our ability to service our debt obligations&#59; and scientific studies and the conclusions we draw from them. These statements are only predictions or conclusions based on current information and expectations and involve a number of risks and uncertainties. The underlying information and expectations are likely to change over time. Actual events or results may differ materially from those projected in the forward-looking statements due to various factors, including, but not limited to, those set forth under the caption &#8220;Risk Factors&#8221; and elsewhere in this report. In addition, statements like &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Afrezza, Technosphere&#174;, BluHale&#174;, Dreamboat&#174; and V-Go, and MannKind Corporation are our trademarks in the United States. We have also applied for or have registered company trademarks in other jurisdictions. This document also contains trademarks and service marks of other companies that are the property of their respective owners.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risk Factor Summary</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.83%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Below is a summary of the material factors that make an investment in our common stock speculative or risky. This summary does not address all of the risks that we face. Additional discussion of the risks summarized in this risk factor summary, and other risks that we face, can be found under the heading &#8220;Risk Factors&#8221; in Part I of this Annual Report on Form 10-K and should be carefully considered, together with other information in this Annual Report on Form 10-K and our other filings with the Securities and Exchange Commission (&#8220;SEC&#8221;) before making investment decisions regarding our common stock.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO OUR BUSINESS </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">The products that we or our collaboration partner are commercializing may only achieve a limited degree of commercial success. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Manufacturing risks may adversely affect our ability to manufacture our products and Tyvaso DPI, which could reduce our gross margin and profitability.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If our suppliers fail to deliver materials and services needed for commercial manufacturing in a timely and sufficient manner or fail to comply with applicable regulations, and if we fail to timely identify and qualify alternative suppliers, our business, financial condition and results of operations would be harmed and the market price of our common stock and other securities could decline.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If third-party payers do not cover our approved products, such products might not be prescribed, used or purchased, which would adversely affect our revenues.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">We may need to raise additional capital to fund our operations.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We expect that our results of operations will fluctuate for the foreseeable future, which may make it difficult to predict our future performance from period to period.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We have a history of operating losses. We expect to incur losses in the future and we may not generate positive cash flow from operations in the future.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We have a substantial amount of debt, and we may be unable to make required payments of interest and principal as they become due.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Our business, product sales, results of operations and ability to access capital could be adversely affected by the effects of health pandemics or epidemics, in regions where we or third parties distribute our products or where we or third parties on which we rely have significant manufacturing facilities, concentrations of clinical trial sites or other business operations.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Continued testing of our products and product candidates may not yield successful results, and even if it does, we may still be unable to successfully commercialize our current or future products.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If we do not achieve our projected development goals in the timeframes we expect, our business, financial condition and results of operations will be harmed and the market price of our common stock and other securities could decline.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>The long-term safety and efficacy of approved products may differ from clinical studies, which could negatively impact sales and could lead to reputational harm or other negative effects.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Our products and product candidates may be rendered obsolete by rapid technological change.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We may undertake internal restructuring activities in the future that could result in disruptions to our business or otherwise materially harm our results of operations or financial condition.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions&#59; litigation&#59; fines and penalties&#59; disruptions of our business operations&#59; reputational harm&#59; loss of revenue or profits&#59; loss of customers or sales&#59; and other adverse consequences.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.83%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO GOVERNMENT REGULATION</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Our product candidates must undergo costly and time-consuming rigorous nonclinical and clinical testing and we must obtain regulatory approval prior to the sale and marketing of any product in each jurisdiction. The results of this testing or issues that develop in the review and approval by a regulatory agency may subject us to unanticipated delays or prevent us from marketing any products.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If we do not comply with regulatory requirements at any stage, whether before or after marketing approval is obtained, we may be fined or forced to remove a product from the market, subject to criminal prosecution, or experience other adverse consequences, including restrictions or delays in obtaining regulatory marketing approval.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We are subject to stringent, ongoing government regulation.</p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>If we or any future partner fails to comply with federal and state healthcare laws, including fraud and abuse and health information laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We are subject to stringent and changing U.S. and foreign laws, regulations, rules, contractual obligations, policies and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions&#59; litigation&#59; fines and penalties&#59; disruptions of our business operations&#59; reputational harm&#59; loss of revenue or profits&#59; loss of customers or sales&#59; and other adverse business consequences.</p></td></tr></table></div>
<p style="margin-top:18pt;margin-bottom:8pt;margin-left:4.83%;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO OUR COMMON STOCK</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>We may not be able to generate sufficient cash to service all of our indebtedness and commitments. We may be forced to take other actions to satisfy our obligations or we may experience a financial failure.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Our stock price is volatile.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span>Future sales of shares of our common stock in the public market, or the perception that such sales may occur, may depress our stock price and adversely impact the market price of our common stock and other securities.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:8.51%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GENERAL RISK FACTORS</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Unstable market, economic and geopolitical conditions may have serious adverse consequences on our business, financial condition and stock price.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.83%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART I</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">Item&#160;1.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Business </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless the context requires otherwise, the words &#8220;MannKind,&#8221; &#8220;we,&#8221; &#8220;Company,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to MannKind Corporation and its subsidiaries.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Our signature technologies &#8211; Technosphere dry-powder formulations and Dreamboat inhalation devices &#8211; offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In our endocrine business unit, we currently commercialize two products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. Afrezza was developed by us and received approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in June&#160;2014. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Administered at the beginning of a meal, Afrezza dissolves rapidly upon inhalation to the lung and delivers insulin quickly to the bloodstream. V-Go received 510(k) clearance by the FDA in 2010 and has been available commercially since 2012. In May 2022, we acquired V-Go from Zealand Pharma A/S and Zealand Pharma US, Inc. (together &#8220;Zealand&#8221;) and began integrating the product into our endocrine business unit. V-Go is a mechanical basal-bolus insulin delivery system that is worn like a patch and can eliminate the need for taking multiple daily shots. V-Go administers a continuous preset basal rate of insulin over 24 hours and provides discreet on-demand bolus dosing at mealtimes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are solely responsible for the commercialization of Afrezza and V-Go in the United States. Outside of the U.S., our strategy has been to establish regional partnerships in foreign jurisdictions where there are commercial opportunities, subject to the receipt of necessary foreign regulatory approvals. Our partner in Brazil, Biomm S.A. (&#8220;Biomm&#8221;), commenced commercialization of Afrezza in January 2020. Our partner in India, Cipla Ltd. (&#8220;Cipla&#8221;), is currently conducting a clinical study of Afrezza in order to meet the requirements for a regulatory submission to the Drug Controller General of India.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The proprietary formulation and inhaler technologies used in Afrezza have also been deployed in our efforts to develop products to treat orphan lung diseases. The first product to come out of our orphan lung disease pipeline, Tyvaso DPI (treprostinil) inhalation powder, received FDA approval in May 2022 for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Tyvaso DPI is the first and only approved dry powder inhaled treatment for PAH and PH-ILD. Our collaboration partner, United Therapeutics Corporation (&#8220;United Therapeutics&#8221; or &#8220;UT&#8221;) began commercializing Tyvaso DPI in June 2022. UT pays us a royalty on net sales of Tyvaso DPI as well as a margin on supplies of Tyvaso DPI that we manufacture for UT. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The next most advanced program in our pipeline of potential treatments for orphan lung diseases is MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial (NTM) lung disease. We believe an orally inhaled formulation of clofazimine could potentially provide several clinical advantages over the current solid oral dosage form of this drug. The FDA has designated MNKD-101 as both an orphan drug and a qualified infectious disease product for the treatment of pulmonary NTM infections. We recently completed an initial clinical study of MNKD 101 in Australia and we plan to initiate a Phase 2/3 clinical study in the United States in 2023. In connection with the development of MNKD-101, we are also evaluating the feasibility of developing a dry-powder formulation of clofazimine using our Technosphere formulation technology.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have formulated other drugs and biologics for the treatment of orphan lung disease and plan to continue their development as dictated by the results achieved in preclinical studies and by resource requirements. We have also partnered with several third parties that have proprietary rights to certain compounds in order to evaluate the feasibility of developing dry-powder formulations of such compounds. We may seek to convert certain of these exploratory programs into full development programs funded by the external parties. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To aid in the development of oral inhalation products, we have created a number of innovative tools, including a novel inhalation profiling apparatus, known as BluHale that uses miniature sensors to assess the drug delivery process at the level of an individual inhaler. The BluHale apparatus medical device provides real-time data regarding patient usage and delivery system performance that is transmitted to a user interface, such as a smartphone application. During 2020, we released a BluHale Professional version of the apparatus for use as a training tool in certain physician&#8217;s offices. A consumer version of the apparatus, with additional features, is planned for release in 2023.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing and Supply</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Technosphere powders are based on our proprietary excipient, fumaryl diketopiperazine (&#8220;FDKP&#8221;), which is a pH-sensitive organic molecule that self-assembles into small particles under acidic conditions. Certain drugs can be loaded onto these particles by combining a solution of the drug with a solution or suspension of Technosphere material, which is then dried to powder form. The resulting powder has a consistent and narrow range of particle sizes with good aerodynamic properties that enable efficient delivery deep into the lungs. Technosphere powders dissolve quickly when the particles contact the moist lung surface with its neutral pH, releasing the drug molecules to diffuse across a thin layer of cells into the arterial circulation, bypassing the liver to provide excellent systemic exposure. In our Danbury, Connecticut facility, we can develop novel Technosphere formulations of different pharmaceutical ingredients and manufacture clinical and commercial supplies of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">these powders. In this facility, we currently</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> formulate both the Afrezza and T</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">yvaso DPI </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inhalation powders</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at commercial scale</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, fill plastic cartridges with the powders</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> package the cartridges in</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> blister packs. We utilize a contract packager to assemble the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">blister packs </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of Afrezza </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and Tyvaso DPI cartridges </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">along with inhalers</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the applicable</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> package inserts</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, into final kits for sale</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Technosphere powders are intended to be administered with our innovative, breath-powered, dry powder inhalers. Our inhalers are easy to use, cost-effective and can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format. Both the reusable and single-use inhaler formats use the same internal air-flow design. Afrezza and Tyvaso DPI both use the reusable format (also known as Dreamboat). Being breath-powered, our inhalers require only the patient&#8217;s inhalation effort to deliver the powder. To administer a dose of the inhalation powder, a patient loads a cartridge into our inhaler and inhales through the mouthpiece. Upon inhalation, the dry powder is lifted out of the cartridge and broken up (or de-agglomerated) into small particles. The inhalers are engineered to produce an aggressive airstream that de-agglomerates the powder while keeping the powder moving relatively slowly. This slow-moving powder effectively navigates the patient&#8217;s airways to reach the deep lung with minimal deposition at the back of the throat. Our inhalers show very little change in performance (i.e., efficient cartridge emptying) over a wide range of inhalation efforts. We have a supply agreement with the contract manufacturer that produces the plastic-molded parts for our inhaler and the corresponding cartridges. We expect to be able to qualify an additional vendor of plastic-molding contract manufacturing services, if warranted by demand. We then assemble the inhalers from the individual components at our Connecticut facility.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The quality management systems of our Connecticut facility have been certified to be in conformance with the ISO 13485:2016 standard. Our facility is inspected on a regular basis by the FDA, most recently in July 2021 when the FDA conducted a pre-approval inspection related to Tyvaso DPI and a GMP inspection related to Afrezza. The FDA made one observation during its most recent inspection, which we corrected and addressed with the FDA following the site visit. We were also inspected by the Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (&#8220;ANVISA&#8221;) (Brazil National Health Surveillance Agency) in May 2018. ANVISA renewed its certificate in 2020 on the basis of a virtual inspection. The FDA and other foreign jurisdictions are expected to conduct additional inspections of our facility from time to time.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our Connecticut facility has enough capacity to satisfy the current demand for Afrezza and Tyvaso DPI. In addition, we are currently expanding production capacity with additional filling lines and other equipment in order to meet the demand for Tyvaso DPI projected by UT over the next several years. The costs of this expansion project are being borne by UT. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the only source of insulin that we have qualified for Afrezza is manufactured by Amphastar France Pharmaceuticals S.A.S. (&#8220;Amphastar&#8221;). In April 2014, we entered into a supply agreement with Amphastar (as amended, the &#8220;Insulin Supply Agreement&#8221;) to purchase certain annual minimum quantities with an aggregate purchase commitment of &#8364;120.1&#160;million over a term that currently extends through December 31, 2027. As of December 31, 2022, there was $72.3 million remaining in aggregate purchase commitments under this agreement. See additional information in Note 16 &#8211; Commitments and Contingencies to the consolidated financial statements for further information related to the Insulin Supply Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The treprostinil used to produce Tyvaso DPI is supplied to us at no cost by United Therapeutics.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, we purchase FDKP, the primary component of our Technosphere powders, from a major chemical manufacturer with facilities in Europe and North America. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also have an agreement with the contractor that performs the final packaging of Afrezza and Tyvaso DPI overwraps, inhalers and printed material into patient kits. We expect to be able to qualify an additional vendor of packaging services, if warranted by demand.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go is manufactured for us by a contract manufacturer (&#8220;CMO&#8221;) in Southern China using MannKind-owned, custom-designed, semi-automated manufacturing equipment and production lines that can be brought online and/or staffed up as demand increases. We believe these production lines will have the ability to meet our current and expected near-term demand for V-Go. Additional CMOs in China perform release testing, sterilization, inspection and packaging functions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go is assembled from components that are manufactured to our specifications. Each completed device is tested to ensure compliance with our engineering and quality assurance specifications. A series of automated inspection checks, including x-ray assessments and lot-released testing, are also conducted throughout the manufacturing process to verify proper assembly and functionality. When mechanical components are sourced from outside vendors, those vendors must meet our detailed qualification and process control requirements. We maintain a team of product and process engineers, supply chain and quality personnel who provide product and production line support for V-Go. We also employ a full-time dedicated contractor based in China.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some of the parts and components of V-Go are purchased from sole-source vendors, and we manage any single-source components and suppliers through our global supply chain operation. We believe that, if necessary, alternative sources of supply would, in most cases, be available in a relatively short period of time and on commercially reasonable terms. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The BluHale device is assembled for us by a CMO using components that are sourced from multiple vendors. Similarly, the clofazimine inhalation solution being evaluated in the MNKD-101 program is manufactured for us by a CMO. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In general, our suppliers and contract manufacturers are sophisticated and mature organizations, often with multinational operations, that have significant experience with pharmaceutical and medical device manufacturing. Our quality and manufacturing personnel conduct </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">extensive inspections to qualify new vendors and periodic GMP audits of their operations on an ongoing basis.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> O</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ur </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CMO</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> facilities and the facilities of our critical suppliers are subject to periodic inspection by the FDA and corresponding state and foreign agencies.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> With the expansion of our supply chain into the electronic components that are required for BluHale devices, we have begun to require our vendors to confirm that conflict minerals are not knowingly or intentionally added during the manufacturing process for, or are unnecessary to the functionality or production of, the components that we source from such vendors. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intellectual Property</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success will depend in large measure on our ability to continue enforcing our intellectual property rights, effectively maintain our trade secrets and avoid infringing the proprietary rights of third parties. Our policy is to file patent applications on what we deem to be important technological developments that might relate to our product candidates or methods of using our product candidates and to seek intellectual property protection for all inventions in the United States, Europe, Japan and, depending on the nature of the invention, selected other jurisdictions. We have obtained, are seeking, and will continue to seek patent protection on the compositions of matter, methods of treatment and manufacturing processes flowing from our research and development efforts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Technosphere drug delivery platform enjoys patent protection relating to the powder, its manufacture, its use for pulmonary delivery of drugs as well as protection related to our inhalers and associated cartridges. We have additional patent coverage relating to methods for the treatment of diabetes using Afrezza. Overall, Afrezza is protected by approximately 670 issued patents and 55 pending patent applications in the United States and selected jurisdictions around the world, the longest-lived of which will expire in 2032. Similarly, Tyvaso DPI is protected by approximately 450 issued patents in the United States and elsewhere and an additional 40 pending patent applications. The longest-lived patent protection for Tyvaso DPI will expire in 2035. Various features of the commercial V-Go device are protected by a portfolio of approximately 200 issued patents and another 25 pending patent applications, the longest-lived of which will expire in 2033. Additional patents and patent applications are expected to provide protection for MNKD-101, our BluHale inhalation-profiling apparatus and various development tools. Our entire worldwide portfolio consists of approximately 1,350 issued patents and approximately 215 pending patent applications We expect to file further patent applications as our research and development efforts continue.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Drug delivery is a crowded field and a substantial number of patents have been issued to innovators in this space. In addition, because patent positions can be highly uncertain and frequently involve complex legal and factual questions, the breadth of claims obtained in any application or the enforceability of issued patents cannot be confidently predicted. Further, there can be substantial delays in commercializing pharmaceutical products, which can partially consume the statutory period of exclusivity through patents. For some of our inventions, particularly manufacturing processes and improvements, we have chosen to rely on trade secrets and know-how, which are not protected by patents, to maintain our competitive position.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use trademarks and service marks to protect our corporate brand as well as the branding associated with Afrezza, V-Go, our Technosphere formulation technology, our device platform and the product support programs that we have developed. Our current portfolio consists of approximately 240 registered trademarks and 55 applications in the U.S. and selected foreign jurisdictions. We routinely monitor competing trademarks and, when necessary, oppose marks that we believe would be confusing to consumers. We also enforce against the unauthorized use or misappropriation of our marks.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Competition</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The pharmaceutical and biotechnology industries are highly competitive and characterized by rapidly evolving technology and intense research and development efforts. We compete with companies, including major global pharmaceutical companies, and other institutions that have substantially greater financial, research and development, marketing and sales capabilities and have substantially greater experience in undertaking preclinical and clinical testing of products, obtaining regulatory approvals and marketing and selling biopharmaceutical products. We face competition based on, among other things, product efficacy and safety, the timing and scope of regulatory approvals, product ease of use and price.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Afrezza is administered at the beginning of a meal, so its principal competitors are rapid-acting&#8221; insulin analogs that are used for mealtime insulin injections. The products in this category are marketed by Eli Lilly and Company, Sanofi S.A. and Novo Nordisk A/S. V-Go is typically used by patients as part of a basal-bolus insulin regimen. Like Afrezza, it competes with injectable mealtime insulin products but also with long-acting, or basal, injectable insulins. The principal products in this category are marketed by Novo Nordisk and Sanofi. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Both Afrezza and V-Go also face some competition from glucagon-like peptide-1, or GLP-1, analog injection products. These products are often used in combination with oral medications or basal insulin injection before a patient progresses to a basal-bolus insulin regimen. As a result, we also compete with the manufacturers of GLP-1 analog injection products, such as AstraZeneca PLC, Novo Nordisk A/S and Eli Lilly and Company. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Government Regulation</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and comparable regulatory agencies in state and local jurisdictions impose substantial requirements upon the research, clinical development, testing, manufacture, labeling, storage, shipping, approval, recordkeeping, advertising, promotion, sale and distribution of medical devices and new drug and biologic products. In addition, to the extent that our products are marketed abroad, they are also subject to export requirements and to regulation by foreign governments. The regulatory approval process is generally lengthy, expensive and uncertain. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Failure to comply with applicable FDA and other regulatory requirements can result in sanctions being imposed on us, including </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">warning letters, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hold letters on clinical research, product recalls or seizures, total or partial suspension of production or injunctions, refusals to permit products to be imported into or exported out of the United States, refusals of the FDA to grant approval of drugs or to allow us to enter into government supply contracts, withdrawals of previously approved marketing applications</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> civil or criminal fines or other penalties.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As the holder of marketing approvals for Afrezza and V-Go, we are subject to continuing regulation by the FDA, including post marketing study commitments or requirements, record-keeping requirements, reporting of adverse experiences with our products, submitting periodic reports, drug sampling and distribution requirements, notifying the FDA and gaining its approval of certain manufacturing or labeling changes, and complying with certain electronic records and signature requirements. For example, as part of the approval of Afrezza, the FDA required us to conduct certain additional clinical studies of Afrezza in pediatric patients<span style="color:#000000;">. In 2021, we initiated a Phase 3 clinical trial to evaluate the safety and efficacy of Afrezza in combination with basal insulin versus multiple daily injections of insulin in children and adolescents aged 4-17 who are living with type 1 or type 2 diabetes. This study, known as the INHALE-1 study, is expected to complete enrollment by the end of 2023. When Afrezza was approved, the FDA also required us to conduct an additional long-term safety study that was originally intended to compare the incidence of pulmonary malignancy observed with Afrezza to that observed in a standard of care control group. We have an ongoing dialogue with the FDA regarding the agency&#8217;s current interest in the long-term safety of Afrezza and an appropriate study design to address any concerns.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a manufacturer of multiple therapeutic products, including Tyvaso DPI, our Connecticut facility is subject to federal registration and listing requirements and, if applicable, to state licensing requirements. It is also subject to inspection by the FDA and other national regulatory bodies and must comply with current good manufacturing practices (&#8220;cGMPs&#8221;), quality system regulations for medical devices (&#8220;QSR&#8221;) and other requirements enforced by these regulatory bodies. So too are the facilities of our insulin supplier and the supplier(s) of FDKP. Likewise, the supplier of our inhaler and cartridges and the CMOs for V-Go are subject to QSR, which requires manufacturers to follow elaborate design, testing, control, documentation and other quality assurance procedures during the manufacturing process of medical devices, among other requirements. A failure, including those of our suppliers, to obtain and maintain applicable federal registrations or state licenses, or to meet the inspection criteria of the FDA or the other national regulatory bodies, would disrupt our manufacturing processes and would harm our business. In complying with standards set forth in these regulations, manufacturers must continue to expend time, money and effort in the area of production and quality control to ensure full compliance. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the FDA imposes complex regulations on entities that advertise and promote drugs, which include, among other requirements, standards for and regulation of direct-to-consumer advertising, industry sponsored scientific and educational activities, promotional activities involving the Internet, and restrictions on off-label promotion. The FDA has very broad enforcement authority, and failure to comply with these<span style="font-size:12pt;"> </span>regulations can result in penalties, including the issuance of a warning letter, requirements for corrective advertising to healthcare providers, a requirement that future advertising and promotional materials be pre-cleared by the FDA, and state and federal civil and criminal investigations and prosecutions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Products manufactured in the United States and marketed outside the United States are subject to certain FDA regulations, as well as regulation by the country in which the products are to be sold. We are also subject to foreign regulatory requirements governing clinical trials and drug product sales if products are studied or marketed abroad. Whether or not FDA approval has been obtained, approval of a product by the comparable regulatory authorities of foreign countries usually must be obtained prior to the marketing of the product in those countries. The approval process varies from jurisdiction to jurisdiction and the time required may be longer or shorter than that required for FDA approval.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Pricing and Reimbursement</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Government coverage and reimbursement policies both directly and indirectly affect our ability to successfully commercialize our approved products, and such coverage and reimbursement policies will be affected by future healthcare reform measures. Third-party payers, such as government health administration authorities, private health insurers and other organizations that provide healthcare coverage, generally decide which drugs they will pay for and establish reimbursement levels for covered drugs. In particular, in the United States, private third-party payers often provide reimbursement for products and services based on the level at which the government (through the Medicare or Medicaid programs) provides reimbursement for such products and services. In the United States, the European Union and other potentially significant markets for our product candidates, government authorities and other third-party payers are increasingly attempting to limit or regulate the price of medical products and services, particularly for new and innovative products and therapies, which has resulted in lower average selling prices. Further, the increased emphasis on managed healthcare in the United States will put additional pressure on product pricing, reimbursement and usage, which may adversely affect our future product sales and results of operations. Recently, in the United States there has been heightened governmental scrutiny of the manner in which drug manufacturers set prices for their marketed products. Pricing pressures can arise from rules and practices of managed care organizations, judicial decisions and governmental laws and regulations related to Medicare, Medicaid, healthcare reform, pharmaceutical reimbursement policies and pricing in general.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The United States and some foreign jurisdictions have enacted or are considering a number of additional legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payers</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the U.S. and elsewhere, there is significant interest</span><span style="font-size:12pt;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives, including the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, &#8220;PPACA&#8221;), </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">which was </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enacted in March 2010. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the years since the PPACA was enacted, t</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">here have been </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a number of executive, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">judicial and congressional challenges to certain aspects of PPACA</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While Congress has not passed comprehensive repeal legislation, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">several </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">bills affecting the implementation of certain </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provisions of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the PPACA have been signed into law. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, l</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">egislation enacted in 2017, informally titled the Tax Cuts and Jobs Act of 2017 (&#8220;Tax Act&#8221;), includes a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the PPACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate&#8221;. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subsequently</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, a Texas U.S. District Court Judge ruled </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> December 2018</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">that the PPACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress as part of the Tax Act. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ultimately, in June 2021 the Supreme Court dismissed this challenge to the constitutionality of the PPACA, so it remains in effect in its current form. However, i</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n the future, there are likely to be additional proposals relating to the reform of the U.S. health care system, some of which could further limit the prices we are able to charge for our products, or the amounts of reimbursement available for our products. If drug products are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional laws and requirements apply. All of these activities are also potentially subject to federal and state consumer protection and unfair competition laws.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, in the United States, there have been several presidential executive orders, congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. For example, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s average manufacturer price, for single source and innovator multiple source drugs, beginning January 1, 2024. More recently, the Inflation Reduction Act (the &#8220;IRA&#8221;), which was signed into law in August 2022, limits insulin copays to $35 per month for Medicare Part D beneficiaries starting in 2023 and extends enhanced subsidies for individuals purchasing health insurance coverage in PPACA marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program. In addition, the IRA, among other things, (1) directs the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions will take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Health Care Fraud and Abuse and Transparency Laws</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a drug product is reimbursed by Medicare, Medicaid or other federal or state healthcare programs, we must comply with, among others, the federal civil and criminal false claims laws, including the civil False Claims Act, as amended, the federal Anti-Kickback Statute, as amended, and similar state laws. Similarly, if a drug product is reimbursed by Medicare or Medicaid, pricing and rebate programs must comply with, as applicable, the Medicaid rebate requirements of the Omnibus Budget Reconciliation Act of 1990, as amended, and the Medicare Prescription Drug Improvement and Modernization Act of 2003.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal healthcare Anti-Kickback Statute prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, federal civil and criminal false claims laws, including the civil False Claims Act, which can be enforced through civil whistleblower or qui tam actions, and civil monetary penalty laws impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment or approval that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) imposes criminal and civil liability for, among other things, executing a scheme to defraud any healthcare benefit program and also created federal criminal laws that prohibit knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or services.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Physician Payments Sunshine Act within PPACA, and its implementing regulations, require certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to (i) report information related to certain payments or other transfers of value made or distributed to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other healthcare professionals (such as physician assistants and </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nurse practitioners),</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and (ii) report annually certain ownership and investment interests held by physicians and their immediate family members.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many states have similar healthcare statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, that apply regardless of the payer. Additional state laws require pharmaceutical companies to implement a comprehensive compliance program, comply with industry&#8217;s compliance guidelines and relevant compliance guidance promulgated by the federal government and register pharmaceutical sales representatives and limit expenditure for, or payments to, individual medical or health professionals. In addition, certain state and local laws require pharmaceutical companies to report expenses relating to the marketing and promotion of pharmaceutical products and to report gifts and payments to individual physicians in the states&#59; register pharmaceutical sales representatives, and report pricing with respect to certain drug products.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Privacy</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology and Clinical Health Act (&#8220;HITECH&#8221;), and their respective implementing regulations, imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates&#8221; &#8212; independent contractors or agents of covered entities, which include certain healthcare providers, health plans, and healthcare clearinghouses, that receive or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State laws also govern the privacy and security of personal data, including health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. For example, the California Consumer Privacy Act of 2018 (&#8220;CCPA&#8221;) imposes obligations on covered businesses. These obligations include, but are not limited to, providing specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA allows for statutory fines for noncompliance (up to $7,500 per violation). Although the CCPA exempts some data processed in the context of clinical trials, the CCPA may increase compliance costs and potential liability with respect to other personal data we maintain about California residents. In addition, the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;), which became effective January 1, 2023, expands the CCPA. The CPRA establishes a new California Privacy Protection Agency to implement and enforce the CPRA, which could increase the risk of enforcement. Other states have enacted data privacy laws. For example, Virginia passed the Consumer Data Protection Act, and Colorado passed the Colorado Privacy Act, both of which become effective in 2023. U.S. federal and state consumer protection laws require us to publish statements that accurately and fairly describe how we handle personal data and choices individuals may have about the way we handle their personal data.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign data privacy and security laws impose significant and complex compliance obligations on entities that are subject to those laws. As one example, the European Union&#8217;s General Data Protection Regulation 2016/679 (&#8220;EU GDPR&#8221;) contains provisions specifically directed at the processing of health information, higher sanctions and extra-territoriality measures that are intended to bring non-EU companies under the data security and privacy legal framework specified in the regulation. We anticipate that over time we may expand our business operations to include operations in the EU, including potentially conducting preclinical and clinical trials. With such expansion, we would be subject to increased governmental regulation in the EU countries in which we might operate, including the EU GDPR. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other regulation</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the foregoing, we are subject to numerous federal, state and local laws relating to such matters as laboratory practices, the experimental use of animals, the use and disposal of hazardous or potentially hazardous substances, controlled drug substances, safe working conditions, manufacturing practices, environmental protection and fire hazard control.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may incur significant costs to comply with these laws and regulations now or in the future. If our operations are found to be in violation of any of the federal and state laws described above or any other governmental regulations that apply to us, we may be subject to penalties, including significant criminal, civil and administrative penalties, damages, fines, imprisonment, disgorgement, exclusion from government healthcare programs, additional reporting requirements and/or oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ethical Business Practices and Sustainability</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Ethical Marketing</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We require that our employees abide by our Code of Business Conduct and Ethics, our policy on interactions with healthcare professionals and patients, U.S. federal and state laws and applicable foreign laws. We are committed to protecting the health and well-being of patients by ensuring that medically sound knowledge of the benefits and risks of our products is understood and communicated thoroughly and accurately to patients, physicians and global health authorities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our policy on interactions with healthcare professionals and patients requires that our employees promote our products fairly, truthfully, accurately and on-label. Off-label promotion of our products is explicitly prohibited, as are sales activities that would interfere with a healthcare provider&#8217;s independent medical judgment or the doctor-patient relationship. All sales staff receive compliance training upon hire and on an annual basis. We also routinely monitor sales calls. We expect that consistent enforcement of, and training on, our Code of Business Conduct and Ethics and our policy on interactions with healthcare professionals and patients will help us to avoid the incidence of unethical marketing practices.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of our commitment to patient support and education, our employees and consultants may attend and participate in certain patient events, such as health fairs or local disease awareness and advocacy events. In all cases, interactions with patients and patient groups may only be conducted in settings that are suitable for patient education and separate from the usual place(s) of clinical business of healthcare providers or institutions. In addition, our sponsorship of such events, if any, must be clearly disclosed through prominent signage.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Drug Safety</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The safety of our products at all stages &#8211; from clinical trials to the administration and use and through to safe disposal &#8211; is a key area of attention for us. We manufacture our approved and investigational products in accordance with the applicable cGMPs, QSR and other requirements enforced by the FDA and other regulatory bodies that have oversight over our products. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, all sales packs of our drugs that are placed in the distribution chain are serialized in accordance with the requirements of the Drug Quality and Security Act, which requires drug manufacturers to assign a unique identifier to each sales pack (and each aggregate of such sales pack, such as a case or pallet). These identifiers remain on such pack or aggregate through the whole supply chain until its consumption or destruction. This system is intended to improve detection and removal of drugs that may be counterfeit, stolen, contaminated, or otherwise harmful from the drug supply chain.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of our employees are required to adhere to a standard operating procedure for capturing and reporting adverse events, safety information, and product complaints/adverse incidents involving any drug products marketed by us. These reports, as well as those that are collected by our third-party call center, are evaluated, processed and reported to regulatory authorities in accordance with FDA regulations and guidance on the post-marketing reporting of adverse experiences involving drugs, medical devices and combination products.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Safety of Clinical Trial Participants</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When we are actively conducting clinical trials, the safety of our clinical trials plays a crucial role in the development of new products and our continuing prosperity. We take numerous steps to maximize the safety of our clinical trial participants.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The health of subjects in clinical trials is a priority for us and we are committed to conducting clinical trials according to uniformly high ethical standards. We apply those standards to trials that we sponsor and conduct directly as well as those conducted on our behalf by clinical research organizations. We conduct trials in accordance with all applicable laws, the standards of International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Guidelines and following the ethical principles that have their origin in the Declaration of Helsinki.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We require that informed consent be obtained in all trials to ensure that participants understand the risks and benefits of the procedures, how personal medical data is collected and used, and that participation in the trial is voluntary, among other information. We retain documentation that all participants in our trials have provided informed consent.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We monitor clinical trials through audits and inspections conducted by us and by clinical research organizations (CROs) that we engage. We also inspect our CROs prior to, and during, an engagement. These inspections verify that our policies, good clinical practices and applicable laws are being adhered to.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to ensure the safety of clinical trial participants is critical to securing regulatory approval and continued product development success. Moreover, our inability to conduct safe and effective clinical trials could increase our development costs over time. We will continue to hold ourselves to high standards in our oversight and management of clinical trials.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our policy is to disclose the basic results of all clinical trials that we conduct to test the effectiveness of investigational drugs intended to treat serious or life-threatening diseases or conditions (i.e., phase 2-4 clinical studies). Additionally, we may voluntarily disclose the results of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">initial safety studies (i.e., phase 1 clinical studies). In our disclosure of clinical trial results, our policy is to include all serious adverse events and those non-serious adverse events that have a frequency of at least five percent. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Corruption and Bribery</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Code of Business Conduct and Ethics reflects the business practices and principles of behavior that we expect of every employee, officer and director. All new employees are trained on the Code of Business Conduct and Ethics and existing employees are required to acknowledge annually that they have refreshed their familiarity with the policies contained within it. Our Code of Business Conduct and Ethics includes clear guidelines on anti-bribery and anti-corruption practices. In addition, we have adopted a separate anti-corruption policy. Currently, we have very limited operations outside the United States&#59; however, as we expand our global reach through collaborations or through our own growth, we acknowledge that certain regions may pose a higher risk for corrupt practices. We intend to continue our internal training programs and oversight over collaborators on anti-bribery, anti-corruption and other unethical practices in order to reduce these risks.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bribing healthcare professionals to use or recommend our products can create adverse publicity and damage our ability to use a critical channel of influence. We have adopted and implemented PhRMA&#8217;s Code on Interactions with Healthcare Professionals as part of our policy on interactions with healthcare professionals and patients. We believe that training on, and enforcement of, these codes will limit the incidence of unethical interactions between our personnel and healthcare professionals.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Lived Assets</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our long-lived assets are located in the United States and China and totaled $53.0&#160;million and $38.9&#160;million as of December&#160;31, 2022 and 2021, respectively. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employees and Human Capital</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our human capital helps us develop and commercialize new products, conduct clinical trials and navigate government regulations. Our ability to recruit, develop and retain highly skilled talent is a significant determinant of our success. Our Code of Business Conduct and Ethics codifies our commitment to diversity and to providing equal opportunity and a positive working environment in all aspects of employment. We also have policies setting forth our expectations for nondiscrimination and a harassment-free work environment. Specifically, our policy is that no aspect of employment, including hiring and promotional opportunities, will be subject to unlawful discrimination or harassment (including sexual harassment) based on race, creed, color, religion, national origin, ancestry, gender (including pregnancy, breastfeeding or medical conditions related to pregnancy or breastfeeding), age, physical or intellectual disability, sexual orientation, gender identity, gender expression, gender stereotyping, marital status, military or veteran status, citizenship, genetic characteristic or information, or any other characteristic protected by applicable federal, state or local law. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, we had 395 total at-will employees, of which 391 were full-time. Of our full-time employees, 210 were engaged in manufacturing, 25 in research and development, 55 in general and administrative and 101 in selling and marketing. Sixteen of these employees had a Ph.D. degree and/or M.D. degree and were engaged in activities relating to research and development, manufacturing, quality assurance or business development.<span style="font-size:12pt;"> </span>As of December 31, 2022, our workforce was distributed along genders and ethnic minorities as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grade Levels</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Female (%)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ethnic minority (%)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President and above</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18%</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24%</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Director, Director and Senior Manager</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48%</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25%</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Managers and below</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41%</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44%</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">All employees</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">395</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">42%</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">37%</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None of our employees are subject to a collective bargaining agreement. We believe relations with our employees are good. In managing our business, we monitor several human capital measures, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">performance against a set of specified corporate objectives for each calendar year, some of which are milestone-based, such as achieving deliverables under our collaboration agreements, and some of which are quantitative, such as achieving target net sales of Afrezza. These objectives are intended to stretch employees and serve as development opportunities but also form the basis for our incentive compensation programs.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">churn rate &#8211; the number of new hires and terminations each month as a percentage of the employee base &#8211; as well as the number of regrettable losses. These metrics help us to identify areas within the company where there may be a need for greater management attention and intervention.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">responses to periodic employee surveys, which are designed to give us insight into employees&#8217; perception of company culture and areas where management&#8217;s efforts are perceived positively or negatively as well as open-ended feedback in the form of anonymous comments and questions. We strive to conduct employee surveys approximately every six months. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We offer our employees a portfolio of rewards (our &#8220;Total Rewards Program&#8221;) to recruit and retain a high level of talent across the Company. Our Total Rewards program is offered to each employee and currently consists of the seven </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">components</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Base salary &#8211; We offer a market-competitive base salary.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Annual bonus program &#8211; We offer quarterly sales incentive bonuses to our sales force and annual bonuses to the remainder of our employees.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Annual equity program &#8211; We offer a new hire and annual equity awards that consist of time- and, in some cases, performance-based restricted stock units and non-qualified stock options.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Health and wellness program &#8211; A variety of insurance plans that allow employees to select among different options, including a health maintenance organization, a preferred provider organization and a high-deductible health plan, as well as flexible spending and health savings accounts.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Paid time off program &#8211; In addition to the paid time off that is accrued throughout the year, we offer paid holidays, including two week-long company shutdowns in July and December.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Retirement savings program &#8211; A 401(k) retirement plan pursuant to which we match 50% of employee contributions up to a specified limit on their annual eligible earnings.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Employee stock purchase plan (&#8220;ESPP&#8221;) program &#8211; The ESPP provides the opportunity to purchase shares of our common stock through payroll deductions every six months at a 15% discount to the market price at the beginning or end of each offering period, whichever is lower.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">Employee Recognition Program &#8211; We provide a company-wide Spot and Peer to Peer Recognition Program to more directly reward performance and behaviors and drive cultural improvement.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of our employees are essential workers involved in the production of medicine for chronic diseases. As such, they cannot work remotely and must perform their job duties in our Connecticut facility according to a 24/7 shift schedule. Other employees have work responsibilities that can be performed somewhat asynchronously and in different locations. For such employees, our general preference is that in-office employees be in the office during core business hours at least four days per week in order to maximize the productivity gains that come from having a collaborative culture and a common workplace&#59; however, we also recognize that such employees can be equally productive working from home some of the time or with a flexible workday that they can structure around significant events outside of the workplace, such as commute times or childcare responsibilities.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Occupational Health and Safety</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Hazardous materials are inherent in our operations, and it is not possible to eliminate completely the risk of accidental exposure from our operations. We have established procedures to comply with governmental regulations regarding workplace safety, including training employees to enable them to recognize risks and empower them to learn, discover, work safely, and to minimize injuries, illnesses, environmental impact and regulatory risks. In 2022, our total illness and injury incidence rate was 0.3 per 100 employees compared to the 2021 industry average of 1.6, as reported by the U.S. Department of Labor, and our DART (days away/restricted or job transfer) incident rate was 0.3 per 100 employees compared to the 2021 industry average of 1.2. We will continue our efforts to ensure a high level of workplace safety.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Corporate Information</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in the State of Delaware on February&#160;14, 1991. Our principal executive offices are located at 1 Casper Street, Danbury, Connecticut 06810, and our general telephone number is (818)&#160;661-5000. Our website address is http://www.mannkindcorp.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, are available free of charge on our website as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The contents of our websites are not incorporated into this Annual Report. Further, our references to the URLs for these websites are intended to be inactive textual reference only.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Scientific Advisors</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We seek advice from a number of leading scientists and physicians on scientific, technical and medical matters. These advisors are leading scientists in endocrinology, pulmonology and other areas of scientific or clinical interest. Our scientific advisors are consulted regularly to assess, among other things:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our research and development programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">the design and implementation of our clinical programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">our patent and publication strategies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">market opportunities from a clinical perspective&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">new technologies relevant to our research and development programs&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;">specific scientific and technical issues relevant to our business.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A partial listing of our current scientific advisors is maintained on our corporate website at <span style="text-decoration:none;">www.mannkindcorp.com</span>. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Information about our Executive Officers </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth our current executive officers and their ages: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Age</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:63%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Position(s)</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="width:30%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10pt;;text-indent:-10pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael E. Castagna, Pharm.D.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:5%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:63%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer </p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10pt;;text-indent:-10pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steven B. Binder</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:63%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10pt;;text-indent:-10pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sanjay Singh, M Pharm, MBA</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:63%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Executive Vice President, Technical Operations</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10pt;;text-indent:-10pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stuart A. Tross, Ph.D.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:63%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief People and Workplace Officer</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="width:30%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10pt;;text-indent:-10pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David B. Thomson, Ph.D., J.D.</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:5%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:63%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General Counsel and Secretary</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Michael E. Castagna, Pharm.D.<span style="font-style:normal;"> has been our Chief Executive Officer since May 2017 and was our Chief Commercial Officer from March 2016 until May 2017. From November 2012 until he joined us, Dr.&#160;Castagna was at Amgen, Inc., where he initially served as Vice President, Global Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#8217;s Biosimilar Business Unit. From 2010 to 2012, he was Executive Director, Immunology, at Bristol-Myers Squibb Company (&#8220;BMS&#8221;), an innovative global biopharmaceutical company. Before BMS, Dr.&#160;Castagna served as Vice President&#160;&#38; Head, Biopharmaceuticals, North America, at Sandoz, a division of Novartis. He has also held positions with commercial responsibilities at EMD (Merck) Serono, Pharmasset and DuPont Pharmaceuticals. He received his pharmacy degree from the University of the Sciences-Philadelphia College of Pharmacy, a PharmD. from Massachusetts College of Pharmacy&#160;&#38; Sciences and an MBA from The Wharton School of Business at the University of Pennsylvania.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Steven B. Binder <span style="font-style:normal;">has been our Chief Financial Officer since July 2017. Before joining us, since 2013 Mr. Binder served as Vice President and Chief Financial Officer of the International Group of Stryker Corporation, a leading global medical technology company, based in Singapore. Prior to Stryker, Mr. Binder served in a series of senior leadership roles at BMS. His last four positions at BMS were Vice President, Finance roles over different geographic operating units: United States (2012-2013), Europe (2008-2011), AsiaPacific (2005-2007), and Japan (2003-2005). Prior to his international experience, Mr. Binder served in three senior leadership roles for Oncology Therapeutics Network, a U.S. based independent subsidiary of BMS: Vice President, Strategic Development (2001-2003), Vice President, Customer Operations (2000-2001), and Chief Financial Officer (1997-2000). Before Oncology Therapeutics Network, Mr. Binder progressed through three finance and accounting roles for BMS Worldwide Medicines Group after joining the company in 1992. Before BMS, he worked for Deloitte &#38; Touche LLP in a series of auditing roles with increasing responsibility over an eight-year period beginning in 1984. Mr. Binder received a B.S. degree in Accounting and Business Administration from Muhlenberg College and is a Certified Public Accountant.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sanjay Singh<span style="font-style:normal;"> has been our Executive Vice President, Technical Operations since October 2022. Before joining us, since 2011 Mr. Singh served as Sr. Vice President and Associate President Technical Operations in India and USA at Aurobindo Pharma , a leading generic pharmaceutical manufacturing company, headquartered in Hyderabad, India. Prior to Aurobindo, Mr. Singh worked in various leadership roles at Cipla Ltd (2000 &#8211; 2007, 2008-2011), Glenmark Pharma (2007-2008), Nicholas Piramal India Ltd (1992-2000) and Cadila Laboratories (1990-1991). Mr. Singh has been associated with the Parenteral Drug Association (PDA) and was the founding president of the PDA, India chapter before moving to the US in 2015. Mr. Singh received an M. Pharma. degree in Pharmaceutical Chemistry from LM College of Pharmacy, Ahmedabad, India and an MBA degree from Institute of Management Studies, Indore, India. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stuart A. Tross, Ph.D.<span style="font-style:normal;"> has been our Chief People and Workplace Officer since December 2016, with responsibilities for human resources, information technology, corporate communications and west coast facilities. From 2006 to 2016 he served in various roles of increasing responsibility at Amgen, Inc., most recently as Senior Vice President and Chief Human Resources Officer responsible for human resources and security on a global basis. From 1998 to 2006 he served in a series of leadership roles at BMS, most recently as Vice President and</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">Global Head of Human Resources for Mead Johnson Company. Mr. Tross received a B.S. degree from Cornell University and M.Sc. and Ph.D. degrees in Industrial-Organizational Psychology from the Georgia Institute of Technology.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">David B. Thomson, Ph.D., J.D.<span style="font-style:normal;"> has been our General Counsel and Corporate Secretary since January 2002. Prior to joining us, he practiced corporate/commercial and securities law at a major Toronto law firm. Earlier in his career, Dr.&#160;Thomson was a post-doctoral fellow at the Rockefeller University. Dr.&#160;Thomson obtained his B.S., M Sc. and Ph.D. degrees from Queens University and obtained his J.D. degree from the University of Toronto.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="Item_1A_RISK_FACTORS">Item&#160;1A.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Risk Factors</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">You should consider carefully the following information about the risks described below, together with the other information contained in this Annual Report before you decide to buy or maintain an investment in our common stock. We believe the risks described below are the risks that are material to us as of the date of this Annual Report. Additional risks and uncertainties that we are unaware of may also become important factors that affect us. If any of the following risks actually occur, our business, financial condition, results of operations and future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock could decline, and you may lose all or part of the money you paid to buy our common stock.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO OUR BUSINESS </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The products that we or our collaboration partner are commercializing may only achieve a limited degree of commercial success.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Successful commercialization of therapeutic products is subject to many risks, including some that are outside our control. There are numerous examples of failures to fully exploit the market potential of therapeutic products, including by biopharmaceutical and device companies with more experience and resources than us. The products, including products that we commercialize ourselves and any future, products that we may develop or acquire in the future and the product that is commercialized by our collaboration partner and future products that may be commercialized by a collaboration partner, may not gain market acceptance among physicians, patients, third-party payers and the healthcare community. The degree of market acceptance of our or a collaboration partner&#8217;s products depends on many factors, including the following: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">approved labeling claims&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">effectiveness of efforts by us and/or any current or future collaboration or marketing partner to support and educate patients and physicians about the benefits and proper administration of our products, and the perceived advantages of our products and the disadvantages of competitive products&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">willingness of the healthcare community and patients to adopt new technologies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">ability to manufacture the product in sufficient quantities with acceptable quality and cost&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">perception of patients and the healthcare community, including third-party payers, regarding the safety, efficacy and benefits compared to competing products or therapies&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">convenience and ease of administration relative to existing treatment methods&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">coverage and reimbursement, as well as pricing relative to other treatment therapeutics and methods&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">marketing and distribution support.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of these and other factors, the products described above may not gain market acceptance or otherwise be commercially successful. Failure to achieve market acceptance would limit our ability to generate revenue and would adversely affect our results of operations. We or our current or any future collaboration partner may need to enhance our/their commercialization capabilities in order to successfully commercialize such products in the United States or any other jurisdiction in which the product is approved for commercial sale, and we or the collaboration partner may not have sufficient resources to do so. The market for skilled commercial personnel is highly competitive, and we may not be able to hire all of the personnel we need on a timely basis or retain them for a sufficient period. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-align:justify;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">In order to increase adoption and sales of our products, we need to continue to develop our commercial organization, including maintaining and growing a highly experienced and skilled workforce with qualified sales representatives.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to successfully commercialize our products in the United States, we have built a sales force that promotes Afrezza and V-Go to endocrinologists and selected primary care physicians. In order to successfully commercialize any approved products, we must continue to build our sales, marketing, distribution, managerial and other non-technical capabilities.&#160;Factors that may hinder our ability to successfully market and commercially distribute our products include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">inability to recruit, retain and effectively manage adequate numbers of effective sales personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies that have more extensive product lines&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">unforeseen delays, costs and expenses associated with maintaining our sales organization.</span></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we are unable to maintain an effective sales force for our products, including any other potential future approved products, we may not be able to generate sufficient product revenue in the United States.&#160;We are required to expend significant time and resources to train our sales force to be credible and persuasive in convincing physicians to prescribe and pharmacists to dispense our products.&#160;In addition, we must continually train our sales force and equip them with effective marketing materials to ensure that a consistent and appropriate message about our products is being delivered to our potential customers.&#160;We currently have limited resources compared to some of our competitors, and the continued development of our own commercial organization to market our products and any additional products we may develop or acquire will be expensive and time-consuming.&#160;We also cannot be certain that we will be able to continue to successfully develop this capability.</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Similarly, if United Therapeutics does not effectively engage or maintain its sales force for Tyvaso DPI, our ability to recognize royalties and manufacturing revenue from this collaboration will be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Manufacturing risks may adversely affect our ability to manufacture our products and Tyvaso DPI, which and could reduce our gross margin and profitability.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We use our Danbury, Connecticut facility to formulate both the Afrezza and Tyvaso DPI inhalation powders, fill plastic cartridges with the powders, and package the cartridges into secondary packaging. We also assemble the inhalers from their individual molded parts. These semi-finished goods are then assembled into the final kits for commercial sale by a contract packager.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The manufacture of pharmaceutical products requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of pharmaceutical products often encounter difficulties in production, especially in scaling up production to commercial batch sizes. These problems include difficulties with production costs, capacity utilization and yields. We may experience shortages of qualified personnel, which could impact our ability to meet manufacturing requirements. There is also a need to comply with strictly enforced federal, state and foreign regulations, including inspections. Our facility is inspected on a regular basis by the FDA, most recently in July 2021 when the FDA conducted a pre-approval inspection related to Tyvaso DPI and a GMP inspection related to Afrezza. The FDA made one observation during its most recent inspection, which we corrected and addressed with the FDA following the site visit. If the FDA makes any major observations during future inspections, the corrective actions required could be onerous and time-consuming.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of these factors could cause us to delay or suspend production, could entail higher costs and may result in our being unable to obtain sufficient quantities for the commercialization of drug products at the costs that we currently anticipate. Furthermore, if we or a third-party manufacturer fail to deliver the required commercial quantities of the product or any raw material on a timely basis, and at commercially reasonable prices, sustainable compliance and acceptable quality, and we were unable to promptly find one or more replacement manufacturers capable of production at a substantially equivalent cost, in substantially equivalent volume and quality on a timely basis, we would likely be unable to meet demand for such drug products and we would lose potential revenues.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we rely on our contract manufacturers in Southern China to manufacture V-Go. Our contract manufacturer uses MannKind-owned custom-designed, semi-automated manufacturing equipment and production lines to meet our quality requirements. Separate contract manufacturers in China perform release testing, sterilization, inspection and packaging functions. As a result, our business is subject to risks associated with doing business in China, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">adverse political and economic conditions, particularly those potentially negatively affecting the trade relationship between the United States and China&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">trade protection measures, such as tariff increases, and import and export licensing and control requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">potentially negative consequences from changes in tax laws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">difficulties associated with the Chinese legal system, including increased costs and uncertainties associated with enforcing contractual obligations in China&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">historically lower protection of intellectual property rights&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">unexpected or unfavorable changes in regulatory requirements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">changes and volatility in currency exchange rates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">possible patient or physician preferences for more established pharmaceutical products and medical devices manufactured in the United States&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">difficulties in managing foreign relationships and operations generally.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These risks are likely to be exacerbated by our limited experience with V-Go and its manufacturing processes. As demand increases, we may have to invest additional resources to purchase components, hire and train employees, and enhance our manufacturing processes. If we fail to increase our production capacity efficiently, our sales may not increase in line with our forecasts and our operating margins could fluctuate or decline. In addition, we may be unable to support commercialization of Tyvaso DPI.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our suppliers fail to deliver materials and services needed for commercial manufacturing in a timely and sufficient manner or fail to comply with applicable regulations, and if we fail to timely identify and qualify alternative suppliers, our business, financial condition and results of operations would be harmed and the market price of our common stock and other securities could decline.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the commercial manufacture of inhaled drug products, we need access to sufficient, reliable and affordable supplies of FDKP, the inhaler, the related cartridges and other materials. For Afrezza, we also require a supply of insulin. Currently, the only source of insulin that we have qualified for Afrezza is manufactured by Amphastar. We must rely on all of our suppliers to comply with relevant regulatory and other legal requirements, including the production of insulin and FDKP in accordance with current good manufacturing practices (&#8220;cGMP&#8221;) for drug products, and the molding of the inhaler and cartridges components in accordance with quality system regulations (&#8220;QSRs&#8221;). </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For V-Go, w</span><span style="color:#000000;">e obtain parts from a small number of suppliers, including some parts and components that are purchased from single-source vendors. Depending on a limited number of suppliers exposes us to risks, including limited control over pricing, availability, quality and delivery schedules. In addition, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">w</span><span style="color:#000000;">e do not have long-term supply agreements with most of our suppliers and, in many cases, we make our purchases on a purchase order basis. Under many of our supply agreements, we have no obligation to buy any given quantity of components, and our suppliers have no obligation to manufacture for us or sell to us any given quantity of components. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we do not have long-standing relationships with our suppliers, we may not be able to convince them to continue to make components available to us unless there is demand for such components from their other customers. If any one or more of our suppliers cease to provide us with sufficient quantities of components in a timely manner or on terms acceptable to us, we would have to seek alternative sources of supply. Because of factors such as the proprietary nature of our product, our quality control standards and regulatory requirements, we cannot quickly engage additional or replacement suppliers for some of our critical components. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also have difficulty obtaining similar components from other suppliers that meet the requirements of the FDA or other regulatory agencies. <span style="color:#000000;">Although we conduct our own inspections and review and/or approve investigations of each supplier, there can be no assurance that the FDA, upon inspection, would find that the supplier substantially complies with the QSR or cGMP requirements, where applicable. If a supplier fails to comply with these requirements or the comparable requirements in foreign countries, regulatory authorities may subject us to regulatory action, including criminal prosecutions, fines and suspension of the manufacture of our products. If we are required to find a new or additional supplier, we will need to evaluate that supplier&#8217;s ability to provide material that meets regulatory requirements, including cGMP or QSR requirements, as well as our specifications and quality requirements, which would require significant time and expense and could delay production. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result, our ability to purchase adequate quantities of the components for our products may be limited. Additionally, our suppliers may encounter problems that limit their ability to manufacture components for us, including financial difficulties or damage to their manufacturing equipment or facilities. <span style="color:#000000;">In general, if any of our suppliers is unwilling or unable to meet its supply obligations or if we encounter delays or difficulties in our relationships with manufacturers or suppliers, and we are unable to secure an alternative supply source in a timely manner and on favorable terms, our business, financial condition, and results of operations may be harmed and the market price of our common stock and other securities may decline. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If third-party payers do not cover our approved products, such products might not be prescribed, used or purchased, which would adversely affect our revenues.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States and elsewhere, sales of prescription pharmaceuticals still depend in large part on the availability of coverage and adequate reimbursement to the consumer from third-party payers, such as government health administration authorities and private insurance plans. Third-party payers are increasingly challenging the prices charged for medical products and services. The market for our approved products will depend significantly on access to third-party payers&#8217; formularies, which are the lists of medications and devices for which third-party payers provide coverage and reimbursement. The industry competition to be included in such formularies often leads to downward pricing pressures on pharmaceutical and device companies. Also, third-party payers may refuse to include a particular branded product in their formularies or otherwise restrict patient access to a branded product when a less costly generic equivalent or other alternative is available. Even if favorable coverage and reimbursement status is attained for our products, less favorable coverage policies and reimbursement rates may be implemented in the future. In addition, because each third-party payer individually approves coverage and reimbursement levels, obtaining coverage and adequate reimbursement is a time-consuming and costly process. We may be required to provide scientific and clinical support for the use of any product to each third-party payer separately with no assurance that approval would be obtained. This process could delay the market acceptance of any product and could have a negative effect on our future revenues and operating results. Even if we succeed in bringing more products to market, we cannot be certain that any such products would be considered cost-effective or that coverage and adequate reimbursement to the consumer would be available. Patients will be unlikely to use our products unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future revenues and ability to generate positive cash flow from operations may be affected by the continuing efforts of government and other third-party payers to contain or reduce the costs of healthcare through various means. In the United States, there have been several congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. For example, the IRA, which was signed into law in August 2022, will limit insulin copays to $35 per month for Medicare Part D beneficiaries starting in 2023. In certain foreign markets the pricing of prescription pharmaceuticals is subject to direct governmental control. The European Union provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we or any collaboration or marketing partner is unable to obtain and maintain coverage of, and adequate third-party reimbursement for, our approved products, physicians may limit how much or under what circumstances they will prescribe or administer them and patients may decline to purchase them. This in turn could affect our or any collaboration or marketing partner&#8217;s ability to successfully commercialize such products and would impact our profitability, results of operations, financial condition, and prospects.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may need to raise additional capital to fund our operations.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may need to raise additional capital, whether through the sale of equity or debt securities, additional strategic business collaborations, the establishment of other funding facilities, licensing arrangements, asset sales or other means, in order to support our ongoing activities, including the commercialization of our products and the development of our product candidates<span style="color:#000000;">.</span> It may be difficult for us to raise additional funds on favorable terms, or at all. The extent of our additional funding requirements will depend on a number of factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the degree to which we are able to generate revenue from products that we or a collaboration partner commercialize&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the costs of developing Afrezza and of commercializing Afrezza and V-Go on our own in the United States&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the degree to which revenue from Afrezza exceeds or does not exceed the minimum revenue covenants under our credit and security agreement with MidCap Financial Trust (the &#8220;MidCap credit facility&#8221;), if applicable&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the demand by any or all of the holders of our debt instruments to require us to repay or repurchase such debt securities if and when required&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability to repay or refinance existing indebtedness, and the extent to which our notes with conversion options or any other convertible debt securities we may issue are converted into or exchanged for shares of our common stock&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the rate of progress and costs of our clinical studies and research and development activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the costs of procuring raw materials and operating our manufacturing facility&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our obligation to make lease payments and milestone payments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our success in establishing additional strategic business collaborations or other sales or licensing of assets, and the timing and amount of any payments we might receive from any such transactions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">actions taken by the FDA and other regulatory authorities affecting Afrezza, V-Go, Tyvaso DPI, our product candidates or competitive products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the emergence of competing technologies and products and other market developments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the costs of preparing, filing, prosecuting, maintaining and enforcing patent claims and other intellectual property rights or defending against claims of infringement by others&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the level of our legal and litigation expenses&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the costs of discontinuing projects and technologies, and/or decommissioning existing facilities, if we undertake any such activities.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have raised capital in the past through the sale of equity and debt securities and we may in the future pursue the sale of additional equity and/or debt securities, or the establishment of other funding facilities including asset-based borrowings. There can be no assurances, however, that we will be able to raise additional capital in the future on acceptable terms, or at all. Volatility and disruptions of the global supply chain and financial markets, if sustained or recurrent, could prevent us or make it more difficult for us to access capital.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuances of additional debt or equity securities or the issuance of common stock upon conversion of outstanding convertible debt securities for shares of our common stock could impact the rights of the holders of our common stock and will dilute their ownership percentage. Moreover, the establishment of other funding facilities may impose restrictions on our operations. These restrictions could include limitations on additional borrowing and specific restrictions on the use of our assets, as well as prohibitions on our ability to create liens, pay dividends, redeem our stock or make investments. We <span style="color:#000000;">may </span>also raise additional capital by pursuing opportunities for the licensing or sale of certain intellectual property and other assets. We cannot offer assurances, however, that any strategic <span style="color:#000000;">collaboration</span>, sales of securities or sales or licenses of assets will be available to us on a timely basis or on acceptable terms, if at all. We may be required to enter into relationships with third parties to develop or commercialize products or technologies that we otherwise would have sought to develop independently, and any such relationships may not be on terms as commercially favorable to us as might otherwise be the case.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that sufficient additional funds are not obtained through strategic collaboration opportunities, sales of securities, funding facilities, licensing arrangements<span style="color:#000000;">, borrowing arrangements</span> and/or asset sales on a timely basis, we may be required to reduce expenses through the delay, reduction or curtailment of our projects, or further reduction of costs for facilities and administration.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot provide assurances that changed or unexpected circumstances will not result in the depletion of our capital resources more rapidly than we currently anticipate. There can be no assurances that we will be able to raise additional capital in sufficient amounts or on favorable terms, or at all. If we are unable to raise adequate additional capital when required or in sufficient amounts or on terms acceptable to us, we may have to delay, scale back or discontinue one or more product development programs, curtail our commercialization activities, significantly reduce expenses, sell assets (potentially at a loss), enter into relationships with third parties to develop or commercialize products or technologies that we otherwise would have sought to develop or commercialize independently, cease operations altogether, pursue an acquisition of our company at a price that may result in up to a total loss on investment for our stockholders, file for bankruptcy or seek other protection from creditors, or liquidate all of our assets.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We expect that our results of operations will fluctuate for the foreseeable future, which may make it difficult to predict our future performance from period to period.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our operating results have fluctuated in the past and are likely to do so in future periods. Some of the factors that could cause our operating results to fluctuate from period to period include the factors that will affect our funding requirements described above under &#8220;Risk Factors &#8212; We may need to raise additional capital to fund our operations.&#8221; In addition, the current inflationary environment related to increased aggregate demand and supply chain constraints has the potential to adversely affect our operating expenses.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that comparisons from period to period of our financial results are not necessarily meaningful and should not be relied upon as indications of our future performance.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have a history of operating losses. We expect to incur losses in the future and we may not generate positive cash flow from operations in the future.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not currently profitable and have rarely generated positive net cash flow from operations. As of December 31, 2022, we had an accumulated deficit of $3.2&#160;billion. The accumulated deficit has resulted principally from costs incurred in our research and development programs, the write-off of assets (including goodwill, inventory and property, plant and equipment) and general operating expenses. We expect to make substantial expenditures and to incur increasing operating losses in the future in order to continue commercializing our products and to advance development of product candidates in our pipeline. In addition, under our Insulin Supply Agreement with Amphastar, we agreed to purchase certain annual minimum quantities of insulin through 2027. As of December 31, 2022, there was approximately $72.3 million remaining in aggregate purchase commitments under this agreement. We may not have the necessary capital resources to service this contractual commitment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our losses have had, and are expected to continue to have, an adverse impact on our working capital, total assets and stockholders&#8217; equity. Our ability to achieve and sustain positive cash flow from operations and profitability depends heavily upon successfully commercializing our products, and we cannot be sure when, if ever, we will generate positive cash flow from operations or become profitable.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We have a substantial amount of debt, and we may be unable to make required payments of interest and principal as they become due.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The notes to our consolidated financial statements in this Annual Report on Form 10-K provide details about our various debt obligations. As of December 31, 2022, we had <span style="color:#000000;">$278.8</span> million principal amount of outstanding debt, consisting of: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">$230.0 million aggregate principal amount of Senior convertible notes bearing interest at 2.50% payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2021 and will mature on March 1, 2026, unless earlier converted, redeemed or repurchased. The Senior convertible notes are convertible at an initial conversion price of approximately $5.21 per share of common stock. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the Indenture.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">$40.0 million principal amount under the MidCap credit facility, bearing interest at an annual rate equal to one-month Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 6.25% (cap of 8.25%), subject to a one-month SOFR floor of 1.00%, payable in equal monthly installments beginning in September 2023 through maturity in August 2025. In August 2022, we amended the MidCap credit facility and transitioned the benchmark interest rate from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) to the SOFR. The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">$8.8 million principal amount of indebtedness under a $35.0 million note that we issued to The Mann Group LLC (&#8220;Mann Group&#8221;) in August 2019 that is convertible into shares of our common stock at the option of Mann Group at a conversion price of $2.50 per share (the &#8220;Mann Group convertible note&#8221;), bearing interest at a fixed rate of 2.50% per annum compounded quarterly and maturing in December 2025. Interest is paid-in-kind from August 2019 until the end of 2020, after which we have the option to pay interest in-kind or in shares.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The MidCap credit facility requires us, and any debt arrangements we may enter into in the future may require us, to comply with various covenants that limit our ability to, among other things:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">dispose of assets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">complete mergers or acquisitions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">incur indebtedness or modify existing debt agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">amend or modify certain material agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">engage in additional lines of business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">encumber assets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">pay dividends or make other distributions to holders of our capital stock&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">make specified investments&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">change certain key management personnel or organizational documents&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">engage in transactions with our affiliates.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may be required to comply with additional covenants in the future under certain circumstances. <span style="color:#000000;">The restrictive covenants in the MidCap credit facility could prevent us from pursuing business opportunities that we or our stockholders may consider beneficial.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If our <span style="color:#000000;">unrestricted cash and short-term investments </span>balance falls below $90.0 million, we will be subject to a covenant relating to trailing twelve-month minimum Afrezza net revenue, tested on a monthly basis, which is set forth in the MidCap credit facility Agreement, as amended.<span style="color:#000000;"> I</span>f we fail to meet this covenant, any outstanding borrowings, together with accrued interest, under the MidCap credit facility could be declared immediately due and payable. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A breach of any of these covenants could result in an event of default under the MidCap credit facility. If we default on our obligations under the MidCap credit facility, the lender could proceed against the collateral granted to them to secure our indebtedness or declare all obligations under the MidCap credit facility to be due and payable. In certain circumstances, procedures by the lender could result in a loss by us of all of our equipment and inventory, which are included in the collateral granted to the lender. In addition, upon any distribution of assets pursuant to any liquidation, insolvency, dissolution, reorganization or similar proceeding, the holders of secured indebtedness will be entitled to receive payment in full from the proceeds of the collateral securing our secured indebtedness before the holders of other indebtedness or our common stock will be entitled to receive any distribution with respect thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that we will have sufficient resources to make any required repayments of principal under the terms of our indebtedness when required. While we have been able to timely make our required interest payments to date, we cannot guarantee that we will be able to do so in the future. If we fail to pay interest on, or repay, our outstanding term loan under the MidCap credit facility or borrowings under either of the Mann Group convertible note or the non-convertible note issued to Mann Group in August 2019 in an aggregate principal amount of $35.1 million (the &#8220;Mann Group non-convertible note&#8221; and, together with the Mann Group convertible note, the &#8220;Mann Group promissory notes&#8217;) when required, we will be in default under the instrument for such debt securities or loans, and may also suffer an event of default under the terms of other borrowing arrangements that we may enter into from time to time. Any of these events could have a material adverse effect on our business, results of operations and financial condition, up to and including the note holders initiating bankruptcy proceedings or causing us to cease operations altogether.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our business, product sales, results of operations and ability to access capital could be adversely affected by the effects of health pandemics or epidemics, in regions where we or third parties distribute our products or where we or third parties on which we rely have significant manufacturing facilities, concentrations of clinical trial sites or other business operations.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business could be adversely affected by the effects of health pandemics or epidemics in regions where we have business operations, and we could experience significant disruptions in the operations of third-party manufacturers and distributors upon whom we rely. For example, sales and demand for Afrezza were previously adversely affected by the global COVID-19 pandemic, and a resurgence of the COVID-19 pandemic or future pandemics or epidemics could adversely affect the demand for and sales of our products in the future. Quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could impact personnel at third-party manufacturing facilities in the United States and other countries, or the availability or cost of materials, which would disrupt our supply chain. In particular, our contract manufacturers in China could be impacted by that country&#8217;s recent policy of strict lockdowns in order to reduce the spread of disease. Disruptions in sales and demand for our products would be expected to occur:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">if patients are physically quarantined or are unable or unwilling to visit healthcare providers, </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">if physicians restrict access to their facilities for a material period of time, </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">if healthcare providers prioritize treatment of acute or communicable illnesses over chronic disease management, </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">if pharmacies are closed or suffering supply chain disruptions, </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">if patients lose access to employer-sponsored health insurance due to periods of high unemployment, or </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">as a result of general disruptions in the operations of payers, distributors, logistics providers and other third parties that are necessary for our products to be prescribed and reimbursed.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, clinical trials of our products previously experienced delays as a result of the COVID-19 pandemic and may be affected by a resurgence in the COVID-19 pandemic or a future health pandemic or epidemic. Clinical site initiation and patient enrollment may be delayed due to prioritization of hospital resources toward the health pandemic or epidemic. Some patients may not be able or willing to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. Similarly, our ability to recruit and retain patients and principal investigators and site staff would adversely impact our clinical trial operations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A pandemic or epidemic also has the potential for disruption of global financial markets. This disruption, if sustained or recurrent, could make it more difficult for us to access capital, which could negatively affect our liquidity. In addition, a recession or market correction as a result of a health pandemic or epidemic could materially affect our business and the value of our common stock. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we do not obtain regulatory approval of our products in foreign jurisdictions, we will not be able to market in such jurisdictions, which could limit our commercial revenues. We may not be able to establish additional regional partnerships or other arrangements with third parties for the commercialization of our products outside of the United States.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although Afrezza has been approved in the United States by the FDA and in Brazil by ANVISA, we have not yet <span style="color:#000000;">obtained</span> approval in any other jurisdiction. Similarly, V-Go has received 510(k) clearance from the FDA, but has not received a comparable approval in any other country. In order to market our products in a foreign jurisdiction, we must obtain regulatory approval in each such foreign jurisdiction, and we may never be able to obtain such approvals. The research, testing, manufacturing, labeling, sale, import, export, marketing, and distribution of therapeutic products outside the United States are subject to extensive regulation by foreign regulatory authorities, whose regulations differ from country to country. We will be required to comply with the different regulations and policies of the jurisdictions where we seek approval for our products, and we have not yet identified all of the requirements that we will need to satisfy to submit our products for approval for other jurisdictions. This will require additional time, expertise and expense, including the potential need to conduct additional studies or development work for other jurisdictions beyond the work that we have conducted to support the approval of our products in the United States.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current strategy for the future commercialization of our products outside of the United States, subject to receipt of the necessary regulatory approvals, is to seek, establish and maintain regional partnerships in foreign jurisdictions where there are commercial opportunities. It may be difficult to find<span style="color:#000000;"> or maintain</span> collaboration partners that are able and willing to devote the time and resources necessary to successfully commercialize our products. Collaborations with third parties may require us to relinquish material rights, including revenue from commercialization, agree to unfavorable terms or assume material ongoing development obligations that we would have to fund. These collaboration arrangements are complex and time-consuming to negotiate, and if we are unable to reach agreements with third-party collaborators, we may fail to meet our business objectives and our financial condition may be adversely affected. We may also face significant competition in seeking collaboration partners, and may not be able to find a suitable collaboration partner in a timely manner on acceptable terms, or at all. Any of these factors could cause delay or prevent the successful commercialization of our products in foreign jurisdictions and could have a material and adverse impact on our business, financial condition and results of operations and the market price of our common stock and other securities could decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Continued testing of our products and product candidates may not yield successful results, and even if it does, we may still be unable to successfully commercialize our current or future products.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have generally sought to develop product candidates through our internal research programs. All such product candidates will require additional research and development and, in some cases, significant preclinical, clinical and other testing prior to seeking regulatory approval to market them. Accordingly, these product candidates will not be commercially available for a number of years, if at all. Further research and development on these programs will require significant financial resources. Given our limited financial resources, we may not be able to advance these programs into clinical development unless we are able to obtain specific funding for these programs or enter into collaborations with third parties.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development programs are designed to test the safety and efficacy of our product candidates through extensive nonclinical and clinical testing. We may experience numerous unforeseen events during, or as a result of, the testing process that could delay or impact commercialization of any of our product candidates, including the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">safety and efficacy results obtained in our nonclinical and early clinical testing may be inconclusive or may not be predictive of results that we may obtain in our future clinical studies or following long-term use, and we may as a result be forced to stop developing a product candidate or alter the marketing of an approved product&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the analysis of data collected from clinical studies of our product candidates may not reach the statistical significance necessary, or otherwise be sufficient to support FDA or other regulatory approval for the claimed indications&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">after reviewing clinical data, we or any collaborators may abandon projects that we previously believed were promising&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our product candidates may not produce the desired effects or may result in adverse health effects or other characteristics that preclude regulatory approval or limit their commercial use once approved&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">disruptions caused by man-made or natural disasters or public health pandemics or epidemics or other business interruptions</span><span style="font-size:10pt;">. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;letter-spacing:-0.15pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of any of these events, we, any collaborator, the FDA, or any other regulatory authorities, may suspend or terminate clinical studies or marketing of the drug at any time. Any suspension or termination of our clinical studies or marketing activities may harm our business, financial condition and results of operations and the market price of our common stock and other securities may decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we do not achieve our projected development goals in the timeframes we expect, our business, financial condition and results of operations will be harmed and the market price of our common stock and other securities could decline.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For planning purposes, we estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include the commencement or completion of scientific studies and clinical studies and the submission of regulatory filings. From time to time, we publicly announce the expected timing of some of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">these milestones. All of these milestones are based on a variety of assumptions. The actual timing of the achievement of these milestones can vary dramatically from our estimates, in many cases for reasons beyond our control, depending on numerous factors, including:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the rate of progress, costs and results of our clinical studies and preclinical research and development activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability to identify and enroll patients who meet clinical study eligibility criteria&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability to access sufficient, reliable and affordable supplies of components used in the manufacture of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the costs of expanding and maintaining manufacturing operations, as necessary&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the extent to which our clinical studies compete for clinical sites and eligible subjects with clinical studies sponsored by other companies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">actions by regulators&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">disruptions caused by geopolitical conflicts, man-made&#160;or natural disasters or public health pandemics or epidemics or other business interruptions.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we fail to commence or complete, or experience delays in or are forced to curtail, our proposed development programs or otherwise fail to adhere to our projected development goals in the timeframes we expect (or within the timeframes expected by analysts or investors), our business, financial condition and results of operations may be harmed and the market price of our common stock and other securities may decline. In addition, we may be delayed or prevented from generating revenues from milestone or other payments that depend on our ability to achieve any milestone obligations specified in an out-licensing arrangement. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The long-term safety and efficacy of approved products may differ from clinical studies, which could negatively impact sales and could lead to reputational harm or other negative effects.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effects of approved therapeutic products over terms longer than the clinical studies or in much larger populations may not be consistent with earlier clinical results. If long-term use of an approved therapeutic product results in adverse health effects or reduced efficacy or both, the FDA or other regulatory agencies may terminate our or any marketing or collaboration partner&#8217;s ability to market and sell the product, may narrow the approved indications for use or otherwise require restrictive product labeling or marketing, or may require further clinical studies, which may be time-consuming and expensive and may not produce favorable results.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go received pre-market clearance in 2010 under Section 510(k) of the U.S. Federal Food, Drug, and Cosmetic Act, or FDCA. This process typically requires the submission of less supporting documentation than other FDA approval processes and does not always require long-term clinical studies. As a result, we currently lack significant published long-term clinical data supporting the safety and efficacy of V-Go and the benefits it offers that might have been generated in connection with other approval processes. For these reasons, adults who require insulin and their healthcare providers may be slower to adopt or recommend V-Go, we may not have comparative data that our competitors have or are generating, and third-party payers may not be willing to provide coverage or reimbursement for V-Go. Further, future studies or clinical experience may indicate that treatment with V-Go is not superior to treatment with competitive products. Such results could slow the adoption of V-Go and significantly reduce our sales, which could prevent us from achieving our forecasted sales targets or achieving or sustaining profitability. Moreover, if future results and experience indicate that V-Go causes unexpected or serious complications or other unforeseen negative effects, we could be subject to mandatory product recalls, suspension or withdrawal of FDA clearance or approval, significant legal liability or harm to our business reputation.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not realize the benefit of our recent acquisition of V-Go or any future acquisition or strategic transaction&#59; we may be unable to successfully integrate new products or businesses we may acquire.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We periodically evaluate and pursue acquisition of therapeutic products. We completed the acquisition of V-Go on May 31, 2022 and it remains to be seen whether the acquisition will further our business strategy as anticipated or generate significant revenues. Moreover, the integration of any acquired business, product or other assets into our company may be complex and time-consuming and, if such businesses, products or assets are not successfully integrated, we may not achieve the anticipated benefits, cost-savings or growth opportunities. Potential difficulties that may be encountered in the integration process include the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">unanticipated liabilities related to acquired assets, companies or joint ventures&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">integrating personnel, operations and systems, while maintaining focus on producing and delivering consistent, high quality products&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">coordinating geographically dispersed organizations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">diversion of management time and focus from operating our business to management of strategic alliances or joint ventures or acquisition integration challenges&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">retention of key employees&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">increases in our expenses and reductions in our cash available for operations and other uses&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">retaining existing customers and attracting new customers&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">managing inefficiencies associated with integrating the operations of our company&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">possible write-offs or impairment charges relating to acquired assets, businesses or joint ventures.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, these acquisitions and other arrangements, even if successfully integrated, may fail to further our business strategy as anticipated, expose us to increased competition or challenges with respect to our products or geographic markets, and expose us to additional liabilities associated with an acquired business, product, technology or other asset or arrangement. Any one of these challenges or risks could impair our ability to realize any benefit from our acquisitions or arrangements after we have expended resources on them.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future acquisitions or dispositions could also result in potentially dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities or amortization expenses or write-offs of goodwill, any of which could harm our financial condition.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our products and product candidates may be rendered obsolete by rapid technological change.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The rapid rate of scientific discoveries and technological changes could result in our approved products or one or more of our product candidates becoming obsolete or noncompetitive. Our competitors may develop or introduce new products that render our technology or products less competitive, uneconomical or obsolete. Our future success may depend not only on our ability to develop our product candidates, but also our ability to improve them in order to keep pace with emerging industry developments. We cannot assure you that we will be able to do so.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also expect to face competition from universities and other non-profit research organizations. These institutions carry out a significant amount of research and development in various areas of unmet medical need. These institutions are becoming increasingly aware of the commercial value of their findings and are more active in seeking patent and other proprietary rights as well as<span style="letter-spacing:-0.1pt;"> licensing revenues.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reports of side effects or safety concerns in related technology fields or in other companies&#8217; clinical studies could delay or prevent us from obtaining regulatory approval for our product candidates or negatively impact public perception of our approved products.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are a number of clinical studies being conducted by other pharmaceutical companies involving compounds similar to, or potentially competitive with, our product candidates. Adverse results reported by these other companies in their clinical studies or by companies that use our proprietary formulation and inhaler technologies could delay or prevent us from obtaining regulatory approval, may subject our products to class warnings in their labels or negatively impact public perception of our product candidates, which could harm our business, financial condition and results of operations and cause the market price of our common stock and other securities to decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If product liability claims are brought against us, we may incur significant liabilities and suffer damage to our reputation.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The testing, manufacturing, marketing and sales of our products and any clinical testing of our product candidates expose us to potential product liability claims. A product liability claim may result in substantial judgments as well as consume significant financial and management resources and result in adverse publicity, decreased demand for a product, injury to our reputation, withdrawal of clinical studies volunteers and loss of revenues. We currently carry worldwide product liability insurance in the amount of $10.0&#160;million as well as an errors and omissions policy in the amount of $1.0 million. Our insurance coverage may not be adequate to satisfy any liability that may arise, and because insurance coverage in our industry can be very expensive and difficult to obtain, we cannot assure you that we will seek to obtain, or be able to obtain if desired, sufficient additional coverage. If losses from such claims exceed our liability insurance coverage, we may incur substantial liabilities that we may not have the resources to pay. If we are required to pay a product liability claim our business, financial condition and results of operations would be harmed and the market price of our common stock and other securities may decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we lose any key employees or scientific advisors, our operations and our ability to execute our business strategy could be materially harmed.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We face intense competition for qualified employees among companies in the biotechnology and biopharmaceutical industries. Our success depends upon our ability to attract, retain and motivate highly skilled employees. We may be unable to attract and retain these individuals on acceptable terms, if at all. In addition, we may be required to expand our workforce. These activities will require the addition of new personnel, including management, and the development of additional expertise by existing personnel, and we cannot assure you that we will be able to attract or retain any such new personnel on acceptable terms, if at all.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The loss of the services of any principal member of our management<span style="color:#000000;">, commercial</span> and scientific staff could significantly delay or prevent the achievement of our scientific and business objectives. All of our employees are &#8220;at will&#8221; and we currently do not have employment agreements with any of the principal members of our management<span style="color:#000000;">, commercial</span> or scientific staff, and we do not have key person life insurance to cover the loss of any of these individuals. Replacing key employees may be difficult and time-consuming because of the limited number of individuals in our industry with the skills and experience required to develop, gain regulatory approval of and commercialize products successfully.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have relationships with scientific advisors at academic and other institutions to conduct research or assist us in formulating our research, development or clinical strategy. These scientific advisors are not our employees and may have commitments to, and other obligations with, other entities that may limit their availability to us. We have limited control over the activities of these scientific advisors and can generally expect these individuals to devote only limited time to our activities. Failure of any of these persons to devote sufficient time and resources to our programs could harm our business. In addition, these advisors are not prohibited from, and may have arrangements with, other companies to assist those companies in developing technologies that may compete with our products.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our internal controls over financial reporting are not considered effective, our business, financial condition and market price of our common stock and other securities could be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;404 of the Sarbanes-Oxley Act of 2002 requires us to evaluate the effectiveness of our internal controls over financial reporting as of the end of each fiscal year, and to include a management report assessing the effectiveness of our internal controls over financial reporting in our annual report on Form 10-K for that fiscal year. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our internal controls over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud involving a company have been, or will be, detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. A material weakness in our internal controls has been identified in the past, and we cannot assure you that we or our independent registered public accounting firm will not identify a material weakness in our internal controls in the future. A material weakness in our internal controls over financial reporting would require management and our independent registered public accounting firm to evaluate our internal controls as ineffective. If our internal controls over financial reporting are not considered effective, we may experience a loss of public confidence, which could have an adverse effect on our business, financial condition and the market price of our common stock and other securities.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Changes or modifications in financial accounting standards may harm our results of operations.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, the Financial Accounting Standards Board (&#8220;FASB&#8221;), either alone or jointly with other organizations, promulgates new accounting principles that could have an adverse impact on our financial position, results of operations and presentation or classification of cash flows. New pronouncements and varying interpretations of pronouncements have occurred with frequency in the past and are expected to occur again in the future and as a result we may be required to make changes in our accounting policies. Any difficulties in adopting or implementing new accounting standards, and updating or modifying our internal controls as needed on a timely basis, could result in our failure to meet our financial reporting obligations, which could result in regulatory discipline and harm investors&#8217; confidence in us. Finally, if we were to change our critical accounting estimates, including those related to the recognition of collaboration revenue and other revenue sources, our operating results could be significantly affected.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Act, the Coronavirus Aid, Relief, and Economic Security Act and the IRA enacted many significant changes to the U.S. tax laws. Further guidance from the Internal Revenue Service and other tax authorities with respect to such legislation may affect us, and certain aspects of such legislation could be repealed or modified in future legislation. In addition, it is uncertain if and to what extent various states will conform to federal tax laws. Future tax reform legislation could have a material impact on the value of our deferred tax assets and could increase our future U.S. tax expense. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2022, the Tax Act eliminated the option to deduct research and development expenses for tax purposes in the year incurred and requires taxpayers to capitalize and subsequently amortize such expenses over five years for research activities conducted in the United States and over 15 years for research activities conducted outside the United States. Unless the United States Department of the Treasury issues regulations that narrow the application of this provision to a smaller subset of our research and development expenses or the provision is deferred, modified, or repealed by Congress, it could harm our future operating results by effectively increasing our future tax obligations. The actual impact of this provision will depend on multiple factors, including the amount of research and development expenses we will incur, whether we achieve sufficient income to fully utilize such deductions and whether we conduct our research and development activities inside or outside the United States.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Our ability to use net operating losses to offset future taxable income may be subject to limitations.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, the Company had federal and state net operating loss carryforwards of approximately $2.2&#160;billion and $1.7&#160;billion available, respectively, to reduce future taxable income. $499.6 million of the federal losses do not expire and the remaining federal losses have started expiring, beginning in the current year through various future dates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to IRC Sections 382 and 383, annual use of the Company&#8217;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. As a result of the Company's initial public offering, an ownership change within the meaning of IRC Section 382 occurred in August 2004. As a result, federal net operating loss and credit carryforwards of approximately $105.8 million are subject to an annual use limitation of approximately $13.0 million. The annual limitation is cumulative and therefore, if not fully utilized in a year can be utilized in future years in addition to the Section 382 limitation for those years. We have completed a Section 382 analysis beginning from the date of our initial public offering through December 31, 2022, to determine whether additional limitations may be placed on the net operating loss carryforwards and other tax attributes, and no additional changes in ownership that met Section 382 study ownership change threshold has been identified through December 31, 2022. There is a risk that changes in ownership may occur in tax years after December 31, 2022. If a change in ownership were to occur, our net operating loss carryforwards and other tax attributes could be further limited or restricted. If limited, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, related to the Company&#8217;s operations in the U.S. will not impact the Company&#8217;s effective tax rate.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, at the state level, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. As a result, if we earn net taxable income, we may be unable to use all or a material portion of our net operating loss carryforwards and other tax attributes, which could potentially result in increased future tax liability to us and adversely affect our future cash flows. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Tax authorities may disagree with our positions and conclusions regarding certain tax positions, resulting in unanticipated costs, taxes or non-realization of expected benefits. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A tax authority may disagree with tax positions that we have taken, which could result in increased tax liabilities. For example, the U.S. Internal Revenue Service or another tax authority could challenge our allocation of income by tax jurisdiction and the amounts paid between our affiliated companies pursuant to our intercompany arrangements and transfer pricing policies, including amounts paid with respect to our intellectual property development. Similarly, a tax authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable nexus, often referred to as a &#8220;permanent establishment&#8221; under international tax treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. A tax authority may take the position that material income tax liabilities, interest and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly and if we were unsuccessful in disputing the assessment, the implications could increase our anticipated effective tax rate, where applicable.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may undertake internal restructuring activities in the future that could result in disruptions to our business or otherwise materially harm our results of operations or financial condition.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, we may undertake internal restructuring activities as we continue to evaluate and attempt to optimize our cost and operating structure in light of developments in our business strategy and long-term operating plans. These activities may result in write-offs or other restructuring charges. There can be no assurance that any restructuring activities that we undertake will achieve the cost savings, operating efficiencies or other benefits that we may initially expect. Restructuring activities may also result in a loss of continuity, accumulated knowledge and inefficiency during transitional periods and thereafter. In addition, internal restructurings can require a significant amount of time and focus from management and other employees, which may divert attention from commercial operations. If we undertake any internal restructuring activities and fail to achieve some or all of the expected benefits therefrom, our business, results of operations and financial condition could be materially and adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our operations might be interrupted by the occurrence of a natural disaster or other catastrophic event.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At least for the foreseeable future, we expect that our manufacturing facility in Connecticut will be the sole location for the manufacturing of Afrezza and<span style="color:#000000;"> Tyvaso DPI. Similarly, our contract manufacturer in Southern China is the only location for the assembly of V-Go. Additional contract manufacturers in China perform release testing, sterilization, inspection and packaging functions. </span>These facilities and the specialized manufacturing equipment we use at them would be costly to replace and could require substantial lead-time to repair or replace. We depend on our facilities and on collaborators, contractors and vendors for the continued operation of our business. Natural disasters or other catastrophic events, including interruptions in the supply of natural resources, political and governmental changes, severe weather conditions, public health pandemics or epidemics, <span style="Background-color:#FFFFFF;color:#000000;">wars, conflicts (including the current&#160;Russia-Ukraine&#160;conflict), </span>wildfires and other fires, explosions, actions of animal rights activists, terrorist attacks, volcanic eruptions, earthquakes and wars could disrupt our operations or those of our collaborators, contractors and vendors. We might suffer losses as a result of business interruptions that exceed the coverage available under our and our contractors&#8217; insurance policies or for which we or our contractors do not have coverage. For example, we are not insured against a terrorist attack. Any natural disaster or catastrophic event could have a significant negative impact on our operations and financial results. Moreover, any such event could delay our research and development programs or cause interruptions in our commercialization of our products.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We deal with hazardous materials and must comply with environmental laws and regulations, which can be expensive and restrict how we do business.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development work involves the controlled storage and use of hazardous materials, including chemical and biological materials. Our operations also produce hazardous waste products. We are subject to federal, state and local laws and regulations (i)&#160;governing how we use, manufacture, store, handle and dispose of these materials (ii)&#160;imposing liability for costs of cleaning up, and damages to natural resources from past spills, waste disposals on and off-site, or other releases of hazardous materials or regulated substances, and (iii)&#160;regulating workplace safety. Moreover, the risk of accidental contamination or injury from hazardous materials cannot be completely eliminated, and in the event of an accident, we could be held liable for any damages that may result, and any liability could fall outside the coverage or exceed the limits of our insurance. Currently, our general liability policy provides coverage up to $1.0&#160;million per occurrence and $2.0&#160;million in the aggregate and is supplemented by an umbrella policy that provides a further $20.0&#160;million of coverage&#59; however, our insurance policy excludes pollution liability coverage and we do not carry a separate hazardous materials policy. In addition, we could be required to incur significant costs to comply with environmental laws and regulations in the future. Finally, current or future environmental laws and regulations may impair our research, development or production efforts or have an adverse impact on our business, results of operations and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When we purchased our facility in Connecticut in 2001, a soil and groundwater investigation and remediation was being conducted by a former site operator (a &#8220;responsible party&#8221;) under the oversight of the Connecticut Department of Energy &#38; Environmental Protection (formerly the Connecticut Department of Environmental Protection), which investigation and remediation is ongoing. The former site operator and responsible party will make further filings necessary to achieve closure for the environmental investigation and remediation it has conducted at the site, and has agreed to indemnify us for any future costs and expenses we may incur that are directly related to its prior operations at the facility. If we are unable to collect these future costs and expenses, if any, from the responsible party, our business, financial condition and results of operations may be harmed. When we sold a portion of the property upon which our facility is located to the entity that is now our landlord, we became an additional responsible party for any environmental investigation and remediation on that portion of the property, including with respect to investigation or remediation that may be required as a result of our activities since 2001. To date, we have not identified any material environmental investigation or remediation activities that we are required to perform.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions&#59; litigation&#59; fines and penalties&#59; disruptions of our business operations&#59; reputational harm&#59; loss of revenue or profits&#59; loss of customers or sales&#59; and other adverse consequences.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We, and third parties acting on our behalf, employ and are increasingly dependent upon information technology systems, infrastructure, applications, websites and other resources. Our business requires collecting, receiving, manipulating, analyzing, storing, processing, generating, using, disclosing, protecting, securing, transmitting, sharing, disposing of, and making accessible (collectively &#8220;processing&#8221;) large amounts of data, including proprietary, confidential and sensitive data (such as personal or health-related data), intellectual property, and trade secrets (collectively, &#8220;sensitive information&#8221;). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cyberattacks, malicious internet-based activity, online and offline fraud and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, and those of the third parties upon which we rely. Such threats are prevalent and continue to increase are increasingly difficult to detect, and come from a variety of sources, including traditional computer &#8220;hackers,&#8221; threat actors &#8220;hacktivists,&#8221; organized criminal threat actors, personnel (such as through theft or misuse), sophisticated nation-states, and nation-state-supported actors. Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors, for geopolitical reasons and in conjunction with military conflicts and defense activities. We and the third parties upon which we rely may be subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), denial-of-service attacks (such as credential stuffing), credentials harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, and other similar threats. Ransomware attacks, including by organized criminal threat actors, nation-states, and nation-state-supported actors, are becoming increasingly prevalent and severe and can lead to significant interruptions in our operations, loss of data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. During times of war and other major conflicts, we and the third parties upon which we rely may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services. Some of our workforce works remotely, which also poses increased risks to our information technology systems and data, as employees working from home, in transit or in public locations, utilize network connections, computers and devices outside our premises or network. Future or past business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies. Furthermore, we may discover security issues that were not found during due diligence of such acquired or integrated entities, and it may be difficult to integrate companies into our information technology environment and security program.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, cloud-based infrastructure, data center facilities, encryption and authentication technology, employee email, and other functions. We may also rely on third-party service providers to provide other products or services, or otherwise to operate our business. For example, we rely on an enterprise software system to operate and manage our business. Our business, including our </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ability to manufacture drug products and conduct clinical trials, therefore depends on the continuous, effective, reliable and secure operation of our information technology resources and those of third parties acting on our behalf, including computer hardware, software, networks, Internet servers and related infrastructure. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. In particular, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties and infrastructure in our supply chain or our third-party partners&#8217; supply chains have not been compromised or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our information technology systems (including our products) or the third-party information technology systems that support us and our services. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of the previously identified or similar threats could cause a security incident or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information or our information technology systems, or those of the third parties upon whom we rely. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to provide our products. We may expend significant resources or modify our business activities (including our clinical trial activities) to try to protect against security incidents. Certain data privacy and security obligations may require us to implement and maintain specific security measures, industry-standards or reasonable security measures to protect our information technology systems and sensitive information. While we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective. We have not always been able in the past and may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are often sophisticated in nature, and may not be detected until after a security incident has occurred. For example, like many companies, we use SolarWinds to help manage our information technology systems. A cyberattack on SolarWinds was discovered in December 2020 and widely exploited by threat actors. Upon learning of this vulnerability, we applied the software patch provided by SolarWinds and remediated the incident. The incident did not appear to have any negative impact on our operations or the sensitive information we may process. In addition, a ransomware attack on Ultimate Kronos Group&#8217;s (&#8220;UKG&#8221;) Kronos Private Cloud service was discovered in December 2021. We use UKG Pro, a product offered through UKG that is not in the Kronos Private Cloud, for human capital management. UKG is not aware of an impact on UKG Pro and the incident did not appear to have any negative impact on our operations or the sensitive information we may process. Thus, despite our efforts to identify and remediate vulnerabilities, if any, in our information technology systems, our efforts may not be successful. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Applicable data privacy and security obligations may require us to notify relevant stakeholders of security incidents. Such disclosures are costly, and the disclosures or the failure to comply with such requirements could lead to adverse consequences. If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections)&#59; additional reporting requirements and/or oversight&#59; restrictions on processing sensitive information (including personal data)&#59; litigation (including class claims)&#59; indemnification obligations&#59; negative publicity&#59; reputational harm&#59; monetary fund diversions&#59; interruptions in our operations (including availability of data)&#59; financial loss&#59; and other similar harms. Security incidents and attendant consequences may cause customers to stop using our products, deter new customers from using our products, and negatively impact our ability to grow and operate our business. Additionally, our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our cybersecurity insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Calibri;text-transform:none;font-variant: normal;">Changes in funding for the&#160;FDA, the SEC&#160;and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ability of the&#160;FDA&#160;to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.<span style="color:#000000;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO GOVERNMENT REGULATION</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our product candidates must undergo costly and time-consuming rigorous nonclinical and clinical testing and we must obtain regulatory approval prior to the sale and marketing of any product in each jurisdiction. The results of this testing or issues that develop in the review and approval by a regulatory agency may subject us to unanticipated delays or prevent us from marketing any products.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development activities for product candidates, as well as the manufacturing and marketing of approved products, are subject to regulation, including regulation for safety, efficacy and quality, by the FDA in the United States and comparable authorities in other countries. FDA regulations and the regulations of comparable foreign regulatory authorities are wide-ranging and govern, among other things:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">product design, development, manufacture and testing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">product labeling&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">product storage and shipping&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">pre-market clearance or approval&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">advertising and promotion&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">product sales and distribution.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The requirements governing the conduct of clinical studies as well as the manufacturing and marketing of drug products outside the United States vary widely from country to country. Foreign approvals may take longer to obtain than FDA approvals and can require, among other things, additional testing and different clinical study designs. Foreign regulatory approval processes include essentially all of the risks associated with the FDA approval processes. Some of those agencies also must approve prices of the products. Approval of a product by the FDA does not ensure approval of the same product by the health authorities of other countries. In addition, changes in regulatory policy in the United States or in foreign countries for product approval during the period of product development and regulatory agency review of each submitted new application may cause delays or rejections.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clinical testing can be costly and take many years, and the outcome is uncertain and susceptible to varying interpretations. We cannot be certain if or when regulatory agencies might request additional studies, under what conditions such studies might be requested, or what the size or length of any such studies might be. The clinical studies of our product candidates may not be completed on schedule, regulatory agencies may order us to stop or modify our research, or these agencies may not ultimately approve any of our product candidates for commercial sale. The data collected from our clinical studies may not be sufficient to support regulatory approval of our product candidates. Even if we believe the data collected from our clinical studies are sufficient, regulatory agencies have substantial discretion in the approval process and may disagree with our interpretation of the data. Our failure to adequately demonstrate the safety and efficacy of any of our product candidates would delay or prevent regulatory approval of our product candidates, which could prevent us from achieving profitability.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Questions that have been raised about the safety of marketed drugs generally, including pertaining to the lack of adequate labeling, may result in increased cautiousness by regulatory agencies in reviewing new drugs based on safety, efficacy, or other regulatory considerations and may result in significant delays in obtaining regulatory approvals. Such regulatory considerations may also result in the imposition of more restrictive drug labeling or marketing requirements as conditions of approval, which may significantly affect the marketability of our drug products.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we do not comply with regulatory requirements at any stage, whether before or after marketing approval is obtained, we may be fined or forced to remove a product from the market, subject to criminal prosecution, or experience other adverse consequences, including restrictions or delays in obtaining regulatory marketing approval.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if we comply with regulatory requirements, we may not be able to obtain the labeling claims necessary or desirable for product promotion. We may also be required to undertake post-marketing studies. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, if we or other parties identify adverse effects after any of our products are on the market, or if manufacturing problems occur, regulatory approval may be withdrawn and a reformulation of our products, additional clinical studies, changes in labeling of, or indications of use for, our products and/or additional marketing applications may be required. If we encounter any of the foregoing problems, our business, financial condition and results of operations will be harmed and the market price of our common stock and other securities may decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are subject to stringent, ongoing government regulation.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and comparable foreign regulatory authorities subject any approved therapeutic product to extensive and ongoing regulatory requirements concerning the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs and GCP requirements for any clinical trials that we conduct post-approval. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Later discovery of previously unknown problems, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things: </span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">restrictions on the marketing or manufacturing of our product candidates, withdrawal of the product from the market, or voluntary or mandatory product recalls&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">revisions to the approved labeling to add new safety information&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">fines, warning letters or holds on clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or revocation of approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">product seizure or detention, or refusal to permit the import or export of our product candidates&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">injunctions or the imposition of civil or criminal penalties.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also are required to register our establishments and list our products with the FDA and certain state agencies. We and any third-party manufacturers or suppliers must continually adhere to federal regulations setting forth cGMP (for drugs) and QSR (for medical devices), and their foreign equivalents, which are enforced by the FDA and other national regulatory bodies through their facilities inspection programs. In complying with cGMP and foreign regulatory requirements, we and any of our third-party manufacturers or suppliers will be obligated to expend time, money and effort in production, record-keeping and quality control to ensure that our products meet applicable specifications and other requirements. QSR requirements also impose extensive testing, control and documentation requirements. State regulatory agencies and the regulatory agencies of other countries have similar requirements. In addition, we will be required to comply with regulatory requirements of the FDA, state regulatory agencies and the regulatory agencies of other countries concerning the reporting of adverse events and device malfunctions, corrections and removals (e.g., recalls), promotion and advertising and general prohibitions against the manufacture and distribution of adulterated and misbranded devices. Failure to comply with these regulatory requirements could result in significant civil fines, product seizures, injunctions and/or criminal prosecution of responsible individuals and us. Any such actions would have a material adverse effect on our business, financial condition and results of operations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of the approval of Afrezza, the FDA required us to conduct certain additional clinical studies of Afrezza. We have initiated one of these studies, a Phase 3 clinical trial to evaluate the safety and efficacy of Afrezza in 4-17 year-old children and adolescents. We have engaged a clinical research organization to assist us with conducting this study and have budgeted the projected costs of the study in our operating plans. The other required study is a long-term safety study that was originally intended to compare the incidence of pulmonary malignancy observed with Afrezza to that observed in a standard of care control group. We have an ongoing dialogue with the FDA regarding the agency&#8217;s current interest in the long-term safety of Afrezza and an appropriate study design to address any concerns. To date, we have not commenced a long-term safety study or budgeted any amount for it, but such a study in its original design would be anticipated to require substantial capital resources that we may not be able to obtain. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA and other regulatory authorities impose significant restrictions on approved products through regulations on advertising, promotional and distribution activities. This oversight encompasses, but is not limited to, direct-to-consumer advertising, healthcare provider-directed advertising and promotion, sales representative communications to healthcare professionals, promotional programming and promotional activities involving the Internet.&#160;Regulatory authorities may also review industry-sponsored scientific and educational activities that make representations regarding product safety or efficacy in a promotional context. Prescription drugs may be promoted only for the approved indications in accordance with the approved label. The FDA and other regulatory authorities may take enforcement action against a company for promoting unapproved uses of a product or for other violations of its advertising and labeling laws and regulations. However, physicians may, in their independent medical judgment, prescribe legally available products for off-label uses. The FDA does not regulate the behavior of physicians in their choice of treatments, but the FDA does restrict manufacturer&#8217;s communications on the subject of off-label use of their products. Enforcement action may include product seizures, injunctions, significant civil or criminal penalties or regulatory letters, which may require corrective advertising or other corrective communications to healthcare professionals. Failure to comply with such regulations also can result in adverse publicity or increased scrutiny of company activities by the U.S. Congress or other legislators.&#160;Certain states have also adopted regulations and reporting requirements surrounding the promotion of pharmaceuticals. Failure to comply with state requirements may affect our ability to promote or sell our products in certain states. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates, delay the submission or review of an application or require additional expenditures by us. In addition, interested parties (such as individuals, advocacy groups and competing pharmaceutical companies) can file a citizen petition with the FDA to request policy change or some form of administrative action on the FDA&#8217;s part, including with respect to an NDA. For example, in July 2021, a third party submitted a citizen petition to the FDA requesting that the FDA refuse to approve Tyvaso DPI, and/or impose additional requirements in order to approve the product. This prompted the FDA to request additional information concerning Tyvaso DPI prior to granting approval in May 2022. If successful, a citizen petition can significantly delay, or even prevent, the approval of a drug product.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. We also cannot be sure that actions by foreign regulatory bodies pertaining to the safety of drugs or medical devices will not adversely affect our operations. If we are slow or unable to adapt to changes in existing requirements or the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be denied marketing approval or lose any marketing approval that we have already obtained. There can be no assurance that we will be able to obtain necessary regulatory clearances or approvals on a timely basis, if at all, for any of our product candidates under development, and delays in receipt or failure to receive such clearances or approvals, the loss of previously received clearances or approvals, or failure to comply with existing or future regulatory requirements could have a material adverse effect on our business and results of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Healthcare legislation may make it more difficult to receive revenues.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In both the United States and certain foreign jurisdictions, there has been a number of legislative and regulatory proposals in recent years to change the healthcare system in ways that could impact our ability to sell our products profitably. The most recent significant healthcare legislation was the Patient Protection and Affordable Care Act, as amended by the Health Care Education and Reconciliation Act (collectively, the &#8220;PPACA&#8221;), enacted in March 2010, which substantially changed the way healthcare is financed by both governmental and private insurers and continues to significantly affect the healthcare industry. There have been executive, judicial and congressional challenges to certain provisions of the PPACA, although the constitutionality of the PPACA appears to now be settled. In addition, there have been proposed and enacted health reform initiatives affecting the PPACA. For example, on August 16, 2022, President Biden signed the IRA into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in PPACA marketplaces through plan year 2025, eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and through a newly established manufacturer discount program, and caps the out-of-pocket cost of insulin (including Afrezza) at $35 per month for Medicare recipients beginning in 2023. It is possible that the PPACA will be subject to judicial or Congressional challenges in the future. It is unclear how any such challenges, other litigation, and the healthcare reform measures of the current administration will impact the PPACA.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products. Specifically, there have been several recent U.S. Presidential executive orders, Congressional inquiries and proposed and enacted legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. These new laws and initiatives may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on our customers and accordingly, our financial operations.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future revenues and ability to generate positive cash flow from operations may be affected by the continuing efforts of government and other third-party payers to contain or reduce the costs of healthcare through various means. In the United States, there have been several congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At the federal level, in July 2021, the Biden administration released an executive order, &#8220;Promoting Competition in the American Economy,&#8221; with multiple provisions aimed at prescription drugs. In response to Biden&#8217;s executive order, on September 9, 2021, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs and biologics covered under Medicare and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions will take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. We expect that there will continue to be a number of federal and state proposals to implement similar and/or additional governmental controls. We cannot be certain what legislative proposals will be adopted or what actions federal, state or private third-party payers may take in response to any drug pricing and reimbursement reform proposals or legislation. Further, to the extent that such reforms have a material adverse effect on our ability to commercialize our products and product candidates under development, our business, financial condition and profitability may be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that PPACA, the IRA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product, and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private third-party payers. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we or any future partner fails to comply with federal and state healthcare laws, including fraud and abuse and health information laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a biopharmaceutical company, even though we do not and will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payers, certain federal and state healthcare laws and regulations, including those pertaining to fraud and abuse and patients&#8217; rights, are and will be applicable to our business. The number and scope of these laws, regulations and industry standards are </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changing, subject to differing applications and interpretations, and may be inconsistent between jurisdictions or in conflict with each other, making compliance difficult. The key laws that may affect our ability to operate include, among others:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">The federal Anti-Kickback Statute (as amended by PPACA, which modified the intent requirement of the federal Anti-Kickback Statute so that a person or entity no longer needs to have actual knowledge of the Statute or specific intent to violate it to have committed a violation), which constrains our business activities, including our marketing practices, educational programs, pricing policies, and relationships with healthcare providers or other entities by prohibiting, among other things, knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, to induce, or in return for, either the referral of an individual or the purchase or recommendation of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Federal civil and criminal false claims laws, including without limitation the False Claims Act, and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other federal healthcare programs that are false or fraudulent, and knowingly making, or causing to be made, a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government, and under PPACA, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal false claims laws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">The federal Physician Payments Sunshine Act under PPACA, which requires certain manufacturers of drugs, devices, biologics, and medical supplies to report annually to Centers for Medicare &#38; Medicaid Services (&#8220;CMS&#8221;) information related to payments and other transfers of value to physicians (defined to include defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other healthcare professionals (such as physician assistants and nurse practitioners), and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">The federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), which created new federal criminal statutes that prohibit, among other things, knowingly and willfully executing a scheme to defraud any healthcare benefit program or falsifying, concealing, or covering up a material fact in connection with the delivery of or payment for health care benefits.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), and their respective implementing regulations, which impose certain requirements relating to the privacy, security and transmission of individually identifiable health information on entities subject to the law, such as certain healthcare providers, health plans, and healthcare clearinghouses and their respective business associates that perform services for them that involve the creation, use, maintenance or disclosure of, individually identifiable health information as well as their covered subcontractors.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">Other state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payer, including commercial insurers, and state and foreign laws governing the privacy and security and other processing of personal data (including health information) in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts&#59; state laws that require pharmaceutical companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government that otherwise restricts certain payments that may be made to healthcare providers and entities&#59; state and local laws that require the registration of pharmaceutical sales representatives&#59; and state laws that require drug manufacturers to report information related to payments and other transfer of value to physicians and other healthcare providers and entities, marketing expenditures or drug pricing.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of the breadth of these laws and the narrowness of available statutory exceptions and regulatory safe harbors, it is possible that some of our business activities could be subject to challenge under one or more of such laws. With Afrezza approved in Brazil and as we pursue additional international approvals, we will be subject to similar foreign laws and regulations. If we or our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, or any contractual obligations related to the same, we may be subject to governmental enforcement actions, investigations, litigation (including class action lawsuits) and other penalties, including significant civil, criminal and administrative penalties, damages, fines, imprisonment, disgorgement, defense costs, exclusion from U.S. federal or state healthcare programs, additional reporting requirements and/or oversight (including if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws), bans or restrictions on our processing of personal data, indemnity obligations and the curtailment or restructuring of our operations. Any such event or consequence, including penalties, damages, fines, and curtailment or restructuring of our operations, could materially adversely affect our ability to operate our business, including our ability to run clinical trials, and our financial results and harm our reputation. Although compliance programs can help mitigate the risk of investigation and prosecution for violations of these laws, the risks cannot be eliminated. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state fraud laws may prove costly.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We are subject to stringent and changing U.S. and foreign laws, regulations, rules, contractual obligations, policies and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions&#59; litigation&#59; fines and penalties&#59; disruptions of our business operations&#59; reputational harm&#59; loss of revenue or profits&#59; loss of customers or sales&#59; and other adverse business consequences.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of business, we process sensitive information (as those terms are defined above). Our data processing activities subject us to numerous data privacy and security obligations, such as various laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations relating to data privacy and security. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, federal, state, and local governments have enacted numerous data privacy and security laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). For example, HIPAA, as amended by HITECH, imposes specific requirements relating to the privacy, security, and transmission of individually identifiable health information. In addition, the CCPA imposes obligations on covered businesses. These obligations include, but are not limited to, providing specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA provides for civil penalties (up to $7,500 per violation and allows private litigants affected by certain data breaches to recover significant statutory damages). Although the CCPA exempts some data processed in the context of clinical trials, the CCPA may increase compliance costs and potential liability with respect to other personal data we maintain about California residents. In addition, the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;), which became operative January 1, 2023, expands the CCPA&#8217;s requirements, including by applying to personal information of business representatives and employees. Additionally, the CPRA establishes a new California Privacy Protection Agency to implement and enforce the CPRA, which could increase the risk of enforcement. Other states also have enacted comprehensive data privacy laws. For example, Virginia passed the Consumer Data Protection Act, and Colorado passed the Colorado Privacy Act, both of which become effective in 2023. In addition, data privacy and security laws have been proposed at the federal, state, and local levels in recent years, which could further complicate compliance efforts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outside the United States, an increasing number of laws, regulations, and industry standards apply to data privacy and security. For example, the General Data Protection Regulation (&#8220;GDPR&#8221;) and, the United Kingdom&#8217;s GDPR (&#8220;UK GDPR&#8221;), Brazil&#8217;s General Data Protection Law (Lei Geral de Prote&#231;&#227;o de Dados Pessoais, or &#8220;LGPD&#8221;) (Law No. 13,709/2018), and Australia&#8217;s Privacy Act 1988 impose strict requirements for processing personal data. For example, under the EU GDPR, companies may face temporary or definitive bans on data processing and other corrective actions&#59; fines of up to 20 million euros or 4% of annual global revenue, whichever is greater&#59; or private litigation related to the processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law to represent their interests. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the ordinary course of business, we may transfer personal data from Europe and other jurisdictions to the United States or other countries. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the European Economic Area (EEA) and the United Kingdom (UK) have significantly restricted the transfer of personal data to the United States and other countries whose privacy laws it believes are inadequate. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the United States in compliance with law, such as the EEA and UK&#8217;s standard contractual clauses, these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these reasons to lawfully transfer personal data to the United States. If there is no lawful manner for us to transfer personal data from the EEA, the UK or other jurisdictions to the United States, or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Some European regulators have prevented companies from transferring personal data out of Europe for allegedly violating the GDPR&#8217;s cross-border data transfer limitations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may also be bound by contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. For example, certain privacy laws, such as the GDPR and the CCPA, require our customers to impose specific contractual restrictions on their service providers. We publish privacy policies, marketing materials and other statements, such as compliance with certain certifications or self-regulatory principles, regarding data privacy and security. If these policies, materials or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators or other adverse consequences. In addition, privacy advocates and industry groups have proposed, and may propose, standards with which we are legally or contractually bound to comply.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our obligations related to data privacy and security are quickly changing in an increasingly stringent fashion, creating some uncertainty as to the effective future legal framework. Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions. Preparing for and complying with these obligations requires significant resources and may necessitate changes to our information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail (or be perceived to have failed) to do so. Moreover, despite our efforts, our personnel or third parties upon whom we rely may fail to comply with such obligations, which could negatively impact our business operations and compliance posture. If we or the third parties on which we rely fail, or are perceived to have failed, to address or comply with data privacy and security obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar)&#59; litigation (including class-related claims)&#59; additional reporting requirements and/or oversight&#59; bans on processing personal data&#59; orders to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">destroy or not use personal data&#59; and imprisonment of company officials. Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: loss of customers&#59; interruptions or stoppages in our business operations (including, as relevant, clinical trials)&#59; inability to process personal data or to operate in certain jurisdictions&#59; limited ability to develop or commercialize our products&#59; expenditure of time and resources to defend any claim or inquiry&#59; adverse publicity&#59; or revision or restructuring of our operations.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we fail to comply with our reporting and payment obligations under the Medicaid Drug Rebate Program or other governmental pricing programs in the United States, we could be subject to additional reimbursement requirements, fines, sanctions and exposure under other laws which could have a material adverse effect on our business, results of operations and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We participate in the Medicaid Drug Rebate Program, as administered by CMS, and other federal and state government pricing programs in the United States, and we may participate in additional government pricing programs in the future. These programs generally require us to pay rebates or otherwise provide discounts to government payers in connection with drugs that are dispensed to beneficiaries/recipients of these programs. In some cases, such as with the Medicaid Drug Rebate Program, the rebates are based on pricing that we report on a monthly and quarterly basis to the government agencies that administer the programs. Pricing requirements and rebate/discount calculations are complex, vary among products and programs, and are often subject to interpretation by governmental or regulatory agencies and the courts. The requirements of these programs, including, by way of example, their respective terms and scope, change frequently. For example, on March 11, 2021, President Biden signed the American Rescue Plan Act of 2021 into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s AMP, for single source and innovator multiple source drugs, beginning January 1, 2024. Responding to current and future changes may increase our costs, and the complexity of compliance will be time consuming. Invoicing for rebates is provided in arrears, and there is frequently a time lag of up to several months between the sales to which rebate notices relate and our receipt of those notices, which further complicates our ability to accurately estimate and accrue for rebates related to the Medicaid program as implemented by individual states. Thus, there can be no assurance that we will be able to identify all factors that may cause our discount and rebate payment obligations to vary from period to period, and our actual results may differ significantly from our estimated allowances for discounts and rebates. Changes in estimates and assumptions may have a material adverse effect on our business, results of operations and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Office of Inspector General of the HHS and other Congressional, enforcement and administrative bodies have recently increased their focus on pricing requirements for products, including, but not limited to the methodologies used by manufacturers to calculate AMP and best price (&#8220;BP&#8221;) for compliance with reporting requirements under the Medicaid Drug Rebate Program. We are liable for errors associated with our submission of pricing data and for any overcharging of government payers. For example, failure to submit monthly/quarterly AMP and BP data on a timely basis could result in a civil monetary penalty. Failure to make necessary disclosures and/or to identify overpayments could result in allegations against us under the False Claims Act and other laws and regulations. Any required refunds to the U.S. government or responding to a government investigation or enforcement action would be expensive and time consuming and could have a material adverse effect on our business, results of operations and financial condition. In addition, in the event that the CMS were to terminate our rebate agreement, no federal payments would be available under Medicaid or Medicare for our covered outpatient drugs.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our business could be negatively impacted by environmental, social and corporate governance (ESG) matters or our reporting of such matters.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is an increasing focus from certain investors, employees, partners, and other stakeholders concerning ESG matters. We may be, or be perceived to be, not acting responsibly in connection with these matters, which could negatively impact us. Moreover, the SEC has recently proposed, and may continue to propose, certain mandated ESG reporting requirements, such as the SEC&#8217;s proposed rules designed to enhance and standardize climate-related disclosures, which, if finally approved, would significantly increase our compliance and reporting costs and may also result in disclosures that certain investors or other stakeholders deem to negatively impact our reputation and/or that harm our stock price. We currently do not report our environmental emissions and absent a legal requirement to do so we currently do not plan to report our environmental emissions, and lack of reporting could result in certain investors declining to invest in our common stock. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our portfolio of investment securities may require us to register with the SEC as an &#8220;investment company&#8221; in accordance with the Investment Company Act of 1940 (&#8220;&#8216;40 Act&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The rules and interpretations of the SEC and the courts relating to the definition of "investment company" are very complex. Although we are a biopharmaceutical company and we do not hold ourselves out as an investment company, the value of our investment securities relative to our total assets (exclusive of government securities and cash items) has in the past exceeded safe harbor limits prescribed in the &#8217;40 Act. If our asset mix does not continue to qualify for one of the safe harbor limits prescribed in the &#8216;40 Act, it is possible that the SEC would take the position that we would be required to register under the &#8216;40 Act and comply with the &#8216;40 Act&#8217;s registration and reporting requirements, capital structure requirements, affiliate transaction restrictions, conflict of interest rules, requirements for disinterested directors, and other substantive provisions. If we were required to register as an &#8220;investment company&#8221; and be subject to the restrictions of the &#8216;40 Act, those restrictions likely would require significant changes in the way we do business and add significant administrative costs and burdens to our operations. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO INTELLECTUAL PROPERTY</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we are unable to protect our proprietary rights, we may not be able to compete effectively, or operate profitably.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our commercial success depends, in large part, on our ability to obtain and maintain intellectual property protection for our technology. Our ability to do so will depend on, among other things, complex legal and factual questions, and it should be noted that the standards regarding intellectual property rights in our fields are still evolving. We attempt to protect our proprietary technology through a combination of patents, trade secrets and confidentiality agreements. We own a number of domestic and international patents, have a number of domestic and international patent applications pending and have licenses to additional patents. We cannot assure you that our patents and licenses will successfully preclude others from using our technologies, and we could incur substantial costs in seeking enforcement of our proprietary rights against infringement. Even if issued, the patents may not give us an advantage over competitors with alternative technologies.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, the coverage claimed in a patent application can be significantly reduced before a patent is issued, either in the United States or abroad. Statutory differences in patentable subject matter may limit the protection we can obtain on some of our inventions outside of the United States. For example, methods of treating patients are not patentable in many countries outside of the United States. These and other issues may limit the patent protection we are able to secure internationally. Consequently, we do not know whether any of our pending or future patent applications will result in the issuance of patents or, to the extent patents have been issued or will be issued, whether these patents will be subjected to further proceedings limiting their scope, will provide significant proprietary protection or competitive advantage, or will be circumvented or invalidated.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, patents already issued to us or our pending applications may become subject to disputes that could be resolved against us. In the United States and certain other countries, applications are generally published 18 months after the application&#8217;s priority date. Because publication of discoveries in scientific or patent literature often trails behind actual discoveries, we cannot be certain that we were the first inventor of the subject matter covered by our pending patent applications or that we were the first to file patent applications on such inventions. Assuming the other requirements for patentability are met, in the United States prior to March&#160;15, 2013, the first to make the claimed invention is entitled to the patent, while outside the United States, the first to file a patent application is entitled to the patent. After March&#160;15, 2013, under the Leahy-Smith America Invents Act (&#8220;AIA&#8221;), the United States moved to a first inventor to file system. In general, the AIA and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, the term of a patent is limited and, as a result, the patents protecting our products expire at various dates. As and when these different patents expire, our products could become subject to increased competition. As a consequence, we may not be able to recover our development costs.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An issued patent is presumed valid unless it is declared otherwise by a court of competent jurisdiction. However, the issuance of a patent is not conclusive as to its validity or enforceability and it is uncertain how much protection, if any, will be afforded by our patents. A third party may challenge the validity or enforceability of a patent after its issuance by various proceedings such as oppositions in foreign jurisdictions, or post grant proceedings, including, oppositions, re-examinations or other review in the United States. In some instances, we may seek re-examination or reissuance of our own patents. If we attempt to enforce our patents, they may be challenged in court where they could be held invalid, unenforceable, or have their breadth narrowed to an extent that would destroy their value.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also rely on unpatented technology, trade secrets, know-how and confidentiality agreements. We require our officers, employees, consultants and advisors to execute proprietary information and invention and assignment agreements upon commencement of their relationships with us. These agreements provide that all inventions developed by the individual on behalf of us must be assigned to us and that the individual will cooperate with us in connection with securing patent protection on the invention if we wish to pursue such protection. We also execute confidentiality agreements with outside collaborators. However, disputes may arise as to the ownership of proprietary rights to the extent that outside collaborators apply technological information to our projects that are developed independently by them or others, or apply our technology to outside projects, and there can be no assurance that any such disputes would be resolved in our favor. In addition, any of these parties may breach the agreements and disclose our confidential information or our competitors might learn of the information in some other way. Thus, there can be no assurance, however, that our inventions and assignment agreements and our confidentiality agreements will provide meaningful protection for our inventions, trade secrets, know-how or other proprietary information in the event of unauthorized use or disclosure of such information. If any trade secret, know-how or other technology not protected by a patent were to be disclosed to or independently developed by a competitor, our business, results of operations and financial condition could be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we become involved in lawsuits to protect or enforce our patents or the patents of our collaborators or licensors, we would be required to devote substantial time and resources to prosecute or defend such proceedings.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competitors may infringe our patents or the patents of our collaborators or licensors. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover its technology. A court may also decide to award us a royalty from an infringing party instead of issuing an injunction against the infringing activity. An adverse determination of any litigation or defense proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interference proceedings brought by the USPTO, may be necessary to determine the priority of inventions with respect to our pre-AIA patent applications or those of our collaborators or licensors. Additionally, the AIA has greatly expanded the options for post-grant review of patents that can be brought by third parties. In particular, Inter Partes Review (&#8220;IPR&#8221;), available against any issued United States patent (pre-and post-AIA), has resulted in a higher rate of claim invalidation, due in part to the much reduced opportunity to repair claims by amendment as compared to re-examination, as well as the lower standard of proof used at the USPTO as compared to the federal courts. With the passage of time an increasing number of patents related to successful pharmaceutical products are being subjected to IPR. Moreover, the filing of IPR petitions has been used by short-sellers as a tool to help drive down stock prices. We may not prevail in any litigation, post-grant review, or interference proceedings in which we are involved and, even if we are successful, these proceedings may result in substantial costs and be a distraction to our management. Further, we may not be able, alone or with our collaborators and licensors, to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect such rights as fully as in the United States.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation,<span style="color:#000000;"> there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, the market price of our common stock and other securities may decline.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If our technologies conflict with the proprietary rights of others, we may incur substantial costs as a result of litigation or other proceedings and we could face substantial monetary damages and be precluded from commercializing our products, which would materially harm our business and financial condition.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Biotechnology patents are numerous and may, at times, conflict with one another. As a result, it is not always clear to industry participants, including us, which patents cover the multitude of biotechnology product types. Ultimately, the courts must determine the scope of coverage afforded by a patent and the courts do not always arrive at uniform conclusions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A patent owner may claim that we are making, using, selling or offering for sale an invention covered by the owner&#8217;s patents and may go to court to stop us from engaging in such activities. Such litigation is not uncommon in our industry.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patent lawsuits can be expensive and would consume time and other resources. There is a risk that a court would decide that we are infringing a third party&#8217;s patents and would order us to stop the activities covered by the patents, including the commercialization of our products. In addition, there is a risk that we would have to pay the other party damages for having violated the other party&#8217;s patents (which damages may be increased, as well as attorneys&#8217; fees ordered paid, if infringement is found to be willful), or that we will be required to obtain a license from the other party in order to continue to commercialize the affected products, or to design our products in a manner that does not infringe a valid patent. We may not prevail in any legal action, and a required license under the patent may not be available on acceptable terms or at all, requiring cessation of activities that were found to infringe a valid patent. We also may not be able to develop a non-infringing product design on commercially reasonable terms, or at all.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Moreover, certain components of our products may be manufactured outside the United States and imported into the United States. As such, third parties could file complaints under 19 U.S.C. Section&#160;337(a)(1)(B) (a &#8220;337 action&#8221;) with the International Trade Commission (the &#8220;ITC&#8221;). A 337 action can be expensive and would consume time and other resources. There is a risk that the ITC would decide that we are infringing a third party&#8217;s patents and either enjoin us from importing the infringing products or parts thereof into the United States or set a bond in an amount that the ITC considers would offset our competitive advantage from the continued importation during the statutory review period. The bond could be up to 100% of the value of the patented products. We may not prevail in any legal action, and a required license under the patent may not be available on acceptable terms, or at all, resulting in a permanent injunction preventing any further importation of the infringing products or parts thereof into the United States. We also may not be able to develop a non-infringing product design on commercially reasonable terms, or at all.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although we <span style="color:#000000;">do not believe that</span> our products or product candidates<span style="color:#000000;"> infringe any third-party patents</span>, if a plaintiff was to allege infringement of their patent rights, we would have to establish with the court that their patents are invalid or unenforceable in order to avoid legal liability for infringement of these patents. However, proving patent invalidity or unenforceability can be difficult because issued patents are presumed valid. Therefore, in the event that we are unable to prevail in a non-infringement or invalidity action we will have to either acquire the third-party patents outright or seek a royalty-bearing license. Royalty-bearing licenses effectively increase production costs and therefore may materially affect product profitability. Furthermore, should the patent holder refuse to either assign or license us the infringed patents, it may be necessary to cease manufacturing the product entirely and/or design around the patents, if possible. In either event, our business, financial condition and results of operations would be harmed and our profitability could be materially and adversely impacted.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, during the course of this kind of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, the market price of our common stock and other securities may decline.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, patent litigation may divert the attention of key personnel and we may not have sufficient resources to bring these actions to a successful conclusion. At the same time, some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. An adverse determination in a judicial or administrative proceeding or failure to obtain necessary licenses could prevent us from manufacturing and selling our products or result in substantial monetary damages, which would adversely affect our business, financial condition and results of operations and cause the market price of our common stock and other securities to decline.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not obtain trademark registrations for our potential trade names.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not selected trade names for some of our product candidates in our pipeline&#59; therefore, we have not filed trademark registrations for such potential trade names for our product candidates, nor can we assure that we will be granted registration of any potential trade names for which we do file. No assurance can be given that any of our trademarks will be registered in the United States or elsewhere, or once registered that, prior to our being able to enter a particular market, they will not be cancelled for non-use. Nor can we give assurances, that the use of any of our trademarks will confer a competitive advantage in the marketplace.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furthermore, even if we are successful in our trademark registrations, the FDA has its own process for drug nomenclature and its own views concerning appropriate proprietary names. It also has the power, even after granting market approval, to request a company to reconsider the name for a product because of evidence of confusion in the marketplace. We cannot assure you that the FDA or any other regulatory authority will approve of any of our trademarks or will not request reconsideration of one of our trademarks at some time in the future.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RISKS RELATED TO OUR COMMON STOCK</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">We may not be able to generate sufficient cash to service all of our indebtedness and commitments. We may be forced to take other actions to satisfy our obligations or we may experience a financial failure.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to make scheduled payments on our lease and debt obligations will depend on our financial and operating performance, which is subject to the commercial success of our products, the extent to which we are able to successfully develop and commercialize our products, prevailing economic and competitive conditions, and to certain financial, business and other factors beyond our control. We cannot assure you that we will maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness. If our cash flows and capital resources are insufficient to fund our obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness and lease obligations. We cannot assure you that we would be able to take any of these actions, that these actions would be successful and permit us to meet our scheduled obligations or that these actions would be permitted under the terms of our future debt agreements. In the absence of sufficient operating results and resources, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt service and other obligations. We may not be able to consummate those dispositions or obtain sufficient proceeds from those dispositions to meet our debt service and other obligations when due.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our stock price is volatile.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The trading price of our common stock has been and is likely to continue to be volatile. The volatility of pharmaceutical and biotechnology stocks often does not relate to the operating performance of the companies represented by the stock. Our business and the market price of our common stock may be influenced by a large variety of factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability to obtain marketing approval for our products outside of the United States and to find collaboration partners for the commercialization of our products in foreign jurisdictions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">future estimates of product sales, royalties, prescriptions or other operating metrics&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability to successfully commercialize other products based on our Technosphere drug delivery platform&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the progress and results of preclinical and clinical studies of our product candidates and of post-approval studies of approved products that are required by the FDA&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">general economic, political or stock market conditions, especially for emerging growth and pharmaceutical market sectors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">geopolitical events, such as the current Russia-Ukraine conflict&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">legislative developments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">disruptions caused by man-made&#160;or natural disasters or public health pandemics or epidemics or other business interruptions&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">changes in the structure of the healthcare payment systems&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">announcements by us, our collaborators, or our competitors concerning clinical study results, acquisitions, strategic alliances, technological innovations, newly approved commercial products, product discontinuations, or other developments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the availability of critical materials used in developing and manufacturing our products and product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">developments or disputes concerning our relationship with any of our current or future collaborators or third party manufacturers&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">developments or disputes concerning our patents or proprietary rights&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the expense and time associated with, and the extent of our ultimate success in, securing regulatory approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">announcements by us concerning our financial condition or operating performance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">changes in securities analysts&#8217; estimates of our financial condition or operating performance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">sales of large blocks of our common stock, including sales by our executive officers, directors and significant stockholders&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the trades of short sellers&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">our ability, or the perception of investors of our ability, to continue to meet all applicable requirements for continued listing of our common stock on The Nasdaq Global Market, and the possible delisting of our common stock if we are unable to do so&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">the status of any legal proceedings or regulatory matters against or involving us or any of our executive officers and directors&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">discussion of our products, competitors&#8217; products, or our stock price by the financial and scientific press, the healthcare community and online investor communities such as chat rooms. In particular, it may be difficult to verify statements about us that appear on interactive websites that permit users to generate content anonymously or under a pseudonym. Statements attributed to company officials may, in fact, have originated elsewhere.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of these risks, as well as other factors, could cause the market value of our common stock and other securities to decline.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If we fail to continue to meet all applicable listing requirements, our common stock may be delisted from <span style="color:#000000;">the Nasdaq</span> Global Market, which could have an adverse impact on the liquidity and market price of our common stock.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock is currently listed on The <span style="color:#000000;">Nasdaq</span> Global Market, which has qualitative and quantitative listing criteria. If we are unable to meet any of the <span style="color:#000000;">Nasdaq</span> listing requirements in the future, such as the corporate governance requirements, the minimum closing bid price requirement, or the minimum market value of listed securities requirement, <span style="color:#000000;">Nasdaq</span> could determine to delist our common stock. A delisting of our common stock could adversely affect the market liquidity of our common stock, decrease the market price of our common stock, adversely affect our ability to obtain financing for the continuation of our operations and result in the loss of confidence in our company. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are incorporated in Delaware. Certain anti-takeover provisions under Delaware law and in our certificate of incorporation and amended and restated bylaws, as currently in effect, may make a change of control of our company more difficult, even if a change in control would be beneficial to our stockholders or the holders of our other securities. Our anti-takeover provisions include provisions such as a prohibition on stockholder actions by written consent, the authority of our board of directors to issue preferred stock without stockholder approval, and supermajority voting requirements for specified actions. In addition, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law, which generally prohibits stockholders owning 15% or more of our outstanding voting stock from merging or combining with us in certain circumstances. These provisions may delay or prevent an acquisition of us, even if the acquisition may be considered beneficial by some of our stockholders. In addition, they may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America are the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our amended and restated bylaws provide that, to the fullest extent permitted by law and subject to the court&#8217;s having personal jurisdiction over the indispensable parties named as defendants, the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any derivative action or proceeding brought on our behalf&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any action or proceeding asserting a breach of fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any action or proceeding asserting a claim against us or any of our current or former directors, officers or other employees arising out of or pursuant to any provision of the Delaware General Corporation Law, our amended and certificate of incorporation or amended and restated bylaws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="text-decoration:none;Background-color:#auto;font-size:10pt;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.83%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">any action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This provision does not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section 22 of the Securities Act of 1933, as amended, or the Securities Act, creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated bylaws further provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated bylaws. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive forum provision in our amended and restated bylaws to be<span style="font-family:Calibri;color:#000000;"> inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Because we do not expect to pay dividends in the foreseeable future, you must rely on stock appreciation for any return on any investment in our common stock.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have paid no cash dividends on any of our capital stock to date, and we currently intend to retain our future earnings, if any, to fund the development and growth of our business. As a result, we do not expect to pay any cash dividends in the foreseeable future, and payment of cash dividends, if any, will also depend on our financial condition, results of operations, capital requirements and other factors and will be at the discretion of our board of directors. In addition, pursuant to the MidCap credit facility, we are subject to contractual restrictions on the payment of dividends. There is no guarantee that our common stock will appreciate or maintain its current price. You could lose the entire value of any investment in our common stock.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Future sales of shares of our common stock in the public market, or the perception that such sales may occur, may depress our stock price and adversely impact the market price of our common stock and other securities. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may need to raise substantial additional capital in the future to fund our operations. If we raise additional funds by issuing equity securities or additional convertible debt, the market price of our common stock and other securities may decline. Similarly, if our existing stockholders sell substantial amounts of our common stock in the public market, the market price of our common stock and other securities could decrease . The perception in the public market that we or our existing stockholders might sell shares of common stock could also depress the market price of our common stock and the market price of our other securities. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Likewise, the issuance of additional shares of our common stock upon the exchange or conversion of the Mann Group promissory notes, or the Senior convertible notes, could adversely affect the market price of our common stock and other securities. Moreover, the existence of these notes may encourage short selling of our common stock by market participants, which could adversely affect the market price of our common stock and other securities.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, a substantial number of shares of our common stock is reserved for issuance upon the exercise of stock options, the vesting of restricted stock unit awards<span style="color:#000000;"> and</span> purchases under our employee stock purchase program. The issuance or sale of substantial amounts of common stock, or the perception that such issuances or sales may occur, could adversely affect the market price of our common stock and other securities.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">If other biotechnology and biopharmaceutical companies or the securities markets in general encounter problems, the market price of our common stock and other securities could be adversely affected.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Public companies in general, including companies listed on The Nasdaq Stock Market, have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. There has been particular volatility in the market prices of securities of biotechnology and other life sciences companies, and the market prices of these companies have often fluctuated because of problems or successes in a given market segment or because investor interest has shifted to other segments. These broad market and industry factors may cause the market price of our common stock and other securities to decline, regardless of our operating performance. We have no control over this volatility and can only focus our efforts on our own operations, and even these may be affected due to the state of the capital markets. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the past, following periods of large price declines in the public market price of a company&#8217;s securities, securities class action litigation has often been initiated against that company. Litigation of this type could result in substantial costs and diversion of management&#8217;s attention and resources, which would hurt our business. Any adverse determination in litigation could also subject us to significant liabilities.</span><span style="font-weight:bold;font-style:italic;color:#006EBF;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">GENERAL RISK FACTORS</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Unstable market, economic and geopolitical conditions may have serious adverse consequences on our business, financial condition and stock price.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The global credit and financial markets have experienced extreme volatility and disruptions in the past. These disruptions can result in severely diminished liquidity and credit availability, increase in inflation, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment, higher inflation, or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Our portfolio of corporate and government bonds could also be adversely impacted. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our operations, growth strategy, financial performance and stock price and could require us to delay or abandon clinical development plans. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive an economic downturn or rising inflation, which could directly affect our ability to attain our operating goals on schedule and on budget.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other international and geopolitical events could also have a serious adverse impact on our business. For instance, in February 2022, Russia initiated military action against Ukraine. In response, the United States and certain other countries imposed significant sanctions and trade actions against Russia and could impose further sanctions, trade restrictions, and other retaliatory actions. While we cannot predict the broader consequences, the conflict and retaliatory and counter-retaliatory actions could materially adversely affect global trade, currency exchange rates, inflation, regional economies, and the global economy, which in turn may increase our costs, disrupt our supply chain, impair our ability to raise or access additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">Item&#160;1B.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Unresolved Staff Comments</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_2_PROPERTIES">Item&#160;2.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Properties</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2001, we acquired a facility in Danbury, Connecticut that included two buildings comprised of approximately 190,000 square feet on 17.5 acres. In September 2008, we completed the construction of approximately 140,000 square feet of new manufacturing space providing us with two buildings totaling approximately 328,000 square feet, housing our research and development, manufacturing and certain administrative functions. The Danbury facility contains our principal executive offices. We believe the Danbury facility has sufficient space, including unimproved manufacturing space, to satisfy anticipated commercial demand for Afrezza and Tyvaso DPI. Our obligations under the MidCap Credit Facility are secured by a portion of the facility in Danbury and other assets. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 8, 2021, we sold a portion of the Danbury facility to an affiliate of Creative Manufacturing Properties (the &#8220;Purchaser&#8221;) for a sales price of $102.3 million and entered into a 20-year lease agreement with the Purchaser, with four renewal options of five years each. See Note 7 &#8211; Property and Equipment and Note 16 &#8211; Commitments and Contingencies in the consolidated financial statements included in Part II, Item 8 &#8211; Financial Statements and Supplementary Data.&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<span style="font-size:10pt;">As of December 31, 2022, we leased a total of approximately 24,475 square feet of office space in Westlake Village, California pursuant to a lease that expires in July 2028. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we assumed certain leased real property (the &#8220;Marlborough Lease&#8221;) pursuant to the Asset Purchase Agreement entered into in May 2022 with Zealand Pharma A/S and Zealand Pharma US, Inc. The Marlborough Lease pertains to certain premises in a building located in Marlborough, Massachusetts. As of December 31, 2022, we leased a total of approximately 20,000 square feet of building space pursuant to a lease that expires in February 28, 2026. See <span style="font-family:Calibri;">Note 16 &#8211; Commitments and Contingencies in the consolidated financial statements included in Part II, Item 8 &#8211; Financial Statements and Supplementary Data. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_3_LEGAL_PROCEEDINGS_UPDATE_">Item&#160;3.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Legal Proceedings</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 16 &#8211; Commitments and Contingencies in the consolidated financial statements included in Part II, Item 8 &#8211; Financial Statements and Supplementary Data.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Item&#160;4.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Mine Safety Disclosures</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART II</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">Item&#160;5.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Market</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock has been traded on The Nasdaq Global Market under the symbol &#8220;MNKD&#8221; since July&#160;28, 2004. The closing sales price of our common stock on The Nasdaq Global Market was $5.16 on February 10, 2023 and there were 104 registered holders of record of our common stock as of that date.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Performance Graph</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:3.91%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">This performance graph shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or incorporated by reference into any of our filings under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:7.81%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:3.91%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following graph illustrates a comparison of the cumulative total stockholder return (change in stock price plus reinvested dividends) of our common stock with (i) The Nasdaq Composite Index and (ii) The Nasdaq Biotechnology Index. The graph assumes a $100 investment, on December 31, 2017, in (i) our common stock, (ii) the securities comprising The Nasdaq Composite Index and (iii) the securities comprising The Nasdaq Biotechnology Index.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.91%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g1ow311dygir000001.jpg" title="" alt="" style="width:712px;height:444px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.91%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Dividend Policy</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business. Accordingly, we do not anticipate paying any cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors. In addition, under the terms of the MidCap Credit Facility, we are restricted from declaring and distributing a cash dividend to our stockholders.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Sales of Unregistered Securities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Mann Group convertible note, we pay quarterly interest payments on the first day of each calendar quarter, which we may pay at our election in shares of our common stock. During the year ended December 31, 2022, we elected to pay our April 1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>, July 1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup> and October 1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup>, quarterly interest payments under the Mann Group convertible note by issuing the Mann Group an aggregate of 75,487 shares of common stock. See Note 10 &#8211; <span style="font-style:italic;">Borrowings</span>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We r</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">elied on an exemption from registration provided by Section 3(a)(9)</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or 4(a)(2)</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Securities Act of 1933, as amended, for the issuance of the shares described above.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_6_RESERVED">Item&#160;6.<span style="font-weight:normal;"> </span>[Reserved]<span style="font-style:italic;"> </span><span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Item&#160;7.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and notes thereto included in this Annual Report on Form 10-K. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A discussion of changes in our results of operations during the year ended December 31, 2021 compared to the year ended December 31, 2020 has been omitted from this Annual Report on Form 10-K but may be found in &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022, which discussion is incorporated herein by reference and which is available free of charge on the SEC&#8217;s website at www.sec.gov.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Our signature technologies&#8212;Technosphere dry-powder formulations and Dreamboat inhalation devices&#8212;offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. In our endocrine business unit, we  currently commercialize two products:  Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The first product to come out of our orphan lung disease pipeline, Tyvaso DPI (treprostinil) inhalation powder, received FDA approval in May 2022 for the treatment of PAH and PH-ILD. Our development and marketing partner, United Therapeutics, began commercializing Tyvaso DPI in June 2022 and is obligated to pay us a royalty on net sales of the product. We also receive a margin on supplies of Tyvaso DPI that we manufacture for UT.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business is subject to significant risks, including but not limited to our ability to manufacture sufficient quantities of our products and Tyvaso DPI. Other significant risks also include the risk that our products may only achieve a limited degree of commercial success and the risks inherent in drug development, clinical trials and the regulatory approval process for our product candidates, which in some cases depends upon the efforts of our partners.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, we had an accumulated deficit of $3.2 billion and a stockholders&#8217; deficit of $250.5&#160;million. We had net loss of $87.4&#160;million, $80.9 million and $57.2 million in the years ended December&#160;31, 2022, 2021 and 2020, respectively. To date, we have funded our operations primarily through the sale of our equity and convertible debt securities, from the receipt of upfront and milestone payments from collaborations, from borrowings, from sales of Afrezza and V-Go, from royalties and manufacturing revenue from UT as well as from proceeds of the sale-leaseback of our manufacturing facility in Danbury, CT.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies and Estimates </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our consolidated financial statements is in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The preparation of our consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and related disclosure of contingent assets and liabilities. We consider an accounting estimate to be critical to the consolidated financial statements if (i)&#160;the estimate is complex in nature or requires a high degree of judgment and (ii)&#160;different estimates and assumptions were used, the results could have a material impact on the consolidated financial statements. On an ongoing basis, we evaluate our estimates and the application of our policies. We base our estimates on historical experience, current conditions and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consider our critical accounting policies to be those related to revenue recognition and gross-to-net adjustments, inventory costing and recoverability, recognized loss on purchase commitments, impairment of long-lived assets, milestone rights liability, clinical trial expenses, stock-based compensation and accounting for income taxes. These critical accounting policies are also considered significant accounting policies and are more fully described in Note 2 &#8211; Summary of Significant Accounting Policies of the Notes to Consolidated Financial Statements included in Part II, Item 8 &#8212; Financial Statements and Supplementary Data.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition &#8211; Net Revenue &#8211; Commercial Product Sales <span style="color:#000000;font-weight:normal;font-style:normal;">&#8212; We </span><span style="font-weight:normal;font-style:normal;">sell products to a limited number of wholesale distributors and specialty and retail pharmacies, and durable medical suppliers (&#8220;DME&#8221;) in the U.S. (collectively, &#8220;Customers&#8221;). Wholesale distributors subsequently resell our products to retail pharmacies and certain medical centers or hospitals. Specialty pharmacies sell directly to patients. In addition to distribution agreements with Customers, we enter into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of our products.</span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize revenue on product sales when the Customer obtains control of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">product, which occurs at delivery for wholesale distributors and generally at delivery for </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">specialty pharmacies. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize revenue on product sales to </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">retail pharmac</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the product is dispensed to </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patient</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenues are recorded net of applicable reserves </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</span><span style="color:#000000;">nclud</span><span style="color:#000000;">ing</span><span style="color:#000000;"> discounts</span><span style="color:#000000;">, allowances, rebates, returns and other incentives. See </span><span style="font-style:italic;color:#000000;">Reserves for Variable Consideration </span><span style="color:#000000;">below.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reserves for Variable Consideration <span style="font-style:normal;">&#8212; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between us and our Customers, payers, and other indirect customers relating to the sale of our products. These reserves are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in Accounting Standards Codification (&#8220;<span style="color:#000000;">ASC&#8221;) </span>Topic 606, <span style="font-style:italic;font-family:Calibri;color:#000000;">Revenue from Contracts with Customers</span> (&#8220;ASC 606&#8221;) for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to our best estimates of the amount of consideration to which we are entitled based on the terms of the respective underlying contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. Our analysis also contemplates application of the constraint in accordance with the guidance, under which we determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from our estimates, we will adjust these estimates, which would affect net revenue <span style="font-family:Calibri;">&#8212;</span> commercial product sales and earnings in the period such variances become known.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix unbilled claims, claim submission time lags and inventory levels in the distribution channel.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our reserves for variable consideration are reflected in our gross-to-net adjustments which were 42% of gross revenue, or $40.8 million, for the year ended December 31, 2022, compared to 39% of gross revenue, or $24.9 million, for the year ended December 31, 2021. <span style="color:#000000;">If there is a 10% difference between the estimates for accruals and the actual liability in the reserves for variable consideration, the impact to our revenue for commercial product sales would be $2.0 million or a 4.1% change in the gross-to-net adjustment percentage for the year ended December 31, 2022. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These reserves are further detailed<span style="color:#000000;"> under Reserves for Variable Consideration in Note 2 &#8211; </span><span style="font-style:italic;color:#000000;">Summary of Significant Accounting Policies</span><span style="color:#000000;"> of the Notes to Consolidated Financial Statements included in Part II, Item 8 &#8212; Financial Statements and Supplementary Data.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition &#8211; Collaborations and Services<span style="font-weight:normal;font-style:normal;"> &#8212; We</span><span style="font-weight:normal;font-style:normal;color:#000000;"> enter into licensing, research or other agreements under which we license certain rights to our product candidates to third parties, conduct research or provide other services to third parties. </span><span style="font-weight:normal;font-style:normal;">The terms of these arrangements may include</span><span style="font-weight:normal;font-style:normal;color:#000000;"> but are not limited to</span><span style="font-weight:normal;font-style:normal;"> payment to us of one or more of the following: up-front license fees&#59; development, regulatory, and commercial milestone payments&#59; payments for </span><span style="font-weight:normal;font-style:normal;color:#000000;">commercial manufacturing and clinical </span><span style="font-weight:normal;font-style:normal;">supply services we provide&#59; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, we must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. With respect to our significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (as amended, the &#8220;CSA&#8221;), we have identified three distinct performance obligations:</span><span style="font-weight:normal;font-style:normal;color:#000000;"> (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&#38;D Services and License&#8221;)&#59; (2) development activities for the next generation of the product (&#8220;Next-Gen R&#38;D Services&#8221;)&#59; and (3) a material right associated with current and future commercial manufacturing and supply of product (&#8220;Manufacturing Services&#8221;).</span><span style="font-weight:normal;font-style:normal;"> Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#8217;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represent distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. </span><span style="font-weight:normal;font-style:normal;color:#000000;">See Note 11 &#8211; </span><span style="font-weight:normal;color:#000000;">Collaboration, Licensing and Other Arrangements</span><span style="font-weight:normal;font-style:normal;color:#000000;"> of the Notes to Consolidated Financial Statements included in Part II, Item 8 &#8212; Financial Statements and Supplementary Data. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and we use key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. <span style="color:#000000;">Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration</span> received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12 months. Amounts that we expect will not be recognized within the next 12 months are classified as long-term deferred revenue. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If there is a 10% difference in the estimates used to determine the transaction price</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the CSA entered into in </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 202</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with UT,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the related allocation of the transaction price between performance obligations, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">difference between the estimates for accruals and the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">actual liability </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for deferred revenue and revenue recognized for collaborations and services </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">would be $0.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the year ended December 31, 202</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-Based Compensation<span style="font-weight:normal;font-style:normal;"> &#8212; Share-based payments to employees, including grants of restricted stock units, performance-based awards, restricted stock units with market conditions (&#8220;Market RSUs&#8221;), nonqualified stock options (&#8220;options&#8221;) and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. Restricted stock units are valued based on the market price on the grant date. We evaluate stock awards with performance conditions as to the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The grant date fair value and the effect of the market conditions for the Market RSUs was estimated using a Monte Carlo valuation. We use the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The grant date fair value for the Market RSUs was $6.10 per unit for the Market RSUs granted during the year ended December 31, 2022, compared to $9.30 and $3.77 per unit for the Market RSUs granted during the years ended December 31, 2021 and 2020, respectively.<span style="color:#000000;"> If there is a 10% difference in the grant date fair value of the Market RSUs, the impact to our stock-based compensation expense would be $0.6 million for the year ended December 31, 2022. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Results of Operations</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Trends and Uncertainties</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We continue to maintain an elevated level of safety stock of certain raw materials due to concerns that supply chain interruptions may interfere with the manufacture of Afrezza, V-Go and Tyvaso DPI.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing risks may adversely affect our ability to manufacture our products and could reduce our gross margin.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future success is dependent on our, and our current and future collaboration partners&#8217;, ability to effectively commercialize our approved products. Our future success is also dependent on our pipeline of new products. There is a high rate of failure inherent in the research and development process for new drugs. As a result, there is a high risk that the funds we invest in research programs will not generate sufficient financial returns. Products may appear promising in development but fail to reach market within the expected or optimal timeframe, or at all.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Years ended December&#160;31, 2022 and 2021</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenues</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a comparison of the revenue categories for the years ended December&#160;31, 2022 and 2021 (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$ Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue &#8212; commercial product sales:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross revenue from product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,048</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,025</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wholesaler distribution fees, rebates and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; chargebacks, product returns and other</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; discounts</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40,801</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,855</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,946</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue &#8212; commercial product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,247</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,168</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,079</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross-to-net revenue adjustment percentage</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,924</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,274</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,350</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties &#8212; collaborations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,770</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,442</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,328</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Not meaningful</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Afrezza<span style="font-style:normal;"> &#8212; Gross revenue from sales of Afrezza increased by $7.1 million, or 11%, for the year ended December 31, 2022 compared to the prior year. The increase reflects a combination of higher price (including a more favorable gross-to-net adjustment), higher product demand and a favorable cartridge mix. The gross-to-net adjustment was 39% of gross revenue, or $27.8 million, for the year ended December 31, 2022, compared to 39% of gross revenue or $24.9 million, for the prior year. The gross-to-net percentage remained consistent over the prior year and was primarily impacted by an increase in anticipated product returns, offset by a decrease in co-pay assistance and wholesaler distribution fees (as a percentage of gross sales) due to an increased mix of specialty and retail pharmacy sales.&#160;As a result, net revenue from sales of Afrezza increased by $4.1 million, or 11%, for the year ended December 31, 2022 compared to the prior year. </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">V-Go</span><span style="font-style:normal;"> &#8212; The acquisition of V-Go on May 31, 2022 resulted in an increase in gross revenue from commercial product sales of $25.9 million and net revenue of $12.9 million for the year ended December 31, 2022. The gross-to-net adjustment of 50.2% of gross revenue was mainly attributable to commercial and government rebates and product distribution fees.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Collaborations and Services<span style="font-style:normal;"> &#8212;</span> <span style="font-style:normal;">Net revenue from collaborations and services decreased by $8.4 million, or 23%, for the year ended December 31, 2022 compared to the prior year. The decrease in collaborations and services revenue was primarily attributable to the completion of the R&#38;D Services performance obligation associated with our collaboration with UT during 2021. In August 2021, we entered into a commercial supply agreement with UT (the &#8220;CSA&#8221;). Revenue associated with the CSA was deferred until we began manufacturing and subsequently selling Tyvaso DPI in the second quarter of 2022. During the year ended December 31, 2022, we recognized $24.8 million of revenue under the CSA. We also recognized royalty revenue from our collaboration with UT of $15.6 million during the year ended December 31, 2022.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">See Note 11 &#8211; Collaboration, Licensing and Other Arrangements <span style="font-style:normal;">in the consolidated financial statements included in Part II, Item 8 &#8211; Financial Statements and Supplementary Data. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Commercial product gross profit</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a comparison of the commercial product gross profit categories for the years ended December&#160;31, 2022 and 2021 (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.4%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$ Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial product gross profit:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue &#8212; commercial product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,247</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,168</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,079</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cost of goods sold</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,003</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,833</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.36%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(830</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.36%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial product gross profit:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,244</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,335</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.36%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,909</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.36%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross margin</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.7%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Afrezza &#8212; Commercial product gross profit for Afrezza increased by $12.3 million, or 55%, for the year ended December 31, 2022, compared to the prior year. Gross margin for the year ended December 31 2022 increased to 80% compared to 57% for the prior year. The increase in gross profit and gross margin was attributable to an increase in Afrezza sales as well as a decrease in cost of goods sold. Cost of goods sold decreased by $8.2 million, or 48%, for the year ended December 31, 2022 compared to the prior year. The decrease in cost of goods sold was primarily attributable to a $4.1 million decrease in excess capacity costs as Tyvaso DPI began commercial production a $1.6 million decrease in inventory write-offs in the current year and a $2.0 million fee incurred for the amendment of the Insulin Supply Agreement with Amphastar in the prior year.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go &#8212; The acquisition of V-Go on May 31, 2022 resulted in an increase in commercial product gross profit of $5.6 million with a gross margin of 43% for the year ended December 31, 2022. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Expenses</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a comparison of the expense categories for the years ended December&#160;31, 2022 and 2021 (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$ Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Cost of goods sold</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,003</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,833</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(830</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Cost of revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,494</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,024</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,470</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,721</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,312</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,409</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Selling</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,753</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,528</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,225</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> General and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,720</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,889</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,831</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Asset impairment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Gain on foreign currency translation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,811</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,567</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,756</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Loss on purchase commitments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(339</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163,880</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,464</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,416</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue &#8212; collaborations and services increased by $19.5 million, or 88%, for the year ended December 31, 2022 compared to the prior year. The increase was attributable to an increase in manufacturing activities for Tyvaso DPI product.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses increased by $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.4</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, or </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%, for the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ended </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2022 compared to the prior year. The increase was primarily attributable </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> development activities </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our product pipeline, </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">increased headcount </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pipeline development activities </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the Afrezza pediatrics clinical study (INHALE-1).</span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling expenses increased by $8.2 million, or 18%, for the year ended December 31, 2022, compared to the prior year. The increase was primarily attributable to a pilot promotional effort aimed at primary care physicians that began in the fourth quarter of 2021 and ended in the third quarter of 2022, elimination of a co-promotion for third party product (which permitted some expenses associated with the sales force to be recognized as cost of revenue &#8212; collaborations and services in the same period of 2021), V-Go promotional efforts after the acquisition in the second quarter of 2022, partially offset by the net favorable impact of personnel-related costs due to Afrezza sales force restructuring.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses increased by $5.8 million, or 18%, for the year ended December 31, 2022, compared to the prior year. This increase was primarily attributable to higher stock-based compensation, increased headcount, and higher professional and consulting fees.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on foreign currency translation was $4.8 million for the year ended December 31, 2022 compared to $6.6 million for the prior year. Under the Insulin Supply Agreement with Amphastar, payment obligations are denominated in Euros. We are required to record the foreign currency translation impact of the U.S. dollar to Euro exchange rate associated with the recognized loss on purchase commitments. The decrease in year-over-year gain was due to the translation of Euro to U.S. dollar exchange rates.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Income (Expense)</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a comparison of the other income (expense) categories for the years ended December&#160;31, 2022 and 2021 (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$ Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">% Change</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,513</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,401</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,758</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,373</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,385</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,011</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,204</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(193</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(932</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(932</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on extinguishment of debt</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,200</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,200</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(239</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(137</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,290</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(33,904</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,614</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%)</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Not meaningful</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income, consisting of interest on investments net of amortization, increased by $2.4 million compared to the prior year primarily due to higher yields on our marketable securities and money market funds.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability was $9.8 million for the year ended December 31, 2022 and represented interest incurred on the sale lease-back transaction for our manufacturing facility in Danbury, CT which was entered into in the fourth quarter of 2021.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on notes for the year ended December 31, 2022 was comparable to the prior year. See Note 10 &#8212; <span style="font-style:italic;">Borrowings</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on available-for-sale securities for the year ended December 31, 2022 was $0.9 million as a result of the change in the fair value of the investment that related to credit risk.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on extinguishment of debt of $17.2 million for the year ended December 31, 2021 consisted of a $22.1 million loss on extinguishment of debt for the amendment to the Mann Group convertible note, which did not result in a change in our financial position, partially offset by a $4.9 million gain on extinguishment of debt as a result of the U.S. Small Business Administration&#8217;s (&#8220;SBA&#8221;) forgiveness of the Paycheck Protection Program loan (the &#8220;PPP loan&#8221;). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense or income for the years ended December 31, 2022 and 2021 consisted primarily of the loss associated with a foreign currency hedging transaction which was entered into to mitigate our exposure to foreign currency exchange risks associated with our insulin purchase obligation under the Insulin Supply Agreement with Amphastar. </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our principal sources of liquidity are our cash, cash equivalents, and investments. Our primary uses of cash include the development of our product pipeline, the manufacturing and marketing of Afrezza and V-Go, manufacturing Tyvaso DPI, the funding of general and administrative expenses, and interest expense on our financing liability and debt.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have funded our operations </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">primarily </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">through the sale of equity and convertible debt securities, from the receipt of upfront and milestone payments from collaborations, from borrowings, from sales of Afrezza and V-Go, </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">royalties and manufacturing revenue from UT as well as </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">proceeds from the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ale-</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">l</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">easeback transaction. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.38%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe we will be able to meet our liquidity needs over the next twelve months, as well as longer-term needs, based on the balance of cash, cash equivalents and investments on hand, projected sales of Afrezza and V-Go, and projected royalties and manufacturing revenue from the production and sale of Tyvaso DPI. The following table presents our material cash requirements as of December 31, 2022 associated with contractual commitments for future periods (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2024 - 2025</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2026 - 2027</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,750</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,500</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">232,875</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,125</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,896</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,541</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,437</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,233</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,233</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,774</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,287</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,382</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188,453</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,896</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Insulin purchase agreement <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,390</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,243</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,674</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,307</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total material cash requirements</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,810</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,804</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284,931</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188,453</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">616,998</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">$230.0 million aggregate principal amount of Senior convertible notes bearing interest at 2.50% payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2021 and maturing on March 1, 2026, unless earlier converted, redeemed or repurchased. The Senior convertible notes are convertible at an initial conversion price of approximately $5.21 per share of common stock. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the Indenture.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">$40.0 million principal amount under the MidCap credit facility, bearing interest at an annual rate equal to one-month SOFR plus 6.25% (cap of 8.25%), subject to a one-month SOFR floor of 1.00%, payable in equal monthly installments beginning in September 2023 through maturity in August 2025.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">$8.8 million principal amount of indebtedness under the Mann Group convertible note bearing interest at a fixed rate of 2.50% per annum compounded quarterly and maturing in December 2025, which is convertible into shares of our common stock at the option of Mann Group at a conversion price of $2.50 per share. Interest was paid-in-kind from August 2019 until the end of 2020, after which we have the option to pay interest in-kind or in shares.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">On November 8, 2021, we sold a portion of our manufacturing facility located in Danbury, CT to an affiliate of Creative Manufacturing Properties (the &#8220;Purchaser&#8221;) for a sales price of $102.3 million. We leased the property from the Purchaser for an initial term of 20 years, with four renewal options of five years each. The total annual rent under the lease started at approximately $9.5 million per year, subject to a 50% rent abatement during the first year of the lease, and increases annually by (i) 2.5% in the second through fifth year of the lease and (ii) 3% in the sixth and each subsequent year of the lease, including any renewal term. We are responsible for payment of operating expenses, property taxes and insurance for the leased property. Pursuant to the terms of the lease, we have four options to repurchase the property, in 2026, 2031, 2036 and 2041, for the greater of (i) $102.3 million or (ii) the fair market value of the leased property. Interest expense is calculated using an incremental borrowing rate of 9%.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The July 2014 Insulin Supply Agreement with Amphastar to manufacture and supply us certain quantities of recombinant human insulin for use in Afrezza was amended in May 2021 and expires on December&#160;31, 2027. Unless terminated earlier, the agreement can be renewed for additional, successive two-year terms upon 12 months&#8217; written notice given prior to the end of the initial term or any additional two-year term.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have been able to timely make our required interest payments, but we cannot guarantee that we will be able to do so in the future. If we fail to repurchase the Mann Group promissory notes, we will be in default under the applicable instrument for such indebtedness, and may also suffer an event of default under the terms of other borrowing arrangements that we may enter into from time to time. Any of these events could have a material adverse effect on our business, results of operations and financial condition, up to and including the noteholders initiating bankruptcy proceedings or causing us to cease operations altogether. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July&#160;2013, in connection with our entry into a loan agreement (which has since been repaid) with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. we issued certain milestone rights (the &#8220;Milestone Rights&#8221;) to Deerfield Private Design Fund II, L.P. and Horizon Sant&#233; FLML S&#192;RL (the &#8220;Original Milestone Purchasers&#8221;). The Milestone Rights provided the Original Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable to Barings upon achievement of such milestones. See Note 16&#8211; <span style="font-style:italic;">Commitments and Contingencies</span> and Note 10 &#8211; <span style="font-style:italic;">Borrowings</span> for further information related to the Milestone Rights. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the above, we also expect to have material cash requirements relating to paying our employees and consultants, professional services fees, marketing expenses, manufacturing expenditures, and clinical trial expenses. In addition, <span style="Background-color:#FFFFFF;color:#000000;">we make substantial and often long-term investments in our supply chain in order to ensure we have enough inventory and drug product to meet current and future revenue forecasts, as well as clinical trial needs.</span>&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2018, we entered into a controlled equity offering sales agreement (the &#8220;CF Sales Agreement&#8221;) with Cantor Fitzgerald &#38; Co. (&#8220;Cantor Fitzgerald&#8221;), as sales agent, pursuant to which we may offer and sell, from time to time, through Cantor Fitzgerald, shares of our common stock. Under the Sales Agreement, Cantor Fitzgerald may sell shares by any method deemed to be an <span style="color:#000000;">&#8220;</span>at-the-market offering<span style="color:#000000;">&#8221;</span> as defined in Rule 415 under the Securities Act of 1933, as amended. In February 2022, we filed a sales agreement prospectus under a registration statement on Form S-3 (File No. 333-262981) covering the sale of up to $50.0 million of our common stock through Cantor Fitzgerald under the CF Sales Agreement. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ended </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2022, we used $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80.7</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of cash for our operating activities, which primarily consisted of $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75.1</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of selling, general and administrative expenses, $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.5</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of cost of goods sold, $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.8</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of costs for research and development</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.9</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of cash paid for interest</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on notes and $9.6 million of cash paid for interest on the financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, partially offset by $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108.3</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of revenue.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, we<span style="Background-color:#FFFFFF;color:#000000;"> used $61.7 million of cash for our operating activities, which primarily consisted of $65.8 million of selling, general and administrative expenses, $35.5 million of cost of goods sold and cost of revenue, $11.7 million of costs for research and development and $6.5 million of cash paid for interest, partially offset by $47.6 million of revenue.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided from investing activities of $4.9 million for the year ended December 31, 2022 was primarily due to the maturity of $107.3 million of debt securities, partially offset by the up-front consideration of $15.3 million for certain assets and assumed liabilities related to V-Go, $5.0 million purchase of available-for-sale securities, the purchase of $74.5 million of debt securities and $7.6 million purchase of property and equipment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash used in investing activities of $151.5 million for the year ended December 31, 2021 was primarily due to the purchase of debt securities of $196.1 million, partially offset by proceeds received from sales of debt securities of $59.1 million.<span style="Background-color:#FFFFFF;"> </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash provided by financing activities of $21.4 million for the year ended December 31, 2022 was primarily due to net proceeds from at-the-market offering of $19.8 million, partially offset by the milestone payment of $1.1 million.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Cash provided by financing activities of $270.3 million for the year ended December 31, 2021 was primarily due to net proceeds from the offering of Senior convertible notes of $222.7 million and net proceeds from the sale-leaseback transaction of $99.1 million, partially offset by the repayment of $35.1 million of Mann Group non-convertible notes and related unpaid accrued interest and the repayment of $10.0 million of principal and $1.0 million prepayment penalty for the MidCap credit facility.</span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Future Liquidity Needs</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We are not currently profitable and have rarely generated positive net cash flow from operations. In addition, we expect to continue to incur expenditures for the foreseeable future in support of our manufacturing operations, sales and marketing costs for our products and development costs for other product candidates in our pipeline.</span><span style="color:#000000;"> We believe we will be able to meet our liquidity needs based on our cash, cash equivalents and investments on hand, sales of Afrezza and V-Go, royalties and manufacturing revenue from the production and sale of Tyvaso DPI. As of December 31, 2022, we had capital resources of $69.8 million in cash and cash equivalents, $101.0 </span>million in short-term investments and $2.0 million in long-term investments, and total principal amount of outstanding borrowings of $278.8 million.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">We believe our resources will be sufficient to fund our operations for the next twelve months from the date of issuance of our consolidated financial statements included in Item 8 &#8211; Financial Statements. </span></p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 2 &#8212; <span style="font-style:italic;">Summary of Significant Accounting Policies</span> of the Notes to Consolidated Financial Statements included in Part II, Item 8 &#8212; Financial Statements and Supplementary Data for information regarding accounting standards we adopted in 2022 and other new accounting standards that have been issued by the FASB but are not effective until after December&#160;31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">Item&#160;7A.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Quantitative and Qualitative Disclosures about Market Risk</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Interest Rate Risk</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on borrowings under the MidCap credit facility accrues interest at an annual rate equal to the lesser of (i) 8.25% and (ii) the one-month SOFR (subject to a one-month SOFR floor of 1.00%) plus 6.25%. Accordingly, our interest expense under the MidCap credit facility is subject to changes in the one-month SOFR rate. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other debt has fixed interest rates, so the interest expense associated with such debt is not exposed to changes in market interest rates. Specifically, the interest rate on amounts borrowed under the Mann Group promissory notes is fixed at 2.50% and the interest rate under the Senior convertible notes is fixed at 2.50%. See Note 10 &#8211; <span style="font-style:italic;">Borrowings</span> for information about the principal amount of outstanding debt.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a hypothetical 10% change in the one-month SOFR interest rates on December 31, 2022 were to have occurred, this change would not have had a material effect on our annual interest payment obligation.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Exchange Risk</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In<span style="color:#000000;"> July 2022 and October 2022, we entered into two separate 90-day foreign currency hedging transactions to mitigate our exposure to foreign currency exchange risks associated with our insulin purchase obligation under the Insulin Supply Agreement. The hedging transaction hedges against short-term currency fluctuations for the remaining current year purchase obligation under the Insulin Supply Agreement for a total of &#8364;4.0 million. We realized a $0.1 million loss during the year ended December 31, 2022. This amount is recorded in other income and expense.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We incur and will continue to incur significant expenditures for insulin supply obligations under our Insulin Supply Agreement with Amphastar. Such obligations are denominated in Euros. At the end of each reporting period, the recognized gain or loss on purchase commitment is converted to U.S. dollars at the then-applicable foreign exchange rate. As a result, our business is affected by fluctuations in exchange rates between the U.S. dollar and the Euro. For the year ended December 31, 2022, we realized a $4.8 million currency gain, which was included in (gain) loss on foreign currency translation in the accompanying consolidated statements of operations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exchange rate fluctuations may adversely affect our expenses, results of operations, financial position and cash flows. If a change in the U.S. dollar to Euro exchange rate equal to 10% of the U.S. dollar to Euro exchange rate on December 31, 2022 were to have occurred, this change would have resulted in a foreign currency impact to our pre-tax loss of approximately $7.2 million.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_8_FINANCIAL_STATEMENTS_SUPPLEMENTAR">Item&#160;8.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Financial Statements and Supplementary Data</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item is included in Items 15(a) (1) and (2)&#160;of Part IV of this Annual Report on Form 10-K.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">Item&#160;9.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9A_CONTROLS_PROCEDURES">Item&#160;9A.<span style="font-weight:normal;"> </span><span style="font-style:italic;">&#160;Controls and Procedures</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Evaluation of Disclosure Controls and Procedures</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. <span style="color:#000000;">In designing and evaluating our disclosure controls and procedures, we and our management recognize that there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their desired control objectives. Additionally, in evaluating and implementing possible controls and procedures, our management was required to apply its reasonable judgment.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As required by Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), we carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures were effective as of December&#160;31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Management&#8217;s Report on Internal Control over Financial Reporting</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule&#160;13a-15(f) under the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may not operate effectively because of changes in conditions such as replacing consulting resources with permanent personnel or that the degree of compliance with the policies or procedures may deteriorate. Our management assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2022. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in the Internal Control-Integrated Framework (2013 Framework).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on this assessment, our management concluded that, as of December&#160;31, 2022, our internal control over financial reporting was effective based on those criteria.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The effectiveness of our internal control over financial reporting has been audited by Deloitte &#38; Touche LLP, an independent registered public accounting firm, as stated in their attestation report herein, which expresses an unqualified opinion on the effectiveness of our internal control over financial reporting as of December 31, 2022.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Changes in Internal Control over Financial Reporting</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any changes in our internal control over financial reporting that occurred during our last fiscal quarter and that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.&#160;That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter and that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><span style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Regist</span><span style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ered Public Accounting Firm</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Board of Directors and Stockholders of MannKind Corporation</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Opinion on Internal Control over Financial Reporting<span style="font-weight:normal;"> </span></p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the internal control over financial reporting of MannKind Corporation and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022, based on criteria established in <span style="font-style:italic;">Internal Control &#8212; Integrated Framework (2013)</span>&#160;issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in&#160;<span style="font-style:italic;">Internal Control &#8212; Integrated Framework (2013)</span>&#160;issued by COSO.</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated February 23, 2023, expressed an unqualified opinion on those financial statements.</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis for Opinion<span style="font-weight:normal;"> </span></p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Definition and Limitations of Internal Control over Financial Reporting</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company&#59; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company&#59; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Deloitte&#160;&#38; Touche LLP</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Los Angeles, California</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9B_OR_INFORMATION"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</span><span style="font-weight:normal;"> </span><span style="font-style:italic;">Other</span><span style="font-style:italic;"> Information.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_9C_DISCLOSURE_REGARDING_FOREIGN_JUR">Item&#160;9C.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART III</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_10_DIRECTORS_EXECUTIVE_FICERS_CORPO">Item&#160;10.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Directors, Executive Officers and Corporate Governance.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item and not set forth below will be set forth in the sections headed &#8220;Proposal 1&#8212;Election of Directors&#8221; and &#8220;Corporate Governance Principles and Board and Committee Matters&#8221; in our definitive proxy statement for our 2023 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) to be filed with the SEC on or before May 1, 2023, and is incorporated herein by reference. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <span style="font-style:italic;">Executive Officers &#8212;</span> For information regarding the identification and business experience of our executive officers, see &#8220;Information about our Executive Officers&#8221; in Part I, Item&#160;1 of this Annual Report on Form 10-K.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <span style="font-style:italic;">Directors &#8212;</span> Our board of directors consists of the following members:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">James S. Shannon, M.D., MRCP (UK)<span style="font-style:normal;"> rejoined our board in May 2015 after previously serving as a director from February 2010 until April 2012. Dr. Shannon was appointed Chairman of the Board of Directors in December 2020. From May 2012 until his retirement in April 2015, Dr. Shannon was the Chief Medical Officer of GlaxoSmithKline plc. He formerly held the position of Global Head of Pharma Development at Novartis AG, based in Basel, Switzerland from 2005 until 2008. After joining Sandoz in 1994 as Head of Drug Regulatory Affairs, Dr. Shannon led the Integration Office for R&#38;D overseeing the creation of the Novartis R&#38;D groups from those of Ciba-Geigy Ltd and Sandoz. Following the merger, he was appointed Head of the Cardiovascular Strategic Team and subsequently became Global Head of Project Management before being appointed Global Head of Clinical Development and Medical Affairs in 1999, a position that he held until 2005 when he was appointed to Head Pharma Development. Between 2008 and joining GSK, Dr. Shannon served on the boards of a number of companies, including Biotie, Circassia, Crucell and Endocyte. He also sat on the board of Cerimon Pharmaceuticals where he held the position of interim Chief Executive Officer and President from January 2009 until April 2010. Dr. Shannon currently serves on the boards of ProQR Therapeutics NV, Immodulon Therapeutics Limited, Kyowa Kirin, Inc. &#8211; U.S., Leyden Labs and Horizon Therapeutics plc. He first entered the pharmaceutical industry in 1987 joining Sterling Winthrop Inc., working initially in Europe and subsequently in the USA, where he held positions of increasing responsibility in the management of research and development ultimately serving as Senior Vice-President, Clinical Development. Dr. Shannon is trained in Medicine and Cardiology. He received his undergraduate and postgraduate degrees at Queen&#8217;s University of Belfast and is a Member of the Royal College of Physicians (UK).</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Michael E. Castagna, Pharm.D.<span style="font-style:normal;"> has served as our Chief Executive Officer and as one of our directors since May 2017. Mr. Castagna also served as a Corporate Vice President, Chief Commercial Officer from March 2016 until May 2017. From November 2012 until he joined us, Mr. Castagna was at Amgen, Inc., where he initially served as Vice President, Global Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#8217;s Biosimilar Business Unit. From 2010 to 2012, he was Executive Director, Immunology, at Bristol-Myers Squibb Company (&#8216;&#8216;BMS&#8217;&#8217;). Before BMS, Mr. Castagna served as Vice President and Head, Biopharmaceuticals, North America, at Sandoz, a division of Novartis. Beginning in 1997, he held positions with commercial or medical affairs responsibilities at EMD (Merck) Serono, Pharmasset and DuPont Pharmaceuticals. He received his pharmacy degree from the University of the Sciences-Philadelphia College of Pharmacy, a Pharm.D. from Massachusetts College of Pharmacy &#38; Sciences and an MBA from The Wharton School of Business at the University of Pennsylvania.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Ronald J. Consiglio<span style="font-style:normal;"> has been one of our directors since October 2003. Since 1999, Mr. Consiglio has been the Managing Director of Synergy Trading, a securities-trading partnership. From 1999 to 2001, Mr. Consiglio was Executive Vice President and Chief Financial Officer of Trading Edge, Inc., a national automated bond-trading firm. From January 1993 to 1998 Mr. Consiglio served as Chief Executive Officer of Angeles Mortgage Investment Trust, a publicly traded Real Estate Investment Trust. His prior experience includes serving as Senior Vice President and Chief Financial Officer of Cantor Fitzgerald &#38; Co. and as a member of its board of directors. Mr. Consiglio has served as a member of the board of trustees for the Metropolitan West Funds since 2003. Mr. Consiglio served as a certified public accountant for over 17 years and was a partner in the international accounting firm of Deloitte, Haskins &#38; Sells. He holds a bachelor&#8217;s degree in accounting from California State University at Northridge. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Michael A. Friedman, M.D.<span style="font-style:normal;"> has been one of our directors since December 2003. In 2014, Dr. Friedman completed a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September 2001 until April 2003, Dr. Friedman held the position of Senior Vice President of Research and Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a Senior Vice President of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr. Friedman served as Deputy Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He served on the board of Celgene Corporation from February 2011 to December 2019 and on the board of Smith &#38; Nephew plc from April 2013 to April 2019. Dr. Friedman received a Bachelor of Arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical School. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Jennifer Grancio<span style="font-style:normal;"> has been one of our directors since March 2020. Since October 2020, Ms. Grancio has served as the Chief Executive Officer of Engine No. 1, an impact investment firm. From November 2018 until October 2020, she consulted through Grancio Capital, where she worked with CEOs to accelerate high-growth company success. From 1999 to 2018, she served as a founder and executive with BlackRock&#8217;s iShares business, where she spearheaded the distribution of iShares in the United States and Europe and acted as the Global Head of Marketing and Partnerships for BlackRock&#8217;s index business. Prior to BlackRock, she was a senior associate with PricewaterhouseCoopers, a management consulting firm. Ms. Grancio serves as a board member for Ethic Inc., a sustainable investing firm, and for Harvest Savings &#38; Wealth Technologies, Inc. She is also on the advisory boards of Say Technologies LLC and m+ funds (from Alaia Capital, LLC). Ms. Grancio </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">earned a bachelor&#8217;s degree in economics and international relations from Stanford University, and an MBA degree in strategy and finance from Columbia Business School. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Anthony Hooper<span style="font-style:normal;"> has been one of our directors since January 2020. He is also a director of BeiGene, Ltd. And Amplity Health. Mr. Hooper served as executive vice president of Global Commercial Operations for Amgen Inc. from Oct 2011 until August 2018. Prior to joining Amgen, Mr. Hooper spent more than 15 years at Bristol-Myers Squibb. His last role there was Senior Vice President, Global Commercial Operations and president of the company&#8217;s pharmaceutical business in the Americas, Japan and intercontinental regions. Previously, he was Assistant Vice President of Global Marketing for Wyeth Laboratories and led the international marketing group for Lederle International. Mr. Hooper earned law and MBA degrees from the University of South Africa. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sabrina Kay<span style="font-style:normal;"> has been a member of our Board of Directors since December 2020. Currently, Dr. Kay serves as Founder and CEO of Fremont Private Investments, where she has led the operations and exits of several companies including The Art Institute of Hollywood (sold to Education Management Corp.), Premier Business Bank (sold to First Foundation Inc.), Fashion Umbrella, Fremont College, and Dale Carnegie of Los Angeles. Dr. Kay currently serves on the boards of East West Bank (NASDAQ: EWBC) and Hagerty (NYSE:HGTY).&#160;&#160;She is also a philanthropist, having served on more than 30 charitable and civic boards, including the Los Angeles Sports and Entertainment Commission, Petersen Automotive Museum, Portal Schools, the Leadership Council of International Medical Corps Leadership Council, the Board of Leaders of USC Marshall School and After-School All-Stars Los Angeles, which she chairs. Dr. Kay received Ed.D. and M.Sc. degrees in education from the University of Pennsylvania. She also holds an MBA from the University of Southern California. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Kent Kresa<span style="font-style:normal;"> has been a member of our Board of Directors since June 2004 and served as Chairman of the Board from February 2017 until December 2020. From November 2011 until his appointment as our Chairman, Mr. Kresa served on our Board of Directors as our lead independent director. Mr. Kresa is Chairman Emeritus of Northrop Grumman Corporation, a defense company and from September 1990 until October 2003, he was also its Chairman. He also served as Chief Executive Officer of Northrop Grumman Corporation from January 1990 until March 2003 and as its President from 1987 until September 2001. From 2003 to August 2010, Mr. Kresa served as a director of General Motors Company (or its predecessor). Mr. Kresa has also served on the boards of Fluor Corporation and Avery Dennison Corporation. Mr. Kresa has been a member of the Caltech Board of Trustees since 1994 and also serves on the boards of several non-profit organizations. As a graduate of Massachusetts Institute of Technology, he received a B.S. in 1959, an M.S. in 1961, and an E.A.A. in 1966, all in aeronautics and astronautics. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Christine Mundkur<span style="font-style:normal;"> has been one of our directors since November 2018. Ms. Mundkur most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc., a developer of complex formulations focused on inhaled pharmaceutical products, from February 2013 to February 2017. While at Impopharma, Ms. Mundkur led the transition of the company from a successful clinical research organization into a generic pharmaceutical inhalation development company. Her work included the internal 8 development and filing of Abbreviated New Drug Applications for spray and inhalation products. Ms. Mundkur also previously served as President and Chief Executive Officer of the U.S. Division and Head of Commercial Operations for North America for Sandoz, Inc. from January 2009 to April 2010. She served as Chief Executive Officer of Barr Laboratories, Inc. from April 2008 to December 2008, where she started her career as quality and regulatory counsel in 1993. In addition, Ms. Mundkur has served as a strategic consultant advising several clients on global pharmaceutical business strategies. Ms. Mundkur currently serves on the board of directors of Cardinal Health and served on the board of directors of Lupin Limited from April 2019 through December 2022. Ms. Mundkur holds a J.D. from the St. Louis University School of Law and received her B.S. degree in chemistry from St. Louis University.  </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have adopted a Code of Business Conduct and Ethics Policy that applies to our directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, and have posted the text of the policy on our website (<span style="font-style:italic;">www.mannkindcorp.com</span>) in connection with &#8220;Corporate Governance&#8221; materials. In addition, we intend to promptly disclose on our website (i)&#160;the nature of any amendment to the policy that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions and (ii)&#160;the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals, the name of such person who is granted the waiver and the date of the waiver, to the extent any such waiver is required to be disclosed pursuant to the rules and regulations of the SEC.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_11_EXECUTIVE_COMPENSATION">Item&#160;11.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Executive Compensation</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item will be set forth under the caption &#8220;Executive Compensation,&#8221; &#8220;Compensation of Directors&#8221; and &#8220;Compensation Committee Report&#8221; in the Proxy Statement, and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_12_SECURITY_OWNERSHIP_CERTAIN_BENEF">Item&#160;12.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item will be set forth under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Securities Authorized for Issuance under Equity Compensation Plans&#8221; in the Proxy Statement, and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_13_CERTAIN_RELATIONSHIPS_RELATED_TR">Item&#160;13.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Certain Relationships and Related Transactions, and Director Independence</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item will be set forth under the captions &#8220;Corporate Governance Principles and Board and Committee Matters&#8221; and &#8220;Related Party Transactions, Policy and Procedures&#8221; in the Proxy Statement, and is incorporated herein by reference.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_14_PRINCIPAL_ACCOUNTING_FEES_SERVIC"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;14.</span><span style="font-weight:normal;"> </span><span style="font-style:italic;">Principal Accou</span><span style="font-style:italic;">ntant</span><span style="font-style:italic;"> Fees and Services</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information required by this Item will be set forth under the captions &#8220;Principal Accounting Fees and Services&#8221; and &#8220;Pre-Approval Policies and Procedures&#8221; in the Proxy Statement and is incorporated herein by reference.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the exception of the information specifically incorporated by reference from the Proxy Statement in this Annual Report on Form 10-K, the Proxy Statement shall not be deemed to be filed as part of this report. Without limiting the foregoing, the information under the captions &#8220;Report of the Audit Committee of the Board of Directors&#8221; in the Proxy Statement is not incorporated by reference.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART IV</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">Item&#160;15.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Exhibits and Financial Statement Schedules</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The following documents are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K:</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:8.51%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)(2)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statements and Financial Statement Schedules. The following Financial Statements of MannKind Corporation, Financial Statement Schedules and Report of Independent Registered Public Accounting Firm are included in a separate section of this report beginning on page 63:</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_PUBLIC_ACC_II"><span style="text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></a><span style="text-decoration:none;"> (PCAOB ID No. <ix:nonNumeric id="F_000033" name="dei:AuditorFirmId" contextRef="C_0000899460_20220101_20221231">34</ix:nonNumeric>)</span></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_BALANCE_SHEETS"><span style="text-decoration:none;">Consolidated Balance Sheets</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_OPERATIONS"><span style="text-decoration:none;">Consolidated Statements of Operations</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_COMPREHENSIVE_IN"><span style="text-decoration:none;">Consolidated Statements of Comprehensive Loss</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_STOCKHOLDERS_DEF"><span style="text-decoration:none;">Consolidated Statements of Stockholders&#8217; Deficit</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_OF_CASH_FLOWS"><span style="text-decoration:none;">Consolidated Statements of Cash Flows</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p></td>
</tr>
<tr>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><span style="text-decoration:none;">Notes to Consolidated Financial Statements</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:3%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All financial statement schedules have been omitted because the required information is not applicable or not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements or the notes thereto.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:8.51%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Exhibits. The exhibits listed under Item&#160;15(b) hereof are filed or furnished with, or incorporated by reference into, this Annual Report on Form 10-K. Each management contract or compensatory plan or arrangement is identified separately in Item&#160;15(b) hereof.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Exhibits. The following exhibits are filed or furnished as part of, or incorporated by reference into, this Annual Report on Form 10-K:</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:7.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:91.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Document</p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:91.82%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;2.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520311859/d50698dex21.htm"><span style="text-decoration:none;">Purchase Agreement, dated December 7, 2020 by and among the Company, the Acquired Company, the Sellers and the Securityholders&#8217; Representative (incorporated by reference to Exhibit 2.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 7, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;3.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312516676980/d225552dex31.htm">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to MannKind&#8217;s Quarterly Report on Form&#160;10-Q (File No. 000-50865), filed with the SEC on August 9, 2016).</a></p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;3.2</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517066630/d313758dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of MannKind Corporation (incorporated by reference to Exhibit&#160;3.1 to MannKind&#8217;s Current Report on Form&#160;8-K (File No.&#160;000-50865), filed with the SEC on March&#160;2, 2017).</a></p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;3.3</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517368329/d511527dex31.htm">Certificate of Amendment of Amended and Restated Certificate of Incorporation of MannKind Corporation (incorporated by reference to Exhibit 3.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 13, 2017).</a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;3.4</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520153051/d936164dex31.htm"><span style="text-decoration:none;">Certificate of Amendment of Amended and Restated Certificate of Incorporation of MannKind Corporation (incorporated by reference to Exhibit 3.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on May 27, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;3.5</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520153051/d936164dex32.htm"><span style="text-decoration:none;">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to MannKind&#8217;s Current Report on Form&#160;8-K (File No. 000-50865), filed with the SEC on May 27, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to Exhibits <a href="http://www.sec.gov/Archives/edgar/data/899460/000119312516676980/d225552dex31.htm">3.1</a>, <a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517066630/d313758dex31.htm">3.2</a>, <a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517368329/d511527dex31.htm">3.3</a>, <a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520153051/d936164dex31.htm"><span style="text-decoration:none;">3.4</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520153051/d936164dex32.htm"><span style="text-decoration:none;">3.5</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.2</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517085519/d305327dex42.htm">Form of common stock certificate (incorporated by reference to Exhibit&#160;4.2 to MannKind&#8217;s Annual Report on Form&#160;10-K (File No. 000-50865), filed with the SEC on March 16, 2017).</a></p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.3</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021008440/mnkd-ex43_10.htm"><span style="text-decoration:none;">Description of Common Stock (incorporated by reference to Exhibit 4.3 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 25, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="middle" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.4</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312513279522/d562665dex993.htm">Milestone Rights Purchase Agreement, dated as of July 1, 2013, by and among MannKind, Deerfield Private Design Fund II, L.P. and Horizon Sant&#233; FLML S&#193;RL (incorporated by reference to Exhibit 99.3 to MannKind&#8217;s Current Report on Form&#160;8-K (File No. 000-50865), filed with the SEC on July&#160;1, 2013).</a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:7.2pt;width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-5.4pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.5</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519215305/d757696dex41.htm"><span style="text-decoration:none;">Form of Warrant to Purchase Stock issued to MidCap Financial Trust on August 6, 2019 (incorporated by reference to Exhibit 4.1 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), </span>filed with the SEC on August 7, 2019).</a></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.6</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519215305/d757696dex46.htm"><span style="text-decoration:none;">Convertible Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (incorporated by reference to Exhibit 4.6 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), filed with the SEC on August 7, 2019).</span></a></p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:7.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:91.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Document</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.7</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0000899460/000119312521130221/d174090dex992.htm"><span style="text-decoration:none;">Amendment No.&#160;1 to Convertible Promissory Note, dated April&#160;22, 2021, by and between MannKind Corporation and The Mann Group LLC&#160;(incorporated by reference to Exhibit 99.2 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on April 26, 2021).</span></a></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.8</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519215305/d757696dex47.htm"><span style="text-decoration:none;">Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (incorporated by reference to Exhibit 4.7 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), filed with the SEC on August 7, 2019).</span></a></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.9</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312521070265/d45565dex41.htm"><span style="Background-color:#FFFFFF;text-decoration:none;">Indenture, dated as of March&#160;4, 2021, by and between MannKind Corporation and U.S. Bank National Association, as Trustee&#160;(incorporated by reference to Exhibit 4.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on March 5, 2021).</span></a></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;4.10</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312521070265/d45565dex41.htm#exa"><span style="Background-color:#FFFFFF;text-decoration:none;">Form of Global Note, representing MannKind Corporation&#8217;s 2.50% Convertible Senior Notes due 2026 (included as Exhibit A to the Indenture filed as Exhibit 4.15)&#160;(incorporated by reference to Exhibit 4.2 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on March 5, 2021).</span></a></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:7.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517229404/d406524dex991.htm"><span style="text-decoration:none;">Offer Letter Agreement, dated July 12, 2017, by and between MannKind and Steven B. Binder (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on July 17, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312516505366/d107849dex1038.htm"><span style="text-decoration:none;">Offer Letter, dated March 9, 2016, by and between MannKind and Michael E. Castagna (incorporated by reference to Exhibit 10.38 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 15, 2016).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517085519/d305327dex1036.htm"><span style="text-decoration:none;">Offer Letter, dated December 22, 2016, by and between MannKind and Stuart Tross (incorporated by reference to Exhibit 10.36 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 16, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021008440/mnkd-ex104_262.htm"><span style="text-decoration:none;">Offer Letter, dated May 7, 2020 by and between MannKind and Alejandro Galindo (incorporated by reference to Exhibit 10.4 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 25, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021008440/mnkd-ex105_263.htm"><span style="text-decoration:none;">Offer Letter, dated August 11, 2003, by and between MannKind and Joseph Kocinsky (incorporated by reference to Exhibit 10.5 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 25, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000095012407005167/v34640aexv99w1.htm"><span style="text-decoration:none;">Executive Severance Agreement, dated October 10, 2007, between MannKind and David Thomson (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), as amended, filed with the SEC on October 17, 2007).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000095014804000827/v98169orexv10w1.txt"><span style="text-decoration:none;">Form of Indemnity Agreement entered into between MannKind and each of its directors and officers (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Registration Statement on Form S-1 (File No. 333-115020), filed with the SEC on April 30, 2004, as amended).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517116178/d350284dex991.htm"><span style="text-decoration:none;">Form of Change of Control Agreement (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on April 7, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.9*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312512153102/d328382ddef14a.htm"><span style="text-decoration:none;">2004 Equity Incentive Plan, as amended (incorporated by reference to Appendix A to MannKind&#8217;s proxy statement on Schedule 14A (File No. 000-50865), filed with the SEC on April 6, 2012).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.10*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000095014804000827/v98169orexv10w2.txt"><span style="text-decoration:none;">Form of Stock Option Agreement under the 2004 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 MannKind&#8217;s Registration Statement on Form S-1 (File No. 333-115020), originally filed with the SEC on April 30, 2004, as amended).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.11*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000095012905011954/v15351exv99w1.htm"><span style="text-decoration:none;">Form of Phantom Stock Award Agreement under the 2004 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 14, 2005).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.12*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000095014806000014/v18231exv10w20.htm"><span style="text-decoration:none;">2004 Non-Employee Directors&#8217; Stock Option Plan and form of stock option agreement there under (incorporated by reference to Exhibit 10.20 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 16, 2006).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.13*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459019004263/mnkd-ex1015_871.htm"><span style="text-decoration:none;">Non-Employee Director Compensation Program (incorporated by reference to Exhibit 10.15 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 26, 2019).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.14*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312516676980/d225552dex101.htm"><span style="text-decoration:none;">MannKind Corporation 2013 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on August 9, 2016).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.15*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312513232988/d543380dex992.htm"><span style="text-decoration:none;">Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the MannKind 2013 Equity Incentive Plan (incorporated by reference to Exhibit 99.2 to MannKind&#8217;s registration statement on Form S-8(File No. 000-188790), filed with the SEC on May 23, 2013).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.16*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312513232988/d543380dex993.htm"><span style="text-decoration:none;">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the MannKind 2013 Equity Incentive Plan (incorporated by reference to Exhibit 99.3 to MannKind&#8217;s registration statement on Form S-8 (File No. 000-188790), filed with the SEC on May 23, 2013).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.17*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459020036811/mnkd-ex101_294.htm"><span style="text-decoration:none;">MannKind Corporation 2018 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on August 5, 2020).</span></a></p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:7.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:91.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Document</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.18*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312518241209/d576776dex992.htm">Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the MannKind 2018 Equity Incentive Plan (incorporated by reference to Exhibit 99.2 to MannKind&#8217;s registration statement on Form S-8 (File No. 333-226648), filed with the SEC on August 7, 2018).</a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.19*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312518241209/d576776dex993.htm">Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the MannKind 2018 Equity Incentive Plan (incorporated by reference to Exhibit 99.3 to MannKind&#8217;s registration statement on Form S-8 (File No. 333-226648), filed with the SEC on August 7, 2018).</a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.20*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312518183644/d578515dex991.htm">MannKind Corporation 2004 Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit 99.4 to MannKind&#8217;s registration statement Form S-8 (File No. 333-226648), filed with the SEC on August 7, 2018).</a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.21*</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312518183644/d578515dex991.htm"><span style="text-decoration:none;">MannKind Corporation Market Price Stock Purchase Plan (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s registration statement Form S-8 (File No. 333-225428), filed with the SEC on June 5, 2018).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.22***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021008440/mnkd-ex1023_161.htm"><span style="text-decoration:none;">Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S. (incorporated by reference to Exhibit 10.23 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 25, 2021)</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.23</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517085519/d305327dex1032.htm"><span style="text-decoration:none;">First Amendment to Supply Agreement, dated October 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals, S.A.S. and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.32 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 16, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.24**</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517085519/d305327dex1033.htm"><span style="text-decoration:none;">Second Amendment to Supply Agreement, dated November 9, 2016, by and between MannKind and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.33 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 16, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25**</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459018012419/mnkd-ex108_456.htm"><span style="text-decoration:none;">Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.8 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on May 9, 2018).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.26**</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459019004263/mnkd-ex1050_1079.htm"><span style="text-decoration:none;">Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.50 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 26, 2019)</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.27***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519215305/d757696dex995.htm"><span style="text-decoration:none;">Fifth Amendment to Supply Agreement, dated August 2, 2019, by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 99.5 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), filed with the SEC on August 7, 2019)</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.28***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0000899460/000119312521171623/d153193dex991.htm"><span style="Background-color:#FFFFFF;">Sixth Amendment to Supply Agreement, dated May 24, 2021, by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc. (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on May 25, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.29</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312516505366/d107849dex1037.htm"><span style="text-decoration:none;">Sublease Agreement, dated May 1, 2015, by and between MannKind and the Alfred Mann Foundation for Scientific Research (incorporated by reference to Exhibit 10.37 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on March 15, 2016).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.30</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312517249866/d412831dex103.htm"><span style="text-decoration:none;">Office Lease, dated May 5 2017, by and between MannKind and Russell Ranch Road II LLC. (incorporated by reference to Exhibit 10.3 to MannKind&#8217;s Quarterly Report on Form 10-Q (file No. 000-50865), filed with the SEC on August 7, 2017).&#160;</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.31</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459018003510/mnkd-ex1047_871.htm"><span style="text-decoration:none;">Controlled Equity Offering</span><span style="font-size:7pt;text-decoration:none;"><sup style="font-size:85%;line-height:120%;vertical-align:top">SM</sup></span><span style="text-decoration:none;">&#160;Sales Agreement, by and between MannKind and Cantor Fitzgerald&#160;&#38; Co., dated February 27, 2018 (incorporated by reference to Exhibit 10.47 to MannKind&#8217;s Annual Report on Form 10-K (File No. 000-50865), filed with the SEC on February 27, 2018).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.32**</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459018026006/mnkd-ex108_399.htm"><span style="text-decoration:none;">License and Collaboration Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation (incorporated by reference to Exhibit 10.8 to MannKind&#8217;s Quarterly Report on Form 10-Q (file No. 000-50865), filed with the SEC on November 1, 2018).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.33**</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459018026006/mnkd-ex109_400.htm"><span style="text-decoration:none;">Research Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation (incorporated by reference to Exhibit 10.9 to MannKind&#8217;s Quarterly Report on Form 10-Q (file No. 000-50865), filed with the SEC on November 1, 2018).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.34***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519215305/d757696dex991.htm"><span style="text-decoration:none;">Credit and Security Agreement, dated August 6, 2019, by and among MannKind Corporation, MannKind LLC, the lenders party thereto from time to time and MidCap Financial Trust, as agent (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), filed with the SEC on August 7, 2019).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.35</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312519317492/d780971dex991.htm"><span style="text-decoration:none;">Amendment No. 1 to Credit and Security Agreement, dated December 18, 2019, by and among MannKind Corporation, MannKind LLC, the lenders party thereto from time to time and MidCap Financial Trust, as agent (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No.&#160;000-50865), filed with the SEC on December 18, 2019).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:7.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:91.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Document</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</span></p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0000899460/000119312520230054/d53673dex991.htm"><span style="Background-color:#FFFFFF;text-decoration:none;">Amendment No. 2 to Credit and Security Agreement, dated August 21, 2020, by and among MannKind Corporation, MannKind LLC and MidCap Financial Trust (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on August 25, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.37</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520306330/d73266dex991.htm"><span style="Background-color:#FFFFFF;text-decoration:none;">Amendment No.&#160;3 to Credit and Security Agreement, dated November&#160;30, 2020, by and among MannKind Corporation, MannKind LLC and MidCap Financial Trust</span><span style="text-decoration:none;"> (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 1, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.38</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520311859/d50698dex41.htm"><span style="text-decoration:none;">Amendment No.&#160;4 to Credit and Security Agreement, dated December 7, 2020 by and among the Company, MannKind LLC and MidCap Financial Trust (incorporated by reference to Exhibit 4.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 7, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.39</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312520329209/d56159dex991.htm"><span style="text-decoration:none;">Omnibus Joinder and Amendment No.&#160;5 to Credit and Security Agreement and Amendment No.&#160;1 to Pledge Agreement, dated December&#160;29, 2020 by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on December 30, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.40</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312521070265/d45565dex991.htm"><span style="text-decoration:none;">Amendment No.&#160;6 to Credit and Security Agreement, dated March&#160;1, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust&#160;(incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on March 5, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.41</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000119312521130221/d174090dex991.htm"><span style="text-decoration:none;">Amendment No.&#160;7 to Credit and Security Agreement, dated April&#160;22, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust&#160;(incorporated by reference to Exhibit 99.1 to MannKind&#8217;s Current Report on Form 8-K (File No. 000-50865), filed with the SEC on April 26, 2021).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.42</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1042_615.htm"><span style="text-decoration:none;">Amendment No.&#160;8 to Credit and Security Agreement, dated November 3, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.43</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1043_616.htm"><span style="text-decoration:none;">Amendment No.&#160;9 to Credit and Security Agreement, dated November 8, 2021, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.44</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459022036933/mnkd-ex101_182.htm"><span style="text-decoration:none;">Amendment No. 10 to the Credit and Security Agreement, dated August 29, 2022, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 8, 2022).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.45***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021055727/mnkd-ex101_251.htm"><span style="text-decoration:none;">Commercial Supply Agreement, dated August 12, 2021, by and between MannKind Corporation and United Therapeutics Corporation (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 9, 2021)</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.46***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021055727/mnkd-ex102_250.htm"><span style="text-decoration:none;">First Amendment to Commercial Supply Agreement, dated October 16, 2021, by and between MannKind Corporation and United Therapeutics Corporation (incorporated by reference to Exhibit 10.2 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 9, 2021)</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.47***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459021055727/mnkd-ex103_410.htm"><span style="Background-color:#FFFFFF;text-decoration:none;">Purchase and Sale Agreement, dated September 23, 2021, by and between MannKind Corporation and 1 Casper, LLC </span><span style="text-decoration:none;">(incorporated by reference to Exhibit 10.3 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on November 9, 2021)</span><span style="Background-color:#FFFFFF;text-decoration:none;">.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.48</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/899460/000156459022018245/mnkd-ex101_339.htm"><span style="text-decoration:none;">Third Amendment to Office Lease, dated April 8, 2022, between MannKind Corporation and Russell Ranch Road II LLC (incorporated by reference to Exhibit 10.1 to MannKind&#8217;s Quarterly Report on Form 10-Q (File No. 000-50865), filed with the SEC on May 5, 2022).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.49***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1049_458.htm"><span style="text-decoration:none;">Second Amendment to Commercial Supply Agreement, dated June 15, 2022, by and between MannKind Corporation and United Therapeutics Corporation.</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.50***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1050_456.htm"><span style="text-decoration:none;">Third Amendment to Commercial Supply Agreement, dated August 31, 2022, by and between MannKind Corporation and United Therapeutics Corporation.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.51***</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1051_457.htm"><span style="text-decoration:none;">Fourth Amendment to Commercial Supply Agreement, dated December 22, 2022, by and between MannKind Corporation and United Therapeutics Corporation.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.52</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1052_455.htm"><span style="text-decoration:none;">Office Lease, dated May 10, 2017, by and between Valeritas, Inc. and RFP Lincoln 293 LLC.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.53</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex1053_454.htm"><span style="text-decoration:none;">First Amendment to Office Lease, date February 11, 2019, by and between Valeritas, Inc. and BRP 293 Equity Partners, LLC.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex231_9.htm"><span style="text-decoration:none;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex311_7.htm"><span style="text-decoration:none;">Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</span></a></p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:7.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:91.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description of Document</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.2</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex312_8.htm"><span style="text-decoration:none;">Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.1</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex321_10.htm"><span style="text-decoration:none;">Certification of the Chief Executive Officer pursuant to Rules 13a-14(b) and 15d-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.2</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="mnkd-ex322_6.htm"><span style="text-decoration:none;">Certification of the Chief Financial Officer pursuant to Rules 13a-14(b) and 15d-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline Interactive Data Files pursuant to Rule 405 of Regulation S-T.</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:7.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td colspan="2" valign="top" style="width:0.8%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:91.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cover page has been formatted in Inline XBRL.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:2pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><span style="font-size:10pt;">Indicates management contract or compensatory plan.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the SEC.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Certain portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.25%;text-indent:-4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_16_FORM_10K_SUMMARY">Item&#160;16.<span style="font-weight:normal;"> </span><span style="font-style:italic;">Form 10-K Summary</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.25%;text-indent:-4.25%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:54.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="3" valign="top" style="width:45.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION</p></td>
</tr>
<tr>
<td valign="top" style="width:54.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="middle" style="width:3.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="middle" style="width:42.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:54.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:41.66%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;Michael E. Castagna</p></td>
</tr>
<tr>
<td valign="top" style="width:54.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:41.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael E. Castagna</p></td>
</tr>
<tr>
<td valign="top" style="width:54.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="width:1.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:41.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated: February 23, 2023 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">POWER OF ATTORNEY</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael E. Castagna and David Thomson, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments to this report, and any other documents in connection therewith, and to file the same, with all exhibits thereto, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his substitute or substituted, may lawfully do or cause to be done by virtue hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:34.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</p></td>
<td valign="bottom" style="width:2.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:42.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</p></td>
<td valign="bottom" style="width:2.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ <span style="color:#000000;">Michael E. Castagna</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael E. Castagna</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer and Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Steven B. Binder</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steven B. Binder</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial and Accounting Officer)</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ James S. Shannon</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James S. Shannon, M.D., MRCP (UK)</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chairman of the Board of Directors</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ronald J. Consiglio</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ronald J. Consiglio</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael Friedman</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Friedman, M.D.</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:44.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:20.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Jennifer Grancio</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jennifer Grancio</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Anthony C. Hooper</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anthony C. Hooper </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Sabrina Kay</p></td>
<td valign="bottom" style="width:2.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sabrina Kay</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Kent Kresa</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kent Kresa</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Christine Mundkur</p></td>
<td valign="bottom" style="width:2.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="width:2.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p></td>
</tr>
<tr>
<td valign="top" style="width:34.86%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Christine Mundkur</p></td>
<td valign="bottom" style="width:2.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:42.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">INDEX TO FINANCIAL STATEMENTS </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_PUBLIC_ACC_II"><span style="text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_BALANCE_SHEETS"><span style="text-decoration:none;">Consolidated Balance Sheets</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_OPERATIONS"><span style="text-decoration:none;">Consolidated Statements of Operations</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_COMPREHENSIVE_IN"><span style="text-decoration:none;">Consolidated Statements of Comprehensive Loss</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_STOCKHOLDERS_DEF"><span style="text-decoration:none;">Consolidated Statements of Stockholders&#8217; Deficit</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CONSOLIDATED_STATEMENTS_OF_CASH_FLOWS"><span style="text-decoration:none;">Consolidated Statements of Cash Flows</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p></td>
</tr>
<tr>
<td valign="top" style="width:96.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><span style="text-decoration:none;">Notes to Consolidated Financial Statements</span></a></p></td>
<td valign="bottom" style="width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="width:2.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_PUBLIC_ACC_II">Report of Independent Registered Public Accounting Firm</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Board of Directors and Stockholders of MannKind Corporation</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Opinion on the Financial Statements<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying consolidated balance sheets of MannKind Corporation and subsidiaries (the "Company") as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; deficit, and cash flows for each of the three years in the period ended December 31, 2022 and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with the accounting principles generally accepted in the United States of America. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in&#160;Internal Control &#8212; Integrated Framework (2013)&#160;issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 23, 2023, expressed&#160;an unqualified opinion on the Company's internal control over financial reporting.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis for Opinion<span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Critical Audit Matter</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates<span style="color:#000000;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Net Revenue &#8211; Commercial Product Sales &#8211; Government Rebates &#8211; Refer to Note 2 and 9 to the financial statements</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Critical Audit Matter Description</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As more fully disclosed in Note 2 and 9 to the financial statements, the Company recognizes revenue for commercial product sales at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#8217;s sale of its products. Government rebates are provided to Medicare and state Medicaid programs. Government rebates involve the use of significant assumptions and judgments to estimate for rebate claims related to prior period sales for which an invoice has not yet been received, and related estimates of claims for the current quarter, and estimated future claims that will be made for product sales that have been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period. These significant assumptions and judgments include consideration of historical claims experience, contractual rebate provision, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Given the complexity involved in determining the significant assumptions and judgments used in estimating the government rebates, auditing such estimates required a high degree of auditor judgment and increased extent of audit effort.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>

<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">How the Critical Audit Matter Was Addressed in the Audit</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audit procedures related to management&#8217;s estimates of government rebate estimates, included the following, among others:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">We tested the effectiveness of controls over management&#8217;s processes to account for the variable consideration associated with Government Rebates. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">We evaluated key inputs used in management&#8217;s analysis of the government rebate estimates.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">We inspected contractual documents associated with the government rebates and evaluated the consistency of the methodology with the Company&#8217;s obligations under such contractual documents.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">We tested the mathematical accuracy of the Company&#8217;s calculation of the estimates for government rebates. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">We performed the following procedures to evaluate the significant assumptions and judgments used by management to estimate government rebates:</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">Evaluated the reasonableness of government rebates by comparing the underlying data to historical adjustments.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;">&#160;</p></td>
<td valign="top" style="width:3.12%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:10pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Verdana;font-size:8.5pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;">Evaluated management&#8217;s ability to accurately forecast government rebates by comparing management&#8217;s assumptions of expected government rebates to actuals incurred subsequent to year end.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ <ix:nonNumeric id="F_000034" name="dei:AuditorName" contextRef="C_0000899460_20220101_20221231">Deloitte&#160;&#38; Touche LLP</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000035" name="dei:AuditorLocation" contextRef="C_0000899460_20220101_20221231">Los Angeles, California</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 2001.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_BALANCE_SHEETS">CONSOLIDATED BALANCE SHEETS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.44%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:36.44%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands except share and per share data)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASSETS</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">69,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">124,184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:ShortTermInvestments" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">101,079</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:ShortTermInvestments" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">79,932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,801</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:InventoryNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:InventoryNet" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,152</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,477</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,482</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:AssetsCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">234,896</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:AssetsCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">219,489</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="us-gaap:Goodwill" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other intangible asset</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,153</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:LongTermInvestments" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,961</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:LongTermInvestments" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,619</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,718</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,441</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:Assets" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">295,282</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:Assets" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">321,161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LIABILITIES AND STOCKHOLDERS' DEFICIT</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:AccountsPayableCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,052</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:AccountsPayableCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,956</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,553</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,419</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability &#8212; current</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,565</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,977</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue &#8212; current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,733</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_20211231" decimals="-3" scale="3">827</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized loss on purchase commitments &#8212; current</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000082" name="mnkd:PurchaseObligationCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,393</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000083" name="mnkd:PurchaseObligationCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,170</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000084" name="us-gaap:LiabilitiesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">67,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000085" name="us-gaap:LiabilitiesCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">48,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000086" name="mnkd:PromissoryNotesNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000087" name="mnkd:PromissoryNotesNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,425</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest &#8212; promissory notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000088" name="mnkd:AccruedInterestNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" scale="3">55</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000089" name="mnkd:AccruedInterestNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" scale="3">404</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability &#8212; long term</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000090" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">94,512</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">93,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Midcap credit facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="mnkd:CreditFacilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="mnkd:CreditFacilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000094" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">225,397</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000095" name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">223,944</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized loss on purchase commitments &#8212; long term</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000096" name="mnkd:PurchaseObligationNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">62,916</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000097" name="mnkd:PurchaseObligationNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">76,659</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,040</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue&#160;&#160;&#8212; long term</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,684</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,543</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000102" name="mnkd:MilestoneLiabilitiesNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000103" name="mnkd:MilestoneLiabilitiesNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,838</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deposits from customer</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000104" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000105" name="us-gaap:Liabilities" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">545,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000106" name="us-gaap:Liabilities" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">530,510</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 16)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000107">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000108">&#160;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders' deficit:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Undesignated preferred stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000036" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0000899460_20221231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000037" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0000899460_20211231" decimals="INF">0.01</ix:nonFraction></ix:nonFraction> par value &#8212; <ix:nonFraction unitRef="U_xbrlishares" id="F_000038" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000039" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized&#59;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000040" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0000899460_20221231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000041" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0000899460_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000042" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0000899460_20221231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_000043" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0000899460_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at December 31, 2022 and 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000109">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000110">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000044" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0000899460_20221231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000045" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0000899460_20211231" decimals="INF">0.01</ix:nonFraction></ix:nonFraction> par value &#8212; <ix:nonFraction unitRef="U_xbrlishares" id="F_000046" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000047" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">400,000,000</ix:nonFraction></ix:nonFraction> shares authorized,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <ix:nonFraction unitRef="U_xbrlishares" id="F_000048" name="us-gaap:CommonStockSharesIssued" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000050" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">263,793,305</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_000049" name="us-gaap:CommonStockSharesIssued" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000051" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">251,477,562</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; 2022 and 2021, respectively</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000111" name="us-gaap:CommonStockValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,638</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000112" name="us-gaap:CommonStockValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,515</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000113" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,964,293</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000114" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,918,205</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000115" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0000899460_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,217,469</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000116" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0000899460_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,130,069</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders' deficit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000117" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">250,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000118" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">209,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders' deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000119" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">295,282</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000120" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">321,161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See notes to consolidated financial statements.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_OPERATIONS">CONSOLIDATED STATEMENTS OF OPERATIONS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="9" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.74%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="9" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.74%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands except per share data)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue &#8212; commercial product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000121" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,247</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000122" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,168</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000123" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,324</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,274</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties &#8212; collaborations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,599</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">99,770</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000129" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,442</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000130" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">65,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000131" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,003</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000132" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,084</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:CostOfRevenue" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">41,494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:CostOfRevenue" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,024</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:CostOfRevenue" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,557</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In-process research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:ResearchAndDevelopmentInProcess" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,721</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,248</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:SellingExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">53,753</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:SellingExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,528</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:SellingExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,365</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">37,720</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,675</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset impairment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="us-gaap:AssetImpairmentCharges" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:AssetImpairmentCharges" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Gain) loss on foreign currency translation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,811</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,567</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">8,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on purchase commitments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="mnkd:GainLossOnPurchaseCommitments" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">339</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="us-gaap:CostsAndExpenses" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">163,880</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:CostsAndExpenses" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">122,464</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:CostsAndExpenses" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">113,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:OperatingIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">64,110</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:OperatingIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">47,022</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:OperatingIncomeLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">47,913</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000159" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">112</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:InvestmentIncomeInterest" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">167</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000162" name="mnkd:InterestExpenseOnFinancingLiability" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,758</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="mnkd:InterestExpenseOnFinancingLiability" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,373</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:InterestExpenseDebt" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,011</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000165" name="us-gaap:InterestExpenseDebt" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,204</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000166" name="us-gaap:InterestExpenseDebt" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,471</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000167" name="us-gaap:DebtSecuritiesAvailableForSaleGainLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" scale="3">932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on extinguishment of debt</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000168" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000169" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000170" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" scale="3">102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000171" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" scale="3">239</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000172" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000173" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">23,290</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000174" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">33,904</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000175" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income tax expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000176" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000177" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000178" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,458</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Benefit from income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000179" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000180" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000181" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share &#8212; basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000185" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000186" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000187" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20200101_20201231" decimals="2" sign="-">0.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute net loss per share</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; &#8212; basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000191" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">257,092</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000192" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">249,244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000193" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">222,585</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.12%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See notes to consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_COMPREHENSIVE_IN">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.76%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000198" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive loss:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative translation loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,259</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See notes to consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="CONSOLIDATED_STATEMENTS_STOCKHOLDERS_DEF">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; DEFICIT</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.28%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.28%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-in Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="22" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BALANCE, JANUARY 1, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000204" name="us-gaap:SharesOutstanding" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">211,788</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,118</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,799,278</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" sign="-" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,991,903</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000209" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">190,526</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net issuance of common stock in association</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; with stock options and restricted stock units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000210" name="mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">653</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000212" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000213" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of principal on senior convertible notes</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; through common stock issuance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000214" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000215" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,235</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,261</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of interest on senior convertible notes</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; through common stock issuance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000218" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">188</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">286</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_20200101_20201231" decimals="-3" scale="3">288</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of Mann Group convertible note principal</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000222" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,800</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">28</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000224" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,972</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000225" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the Mann Group convertible note interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000226" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000227" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,988</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock in at-the-market offering</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000230" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,853</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000231" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231" decimals="-3" scale="3">118</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,412</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000233" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,530</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance cost associated with at-the-market offering</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000234" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">519</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000235" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">519</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Stock Purchase Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000236" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">627</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000237" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000238" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">684</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from acquisition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000240" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,067</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000241" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">31</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000242" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,219</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000244" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,511</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,511</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from the exercise of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; warrants</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000246" name="mnkd:StockIssuedDuringPeriodSharesExerciseOfWarrants" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">73</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,527</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000249" name="mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from market</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; price stock purchase</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000250" name="mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">80</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000251" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000252" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">214</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000253" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of warrants pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Midcap Credit Facility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000254" name="mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" scale="3">275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000255" name="mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative translation loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000256" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000257" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000259" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BALANCE, DECEMBER 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000260" name="us-gaap:SharesOutstanding" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">242,118</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000261" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,421</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000262" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,866,303</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000263" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,049,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000264" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">180,419</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net issuance of common stock associated</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; with stock options and restricted stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000265" name="mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,572</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000266" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000267" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" sign="-" scale="3">514</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" scale="3">498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Stock Purchase Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000269" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">527</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000270" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000271" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,085</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,090</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the Mann Group</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; convertible note</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000275" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,830</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">38</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000277" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,535</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,573</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the Mann Group</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; convertible note interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000279" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">170</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">425</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-3" scale="3">427</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the 2024 convertible notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000283" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,667</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,983</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; payoff of the 2024 convertible note</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000287" name="mnkd:StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_20210101_20211231" decimals="-3" scale="3">143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of at-the-market placement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000290" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231" decimals="-3" scale="3">578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,880</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs associated with at-the-market placement</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">38</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">38</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premium on Mann Group convertible note</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,107</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,107</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from market</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; price stock purchase</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000298" name="mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">25</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000299" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; to a warrant conversion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000301" name="mnkd:IssuanceOfCommonStockPursuantToWarrantConversionShares" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">964</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="mnkd:IssuanceOfCommonStockPursuantToWarrantConversion" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-3" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="mnkd:IssuanceOfCommonStockPursuantToWarrantConversion" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231" decimals="-3" sign="-" scale="3">10</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BALANCE, DECEMBER 31, 2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000306" name="us-gaap:SharesOutstanding" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">251,478</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,515</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,918,205</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,130,069</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">209,349</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net issuance of common stock associated</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; with stock options and restricted stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000311" name="mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,242</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" scale="3">297</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000314" name="mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">319</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Stock Purchase Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000315" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000316" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000317" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,076</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000318" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,082</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000319" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,447</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,447</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the Mann Group</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; convertible note</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000321" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,838</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">39</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,557</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,596</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock pursuant to</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; conversion of the Mann Group</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; convertible note interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000325" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" scale="3">672</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_20220101_20221231" decimals="-3" scale="3">674</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of at-the-market placement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000329" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">51</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,790</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs associated with at-the-market placement</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" scale="3">381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from market</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; price stock purchase plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000335" name="mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">252</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231" decimals="-3" scale="3">681</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">684</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative loss on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BALANCE, DECEMBER 31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000341" name="us-gaap:SharesOutstanding" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">263,793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,638</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,964,293</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,217,469</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="us-gaap:StockholdersEquity" contextRef="C_0000899460_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">250,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See notes to consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;" id="CONSOLIDATED_STATEMENTS_OF_CASH_FLOWS">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED STATEMENTS OF CASH FLOWS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CASH FLOWS FROM OPERATING ACTIVITIES:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000346" name="us-gaap:ProfitLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000347" name="us-gaap:ProfitLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000348" name="us-gaap:ProfitLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; operating activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000349" name="us-gaap:ShareBasedCompensation" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,447</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000350" name="us-gaap:ShareBasedCompensation" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000351" name="us-gaap:ShareBasedCompensation" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,511</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation, amortization and accretion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000352" name="us-gaap:DepreciationAndAmortization" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,124</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000353" name="us-gaap:DepreciationAndAmortization" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000354" name="us-gaap:DepreciationAndAmortization" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,149</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000355" name="us-gaap:InterestExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000356" name="us-gaap:InterestExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,372</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on milestone right</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000357" name="mnkd:InterestOnMilestonePayment" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,663</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-off of inventory</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000358" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000359" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000360" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">496</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on Mann Group promissory notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000361" name="mnkd:InterestExpenseOnPromissoryNotes" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000362" name="mnkd:InterestExpenseOnPromissoryNotes" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,598</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000363" name="mnkd:InterestExpenseOnPromissoryNotes" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,148</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of right-of-use assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000364" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,987</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000365" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,258</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000366" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,177</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000367" name="us-gaap:DebtSecuritiesAvailableForSaleGainLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on extinguishment of debt, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000368" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000369" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asset impairment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000370" name="us-gaap:AssetImpairmentCharges" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000371" name="us-gaap:AssetImpairmentCharges" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Gain) loss on foreign currency translation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000372" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,811</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000373" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,567</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000374" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">8,006</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In-process research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000375" name="us-gaap:ResearchAndDevelopmentInProcess" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000376" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000377" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000378" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,807</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000379" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">776</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000380" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">705</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000381" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,670</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000382" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,081</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000383" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,314</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000384" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,552</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000385" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000386" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">154</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000387" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">523</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000388" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">138</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000389" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000390" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,096</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000391" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,374</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000392" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000393" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" scale="3">723</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000394" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,814</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000395" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,346</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000396" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,047</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000397" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">14,567</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000398" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,910</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized loss on purchase commitments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000399" name="mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,709</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000400" name="mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,892</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000401" name="mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,751</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000402" name="mnkd:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,309</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000403" name="mnkd:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,135</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000404" name="mnkd:IncreaseDecreaseInOperatingLeaseLiabilities" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest on Mann Group promissory notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000405" name="mnkd:IncreaseDecreaseInAccruedInterestOnPromissoryNotes" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deposits from customer</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000406" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000407" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,950</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:54.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000408" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000409" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">61,709</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000410" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">28,128</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CASH FLOWS FROM INVESTING ACTIVITIES:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of held-to-maturity debt securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000411" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">74,536</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000412" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">196,131</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from maturity of debt securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000413" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">107,340</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000414" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">59,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisition of V-Go</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000415" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,341</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of property and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000416" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,589</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000417" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,466</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000418" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">801</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase of available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000419" name="mnkd:PurchaseOfAvailableForSaleSecurities" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000420" name="mnkd:PurchaseOfAvailableForSaleSecurities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from sale of treasury bills</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000421" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisition of in-process research and development,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of cash acquired</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000422" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,983</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:54.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000423" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,874</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000424" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">151,537</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000425" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,216</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CASH FLOWS FROM FINANCING ACTIVITIES:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from at-the-market-offering</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000426" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,790</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000427" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000428" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,450</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone payment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000429" name="mnkd:MilestonePayments" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,088</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000430" name="mnkd:MilestonePayments" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs associated with at the market offering</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000431" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231" decimals="-3" scale="3">381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000432" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231" decimals="-3" scale="3">38</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000433" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231" decimals="-3" scale="3">518</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net issuance of common stock associated with stock options and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">restricted stock units</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000434" name="mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">319</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000435" name="mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" scale="3">498</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000436" name="mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from market price stock purchase plan and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from employee stock purchase plan</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000437" name="mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000438" name="mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">106</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000439" name="mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment on financing liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000440" name="mnkd:PaymentOnFinancingLiability" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">18</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock from the exercise of warrants</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000441" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,600</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from MidCap credit facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000442" name="us-gaap:ProceedsFromLinesOfCredit" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from PPP loan</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000443" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from the Senior convertible notes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000444" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">230,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs associated with Senior convertible notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000445" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from the sale-leaseback transaction</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000446" name="mnkd:ProceedsFromSaleLeasebackTransaction" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">102,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance costs associated with the sale-leaseback transaction</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000447" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,120</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deposit for the sale-leaseback transaction</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000448" name="mnkd:DepositForSaleLeasebackTransaction" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal payments on Mann Group promissory notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000449" name="us-gaap:RepaymentsOfNotesPayable" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,051</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of MidCap credit facility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000450" name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of MidCap credit facility prepayment penalty</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000451" name="mnkd:PaymentOfCreditFacilityPrepaymentPenalty" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:54.7pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000452" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,388</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000453" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">270,267</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000454" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">49,853</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NET INCREASE IN CASH AND CASH EQUIVALENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; AND RESTRICTED CASH</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000455" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">54,417</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000456" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">57,021</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000457" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,941</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CASH AND CASH EQUIVALENTS AND RESTRICTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; CASH, BEGINNING OF PERIOD</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000458" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">124,184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000459" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">67,163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000460" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,222</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CASH AND CASH EQUIVALENTS AND RESTRICTED</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; CASH, END OF PERIOD</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000461" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">69,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000462" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">124,184</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.16%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000463" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">67,163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:49.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SUPPLEMENTAL CASH FLOWS DISCLOSURES:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Interest paid in cash</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000464" name="us-gaap:InterestPaidNet" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,852</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000465" name="us-gaap:InterestPaidNet" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000466" name="us-gaap:InterestPaidNet" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,558</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">NON-CASH INVESTING AND FINANCING ACTIVITIES:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of investments from long-term to current</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000467" name="mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">82,850</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000468" name="mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,654</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of Thirona convertible notes and interest receivable</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; from long-term to current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000469" name="mnkd:ReclassificationOfConvertibleNotesAndInterestReceivable" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,375</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premium on Mann Group convertible note</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000470" name="mnkd:PremiumOnConvertibleNote" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,107</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments on debt and interest through common stock issuance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000471" name="mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,270</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000472" name="mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000473" name="mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,549</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forgiveness of PPP loan</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000474" name="us-gaap:DebtInstrumentDecreaseForgiveness" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Addition of right-of-use-asset</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000475" name="mnkd:AdditionOfRightOfUseAssets" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000476" name="mnkd:AdditionOfRightOfUseAssets" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,425</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use asset modification</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000477" name="mnkd:RightOfUseAssetsModification" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000478" name="mnkd:RightOfUseAssetsModification" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">278</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash construction in progress and property and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; equipment</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000479" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,298</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000480" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000481" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">92</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee Stock Purchase Plan</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000482" name="mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,090</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000483" name="mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">684</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent milestone liability</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="mnkd:ContingentMilestoneLiability" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">610</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock for acquisition of in-process</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; research and development</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000485" name="mnkd:CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of warrants associated with the</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; MidCap Credit Facility</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000486" name="mnkd:IssuanceOfWarrantsAssociatedWithCreditFacility" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Receivable from at-the-market offering</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000487" name="mnkd:ReceivableFromCommonStockOffering" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">226</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See notes to consolidated financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION AND SUBSIDIARIES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p><ix:nonNumeric id="F_000489" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Description of Business</p><ix:nonNumeric id="F_000507" name="mnkd:BusinessPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Business <span style="font-style:normal;">&#8212; MannKind Corporation and its subsidiaries (the &#8220;Company&#8221;) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company is currently commercializing Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The Company also collaborates with third parties to formulate their drugs on the Company&#8217;s Technosphere drug delivery platform. Tyvaso DPI (treprostinil) inhalation powder received FDA approval in May 2022, for the treatment of pulmonary arterial hypertension and for the treatment of pulmonary hypertension associated with interstitial lung disease. UT began commercializing Tyvaso DPI in June 2022 and is obligated to pay the Company a royalty on net sales of the product. The Company also receives a margin on supplies of Tyvaso DPI that it manufactures for UT.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000508" name="mnkd:BasisOfPresentationPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation<span style="font-style:normal;"> &#8212; The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). </span></p></ix:nonNumeric><ix:nonNumeric id="F_000509" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Principles of Consolidation<span style="font-style:normal;"> &#8212; The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. </span></p></ix:nonNumeric><ix:nonNumeric id="F_000510" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications<span style="font-style:normal;"> &#8212; Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000511" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Segment Information<span style="font-style:normal;"> &#8212; Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. To date, the Company has viewed its operations and manages its business as <ix:nonFraction unitRef="U_mnkdSegment" id="F_000582" name="us-gaap:NumberOfOperatingSegments" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> segment operating in the United States of America.</span></p></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric id="F_000490" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000490_dcnt_be66310b-6e4e-4a09-aa44-24b3573a7000">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p><ix:nonNumeric id="F_000512" name="us-gaap:UseOfEstimates" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> &#8212; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000513" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> The Company recognizes revenue when its customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to be entitled in exchange for those goods or services.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To determine revenue recognition for arrangements that are within the scope of Accounting Standards Codification (&#8220;<span style="color:#000000;">ASC&#8221;) </span>Topic 606, <span style="font-style:italic;font-family:Calibri;color:#000000;">Revenue from Contracts with Customers </span><span style="font-family:Calibri;color:#000000;">(&#8220;ASC 606&#8221;),</span> the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under ASC 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company has two types of contracts with customers: (i) contracts for commercial product sales with wholesale distributors, specialty and retail pharmacies and (ii) collaboration arrangements.</p></ix:nonNumeric><ix:nonNumeric id="F_000514" name="mnkd:RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000514_dcnt_0cd519ff-158d-48fa-b64e-e03196f45e1f">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8211; Net Revenue &#8211; Commercial Product Sales &#8211;<span style="font-style:normal;"> The Company sells its products to a limited number of wholesale distributors, specialty and retail pharmacies, and durable medical equipment suppliers (&#8220;DME&#8221;) in the U.S. (collectively, its &#8220;Customers&#8221;). Wholesale distributors</span><span style="color:#000000;font-style:normal;"> subsequently resell the Company&#8217;s products to retail pharmacies and certain medical centers or hospitals. Specialty and retail pharmacies sell directly to patients. In addition to distribution agreements with Customers, the Company enters into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of the Company&#8217;s products.</span></p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_be66310b-6e4e-4a09-aa44-24b3573a7000" continuedAt="F_000490_dcnt_96fdf2b7-d1e4-4372-a187-57f9365e7072"><ix:continuation id="F_000514_dcnt_0cd519ff-158d-48fa-b64e-e03196f45e1f" continuedAt="F_000514_dcnt_72f55ddc-9330-43e7-bb40-a51457e2e256">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue on product sales when the Customer obtains control of the Company's product, which occurs at delivery for wholesale distributors and </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generally </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delivery </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for specialty pharmacies. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> revenue on product sales to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> retail pharmac</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as the product is dispensed to patients. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenues are recorded net of applicable reserves</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including discounts, allowances, rebates, returns and other incentives</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. See </span><span style="font-style:italic;">Reserves for Variable Consideration</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> below.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Free Goods Program &#8211; <span style="font-style:normal;">From time to time, the Company offers programs to potential new patients that allow them to obtain free goods (prescription fills) from a pharmacy. The Company excludes such amounts related to these programs from both gross and net revenue.&#160;The cost of product associated with the free goods program is recognized as cost of goods sold in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reserves for Variable Consideration <span style="font-style:normal;">&#8212; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#8217;s sale of its products. These reserves, as further detailed below, are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. The Company&#8217;s analysis also contemplates application of the constraint in accordance with the guidance, under which it determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company will adjust these estimates, which would affect net revenue <span style="font-family:Calibri;">&#8212;</span> commercial product sales and earnings in the period such variances become known.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix, unbilled claims, claim submission time lags and inventory levels in the distribution channel.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances <span style="font-style:normal;">&#8212; The Company generally provides Customers with discounts which include incentives, such as prompt pay discounts, that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company compensates (through trade discounts and allowances) its Customers for sales order management, data, and distribution services. However, the Company has determined such services received to date are not distinct from the Company&#8217;s sale of products to the Customer and, therefore, these payments have been recorded as a reduction of revenue and as a reduction to accounts receivable, net. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Returns <span style="font-style:normal;">&#8212; Consistent with industry practice, the Company generally offers Customers a right of return for unopened product that has been purchased from the Company for a period beginning <ix:nonNumeric id="F_000583" name="mnkd:SalesReturnPeriod" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMinimumMember_20220101_20221231" format="ixt-sec:durwordsen">six months</ix:nonNumeric> prior to and ending <ix:nonNumeric id="F_000584" name="mnkd:SalesReturnPeriod" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMaximumMember_20220101_20221231" format="ixt-sec:durmonth">12</ix:nonNumeric> months after its expiration date, which lapses upon shipment to a patient. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net. The Company currently estimates product returns using available industry data and its own sales information, including its visibility into the inventory remaining in the distribution channel. The Company&#8217;s current return reserve percentage is estimated to be in the single-</span><span style="font-family:Calibri;font-style:normal;">digits. </span><span style="font-family:Calibri;font-style:normal;color:#000000;">Adjustments to the returns reserve have been made in the past and may be necessary in the future based on revised estimates to the Company&#8217;s assumptions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Provider Chargebacks and Discounts <span style="font-style:normal;">&#8212; Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase products from the Company. Customers charge the Company for the difference between what they pay for products and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is recorded in accrued expenses and other current liabilities. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers, and the Company generally issues credits for such amounts within a few weeks of the Customer&#8217;s notification to the Company of the resale. Reserves for chargebacks consist of credits that the Company expects to issue for units that remain in the distribution channel inventories at each reporting period-end that the Company expects will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which the Company has not yet issued a credit.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Government Rebates <span style="font-style:normal;">&#8212; The Company is subject to discount obligations under Medicare and state Medicaid programs. These reserves are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities. Estimates around Medicaid have historically required significant </span></p></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_96fdf2b7-d1e4-4372-a187-57f9365e7072" continuedAt="F_000490_dcnt_1811ce30-a917-4d41-8db7-7f9cfc6e9a28"><ix:continuation id="F_000514_dcnt_72f55ddc-9330-43e7-bb40-a51457e2e256">
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">judg</span><span style="font-style:normal;">ment due to timing lags in receiving invoices for claims from states.</span><span style="font-style:normal;color:#000000;"> </span><span style="font-style:normal;">For </span><span style="font-style:normal;">Afrezza</span><span style="font-style:normal;">, the Company also estimates the number of patients in the prescription drug coverage gap for whom the Company will owe an additional liability under the Medicare Part D program. The Company&#8217;s liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product</span><span style="font-style:normal;">s</span><span style="font-style:normal;"> that ha</span><span style="font-style:normal;">ve</span><span style="font-style:normal;"> been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span><span style="font-style:normal;"> The Company&#8217;s estimates include consideration of historical claims expe</span><span style="font-style:normal;">rience, paye</span><span style="font-style:normal;">r channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Payer Rebates <span style="font-style:normal;">&#8212; The Company contracts with certain private payer organizations, primarily insurance companies and pharmacy benefit managers, for the payment of rebates with respect to utilization of its products. The Company estimates these rebates, including estimates for product that has been recognized as revenue, but which remains in the distribution channel, and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities. The Company&#8217;s estimates include consideration of historical claims experience, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Incentives <span style="font-style:normal;">&#8212; Other incentives which the Company offers include voluntary patient support programs, such as the Company's co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with co-payments required by payers. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with the products that have been recognized as revenue, but remains in the distribution channel inventories at the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities.</span></p></ix:continuation><ix:nonNumeric id="F_000515" name="mnkd:RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000515_dcnt_cd68b48a-07dc-4d27-8c56-4069bacf6db0">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Revenue &#8212; Collaborations and Services &#8212;<span style="font-style:normal;"> The Company enters into licensing, research or other agreements under which the Company licenses certain rights to its product candidates to third parties, conducts research or provides other services to third parties. The terms of these arrangements may include, but are not limited to payment to the Company of one or more of the following: up-front license fees&#59; development, regulatory, and commercial milestone payments&#59; payments for commercial manufacturing and clinical supply services the Company provides&#59; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. </span><span style="color:#000000;font-style:normal;">With respect to our </span><span style="font-style:normal;">significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (&#8220;as amended, the CSA&#8221;), we have identified three distinct performance obligations: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&#38;D Services and License&#8217;), (2) development activities for the next generation of the product (&#8220;Next-Gen R&#38;D Services&#8221;), and (3) a material right associated with current and future manufacturing and supply of product (&#8220;Manufacturing Services&#8221;). Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#8217;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represents distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and the Company uses key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next <ix:nonNumeric id="F_000585" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231" format="ixt-sec:durmonth">12</ix:nonNumeric> months. Amounts that the Company expects will not be recognized within the next 12 months are classified as long-term deferred revenue. For further information, see Note 11<span style="font-style:italic;"> &#8211; Collaboration, Licensing and Other Arrangements.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes upfront license payments as revenue upon delivery of the license only if the license is determined to be a separate unit of accounting from the other undelivered performance obligations.&#160;The undelivered performance obligations typically include manufacturing or development services or research and/or steering committee services. If the license is not considered as a distinct performance obligation, then the license and other undelivered performance obligations would be evaluated to determine if such should be accounted for as a single unit of accounting.&#160;If concluded to be a single performance obligation, the transaction price for the single performance obligation is recognized as revenue over the estimated period of when the performance obligation is satisfied. If the license is considered to be a distinct performance obligation, then the estimated revenue is included in the transaction price for the contract, which is then allocated to each performance obligation based on the respective standalone selling prices.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whenever the Company determines that an arrangement should be accounted for over time, the Company determines the period over which the performance obligations will be performed, and revenue will be recognized over the period the Company is expected to complete its performance obligations. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete its performance obligations under an arrangement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaboration agreements typically entitle the Company to additional payments upon the achievement of development, regulatory and sales milestones. If the achievement of a milestone is considered probable at the inception of the collaboration, the related milestone payment is included with other collaboration consideration, such as upfront fees and research funding, in the Company&#8217;s revenue </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_1811ce30-a917-4d41-8db7-7f9cfc6e9a28" continuedAt="F_000490_dcnt_7b75ca19-45cd-49cf-b0be-484cc8179f2a"><ix:continuation id="F_000515_dcnt_cd68b48a-07dc-4d27-8c56-4069bacf6db0" continuedAt="F_000515_dcnt_5634632b-8a19-48d6-ac36-4a8b6a90b362">
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">calculation. If these milestones are not considered probable at the inception of the collaboration, the milestones will typically be recognized in one of two ways depending on the timing of when the milestone is achieved.&#160;If the milestone is improbable at inception and subsequently deemed probable of achievement, such will be added to the transaction price, resulting in a cumulative adjustment to revenue.&#160;If the milestone is achieved after the performance period has</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> been</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> completed and all performance obligations have been delivered, the Company will recognize the milestone payment as revenue in its entirety in the period the milestone was achieved. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaborative agreements, for accounting purposes, represent contracts with customers and therefore are not subject to accounting literature on collaborative agreements. The Company grants licenses to its intellectual property, supplies raw materials, semi-finished goods or finished goods, provides research and development services and offers sales support for the co-promotion of products, all of which are outputs of the Company&#8217;s ongoing activities, in exchange for consideration. Accordingly, the Company concluded that its collaborative agreements must generally be accounted for pursuant to ASC 606.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For collaboration agreements that allow collaboration partners to select additional optioned products or services, the Company evaluates whether such options contain material rights (i.e., have exercise prices that are discounted compared to what the Company would charge for a similar product or service to a new collaboration partner). The exercise price of these options includes a combination of licensing fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, the Company concludes the option does not contain a material right, and therefore is not included in the transaction price at contract inception. The Company assessed the CSA agreement with UT and determined that a material right existed for the manufacturing services performance obligation. The transaction price is allocated to the material right as well as the remaining performance obligations in accordance with ASC 606. The Company also evaluates grants of additional licensing rights upon option exercises to determine whether such should be accounted for as separate contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Royalties &#8212;<span style="font-style:normal;"> The Company recognizes royalty revenue for a sales-based or usage-based royalty if it is promised in exchange for an intellectual property license. The royalty revenue is recognized as the latter of the subsequent sale of the product occurs or if the performance obligation to which the royalty has been allocated has been satisfied or partially satisfied. The Company&#8217;s collaborative agreement with UT entitles it to receive low double-digit royalties on net sales of Tyvaso DPI for the license of the Company&#8217;s IP that was considered to be interdependent with the development activities that supported the approval of Tyvaso DPI.</span></p><ix:nonNumeric id="F_000540" name="us-gaap:DisaggregationOfRevenueTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000586" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">81,073</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,435</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,324</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,098</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,007</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,599</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">99,770</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,442</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">65,144</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amounts represent revenue generated from the Company&#8217;s collaboration arrangements, including Next-Gen R&#38;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements</span><span style="font-size:9pt;color:#000000;">. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.38%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amounts represent royalties on UT&#8217;s net sales of Tyvaso DPI.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold and cost of revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">55,071</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,084</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,426</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,024</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,557</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cost of goods sold and cost of revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">57,497</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,857</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:OperatingExpenses" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_7b75ca19-45cd-49cf-b0be-484cc8179f2a" continuedAt="F_000490_dcnt_0164c559-612e-4a22-a209-25a77ed92be6"><ix:continuation id="F_000515_dcnt_5634632b-8a19-48d6-ac36-4a8b6a90b362">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows detailed accounting guidance in measuring revenue and certain judgments affect the application of its revenue policy. For example, in connection with its existing collaboration agreements, the Company has recorded on its consolidated balance sheets short-term and long-term deferred revenue based on its best estimate of when such revenue will be recognized. Short-term deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12&#160;months. Amounts that the Company expects will not be recognized within the next 12&#160;months are classified as long-term deferred revenue. However, this estimate is based on the Company&#8217;s current project development plan and, if the development plan should change in the future, the Company may recognize a different amount of deferred revenue over the next <ix:nonNumeric id="F_000605" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231" format="ixt-sec:durmonth">12</ix:nonNumeric>-month period. </p></ix:continuation><ix:nonNumeric id="F_000516" name="us-gaap:DebtPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Payments<span style="font-style:normal;"> &#8212; At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the customer, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as, or when, the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect license, collaboration, other revenue, and earnings in the period of adjustment</span><span style="font-family:Calibri;font-style:normal;">.</span></p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000517" name="us-gaap:CostOfSalesPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">Cost of Goods Sold<span style="font-style:normal;"> &#8212; Cost of goods sold includes material, labor costs and manufacturing overhead. Cost of goods sold also includes a component of current period manufacturing costs in excess of costs capitalized into inventory (&#8220;excess capacity costs&#8221;).&#160;These costs, in addition to the impact of the revaluation of inventory for standard costing, and write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of goods sold excludes the cost of insulin purchased under the Company&#8217;s Insulin Supply Agreement (the &#8220;Insulin Supply Agreement&#8221;) with Amphastar Pharmaceuticals, Inc. (&#8220;Amphastar&#8221;). All insulin inventory on hand was written off and the full purchase commitment contract to purchase future insulin was accrued as a recognized loss on purchase commitments as of the end of 2016.</span></ix:nonNumeric> </p><ix:nonNumeric id="F_000518" name="mnkd:CostOfRevenuesPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cost of Revenues &#8211; Collaborations and Services<span style="font-style:normal;"> &#8212; Cost of revenues &#8211; collaborations and services includes material, labor costs, manufacturing overhead, and excess capacity costs.&#160;These costs, in addition to the write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of revenues &#8211; collaborations and services also includes the cost of product development.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000519" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents and Restricted Cash<span style="font-style:normal;"> &#8212; The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December 31, 2022 and 2021, cash equivalents were comprised of money market, corporate bonds and commercial paper accounts with original maturities less than 90 days from the date of purchase.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records restricted cash when cash and cash equivalents are restricted as to withdrawal or usage. The Company presents amounts of restricted cash that will be available for use within 12 months of the reporting date as restricted cash in current assets. </p></ix:nonNumeric><ix:nonNumeric id="F_000520" name="us-gaap:HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Held-to-Maturity Investments<span style="font-style:normal;"> &#8212; The Company&#8217;s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2022, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity&#59; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. The amortization or accretion of the Company&#8217;s investments is recognized as interest income in the consolidated statements of operations.</span></p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000521" name="us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" contextRef="C_0000899460_20220101_20221231" escape="true">Available-for-Sale Investment<span style="font-style:normal;"> &#8212; In June 2021, the Company purchased a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="mnkd:PurchaseOfAvailableForSaleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210601_20210630" decimals="-5" scale="6">3.0</ix:nonFraction> million convertible promissory note (the &#8220;Thirona convertible note&#8221;) issued by Thirona Bio, Inc. (&#8220;Thirona&#8221;). In January 2022, the Company purchased an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="mnkd:PurchaseOfAvailableForSaleSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20220101_20220101" decimals="-5" scale="6">5.0</ix:nonFraction> million convertible promissory note issued by Thirona. Unless earlier converted into conversion shares pursuant to the note purchase agreement, the principal and accrued interest shall be due and payable by Thirona on demand by the Company at any time after the maturity date of <ix:nonNumeric id="F_000608" name="us-gaap:InvestmentMaturityDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630" format="ixt:datemonthdayyearen">December 31, 2023</ix:nonNumeric>. Interest accrues at a rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000609" name="us-gaap:InvestmentInterestRate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630" decimals="2" scale="-2">6</ix:nonFraction>% per annum. The Thirona convertible notes are general unsecured obligations of Thirona. The Thirona convertible notes are classified as an available-for-sale security and are included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company assesses whether it has any intention to sell the investment, determines fair value of its available-for-sale investments using level 3 inputs as well as assesses its allowance for credit losses associated with the available for sale investment. In June 2021, the Company and Thirona also entered into a collaboration agreement to develop a compound for the treatment of fibrotic lung diseases. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;"> for additional information. </span></ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000522" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0000899460_20220101_20221231" escape="true">Concentration of Credit Risk<span style="font-style:normal;"> &#8212; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span></ix:nonNumeric> </p><ix:nonNumeric id="F_000523" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000523_dcnt_6439f2ea-8731-4dbc-83e2-88ea85f9c4bc"></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_0164c559-612e-4a22-a209-25a77ed92be6" continuedAt="F_000490_dcnt_c1f83d94-5c46-44da-8c9a-82dcb736f004"><ix:continuation id="F_000523_dcnt_6439f2ea-8731-4dbc-83e2-88ea85f9c4bc">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Receivable and Allowance for Credit Losses<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> Accounts receivable are recorded at the invoiced amount and are not interest bearing. Accounts receivable are presented net of an allowance for credit losses if there are estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for credit losses. The allowance for expected credit losses is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. Accounts receivable are also presented net of an allowance for product returns and trade discounts and allowances because the Company&#8217;s customers have the right of setoff for these amounts against the related accounts receivable.</span></p></ix:continuation><ix:nonNumeric id="F_000524" name="mnkd:PreLaunchInventoryPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Pre-Launch Inventory <span style="font-style:normal;">&#8212; An improvement to the manufacturing process for the Company&#8217;s primary excipient fumaryl diketopiperazine (&#8220;FDKP&#8221;) was demonstrated to be viable and management expects to realize an economic benefit in the future as a result of such process improvement. Accordingly, the Company is required to assess whether to capitalize inventory costs related to such excipient prior to regulatory approval of the new supplier and the improved manufacturing process. In doing so, management must consider a number of factors in order to determine the amount of inventory to be capitalized, including the historical experience of achieving regulatory approvals for the Company&#8217;s manufacturing process, feedback from regulatory agencies on the changes being effected and the amount of inventory that is likely to be used in commercial production. The shelf life of the excipient will be determined as part of the regulatory approval process&#59; in the interim, the Company must assess the available stability data to determine whether there is likely to be adequate shelf life to support anticipated future sales occurring beyond the expected approval date of the new raw material. If management is aware of any specific material risks or contingencies other than the normal regulatory review and approval process, or if the criteria for capitalizing inventory produced prior to regulatory approval are otherwise not met, the Company would not capitalize such inventory costs, choosing instead to recognize such costs as a research and development expense in the period incurred.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000525" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Inventories<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes inventory costs associated with the Company&#8217;s products based on management&#8217;s judgment that future economic benefits </span><span style="font-style:normal;">are</span><span style="color:#000000;font-style:normal;"> expected to be realized&#59; otherwise, such costs are expensed as incurred as cost of goods sold. The Company uses a contract manufacturing organization outside of the U.S. for certain stages of V-Go inventory. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value and writes down such inventories, as appropriate. In addition, the Company&#8217;s products are subject to strict quality control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or may become obsolete or are forecasted to become obsolete due to expiration, the Company will record a charge to write down such unmarketable inventory to its estimated net realizable value. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company performs an assessment of projected sales and evaluates the lower of cost or net realizable value and the potential excess inventory on hand at the end of each reporting period.</p></ix:nonNumeric><ix:nonNumeric id="F_000526" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Property and equipment<span style="font-style:normal;"> &#8212; Property and equipment is recorded at historical cost, net of accumulated depreciation. Depreciation expense is recorded over the assets&#8217; useful lives on a straight-line basis. See Note 7 &#8211; </span>Property and Equipment<span style="font-style:normal;">.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000527" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets<span style="font-style:normal;">&#160;&#8212; Long-lived assets include property and equipment, operating lease right-of-use assets and other intangible asset. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Assets are considered to be impaired if the carrying value is considered to be unrecoverable.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the asset exceeds the fair value of the asset. Fair value is determined using the market, income or cost approaches as appropriate for the asset. Any write-downs are treated as permanent reductions in the carrying amount of the asset and recognized as an operating loss.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In August 2019, the Company recorded a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000610" name="mnkd:CommitmentAsset" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831" decimals="-5" scale="6">1.5</ix:nonFraction>&#160;million&#160;commitment asset and a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000611" name="us-gaap:OtherAssets" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831" decimals="-5" scale="6">0.4</ix:nonFraction>&#160;million other asset for deferred debt issuance costs related to the future funding commitments of the MidCap Credit Facility. A quarterly assessment was performed during the second quarter of 2020 to determine if the Company was on target to achieve certain required milestone conditions in order for the Company to access further borrowings under the MidCap Credit Facility.&#160;The Company determined that such milestone conditions related to Afrezza trailing net revenue were unlikely to be achieved.&#160;As a result, an asset impairment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000612" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_us-gaapLongLivedAssetsHeldForSaleByAssetTypeAxis_mnkdCommitmentAssetMember_20200401_20200630" decimals="-5" scale="6">1.9</ix:nonFraction>&#160;million was recognized during the second quarter of 2020 and is reflected in&#160;the Company&#8217;s consolidated statement of operations. See Note 10 &#8211;&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Borrowings</span><span style="Background-color:#FFFFFF;">&#160;for further information on the MidCap Credit Facility.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded $<ix:nonFraction unitRef="U_iso4217USD" id="F_000613" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million of asset impairments for the year ended December 31, 2021. There were no asset impairments for the year ended December 31, 2022.</p></ix:nonNumeric><ix:nonNumeric id="F_000528" name="us-gaap:BusinessCombinationsPolicy" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000528_dcnt_710399a7-3719-4b90-a687-7a22a7322de5">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisitions &#8212; <span style="font-style:normal;">The Company first determines whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired do not constitute a business, the Company accounts for the transaction as an asset acquisition. Business combinations are accounted for by means of the acquisition method of accounting. Under the acquisition method, assets acquired, </span></p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_c1f83d94-5c46-44da-8c9a-82dcb736f004" continuedAt="F_000490_dcnt_076cb77c-9aef-4b3a-bb56-dbf3b697b10a"><ix:continuation id="F_000528_dcnt_710399a7-3719-4b90-a687-7a22a7322de5">
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">including in-process research and development (&#8220;IPR&#38;D&#8221;) projects, and liabilities assumed are recorded at their respective fair values as of the acquisition date in the Company&#8217;s consolidated financial statements. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Contingent consideration obligations incurred in connection with a business combination (including the assumption of an acquiree&#8217;s liability arising from an acquisition it consummated prior to the Company&#8217;s acquisition) are recorded at their fair values on the acquisition date and remeasured at their fair values each subsequent reporting period until the related contingencies have been resolved. The resulting changes in fair values are recorded in earnings. In contrast, asset acquisitions are accounted for by using a cost accumulation and allocation model. Under this model, the cost of the acquisition is allocated to the assets acquired and liabilities assumed. IPR&#38;D projects with no alternative future use are recorded in R&#38;D expense upon acquisition, and contingent consideration obligations incurred in connection with an asset acquisition are recorded when it is probable that they will occur and they can be reasonably estimated. See Note 3 &#8211; </span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisition</span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">s</span><span style="font-style:normal;">.</span></p></ix:continuation><ix:nonNumeric id="F_000529" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Goodwill and Other Intangible Assets </span>&#8212; <span style="Background-color:#FFFFFF;font-style:normal;">The fair value of acquired intangible assets is determined using an income-based approach referred to as the excess earnings method utilizing Level 3 fair value inputs. Market participant valuations assume a global view considering all potential jurisdictions and indications based on discounted after-tax cash flow projections, risk adjusted for estimated probability of technical and regulatory success. </span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company tests for impairment annually on a reporting unit basis, at the beginning of the Company&#8217;s fourth fiscal quarter and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. To the extent the carrying amount of a reporting unit is less than its estimated fair value, an impairment charge will be recorded.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life. Estimated useful lives are determined considering the period assets are expected to contribute to future cash flows. Finite-lived intangible assets are tested for impairment when facts or circumstances suggest that the carrying value of the asset may not be recoverable.&#160;If the carrying value exceeds the projected undiscounted pretax cash flows of the intangible asset, an impairment loss equal to the excess of the carrying value over the estimated fair value (discounted after-tax cash flows) is recognized.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000614" name="us-gaap:GoodwillImpairmentLoss" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000615" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span> impairments to goodwill or other intangible assets were recorded during the year ended December 31, 2022.</p></ix:nonNumeric><ix:nonNumeric id="F_000530" name="mnkd:LossOnPurchaseCommitmentsPolicyPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recognized Loss on Purchase Commitments &#8212;<span style="font-style:normal;"> The Company assesses whether losses on long-term purchase commitments should be accrued. Losses that are expected to arise from firm, non-cancellable, commitments for the future purchases are recognized unless recoverable. When making the assessment, the Company also considers whether it is able to renegotiate with its vendors. The recognized loss on purchase commitments is reduced as inventory items are received. If, subsequent to an accrual, a purchase commitment is successfully renegotiated, the gain is recognized in the Company&#8217;s consolidated statements of operations. The liability balance of the recognized loss on insulin purchase commitments as of December 31, 2022 and 2021 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000616" name="us-gaap:PurchaseObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20221231" decimals="-5" scale="6">72.3</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000617" name="us-gaap:PurchaseObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20211231" decimals="-5" scale="6">82.8</ix:nonFraction> million, respectively. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"><ix:nonFraction unitRef="U_mnkdContract" id="F_000618" name="mnkd:LossOnPurchaseCommitmentsNumberOfContractsRecognized" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span>&#160;new contracts were identified in 2022 that required a new loss on purchase commitment accrual.</p></ix:nonNumeric><ix:nonNumeric id="F_000531" name="mnkd:MilestoneRightsLiabilityPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights Liability<span style="font-style:normal;">&#160;&#8212; </span><span style="font-style:normal;color:#000000;">In July 2013, in conjunction with the execution of a (now repaid) loan agreement with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (collectively, &#8220;Deerfield&#8221;), the Company entered into Milestone Rights Purchase Agreement (the &#8220;Milestone Rights Agreement&#8221;) pursuant to which the Company issued certain milestone rights to Deerfield Private Design Fund II, L.P. and Horizon Sant&#233; FLML S&#192;RL, (the &#8220;Original Milestone Purchasers&#8221;). The foregoing milestone rights provided the Original Milestone Purchasers certain rights to receive payments of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000620" name="mnkd:ContingentLiability" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">90.0</ix:nonFraction> million upon the occurrence of specified strategic and sales milestones, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000619" name="mnkd:ContingentLiabilityRemainingPayableAmount" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">60.0</ix:nonFraction> million of which remains payable upon achievement of such milestones (collectively, the &#8220;Milestone Rights&#8217;). In December 2021, the Milestone Rights were purchased by Barings Global Special Situations Credit Fund 4 (Delaware), L.P. and Barings Global Special Situations Credit 4 (LUX) S.ar.l. (together the &#8220;Milestone Purchasers&#8221;). As a result, the Milestone Purchasers have assumed the obligations of the Original Milestone Purchasers and is now entitled to all rights under the Milestone Rights Agreement. As of December 31, 2022, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000621" name="mnkd:ContingentLiabilityRemainingPayableAmount" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">60.0</ix:nonFraction> million remained payable pursuant to the Milestone Rights Agreement upon achievement of Afrezza net sales milestones. The Milestone Rights liability is reported at fair value at the date of the agreement which is periodically offset against payments. See Note 12</span><span style="font-style:normal;"> &#8211; </span>Fair Value of Financial Instruments<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#8217;s consolidated statements of operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. See Note&#160;10 &#8211; <span style="font-style:italic;">Borrowings</span>.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_076cb77c-9aef-4b3a-bb56-dbf3b697b10a" continuedAt="F_000490_dcnt_703eb5e3-e38f-438f-8700-460736c11099"><ix:nonNumeric id="F_000532" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments<span style="font-style:normal;"> &#8212;The Company applies various valuation approaches in determining the fair value of its financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#160;&#8212;&#160;Quoted prices for identical instruments in active markets.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#160;&#8212;&#160;Quoted prices for similar instruments in active markets&#59; quoted prices for identical or similar instruments in markets that are not active&#59; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#160;&#8212;&#160;Significant inputs to the valuation model are unobservable.</p></ix:nonNumeric><ix:nonNumeric id="F_000533" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Income Taxes<span style="font-style:normal;">&#160;&#8212; The provisions for federal, foreign, state and local income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets to amounts that are more likely than not to be realized.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For uncertain tax positions, the Company determines whether it is &#8220;more likely than not&#8221; that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, no tax benefit is recognized. </span>Penalties, if probable and reasonably estimable, are recognized as a component of income tax expense.<span style="Background-color:#FFFFFF;"> The Company has reduced its deferred tax assets for uncertain tax positions but has not recorded liabilities for income tax expense, penalties, or interest.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000534" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingencies<span style="font-style:normal;"> &#8212; The Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals represent management&#8217;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation and may revise its estimates.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000535" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation<span style="font-style:normal;"> &#8212; Share-based payments to employees, including grants of RSUs, performance-based non-qualified stock options awards (&#8220;PNQs&#8221;), restricted stock units with market conditions (&#8220;Market RSUs&#8221;), options and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. RSUs are valued based on the market price on the grant date. Market RSUs are valued using a Monte Carlo valuation model and RSUs with performance conditions are evaluated for the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000536" name="mnkd:ClinicalTrialExpensePolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Trial Expenses<span style="font-style:normal;"> &#8212; Clinical trial expenses, which are primarily reflected in research and development expenses in the accompanying consolidated statements of operations, result from obligations under contracts with vendors, consultants and clinical site agreements in addition to internal costs associated with conducting clinical trials.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000537" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Income (Loss) Per Share of Common Stock<span style="font-style:normal;"> &#8212; Basic net income or loss per share excludes dilution for potentially dilutive securities and is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted net loss per share as they would be anti-dilutive.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000538" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards <span style="font-style:normal;">&#8212; </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued a new accounting standard to ease the financial reporting burdens caused by the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, commonly referred to as reference rate reform. The new standard provides temporary optional expedients and exceptions to current GAAP guidance on contract modifications and hedge accounting. In January 2021, the FASB issued a new accounting standard that expanded the scope of the original March 2020 standard to include derivative instruments on discounting transactions. In December 2022, the FASB deferred the sunset date to an alternative reference rate from December 31, 2022 to December 31, 2024. The Company adopted these standards in the third quarter of 2022 using the prospective method and determined there was no impact on the Company&#8217;s consolidated financial statements.</span></p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000490_dcnt_703eb5e3-e38f-438f-8700-460736c11099"><ix:nonNumeric id="F_000539" name="mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Standards<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">In November 2021, the FASB issued a new accounting standard around the recognition and measurement of contract assets and contract liabilities from revenue contracts with customers acquired in a business combination. The new standard clarifies that contract assets and contract liabilities acquired in a business combination from an acquiree should initially be recognized by applying revenue recognition principles and not at fair value. The standard is effective for interim and annual periods beginning on January 1, 2023, and early adoption is permitted. The impact of this standard will depend on the facts and circumstances of future transactions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial position or results of operations upon adoption.</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000491" name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000491_dcnt_88ad2d0c-ad42-405f-a9e3-08718168356e">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Acquisitions</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">V-Go</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_000622">May 2022</span>, the Company entered into an Asset Purchase Agreement (the &#8220;APA&#8221;) to purchase from Zealand Pharma A/S and Zealand Pharma US, Inc. (together &#8220;Zealand&#8221;) certain assets and assume certain liabilities associated with the V-Go wearable insulin delivery device. The transaction closed on <ix:nonNumeric id="F_000623" name="us-gaap:AssetAcquisitionEffectiveDateOfAcquisition" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" format="ixt:datemonthdayyearen">May 31, 2022</ix:nonNumeric> (the &#8220;Acquisition Date&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the APA, the Company paid up-front consideration of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000624" name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-5" scale="6">15.3</ix:nonFraction> million for certain assets and assumed liabilities related to V-Go. In addition, the Company will be obligated to make one-time, sales-based milestone payments to Zealand totaling up to a maximum of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000625" name="mnkd:AssetAcquisitionMilestonePaymentPayable" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531" decimals="-5" scale="6">10.0</ix:nonFraction> million upon the achievement of specified annual revenue milestones between $<ix:nonFraction unitRef="U_iso4217USD" id="F_000626" name="mnkd:AnnualRevenueMilestonesRangesForMilestonePayments" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-6" scale="6">40</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000627" name="mnkd:AnnualRevenueMilestonesRangesForMilestonePayments" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-6" scale="6">100</ix:nonFraction> million.</p><ix:nonNumeric id="F_000541" name="us-gaap:AssetAcquisitionTableTextBlock" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total preliminary purchase consideration for V-Go was as follows (in tho<span style="Background-color:#FFFFFF;color:#000000;">usands):</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair value of consideration:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000628" name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">15,341</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of contingent consideration</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000629" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-3" scale="3">610</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000630" name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">15,951</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The transaction was accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and liabilities assumed to be recognized at their respective fair values as of the Acquisition Date. The excess of the purchase price over those fair values was recorded as goodwill, which will be amortized over a period of <ix:nonNumeric id="F_000631" name="mnkd:GoodwillAmortizationPeriod" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531" format="ixt-sec:duryear">15</ix:nonNumeric> years for tax purposes. The estimates and assumptions used include the projected timing and amount of future cash flows and discount rates to reflect the risk inherent in the future cash flows. The estimated fair values of assets acquired and liabilities assumed and resulting goodwill are subject to adjustment as the Company finalizes its purchase price accounting. The significant items for which a final fair value has not been determined include, but are not limited to the valuation of the intangible asset and assumed liabilities for rebates and return reserves. The Company does not expect its fair value determinations to materially change&#59; however, there may be differences between the amounts recorded at the Acquisition Date and the final fair value analysis, which is expected to be complete no later than the second quarter of 2023.</span></p><ix:nonNumeric id="F_000542" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands): </span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000632" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">11,152</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000633" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">2,921</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000634" name="us-gaap:Goodwill" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">2,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible asset - Developed technology</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000635" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">1,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000636" name="mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">1,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000637" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">19,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000638" name="mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">1,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000639" name="mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">1,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000640" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">3,562</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net assets acquired</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000641" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-3" format="ixt:numdotdecimal" scale="3">15,951</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000642" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531" decimals="-5" scale="6">11.2</ix:nonFraction> million consisted of raw materials, semi-finished goods and finished goods. The fair value of the inventory was determined based on the estimated selling price to be generated from the finished goods, less costs to sell, including a reasonable margin, which are level 3 inputs not observable in the market. Property and equipment and assumed liabilities were recorded at their carrying amounts which were deemed to approximate their fair values based on level 3 unobservable inputs. The fair values of the right-of-use assets and lease liabilities for assumed operating leases were assessed in accordance with ASC Topic 842, Leases, based on discounted cash flow from lease payments, utilizing the Company&#8217;s incremental borrowing rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000643" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0000899460_20220531" decimals="4" scale="-2">7.25</ix:nonFraction>%.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value of the intangible asset was determined by applying the income approach based on significant level 3 unobservable inputs. </span></p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000491_dcnt_88ad2d0c-ad42-405f-a9e3-08718168356e">
<p style="margin-top:12pt;margin-bottom:8pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value of the contingent milestone liability was estimated using the Monte Carlo simulation method for the calculation of the potential payment and the Geometric Brownian Motion forecasting model to estimate the underlying revenue. Market based inputs and other level 3 inputs were used to forecast future revenue. The key inputs used included a risk-free rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000644" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_20220531" decimals="2">2.95</ix:nonFraction>%, dividend yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_000645" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20220531" decimals="0">0</ix:nonFraction>%, volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_000646" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20220531" decimals="0">65</ix:nonFraction>%, period of <ix:nonFraction unitRef="U_mnkdYear" id="F_000647" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_20220531" decimals="0">15</ix:nonFraction> years and credit risk of <ix:nonFraction unitRef="U_xbrlipure" id="F_000648" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputEntityCreditRiskMember_20220531" decimals="0">12</ix:nonFraction>%.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company incurred acquisition-related costs of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000649" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220101_20221231" decimals="-5" scale="6">0.4</ix:nonFraction> million for the year ended December 31, 2022.</span></p><ix:nonNumeric id="F_000543" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Net revenue and loss from operations for the year ended December 31, 2022 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000650" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">12.9</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000651" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">0.3</ix:nonFraction> million, respectively</span>, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):</p>
<p style="margin-top:18pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Supplemental Pro Forma Information (unaudited)</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.08%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000652" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">109,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000653" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,278</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000654" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">86,967</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000655" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,806</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000656" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000657" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">QrumPharma<span style="font-style:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_000660">December 2020</span>, the Company acquired QrumPharma, Inc., a privately held pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. <ix:nonNumeric id="F_000544" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000544_cnt_1">The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company&#8217;s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands):</ix:nonNumeric> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000544_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Consideration</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000661" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,574</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock consideration (<ix:nonFraction unitRef="U_xbrlishares" id="F_000668" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="INF" format="ixt:numdotdecimal">3,067,179</ix:nonFraction> shares at $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000669" name="us-gaap:BusinessAcquisitionSharePrice" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201231" decimals="2">3.01</ix:nonFraction> per share)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000662" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transaction costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000663" name="us-gaap:PaymentsForMergerRelatedCosts" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" scale="3">531</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of debt</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000664" name="mnkd:BusinessAcquisitionRepaymentOfDebt" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" scale="3">11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000665" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" scale="3">22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash acquired</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000666" name="us-gaap:CashAcquiredFromAcquisition" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" scale="3">155</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total consideration paid for IPR&#38;D</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000667" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,233</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The stock purchase of QrumPharma was accounted for under ASC 805, Business Combinations, as an asset acquisition since the transaction did not include the acquisition of inputs or processes and the fair value of the assets acquired were concentrated in a single identifiable asset, MNKD-101, which consisted of an in-process research and development asset (&#8220;IPR&#38;D&#8221;). Under ASC 805, an entity that acquires IPR&#38;D in an asset acquisition should follow the guidance in ASC 730, Research and Development, which requires that both tangible and intangible identifiable research and development assets with no alternative future use be allocated a portion of the consideration transferred and charged to expense at the acquisition date. Due to the stage of development of MNKD-101 at the date of acquisition, significant risk remained that the product would not obtain regulatory approval and it was not yet probable that there would be future economic benefit for the Company. Absent successful clinical results and regulatory approval, it was determined that there was no alternative future use associated with MNKD-101. Accordingly, the value of this asset was expensed at the time of acquisition and the total accumulated cost of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000670" name="mnkd:BusinessCombinationAccumulatedCost" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="-5" scale="6">13.2</ix:nonFraction> million, was allocated to the IPR&#38;D asset using a relative fair value basis and the total consideration was recognized as in-process research and development expense in the consolidated statement of operations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The acquisition of QrumPharma also included a potential future royalty payment of <ix:nonFraction unitRef="U_xbrlipure" id="F_000671" name="mnkd:PercentageOfRoyaltyPaymentOnNetSales" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201231" decimals="3" scale="-2">1.5</ix:nonFraction>% of net sales in each of the calendar years in which the total annual and global adjusted net sales of specified products exceeds $<ix:nonFraction unitRef="U_iso4217USD" id="F_000672" name="mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201201_20201231" decimals="-6" scale="6">50</ix:nonFraction> million and a royalty payment of <ix:nonFraction unitRef="U_xbrlipure" id="F_000673" name="mnkd:PercentageOfRoyaltyPaymentOnNetSales" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201231" decimals="3" scale="-2">1.0</ix:nonFraction>% of net sales in each of the calendar years in which the total annual and global adjusted net sales of nebulized clofazimine are greater than or equal to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000674" name="mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201201_20201231" decimals="-6" scale="6">200</ix:nonFraction> million. The contingent consideration in the form of royalty payments will be expensed as incurred since the probability of MNKD-101 obtaining FDA approval and generating net sales that exceed the specified thresholds could not be reasonably estimated on the date of acquisition.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000492" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Investments</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash Equivalents <span style="font-style:normal;">&#8212; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $<ix:nonFraction unitRef="U_iso4217USD" id="F_000675" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231" decimals="-5" scale="6">69.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000676" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-5" scale="6">124.2</ix:nonFraction> million, respectively, of cash and cash equivalents.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Available-for-Sale Investment</span><span style="Background-color:#FFFFFF;font-style:normal;"> &#8212; The Thirona convertible note is classified as an available-for-sale security and is included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using level 3 inputs. As of December 31, 2022, the Company evaluated the fair value of its investment in Thirona using a Monte Carlo simulation which resulted in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000677" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231" decimals="-5" scale="6">7.1</ix:nonFraction> million. </span><span style="font-style:normal;color:#000000;">In addition, the Company determined that there was a related credit loss of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000678" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231" decimals="-5" scale="6">0.9</ix:nonFraction> million on the investment which was recognized in the consolidated statements of operations for the year ended December 31, 2022.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Held-to-Maturity Investments <span style="font-style:normal;">&#8212; Investments consist of highly liquid investments that are intended to facilitate liquidity and capital preservation. As of December 31, 2022, the Company held $<ix:nonFraction unitRef="U_iso4217USD" id="F_000679" name="us-gaap:ShortTermInvestments" contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231" decimals="-5" scale="6">101.1</ix:nonFraction> million of short-term investments and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000681" name="us-gaap:LongTermInvestments" contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231" decimals="-5" scale="6">2.0</ix:nonFraction> million of long-term investments. As of December 31, 2021, the Company held $<ix:nonFraction unitRef="U_iso4217USD" id="F_000680" name="us-gaap:ShortTermInvestments" contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231" decimals="-5" scale="6">79.9</ix:nonFraction> million of short-term investments and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000682" name="us-gaap:LongTermInvestments" contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231" decimals="-5" scale="6">56.6</ix:nonFraction> million of long-term investments.</span> The amortization or accretion of the Company&#8217;s investments is recognized as interest income in the consolidated statements of operations and was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000683" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000684" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">0.5</ix:nonFraction> million for the years ended December 31, 2022 and 2021, respectively. <ix:nonFraction unitRef="U_iso4217USD" id="F_000685" name="us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" contextRef="C_0000899460_20221231" decimals="INF" format="ixt-sec:numwordsen" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000686" name="us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" contextRef="C_0000899460_20211231" decimals="INF" format="ixt-sec:numwordsen" scale="6">No</ix:nonFraction></ix:nonFraction> allowance for credit losses on held-to-maturity securities was required as of December 31, 2022 or 2021.</p><ix:nonNumeric id="F_000545" name="us-gaap:HeldToMaturitySecuritiesTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The contractual maturities of the Company&#8217;s held to maturity investments as of December 31, 2022 and 2021 are summarized below (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due in one year or less<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000687" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">152,862</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000693" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">156,976</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000688" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">103,733</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000694" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">103,669</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due after one year through five years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000689" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,961</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000695" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,948</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000690" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,619</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000696" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">56,433</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000691" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">154,823</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000697" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">158,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000692" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">160,352</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000698" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">160,102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;font-size:9pt;"><ix:footnote id="FNT_000000" xml:lang="en-US">The investments due in one year or less include cash equivalents of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000699" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20221231" decimals="-5" scale="6">51.8</ix:nonFraction> million as of December 31, 2022 and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000700" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20211231" decimals="-5" scale="6">23.8</ix:nonFraction> million as of December 31, 2021.</ix:footnote></span><span style="color:#000000;"> </span></p></td></tr></table></div></ix:nonNumeric><ix:nonNumeric id="F_000546" name="mnkd:ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the cash equivalents, long-term and short-term investments are disclosed below (in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000701" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">66.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000702" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231" decimals="-5" scale="6">0.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000703" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">66.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000704" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">51.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000705" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">51.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000706" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">36.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000707" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231" decimals="-5" scale="6">0.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000708" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">35.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000709" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">154.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000710" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231" decimals="-5" scale="6">1.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000711" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">153.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000712" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">51.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000713" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">51.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000714" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231" decimals="-5" scale="6">103.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000715" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231" decimals="-5" scale="6">1.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000716" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231" decimals="-5" scale="6">101.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000717" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">115.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000718" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231" decimals="-5" scale="6">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000719" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">115.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000720" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">21.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000721" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">21.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000722" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">23.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000723" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231" decimals="-5" scale="6">0.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000724" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">23.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000725" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">160.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000726" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231" decimals="-5" scale="6">0.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000727" name="mnkd:CashEquivalentsAndInvestments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">160.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000728" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">23.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000729" name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">23.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000730" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231" decimals="-5" scale="6">136.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000731" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231" decimals="-5" scale="6">0.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000732" name="us-gaap:Investments" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231" decimals="-5" scale="6">136.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, there was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000733" name="mnkd:AccruedInterestReceivable" contextRef="C_0000899460_20221231" decimals="-5" scale="6">0.6</ix:nonFraction> million of accrued interest receivable and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000735" name="mnkd:AmountReceivableOnMaturedInvestment" contextRef="C_0000899460_20221231" decimals="-5" scale="6">5.1</ix:nonFraction> million of amount receivable on matured investment recognized as prepaid expense and other current assets in our consolidated balance sheets. As of December 31, 2021, there was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000734" name="mnkd:AccruedInterestReceivable" contextRef="C_0000899460_20211231" decimals="-5" scale="6">0.3</ix:nonFraction> million of accrued interest receivable recognized as other assets in our consolidated balance sheets.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000493" name="us-gaap:FinancingReceivablesTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Accounts Receivable</p><ix:nonNumeric id="F_000547" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; commercial</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000736" name="us-gaap:AccountsReceivableGrossCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,359</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000737" name="us-gaap:AccountsReceivableGrossCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,939</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wholesaler distribution fees and prompt pay discounts</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000738" name="mnkd:WholesalerDistributionFeesAndPromptPayDiscounts" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,536</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000739" name="mnkd:WholesalerDistributionFeesAndPromptPayDiscounts" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,696</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for returns</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000740" name="mnkd:ReserveForReturns" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000741" name="mnkd:ReserveForReturns" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,797</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; commercial, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000742" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,715</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000743" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,446</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000744" name="us-gaap:AccountsReceivableGrossCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,086</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000745" name="us-gaap:AccountsReceivableGrossCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000746" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231" decimals="-3" scale="3">767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; collaborations and services, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000747" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,086</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000748" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,293</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000749" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,801</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000750" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022 and December 31, 2021, the allowance for credit losses was <span style="font-style:italic;">de minimis</span>. As of December 31, 2022 and December 31, 2021, the Company had <ix:nonFraction unitRef="U_mnkdDistributor" id="F_000751" name="mnkd:NumberOfWholesaleDistributors" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_mnkdDistributor" id="F_000752" name="mnkd:NumberOfWholesaleDistributors" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></ix:nonFraction> wholesale distributors representing approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_000753" name="mnkd:PercentageOfAccountsReceivableFromMajorCustomers" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231" decimals="2" scale="-2">74</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000754" name="mnkd:PercentageOfAccountsReceivableFromMajorCustomers" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231" decimals="2" scale="-2">80</ix:nonFraction>% of gross sales and <ix:nonFraction unitRef="U_xbrlipure" id="F_000755" name="mnkd:PercentageOfSalesFromMajorCustomers" contextRef="C_0000899460_20220101_20221231" decimals="2" scale="-2">79</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000756" name="mnkd:PercentageOfSalesFromMajorCustomers" contextRef="C_0000899460_20210101_20211231" decimals="2" scale="-2">79</ix:nonFraction>% of accounts receivable, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, there was <ix:nonFraction unitRef="U_iso4217USD" id="F_000757" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0000899460_20221231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> allowance for credit losses for accounts receivable &#8211; collaborations and revenue. &#160;The Company had one collaboration partner, United Therapeutics, that comprised <ix:nonFraction unitRef="U_xbrlipure" id="F_000758" name="mnkd:PercentageOfCollaborationsAndServicesNetAccountsReceivables" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231" decimals="2" scale="-2">100</ix:nonFraction>% of the collaboration and services net accounts receivable as of December 31, 2022 and approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_000759" name="mnkd:PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" contextRef="C_0000899460_20220101_20221231" decimals="2" scale="-2">98</ix:nonFraction>% of gross revenue from collaborations and services for the year ended December 31, 2022.</p><ix:nonNumeric id="F_000548" name="mnkd:ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue net of gross-to-net adjustments<span style="color:#000000;">.</span> The activities and ending reserve balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prompt Pay Discount Reserve, Allowance for Wholesale Distribution Fees</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and Accounts Receivables Return Reserve:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000760" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,493</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000761" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000762" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,471</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000763" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000764" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">15,320</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000765" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">10,874</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000766" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,644</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000767" name="mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,493</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000494" name="us-gaap:InventoryDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Inventories</p><ix:nonNumeric id="F_000549" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories consist of the following (in thousands): </p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000768" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000769" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work-in-process</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000770" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,815</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000771" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000772" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000773" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,927</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventory</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000774" name="us-gaap:InventoryNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000775" name="us-gaap:InventoryNet" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,152</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work-in-process and finished goods as of December 31, 2022 and 2021 include conversion costs and exclude the cost of insulin. All insulin inventory on hand was written off and the projected loss on the purchase commitment contract to purchase future insulin was accrued as of the end of 2016. Raw materials inventory included $<ix:nonFraction unitRef="U_iso4217USD" id="F_000777" name="us-gaap:InventoryRawMaterials" contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20211231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000776" name="us-gaap:InventoryRawMaterials" contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20221231" decimals="-5" scale="6">0.8</ix:nonFraction></ix:nonFraction> million of pre-launch inventory as of December 31, 2022 and 2021, which consisted of FDKP received in November 2019 that will be used to manufacture Afrezza under an enhanced manufacturing process for FDKP. The Company expects to receive FDA approval of the new source of FDKP in 2024. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company analyzed its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company also performed an assessment of projected sales and evaluated the lower of cost or net realizable value and the potential excess inventory on hand at December 31, 2022 and 2021. Inventory that was forecasted to become obsolete due to expiration as well as inventory that does not meet acceptable standards is recorded in costs of goods sold in the accompanying consolidated statements of operations. <span style="font-family:Calibri;">T</span><span style="Background-color:#FFFFFF;color:#000000;">here was an inventory write-off of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000778" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">2.2</ix:nonFraction> million as a result of this assessment for the year ended December 31, 2022. </span>For the year ended December 31, 2021, there was an inventory write-off of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000779" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">1.9</ix:nonFraction> million as a result of this assessment, including $<ix:nonFraction unitRef="U_iso4217USD" id="F_000781" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdAgreementWithRetailPharmacyMember_20210101_20211231" decimals="-5" scale="6">0.7</ix:nonFraction> million related to the start of an agreement with a retail pharmacy. There was an inventory write-off of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000780" name="us-gaap:ProductionRelatedImpairmentsOrCharges" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">0.5</ix:nonFraction> million for the year ended December 31, 2020.&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000495" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Property and Equipment</p><ix:nonNumeric id="F_000550" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Land</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000782" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20221231" decimals="-3" scale="3">875</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000783" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20211231" decimals="-3" scale="3">875</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000802">39-40</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000784" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000785" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building improvements</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">5-40</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000786" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,952</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000787" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,651</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Machinery and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">3-15</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000788" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">58,542</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000789" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">55,334</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture, fixtures and office equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">5-10</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000790" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,976</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000791" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,969</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000810">3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000792" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,246</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000793" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000794" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,706</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000795" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,892</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000796" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">143,686</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000797" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">134,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000798" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">98,560</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000799" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">97,661</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000800" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,126</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000801" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">As of December 31, 2021 construction in progress included $<ix:nonFraction unitRef="U_iso4217USD" id="F_000811" name="us-gaap:ConstructionInProgressGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20211231" decimals="-5" scale="6">4.7</ix:nonFraction> million of equipment under construction for the manufacturing expansion for UT (the &#8220;UT Equipment&#8221;). There is <ix:nonFraction unitRef="U_iso4217USD" id="F_000812" name="us-gaap:ConstructionInProgressGross" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20221231" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> balance under construction for the UT Equipment as of December 31, 2022. The Company acts as agent on behalf of UT for the procurement of the UT Equipment. The Company has received $<ix:nonFraction unitRef="U_iso4217USD" id="F_000813" name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20210101_20211231" decimals="-5" scale="6">5.0</ix:nonFraction> million in deposit for this service, which was recognized as deposits from customer in the consolidated balance sheet as of December 31, 2021. In April 2022, the Company and UT agreed that UT would hold title to the UT Equipment at all times. As such, there is <ix:nonFraction unitRef="U_iso4217USD" id="F_000814" name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20220101_20221231" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction> balance related to the UT Equipment included in construction in progress or deposits from customer in our consolidated balance sheet as of December 31, 2022. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements.</span></p></td></tr></table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000815" name="us-gaap:Depreciation" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">3.3</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000816" name="us-gaap:Depreciation" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000817" name="us-gaap:Depreciation" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">1.8</ix:nonFraction>&#160;million, respectively. During the years ended December 31, 2022 and 2021, the Company retired $<ix:nonFraction unitRef="U_iso4217USD" id="F_000818" name="us-gaap:PropertyPlantAndEquipmentDisposals" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20220101_20221231" decimals="-5" scale="6">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000819" name="us-gaap:PropertyPlantAndEquipmentDisposals" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20210101_20211231" decimals="-5" scale="6">1.1</ix:nonFraction> million, respectively of manufacturing equipment, computer hardware and software, computer equipment, lab equipment, and building improvements, as it was no longer in service. The net book value for the disposed assets was <span style="font-style:italic;">de minimis</span>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On <ix:nonNumeric id="F_000823" name="us-gaap:SaleLeasebackTransactionDate" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">November 8, 2021</ix:nonNumeric>, the Company sold certain land, building and improvements located in Danbury, CT (the &#8220;Property&#8221;) to an affiliate of Creative Manufacturing Properties (the &#8220;Purchaser&#8221;) for a sales price of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000820" name="us-gaap:ProceedsFromSaleOfRealEstate" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108" decimals="-5" scale="6">102.3</ix:nonFraction> million, subject to the terms and the conditions contained in a purchase and sale agreement. Effective with the closing of this transaction, the Company entered into a <ix:nonNumeric id="F_000821" name="mnkd:SaleLeasebackTransactionLeaseAgreementPeriods" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108" format="ixt-sec:duryear">20</ix:nonNumeric>-year lease agreement with the Purchaser (the &#8220;Sale-Leaseback Transaction&#8221;). The sale of the Property and subsequent lease did not result in the transfer of control of the Property to the Purchaser&#59; therefore, the Sale-Leaseback Transaction qualified as a failed sale leaseback transaction whereby the lease is accounted for as finance lease and the Property remains as a long-lived asset of the Company and is depreciated at its remaining useful life of <ix:nonNumeric id="F_000822" name="mnkd:SaleLeasebackTransactionLeaseAgreementPeriods" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108" format="ixt-sec:duryear">20</ix:nonNumeric> years or less. See Note 16 &#8211; <span style="font-style:italic;">Commitments and Contingencies</span><span style="font-family:Calibri;">.</span></p></ix:nonNumeric><ix:nonNumeric id="F_000496" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000496_dcnt_0038fb93-e460-4add-8178-eb46d698a68c">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.<span style="Background-color:#FFFFFF;color:#000000;"> Goodwill and Other Intangible Asset&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill<span style="font-style:normal;"> &#8212; Goodwill represents the excess of the purchase price over the identifiable tangible and intangible assets acquired plus liabilities assumed arising from business combinations. The balance of goodwill was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000824" name="us-gaap:Goodwill" contextRef="C_0000899460_20221231" decimals="-5" scale="6">2.4</ix:nonFraction> million as of December 31, 2022 as a result of our acquisition of V-Go in May 2022. Goodwill is tested at least annually for impairment by assessing qualitative factors in determining whether it is more likely than not that the fair value of net assets is below their carrying amounts. See Note 2 &#8211; </span>Summary of Significant Accounting Policies<span style="font-style:normal;">.</span></p><ix:nonNumeric id="F_000551" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Intangible Asset <span style="font-style:normal;">&#8212; Other intangible asset consisted of the following (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">15</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000832" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000833" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231" decimals="-3" scale="3">47</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000834" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,153</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization expense related to the other intangible asset was <span style="font-style:italic;">de minimis</span> for the year ended December 31, 2022. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated annual amortization expense for the other intangible asset for the years ended December 31, 2023 through 2027 will be approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000825" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="C_0000899460_20221231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000826" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="C_0000899460_20221231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000829" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="C_0000899460_20221231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000827" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="C_0000899460_20221231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000828" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="C_0000899460_20221231" decimals="-5" scale="6">0.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million per year and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000830" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="C_0000899460_20221231" decimals="-5" scale="6">0.7</ix:nonFraction> million, thereafter.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its other intangible asset for potential impairment when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. <span style="font-style:italic;">See Note 2 &#8211; Summary of Significant Accounting Policies</span>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000496_dcnt_0038fb93-e460-4add-8178-eb46d698a68c">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000497" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Accrued Expenses and Other Current Liabilities</p><ix:nonNumeric id="F_000552" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities are comprised of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Salary and related expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000835" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,906</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000836" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,022</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000837" name="mnkd:CustomerDiscountsAndAllowances" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,504</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000838" name="mnkd:CustomerDiscountsAndAllowances" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Returns reserve for acquired product</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000839" name="mnkd:ReturnsReserveForAcquiredProduct" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,013</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000840" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,136</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000841" name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="C_0000899460_20211231" decimals="-3" scale="3">895</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred lease liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000842" name="us-gaap:DirectFinancingLeaseDeferredSellingProfit" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,304</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000843" name="us-gaap:DirectFinancingLeaseDeferredSellingProfit" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,380</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of milestone rights liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000844" name="mnkd:CurrentPortionOfMilestoneRightLiability" contextRef="C_0000899460_20221231" decimals="-3" scale="3">924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000845" name="mnkd:CurrentPortionOfMilestoneRightLiability" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,088</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000846" name="us-gaap:InterestPayableCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,201</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000847" name="us-gaap:InterestPayableCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,166</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Retail inventory purchase</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000848" name="mnkd:RetailInventoryPurchase" contextRef="C_0000899460_20211231" decimals="-3" scale="3">875</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Danbury facility buildout</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000849" name="us-gaap:ConstructionPayableCurrent" contextRef="C_0000899460_20221231" decimals="-3" scale="3">846</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000850" name="us-gaap:ConstructionPayableCurrent" contextRef="C_0000899460_20211231" decimals="-3" scale="3">786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000851" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,719</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000852" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,980</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000853" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,553</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000854" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,419</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000553" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The provision for discounts and allowances for commercial product sales is reflected as a component of net revenues. The activities and ending balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000855" name="mnkd:DiscountsAndAllowancesForCommercialProductSales" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000856" name="mnkd:DiscountsAndAllowancesForCommercialProductSales" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,688</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000857" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,369</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000858" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,057</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000859" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,603</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000860" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,518</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go opening balance sheet</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000861" name="mnkd:DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,511</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000862" name="mnkd:DiscountsAndAllowancesForCommercialProductSales" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,504</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000863" name="mnkd:DiscountsAndAllowancesForCommercialProductSales" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,227</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000498" name="us-gaap:DebtDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000498_dcnt_5ec86480-2d7f-4f07-b067-94663f005480">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10. Borrowings</p><ix:nonNumeric id="F_000554" name="us-gaap:ScheduleOfDebtTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amount of the Company&#8217;s borrowings consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000864" name="us-gaap:SeniorNotes" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">225,397</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000865" name="us-gaap:SeniorNotes" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">223,944</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group promissory notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000866" name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000867" name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,425</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000868" name="us-gaap:LineOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000869" name="us-gaap:LineOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,833</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt &#8212; net carrying amount</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000870" name="us-gaap:LongTermDebt" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">273,490</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000871" name="us-gaap:LongTermDebt" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">281,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000001" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The amendment to the Mann Group convertible note in the second quarter of 2021 resulted in a substantial premium of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000872" name="mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231" decimals="-5" scale="6">22.1</ix:nonFraction> million based on the fair value post modification, which contributed to the loss on extinguishment in the consolidated statement of operations for the year ended December 31, 2021 and was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000873" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" sign="-" scale="6">22.1</ix:nonFraction> million loss on extinguishment did not result in a change in the financial position of the Company.</span></p></ix:footnote></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p><ix:nonNumeric id="F_000555" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000555_dcnt_862f04ae-fd99-45d5-8fce-6415f7b095f9">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of the Company&#8217;s debt and key terms: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.12%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount Due</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terms</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual&#160;Interest&#160;Rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maturity Date</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Conversion Price</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000874" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="-5" scale="6">230.0</ix:nonFraction>&#160;million</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000877" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231" decimals="-5" scale="6">230.0</ix:nonFraction> million</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000886" name="mnkd:DebtInstrumentMaturityMonthAndYear" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231" format="ixt:datemonthyearen">March 2026</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5.21</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000875" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">40.0</ix:nonFraction>&#160;million</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000878" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">40.0</ix:nonFraction> million</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">one-month</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SOFR (1% floor)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plus&#160;6.25%&#59;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cap of 8.25%</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000887" name="mnkd:DebtInstrumentMaturityMonthAndYear" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231" format="ixt:datemonthyearen">August&#160;2025</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_000876" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231" decimals="-5" scale="6">8.8</ix:nonFraction> million</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">$18.4 million (plus $0.4 million accrued interest paid-in-kind)</span></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000888" name="mnkd:DebtInstrumentMaturityMonthAndYear" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" format="ixt:datemonthyearen">December 2025</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.50</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000002" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $<ix:nonFraction unitRef="U_iso4217USD" id="F_000889" name="us-gaap:EarlyRepaymentOfSeniorDebt" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430" decimals="-5" scale="6">10.0</ix:nonFraction> million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (<ix:nonFraction unitRef="U_xbrlipure" id="F_000890" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210430" decimals="2" scale="-2">2</ix:nonFraction>% floor) plus <ix:nonFraction unitRef="U_xbrlipure" id="F_000891" name="mnkd:DebtInstrumentFloorRate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210401_20210430" decimals="4" scale="-2">6.75</ix:nonFraction>% and the maturity date was in <ix:nonNumeric id="F_000892" name="mnkd:DebtInstrumentMaturityMonthAndYear" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_20210401_20210430" format="ixt:datemonthyearen">August 2024</ix:nonNumeric>. </span><span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The interest rate prior to the amendment was one-month LIBOR (<ix:nonFraction unitRef="U_xbrlipure" id="F_000896" name="mnkd:DebtInstrumentFloorRate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831" decimals="2" scale="-2">1</ix:nonFraction>% floor) plus <ix:nonFraction unitRef="U_xbrlipure" id="F_000895" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220831" decimals="4" scale="-2">6.25</ix:nonFraction>% (cap of <ix:nonFraction unitRef="U_xbrlipure" id="F_000897" name="mnkd:DebtInstrumentCapInterestRate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831" decimals="4" scale="-2">8.25</ix:nonFraction>%).</span></p></ix:footnote></td></tr></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000498_dcnt_5ec86480-2d7f-4f07-b067-94663f005480" continuedAt="F_000498_dcnt_d1df482e-c8ff-405b-bc1f-dbde95f7b2e6"><ix:continuation id="F_000555_dcnt_862f04ae-fd99-45d5-8fce-6415f7b095f9">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;"><ix:footnote id="FNT_000003" xml:lang="en-US">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was <ix:nonFraction unitRef="U_xbrlipure" id="F_000893" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210430" decimals="4" scale="-2">7.00</ix:nonFraction>% and the maturity date was in <ix:nonNumeric id="F_000894" name="mnkd:DebtInstrumentMaturityMonthAndYear" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210401_20210430" format="ixt:datemonthyearen">November 2024</ix:nonNumeric>.</ix:footnote></span></p></td></tr></table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000556" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The maturities of the Company&#8217;s borrowings as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amounts</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000898" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,667</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000899" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000900" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000901" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">230,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000902" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">278,830</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000903" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0000899460_20221231" decimals="-3" scale="3">235</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000904" name="us-gaap:DeferredFinanceCostsNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,105</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000905" name="us-gaap:LongTermDebt" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">273,490</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Senior convertible notes &#8211; <span style="font-style:normal;">In March 2021, the Company issued $<ix:nonFraction unitRef="U_iso4217USD" id="F_000906" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210331" decimals="-5" scale="6">200.0</ix:nonFraction> million aggregate principal amount of Senior convertible notes in a private offering. Pursuant to an option to purchase additional senior convertible notes in the purchase agreement between the Company and the initial purchasers of the Senior convertible notes, the Company issued an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000907" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210315" decimals="-5" scale="6">30.0</ix:nonFraction> million aggregate principal amount of Senior convertible notes on March 15, 2021. The Senior convertible notes were issued pursuant to an indenture, dated March 4, 2021 (the &#8220;Indenture&#8221;), between the Company and U.S. Bank National Association, as trustee.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Senior convertible notes are general unsecured obligations of the Company and will mature on <ix:nonNumeric id="F_000908" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231" format="ixt:datemonthdayyearen">March 1, 2026</ix:nonNumeric>, unless earlier converted, redeemed or repurchased. The Senior convertible notes will bear cash interest from March 4, 2021 at an annual rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000909" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="4" scale="-2">2.50</ix:nonFraction>% payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2021. The Senior convertible notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000910" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="2">0.01</ix:nonFraction> per share, for at least <ix:nonFraction unitRef="U_utrD" id="F_000911" name="mnkd:NumberOfTradingDays" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="INF">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="U_utrD" id="F_000912" name="mnkd:ConsecutiveTradingDays" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="INF">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000913" name="mnkd:DebtInstrumentConvertibleConversionPricePercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231" decimals="2" scale="-2">130</ix:nonFraction>% of the conversion price for the Senior convertible notes on each applicable trading day&#59; (2) during the five business day period after any ten consecutive trading day period in which the trading price (as defined in the Indenture) per $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000914" name="mnkd:PrincipalAmountPerShare" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231" decimals="0" format="ixt:numdotdecimal">1,000</ix:nonFraction> principal amount of the Senior convertible notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000915" name="mnkd:MeasurementPeriodPercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231" decimals="2" scale="-2">98</ix:nonFraction>% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day&#59; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Senior convertible notes called (or deemed called) for redemption&#59; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after December 1, 2025 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the common stock or a combination of cash and shares of common stock, at the Company&#8217;s election, in the manner and subject to the terms and conditions provided in the Indenture.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial conversion rate is <ix:nonFraction unitRef="U_xbrlipure" id="F_000919" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="4">191.8281</ix:nonFraction> shares of common stock per $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000916" name="mnkd:PrincipalAmountPerShare" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="0" format="ixt:numdotdecimal">1,000</ix:nonFraction> principal amount of Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000917" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304" decimals="INF">5.21</ix:nonFraction> per share of common stock). The initial conversion price of the Senior convertible notes represents a premium of approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_000918" name="mnkd:DebtInstrumentInitialConversionPriceOfPremiumPercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="2" scale="-2">30</ix:nonFraction>% to the last reported sale price of the common stock on the Nasdaq Global Market on March 1, 2021. The conversion rate for the Senior convertible notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date of the Senior convertible notes or if the Company delivers a notice of redemption in respect of the Senior convertible notes, the Company will, in certain circumstances, increase the conversion rate of the Senior convertible notes for a holder who elects to convert its Senior convertible notes in connection with such a corporate event or convert its Notes called for redemption during the related redemption period (as defined in the Indenture), as the case may be.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may not redeem the Senior convertible notes prior to March 6, 2024. <ix:nonNumeric id="F_000928" name="us-gaap:DebtInstrumentRedemptionDescription" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231">The Company may redeem for cash all or any portion of the Senior convertible notes, at its option, on or after <ix:nonNumeric id="F_000923" name="us-gaap:DebtInstrumentRedemptionPeriodStartDate" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" format="ixt:datemonthdayyearen"><ix:nonNumeric id="F_000924" name="us-gaap:DebtInstrumentRedemptionPeriodStartDate" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" format="ixt:datemonthdayyearen">March 6, 2024</ix:nonNumeric></ix:nonNumeric> and prior to the 36th scheduled trading day immediately preceding the maturity date, if the last reported sale price of common stock has been at least <ix:nonFraction unitRef="U_xbrlipure" id="F_000922" name="mnkd:DebtInstrumentConvertibleConversionPricePercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="2" scale="-2">130</ix:nonFraction>% of the conversion price for the Senior convertible notes then in effect for at least <ix:nonFraction unitRef="U_utrD" id="F_000920" name="mnkd:NumberOfTradingDays" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304" decimals="INF">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="U_utrD" id="F_000921" name="mnkd:ConsecutiveTradingDays" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304" decimals="INF">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000925" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal amount of the Senior convertible notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem less than all of the outstanding Senior convertible notes, at least $<ix:nonFraction unitRef="U_iso4217USD" id="F_000926" name="mnkd:DebtInstrumentOutstandingPrincipalAmountRedeemed" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304" decimals="-5" scale="6">75.0</ix:nonFraction> million aggregate principal amount of Senior convertible notes must be outstanding and not subject to redemption as of the relevant redemption notice date. <ix:nonFraction unitRef="U_iso4217USD" id="F_000927" name="us-gaap:DebtInstrumentSinkingFundPayment" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="INF" format="ixt-sec:numwordsen" scale="3">No</ix:nonFraction> sinking fund is provided for the Senior convertible notes.</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as described in the Indenture, holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000929" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal amount of the Senior convertible notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000498_dcnt_d1df482e-c8ff-405b-bc1f-dbde95f7b2e6" continuedAt="F_000498_dcnt_aed47f8f-ed53-4782-8fa1-80a2edb2483b">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Indenture includes customary covenants and sets forth certain events of default after which the Senior convertible notes may be declared immediately due and payable. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000932" name="us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231">If certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries) occur, <ix:nonFraction unitRef="U_xbrlipure" id="F_000930" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal of and accrued and unpaid interest on the Senior convertible notes will automatically become due and payable. If an event of default with respect to the Senior convertible notes, other than certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries), occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Senior convertible notes by notice to the Company and the trustee, may, and the trustee at the request of such holders shall, declare <ix:nonFraction unitRef="U_xbrlipure" id="F_000931" name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304" decimals="INF" scale="-2">100</ix:nonFraction>% of the principal of and accrued and unpaid interest, if any, on all the Senior convertible notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the Senior convertible notes as set forth in the Indenture</ix:nonNumeric>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Indenture provides that the Company shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of the consolidated properties and assets of the Company and its subsidiaries, taken as a whole, to, another person (other than any such sale, conveyance, transfer or lease to one or more of the Company&#8217;s direct or indirect wholly owned subsidiaries), unless: (i) the resulting, surviving or transferee person (if not the Company) is a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and such corporation (if not the Company) expressly assumes by supplemental indenture all of the Company&#8217;s obligations under the Senior convertible notes and the Indenture&#59; and (ii) immediately after giving effect to such transaction, no default or event of default has occurred and is continuing under the Indenture.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company&#8217;s net proceeds from the offering were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000933" name="us-gaap:ProceedsFromConvertibleDebt" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210101_20211231" decimals="-5" scale="6">222.7</ix:nonFraction> million, after deducting the initial purchasers&#8217; discounts and commissions and the estimated offering expenses payable by the Company. As of December 31, 2022 and 2021, the unamortized debt issuance cost was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000935" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231" decimals="-5" scale="6">4.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000934" name="us-gaap:UnamortizedDebtIssuanceExpense" contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231" decimals="-5" scale="6">6.1</ix:nonFraction> million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility &#8212; In August 2019, the Company entered into the MidCap credit facility and borrowed the first advance of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000936" name="us-gaap:ProceedsFromSecuredLinesOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831" decimals="-5" scale="6">40.0</ix:nonFraction> million (&#8220;Tranche 1&#8221;) in August 2019 and the second advance of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000937" name="us-gaap:ProceedsFromSecuredLinesOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20200101_20201231" decimals="-5" scale="6">10.0</ix:nonFraction> million (&#8220;Tranche 2&#8221;) in December 2020. In April 2021, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000938" name="mnkd:PrepaymentOfSecuredLinesOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430" decimals="-5" scale="6">10.0</ix:nonFraction> million was prepaid. Under the terms of the MidCap credit facility, a third advance of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000939" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20190831" decimals="-5" scale="6">60.0</ix:nonFraction> million (&#8220;Tranche 3&#8221;) became available to the Company after the Tyvaso DPI approval by the FDA through June 30, 2022 (see Note 11 &#8211; Collaboration, Licensing and Other Arrangements). The Company did not exercise its right to borrow Tranche 3.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000945" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20220101_20221231">The Mid Cap credit facility has been amended several times, including in April 2021, when the parties agreed to, among other things, (i) increase the amount available under the third advance from $<ix:nonFraction unitRef="U_iso4217USD" id="F_000940" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210331" decimals="-5" scale="6">25.0</ix:nonFraction> million to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000941" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422" decimals="-5" scale="6">60.0</ix:nonFraction> million and extend the date through which the third advance is available to <ix:nonNumeric id="F_000942" name="mnkd:DebtInstrumentAdvanceAvailableDate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422" format="ixt:datemonthdayyearen">June 30, 2022</ix:nonNumeric>, (ii) amend the conditions to the third advance of $60.0 million being available to draw, including certain milestone conditions associated with Tyvaso DPI, (iii) remove the Company&#8217;s obligation to issue a warrant to purchase shares of the Company&#8217;s common stock upon drawing down the third advance, (iv) extend the interest-only period until <ix:nonNumeric id="F_000943" name="mnkd:DebtInstrumentExtendedInterestOnlyDate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422" format="ixt:datemonthdayyearen">September 1, 2023</ix:nonNumeric> and extend the maturity date until <ix:nonNumeric id="F_000944" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422" format="ixt:datemonthdayyearen">August 1, 2025</ix:nonNumeric>, (v) amend the financial covenant relating to trailing 12 month minimum Afrezza net revenue, (vi) decrease the minimum cash covenant, (vii) decrease the interest rate on any amounts outstanding, now or in the future, under the MidCap credit facility, (viii) permit the Company to make certain acquisitions, subject to requirements, and (ix) permit the Company to make investments of up to an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000946" name="mnkd:MaximumValueOfAdditionalInvestmentLimit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422" decimals="INF" scale="6">9.0</ix:nonFraction> million so long as the Company has $<ix:nonFraction unitRef="U_iso4217USD" id="F_000947" name="mnkd:DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422" decimals="-5" scale="6">90.0</ix:nonFraction> million or more of unrestricted cash and short-term investments following such investment.</ix:nonNumeric> Concurrent with entering into this amendment, the Company made a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000948" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422" decimals="-5" scale="6">10.0</ix:nonFraction> million principal prepayment against outstanding term loans under the MidCap credit facility and paid a related $<ix:nonFraction unitRef="U_iso4217USD" id="F_000949" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422" decimals="-5" scale="6">1.0</ix:nonFraction> million exit fee in lieu of the unaccrued portion of the original exit fee and prepayment penalties that would otherwise have been due with respect to the partial prepayment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the prepayment penalty of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000950" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231" decimals="-5" scale="6">1.0</ix:nonFraction> million related to the payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000951" name="mnkd:PrepaymentOfSecuredLinesOfCredit" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231" decimals="-5" scale="6">10.0</ix:nonFraction> million was capitalized and will be amortized over the remaining life of the debt. As of December 31, 2022, the unamortized debt discount was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000953" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">0.2</ix:nonFraction> million and the unamortized prepayment penalty was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000955" name="mnkd:DebtInstrumentUnamortizedPrepaymentPenalty" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">0.5</ix:nonFraction> million. As of December 31, 2021, the unamortized debt discount was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000952" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">0.4</ix:nonFraction> million and the unamortized prepayment penalty was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000954" name="mnkd:DebtInstrumentUnamortizedPrepaymentPenalty" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">0.8</ix:nonFraction> million.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2022, the Company entered into the tenth amendment to the MidCap credit facility to change the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;).</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000498_dcnt_aed47f8f-ed53-4782-8fa1-80a2edb2483b" continuedAt="F_000498_dcnt_86e364bc-b2db-42d4-ba22-f064d5477cbc">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tranche 1 and Tranche 2 accrue interest at an annual rate equal to the lesser of (i) <ix:nonFraction unitRef="U_xbrlipure" id="F_000956" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831" decimals="4" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000957" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231" decimals="4" scale="-2">8.25</ix:nonFraction></ix:nonFraction>% and (ii) the one-month SOFR (subject to a one-month SOFR floor of <ix:nonFraction unitRef="U_xbrlipure" id="F_000960" name="mnkd:DebtInstrumentFloorRate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831" decimals="4" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000961" name="mnkd:DebtInstrumentFloorRate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231" decimals="4" scale="-2">1.00</ix:nonFraction></ix:nonFraction>%) plus <ix:nonFraction unitRef="U_xbrlipure" id="F_000958" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831" decimals="4" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000959" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231" decimals="4" scale="-2">6.25</ix:nonFraction></ix:nonFraction>%. Interest on each term loan advance is due and payable monthly in arrears. <ix:nonNumeric id="F_000968" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0000899460_20220101_20221231">Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in <ix:nonFraction unitRef="U_mnkdInstallment" id="F_000962" name="mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831" decimals="INF"><ix:nonFraction unitRef="U_mnkdInstallment" id="F_000963" name="mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231" decimals="INF">24</ix:nonFraction></ix:nonFraction> equal monthly installments beginning <ix:nonNumeric id="F_000964" name="mnkd:LineOfCreditFacilityPrincipalPaymentStartDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831" format="ixt:datemonthdayyearen"><ix:nonNumeric id="F_000965" name="mnkd:LineOfCreditFacilityPrincipalPaymentStartDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231" format="ixt:datemonthdayyearen">September 1, 2023</ix:nonNumeric></ix:nonNumeric>, until paid in full on <ix:nonNumeric id="F_000966" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831" format="ixt:datemonthdayyearen"><ix:nonNumeric id="F_000967" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231" format="ixt:datemonthdayyearen">August 1, 2025</ix:nonNumeric></ix:nonNumeric>.</ix:nonNumeric> The Company has the option to prepay its existing term loans, in whole or in part, subject to early termination fees in an amount equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000970" name="mnkd:EarlyTerminationFeesPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodOneMember_20220101_20221231" decimals="4" scale="-2">3.00</ix:nonFraction>% of principal prepaid if prepayment occurs on or prior to April 22, 2022&#59; <ix:nonFraction unitRef="U_xbrlipure" id="F_000969" name="mnkd:EarlyTerminationFeesPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20220101_20221231" decimals="4" scale="-2">2.00</ix:nonFraction>% of principal prepaid if prepayment occurs on or after April 23, 2022 through and including April 22, 2023&#59; and <ix:nonFraction unitRef="U_xbrlipure" id="F_000971" name="mnkd:EarlyTerminationFeesPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodThreeMember_20220101_20221231" decimals="4" scale="-2">1.00</ix:nonFraction>% of principal prepaid if prepayment occurs on or after April 23, 2023 through the maturity date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s obligations under the MidCap credit facility are secured by a security interest on substantially all of its assets, including intellectual property.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The MidCap credit facility, as amended, contains customary affirmative covenants and customary negative covenants limiting the Company&#8217;s ability and the ability of the Company&#8217;s subsidiaries to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock and make investments, in each case subject to certain exceptions. The Company must also comply with a financial covenant relating to trailing twelve month minimum Afrezza net revenue, tested on a monthly basis, unless the Company has $<ix:nonFraction unitRef="U_iso4217USD" id="F_000972" name="mnkd:DebtInstrumentMinimumCashCovenant" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831" decimals="-5" scale="6">90.0</ix:nonFraction> million or more of unrestricted cash and short-term investments. As of December 31, 2022, the Company was in compliance with the financial covenants.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The MidCap credit facility also contains customary events of default relating to, among other things, payment defaults, breaches of covenants, a material adverse change, listing of the Company&#8217;s common stock, bankruptcy and insolvency, cross defaults with certain material indebtedness and certain material contracts, judgments, and inaccuracies of representations and warranties. Upon an event of default, the agent and the lenders may declare all or a portion of the Company&#8217;s outstanding obligations to be immediately due and payable and exercise other rights and remedies provided for under the MidCap credit facility. During the existence of an event of default, interest on the term loans could be increased by <ix:nonFraction unitRef="U_xbrlipure" id="F_000973" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190806_20190806" decimals="4" scale="-2">2.00</ix:nonFraction>%.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also agreed to issue warrants to purchase shares of the Company&#8217;s common stock (the &#8220;MidCap warrants&#8221;) upon the drawdown of Tranches 1 and 2 in an aggregate amount equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000974" name="mnkd:TermLoanAdvancePercentageOfAmountDrawdown" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190801_20190831" decimals="4" scale="-2">3.25</ix:nonFraction>% of the amount drawn, divided by the exercise price per share for that tranche. The exercise price per share is equal to the volume-weighted average closing price of the Company&#8217;s common stock for the ten business days immediately preceding the second business day before the issue date. As a result of Tranche 1, the Company issued warrants to purchase an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000975" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831" decimals="INF" format="ixt:numdotdecimal">1,171,614</ix:nonFraction> shares of the Company&#8217;s common stock, at an exercise price equal to $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000977" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831" decimals="2">1.11</ix:nonFraction> per share. As a result of Tranche 2, the Company issued warrants to purchase an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_000976" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231" decimals="INF" format="ixt:numdotdecimal">111,853</ix:nonFraction> shares of the Company&#8217;s common stock, at an exercise price equal to $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000978" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231" decimals="2">2.91</ix:nonFraction> per share. The Company determined that these warrants met the criteria for equity classification and accounted for such warrants in additional paid-in capital. During the year ended December 31, 2021, the Tranche 1 and Tranche 2 MidCap warrants were exercised in full.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Mann Group promissory notes<span style="font-style:normal;"> &#8212; In August 2019, the Company issued a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000979" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831" decimals="-5" scale="6">35.0</ix:nonFraction> million </span><span style="font-style:normal;color:#000000;">note that is convertible into shares of the Company&#8217;s common stock at $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000980" name="us-gaap:SharePrice" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831" decimals="2">2.50</ix:nonFraction> per share (the &#8220;Mann Group convertible note&#8221;)</span><span style="font-style:normal;"> and issued a non-convertible note to Mann Group in an aggregate principal amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000981" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertibleNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831" decimals="-5" scale="6">35.1</ix:nonFraction> million (the &#8220;Mann Group non-convertible note&#8221; and</span><span style="font-style:normal;color:#000000;">, together with the Mann Group convertible note, the &#8220;Mann Group promissory notes&#8221;)</span><span style="font-style:normal;"> as part of a restructuring of its then existing indebtedness to Mann Group.</span> </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mann Group promissory notes originally accrued interest at the rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000982" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831" decimals="INF" scale="-2">7.00</ix:nonFraction>% per year on the principal amount, payable <ix:nonNumeric id="F_000984" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">quarterly</ix:nonNumeric> in arrears on the first day of each calendar quarter beginning <ix:nonNumeric id="F_000985" name="us-gaap:DebtInstrumentDateOfFirstRequiredPayment1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831" format="ixt:datemonthdayyearen">October 1, 2019</ix:nonNumeric>. In April 2021, the Company repaid the entire principal amount of $35.1 million outstanding under the Mann Group non-convertible note, together with all accrued and unpaid interest thereon. On the same date, the Company and Mann Group amended the Mann Group convertible note, pursuant to which the parties agreed to (i) reduce the interest rate from 7.0% to <ix:nonFraction unitRef="U_xbrlipure" id="F_000983" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210422" decimals="INF" scale="-2">2.5</ix:nonFraction>% effective on April 22, 2021, and (ii) extend the maturity date from <ix:nonNumeric id="F_000986" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_20190801_20190831" format="ixt:datemonthdayyearen">November 3, 2024</ix:nonNumeric> to <ix:nonNumeric id="F_000987" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_20210422_20210422" format="ixt:datemonthdayyearen">December 31, 2025</ix:nonNumeric>. </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendment to the Mann Group convertible note resulted in a debt extinguishment with a substantial premium based on the fair value post extinguishment. The fair value in excess of the face amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000988" name="mnkd:DebtInstrumentFairValueInExcessOfFaceAmount" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231" decimals="-5" scale="6">18.4</ix:nonFraction> million contributed to a loss on extinguishment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000989" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">22.1</ix:nonFraction> million in the consolidated statement of operations for the year ended December 31, 2021 and resulted in a corresponding debt premium of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000991" name="mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231" decimals="-5" scale="6">22.1</ix:nonFraction> million which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000990" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">22.1</ix:nonFraction> million loss on extinguishment did not result in a change in the financial position of the Company. The Company wrote off a <span style="font-style:italic;">de minimis</span> amount of debt issuance cost.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The principal and any accrued and unpaid interest under the Mann Group convertible note may be converted, at the option of Mann Group, at any time on or prior to the close of business on the business day immediately preceding the stated maturity date, into shares of the Company&#8217;s common stock at a conversion rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_000992" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831" decimals="0">400</ix:nonFraction> shares per $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000993" name="mnkd:PrincipalAmountPerShare" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831" decimals="0" format="ixt:numdotdecimal">1,000</ix:nonFraction> of principal and/or accrued and unpaid interest, which is equal to a conversion price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000994" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831" decimals="2">2.50</ix:nonFraction> per share. The conversion rate will be subject to adjustment under certain circumstances described in the Mann Group convertible note. Interest on the convertible note will be payable in kind by adding the amount thereof to the principal amount&#59; provided that with respect to interest accruing from and after January 1, 2021, the Company may, at its option, elect to pay any such interest on any interest payment date, if certain conditions are met, in shares of the Company&#8217;s common stock at a price per shall equal to the last reported sale price on the trading day immediately prior to the payment date.&#160;&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000498_dcnt_86e364bc-b2db-42d4-ba22-f064d5477cbc">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the Mann Group convertible note, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000995" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">3.0</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of accrued interest and $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000996" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">7.0</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal into </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000998" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">1.2</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares and </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000997" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">2.8</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares, respectively, of the Company&#8217;s common stock in the fourth quarter of 2020. During the year ended December 31, 2021, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000999" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" scale="6">0.4</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of interest and $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001001" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" scale="6">9.6</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal into 4,000,000 shares of common stock.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> During the year ended December 31, 2022, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001000" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="-5" scale="6">10.0</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal and capitalized interest into </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001002" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_001003" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="0" format="ixt:numdotdecimal">4,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of common stock. In addition, the Company paid $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001004" name="us-gaap:InterestExpenseDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="-5" scale="6">0.3</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of interest by issuing the Mann Group </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001005" name="mnkd:CommonStockIssuedToPayInterest" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">75,487</ix:nonFraction></span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of common stock</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the year ended December 31, 2022</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">PPP loan<span style="font-style:normal;"> &#8211; In April 2020, the Company received the proceeds from the PPP loan from JPMorgan Chase Bank, N.A., as lender, in the amount of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001006" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430" decimals="-5" scale="6">4.9</ix:nonFraction> million pursuant to the PPP of the CARES Act. In July 2021, the Company received notification from the U.S Small Business Administration that the full principal amount of the PPP loan was forgiven. The Company recognized a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001009" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20210101_20211231" decimals="-5" scale="6">4.9</ix:nonFraction> million gain on extinguishment of debt for the forgiveness of the principal amount and accrued but unpaid interest for the year ended December 31, 2021. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to being forgiven, the PPP loan was evidenced by a promissory note dated April 9, 2020 that matured on <ix:nonNumeric id="F_001007" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430" format="ixt:datemonthdayyearen">April 9, 2022</ix:nonNumeric> and bore interest at a rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001008" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200430" decimals="INF" scale="-2">0.98</ix:nonFraction>% per annum (which was being deferred). The Company used all proceeds from the PPP loan to retain employees, maintain payroll and make lease, interest and utility payments. </p><ix:nonNumeric id="F_000557" name="mnkd:ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of the premium and accretion of debt issuance costs related to all borrowings for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001010" name="mnkd:AmortizationOfDebtDiscount" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">431</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001011" name="mnkd:AmortizationOfDebtDiscount" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">377</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001012" name="mnkd:AmortizationOfDebtDiscount" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001013" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001014" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001015" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights &#8212;<span style="font-style:normal;"> As of December 31, 2022 and 2021, the remaining Milestone Rights liability balance was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001016" name="mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent" contextRef="C_0000899460_20221231" decimals="-5" scale="6">4.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001017" name="mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent" contextRef="C_0000899460_20211231" decimals="-5" scale="6">5.9</ix:nonFraction> million, respectively, which was based on initial fair value estimates calculated using the income approach and reduced by milestone achievement payments made. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">During the second quarter of 2022, the Company achieved an Afrezza net sales milestone specified by the Milestone Rights.</span><span style="font-style:normal;"> </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">The carrying value of the Milestone Rights liability related to the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001020" name="mnkd:PaymentForMilestoneRightsLiabilities" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">5.0</ix:nonFraction>&#160;million payment, which was made in the third quarter of 2022, was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001022" name="mnkd:MilestoneRightsLiabilityCurrent" contextRef="C_0000899460_20221231" decimals="-5" scale="6">1.1</ix:nonFraction>&#160;million and represented the fair value as determined in 2013 (the most recent measurement date).</span><span style="font-style:normal;"> As of December 31, 2022, the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001018" name="mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent" contextRef="C_0000899460_20221231" decimals="-5" scale="6">4.8</ix:nonFraction> million liability consisted of a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001024" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0000899460_20221231" decimals="-5" scale="6">0.9</ix:nonFraction> million current liability which was presented as accrued expenses and other current liabilities and a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001026" name="mnkd:MilestoneLiabilitiesNoncurrent" contextRef="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20221231" decimals="-5" scale="6">3.9</ix:nonFraction> million long-term liability which was presented in milestone liabilities in our consolidated balance sheets. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the first quarter of 2021, the Company achieved the second Afrezza net sales milestone specified by the Milestone Rights. <span style="color:#000000;">The milestone </span>carrying value of the Milestone Rights liability related to the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001021" name="mnkd:PaymentForMilestoneRightsLiabilities" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">5.0</ix:nonFraction> million payment, which was made in the second quarter of 2021, was approxim<span style="color:#000000;">ately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001023" name="mnkd:MilestoneRightsLiabilityCurrent" contextRef="C_0000899460_20211231" decimals="-5" scale="6">1.3</ix:nonFraction> million, and represented the fair value as determined in 2013 (the most recent measurement date).</span> As of December 31, 2021, the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001019" name="mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent" contextRef="C_0000899460_20211231" decimals="-5" scale="6">5.9</ix:nonFraction> million liability consisted of a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001025" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0000899460_20211231" decimals="-5" scale="6">1.1</ix:nonFraction> million current liability which was presented as accrued expenses and other current liabilities and a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001027" name="mnkd:MilestoneLiabilitiesNoncurrent" contextRef="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20211231" decimals="-5" scale="6">4.8</ix:nonFraction> million long-term liability which was presented in milestone liabilities in our consolidated balance sheets.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Milestone Rights Agreement includes customary representations and warranties and covenants by the Company, including restrictions on transfers of intellectual property related to Afrezza. The Milestone Rights are subject to acceleration in the event the Company transfers its intellectual property related to Afrezza in violation of the terms of such agreement. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000499" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000499_dcnt_70b2f8de-c933-4d5c-8c0a-e1046e9a584f">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. Collaboration, Licensing and Other Arrangements</p><ix:nonNumeric id="F_000558" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000558_cnt_1">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from collaborations and services for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p></ix:nonNumeric><ix:continuation id="F_000558_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001028" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,826</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001029" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231" decimals="-3" scale="3">267</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (2)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001030" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,426</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001031" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001032" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vertice Pharma Co-Promotion Agreement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001033" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20220101_20221231" decimals="-3" scale="3">325</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001034" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001035" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20220101_20221231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001036" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20210101_20211231" decimals="-3" scale="3">323</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cipla License and Distribution Agreement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001037" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20220101_20221231" decimals="-3" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001038" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20210101_20211231" decimals="-3" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001039" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20200101_20201231" decimals="-3" scale="3">147</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Receptor CLA</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001040" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231" decimals="-3" scale="3">245</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001041" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20200101_20201231" decimals="-3" scale="3">250</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT Research Agreement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001042" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdResearchAgreementMember_20200101_20201231" decimals="-3" scale="3">210</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001043" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001044" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,274</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001045" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000004" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000005" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Next-Gen R&#38;D Services and R&#38;D Services and License for the periods presented.</span></p></ix:footnote></td></tr></table></div></ix:continuation><ix:nonNumeric id="F_000559" name="mnkd:ContractWithCustomerLiabilityTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000559_dcnt_fe75e3f9-f19f-4061-9e79-500350968867">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000499_dcnt_70b2f8de-c933-4d5c-8c0a-e1046e9a584f" continuedAt="F_000499_dcnt_5130b94d-0085-4906-a6f4-8e80e01787f5"><ix:continuation id="F_000559_dcnt_fe75e3f9-f19f-4061-9e79-500350968867">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The activity related to deferred revenue and the related revenue recognized for collaborations and services is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001046" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,370</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001047" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,937</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001048" name="mnkd:ContractWithCustomerLiabilityAdditions" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">46,971</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001049" name="mnkd:ContractWithCustomerLiabilityAdditions" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,707</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001050" name="mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">27,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001051" name="mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">36,274</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001052" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,417</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001053" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,370</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">United Therapeutics License Agreement<span style="font-style:normal;"> &#8212; In September 2018, the Company and UT entered into an exclusive global license and collaboration agreement (the &#8220;UT License Agreement&#8221;), pursuant to which UT is responsible for global development, regulatory and commercial activities with respect to Tyvaso DPI. The Company is responsible for manufacturing clinical supplies and commercial supplies of Tyvaso DPI.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000560" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from UT for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UT Revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001054" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,826</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001055" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231" decimals="-3" scale="3">267</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001056" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,426</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001057" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,145</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001058" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties &#8212; Collaborations <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001059" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdRoyaltiesArrangementMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,599</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from UT</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001060" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,851</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001061" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,412</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001062" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000006" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Amount consists of royalties associated with the UT License Agreement. </span></p></ix:footnote></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:3.12%;text-indent:1.13%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The current portion of contract assets related to the royalties is included in prepaid expense and other current assets in the consolidated balance sheets.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the UT License Agreement, the Company received an upfront payment of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001063" name="mnkd:UpfrontPaymentReceived" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20181031" decimals="-5" scale="6">45.0</ix:nonFraction> million in October 2018 and four $<ix:nonFraction unitRef="U_iso4217USD" id="F_001064" name="mnkd:MilestonePaymentReceived" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20190401_20201130" decimals="-5" scale="6">12.5</ix:nonFraction> million milestone payments between April 2019 and November 2020. The Company will also be entitled to receive low double-digit royalties on net sales of Tyvaso DPI as well as a manufacturing margin on commercial supplies of the product. UT, at its option, may expand the scope of the products covered by the UT License Agreement to include products with certain other active ingredients for the treatment of pulmonary arterial hypertension. Each such optioned product would be subject to UT&#8217;s payment to the Company of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_001065" name="mnkd:AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="INF" scale="6">40.0</ix:nonFraction> million in additional option exercise and development milestone payments, as well as a low double-digit royalty on net sales of any such product. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the inception of the agreement, the Company identified one distinct, performance obligation. The Company determined that the key deliverables include the license, supply of product to be used in clinical development, and certain research services upon achievement of specified development targets (&#8220;R&#38;D Services&#8221;). Due to the specialized and unique nature of these services and their direct relationship with the license, the Company has determined that these deliverables represent one distinct bundle and thus, one performance obligation. The Company also determined that UT&#8217;s option to expand the scope of the products to include products with other active ingredients is not a material right, and thus, not a performance obligation at the onset of the agreement. The consideration for the option will be accounted for upon exercise of the option.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expected to complete the activities specified in the initial development plan and to achieve the milestone events by December 31, 2021 for total consideration of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001066" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">105.8</ix:nonFraction> million, which included an upfront payment, four milestone payments, various pass-through costs and payments for clinical supplies. <ix:nonNumeric id="F_000561" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000561_cnt_1">Revenue was allocated as follows:</ix:nonNumeric>&#160;&#160;</p><ix:continuation id="F_000561_cnt_1" continuedAt="F_000561_cnt_2">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Period</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001067" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">105.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001068" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="2" scale="-2">100</ix:nonFraction>%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001069" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Ratably</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001070" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Sep 2018 - Dec 2021</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000007" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Recognition period represents the estimated period to satisfy the performance obligation.</span></p></ix:footnote></td></tr></table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, UT and the Company updated the development plan under the UT License Agreement to provide for additional process-development and stability-testing activities as well as the expansion of the Company&#8217;s commercial manufacturing capacity. The activities and deliverables under the current development plan resulted in four distinct performance obligations which include: (1) the continued development and approval process for an NDA (&#8220;R&#38;D Services&#8221;)&#59; (2) certain pre-commercial services in preparation for commercial launch of Tyvaso DPI (&#8220;Pre-Commercial Services&#8221;)&#59; (3) development activities for the next generation of Tyvaso DPI (&#8220;Next-Gen R&#38;D Services&#8221;)&#59; and (4) certain design and construction activities in anticipation of expansion of the Company&#8217;s commercial manufacturing facility (&#8220;Facility Expansion Services&#8221;).</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000499_dcnt_5130b94d-0085-4906-a6f4-8e80e01787f5" continuedAt="F_000499_dcnt_6c2073c9-4f78-44b6-ad7e-f94492f36b7f">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he total consideration for the updated development plan of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_001071" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">50.9</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million was allocated to the four distinct performance obligations based on management&#8217;s assessment of the stand-alone selling price of each performance obligation. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reve</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nue was allocated as follows:</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><ix:continuation id="F_000561_cnt_2">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total transaction price</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001072" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_20211031" decimals="-5" scale="6">50.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001073" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031" decimals="-5" scale="6">18.4</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001077" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">Ratably</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001080" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">May 2021 - Oct 2021</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-Commercial Services</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001074" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031" decimals="-5" scale="6">4.6</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001078" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001081" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&#38;D Services</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001075" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031" decimals="-5" scale="6">7.2</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001079" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001082" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility Expansion Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001076" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031" decimals="-5" scale="6">20.7</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001083" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031_20211031">Transfer of control</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
<tr>
<td colspan="16" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000008" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000010" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&#38;D Services performance obligation will be substantially complete.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000011" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&#38;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000009" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $<ix:nonFraction unitRef="U_iso4217USD" id="F_001084" name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="C_0000899460_20211031_20211031" decimals="-5" scale="6">5.0</ix:nonFraction> million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000012" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.</span></p></ix:footnote></td></tr></table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2021, the Company and UT entered into a commercial supply agreement (as amended, the &#8220;CSA&#8221;), pursuant to which the Company is responsible for manufacturing and supplying to UT, and UT is responsible for purchasing from the Company on a cost-plus basis, Tyvaso DPI and BluHale inhalation profiling devices, as required for commercial distribution and sale by UT. In addition, UT is responsible for supplying treprostinil at its expense in quantities necessary to enable the Company to manufacture Tyvaso DPI as required by the CSA. Also pursuant to the CSA, UT will remit a reimbursement of certain pre-production costs incurred by the Company to support the manufacturing and supply of Tyvaso DPI.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The activities and deliverables under the CSA and the current development plan resulted in three distinct performance obligations which include: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&#38;D Services and License&#8221;)&#59; (2) development activities for the next generation of Tyvaso DPI (&#8220;Next-Gen R&#38;D Services&#8221;)&#59; and (3) a material right associated with current and future commercial manufacturing and supply of product (&#8220;Manufacturing Services&#8221;). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total revised anticipated cash flows of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001085" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210831" decimals="-5" scale="6">221.5</ix:nonFraction> million from the transaction was allocated to the three distinct performance obligations as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000562" name="mnkd:ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000562_dcnt_c21e18cf-1a04-4cf3-a849-0dcf6e68ff93">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001086" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812" decimals="-5" scale="6">221.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001087" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812" decimals="-5" scale="6">6.0</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001090" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">Ratably</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001092" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">Aug 2021 - Oct 2021</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&#38;D Services</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001088" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812" decimals="-5" scale="6">8.8</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001091" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001093" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001089" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812" decimals="-5" scale="6">206.7</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001094" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">Transfer of control</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;"><ix:footnote id="FNT_000013" xml:lang="en-US">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license&#59; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.</ix:footnote></span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&#38;D Services performance obligation will be substantially complete.</span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000014" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Next-Gen R&#38;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000015" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer&#59; therefore, <ix:nonFraction unitRef="U_iso4217USD" id="F_001095" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></ix:footnote></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000499_dcnt_6c2073c9-4f78-44b6-ad7e-f94492f36b7f" continuedAt="F_000499_dcnt_78baf6f2-b809-4ef9-8e5f-69e151335aa7"><ix:continuation id="F_000562_dcnt_c21e18cf-1a04-4cf3-a849-0dcf6e68ff93">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001096" name="mnkd:AgreementAmendmentDescription" contextRef="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">As amended , the term of the CSA continues until December 31, 2031 (unless earlier terminated) and is thereafter renewed automatically for additional, successive two-year terms unless (i) United Therapeutics provides notice to the Company at least 24 months in advance of such renewal that United Therapeutics does not wish to renew the CSA or (ii) the Company provides notice to United Therapeutics at least 48 months in advance of such renewal that the Company does not wish to renew the CSA.</ix:nonNumeric> The Company and United Therapeutics each have normal and customary termination rights, including termination for material breach that is not cured within a specific timeframe or in the event of liquidation, bankruptcy or insolvency of the other party.</p><ix:nonNumeric id="F_000563" name="mnkd:ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounted for the contract modification as if it were part of the existing contract since the amendment modified the scope and price of the CSA by extending the term and increasing the occupancy rate. The effect of the modification on the transaction price and on the measure of progress is recognized as an adjustment to revenue as of the date of the modification. The modification did not result in a change the activities and deliverables under the CSA. The total revised anticipated cash flows of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001097" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">463.5</ix:nonFraction> million from the transaction was allocated to the three distinct performance obligations as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001098" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">463.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001101" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">Ratably</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001103" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">Aug 2021 - Oct 2021</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&#38;D Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001099" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">4.8</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001102" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001104" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(6)</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(7)</sup></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001100" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">458.7</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001105" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">Transfer of control</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(8)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000016" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001106" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">64.3</ix:nonFraction> million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&#38;D Services performance obligations and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001107" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016" decimals="-5" scale="6">399.2</ix:nonFraction> million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000019" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license&#59; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000020" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&#38;D Services performance obligation was recognized.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000017" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The standalone selling price (&#8220;SSP&#8221;) for the Next-Gen R&#38;D Services performance obligation was based on industry ratios as well as the Company&#8217;s historical R&#38;D projects. The transaction price for the Next-Gen R&#38;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Next-Gen R&#38;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</span></p></td>
<td valign="top"><ix:footnote id="FNT_000018" xml:lang="en-US">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#8217;s Manufacturing Services performance obligation, given the nature of the Company&#8217;s contractual responsibilities and ASC 606 requirements.</span></p></ix:footnote></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(8)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><ix:footnote id="FNT_000021" xml:lang="en-US"><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001108" name="mnkd:AllocatedTransactionPrice" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016" decimals="-5" scale="6">144.5</ix:nonFraction> million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received</span>.</ix:footnote></p></td></tr></table></div></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000499_dcnt_78baf6f2-b809-4ef9-8e5f-69e151335aa7" continuedAt="F_000499_dcnt_abf3c18b-8ed6-4a0d-a8e4-8163288edf91">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2022,&#160;the Company and UT agreed to fund $<ix:nonFraction unitRef="U_iso4217USD" id="F_001116" name="us-gaap:PaymentsForCapitalImprovements" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430" decimals="-5" scale="6">2.3</ix:nonFraction> million in capital improvements to support commercialization and continuous improvement activities and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001117" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430" decimals="-5" scale="6">0.7</ix:nonFraction> million in the development of alternative manufacturing processes. The Company determined that the capital improvements and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&#38;D Services and as such no additional performance obligations were noted. <span style="color:#000000;">The total revised anticipated cash flows of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001115" name="mnkd:AllocatedTransactionPrice" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430" decimals="-5" scale="6">483.2</ix:nonFraction> million from the transaction was allocated to the three distinct performance obligations as follows.</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001118" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430" decimals="-5" scale="6">483.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001121" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">Ratably</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001123" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">Aug 2021 - Oct 2021</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&#38;D Services</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001119" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430" decimals="-5" scale="6">5.9</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001122" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001124" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Product Sales<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001120" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430" decimals="-2" scale="3">477.2</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001125" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">Transfer of control</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001126" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430" decimals="-5" scale="6">71.5</ix:nonFraction> million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&#38;D Services performance obligations and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001127" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430" decimals="-5" scale="6">411.7</ix:nonFraction> million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $150.2 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2022,&#160;the Company and UT agreed to fund an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_001129" name="us-gaap:PaymentsForCapitalImprovements" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231" decimals="-5" scale="6">39.5</ix:nonFraction> million to support capital and continuous improvement activities and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001130" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231" decimals="-5" scale="6">2.3</ix:nonFraction> million in the development of alternative manufacturing processes. The Company determined that the capital and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&#38;D Services. <span style="color:#000000;">The total revised anticipated cash flows of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001128" name="mnkd:AllocatedTransactionPrice" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221201_20221231" decimals="-5" scale="6">722.3</ix:nonFraction> million from the transaction was allocated to the three distinct performance obligations as follows.</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001131" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">722.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&#38;D Services and License</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001134" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Ratably</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001136" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Aug 2021 - Oct 2021</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&#38;D Services</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001132" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">10.0</ix:nonFraction></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001135" name="us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Input</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001137" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">% of completion of costs</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Product Sales<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001133" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-2" scale="3">712.3</ix:nonFraction></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001138" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">Transfer of control</ix:nonNumeric></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001139" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">120.0</ix:nonFraction> million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&#38;D Services performance obligations and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001140" name="mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow" contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">602.3</ix:nonFraction> million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $220.8 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, deferred revenue consisted of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001110" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231" decimals="-5" scale="6">37.9</ix:nonFraction> million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001112" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231" decimals="-5" scale="6">1.6</ix:nonFraction> million was classified as current and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001114" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231" decimals="-5" scale="6">36.3</ix:nonFraction> million was classified as long-term on the consolidated balance sheet. As of December 31, 2021, deferred revenue consisted of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001109" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">18.6</ix:nonFraction> million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001111" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">0.6</ix:nonFraction> million was classified as current and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001113" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231" decimals="-5" scale="6">18.0</ix:nonFraction> million was classified as long-term on the consolidated balance sheet.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Vertice Pharma Co-Promotion Agreement<span style="font-style:normal;"> &#8212; In December 2020, the Company entered into a co-promotion agreement with Vertice Pharma pursuant to which the Company&#8217;s sales force promoted Thyquidity to healthcare providers who treat hypothyroidism. Vertice Pharma was obligated to pay fixed quarterly payments to the Company, as well as variable consideration based on gross profits resulting from all sales of Thyquidity. Vertice Pharma launched Thyquidity in collaboration with the Company in February 2021.</span></p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000499_dcnt_abf3c18b-8ed6-4a0d-a8e4-8163288edf91">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At inception of the agreement, the Company identified a single performance obligation that the Company will satisfy over time. The Company estimated the total transaction price was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001141" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231" decimals="-5" scale="6">6.3</ix:nonFraction> million, consisting of fixed consideration and the unconstrained amount of estimated variable consideration, which was based on gross profit applied to defined revenue benchmarks. The amount of variable consideration was constrained to the amount for which it was probable that a significant reversal of cumulative revenue recognized will not occur and the payments will be received. At the end of each subsequent reporting period, the Company re-evaluated the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusted its estimate of the overall transaction price. Any such adjustments were recorded on a cumulative catch-up basis in the period of adjustment. The total transaction price was recognized over a <span style="-sec-ix-hidden:F_001143">two-year</span> period during which the Company was required to satisfy its performance obligation, using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponded with, and thereby best depicts, the transfer of control to the customer. In July 2021, the Company and Vertice Pharma entered into an amendment to the Vertice Pharma Co-Promotion Agreement that modified the terms of payment where <ix:nonFraction unitRef="U_xbrlipure" id="F_001142" name="mnkd:PercentageOfModificationOfPreviouslyFixedConsideration" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdAmendmentToCoPromotionAgreementMember_20210701_20210701" decimals="2" scale="-2">50</ix:nonFraction>% of the previously fixed consideration was subject to certain promotional conditions, resulting in variable consideration.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2021, the Company and Vertice Pharma mutually agreed that the Company would cease promotional activities under the co-promotion agreement effective September 30, 2021, other than certain transitional activities that continued until October 15, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company fully reserved $<ix:nonFraction unitRef="U_iso4217USD" id="F_001144" name="us-gaap:ContractWithCustomerReceivableAllowanceForCreditLoss" contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20211231" decimals="-5" scale="6">0.8</ix:nonFraction> million of revenue from the co-promotion of Thyquidity, which was recognized as allowance for credit losses &#8211; collaborations and services, which is included in accounts receivable, net in the consolidated balance sheet. In addition, the Company recognized an impairment on contract assets of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001145" name="us-gaap:CapitalizedContractCostImpairmentLoss" contextRef="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million related to variable consideration from gross profits which was recognized during the year ended December 31, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2022, the Company and Vertice Pharma reached a final settlement of all obligations related to the termination of the co-promotion agreement of $0.3 million, which was recognized as revenue from collaboration and services in the Company&#8217;s consolidated statement of operations and the balance was written off against the reserve.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Thirona Collaboration Agreement<span style="font-style:normal;"> &#8212; In June 2021, the Company and Thirona entered into a collaboration agreement to evaluate the therapeutic potential of Thirona&#8217;s compound for the treatment of pulmonary fibrosis. If initial studies are promising, the Company can exercise certain rights to seek a full license to the compound for clinical development and commercialization. The parties will perform their respective obligations and provide reasonable support for research, clinical development and regulatory strategy. The collaboration agreement will be accounted for under ASC 808, Collaborative Agreements&#59; however, no consideration will be exchanged between the parties. The Company will expense the costs incurred as research and development in the consolidated statements of operations. In December 2022, the Company and Thirona extended the collaboration agreement through February 28, 2023.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Biomm Supply and Distribution Agreement<span style="font-style:normal;"> &#8212; In May 2017, the Company and Biomm S.A. (&#8220;Biomm&#8221;) entered into a supply and distribution agreement for the commercialization of Afrezza in Brazil. Under this agreement, Biomm was responsible for pursuing regulatory approvals of Afrezza in Brazil, including from the ANVISA and, with respect to pricing matters, from the Camara de Regula&#231;&#227;o de Mercado de Medicamentos (&#8220;CMED&#8221;), both of which have&#160;&#160;been received. Biomm commenced product sales in January 2020. During the year ended December 31, 2020, the Company sold $<ix:nonFraction unitRef="U_iso4217USD" id="F_001148" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20200101_20201231" decimals="-5" scale="6">0.2</ix:nonFraction> million of product to Biomm. <ix:nonFraction unitRef="U_iso4217USD" id="F_001147" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_001146" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen" scale="6">No</ix:nonFraction></ix:nonFraction> shipments of product were made to Biomm during the years ended December 31, 2022 and 2021.</span><span style="font-size:12pt;font-style:normal;">&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cipla License and Distribution Agreement <span style="font-style:normal;">&#8212; In <ix:nonNumeric id="F_001149" name="mnkd:DateOfAgreementInitiationForMarketingAndDistribution" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180501_20180531" format="ixt:datemonthyearen">May 2018</ix:nonNumeric>, the Company and Cipla Ltd. (&#8220;Cipla&#8221;) entered into an exclusive agreement for the marketing and distribution of Afrezza in India and the Company received a $<ix:nonFraction unitRef="U_iso4217USD" id="F_001150" name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531" decimals="-5" scale="6">2.2</ix:nonFraction></span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">million nonrefundable</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">license fee. Under the terms of the agreement, Cipla is responsible for obtaining regulatory approvals to distribute Afrezza in India and for all marketing and sales activities of Afrezza in India. The Company is responsible for supplying Afrezza to Cipla. The Company has the potential to receive an additional regulatory milestone payment,</span><span style="font-size:12pt;font-style:normal;">&#160;</span><span style="font-style:normal;">minimum purchase commitment revenue and royalties on Afrezza sales in India once cumulative gross sales have reached a specified threshold.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The nonrefundable licensing fee was recorded in deferred revenue and is being recognized in net revenue &#8211; collaborations over <ix:nonNumeric id="F_001151" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531" format="ixt-sec:duryear">15</ix:nonNumeric> years, representing the estimated period to satisfy the performance obligation. The additional milestone payments represent variable consideration for which the Company has not recognized any revenue because of the uncertainty of obtaining marketing approval. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, the deferred revenue balance was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001153" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231" decimals="-5" scale="6">1.5</ix:nonFraction> million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001155" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231" decimals="-5" scale="6">0.1</ix:nonFraction> million is classified as current and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001157" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231" decimals="-5" scale="6">1.4</ix:nonFraction> million is classified as long term in the consolidated balance sheets. As of December 31, 2021, the deferred revenue balance was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001152" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231" decimals="-5" scale="6">1.7</ix:nonFraction> million, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001154" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million is classified as current and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001156" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231" decimals="-5" scale="6">1.6</ix:nonFraction> million is classified as long term in the consolidated balance sheets.</p></ix:continuation><ix:nonNumeric id="F_000500" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000500_dcnt_0149a271-12a9-4eeb-8595-34b907151f30">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12. Fair Value of Financial Instruments </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The availability of observable inputs can vary among the various types of financial assets and liabilities. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level input that is significant to the overall fair value measurement. The Company uses the exit price method for estimating the fair </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000500_dcnt_0149a271-12a9-4eeb-8595-34b907151f30" continuedAt="F_000500_dcnt_e06d2ac5-4ca1-40f9-819d-260cc7084f4c">
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">value of loans for disclosure purposes.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows:</span></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1 &#8212; Quoted prices for identical instruments in active markets.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 &#8212; Quoted prices for similar instruments in active markets&#59; quoted prices for identical or similar instruments in markets that are not active&#59; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3 &#8212; Significant inputs to the valuation model are unobservable.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying amounts reported in the accompanying consolidated financial statements for cash, accounts receivable, accounts payable, and accrued expenses and other current liabilities (excluding the Milestone Rights liability) approximate their fair value due to their relatively short maturities. The fair value of the cash equivalents, long- and short-term investments, <span style="color:#000000;">MidCap credit facility, </span>Mann Group promissory notes, 2024 convertible notes, Senior convertible notes, <span style="color:#000000;">Milestone Rights liabilities</span> and Financing liability are disclosed below (amounts in millions).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash Equivalents <span style="font-style:normal;">&#8212; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $<ix:nonFraction unitRef="U_iso4217USD" id="F_001158" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231" decimals="-5" scale="6">69.8</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001159" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231" decimals="-5" scale="6">124.2</ix:nonFraction> million, respectively, of cash and cash equivalents.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Liabilities<span style="font-style:normal;"> &#8212; <ix:nonNumeric id="F_000564" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000564_cnt_1">The following tables set forth the fair value of the Company&#8217;s financial instruments (Level 3 in the fair value hierarchy) (in millions):</ix:nonNumeric></span></p><ix:continuation id="F_000564_cnt_1" continuedAt="F_000564_dcnt_8ba61bc8-fc79-4ff6-8c52-d817cdc8e250">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001160" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231" decimals="-5" scale="6">225.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001161" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231" decimals="-5" scale="6">253.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001162" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231" decimals="-5" scale="6">253.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001163" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231" decimals="-5" scale="6">39.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001164" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231" decimals="-5" scale="6">41.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001165" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">41.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001166" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231" decimals="-5" scale="6">8.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001167" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231" decimals="-5" scale="6">20.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001168" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20221231" decimals="-5" scale="6">20.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone rights<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001169" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231" decimals="-5" scale="6">4.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001170" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231" decimals="-5" scale="6">12.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001171" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">12.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent milestone liability <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001172" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231" decimals="-5" scale="6">0.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001173" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231" decimals="-5" scale="6">1.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001174" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_20221231" decimals="-5" scale="6">1.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001175" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231" decimals="INF">13</ix:nonFraction>%, volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_001178" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231" decimals="INF">75.8</ix:nonFraction>% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; <ix:nonFraction unitRef="U_xbrlipure" id="F_001180" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20220101_20221231" decimals="INF" scale="-2">2</ix:nonFraction>% would result in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001184" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231" decimals="-5" scale="6">245.0</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001187" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231" decimals="-5" scale="6">263.4</ix:nonFraction> million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001176" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="INF">12</ix:nonFraction>%. A change in yield of + or &#8211; <ix:nonFraction unitRef="U_xbrlipure" id="F_001181" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231" decimals="INF" scale="-2">2</ix:nonFraction>% would result in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001185" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">40.0</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001188" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231" decimals="-5" scale="6">42.4</ix:nonFraction> million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:10pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001183" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231" decimals="-5" sign="-" scale="6">22.1</ix:nonFraction> million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001190" name="mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231" decimals="-5" scale="6">22.1</ix:nonFraction> million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2022 was determined by applying a discounted cash flow analysis with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001177" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231" decimals="INF">13</ix:nonFraction>% and volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_001179" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231" decimals="INF">77.8</ix:nonFraction>% to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; <ix:nonFraction unitRef="U_xbrlipure" id="F_001182" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231" decimals="INF" scale="-2">2</ix:nonFraction>% would result in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001186" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231" decimals="-5" scale="6">20.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001189" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231" decimals="-5" scale="6">21.2</ix:nonFraction> million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001191" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231" decimals="-5" scale="6">223.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001192" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231" decimals="-5" scale="6">237.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001193" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231" decimals="-5" scale="6">237.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001194" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231" decimals="-5" scale="6">38.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001195" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231" decimals="-5" scale="6">40.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001196" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">40.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001197" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231" decimals="-5" scale="6">18.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001198" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231" decimals="-5" scale="6">37.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001199" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20211231" decimals="-5" scale="6">37.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001200" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231" decimals="-5" scale="6">5.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001201" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231" decimals="-5" scale="6">18.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001202" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20211231" decimals="-5" scale="6">18.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001203" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231" decimals="INF">12</ix:nonFraction>%, volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_001206" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231" decimals="INF">90</ix:nonFraction>% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; <ix:nonFraction unitRef="U_xbrlipure" id="F_001208" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20210101_20211231" decimals="INF" scale="-2">2</ix:nonFraction>% would result in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001212" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231" decimals="-5" scale="6">226.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001215" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231" decimals="-5" scale="6">249.4</ix:nonFraction> million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001204" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="INF">10</ix:nonFraction>%. A change in yield of + or &#8211; <ix:nonFraction unitRef="U_xbrlipure" id="F_001209" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231" decimals="INF" scale="-2">2</ix:nonFraction>% would result in a fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001213" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">39.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001216" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231" decimals="-5" scale="6">42.7</ix:nonFraction> million, respectively.</span></p></td></tr></table></div></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000500_dcnt_e06d2ac5-4ca1-40f9-819d-260cc7084f4c"><ix:continuation id="F_000564_dcnt_8ba61bc8-fc79-4ff6-8c52-d817cdc8e250">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="text-decoration:none;Background-color:#auto;font-size:7pt;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of </span><span style="font-size:9pt;color:#000000;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_001218" name="mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231" decimals="-5" scale="6">22.1</ix:nonFraction></span><span style="font-size:9pt;color:#000000;"> million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the </span><span style="font-size:9pt;color:#000000;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_001211" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231" decimals="-5" sign="-" scale="6">22.1</ix:nonFraction></span><span style="font-size:9pt;color:#000000;"> million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2021 was determined by applying a discounted cash flow analysis with a hypothetical yield of </span><span style="font-size:9pt;color:#000000;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001205" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231" decimals="INF">12</ix:nonFraction>%</span><span style="font-size:9pt;color:#000000;"> and volatility of </span><span style="font-size:9pt;color:#000000;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001207" name="us-gaap:DebtInstrumentMeasurementInput" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231" decimals="INF">85</ix:nonFraction>%</span><span style="font-size:9pt;color:#000000;"> to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; </span><span style="font-size:9pt;color:#000000;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001210" name="mnkd:NotePayablePercentageOfInterestRateChange" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231" decimals="INF" scale="-2">2</ix:nonFraction>%</span><span style="font-size:9pt;color:#000000;"> would result in a fair value of </span><span style="font-size:9pt;color:#000000;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_001214" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231" decimals="-5" scale="6">36.9</ix:nonFraction></span><span style="font-size:9pt;color:#000000;"> million and </span><span style="font-size:9pt;color:#000000;">$<ix:nonFraction unitRef="U_iso4217USD" id="F_001217" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231" decimals="-5" scale="6">38.8</ix:nonFraction></span><span style="font-size:9pt;color:#000000;"> million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation.</span></p></td></tr></table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights Liability<span style="font-style:normal;"> &#8212; The fair value measurement of the Milestone Rights liability is sensitive to the discount rate and the timing of achievement of milestones. The Company utilized Monte-Carlo Simulation Method to simulate the Afrezza net sales under a neutral framework to estimate the payment. The Company then discounted the future expected payments at cost of debt with a term equal to the simulated time to payout based on cumulative sales.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingent milestone liability<span style="font-style:normal;"> &#8212; The acquisition of V-Go in May 2022 resulted in a contingent milestone liability which could result in obligations to the seller if certain revenue thresholds are met. The initial fair value of the contingent milestone liability was recorded as an adjustment to the purchase price. Subsequent changes in the fair value are reported in general and administrative expenses.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financing Liability<span style="font-style:normal;"> &#8212; The failed Sale Leaseback Transaction in November 2021 resulted in a financing liability which is included in the Company&#8217;s&#160;&#160;consolidated balance sheets as a current financing liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001220" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="C_0000899460_20211130" decimals="-5" scale="6">9.6</ix:nonFraction> million and a long-term financing liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001219" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="C_0000899460_20211130" decimals="-5" scale="6">94.5</ix:nonFraction> million. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">The fair value of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001221" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="C_0000899460_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20211130" decimals="-5" scale="6">103.2</ix:nonFraction> million was determined using level 3 inputs. As of December 31, 2022, the fair value was determined using a discounted cash flow analysis with a hypothetical yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001222" name="mnkd:DebtInstrumentMeasurementInputAfterChange" contextRef="C_0000899460_20221231" decimals="2" scale="-2">10</ix:nonFraction>%. As December 31, 2021, the Company evaluated the fair value of its financing liability and determined that the fair value approximates the carrying value.</span></p></ix:continuation><ix:nonNumeric id="F_000501" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000501_dcnt_7c2da650-0c0d-4b4c-86f2-4e28bdc8cf96">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. Common and Preferred Stock </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is authorized to issue <ix:nonFraction unitRef="U_xbrlishares" id="F_001223" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">400,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001224" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0000899460_20221231" decimals="INF">0.01</ix:nonFraction> per share, and <ix:nonFraction unitRef="U_xbrlishares" id="F_001225" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> shares of undesignated preferred stock, par value $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001226" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0000899460_20221231" decimals="INF">0.01</ix:nonFraction> per share, issuable in one or more series as designated by the Company&#8217;s board of directors. No other class of capital stock is authorized. As of December&#160;31, 2022 and 2021, <ix:nonFraction unitRef="U_xbrlishares" id="F_001227" name="us-gaap:CommonStockSharesIssued" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_001229" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">263,793,305</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_001228" name="us-gaap:CommonStockSharesIssued" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_001230" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">251,477,562</ix:nonFraction></ix:nonFraction> shares of common stock, respectively, were issued and outstanding and <ix:nonFraction unitRef="U_xbrlishares" id="F_001232" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0000899460_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001231" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0000899460_20221231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> shares of preferred stock were outstanding. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_001235">February 2018</span>, the Company entered into a controlled equity offering sales agreement (the &#8220;CF Sales Agreement&#8221;) with Cantor Fitzgerald &#38; Co. (&#8220;Cantor Fitzgerald&#8221;), as sales agent, pursuant to which the Company may offer and sell, from time to time, through Cantor Fitzgerald, shares of the Company&#8217;s common stock in such amount &#160;as may be permitted by the Sales Agreement. The original amount of common stock authorized for sale under the CF Sales Agreement was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001233" name="us-gaap:CommonStockValue" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180228" decimals="-5" scale="6">50.0</ix:nonFraction> million. Under the Sales Agreement, Cantor Fitzgerald may sell shares by any method deemed to be an <span style="color:#000000;">&#8220;</span>at-the-market offering<span style="color:#000000;">&#8221;</span> as defined in Rule 415 under the Securities Act of 1933, as amended. In February 2022, the Company filed a sales agreement prospectus under a registration statement on Form S-3 (File No. 333-262981) covering the sale of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_001234" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20220201_20220228" decimals="-5" scale="6">50.0</ix:nonFraction> million of common stock through Cantor Fitzgerald under the CF Sales Agreement. For the year ended December 31, 2022, the Company sold <ix:nonFraction unitRef="U_xbrlishares" id="F_001236" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">5,059,856</ix:nonFraction> shares of common stock at a weighted average purchase price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001241" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20221231" decimals="2">3.91</ix:nonFraction> per share for gross proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001242" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231" decimals="-5" scale="6">19.8</ix:nonFraction> million pursuant to the CF Sales Agreement. For the year ended December 31, 2021, the Company sold an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001237" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">578,063</ix:nonFraction> shares of the Company&#8217;s common stock at a weighted average purchase price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001239" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20211231" decimals="2">3.26</ix:nonFraction> per share for aggregate gross proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001243" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231" decimals="-5" scale="6">1.9</ix:nonFraction> million pursuant to the Sales Agreement. <span style="color:#000000;">For the year ended December 31, 2020, the Company sold an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001238" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">11,851,566</ix:nonFraction> shares of the Company&#8217;s common stock at a weighted average purchase price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001240" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20201231" decimals="2">1.99</ix:nonFraction> per share for&#160;&#160;aggregate gross proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001244" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231" decimals="-5" scale="6">23.5</ix:nonFraction> million pursuant to the CF Sales Agreement.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, the Company prepaid the June 2020 note with the issuance of&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_001245" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdJuneTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200624_20200624" decimals="INF" format="ixt:numdotdecimal">1,235,094</ix:nonFraction>&#160;shares of the Company&#8217;s common stock, in accordance with the terms of the June 2020 note. In October 2020, the Company prepaid the December 2020 note with the issuance of&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_001246" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdDecemberTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201009_20201009" decimals="INF" format="ixt:numdotdecimal">1,377,356</ix:nonFraction>&#160;shares of the Company&#8217;s common stock, in accordance with the terms of the December 2020 note. The number of shares issued for the prepayments in June and October 2020 were determined based on the Company&#8217;s closing stock price on the day preceding the settlement date. See Note 10 &#8211;&#160;<span style="font-style:italic;">Borrowings</span>.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, <ix:nonFraction unitRef="U_xbrlishares" id="F_001247" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630" decimals="INF" format="ixt:numdotdecimal">7,250,000</ix:nonFraction> warrants were exercised at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001248" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630" decimals="2">1.60</ix:nonFraction> per share. The warrants were issued pursuant to an underwriting agreement with Leerink Partners LLC for a public offering of <ix:nonFraction unitRef="U_xbrlishares" id="F_001249" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630" decimals="INF" format="ixt:numdotdecimal">26,666,667</ix:nonFraction> shares of the Company&#8217;s common stock and warrants to purchase up to an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001250" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630" decimals="INF" format="ixt:numdotdecimal">26,666,667</ix:nonFraction> shares of the Company&#8217;s common stock. There are <ix:nonFraction unitRef="U_xbrlishares" id="F_001251" name="mnkd:RemainingWarrantsAvailableForPurchase" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> remaining warrants outstanding under this agreement.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the fourth quarter of 2020, the Mann Group converted $<ix:nonFraction unitRef="U_iso4217USD" id="F_001252" name="mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">3.0</ix:nonFraction> million of accrued interest and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001255" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">7.0</ix:nonFraction> million of principal under the Mann Group convertible note into <ix:nonFraction unitRef="U_xbrlishares" id="F_001254" name="mnkd:DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">1.2</ix:nonFraction> million shares and <ix:nonFraction unitRef="U_xbrlishares" id="F_001257" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231" decimals="-5" scale="6">2.8</ix:nonFraction> million shares, respectively, of the Company&#8217;s common stock, in accordance with the terms of the convertible note. &#160;&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company issued <ix:nonFraction unitRef="U_xbrlishares" id="F_001259" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdMidCapCreditFacilityMember_20201231" decimals="INF" format="ixt:numdotdecimal">111,853</ix:nonFraction> warrants to purchase shares of the Company&#8217;s common stock in connection with the third amendment to the Midcap Credit Facility. &#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company issued <ix:nonFraction unitRef="U_xbrlishares" id="F_001260" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231" decimals="INF" format="ixt:numdotdecimal">3,067,179</ix:nonFraction> shares of the Company&#8217;s common stock as consideration for the acquisition of QrumPharma. See Note 3 &#8211; <span style="font-style:italic;">Acquisitions</span>.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000501_dcnt_7c2da650-0c0d-4b4c-86f2-4e28bdc8cf96">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">converted $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001261" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228" decimals="-5" scale="6">5.0</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">principal amount of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024 convertible note</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> into </span><ix:nonFraction unitRef="U_xbrlishares" id="F_001262" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228" decimals="INF" format="ixt:numdotdecimal">1,666,667</ix:nonFraction><span style="color:#000000;"> shares of</span><span style="color:#000000;"> </span><span style="color:#000000;">the Company&#8217;s </span><span style="color:#000000;">common stock</span><span style="color:#000000;">. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2021, MidCap exercised <ix:nonFraction unitRef="U_xbrlishares" id="F_001263" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20211031" decimals="INF" format="ixt:numdotdecimal">1,171,614</ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_001264" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20211031" decimals="INF" format="ixt:numdotdecimal">111,853</ix:nonFraction> warrants issued in association with Tranches 1 and 2, respectively, under the MidCap credit facility, as amended, to purchase an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001265" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031" decimals="INF" format="ixt:numdotdecimal">1,283,467</ix:nonFraction> shares of the Company&#8217;s common stock through a cashless exercise that resulted in the net issuance of <ix:nonFraction unitRef="U_xbrlishares" id="F_001266" name="us-gaap:CommonStockSharesIssued" contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031" decimals="INF" format="ixt:numdotdecimal">964,113</ix:nonFraction> shares. See Note 10 &#8211; <span style="font-style:italic;">Borrowings</span>. </p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 31, 2021, the Mann Group converted $<ix:nonFraction unitRef="U_iso4217USD" id="F_001253" name="mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" scale="6">0.4</ix:nonFraction> million of interest and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001256" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" scale="6">9.6</ix:nonFraction> million of principal into <ix:nonFraction unitRef="U_xbrlishares" id="F_001258" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231" decimals="-5" scale="6">4.0</ix:nonFraction> million shares of common stock.<span style="color:#000000;"> </span>See Note 10 &#8211;&#160;<span style="font-style:italic;">Borrowings</span>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company received $<ix:nonFraction unitRef="U_iso4217USD" id="F_001267" name="us-gaap:ProceedsFromStockPlans" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million from the market price stock purchase plan (&#8220;MPSPP&#8221;) for <ix:nonFraction unitRef="U_xbrlishares" id="F_001268" name="mnkd:MarketPriceStockPurchasePlan" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">25,000</ix:nonFraction> shares and a <span style="font-style:italic;">de minimis</span> amount during the year ended December 31, 2020.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2022, pursuant to the terms of the Mann Group convertible note, Mann Group converted $<ix:nonFraction unitRef="U_iso4217USD" id="F_001270" name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="-5" scale="6">10.0</ix:nonFraction> million of principal and capitalized interest into <ix:nonFraction unitRef="U_xbrlishares" id="F_001271" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">4,000,000</ix:nonFraction> shares of common stock. In addition, the Company paid quarterly interest payments on the Mann Group convertible note on April 1, 2022, July 1, 2022 and October 1, 2022 by issuing Mann Group an aggregate of <ix:nonFraction unitRef="U_xbrlishares" id="F_001269" name="mnkd:CommonStockIssuedToPayInterest" contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">75,487</ix:nonFraction> shares of common stock. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2022, the Company received&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_001272" name="us-gaap:ProceedsFromStockPlans" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">0.7</ix:nonFraction> million from the market price stock purchase plan (&#8220;MPSPP&#8221;) for <ix:nonFraction unitRef="U_xbrlishares" id="F_001273" name="mnkd:MarketPriceStockPurchasePlan" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">252,176</ix:nonFraction> shares.</p></ix:continuation><ix:nonNumeric id="F_000502" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14. Earnings per Common Share (&#8220;EPS&#8221;)</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic EPS excludes dilution for potentially dilutive securities and is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted EPS as they would be antidilutive.</p><ix:nonNumeric id="F_000565" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EPS &#8212; basic and diluted:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss (numerator)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001274" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001275" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001276" name="us-gaap:NetIncomeLoss" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares (denominator)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001277" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">257,092</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001278" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">249,244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001279" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">222,585</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001280" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20220101_20221231" decimals="2" sign="-">0.34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001281" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20210101_20211231" decimals="2" sign="-">0.32</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001282" name="us-gaap:EarningsPerShareBasic" contextRef="C_0000899460_20200101_20201231" decimals="2" sign="-">0.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common shares issuable represents incremental shares of common stock which consist of stock options, restricted stock units, warrants, and shares that could be issued upon conversion of the Senior convertible notes and the Mann Group convertible notes.</p><ix:nonNumeric id="F_000566" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potentially dilutive securities outstanding that are considered antidilutive are summarized as follows (in shares):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001286" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">44,120,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001287" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">44,120,463</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options and PNQs</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001288" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">9,074,587</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001289" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">10,655,146</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001290" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">12,264,616</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible notes</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001291" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">3,370,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001292" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">7,370,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001293" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">11,200,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants associated with MidCap credit facility</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001294" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdWarrantsAssociatedWithMidcapCreditFacilityMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,283,467</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024 convertible notes</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001295" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdConvertibleNotesMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,666,667</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and Market RSUs<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001296" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">18,886,710</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001297" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">7,609,025</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001298" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">6,037,542</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001299" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">243,375</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001300" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">292,981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001301" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">75,451,760</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001302" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt:numdotdecimal">69,998,009</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001303" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0000899460_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">32,745,273</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.39%;"></td>
<td style="width:95.61%;"></td>
</tr>
<tr>
<td valign="top" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Market RSUs are included at the maximum share delivery percentage.</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000503" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000503_dcnt_0e7169c3-e0d5-4d8a-b352-4254d21114d4">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15. Stock Award Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, the Company adopted the 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) as the successor to and continuation of the 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). The 2018 Plan initially consisted of <ix:nonFraction unitRef="U_xbrlishares" id="F_001304" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20180531" decimals="INF" format="ixt:numdotdecimal">12,000,000</ix:nonFraction> new shares plus the number of unallocated shares remaining available for grant for new awards under the 2013 Plan. In May 2020, the 2018 Plan was amended to increase the number of shares of common stock that may be issued under the 2018 Plan by <ix:nonFraction unitRef="U_xbrlishares" id="F_001305" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531" decimals="INF" format="ixt:numdotdecimal">12,500,000</ix:nonFraction> shares. </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000503_dcnt_0e7169c3-e0d5-4d8a-b352-4254d21114d4" continuedAt="F_000503_dcnt_132005f3-966c-48ea-9def-a83a6e9d4652">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective upon the approval of the 2018 Plan by the Company&#8217;s stockholders in May 2018, <ix:nonFraction unitRef="U_xbrlishares" id="F_001306" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20180516" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> additional awards have been or may be granted under the 2013 Plan. Any Prior Plans&#8217; (as defined below) returning shares will increase the number of shares issuable under the 2018 Plan. The Prior Plans&#8217; returning shares are shares subject to outstanding stock awards granted under the 2013 Plan or the 2004 Equity Incentive Plan (collectively, &#8220;Prior Plans&#8221;) that, from and after the effective date of the 2018 Plan, (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii) other than with respect to outstanding stock options and stock appreciation rights granted under the Prior Plans with an exercise or strike price of at least <ix:nonFraction unitRef="U_xbrlipure" id="F_001307" name="mnkd:ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531" decimals="INF" scale="-2">100</ix:nonFraction>% of the fair market value of the underlying common stock on the date of grant, are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a stock award.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan provides for the granting of stock awards including stock options and restricted stock units to employees, directors and consultants. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s board of directors or its compensation committee determines eligibility, vesting schedules and criteria, and exercise prices for stock awards granted under the 2018 Plan. Options and restricted stock unit awards under the 2018 Plan, or the Prior Plans expire not more than <ix:nonNumeric id="F_001308" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> from the date of the grant and are exercisable upon vesting. Stock options that vest over time generally vest over <ix:nonNumeric id="F_001309" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231" format="ixt-sec:durwordsen">four years</ix:nonNumeric>. Current time-based vesting stock option grants vest and become exercisable at the rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001310" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231" decimals="2" scale="-2">25</ix:nonFraction>% after one year and ratably on a monthly basis over a period of <ix:nonNumeric id="F_001311" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231" format="ixt-sec:durmonth">36</ix:nonNumeric> months thereafter. The Company also issues PNQ awards with performance conditions. For PNQs, the Company evaluates the probability that the performance conditions will be met and estimates the service period for recognition of the associated expense. RSUs with time-based vesting generally vest at a rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001312" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20220101_20221231" decimals="2" scale="-2">25</ix:nonFraction>%&#160;per year over <ix:nonNumeric id="F_001313" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20220101_20221231" format="ixt-sec:durwordsen">four years</ix:nonNumeric> with consideration satisfied by service to the Company. Certain RSUs issued to nonemployee directors vest immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service such as resignation, retirement or death. The Company also issued Market RSUs. The grant date fair value and the effect of the market conditions was estimated using a Monte Carlo valuation. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Market RSUs issued during the year ended December 31, 2022 had a grant date fair value of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001314" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231" decimals="2">6.10</ix:nonFraction> per share and will vest on <ix:nonNumeric id="F_001315" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220101_20221231" format="ixt:datemonthdayyearen">May 10, 2025</ix:nonNumeric> provided that the closing price of the Company&#8217;s common stock on such vesting date is not less than the closing price on May 10, 2022. The fair value of the Market RSUs was determined using a share price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001316" name="us-gaap:SharePrice" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517" decimals="2">2.95</ix:nonFraction>, risk-free interest rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001317" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517" decimals="4" scale="-2">2.81</ix:nonFraction>%, volatility of <ix:nonFraction unitRef="U_xbrlipure" id="F_001318" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517" decimals="2" scale="-2">75</ix:nonFraction>%, and a dividend yield of <ix:nonFraction unitRef="U_xbrlipure" id="F_001319" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517" decimals="2" scale="-2">0</ix:nonFraction>%. The number of shares delivered on the vesting date is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025&#160;&#160;relative to the TSR of the Russell 3000 Pharmaceutical &#38; Biotechnology Index over the same period, as follows: less than <ix:nonFraction unitRef="U_xbrlipure" id="F_001320" name="mnkd:PercentileRankOfShareholderReturnOfStock" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231" decimals="2" scale="-2">25</ix:nonFraction>th percentile&#61;<ix:nonFraction unitRef="U_xbrlipure" id="F_001321" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231" decimals="2" scale="-2">0</ix:nonFraction>% of target, <ix:nonFraction unitRef="U_xbrlipure" id="F_001322" name="mnkd:PercentileRankOfShareholderReturnOfStock" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231" decimals="2" scale="-2">25</ix:nonFraction>th percentile&#61;<ix:nonFraction unitRef="U_xbrlipure" id="F_001323" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231" decimals="2" scale="-2">50</ix:nonFraction>% of target, <ix:nonFraction unitRef="U_xbrlipure" id="F_001324" name="mnkd:PercentileRankOfShareholderReturnOfStock" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231" decimals="2" scale="-2">50</ix:nonFraction>th percentile&#61;<ix:nonFraction unitRef="U_xbrlipure" id="F_001325" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231" decimals="2" scale="-2">100</ix:nonFraction>% of target, <ix:nonFraction unitRef="U_xbrlipure" id="F_001326" name="mnkd:PercentileRankOfShareholderReturnOfStock" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231" decimals="2" scale="-2">75</ix:nonFraction>th percentile&#61;<ix:nonFraction unitRef="U_xbrlipure" id="F_001327" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231" decimals="2" scale="-2">200</ix:nonFraction>% of target, <ix:nonFraction unitRef="U_xbrlipure" id="F_001328" name="mnkd:PercentileRankOfShareholderReturnOfStock" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231" decimals="2" scale="-2">90</ix:nonFraction>th percentile or higher&#61;<ix:nonFraction unitRef="U_xbrlipure" id="F_001329" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231" decimals="2" scale="-2">300</ix:nonFraction>% maximum. Payout values will be interpolated between the percentile rankings above. The resulting stock-based compensation expense will be recognized over the service period regardless of whether the market conditions are achieved, as long as the service condition is satisfied.<span style="font-size:12pt;">&#160;</span></p><ix:nonNumeric id="F_000567" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about the Company&#8217;s stock-based award plans as of December&#160;31, 2022:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Units</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares&#160;Available</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Future</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Issuance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2004 Equity Incentive Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001330" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdTwoThousandFourEquityIncentivePlanMember_20221231" decimals="INF" format="ixt:numdotdecimal">1,320</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2013 Equity Incentive Plan</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20221231" decimals="INF" format="ixt:numdotdecimal">3,240,690</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 Equity Incentive Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001332" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231" decimals="INF" format="ixt:numdotdecimal">5,832,577</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001334" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231" decimals="INF" format="ixt:numdotdecimal">11,838,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001336" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231" decimals="INF" format="ixt:numdotdecimal">2,802,796</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001333" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">9,074,587</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001335" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">11,838,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001337" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">2,802,796</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based payment transactions are recognized as compensation cost based on the fair value of the instrument on the date of grant. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee stock options. The expected term of an option granted is based on combining historical exercise data with expected weighted time outstanding. Expected weighted time outstanding is calculated by assuming the settlement of outstanding awards is at the midpoint between the remaining weighted average vesting date and the expiration date. The Company recognizes forfeitures as they occur. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recorded RSU and option-based stock compensation expense of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001340" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20220101_20221231" decimals="-5" scale="6">12.8</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001338" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20210101_20211231" decimals="-5" scale="6">11.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001339" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20200101_20201231" decimals="-5" scale="6">6.2</ix:nonFraction> million, respectively and employee stock purchase plan compensation of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001343" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20220101_20221231" decimals="-5" scale="6">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001341" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231" decimals="-5" scale="6">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001342" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231" decimals="-5" scale="6">0.3</ix:nonFraction> million, respectively.</p><ix:nonNumeric id="F_000568" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense recognized in the accompanying consolidated statements of operations is included in the following categories (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001344" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20220101_20221231" decimals="-3" scale="3">329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001345" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231" decimals="-3" scale="3">407</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001346" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231" decimals="-3" scale="3">446</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue &#8212; collaborations and services</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001347" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,425</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001348" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,708</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001349" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20200101_20201231" decimals="-3" scale="3">626</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001350" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,044</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001351" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231" decimals="-3" scale="3">614</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001352" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" scale="3">338</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001353" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001354" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001355" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,158</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001356" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,455</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001357" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,893</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001358" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,943</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001359" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,447</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001360" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001361" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,511</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000503_dcnt_132005f3-966c-48ea-9def-a83a6e9d4652" continuedAt="F_000503_dcnt_397f6be9-f847-417b-89e4-b9e6fdb58328">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected volatility assumption used in the Company&#8217;s Black-Sholes option valuation model is based on an assessment of the historical volatility derived from an analysis of historical trade activity. The Company has selected risk-free interest rates based on U.S. Treasury securities with an equivalent expected term in effect on the date the options were granted. Additionally, the Company uses historical data and management judgment to estimate stock option exercise behavior and employee turnover rates to estimate the number of stock option awards that will eventually vest. There were <ix:nonFraction unitRef="U_xbrlishares" id="F_001362" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001363" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> options issued in the years ended December 31, 2022 and 2021. <ix:nonNumeric id="F_000569" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000569_cnt_1">The Company calculated the fair value of employee stock options granted during the year ended December&#160;31, 2020 using the following assumptions:</ix:nonNumeric></p><ix:continuation id="F_000569_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001364">0.39% &#8212; 1.52%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected lives</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001366">5.67 &#8212; 7.0 years</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001368">93.83% &#8212; 94.25%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividends</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000570" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to stock options:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value ($000)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001370" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">10,732,513</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001376" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0000899460_20211231" decimals="2">3.01</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001382">5.49</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001385" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,543</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001371" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">1,196,391</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001377" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0000899460_20220101_20221231" decimals="2">1.79</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001372" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">116,767</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001378" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0000899460_20220101_20221231" decimals="2">1.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expired</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001373" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">344,768</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001379" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_0000899460_20220101_20221231" decimals="2">6.31</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001374" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">9,074,587</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001380" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0000899460_20221231" decimals="2">3.06</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001383">5.10</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001386" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,512</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001375" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">7,776,518</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001381" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_0000899460_20221231" decimals="2">3.23</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001384">5.15</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001387" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,315</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were <ix:nonFraction unitRef="U_xbrlishares" id="F_001388" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_xbrlishares" id="F_001389" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> options granted in the years ended December 31, 2022 and 2021. The weighted average grant date fair value of the stock options granted during the year ended December&#160;31, 2020 was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001390" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20200101_20201231" decimals="-4" scale="6">0.97</ix:nonFraction>. Total fair value of stock options vested during the years ended December 31, 2022, 2021 and 2020 was <ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001392" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">3.2</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001391" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001393" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">4.5</ix:nonFraction> million, respectively. The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001395" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">2.4</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001394" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001396" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">0.5</ix:nonFraction> million, respectively. Intrinsic value is measured using the fair market value at the date of exercise for options exercised or at December&#160;31 for outstanding options, less the applicable exercise price. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash received from the exercise of options during the years ended December&#160;31, 2022, 2021 and 2020 was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001399" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">3.0</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001397" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001398" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">0.6</ix:nonFraction> million, respectively. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, 2021 and 2020, the Company recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_001402" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20220101_20221231" decimals="-5" scale="6">0.1</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001400" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20210101_20211231" decimals="-5" scale="6">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001401" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20200101_20201231" decimals="-5" scale="6">0.2</ix:nonFraction> million, respectively, of compensation costs related to the performance-based stock options. As of December 31, 2022 and 2021, there were $<ix:nonFraction unitRef="U_iso4217USD" id="F_001404" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20221231" decimals="-5" scale="6">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001403" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20211231" decimals="-5" scale="6">0.3</ix:nonFraction> million, respectively of unrecognized compensation costs related to performance-based stock options subject to performance conditions.</p><ix:nonNumeric id="F_000571" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to restricted stock units: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001405" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0000899460_20211231" decimals="INF" format="ixt:numdotdecimal">9,538,032</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001410" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20211231" decimals="2">3.40</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001406" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">5,120,682</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001411" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20220101_20221231" decimals="2">3.95</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001407" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">1,551,088</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001412" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20220101_20221231" decimals="2">2.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_001408" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">1,269,297</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001413" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20220101_20221231" decimals="2">3.97</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001409" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_0000899460_20221231" decimals="INF" format="ixt:numdotdecimal">11,838,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001414" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="C_0000899460_20221231" decimals="2">3.65</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total fair value of restricted stock units vested during the years ended December 31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001417" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">4.4</ix:nonFraction> million $<ix:nonFraction unitRef="U_iso4217USD" id="F_001415" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">6.7</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001416" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">2.5</ix:nonFraction> million, respectively. Intrinsic value of restricted stock units vested is measured using the closing share price on the day prior to the vest date. The total grant date fair value of restricted stock units outstanding as of December 31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001420" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" contextRef="C_0000899460_20221231" decimals="-5" scale="6">43.2</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001418" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" contextRef="C_0000899460_20211231" decimals="-5" scale="6">19.3</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001419" name="mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" contextRef="C_0000899460_20201231" decimals="-5" scale="6">13.3</ix:nonFraction> million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001421" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockOptionsAndPerformanceBasedOptionsMember_20221231" decimals="-5" scale="6">0.6</ix:nonFraction> million of unrecognized compensation expense related to options and PNQs and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001422" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231" decimals="-5" scale="6">25.0</ix:nonFraction> million of unrecognized compensation expense related to restricted stock units and market based stock units, which are expected to be recognized over the weighted average period of <span style="-sec-ix-hidden:F_001423">2.08 to 2.22 years</span>. The Company evaluates stock awards with performance conditions as to the probability that </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000503_dcnt_397f6be9-f847-417b-89e4-b9e6fdb58328">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the performance conditions will be met and uses that information to estimate the date at which those performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.99%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#65279;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides all employees, including executive officers, the ability to purchase its common stock at a discount under the Company&#8217;s<span style="color:#000000;"> 2004 employee stock purchase plan (the &#8220;ESPP&#8221;). The ESPP is designed to comply with Section 423 of the Internal Revenue Code (&#8220;IRC&#8221;) and provides all employees with the opportunity to purchase up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_001425" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231" decimals="0" format="ixt:numdotdecimal">25,000</ix:nonFraction> worth of common stock (based on the undiscounted fair market value at the commencement of the offering period) each year at a purchase price that is the lower of <ix:nonFraction unitRef="U_xbrlipure" id="F_001426" name="mnkd:DiscountOnPurchasePricePercentageOfFairMarketValue" contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20220101_20221231" decimals="0">85</ix:nonFraction>% of the fair market value of the common stock on either the date of purchase or the commencement of the offering period. An employee may not purchase more than <ix:nonFraction unitRef="U_xbrlishares" id="F_001427" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231" decimals="INF" format="ixt:numdotdecimal">5,000</ix:nonFraction> shares of common stock on any purchase date. The executives&#8217; rights under the ESPP are identical to those of all other employees.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#160;issued <ix:nonFraction unitRef="U_xbrlishares" id="F_001428" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231" decimals="-5" scale="6">0.7</ix:nonFraction> million,&#160;<ix:nonFraction unitRef="U_xbrlishares" id="F_001430" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231" decimals="-5" scale="6">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="U_xbrlishares" id="F_001429" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-5" scale="6">0.6</ix:nonFraction> million shares&#160;of common stock pursuant to the ESPP for the years ended&#160;December 31, 2022, 2021 and 2020, respectively. There&#160;were&#160;approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_001431" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20221231" decimals="-5" scale="6">0.4</ix:nonFraction> million&#160;shares of common stock available for issuance under the&#160;ESPP as of December 31, 2022.</p></ix:continuation><ix:nonNumeric id="F_000504" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000504_dcnt_dcf0eb24-d162-4e69-8d2a-35b5a0a5352b">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16. Commitments and Contingencies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Guarantees and Indemnifications <span style="font-style:normal;">&#8212; In the ordinary course of its business, the Company makes certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. The Company, as permitted under Delaware law and in accordance with its Bylaws, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The term of the indemnification period is for the officer&#8217;s or director&#8217;s lifetime. The maximum amount of potential future indemnification is unlimited&#59; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company believes the fair value of these indemnification agreements is minimal. The Company has not recorded any liability for these indemnities in the accompanying consolidated balance sheets. However, the Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount can be reasonably estimated. No such losses have been recorded to date. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Litigation <span style="font-style:normal;">&#8212; The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. As of December 31, 2022, the Company believes that the final disposition of such matters will not have a material adverse effect on the financial position, results of operations or cash flows of the Company and no accrual has been recorded. The Company maintains liability insurance coverage to protect the Company&#8217;s assets from losses arising out of or involving activities associated with ongoing and normal business operations. The Company records a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company&#8217;s policy is to accrue for legal expenses in connection with legal proceedings and claims as they are incurred. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingencies <span style="font-style:normal;">&#8212; In July&#160;2013, the Company entered into the Milestone Rights Agreement with the Original Milestone Purchasers, pursuant to which the Company granted the Milestone Rights to receive payments up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_001432" name="mnkd:ContingentLiability" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20130701" decimals="INF" scale="6">90.0</ix:nonFraction> million upon the occurrence of specified strategic and sales milestones, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001433" name="mnkd:ContingentLiabilityRemainingPayableAmount" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">60.0</ix:nonFraction> million of which remains payable to the Original Purchasers upon achievement of such milestones (see Note 10 &#8212; </span>Borrowings<span style="font-style:normal;">). As of December 31, 2022, the initial fair value of the Milestone Rights is recorded in the consolidated balance sheet, including $<ix:nonFraction unitRef="U_iso4217USD" id="F_001434" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">0.9</ix:nonFraction> million in</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">accrued expenses and other current liabilities and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001435" name="mnkd:MilestoneRightLiability" contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231" decimals="-5" scale="6">3.9</ix:nonFraction> million in milestone rights liability. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sale-Leaseback Transaction <span style="font-style:normal;">&#8212; In November 2021, the Company sold the Property to the Purchaser for a sales price of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001436" name="us-gaap:ProceedsFromSaleOfRealEstate" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211101_20211130" decimals="-5" scale="6">102.3</ix:nonFraction> million, subject to terms and the conditions contained in a purchase and sale agreement. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser entered into a lease agreement (the &#8220;Lease&#8221;), pursuant to which the Company leased the Property from the Purchaser for an initial term of <ix:nonNumeric id="F_001437" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108" format="ixt-sec:duryear">20</ix:nonNumeric> years, with four <ix:nonNumeric id="F_001439" name="us-gaap:LesseeOperatingSubleaseOptionToExtend" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">renewal options of five years</ix:nonNumeric> each. <ix:nonNumeric id="F_001442" name="us-gaap:SaleLeasebackTransactionLeaseTerms" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">The total annual rent under the Lease starts at approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001441" name="us-gaap:OperatingLeaseCost" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108" decimals="-5" scale="6">9.5</ix:nonFraction> million per year, subject to a 50% rent abatement during the first year of the Lease, and will increase annually by (i) 2.5% in the second through fifth year of the Lease and (ii) 3% in the sixth and each subsequent year of the Lease, including any renewal term.</ix:nonNumeric> The Company is responsible for payment of operating expenses, property taxes and insurance for the Property. The Purchaser will hold a security deposit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001443" name="us-gaap:SecurityDeposit" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108" decimals="-5" scale="6">2.0</ix:nonFraction> million during the Lease term. Pursuant to the terms of the Lease, <ix:nonNumeric id="F_001445" name="mnkd:LeaseRepurchaseDescription" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">the Company has four options to repurchase the Property, in 2026, 2031, 2036 and 2041, for the greater of (i) $<ix:nonFraction unitRef="U_iso4217USD" id="F_001444" name="us-gaap:SaleLeasebackTransactionNetBookValue" contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_srtRangeAxis_srtMinimumMember_20211108" decimals="-5" scale="6">102.3</ix:nonFraction> million and (ii) the fair market value of the Property.</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser also entered into a right of first refusal agreement (the &#8220;ROFR&#8221;), pursuant to which the Company has a right to re-purchase the Property from the Purchaser in accordance with terms and conditions set forth in the ROFR. Specifically, if the Purchaser receives, and is willing to accept, a bona fide purchase offer for the Property from a third-party purchaser, the Company has certain rights of first refusal to purchase the Property on the same material terms as proposed in such bona fide purchase offer.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, the related financing liability was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001447" name="us-gaap:FinanceLeaseLiability" contextRef="C_0000899460_20221231" decimals="-5" scale="6">104.1</ix:nonFraction> million, which was recognized in the Company&#8217;s  consolidated balance sheet as $<ix:nonFraction unitRef="U_iso4217USD" id="F_001449" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-5" scale="6">94.5</ix:nonFraction> million of financing liability &#8212; long-term and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001451" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="C_0000899460_20221231" decimals="-5" scale="6">9.6</ix:nonFraction> million of financing liability &#8212; short-term. As of December 31, </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000504_dcnt_dcf0eb24-d162-4e69-8d2a-35b5a0a5352b" continuedAt="F_000504_dcnt_18d00f2e-c7ab-4482-9e37-5485eb687e52">
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021, the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001446" name="us-gaap:FinanceLeaseLiability" contextRef="C_0000899460_20211231" decimals="-5" scale="6">100.5</ix:nonFraction></span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which was recognized in our consolidated balance sheet as $</span><ix:nonFraction unitRef="U_iso4217USD" id="F_001448" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-5" scale="6">93.5</ix:nonFraction><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8212; long-term and $</span><ix:nonFraction unitRef="U_iso4217USD" id="F_001450" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="C_0000899460_20211231" decimals="-5" scale="6">7.0</ix:nonFraction><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8212; short-term. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000572" name="mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000572_cnt_1">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability information is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001452">18.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001453">19.8</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001454" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="C_0000899460_20221231" decimals="3" scale="-2">9.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001455" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="C_0000899460_20211231" decimals="3" scale="-2">9.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000573" name="us-gaap:LeaseCostTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000573_cnt_1">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001456" name="mnkd:InterestExpenseOnFinancingLiability" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,758</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001457" name="mnkd:InterestExpenseOnFinancingLiability" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,373</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000574" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability payments as of December 31, 2022 was as follows (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.06%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001458" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,774</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001459" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,018</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001460" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001461" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,533</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001462" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,849</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001463" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">188,453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001464" name="mnkd:FinanceLeaseLiabilityDiscountedPaymentsDue" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">239,896</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest payments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001465" name="mnkd:FinanceLeaseLiabilityDiscountedExcessAmount" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">132,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001466" name="mnkd:FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,883</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financing liability</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001467" name="mnkd:FinanceLeaseLiabilityDiscounted" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">104,077</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Commitments <span style="font-style:normal;">&#8212; In July&#160;2014, the Company entered into the Insulin Supply Agreement with Amphastar pursuant to which Amphastar manufactures for and supplies to the Company certain quantities of recombinant human insulin for use in Afrezza. Under the terms of the Insulin Supply Agreement, Amphastar is responsible for manufacturing the insulin in accordance with the Company&#8217;s specifications and agreed-upon quality standards.</span></p><ix:nonNumeric id="F_000575" name="us-gaap:LongTermPurchaseCommitmentTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $<ix:nonFraction unitRef="U_iso4217USD" id="F_001468" name="mnkd:PaymentOfLongTermPurchaseCommitmentAmendmentFee" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">2.0</ix:nonFraction> million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( &#8364; in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217EUR" id="F_001469" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" contextRef="C_0000899460_20221231" decimals="-5" scale="6">8.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217EUR" id="F_001470" name="us-gaap:PurchaseObligationDueInSecondYear" contextRef="C_0000899460_20221231" decimals="-5" scale="6">14.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217EUR" id="F_001471" name="us-gaap:PurchaseObligationDueInThirdYear" contextRef="C_0000899460_20221231" decimals="-5" scale="6">15.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217EUR" id="F_001472" name="us-gaap:PurchaseObligationDueInFourthYear" contextRef="C_0000899460_20221231" decimals="-5" scale="6">19.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217EUR" id="F_001473" name="us-gaap:PurchaseObligationDueInFifthYear" contextRef="C_0000899460_20221231" decimals="-5" scale="6">9.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the amendment, the term of the Insulin Supply Agreement expires on <ix:nonNumeric id="F_001474" name="mnkd:LongTermPurchaseCommitmentExpirationDate" contextRef="C_0000899460_20220101_20221231" format="ixt:datemonthdayyearen">December&#160;31, 2027</ix:nonNumeric>, unless terminated earlier, and can be renewed for additional, successive two-year terms upon 12 months&#8217; written notice given prior to the end of the initial term or any additional <span style="-sec-ix-hidden:F_001475">two-year</span> term. The Company and Amphastar each have normal and customary termination rights, including termination for a material breach that is not cured within a specific time frame or in the event of liquidation, bankruptcy or insolvency of the other party. In addition, the Company may terminate the Insulin Supply Agreement upon two years&#8217; prior written notice to Amphastar without cause or upon 30 days&#8217; prior written notice to Amphastar if a controlling regulatory authority withdraws approval for Afrezza, provided, however, in the event of a termination pursuant to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require the Company to pay the full amount of all unpaid purchase commitments due over the initial term within 60 calendar days of the effective date of such termination. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Vehicle Leases &#8211; <span style="font-style:normal;">During the second quarter of 2018, the Company entered into a lease agreement with Enterprise Fleet Management Inc. During 2021, <ix:nonFraction unitRef="U_mnkdVehicle" id="F_001476" name="mnkd:NumberOfVehicleLeasesRetired" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231" decimals="INF"><ix:nonFraction unitRef="U_mnkdVehicle" id="F_001477" name="mnkd:NumberOfVehicleLeasesReplaced" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231" decimals="INF">85</ix:nonFraction></ix:nonFraction> vehicles were retired and all of those vehicles were replaced, resulting in a fleet size of <ix:nonFraction unitRef="U_mnkdVehicle" id="F_001478" name="mnkd:NumberOfVehicleLeases" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231" decimals="INF">89</ix:nonFraction> vehicles. The Company received proceeds for the gain on the retired vehicles residual value in the amount of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001480" name="us-gaap:GainLossOnTerminationOfLease" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231" decimals="-5" scale="6">0.5</ix:nonFraction> million, which is included as a reduction to the Company&#8217;s lease expense. The revised monthly payment inclusive of maintenance fees, insurance and taxes is approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001479" name="us-gaap:OperatingLeaseExpense" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231" decimals="-5" scale="6">0.1</ix:nonFraction> million. The lease expense is included in selling expenses in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Office Leases<span style="font-style:normal;"> &#8212; In May&#160;2017, the Company executed an office lease with Russell Ranch Road II LLC for offices in Westlake Village, California. The office lease commenced in August&#160;2017. The Company agreed to pay initial monthly lease payments of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001481" name="us-gaap:OperatingLeaseExpense" contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531" decimals="0" format="ixt:numdotdecimal">40,951</ix:nonFraction>, subject to <ix:nonFraction unitRef="U_xbrlipure" id="F_001482" name="mnkd:OperatingLeasesAnnualIncreaseInRentExpense" contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531" decimals="2" scale="-2">3</ix:nonFraction>% annual increases, plus the estimated cost of maintaining the property and common areas by the landlord, with a five-month concession from </span></p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000504_dcnt_18d00f2e-c7ab-4482-9e37-5485eb687e52">
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">October 2017 through February 2018. </span><span style="font-style:normal;">The lease also provides for allowances for tenant alterations and maintenanc</span><span style="font-style:normal;">e.</span><span style="font-style:normal;"> The lease expense is included in general and administrative expenses in </span><span style="color:#000000;font-style:normal;">the accompanying consolidated statement of operations</span><span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2017, the Company executed an office lease with Russell Ranch Road II LLC to expand the office space for the Company&#8217;s corporate offices in Westlake Village, California which was renewed in April 2022. Pursuant to the renewal, the Company will pay initial monthly lease payments of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001483" name="us-gaap:OperatingLeaseExpense" contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130" decimals="0" format="ixt:numdotdecimal">79,543</ix:nonFraction>, beginning in February 2023, subject to a <ix:nonFraction unitRef="U_xbrlipure" id="F_001484" name="mnkd:OperatingLeasesAnnualIncreaseInRentExpense" contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130" decimals="2" scale="-2">3</ix:nonFraction>% annual increase, plus the estimated operating cost of maintaining the property by the landlord. <ix:nonNumeric id="F_001486" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextRef="C_0000899460_20220101_20221231">The Company will receive a six-month concession at the start of the lease extension period on <ix:nonNumeric id="F_001485" name="mnkd:LeaseExpirationMonthAndYear" contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20220101_20221231" format="ixt:datemonthyearen" continuedAt="C_4fd59c90-fccb-43a2-8ed6-4f2c4987bd11">July</ix:nonNumeric> 31,<ix:continuation id="C_4fd59c90-fccb-43a2-8ed6-4f2c4987bd11"> 2023</ix:continuation>. The Company has no further right to extend the lease term beyond the extension period.</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company assumed certain leased real property (the &#8220;Marlborough Lease&#8221;) pursuant to the APA entered into in May 2022. The Marlborough Lease pertains to certain premises in a building located in Marlborough, Massachusetts. The Company has paid initial monthly payments of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001487" name="us-gaap:OperatingLeaseExpense" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630" decimals="-3" format="ixt:numdotdecimal" scale="3">28,895</ix:nonFraction>, beginning in June 2022, subject to approximately <ix:nonFraction unitRef="U_xbrlipure" id="F_001488" name="mnkd:OperatingLeasesAnnualIncreaseInRentExpense" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630" decimals="2" scale="-2">3</ix:nonFraction>% annual increases through February 28, 2026.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also acquired rights to a manufacturing service agreement where V-Go is manufactured using Company-owned equipment located at the manufacturing facility. The Company determined that this arrangement results in an embedded lease which grants the Company exclusive use of space within the manufacturing facility. The Company assessed the embedded lease cost to be $<ix:nonFraction unitRef="U_iso4217USD" id="F_001489" name="us-gaap:LeaseCost" contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20220601_20220630" decimals="-3" format="ixt:numdotdecimal" scale="3">14,370</ix:nonFraction> per month through February 28, 2026.</p><ix:continuation id="F_000572_cnt_1">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Lease information is as follows (in thousands):</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001490" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,714</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001491" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,284</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-current <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001494" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,304</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001495" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,380</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-long-term</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001498" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001499" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,040</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001502" name="us-gaap:OperatingLeaseLiability" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001503" name="us-gaap:OperatingLeaseLiability" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,420</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001504">4.6</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001505">2.6</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001506" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0000899460_20221231" decimals="3" scale="-2">7.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001507" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_0000899460_20211231" decimals="3" scale="-2">7.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:continuation>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the consolidated balance sheets.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.25%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-size:9pt;color:#000000;">Operating lease liability &#8211; current are included in accrued expenses and other current liabilities in the consolidated balance sheets.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.12%;text-indent:0%;font-size:10pt;">&#160;</p><ix:continuation id="F_000573_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.8%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001508" name="us-gaap:OperatingLeaseCost" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001509" name="us-gaap:OperatingLeaseCost" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">863</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001510" name="us-gaap:OperatingLeaseCost" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,403</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001511" name="us-gaap:VariableLeaseCost" contextRef="C_0000899460_20220101_20221231" decimals="-3" scale="3">274</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001512" name="us-gaap:VariableLeaseCost" contextRef="C_0000899460_20210101_20211231" decimals="-3" scale="3">515</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001513" name="us-gaap:VariableLeaseCost" contextRef="C_0000899460_20200101_20201231" decimals="-3" scale="3">394</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001514" name="us-gaap:OperatingLeasePayments" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,823</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001515" name="us-gaap:OperatingLeasePayments" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,867</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001516" name="us-gaap:OperatingLeasePayments" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,797</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000576" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001517" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,368</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001518" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,892</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001519" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,861</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001520" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,140</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001521" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,072</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001522" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" scale="3">643</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001523" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,976</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001524" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001525" name="us-gaap:OperatingLeaseLiability" contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric></ix:continuation><ix:nonNumeric id="F_000505" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17. Employee Benefit Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company administers a defined contribution 401(k) savings retirement plan for its employees. The Company may make discretionary matching contributions. For the years ended December 31, 2022 and 2021, the Company matched each participant&#8217;s deferral at the rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001526" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextRef="C_0000899460_20220101_20221231" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_001527" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextRef="C_0000899460_20210101_20211231" decimals="2" scale="-2">50</ix:nonFraction></ix:nonFraction>% of each participant&#8217;s deferral up to the first <ix:nonFraction unitRef="U_xbrlipure" id="F_001530" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20210101_20211231" decimals="INF" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_001529" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231" decimals="INF" scale="-2">10</ix:nonFraction></ix:nonFraction>% of compensation. Participants hired after March 31, 2021 became vested in Company contributions at <ix:nonFraction unitRef="U_xbrlipure" id="F_001533" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" contextRef="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20220101_20221231" decimals="2" scale="-2">100</ix:nonFraction>% after two years of service. For the year ended December 31, 2020, the Company matched each participant&#8217;s deferral at the rate of <ix:nonFraction unitRef="U_xbrlipure" id="F_001528" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextRef="C_0000899460_20200101_20201231" decimals="2" scale="-2">50</ix:nonFraction>% of each participant&#8217;s deferral up to the first <ix:nonFraction unitRef="U_xbrlipure" id="F_001531" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231" decimals="INF" scale="-2">6</ix:nonFraction>% of compensation. Participants are vested in Company contributions at <ix:nonFraction unitRef="U_xbrlipure" id="F_001532" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" contextRef="C_0000899460_srtStatementScenarioAxis_mnkdOneYearServiceMember_20200101_20201231" decimals="2" scale="-2">50</ix:nonFraction>% after one year of service and are <ix:nonFraction unitRef="U_xbrlipure" id="F_001534" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" contextRef="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20200101_20201231" decimals="2" scale="-2">100</ix:nonFraction>% vested after two years of service. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s total discretionary matching contributions were $<ix:nonFraction unitRef="U_iso4217USD" id="F_001535" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="C_0000899460_20220101_20221231" decimals="-5" scale="6">1.8</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_001536" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="C_0000899460_20210101_20211231" decimals="-5" scale="6">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001537" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="C_0000899460_20200101_20201231" decimals="-5" scale="6">0.9</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000506" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000506_dcnt_5d785995-06af-4e37-afce-8e8f05cca4c7">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18. Income Taxes </p><ix:nonNumeric id="F_000577" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from continuing operations before provision for income taxes for the Company&#8217;s domestic and international operations was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001538" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001539" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001540" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,458</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before provision for income taxes</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001541" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87,400</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001542" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">80,926</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001543" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">57,458</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2022, the Company has concluded that it is more likely than not that the Company may not realize the benefit of its deferred tax assets due to its history of losses. The Company has incurred operating losses since inception. Accordingly, the net deferred tax assets have been fully reserved. <ix:nonNumeric id="F_000578" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000578_cnt_1">The provision for income taxes consists of the following (in thousands):&#160;  &#160;</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000578_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001544" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001545" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001546" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,606</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001547" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,170</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001548" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,377</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001549" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,334</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001550" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">14,461</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001551" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">469</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001552" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,940</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001553" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19,631</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001554" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,846</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001555" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0000899460_20220101_20221231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">9,940</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001556" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0000899460_20210101_20211231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19,631</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001557" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,846</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001558" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0000899460_20200101_20201231" decimals="-3" sign="-" scale="3">218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes. A valuation allowance is established when uncertainty exists as to whether all or a portion of the net deferred tax assets will be realized. <ix:nonNumeric id="F_000579" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true" continuedAt="F_000579_cnt_1">Components of the net deferred tax assets as of December&#160;31, 2022 and 2021, are approximately as follows (in thousands):</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000579_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001559" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">542,537</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001560" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">542,800</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001561" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">78,804</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001562" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">78,804</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001563" name="mnkd:DeferredTaxAssetsCapitalizedResearchExpenses" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,369</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001564" name="mnkd:DeferredTaxAssetsMilestoneRights" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,331</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001565" name="mnkd:DeferredTaxAssetsMilestoneRights" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,440</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001566" name="mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,675</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001567" name="mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,591</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on purchase commitment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001568" name="mnkd:DeferredTaxAssetsLossOnPurchaseCommitment" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,117</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001569" name="mnkd:DeferredTaxAssetsLossOnPurchaseCommitment" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">24,845</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-qualified stock option expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001570" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,686</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001571" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,684</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized patent costs</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001572" name="mnkd:DeferredTaxAssetsCapitalizedCosts" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,058</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001573" name="mnkd:DeferredTaxAssetsCapitalizedCosts" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,518</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001574" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,204</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001575" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,568</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001576" name="mnkd:DeferredTaxAssetsLeaseLiabilities" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,624</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001577" name="mnkd:DeferredTaxAssetsLeaseLiabilities" contextRef="C_0000899460_20211231" decimals="-3" scale="3">588</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense limitation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001578" name="mnkd:DeferredTaxAssetsInterestExpenseLimitation" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,991</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001579" name="mnkd:DeferredTaxAssetsInterestExpenseLimitation" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,696</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001580" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,157</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001581" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,983</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred Product Revenue &#38; Costs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001582" name="mnkd:DeferredTaxAssetsProductRevenueAndCosts" contextRef="C_0000899460_20221231" decimals="-3" scale="3">370</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001583" name="mnkd:DeferredTaxAssetsProductRevenueAndCosts" contextRef="C_0000899460_20211231" decimals="-3" scale="3">404</ix:nonFraction></p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001584" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">706,923</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001585" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">695,921</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001586" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">705,034</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001587" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">695,094</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001588" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001589" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_0000899460_20211231" decimals="-3" scale="3">827</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001590" name="mnkd:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,640</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001591" name="mnkd:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_0000899460_20211231" decimals="-3" scale="3">555</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other prepaids</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001592" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" contextRef="C_0000899460_20221231" decimals="-3" scale="3">249</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001593" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" contextRef="C_0000899460_20211231" decimals="-3" scale="3">272</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001594" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,889</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001595" name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="C_0000899460_20211231" decimals="-3" scale="3">827</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000506_dcnt_5d785995-06af-4e37-afce-8e8f05cca4c7" continuedAt="F_000506_dcnt_5682f65e-84b5-46c4-a0b6-1586dcd927e5">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000580" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s effective tax rate differs from the statutory federal income tax rate as follows for the years ended December&#160;31, 2022, 2021 and 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal tax benefit rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001596" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0000899460_20220101_20221231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001597" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0000899460_20210101_20211231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001598" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0000899460_20200101_20201231" decimals="INF" scale="-2">21.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001599" name="mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0000899460_20220101_20221231" decimals="3" sign="-" scale="-2">1.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001600" name="mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0000899460_20210101_20211231" decimals="3" sign="-" scale="-2">4.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001601" name="mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems" contextRef="C_0000899460_20200101_20201231" decimals="3" sign="-" scale="-2">6.1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001602" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0000899460_20220101_20221231" decimals="3" scale="-2">0.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001603" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0000899460_20210101_20211231" decimals="3" scale="-2">0.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001604" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0000899460_20200101_20201231" decimals="3" sign="-" scale="-2">0.5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax attribute expirations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001605" name="mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" contextRef="C_0000899460_20220101_20221231" decimals="3" sign="-" scale="-2">13.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001606" name="mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" contextRef="C_0000899460_20210101_20211231" decimals="3" sign="-" scale="-2">5.9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001607" name="mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" contextRef="C_0000899460_20200101_20201231" decimals="3" sign="-" scale="-2">6.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign withholding tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001608" name="mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" contextRef="C_0000899460_20220101_20221231" decimals="3" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001609" name="mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" contextRef="C_0000899460_20210101_20211231" decimals="3" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001610" name="mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" contextRef="C_0000899460_20200101_20201231" decimals="3" scale="-2">0.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001611" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20220101_20221231" decimals="3" scale="-2">7.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001612" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20210101_20211231" decimals="3" scale="-2">11.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-<ix:nonFraction unitRef="U_xbrlipure" id="F_001613" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20200101_20201231" decimals="3" scale="-2">7.8</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001614" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0000899460_20220101_20221231" decimals="3" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001615" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0000899460_20210101_20211231" decimals="3" scale="-2">0.2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001616" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="C_0000899460_20200101_20201231" decimals="3" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001617" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0000899460_20220101_20221231" decimals="3" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001618" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0000899460_20210101_20211231" decimals="3" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_001619" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_0000899460_20200101_20201231" decimals="3" scale="-2">0.4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022 and 2021, management assessed the realizability of deferred tax assets. Management evaluated the need for an amount of any valuation allowance for deferred tax assets on a jurisdictional basis. This evaluation utilizes the framework contained in ASC 740, Income Taxes, wherein management analyzes all positive and negative evidence available at the balance sheet date to determine whether all or some portion of our deferred tax assets will not be realized. Under this guidance, a valuation allowance must be established for deferred tax assets when it is more likely than not (a probability level of more than 50 percent) that they will not be realized. In assessing the realization of the Company's deferred tax assets, the Company considers all available evidence, both positive and negative.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In concluding on the evaluation, management placed significant emphasis on guidance in ASC 740, which states that &#8220;a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome.&#8221; Based upon available evidence as of December 31, 2022, it was concluded on a more-likely-than-not basis that all deferred tax assets were not realizable. Accordingly, a valuation allowance of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001620" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0000899460_20221231" decimals="-5" scale="6">705.0</ix:nonFraction> million has been recorded to offset this deferred tax asset. During the years ended December&#160;31, 2022 and 2021, the change in valuation allowance was $<ix:nonFraction unitRef="U_iso4217USD" id="F_001621" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0000899460_20220101_20221231" decimals="-5" sign="-" scale="6">9.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001622" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0000899460_20210101_20211231" decimals="-5" sign="-" scale="6">19.6</ix:nonFraction>&#160;million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, the Company had federal and state net operating loss carryforwards of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001623" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="C_0000899460_20221231" decimals="-8" scale="9">2.2</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001624" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="C_0000899460_20221231" decimals="-8" scale="9">1.7</ix:nonFraction>&#160;billion available, respectively, to reduce future taxable income. $<ix:nonFraction unitRef="U_iso4217USD" id="F_001625" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" contextRef="C_0000899460_20221231" decimals="-5" scale="6">499.6</ix:nonFraction> million of the federal losses do not expire and the remaining federal losses have started expiring, beginning in the current year through various future dates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_001626" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" contextRef="C_0000899460_20220101_20221231">Pursuant to IRC Sections 382 and 383, annual use of the Company&#8217;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.</ix:nonNumeric> As a result of the Company's initial public offering, an ownership change within the meaning of IRC Section 382 occurred in August 2004. As a result, federal net operating loss and credit carryforwards of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001627" name="mnkd:OperatingLossCarryforwardsSubjectToLimitation" contextRef="C_0000899460_20040831" decimals="-5" scale="6">105.8</ix:nonFraction> million are subject to an annual use limitation of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001628" name="mnkd:NetOperatingLossCarryforwardAnnualLimitation" contextRef="C_0000899460_20040801_20040831" decimals="-5" scale="6">13.0</ix:nonFraction> million. The annual limitation is cumulative and therefore, if not fully utilized in a year can be utilized in future years in addition to the Section 382 limitation for those years. We have completed a Section 382 analysis beginning from the date of our initial public offering through December 31, 2022, to determine whether additional limitations may be placed on the net operating loss carryforwards and other tax attributes, and no additional changes in ownership that met Section 382 study ownership change threshold has been identified through December 31, 2022. There is a risk that changes in ownership may occur in tax years after December 31, 2022. If a change in ownership were to occur, our net operating loss carryforwards and other tax attributes could be further limited or restricted. If limited, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, related to the Company&#8217;s operations in the U.S. will not impact the Company&#8217;s effective tax rate.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="U_iso4217USD" id="F_001629" name="mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20221231" decimals="-5" scale="6">54.2</ix:nonFraction> million of U.S. federal research and development credits which expire beginning in <ix:nonNumeric id="F_001631" name="mnkd:ResearchAndDevelopmentCreditsBeginToExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20220101_20221231">2024</ix:nonNumeric>, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001630" name="mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20221231" decimals="-5" scale="6">24.6</ix:nonFraction>&#160;million of state research and development credits. The California credits are indefinite and do not expire and $<ix:nonFraction unitRef="U_iso4217USD" id="F_001634" name="mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdCaliforniaDivisionOfTaxationMember_20221231" decimals="-5" scale="6">0.2</ix:nonFraction> million of the available New Jersey credits expire at the end of <ix:nonNumeric id="F_001632" name="mnkd:ResearchAndDevelopmentCreditsBeginToExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapNewJerseyDivisionOfTaxationMember_20220101_20221231">2023</ix:nonNumeric>. The Company also had two types of credits in Connecticut of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_001633" name="mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdConnecticutTaxAuthorityMember_20221231" decimals="-5" scale="6">19.8</ix:nonFraction> million do not expire and the $<ix:nonFraction unitRef="U_iso4217USD" id="F_001635" name="mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" contextRef="C_0000899460_20221231" decimals="-5" scale="6">1.1</ix:nonFraction> million of the R&#38;D credit expire at the end of <ix:nonNumeric id="F_001636" name="mnkd:ResearchAndDevelopmentCreditsBeginToExpire" contextRef="C_0000899460_20220101_20221231">2023</ix:nonNumeric>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files U.S. federal and state income tax returns in jurisdictions with varying statutes of limitations. In the normal course of business the Company is subject to examination by taxing authorities throughout the country. These audits could include examining the timing and amount of deductions, the allocation of income among various tax jurisdictions and compliance with federal, state, and local tax laws. The Company's tax years since 2018 remain subject to examination by federal, state and foreign tax authorities.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:continuation id="F_000506_dcnt_5682f65e-84b5-46c4-a0b6-1586dcd927e5">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><ix:nonNumeric id="F_000581" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" contextRef="C_0000899460_20220101_20221231" escape="true">
<p style="margin-top:2pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of beginning and ending amounts of unrecognized tax benefits in 2022, 2021 and 2020, respectively, was as follows (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized Tax Benefit</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning of Year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001637" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001638" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross increases for tax positions of prior years</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001639" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0000899460_20220101_20221231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001640" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0000899460_20210101_20211231" decimals="-3" format="ixt:zerodash">&#8212;</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001641" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0000899460_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross decreases for tax positions of current year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute of limitations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">End of Year</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001642" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0000899460_20221231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001643" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0000899460_20211231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001644" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0000899460_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">268,902</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2022, 2021 and 2020, the Company has not recognized a liability for unrecognized tax benefits. If any were recognized, it would affect the Company&#8217;s effective tax rate. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense. During the years ended December 31, 2022, 2021 and 2020, the Company did <ix:nonFraction unitRef="U_iso4217USD" id="F_001646" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0000899460_20210101_20211231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_001647" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0000899460_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_001645" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0000899460_20220101_20221231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t recognize any interest and/or penalties.&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.42
<SEQUENCE>2
<FILENAME>mnkd-ex1042_615.htm
<DESCRIPTION>EX-10.42
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1042_615.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-size:12pt;font-weight:bold;font-family:Times New Roman;text-transform:none;font-variant: normal;">Exhibit 10.42</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:bold;font-style:italic;;">&nbsp;</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;;font-weight:bold;font-style:italic;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Execution<font style="letter-spacing:-0.1pt;"> </font>Version</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AMENDMENT</font><font style="text-decoration:underline;letter-spacing:-0.15pt;"> </font><font style="text-decoration:underline;">NO.</font><font style="text-decoration:underline;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;">8</font><font style="text-decoration:underline;letter-spacing:-0.1pt;"> </font><font style="text-decoration:underline;">TO</font><font style="text-decoration:underline;letter-spacing:-0.05pt;"> </font><font style="text-decoration:underline;">CREDIT</font><font style="text-decoration:underline;letter-spacing:-0.15pt;"> </font><font style="text-decoration:underline;">AND</font><font style="text-decoration:underline;letter-spacing:-0.15pt;"> </font><font style="text-decoration:underline;">SECURITY</font><font style="text-decoration:underline;letter-spacing:-0.15pt;"> </font><font style="text-decoration:underline;">AGREEMENT</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;margin-left:6.67%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This<font style="letter-spacing:0.4pt;"> </font>AMENDMENT<font style="letter-spacing:0.35pt;"> </font>NO.<font style="letter-spacing:0.25pt;"> </font>8<font style="letter-spacing:0.35pt;"> </font>TO<font style="letter-spacing:0.3pt;"> </font>CREDIT<font style="letter-spacing:0.35pt;"> </font>AND<font style="letter-spacing:0.3pt;"> </font>SECURITY<font style="letter-spacing:0.35pt;"> </font>AGREEMENT<font style="letter-spacing:0.35pt;"> </font>(this<font style="letter-spacing:0.4pt;"> </font>&#8220;<font style="font-weight:bold;">Agreement</font>&#8221;) is<font style="letter-spacing:-0.7pt;"> </font>made<font style="letter-spacing:-0.55pt;"> </font>as<font style="letter-spacing:-0.55pt;"> </font>of<font style="letter-spacing:-0.6pt;"> </font>this<font style="letter-spacing:-0.55pt;"> </font>3rd<font style="letter-spacing:-0.6pt;"> </font>day<font style="letter-spacing:-0.55pt;"> </font>of<font style="letter-spacing:-0.65pt;"> </font>November,<font style="letter-spacing:-0.6pt;"> </font>2021,<font style="letter-spacing:-0.55pt;"> </font>by<font style="letter-spacing:-0.7pt;"> </font>and<font style="letter-spacing:-0.65pt;"> </font>among<font style="letter-spacing:-0.7pt;"> </font><font style="font-weight:bold;">MANNKIND</font><font style="font-weight:bold;letter-spacing:-0.65pt;"> </font><font style="font-weight:bold;">CORPORATION</font>,<font style="letter-spacing:-0.65pt;"> </font>a<font style="letter-spacing:-0.55pt;"> </font>Delaware<font style="letter-spacing:-2.65pt;"> </font>corporation (&#8220;<font style="font-weight:bold;">MannKind</font>&#8221;), <font style="font-weight:bold;">MANNKIND LLC</font>, a Delaware limited liability company (&#8220;<font style="font-weight:bold;">MannKind</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">LLC</font>&#8221;),<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">QRUMPHARMA,</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">INC.</font>,<font style="letter-spacing:0.05pt;"> </font>a<font style="letter-spacing:0.05pt;"> </font>Delaware<font style="letter-spacing:0.05pt;"> </font>corporation<font style="letter-spacing:0.05pt;"> </font>(&#8220;<font style="font-weight:bold;">QP</font>&#8221;),<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">TECHNOSPHERE</font><font style="font-weight:bold;letter-spacing:-2.6pt;"> </font><font style="font-weight:bold;">INTERNATIONAL, INC.</font>, a Delaware corporation (&#8220;Technosphere&#8221;, and, Technosphere, together with<font style="letter-spacing:0.05pt;"> </font>MannKind, MannKind LLC and QP, each a &#8220;<font style="font-weight:bold;">Borrower</font>&#8221; and collectively, the &#8220;<font style="font-weight:bold;">Borrowers</font>&#8221;), <font style="font-weight:bold;">MIDCAP</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">FINANCIAL</font><font style="font-weight:bold;letter-spacing:-0.15pt;"> </font><font style="font-weight:bold;">TRUST</font>,<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>Agent<font style="letter-spacing:-0.1pt;"> </font>(in<font style="letter-spacing:-0.25pt;"> </font>such<font style="letter-spacing:-0.1pt;"> </font>capacity,<font style="letter-spacing:-0.1pt;"> </font>together with<font style="letter-spacing:-0.25pt;"> </font>its<font style="letter-spacing:-0.2pt;"> </font>successors<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>assigns,<font style="letter-spacing:-0.1pt;"> </font>&#8220;<font style="font-weight:bold;">Agent</font>&#8221;)<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-2.65pt;"> </font>the financial institutions or other entities from time to time parties to the Credit Agreement referenced<font style="letter-spacing:0.05pt;"> </font>below,<font style="letter-spacing:-0.05pt;"> </font>each<font style="letter-spacing:-0.15pt;"> </font>as<font style="letter-spacing:0.05pt;"> </font>a Lender.</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">RECITALS</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">A.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Lenders</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entered</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">into</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">August</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">6,</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">2019</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">(as</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">amended</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">1</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">Agreement, dated as of December 18, 2019, that certain Amendment No. 2 to Credit and Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">August</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">21,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">2020,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">3</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">November</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">30,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">2020,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">4</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">December</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">7,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">2020, that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Omnibus</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Joinder and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment No.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">5</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement and Amendment No. 1 to Pledge Agreement, dated as of December 29, 2020, that certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">6</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">March</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">1,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">2021,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Amendment No. 7 to Credit and Security Agreement, dated as of April 22, 2021, as supplemented by that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain Omnibus Joinder to Credit and Security Agreement and Amendment No. 2 to Pledge Agreement,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">August</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">6,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">2021,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">further</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">amended,</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">supplemented</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">otherwise</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">modified</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">from</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">time</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">time</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">prior to the date hereof, the &#8220;</font><font style="font-weight:bold;color:#000000;">Existing Credit Agreement</font><font style="color:#000000;">&#8221; and, as the same is amended hereby and as it</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">further</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">amended,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">modified,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">supplemented</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">restated</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">from</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">time</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">time,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">&#8220;</font><font style="font-weight:bold;color:#000000;">Credit</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-weight:bold;color:#000000;">Agreement</font><font style="color:#000000;">&#8221;),</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">pursuant</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Lenders</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">agreed</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">make</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">advances</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">money</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">extend</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">certain financial accommodations to the Borrowers in the amounts and manner set forth in the Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">B.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">requested,</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Lenders</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">agreed,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">on</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">subject</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">terms</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">and conditions set forth in this Agreement, the Credit Agreement and the other Financing Documents, to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">amend</font><font style="color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">provisions</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">the Existing</font><font style="color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">AGREEMENT</p>
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this<font style="letter-spacing:0.05pt;"> </font>Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby<font style="letter-spacing:0.05pt;"> </font>acknowledged,<font style="letter-spacing:-0.05pt;"> </font>Agent, Lenders<font style="letter-spacing:-0.1pt;"> </font>and Borrower<font style="letter-spacing:0.05pt;"> </font>hereby<font style="letter-spacing:-0.2pt;"> </font>agree<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="1._Recitals.__This_Agreement_shall_const"></a><font style="Background-color:#auto;text-decoration:none;">1.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;letter-spacing:-0.05pt;color:#000000;">Recitals</font><font style="letter-spacing:-0.05pt;color:#000000;">.</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">This</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">constitute</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Financing</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Document</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">Recitals</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">unless</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">otherwise</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">expressly</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">noted,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">will</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">deemed</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement as amended hereby.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Capitalized terms used but not otherwise defined herein shall have the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">meanings ascribed to them in the Credit Agreement (including those capitalized terms used in the Recitals</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">hereto).</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="2._Amendments_to_Existing_Credit_Agreeme"></a><font style="Background-color:#auto;text-decoration:none;">2.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Amendments to Existing Credit Agreement</font><font style="color:#000000;">. Subject to the terms and conditions of this</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:0.25pt;color:#000000;"> </font><font style="color:#000000;">including,</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="color:#000000;">without</font><font style="letter-spacing:0.35pt;color:#000000;"> </font><font style="color:#000000;">limitation,</font><font style="letter-spacing:0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.25pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="color:#000000;">effectiveness</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="color:#000000;">set</font><font style="letter-spacing:0.2pt;color:#000000;"> </font><font style="color:#000000;">forth</font><font style="letter-spacing:0.2pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Section</font><font style="text-decoration:underline;letter-spacing:0.3pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">5</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="color:#000000;">below,</font><font style="letter-spacing:0.1pt;color:#000000;"> </font><font style="color:#000000;">the Existing</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.85pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">is</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">hereby</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">amended</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:0.8pt;color:#000000;"> </font><font style="color:#000000;">deleting</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">text</font><font style="letter-spacing:0.75pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">subclause</font><font style="letter-spacing:0.55pt;color:#000000;"> </font><font style="color:#000000;">(f)</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.8pt;color:#000000;"> </font><font style="color:#000000;">Section</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">7.9</font><font style="letter-spacing:0.65pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.7pt;color:#000000;"> </font><font style="color:#000000;">the </font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Existing</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">and replacing</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">it</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">with &#8220;[reserved]&#8221;.</font></p>
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="3._Representations_and_Warranties;_Reaff"></a><font style="Background-color:#auto;text-decoration:none;">3.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Representations and Warranties; Reaffirmation of Security Interest</font><font style="font-weight:bold;color:#000000;">. </font><font style="color:#000000;">Each Borrower</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">hereby</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">(a)</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">confirms</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">representations</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">warranties</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">set</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">forth</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">are</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">true</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">and correct in all material respects (without duplication of any materiality qualifier in the text of such</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">warranty)</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">respect</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">hereof</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">extent</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">such</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">warranty</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">relates</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">specific</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">case</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">warranty</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">true</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">correct</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">earlier</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">date,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">(b)</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">covenants</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">perform</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">obligations</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">under</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Credit</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Agreement.</font><font style="letter-spacing:1.4pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Each</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Borrower</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">confirms</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">agrees</font><font style="letter-spacing:-0.8pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">security</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">interests</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Liens</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">granted</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">continue</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">full</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">force</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">effect,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Collateral</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">remains</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">free</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">clear</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Liens,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">than</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Permitted</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">Liens.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Nothing herein is intended to impair or limit the validity, priority or extent of Agent&#8217;s security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">interests</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Liens</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">on</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Collateral.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">acknowledges</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agrees</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement, the other Financing Documents and this Agreement constitute the legal, valid and binding</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">obligation</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">of</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">such</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Borrower,</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">are</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">enforceable</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">against</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">accordance</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">enforceability</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">thereof</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">limited</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">bankruptcy,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">insolvency</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">similar</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">laws</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">relating</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">enforcement of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">creditors&#8217;</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">rights generally</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and by</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">general equitable principles.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="4._Costs_and_Fees.__Borrowers_shall_be_r"></a><font style="Background-color:#auto;text-decoration:none;">4.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Costs and Fees</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrowers shall be responsible for the payment of all reasonable and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">documented</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">out-of-pocket</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">costs</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">fees</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Agent&#8217;s</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">counsel</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">incurred</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">preparation</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">and any related</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">documents.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="5._Conditions_to_Effectiveness.__This_Ag"></a><font style="Background-color:#auto;text-decoration:none;">5.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Conditions to Effectiveness</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement shall become effective as of the date on</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">following</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">has</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">been</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">satisfied,</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">determined</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">sole</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">discretion:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(a)_Agent_shall_have_received_(including"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent shall have received (including by way of facsimile or other electronic</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">transmission)</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">duly</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">authorized,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">executed</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">delivered</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">counterpart</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">signature</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">page</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment from</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each Borrower, Agent</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the Lenders;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(b)_all_representations_and_warranties_o"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">all representations and warranties of Borrower contained herein shall be true and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">correct</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">material</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">respects</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(without</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">duplication</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">materiality</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">qualifier</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">text</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">representation or warranty) as of the date hereof except to the extent that any such representation or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">warranty relates to a specific date in which case such representation or warranty shall be true and correct</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">as of such earlier date (and such parties&#8217; delivery of their respective signatures hereto shall be deemed to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">its certification</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">thereof);</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(c)_prior_to_and_after_giving_effect_to_"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">prior to and after giving effect to the agreements set forth herein, no Default or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Event of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Default</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shall exist</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">under</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the Financing</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Documents; and</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(d)_Agent_shall_have_received_such_other"></a><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent shall have received such other documents, information, certificates, and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">information</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">as Agent</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">reasonably</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">request</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">connection with this</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="6._Release.__In_consideration_of_the_agr"></a><font style="Background-color:#auto;text-decoration:none;">6.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Release</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">In consideration of the agreements of Agent and Lenders contained herein and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">predecessors, successors, and assigns, and each of its respective current and former directors, officers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shareholders,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">agents,</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">employees,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">predecessors,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">successors,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">heirs,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">assigns</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">(individually and collectively, the &#8220;</font><font style="font-weight:bold;color:#000000;">Releasing Parties</font><font style="color:#000000;">&#8221;) does hereby fully and completely release, acquit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.95pt;color:#000000;"> </font><font style="color:#000000;">forever</font><font style="letter-spacing:1.05pt;color:#000000;"> </font><font style="color:#000000;">discharge</font><font style="letter-spacing:1pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.9pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:1pt;color:#000000;"> </font><font style="color:#000000;">Agent,</font><font style="letter-spacing:0.95pt;color:#000000;"> </font><font style="color:#000000;">Lenders,</font><font style="letter-spacing:1pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.85pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.95pt;color:#000000;"> </font><font style="color:#000000;">their</font><font style="letter-spacing:0.9pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:1pt;color:#000000;"> </font><font style="color:#000000;">parents,</font><font style="letter-spacing:0.8pt;color:#000000;"> </font><font style="color:#000000;">subsidiaries,</font><font style="letter-spacing:0.85pt;color:#000000;"> </font><font style="color:#000000;">affiliates, members,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">managers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shareholders,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">directors,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">officers</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">employees,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">their</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">predecessors,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">successors,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">heirs,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">assigns</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">(individually</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">collectively,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">&#8220;</font><font style="font-weight:bold;color:#000000;">Released</font><font style="font-weight:bold;letter-spacing:-0.25pt;color:#000000;"> </font><font style="font-weight:bold;color:#000000;">Parties</font><font style="color:#000000;">&#8221;),</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly),</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">based in whole or in part on facts, whether or not now known, existing on or before the date hereof, that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">relate to, arise out of or otherwise are in connection with: (i) any or all of the Financing Documents or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">transactions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">contemplated</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">thereby</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">actions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">omissions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">therewith</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">(ii)</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">aspect</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">the dealings or relationships between or among any Borrower, on the one hand, and any or all of the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Released Parties, on the other hand, relating to any or all of the documents, </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;text-transform:uppercase;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">transactions, actions or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">omissions referenced in clause (i) hereof, in each case, based in whole or in part on facts, whether or not</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">now</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">known,</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">existing</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">before</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">hereof.</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">acknowledges</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">foregoing</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">release</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">is</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">material</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">inducement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agent&#8217;s</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Lender&#8217;s</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">decision</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">enter</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">into</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agree</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">therewith.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="7._No_Waiver_or_Novation.__The_execution"></a><font style="Background-color:#auto;text-decoration:none;">7.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">No Waiver or Novation</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The execution, delivery and effectiveness of this Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">not,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">expressly</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">provided</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">operate</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">waiver</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">right,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">power</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">remedy</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any other documents, instruments and agreements executed or delivered in connection with any of the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">foregoing.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of Default under the Credit Agreement or the other Financing Documents or any of Agent&#8217;s rights and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">remedies in respect of such Defaults or Events of Default. Except as expressly provided herein, nothing in</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">construed</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">an</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">amendment</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">waiver</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">condition</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">precedent</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">funding</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">of Credit Extensions by the Lenders under the Credit Agreement, including those conditions set forth in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Section 3.2 of the Credit Agreement.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement (together with any other document executed in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">herewith)</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">is</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">not</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">intended</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">be,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">nor</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">it</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">construed</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">as,</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">novation</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="8._Affirmation.__Except_as_specifically_"></a><font style="Background-color:#auto;text-decoration:none;">8.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Affirmation</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Except as specifically amended pursuant to the terms hereof, Borrower</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">hereby acknowledges and agrees that the Credit Agreement and all other Financing Documents (and all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ratified and confirmed in all respects by Borrower.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower covenants and agrees to comply with all of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">covenants</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Financing</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Documents,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent&#8217;s or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any Lender&#8217;s part which might otherwise constitute or be construed as a waiver of or amendment to such</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">covenants and conditions.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="9._Miscellaneous."></a><font style="Background-color:#auto;text-decoration:none;">9.</font><font style="font-weight:bold;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;font-weight:bold;color:#000000;">Miscellaneous</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(a)_Reference_to_the_Effect_on_the_Credi"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Reference to the Effect on the Credit Agreement</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Upon the effectiveness of this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement, each reference in the Credit Agreement to &#8220;this Agreement,&#8221; &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;herein,&#8221;</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Except</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">as specifically amended</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">above,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement, and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">other Financing</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Documents (and all covenants, terms, conditions and agreements therein), shall remain in full force and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">effect,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">are</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">hereby</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">ratified and</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">confirmed</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">respects by Borrower.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(b)_GOVERNING_LAW.__THIS_AGREEMENT_AND_A"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">GOVERNING</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">LAW</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AGREEMENT</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ALL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">DISPUTES</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OTHER MATTERS RELATING HERETO OR THERETO OR ARISING THEREFROM (WHETHER</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">SOUNDING</font><font style="letter-spacing:1.1pt;color:#000000;"> </font><font style="color:#000000;">IN</font><font style="letter-spacing:1.25pt;color:#000000;"> </font><font style="color:#000000;">CONTRACT</font><font style="letter-spacing:1.2pt;color:#000000;"> </font><font style="color:#000000;">LAW,</font><font style="letter-spacing:1.15pt;color:#000000;"> </font><font style="color:#000000;">TORT</font><font style="letter-spacing:1.2pt;color:#000000;"> </font><font style="color:#000000;">LAW</font><font style="letter-spacing:1.2pt;color:#000000;"> </font><font style="color:#000000;">OR</font><font style="letter-spacing:1.1pt;color:#000000;"> </font><font style="color:#000000;">OTHERWISE),</font><font style="letter-spacing:1.2pt;color:#000000;"> </font><font style="color:#000000;">SHALL</font><font style="letter-spacing:1.25pt;color:#000000;"> </font><font style="color:#000000;">BE</font><font style="letter-spacing:1.2pt;color:#000000;"> </font><font style="color:#000000;">GOVERNED</font><font style="letter-spacing:1.1pt;color:#000000;"> </font><font style="color:#000000;">BY,</font></p>
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:13.33%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE<font style="letter-spacing:0.05pt;"> </font>STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES (OTHER<font style="letter-spacing:0.05pt;"> </font>THAN<font style="letter-spacing:-0.1pt;"> </font>SECTION<font style="letter-spacing:-0.05pt;"> </font>5-1401 OF<font style="letter-spacing:-0.1pt;"> </font>THE GENERAL<font style="letter-spacing:-0.05pt;"> </font>OBLIGATIONS<font style="letter-spacing:-0.05pt;"> </font>LAW).</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(c)_WAIVER_OF_JURY_TRIAL"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">WAIVER OF JURY TRIAL</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">BORROWER, AGENT AND THE LENDERS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">PARTY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">HERETO</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">HEREBY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">IRREVOCABLY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">WAIVES</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">ANY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">ALL</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">RIGHT</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">TRIAL</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">BY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">IN</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ANY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">LEGAL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ACTION</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">PROCEEDING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ARISING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OUT</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OF</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELATING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND AGREES THAT ANY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">JURY. BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT, AND THAT EACH WILL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">CONTINUE</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ON</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">WAIVER</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">IN</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THEIR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELATED</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">FUTURE</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">DEALINGS.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">BORROWER,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AGENT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">EACH</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">LENDER</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">WARRANTS</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">REPRESENTS</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">THAT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">IT</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">HAS</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">HAD</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">THE</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">OPPORTUNITY</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">OF</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">REVIEWING</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">WAIVER</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">WITH</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">LEGAL</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">COUNSEL,</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">THAT</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">IT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">KNOWINGLY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">VOLUNTARILY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">WAIVES</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">ITS</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">TRIAL</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">RIGHTS.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;text-transform:uppercase;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(d)_Incorporation_of_Credit_Agreement_Pr"></a><font style="text-decoration:none;Background-color:#auto;">(d)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Incorporation</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">of</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Credit</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Agreement</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Provisions</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">provisions</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">contained</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Article</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">12</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(Choice</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">law;</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">venue</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">jury</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">trial</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">waiver;</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">California</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">waivers)</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Section</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">13.2</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(Indemnification) of the Credit Agreement are incorporated herein by reference to the same extent as if</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">reproduced</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">herein in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">their</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entirety.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(e)_Headings.__Section_headings_in_this_"></a><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Headings</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Section headings in this Agreement are included for convenience of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">only</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">not</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">constitute a</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">part</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">this Agreement for</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">purpose.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(f)_Counterparts.__This_Agreement_may_be"></a><font style="Background-color:#auto;text-decoration:none;">(f)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Counterparts</font><font style="color:#000000;">.</font><font style="letter-spacing:1.95pt;color:#000000;"> </font><font style="color:#000000;">This</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">signed</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">number</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">counterparts,</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">deemed</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">an</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">original</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">when</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">taken</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">together</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">constitute</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">one</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">same</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">instrument.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in this Amendment</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shall be deemed to include electronic signatures or electronic records, each of which shall be of the same</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">legal effect, validity or enforceability as a manually executed signature or the use of a paper-based</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">recordkeeping</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">system,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">case</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">be,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">extent</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">provided</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">for</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">applicable</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">law,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">including</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Act.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(g)_Entire_Agreement._This_Agreement_con"></a><font style="Background-color:#auto;text-decoration:none;">(g)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Entire Agreement</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">constitutes</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entire</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">understanding among the parties hereto and supersedes any and all prior agreements and understandings,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">oral</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">written, relating to the subject</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">matter</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">hereof.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(h)_Severability.__In_case_any_provision"></a><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Severability</font><font style="color:#000000;">. In case any provision of or obligation under this Agreement shall be</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">not in any way be</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">affected</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">impaired</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">thereby.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(i)_Successors/Assigns.__This_Agreement_"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Successors/Assigns</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement shall bind, and the rights hereunder shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the other</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Financing Documents.</font></p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[SIGNATURES<font style="letter-spacing:-0.25pt;"> </font>APPEAR<font style="letter-spacing:-0.1pt;"> </font>ON<font style="letter-spacing:-0.25pt;"> </font>FOLLOWING<font style="letter-spacing:-0.2pt;"> </font>PAGES]</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;text-transform:uppercase;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN<font style="letter-spacing:1.5pt;"> </font>WITNESS<font style="letter-spacing:1.55pt;"> </font>WHEREOF,<font style="letter-spacing:1.55pt;"> </font>intending<font style="letter-spacing:1.6pt;"> </font>to<font style="letter-spacing:1.55pt;"> </font>be<font style="letter-spacing:1.5pt;"> </font>legally<font style="letter-spacing:1.55pt;"> </font>bound,<font style="letter-spacing:1.6pt;"> </font>the<font style="letter-spacing:1.65pt;"> </font>undersigned<font style="letter-spacing:1.55pt;"> </font>have<font style="letter-spacing:1.6pt;"> </font>executed<font style="letter-spacing:1.55pt;"> </font>this<font style="letter-spacing:-2.6pt;"> </font>Agreement as<font style="letter-spacing:-0.1pt;"> </font>of<font style="letter-spacing:-0.1pt;"> </font>the<font style="letter-spacing:-0.1pt;"> </font>day and year<font style="letter-spacing:0.05pt;"> </font>first<font style="letter-spacing:0.05pt;"> </font>hereinabove<font style="letter-spacing:-0.05pt;"> </font>set<font style="letter-spacing:-0.1pt;"> </font>forth.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">AGENT:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FINANCIAL TRUST,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:50.84%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FUNDING XIII TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:50.84%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FINANCIAL TRUST,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:50.84%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ELM<font style="letter-spacing:-0.1pt;"> </font>2020-3<font style="letter-spacing:-0.05pt;"> </font>TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap Financial Services Capital Management,<font style="letter-spacing:-2.6pt;"> </font></p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LLC,<font style="letter-spacing:-0.05pt;"> </font>as Servicer</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:50.84%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized<font style="letter-spacing:-0.1pt;"> </font>Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ELM<font style="letter-spacing:-0.1pt;"> </font>2020-4<font style="letter-spacing:-0.05pt;"> </font>TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap Financial Services Capital Management,<font style="letter-spacing:-2.6pt;"> </font></p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LLC,<font style="letter-spacing:-0.05pt;"> </font>as Servicer</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:50.84%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:50.84%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:50.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized<font style="letter-spacing:-0.1pt;"> </font>Signatory</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">APOLLO<font style="letter-spacing:0.2pt;"> </font>INVESTMENT<font style="letter-spacing:0.1pt;"> </font>CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Investment<font style="letter-spacing:0.05pt;"> </font>Management,<font style="letter-spacing:0.05pt;"> </font>L.P.,<font style="letter-spacing:-0.05pt;"> </font>as Advisor</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ACC<font style="letter-spacing:-0.05pt;"> </font>Management, LLC,<font style="letter-spacing:-0.05pt;"> </font>as<font style="letter-spacing:0.1pt;"> </font>its<font style="letter-spacing:0.05pt;"> </font>General<font style="letter-spacing:0.05pt;"> </font>Partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Joseph D Glatt</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:51.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Joseph D Glatt</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice<font style="letter-spacing:-0.2pt;"> </font>President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">BORROWERS:</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:51.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General Counsel</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND LLC</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:51.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">QRUMPHARMA, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:51.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:56.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">TECHNOSPHERE INTERNATIONAL, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:51.1%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:51.1%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:43.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:51.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;text-transform:uppercase;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;font-variant: normal;">8</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.19%;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>8</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.43
<SEQUENCE>3
<FILENAME>mnkd-ex1043_616.htm
<DESCRIPTION>EX-10.43
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1043_616.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;;font-style:normal;font-size:11pt;font-weight:bold;font-family:Times New Roman;text-transform:none;font-variant: normal;">Exhibit 10.43</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-weight:bold;font-style:italic;;">&nbsp;</p>
<p style="margin-top:0pt;text-align:right;margin-bottom:0pt;text-indent:0%;;font-size:11pt;font-weight:bold;font-style:italic;font-family:Times New Roman;text-transform:none;font-variant: normal;">Execution<font style="letter-spacing:-0.1pt;"> </font>Version</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AMENDMENT NO. 9 AND LIMITED CONSENT TO CREDIT AND SECURITY AGREEMENT</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This<font style="letter-spacing:3.65pt;"> </font>AMENDMENT<font style="letter-spacing:3.65pt;"> </font>NO.<font style="letter-spacing:3.6pt;"> </font>9<font style="letter-spacing:3.65pt;"> </font>AND<font style="letter-spacing:3.55pt;"> </font>LIMITED<font style="letter-spacing:3.6pt;"> </font>CONSENT<font style="letter-spacing:3.6pt;"> </font>TO<font style="letter-spacing:3.6pt;"> </font>CREDIT<font style="letter-spacing:3.6pt;"> </font>AND<font style="letter-spacing:3.6pt;"> </font>SECURITY AGREEMENT (this &#8220;<font style="font-weight:bold;">Agreement</font>&#8221;) is made as of this 8th day of<font style="letter-spacing:0.05pt;"> </font>November, 2021, by and among<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">MANNKIND</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">CORPORATION</font>,<font style="letter-spacing:0.05pt;"> </font>a<font style="letter-spacing:0.05pt;"> </font>Delaware<font style="letter-spacing:0.05pt;"> </font>corporation<font style="letter-spacing:0.05pt;"> </font>(&#8220;<font style="font-weight:bold;">MannKind</font>&#8221;),<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">MANNKIND</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">LLC</font>,<font style="letter-spacing:0.05pt;"> </font>a<font style="letter-spacing:0.05pt;"> </font>Delaware<font style="letter-spacing:0.05pt;"> </font>limited<font style="letter-spacing:0.05pt;"> </font>liability<font style="letter-spacing:0.05pt;"> </font>company<font style="letter-spacing:0.05pt;"> </font>(&#8220;<font style="font-weight:bold;">MannKind</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">LLC</font>&#8221;),<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">QRUMPHARMA,</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">INC.</font>,<font style="letter-spacing:0.05pt;"> </font>a<font style="letter-spacing:0.05pt;"> </font>Delaware<font style="letter-spacing:0.05pt;"> </font>corporation<font style="letter-spacing:0.05pt;"> </font>(&#8220;<font style="font-weight:bold;">QP</font>&#8221;),<font style="letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">TECHNOSPHERE</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">INTERNATIONAL,</font><font style="font-weight:bold;letter-spacing:0.05pt;"> </font><font style="font-weight:bold;">INC.</font>,<font style="letter-spacing:0.05pt;"> </font>a<font style="letter-spacing:0.05pt;"> </font>Delaware<font style="letter-spacing:0.05pt;"> </font>corporation<font style="letter-spacing:0.05pt;"> </font>(&#8220;<font style="font-weight:bold;">Technosphere</font>&#8221;, Technosphere, together with MannKind, MannKind LLC and QP, each a &#8220;<font style="font-weight:bold;">Borrower</font>&#8221;<font style="letter-spacing:0.05pt;"> </font>and<font style="letter-spacing:-0.65pt;"> </font>collectively,<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.55pt;"> </font>&#8220;<font style="font-weight:bold;">Borrowers</font>&#8221;),<font style="letter-spacing:-0.6pt;"> </font><font style="font-weight:bold;">MIDCAP</font><font style="font-weight:bold;letter-spacing:-0.6pt;"> </font><font style="font-weight:bold;">FINANCIAL</font><font style="font-weight:bold;letter-spacing:-0.65pt;"> </font><font style="font-weight:bold;">TRUST</font>,<font style="letter-spacing:-0.6pt;"> </font>as<font style="letter-spacing:-0.55pt;"> </font>Agent<font style="letter-spacing:-0.55pt;"> </font>(in<font style="letter-spacing:-0.6pt;"> </font>such<font style="letter-spacing:-0.6pt;"> </font>capacity,<font style="letter-spacing:-0.6pt;"> </font>together<font style="letter-spacing:-2.65pt;"> </font>with its successors and assigns, &#8220;<font style="font-weight:bold;">Agent</font>&#8221;) and the financial institutions or other entities from time to time<font style="letter-spacing:0.05pt;"> </font>parties<font style="letter-spacing:-0.05pt;"> </font>to<font style="letter-spacing:-0.1pt;"> </font>the Credit<font style="letter-spacing:-0.15pt;"> </font>Agreement<font style="letter-spacing:0.05pt;"> </font>referenced below,<font style="letter-spacing:-0.1pt;"> </font>each<font style="letter-spacing:-0.05pt;"> </font>as a Lender.</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">RECITALS</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">A.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Lenders</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entered</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">into</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">August</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">6,</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">2019</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">(as</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">amended</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">1</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">Agreement, dated as of December 18, 2019, that certain Amendment No. 2 to Credit and Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">August</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">21,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">2020,</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">3</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">November</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">30,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">2020,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Amendment</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">No.</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">4</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">dated</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">December</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">7,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">2020, that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Omnibus</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Joinder and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment No.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">5</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement and Amendment No. 1 to Pledge Agreement, dated as of December 29, 2020, that certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment No. 6 to Credit and Security Agreement, dated as of March 1, 2021, that certain Amendment</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">No. 7 to Credit and Security Agreement, dated as of April 22, 2021, as supplemented by that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Omnibus Joinder to Credit and Security Agreement and Amendment No. 2 to Pledge Agreement, dated as</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of August 6, 2021, and that certain Amendment No. 8 to Credit and Security Agreement, dated as of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">November 3, 2021, and as further amended, supplemented or otherwise modified from time to time prior</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">hereof,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">&#8220;</font><font style="font-weight:bold;color:#000000;">Existing</font><font style="font-weight:bold;color:#000000;"> </font><font style="font-weight:bold;color:#000000;">Credit</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;"> </font><font style="font-weight:bold;color:#000000;">Agreement</font><font style="color:#000000;">&#8221;</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">and, as</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">same</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">is amended</font><font style="color:#000000;"> </font><font style="color:#000000;">hereby</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">it</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">further amended, modified, supplemented and restated from time to time, the &#8220;</font><font style="font-weight:bold;color:#000000;">Credit Agreement</font><font style="color:#000000;">&#8221;),</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">pursuant to which the Lenders have agreed to make certain advances of money and to extend certain</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">financial</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">accommodations</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="color:#000000;"> </font><font style="color:#000000;">the</font><font style="color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">amounts</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">manner set</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">forth</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="color:#000000;"> </font><font style="color:#000000;">the</font><font style="color:#000000;"> </font><font style="color:#000000;">Credit Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">B.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Borrowers have notified Agent and Lenders that the Borrowers wish to sell, transfer and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">assign to 1 Casper, LLC, a Delaware limited liability company (&#8220;</font><font style="font-weight:bold;color:#000000;">Casper</font><font style="color:#000000;">&#8221;) a portion of the Owned Real</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Property (the &#8220;</font><font style="font-weight:bold;color:#000000;">Owned Real Property Sale</font><font style="color:#000000;">&#8221;) pursuant to that certain Purchase and Sale Agreement, dated</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">as of September 23, 2021 (the &#8220;</font><font style="font-weight:bold;color:#000000;">Casper Purchase Agreement</font><font style="color:#000000;">&#8221;) by and between MannKind, as seller, and</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Casper,</font><font style="color:#000000;"> </font><font style="color:#000000;">as buyer.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">C.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Pursuant</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Section</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">7.1</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">not,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">nor</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">permit</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Party</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Transfer</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">part</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">business</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">property,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">subject</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">exceptions.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:-0.05pt;"><font style="Background-color:#auto;text-decoration:none;">D.</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">requested,</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Lenders</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">have</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">agreed,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">on</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">subject</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">terms</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.5pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">set</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">forth</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.3pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:0.5pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.45pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:0.55pt;color:#000000;"> </font><font style="color:#000000;">Financing</font><font style="letter-spacing:0.4pt;color:#000000;"> </font><font style="color:#000000;">Documents,</font><font style="letter-spacing:0.4pt;color:#000000;"> </font><font style="color:#000000;">to</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">consent</font><font style="letter-spacing:1.6pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:1.6pt;color:#000000;"> </font><font style="color:#000000;">Owned</font><font style="letter-spacing:1.45pt;color:#000000;"> </font><font style="color:#000000;">Real</font><font style="letter-spacing:1.8pt;color:#000000;"> </font><font style="color:#000000;">Property</font><font style="letter-spacing:1.7pt;color:#000000;"> </font><font style="color:#000000;">Sale</font><font style="letter-spacing:1.6pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="color:#000000;">(ii)</font><font style="letter-spacing:1.7pt;color:#000000;"> </font><font style="color:#000000;">amend</font><font style="letter-spacing:1.65pt;color:#000000;"> </font><font style="color:#000000;">certain</font><font style="letter-spacing:1.75pt;color:#000000;"> </font><font style="color:#000000;">provisions</font><font style="letter-spacing:1.6pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:1.6pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:1.7pt;color:#000000;"> </font><font style="color:#000000;">Existing</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement in connection with</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the Owned</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Real</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Property Sale.</font></p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">AGREEMENT</p>
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this<font style="letter-spacing:0.05pt;"> </font>Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby<font style="letter-spacing:0.05pt;"> </font>acknowledged,<font style="letter-spacing:-0.05pt;"> </font>Agent, Lenders<font style="letter-spacing:-0.1pt;"> </font>and Borrower<font style="letter-spacing:0.05pt;"> </font>hereby<font style="letter-spacing:-0.2pt;"> </font>agree<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">1.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;letter-spacing:-0.05pt;color:#000000;">Recitals</font><font style="letter-spacing:-0.05pt;color:#000000;">.</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">This</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">constitute</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Financing</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Document</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">Recitals</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">unless</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">otherwise</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">expressly</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">noted,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">will</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">deemed</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement as amended hereby.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Capitalized terms used but not otherwise defined herein shall have the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">meanings ascribed to them in the Credit Agreement (including those capitalized terms used in the Recitals</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">hereto).</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:bold;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">2.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Limited</font><font style="text-decoration:underline;letter-spacing:-0.15pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Consent</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Subject to the terms and conditions set forth herein, including without limitation</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the conditions set forth in </font><font style="text-decoration:underline;color:#000000;">Section 6</font><font style="color:#000000;"> hereof, notwithstanding Section 7.1 of the Credit Agreement, Agent</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and the Lenders party hereto (which Lenders constitute at least the Required Lenders) hereby consent to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the consummation of the Owned Real Property Sale; </font><font style="font-style:italic;color:#000000;">provided </font><font style="color:#000000;">that (i) the Owned Real Property Sale shall</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">be consummated in all material respects in accordance with the terms of the Casper Purchase Agreement,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">without</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">giving effect</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to any</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">amendments,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">consents, waivers or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">other modifications thereto that are</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">materially</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">adverse</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Lenders,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">(ii)</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">no</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Default</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Event</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Default</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">exists</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">would</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">(after</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">giving</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">effect</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Agreement)</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">result</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">therefrom,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">(iii)</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Owned</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Real</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">Property</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Sale</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">transaction</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">contemplated</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">the Casper Purchase Agreement</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">consummated no</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">later</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">than</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">November</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">9,</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">2021.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The limited consent set forth in this </font><font style="text-decoration:underline;color:#000000;">Section 2</font><font style="color:#000000;"> is effective solely for the purposes</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">set forth herein and shall be limited precisely as written and shall not be deemed to (i) be a consent to any</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">amendment,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">waiver</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">modification</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">term</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">condition</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Financing Document; (ii) prejudice any right that Agent or Lenders have or may have in the future under</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">or in connection with the Credit Agreement or any other Financing Document; (iii) constitute a consent to</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">or waiver of any past, present or future Default or Event of Default or other violation of any provisions of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the Credit Agreement or any other Financing Documents, (iv) create any obligation to forbear from taking</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">any enforcement action, or to make any further extensions of credit or (v) establish a custom or course of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">dealing</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">among any</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">the Credit Parties, on</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the one</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">hand, or Agent</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">or any</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Lender,</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">on the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">hand.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">3.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Amendments to Existing Credit Agreement</font><font style="color:#000000;">. Subject to the terms and conditions of this</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement, including, without limitation, the conditions to effectiveness set forth in </font><font style="text-decoration:underline;color:#000000;">Section 6</font><font style="color:#000000;"> below, the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Existing</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">is hereby amended</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">follows:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The definition of &#8220;</font><font style="font-weight:bold;color:#000000;">Material Agreement</font><font style="color:#000000;">&#8221; in Section 15 of the Existing Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement is hereby</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">amended and</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">restated</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">follows:</font></p>
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:13.33%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Material</font><font style="font-weight:bold;letter-spacing:-0.3pt;"> </font><font style="font-weight:bold;">Agreement</font>&#8221;<font style="letter-spacing:-0.35pt;"> </font>means<font style="letter-spacing:-0.3pt;"> </font>(a)<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>agreements<font style="letter-spacing:-0.35pt;"> </font>listed<font style="letter-spacing:-0.3pt;"> </font>in<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.35pt;"> </font><font style="font-weight:bold;">Disclosure</font><font style="font-weight:bold;letter-spacing:-0.3pt;"> </font><font style="font-weight:bold;">Schedule</font><font style="font-weight:bold;letter-spacing:-0.3pt;"> </font>to<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-2.6pt;"> </font><font style="font-weight:bold;">Disclosure</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font><font style="font-weight:bold;">Letter</font>,<font style="letter-spacing:-0.2pt;"> </font>(b)<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>United<font style="letter-spacing:-0.15pt;"> </font>Therapeutics<font style="letter-spacing:-0.15pt;"> </font>License,<font style="letter-spacing:-0.15pt;"> </font>(c)<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>Casper<font style="letter-spacing:-0.15pt;"> </font>Lease<font style="letter-spacing:-0.15pt;"> </font>Agreement,<font style="letter-spacing:-0.35pt;"> </font>(d)<font style="letter-spacing:-0.15pt;"> </font>each<font style="letter-spacing:-2.65pt;"> </font>other agreement or contract that is filed with the SEC as a material agreement, including pursuant<font style="letter-spacing:-2.6pt;"> </font>to Item 601(b)(10) of Regulation S-K, and (e) each agreement or contract to which such Credit<font style="letter-spacing:0.05pt;"> </font>Party or its Subsidiaries is a party the termination of which could reasonably be expected to result<font style="letter-spacing:-2.6pt;"> </font>in<font style="letter-spacing:-0.05pt;"> </font>a<font style="letter-spacing:-0.1pt;"> </font>Material<font style="letter-spacing:0.05pt;"> </font>Adverse Change.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Section 15 of the Existing Credit Agreement is hereby amended by adding the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">following</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">new</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">defined</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">terms in</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">appropriate</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">alphabetical</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">order:</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:13.33%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-weight:bold;">Casper Lease Agreement</font>&#8221; means that certain Lease Agreement, dated as of November<font style="letter-spacing:-2.65pt;"> </font>8, 2021, by and between MannKind and 1 Casper, LLC, a Delaware limited liability<font style="letter-spacing:0.05pt;"> </font>company (&#8220;<font style="font-weight:bold;">Casper</font>&#8221;), pursuant to which MannKind leases from Casper certain real<font style="letter-spacing:0.05pt;"> </font>property,<font style="letter-spacing:-0.1pt;"> </font>as<font style="letter-spacing:-0.1pt;"> </font>set<font style="letter-spacing:-0.1pt;"> </font>forth<font style="letter-spacing:-0.1pt;"> </font>therein.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">4.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Representations and Warranties; Reaffirmation of Security Interest</font><font style="font-weight:bold;color:#000000;">. </font><font style="color:#000000;">Each Borrower</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">hereby</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">(a)</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">confirms</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">representations</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">warranties</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">set</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">forth</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">are</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">true and correct in all material respects (without duplication of any materiality qualifier in the text of such</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">warranty)</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">respect</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">hereof</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">extent</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">such</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">warranty</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">relates</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">specific</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">case</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">representation</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">warranty</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">true</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">correct</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">earlier</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">date,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">(b)</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">covenants</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">perform</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">obligations</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">under</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Credit</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Agreement.</font><font style="letter-spacing:1.4pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Each</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Borrower</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">confirms</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">agrees</font><font style="letter-spacing:-0.8pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">security</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">interests</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">Liens</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">granted</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">continue</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">full</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">force</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">effect,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Collateral</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">remains</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">free</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">clear</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Liens,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">than</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">Permitted</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">Liens.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Nothing herein is intended to impair or limit the validity, priority or extent of Agent&#8217;s security</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">interests</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Liens</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">on</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Collateral.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">acknowledges</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agrees</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Agreement, the other Financing Documents and this Agreement constitute the legal, valid and binding</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">obligation</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">of</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">such</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">Borrower,</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">are</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">enforceable</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">against</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">accordance</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.75pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">enforceability</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">thereof</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">limited</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">bankruptcy,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">insolvency</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">similar</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">laws</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">relating</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">enforcement of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">creditors&#8217;</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">rights generally</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">and by</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">general equitable principles.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">5.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Costs and Fees</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrowers shall be responsible for the payment of all reasonable and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">documented</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">out-of-pocket</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">costs</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">fees</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Agent&#8217;s</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">counsel</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">incurred</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">preparation</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">and any related</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">documents.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">6.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Conditions to Effectiveness</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement shall become effective as of the date on</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">following</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">has</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">been</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">satisfied,</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">determined</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">sole</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">discretion:</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent shall have received (including by way of facsimile or other electronic</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">transmission)</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">duly</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">authorized,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">executed</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">delivered</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">counterpart</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">signature</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">page</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Amendment from</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each Borrower, Agent</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the Lenders;</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">shall have</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">received</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">fully-executed</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">copy</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Deed</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Partial Release;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">all representations and warranties of Borrower contained herein shall be true and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">correct</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">material</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">respects</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(without</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">duplication</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">materiality</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">qualifier</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">text</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">such</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">representation or warranty) as of the date hereof except to the extent that any such representation or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">warranty relates to a specific date in which case such representation or warranty shall be true and correct</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">as of such earlier date (and such parties&#8217; delivery of their respective signatures hereto shall be deemed to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">its certification</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">thereof);</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">prior to and after giving effect to the agreements set forth herein, no Default or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Event of Default shall exist under any of the Financing Documents or shall exist after giving effect to the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">transactions</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">contemplated</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">by the Casper Purchase Agreement;</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Agent shall have received such other documents, information, certificates, and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">information</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">as Agent</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">reasonably</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">request</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">connection with this</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">7.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Post-Closing Requirements</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrowers hereby covenant and agree that by the date that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">is thirty (30) days following the date hereof (or such later date as Agent may agree in its sole discretion),</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">deliver</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">Agent</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">fully-execute</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">copy</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">an</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">Access</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">with</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">respect</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">premises</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">leased</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">by</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Borrowers</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">pursuant</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Casper</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Lease</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">form</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">substance</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">reasonably</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">acceptable</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">to Agent. Each Borrower hereby agrees that failure to comply with the requirements set forth in </font><font style="text-decoration:underline;color:#000000;">Section 7</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of this Agreement</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">constitute an</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">immediate and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">automatic Event</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">of Default.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">8.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Release</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">In consideration of the agreements of Agent and Lenders contained herein and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">predecessors, successors, and assigns, and each of its respective current and former directors, officers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shareholders,</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">agents,</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">employees,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">its</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">predecessors,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">successors,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">heirs,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">assigns</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">(individually and collectively, the &#8220;</font><font style="font-weight:bold;color:#000000;">Releasing Parties</font><font style="color:#000000;">&#8221;) does hereby fully and completely release, acquit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and forever discharge each of Agent, Lenders, and each their respective parents, subsidiaries, affiliates,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">members,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">managers,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shareholders,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">directors,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">officers</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">employees,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">their</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">respective</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">predecessors,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">successors,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">heirs,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">assigns</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">(individually</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">collectively,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">&#8220;</font><font style="font-weight:bold;color:#000000;">Released</font><font style="font-weight:bold;letter-spacing:-0.25pt;color:#000000;"> </font><font style="font-weight:bold;color:#000000;">Parties</font><font style="color:#000000;">&#8221;),</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly),</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">based in whole or in part on facts, whether or not now known, existing on or before the date hereof, that</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">relate to, arise out of or otherwise are in connection with: (i) any or all of the Financing Documents or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">transactions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">contemplated</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">thereby</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">actions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">omissions</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">therewith</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">(ii)</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">aspect</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">the dealings or relationships between or among any Borrower, on the one hand, and any or all of the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Released Parties, on the other hand, relating to any or all of the documents, transactions, actions or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">omissions referenced in clause (i) hereof, in each case, based in whole or in part on facts, whether or not</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">now</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">known,</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="letter-spacing:-0.05pt;color:#000000;">existing</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">before</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">date</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">hereof.</font><font style="letter-spacing:1.55pt;color:#000000;"> </font><font style="color:#000000;">Borrower</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">acknowledges</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">that</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">foregoing</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">release</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">is</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.7pt;color:#000000;"> </font><font style="color:#000000;">material</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">inducement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agent&#8217;s</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Lender&#8217;s</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">decision</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">enter</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">into</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agree</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">therewith.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">9.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">No Waiver or Novation</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The execution, delivery and effectiveness of this Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">not,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">except</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">expressly</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">provided</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">operate</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.65pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">waiver</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">right,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">power</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">remedy</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any other documents, instruments and agreements executed or delivered in connection with any of the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">foregoing.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">of Default under the Credit Agreement or the other Financing Documents or any of Agent&#8217;s rights and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">remedies in respect of such Defaults or Events of Default. Except as expressly provided herein, nothing in</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">this</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">construed</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">an</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">amendment</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">waiver</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">condition</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">precedent</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">funding</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">of Credit Extensions by the Lenders under the Credit Agreement, including those conditions set forth in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Section 3.2 of the Credit Agreement.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement (together with any other document executed in</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">connection</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">herewith)</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">is</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">not</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">intended</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">be,</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">nor</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">it</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">construed</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">as,</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">a</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">novation</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">10.</font><font style="margin-left:36pt;color:#000000;"></font><font style="font-weight:bold;text-decoration:underline;color:#000000;">Affirmation</font><font style="font-weight:bold;color:#000000;">.</font><font style="font-weight:bold;letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Except as specifically amended pursuant to the terms hereof, Borrower</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">hereby acknowledges and agrees that the Credit Agreement and all other Financing Documents (and all</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ratified and confirmed in all respects by Borrower.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Borrower covenants and agrees to comply with all of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">covenants</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">conditions</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Financing</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Documents,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent&#8217;s or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any Lender&#8217;s part which might otherwise constitute or be construed as a waiver of or amendment to such</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">terms,</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">covenants and conditions.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:10pt;text-indent:6.67%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">11.</font><font style="font-weight:bold;margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;font-weight:bold;color:#000000;">Miscellaneous</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Reference to the Effect on the Credit Agreement</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Upon the effectiveness of this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement, each reference in the Credit Agreement to &#8220;this Agreement,&#8221; &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;herein,&#8221;</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement.</font><font style="letter-spacing:2.6pt;color:#000000;"> </font><font style="color:#000000;">Except</font><font style="letter-spacing:2.55pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:2.55pt;color:#000000;"> </font><font style="color:#000000;">specifically</font><font style="letter-spacing:2.55pt;color:#000000;"> </font><font style="color:#000000;">amended</font><font style="letter-spacing:2.65pt;color:#000000;"> </font><font style="color:#000000;">above,</font><font style="letter-spacing:2.7pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:2.65pt;color:#000000;"> </font><font style="color:#000000;">Credit</font><font style="letter-spacing:2.7pt;color:#000000;"> </font><font style="color:#000000;">Agreement,</font><font style="letter-spacing:2.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:2.65pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:2.6pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:2.55pt;color:#000000;"> </font><font style="color:#000000;">Financing</font></p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:13.33%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Documents<font style="letter-spacing:0.7pt;"> </font>(and<font style="letter-spacing:0.8pt;"> </font>all<font style="letter-spacing:0.8pt;"> </font>covenants,<font style="letter-spacing:0.8pt;"> </font>terms,<font style="letter-spacing:0.8pt;"> </font>conditions<font style="letter-spacing:0.8pt;"> </font>and<font style="letter-spacing:0.75pt;"> </font>agreements<font style="letter-spacing:0.8pt;"> </font>therein),<font style="letter-spacing:0.8pt;"> </font>shall<font style="letter-spacing:0.85pt;"> </font>remain<font style="letter-spacing:0.8pt;"> </font>in<font style="letter-spacing:0.8pt;"> </font>full<font style="letter-spacing:0.8pt;"> </font>force<font style="letter-spacing:0.85pt;"> </font>and<font style="letter-spacing:-2.6pt;"> </font>effect,<font style="letter-spacing:-0.2pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>are<font style="letter-spacing:-0.1pt;"> </font>hereby<font style="letter-spacing:-0.1pt;"> </font>ratified and<font style="letter-spacing:-0.1pt;"> </font>confirmed<font style="letter-spacing:-0.05pt;"> </font>in<font style="letter-spacing:-0.15pt;"> </font>all<font style="letter-spacing:0.05pt;"> </font>respects by Borrower.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">GOVERNING</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">LAW</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AGREEMENT</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ALL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">DISPUTES</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OTHER MATTERS RELATING HERETO OR THERETO OR ARISING THEREFROM (WHETHER</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES (OTHER</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THAN</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">SECTION</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">5-1401 OF</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">THE GENERAL</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">OBLIGATIONS</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">LAW).</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">WAIVER OF JURY TRIAL</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">BORROWER, AGENT AND THE LENDERS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">PARTY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">HERETO</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">HEREBY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">IRREVOCABLY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">WAIVES</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">ANY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">ALL</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">RIGHT</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">TRIAL</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">BY</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">IN</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ANY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">LEGAL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ACTION</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">PROCEEDING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ARISING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OUT</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OF</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">OR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELATING</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND AGREES THAT ANY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">JURY. BORROWER, AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT, AND THAT EACH WILL</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">CONTINUE</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">TO</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELY</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">ON</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">WAIVER</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">IN</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">THEIR</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">RELATED</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">FUTURE</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">DEALINGS.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">BORROWER,</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AGENT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">EACH</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">LENDER</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">WARRANTS</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">REPRESENTS</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">THAT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">IT</font><font style="letter-spacing:-0.2pt;color:#000000;"> </font><font style="color:#000000;">HAS</font><font style="letter-spacing:-0.25pt;color:#000000;"> </font><font style="color:#000000;">HAD</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">THE</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">OPPORTUNITY</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">OF</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">REVIEWING</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">THIS</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">WAIVER</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">WITH</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">LEGAL</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">COUNSEL,</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">THAT</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">IT</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">KNOWINGLY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">AND</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">VOLUNTARILY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">WAIVES</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">ITS</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">JURY</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">TRIAL</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">RIGHTS.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Incorporation</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">of</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Credit</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Agreement</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Provisions</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">provisions</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">contained</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">in </font><font style="text-decoration:underline;color:#000000;">Article</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">12</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(</font><font style="font-style:italic;color:#000000;">Choice</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">of</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">law;</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">venue</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">and</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">jury</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">trial</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">waiver;</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">California</font><font style="font-style:italic;letter-spacing:0.05pt;color:#000000;"> </font><font style="font-style:italic;color:#000000;">waivers</font><font style="color:#000000;">)</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">Section</font><font style="text-decoration:underline;letter-spacing:0.05pt;color:#000000;"> </font><font style="text-decoration:underline;color:#000000;">13.2</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">(</font><font style="font-style:italic;color:#000000;">Indemnification</font><font style="color:#000000;">) of the Credit Agreement are incorporated herein by reference to the same extent as if</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">reproduced</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">herein in</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">their</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entirety.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Headings</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Section headings in this Agreement are included for convenience of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">reference</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">only</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">not</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">constitute a</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">part</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">this Agreement for</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.05pt;color:#000000;"> </font><font style="color:#000000;">other</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">purpose.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(f)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Counterparts</font><font style="color:#000000;">.</font><font style="letter-spacing:1.95pt;color:#000000;"> </font><font style="color:#000000;">This</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">signed</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">number</font><font style="letter-spacing:-0.3pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.35pt;color:#000000;"> </font><font style="color:#000000;">counterparts,</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">each</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">be</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">deemed</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">an</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">original</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">all</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">of</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">which</font><font style="letter-spacing:-0.6pt;color:#000000;"> </font><font style="color:#000000;">when</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">taken</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">together</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">shall</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">constitute</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">one</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">same</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">instrument.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in this Amendment</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">shall be deemed to include electronic signatures or electronic records, each of which shall be of the same</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">legal effect, validity or enforceability as a manually executed signature or the use of a paper-based</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">recordkeeping</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">system,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">case</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">may</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">be,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">to</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">extent</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:-0.45pt;color:#000000;"> </font><font style="color:#000000;">as</font><font style="letter-spacing:-0.4pt;color:#000000;"> </font><font style="color:#000000;">provided</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">for</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">in</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">any</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">applicable</font><font style="letter-spacing:-0.5pt;color:#000000;"> </font><font style="color:#000000;">law,</font><font style="letter-spacing:-0.55pt;color:#000000;"> </font><font style="color:#000000;">including</font><font style="letter-spacing:-2.65pt;color:#000000;"> </font><font style="color:#000000;">the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">Act.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(g)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Entire Agreement</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">constitutes</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">entire</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">agreement</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">and</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">understanding among the parties hereto and supersedes any and all prior agreements and understandings,</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">oral</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">written, relating to the subject</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">matter</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">hereof.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Severability</font><font style="color:#000000;">. In case any provision of or obligation under this Agreement shall be</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">not in any way be</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">affected</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">impaired</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">thereby.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(h)_Severability.__In_case_any_provision"></a><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Severability</font><font style="color:#000000;">. In case any provision of or obligation under this Agreement shall be</font><font style="letter-spacing:-2.6pt;color:#000000;"> </font><font style="color:#000000;">invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">not in any way be</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">affected</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">or</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">impaired</font><font style="letter-spacing:-0.1pt;color:#000000;"> </font><font style="color:#000000;">thereby.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:13.33%;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="(i)_Successors/Assigns.__This_Agreement_"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Successors/Assigns</font><font style="color:#000000;">.</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">This Agreement shall bind, and the rights hereunder shall</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Agreement and</font><font style="letter-spacing:-0.15pt;color:#000000;"> </font><font style="color:#000000;">the other</font><font style="letter-spacing:0.05pt;color:#000000;"> </font><font style="color:#000000;">Financing Documents.</font></p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[SIGNATURES<font style="letter-spacing:-0.25pt;"> </font>APPEAR<font style="letter-spacing:-0.1pt;"> </font>ON<font style="letter-spacing:-0.25pt;"> </font>FOLLOWING<font style="letter-spacing:-0.2pt;"> </font>PAGES]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, intending to be legally bound, the undersigned have executed this Agreement as of the day and year first hereinabove set forth.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">AGENT:</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FINANCIAL TRUST,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FUNDING XIII TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MIDCAP FINANCIAL TRUST,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management, L.P.,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its investment manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Capital Management GP, LLC,</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its general partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maurice Amsellem</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Signatory</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:bold;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ELM<font style="letter-spacing:-0.1pt;"> </font>2020-3<font style="letter-spacing:-0.05pt;"> </font>TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap Financial Services Capital Management,<font style="letter-spacing:-2.6pt;"> </font></p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LLC,<font style="letter-spacing:-0.05pt;"> </font>as Servicer</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized<font style="letter-spacing:-0.1pt;"> </font>Signatory</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ELM<font style="letter-spacing:-0.1pt;"> </font>2020-4<font style="letter-spacing:-0.05pt;"> </font>TRUST</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap Financial Services Capital Management,<font style="letter-spacing:-2.6pt;"> </font></p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LLC,<font style="letter-spacing:-0.05pt;"> </font>as Servicer</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John O'Dea</p></td>
</tr>
<tr>
<td valign="top"  style="width:50%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized<font style="letter-spacing:-0.1pt;"> </font>Signatory</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap<font style="letter-spacing:-0.1pt;"> </font>/<font style="letter-spacing:-0.1pt;"> </font>MannKind<font style="letter-spacing:-0.1pt;"> </font>/ Amendment<font style="letter-spacing:-0.1pt;"> </font>No.<font style="letter-spacing:-0.1pt;"> </font>9<font style="letter-spacing:-0.1pt;"> </font>and<font style="letter-spacing:-0.1pt;"> </font>Limited<font style="letter-spacing:-0.1pt;"> </font>Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">LENDERS:</p></td>
<td colspan="2" valign="top"  style="width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">APOLLO<font style="letter-spacing:0.2pt;"> </font>INVESTMENT<font style="letter-spacing:0.1pt;"> </font>CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Apollo Investment<font style="letter-spacing:0.05pt;"> </font>Management,<font style="letter-spacing:0.05pt;"> </font>L.P.,<font style="letter-spacing:-0.05pt;"> </font>as Investment Adviser</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ACC<font style="letter-spacing:-0.05pt;"> </font>Management, LLC,<font style="letter-spacing:-0.05pt;"> </font>as<font style="letter-spacing:0.1pt;"> </font>its<font style="letter-spacing:0.05pt;"> </font>General<font style="letter-spacing:0.05pt;"> </font>Partner</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Joseph D Glatt</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Joseph D Glatt</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice<font style="letter-spacing:-0.2pt;"> </font>President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap / MannKind / Amendment No. 9 and Limited Consent</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">BORROWERS:</p></td>
<td colspan="2" valign="top"  style="width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General Counsel</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">MANNKIND LLC</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">QRUMPHARMA, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:49.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">TECHNOSPHERE INTERNATIONAL, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:44.26%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.05pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:44.26%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Thomson</p></td>
</tr>
<tr>
<td valign="top"  style="width:50.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:44.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap / MannKind / Amendment No. 9 and Limited Consent</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.49
<SEQUENCE>4
<FILENAME>mnkd-ex1049_458.htm
<DESCRIPTION>EX-10.49
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1049_458.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.49</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">SECOND AMENDMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">TO</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">COMMERCIAL SUPPLY AGREEMENT</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This amendment is effective the last date signed by a party, <font style="letter-spacing:-0.1pt;color:#000000;">between </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at One Casper Street, Danbury, Connecticut 06810, and </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware public benefit corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at 1040 Spring Street, Silver Spring, Maryland 20910.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">, the parties to this amendment entered into a Commercial Supply Agreement effective as of August 12, 2021 (as amended on October 16, 2021, the &#8220;</font>Agreement<font style="font-weight:normal;">&#8221;), and the parties now wish to amend the Agreement as set forth below.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE<font style="font-weight:normal;">, in consideration of the terms and conditions specified herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>AMENDMENT<font style="font-weight:normal;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">a.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Section 1.2 (<font style="font-style:italic;">Annual Budget</font>) is deleted and replaced with the following:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:12pt;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;"><font style="font-weight:bold;">&#8220;Annual Budget&#8221;</font> means an annual budget for all amounts to be invoiced to United Therapeutics pursuant to this Agreement in respect of a calendar year, in a format reasonably agreed to by United Therapeutics and MannKind, and at a minimum providing a breakdown of costs by Price, Staffing Payments, Facility Utilization Fees, and Packaging Services, and other discrete categories and subcategories as reasonably requested by United Therapeutics.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">b.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>The second sentence of Section 1.11 (<font style="font-style:italic;">Cost of Goods</font>), set forth below as follows, is deleted:</p></td></tr></table></div>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:21.15%;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><strike>In addition, COGs will include an annual facility utilization expense (or rent) of $</strike><font style="font-weight:bold;color:#000000;">[***]</font><strike> (increasing to $</strike><font style="font-weight:bold;color:#000000;">[***]</font><strike> on December 1, 2021 and thereafter) per square foot for the portion of the Facility allocated to activities under this Agreement; provided, however, that such facility utilization expense shall not be subject to the Margin</strike><font style="color:#000000;"><strike>.</strike></font></p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:21.15%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 1</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">c.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>The following defined term is added to the Agreement as new Section 1.14A:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.14A</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&#8220;<font style="font-weight:bold;">Facility Utilization Fee</font>&#8221; means an amount equal to $<font style="font-weight:bold;">[***]</font>per month during the Term <font style="color:#000000;">to compensate MannKind for the portion of the Facility used for Manufacturing and other activities covered by this Agreement, as has been reasonably determined by United Therapeutics and MannKind as of June 15, 2022, with the understanding that such amount will be reasonably adjusted by mutual agreement memorialized in an amendment to this Agreement or a letter agreement referencing this Agreement if and when there is a significant change to the amount of Facility space dedicated to Manufacturing and other activities covered by this Agreement.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">d.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Section 2.4.1 of the Agreement (&#8220;Rolling Forecast&#8221;) is deleted in its entirety and replaced with the following:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:15.38%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.4.1</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">The &#8220;<font style="font-weight:bold;">Rolling Forecast</font>&#8221; is defined as the 18-month Manufacturing forecast for Product and Semi-finished Product submitted by United Therapeutics, as updated monthly within the first 10 business days of each month by United Therapeutics during the Term in accordance with Section 2.4.2, 2.4.3, and 2.4.4. The first six months of the Rolling Forecast shall be considered binding upon the parties (i.e., United Therapeutics shall place Purchase Orders for, and MannKind shall Supply, not less than the minimum quantity of Product and Semi-Finished Product specified in such Rolling Forecast during such period), and the remaining 12 months will be considered good faith estimates, but may be adjusted as necessary to meet United Therapeutics&#8217; requirements, provided that notwithstanding the limited six-month binding portion of the Rolling Forecast, the Rolling Forecast in effect as of June 2, 2022 shall be considered binding through March 31, 2023.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">e.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Section 3.2 of the Agreement (&#8220;Staffing Payments&#8221;) is deleted in its entirety and replaced with the following:</p></td></tr></table></div><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 2</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">3.2. </font><font style="font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Staffing Payments and F</font><font style="font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">acility Utilization Fee.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2.1</font><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;"><font style="text-decoration:underline;">Staffing Payments</font>. <font style="color:#000000;">United Therapeutics shall reimburse MannKind monthly for the Staffing Payment, subject to the limits set forth in Appendix E in 2022, and subject to the limits set forth in the Annual Budget in subsequent years during the effective Term, in each case upon receipt of an invoice in accordance with Section 3.3. United Therapeutics and MannKind agree to reasonably account for Staffing Payments in calendar year 2023 and beyond through the Annual Budget process, and further agree that the per-item Prices shall exclude the components of COGs that are being invoiced in such Staffing Payments.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2.2</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;"><font style="text-decoration:underline;">Facility Utilization Fee</font>. Effective as of May 1, 2022, United Therapeutics shall be responsible for the monthly Facility Utilization Fee upon receipt of an invoice in accordance with Section 3.3, such invoice specifying the fee owed as specified in section 1.14A. MannKind shall ensure that no depreciation for the building, United Therapeutics funded capital, or other overhead is separately charged to United Therapeutics, or forms the basis of any Product or Semi-Finished Product Price, by virtue of the definitions of &#8220;COGs&#8221; or &#8220;Fixed Overhead&#8221;, for the portion of the Facility that gives rise to the Facility Utilization Fee.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">f.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Section 3.3.1 of the Agreement is deleted and replaced with the following:</p></td></tr></table></div>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On the fifth business day of each month, MannKind shall invoice United Therapeutics for any Staffing Payment owed pursuant to section 3.2.1 and any Facility Utilization Fee owed pursuant to section 3.2.2, in each case in respect of the immediately preceding calendar month.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">g.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><a name="_DV_M428"></a><a name="_DV_M429"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Appendices B and E of the Agreement are deleted in their entirety and replaced with the updated versions of Appendices B and E attached hereto, and all references to Appendices B and E in the Agreement shall be construed as references to the updated versions attached hereto<a name="_DV_M428"></a><a name="_DV_M429"></a>.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>GENERAL. <font style="font-weight:normal;">All terms of the Agreement that are not specifically modified by this amendment remain in full force and effect. The parties may execute this amendment in counterparts, each of which is deemed an original for all purposes, and which together will constitute the same instrument. The parties may execute this amendment by electronic means (electronic signature through generally recognized e-signature vendors), by scanned pdfs of wet-ink signed documents, or by return of originals.</font></p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp; *</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">Signature page follows<font style="font-style:normal;"><br /></font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 3</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;"></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the parties have caused this amendment to be signed by their duly authorized representatives as of the date indicated below.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:-0.05%;width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">United Therapeutics Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Patrick Poisson</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:  Patrick Poisson </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:  EVP, Technical Operations&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 15-June-2022</p></td>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">MannKind Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Joe Kocinsky</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Joe Kocinsky</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: &nbsp;&nbsp; Chief Technology Officer</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 15-June-2022</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 4</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX B</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PRICE AND PRICE ADJUSTMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 5</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX E</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">STAFFING PAYMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 6</a> of 7</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.50
<SEQUENCE>5
<FILENAME>mnkd-ex1050_456.htm
<DESCRIPTION>EX-10.50
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1050_456.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.50</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">THIRD AMENDMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">TO</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">COMMERCIAL SUPPLY AGREEMENT</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This amendment is effective the last date signed by a party, <font style="letter-spacing:-0.1pt;color:#000000;">between </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at One Casper Street, Danbury, Connecticut 06810, and </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware public benefit corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at 1040 Spring Street, Silver Spring, Maryland 20910.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">, the parties to this amendment entered into a Commercial Supply Agreement effective as of August 12, 2021 (such agreement, as amended in a First Amendment effective October 16, 2021, and in a Second Amendment effective June 15, 2022, the &#8220;</font>Agreement<font style="font-weight:normal;">&#8221;), and the parties now wish to amend the Agreement as set forth below.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE<font style="font-weight:normal;">, in consideration of the terms and conditions specified herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>AMENDMENTS<font style="font-weight:normal;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">a.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><a name="_DV_M428"></a><a name="_DV_M429"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Appendices A and B are deleted in their entirety and replaced with the revised versions of Appendices A and B attached hereto, and all references to Appendices A and B in the Agreement shall be construed as references the updated versions attached hereto<a name="_DV_M428"></a><a name="_DV_M429"></a>.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:12pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:12pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:12pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>GENERAL. <font style="font-weight:normal;">All terms of the Agreement that are not specifically modified by this amendment remain in full force and effect. The parties may execute this amendment in counterparts, each of which is deemed an original for all purposes, and which together will constitute the same instrument. The parties may execute this amendment by electronic means (electronic signature through generally recognized e-signature vendors), by scanned pdfs of wet-ink signed documents, or by return of originals.</font></p></td></tr></table></div>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; *</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">Signature page follows</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 1</a> of 4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the parties have caused this amendment to be signed by their duly authorized representatives as of the date indicated below.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:-0.05%;width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">United Therapeutics Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Patrick Poisson</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:  Patrick Poisson </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:  &nbsp;&nbsp; EVP, Technical Operations&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 31-Aug-2022</p></td>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">MannKind Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Joe Kocinsky</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Joe Kocinsky</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: &nbsp;&nbsp; Chief Technology Officer</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 31-Aug-2022</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 2</a> of 4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX A</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PRODUCT AND SEMI-FINISHED PRODUCT DESCRIPTIONS AND SPECIFICATIONS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 3</a> of 4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX B</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PRICE AND PRICE ADJUSTMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 4</a> of 4</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.51
<SEQUENCE>6
<FILENAME>mnkd-ex1051_457.htm
<DESCRIPTION>EX-10.51
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1051_457.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.51</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">FOURTH AMENDMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">TO</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">COMMERCIAL SUPPLY AGREEMENT</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This amendment is effective the last date signed by a party, <font style="letter-spacing:-0.1pt;color:#000000;">between </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">MannKind</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at One Casper Street, Danbury, Connecticut 06810, and </font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics Corporation</font><font style="letter-spacing:-0.1pt;color:#000000;">, a Delaware public benefit corporation (&#8220;</font><font style="font-weight:bold;letter-spacing:-0.1pt;color:#000000;">United Therapeutics</font><font style="letter-spacing:-0.1pt;color:#000000;">&#8221;), having a principal place of business at 1040 Spring Street, Silver Spring, Maryland 20910.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS<font style="font-weight:normal;">, the parties to this amendment entered into a Commercial Supply Agreement effective as of August 12, 2021 (such agreement, as amended in a First Amendment effective October 16, 2021, a Second Amendment effective June 15, 2022, and a Third Amendment effective August 31, 2022, the &#8220;</font>Agreement<font style="font-weight:normal;">&#8221;), and the parties now wish to amend the Agreement as set forth below.</font></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE<font style="font-weight:normal;">, in consideration of the terms and conditions specified herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>AMENDMENTS<font style="font-weight:normal;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">a.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>The following section is added as section 2.2.7 to the Agreement:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:13.46%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:9.62%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.7</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Calibri;font-size:12pt;">By October 15 of each year during the Term, MannKind shall provide United Therapeutics with a complete written listing of all equipment maintained by MannKind at the Facility that is titled to United Therapeutics as of October 1 of the same year, including, without limitation, Expansion Equipment, as evidenced by a bill of sale executed by the parties on or prior to October 1.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">b.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>The following phrase in the first sentence of Section 3.3 of the Agreement is deleted in its entirety: &#8220;[***]@unither.com, and/or&#8221;. MannKind shall continue to send all invoices to United Therapeutics by email to AP@unither.com, and United Therapeutics will instruct MannKind as to any additional email addresses that should be cc&#8217;ed on such emails. All other invoicing procedures shall remain unchanged.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">c.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><a name="_DV_M428"></a><a name="_DV_M429"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font>Appendices A and B of the Agreement are deleted in their entirety and replaced with the revised versions of Appendices A and B attached hereto, and all references to Appendices A and B in the Agreement shall be construed as references the updated versions attached hereto<a name="_DV_M428"></a><a name="_DV_M429"></a>.</p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 1</a> of 5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:12pt;font-family:Calibri;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="font-weight:normal;color:#000000;"></font>GENERAL. <font style="font-weight:normal;">All terms of the Agreement that are not specifically modified by this amendment remain in full force and effect. The parties may execute this amendment in counterparts, each of which is deemed an original for all purposes, and which together will constitute the same instrument. The parties may execute this amendment by electronic means (electronic signature through generally recognized e-signature vendors), by scanned pdfs of wet-ink signed documents, or by return of originals.</font></p></td></tr></table></div>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">*&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;*</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">Signature page follows<font style="font-style:normal;"><br /></font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 2</a> of 5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-style:italic;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;"></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the parties have caused this amendment to be signed by their duly authorized representatives as of the date indicated below.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:-0.05%;width:99.89%;">
<tr>
<td style="width:49.95%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">United Therapeutics Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Patrick Poisson</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:  Patrick Poisson </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:  &nbsp;&nbsp; EVP, Technical Operations&nbsp;&nbsp;&nbsp;&nbsp; </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 22-Dec-2022</p></td>
<td valign="top" >
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;text-transform:uppercase;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-style:normal;font-variant: normal;">MannKind Corporation </p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: /s/ Sanjay Singh</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Sanjay Singh</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: &nbsp;&nbsp; EVP, Technical Operations</p>
<p style="margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;letter-spacing:-0.1pt;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 22-Dec-2022</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 3</a> of 5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX A</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PRODUCT AND SEMI-FINISHED PRODUCT DESCRIPTIONS AND SPECIFICATIONS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 4</a> of 5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&#160;NOT MATERIAL AND (II)&#160;IS THE TYPE THAT MANNKIND CORPORATION TREATS AS PRIVATE OR CONFIDENTIAL.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">APPENDIX B</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">PRICE AND PRICE ADJUSTMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">[***]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Page 5</a> of 5</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.52
<SEQUENCE>7
<FILENAME>mnkd-ex1052_455.htm
<DESCRIPTION>EX-10.52
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1052_455.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.52</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OFFICE LEASE AGREEMENT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">BY AND BETWEEN</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RFP LINCOLN 293, LLC</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AND</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">VALERITAS, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DATED<font style="font-weight:normal;"> : </font>May 10, 2017</p><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="EXHIBIT104_HTM_S91395194467CCB158EF8FE36"></a><a name="EXHIBIT104_HTM_SF24DD6C5B846D1414ECDFE36"></a>&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:16.74%;"></td>
<td style="width:69.69%;"></td>
<td style="width:13.57%;"></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PAGE</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE I</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SUMMARY OF BASIC LEASE PROVISIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INTRODUCTION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BASIC DATA</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ENUMERATION OF EXHIBITS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE II</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DESCRIPTION OF PREMISES AND APPURTENANT RIGHTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LOCATION OF PREMISES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">APPURTENANT RIGHTS AND RESERVATIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RIGHT OF FIRST OFFER</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE III</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TERM OF LEASE: CONDITION OF PREMISES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TERM OF LEASE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXTENSION OPTION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONDITION OF PREMISES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EARLY POSSESSION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S WORK</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT ALLOWANCE; TENANT OBLIGATION TO FUND TENANT&#8217;S SHARE OF EXCESS LANDLORD&#8217;S WORK COSTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.7</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S AND TENANT INITIAL WORK; DELAYS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GENERAL PROVISIONS APPLICABLE TO CONSTRUCTION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.9</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONSTRUCTION REPRESENTATIVES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IV</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RENT PAYMENTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">REAL ESTATE TAX</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S SHARE OF OPERATING COSTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INSPECTION RIGHT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BASE RENT DURING ANY EXTENSION TERM</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE V</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">USE OF PREMISES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PERMITTED USE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COMPLIANCE WITH LAWS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INSURANCE RISKS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ELECTRICAL EQUIPMENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S OPERATIONAL COVENANTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.6</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SIGNS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HAZARDOUS MATERIALS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VI</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INSTALLATIONS, ALTERATIONS, AND ADDITIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VII</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASSIGNMENT AND SUBLETTING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PROHIBITION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ACCEPTANCE OF RENT FROM TRANSFEREE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SUBLEASE RENTALS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RIGHT OF RECAPTURE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VIII</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">REPAIRS AND MAINTENANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT OBLIGATIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD OBLIGATIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IX</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SERVICES TO BE FURNISHED BY LANDLORD; UTILITIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S SERVICES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CAUSES BEYOND CONTROL OF THE PARTIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEPARATELY METERED UTILITIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INTERRUPTION OF SERVICES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE X</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INDEMNITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INDEMNITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S RISK</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:16.74%;"></td>
<td style="width:69.69%;"></td>
<td style="width:13.57%;"></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PAGE</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INJURY CAUSED BY THIRD PARTIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECURITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XI</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PUBLIC LIABILITY INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HAZARD INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONSTRUCTION PERIOD INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EVIDENCE OF INSURANCE; INSURANCE STANDARDS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="eolPage45"></a>11.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RENTAL ABATEMENT INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.6</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MUTUAL WAIVER OF SUBROGATION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.7</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S INSURANCE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XII</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CASUALTY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DEFINITION OF &#8220;SUBSTANTIAL DAMAGE&#8221; AND &#8220;PARTIAL DAMAGE&#8221;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PARTIAL DAMAGE TO THE BUILDING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SUBSTANTIAL DAMAGE TO THE BUILDING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ABATEMENT OF RENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MISCELLANEOUS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XIII</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EMINENT DOMAIN</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RIGHTS OF TERMINATION FOR TAKING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PAYMENT OF AWARD</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ABATEMENT OF RENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MISCELLANEOUS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XIV</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DEFAULT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S DEFAULT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S DEFAULT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XV</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THE LANDLORD&#8217;S ACCESS TO PREMISES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THE LANDLORD&#8217;S RIGHT OF ACCESS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XVI</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RIGHTS OF MORTGAGEES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SUBORDINATION AND ATTORNMENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOTICE TO MORTGAGEE AND GROUND LESSOR; OPPORTUNITY TO CURE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASSIGNMENT OF RENTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NON-DISTURBANCE AGREEMENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XVII</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MISCELLANEOUS PROVISIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.1</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CAPTIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.2</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BIND AND INURE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.3</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NO WAIVER</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.4</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NO ACCORD AND SATISFACTION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="eolPage46"></a>17.5</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CUMULATIVE REMEDIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.6</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PARTIAL INVALIDITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.7</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD&#8217;S RIGHT TO CURE; SURVIVAL</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.8</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ESTOPPEL CERTIFICATES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.9</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BROKERAGE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.10</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ENTIRE AGREEMENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.11</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HOLDOVER</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.12</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COUNTERPARTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.13</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONSTRUCTION AND GRAMMATICAL USAGE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.14</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEN LEASE BECOMES BINDING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.15</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECURITY DEPOSIT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.16</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LEGAL EXPENSES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.17</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NO SURRENDER</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:16.74%;"></td>
<td style="width:69.69%;"></td>
<td style="width:13.57%;"></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PAGE</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.18</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVENANT OF QUIET ENJOYMENT</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.19</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NO PERSONAL LIABILITY OF THE LANDLORD</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.20</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOTICES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.21</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MECHANIC&#8217;S LIENS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.22</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RECORDING</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.23</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT&#8217;S FINANCIAL CONDITION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.24</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WAIVER OF COUNTERCLAIMS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.25</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONSENTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.26</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EASEMENTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.27</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CHANGES TO PROPERTY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.28</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVENANTS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.29</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AUCTIONS</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.30</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AUTHORITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.31</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RELATIONSHIP OF PARTIES</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.32</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RIGHT TO LEASE</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.33</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONFIDENTIALITY</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.34</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">USA PATRIOT ACT CERTIFICATION</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="eolPage47"></a>17.35</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:21.6pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WAIVER OF JURY TRIAL</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:3.47%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">LEASE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease, by and between Landlord and Tenant (as defined below), relates to the space in the building (the &#8220; <font style="text-decoration:underline;">Building</font> &#8221;) located at 293 Boston Post Road, Marlborough, Massachusetts and known as Boston Post Road Corporate Center. The term &#8220; <font style="text-decoration:underline;">Lot</font> &#8221; shall mean the parcel of land on which the Building is located, known as Block 77, Lot 11on the Marlborough Tax Map; and the term &#8220; <font style="text-decoration:underline;">Property</font> &#8221; shall mean the Lot and all improvements thereon from time to time, including the Building.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The parties to this instrument hereby agree with each other as follows:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE I<font style="font-size:10pt;"> <br /> </font><font style="text-decoration:underline;">SUMMARY OF BASIC LEASE PROVISIONS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INTRODUCTION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As further supplemented in the balance of this instrument and its Exhibits, the following sets forth the basic terms of this Lease, and, where appropriate, constitutes definitions of certain terms used in this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> BASIC DATA</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="eolPage49"></a><a name="FIS_UNIDENTIFIED_TABLE_27"></a>&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td colspan="2" valign="middle" >
<p style="margin-bottom:6pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:6pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:6pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 10, 2017.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RFP LINCOLN 293, LLC, a Massachusetts limited liability company</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present Mailing Address of Landlord:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RFP LINCOLN 293, LLC<br />225 Franklin Street<br />Boston, Massachusetts 02110<br />Attention: Sean V. Chrisom, Senior Vice President</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment Address:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LPC Commercial Services, Inc.<br />225 Franklin Street<br />Boston, Massachusetts 02110</p>
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Sean V. Chrisom, Senior Vice President</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Managing Agent:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LPC Commercial Services, Inc.<br />225 Franklin Street<br />Boston, Massachusetts 02110<br />Attention: Scott A. Brown, Senior Vice President</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valeritas, Inc., a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present Mailing Address of Tenant:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valeritas, Inc.<br />800 Boston Turnpike<br />Shrewsbury, Massachusetts 01545<br />Attention: Scott Huie, VP, RA/QA &amp; Compliance</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mailing Address of Tenant after Tenant takes occupancy of the Premises:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valeritas, Inc.<br />293 Boston Post Road<br />Marlborough, Massachusetts 01752<br />Attention: Scott Huie, VP, RA/QA &amp; Compliance</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premises:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An area containing approximately 10,203 rentable square feet of space Premises (based upon actual square footage Premises plus an &#8220;add-on&#8221; factor of 1.175%), located on the third floor of the Building (the &#8220; <font style="text-decoration:underline;">Third Floor Space</font> &#8221;), as shown on Exhibit A-1 attached hereto. Also included within the Premises is an area containing approximately 4,968 rentable square feet (based upon actual square footage Premises plus an &#8220;add-on&#8221; factor of 1.175%) on the lower level of the Building (the &#8220; <font style="text-decoration:underline;">Lower Level Space</font> &#8221; and when referenced herein together with the Third Floor Space, the &#8220; <font style="text-decoration:underline;">Premises</font> &#8221;), as shown on Exhibit A-2 attached hereto.</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Term:</font></p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seventy-six (76) months commencing on the Term Commencement Date.</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term Commencement Date:</p></td>
<td valign="top" >
<p style="margin-bottom:6pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Substantial completion of Landlord&#8217;s Work, and Landlord has given Tenant at least five (5) business days prior notice thereof. The anticipated Term Commencement Date is October 15, 2017 (see Section 3.7 as to this &#8220; <font style="text-decoration:underline;">Outside Date</font> &#8221;)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base Rent:</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:4.43%;text-indent:-4.43%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.&#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Third Floor Space</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.55%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:27.99%;"></td>
<td style="width:19.04%;"></td>
<td style="width:32.94%;"></td>
<td style="width:20.03%;"></td>
</tr>
<tr>
<td colspan="4" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="FIS_UNIDENTIFIED_TABLE_28"></a><a name="FIS_UNIDENTIFIED_TABLE_28"></a>Lease Year* or</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Monthly Period</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Annual Base</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Rent</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per Square</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Foot</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Monthly Rent</font></p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 1-4:</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$***</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 5-12:</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$148,000.00*</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$18.50*</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$12,333.33*</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 13-24</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$196,407.75</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$19.25</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$16,367.31</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 25-36</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$204,060.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$20.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$17,005.00</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 37-48</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$211,712.25</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$20.75</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$17,642.69</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 49-60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$219,364.50</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$21.50</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$18,280.38</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 61-76</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$227,016.75</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$22.25</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$18,918.06</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="eolPage51"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.&#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Lower Level Space</font></p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:27.99%;"></td>
<td style="width:19.04%;"></td>
<td style="width:32.94%;"></td>
<td style="width:20.03%;"></td>
</tr>
<tr>
<td colspan="4" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="FIS_UNIDENTIFIED_TABLE_29"></a><a name="FIS_UNIDENTIFIED_TABLE_29"></a>Lease Year** or</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Monthly Period</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Annual Base</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Rent</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per Square</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Foot</font></p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Monthly Rent</font></p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 1-4:</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$***</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 5-12:</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$34,776.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2,898.00</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 13-24</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$36,018.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.25</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,001.50</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 25-36</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$37,260.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.50</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,105.00</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 37-48</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$38,502.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.75</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,208.50</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 49-60</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$39,744.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,312.00</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Months 61-76</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40,986.00</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.25</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,415.50</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td colspan="2" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*For months 5-12 of the initial Lease Year, the monthly Base Rent on a one-time basis shall be hypothetically based upon 8,000.00 rentable square feet and applying the applicable per square foot pricing.</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**For the purposes of this Lease, &#8220; <font style="text-decoration:underline;">Lease Year</font> &#8221; shall be defined as each successive 12-month period included in whole or in part in the Lease Term; the first Lease Year beginning on the Term Commencement Date and ending at midnight on the day before the first anniversary of the Term Commencement Date. Base Rent for any partial calendar month at the beginning or the end of the Term shall be appropriately prorated.</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">***<font style="font-weight:normal;"> &#160; </font><font style="text-decoration:underline;font-weight:normal;">Free Rent</font><font style="font-weight:normal;"> : Notwithstanding the stated Base Rent set forth above or any other term or provision contained in this Lease to the contrary, so long as Tenant is not in default under this Lease beyond any applicable notice, if any, and the expiration of any applicable cure period during the Free Rent Period (as defined below), Tenant shall be entitled to an abatement of the monthly installment of Base Rent (but remain liable for any other applicable charges due hereunder, if any, including Additional Rent and electricity costs), or so-called &#8220;free rent&#8221; period, equal to the first full four (4) calendar months of the Lease Term (&#8220; </font><font style="text-decoration:underline;font-weight:normal;">Free Rent Period</font><font style="font-weight:normal;"> &#8221;).</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td colspan="2" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;"><a name="FIS_UNIDENTIFIED_TABLE_30"></a>&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Security Deposit Amount:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Security Deposit shall initially be $94,138.13 as subject to the following reductions:</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:36pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> &#160;so long as no Default of Tenant is then occurring on the three (3) year anniversary of the last day of the Free Rent Period, the Security Deposit on the third anniversary of the calendar month following Tenant&#8217;s commencement of paying Rent hereunder shall be reduced to $18,627.63, with such amount being returned to Tenant, with such balance remaining as the Security Deposit for the balance of the following twelve (12) month period of the Lease Term;</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:36pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> so long as no Default of Tenant is then occurring on the four (4) year anniversary of the last day of the Free Rent Period, the Security Deposit on the fourth anniversary of the calendar month following Tenant&#8217;s commencement of paying Rent hereunder shall be reduced by an additional $18,627.63, with such amount being returned to Tenant, with such balance remaining as the Security Deposit for the balance of the next twelve (12) month period of the Lease Term; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:36pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> so long as no Default of Tenant is then occurring on the five (5) year anniversary of the last day of the Free Rent Period, the Security Deposit on the fifth anniversary of the calendar month following Tenant&#8217;s commencement of paying Rent hereunder shall be reduced by an additional $18,627.63, with such amount being returned to Tenant, with such balance remaining as the Security Deposit for the balance of the Lease Term.</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:36pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> The Security Deposit shall otherwise be governed by Section 17.15 of this Lease. Such amounts shall be defined herein as the &#8220; <font style="text-decoration:underline;">Security Deposit Amount</font> .&#8221;</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:1.5pt;;text-indent:36pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Guarantor:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permitted Use:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General office, research and development, manufacturing, laboratory and/or any lawful use incidental thereto, and any other use with the consent of the Landlord, which consent shall not be unreasonably withheld so long as such other use is (i) legal as a matter of right based upon applicable zoning and other governmental regulations, and (ii) consistent with and complimentary to the then-current use(s) of the remaining leased space in the Building.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="FIS_UNIDENTIFIED_TABLE_31"></a>&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td colspan="2" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant&#8217;s Proportionate Share:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.49% based upon the rentable square feet of the Premises (including both the Third Floor Space and the Lower Level Space) based upon actual square footage Premises plus an &#8220;add-on&#8221; factor of 1.175% with respect to the Premises) and total rentable Building square footage of approximately 178,697 square feet. Tenant&#8217;s Proportionate Share may be adjusted by Landlord from time to time in the event of any increase or decrease in the total square footage of rentable floor area contained within the Premises and/or the Building, based upon the square footage of rentable floor area contained within the Premises as compared to the square footage of rentable floor area contained within the Building, as it may be physically increased or decreased from time to time.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:41.03%;"></td>
<td style="width:58.97%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base Tax Amount:</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Taxes (as defined in Section 4.2(a)) assessed for fiscal tax year 2018 (i.e., July 1, 2017 &#8211; June 30, 2018), i.e., the &#8220; <font style="text-decoration:underline;">Base Tax Year</font> .&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Base Operating Costs:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Operating Costs (as defined in Section 4.3) for calendar year 2017, i.e., the &#8220; <font style="text-decoration:underline;">Base Operating Year</font> .&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Parking and Loading Dock:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consistent with Section 2.2 of this Lease, Tenant shall be granted the right to use 42 parking spaces in the parking areas serving the Building, on a non-exclusive, &#8220;as available&#8221; basis.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Broker(s):</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LPC Commercial Services, Inc.<br />225 Franklin Street<br />Boston, MA 02110<br />Attn: Tim Latham</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cushman &amp; Wakefield U.S., Inc.<br />225 Franklin Street<br />Boston, MA 02110<br />Attn: Paul Leone</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord&#8217;s Construction</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Representative:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LPC Commercial Services, Inc.<br />225 Franklin Street<br />Boston, MA 02110</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant&#8217;s Construction<br />Representative:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valeritas, Inc.<br />800 Boston Turnpike<br />Shrewsbury, Massachusetts 01545<br />Attention: Scott Huie, VP, RA/QA &amp; Compliance</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3 <font style="margin-left:36pt;">ENUMERATION OF EXHIBITS</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit A-1:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan showing the Third Floor Space</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit A-2:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan showing Lower Level Space</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit B:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intentionally Deleted</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit C:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Rules and Regulations</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit D:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Legal Holidays Observed by Building</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="eolPage54"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit E:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cleaning Specifications</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="eolPage55"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE II <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">DESCRIPTION OF PREMISES AND APPURTENANT RIGHTS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LOCATION OF PREMISES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Landlord hereby leases to Tenant, and Tenant hereby accepts from Landlord, the Premises identified on Exhibits A-1 and A-2 in the Building, subject to the terms and conditions of this Lease. Nothing in Exhibit A shall be treated as a representation that the Premises or the Building shall be precisely of the area, dimensions, or shapes as shown, it being the intention of the parties only to show diagrammatically, rather than precisely, on Exhibits A-1 and A-2 the layout of the Premises and the Building. However, for the purposes of this Lease the rentable square footage of (i) the Third Floor Space will be 10,203, (ii) the Lower Level Space will be 4,968, and (iii) the Building will be 178,697 and not subject to re-measurement during the initial or any renewal term of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> APPURTENANT RIGHTS AND RESERVATIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall have, as appurtenant to the Premises, rights to use in common with others entitled thereto the common facilities included in the Building or the Lot, including common walkways, driveways, lobbies, hallways, ramps, elevators and stairways and the cafeteria and exercise room in the Building. Such rights shall always be subject to reasonable rules and regulations from time to time established by Landlord by suitable notice, and to the right of Landlord to designate and to change from time to time the areas and facilities so to be used, provided that any such change shall not materially adversely affect Tenant&#8217;s access to and use of the Premises. Tenant shall be afforded the non-exclusive right to use up to 52 parking spaces within the parking areas based on a parking ratio of 3.4 spaces per 1,000 rentable square feet of the Premises. Nothing contained in the Lease shall prohibit or otherwise restrict Landlord from changing, from time to time, without notice to Tenant, the layout or type of such parking areas, provided that Landlord shall not reduce the number of parking spaces available for Tenants&#8217; use and provided that such changed layout or type of spaces shall be at least as convenient to the Building as currently configured. Subject to reasonable rules from time to time made by Landlord of which Tenant is given notice, Tenant shall have the right, in common with all other tenants of the Building, to use such parking areas, without charge through the Lease Term, on a first-come, first-served basis up to the number of Tenant&#8217;s parking spaces set forth in Section 1.2. Landlord shall uniformly and diligently enforce the parking requirements of each tenant&#8217;s lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not included in the Premises are the roof or ceiling, the floor and all perimeter walls of the space identified in Exhibit A, except the inner surfaces thereof and the perimeter doors and windows (excluding exterior windows). The Landlord reserves the right to install, use, maintain, repair and replace in the Premises (but in such manner as not unreasonably to interfere with Tenant&#8217;s use of the Premises) utility lines, shafts, pipes, and the like, in, over and upon the Premises, provided that the same are located above the dropped ceiling (or, if there is no dropped ceiling, then within three (3) feet of the roof and/or floor deck), below the floor surfaces or tight against demising walls or columns.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord agrees to repair any damage to the Premises caused by the installation of any such items. Such utility lines, shafts, pipes and the like shall not be deemed part of the Premises under this Lease. The Landlord also reserves the right to alter or relocate any common facility, so long as the cafeteria and fitness center remain in the Building, and to change the lines of the Building parking lot.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RIGHT OF FIRST OFFER</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provided no Default of Tenant (as defined in Article XIV) has occurred and is continuing beyond any applicable notice and cure period at the time Tenant elects to exercise its rights hereunder, Tenant shall have the one-time right from and after the date of this Lease through the entire Lease Term (as may be extended hereunder) of first offer to lease any space contiguous to the Premises on the third floor of the Building that becomes available for occupancy (the &#8220; <font style="text-decoration:underline;">Available Space</font> &#8221;), subject to and in accordance with the terms and conditions set forth in this Section 2.3 and any rights of then-existing tenants of such Available Space. If at any time from and after the date of this Lease through the remaining Term of this Lease (as may be extended hereunder) there shall be any Available Space, Landlord shall notify Tenant thereof in writing (&#8220; <font style="text-decoration:underline;">Landlord&#8217;s Available Space Notice</font> &#8221;), which notice shall include the anticipated date upon which such Available Space shall be available for occupancy by Tenant along with a floor plan </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">showing the approximate rentable square footage thereof as reasonably determined by Landlord. Tenant shall have the right to lease all or a portion of such Available Space only by giving written notice to Landlord within thirty (30) days after Tenant receives Landlord&#8217;s Available Space Notice, time being of the essence. If Tenant so elects to lease all or a portion of the Available Space, such Available Space shall be leased upon the same terms and conditions contained in this Lease, and the term shall expire on the same date as the existing Lease, except that: the Base Rent for such space shall be equal to then-current Base Rent (on a per rentable square foot basis) payable under this Lease for the Premises; provided, however, with respect to the applicable Available Space, the base year for operating expense escalation shall be the first full calendar year following Tenant&#8217;s occupancy of the applicable Available Space and for real estate tax escalation shall be the first full fiscal year following Tenant&#8217;s occupancy of the applicable Available Space, and, subject to the foregoing, the applicable Available Space shall be and become part of the Premises hereunder upon the delivery of such Available Space to Tenant. Landlord shall deliver exclusive, broom clean possession of such Available Space to Tenant with the heating, ventilating and air conditioning (HVAC), electrical, plumbing, mechanical and fire/life safety systems serving the Available Space in good working order. It is understood and agreed that the applicable Available Space shall otherwise be leased by Tenant in its then &#8220;as is&#8221;, &#8220;where-is&#8221; condition, without warranty or representation by Landlord and Landlord shall have no obligation to complete any work to prepare the Available Space for Tenant&#8217;s use and occupancy. Following such election by Tenant, and effective as of the delivery of the applicable Available Space and for the balance of the Term and any extension thereof: (a) the &#8220;Premises&#8221;, as used in this Lease, shall include the applicable Available Space; (b) the rentable square feet of the Premises shall be increased to include the rentable square footage of the applicable Available</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Space; (c) the annual Base Rent shall equal the sum of the Base Rent provided for in this Lease plus the Base Rent for the applicable Available Space as determined as set forth herein; (d) Tenant shall have the right to use up to an additional 3.4 parking spaces per 1,000 rentable square feet of the Available Space, without charge; and (e) &#8220;Tenant&#8217;s Proportionate Share&#8221;, solely for the applicable Available Space, shall be a percentage computed in the manner set forth in Section 1.2 of this Lease with the rentable square footage of the applicable Available Space. To confirm the inclusion of the Available Space as set forth above, Landlord shall prepare, and Landlord and Tenant shall promptly execute and deliver, an Amendment to Lease reflecting the foregoing terms and incorporation of any Available Space. Landlord agrees to use reasonable efforts to remove any hold over occupant of the Available Space and to otherwise obtain possession of the Available Space, including, without limitation, the institution and diligent prosecution of hold-over proceedings. Notwithstanding anything to the contrary set forth in this Section 2.3, if for any reason Landlord fails to deliver the Available Space to Tenant within ninety (90) days after the date stated in Landlord&#8217;s Available Space Notice upon which the Available Space will be available for occupancy by Tenant, Tenant shall have the right to terminate its acceptance of Landlord&#8217;s offer of the Available Space and shall be relieved of any obligation to lease the Available Space pursuant to this Section 2.3. For the purposes hereof, space shall be deemed &#8220; <font style="text-decoration:underline;">available for occupancy</font> &#8221; when any lease or occupancy agreement (including extension periods) has expired or is due to expire within six (6) months, or Landlord has elected not to renew the lease of the present tenant, and any prior options, rights or rights to lease with respect to such Available Space in effect as of the date of this Lease have expired or been waived and Landlord is free to lease such space to third parties without restriction.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Tenant fails to timely exercise any of its rights hereunder, the right(s) granted hereunder as to the applicable Available Space shall be deemed waived for all purposes, and Landlord may lease the applicable Available Space to any party and upon any terms free of any rights of Tenant.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant understands that its rights under this Section are and shall be subject and subordinate to the following rights of first offer granted to other tenants of the Building having space on the third floor of the Building prior to the date of execution and delivery of this Lease:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vasco Data Security &#8211; currently tenant in Suite 340</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FC USA, Inc. &#8211; currently tenant in Suite 301</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE III </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /> </font><font style="text-decoration:underline;">TERM OF LEASE: CONDITION OF PREMISES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TERM OF LEASE</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term of this Lease shall be the period specified in Section 1.2 hereof as the &#8220;Lease Term&#8221; commencing on the Term Commencement Date and terminating the last day of the seventy-sixth (76 <font style="font-size:8pt;">th</font> ) calendar month thereafter (the &#8220; <font style="text-decoration:underline;">Lease Term</font> &#8221;)(plus any partial calendar month if the Term Commencement Date occurs on any other day other than the first day of a calendar month), unless the Lease Term is extended under Section 3.2 below or terminated early pursuant to the terms hereof, including such rights afforded Landlord under Article XIV.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> EXTENSION OPTION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant may elect to extend the term of this Lease for one (1) sixty (60) month period with respect to the entire Premises or the Third Floor Space only (the &#8220; <font style="text-decoration:underline;">Extension Term</font> &#8221;), by giving Landlord notice of such election no later than nine (9) months before the expiration of the Lease Term, provided Tenant is not in default hereunder beyond applicable notice and cure periods, both on the date such notice is given and on the commencement date of the Extension Term. Such extension shall be upon the same terms, covenants, and conditions contained in this Lease except that (a) Tenant shall have no further right to extend the Lease Term past this 60 month Extension Term, (b) there shall be no free rent period with respect to the Extension Term (except as otherwise provided in the determination of the Fair Market Rental Value), and (c) the Base Rent for the Extension Term shall be at a rate equal to the Fair Market Rental Value therefore determined as set forth in Section 4.5 below (including the application of updated Base Years for Operating Costs and Taxes).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CONDITION OF PREMISES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as otherwise expressly provided in this Lease, Tenant is leasing the Premises in &#8220;as is, where is&#8221; condition with all faults and without representation or warranty by Landlord of any kind or nature, express or implied in fact or in law by Landlord and without recourse to Landlord as to the nature, condition or usability thereof. With the exception of the Landlord&#8217;s Work, Tenant, at its sole cost, expense and risk, shall perform and make any alterations, improvements or installations in the Premises which are necessary for Tenant&#8217;s use and/or occupancy of the Premises. Notwithstanding the above, in addition to Landlord&#8217;s Work, Landlord, at its expense, shall deliver the Premises on the Term Commencement Date (i) free from asbestos-containing materials and any other materials recognized by law to be "hazardous" or "toxic," and (ii) otherwise in compliance with all applicable laws and codes, (iii) with the heating, ventilating and air conditioning (HVAC), electrical, plumbing, mechanical and fire/life safety systems serving the Premises in good working order, and (iv) vacant, free from personal property and with all wire fencing in the Lower Level Premises removed. Notwithstanding the foregoing, nothing under this Section 3.3 shall obligate Landlord to install prior to delivery of the Premises any heating, ventilating, air conditioning, electrical, plumbing, mechanical and fire/life safety systems in the Lower Level Premises to the extent not installed as of such delivery date but rather are within the scope of Landlord&#8217;s Work.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> EARLY POSSESSION</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provided that (a) Tenant does not interfere with or delay the completion by Landlord or its agents or contractors of the Landlord&#8217;s Work, and (b) Tenant has timely paid all amounts due as the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs, Tenant shall have the right to enter the Premises up to thirty (30) days prior to the Term Commencement Date for the purpose of installing equipment, furniture, wiring and establishing general operations. Tenant shall be liable for any damages or delays caused by Tenant&#8217;s activities at the Premises. Provided that Tenant has not begun operating its business from the Premises, and subject to all of the terms and conditions of the Lease (other than the obligation to pay Rent), the foregoing activity shall not constitute the delivery of possession of the Premises to Tenant and the Lease term shall not commence as a result of said activities. Prior to entering the Premises, Tenant shall obtain all insurance it is required to obtain by the Lease and shall provide certificates of said insurance to Landlord. Tenant shall coordinate such entry with Landlord&#8217;s Building manager, and such entry shall be made in compliance with all terms and conditions of this Lease and the Rules and Regulations attached hereto as Exhibit C.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> LANDLORD&#8217;S WORK.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> No later than the Effective Date, Landlord shall cause to be delivered to Tenant for Tenant&#8217;s review (or otherwise make available to Tenant in the plan room located in the lower level of the Building) all construction and mechanical engineering plans and documents (both those in hard copy and CAD) in Landlord&#8217;s possession in order for Tenant&#8217;s architect to review and complete the Tenant fitout planning for Landlord&#8217;s Work for the Premises containing sufficient detail in order for Landlord (or the Approved Contractor) to obtain all applicable permits and governmental approvals and otherwise consistent with the Landlord&#8217;s Work (the &#8220; <font style="text-decoration:underline;">Construction Drawings&#8221;)</font> . Landlord represents to Tenant it has provided to Tenant a full set of CAD drawings for the third floor of the Building and hard copy plans for the remainder of the Building, but otherwise cannot assure Tenant or its architect that it can provide further existing architectural or mechanic plans for the Building that Tenant or its architect may require. Tenant shall cause to be delivered to Landlord on or before <font style="font-weight:bold;text-decoration:underline;">June 15, 2017</font> the Construction Drawings for Landlord&#8217;s approval, which approval of Landlord shall not be unreasonably withheld, conditioned or delayed and will be granted or withheld within five (5) days after Tenant&#8217;s delivery of same to Landlord. If Landlord disapproves the proposed Construction Drawings, Landlord shall specify the basis for such disapproval in reasonable detail, and Tenant will cause its architect to revise the Construction Drawings to address such deficiencies and promptly submit the same to Landlord. The scope of Landlord&#8217;s review of any such revised Construction Drawings will be limited to Tenant&#8217;s architect&#8217;s correction of the items specified by Landlord in Landlord&#8217;s notice of disapproval. Landlord will notify Tenant of Landlord&#8217;s approval or disapproval of such revised Construction Drawings within five (5) days following receipt of same, and this process shall continue until Landlord has approved the Construction Drawings (with such approved Construction Drawings constituting the &#8220; <font style="text-decoration:underline;">Approved Construction Drawings</font> &#8221;). Landlord and Tenant confirm and agree that the Approved Constructing Drawings shall be fully approved by <font style="font-weight:bold;text-decoration:underline;">July 1, 2017</font> in order to allow the parties sufficient time to timely</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approve the Landlord&#8217;s Approved Contractor and complete Landlord&#8217;s Work in accordance with this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> As set forth in the prior paragraph (a), Landlord and Tenant shall on or before <font style="font-weight:bold;text-decoration:underline;">July 1, 2017</font> agree upon the work to be done within the Premises as shown on the Approved Construction Drawings by the Landlord (by and through the Approved Contractor) prior to the Term Commencement Date (the &#8220; <font style="text-decoration:underline;">Landlord&#8217;s Work</font> &#8221;) pursuant to the Approved Construction Drawings. Tenant shall have the right, as part of Landlord&#8217;s Work, to install in the Premises and thereafter maintain and operate its own heating, ventilating, and/or air-conditioning units to provide heating, ventilating and cooling to the Premises, including without limitation, equipment and support structures in a portion of the Building or Land outside the Premises as requested by Tenant and reasonably approved by Landlord (collectively, the &#8220; <font style="text-decoration:underline;">Supplemental HVAC</font> &#8221;), which Supplemental HVAC shall be subject to Landlord&#8217;s reasonable approval, as more particularly described in Section 3.5(a) hereof. Landlord and Tenant agree to mutually cooperate with one another in finalizing the Landlord&#8217;s Work schedule. The portion of the cost of Landlord's Work in the amount of the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs shall be borne by Tenant, with the balance borne and paid for entirely by Landlord, as more fully set forth below in Section 3.6. The Landlord's Work shall be performed by Landlord's Approved Contractor to be selected in accordance with this Lease and the cost of Landlord's Work shall include, without limiting the generality of the foregoing, (a) the entire cost of demolishing the existing improvements and building out the Premises in accordance with the Approved Construction Drawings, (b) the cost of all materials and labor related to the Landlord's Work and all permit fees, (c) the cost of full scale architectural and engineering costs in connection therewith (including the cost of Tenant&#8217;s architect), (d) a construction management fee payable to Lincoln Property Company (or any affiliated entity) equal to three percent (3%) of the so-called &#8220;hard costs&#8221; of the Landlord&#8217;s Work, and (e) the "Cost of the Work", as defined in AIA Document A111 (1987 Edition) (and also specifically including the cost of the general conditions of the Approved Contractor). Landlord&#8217;s Work shall otherwise be performed in a good and workmanlike manner.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything to the contrary contained in this Lease, Landlord and Tenant hereby agree that Landlord, unless included in Landlord&#8217;s Work, shall not be responsible for the construction, relocation or installation of security card readers, office furniture, security systems, internal/external telecommunications, voice and data cabling or other telephone, data and communications equipment (collectively the &#8220; <font style="text-decoration:underline;">Tenant&#8217;s Initial Work</font> &#8221;) nor shall Landlord have any obligation to pay therefore. Tenant shall have the right to install as part of Tenant&#8217;s Initial Work its own security system at the entry to and within the Premises.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TENANT ALLOWANCE; TENANT OBLIGATION TO FUND TENANT&#8217;S SHARE OF EXCESS LANDLORD&#8217;S WORK COSTS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Landlord agrees to fund the cost of the Landlord&#8217;s Work in an amount not to exceed $357,105.00 (the &#8220; <font style="text-decoration:underline;">TI Allowance</font> &#8221;), and Tenant (at Landlord&#8217;s sole election) shall be liable to pay to the Approved Contractor or Landlord (as first dollars paid under the Approved Contractor&#8217;s General Contract (&#8220; <font style="text-decoration:underline;">General Contract</font> &#8221;) until the balance due under the General Contract equals the TI Allowance) any and all costs of the Landlord&#8217;s Work in excess of the TI Allowance (the &#8220; <font style="text-decoration:underline;">Tenant&#8217;s Share of the Landlord&#8217;s Work Costs</font> &#8221;). If the total cost of Landlord&#8217;s Work is less than the TI Allowance, Tenant shall have the right to allocate such unused portion of the TI Allowance as a monthly credit against Base Rent until fully applied. The Tenant&#8217;s Share of the Landlord&#8217;s Work Costs, at the Landlord&#8217;s sole election and direction, shall either (i) be paid by Tenant directly to the Approved Contractor (who shall be engaged by Landlord), or (ii) be paid to Landlord prior to Landlord having to fund any TI Allowance funds towards the General Contract until such time as the remaining cost of Landlord&#8217;s Work is equal to the TI Allowance (taking into account all amounts paid on prior requisitions and upon payment of any pending requisition by the Approved Contractor). Landlord upon request by Tenant shall provide to Tenant sufficient backup and detail (including all executed lien waivers delivered to Landlord and/or Approved Contractor to date for work and materials in place and evidence that Landlord shall fund in full the TI Allowance) to evidence (i) the total cost of the Landlord&#8217;s Work to date as requisitioned by and paid by Tenant as provided hereunder, as set forth on standard AIA forms, and (ii) the total remaining costs to complete the Landlord&#8217;s Work and the amounts previously funded by Tenant as the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs. Tenant shall pay the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs (to either the Approved Contractor or Landlord) within ten (10) business days of written direction by Landlord absent any good faith dispute to be delivered by Tenant to Landlord during such ten (10) business day period (and shall include a detailed basis for such dispute), if at all. If Tenant does have a good faith dispute as to any amounts alleged owed, it shall timely pay all amounts not in dispute to the Landlord or Approved Contractor, as the case may be. The determination as to the payment of any disputed amounts shall be determined by the Landlord&#8217;s architect within ten (10) business days of receipt of a copy of such Tenant dispute notice, whose decision in such matters shall be final and binding on the parties. If Tenant fails to timely pay any Tenant&#8217;s Share of the Landlord&#8217;s Work Costs following such ten (10) business day period absent any good faith dispute, or fails to timely pay such amounts within ten (10) business days of the final determination of Landlord&#8217;s architect as to any dispute this failure shall constitute a monetary default under this Lease, and thereafter Landlord may elect to exercise any of it remedies set forth herein relative thereto. In the event that the cost of Landlord&#8217;s Work is less than the TI Allowance, Landlord will be reimburse any overpayment made by Tenant of Tenant&#8217;s Share of the Landlord&#8217;s Work Costs within ten (10) business days of Tenant&#8217;s receipt of the confirmation from Landlord, as provided in (i) and (ii) above in this paragraph evidencing Landlord&#8217;s Work Costs. If Tenant fails to timely pay the Tenant&#8217;s Share of Landlord&#8217;s Work Costs, all such amounts due and owing shall accrue at the Lease Interest Rate which interest amounts shall accrue and be paid in addition to the unpaid Tenant&#8217;s Share of Landlord Work Costs. Once Landlord is obligated to fund the TI Allowance hereunder, it shall timely pay the Approved Contractor directly all such amounts required in order to pay for completion of Landlord&#8217;s Work (subject to any agreed-upon change orders and any associated costs but otherwise on a timely basis in accordance with Landlord&#8217;s General Contract with Approved Contractor to complete such work) subject to procurement from the Approved Contractor of all backup and detail (including all executed lien waivers) as required of Approved Contractor under its General Contract with Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under no circumstances shall the Landlord have a right to agree to any change order proposed by the Approved Contractor or otherwise agree to increase the cost of the Landlord&#8217;s Work resulting in any increase in the Tenant&#8217;s Share of Landlord&#8217;s Work Costs absent the prior written consent of the Tenant. In the event Landlord and Tenant agree to a change order which increases the cost of the Landlord&#8217;s Work, such shall be evidenced by the appropriate AIA form and Tenant shall expressly agree with Landlord to increase the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs attributable to such General Contract cost increase prior to Landlord being obligated to execute and deliver same or direct the Approved Contractor to modify the scope of the Landlord&#8217;s Work accordingly.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.7 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD&#8217;S AND TENANT INITIAL WORK; DELAYS.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Subject to any Tenant Delays, Landlord agrees to use due diligence to cause to be completed the Landlord&#8217;s Work on or before October 15, 2017 (&#8220; <font style="text-decoration:underline;">Outside Date</font> &#8221;).&#160; Landlord shall not be required to install any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">improvements which are not in conformity with the Approved Construction </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Drawings</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or which do not comply with applicable law, ordinances or codes. In case of delays due to governmental regulation, unusual </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">scarcity</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or inability to obtain labor or materials, labor difficulties, casualty or other causes reasonably beyond Landlord&#8217;s control (other than lack of funds), the Outside Date shall be extended for the period of such delays.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If the Landlord is unable to give possession of the Premises on the Outside Date because the Premises are not substantially complete due to Tenant Delays (as said term is hereinafter defined), the Term Commencement Date (and Outside Date) shall be extended for each day following the date that Landlord could have delivered the Premises (after having substantially completed the Landlord&#8217;s Work) but for the Tenant Delay, and Landlord shall otherwise be obligated thereafter to timely deliver the Premises in accordance with this Lease as soon as practicable once Tenant cures such Tenant Delay. In such an event of Tenant Delay, for each day the Outside Date is extended the Free Rent Period shall be shortened. The term &#8220; <font style="text-decoration:underline;">Tenant Delay</font> &#8221; shall mean any of the following, if applicable: (i) Tenant&#8217;s failure to timely pay to the Landlord or Approved Contractor any amount due as the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs, (ii) Tenant&#8217;s failure to deliver the plans and specifications to Landlord, in accordance with any time frames provided by Landlord herein, for the completion of or in performing the Landlord&#8217;s Work, including, without limitation, Tenant&#8217;s failure to cause the Construction Drawings to be delivered to Landlord by June 15, 2017; or (iii) any delay in achieving substantial completion of Landlord&#8217;s Work caused by or related to Tenant&#8217;s change orders, requests for change orders or the time involved in processing, authorizing and/or withdrawing requests for change orders or selection of materials or in considering whether to proceed with a change order; (iv) any delay by Tenant in providing its approval of any items, materials or other Landlord&#8217;s Work related work or materials; (v) Tenant errors in or incompletion respecting the plans or specifications related thereto; (vi) delays caused by Tenant&#8217;s architect (if one is so engaged), or (vii) any other delay in achieving substantial completion caused by Tenant or its employees, agents or contractors(notice of which will be provided by Landlord to Tenant); provided however, there shall be no postponement of the Outside Date or reduction of the Free Rent Period until the date that is two (2) business days after the delivery of such notice by Landlord, unless Tenant cures such Tenant Delay within such two (2) business day period.&#160; In determining the length of any delay related to a Tenant Delay, the cumulative effect of such delay shall apply.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Subject to Tenant Delays and Force Majeure Events (as defined below) or any other delays beyond Landlord&#8217;s reasonable control (other than lack of funds), if Landlord shall be unable to give possession of the Premises on the Outside Date (as same may have been extended as provided herein) because the Landlord&#8217;s Work is not substantially completed or because the Premises are not completed and ready for occupancy, and such delay continues past the Outside Date, Tenant have the elective right to do as follows: (i) if the delay continues past December 15, 2017, it may, but is not obligated, to complete the Landlord&#8217;s Work, at its sole cost and expense, and following taking possession have the right to credit such amounts against future Base Rent (following any Free Rent Period) due and owing hereunder from the Term Commencement Date, as defined herein, (and shall provide Landlord with written backup documentation as to Tenant&#8217;s payment of such costs prior to applying any such Base Rent credit), (ii) if the delay continues past December 15, 2017, it may terminate this Lease effective as of December 15, 2017, by providing written notice to Landlord by December 24, 2017 following which this Lease shall terminate and the Parties shall have no further obligations hereunder, other than to return to Tenant the security deposit and prepaid rent, and except pursuant to those provisions of this Lease which expressly survive the expiration or sooner termination thereof, or (iii) if the delay continues past the Outside Date, it may elect by providing notice to Landlord within five (5) days after the Outside Date to extend the time for completion of Landlord&#8217;s Work in which case it shall receive a per diem Base Rent credit for each day substantial completion of Landlord&#8217;s Work occurs after the Outside Date, which Base Rent credit shall be in addition to the Free Rent Period but shall not exceed as a cap a Base Rent credit equivalent to a sixty (60) day delay even if such delay is longer than sixty (60) days.&#160; Notwithstanding the foregoing, Tenant shall have no rights under this Section 3.7(c) in the event it has failed to timely pay any Tenant&#8217;s Share of the Landlord&#8217;s Work Costs unless such failure involves only those unpaid amounts subject to a good faith dispute as contemplated under Section 3.5.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Following the Tenant&#8217;s delivery of the Construction Drawings to Landlord, the Landlord shall competitively bid out the Landlord&#8217;s Work to at least three (3) mutually acceptable qualified general contractors (if there are changes to the Construction Drawings before same become the Approved Construction Drawings, such changes shall be addressed as addendum or change order during the bidding process). Tenant shall have the right to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">include one additional prospective general contractor from whom Landlord shall procure a bid for Landlord&#8217;s Work. Following this competitive bidding process, Landlord and Tenant shall work cooperatively with each other in</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">selecting a mutually acceptable and duly qualified general contractor (including without limitation, Tenant&#8217;s right to interview the proposed general contractors and determine if the bids are responsive). In the event Landlord and Tenant are unable to agree on a mutually acceptable general contractor despite such efforts, Tenant shall have the final right to select the general contractor (the general contractor finally selected, the &#8220; </font><font style="text-decoration:underline;">Approved Contractor</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;) with Landlord&#8217;s approval, not to be unreasonably, withheld, conditioned or delayed so long as such contractor shall be fully qualified to timely undertake and complete the Landlord&#8217;s Work, and be fully and lawfully insured and licensed. Tenant shall, within one (1) week after its receipt of the final bid estimate from the Approved Contractor or the final bid and a detailed statement of the cost of Landlord&#8217;s Work, be entitled to approve or disapprove such cost for Landlord&#8217;s Work in writing. If Tenant disapproves such cost, Tenant shall meet with Landlord and the Approved Contractor within five (5) days after Landlord&#8217;s receipt of Tenant&#8217;s disapproval notice to (a) agree upon revisions to the Construction Drawings or Approved Construction Drawings so that the cost of Landlord&#8217;s Work shall be reduced to an amount that is either (</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) equal to or less than the TI Allowance or (ii) acceptable to Tenant or (b) negotiate with the Approved Contractor for a reduction in the cost of Landlord&#8217;s Work. In all cases the Approved Contractor shall be selected and engaged on or before </font><font style="font-weight:bold;text-decoration:underline;">July 15, </font><font style="font-weight:bold;text-decoration:underline;">2017</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in order to afford sufficient time for the timely completion of Landlord&#8217;s Work.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> All of the Tenant&#8217;s Initial Work shall be coordinated with Landlord&#8217;s Work, and any other work being performed by Landlord and in such manner as to maintain harmonious labor relations and not damage the Building or interfere with Building operation and, except for installation of furnishings, shall be performed by contractors or workmen first approved by Landlord, which approval will not be unreasonably withheld.&#160; Except for work by the Approved Contractor, Tenant before Tenant&#8217;s Initial Work and/or any Tenant alteration work is started, Tenant shall:&#160; secure all licenses and permits necessary therefore; deliver to Landlord a statement of the names of all its contractors and subcontractors; and cause each contractor to carry workmen&#8217;s compensation insurance in statutory amounts covering all the contractor&#8217;s and subcontractor&#8217;s employees and commercial general liability insurance and property damage insurance in limits with respect to commercial general insurance, $1,000,000/$2,000,000 and with respect to property damage insurance, $500,000 (all such insurance to be written in companies reasonably approved by Landlord and naming Tenant as insured and naming Landlord, and&#160; Landlord&#8217;s mortgagee as additional insureds), and to deliver to Landlord certificates of all such insurance. Tenant agrees to pay promptly when due the entire cost of any work done on the Premises for the Tenant&#8217;s Initial Work, and not to cause or permit any liens for labor or materials performed or furnished in connection therewith to attach to the Premises or the Property and immediately to discharge any such liens (or bond the same off within thirty (30) days after notice of the filing thereof) which may so attach.&#160; Upon completion of Tenant&#8217;s Initial Work, Tenant shall promptly deliver to Landlord original lien releases and waivers executed by each contractor, subcontractor, supplier materialmen, architect, engineer or other party which furnished labor, materials or other services in connection with such work and pursuant to which all liens, claims and other rights of such party with respect to labor, material or services furnished in connection with such work are unconditionally released and waived.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> The Landlord&#8217;s Work and any other work required of Landlord pursuant to this Section 3 shall be deemed approved by Tenant when Tenant commences occupancy of the Premises for the Permitted Uses, except for any &#8220;punch list items&#8221; and any latent defects. Promptly upon the receipt of a list of such punch list items, Landlord shall commence and diligently pursue completion of such items and complete same within thirty (30) days of receipt of such punch list items.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant assumes full and complete responsibility to ensure that Landlord&#8217;s Work is adequate to fully meet the needs and requirements of Tenant&#8217;s business operations within the Premises and Tenant&#8217;s use of the Premises.&#160; Neither the approval by Landlord of the Approved Construction Drawings or any plans, specifications, drawings or other items associated with Landlord&#8217;s Work nor Landlord&#8217;s performance, supervision or monitoring of the Landlord&#8217;s Work shall constitute any warranty or covenant by Landlord to Tenant as to the adequacy of the design for Tenant&#8217;s intended use of the Premises.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> GENERAL PROVISIONS APPLICABLE TO CONSTRUCTION.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All construction work required or permitted by this Lease by Tenant and Landlord (including the Approved Contractor) shall be done in a good and workmanlike manner and in compliance with all applicable laws and all ordinances, regulations and orders of governmental authority. Landlord and Tenant may each inspect the work of the other at reasonable times and shall give notice of observed defects.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.9 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CONSTRUCTION REPRESENTATIVES.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each party authorizes the other to rely in connection with plans and construction upon approval and other actions on the party's behalf by any Construction Representative of the party named in Section 1.2 or any person hereafter designated in substitution or addition by notice to the party relying thereon.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IV <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">RENT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RENT PAYMENTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Base Rent (at the rates specified in Section 1.2 hereof) and the additional rent or other charges payable pursuant to this Lease shall be payable by Tenant to Landlord at the Payment Address or such other place as Landlord may from time to time designate by notice to Tenant without any demand, counterclaim offset, or deduction whatsoever unless and except as otherwise specifically provided in this Lease.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Subject to the Free Rent Period during which period Base Rent shall be abated, commencing on the Term Commencement Date, Base Rent and the monthly installments of Tenant&#8217;s Proportionate Share of the Tax Excess and Tenant&#8217;s Proportionate Share of Operating Costs Excess shall be payable in advance on the first day of each and every calendar month during the term of this Lease. As used in this Lease, the term &#8220; <font style="text-decoration:underline;">lease year</font> &#8221; shall mean any calendar year or part thereof falling within the Lease Term.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Base Rent and the monthly installments of Tenant&#8217;s Proportionate Share of the Tax Excess and Tenant&#8217;s Proportionate Share of Operating Costs Excess for any partial month shall be paid by Tenant to Landlord at such rate on a <font style="text-decoration:underline;">pro</font> <font style="text-decoration:underline;">rata</font> basis based on the number of days in such month and the number of days in such year. Any other charges payable by Tenant on a monthly basis, as hereinafter provided, shall likewise be prorated.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> For purposes herein, Base Rent and the monthly installments of Tenant&#8217;s Proportionate Share of the Tax Excess and Tenant&#8217;s Proportionate Share of Operating Costs Excess for any partial month, as well as any other charges due by Tenant hereunder, shall be deemed &#8220; <font style="text-decoration:underline;">Rent</font> .&#8221; &#8220; <font style="text-decoration:underline;">Additional Rent</font> &#8221; or &#8220; <font style="text-decoration:underline;">additional rent</font> &#8221; consists of all such other sums of money as shall become due from and payable by Tenant to Landlord hereunder other than Base Rent, and, unless another due date is provided for in this Lease with respect thereto, additional rent shall be paid within thirty (30) days after written demand by Landlord, accompanied by invoices substantiating same.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Rent not paid within ten (10) days of the date due shall bear interest at a rate (the &#8220; <font style="text-decoration:underline;">Lease Interest Rate</font> &#8221;) equal to the lesser of (i) the so-called prime rate of interest charged from time to time by Bank of America, or its successor, <font style="text-decoration:underline;">plus</font> two percent (2%) per annum or (ii) the maximum legally permissible rate, from the due date until paid.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If any Rent or any other payments due hereunder from Tenant are not paid within ten (10) days of the due date thereof, Tenant shall be charged a late fee of $250.00 for each late payment for each month or portion thereof that said payment remains outstanding. Said late fee shall be payable in addition to and not in exclusion of any other remedies of Landlord on account of such late payments, including without limitation the obligation to pay interest on late payments, as provided above.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> REAL ESTATE TAX</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> The term &#8220; <font style="text-decoration:underline;">Taxes</font> &#8221; shall mean all taxes and assessments (including without limitation, assessments for public improvements or benefits) and other charges or fees in the nature of taxes for municipal services which at any time during or in respect of the Lease Term may be assessed, levied, confirmed or imposed on or in respect of, or be a </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lien upon, the Building and the Lot, or any part thereof, or any rent therefrom or any estate, right, or interest therein, or any occupancy, use, or possession of such property or any part thereof, and ad valorem taxes for any personal property used in connection with</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Building or Lot. Taxes shall not include any penalties incurred </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as a result of</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Landlord&#8217;s non-payment of Taxes or to file any tax or information returns when due. Landlord represents that the Building and the Lot are fully-</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">assessed, and</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> are not subject to any Tax abatements or exemptions or special assessments.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Should the Commonwealth of Massachusetts, or any political subdivision thereof, or any other governmental authority having jurisdiction over the Building, (1) impose a tax, assessment, charge or fee, which Landlord shall be required to pay, by way of substitution for or as a supplement to such Taxes, or (2) impose a tax on rents in substitution for or as a supplement to a tax levied against the Building or the Lot or any part thereof and/or the personal property used in connection with the Building or the Lot or any part thereof, all such taxes, assessments, fees or charges (&#8220; <font style="text-decoration:underline;">Substitute Taxes</font> &#8221;) shall be deemed to constitute Taxes hereunder, but any such Substitute Taxes shall be computed as if the Building and Land were the only property of Landlord and the rents received by Landlord were the only income of Landlord. Taxes shall also include, in the year paid, all reasonable fees and costs incurred by Landlord in seeking to obtain a reduction of, or a limit on the increase in, any Taxes, regardless of whether any reduction or limitation is obtained. Tenant shall receive a proportionate credit for any such net tax abatements that Landlord receives during the Term, based on Tenant&#8217;s Base Tax Year and previous payments. Except as hereinabove provided with regard to Substitute Taxes, Taxes shall not include any inheritance, excise, estate, succession, transfer, gift, franchise, net income or capital stock tax.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220; <font style="text-decoration:underline;">Tax Period</font> &#8221; shall mean the period during the Term during which Taxes are required to be paid under applicable law. Thus, under the law presently in effect in the Commonwealth of Massachusetts, Tax Period means the period from July 1 of a calendar year to June 30 of the subsequent calendar year.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Commencing on the Tax Period beginning July 1, 2018, in the event that the Taxes during any Tax Period exceed the Base Tax Amount, Tenant shall pay to Landlord, as additional rent, Tenant&#8217;s Proportionate Share of such excess (the &#8220; <font style="text-decoration:underline;">Tax Excess</font> &#8221;). Tenant shall pay to Landlord, together with monthly payments of Base Rent, <font style="text-decoration:underline;">pro rata</font> monthly installments on account of the projected Tax Excess for each Tax Period reasonably calculated by Landlord from time to time by Landlord with an adjustment made after the close of the Tax Period, to account for actual Tax Excess for such Tax Period. Landlord shall provide Tenant with copies of all tax bills for a Tax Period with any notice or payment requested made under this subsection. If the total of such monthly installments in any Tax Period is greater than Tenant&#8217;s Proportionate Share of actual Tax Excess for such Tax Period, Tenant shall be entitled to a credit against Tenant&#8217;s rental obligations hereunder in the amount of such difference or, if the Lease Term has expired and Tenant has no outstanding monetary obligations to Landlord, Landlord shall promptly pay such amount to Tenant. If the total of such monthly installments is less than such liability for such Tax Period, Tenant shall pay to Landlord the amount of such difference within thirty (30) days after Tenant receives Landlord&#8217;s invoice therefore, together with all supporting and backup documentation relevant thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If any Taxes, with respect to which Tenant shall have paid Tenant&#8217;s Proportionate Share of Tax Excess, shall be adjusted to take into account any abatement or refund, Tenant shall be entitled to a credit against rental obligations hereunder, in the amount of Tenant&#8217;s Proportionate Share of such abatement or refund less Landlord&#8217;s costs or expenses, including without limitation appraiser&#8217;s and attorneys&#8217; fees, of securing such abatement or refund (to the extent such costs were not originally included in Taxes) or, if the Lease Term has expired and Tenant has no outstanding monetary obligations to Landlord, Landlord shall promptly pay such amount to Tenant. Tenant shall not apply for any real estate tax abatement without the prior written consent of Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant shall pay prior to delinquency all taxes assessed against and levied upon trade fixtures, furnishings, inventory, equipment and all other personal property of Tenant contained in, on, upon or around the Premises or related to Tenant&#8217;s use of the Premises. If any of Tenant&#8217;s personal property shall be assessed with Landlord&#8217;s real or personal property, Tenant shall pay to Landlord the taxes attributable to Tenant within twenty (20) days after receipt of a written statement from Landlord setting forth the taxes applicable to Tenant&#8217;s property.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TENANT&#8217;S SHARE OF OPERATING COSTS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commencing on January 1, 2018, in the event that the Operating Costs (defined below) during any calendar year during the Lease Term exceed Operating Costs for the Base Operating Year (i.e., the Base Operating Costs), Tenant shall pay to Landlord, as additional rent, Tenant&#8217;s Proportionate Share of such excess (the &#8220; <font style="text-decoration:underline;">Operating Costs Excess</font> &#8221;). Tenant shall pay to Landlord <font style="text-decoration:underline;">pro</font> <font style="text-decoration:underline;">rata</font> monthly installments on account of the projected Operating Costs Excess for each Lease calendar year during the Lease Term in amounts reasonably calculated from time to time, but not more than once during the Lease calendar year, by Landlord with an adjustment made after the close of the Lease calendar year, to account for actual Operating Costs Excess for such Lease calendar year. Landlord shall deliver a statement of actual expenses in line-item detail, consistently applied throughout the Lease Term, within ninety (90) days after the close of each Lease calendar Year. If the total of such monthly installments in any Lease calendar year is greater than Tenant&#8217;s Proportionate Share of actual Operating Costs Excess for such Lease calendar year, Tenant shall be entitled to a credit against Tenant&#8217;s monthly installments on account of projected Operating Costs Excess hereunder in the amount of such difference or, if the Lease Term has expired and Tenant has no outstanding monetary obligations to Landlord, Landlord shall promptly pay such amount to Tenant. If the total of such monthly installments is less than such liability for such Lease calendar year, Tenant shall pay to Landlord the amount of such difference, as additional rent, within thirty (30) days after Tenant receives Landlord&#8217;s invoice therefore, together with all supporting and backup documentation relevant thereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As used in this Lease, the term &#8220; <font style="text-decoration:underline;">Operating Costs</font> &#8221; shall mean all costs and expenses incurred by Landlord in connection with the operation, insuring, repair, equipping, maintenance, replacement, management, cleaning and protection (collectively, &#8220;the <font style="text-decoration:underline;">Operation</font> &#8221;) of the Building, the Building heating, ventilating, electrical, plumbing, and other systems and the Lot (collectively, &#8220; <font style="text-decoration:underline;">the Property</font> &#8221;), including, without limitation, the following:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> All expenses incurred by Landlord or its agents which shall be related to employment of day and night supervisors, janitors, handymen, carpenters, engineers, firemen, mechanics, electricians, plumbers, guards, cleaners and other personnel (including amounts incurred for wages, salaries and other compensation for services, payroll, social security, unemployment and similar taxes, workmen&#8217;s compensation insurance, disability benefits, pensions, hospitalization, retirement plans and group insurance, uniforms and working clothes and the cleaning thereof, and expenses imposed on Landlord or its agents pursuant to any collective bargaining agreement), for services in connection with the Operation of the Property, and personnel engaged in supervision of any of the persons mentioned above; provided, however, that the costs of employing personnel who work less than full-time in connection with the Operation of the Property shall be equitably adjusted; (2) The cost of services, materials and supplies furnished or used in the Operation of the Property, including, without limitation, the cost to perform Landlord&#8217;s obligations under Sections 8.2 and 9.1 of this Lease; (3) The amounts paid for legal and other professional fees relating to the Operation of the Property, but excluding such fees paid in connection with (x) negotiations for or the enforcement of leases; and (y) seeking abatements of Taxes; (4) Insurance premiums and commercially reasonable deductibles, in Landlord&#8217;s good faith determination, to the extent required, including without limitation rental abatement insurance pursuant to Section 11.5 of this Lease and casualty insurance required of Landlord under Section 11.7 of this Lease; (5) Costs for electricity, oil, natural gas, steam, water and other utilities required in the Operation of the Property; (6) Water and sewer use charges within the Building (as limited to domestic use and including other costs and expenses relating to the Building&#8217;s sewer or septic system components but <font style="text-decoration:underline;">excluding</font> all water and sewer use charges resulting from the use of any tenant in any demised premises within the Building); (7) The costs of snow-plowing and removal, landscaping and maintaining and operating irrigation systems; (8) Amounts paid to independent contractors for services, materials and supplies furnished for the Operation of the Property; (9) the cost of operating, replacing, modifying and/or adding improvements or equipment (i) mandated by any law, statute, regulation or directive of any governmental agency first in effect after the date of this Lease and any repairs or removals necessitated thereby, (ii) necessitated by the failure of Building machinery or equipment for which a prudent owner of comparable properties, in accordance with reasonable and customary building management practices, would elect to replace such machinery or equipment instead of repair or (iii) intended to improve the utility, efficiency or capacity of any Building System; (11) the cost of installing intrabuilding networking or related cabling (&#8220; <font style="text-decoration:underline;">INC</font> &#8221;) and maintaining, repairing, securing and replacing existing INC for use by all tenants in the Building (and excluding such work by Landlord to the extent any INC is serving only a single tenant), (12) payments to independent contractors under service contracts for cleaning, operating, managing, maintaining and repairing the Building and said common areas (which payments may be to affiliates of Landlord); (13) </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Management fee based on a percentage of the gross</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rentals of the Building; provided, however, that management fees shall not exceed 3% of gross rental income; and (14) all other net expenses incurred in connection with the Operation of the health club, cafeteria facility, or other common amenity therein; provided that any associated revenues (by means of rental payments, membership fees or the like) shall have been first applied in determining any such net expenses. Operating Costs shall also include the Building&#8217;s share (as reasonably determined and allocated by Landlord), if any, of: (</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) the costs incurred by or attributable to Landlord in operating, maintaining, repairing, insuring and paying real estate taxes upon any common or shared facilities from time to time serving the Lot or Building in common with other buildings or parcels of land, such as any so-called &#8220;loop&#8221; access roads, retention ponds, sewer and other utility lines, amenities and the like; (ii) shuttle bus service (if and so long as Landlord shall provide the same); (iii) related personnel and the cost of administrative and or service personnel whose duties are not limited solely to the Building and/or the Lot, as allocated to the Building and/or Property by Landlord; and (iv) payments made by Landlord under any easement, license, operating agreement, declaration, restrictive covenant, or instrument pertaining to operating, maintaining, repairing, managing, insuring and paying real estate taxes among other buildings or parcels of land; provided, however, as of the date hereof, there are no such Operating Costs described in this sentence being passed along to Building tenants. Operating Costs may be incurred directly or by way of </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reimbursement, and</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall include taxes applicable thereto.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, any costs not enumerated above or otherwise approved by Tenant in writing shall be excluded from Operating Costs, including the following: (i) costs of curing design or construction defects; (ii) depreciation; (iii) interest and principal payments on mortgages and other debt costs and ground lease payments, if any, and any penalties assessed as a result of Landlord&#8217;s late payments of such amounts; (iv) real estate broker leasing commissions or compensation; (v) any cost or expenditure (or portion thereof) for which Landlord is reimbursed, whether by insurance proceeds or otherwise; (vi) attorneys&#8217; fees, costs, disbursements, advertising and marketing and other expenses incurred in connection with the negotiation and/or enforcement of leases with current and prospective tenants of the Building; (vii) rent for space which is not actually used by Landlord in connection with the management and operation of the Building; (viii) all costs or expense (including fines, penalties and legal fees) incurred due to the violation by Landlord, its employees, agents, contractors or assigns of the terms and conditions of the Lease, or any valid applicable building code, governmental rule, regulation or law, (ix) except for the above-referenced management fees, any overhead or profit increments to any subsidiary of affiliate of Landlord for services on or to the Building, to the extent that the costs of such services exceed competitive costs for such services; (x) the cost of constructing tenant improvements for Tenant or any other tenant of the Building; (xi) Operating Costs specially charged to and paid by any other tenant of the Building; (xii) the cost of special services, goods, or materials provided to any other tenant of the Building or Property; (xiii) capital improvements <font style="text-decoration:underline;">unless</font> (X) required to comply with Laws and Restrictions first in effect after the Term Commencement Date of this Lease, (Y) necessary because of the failure of existing Building machinery or equipment for which a prudent owner of comparable properties, in accordance with reasonable and customary building management practices, would elect to replace such machinery or equipment instead of repair, or (Z) which are intended to improve the utility, efficiency or capacity of any Building system, in each case to be amortized over the useful life thereof together with interest on the unamortized balance thereof on any funds borrowed by Landlord to finance such capital improvements; or to extent such sums are not borrowed by Landlord to finance such capital improvements, with no additional interest costs included; (xiv) costs and expenses incurred in connection with disputes with individual tenants and/or the existence, maintenance or non-Property related operations of the legal entity or entities of which Landlord is comprised; (xv) costs of repairs necessitated by the negligence or willful misconduct of Landlord, its agents, contractors, employees, lenders or prospective purchasers; (xvi) subject to (xiii) above, the costs of developing and constructing the property or other improvements or additions at the Property, whether capital expenditures or otherwise; (xvii) Taxes and any other governmental payment incurred by Landlord in connection with the development or construction of the Property; (xviii) the cost of removing or remediating Hazardous Matters from the Property; (xix) any amounts paid to a person, firm, corporation or other entity under common ownership and control with Landlord that is in excess of the amount that would have been paid on an arms-length basis in the absence of such relationship; (xx) the cost of acquiring sculptures, paintings and other objects of art; (xxi) salaries and bonuses and benefits of officers, executives of Landlord and administrative employees above the grade of property manager or building supervisor, and if a property manager or building supervisor or any personnel below such grades are shared with other buildings or has other duties not related to the building containing the Premises, only the allocable portion of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such person or persons salary, bonuses, and benefits shall be included in Operating Costs; and (xxii) replacement and contingency reserves.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything contained herein to the contrary, Tenant&#8217;s Proportionate Share of any Operating Costs Excess for each Lease year following the first Lease Year, exclusive of real estate taxes (the Building&#8217;s proportionate share thereof), Landlord&#8217;s Insurance, snow and ice removal, and utilities (the &#8220; <font style="text-decoration:underline;">Uncontrollable Cam Expenses</font> &#8221;), shall not exceed 105% per year, on a non-cumulative basis, of the portion of Tenant&#8217;s Proportionate Share of Operating Costs Excess attributable to these same Operating Costs (as subject to same exclusions) actually paid by Tenant for the prior Lease year.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If during all or part of any Lease calendar year (including, without limitation, the calendar year in which occurs any part of the term of this Lease and includes the Base Operating Year), Landlord is not performing or furnishing any item to any portion of the Building (the cost of which, if performed or furnished by Landlord to such portion of the Building would constitute a part of Operating Costs) on account of such portion of the Building not being occupied or leased, then Operating Costs shall be deemed to be increased by an amount equal to the additional costs and expenses which would reasonably have been incurred during such period by Landlord if it had performed or furnished such item to 95% of the Building.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INSPECTION RIGHT.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall permit Tenant, at Tenant&#8217;s expense and during normal business hours, but only one time with respect to any Lease calendar year, including the Base Operating Year, to review Landlord&#8217;s invoices and statements relating to the Operating Costs for the applicable Lease calendar year for the purpose of verifying the Operating Costs and Tenant&#8217;s share thereof, provided that notice of Tenant&#8217;s desire to so review is given to Landlord not later than 120 days after Tenant receives an annual statement from Landlord, and provided that such review is thereafter commenced and prosecuted by Tenant with due diligence. Landlord shall make available to Tenant as part of any such review backup documentation relative to the Operating Costs for any such period. Any Operating Costs statement or accounting by Landlord shall be binding and conclusive upon Tenant unless (i) Tenant duly requests such review within such 120 day period, and (ii) within 120 days after such review request, Tenant shall notify Landlord in writing that Tenant disputes the correctness of such statement, specifying the particular respects in which the statement is claimed to be incorrect. The accountant or accounting firm conducting the review shall not be compensated based upon a percentage of alleged overcharges discovered. No subtenant shall have any right to conduct a review, and no assignee shall conduct a review for any period during which such assignee was not in possession of the Premises. Tenant agrees that the results of any Operating Costs review shall be kept strictly confidential by Tenant and shall not be disclosed to any other person or entity other than Tenant&#8217;s officers, employees, accountants, attorneys, and lenders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> BASE RENT DURING ANY EXTENSION TERM.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the Extension Term of this Lease (if Tenant exercises its option to extend the Term hereof in accordance with Section 3.2 above), the annual Base Rent to be paid by Tenant shall be the Fair Market Rental Value of the Premises determined as of the first day of the applicable Extension Term.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The &#8220; <font style="text-decoration:underline;">Fair Market Rental Value</font> &#8221; shall mean the market rate for the rental of the Premises for the Extension Term, including updated base years for Operating Costs and Taxes, based upon rents then being paid for arm&#8217;s length transactions for comparable space in the area in which the Property is located, including all relevant factors. The Fair Market Rental Value shall be determined as follows:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Within thirty (30) days after the exercise by Tenant of its option to extend the Term, Landlord shall advise Tenant in writing of Landlord&#8217;s determination of the Fair Market Rental Value. Tenant shall be deemed to have accepted the rental amount contained in Landlord&#8217;s said notice, and such rental rate shall be conclusively deemed to be the Fair Market Rental Value, unless Tenant notifies Landlord in writing, within seven (7) business days after Landlord&#8217;s notice, that Tenant disputes the aforementioned determination by Landlord, in which event the parties shall proceed to the Fair Market Rental Value determination as set forth below.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that Tenant so disputes the determination of the Fair Market Rental Value by Landlord, and Landlord and Tenant are unable to agree on the Fair Market Rental Value within 30 days, the same shall be determined as follows: Landlord and</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant each shall, within ten days after the expiration of such thirty (30) day period, appoint an independent appraiser who shall be instructed to determine independently the Fair Market Rental Value. If the difference between the amounts so determined by such appraisers does not exceed ten percent (10%) of the lesser of such amounts, then the Fair Market Rental Value shall be an amount equal to fifty percent (50%) of the total of the amounts so determined. If the difference between the amounts so determined shall exceed ten percent (10%) of the lesser of such amounts, then such two (2) appraisers shall have ten (10) days thereafter to appoint a third appraiser, but if such appraisers fail to do so within such ten (10) day period, then either Landlord or Tenant may request the Greater Boston Real Estate Board or any successor organization thereto to appoint an appraiser within ten (10) days of such request, and both Landlord and Tenant shall be bound by any appointment so made within such ten (10) day period.&#160;If no such appraiser shall have been appointed within such ten (10) days either Landlord or Tenant may apply to any court having jurisdiction to have such appointment made by such court. Any appraiser appointed by the original appraisers, by the Greater Boston Real Estate Board or by such court shall be instructed to determine the Fair Market Rental Value in accordance with the definition of such term contained herein and within twenty (20) days after its appointment. If the third appraisal shall exceed the higher of the first two appraisals, the Fair Market Rental Value shall be the higher of the first two appraisals; if the third appraisal is less than the lower of the first two appraisals, the Fair Market Rental Value shall be the lower of the first two appraisals. In all other cases, the Fair Market Rental Value shall be equal to the third appraisal. Notwithstanding the foregoing, if either party shall fail to appoint its appraiser within the 10 day period specified above (such party being referred to herein as the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220; </font><font style="text-decoration:underline;">failing</font><font style="text-decoration:underline;"> party</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;), the other party may serve notice on the failing party requiring the failing party to appoint its appraiser within ten (10) days of the giving of such notice. If the failing party shall not respond by appointment of its appraiser within said </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ten day</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> period, then the appraiser appointed by the other party shall be the sole appraiser whose determination of the Fair Market Rental Value shall be binding and conclusive upon Tenant and Landlord. Each party shall pay for the fees and expenses of the appraiser appointed by it, but the fees and expenses of the third appraiser shall be shared equally by the parties. All appraisers appointed hereunder shall be real estate brokers or MAI appraisers having not less than ten (10) years&#8217; experience in leasing space or in appraising the value of leasehold interests in real estate similar to the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> located in the Boston Metro-West market. The foregoing determination shall be conclusive, </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">final</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and binding on the parties and enforceable in any court having jurisdiction over the parties.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the parties are unable to agree on the Fair Market Rental Value (or the arbitration procedure set forth above has not concluded) prior to the first day of the Extension Term, Tenant shall make monthly payments on account of Base Rent (in addition to all additional rent and other payments hereunder) in accordance with the increase in Base Rent established in the Lease for the last month of the initial term until the Fair Market Rental Value has been finally established as herein provided, at which time an appropriate retroactive Base Rent adjustment payment or refund shall be made, if necessary.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE V <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">USE OF PREMISES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PERMITTED USE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees that the Premises shall be used and occupied by Tenant only for the purposes specified as the Permitted Use thereof in Section 1.2 of this Lease, and for no other purpose or purposes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall comply and shall cause its employees, agents, and invitees to comply with such reasonable rules and regulations as Landlord shall from time to time establish for the proper regulation of the Building and the Lot, provided that Landlord gives Tenant reasonable advance notice thereof and that such additional rules and regulations shall be of general application to all the tenants in the Building, except where different circumstances justify different treatment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> COMPLIANCE WITH LAWS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall, at Tenant&#8217;s sole expense, promptly comply with all applicable laws, ordinances, rules, regulations, orders, certificates of occupancy, conditional use or other permits, variances, covenants and restrictions of record, the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recommendations of Landlord&#8217;s engineers or other consultants, and requirements of any fire insurance underwriters, rating bureaus or government agencies, now in effect or which may hereafter come into effect (collectively, &#8220; </font><font style="text-decoration:underline;">Laws and Restrictions</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;), whether or not they reflect a change in policy from that now existing, during the term or any part of the term hereof, relating in any manner to the occupation and use by Tenant of the Premises, completion of Tenant&#8217;s Initial Work and any Alterations performed by Tenant except that the Tenant may defer compliance so long as the validity of any such Laws and Restrictions shall be contested by Tenant in good faith and by appropriate legal proceedings. Landlord shall, at its own cost and expense, comply with all Laws and Restrictions generally applicable to the Building as a whole, and notwithstanding anything to the contrary contained herein, Tenant shall not be required to make any structural change, alteration, addition or correction required by any Law and Restrictions which may be adopted or promulgated after the date of this Lease, unless necessitated by Tenant&#8217;s acts, Tenant&#8217;s Alterations or Tenant&#8217;s particular use of the Premises for purposes other than the Permitted Uses. Landlord agrees to promptly remedy any violations noted or issued with respect to the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> which shall either prevent Tenant from making any Alterations in the Premises or from opening for or conducting business in the Premises. Tenant agrees that no trade or occupation shall be conducted in the Premises or use made thereof which will be unlawful, improper, or contrary to any Laws and Restrictions or which will disturb the quiet enjoyment of the other tenants of the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Other than the Certificate of Occupancy required for the Premises to be procured upon completion of Landlord&#8217;s Work (which is Landlord&#8217;s responsibility), Tenant shall obtain any and all approvals, permits, licenses, variances and the like from governmental or quasi-governmental authorities, including without limitation any Architectural Access Board and Board of Fire Underwriters (collectively, &#8220; </font><font style="text-decoration:underline;">Approvals</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;) which are required for</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant&#8217;s use of the Premises, including, without limitation, any which may be required for any construction work and installations in conjunction with the Tenant&#8217;s Initial Work, alterations, or additions made by Tenant to, in, on, or about the Premises; provided, however, that Tenant shall not seek or apply for any Approvals without first having given Landlord a reasonable opportunity to review any applications for Approvals and all materials and plans to be submitted in connection therewith and obtaining Landlord&#8217;s written consent, which consent shall not be unreasonably withheld, conditioned or delayed. Upon Tenant&#8217;s request and at Tenant&#8217;s expense, Landlord shall join in the application for any Approvals whenever such joining by Landlord shall be required by any governmental agency having jurisdiction, and Landlord shall otherwise reasonably cooperate with Tenant in connection therewith upon Tenant&#8217;s request. In any event, Tenant shall be responsible for all costs, expenses, and fees in connection with obtaining all Approvals. Without limiting the general application of the foregoing, other than Landlord&#8217;s Work, Tenant shall be responsible for compliance of the Premises, including, without limitation, any alterations it may make to the Premises, with the requirements of the Americans with Disabilities Act (42 U.S.C. Section 12101 et seq.) and the regulations and Accessibility Guidelines for Buildings and Facilities issued pursuant thereto, as the same may be amended from time to time (collectively, the &#8220; </font><font style="text-decoration:underline;">ADA</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;). Other than Landlord&#8217;s Work, Tenant shall be responsible for compliance of the Premises with the ADA throughout the term of the Lease. Tenant&#8217;s inability to obtain or delay in obtaining any such Approval shall in no event reduce, delay, or terminate Tenant&#8217;s rental, payment, and performance obligations hereunder. Tenant shall, at its own cost and expense, (</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) make all installations, repairs, alterations, additions, or improvements to the Premises required by any Laws and Restrictions </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as a result of</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Tenant&#8217;s particular use of the Premises; (ii) keep the Premises equipped with all required safety equipment and appliances; and (iii) comply with all of Landlord&#8217;s and Tenant&#8217;s insurers reasonable requirements applicable to the Premises, Building and Lot. Tenant shall not place a load upon any floor in the Premises exceeding the lesser of (a) the floor load per square foot of area which such floor was designed to carry as certified by Landlord&#8217;s architect and (b) the floor load per square foot of area which is allowed by law. Landlord reserves the right to prescribe the weight and position of all business machines and mechanical equipment, including safes, which shall be placed </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">so as to</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> distribute the weight.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INSURANCE RISKS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall not permit any use of the Premises which will make voidable or, unless Tenant pays the extra insurance premium attributable thereto as provided below, increase the premiums for any insurance on the Building or on the contents of said property or which shall be contrary to any law or regulation from time to time established by the New England Fire Insurance Rating Association (or any successor organization) or which shall require any alteration or addition to the Building. Landlord shall notify Tenant of any such condition in writing and Tenant shall have thirty (30) days after such notice to cure. If Tenant does not cure within the prescribed timeframe, Tenant shall, within thirty (30) days after written demand therefore, reimburse Landlord for the costs of all extra insurance premiums caused by Tenant&#8217;s use of the Premises. Any such amounts shall be deemed to be additional rent hereunder.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ELECTRICAL EQUIPMENT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than typical office equipment, light manufacturing, laboratory, research and development equipment, including, without limitation, computers, copiers, and printers, Tenant shall not, without Landlord&#8217;s written consent in each instance, which consent shall not be unreasonably withheld, conditioned or delayed, connect to the electrical distribution system any fixtures, appliances, or equipment which will operate individually or collectively at a wattage in excess of the capacity of the electrical system serving the Premises as the same may be reasonably determined by Landlord who may audit Tenant&#8217;s use of electric power to determine Tenant&#8217;s compliance herewith. If Landlord, in its sole discretion, permits such excess usage, Tenant will pay for the cost of such excess power as additional rent, together with the cost of installing any additional risers, meters, or other facilities that may be required to furnish or measure such excess power to the Premises.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.5 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TENANT&#8217;S OPERATIONAL COVENANTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> <font style="text-decoration:underline;">Affirmative Covenants</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to Landlord&#8217;s obligations with respect to cleaning, repair and maintenance, in regard to the use and occupancy of the Premises, and in addition to those covenants set forth in other sections of this Lease, Tenant will, at its sole expense: (1) keep the inside of all glass in the doors and windows of the Premises reasonably clean (2) replace promptly any cracked or broken glass of the Premises that was broken by Tenant with glass of like kind and quality; (3) maintain the Premises in a clean, orderly and sanitary condition (provided, however, Landlord shall be responsible for the regular cleaning of the Premises unless Tenant upon written notice to Landlord elects to conduct this regular cleaning with its own agents in which case it shall do so at its own expense without any credit under this Lease); (4) keep any garbage, trash, rubbish or other refuse within the interior of the Premises until removed by Landlord or Landlord&#8217;s agent; (5) keep all Tenant&#8217;s mechanical apparatus free of vibration and loud noise which may be transmitted beyond the Premises; and (6) comply with and observe all rules and regulations reasonably established by Landlord from time to time and provided to the Tenant, including, without limitation, those rules and regulations set forth in Exhibit C attached hereto.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> <font style="text-decoration:underline;">Negative Covenants</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In regard to the use and occupancy of the Premises and common areas, Tenant will not, in Landlord&#8217;s reasonable judgment: (1) place or maintain any trash, refuse or other articles in any vestibule or entry of the Premises, on the sidewalks or corridors adjacent thereto or elsewhere on the exterior of the Premises so as to obstruct any corridor, stairway, sidewalk or common area; (2) cause or permit objectionable odors to emanate or to be dispelled from the Premises; or (3) commit, or suffer to be committed, any waste upon the Premises or any public or private nuisance or other act or thing which may disturb the quiet enjoyment of any other tenant or occupant of the Building, or use or permit the use of any portion of the Premises for any unlawful purpose.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.6 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SIGNS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as otherwise set forth herein, Tenant shall not place any signs, placards, or the like on the Building or in the Premises that will be visible from outside the Premises (including without limitation both interior and exterior surfaces of windows). Landlord shall provide, at Landlord&#8217;s expense, building standard lettering on Tenant&#8217;s Proportionate Share of the mahogany tenant roster kiosk in the Building lobby to identify Tenant&#8217;s official name and Building address. Tenant at its own cost shall provide its own signage for the Premises, with the prior approval of Landlord, not to be unreasonably withheld, as to design and appearance to maintain consistency with other tenant signage in the Building. Following installation, Tenant shall maintain its existing signage at the entrance to the Premises and shall procure Landlord&#8217;s consent, not to be unreasonably withheld, with respect to any modifications thereto. With respect to any monument signage located on the Lot at the entrance to the Boston Post Road Corporate Center, Tenant shall be provided, at Landlord&#8217;s expense, an area of signage on this monument based upon its Tenant&#8217;s Proportionate Share and the overall available signage area.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.7 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> HAZARDOUS MATERIALS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Neither Tenant nor any of its employees, agents, invitees, licensees, contractors, representative or any other person or entity for whom Tenant is responsible (collectively, &#8220; <font style="text-decoration:underline;">Tenant&#8217;s Agents</font> &#8221;) shall use, maintain, generate, allow or bring on the Premises or the Property or transport or dispose of, on or from the Premises or the Property (whether into the ground, into any sewer or septic system, into the air, by removal off&#8209;site or otherwise) any Hazardous Matter (as hereinafter defined) without Landlord&#8217;s consent. Tenant shall promptly deliver to Landlord copies of any notices, orders or other communications received from any governmental agency or official affecting the Premises and concerning alleged violations of the Environmental Requirements (hereinafter defined). Any Hazardous Matter in the Premises, and all containers therefore, shall be used, kept, stored and disposed of in conformity with all applicable Laws and Restrictions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall save Landlord (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents contractors, and mortgagees) harmless and indemnified from and against any and all Environmental Damages (hereinafter defined) which the indemnified parties may sustain or be put to on account of: (1) the presence or release of any Hazardous Matter upon, in or from the Premises during the Term and during any period when Tenant, or Tenant&#8217;s Agents, are occupying the Premises or any part thereof, caused by Tenant or Tenant&#8217;s Agents; (2) the presence or release of any Hazardous Matter upon, in or from the Property caused by the act, omission or default of Tenant or Tenant&#8217;s Agents; (3) the activities or other action or inaction of Tenant or Tenant&#8217;s Agents in violation of Environmental Requirements; and (4) the breach beyond any applicable notice and cure period of any of Tenant&#8217;s obligations under this Section 5.7, except Tenant&#8217;s indemnity shall not cover the willful misconduct or negligence of Landlord or Landlord&#8217;s Agents. The provisions of this Section shall be in addition to any other obligations and liabilities Tenant may have to Landlord under this Lease or otherwise at law or in equity, and in the case of conflict between this Section 5.7 and any other provision of this Lease, the provision imposing the most stringent requirement on Tenant shall control. The obligations of Tenant under this Section 5.7 shall survive the expiration or termination of this Lease and the transfer of title to the Premises. The following terms as used herein shall have the meanings set forth below: &#8220; <font style="text-decoration:underline;">Hazardous Matter</font> &#8221; shall mean any substance: (i) which is or becomes defined as Hazardous Substance, Hazardous Waste, Hazardous Material or Oil under The Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. Section 9601 et seq., M.G.L. Chapter 21C, M.G.L. Chapter 21D or M.G.L. Chapter 21E, and the regulations promulgated thereunder, as same may be amended from time to time; or (ii) which is toxic, explosive, corrosive, flammable, infectious, radioactive, carcinogenic, mutagenic or otherwise hazardous to health or the environment and which is or becomes regulated and the presence of which requires investigation or remediation pursuant to any applicable law. &#8220; <font style="text-decoration:underline;">Environmental Requirements</font> &#8221; shall mean all applicable law, the provisions of any and all approvals, and the terms and conditions of this Lease insofar as same relate to the release, maintenance, use, keeping in place, transportation, disposal or generation of Hazardous Matter, including without limitation those pertaining to reporting, licensing, permitting, health and safety of persons, investigation, containment, remediation, and disposal. &#8220; <font style="text-decoration:underline;">Environmental Damages</font> &#8221; shall mean all liabilities, injuries, losses, claims, damages (whether special, consequential or otherwise), settlements, attorneys&#8217; and consultants&#8217; fees, fines and penalties, interest and expenses, and costs of environmental site investigations, reports and cleanup, including without limitation costs incurred in connection with: any investigation or assessment of site conditions or of health of persons using the Building or the Lot; risk assessment and monitoring; any cleanup, remedial, removal or restoration work required by any governmental agency or reasonably recommended by Landlord&#8217;s environmental consultant; any reasonable decrease in value of Landlord&#8217;s Property; any reasonable damage caused by loss or restriction of rentable or usable space in Landlord&#8217;s Property; or any reasonable damage caused by adverse impact on marketing or financing of Landlord&#8217;s Property. No consent or approval of Landlord shall in any way be construed as imposing upon Landlord any liability for the means, methods, or manner of removal, containment or other compliance with applicable law for and with respect to the foregoing. The terms of this Section 5.7 shall apply to any transportation, storage, use or disposal of Hazardous Materials irrespective of whether Tenant has obtained Landlord&#8217;s consent therefore but nothing in this Lease shall limit or otherwise modify the requirement of obtaining Landlord&#8217;s prior consent as set forth in the first sentence of this Section 5.7. The consent requirement contained herein shall not apply to ordinary office products or products used in connection with the Permitted Uses that may contain de minimus quantities of hazardous materials and Hazardous Matters; however, Tenant indemnification obligations are not diminished with respect to the presence of such products.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall save Tenant (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents and contractors) harmless and indemnified from and against any and all Environmental Damages (as defined above) which the indemnified parties may sustain or be put to on account of the presence or release of any Hazardous Matter upon, in or from the Property, </font><font style="font-weight:bold;font-style:italic;text-decoration:underline;">except to the extent caused by</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (1) the presence or release of any Hazardous Matter upon, in or from the Premises during the Term and during any period when Tenant, or Tenant&#8217;s Agents, are occupying the Premises or any part thereof, caused by Tenant or Tenant&#8217;s Agents; (2) the presence or release of any Hazardous Matter upon, in or from the Property caused by the act, omission or default of Tenant or Tenant&#8217;s Agents; (3) the activities or other action or inaction of Tenant or Tenant&#8217;s Agents in violation of Environmental Requirements; and (4) the breach of any of Tenant&#8217;s obligations under this Section 5.7, except Landlord&#8217;s indemnity shall not cover the negligence or willful misconduct of Tenant or the Tenant&#8217;s Agents. The provisions of this Section shall be in addition to any other obligations and liabilities Landlord may have to Tenant under this Lease or otherwise at law or in equity, and in the case of conflict between this Section 5.7 and any other provision of this Lease, the provision imposing the most stringent requirement on Landlord shall control.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything herein to the contrary, Tenant shall not be responsible for the costs and expenses incurred in connection with the removal or remediation of Hazardous Material that is not in compliance with applicable law on, the Term Commencement Date and which is located in, on or under the Building or the Property prior to the Term Commencement Date and was not brought on to the Property by Tenant or its agents. Landlord warrants and represents that there are currently no Hazardous Materials in the Premises.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VI <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">INSTALLATIONS, ALTERATIONS, AND ADDITIONS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following completion of the Landlord&#8217;s Work, Tenant after the Term Commencement Date shall not make any alterations, improvements, additions, utility installations or repairs (hereinafter collectively referred to as &#8220; <font style="text-decoration:underline;">Alterations</font> &#8221;) to the Premises, except in accordance with this Article VI and with the prior written consent of Landlord, which Landlord agrees not unreasonably to withhold, condition or delay as to nonstructural Alterations (nonstructural Alterations being those that do not affect the Building&#8217;s structure, roof, exterior or mechanical, electrical, plumbing, life safety or other Building systems of the Building or Premises) within the ten (10) day period below. Tenant shall submit, together with Tenant&#8217;s request for approval to perform any such alterations, additions or improvements, a specific request for Landlord&#8217;s decision as to whether or not such alterations, additions or improvements must be removed upon the expiration or earlier termination of the Lease, and Landlord shall inform Tenant of its decision as to Alterations, the removal thereof, and Tenant&#8217;s contractors within ten (10) days of such request; provided, however, Tenant shall have no demolition obligation and shall not be required to remove any Alterations unless the same are not generally usable by other office tenants. Such decision shall be binding upon both Landlord and Tenant, their successors and assigns. In the event that Landlord fails to supply Tenant with an answer in writing, Tenant will not be required to remove said alterations, additions or improvements upon the expiration or earlier termination of the Lease, and such Alterations and contractors shall be approved. In no event shall Landlord&#8217;s approval of any proposed Alterations to the Premises constitute a representation by Landlord that such work complies with the requirements of any applicable Laws and Restrictions, including without limitation the requirements of the ADA. Without limiting any of the terms hereof, Landlord will not approve any Alterations increasing the cost of construction, insurance or taxes on the Building or of Landlord&#8217;s services to the Premises, unless Tenant first gives assurances acceptable to Landlord for payment of such increased cost. All Alterations made by Tenant shall be made in accordance with plans and specifications (to the extent plans and specifications are required by Laws and Requirements to be submitted to any governmental authority) which have been reasonably approved in writing by the Landlord, pursuant to a duly issued permit, and in accordance with all Laws and Restrictions, the provisions of this Lease and in a good and first-class workmanlike manner using new materials of same or better quality as base building standard materials, free of all liens and encumbrances and prior to Tenant&#8217;s use of the Premises, after the performance of any such Alterations, Tenant shall procure (other than the Certificate of Occupancy) any required certificates. All Alterations shall be performed by a contractor or contractors selected by Tenant and reasonably approved in writing by Landlord. Tenant shall reimburse Landlord for any reasonable out-of-pocket costs it incurs in reviewing the plans therefore. If, as a result of any Alterations made by Tenant, Landlord is obligated to comply with ADA or any other Laws or Restrictions and such compliance requires Landlord to make any improvement or Alteration to any portion of the Building, as a condition to Landlord&#8217;s consent, Landlord shall have the right to require Tenant to pay to Landlord prior to the construction of any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alteration by Tenant, the entire reasonable cost of any improvement or Alteration Landlord is obligated to complete by such Law and Restriction. After the expiration of any applicable notice and cure period, Landlord shall have the right to stop any work not being performed in conformance with this Lease, and, at its option, may repair or remove non-conforming work at the expense of Tenant. Tenant hereby indemnifies and holds Landlord harmless from and against any liens, encumbrances and violations of Laws and Restrictions caused by Tenant&#8217;s Alterations. The filing of any lien or encumbrance, or the violation of Laws or Restrictions caused by Tenant&#8217;s Alterations, beyond any applicable notice and cure period, shall constitute a default hereunder, and Tenant, at its expense, shall satisfy, cancel or discharge all such liens relating to any Alterations, and remove same from the record (or may bond such liens) within thirty (30) days after Landlord makes written demand therefor as set forth in Section 17.21 hereof. The repair and indemnity obligations of Tenant hereunder, including Tenant&#8217;s obligations to repay Landlord the cost of repairing or removing Alterations, shall survive the termination of this Lease. All Alterations performed by Tenant in the Premises shall remain therein (unless Landlord directs Tenant to remove the same on termination or expiration of this Lease in accordance with the provisions set forth above) and, at termination or expiration, shall be surrendered as a part thereof, except for Tenant&#8217;s usual trade furniture and</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">equipment, if movable, installed prior to or during the Lease term at Tenant&#8217;s cost, which trade furniture and equipment Tenant shall remove in their entirety prior to the termination or expiration of this Lease. Tenant agrees to repair any and all damage to the Premises resulting from such removal (including removal of Tenant&#8217;s Alterations directed by Landlord in accordance with the provisions set forth above) or, if Landlord so elects, to pay Landlord for the reasonable cost of any such repairs forthwith after </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">billing</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> therefore. At all times when any Alterations by Tenant are in progress, there shall be maintained, at Tenant&#8217;s cost and expense, insurance meeting the requirements under Article 11 of this Lease and certificates of insurance evidencing such coverage shall be furnished to Landlord prior to the commencement of any such work. Notwithstanding the above, Tenant may make cosmetic alterations without Landlord&#8217;s approval, provided Tenant complies with the requirements for performing work in the Premises and for removal thereof upon expiration or termination of Lease Term in accordance with this Lease.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VII <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">ASSIGNMENT AND SUBLETTING</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PROHIBITION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding any other provision of this Lease, and other than in the case of a Permitted Transfer, Tenant shall not, directly or indirectly, assign, mortgage, pledge or otherwise transfer, voluntarily or involuntarily, this Lease or any interest herein or sublet (which term without limitation, shall include granting of concessions, licenses, and the like) or allow any other person or entity to occupy the whole or any part of the Premises, without, in each instance, having first received the express written consent of Landlord, which consent shall not be unreasonably withheld, conditioned or delayed. Without limitation, it shall not be unreasonable for Landlord to withhold such approval from any assignment or subletting where, in Landlord&#8217;s reasonable opinion: (i) the proposed sublessee or assignee is a current tenant or a prospective tenant (meaning such tenant has been shown space or has been presented with or has made an offer to lease space within the last three months) of the Building at any time that Landlord has space in the Building to offer such Tenant comparable to the Premises; (ii) the use of the Premises by any sublessee or assignee (even though a Permitted Use) violates any use restriction granted by Landlord in any other lease or would otherwise cause Landlord to be in violation of its obligations under another lease or agreement to which Landlord is a party of which Tenant has received prior notice; (iii) Landlord has sued or been sued by the proposed assignee or subtenant or has otherwise been involved in a legal dispute with the proposed assignee or subtenant; (iv) the proposed assignee&#8217;s or subtenant&#8217;s business will impose a burden on the Property&#8217;s parking facilities, elevators, common areas, facilities, or utilities that is materially greater than the burden imposed by Tenant, in Landlord&#8217;s reasonable judgment; (v) Tenant is in default of any of its obligations under the Lease beyond applicable notice and cure periods at the time of the request; (vi) the assignee or subtenant is involved in a business which conflicts with the Permitted Use hereunder; (vii) the assignee or subtenant intends to use the Premises as an executive suite; or ( viii) the assignee or subtenant is a governmental or quasi-governmental entity or an agency, department or instrumentality of a governmental or quasi-governmental agency that does not presently occupy any space in the Building. In no event, however, shall Tenant assign this Lease or sublet the whole or any part of the Premises to a proposed assignee or sublessee which at the time of the request is judicially declared bankrupt or insolvent according to law, or with respect to which at the time of the request an assignment has been made of property for the benefit of creditors, or with respect to which at the time of the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">request a receiver, guardian, conservator, trustee in involuntary bankruptcy or similar officer has been appointed to take charge of all or any substantial part of the proposed assignee&#8217;s or sublessee&#8217;s property by a court of competent jurisdiction, or with respect to which at the time of the request a petition has been filed for reorganization under any provisions of the Bankruptcy Code now or hereafter enacted, or if at the time of the request a proposed assignee or sublessee has filed a petition for such reorganization, or for arrangements under any provisions of the Bankruptcy Code now or hereafter enacted and providing a plan for a debtor to settle, satisfy or extend the time for the payment of debts. Any assignment of this Lease or subletting of the whole or any part of the Premises (other than Permitted Transfers as set forth below) by Tenant without Landlord&#8217;s express consent shall be invalid, void and of no force or effect. This prohibition includes, without limitation, any assignment, subletting, or other transfer that would occur by operation of law, merger, consolidation, reorganization, acquisition, transfer, or other change of Tenant&#8217;s corporate or proprietary structure, subject, however to the provisions set forth in the last paragraph of this Section 7.1. Any request for consent under this Section 7.1 shall set forth, in detail reasonably satisfactory to Landlord, the identification of the proposed assignee or sublessee, and the material terms on which the proposed assignment or subletting is to be made, including, without limitation, the rent to be paid in respect thereto and such request shall be treated as Tenant&#8217;s representation in respect to the information submitted therewith (&#8220; </font><font style="text-decoration:underline;">Tenant&#8217;s Offer Notice</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;), and Landlord shall, within twenty (20) days after receipt of the Tenant&#8217;s Offer Notice, either (a) reasonably consent or deny its consent to such assignment or subletting, or (b) if Section 7.4 hereof is applicable, exercise its recapture right. </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Landlord fails to supply Tenant with an answer in writing within such twenty (20) day period, such proposed assignment or sublease shall be deemed approved by Landlord, and Landlord shall have waived its recapture right in Section 7.4.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In any case where Landlord shall consent to any assignment or subletting, Tenant originally named herein shall remain fully liable for Tenant obligations hereunder, including, without limitation, the obligation to pay the rent and other amounts provided under this Lease and such liability shall not be affected in any way by any future amendment, modification, or extension of this Lease or any further assignment, other transfer, or subleasing and Tenant hereby irrevocably consents to any and all such transactions; provided, however, if this Lease be modified after any such assignment so as to increase Tenant&#8217;s obligations, then the originally named Tenant, unless it consented to such modification, shall be liable only for the obligations under this Lease as same existed prior to such modifications. Tenant agrees to pay to Landlord, within thirty (30) days of billing therefor, all reasonable legal and other out-of-pocket expenses incurred by Landlord in connection with any request to assign or sublet, excluding Permitted Transfers, not to exceed $2,000.00 in the aggregate per assignment or sublet. It shall be a condition of the validity of any permitted assignment that the assignee agree, in commercially reasonable form satisfactory to Landlord, to be bound by all Tenant obligations hereunder, including, without limitation, the obligation to pay all Rent and other amounts provided for under this Lease and the covenant against further assignment or other transfer or subletting.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Without limitation of the rights of Landlord hereunder in respect thereto, if there is any assignment of this Lease by Tenant for consideration or a subletting of the whole of the Premises by Tenant (except any Permitted Transfer set forth below) at a rent which exceeds the rent payable hereunder by Tenant, or if there is a subletting of a portion of the Premises by Tenant at a rent in excess of the subleased portion&#8217;s <font style="text-decoration:underline;">pro</font> <font style="text-decoration:underline;">rata</font> share of the Rent payable hereunder by Tenant, then Tenant shall pay to Landlord, as additional rent, forthwith upon Tenant&#8217;s receipt of the consideration (or the cash equivalent thereof) therefor, in the case of both an assignment and a subletting, fifty (50%) percent of the amount of any such excess rent after Tenant&#8217;s recuperation of reasonable attorneys&#8217; fees, brokerage commissions, advertising expenses, cash allowance, tenant improvement costs and free rent pertaining to any sublease or assignment. The provisions of this paragraph 7.1 shall apply to each and every assignment of this Lease and each and every subletting of all or a portion of the Premises, except to a Permitted Transferee. For the purposes of this Section 7.1, the term &#8220; <font style="text-decoration:underline;">rent</font> &#8221; shall mean all rent and additional rent, in each case after deducting therefrom Tenant&#8217;s costs in connection with such transaction, including, without limitation, broker&#8217;s fees and commissions, legal fees and improvement expenses, free rent and allowances and advertising expenses.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding any other provision of this Article VII, Tenant may assign this Lease or sublease the Premises or any part thereof without the consent of Landlord to (i) any wholly owned subsidiary or to any parent corporation of Tenant; (ii) any affiliate or entity under common control with Tenant or any affiliate or entity under common control with a parent or subsidiary of Tenant;&#8217; (iii) any entity of which Tenant, a Tenant affiliate, Tenant partners, Tenant subsidiary, Tenant parent, or entity under common control with Tenant is a shareholder or partner or other equity interest holder; or (iv) any entity which acquires all or substantially all of the assets or stock or equity interest of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant, by merger, consolidation, acquisition or other business reorganization (each of (</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), (ii), (iii) or (iv) a &#8220; </font><font style="text-decoration:underline;">Permitted Transfer</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221; and each assignee or subtenant thereunder a &#8220; </font><font style="text-decoration:underline;">Permitted Transferee</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;), which Permitted Transfer shall </font><font style="text-decoration:underline;">not</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> be deemed to be an assignment or subletting within the meaning of this Section 7.1 nor require Landlord&#8217;s consent or approval or be subject to payment of any excess rent pursuant to the immediately preceding paragraph provided that in any of such events (1) Landlord receives prior written notice of any such transactions (unless such advanced notice is prohibited under applicable laws or by confidentiality), and (2) in no event shall Tenant be released from its obligations under this Lease. If requested by Landlord in connection with an assignment of the Lease, the Permitted Transferee shall sign and deliver to Landlord a commercially reasonable form of assumption agreement. It is further understood that (a)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shares of ownership or similar interests in Tenant or an entity with which it may merge or consolidate may be periodically offered for sale on public or private basis, and (b) shares of stock or other equity interests of Tenant may be transferred through the &#8220;over the counter&#8221; market or through any recognized stock exchange or in connection with a public offering of shares or other equity interests of Tenant, and no prohibitions or conditions on assignment or subletting under this Article VII shall apply to any such activities.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything contained in this Lease to the contrary, Tenant may, without Landlord&#8217;s consent and without being obligated to remit any profit or overage to Landlord, permit third parties (individually, a &#8220; <font style="text-decoration:underline;">Space Sharer</font> &#8221;) to use and occupy portions of the Premises in common with Tenant not to exceed twenty (20%) of the total area of the Premises, provided that (i) such arrangement will terminate automatically upon a default occurring and continuing beyond any applicable notice and grace period under this Lease; (ii) any Space Sharer shall use the Premises in conformity with all applicable provisions of this Lease, including, without limitation, Article 2 hereof; (iii) in no event shall the use of any portion of the Premises by a Space Sharer create or be deemed to create any right, title or interest in or to the Premises for such Space Sharer; and (iv) the portion of the Premises occupied by any Space Sharer and the portion of the Premises occupied by Tenant shall not be, and shall not be required by law to be, separated by legal demising walls within the Premises or so as to create separate entrances from the elevator landing or public corridors. Any such use of all or any portion of the Premises by such Space Sharer shall not constitute or be deemed a sublease and shall not relieve Tenant of any of its obligations or liabilities under this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> ACCEPTANCE OF RENT FROM TRANSFEREE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The acceptance by Landlord of the payment of Rent, additional rent, or other charges following assignment, subletting, or other transfer prohibited by this Article VII shall not be deemed to be a consent by Landlord to any such assignment, subletting, or other transfer, nor shall the same constitute a waiver of any right or remedy of Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SUBLEASE RENTALS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following terms and conditions shall apply to any subletting by Tenant of all or any part of the Premises and shall be deemed included in all subleases under this Lease whether or not expressly incorporated therein:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant hereby absolutely and unconditionally assigns and transfers to Landlord all of Tenant&#8217;s interest in all rentals and income arising from any sublease entered into by Tenant, and Landlord may collect such rent and income and apply same toward Tenant&#8217;s obligations under this Lease; provided, however, that until a default occurs in the performance of Tenant&#8217;s obligations under this Lease beyond applicable notice and cure periods, Tenant may receive, collect and enjoy the rents accruing under such sublease. Landlord shall not, by reason of this or any other assignment of such rents to Landlord nor by reason of the collection of the rents from a subtenant, be deemed to have assumed or recognized any sublease or to be liable to the subtenant for any failure of Tenant to perform and comply with any of Tenant&#8217;s obligations to such subtenant under such sublease, including, but not limited to, Tenant&#8217;s obligation to return any security deposit. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a written notice from Landlord stating that a monetary default exists in the performance of Tenant&#8217;s obligations under this Lease beyond any applicable notice and cure period, to pay to Landlord the rents due as they become due under the sublease. In the event Landlord terminates this Lease by reason of a default of Tenant, Landlord at its option and without any obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of Tenant under such sublease from the time of the exercise of said option to the termination of such sublease; provided, however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to Tenant or for any other prior defaults of Tenant under such sublease.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.4 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> RIGHT OF RECAPTURE.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except in connection with Permitted Transfers or Space Sharers, with respect to any assignment of this Lease or a sublease of the entire Premises for the entire remaining Term of this Lease requiring Landlord&#8217;s consent, in lieu of consenting to any proposed assignment or sublease, Landlord shall have the right, but not the obligation, to terminate this Lease and recapture the Premises upon thirty (30) days&#8217; notice to Tenant unless, within five (5) business days after Landlord&#8217;s notice to Tenant exercising its option to terminate this Lease, Tenant notifies Landlord in writing that Tenant is withdrawing its request for Landlord&#8217;s consent to such assignment or sublease, in which event such exercise by Landlord of such option to terminate shall be void and of no further force and effect.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VIII <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">REPAIRS AND MAINTENANCE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TENANT OBLIGATIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant covenants and agrees that Tenant will keep neat and clean and maintain in good order, condition and repair, the Premises and every part thereof (and any signs permitted hereunder) throughout the Lease Term, excepting only those repairs for which Landlord is responsible under the terms of this Lease (including without limitation, subject to the provisions of Section 11.6, Landlord shall reimburse Tenant for the costs of maintaining, repairing, or otherwise correcting any condition caused by an act, omission, neglect or default under this Lease of Landlord or any employee, agent, or contractor of Landlord or any other party for whose conduct Landlord is responsible), damage by fire or other casualty or as a consequence of the exercise of the power of eminent domain and reasonable wear and tear and Tenant shall surrender the Premises at the expiration or termination of the Lease Term in such condition. Reasonable wear and tear shall not include any damage or deterioration that would have been prevented by proper maintenance by Tenant or Tenant otherwise performing all of its obligations under this Lease. Tenant shall be responsible for the cost of repairs which may be made necessary by reason of damage to any areas in the Building, including the Premises, by Tenant, Tenant&#8217;s contractors or Tenant&#8217;s agents, employees, invitees, or anyone claiming by, through or under Tenant. If repairs are required to be made by Tenant pursuant to the terms hereof, Landlord may demand that Tenant make the same forthwith, and if Tenant fails, refuses or neglects to commence such repairs and complete the same with reasonable dispatch after such demand, Landlord may (but shall not be obligated to) make or cause such repairs to be made and shall not be responsible to Tenant for any loss or damage that may accrue to Tenant&#8217;s stock or business by reason thereof. If Landlord makes or causes such repairs to be made, Tenant agrees that Tenant will forthwith, on demand, pay to Landlord the reasonable out-of-pocket cost thereof, and if Tenant shall fail to so reimburse Landlord upon demand, Landlord shall have the remedies provided for the nonpayment of rent or other charges payable hereunder.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD OBLIGATIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as may be provided in Articles XII and XIII, Landlord agrees to keep in the same good order, condition, and repair as of the date of this Lease the structural components and the roof of the Building, the common utility and Building systems, the common hallways, entrances, restrooms, elevators, cafeteria and exercise room, the paved surface of the parking areas serving the Building and the sprinkler system and all other common facilities of the Property, except that, subject to the provisions of Section 11.6, Tenant shall reimburse Landlord, as additional rent hereunder, for the costs of maintaining, repairing, or otherwise correcting any condition caused by an act, omission, neglect or default under this Lease of Tenant or any employee, agent, or contractor of Tenant or any other party for whose conduct Tenant is responsible. Without limitation, Landlord shall not be responsible to make any improvements or repairs other than as expressly provided in this Section 8.2 and Landlord shall not be liable for any failure to make such repairs unless Tenant has given notice to Landlord of the need to make such repairs and Landlord has failed to commence to make such repairs within a reasonable time thereafter.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall uniformly enforce the rules and regulations set forth in Exhibit C attached hereto, but Landlord shall not be liable to Tenant for violation of the same by any other tenant or occupant of the Building, or persons having business with them.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IX </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></font><font style="text-decoration:underline;">SERVICES TO BE FURNISHED BY </font><font style="text-decoration:underline;">LANDLORD;</font><font style="text-decoration:underline;"> UTILITIES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD&#8217;S SERVICES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord agrees, at its expense, during the Lease Term: (i) to provide, during the hours of 8:00 A.M. to 6:00 P.M., Monday through Friday and 8:00 A.M. to 1:00 P.M., Saturday, legal holidays excepted, a list of which can be found in Exhibit D, heating and air-conditioning in the Premises during the normal heating and air conditioning seasons, substantially equivalent to that being furnished in comparably aged, similarly equipped office buildings in the suburban Greater Boston area; (ii) to furnish hot and cold water for ordinary toilet, drinking, sprinkler, pantry, lavatory, cleaning and drinking purposes. If Tenant requires water for any other purpose, including without limitation, in connection with the business conducted in the Premises, Tenant shall pay the landlord an appropriate charge stipulated by Landlord to reimburse Landlord for the cost of such extraordinary water and related sewer use charge (including a charge to reimburse Landlord for the cost of metering Tenant&#8217;s usage); (iii) to furnish non-exclusive passenger elevator service; (iv) to furnish, through Landlord&#8217;s employees or independent contractors, general cleaning services in accordance with the specifications attached hereto as Exhibit E; and (v) to furnish, through Landlord&#8217;s employees or independent contractors, additional Building operation services available from Landlord upon reasonable advance request of Tenant at rates from time to time established by Landlord to be paid by Tenant provided the same may be reasonably and conveniently provided by Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Landlord further agrees to cause the parking areas, driveways, and walkways on the Lot to be kept reasonably clear of accumulations of dirt, litter, rubbish, ice and snow, cause the landscaping on the Lot to be kept in a neat and attractive condition, keep the parking areas on the lot lighted as reasonably necessary and perform its obligations with respect to maintenance and repair set forth in Section 8.2 above. Upon the request of Tenant from time to time, Landlord shall use reasonable efforts to provide services at hours other than the times set forth above and Tenant shall reimburse Landlord as Additional Rent for the reasonable cost of such services (as determined and/or allocated by Landlord in its good faith) within thirty (30) days after invoice therefore (provided, however, these overtime services shall not apply to submetered electric for the Third Floor Space). Landlord shall have no obligation to provide utilities or equipment other than the utilities and equipment within the Premises as of the Term Commencement Date of this Lease. Tenant shall not, without first having obtained Landlord&#8217;s prior written consent (which consent Landlord shall not unreasonably withhold), install or use any additional air-conditioning or heating equipment in the Premises. In the event that Tenant should require additional utilities, appliances, machines or equipment, the installation, maintenance and costs thereof shall be Tenant&#8217;s sole obligation, provided that any such installation shall require the written consent of Landlord, which consent Landlord shall not unreasonably withhold.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CAUSES BEYOND CONTROL OF THE PARTIES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the maximum extent this Lease may be made effective according to law, the Landlord and Tenant shall in no event be liable for failure to perform any of their obligations under this Lease when prevented from doing so by virtue of a Force Majeure Event (as defined herein) or for any cause due to any act, neglect, or default of the other party or the parties&#8217; servants, contractors, agents, employees, licensees or any person claiming by, through or under Landlord or Tenant, and in no event shall either party ever be liable to the other for any indirect, special or consequential damages under the provisions of this Section 9.2 or any other provision of this Lease unless specifically allowed under the terms of this Lease; provided, however, in no event shall a Force Majeure Event excuse Tenant from paying Rent.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SEPARATELY METERED UTILITIES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall pay directly to the utility, as they become due, all bills for electricity (whether used for furnishing heat or for other purposes) that are furnished to the Premises and now separately metered or billed by the utility to the Premises. Electricity for the Premises shall be separately metered and such meter shall be placed in Tenant&#8217;s name and electric bills related thereto shall be paid directly to the electric company by Tenant. This electrical service for the Premises shall include all electric charges associated with Tenant&#8217;s lights, plugs, and the electrical service necessary to operate the heating component of the Variable Air Volume forced air system. Notwithstanding the foregoing, Landlord and Tenant confirm and agree that the Lower Level Space is presently not separately metered with respect to electricity </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">usage. If Tenant elects to cause the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lower Level</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Space to be separately metered for electricity usage, such meters may be included in Landlord&#8217;s Work. In the event that Tenant elects not to cause the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lower Level</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Space to be separately metered for electricity usage, Landlord shall have a right to invoice Tenant, and Tenant shall pay when Rent is due its equitable portion of electricity usage for the Lower Level Space as reasonably determined by Landlord. Landlord upon request of Tenant shall provide reasonable backup for such electricity usage charges invoiced to Tenant.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INTERRUPTION OF SERVICES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything to the contrary in this Lease, if all or a material portion of either floor of the Premises is rendered untenantable or services to such floor(s) of the Premises are interrupted such that Tenant cannot reasonably operate at such floor(s) of the Premises for a period of three (3) consecutive days or more by virtue of a condition resulting from a Force Majeure Event (as defined in this Lease) or for any other reason (other than as result of the acts, omissions or negligence of Tenant or its agents), Rent shall be abated with respect to such floor(s) of the Premises until such floor(s) of the Premises shall have been restored to the condition in which they were prior to such untenantability or interruption of services by Landlord.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE X<br /><font style="text-decoration:underline;">INDEMNITY</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INDEMNITY</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the maximum extent this agreement may be made effective according to law, Tenant shall indemnify, defend and save harmless Landlord (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents, contractors, and mortgagees), against and from claims, expenses, or liabilities (a) arising directly or indirectly from any default or breach by Tenant or Tenant&#8217;s contractors, licensees, agents, servants, successors, assigns or employees under any of the terms or covenants of this Lease (including without limitation any violation of Landlord&#8217;s Rules and Regulations, as set forth in Exhibit C, and any failure to maintain or repair equipment or installations to be maintained or repaired by Tenant hereunder) or the failure of Tenant or such persons to comply with any rule, order, regulation, or lawful direction now or hereafter in force of any public authority, in each case to the extent the same are related, directly or indirectly, to the Premises or the Building, or Tenant&#8217;s use thereof; or (b) arising directly or indirectly from any accident, injury, or damage,&#160; to any person or property, on or about the Premises (except to the extent caused by Landlord or its employees, agents, contractors, including, without limitation, any such claims related to or arising out of Landlord&#8217;s Work), for the Tenant&#8217;s negligent acts or omissions occurring either prior to (which would be from the date Tenant is permitted early access pursuant to Section 3.4) or subsequent to the Term Commencement Date; or (c) arising directly or indirectly from any accident, injury, or damage to any person or property occurring outside the Premises but within the Building or on the Lot, where such accident, injury, or damage results, or is claimed to have resulted, from any negligence or willful misconduct on the part of Tenant, or Tenant&#8217;s contractors, licensees, agents, servants, employees, or customers, or anyone claiming by or through Tenant; provided, that the foregoing indemnity shall not apply to the extent such claim results from the negligence or willful misconduct of Landlord, its agents, servants and employees.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This indemnity shall include, without limitation, indemnity against all expenses, reasonable attorney&#8217;s fees and liabilities incurred in connection with any such claim or proceeding brought thereon and the defense thereof with counsel acceptable to Landlord, and counsel for Tenant&#8217;s insurer is acceptable to Landlord. At the request of Landlord, Tenant shall defend any such claim or proceeding directly on behalf and for the benefit of Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the maximum extent this agreement may be made effective according to law, Landlord shall indemnify, defend and save harmless Tenant (together with its officers, directors, stockholders, partners, beneficial owners, trustees, managers, members, employees, agents and contractors), against and from claims, expenses, or liabilities (a) arising directly or indirectly from any default or breach by Landlord or Landlord&#8217;s contractors, licensees, agents, servants, successors, assigns or employees under any of the terms or covenants of this Lease or the failure of Landlord or such persons to comply with any rule, order, regulation, or lawful direction now or hereafter in force of any public authority; or (b) arising directly or indirectly from any accident, injury, or damage to any person or property within the Building or on the Lot, where such accident, injury, or damage results, or is claimed to have resulted, from any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">negligence or willful misconduct on the part of Landlord, or Landlord&#8217;s contractors, licensees, agents, servants, employees, or customers; provided, that the foregoing indemnity shall not apply to the extent such claim results from the negligence or willful misconduct of Tenant, its agents, servants and employees.. This indemnity and hold harmless agreement shall include, without limitation, indemnity against all expenses, reasonable attorney&#8217;s fees and liabilities incurred in connection with any such claim or proceeding brought thereon and the defense thereof with counsel acceptable to Tenant, and counsel for Landlord&#8217;s insurer is acceptable to Tenant. At the request of Tenant, Landlord shall defend any such claim or proceeding directly on behalf and for the benefit of Tenant.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TENANT&#8217;S RISK</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the maximum extent this agreement may be made effective according to law, Tenant agrees its use and occupancy of the Premises (and Building) shall be at Tenant&#8217;s sole risk; and Landlord shall have no responsibility or liability for any loss of or damage to furniture, fixtures, equipment or other personal property of Tenant for any reason whatsoever; and Landlord shall not be responsible or liable for any loss or damage resulting to Tenant or those claiming by, through or under Tenant, or its or their property, from the breaking, bursting, stopping or leaking of electric cables and wires, water, gas, sewer or steam pipes, sprinklers, and from roof leaks and the like, except in connection with damage or injury resulting from the negligence or willful misconduct of Landlord or its authorized agents. The provisions of this Section 10.2 shall be applicable from and after the execution of this Lease, and until the end of the Lease Term, and during such further period as Tenant may use or be in occupancy of any part of the Premises or of the Building.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> INJURY CAUSED BY THIRD PARTIES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees that Landlord shall not be responsible or liable to Tenant, or to those claiming by, through, or under Tenant, for any loss or damage resulting to Tenant or those claiming by, through, or under Tenant, or its or their property, that may be occasioned by or through the acts or omissions of persons occupying any part of the Building, or for any loss or damage from the breaking, bursting, crossing, stopping, or leaking of electric cables and wires, and water, gas, sewer, or steam pipes, or like matters, except in connection with damage or injury resulting from the negligence or willful misconduct of Landlord or its authorized agents.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SECURITY</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall continue to provide the card key access system to the Building and other security procedures currently in place as of the date of this Lease, and Landlord agrees that the Premises will be accessible 24 hours a day 7 days per week, subject to applicable Laws and Requirements and Landlord&#8217;s reasonable security procedures. Notwithstanding the foregoing, Tenant assumes all responsibility for the protection of Tenant, its agents, employees, contractors and invitees and the property of Tenant and of Tenant&#8217;s agents, employees, contractors and invitees from acts of third parties. Nothing herein contained shall prevent Landlord, at Landlord&#8217;s sole option, from implementing security measures for the Building or any part thereof comparable to other security measures at other first class properties in the area in which the Building is located, in which event Tenant shall participate in such security measures and the reasonable cost thereof shall be included within the definition of Operating Costs. Landlord shall have the right, but not the obligation, to require all persons entering or leaving the Building to identify themselves to a security guard and to reasonably establish that such person should be permitted access to the Building.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XI<br /><font style="text-decoration:underline;">INSURANCE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PUBLIC LIABILITY INSURANCE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall obtain and keep in force and effect from the date upon which Tenant first enters the Premises for any reason, throughout the Lease Term, and thereafter so long as Tenant is in occupancy of any part of the Premises, at its own cost and expense commercial general liability and property damage insurance, on an occurrence basis, such insurance to afford protection in an amount of not less than $1,000,000 per occurrence/ $2,000,000 in the aggregate for injury, death, property damage or other insured loss arising out of any one occurrence, protecting Tenant as insured, </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and naming Landlord, Landlord&#8217;s mortgagees, property managers and managing agents as additional insureds, against claims for bodily injury, personal injury, death, property damage or other general liability insured loss occurring in, upon, adjacent to or connected with the Premises or any part thereof. Each such policy shall be reasonably satisfactory to Landlord. Business Auto Liability insurance shall not be required so long as Tenant does not own or lease any company vehicles. In addition, commencing as of the Term Commencement Date, and thereafter throughout the Term, Tenant shall, at Tenant's sole cost and expense, provide and maintain or cause to be provided and maintained workers' compensation insurance (meeting the requirements of the state workers' compensation laws) and employer liability insurance covering all of Tenant's employees at the Premises. Tenant shall also use good faith efforts to ensure all contractors, sub-contractors, vendors, leased employees, and temporary employees are properly insured for workers' compensation.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> HAZARD INSURANCE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees to maintain in full force from the date upon which Tenant first enters the Premises for any reason, throughout the Lease Term, and thereafter so long as Tenant is in occupancy of any part of the Premises insuring any leasehold improvements paid for by Tenant and all fixtures, equipment, and other personal property of Tenant against damage or destruction by fire or other casualty in an amount equal to the full replacement cost of such property. Any such coverages may be effected directly and/or through the use of blanket or umbrella insurance coverage covering more than one location. Tenant agrees to maintain in full force from the date upon which Tenant first enters the Premises for any reason, throughout the Lease Term, and thereafter so long as Tenant is in occupancy of any part of the Premises, workers&#8217; compensation and employers&#8217; liability insurance with a limit of liability as required by law to be maintained.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CONSTRUCTION PERIOD INSURANCE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At any time when non-cosmetic Alterations, demolition or construction work is being performed on or about the Premises or Building by or on behalf of Tenant, including at all times when Tenant&#8217;s Initial Work is being undertaken, Tenant shall keep, and require its contractors to keep, in full force and effect the following insurance coverage in each instance with policies reasonably acceptable to Landlord:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Builder&#8217;s risk and property insurance on Tenant&#8217;s improvements and betterments and personal property during the course of construction or alteration. Tenant may provide Builder&#8217;s Risk coverage in lieu of Tenant&#8217;s contractor; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> workers&#8217; compensation or similar insurance in form and amounts required by law.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall cause a certificate or certificates of such insurance to be delivered to Landlord prior to the commencement of any work in or about the Building or the Premises, in default of which Landlord shall have the right, but not the obligation, to obtain any or all such insurance at the expense of Tenant, in addition to any other right or remedy of Landlord. The provisions of this Section 11.3 shall survive the expiration or earlier termination of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> EVIDENCE OF INSURANCE; INSURANCE STANDARDS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant&#8217;s insurers shall endeavor to provide Landlord with thirty (30) days prior notice of a cancellation of the policy. Prior to Tenant&#8217;s entry onto the Premises, appropriate certificates of such policies shall be deposited with the Landlord. Certificates of Insurance shall state that insurers shall endeavor to provide at least thirty (30) days notice of cancellation. Certificates of renewal policies shall be provided to Landlord upon expiration of prior policies. Any renewals, replacements and endorsements shall also be deposited with Landlord, in the case of renewals, same shall be so deposited within 10 days of the expiration of the prior policy. The insurance required hereunder shall be written in form and substance reasonably satisfactory to Landlord by a good and solvent insurance company of recognized standing, admitted to do business in Massachusetts, with a general policyholder&#8217;s rating of not less than A- and financial rating of not less than Class VII (as rated in the most current Best&#8217;s Insurance Reports), which company shall be reasonably satisfactory to Landlord. Tenant shall procure, maintain and place such insurance and pay all premiums and charges therefore, and upon failure of Tenant to maintain such insurance (and without limiting any other remedies </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on account thereof), Landlord may, but shall not be obligated to, procure, maintain and place such insurance or make such payments, and in such event, Tenant agrees to pay the amount thereof to Landlord on demand, as additional rent hereunder.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.5 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RENTAL ABATEMENT INSURANCE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord may elect to keep and maintain in full force and effect during the Lease Term, market rate rental abatement insurance against abatement or loss of Rent in case of fire or other casualty, in an amount at least equal to the amount of the Rent payable by Tenant during the then current lease year as reasonably determined by Landlord. All premiums for such insurance shall be included in Operating Costs for the purposes of this Lease; provided, however, to the extent market rate rental abatement insurance is not included in the Operating Costs for the Base Operating Year, for purposes of calculating Tenant&#8217;s Proportionate Share of the Operating Costs Excess for any particular Lease Year, the cost attributable to the market rate rental abatement insurance shall be included in the Operating Costs for the Base Operating Year on a hypothetical basis in calculating the Tenant&#8217;s Proportionate Share of the Operating Costs Excess for such Lease Year.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.6 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> MUTUAL WAIVER OF SUBROGATION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The parties hereto shall each procure an appropriate clause in, or endorsement on, any property insurance policy maintained or required to be maintained by the parties hereunder on the Property, Premises or any personal property, fixtures or equipment located thereon or therein, pursuant to which the insurer waives subrogation or consents to a waiver of right of recovery in favor of either party, its respective agents or employees. Having obtained such clauses and/or endorsements, each party hereby agrees that it will not make any claim against or seek to recover from the other or its agents or employees for any loss or damage to its property or the property of others resulting from fire or other perils covered by such property insurance regardless of the cause or origin of such loss or damage, including, but not limited to, the negligence of such other party or its agents or employees.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.7 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD&#8217;S INSURANCE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall maintain and keep in effect throughout the Lease Term (a) insurance against loss or damage to the Building by fire or other casualty as may be included within either fire and extended coverage insurance or &#8220;special form &#8220; insurance in commercially reasonable amounts at least equal to the full replacement cost thereof, (b) commercial general liability insurance in amounts reasonably determined by Landlord to equal amounts carried by prudent owners of properties in the area in which the Property is located, and (c) such other insurance coverages and policies as Landlord determines. Any such coverages may be effected directly and/or through the use of blanket insurance coverage covering more than one location and may contain such commercially reasonable deductibles as Landlord may elect in its discretion. The cost of all such insurance shall be included as part of Operating Costs.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XII <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">CASUALTY</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> DEFINITION OF &#8220;SUBSTANTIAL DAMAGE&#8221; AND &#8220;PARTIAL DAMAGE&#8221;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220; <font style="text-decoration:underline;">substantial damage</font> ,&#8221; as used herein, shall refer to damage which is of such a character that in Landlord&#8217;s reasonable, good faith estimate the same cannot, in ordinary course, be expected to be repaired within ninety (90) calendar days from the time that such repair work would commence. Any damage which is not &#8220;substantial damage&#8221; is &#8220; <font style="text-decoration:underline;">partial damage</font> .&#8221; Within thirty (30) days after the occurrence of any damage, Landlord shall notify Tenant (&#8220; <font style="text-decoration:underline;">Landlord&#8217;s Casualty Notice</font> &#8221;) of the reasonable determination of landlord&#8217;s architect whether such damage is &#8220;substantial&#8221; or &#8220;partial.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PARTIAL DAMAGE TO THE BUILDING</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If during the Lease Term there shall be partial damage to the Building by fire or other casualty and if such damage shall materially interfere with Tenant&#8217;s use of the Premises as contemplated by this Lease, Landlord shall promptly proceed to restore the Building to substantially the condition in which it was immediately prior to the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">occurrence of such damage, provided however, that in no event shall Landlord be obligated to expend more than the insurance proceeds actually received by Landlord, plus any deductible carried by Landlord.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SUBSTANTIAL DAMAGE TO THE BUILDING</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If during the Lease Term there shall be substantial damage to the Building by fire or other casualty and if such damage shall materially interfere with Tenant's use of the Premises as contemplated by this Lease, Landlord shall promptly restore the Building to the extent reasonably necessary to enable Tenant's use of the Premises, unless Landlord, within ninety (90) days after the occurrence of such damage, shall give notice to Tenant of Landlord's election to terminate this Lease, provided however, that in no event shall Landlord be obligated to expend more than the insurance proceeds actually received by Landlord, plus any deductible carried by Landlord, and provided that Landlord may not terminate this Lease unless Landlord similarly terminates the leases of other tenants in the Building aggregating at least 80% of the portion of the Building immediately prior to such damage. The Landlord shall have the right to make such election in the event of substantial damage to the Building whether or not such damage materially interferes with Tenant's use of the Premises. If Landlord shall give such notice, then this Lease shall terminate as of the date of such notice with the same force and effect as if such date were the date originally established as the expiration date hereof. If Landlord has not restored the Premises to the extent required under this Section 12.3 within nine (9) months after the date of such damage or destruction, such nine-month period to be extended to the extent of any delays of the completion of such restoration due to matters beyond Landlord's reasonable control, or if the Premises shall be substantially damaged during the last twelve (12) months of the Lease Term then, Tenant may elect to terminate this Lease by giving written notice of such election to Landlord within thirty (30) days after the end of such nine-month period and before the substantial completion of such restoration or, if during the last twelve (12) months, at the time of such casualty, as the case may be. If Tenant so elects to terminate this Lease, then this Lease and the term hereof shall cease and come to an end on the date that is thirty (30) days after the date that Landlord receives Tenant's termination notice, unless on or before such date Landlord has substantially completed such restoration.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> ABATEMENT OF RENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If during the Lease Term the Building shall be damaged by fire or casualty and if such damage shall materially interfere with Tenant&#8217;s use of the Premises as contemplated by this Lease, a just proportion of the Rent payable by Tenant hereunder shall abate proportionately for the period in which, by reason of such damage, there is such interference with Tenant&#8217;s use of the Premises, having regard to the extent to which Tenant may be required to discontinue Tenant&#8217;s use of the Premises, but such abatement or reduction shall end twenty (20) days of when Landlord shall have substantially restored the Premises or so much thereof as shall have been originally constructed by Landlord (exclusive of any of Tenant&#8217;s fixtures, furnishings, equipment and the like or work performed therein by Tenant) to substantially the condition in which the Premises were prior to such damage.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> MISCELLANEOUS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In no event shall Landlord have any obligation to make any repairs or perform any restoration work under this Article XII if prevented from doing so by reason of any cause beyond its reasonable control, including, without limitation, the requirements of any applicable laws, codes, ordinances, rules, or regulations, the refusal of the holder of a mortgage or ground lease affecting the Premises to make available to Landlord the net insurance proceeds attributable to such restoration, or the inadequacy of such proceeds to fund the full cost of such repairs or restoration, but reasonably promptly after Landlord ascertains the existence of any such cause, it shall either terminate this Lease or waive such condition to its restoration obligations and proceed to restore the Premises as otherwise provided herein. Further, Landlord shall not be obligated in any event to make any repairs or perform any restoration work to any alterations, additions, or improvements to the Premises performed by or for the benefit of Tenant (all of which Tenant shall repair and restore) or to any fixtures in or portions of the Premises or the Building which were constructed or installed by or for some party other than Landlord or which are not the property of Landlord.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XIII </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></font><font style="text-decoration:underline;">EMINENT DOMAIN</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RIGHTS OF TERMINATION FOR TAKING</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Premises, or such portion thereof as to render the balance (if reconstructed to the maximum extent practicable in the circumstances) physically unsuitable for Tenant&#8217;s purposes, shall be taken (including a temporary taking in excess of 180 days) by condemnation or right of eminent domain or sold in lieu of condemnation, Landlord or Tenant may elect to terminate this Lease by giving notice to the other of such election not later than thirty (30) days after Tenant has been deprived of possession.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further, if so much of the Building (which may include the Premises) or the Lot shall be so taken, condemned or sold or shall receive any direct or consequential damage by reason of anything done pursuant to public or quasi-public authority such that continued operation of the same would be uneconomical, Landlord or Tenant may elect to terminate this Lease by giving notice to the other party of such election not later than thirty (30) days after the effective date of such taking.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Should any part of the Premises be so taken or condemned or receive such damage and should this Lease be not terminated in accordance with the foregoing provisions, Landlord shall promptly after the determination of Landlord&#8217;s award on account thereof, expend so much as may be necessary of the net amount which may be awarded to Landlord in such condemnation proceedings in restoring the Premises to an architectural unit that is reasonably suitable to the uses of Tenant permitted hereunder. Should the net amount so awarded to Landlord be insufficient to cover the cost of so restoring the Premises, in the reasonable estimate of Landlord, Landlord may, but shall have no obligation to, supply the amount of such insufficiency and restore the Premises to such an architectural unit, with all reasonable diligence, or Landlord may terminate this Lease by giving notice to Tenant within a reasonable time after Landlord has determined the estimated cost of such restoration; provided that Landlord may not terminate this Lease unless Landlord similarly terminates the leases of other tenants in the Building aggregating at least 80% of the portion of the Building immediately prior to such taking or condemnation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Landlord has not restored the Premises to the extent required under this Section 13.1 within nine (9) months after the date of such taking, such nine-month period to be extended to the extent of any delays of the completion of such restoration due to matters beyond Landlord's reasonable control, or if the Premises or any portion thereof shall be taken during the last twelve (12) months of the Lease Term then, in either such case, Tenant may elect to terminate this Lease by giving written notice of such election to Landlord within thirty (30) days after the end of such nine-month period or, if during the last twelve (12) months, at the time of the taking and before the substantial completion of such restoration, as the case may be. If Tenant so elects to terminate this Lease, then this Lease and the term hereof shall cease and come to an end as if such expiration date were the original expiration date of this Lease on the date that is thirty (30) days after the date that Landlord receives Tenant's termination notice, unless on or before such date Landlord has substantially completed such restoration.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord warrants and represents that it is unaware of any currently pending or potential governmental takings or planned takings of any of the Premises.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PAYMENT OF AWARD</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Landlord shall have and hereby reserves and accepts, and Tenant hereby grants and assigns to Landlord, all rights to recover for damages to the Building and the Lot and the leasehold interest hereby created, and to compensation accrued or hereafter to accrue by reason of such taking or damage, as aforesaid. Tenant covenants to deliver such further assignments and assurances thereof as Landlord may from time to time request. Nothing contained herein shall be construed to prevent Tenant from prosecuting in any condemnation proceedings a claim for the value of any of Tenant&#8217;s trade fixtures installed in the Premises by Tenant at Tenant&#8217;s expense, for relocation expenses, Tenant&#8217;s Alterations, and for Tenant&#8217;s leasehold interest hereby created, provided that such action shall not affect the amount of compensation otherwise recoverable hereunder by Landlord from the taking authority.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.3 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ABATEMENT OF RENT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of any such taking of the Premises, the Rent or a fair and just proportion thereof, according to the nature and extent of the damage sustained, shall be suspended or abated, as appropriate and equitable in the circumstances, and based on the useable to non-useable square footage of the Premises.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> MISCELLANEOUS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="FIS_UNIDENTIFIED_TABLE_32"></a>In no event shall Landlord have any obligation to make any repairs under this Article XIII if prevented from doing so by reason of any cause beyond its reasonable control, including, without limitation, requirements of any applicable laws, codes, ordinances, rules, or regulations or requirements of any mortgagee. Further, Landlord shall not be obligated to make any repairs to any portions of the Premises or the Building which were constructed or installed by some party other than Landlord<a name="FIS_UNIDENTIFIED_TABLE_32"></a> or which are not the property of Landlord, and Tenant shall be obligated to perform any repairs on and restorations to any of Tenant&#8217;s alterations, additions, or improvements to the Premises performed by or for the benefit of Tenant.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XIV <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> <font style="text-decoration:underline;"><br />DEFAULT</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TENANT&#8217;S DEFAULT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If at any time any one or more of the following events (herein referred to as a &#8220; <font style="text-decoration:underline;">Default of Tenant</font> &#8221;) shall occur:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant shall fail to make payment of Rent or any other monetary amount due under this Lease, including the Tenant&#8217;s Share of the Landlord&#8217;s Work Costs, within five (5) business days after Landlord has sent to Tenant written notice of such default;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant shall fail to perform or observe any other covenant or provision herein contained on Tenant&#8217;s part to be performed or observed and Tenant shall fail to remedy the same within thirty (30) days after notice to Tenant specifying such neglect or failure, or, if such failure is of such a nature that Tenant cannot reasonably remedy the same within such thirty (30) day period, Tenant shall fail to commence promptly to remedy the same and to prosecute such remedy to completion with diligence and continuity, except to the extent that Tenant is delayed by cause of Force Majeure as defined in Article 14.2 of this Lease (and this Lease and the obligations of Landlord hereunder shall not be affected or impaired because Tenant is unable to fulfill any of its obligations hereunder or is delayed in doing so, if such inability or delay is caused by reason of a Force Majeure Event, and the time for Tenant&#8217;s performance shall be extended for the period of any such delay);</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> except as otherwise provided by applicable law, if the estate hereby created shall be taken on execution or by other process of law, or if Tenant shall be judicially declared bankrupt or insolvent according to law, or if any assignment shall be made of the property of Tenant for the benefit of creditors, or if a receiver, guardian, conservator, trustee in involuntary bankruptcy or other similar officer shall be appointed to take charge of all or any substantial part of Tenant&#8217;s property by a court of competent jurisdiction, or if a petition shall be filed for the reorganization of Tenant under any provisions of law now or hereafter enacted, and such proceeding is not dismissed within sixty (60) days after it is begun, or if Tenant shall file a petition for such reorganization, or for arrangements under any provisions of such laws providing a plan for a debtor to settle, satisfy, or extend the time for the payment of debts;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">then, in any such case, Landlord may, in addition to any remedies otherwise available to Landlord, immediately or at any time thereafter, in accordance with all applicable Laws, repossess the same as of Landlord&#8217;s former estate, and expel Tenant and those claiming by, through or under it and remove its or their effects without being deemed guilty of any manner of trespass, and without prejudice to any remedies which might otherwise be used for arrears of rent or preceding breach of covenant and/or Landlord may terminate this Lease by notice to Tenant and this Lease shall come to an end on the 5th day after such notice as fully and completely as if such 5th day were on the date herein originally fixed for the expiration of the term of this Lease (Tenant hereby waiving any rights of redemption, if any, under M.G.L. c.186, &#167;11 to extent that such rights may be lawfully waived), and Tenant will then quit and surrender the Premises to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord, but Tenant shall remain liable as herein provided. To the extent permitted by law, Tenant hereby expressly waives </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any and all</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> rights of redemption granted by or under any present or future laws in the event of Tenant being evicted or dispossessed, or in the event of Landlord obtaining possession of the Premises, by reason of the violation by Tenant of any of the covenants and conditions of this Lease. In the event of any such termination, entry or re-entry, Landlord shall have the right to the extent permitted under applicable law to remove and store Tenant&#8217;s property and that of persons claiming by, through or under Tenant at the sole risk and expense of Tenant and, if the Tenant does not make arrangements to collect such property within thirty (30) days of termination, entry or re-entry and if Landlord so elects, (x) to sell such property at public auction or private sale and apply the net proceeds to the payment of all sums due to Landlord from Tenant and pay the balance, if any, to Tenant, or (y) to dispose of such property in any manner in which Landlord shall elect, Tenant hereby agreeing to the fullest extent permitted by law that it shall have no right, title or interest in any property remaining in the Premises thirty (30) days after such termination, entry or re-entry.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant covenants and agrees, notwithstanding any termination of this Lease as aforesaid or any entry or re&#8209;entry by Landlord, whether by summary proceedings, termination, or otherwise, to pay and be liable for on the days originally fixed herein for the payment thereof, amounts equal to the several installments of Rent and other charges reserved as they would become due under the terms of this Lease if this Lease had not been terminated or if Landlord had not entered or re&#8209;entered, as aforesaid, and whether the Premises be re-let or remain vacant, in whole or in part, or for a period less than the remainder of the Term, or for the whole thereof; but in the event the Premises be re-let by Landlord, Tenant shall be entitled to a credit in the net amount of rent received by Landlord in re-letting, after deduction of all expenses incurred in re-letting the Premises (including, without limitation, reasonable preparation of the space for reletting; brokerage fees, attorneys&#8217; fees and the like), and in collecting the rent in connection therewith. As an alternative, at the election of Landlord, Tenant will upon such termination pay to Landlord, as damages, such a sum as at the time of such termination represents the amount of the excess, if any, discounted to present value, of the then fair market value of the total Rent and other benefits which would have accrued to Landlord under this Lease for the remainder of the Lease Term if the lease terms had been fully complied with by Tenant over and above the then cash rental value (in advance) of the Premises for what would be the then unexpired Lease Term if the same remained in effect. For the purposes of this Section, the " <font style="text-decoration:underline;">remainder of the Lease Term</font> " shall not include the Extension Term available to Tenant under Section 3.2 of this Lease except to the extent that the extension option for such Extension Term has already been exercised by Tenant in accordance with the provisions of Section 3.2. For purposes of this Article, if Landlord elects to require Tenant to pay damages in accordance with immediately preceding sentence, the total amount due shall be computed by assuming that Tenant&#8217;s Proportionate Share of Taxes and Tenant&#8217;s Proportionate Share of Operating Costs would be, for the balance of such unexpired term, the amount thereof respectively for the tax and lease years in which such termination, entry or re-entry shall occur.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> In case of any Default of Tenant, re-entry, entry, expiration and dispossession by summary proceedings or otherwise, Landlord may (i) re-let the Premises or any part or parts thereof, either in the name of Landlord or otherwise, for a term or terms which may at Landlord&#8217;s option be equal to or less than or exceed the period which would otherwise have constituted the balance of the Lease Term and may grant reasonable concessions or free rent to the extent that Landlord considers advisable or necessary to re-let the Premises and (ii) make such alterations, repairs and decorations in the Premises as Landlord, in its sole judgment, considers advisable or necessary for the purpose of re-letting the Premises; and no action by Landlord in accordance with the foregoing shall operate or be construed to release Tenant from liability hereunder as aforesaid. It is specifically understood and agreed that Landlord shall be entitled to take into account in connection with any re-letting of the Premises all relevant factors which would be taken into account by a sophisticated developer in securing a replacement tenant for the Premises, such as, but not limited to, the first class quality of the Building and the financial responsibility of any such replacement tenant. Landlord shall in no event be liable in any way whatsoever for failure to re-let the Premises, or, in the event that the Premises are re-let, for failure to collect the rent under such re-letting, and Tenant hereby waives, to the extent permitted by applicable law, any obligation Landlord may have to mitigate Tenant&#8217;s damages. The Landlord agrees to list the Premises with a broker in the event of a termination, entry or re-entry under this ARTICLE XIV, provided that Landlord&#8217;s obligation to list the Premises as provided herein is independent of Tenant&#8217;s obligations under this ARTICLE XIV and shall not be construed to entitle Tenant to set-off against any amounts payable by Tenant hereunder in the event of a breach or alleged breach by Landlord of such obligation. In no event shall Landlord be obligated to give priority to the re-letting of the Premises over any other Premises in the Building or any other building owned by Landlord. Notwithstanding anything to the contrary herein, Landlord agrees that it shall use reasonable efforts to mitigate its damages as a result of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant&#8217;s default. It is agreed and understood that Landlord&#8217;s obligation to mitigate damages shall be deemed satisfied by its providing adequate information to a commercial broker as to the availability of such space (based on a customary brokerage fee being earned by such broker), having the Premises available for inspection by prospective tenants during reasonable business hours, and by acceptance of a commercially reasonable offer for the Premises (or reasonable portion thereof) from a creditworthy person or entity based on a form of lease agreement which is substantially the same as the form utilized for other space tenants in the Building, without material change therefrom (and Landlord shall be under no obligation to accept any offer other than a commercially reasonable offer from a creditworthy person or entity at then going rental rates for the Building).</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If there is at any time an assignee of this Lease or any interest of Tenant herein, the happening of any of the events described in paragraph (a)(iii) of this Section with respect to such assignee shall constitute a Default of Tenant hereunder.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> The specified remedies to which Landlord may resort hereunder are not intended to be exclusive of any remedies or means of redress to which Landlord may, at any time, be entitled lawfully and Landlord may invoke any remedy (including the remedy of specific performance) allowed at law or in equity as if specific remedies were not herein provided for.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Subject to Section 17.16 hereunder which provisions shall control as to the allocation of such liabilities as between Landlord and Tenant, all costs and expenses incurred by or on behalf of Landlord (including, without limitation, reasonable attorneys&#8217; fees and expenses) in enforcing its rights hereunder or occasioned by any Default of Tenant shall be paid by Tenant provided Landlord is the prevailing party or a settlement is made in favor of Landlord in connection therewith.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(g) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Upon any Default of Tenant or the expiration or termination of this Lease, Landlord shall have the right of summary process under Massachusetts General Laws Chapter 239, or other applicable statutes, and such other rights to recover possession as permitted by law.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nothing contained in this Lease shall limit or prejudice the right of Landlord to prove for and obtain in proceedings for bankruptcy, insolvency, or like proceedings by reason of the termination of this Lease, an amount equal to the maximum allowed by any statute or rule of law in effect at the time when, and governing the proceedings in which, the damages are to be proved, whether or not the amount be greater than, equal to, or less than the amount of the loss or damages referred to above.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All references contained in this Lease to the terms &#8220; <font style="text-decoration:underline;">Default</font> &#8221;, &#8220; <font style="text-decoration:underline;">default</font> ,&#8221; &#8220; <font style="text-decoration:underline;">breach</font> ,&#8221; &#8220; <font style="text-decoration:underline;">event of default</font> &#8221; or words of similar import shall be construed to mean default beyond any applicable notice and grace period. All references to the terms &#8220; <font style="text-decoration:underline;">expenditures</font> &#8221;, &#8220; <font style="text-decoration:underline;">fees</font> &#8221;, &#8220; <font style="text-decoration:underline;">expenses</font> &#8221; and words of similar import contained in the lease shall be construed to mean reasonable third party expenditures, fees and expenses actually incurred.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD&#8217;S DEFAULT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall in no event be in default in the performance of any of Landlord&#8217;s obligations hereunder unless and until Landlord shall have failed to perform such obligations within 30 days, or such additional time as is reasonably required to correct any such default after notice by Tenant to Landlord properly specifying wherein Landlord has failed to perform any such obligation, provided that Landlord commences such cure within thirty (30) days of such notice, except in the event of an emergency situation, whereby Landlord should proceed to cure immediately upon Tenant&#8217;s notice thereof. It is the express understanding and agreement of the parties and a condition of Landlord&#8217;s agreement to execute this Lease that in no event shall Tenant have the right to terminate this Lease or seek an abatement to or offset from Base Rent or other Rent as a result of Landlord&#8217;s default, but Tenant shall be entitled to seek all other remedies, at law or equity, as a result of such default. Tenant hereby waives its right to recover punitive or consequential damages arising out of any act, omission or default by Landlord. This Lease and the obligations of Tenant hereunder shall not be affected or impaired because Landlord is unable to fulfill any of its obligations hereunder or is delayed in doing so, if such inability or delay is caused by reason of a Force Majeure Event (as defined below), and the time for Landlord&#8217;s performance shall be extended for the period of any such delay. As used herein, a &#8220; <font style="text-decoration:underline;">Force Majeure Event</font> &#8221; shall be any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delay caused by or resulting from acts of God, war, civil commotion, fire, flood or other casualty, labor difficulties, shortages of or inability to obtain labor, materials or equipment, governmental regulations, unusually severe weather, or other causes beyond such party&#8217;s reasonable control (other than lack of funds).</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XV <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /><font style="text-decoration:underline;">THE LANDLORD&#8217;S ACCESS TO PREMISES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> THE LANDLORD&#8217;S RIGHT OF ACCESS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Landlord and its agents, contractors, and employees shall have the right to enter the Premises at all reasonable hours upon not less than twenty four (24) hours advance notice, except in exigent circumstances, or any time in case of emergency, while accompanied by a representative of Tenant (provided one is made reasonably available by Tenant), for the purpose of inspecting or of making repairs or alterations, to the Premises or the Building or additions to the Building, and Landlord shall also have the right to make access available at all reasonable hours upon not less than twenty four (24) hours&#8217; notice to prospective or existing mortgagees or purchasers of any part of the Building. To assure access by Landlord to the Premises, Tenant shall provide Landlord with duplicate copies of all keys used by Tenant in providing access to the Premises. Landlord will use commercially reasonable efforts to conduct any Landlord required repairs within the Premises without interference to the ability of Tenant to conduct its business at the Premises.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="FIS_UNIDENTIFIED_TABLE_33"></a>For a period commencing nine (9) months prior to the expiration of the Lease Term, Landlord may have reasonable access to the Premises at all reasonable hours upon not less than twenty four<a name="FIS_UNIDENTIFIED_TABLE_33"></a> (24) hours advance notice for the purpose of exhibiting the same to prospective tenants.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XVI <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><br /> <font style="text-decoration:underline;">RIGHTS OF MORTGAGEES</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SUBORDINATION AND ATTORNMENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If any holder of a mortgage or holder of a ground lease of property which includes the Premises, executed and recorded subsequent to the date of this Lease, shall so elect, the interest of Tenant hereunder shall be subordinate to the rights of such holder, provided that such holder shall, by a commercially reasonable non-disturbance agreement, agree to recognize in writing the rights of Tenant under this Lease upon the terms and conditions set forth herein, and the performance by Tenant of Tenant&#8217;s obligations hereunder; or</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> If any holder of a mortgage or holder of a ground lease of property which includes the Premises executed and recorded prior to the date of this Lease shall so elect, this Lease, and the rights of Tenant hereunder, shall be superior in right to the rights of such holder, with the same force and effect as if this Lease had been executed and delivered, and recorded, or a statutory notice hereof recorded, prior to the execution, delivery and recording of any such mortgage.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The election of any such holder as to Subsection (a) above shall be exercised by notice to Tenant, in the same fashion as notices under this Lease are given by Landlord to Tenant, and, if such notice is given, such subordination shall be effective as to all advances then or thereafter made by such holder under such mortgage or in connection with such ground lease. Any election as to Subsection (b) above shall become effective upon either notice from such holder to Tenant in the same fashion as notices from Landlord to Tenant are to be given hereunder or by the recording in the appropriate registry or recorder&#8217;s office of an instrument, in which such holder subordinates its rights under such mortgage or ground lease to this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Forthwith upon the request of Landlord, the holder of any mortgage or deed of trust affecting the Premises, or the lessor under any ground lease affecting the Premises, Tenant shall execute and deliver to such party an attornment agreement providing that Tenant shall attorn to such holder or lessor in the event of a foreclosure of such mortgage or deed of trust or transfer in lieu thereof or a termination of such ground lease and incorporating such other terms and conditions as such party may reasonably require, provided that such agreement includes a commercially reasonable non-disturbance agreement by such other party to recognize the rights of Tenant under this Lease. Subject to </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the such attornment agreement, Tenant shall, in the event any proceedings are brought for the foreclosure of, or in the event of exercise of the power of sale under, any mortgage or deed of trust made by Landlord, its successors or assigns,</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">encumbering the Premises, or any part thereof, or in the event of termination of any ground lease, if so requested, attorn to the purchaser or ground lessor upon such foreclosure, sale or termination or upon any grant of a deed in lieu of foreclosure and recognize such purchaser or ground lessor as Landlord under this Lease.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> Tenant agrees on request of Landlord to execute and deliver from time to time any instrument that Landlord may reasonably deem necessary to implement the provisions of this Section 16.1, provided that such instrument does not increase the obligations or decrease the rights of Tenant hereunder or decrease Landlord&#8217;s obligations hereunder or otherwise adversely affect the leasehold interest hereby created.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NOTICE TO MORTGAGEE AND GROUND LESSOR; OPPORTUNITY TO CURE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After receiving written notice from any person, firm, or other entity (or from Landlord on behalf of any such person, etc.) that it holds a mortgage which includes the Premises as part of the mortgaged premises, or that it is the ground lessor under a lease with Landlord as ground lessee, which includes the Premises as a part of the demised premises, Tenant will copy such mortgagor or ground lessor on any notice given to Landlord and the curing of any of Landlord&#8217;s defaults by such holder or ground lessor shall be treated as performance by Landlord. Accordingly, no act or failure to act on the part of Landlord which would entitle Tenant under the terms of this Lease, or by law, to be relieved of Tenant&#8217;s obligations hereunder shall have such an effect unless and until such holder or ground lessor, after receipt of a copy of such notice, has failed or refused to correct or cure the condition complained of within thirty (30) days after notice of such default by Landlord beyond the applicable notice and cure period, or if such default cannot be cured in that time, if within such thirty (30) days such holder or ground lessor has not commenced pursing the remedies necessary to cure such default and does not diligently pursue such remedies , but nothing contained in this Section 16 or elsewhere in this Lease shall be deemed to impose any obligation on any such holder or ground lessor to correct or cure any such condition</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> ASSIGNMENT OF RENTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With reference to any assignment by Landlord of Landlord&#8217;s interest in this Lease, or the rents payable hereunder, conditional in nature or otherwise, which assignment is made to the holder of a mortgage or ground lease on property which includes the Premises, Tenant agrees:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> that the execution thereof by Landlord, and the acceptance thereof by the holder of such mortgage, or the ground lessor, shall never be treated as an assumption by such holder or ground lessor of any of the obligations of Landlord hereunder, unless such holder or ground lessor shall, by notice sent to Tenant, specifically otherwise elect; and</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> that, except as aforesaid, such holder or ground lessor shall be treated as having assumed Landlord&#8217;s obligations hereunder only upon foreclosure of such holder&#8217;s mortgage and the taking of possession of the Premises, or in the case of a ground lessor, the assumption of Landlord&#8217;s position hereunder by such ground lessor.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord hereby agrees that Tenant&#8217;s compliance with the assignment of any rents payable hereunder, to any such holder or ground lessor under this Article 16.3 shall not be deemed a violation of the Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NON-DISTURBANCE AGREEMENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord represents that as of the date of execution hereof, (i) there are no existing superior mortgages other than mortgage(s) held by Santander Bank, N.A. (&#8220; <font style="text-decoration:underline;">Existing Mortgagee</font> &#8221;) and (ii)&#160;there are no existing superior leases. Within thirty (30) days after the Date of this Lease, Landlord will obtain for Tenant, at no cost to Tenant, a commercially reasonable non-disturbance agreement (&#8220; <font style="text-decoration:underline;">SNDA</font> &#8221;) with respect to this Lease from the Existing Mortgagee. Landlord shall also obtain an SNDA for Tenant from any future lessor or holder of a superior mortgage as described herein.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XVII </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /> </font><font style="text-decoration:underline;">MISCELLANEOUS PROVISIONS</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.1 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CAPTIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The captions throughout this Lease are for convenience or reference only and shall in no way be held or deemed to define, limit, explain, describe, modify, or add to the interpretation, construction, or meaning of any provision of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.2 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> BIND AND INURE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as herein otherwise expressly provided, the obligations of this Lease shall run with the land, and this Lease shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. The reference herein to successors and assigns of Tenant is not intended to constitute a consent to assignment by Tenant, but has reference only to those instances in which Landlord may later give consent to a particular assignment as required by the provisions of Article VII. Neither the assignment by Landlord of its interest in this Lease as security to a lender holding a mortgage on the Building, nor the acceptance thereof by such lender, nor the exercise by such lender of any of its rights pursuant to said assignment shall be deemed in any way an assumption by such lender of any of the obligations of Landlord hereunder unless such lender shall specifically otherwise elect in writing or unless such lender shall have completed foreclosure proceedings under said mortgage. Whenever the Premises are owned by a trustee or trustees, the obligations of Landlord shall be binding upon Landlord&#8217;s trust estate, but not upon any trustee, beneficiary or shareholder of the trust individually.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.3 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NO WAIVER</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The failure of Landlord or of Tenant to seek redress for violation of, or to insist upon the strict performance of any covenant or condition of this Lease shall not be deemed to be a waiver of such violation or to prevent a subsequent act, which would originally have constituted a violation, from having all the force and effect of an original violation. The receipt by Landlord of Rent or additional rent with knowledge of the breach of any covenant of this Lease shall not be deemed to be a waiver of such breach by Landlord unless such waiver is in writing signed by Landlord. No consent or waiver, express or implied, by Landlord or Tenant to or of any breach of any agreement or duty shall be construed as a waiver or consent to or of any other breach of the same or any other agreement or duty.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.4 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NO ACCORD AND SATISFACTION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No acceptance by Landlord of a lesser sum than the minimum and additional rent then due shall be deemed to be other than on account of the earliest installment of such rent due, nor shall any endorsement or statement on any check or any letter accompanying any check or payment as rent be deemed to be an accord and satisfaction, and Landlord may accept such check or payment without prejudice to Landlord&#8217;s right to recover the balance of such installment or pursue any other remedy in this Lease or at law or in equity provided.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.5 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CUMULATIVE REMEDIES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The specific remedies to which Landlord may resort under the terms of this Lease are cumulative and not intended to be exclusive of any other remedies or means of redress to which it may be lawfully entitled in case of any breach by Tenant of any provisions of this Lease. In addition to the other remedies provided in this Lease, Landlord shall be entitled to the restraint by injunction of the violation or attempted of any of the covenants, conditions or provisions of this Lease or to a decree compelling specific performance of any such covenants, conditions or provisions. Except as otherwise set forth herein, any obligations of Tenant as set forth herein (including, without limitation, rental and other monetary obligations, repair obligations and obligations to indemnify Landlord) shall survive the expiration or earlier termination of this Lease, and after the expiration of any applicable notice and cure period, Tenant shall immediately reimburse Landlord for any expense incurred by Landlord in curing Tenant&#8217;s failure to satisfy any such obligation (notwithstanding the fact that such cure might be effected by Landlord following the expiration or earlier termination of this Lease. Notwithstanding anything to the contrary contained in this Lease, in the event Landlord fails to bill Tenant for any Rent on or before the date which is two (2) years after the last day of the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">year to which such bill applies, then Landlord shall be deemed to have waived the payment of any then unpaid Rent which would have been due pursuant to said bill relate (i.e., Landlord may not render bills or corrected, revised or updated bills in respect of any year more than two (2) years after the expiration of such year).</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.6 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> PARTIAL INVALIDITY</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any term or provision of this Lease or any portion thereof or the application thereof to any person or circumstances shall, to any extent, be invalid or unenforceable, then the remainder of this Lease and of such term or provision and the application of this Lease and of such term and provision to persons or circumstances other than those as to which it is invalid or unenforceable, shall not be affected thereby, and each term of this Lease shall be valid and enforceable to the fullest extent permitted by law.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.7 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LANDLORD&#8217;S RIGHT TO CURE; SURVIVAL</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Tenant shall at any time default in the performance of any obligation under this Lease beyond applicable notice and cure periods, Landlord shall have the right, but not the obligation, to enter upon the Premises and/or to perform such obligation, notwithstanding the fact that no specific provision for such substituted performance by Landlord is made in this Lease with respect to such default. In performing any such obligations, Landlord may make any payment of money or perform any other act. All reasonable sums so paid by Landlord (together with interest at the Lease Interest Rate) and all necessary incidental costs and expenses in connection with the performance of any such act by Landlord, shall be deemed to be additional rent under this Lease and shall be payable to Landlord immediately upon written demand; and if Tenant shall default in such payment, Landlord shall have the same rights and remedies as Landlord has hereunder for the failure of Tenant to pay Rent. Landlord may exercise the foregoing rights without waiving any other of its rights or releasing Tenant from any of its obligations under this Lease. Except as otherwise set forth herein, any obligations of Tenant as set forth herein (including, without limitation, rental and other monetary obligations, and obligations to indemnify Landlord), shall survive the expiration or earlier termination of this Lease, and Tenant shall immediately reimburse Landlord for any expense incurred by Landlord in curing Tenant&#8217;s failure to satisfy any such obligation (notwithstanding the fact that such cure might be effected by Landlord following the expiration or earlier termination of this Lease).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.8 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> ESTOPPEL CERTIFICATES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees on the Term Commencement Date and from time to time thereafter, upon not less than fifteen (15) days&#8217; prior written request by Landlord, to execute, acknowledge and deliver to Landlord a statement in writing, certifying that this Lease is unmodified and in full force and effect, that Tenant has no defenses, offsets or counterclaims against its obligations to pay rent and other charges required under this Lease and to perform its other covenants under this Lease and that there are no uncured defaults of Landlord or Tenant under this Lease (or, if there have been any modifications, that this Lease is in full force and effect, as modified, and stating the modifications, and, if there are any defenses, offsets, counterclaims or defaults, setting them forth in reasonable detail), and the dates to which the Rent and other charges have been paid. Any such statement delivered pursuant to this Section 17.8 may be relied upon by any prospective purchaser or mortgagee of the property which includes the Premises or any prospective assignee of any such mortgagee, however, Tenant shall incur no liability for its certifications reasonably made by Tenant in good faith.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord agrees on the Term Commencement Date and from time to time thereafter, upon not less than fifteen (15) days&#8217; prior written request by Tenant, to execute, acknowledge and deliver to Tenant a statement in writing, certifying that this Lease is unmodified and in full force and effect, that Landlord has no defenses, offsets or counterclaims with respect to its obligations under this Lease and to perform its other covenants under this Lease and that there are no uncured defaults of Landlord or Tenant under this Lease (or, if there have been any modifications, that this Lease is in full force and effect, as modified, and stating the modifications, and, if there are any defenses, offsets, counterclaims or defaults, setting them forth in reasonable detail), and the dates to which the Rent and other charges have been paid. Any such statement delivered pursuant to this Section 17.8 may be relied upon by any prospective purchaser or mortgagee of the property which includes the Premises or any prospective assignee of any such mortgagee or any other party.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.9 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> BROKERAGE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each party hereto warrants and represents that it has dealt with no real estate broker or agent other than the Broker(s) named in Section 1.2 above in connection with this transaction and agrees to defend, indemnify and save the other party harmless from and against any and all claims for commissions or fees arising out of this Lease which, as to the respective parties, are inconsistent with such party&#8217;s warranties and representations. Landlord shall be responsible for any commissions or fees owed to the Brokers in connection with this transaction in accordance with a separate agreement between the Brokers and Landlord. This Section shall survive the expiration or earlier termination of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.10 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> ENTIRE AGREEMENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All negotiations, considerations, representations, and understandings between Landlord and Tenant are incorporated herein and this Lease expressly supersedes any proposals or other written documents relating hereto. No prior or contemporaneous agreement or understanding pertaining to any such matter shall be effective. Except as otherwise stated in this Lease, Tenant hereby acknowledges that no real estate broker nor Landlord or any employee or agents of any of said persons has made any oral or written warranties or representations to Tenant concerning the condition or use by Tenant of the Premises or the Property or concerning any other matter addressed by this Lease. This Lease may be modified or altered only by written agreement between Landlord and Tenant, and no act or omission of any employee or agent of Landlord shall alter, change, or modify any of the provisions hereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.11 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> HOLDOVER</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If for any reason Tenant holds over or occupies the Premises (or any portion thereof) beyond the Lease Term without the written consent of Landlord, Tenant shall have no more rights than a tenant by sufferance (or, at Landlord&#8217;s sole option, such holding over shall constitute a tenancy from month to month, terminable by either party upon 30 days prior written notice to the other); and, in any case, Tenant shall be liable for payment of Rent during such period in an amount equal to one hundred fifty percent (150%) of the Base Rent payable immediately preceding the termination date of this Lease, with such tenancy otherwise on the same terms and conditions as set forth in the Lease, as far as applicable. In addition, if Tenant shall hold over for more than 30 days beyond such expiration or earlier termination without Landlord&#8217;s written consent, Tenant shall be subject to costs, losses and damages related to such holding over (including reasonable attorneys&#8217; fees) Landlord may incur as a result of Tenant&#8217;s failure to surrender possession of the Premises to Landlord upon the termination of this Lease. Nothing in this Section shall be construed to permit such holding over, or to limit Landlord&#8217;s other rights and remedies on account thereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.12 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> COUNTERPARTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease is executed in any number of counterparts, each copy of which is identical, and any one of which shall be deemed to be complete in itself and may be introduced in evidence or used for any purpose without the production of the other copies. Delivery of an executed counterpart of this Lease by facsimile or portable document format (PDF) shall be equally effective as delivery of an original executed counterpart.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.13 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CONSTRUCTION AND GRAMMATICAL USAGE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease shall be governed, construed and interpreted in accordance with the laws of The Commonwealth of Massachusetts, and Tenant agrees to submit to the personal jurisdiction of any court (federal or state) in said Commonwealth for any dispute, claim or proceeding arising out of or relating to this Lease. In construing this Lease, feminine or neuter pronouns shall be substituted for those masculine in form and vice versa, and plural terms shall be substituted for singular and singular for plural in any place in which the context so admits or requires. If there be more than one party tenant, the covenants of Tenant shall be the joint and several obligations of each such party and, if Tenant is a partnership, the covenants of Tenant shall be the joint and several obligations of each of the partners and the obligations of the firm.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.14 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> WHEN LEASE BECOMES BINDING</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employees or agents of Landlord have no authority to make or agree to make a lease or any other agreement or undertaking in connection herewith. The submission of this document for examination and negotiation does not constitute an offer to lease, or a reservation of, or option for, the Premises, and this document shall become effective and binding only upon the execution and delivery hereof by both Landlord and Tenant.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.15 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> SECURITY DEPOSIT</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Simultaneously with the execution and delivery of this Lease, Tenant shall deliver to Landlord a security deposit (the &#8220;Security Deposit&#8221;), which Security Deposit shall be in the Security Deposit Amount (as defined in Section 1.2) and shall consist of cash. During the Term hereof, and any extensions thereof, and for 60 days after the expiration of the Term, or for so long thereafter as Tenant is in possession of the Premises or has unsatisfied obligations hereunder to Landlord, the Security Deposit shall be security for the full and timely performance of Tenant&#8217;s obligations under this Lease; which cash may be used and applied from time to time against outstanding obligations of Tenant hereunder without notice or demand, subject to applicable notice and cure periods. Tenant shall have no right to require Landlord to so apply the Security Deposit, nor shall Tenant be entitled to credit the same against Rent or other sums payable hereunder; no interest shall accrue thereon. No trust relationship is created herein between Landlord and Tenant with respect to said Security Deposit. Tenant acknowledges that the Security Deposit is not an advance payment of any kind or a measure of Landlord&#8217;s damages in the event of Tenant&#8217;s default; Landlord shall not be obliged to keep the Security Deposit as a separate fund or pay interest thereon but may commingle the Security Deposit with its own funds. Tenant hereby waives the provisions of any law which is inconsistent with this Section 17.15. The Security Deposit shall be reduced during the Lease Term commencing on the third anniversary of the month Tenant commences paying Rent in accordance with the provisions under Section 1.2 of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.16 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> LEGAL EXPENSES</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If either party hereto be made or becomes a party to any litigation commenced by or against the other party involving the enforcement of any of the rights and remedies of such party, or arising on account of the default of the other party in the performance of such party&#8217;s obligations hereunder, then the prevailing party in any such litigation, or the party becoming involved in such litigation because of a claim against such other party, as the case may be, shall receive from the other party all costs and reasonable attorneys&#8217; fees incurred by such party at trial and on appeal in connection with such litigation.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.17 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NO SURRENDER</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The delivery of keys to any employee of Landlord or to Landlord&#8217;s agents or employees shall not operate as a termination of this Lease or a surrender of the Premises.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.18 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> COVENANT OF QUIET ENJOYMENT</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and provisions of this Lease and on payment of the Rent, additional rent, and other sums due hereunder and compliance with all of the terms and provisions of this Lease within any applicable notice and cure period, Tenant shall have the right to lawfully, peaceably, and quietly have, hold, occupy, and enjoy the Premises during the term hereof, without hindrance or ejection by Landlord or by any persons lawfully claiming under Landlord, or by any of Landlord&#8217;s other tenants; the foregoing covenant of quiet enjoyment is in lieu of any other covenant, express or implied.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.19 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> NO PERSONAL LIABILITY OF THE LANDLORD</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees to look solely to Landlord&#8217;s then equity interest in the Building and the Lot at the time owned or in which Landlord holds an interest as ground lessee, and the rents, income and other proceeds therefrom, for recovery of any judgment from Landlord; it being specifically agreed that neither any member of Landlord (whether Landlord be an individual, partnership, firm, corporation, trustee, or other fiduciary) nor any partner, policyholder, officer, manager, member, shareholder or director of Landlord, nor any trust of which any person holding Landlord&#8217;s interest is trustee nor any successor in interest to any of the foregoing shall ever be personally liable for any such judgment, or for the payment of any monetary obligation to Tenant. The covenants of Landlord contained in this Lease shall be binding upon Landlord and Landlord&#8217;s successors only with respect to breaches occurring during Landlord&#8217;s and Landlord&#8217;s successors&#8217; respective periods of ownership of Landlord&#8217;s interest hereunder. Notwithstanding any other provision of this Lease to the contrary, in no event shall Landlord ever be liable for any indirect, special or consequential damages suffered by Tenant or Tenant&#8217;s agents from any cause whatsoever. Notwithstanding any other provision of this Lease to the contrary, in no event shall Tenant ever be liable for any indirect, special or consequential damages suffered by Landlord or Landlord&#8217;s agents from any cause whatsoever, except as provided in Sections 5.7 and 17.11.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.20 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> NOTICES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whenever, by the terms of this Lease, notice shall or may be given either to Landlord or to Tenant, such notice shall be in writing and shall be delivered by hand or sent by registered or certified mail, postage prepaid or by so-called &#8220;express&#8221; mail (such as Federal Express or U.S. Postal Service Express Mail):</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If intended for Landlord, addressed to Managing Agent at the address set forth in Section 1.2 with a copy to Landlord at the address set forth in Section 1.2 and to (i) Thomas W. Tavenner, Jr. Esq., Dalton &amp; Finegold LLP, 34 Essex Street, Andover, Massachusetts 01810, and (ii) Lincoln Property Company, 1000 McKinney Avenue, Suite 1000, Dallas, Texas 75201, or to such other addresses as may from time to time hereafter be designated by Landlord by like notice.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If intended for Tenant, addressed to Tenant at the address set forth on the first page of this Lease, with a copy of any default notice to Tenant&#8217;s counsel, J. Goodwin Bland, Esq., Morgan Lewis &amp; Bockius LLP, 101 Park Avenue, New York, New York 10178, or to such other address or addresses as may from time to time hereafter be designated by Tenant by like notice.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All such notices shall be effective upon delivery, attempted delivery, or refusal, whichever occurs first, at the address or addresses of the intended recipient, as set forth above.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.21 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> MECHANIC&#8217;S LIENS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees immediately to discharge (either by payment or by the filing of the necessary bond, or otherwise) any mechanics&#8217;, materialmen&#8217;s or other lien or encumbrance against the Premises and/or Landlord&#8217;s interest therein, which liens may arise out of any payment due, or purported to be due, for any labor, services, materials, supplies or equipment alleged to have been furnished to or for Tenant in, upon or about the Premises, excluding any for Landlord&#8217;s Work as defined in this Lease. If Tenant shall fail to so discharge such lien or encumbrance within thirty (30) days of notice of filing then, in addition to any other right or remedy of Landlord, Landlord may, but shall not be obligated to, discharge same (either by payment or by filing of the necessary bond or otherwise) and any amount paid by Landlord for any of the aforesaid purposes, and all actual and legal and other expenses of Landlord, including actual counsel fees, in or about procuring the discharge of such lien, together with all necessary disbursements in connection therewith, and together with interest thereon at the rate set forth in Section 12.3 from the date of payment, shall be repaid by Tenant to Landlord, within ten (10) days of rendition of any bill or statement to Tenant therefore and if unpaid may be treated as additional rent. Nothing contained in this Lease shall prevent Tenant from granting a security interest or chattel mortgage in any of Tenant&#8217;s property, and nothing herein shall prevent Tenant from contesting any such lien in good faith.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.22 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> RECORDING</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant agrees not to record the within Lease, but, if required by applicable law in order to protect Tenant&#8217;s interest in the Premises, each party hereto agrees, on the request of the other, to execute a so-called memorandum of lease or short form lease in recordable form and complying with applicable law and reasonably satisfactory to Landlord&#8217;s attorneys. In no event shall such document set forth the rent or other charges payable by Tenant under this Lease; and any such document shall expressly state that it is executed pursuant to the provisions contained in this Lease and is not intended to vary the terms and conditions of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.23 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> TENANT&#8217;S FINANCIAL CONDITION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant warrants and represents that all information furnished to Landlord or Landlord&#8217;s representatives in connection with this Lease are true and correct and in respect of the financial condition of Tenant, properly reflect the same without material adverse change, as of the date hereof. Upon Landlord&#8217;s request, which may be made no more often than annually, Tenant shall furnish to Landlord, at Tenant&#8217;s sole cost and expense, then current financial statements of Tenant (if audited statements have been recently prepared on behalf of Tenant, or otherwise certified as being true and correct by the chief financial officer of Tenant). All information provided to Landlord shall be held strictly confidential. Notwithstanding the above, in the event the capital stock of Tenant is then traded on a National Exchange (as defined under Federal securities law) and Tenant&#8217;s most recent 10-K (and, if more recent, 10-Q), or similar financial document provided for entities listed on the Australian national stock exchange, is readily available to the public for review (i.e., via the internet), Landlord shall obtain same from such sources and such document will satisfy the requirements of Section 17.23 of this Lease.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.24 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> WAIVER OF COUNTERCLAIMS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Landlord commences any summary proceeding for possession of the Premises based on an event of default by Tenant hereunder, Tenant hereby waives the right to interpose any non&#8209;compulsory counterclaim of whatever nature or description in any such proceeding; provided, however, that Tenant shall have the right to bring a separate action against Landlord to the extent otherwise allowed under this Lease as long as Tenant does not attempt to have such action joined or otherwise consolidated with Landlord&#8217;s summary proceeding.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.25 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> CONSENTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except as otherwise specifically provided in this Lease, any consent or approval to be given by Landlord under this Lease may be withheld or denied at Landlord&#8217;s sole and absolute reasonable discretion. Whenever in this Lease the consent or approval of Landlord is required, and it is specifically provided that such consent or approval is not to be unreasonably withheld, delayed or conditioned, but nevertheless Landlord shall refuse or delay or condition such consent or approval, Tenant shall not be entitled to make any claim, and Tenant hereby waives any claim, for money damages (nor shall Tenant claim any money damages by any setoff, counterclaim or defense) based upon any claim or assertion by Tenant that Landlord unreasonably withheld or delayed or conditioned its consent or approval; and Tenant&#8217;s sole remedy in such circumstances shall be an action or proceeding for specific performance, injunctive relief or declaratory judgment, plus reasonable attorney&#8217;s fees.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.26 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> EASEMENTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord reserves to itself the right, from time to time, to grant such easements, rights and dedications that Landlord deems necessary or desirable, and to cause the recordation of parcel maps and restrictions, so long as such easements, rights, dedications, maps and restrictions do not unreasonably materially interfere with the use of the Premises by Tenant. Tenant shall sign any of the aforementioned documents within ten (10) days after Landlord&#8217;s request and Tenant&#8217;s failure to do so shall constitute a default by Tenant. The obstruction of Tenant&#8217;s view, air, or light by any structure erected in the vicinity of the Property, whether by Landlord or third parties, shall in no way affect this Lease or impose any liability upon Landlord.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.27 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> CHANGES TO PROPERTY</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord shall have the right, from time to time, to make changes to the size, shape, location, number and extent of the improvements comprising the Property (hereinafter referred to collectively as &#8220; <font style="text-decoration:underline;">Changes</font> &#8221;) including, but not limited to, the Building interior and exterior, the common areas and elements thereof, elevators, escalators, restrooms, HVAC, electrical systems, communication systems, fire protection and detection systems, plumbing systems, security systems, parking control systems, driveways, entrances, parking spaces, parking areas and landscaped areas; provided that such Change shall not (a) unreasonably diminish Tenant&#8217;s ingress and egress to and from the Building and the Premises, (b) unreasonably diminish elevator or other services or facilities from the level required of Landlord in this Lease as a result thereof, or (c) adversely affect Tenant&#8217;s use of the Premises for the Permitted Uses. In connection with the Changes, Landlord may, among other things, erect scaffolding or other necessary structures at the Property, limit or eliminate access to portions of the Property, including portions of the common areas, or perform work in the Building, which work may create noise, dust or leave debris in the Building. Tenant hereby agrees that such Changes and Landlord&#8217;s actions in connection with such Changes shall in no way constitute a constructive eviction of Tenant or entitle Tenant to any abatement of rent. Notwithstanding anything to the contrary contained herein, although Landlord shall use commercially reasonable efforts to minimize any material interference of Tenant&#8217;s use or occupancy of or access to the Premises, Landlord shall have no responsibility or for any reason be liable to Tenant for any direct or indirect injury to or interference with Tenant&#8217;s business arising from the Changes unless caused by Landlord&#8217;s gross negligence or willful misconduct, nor shall Tenant be entitled to any compensation or damages from Landlord for any inconvenience or annoyance occasioned by such Changes or Landlord&#8217;s actions in connection with such Changes unless caused by Landlord&#8217;s gross negligence or willful misconduct and causes Tenant to be unable to conduct its business at any portion of the Premises for more than three (3) consecutive days, then Tenant&#8217;s Rent with respect to such portion of the Premises will abate from the fourth (4 <font style="font-size:8pt;">th</font> ) day until the day that Tenant may reasonably resume its business in such portion of the Premises.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.28 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> COVENANTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Lease shall be construed as though Landlord&#8217;s covenants contained herein are independent and not dependent and Tenant hereby waives the benefit of any law to the contrary. All provisions of this Lease to be observed or performed by Tenant are both covenants and conditions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.29 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> AUCTIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall not conduct, nor permit to be conducted, either voluntarily or involuntarily, any auction upon the Premises or the Property. The holding of any auction on the Premises or common areas in violation of this Section shall constitute a default hereunder.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.30 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> AUTHORITY</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Tenant is a corporation, limited liability corporation, trust, or general or limited partnership, Tenant, and each individual executing this Lease on behalf of such entity, represents and warrants that such individual is duly authorized to execute and deliver this Lease on behalf of said entity, that said entity is duly authorized to enter into this Lease, and that this Lease is enforceable against said entity in accordance with its terms. If Tenant is a corporation, trust or partnership, Tenant shall deliver to Landlord upon request evidence of such authority satisfactory to Landlord.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.31 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RELATIONSHIP OF PARTIES</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nothing contained in this Lease shall be deemed or construed by the parties hereto or by any third party to create the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.32 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> RIGHT TO LEASE</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord reserves the absolute right to effect such other tenancies in the Property as Landlord in its sole discretion shall determine, and Tenant is not relying on any representation that any specific tenant or number of tenants will occupy the Property.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.33 </font><font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> CONFIDENTIALITY</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The parties acknowledge and agree that the terms of this Lease are confidential. Disclosure of the terms hereof could adversely affect the ability of Landlord to negotiate other leases with respect to the Building and may impair Landlord&#8217;s relationship with other tenants of the Building. Tenant agrees that it and its partners, officers, directors, employees, brokers, and attorneys, if any, shall not disclose the terms and conditions of this Lease to any other person or entity without the prior written consent of Landlord which may be given or withheld by Landlord, in Landlord&#8217;s sole discretion, except as required for financial disclosures or securities filings or in connection with proposed assignments or subleases, lenders, proposed joint venturers or investors, or in connection with Tenant&#8217;s legitimate business reasons <font style="font-weight:bold;font-style:italic;">.</font> It is understood and agreed that Landlord&#8217;s sole remember for a breach of this provision shall be to seek specific performance of this provision and to seek injunctive relief to prevent its breach or continued breach.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.34 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> USA PATRIOT ACT CERTIFICATION</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> <font style="text-decoration:underline;">Certification</font> . Pursuant to Executive Order 13224, signed by President George W. Bush on September 24, 2001, each of Lender and Tenant hereby certifies to the other that:</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:6.25%;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> It is not acting, directly or indirectly, for or on behalf of any person, group, entity, or nation named by any Executive Order or the United States Treasury Department as a terrorist, &#8220;Specially Designated National and Blocked Person,&#8221; or other banned or blocked person, entity, nation, or transaction pursuant to any law, order, rule, or regulation that is enforced or administered by the Office of Foreign Assets Control; and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.25%;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> It is not engaged in this transaction, directly or indirectly on behalf of, or instigating or facilitating this transaction directly or indirectly on behalf of, any such person, group, entity, or nation.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> <font style="text-decoration:underline;">Indemnification</font> . Each of Landlord and Tenant hereby agrees to defend, indemnify and hold harmless the other from and against any and all claims, damages, losses, risks, liabilities and expenses (including reasonable attorneys&#8217; fees and costs) arising from or related to any breach of the foregoing certification.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.35 <font style="font-size:10pt;">&#160;&#160;&#160;&#160;</font> WAIVER OF JURY TRIAL</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD AND TENANT HEREBY WAIVE THEIR RESPECTIVE RIGHT TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, COUNTERCLAIM OR CROSS-COMPLAINT IN ANY ACTION, PROCEEDING AND/OR HEARING BROUGHT BY EITHER LANDLORD AGAINST TENANT OR TENANT AGAINST LANDLORD ON ANY MATTER WHATSOEVER ARISING OUT OF, OR IN ANY WAY CONNECTED WITH, THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT, TENANT&#8217;S USE OR OCCUPANCY OF THE PREMISES, OR ANY CLAIM OF INJURY OR DAMAGE, OR THE ENFORCEMENT OF ANY REMEDY UNDER ANY LAW, STATUTE, OR REGULATION, EMERGENCY OR OTHERWISE, NOW OR HEREAFTER IN EFFECT.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS SPACE LEFT BLANK &#8211; SIGNATURE PAGE TO FOLLOW</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="EXHIBIT104_HTM_SF072575FE54C2D34F134FE36"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="FIS_UNIDENTIFIED_TABLE_34"></a><a name="FIS_UNIDENTIFIED_TABLE_34"></a>IN WITNESS WHEREOF, the parties hereto have executed this instrument under seal as of the date set forth in Section 1.2, above.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD</p></td>
<td colspan="4" valign="top"  style="width:68.18%;">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RFP LINCOLN 293, LLC</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td colspan="4" valign="top"  style="width:68.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Massachusetts limited liability company</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:65.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td colspan="3" valign="top"  style="width:65.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lincoln Route 20 (MA), a Delaware limited liability</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:65.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">company, its Managing Member</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:65.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:4.1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td colspan="2" valign="top"  style="width:61.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-Member Manager, Inc., a Texas corporation, its Manager</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:5.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:59.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:65.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:4.5pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Gregory S. Courtwright</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:5.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;letter-spacing:-0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:59.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gregory S. Courtwright</p></td>
</tr>
<tr>
<td valign="top"  style="width:31.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:3.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:5.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:59.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT</p></td>
<td colspan="3" valign="top"  style="width:67.7%;">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">VALERITAS, INC.</p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td colspan="3" valign="top"  style="width:67.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Delaware corporation</p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:65.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:65.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td colspan="2" valign="top"  style="width:65.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">/s/ Erick Lucera</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;letter-spacing:-0.05pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:60.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Erick Lucera</p></td>
</tr>
<tr>
<td valign="top"  style="width:32.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:2.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top"  style="width:5.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:60.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CFO</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="EXHIBIT104_HTM_S30C8246D1A1199C9BF45FE36"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EXHIBIT A-1</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Plan showing the existing Third Floor Space</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3puwq45lgum000001.jpg" title="" alt="" style="width:747px;height:579px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit A-2</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:24pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Plan showing Lower Level Space</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g3puwq45lgum000002.jpg" title="" alt="" style="width:603px;height:780px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit B</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intentionally Deleted</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;"><br /></font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EXHIBIT C</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RULES AND REGULATIONS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293 Boston Post Road</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marlborough, Massachusetts</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of a conflict between the terms of the Lease and the Rules and Regulations, the terms of the Lease shall control.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heating, lighting and plumbing: The Landlord should be notified at once of any trouble with heating, lighting or plumbing fixtures. Tenants must not leave the doors of the Premises unlocked at night.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The entrances, sidewalks, ways, vestibules, passages, corridors, halls, elevators and stairways shall not be encumbered nor obstructed by Tenant, Tenant&#8217;s agents, servants, employees, licensees or visitors, or be used by them for any purpose other than ingress or egress to and from the Premises. Landlord reserves the right to reasonably restrict and regulate the use of aforementioned public areas of the Building by Tenant, Tenant&#8217;s agents, employees, servants, licensees and visitors and by persons making deliveries to Tenant.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The water and wash closets and other plumbing fixtures shall not be used for any purposes other than those for which they were constructed, and no sweepings, rubbish, rags, or other substances shall be thrown or placed therein. Damages or maintenance expense resulting from any negligent misuse of fixtures or disposal of the above by Tenant, its servants, employees, agents, visitors, or licensees, shall be borne by Tenant.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weight and position of all safes and heavy equipment or machines shall be subject to the approval of the Landlord.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lettering on doors, tablets and building directory shall be subject to the approval of the Landlord; no lettering shall be allowed on outside windows.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr style="height:4pt;">
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No wires for telephone service, electric lights, messenger service or for any other purpose shall be put in the Premises without the consent of the Landlord.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No glass in doors or elsewhere through which light is admitted in to any part of the building shall be obstructed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No bicycles, vehicles, or animals, except for the disabled, shall be brought into or kept in or about the Premises or Building, except bicycles may be stored at the designated bicycle rack.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.3%;"></td>
<td style="width:96.7%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After the conclusion of Tenant&#8217;s initial move into the Premises, other movement in or out of the Building of furniture or office equipment which requires the use of elevators or stairways or the movement through the main Building entrance shall be restricted to the after business hours designated by Landlord. All such movement shall be under the supervision of Landlord and performed in the manner agreed upon between Tenant and Landlord by pre-arrangement before performance. Such pre-arrangement initiated by Tenant will include the determination by Landlord and subject to Landlord&#8217;s reasonable discretion, relating to the time, method, and routing of the items&#8217; movement, as well as reasonable limitations imposed by safety, appearance or other reasonable concerns which may include the prohibition of equipment or any other item from being brought into the Building, as well as the method of the items&#8217; movement through the Building. Tenant shall assume with its contractors, all risk as to damage caused by any such movement or property being moved or injury to persons or public engaged or not engaged in such movement, including equipment, property, and personnel of Landlord if damaged or injured as a result of Tenant or its contractor&#8217;s negligent or willful acts in connection with such Tenant arranged moving from the time of entering the property to the completion of work. Landlord shall not be liable for the acts of any person engaged in, or any damage or loss to any of said property or persons resulting from any act in connection with such moving performed by Tenant arrangement, except relating to Landlord&#8217;s or its agent&#8217;s or contractor&#8217;s negligence or misconduct.</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nothing shall be thrown from or taken in through the windows, nor shall anything be left outside the Building on the window sills of the Premises.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.83%;"></td>
<td style="width:95.17%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No person shall loiter in the halls, corridors, or lavatories.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Landlord, its agents and employees shall have access at reasonable times and upon reasonable notice to perform their duties in the maintenance and operation of the Premises.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No Tenant shall use any method of heating other than that provided for in the Tenant&#8217;s Lease without the consent of the Landlord.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any damage caused to the Building or the Premises or to any person or property herein as a result of any breach of any of the rules and regulations by the Tenant shall be borne by Tenant.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After the conclusion of Tenant move-in, all deliveries, inclusive of packages, office supplies, etc., must be made via the freight elevator during normal business hours. Landlord&#8217;s written approval must be obtained for any delivery made after business hours and Tenant will be responsible for the expense of the security attendant who monitors access to the Building during the period of such delivery.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall not permit the parking or standing of delivery vehicles to interfere with the use of any driveway, walk, parking area or other common areas.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No hand trucks or delivery dollies, except those equipped with rubber tires and padded side guards, shall be used in any space, or in public halls of the building, either by Tenant or by jobbers or others in the delivery or receipt of merchandise.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All deliveries to Tenant must be accepted by Tenant. The Landlord and its agents or employees will not accept, sign for, or hold Tenant mail, packages, or deliveries.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall not make, or permit to be made, any unseemly or disturbing noises, odors, or vibrations to emanate from premises or otherwise unreasonably disturb or interfere with the occupancy of the Building whether by the use of any equipment, musical instrument, radio, television, talking machine, unmusical noise, whistling, singing, or in any other way.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No additional locks or security devices will be installed without prior notification and approval by Landlord. New locks or re-keying must be coordinated with Landlord and keyed on building master system.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall be responsible for persons it authorizes to have access to the Building during non-business hours and shall be liable for and shall coordinate which persons should have access cards issued. Tenant shall keep access card records current and properly identified by employee name.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All service requests of Tenant required of Landlord shall be administered through Building management office. Tenants will not contract independently with employees and agents of Landlord without the coordination of the management office, nor shall Tenant request employees or agents of Landlord to receive or carry messages for or to any Tenant or other person.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None of the entries, passages, doors, elevators, elevator doors, hallways, or stairways shall be blocked or obstructed, nor shall any rubbish, litter, trash, or material of any nature be placed, emptied, or thrown into these areas, nor shall such areas be used at any time except for ingress and egress by Tenant, Tenant&#8217;s agents, employees, or invitees.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24.</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No boxes, crates, pallets, or other such materials shall be stored in building hallways or other common areas. When Tenant must dispose of crates, boxes, etc., it will be the responsibility of Tenant to dispose of same prior to, or after the hours of 8:00 a.m. and 6:00 p.m., so as to avoid having such debris visible or being moved in the Common Areas during normal business hours. Such items will be removed as part of evening janitorial service at Landlord&#8217;s expense.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Tenant shall cooperate with Landlord&#8217;s employees in keeping leased premises neat and clean.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless otherwise provided for in this Lease, Tenant shall not mark, paint, drill into, or in any way deface any part of the Premises, the Building except for Tenant&#8217;s interior design components and furnishings in the Premises or the approved signage. Other than for initial move-in, no boring, cutting, or stringing for wires shall be permitted without the prior written consent of Landlord and as Landlord may direct.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unless otherwise provided in this Lease, neither Tenant, nor its servants, employees, agents, visitors, or licensees, shall at any time bring or keep upon the Premises any flammable, combustible, or explosive fluid, chemical or substance (including Christmas trees and ornaments) except such items as may be incidentally used, provided Tenant notifies Landlord of the location thereof and makes adequate provision for safe storage. No space heaters or fans shall be operated or located in the Premises, other than UL approved or Landlord installed appliances.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant will not locate furnishings or cabinets adjacent to mechanical or electrical panels, HVAC equipment or other mechanical equipment so as to prevent personnel from servicing such units or equipment as routine or emergency access may require. Cost of moving such furnishings for Landlord&#8217;s access will be borne by Tenant.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No space in the Premises or Building shall be used for manufacturing, for lodging, sleeping, storage of drugs or medicine not typically found of quality or quantity in First Aid supply kits or for legal purposes.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall not place, install or operate on the demised premises or in any part of Building, any engine, stove, or machinery, or conduct mechanical operations or cook thereon or therein except Tenants microwave, refrigerator, additional cooling equipment for file server room (subject to Landlord&#8217;s reasonable approval), office and communication equipment.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant will coordinate with Landlord all Tenant arranged contractors, and installation technicians, rendering any construction or installation service to Tenant before performance of any such service. This provision shall apply to all work performed in the Building by Tenant arranged contractors including the installation of telephones, telegraph equipment, electrical devices and attachments, and the installation of any nature affecting the floors, walls, woodwork, trim, windows, ceiling, equipment (other than Tenant&#8217;s office equipment), or any other physical portion of the Building.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smoking is prohibited in common entrances, vestibules, passages, corridors, halls, elevators, stairways, and toilet rooms of the Building. Tenant is responsible for informing all of its vendors, service providers, agents, employees, licensees, and visitors of this policy. Landlord reserves the right to request that any person(s) engaged in the act of smoking (in the common areas recited above), at this or her choice, either cease smoking or leave the common areas of the Building immediately.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canvassing, soliciting, and peddling in the Building and Parking Lot is prohibited. Landlord and Tenant shall cooperate to prevent same.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant shall restrict parking by Tenant, its employees, service providers, agents, and visitors to the number of parking spaces specified in the lease and to the parking areas designated by Landlord and they shall comply with reasonable parking rules and regulations as may be posted and distributed from time to time.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant will evacuate the Premises and Building in the event of emergency or catastrophe notification; whether practice drill, false alarm, or actual occurrence.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36.</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant will notify Landlord of any incidents, accidents, injuries, or hazards which Tenant is aware of, which occur, or are present in Premises or Building.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tenant will be requested to participate in recycling and other expense reduction programs offered by Building.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Landlord reserves the right to rescind any of these rules and make such other and further reasonable rules and regulations as in Landlord&#8217;s judgment shall from time to time be needed for the safety, protection, care and cleanliness of the Premises and/or Building, the operation thereof, the preservation of good order therein, and the protection and comfort of its Tenants, their agents, employees, and invitees, which rules when made and notice thereof given to a Tenant shall be binding upon Tenant in the manner as if originally prescribed and enforced by Landlord without discrimination.</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU7"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="EXHIBIT104_HTM_S695DBC7C829F8D07BD9DFE36"></a>EXHIBIT D</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LEGAL HOLIDAYS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BOSTON POST ROAD CORPORATE CENTER</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MARLBOROUGH, MASSACHUSETTS</p>
<p style="margin-bottom:0pt;margin-top:24pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New Year&#8217;s Day</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Memorial Day</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Independence Day</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Labor Day</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thanksgiving Day</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:31.25%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Christmas Day</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building Services will be provided on all other holidays based upon building occupancy at the discretion of the Manager.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT E:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CLEANING SCHEDULE</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">293 BOSTON POST ROAD</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MARLBORO, MASSACHUSETTS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Janitorial services in accordance with the following schedule.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cleaning in Premises to be performed after 6:00 P.M.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">FIVE TIMES PER WEEK</font></p>
<p style="margin-bottom:0pt;margin-top:24pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Lobbies, Entries and Hallways (Building Common Area)</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum entire carpeted area, replace furniture to its original position when completed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean carpet and remove other foreign substances from carpet.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Damp mop spills as needed leaving floor in a clean, streak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty all waste containers, spot cleaning exterior surfaces and replacing liners as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all main lobby furniture and all horizontal and vertical surfaces within reach, returning to original position when completed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean and polish elevator tracks, spot clean elevator paneling, saddles and doors inside and out as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean elevator carpet, removing gum and other foreign substances as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Police exterior front entrance, removing debris as needed (cigarette butts, etc.).</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean and polish all metal bright work leaving a bright, streak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean all walls, doors and partition glass.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean and disinfect all drinking fountains.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust fire extinguisher boxes.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properly arrange all furniture and reading material.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Restrooms</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sweep and dam mop with disinfectant entire floor surface with approved disinfectant floor cleaner and dry, leaving floor in a clean, streak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean and disinfect all sink basins, urinals and toilets completely, leaving toilet seat lids in an upright position.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty and wash all waste receptacles replacing liners as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.55%;"></td>
<td style="width:93.45%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty and clean sanitary napkin waste receptacle and replace liners as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean and polish all mirrors, chrome fixtures, metal bright work and dispensers.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</font></p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restock all toilet, towel, seat cover, soap and sanitary napkin dispensers.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.48%;"></td>
<td style="width:93.52%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean walls around sinks, towel dispensers, urinals, partitions and doors.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust partitions, top of mirrors and frames.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">C.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Conference Room / Classroom Areas</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty all waste containers, spot cleaning exterior surfaces and replacing liners as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all desks, chairs, chair bases, tables, file cabinets, and other furniture.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean counters and telephones.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properly arrange all furniture and reading literature.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean carpet and carpet protectors.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Office Areas</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty all waste containers, replacing liners as needed to prevent odors, spills or any offensive appearance.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.55%;"></td>
<td style="width:93.45%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sweep and dust mop all hard floor surfaces with dust control treated dust mop.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all horizontal and vertical surfaces within reach (such as desks, table and cabinet tops, and credenzas) without disturbing papers or accessories on desks.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Damp mop spills, leaving floor in a clean, steak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean carpets as needed, removing gum and other foreign substances.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum all carpeted traffic aisles, offices, classrooms, conference and cubicle areas.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum and clean all tenant lunchroom/coffee kitchen/eating areas. Spot clean tables,</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restock lunchroom/coffee kitchen/eating areas with paper towels.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properly arrange all furniture and reading material.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">E.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Stairways and Elevators</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Police stairwells, removing debris as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean doors and al walls (especially stairway walls.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum all carpets and area rugs.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean and shine elevator tracks.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">F.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Other Services</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Police outside by entries.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Keep janitor closets neat and orderly.&#160;&#160;&#160;&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leave on only designated lights.</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inform Lincoln Properties of any problems notices (i.e., lights burned out, dispensers broken, door handles broken, etc.) within 24 hours.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">G.&#160;&#160;&#160;&#160; <font style="font-weight:bold;text-decoration:underline;">Exterior of Building</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Empty exterior trash receptacles and clean cigarette ash urns where applicable.&#160;&#160;&#160;&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">THREE TIMES PER WEEK</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A.&#160;&#160;&#160;&#160; <font style="font-weight:bold;text-decoration:underline;">Entrance Lobby</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sweep and damp mop entire hard surfaced flooring, replacing all furniture to its original position when completed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ONE TIME PER WEEK</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Lobbies, Entries and Hallways</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Clean stairwell glass leaving a bright streak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brush and clean door thresholds as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buff hard surface floors, if needed, so as to enable them to present the best possible appearance.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all window ledges and flat surfaces within reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust vents, diffusers and grills.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum all upholstered furniture.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all high partition ledges, moldings, window ledges, baseboards and low ledges.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Stairways and Elevators</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum carpeted stairs and landings.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Police and remove all waste and debris.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean carpet as needed, removing gum and other foreign substances.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust handrails, door frames, ledges and other flat surfaces within reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all vents, diffusers and grills.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all high partition ledges, moldings, window ledges, baseboards and low ledges.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">C.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Office Areas</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean smudges and handprints from walls, doors and light switches.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sweep and damp mop all hard surface floors, leaving in a clean, streak free condition.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Damp wipe telephone using a disinfectant.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust chair bases and other low ledges.</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all window ledges and other flat surfaces within reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust vents, diffusers and grills.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum all upholstered furniture.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all high partition ledges, moldings, window ledges, baseboards and low ledges.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">D.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Restrooms</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust all horizontal surfaces within reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">E.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Exterior of Building</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sweep all exterior stairways and landings.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ONE TIME PER MONTH</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Lobbies, Entries and Hallways</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum edges along baseboards and interior of elevators.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean smudges and scuffs from baseboards as needed.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust mini blinds.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Stairways and Elevators</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dust handrails.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spot clean doors and wall surfaces within reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum edges of carpets and concrete along baseboards where upright vacuum cleaner will not reach.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.25%;"></td>
<td style="width:93.75%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacuum edges of cement stairwells.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ONE TIME PER QUARTER</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">A.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Lobbies, Entries and Hallways (Common Areas of Building)</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Strip wax, scrub and wax tile floors once every three months (four times per year).</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.&#160;&#160;&#160;&#160;<font style="font-weight:normal;"> </font><font style="text-decoration:underline;">Restrooms</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:6.42%;"></td>
<td style="width:93.58%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Strip wax, scrub and wax tile floors once every three months (four times per year).</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</a></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.53
<SEQUENCE>8
<FILENAME>mnkd-ex1053_454.htm
<DESCRIPTION>EX-10.53
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex1053_454.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="EXHIBIT1018819_HTM_S9F7072A80F11AB0E5274"></a>Exhibit 10.53</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FIRST AMENDMENT TO LEASE</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS FIRST AMENDMENT TO LEASE (the &#8220; <font style="text-decoration:underline;">Amendment</font> &#8221;) is made as of the 11th day of February 2019 (the &#8220;<font style="text-decoration:underline;">Effective Date</font> &#8221;) by and between <font style="font-weight:bold;">BPR 293 EQUITY PARTNERS, LLC</font> , a Massachusetts limited liability company (&#8220;<font style="text-decoration:underline;">Landlord</font> &#8221;), and <font style="font-weight:bold;">VALERITAS, INC</font> ., a Delaware corporation (&#8220; <font style="text-decoration:underline;">Tenant</font> &#8221;).</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RECITALS</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A. Pursuant to that certain lease dated as of May 10, 2017 (the &#8220; <font style="text-decoration:underline;">Original Lease</font> &#8221;), Landlord, as successor-in-interest to RFP Lincoln 293, LLC, a Massachusetts limited liability company, leases to Tenant certain premises in a building located at 293 Boston Post Road, Marlborough, Massachusetts (the &#8220; <font style="text-decoration:underline;">Building</font> &#8221;), which premises consist of approximately 10,203 rentable square feet of space on the third (3rd) floor of the Building (the &#8220; <font style="text-decoration:underline;">Third Floor Space</font> &#8221;) and approximately 4,968 rentable square feet of space on the lower level of the Building (the &#8220; <font style="text-decoration:underline;">Lower Level Space</font> &#8221;), which Original Lease was amended by that certain Term Commencement Date Agreement dated as of December 19, 2017 (the Original Lease, as so amended, the &#8220; <font style="text-decoration:underline;">Existing Lease</font> &#8221;). The Third Floor Space and the Lower Level Space collectively contain approximately 15,171 rentable square feet and are collectively referred to herein as the &#8220; <font style="text-decoration:underline;">Existing Premises</font> .&#8221;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">B. &#160;&#160;&#160;&#160; Landlord and Tenant now desire to amend the Existing Lease to add certain additional space on the third (3rd) floor of the Building, adjacent to the Third Floor Space (the &#8220; <font style="text-decoration:underline;">Expansion Premises</font> &#8221;), as shown on <font style="text-decoration:underline;">Exhibit A</font> hereto, to extend the term thereof, and in certain other respects, all as more particularly set forth below.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C. &#160;&#160;&#160;&#160; NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Definitions</font> . Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to such terms in the Existing Lease. The Existing Lease, as amended and affected by this Amendment, is hereinafter referred to as the &#8220; <font style="text-decoration:underline;">Lease</font> .&#8221; The above recitals are incorporated into and made a part of this Amendment by this reference.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Premises</font> . As of the Expansion Premises Commencement Date (as defined in <font style="text-decoration:underline;">Section 7(a)</font> below), Landlord hereby leases to Tenant, and Tenant hereby accepts, the Expansion Premises, subject to and with the benefit of the terms, covenants, conditions, and provisions of the Lease, and the lease of the Expansion Premises by Tenant shall be on all of the terms, covenants and provisions of the Existing Lease, except as modified by this Amendment. The anticipated Expansion Premises Commencement Date is estimated to be May 15, 2019 (the &#8220; <font style="text-decoration:underline;">Target Expansion Premises Commencement Date</font> &#8221;). From and after the Expansion Premises Commencement Date, all references to the &#8220;Premises&#8221; in this Amendment and the Lease shall be deemed to refer to the Existing Premises and the Expansion Premises. Landlord and Tenant hereby acknowledge and agree that, notwithstanding anything to the contrary contained in the Existing Lease, from and after the Expansion Premises Commencement Date, the Third Floor Space and the Expansion Premises shall be deemed to contain 15,259 rentable square feet in the aggregate. In addition to Landlord&#8217;s Expansion Premises Work, Landlord, at its expense, shall deliver the Expansion Premises on the Expansion Premises Commencement Date (i) free from asbestos-containing materials and any other materials recognized by law to be &#8220;hazardous&#8221; or &#8220;toxic,&#8221; (ii) otherwise in compliance with all applicable laws and codes, (iii) with the heating, ventilating and air conditioning (HVAC), electrical, plumbing, mechanical and fire/life safety systems serving the Expansion Premises in good working order, and (iv) vacant, free from personal property. Notwithstanding anything herein to the contrary, Tenant shall not be responsible for the costs and expenses incurred in connection with the removal or remediation of Hazardous Material that is not in compliance with applicable law as of the Expansion Premises Commencement Date and which is located in, on or under the Building or the Property prior to the Expansion Premises Commencement Date unless such Hazardous Material was brought on to the Property by Tenant or its agents. Landlord hereby represents that, to its actual knowledge, there are currently no Hazardous Materials in the Expansion Premises.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="text-decoration:underline;">Term</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> .</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Notwithstanding anything to the contrary contained in the Existing Lease, the Lease Term is hereby extended by two (2) years, commencing on March 1, 2024 and, unless earlier terminated or extended in accordance with the Lease, terminating on February 28, 2026 (the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220; </font><font style="text-decoration:underline;">Extended</font><font style="text-decoration:underline;"> Term</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8221;). Notwithstanding the foregoing, Landlord and Tenant hereby acknowledge and agree that the extension of the Lease Term for the Extended Term is subject to Landlord&#8217;s delivery of the Expansion Premises to Tenant in accordance herewith.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Base Rent</font> . Notwithstanding anything to the contrary in the Existing Lease, from and after the Expansion Premises Commencement Date (but in no event earlier than June 1, 2019), Tenant shall pay Base Rent for the Premises as follows:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Third Floor Space and Expansion Premises</font> :</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="FIS_UNIDENTIFIED_TABLE_21"></a>&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:44.95%;"></td>
<td style="width:37.97%;"></td>
<td style="width:17.08%;"></td>
</tr>
<tr>
<td colspan="3" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lease Period</p></td>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual Base Rent</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Monthly</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Installment</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Base Rent</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From the later of (i) the Expansion Premises Commencement Date; and (ii) June 1, 2019 until the day immediately prior to the four (4) month anniversary thereof</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$196,407.75<br />(calculated on the basis of $19.25/r.s.f. on 10,203 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$16,367.31</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From the four (4) month anniversary of the later of (i) the Expansion Premises Commencement Date; and (ii) June 1, 2019 until October 31, 2019</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$274,870.75<br />(calculated on the basis of $19.25/r.s.f. on 14,279 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$22,905.90</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2019 to October 31, 2020</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$285,580.00<br />(calculated on the basis of $20.00/r.s.f. on 14,279 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$23,798.33</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2020 to October 31, 2021</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$296,289.25<br />(calculated on the basis of<br />$20.75/r.s.f. on 14,279 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$24,690.77</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2021 to October 31, 2022</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$306,998.50<br />(calculated on the basis of $21.50/r.s.f. on 14,279 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$25,583.21</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2022 to February 29, 2024</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$317,707.75<br />(calculated on the basis of $22.25/r.s.f. on 14,279 r.s.f. only)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$26,475.65</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 1, 2024 to February 28, 2025</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$350,957.00 &#160;<br /> (calculated on the basis of $23.00/r.s.f. on 15,259 r.s.f.)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$29,246.42</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 1, 2025 to February 28, 2026</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$362,401.25 &#160;<br /> (calculated on the basis of $23.75/r.s.f. on 15,259 r.s.f.)</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$30,200.10</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Lower Level Space which includes 4,968 rentable square feet</font> :</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="FIS_UNIDENTIFIED_TABLE_22"></a>&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:44.87%;"></td>
<td style="width:17.06%;"></td>
<td style="width:17.05%;"></td>
<td style="width:21.02%;"></td>
</tr>
<tr>
<td colspan="4" valign="middle" >
<p style="text-align:center;margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="text-align:center;margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lease Period</p></td>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Base Rent</p></td>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Per Square</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Foot</p></td>
<td valign="middle"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Monthly</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Installment of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Base Rent</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 1, 2019 to October 31, 2019</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$36,018.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.25</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,001.50</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2019 to October 31, 2020</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$37,260.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.50</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,105.00</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2020 to October 31, 2021</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$38,502.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$7.75</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,208.50</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2021 to October 31, 2022</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$39,744.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,312.00</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November 1, 2022 to February 29, 2024</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40,986.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.25</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,415.50</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 1, 2024 to February 28, 2025</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$42,228.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.50</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,519.00</p></td>
</tr>
<tr>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 1, 2025 to February 28, 2026</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$43,470.00</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.75</p></td>
<td valign="top"  style=" border-top:solid 0.75pt #00000A; border-bottom:solid 0.75pt #00000A; border-left:solid 0.75pt #00000A; border-right:solid 0.75pt #00000A;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:2.25pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$3,622.50</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Tenant&#8217;s Proportionate Share</font> . Notwithstanding anything to the contrary in the Existing Lease, from and after the Expansion Premises Commencement Date, Tenant&#8217;s Proportionate Share shall be 11.32% (based upon the rentable square feet of the Premises (including the Third Floor Space, the Lower Level Space and the Expansion Premises) of approximately 20,227, and total rentable Building square footage of approximately 178,697 square feet).</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Parking</font> . Notwithstanding anything to the contrary in the Existing Lease, from and after the Expansion Premises Commencement Date, Tenant shall have the right to use sixty-eight (68) parking spaces in the parking areas serving the Building, on a non-exclusive, &#8220;as available&#8221; basis, based on a parking ratio of 3.4 spaces per 1,000 rentable square feet of the Premises.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Expansion Premises Work</font> .</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) &#160;&#160;&#160;&#160; Landlord shall perform work in the Expansion Premises to prepare it for Tenant&#8217;s occupancy (the &#8220; <font style="text-decoration:underline;">Expansion Premises Work</font> &#8221;), pursuant to the plan attached hereto as <font style="text-decoration:underline;">Exhibit B</font> (&#8220; <font style="text-decoration:underline;">Approved Plans</font> &#8221;), using Building standard materials and finishes. Subject to any Tenant Delays and Force Majeure Events, Landlord shall use commercially reasonable efforts to substantially complete the Expansion Premises Work on or before the Target Expansion Premises Commencement Date; provided, however, that Landlord shall have no liability whatsoever to Tenant in the event that Landlord shall fail for any reason whatsoever to substantially complete the Expansion Premises Work on or before such date. Notwithstanding the foregoing, in the event Landlord fails to substantially compete the Expansion Premises Work on or before September 15, 2019, Tenant shall have the right, upon thirty (30) days&#8217; prior written notice to Landlord and Landlord&#8217;s Mortgagee, to perform or cause to be performed the Expansion Premises Work in accordance with the plans and specifications therefor, unless, within such thirty (30) day period, Landlord substantially completes the Expansion Premises Work. In the event that Tenant exercises this option of self-help, Landlord shall reimburse Tenant for the costs reasonably incurred by Tenant in connection therewith within thirty (30) days of receipt of a request from Tenant together with reasonable and customary back-up documentation. Landlord hereby grants to Tenant, its contractors, agents and employees a temporary right and easement to enter upon any portion of the Expansion Premises for the purpose of performing any such portion or all of the Expansion Premises Work. Tenant shall not be obligated to pay Rent with respect to the Expansion Space while Tenant is performing the Expansion Premises Work. Landlord covenants and represents that the Expansion Work shall be completed in a good and workmanlike manner and in compliance with all applicable Legal Requirements, including without limitation, all applicable permits and governmental approvals in connection therewith. Furthermore, during the performance of the Expansion Premises Work, Landlord agrees to use commercially reasonable efforts to minimize any material interference with Tenant&#8217;s business in the Existing Premises. The Expansion Premises Work shall be deemed to be substantially completed as of the date (i) when the Expansion Premises are in substantial accordance with <font style="text-decoration:underline;">Exhibit B</font> , even though minor details of construction, decoration, and mechanical adjustments remain to be completed by Landlord, as determined by Landlord&#8217;s architect, in such architect&#8217;s sole reasonable discretion; and (ii) Tenant is permitted, in accordance with applicable Legal Requirements, to occupy the Expansion Premises for the conduct of its business and Tenant has been notified thereof (which notification may be verbal). Such date is referred to herein as the &#8220; <font style="text-decoration:underline;">Expansion Premises Commencement Date</font> .&#8221; Landlord hereby agrees that it shall keep Tenant reasonably appraised of the status of the Expansion Premises Work and the anticipated Expansion Premises Commencement Date. Landlord shall have no obligation to perform any work not shown on <font style="text-decoration:underline;">Exhibit B</font> . Landlord shall complete any punch-list items that remain to be performed by Landlord, if any, within thirty (30) days after the Expansion Premises Commencement Date. Tenant shall notify Landlord within thirty (30) days of Tenant&#8217;s occupancy of the Expansion Premises of any portion of the Expansion Premises Work, including punch-list items, that remains incomplete or any manner in which the Expansion Premises is not in the condition required to be delivered pursuant to this <font style="text-decoration:underline;">Section 7</font> . Except as identified in any such notice from Tenant to Landlord, Tenant shall have no right to make any claim that Landlord has failed to perform any of the Expansion Premises Work fully, properly and in accordance with the terms hereof or to require Landlord to perform any further Expansion Premises Work.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) &#160;&#160;&#160;&#160; Subject to <font style="text-decoration:underline;">Section 7(c</font> ) below and Tenant&#8217;s obligation to pay for the cost of all Change Orders in accordance therewith, Tenant shall be responsible for Sixteen Thousand Five Hundred and 00/100 Dollars ($16,500.00) of the cost of the Expansion Premises Work (the &#8220; <font style="text-decoration:underline;">Tenant&#8217;s Cost</font> &#8221;) and Landlord shall be responsible for the balance of the cost of the Expansion Premises Work. Tenant shall pay Tenant&#8217;s Cost to Landlord within thirty (30) days of the Effective Date and any delay by Tenant in paying the Tenant&#8217;s Cost to Landlord shall constitute a Tenant Delay </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hereunder. Landlord shall have no obligation hereunder to commence the Expansion Premises Work until Tenant has paid the Tenant&#8217;s Cost to Landlord. Landlord and Tenant hereby acknowledge and agree that the cost of the Expansion Premises Work shall include a construction management fee payable to Landlord equal to three percent of the total cost of the Expansion Premises Work, as well as costs in connection with engineering and design, as well as construction-related costs and expenses.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) &#160;&#160;&#160;&#160; To the extent that Tenant requests any modifications to the Approved Drawings (a &#8220; <font style="text-decoration:underline;">Change Order</font> &#8221;), and such modification is reasonably acceptable to Landlord and the parties agree in writing to the costs of such Change Order, Tenant shall pay to Landlord, promptly on demand, all costs of such Change Order as reasonably estimated by Landlord&#8217;s contractor as of the time of Landlord&#8217;s approval of any such modifications requested by Tenant. Tenant shall, if requested by Landlord, execute a work letter confirming such excess costs prior to the time Landlord shall be required to commence work. Landlord shall have no obligation to commence such work unless and until the Tenant shall have paid such excess costs to Landlord. In the event that the actual cost to Landlord of completing any Change Order is greater than the estimate of Landlord&#8217;s contractor, then Tenant shall pay to Landlord such difference within ten (10) days after Landlord advises Tenant of such actual cost and submits to Tenant reasonable and customary evidence substantiating such actual cost. The costs of any Change Order may include a construction management fee, as more particularly described above.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) &#160;&#160;&#160;&#160; As used in this Amendment, a &#8220; <font style="text-decoration:underline;">Tenant Delay</font> &#8221; means each day of delay in the performance of the Expansion Premises Work that occurs because (a) Tenant requests any change to the Approved Plans, or (b) Tenant or any agent, contractor, or employee of Tenant otherwise delays the completion of the Expansion Premises Work (provided that Landlord shall notify Tenant within twenty-four (24) hours of such request or act or omission of Tenant or any agent, contractor or employee of Tenant that such request, act or omission constitutes a Tenant Delay hereunder). In the event that the Expansion Premises Work shall not be substantially completed by Landlord on or before the day immediately preceding the Target Expansion Premises Commencement Date as a result of the occurrence of a Tenant Delay, then in such event, (a) for all intents and purposes of this Amendment, the Expansion Premises Work shall be deemed to have been substantially completed by Landlord as of the date Landlord shall determine, in its reasonable discretion, that Landlord would have substantially completed the Expansion Premises Work but for the occurrence of such Tenant Delay; and (b) the Expansion Premises Commencement Date shall be the day after the date determined by Landlord to be the date as of which Landlord would have substantially completed the Expansion Premises Work but for the occurrence of such Tenant Delay.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e) &#160;&#160;&#160;&#160; Provided no Default of Tenant or event that, with the passage of time or notice would constitute a Default of Tenant under the Lease, then exists under the Lease, Tenant and Tenant&#8217;s vendors shall have access to the Expansion Premises prior to the Expansion Premises Commencement Date for the sole purpose of installing telecommunications, audio-visual and other similar wiring and equipment and Tenant&#8217;s furniture and fixtures therein. Any such early entry upon the Expansion Premises by Tenant or any of the agents, employees, and contractors of Tenant shall be at Tenant&#8217;s sole risk and expense and shall be upon all of the terms and conditions of the Lease (including, without limitation, all of the terms and conditions of the Lease with respect to insurance and indemnification obligations) except for Tenant&#8217;s obligation to pay Rent or Additional Rent with respect to the Expansion Premises. Further and at Tenant&#8217;s sole cost and expense, Tenant shall cooperate, fully and in all respects, and cause its agents, employees, and contractors to cooperate, fully and in all respects, with Landlord and all of the agents, employees, and contractors of Landlord so as not to delay, hinder, limit, or in any way impede the construction and/or installation by Landlord of any of the Expansion Premises Work.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Utilities</font> .&#160;&#160;&#160;&#160;Landlord and Tenant hereby acknowledge and agree that, notwithstanding anything to the contrary contained in the Existing Lease, the Lower Level Space is presently separately metered with respect to electricity usage and that the Expansion Premises are not presently separately metered with respect to electricity usage. If Tenant elects to cause the Expansion Premises to be separately metered for electricity usage, such meters may be included in the Expansion Premises Work as a Change Order and the cost thereof shall be paid by Tenant in accordance with <font style="text-decoration:underline;">Section 7(c)</font> above. In the event that Tenant elects not to cause the Expansion Premises to be separately metered, Landlord shall have the right to invoice Tenant, and Tenant shall pay when Rent is due its equitable portion of electricity usage for the Expansion Premises as reasonably determined by Landlord. Landlord, upon request of Tenant, shall provide reasonable backup for such electricity usage charges invoiced to Tenant. Landlord and Tenant hereby acknowledge and agree that </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the current charge for electricity usage for the Expansion Premises shall be [$2.36] per square foot of the Expansion Premises per annum.</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Condition of the Premises</font> . Tenant acknowledges and agrees that, subject to Landlord&#8217;s obligations as expressly set forth in the Existing Lease and in this Amendment, Tenant is leasing the Premises in their &#8220;as is,&#8221; &#8220;where is&#8221; condition and with all faults, without representations or warranties, express or implied, in fact or by law, and without recourse to Landlord. Tenant acknowledges that it has been occupying the Existing Premises and has found the same satisfactory. Tenant agrees that, subject to Landlord&#8217;s obligations as expressly set forth in the Lease, Landlord shall have no obligation to perform any work of construction or repair to render the Existing Premises or the Expansion Premises fit for use or occupation, or for Tenant&#8217;s particular purposes or to make them acceptable to Tenant. Except as expressly provided herein, Landlord shall not be obligated to provide any rental abatements, improvement allowances, or other payments, credits or allowances of any kind with respect to this Amendment.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Brokerage</font> . Landlord and Tenant hereby each represent and warrant that it has dealt with no broker in connection with the negotiation or execution of this Amendment other than Lincoln Property Group (the &#8220; <font style="text-decoration:underline;">Broker</font> &#8221;). Landlord and Tenant agree to indemnify each other against any costs incurred by the other party (including reasonable attorneys&#8217; fees) if the foregoing representations are untrue. Landlord shall pay directly to the Broker any commissions and/or fees that are payable to the Broker with respect to this Amendment under the terms of a separate agreement. The foregoing indemnification obligations shall survive the expiration or any termination of the Lease.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Ratification of Lease</font> . Except as amended and modified by this Amendment, all the terms, provisions, agreements, covenants and conditions of the Lease are hereby affirmed and ratified, including without limitation, Tenant&#8217;s right to extend the Lease Term pursuant to <font style="text-decoration:underline;">Section 3.2</font> of the Existing Lease and Tenant&#8217;s right of first offer pursuant to <font style="text-decoration:underline;">Section 2.3</font> of the Existing Lease From and after the date hereof, all references to the Lease shall mean the Lease as amended hereby, and to the extent there is any conflict between the provisions of the Lease prior to the date hereof and this Amendment, the terms of this Amendment shall take precedence and be controlling. Landlord and Tenant each hereby ratifies and confirms its obligations under the Lease, and represents and warrants to the other that, to its knowledge, it has no defenses thereto. Additionally, Landlord and Tenant further confirm and ratify that, as of the date hereof, (a) Landlord and Tenant are and remain in good standing and the Lease is in full force and effect, and (b) neither Landlord nor Tenant has any claims, counterclaims, set-offs or defenses against the other arising out of the Lease or in any way relating thereto or arising out of any other transaction between Landlord and Tenant.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Execution/Entire Agreement</font> . This Amendment, together with the Lease as affected hereby, constitutes the entire agreement of the parties, and may not be amended except by written instrument signed by all parties. This Amendment shall have the effect of an agreement under seal and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. This Amendment may be executed in counterparts all of which taken together shall constitute an original executed document.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13. &#160;&#160;&#160;&#160; <font style="text-decoration:underline;">Transmission of Amendment by Facsimile or PDF</font> . The transmission of a signed counterpart of this Amendment by facsimile or by portable document file (&#8220;PDF&#8221;) shall have the same force and effect as delivery of an original signed counterpart of this Amendment, and shall constitute valid and effective delivery for all purposes. If either party delivers a signed counterpart of this Amendment by transmission of a facsimile or PDF, it shall also send to the other party, promptly upon the request of such other party, by overnight courier or personal delivery a signed original counterpart of this Amendment, but failure to do so shall not render this Amendment void or voidable by either party.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="EXHIBIT1018819_HTM_SAA4A392D6A54853E1381"></a>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, this Amendment has been executed as of the day and year first above written.</p>
<p style="margin-bottom:0pt;line-height:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:576pt;;">
<tr>
<td style="width:288pt;"></td>
<td style="width:288pt;"></td>
</tr>
<tr>
<td colspan="2" valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="middle" >
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LANDLORD:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">BPR 293 EQUITY PARTNERS, LLC<font style="font-weight:normal;"> ,</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a Massachusetts limited liability company</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: <font style="text-decoration:underline;">s/ Kambiz Shahbazi</font> ____________</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Kambiz Shahbazi, Manager</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TENANT:</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">VALERITAS, INC.</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: <font style="text-decoration:underline;">s/ Erick Lucera</font> ______________</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Erick Lucera</p></td>
</tr>
<tr>
<td valign="bottom" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.5pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="eolPage47"></a><a name="EXHIBIT3118819_HTM"></a><a name="FIS_EXHIBIT_31"></a>&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>mnkd-ex231_9.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex231_9.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:14pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>
<p style="margin-bottom:10pt;margin-top:4pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in Registration Statement Nos. 333-182457, 333-188790, 333-213366, 333-225428, 333-226648, and 333-242367 on Form S-8, and Registration Statement No. 333-262981 on Form S-3 of our reports dated February 23, 2023, relating to the financial statements of MannKind Corporation and subsidiaries (&#8220;MannKind Corporation&#8221;) and the effectiveness of MannKind Corporation&#8217;s internal control over financial reporting appearing in this Annual Report on Form 10-K of MannKind Corporation for the year ended December&#160;31, 2022.</p>
<p style="margin-bottom:10pt;margin-top:4pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Deloitte&#160;&amp; Touche LLP</p>
<p style="margin-bottom:10pt;margin-top:9pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Los Angeles, CA</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 23, 2023</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>mnkd-ex311_7.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex311_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">RULE 13a-14(a)/15d-14(a) CERTIFICATION </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Michael E. Castagna, certify that: </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. I have reviewed this Annual Report on Form 10-K of MannKind Corporation; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Evaluated the effectiveness of the registrant<font style="color:#000000;">&#8217;</font>s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Disclosed in this report any change in the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting that occurred during the registrant<font style="color:#000000;">&#8217;</font>s most recent fiscal quarter (the registrant<font style="color:#000000;">&#8217;</font>s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting; and </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant<font style="color:#000000;">&#8217;</font>s auditors and the audit committee of the registrant<font style="color:#000000;">&#8217;</font>s board of directors (or persons performing the equivalent functions): </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant<font style="color:#000000;">&#8217;</font>s ability to record, process, summarize and report financial information; and </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:45%;">
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;width:100%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael E. Castagna</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;width:100%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael E. Castagna</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer and Director </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 23, 2023</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>mnkd-ex312_8.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex312_8.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">RULE 13a-14(a)/15d-14(a) CERTIFICATION </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Steven B. Binder, certify that: </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. I have reviewed this Annual Report on Form 10-K of MannKind Corporation; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c) Evaluated the effectiveness of the registrant<font style="color:#000000;">&#8217;</font>s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Disclosed in this report any change in the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting that occurred during the registrant<font style="color:#000000;">&#8217;</font>s most recent fiscal quarter (the registrant<font style="color:#000000;">&#8217;</font>s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting; and </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant<font style="color:#000000;">&#8217;</font>s auditors and the audit committee of the registrant<font style="color:#000000;">&#8217;</font>s board of directors (or persons performing the equivalent functions): </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant<font style="color:#000000;">&#8217;</font>s ability to record, process, summarize and report financial information; and </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant<font style="color:#000000;">&#8217;</font>s internal control over financial reporting. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:45%;">
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;width:100%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Steven B. Binder</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;width:100%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steven B. Binder</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: February 23, 2023</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>mnkd-ex321_10.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex321_10.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1 </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup>&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirement set forth in Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the <font style="color:#000000;">&#8220;</font>Exchange Act<font style="color:#000000;">&#8221;</font>), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. <font style="color:#000000;">&#167;</font>1350), Michael E. Castagna, Chief Executive Officer of MannKind Corporation (the <font style="color:#000000;">&#8220;</font>Company<font style="color:#000000;">&#8221;</font>), hereby certifies that, to the best of his knowledge: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The Company<font style="color:#000000;">&#8217;</font>s Annual Report on Form 10-K for the period ended December 31, 2022, to which this Certification is attached as Exhibit 32.1 (the <font style="color:#000000;">&#8220;</font>Annual Report<font style="color:#000000;">&#8221;</font>) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In Witness Whereof, the undersigned has set his hand hereto as of the 23rd day of February, 2023. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td style="width:40%;"></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael E. Castagna</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael E. Castagna</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-right:78.57%;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup></font></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MannKind Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report on Form 10-K to which this certification relates), irrespective of any general incorporation language contained in such filing. </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>mnkd-ex322_6.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
mnkd-ex322_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2 </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup>&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirement set forth in Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the <font style="color:#000000;">&#8220;</font>Exchange Act<font style="color:#000000;">&#8221;</font>), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. <font style="color:#000000;">&#167;</font>1350), Steven B. Binder, Chief Financial Officer of MannKind Corporation (the <font style="color:#000000;">&#8220;</font>Company<font style="color:#000000;">&#8221;</font>), hereby certifies that, to the best of his knowledge: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The Company<font style="color:#000000;">&#8217;</font>s Annual Report on Form 10-K for the period ended December 31, 2022, to which this Certification is attached as Exhibit 32.2 (the <font style="color:#000000;">&#8220;</font>Annual Report<font style="color:#000000;">&#8221;</font>) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In Witness Whereof, the undersigned has set his hand hereto as of the 23rd day of February, 2023. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td style="width:40%;"></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Steven B. Binder</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steven B. Binder</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;margin-right:78.57%;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.86%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup></font></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;color:#000000;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of MannKind Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report on Form 10-K to which this certification relates), irrespective of any general incorporation language contained in such filing. </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g3puwq45lgum000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3puwq45lgum000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" <4"2(# 2(  A$! Q$!_\0
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M@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10
MF!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M
M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?
ME2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C
M]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\
MJ,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'
MH/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M% "8'H/RHP/0?E2T4
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MZ#\J,#T'Y4M% "8'H/RHP/0?E2T4 )@>@_*C ]!^5+10 F!Z#\J,#T'Y4M%
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M"!Z#J.WN*=2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]
M!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]
M!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA6MK;VFN:1XMAMG-@9]0CB%W);O*BQLKRLOSD$!"17XR?\&WW_!0?Q[I5_\
M$K_@E?\ MA>(&B^/'[.?B+4='^'-_KURZ:EXL\.6MRUM!86HN&\VZAL(,&VF
M!D#1A1R6)'--JM>=M=+[>NRZI==FOB2DKDWUMV_X'^>OR/[ (F#J&&<X^G?-
M2U1M$E0NLKE_FR@QC8OH??KU]JO5S6Y=%MT^>I3T^Y?BKA1110(**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I#T_$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!F\>_P#G\:1G&T\E
M>.OI4AY!'K4)3MU![\@?G2:3W0#"6\N21OE0 LH7AL+ZGOG&1]:_SRO^#FS4
M?&G[ G_!4/\ 9L_X*'_!.#3]-\8G3-)L8(+FV_XENHW_ (>M+IKMKF,8$SWD
M,ERDC#)0LLA1@N*_T-"N]95#$;_EVGL",<>@/)S_ %K\V?\ @HE_P2]_9L_X
M*6^!M#\(?'_P^T^I>"CJ%UX%\16S%+K1-5O;:2!;L*N/.C0LK/&Y*[0< [B*
MZ*35FF^5/32^EN6TK+>S7YDS;BKI7VO\VM-?GTWLD<)_P2N_X*7_  <_X*M?
MLM:?\0M#32!XNM;.#0/B[\,]0:SN)K#5I+;9?EM.D+RR:==.))(Y!'Y*Y5=P
M)45_,S_P<C_\$'_A-X(^#_B7]O']E'3].^'6H> M5E\3_$WP=I=M)%!JAN;A
M7@U'0883LL[NVN@LLC;1]T,<@U^"WQR^%?[?_P#P;??MVMK7PI\0>)!X-U?5
MFN/#NLVL5W-X1^)GA2:[)?0]8M8TDM1>RP/]G5UC^T XQNV[&_TD_@UJMG_P
M4W_X)[>&YOC9X'?P?9_'_P"&UJOBSPW-$=UC<:E8J[RVZ3?>*3A9%SC&,# K
MHYW3YN76$FN>%M&G97771W<7HUL[JUG[W+=)WLNG7SZ(_EK_ .#<S_@X.\0?
M%.7X8?\ !/S]HW0=2\1>,;.Q_LKX>_%47 E-WIUELCAT_P 0(<S3W<:21QPS
M$ ;0%!8*PK^ZXQ;"<99OEW%.'['D\?)Z#\.F:_EX_P""6_\ P;6_"+_@GU^U
M5X__ &D/$7BS_A8KVE]?)\(-+GC5%\.:?>323FZF4*/]*M\QQQAOFQ&G\(P/
MZBHY/W89G&5 RYP%?L,GL3Z?2N.M*G*4'!6G[W.];-7TMYI=>Z^]QO;7JK+Y
M<K=RI++Y+!U $>0SN%+Y7 W?*.3QD$ 'K7\,/_!9*R\%_L4?\%W?V%OVM?#>
MB0^'[CXAZOHWA3Q4-.B%E::I)<E-,AO+E4VK+<2O<L\Y8?.Y4MG Q_6[^W=X
MG_:'\#_LO?%OQ?\ LM:';^)?C-X<T"[USPWH=V?WEZUHAE:UL(L@W%Q(BE8X
MARV3Z5_G/?MP?M[?%_\ X*Z_M9?L _ [QI\'];^&?[1GPC^)WANW^(N@7FGR
MVLTMUIVKV=_?W<*D;R)(+61\!MJ#D=,5U0:4+VCT5MKN\6GU2]W5=4ME9A;J
M?ZDFE7,=Y965_&25U"QM+U,\_+<6\<J_^.M6G7.^%XI+70M$L9>)K+0]'MIT
M889)8M/@1EQU^\IW9Z$5T5<;\OZ_( HHHI %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1<UXI=O75=/NZ:;,_JYG\P2K*N\)C&W84E4DD?QCYH_4$$$<XKX-UK_@FO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4AZ?B/YBEI#T_$?S% "T444 (.@^@_E2T@Z#Z#^5
M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4C=#D9_3O2TC' )H  ,#IC]?UJ&=P@#O\L:!WED+;5C10"SM[  DGMC-)
M(':-B'*D9Z=#TZ_F?TK\\?\ @J7\:OBG^SQ^P!^TM\7?@]HMYXF^(WA?P!J;
M^'M,LHGGNC)>(+*XG@C0%BUK;SR7.0/E\O.>*J$>>2A_,TEI>[;$W9-GY/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %(>GXC^8I:0]/Q'\Q0 M%%% "#H/H/Y4M(.@^@_E2T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPA\,O .B:OIY<-<6>I6/AO3;>_CE3[Z!;U+A06 YZ9K_ "C-9_:E_;2^*/\
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M^P'O0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *0]/Q'\Q2TAZ?B/YB@!:***
M $'0?0?RI:0=!]!_*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA6E:+X0T+Q0/AY\?;BVE75/@YXZ<Z/XGN=6L(PVKIH]M>I!YL-O.&5$(1BH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHI,\X[T +1110 4444 %%%% !129&<=_
M2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHINY?7^= #J*;N7U_G_A1N7U_G_A0 ZBD!!Z'^=+1< HHHHO_7]>J^\
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MC/;UI-R^O\_\* '44W<OK_/_  I00>E "T444 %%)D>HI<T7 **** "BC-%
M!129'J*-P]1^=%_Z_KU0"T49STHH **** "B@'/2C- !129'J*7.>G-%P"BB
MC/7VZT %%%% !112;EQU%%P%HI 0>AS2T7 **,Y_/%% !1110 4444 %%%%
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MKS0%_P"OZ]1H?UY_*G;Q[_Y_&E.T?P_DN?T )_2FDJ/X&/L$/]0!0 N\>_\
MG\:-X]_\_C1E<9VGZ;>1^G\LT#:<X4C'JA'Y9 S0%QQ8#KG_ #V^M)N^N< X
MQSS3"&!P-Q![\_J?\\4@WXSAA[9IV_JX:^7]?/\ X8EW?4\XZ?YXHSD''O\
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M'3\,TG&O]FG'?:R^:O:U_3K?9@ZB2_B2BKK5W?:WW?I;L=5D>_Y'_"C(]_\
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M?L:@$_\ #0WPV(!Y_P"*BL__ (NJ\G_!03]C", M^T1\-QG_ *F"S/\ [/\
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M3?\ X*:?L)QPF=OVD_AR8UZL-8AX_450_P"'I/[!&"?^&E_AYCIG^U%(.3C
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M!CQU)QD9&:?*^VZN*4K-/D_!]T^J_P"&V/['?F[X^GMW'?K1ST(&#[XP.P_
M_7K7\@:?\'C7["!ENU;X7?$9!;D^4QU#3B+D9)W1_P"C8 (P1GGGTQ5:;_@\
M>_85508OA)\2IF* A1J.F@\=O^/?L.W!S5*DY=-.NJOT]/Z7D3S/^1[[:_Y7
M/[ -KO\ -N]B,>WUQ_A^M&&7KD^_''Z_YS7\=<__  >5?L1PQ1O'\%?B>[R
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MW_'MGKQD_P#ZFHMZI?D3S_UR_P# OU7WG]>>QO3_ #^% 4GV^O']*_DBTO\
MX/"/V ;Q2;[P3X\TQPP79+=64Q(/\0,5O@CD<#W]*Z!?^#O+_@G>3\VB^,0.
MQ\^T_5?)+#\12<+/F:V\_3I_7<3FFK-7O9:1?EY?U?T/ZOPK#H1_G\*< V>2
M,?Y]J_EDTO\ X.UO^";=^5^V7'B/3 4W$S2V[;3G[I"(.>_;\*[JT_X.L?\
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MXL;2_MAZV6D_UJS:_KIVY^\/^0CUZ9/_ -:H+C_@V,_X*XW$<PO/VN+FXC*
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M^/QYJR/^#0#_ ()BGS0+[XO;5*+&?^$J;/3DL=WS$]1D_G4\K\OO7^8OJO\
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M/Q=\2KAG;#+%X.<8P><G[:W3'/ K,D_X.TO^"4*.L?\ ;WQ3?<,DIX,8X_\
M)WG\Q7%K_P &AG_!*Q)RP7XR%"N K^,I'4'J2"0/_0>.E+/_ ,&AG_!+8C=;
MCXNHW;_BK2_XC@?IS6D;.V]]MWTMY^?YF3H-M?OJ6NUXSZVMJX=N_;J=T?\
M@[._X).I;R79\2?%/"# 0>"6+-C(P!]OP/3H>QJI'_P=M_\ !)R2))#XA^*J
ML6V[&\$-N'/4_P"G ^^,>U<0?^#0G_@EX83'YOQ>R64JP\4D-PP\P9!STSCT
MZ>M*G_!H9_P2U61BW_"X'C##"#Q8V2F.1G.=V?XOTYX7NZ?=N[]-K-]WMV&L
M/-Z^UI:]E+^[_<WUO\O)L[^#_@[0_P""3USYQ'B7XIKY8&W/@IOG#8SC_3AM
M_7IVJFG_  =K?\$GS)*A\0?%;]UG'_%%L0P'H/M@P/SKE1_P:)?\$IV> BV^
M,Z@>9N4^-'PW'R[\QG&.W#;O]FEE_P"#0[_@E;(Z;(_C%&JISM\8$ACD8R=@
MYQVP>.]:^Y;[2V[_ -WT_I._5![&IMSK_P !?EK\/]6^_IF_X.WO^"3PC:1=
M;^+#!3R!X)?/4C_G]]JRG_X.\?\ @E""1]M^,3$'MX$EVGGJ&%U@_P#UZI+_
M ,&B?_!*='R\'QA9%V?*?&1&2>N6\HEL_P"Z,>IZC=7_ (-+?^"4B1>5_8?Q
M2?9PK_\ "69?'N?)^;IUX_7-*T':SE?SYM[+YK?S%[&4K)U7376<:?,U?EZ2
MC;K^?9&>?^#O'_@E"%#?;?C$3_='@24G_P!*OZ5$G_!WK_P2?8X:Z^,R@>O@
M"?'M_P O('Z\5N1_\&F?_!*6.$@:!\4&SDDGQ9EOR\GM]:NK_P &H?\ P2EB
M\ED\)_$EF0?>/B;?NYS\V8AC\"?PI<B[_P#I?E_PWS2]3ZMWQ]72W_,/3;^S
M_=\W\O1HXR7_ (._?^"4<<FQ6^-<B_WU\ 7!7]+@_P ZC3_@\ _X)2-(R%?C
M<JKDAS\/[G!QZ9G'/T)KTK_B%3_X)4,$(\'?$%F'<^) >_<&$?S/K5ZW_P"#
M5W_@E;;,QC\$^.3N'S!_$*MD?]^1BGR+K+MTEY/NO5?+MJGAGI;'5?\ P137
M6/\ <?=O?2VNQY)_Q&!?\$I07PGQP. 2,_#^ZPQ'9?WQZ_C6?-_P>&?\$L45
MBFF?&^;:NY1_P@URI9NFW^(@_@?85[C#_P &M7_!*^TE+IX"\;2;C\RG6T?/
M?^X#^E;:_P#!L/\ \$KUM_L\GPV\6,@8MEM9C#$D<C/E$_AG_P"N<D=W+YVE
MTMY_U=?.XX:.G-CJK>G_ ##0\M+I)_Y?)V^8+C_@\6_X)@PB(6WAOXVSB1AY
M@/@ZXC\L'KD>2V2/\>*;<_\ !XK_ ,$P4 6W\.?&V1B3ECX-N%"'C')@.1[]
M/RS7U/;_ /!LI_P2NMHTC3X9>)<HX>,S:K&YRO.W'E_,O/0D5M0?\&U'_!+.
M%_-;X5:N6))'^GQHN6[[?*89]\]<FJ48=_G:?X^]K\QO#T6_>Q]=7W_V>'EM
MK==?/8^)Y_\ @\=_X)NL(?LWA#XQX97:[,WA6X4@K]Q8QY/S[Q]<'TK$G_X/
M)?\ @GPLKI;> OBRT*1[H99/#5V&:3_GFR"+*@#'S# ]S7WO;?\ !M?_ ,$M
M894N(/A1J^Z /M66^C>.4NVXM*IC E*\;22N!T!KK+7_ (-W/^"8D%L[R_!9
M9G95C&_R#MPW,BH%(\QA@L^]3C/%%H:+W=U]B76W2_7YHGZMA_\ H/Q'_@B/
MEY[]_P!>OYD?\1EG[".6_P"+=?$\CM_Q3]YSQW_=_P Z@NO^#RS]AE+5FL_A
MM\2IKK'R12Z%>QQ%O]MA'P*_5M?^#?'_ ()B1#RH/@5IV&C RT-O(>F"2S*G
MS>O%7-(_X-_/^":.FS_:!\"-$F:-F,<=S9VTD39!'SIR&'L<>Y--1I]X]/\
MEVT];6?QW_KUOE]2P]U?-<<M?^?-.W1=M=]MOR/QVE_X/-?V0 A,/PF\<%O[
MK:;J [>R#OT]O6LYO^#SC]E(X\OX/>,"P)+>;8Z@H(_V2JGGKU]>]?ME#_P0
M1_X)K,TLLW[/GA7<Q)55TVU51UZ 9R<^N.W2J</_  0C_P"">,$\D0_9X\%/
M;C[ADT>T8@8YP<@9(YS[D4^6E>RE#2U_<]-GS].KUZ]7JG@\/'7^U,<^JO2A
MY7TTZ^FFQ^)+_P#!Y[^S(MT\2_!/Q.UJL;,DHM]1^:4#*J%[>F<8]\XK(U#_
M (/0_P!GI!(+#X$^(KD%%VI<1:A&I<GYQUYP.1NX)'7M7[P1?\$+O^";L*H/
M^&<_!Y=9!< G2K0@E2,H?5#@\<<?IK'_ ((A?\$ZYE+K^S?X 0N!R=#L\@#'
M .>X'/U(I^RANI4[7W<7^'OZ^NPU0PSWS'&?^$\%V5]+/\7U>Y_-C\5/^#N7
M]D'XZ^ ?$?PP^+W[+#^,_ /BBRET_6?#&K6=Y<V=[;S1LA8-+%-Y$Z$Y25%5
MTYVD U_-!\)OVF_^"67PV_:5\7?%CQ-^S3J'Q$^&6J:M;:QX'^%5\U[;Z1X#
MN8KN*\C:"80[KQ5:-<QLK \#%?Z7+_\ !$__ ()ZPVSQ6O[-7PO>0X \_P .
M6;[1QDKZ$X!XYSSWK3TK_@C+_P $\;.&*-_V8?AA<7-NKDR3>'+)O-,@(*2
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M?M(2Y2']@/1A)QC.L>*R!Z=>/_UU_:_!^Q)^R% 7\C]FCX/Q C#%?!ND#(Z
M?\>_\JMQ?L3_ +(^<C]F_P"$:]P1X/TGZ?\ /"G>/9_='^O^']+3; ?\_<9Y
M>Y1\O^GF_P#7<_B5C_X/(/VIR"[?L!Z.Z2';#LU3Q20&4_,"0N3QZ_KCFTG_
M  >)?M9R*\\/_!/S26M@=Z_\33Q1\L2X\P'HQ.>X!/\ (?VU?\,7?LE?(I_9
MY^$Z^4Q=%7PAI8"L>"V%@ /ISFIA^QW^RM$C)%^S[\*PCJ4=?^$2TL H>6&/
M(.,GT(/O1>'9_P#@,?\ @=OQ9+C@=U6QE[;.-*W32_M/+MWT/XGH?^#Q#]JB
MZ#K:_P#!/*SFE"))\NI>*2L8;HW7)#]!NYYZ9Q3)?^#OO]LEY&6+_@G?I\"L
MRJJMJ'BHLC,.%(D4 ENHW&O[:8/V1_V7+4EK?X!?"Z)C&L3%/">EC*)RH/\
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MP=@_\%'KC)M/^"=MD5?_ %;I#XJD.,<?\N+J?S]JM6/_  =,?\%2KQ96MO\
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MJL/#VB+PFG6B+YIFV+:VX7>1CILQCV]>: YL*T_=JI]+J#73?W4_E\KZ._\
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M.-QSIK@\_3([5:'[+O\ P=,[US\3=9&T;=YUR+;@\Y)_LX8_08[5_HY LIV
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M'_1"$*CH6Z^O3V'' YZ"D\B+=NVY;LQY(^E#Q5=JSJ-KSZ[?Y>@>SIK:*_\
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MI-:=XOM>W?[E_&4O_!FG^RE$RNG[2/Q5D) #B2U@PXQ\V-MRW!7'/M76V_\
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MV?A]-_P;Q?\ !)<VTDDG[)WAU9R#B./4KA^3T^?9T]>,G'K7C_QM_P""(_\
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M)89Q^ROH8\LNNTW]QMQ@CD!,G&!CD5^XXC7@#Y5'W5'W?8 =OZ5'D '"[\L
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MSO!,^!M/]:O_  10_P""J'@K_@J/^S+IOC66YLM"^/G@N*#2_BUX8AF#%;R
M>5#JL,9?)AU,+YIP@V%LY(8 ?K5\0/AUX;^*/PS\8?#'Q;I5IK?AOQGX-NM
MU^SEC5[.\BO-/*!1&P*&,R,)H_1L'MD?YX/_  00@\6_L,?\%Z/C#^QYK5]%
M9>%_&K_$HR6=J66U(LKRXOO"-H8P=IQ:WEO!G;A3#UP0!DI)W2NE=Z73W5UI
MY^\K;;-69G)W=TK7L[>;1_I(VV#"C@ &0!FP<C<>N#Z9J>HHD$8*+@*#\JCH
MH[ =NGITJ6N1[[M]=?D2%%%%( HHHH **** "BBB@ HHHH **** "BBB@ I#
MT_$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *@)'5AD'CC/M_C4]5^>V/<GH!W/\NG--;J^UQ.]M-"
MA<'9%>1JIW"TF<<=]AQ^/X#H37\('_!'T1WW_!SA^WW<7,4<TG_",>.E0RJ'
MVJ8-*#%0P(!/E(,@9"@C/)S_ '?W+&))Y?O116]P]TO5WB6-F"K^'3ISQVK^
M$K_@CU>6M_\ \'-O_!0&ZM(3;V[^&O&WV:)E*NJ"'3U;<#SG=D\_[-'-+ZN[
M_P#/VG^,XK\OS+2E[6_/_P NY;[NT';;YI>;6RW_ +D[O1[CSF%KIN@^0P!9
MI--LV=\\GS,Q'K_G-"Z7J";0NE:%;JN-@BL[9.<YR,)QD\\=_?D=>O3D>G8<
MCM^5(T49(W.V<CCG@CTQTZ_2K]MR0IR:^RE=I7=TG=^MVG?H$N=N5JKB^9ZK
M;II9='O?K;L<\;>]<F)M/L0%"E7C55"MW( 'UX'48R!4+6NK2RA)TMUMXOWD
M9C8QEI%QC=LQ\O.#V^E=2(T&<.W/UI!$F,,V>,=&QC_/KWS4_7(]DO\ @V_K
M[^MR/WW_ $$/[F94Z:D_DM;O'#-@"<#F)U&=N"2<?7\,XJQ''>!P9+A]PY(7
MF/I]WK@]_?.*T%5$'!SC  /3'3&#GI3MWHH_S^5.->,DK)=5M=[QTN^R:5O3
MSL+G6\^;97<>RCT^7X?)8EQ:WKR[OM$RQ,P)=)G5D![(BL >^1CCWI397GFG
M9=S"/;RS2-O;_P >]O\ $5L@%LXZ#M]?3-/49!R,D''/-5[=:62\].GN_CKY
M+7RN'-._:UK?KL_TUZE.%)$4"21\=R9')_,DD;NWMZU8 [;VY^;DGK_=R>U2
M% <^^..W'M1L]SU_3_'W_2LD]7)=7?\ !=_O'^;WW_I?>-ROS $C&3G>W7_O
MK\J;M7"L'<9.,^8QYY[%N<'M^A[O\L?XG'7T_*E\L<=P.WOZBAZ_AOY6N/3K
M>WEOMK^/X#,X_C8_A_\ 7%-QSD22 YR>20>V,%B!_P#K^E3;1Z>G;T_Q[T;1
MZ=\]/T^E!*C'L_6[\O/R_+L1$G<#D^F<_3/'3D_TI,,226)4$MQPW/!  /0?
MC^=3;1CIZ\]^?\\4H '0?I0"5N_S;?YD 3'&24P6)W-O!//KGG_]52*%(!#-
M@=,MT[<Y_K4E%!5WIK_P^FOX$>S &2V1G&">,T@38/O.<GW/Z9J4G )]*C\S
MV_7_ .M0%WW_ *O<, ?+EN3G)/\ 4_YSBC;@9+.><C!(Z^G-&_/5<_Y^E&_M
MMX_S[4G&,K)K1?E^07?=C%B ;>&8 CD$G/O[>_Y4\H,[MQ!(]>OZ\_\ U\T9
M+\=.#[YZ?2G!<#!Y^HZ46BK*R796]%]^JU"[[L-I_O'U]::8SG.]AU_7^=24
M476W3T]+?F@NR$;,_P 7XGC^=&V,\G)QSC/KZ<YX[TNT?[7I]W]?I[=:-H_V
MO^^3Q_\ K[?K2]WLON[V\O-"Z]>FWR_R!EC88/3/8^WUZ>M1F*(= >/<D?S_
M !J7 ]&'X'\OKWS0 !V8_P# ?T.?3VH]WLON]/+S7W@TG=._3[]/^"0[%]/Y
MTH1 , $9Z]^G3O4N!_=;T[=^<_\ UZ,#IM;GZ=OY9_6CW>RZ=/3_ #7WD\J\
MW\WY?Y?UI:%D5MN1G:?E]O\ /^33_+SG@,#C(/J.F,=,=P34F!_=/KV_Q_2E
MV^A('H/\_P"--6Z?UHK?@/E72Z^?E_7Y$>UL\A,8V@?4^_Z_RZT,C-P> <$X
MQ@;?S_S^-/V_[1_^OZ_Y_.C:>?F/^?7U_2F+E\Y?>5VC3<'8-UR%5<#=_>!R
M/:G"-1DK(Z[NHP._X?\ ZJGQ@?WNX!IN?^F?Z?\ UJ ]U6O>_?5]O+O_ ,-J
M,*J0%RPQ_$, ]^,8Z8_&FY"CR\N2<X?:,@>@./\ #K]:ES_TS_3_ .M1D]-G
M7_/I1_7]??\ U9A>/GM;2_EY==/P(A N,%G;//S9//J.P_"FFV7!7S6 /!''
M(/;U'X=:MT4%WEW?X[?>5/LD/RC PO7GDXSU_'GGG/T%/6)4#' Y("D<D#C.
M"?Q_K[V*0_3/M0#E)WN[IJS7?;Y="OLC*X92><Y[TTQP 'Y2 PP<GUX'>K&/
M]CWYQW[#_/X=*3:.A3(![XSSW_#IUZ$^]!'+3_D]?=?=>7EUN5S#$8C%M.T@
M \_X5(L<0VE02$&%] /TYS4NT?W3Z=N@[_4__J]U.!Q@<G'Y\T#48](K:VWI
MY=DD1;4.>'^;^G/UINR,  9X8,3ZX[\U,",XP.K#\A].]*#QT[,<?3MT[T#2
M7\J_+J1!47/W@"<@8'&>I&?6E8[\ Y 'S?\  AT_ U)D''RC[N1_ATIN?^F?
MZ?\ UJ!.RTV]+_I\AC'<1DD >F.<]0<_YZ4A53_$_P"G],5*.>J8_#_ZU+M'
MIVQT_7ZT"Y82U<;^;NNWZ+YW\B +'W7=C^+H<>G!_KTI=L?8,/Q(_J:FV#^7
MZ?AW[T;1Z=\]/T^E [*UDK)6_"W^1 0IZ%U/3@#OUQQSGK_A2A1D?.^.FTXQ
MC/3_ .OFIMH]/7MZ_P"':C:/3MCI^OUH"T>BM\_3]5<B:)&SDGYNF.V!S@_3
M_)I!!&H*]R#U]#V';K^-2%\'ITX'^<4>9[?K_P#6I<TNS_\  E_GZ_T]+O*U
MKZ>O33S\E_29$T"E-N!DXXSC./R[5((8UYVCIS_.E\SV_7_ZU.4[AT]O6FI2
M\U\[BO+N_O\ 3S_KY#/*C^_M]_TQ_GFE"#Z#MCT[5)13YI=V%WW9&J8ZX^@Z
M?RI=@]_\_A3Z*&V_R_K\Q7?Z#,*#_P"R\']#S4;1ACGYAQZ?RJ; ZX&?I2T7
M??I;Y#N^[[%;[.C%6.[*^HQGDT/ C'YB, <#-6:3 /4#\J?-+O\ D(A\F/;M
MQC:,9Z=:%B2,$@Y'<<$?C4^/;KUXI,#I@8^E'-+N!%Y*\%>.0>N<CVH,:.1\
MW*]0&_F,T_:?[Q_S^-($QD@X)ZD#K]>:.:7?^OZ[@!CR1@D =AGGG^5(RDL>
M<# P?H>03[_CQ3MI_O'_ #^-* 1G)SGUHYGW_K3_ "!J^C(@BDDX&/X3VV'J
M!_7^=.V8X7&,<#V_P]ZEQ[?I1^'M2YGW?WD\J[?U_7]7(A%'G.!NZ]>?TQ3'
MC0'>%Y.0>O\ GGUZU8]\<T?7I2<I).S;\M=2DDFM%H^W]=#C/%>AZ1KGAOQ'
MHFKV<-]H^JZ)J5KJME<@/;W-I+93K)%,K @H0>001Z@]*_SJ/^#=#]IBR^ G
M_!:G]K?]F[2=,M;?P]^T'\0/B'X>LY =BZ8G@_Q=KFI6<%K%A4^8R1QH H^4
M;<8Q7^CO<QFY2X@^3;-;3PE2!AM\,B?,/XERW(]*_P L+]@Y;/X5_P#!S$\4
MEU;16R_'KXB 26Z Q*VJ7$[B(*F0'\W(8?WBV>#6M-7A>27I9ZW6G^?RMU%"
M<77MR]TV];_ GNN\NFF^FMC_ %0HHQEH^6V%ER1CH2#D@=#V'3'X&K'E  A5
M7/J22/RQ21ME0V00R*P(&"2PSR?<=/2IP<@'UK%:7MW_ *_S^8G"+;=EKOIO
MMY>7]/:-%4<9R5/Y>U24?A13*2MLB-MC9#=NI..WO5)/(EE>-&Y7L.P'^?ZU
M:;J?J:<D4:G>J*&(Y('//6@/SZZ?<,^S)G/(Y'%/\I!SR/QJ6B@=WW9'L4@\
MG'?D?X4T1)SSD?7I4V/;]*3 ]!^5 B/R8STS^=.V#W_S^%/Z=!10 S8/>F^2
MGO\ G4M% $7E*.1G/UI=@&,L/Q'7]:DHQGJ,_A0%K[J_R$POH.>G IK*#CH/
MPZ_RI_X=.E% K+LON_KLB/RESD\GIGC_ .O1Y2^GZ#_"I**!V\OP_KLON&>6
MG]T4!%QPN,]<BGT4!;R_#^NR^XB\E/0_G2B)0<C/^?PJ2B@226R_K^D1E/3]
M?_U4!/7]/_U5)105=VM?09L'O_G\*4*OU]\_X4ZB@0 8X%,V#W_S^%/HH 9L
M'O2[%]/Y_P"-.HH ;L';C_/O04!YYIU% #=@]S_GVQ2A0.@_G2T4 ,V#W_S^
M%&P>_P#G\*?10 S8/?\ S^%(4]/U_P#U5)36;;@X)'<^@H 9L/M_G\*-A]O\
M_A3 Q8*%R5;<?,)QM8$D#!YZC\C[4X[P=P;I]_/(./X0.WU'K0 NP^W^?PIX
M0=QS^-,!/;/.<J3R.^<]OH:1FV@'> J@EL_,>!V[GD]O3WI--VUL!)L7T_G_
M (T;%]/Y_P"-5%E+E=F6(;Y3R Z'[QQZKT'?\JN\_7G_ "*+R7KY:=N[U 85
M7Z?C_C2@8!VG/UY'Z4N.,'GZ\TO3H*%+FUU^8" GG(].F:0H#ZBG44P(S&IZ
MY_.@1*.F?SJ2B@!FP>_^?PHV#W_S^%/HH 9L'O\ Y_"EV#W/^?;%.HH B\E/
M?\Z7R^2>QZ^O ^F*DHH 9L'O_G\*-@]_\_A3Z* (FB4\_GD]OPH\J,],G\:E
MHQCH,?A3NULV SRU[#'THV#W_P _A3Z*.9]W]X#-@]_\_A1L'O\ Y_"GT4<T
MN[ 9L'O_ )_"C8/?_/X4^BCFEW?]?U_6H#-@]_\ /X4X*!TI:*0#2H/:C8/<
M_P"?;%.HH ;L7T_G_C33$A.><_7TJ2B@!FP>_P#G\*;Y2D[F&6SG(J6BB[6P
M?(CQNR#T7@8_R?:G!0.U.HIW?=A;R_ 0KNZYXINP>_\ G\*?12 C9?NJ/?K^
M=5IVVR*H. 2#^0S^O2KM,= V#M!/J0.A'O0!X9X-^.&@>-_BE\1/A#8:)K]A
MKWPVM=-O=8U#4;)X-(OX-5XA_LJ[Z7+J"!*%.4Z>]>W"+#CYCY:CY8QRIS_$
M3[')_E6?9:)I6GWEWJ4%E;QZEJ"A+V_6)1=74:',<<TP&YTCX"J3@8%:RJ%Y
M&?QYH -B^G\_\:-B^G\_\:=2$$]#B@!-B^G\_P#&C8OI_/\ QI-I_O'_ #^-
M&T_WC_G\:?,^[^\!=B^G\_\ &C8OI_/_ !I-I_O'_/XT;3_>/^?QHNWO=@+L
M7T_G2;![_P"?PHVG^\?\_C1M/]X_Y_&D %/3.??_ /52;./?]/Y4X*0<[B?;
M_)IU $7E Y+?H31Y*>_YU+10!$(L'CIQW.:4IZ?K_P#JJ2B@ HHHH **** "
MBBB@ HHHH **** "BBB@ II0'U%.HI7:>B?JFEV_K^M 9L'O_G\*-@]_\_A3
MZ*?-+S_\"_X/K_3T!FP>_P#G\*-@]_\ /X4^BJYI=W_7]?UJ S8/?_/X4;![
M_P"?PI]%+FEW?]?U_6H#-@]_\_A1L'O_ )_"GT4<S[O[P&;![_Y_"C8/?_/X
M4^BB[>]V S8/?_/X4;![_P"?PI]%("+R4]_SH\E/?\ZEHH C$:CIG\Z78/?_
M #^%/HH 9L'O_G\*-@]_\_A3Z* &;![_ .?PHV#W_P _A3Z* &;![_Y_"C8/
M?_/X4^B@!FP>_P#G\*78OI_/_&G44 -V+Z?S_P :-B^G\_\ &G44 ,90 2!_
M/UIH0GGCG_/I4M% [M;-D+JH*DYV\Y')SZ?D:RI;B3[2D!VDLP(*'F)?E^:7
MT 'KTZFMAVVX)R!S\WH>F,5^:O\ P5,_;M\)_P#!.?\ 9 ^)O[0^N1PZAXCM
M-*U&P\"Z%).D$^N>))K5UM[: NR[S#O2?8,D?*<8K2$;O9:[7[]_DD[]5;4A
MOI]_>VGIKKIN?S)_\'-G[87Q(_:;^-WP;_X)#_LP75YK?B+Q]K>D7GQCM=#S
M/<Q127L!LDE^S[L6EK:/<7%ZDAV'88VY85^AWQD_X(NV_P !O^"<?P+C_9$T
MO3/ W[7_ .R-;:1\8?#OB[3(5M]3\8>-M*MHKGQ#::S<Q>7+=PW%F+F)+:1S
M$&3E6;FOS+_X-A?V:M)_:)^-OQ?_ ."J/[27C+1O%/QM\?\ B;Q!:?!30]3\
M7Z=/K]A:7-[>?VZTFBW%RU_*EE";:SLA% JQI&) <KE_[<;[7=,T]+VY\1ZU
MIFGV \Z"_O=7EBL=,@M)%*W$-U<731P6Z&+<AN)66/G&ZME=JRT2\NWWWWN[
M=7JQ<WL[.[UWUWV^_96\NI\;_P#!-#]M?0/V[/V3? ?QKL%-IXLMHY_!WQ/\
M/W 6*_TSQ[X6*:7XFEGMB1)#'=ZG%-<6Q9=K1OA"=IQ^@=HS,S&<$LS?N>I(
MB/W=W/&?TK^5GX1?$;3_ /@FQ_P5CO?A7X+\2>#]4_85_;E-UX@T'5O#NJ6&
MM:+\//BM:)-'<V%YK.FRS:?ITOB'59I#!;R3)+<;@$1LX/\ 53 ) 29&4@,#
M$H'S*A (5SU/!'L>M85(-:[7L_DK?\-;[]S6$E.+>[OT]>G^=MK>BO;%]/Y_
MXT;%]/Y_XTZBH)&[%]/Y_P"-(P 7IW_7_P#53Z9(<+SZ_P"- $;KF,G)! )_
MG_G\*_FL_P"#J#3([C_@E7\1IF4$6%[%.CDD/YCR(< ="I.?PZ5_2LY&P@=Q
MP/K7\YO_  =% '_@DU\9#F/ -H )%RY;S5R8V)RI&"#^%/!OWI?XI_\ I#_X
M('I/_!M=/)-_P1R_9#5GB<6^B>((AY#%Y(HQK-T425>SG>QD'92A[\?O5L'O
M7X#_ /!LX7_X<[_LK,9(@IT_Q& D<)CDRFKR* []'8@ EQP00.H-?OSRP[K_
M )_"JK)Z)-K2_P"'?Y_*Q$&]5U[>5DOP_KJ-?*J=@Y_7'/3/?_\ 7VK\.O\
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M !1110 4444 %%%% !1110 4444 ,W'^Z>GH>O\ A1N;^Z>V.#^/_P!:GT4
M,W'^Z>OH>G^-.!)ZCOQ]/?WI:* &[0/7H1^?-&T<CGG'Z4ZB@!-OU^]N_&D)
M(/0X[\?R_K3J* &;C_=/3T/7_"C<>?E/;'!_'/\ 2GT4 -!)SP1UP<?E^-&&
M_O?H*=10 W#?WOT%&&_O?H*=10 4444 %(<]CC\,TM% #<-_>_048;^]^@IU
M% #<-_>_04ZBB@ HHHH 1LX..M,&\]21^'_ZJDHH ;AO[WZ"DV^Y].W3N/\
MZ]/HH B(8$@9(X[>G3\J3YO0]<]._P"5344 0_-Z'OV]>O:E&[(X/8=.WY5+
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 FX>H_.D+
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MZ_KS&.HJ,DCC=R.V/ZT N>G]*-;:_AZ*X7'EL=<T9''.,\\TQB<#/WLGK_\
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MI'XJ_##XMRW?[17[)W_!&OQYK_Q(\"Z#(@OM5^)5O:*UO!X3UO4;F&>#59]
M@@%R(KE98QY*[XF0$&Z4(3<E[R2UMJ[K9+YO>^R5NYG.I&_[J,ZD>Z2[I/;_
M !)[?/1G]6G_  2I_P""DJ_\%%_@1JOC;7?A[>_"7XQ> ]4M]*^)GPPU-)HK
MOPW-J44EWI#K%<G[44OK%#-^\7 /&[Y@!^JL,OFQJ_W"1D@CU&>/\\U_&9X>
M_:.;X/\ [77[,G_!7WX7Z+J?A']B/]MZ"#X3_';PE#=Q1Z=X.^)UY=77ASPE
M>:K8VRQV@>U>UN(GN]D4,#0OB-5&P?V.1:O9W-I97NEO%J5EJ%O#<:==VDR2
MVM[;S1K+'-#,C&-XFC<.K@D$<UC5C&.REVVZZ)K3MKM^(X3B]VTUTZ][Z]&M
MO5?/>X)R.3TI:JV\WFH&P.GSX&-K?W??'K5D,#T/\ZQOI>S6VZ_K;KZ%>FOF
M+112$@=3_.I4T]E+_P !?E_G^ "T4PG_ &L#M\N:.?[_ +]!WJPOTZCZ*9S_
M '^^.@ZTX ]VS[8% "T444KKN@"DR/44M(0#U'^?K3O_ %^'Y@&X>H_.ESGI
MS3<+[>O^?\.E *CI@=/_ *W^?Z4KKN@'44F<YP>?Y4F&_O?H*->EO/\ K[P'
M44WD<DY'THW#U]/UZ?IS35_^&3W_ *_/[U=+=H=G'6DW#U'YT$9X(HVCT'^?
M\_C0,-P]1^=&1ZBC:/0>O^?\*;A<# YYV]>H_P ]Z 'T5%AQZ_F#_,T\-C[Q
MY[_Y''2F]//T&]//T'9QUI,CKD8IC-GH1CW!_P #0",88@^F ?\  ?YS2:=K
MV^]/^M1:_P K];:?U_71C]P]1^=+FHF95QP.>0<?_6_S^%+\_P#G;2][R_JW
M_!_#S DHI@W]^/?BFDCLS8Q[]?2FK_\ #+^OZT"]MR6BF*V<#/8?GSFGDXZT
M._1???R_3] N(2!U-)N7U_S^--8Y/&.G<#\.M(,@Y(&,^@Z^O'MZ<?C19VOI
M]_Z?U_FM7JG&U^^O3S]27/?MZTF1ZBFY3&.WI@_X4I&,8'0X/L.I_P ]?UI:
M^7X^5_U_ 8%@/_K4A8@\E<?CT_E48;);=QCHV/\ #&>GX?G36;H2,CVQQZ?_
M *ZI)-VNODUKI>RZ7)BW->Y\712T>CL]-_3U19!STHS^O2HER>F=I_3OUQ_G
M-)N;CO\ AG_Z]%G?=?EVTWW[K^FU=[Z-;I]]+V_0D# G&#FG5$I!8G'J3U..
M/\^OX4JLQ/K^GXTMKW\NO>W^8TU)7B[I;OSV?X_UH.W#GG.*4'/(INT<@=>/
MP[TX# Q1K\@6VN]^FUA:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%!/>:S#"T5N([5Q))(%)W'!^D/\ @H5_P4]\ _M*?\$/=1^(NGZQ<>"OB?\
M%74?#_P(\;Z(ET^F^(_#OCY=6@TW7M*98I(KRVFE5)9TD01OMFP&(&:_*S_@
MH;^V5\3/V%?@9_P0B^./@;Q#J6GZ'HGA'4V\>^$;:[<:'XO\+-=Z='K=KJMC
M&WEW<O\ 9,EW'!O'RN4'N/AK_@N?\"=/TKQW^RW^V1^R[=ZS#^Q%^V7XG\#_
M !9O?#MMJ;77A;PW\9-2U#2Y-:M[VPA,EM8W9 N"HF=7#$KLR01U>["M"-W)
MRE>6T>6]E;32UKMW=[K:Z)JQ;II*45=*[;NWI';I?2U]GUT/M#XG?#/X0_L*
M?L:_MY?#C4O$MP\OP_L_V5OC+\$]/U_6[O4/%C^/IM#LM<NKC1KG4)YM0AL9
M=3.Z]CM)4B<9\T-7]@/_  1U_;V\/?\ !0W]A_X6_&G3KXWGC+3=-M?"?Q3C
MEVA[7QMI</E7J( ?FCEB1'1B 20PYP6/^=[_ ,'+6H>)H/VW? ^D"_N8/"^M
M?L]_!]QI]A<-!:ZE)%X7M,2WR(PBNO+R#$7#;%&%Y.:^O_\ @TV_X*5WW[._
M[2=_^Q)XUEBD^'WQYU-)/!K33)9QZ5X]W9DN)YYF$9CN+1/*5>I+.0,C-3CK
M0<8Q2VC?75<RC>UMTD[:[;KH+!R?)=N+;5]'TU5WM>[6G=^>W^FQ&P(('13C
M\?2G@@YQS@X/U]*I1JQ <_/N+#?$V$9'X1Q@X^[C!Y!JS&I!(!^5?E [YX.2
M>YYK@[^7_#?J=)+4<F-N#ZBI*@FZ?@/YTF[)OR&E=V'N!L)'88%?SH_\'0EL
MEQ_P26^-=P_F>9;K9E-H^0YN0OS^G0$$=?RK^BT_ZH_0_P Z_G=_X.?C*O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(?7GCL.^?:EJ.1BHX],^_7_.?:@:3;L1N0
M,DG S_DC&>/?C^M->>+>J;LG&6]57!.YO;C]35(S(A?RF!=CEO,/R-VRF<#
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M]?PK^'_XY_\ !P]^W_H/Q,\2>&1\#_ _P7T_3M-\ZVTRZUW2O&CQ2,!Y<_\
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MFB."3R" Q.5[_3WK_.=M/^"LG[:VD_VAJ]_\54G.I6[:?(HF<H?,^7%I'O\
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MI81#,Q&9ND:Y+^@![UPJ_M#_  /EOH=-7XH^#C?W#^7;VG]LVHEN'W;<1*9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5=+;.[[:V[^:.FG@JR@_9<E1^]93<5KI=+FM;2_+M>^A^IW_  =0Z'<^$?\
M@H_I_@ZS"+H?@_X:>"?#WAYVD5[AM/TG2K>V@:Y*LVQFB0;@>02<X(Q7\]OA
M3Q3XM^&?C7PG\4_ ^L7.@^*?"&L6&O:9JFFS-#>VEW9RK)YELZ$'YD#HPR-R
MNRY'4?=G[1GP _X*#_&7QO8_$;]HWPYXDUCQ3XD6"RL]9\97L]M-J*XV6Z6<
M]^!O0@X18V8 <<8K%A_X)D?MKPSV>E3?##3]/O-=@4Z9%J_B&TLY9K-DWI<6
M\-R4=X2K9$ZJT>.]*I1Q%;$J+4I-+JM+VCTMO9)>K^[..#KIJ554Z7*F[4W&
M5]=4^7;1^5G?NT?ZIG_!&[_@HOX*_P""BW[&W@/XG:+,T/C;PCHNE^%?B3I5
MPZFYM-;TJT2T>^G4$E1J/V=[Q6[DNV6S7ZUQ.KC<A#1L-RM_>SQD>W'6O\Z#
M_@V4\/?MX?L6?M?:M\!?%GA[PT?V??C-I]SJOQ#AA\0:;JL^F:WH%M]GT>^L
M+J"9VM JRSI=P;5\Q!@D[V _T-O#6NZ%KSW4OAS7M)UZRL6-C=R:1J%MJ$5I
M?QG][:W!M9)%@N(^=T#D2*,;E!R!E5I5J>\6N]]GJM/Z]5>PCKJCD0LO'7C\
MLU)162YOM);>H7&%3L*\=.O;K7\]?_!SC:R2_P#!(O\ :#)BCQ:V5C*9 3\H
M-R0H7W?.#]?>OZ%7) _''Z&OY\/^#G2Y2#_@D7^T,"&+W-E80K@'8 +D;LCU
M&>">F,U=#=^?-^1+77S2_%#O^#8J-HO^"//[-Y,MNWFGQ#+_ **Y>:)3J;H(
M[I6X24"/?A>-C!NM?T#-(N<E@/3Z5_.S_P &Q7B[P]=_\$A_V?\ 2U\3Z(UY
MH?\ ;=O?V>Z"QN-+>34I)E@O6D=#<RR^8Q60]$VKV K^@]O$'AW:"^N:(!CO
MJ5D%SWZRXK22;?;;H_Y8KM_7IJ)3@M'==K-);][ON:[!70KOX/ R#C/^/7IS
M4+(Q14#E64<A20'Z<LV0V0>1S_.LC_A*?"XZ^)/#XVG)W:M8 <?6<#_/O4+^
M,/")Y/BCPP,<?\AW3EX]\3GI_DU%I=G]UO\ +^M6"E3Z7O;O?^7S>BZK?2SW
M-.;3EGF@G=;:XDMSN62ZM()I8\DG]U/(C21$<XV,.>>YS>V)@ L!\^YUR=K8
MR0">N0?3]:YJ/QEX/(94\6^%FSP<>(=-9@?I]HX[=J=_PF'@^/AO%GAG)[?V
MUIK'_P!*#C\JE1E>_1[+[M?Q_JPW-=+M/KIY>?G\E\[=2' [Y7L?\XX'2GAP
MW3/U[#ZFN4;QIX1"@KXK\,+GC+ZYIR@C_=\_CI]#UJ6/Q3X7G&4\3>'9,]?*
MUNP(X_W9_:M.337RUUZVZ=O.^VZOLN==/S2_K?\ /L=+O4@'<,'I0SA<9(&3
MU;[O3/6N97Q5X;$A0>(] D?.WRAJEEE/KME)R,'@C\J2/Q'HETLAM=?T20(Y
M#L-1MG\LC^'&_P"HS]*/92M?TMH_+[NENXO:PVO^7R\OQNK:GYA?\%R LG_!
M*[]L/KS\,+U8Q_><W5N!C_'V/M6__P $9$EC_P"":7[*HE=2P^&>@\@\!186
M^%Y[UQ?_  6ZU/3+K_@E?^V'#%K6ER7<WPOOO)1-0MV<D7=J!Y<0<N7P6P O
M^%=7_P $<+R#_AVE^RJC7EH)XOAGX>2;]]&-C"Q@_P!8,Y#,,L0P_E6G))TW
M#>[BK)??_FWH9N4?:*6FU][/5)+5=7V^^Q^I43!N?^ XYZ^G3VI"X);')&,C
MO^59)NX'WN)X9@C;F:&4%%P.^S(QZ]>OM4GVJ/S$1);=B%WL@G4N P.,@?-T
MZ=JB.':Z/:[[[7W^[H'UA1=G;^K=-=/TL^Y=#H)5^8$EPN,\@GV]*_A*U8Q'
M_@\>L]XE&/ FGB/: 3YO_"))M8_],RQ+$]=M?W51-(URF)8&W ':N&<;>3D@
M<'&>3BOX6-;C-W_P>.6(2/SS'\/].9U6;R?*\CPD!YA;^+8JJYC_ (]V.M4X
M.-E>_P#ES+R6FC^XT]KS1NDM$]K:O339J^NJ_P S^T3XZ_%.U^%'AJ"\N?"'
MBKQPOB2\D\.SV7A2T^UWME%>P^2]W=* 3';1I*=SYSP<'H:_@8_:4\)?&W]F
M[XYZ[^Q=X3^$?Q[\:_L!V7QGTC]IWQ/XDT?P7:WOC"P\5#6O^$GFT31]0,#W
M<]B;G,%RKS$QH<*M?Z(.J6<LZR21.D,BD;G8%U>/'/R[?E.3U]C7#WG@Z*:*
M(W6EZ3>"5B=0DFMDEENE;_5HZE2SQXX:,CYAQBMJ=.+BFY*[:[;I+1+9[I?=
MI<NEBE!2OYIWOLFEZ^6OF>&?L2_M@?#C]M'X.6OQ3^&6C>*/#FAZ;.WAV^T#
MQEI[:=K^F:AI]NJ/;7ELZJRO&D>T\?,<L0,XK^$&T6,?\'7VM;2-A\0N_P F
M6'_'G89SGTQSQQZ=:_T)O"VB?#_X=M?:?I9\$^"TU*[FU*ZTO3WT_01<ZA+&
M5>[GLW>$N[ DNQ7GD]Z_SU5UJ-?^#K?4[^SO+*6*;71 +FU5;FV9)+6S1MGE
MY4LP'#C[I(.>]$H\DN5='#9.R5GWW=[_ "L*-15/>6S_ .!_G_6J7^D#(C-+
MO&-A48.?O<9S^'%6P.,'G_\ 7FHF., = % ^AQ4]<DOL_P"%%V:^>H4445(@
MHHHH **** "BBB@ HHHH **** "BBB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]
M!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "D(SP:6B@!JC&>O7_)I
MU%% #7^Z?P_F*AY. /4?SJ9_NG\/YBH2,C!.,9(^M I;/^NI29@AN2SMN1"[
M*.B1CYB5_P!K&3_C7\*7_!)J\M[O_@Z._P""@$UJQD@F\+>.RCO][Y++0@VW
M_@1(^@-?W6M$TOVC&-TR>23P,*XV9/7/!/:OX4O^"3^DMH/_  =*?M_:2YW&
MT\+>/4!_WK'0)?3_ *:$<U=1OECYN+_+_-A!6Q%1:_P97TTNJ2::?W-_CN?W
M>!?E'7(53^)ZU*.@QTJ '.[']Q,_7BIU!  /^>:PI? OZZ(IN^K]!:***T$%
M%%% !1110 4444 %%%% !113=R^O\Z '4444 %%%% !29'J*6F'=S@<?AZ]?
MR[4 .W#U'YT;AZC\Z9AO[O\ +IW'X^O^)HPV?NC].G8?A^OX4E?R^7HOZ]&G
MY,'%C_#SZ]_Y4W<_]W]#3ER <C'OQS^7I3J2;[Q^7JOZ]6EYM_U_7]?D1[G_
M +OZ&E!8GD<?0T^C/Z<TU?R^7HOZ]&GY-?U_6GK_ %N444WYMW^S^'I^?6DI
M)NUP'4ASVQ^.:6BJ 9E_0=,]#^7UHR_H.W8]_P##O3LCU[9[]*3<OK_.@ ^?
M_9_6DR^<8'UP<4GR9SD]<_YXI=XSCMZ_Y% *_5?J/S^O2@Y[=?>HRP.#Z#/?
MKZ=/UIV\<_H>>?TH#7^OE^OZ" N>WY@T9?T'?L>W^/:EWCZ\^_Y]*3>/Y_AZ
M=N] !E_0=,]#^7U]J,OSP.,=CS]/ZT;Q^F?Q].GZT;QS[8Q[^O;M0 ^BBFMN
MXV_CT_K0 ZF.<#KCGC_Z_P"=)^\_SBD;)&'&?3H,?E36Z]1.]GRI-]$[V^=B
M,2M@DCO@>_O^7K_^MS3!<9QS_/U^F.M1DA5.!PIY_P >_>LO5M5M-(TJ^U:_
ME6"UT^UFN[F4KN,=O"I=V ]@*)PL^=3M&*UCI:UKMO\ -OHNJ+I4J^(DHP@N
M>K*%*E3A[S=2;44N6SD^9M)+=]$7FOD60 LI0MMSG'S8Y&3Z>I/Z<UY%KO[2
M/P(\,^*#X*U_XK^"M(\6A#(?#][K-M'J049R?)W$<8/&<\=,\5_-/^W+_P '
M$7P\\,>'/C-\+_@5H-S>_$'1VU'PIIOBMF:.*QU-#):W-Q%;;LL\:L61U&0P
M#<G '\;.J^//BIXP\:VGQ+\4_$WQCJWC*[U&;6X]6FUJ\5[9I9VN6M7+L3+;
MH[E1$#M"#;7R6:<8Y9@)TJ46JM2<U3:@VVGM=JRU>KT=K=78_L;PJ^AIXA\?
M8&KC\]I3X6PTJ:J8"KB()1Q5-QC-5ISJ2:ITVFUM&?,GLDK_ .NEIFO:7K5I
M#J&CW]EJ5A<1K)!=VMS%)%(K<@J0^3D?R].:LO?#_EF8V;.W:LL;E6[;]K$
M'_\ 77^4KXO_ ."Q?[6GPWN-,\$^'_BYKEIHUM;Q072P:E<C)0 !EF5P(3QR
MH.1_/Z6_9P_X+@?M8Z/J_E:7^T-!#/< 7-W#XFW:G#Y29)BC>XD*AVS@'@Y
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MNYC:S/=^:66Y>VN0D8).0C&()D], ].E,M[>:Y3$5K<[T<++.EM=?N&/\/\
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M[1>\,I%AIH3:?EW&XY!4>OKVIX?1W\WZ[>??;36U_(::TNM+_P"5OQ/X^?\
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MR^&,NCM)>^.)OB9'IYL9[.(F222UN]1*QP!(1M,:L-[+WS7\DWPT_P""K_\
MP<*?'K]IQ?V6/V=?&_@+XJ:K;WSV.M?$:Q^&43^ [&XM6(U)!XK"'346R4;E
M97?S?10"PZ(2?)S.,-;?S7UY;:7:ZW>RLU?0N$J32OAL-\U/R7=_-]K-['T/
M'_P;[?\ !<*S@@N?^'ABK<R R73KX@O"1,3PBG[7C85YXS^%7;;_ (("_P#!
M=&QMI6L/^"C/V=YG63)U^Z^<L<R#F[P<#..A/YU_:%^S'9_&VU^!'PYT[]I3
M4=)UOXX6N@0K\0K[1X([?2[O722TDMG%%^[CB"E579P<9!YKW:9(5@8R1"1
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MYHD7YW"[QA$Q\[= >I%9$W_!R3_P3$2);IO%7Q5\I3^\D/PQUQ8XPW ,C&3
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M#@&A+5)KKZ&4L/5CNG==GU=NBT\[=N]S^N=9E<X4@\D<?> !^\0<\5'YZN9
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M:YPRDXB!.,5RO@[P3\3?&^GW6L:'X9M[2&-_,FDU2_6RN98$.&$,,Y6208]
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M -F'XHW46G2W-KXNMC<V$=PTP\*7OF1%@I-NR",$X.021R:TC+)G:]*BK_\
M3J/EY7^;,/\ 6+B]2?+GF;3VNGC:_9.Z;DKKS7_ / )45+R22VNKY'$:JZO=
M7(8!N& (E^[C@9/X8JX]A%((?)EU)6"@R[KN?R)&R"5;]Z,GN>/PKZ'A_9K^
M(<NJWMBJ>+YXDA@S*W@B^1?FQG]X8><#/(//X4@_91\>+#=3I-X\:9+@Q"$>
M#-1,:  MO7]UAN. .GMVJN?)X2]RG04MFY4HVV3M;;735'1_K/QG3@G+,LPD
MDTKO&U&NBU7-UUOVOZGSQ</##(;5Y+J6*9HA));W-P=K=HE._!5L8/U]*9=6
M-V+Q%L%N[>Z^41))=7 #PG'RHWF>G)QZ_3/7Z/\ "WXBW_Q'?P3J?AKX@:?H
M%M#.R^*H_ NK2,DJQE@IMQ;^7()G^16\S>AYV!1FO9)/V;?$L\L2RZI\14AB
ML\QW*^ -4,X8$XA5?)W,3P-_OQTK:%;+-'S87MI2CIM?IKV_'30YI\3<3U+N
MKF68Z*WNXJK_ ';[/[GZ>C^;)+!YC);W N%NL!G,-S/Y8D'168OG>W;:>3^5
M1(]G#:K#<Q:C$SS^3)BXN-V\8R"WF=?J<=\U[G/\"O%RO&)1\3H4@=O+$?PY
MU>6655.!+)B#+$CYAG\^371']F^_#V[76N?$UH+FW>_F:3X8:LLD,FPD0E3;
MY!+*%#\'G\*N53+Y*\</0Q%EJX0C#D>FZM9W\K=_3*7$?$%E%X[-YQZN.-K0
ML_/773\CYL>W7S7C6XO4MF,?E-'>7)F@/&3*OFE<X)/ /TJP-.,43M<M)=V,
MI**XN)6EDFZ[N7SN. .@%;'@CX:>/=;\>R^'_$/A7XH^'_#4,EZMCXK'P_UR
MX:98G(A,]LUJ(V%P.8]DCD=PIX/I%Y\$_$AO;BTBN/BC<6EK+FRNU^&.KH1+
MG.#!]G^;C';O^<PE@9;Y=27S@K;:[;/9/S^;R>?9Y&TJ>:YM2E_T]Q5:JNG2
M]N[T^^YX6T$\H*P1R6K%6MXHII9$&&X63[P('<G\>>*2*U>U4PRFYNYX8MLT
M44DACE!P $8G)()R,'/'7@5[+-\$=<N]26+4V^*:/\D1O(_AQK"8C?AG\@0#
M:R^F#]*/&'PBU#PEH%UK5GJ_Q*F31QOADU/X9ZKIUBY. BWM_+"L<2R/\J,Y
M^9CC&:ZHT\/:^'P5!2Z)NF[;=-O^!UW.>>><05+5*N;8J3?53J*]FM+7Z;/O
ML>6Q6D5I;I;I:R17=U#)(RN[M*ZGHP))9=G3D_K6<EHNR2W<SR#@JL;2EL[O
MF5^>PZ^XKL_A-X'\2?$.+Q%=>(+GQ_X<U72MD8MM'\ ZGK\K17"AH3*D4#/:
M>>K Q$@;Q\R%E(->ACX':]8>4TE[\7X@0C6\A^#^MNWSL SN/LW.%)8*1@\4
MGAE+3$X3#ZZQ2]G?51MYZWT_I+.&>9AM4S;'<VFTZS739I]MK:'C<D=LJ*$B
M8PA !M>3[23T8 $C !X/'OC/2S;6UE>1YM]WF)^[EB=Y 0B\_,<Y#  XZ=Z]
MU?\ 9[NY+Z1WUKXSR6"&%WU:'X,:\N9V4'[.+<6O"EOE+].]>>^*/@O\9DO8
M;/X7>$?C#XWU>^N?L\NDCX3:[9D6I.([@2+:DEY,XVX^\?FP,D8.E2B]<!14
M>C4J;=E;HK[O?3Y&RSC-'I'.,;+LG4KW^S;5Z[?.WR9Y]J%QI^BVE]KD\KA(
MU,.EB0MYCW?18L=6CW=^N,5@:%X=FL+$^(?$37$.NZN[3B$9*PV,G,,B=2-V
M1GI@#&. *]CLOV?OB3XP\8VO@%])^)5[XB\'VJZEXY\/:?\ #?5;[4/!M^JB
M2*SU:RCMVEBED',8F56<#(!ZUU'B/]G;]H+3+DWGASP?\8_%=A)'L>2Y^$FN
MQ>4'^46T<3VO"1;OEV]" :'*C&#Y:*4TM%=6NN5/RZ77J:RQ&:8FE)5,=7G%
MVNIU)2WLM$W>_9_/L>#I)+--Y;QQW%NK9\[:0\:X&60]VX^N:?;H/ML5M9V_
MEL[2;W<-Y@C<821R<C;(3VZ\?C[/8?LD_MEZI;++I_P?^*WV)VVQL_PTUF*0
MN_S*C+]F!QVY]0>E'CS]E[]L#P%X9L?&WB_X9^,/"_@F6_M=&FUG6?"5]IM_
M+J,DRPQVUO;3PK)/OF*HFSKD'KBN:ABZ-&;DL+3Y[W;Y8I=-7IKM]W4Q^KYL
MI0A'%XFIAKJ5:^)DN:I>/*IIR7/%+>.VZ['A]QIN2+2%4CN;1R]^P7/EP$Y:
M0$@\@'WZCMQ6@(_*2\D3;]FCAB/GQ!3]H1F^4$$$[O7 ]^U?;6B?\$W/V]/$
M1L?[)^#_ (T2?Q#90ZE8W%UX2U"*"?0WMQ.;JXG>#:FZ([A&V,]17F_P?_X)
M[?MS_'%_$.L?#+X9:OXO\-^&/$FK^#[_ %:QLIS;:?KVBLR:G9SV\49!> JX
M"GG/ '%=53.,.Y.V%@IKXG&FM59:72UW^ZQ>)ACZ,U['%SJ<R2E!5N10\DW*
MS^6Q\TS1N+17BC"R7.%CBD0>8\0ZLH QM^N#^)I($M9OWL3,D<R+!>*R;3&T
M7.,X& Q&!ZY[U^BNG_\ !'/_ (*97\<=SI/P<UV[TZ1&NW^V:;=031K$VUXX
M_,BW("V<(.H%>D?\.,?^"F6H:3!=Q?"N[@:<>;>:>;26.01N"T!W>5G<QQG/
M]*Q6;TF],-&Z_N^CTTUVWZ6["C1S2:3=:>O_ %%KR[R_3;8_+18/LB8@<;;G
M[J*BD1Q]P>#@DC/)'6H6BA9)4$:B+">6YC422S$\@8'W=V0?J.E?J9I'_!$'
M_@IC-HNJ"U^%-ZM]:71AN+6XMY=P."5,4CQ\H1W7N?6F>#O^"'W_  5!O](U
MBZU;X/7.GZK:7*IIMM(KR>?&K -*%$7 [@XX&,]#6RS&$K?N$U9:<MM/=ZM+
M6]U_D)T\=&T9^TG+1J?UR"5DE:/Q+\_)'Y?K;74BIY]L(FB^1Y?+'E(0,J.G
M!*X_/O62&9H+A1$#%%*1)=;5 ^]PR9ZA3UQT]>]?MAHO_!";_@H_?*8]:^&]
MSIZW$'F2.$>997/ =5V':1T(_$],5GW_ /P;^?\ !1_3+Z6*3X>W-U8EH'TQ
MXHY-DZ7!'VCSU6/ *+R-P[$5$\TH4M?J#J7[2CY/R[?U=LRG0QTERJJXWZ/$
M)M+36]_-/O\ (_&K[*2;<-<1SQ>1OAN2H*^9CB+/)W9R>>G;'%5[*VN)A,TJ
M;H0[!G*J6D(R%"\<!3UST_,U^BO[4/\ P2J_;:_8P^'$?Q'^*?A :9H/BC7T
M\*^#E6(W$UWK<T8=;?R-FY&VEB&ZY!(&>MG]F7_@D1^WK^T[\(]&^+OPK^'\
MFN^$-<U&_P!.>Y21@7U#37$>IPX5,0/!(<;20=Q P#5QS.G)*7L4D^DH+31:
M7M;NNFG79G-*GC&^3V[;BK?QU=KT3V?G?0_.22WBCNH))DDR4"1 !=@(Z=B!
M].G]=&>V@2?[00A C&U $!)'?'3KU_'FOU[U'_@@1_P4N#*^G?!:]N;.) [F
M2YE#[@1N4'RR0<]!CTXK$N_^"!/_  4ZO78I\#+QH%7YXCJ,D4KAAR4^0$D=
MQ^/&:T^MTFFU"%UK;ECY;_+Y=KW*Y<="W+*<VK;5UY::2_/]=/R@AMXY@#;[
M98;C(DC4(?+E!_' XX/Y>E5X1(]X+6-HOL[-B_>39O9$X46W.!C&'_7G-?JK
MJG_! K_@K3H\%I/X6^ 3R6MRA259]38M&K#+.Q=!@D$Y/7 ..:C@_P""!7_!
M4![:YD'[/MX]Q-&1ITG]KRH"Q!_M(O\ *0"C;C$#UXQZ4Z5;G:3HTEJOLQ7;
M5.VNW6_:Y+GF,M'"=_\ K^O+K?5^6N^I^6/V& S79MV;R_N-;R&,/Y&<B=,G
M&,\\9XJ9+:WCA_?26RSE&\B9&3?P/E#=@0"./QK]A]$_X-__ /@I'>:)-9S_
M +,FH-J#Z<J6VM?\))*A>0-N:)XL9!.,?0>E<Q_Q#X_\%2KO56T[3/V:)('>
M)4A-UXG?%S,J@,T>]3C<PR0..?8UV15)V=2G1Y;K6T=[1\NMNFWSURDL;!<U
M6%2*[K$1W;CV;\]?QZGY/VUC)<0%Y8XE6-,RS[D_>(?XVYSN.>W;\ZJVL2+/
M<I'&DJ+'^Z9W0JAZ[ER>.G<CZ5ZQJ_[%WQ^TC]KGPM^QC?\ A&YB^.WB?5D\
M+_\ "!G67CMVUJ2*:6.#[<<* RPR'H<;?2OTA@_X-N_^"M,5_<:6?V:8UWR2
M(MROC<&+RMQ"?O0,<*.I/XUI.O@XQ=J=)R2U^'R[^5NF[5GJ51EB>;GC??>=
M6,NBTU>_W?+8_(:2U \HO)Y\C*"WSI^[)(/R_-VP!CGBK%A!'+//!<3AYH!N
MAA5X\2R\E"WS8R![_E7['7?_  ;-?\%93Y=O9?L\V2"6-5FN&\=Q_NR3DD'/
M)&>1V YJ+3_^#8[_ (*U"\,%W\!]/55=<7R^.HA@'NK[OFV]">W?K@>9/,(4
MVO9T8VOS>[R[V7;YI6^X[)UL;)*TJ$7;5-P;=W'JFOZT/QO:)K23[3J"QM=R
M2,J0YC.Q>0"P!(]#37M6D@"*C$/(&9F:,$.3E6@^;[H)^8D<8K]I;;_@UT_X
M*V6EY/<W7PUT;4;61Y##9MXRA,D><[2TFX]  !C ..F35>3_ (->_P#@K*L*
M$?"/3_,N#(Z,GCB)OL(#<1E%8YWCD9'?':A9O?;#J_JEMR]_)+OO\CFC2QE[
M^T@M4[1K0AUNMI:]+>1^-S6LRV9='M&D4E4B1HS=,P^^^<YZ#+<\ =.U1QH+
MB*.-U& IE$ENT7FIMSNDDR>B'[W/L!Z?LU<?\&N?_!66*&-X?A5I3RM&FYD\
M;P^;N?"ME0Q*%1RV>H'UJ;3_ /@UH_X*O.+J&[^'.F1%$\NUF3QI"H"RC+$\
MD2;#D,O.>":7]IS>U"FO5)N_NZ[_ / V!T\3)N]1<S_Z?K^[OKZ>7<_%"WMH
M_)N)+JXMR_G928.AD>+/R9R3\Q(P1TR0:?=QDC;"$MS(5+H[1AYFP-N,'!##
MJ.N/K7[C2_\ !JO_ ,%3K-4B/@W0]4\VV4NZ^+H(DB8#*Q;1P&4\9Z@^F:K6
M/_!K-_P51$EO]M^'&D31R9+H_C>(&)E/R'S"PV\#./I4?7JM[^PI/LK17ROY
M_J6J-9VO-+O^_C\[??\ GYGXB36%I#:3)/<KYTRQ_+O0A1D80 -QMSV__7!/
M C1"".Z:$1J J+(FV3(ZL"V<<9SZ5^\P_P"#5/\ X*;&)6E\$:()&E+%/^$V
MMIL*>0"=QP1QWZ_2M+6_^#5;_@IA?:=:Q:/X)T"QU6*,F>]F\;VGER(BDF((
MTGWVQA0.22 .:AYE9ZX.4.[52+VM?:_3Y6LRH1<*B7/*"W3^L1DEHNSMZ>OG
MI^!%L)+5W\F)'26)4NX@R&0K@@/DD_*3@C!R*LBVMX(MT!1$#?Z1&C1AB6YW
M\'#$9 _&OUG_ &-_^#?K]M+]KKPIXY\7^#]%L[K1OA_\1?$?PKUJ:X\3)8W!
M\5>$;E+77K6.)R&D2UE91O (!=<_>7/-?MB?\$+OVJ?V2_'?P(^&?C/2!:ZG
M^T9X^TOX?> ;JRUT7T7]OZHPCAAN)(LJK+)D%"=P[CO41S*$GRQIXB+MI[TK
MZ6OK:^R_S83P,HU5B'B8U6E;V,JBE:ZCK:[U5U*_FC\MX+)VD$<]S'#'%YDT
M<):,1R!Q^[W '=O;/?/)R3FJUS'&UFT5O@.A9KJ*%XR589P,$_>P,].GZ?TK
M^&_^#4K]MK0[".V\1>$M.\4ZVDEP)=7A\;006WE.#Y BB\Q@WE$CH6(P<Y-7
M=8_X-3OVQ[J+3H=&\$6>E7"6S?VI>MXXAE%S<E\B14W\X4[<#GO6<\R]ZUL2
M]-^>7EUVU_K2Y/L8RLU4A3VVJ13W6VORWW]=/YI[)(9;6)'>..U19&/[Q-S2
MXS@C=][.=_&*@B6W@M=YEBS+<DLJR)A7Z#:!@= #G/4U_36O_!J?^UQ90)YW
M@>#4H]B)MB\:1QR+<-Q).8U;=AC\Q/0#VR:_)?\ X*C?\$A/CW_P31T#P1XO
M^*'AB72O#?C+41IEA<66O_VK;S7:X=[<SQ,R1W !&Z,MO ()4 Y/13Q\()\J
MQ%VD[*K+5JSUTM^'4BIA8\R2Q,MKW531?#T7I?37UZ_ *PJD4DP0>? YD:2>
M1,,K<@+\W0#H0/IUJS'-9R>66 628@_O)% $G9^#Q&#Z^WIFOZ0/ /\ P; ?
MM0?$?X,_#KX@:;X(\F]\<>%= \4V_F^,XUD?3]?TVWU*Q:XM6;?;B2TNH9?W
MBC"L#R,&NEO/^#4/]K_4K2T%CX6TS0K^Q93<R2>-K>YCU.$?>@0%R(MW)W>^
M.YIQS>HG[M)371U)*7;^9:VWWV.A8%)768*&U[N4GT4K:K;;YO;0_F;DGA?]
MW+<VTA4G9$LBM(=IZ@;@-H/?KCT[0R6C7$0U**[,?V)MK_O$VE1U#98$9X'
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M;[UW* TFT@$YR.:IP_\ !G-K]OYEQ#^V/H3RRK\EK)X AP!GEE<P@J1R=H'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH /PIH10, 8!.>_7\Z=10!&58\$CKG\OPIY .,CH<CVI:*
MFZ73Y6?EY>GX>0"8&<XYZ9H"A<X&,G)]S2T4)QT^71^7EZ?AY -*J<9 XR!^
M/6DV)Q\H^7IQTI]%%X_ET?E;IZ?@!&(HUQA ,9Q[9ZTX*J]!CC'X>E.HH2:W
MDW_7J 5%(2",$CI_Z%4M12 \'Z?SS5%1W5]O/T)"<8'K7\_G_!S>I/\ P2#_
M &D"H^[9::?^ FY^;_/:OW^D?#*,=^OY>U?@!_P<UN5_X)!?M'@@EGL+ <?]
M?)Y/MCK3HIW2U5Y;6Z.._P OU(>OX?FG^AQ7_!K;;.G_  2;^"EP I$D^M*I
MSRH%\-P^O4GZ8':OZ-RF<G/TS]>>W3TK^;S_ (-9[TR_\$E_A!$VX"UU+68U
M&#\P;4,DCU'(%?TB;>>IZGC)_+KVJJKLUH_LK1>2Z_U^(HIQ37FQ-K?WCCZ\
MX[]NOI1L/J<9.>?R[=?6EV^Y[\Y/X'KVHV^Y[<Y/XGKWK'G\G_5O\_R[Z4)M
MX^;D^N3Q1A3@ ]/?KZT%@.,9]>3W_.F@@<A>GOZT.[Y7YIO\!Z]/+S/YZ_\
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MC7Z[:G/#80W&I3W$%I':VQEEN+N98+.U@C7=-/<3282)$4-ND8X 7FOX,/\
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M EZ8%N2N"K?<ZY->M_&'Q!_P62^%7[>W[*_[#B?\% O!>JR?M%^"?&GC"_\
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MYEIOVK/^"04-K%<G_@G+K4\WVB2-;4^!KV66+9QO!=V"J<< #OUQ3XOVP?\
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M /!67]CJT@?;_P $N/CS)'AG13\.K.1FXR^&DM7=>G0$\YQBN.?_ (+)?L>
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MJ+J:[+5-N_IT^5CH5>+O>MBGY.4%T6JM&W5[*_;4_DXC_P""IGC>:&"'2/\
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M  54_;282+('']O6A.6SMX^T@8'?)^F:&_X(F_%PJ@7_ (*H_MH@#[X_MVS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS_*7_:%BL]%_:M^->G2P&X^S_%S75F=!PR?;2 %P.-N2Q/Z5\)?M=2^=\5-
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M\0>-/'W@.PL]7\-Z]XFO9=1^PZG>6D+SW:+/)*(BTAP.I)7.1FOV=MMPB02
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MRRM$FUVC8,ZL1C#*.@'K5^/.Q<YS@9R,'\:336_]:?\  _ B,^?Y>O9*_P"
MF&!')/TR>G^/:GY]CTST_3Z^U*3@$^E1[_;]?_K5.O3\K_JBA^?8]NWK_AWH
MW#OQSW_G]*0MA=Q!&.HP2:JNQSD< DGG&=IY! (R2?2EKW7W?\$+J^J?R[_<
M_P"O0G+KD<<@$Y/M_G\.U?CO_P %]-W_  Z4_:_P?GD\&Z%L8'A6/C+PZ?P
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MBVU.!<].$.=V2.V:_HO_ ."(<T,G_!/7X5PQS-*;35M;M))#;?9-LL+0*P$
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M;7?G9;,\>55TM:_[V32NU9)WG%75KK>25M-4GHE8[BQ^(?Q(U'XH?!SP3?\
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M]NKZ+[K6VJ5[04(J3=E=.,M;/[EJ]UITVM::P@E&HW3ML^R?:-\&TC>)&;<
MW3(QQQP "/2OX2?B9;M>_P#!X9I,6S4CY?@GPRX&FM&ESMC\*1-N8R84VX+$
MR#[Q3&*_NSMM)FAO;>6,R^0"LSLSX (/^K*$\GWP?SK^$WXHV]U)_P 'AVA1
MK"7D?P7X3=(TN6MV>(^%8@K>8N"25P_E?Q=#6<HIM\K3MRK2SZI6?9NU]?PN
M81G>+=FM]^M^5NVG:_0_O'U.[-I#N62-)0H =QE0?H.Y[YXP<\5^-_[9/_!'
M#]F7]M'XQ:%\7?%\^K?#;QS--;S^,KSX?W!L(_BWI5H=QTCQOB5!?6+Q9A>-
ME8E,C%?L5J5C/-(TL94KLVE&^;<=NW(4C&1VZ]":P9/#$QC7_2I&D!\R%L_-
M$QY90V?E49Y4<'&*UI."A'WHIM-7:;UM%V>MM-]=K:=4;)[IV6O5VTT2>O?O
MW.:^$_P_\(_"'PAH'PI\ >$+#P=X$\(:'#I7AW1M%A$&EVUG!$%*0Q#I+(5>
M1^Y=R><BO\Z/XH/':?\ !U)>M=&RDC?QGHX7SE=H<-#9JH4+\WG J<'H.:_T
MEM)2_"LEUND>'S%61@%Y*L%95R04YP#WS7^;1\7WM;'_ (.I+EY-3B$+>-=$
M N8(%O$$LD=L!;%.0&+AE9^J$^M53IRYIV:E[T-FOM*5F^S]U]_\X;3V:=]K
M.Z?P=5IONNA_I:G;A=OW=@V_[O;'X8J5/NC\?YFHA\W.,$JOR_\  0<'L,9Z
M5*&)_A./7_(KSU)-22Z3U_\  4C4=11126R]%^0!1113 **** "BBB@ HHHH
M **** "BBB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH
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M2?5O%'B/4+\V(\#>%SJT,4E_!$&VW4GG0(%W E<L%(RV?S A\>_\%5?VEO\
M@EE\(_V3?AS^PMX7N?A_Y/@O4]-^*!\73-+J.F>$I(KV-3IPD\J*74<#$FW>
MH(52!FO0I0:JX.7\TX/Y+D\M[J7KIJ9QDY1DK.ZNFNE[6MH?HM_P4!GOF\:_
M\$*[_5&CGO9OBEX.BFG )EE?^SM/ RW0IMQQG./R/U1^VH)$_P""_G_!+N1A
MF*3X1_&I5"C)#?8;\;F] #Z]L\]J_'S]HN;_ (+&_'QOV))[+]@/PSX<'[%7
MB[2/'6F3S^)[ASXN&E6EM:_V3,[N?LZ2_9M^X8^\3C)Y](^,OQ'_ ."RGQ;_
M &V/V9OV[9/^"?\ X,T34OV;?#/BSPC'X&/C6YFA\2Q^,XIH9I!>-*9(FA6=
MMK*^Y>"I  Q=1TW4JRE.*]G*=U=WO*45%[=KW=]&U8JC"JDN6,GK)W26JM;:
M^[_+KT/L[]@:%HO^"[__  45:W8O:GX8O*=P^=9CJUJ-@_GCIQP:^0O^"15R
MFJQ_\' -Q>1M''(_CR"Z&#O*)X,\8J3CKR@/ZXKSKX V7_!;CX)?MN?M ?MO
M1_L+>"M?U;X\^&9="NO 4OB^:UM-$\V47%O=QW2R*9C#.D,C1DE752CAE8K7
MGW[+GP3_ ."VG[,3_MS7&D_L4?#C63^W+_:CZK!>>-FM1X-;5[&_TRY:U0R
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M^S?\%+B7PS\6_C7X0\#ZT ;@Z;XAUBU@U"&.?F*1XC+N\M^L2MM]..:_+/\
MX*-?\%B/V4OV;_V,/BWXJ^&G[0GA'QQ\5O$FAW7A;X;:9X>U2&YOX_%.L[;*
MRDDCBDD:.VM_M!E9P3R!D@5_.S^T#^S%\-?VU_\ @Z$\5_L[_M#WOB?Q)\*-
M3^'L.J/X1L/$NI:=;2W.FZ>9H!%Y$C1VZ(\CM($B!8E=Q.Q0.K_X+O?\$.?V
M)/V%?V"_&OQI^#_ACQ&?'L7C>$Z+J&L^)K^^@T?395S'##;7#&-IHU!_>#!Y
M&,\UZ"C#2#=G)\RC9:VU5G9VU6NK;Z[ZY-M^];Y^>G?^O-VN?NC_ ,$G_P#@
ME?\ L\Z)^Q1X UC]HWX9?#7]H;XK_&\2_&#Q[\0O$=O'K\UW-XV6+6(-%34#
M).R-HID,+0Q2*(V9D8*\94?H5)_P2I_X)RHIF;]C?X,$2/YSL-&N2 W3>W^E
M<'L-JGCI7Y__ /!L'K&IZW_P1\^ U_K6L:GK-ZOB'QI"UYJ]]/J-RD,-W:)!
M;)/=/)(MO"GR01;ML:C"]Z_H/*HX0*1MVYSU7Z$'@YYX-<52,4_*]M;>3ZWW
MOTWL;QK/17=[)NTI)/96TEN?EI\3_P#@F/\ L.ZQ^S_\:?AEX-_9@^%7A;4O
M$G@OQ)/8IHVB"*ZM/$L.D7?_  C6M6EX[":"_L=2-M<VTB.-DB#<<$X_.O\
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M;&QS<:A?R#R[6W0%I'#;0=F*_%7_ ((P? GXQ?%KQQ\?_P#@II^U%IC2>/\
M]HC6KJR^ 5KKD&;[PK\#UN!-X6:&"Z#OI-Y+;(HD\DQLR-[ULM8KFV_+HON[
M[:];$J3NOEUUMIJ_-_UTO_0EX-\/V?A'PKX<\'Z:'_L[PCX>TCPS8O( &>TT
M/3K?3+=SC@.T-JA?'!8FNH3I^/\ 05# #L0/@D(!G/+DCYCCCH<C..<YS5@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !43]?P_J:EJ)^OX?U-3+[/^)">WS7YH1OO'_/:OP7_X.5$C'_!'W]JA
MY%4R'0+(*5!)P+F0ID^QVY],5^]#_>/X?R%?@M_P<J+)_P .?/VI%C8'_B16
MC..ORFXD+<\D8&>WY5IAU?$K>]GMZ+IZV)K;*ZZ1M]\?Z_X!\R_\&FUU%/\
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MK^6_1GYL_P#!8%[>/_@F=^V0]U ]Q"/@UKZ[$QE&=H$24 \?([JQ^E?QE_\
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M "BBB@ HHHH **** "D/3\1_,4M(>GXC^8H 6BBB@!!T'T'\J6D'0?0?RI:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HSC\\444 '\Z_AI_X)X"1/
M^#M;_@H().K>#OB$5SZ?V1X1Q^NXU_<F.OOO/Z _XU_#-_P3V>1?^#M;]O<
M$B3PE\0U?/\ <&A^&VS[#>J_Y-=-!_N,5+^5TX6[\\9[;[7)?QQCWC*5_P##
MRR/[E%?E">X_I_+FK%50 %XP50E5P>^.?SP/Z587[HKDA'EIP5^9VUT\E_F5
MT_"_>UAU%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %,<_+]3_\
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MS>VW_!?'4[5WN?LUQ^R1J%QM>5#;,W]J1[?*C'S!AP23[]*_=RW/[I?EV\G
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ME2&/PU^Q%_P3Y_:X_:\_;B_;6\#_ !4^.W@9--^"O[37PM^)?QLL]%M;D?\
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MQ6E&+6#Y>]13^5Y2L873JIZV5U]_)_6VSV/]%Q3O)/7:S#VP.G'7/3\JEJ+
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MXI6S^SEM0N98YUD;%Y;2<6\G. N/IG%?>Y'3P3A+EA#$.*TJRM/FLHO1-/\
MKU/C\UI866*]K]7JTISC?EO*-F]'HTO1:=_E\:^!?$MUI_P2^#7B#3]3U>TN
M=9^)>C6MQ_8LD5K!"D>KP82"-U#F)NDB@?<R/IS_ ,9V>[_::_;VFA>*>1_
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M_ME#C_DC>MX_"YL:\N_X(6.\G_!,3]FPL<[?#* ?006H_F>_I7J/_!8%MO\
MP3,_;)58Y)#_ ,*;UL'"ECS<69W8[@!?P)6O*/\ @A!O_P"'8G[-Y9F/_%.
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M=UHU>ZUW2-)QIJ;=-\VEN;OHOG_7W?6BXVGUQS[=<4F$]3_G\*$Z-GIC_&E
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M9 1]R)EQ\O?UK^X+XFB4_#'XD*\04-X$\8!0C9)!\/Z@ IY/)R<8X%?Q!?\
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M ?V!/@E(6PP^.=LHC]?^)4>?U/Y5SQ^UY)K\A_G_ ,-_P3]__P#@DC/+<?\
M!._]EQY\AQ\,] 0>ZK8PA?TYK]%IY51"6.!G&?4X/'^'K7YJ?\$?;_\ M/\
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M:>K;3?\ 6W3Z!XF\N9UJ5-7BURM>\E96UO=+KYZ>G\]>GM\"_P#A;W[*6K_
MW3/B#:>(IO$VMV^LW_C][N]T%([:'=&]G!+N ER%\X*,XSG&":^W/$,\GB4_
MM%:M]JMKOQ%;> M6L]2;PM92Z7$R;2/.E>9%26)?^6@7DGG%2?\ !0']AO\
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M*E=ZOSW;T.S"8;"RQ-",L4N6.*P[J2<904>><%5E*4=8Q2;=XZI:KH?P>?M
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M2IW6LII/>-HI.VZM:_W[G93]C*G%I-1LN1+[,;+2SW=W_3V_JD_X-QHKE/\
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MU[5:=F]MUU=];2^5PJTZ$L/.]^=*SUT^R_\ VU/KLM.I\17W[8'Q6_88\0?
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M,27C'4=0@1KJ)(]\B?9RR2%0(V;I7Z?_ + /_!33X&?M^^$M=3P2;OP5\:?
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M6]NGW;=]>A+G)ZU)*WR7_ _S*\PS;7&<9$%QD?6)A_7GMQGOQ_GG?L+/$O\
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MKQ7Z4_\ !W+83WGP"_92MDG,$X^*NKA+V48M(7;3;55DD?[H8':<'MBOQ/\
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M('? XZ]*X?X:2"?X8_#M-R[Y_A[X1>,9P'9] L< '/3'4<8'-?@-_P %A?\
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MGT,WI2:YA^5HU56CE5I 3',?G\OJ0<8]/U"_X.^+:VG^$_[%/VM9V3_A;7B
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MK>R25TEI;I=/?O9>9YOLW2J2I\[FD_XC;:>VJOI\K^G4_E3\$_:8_P#@Y_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#!4*)E_P"#H31U;YR?BO\ "1^#U#2%@/UQCUYK_2E^%/Q"_P"%E^!/A_\
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M(82Z<G,FQ ,JK,"6/(R>:_03]LRXAF_;5_:HM+2817%U\4/$40+X$<7EW1)
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MXPZ>&&B;["K@!0''[P, HP<BJG5IU*%%T]$[.W:_?3SLO)+M9.5*I2LI[_\
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M.7EE51[DG%<Z_CWP6DZQ'QAX/6*7.)O^$GT@[&ZE"IN0<L.%YZ]^:_@VLO\
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M4SJ4(<KISJSMJDH)-V:MK=[K5-?A9F,*.(;:YJ2W5W4VV^5]>MTGOY?T\_\
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M:4KJS:=[QNY;^2NMK>=SED_9P49:I;M;:/6WR]#^AW_@E?\ \$9?VN_V=?\
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MD%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV,;D5L>F0#C\,T^H;9B]O YZM#$QQTRR*>/SJ:N);5/.4OR2 ****I;+T7Y
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M8R!&V#*R\@JH)Z'%?NNXSM'/W@<#J0,U^$7_  5NO;31OVE_^":_B6Z6T?\
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M@+X@?&W]JVQ^'$/AWQG\+_"^DPZYH=GX"U&P^P6NL:M#/N%HP@=9;>1%W22
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M>*_B-_X+,3"#_@Y&_P""3&>!<Z?80$GC[^J7N ?Q0>O6O[=7 9S\Y5D&<CH
M0#AO8UIB&XJ@U=?PUI=?93>V_?U=P6MT]KM?(^._VT/V-O@C^W!\%-:^!/QQ
M\,KJ'A_4K9Y]$\1V[)'KO@O78]K6.MZ%?@>=87UK/'$RRQL,JNTX^\OXK?L2
M_M8?%O\ X)K?&E/^"<O_  4+\77&H^!]1NHM/_9)_:(UJ.5]*\3^'LK;Z?X:
M\2:W<K%;P:CI]N(X1)<S!Y9%^7()4_TQW,,<\,L94@W2^67&>!USSGTZ_E7Q
MM^VS^Q1\$?VY/@EKOP5^,^BPR6\L"2^%/&<*"+Q%X/U^%2=-UK1M3CV7=O/9
MW#"<)'.B2%0&QU.JESV6MHZOKJVM=^CW[[V6J$XVVT?KH]M+K77U^X^M?M<
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M/_QE;2LCM:?M/?&FU C_ -4D<6J6 C2-.BJHX X[>E?T1?=!_$__ %J_#_\
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M]GI?Q\_;H_:?_:3^)GQZ;Q;\8?$_PF\9ZI?V*NAN];OI]$U 2^;"P$D4)9.
MNW!!P!FMJ<DJC3UM:]U?N^M^_3OY(YZL92;46UWM_P!NK\KZ^MM]<7_@U1EB
M@_X*R_M-68D\QS<_%[8X4XD2/Q!K(9P?X<@;L=QQBO\ 27C"B1\*.,X8#&.<
M8QW/7G\*_P T+_@U<NS#_P %COVA=.,A3S8?C3(83C+M#X@UT#/NF#T[U_I?
MKMWNW7!(W=,<\J>W!/!K&O:25DKVV2OU_K_AC2FFE*]]6O\ TF/0=(2%P!US
MTXQ5)496RK%3R0"H(R>I&0<<>GIBKXW=R#_GZ4[WQS6=DMDON_KLC2Y2WRMC
M# ,,_-M7(!ZXR#CMG'6G^8Z<LY. ,X4<D\=A_AUJP0HYV\Y'0>G2DXZ;3\Y.
M>/Y^E*7PO^NR A,CA<L=H;[I !*^_3'IU%?SR?\ !2#]A[X^?!+XW6?_  4R
M_P""<UQ+IOQC\+V\'_"_O@=IJB+0/CMX*L1'/=*^FQ0M;R:Y%;QRRR2NF^=Q
MO!8[E7^B'&%(;&,''Z^M?D5_P5&_;0_:+_8O_P"&>/%/P@^&>@^-/ACXQ^(+
M^'_CQXM\12M#IGP[\(M]G$>MSS A8U8RW RW!$)'3-516MY:]5S:IK33K;Y*
M_D[6"[76U]'YGR-\;/\ @HM\$?\ @HE_P2/_ &WY_!VHS^"OBQX2^ _BO3?B
MK\(?$$BZ5XR\%^)+6UWWUH^F79CO[O3?/LY@EW% 4:,+&SY<%OT*_P""0\4]
MK_P33_8VBEG>X/\ PI;PF []H_L3, @(RJY&0O.,G%?AC_P5-_8:_8__ &UO
M@W^T+^VE^P[^TOX8^'7QT\)_![4[GXT7'PFUN*3PA\0?#GD)/J>C^.=/LY8[
M2WFN"SPM.\+3'+!R&(#=!^P;_P %A?$/[)W[+'[.WPT_:W_9@^)>B^!;#X=^
M%+#PG\:?A5X=N=>^&;:!Y'DVVJ:SJ891;'RB9KB1"0BJQ*G K><8N*M&VK>J
M::NHW2OT:U6RUZ#U7>WX?UL?UFB?*;@"=K[9.@V_T/;GZU(&W897RH^\,#OT
MY ZYZU\=_!7]NS]CW]H.'3$^$7[1'PX\97.IPQ-!I-AKUNFJI+,-WV:YMK@P
M.ES"[>5+'MP)%*Y. :^OK="L., [CN4AE8,IP58$$C!'(Z9K-Q7?KU5NJVOV
MW$0R_P"L1R?F!X8 9"=QT/3K^M3^8C?*69@>P7^>/\Y_"JMT\ZW*+&B,K1-E
MFEB0C!YPK.&(&>H&*Y76/B#X)\+ZOI'A[Q#XO\.Z+XA\0.R:+H^I:G:6U]J+
MIU2U@DF5W/.,XP3P">E3[.?NRIN*3MHE=IZ:V6WG?0=V].QW$4<<8/EKM#')
M ]?\FI",]S],\5!%,2/WFT-U !!W*1D$$$@YZ@@\U+O'3GU[?XTFIK25F^K5
MW?;6^OG^&VHM>PJC&>,9)Z>E0S1+)@LQ4]L#T[<>N?\ .*GW#.,C.,X]J0A2
M><9/OZ4TVM@$0(.%[#T/MS3F.!F@ #IP.M-;YL?, ,\]/3BE?N-;J^U]1H+$
M$ [>I!QT_ Y&*:(V4$$[]QR<XY^O3KSFI0H'(S32^UL'H<8SQ]?K4OE>ZO\
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M::-I8Q\)_&19$7<W_(%N^0"#R/\ /-:45>K27>I#?3[2$]G^A_*Y^U^UU/\
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M/X^?\$G)V($;?M(:H&W?=&ZRT?;GM_%C\*_I=MU TK0Y2I?.B6"@CL?LL?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 0_7'7]>/TK)M'OFN+A)UQ:KGRW_ (OSQ_G\JUF
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH *0]/Q'\Q2TAZ?B/YB@!:***
M$'0?0?RI:0=!]!_*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@!H^\WX?RK_.,_:VDGT;_@ZL\!W-NI*77Q1\/02E1GY723(S^7US]*_T<1P^
M/7D_7D\5_FZ_MRZS-H__  =0?"%2!Y.J_&CPG:D#J/.6<C/XICZ$57*Y8;&*
MUTX0T\^>"7XWN;8>5*.(I>T:3E&HH7UN[*Z?KIIVU/\ 2"G4@M("-YVB//H
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MZEXS-@Z^*/AUX:UP-_:EW#:);HZ7>C!54[X]H9P">M?F+_P3%_:"\ _M$?\
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MV*/9HW[+7C^603-Y@,H@X<QGF3!Z\'\Z_%&WU6_%R;=IHH3%:FV6&,!MBHI
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M&_V1M6\ W*:#X=T+0;+1_%&K064EO>Z+;+'>O-%-<1.8+G:"64<;5"DX9:^
M_P#@I/\ M-_\%H_$O['_ ,1M"_:(F_9[L?ACXIT\>&M?'AWQ#!<ZQ:6EWY-K
MYEO"+J1F<.ZEL*W.?K6W)./*^5M.UU9:V45;KYH=.I1U7M%?7W>K=DE9^KT6
MY^XO_!I5&(O^"3?A)2FP'XC^-9R&Y\SS=1E<,!SUXQ]!Q7]/(()9LXVG&2.,
M8R, XY]Z_!G_ (-U/V7/B%^R5_P3/^%G@[XDZGH6J:IXKN+SQ[I3Z#>)>V:Z
M%XF/V[2X'EC=_P#2HH952=3M8,.47H/WAP9E&[Y7*G<@Z*W&">_ '/7TK&>K
M^!P=M+JUG97^]Z_/LK"?2W9??8GW .!@Y8?>]<#/X5_'!_P3'_9"_9V_:?\
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MEIJ-IXE#2&UMH](,E]<Q7D$)$DT4L,;Q[596Y.UU)S7Z6-(-K<'H?Y5^:/\
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M1M3L[?4;.]ANHS'*DD5W'*J%U=@6C"L.H.0"/PM^,_\ P1HU?X4^.+_X\_\
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M^@=/^#>;]G%4BC?XR?$>=UG,SE],T8F4D8Y<.S CM@_6OR7_ &T/^"27P$\
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MDFW!\C%UE@IZ9!R:P?\ A6WPE$MQ:Z=J/QCC2XG,L&H3ZUXD6\-N#^\4H;K
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M;44RR/M0;0HP  .*X\1'$4(PY8QD]]+-/17MKJM/5-FJI91))/&5VMVX6O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ.A>"/$.NM-*;SPYJ%O?:H!IUQ, 9[*.9EC0Y;RE58V8LI)_JG9=W\15BH)
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MBSM,DXY(AC+$^^<]*T:P$[:6[:^H4444""BBB@ HHHH **** "BBB@ HHHH
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M9Y(XX@TA*K#*V%4G:>E:4XJ<DGHKZOY:=5U _-*7_@V0\=?%#3?A;XU\$?\
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M_>236;ULKZY#''UK_3:._P S;O;..P]\\^Q _6LZR<=N\K>7OM=>Z".WW?\
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M9ZSH>J6;B2UN].OX4N+:6-UX8&-U.>.M=;DX4^I'ZTR1<#T'Y48'H/RI:*
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MIR,?S_#_ !JQ!,9EEWL@"OE]AR0"3A0/7@#\>]07H0E2BD*)D0@?>#8XW>V
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M #_=J2OT0_AL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]P'_!P/^S W[5?[!NM^%=/\(^+_ !QKO@SQ9IOC30_#W@:U%YXBN-4TI)#
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M>'_$>DZ7X@T74(S#J&DZW80:CIU[;L<-%=6=RDD,R'NLB.IZ%2*\U\)?L_?
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M&-+UK4DBCC 2W^UW]M+.]M"K;(X6=H0,$1YY/Z/C]C_]EKRI+=_V;_@@T4C
MR1_\*V\*^4RD@G*MIC#=P?FX!/)'6OBS_@A[)++_ ,$ROV8EG+LZ>"+)'248
M,>V./Y%Q_ ,#9GWK]:2H;((SD8/T]*XZR<JLI.G2D[_%*.J^';RT>AI!I15E
M;TTVMT5K]=_PU./\'>$O"?@?18/#W@?PWH/A'P[9EA::'X;TFST72[9CC>T5
MC8106Z,^!N9(P6P,DD9KL,@]"*0*HZ*!QCIVI0H'0?SHZ)))6Z)#;3V7]6 9
MYSZG'TIKIN_#M^?O3Z*!'FWC'X3_  M^(:6</C_X>>#?&R6CO+:?\)7X;TG7
MOLLK?>:$ZG:7/E%O5-N?<U\?_M8?L.? [XI_LU?&[P#X9^ _P@M/%/BGX?Z]
MIOA^XM? ?ANVNK;4C:L]E-#<P:?'/!,DB?NVA="6PN"#@_H055@0P!!Z\>E1
M2!$1WV;CMP0!DL/[N.>O0\=,YIK=>J _G$_X-Y_C%X/N?V"=6^!OB#Q!HW@_
MXF?LY_$_QQX;^(>A:K<0:%)H=AIVI+;Z7>W<5PZ&VL[I4+132*B2J 5W U^W
M1_:@_9RB#07'[0/P<6[AB/VC/Q%\+AQ+'PP*'4@<#!!&-^<?*3U_E=_X.+OV
M"=-_9U^ /Q?_ ."A?[-?CSQ/\(_'NN^)? 6C_%[X<^$KI[#P7\3[&]U9;*V&
ML002Q%;EV\L74D<:M*93R<$U^:_PV\.?L2Z;\-_!?BC]I[_@G_\ M91^.M=T
M;2]2B\1?#K^W+CP7XJFN8+=\Z;(LSEVNWDWY.%S(:VT;UUUUNDW?2^^OIKM;
MH!_>[I'[0GP5\0Z/KWB/PU\6/ 'BRQ\(Z-J6N:Z/#'BC2-:O;32=(M9;W4KF
M73[*ZDN0D%M%(X<Q[20!N!(-?S5_\$M?@!\'_P#@HI^VE^VU_P %(OBGX&\*
M^-?A]-XTU?X%_!G0/&/AJRU?3=5\':?.[R^+HUU"*:$7LTT#6BR*&DVN2K*P
M5A^&&E^#?%?Q=_X*Q?!;]E3]B3X?_$G]ACP7\2/A]K%QXR@^*=[J-OXD\:^"
M)=+DD\1VSVLUP4::ZTTR1V0";V? P2<5_H ?LR?LN_"[]DKX(^#O@7\+-'AL
M/#/A6R2.:X,82[UK4WDDGO-8U)UR9;RYN9'D9B>%(7)()-.48+W>9-V5]+I*
MVUK6ZZJS5]-@>IFZ3^Q9^R/H$DL^B?LS?!"SFDB6-9H_ASX9^>/&W#>9I[D<
M9Y!#-W/>OHW1M$TK0-'L="T/3=/T;1--M5M+#2]*M(K+3K&!#N2"TLX56*"%
M&)VQQJJJ2< 9K6* *I   "C\L;?RJ7 ].^>G>N>=IJTN9[7U]-M/ZT>XDDME
M_7]?F1A=HP.J #/KD8Z=OUJ6C'MUZ\45$81A\*:[ZZ;+IZW&-<X&?T]?;V]S
MVK!UG1-&\1:?>:5KNE6&M:5?Q&WU'2=6LX-0TV^@_P">,]I<QRV\R<])8W7V
MKH",@@C(/!'L:0  8 P/3M57:VT \#_X9G_9ZBA86_P)^$MJY8/&H\">'%0R
M=FQ!I\1W<<,""#WS5=/@?\(OA_X8\<7_ (.^&7@?PMJ]_P"%_$+WNI:%X<TZ
MPO)VDTJ[W!KF&#SP,-C8K@8XQUS]!%$.,CIPI].<\5SWBM/^*3\4*N,MH&MC
M/7DZ;<CGWSR13BY<VKNFUW7;S?;]!/7_ (8_S+?^#<'%I_P7\^*L"&1@R?'I
M-S YP=6G)W9YX+8'L*_TZP")@W/S <=,]?\ /2O\RC_@W=B$'_!P?\7X6;84
M'QUQC&&_XF#G;^)(Z5_IM]9"QSA<$>O/&/IGD5=1;+XE>73N[_\ !%';[O\
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MDJM;FHP]H_WF]U=*RN[*VMNE[W=C"<E%Q<EO.W_DT5OY7]/0^,/^"A'[$O\
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M%<7E[H>FW%W(?%4KB6XGM8Y93Q PPLC,H(=LXSD$D5O#_@US_P""04;_ #?
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M34+P>7-=:CJ/F#8AWNTO3+<?6'_!*WX0? K_ (*W?%>\\9>$/V)OA?\  WX
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MU>TM=>U@27UV57=JFF+]MP%)YW. 2!C-6OV6_AU^SIJ7Q.\=^'/C'XCU_P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%1_-/\TOT.E_%+_$[^O;\@HHHK<04444 %%%% !1110 4444 %%%% !1110
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M;T74@@0:G8:/86ESY..56>"WC=?EX(4@M@9)KT.$KL 4EE7@,1][U/YYHO\
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M/_!JCH]E:75C<M!\(?&44L*WUKY_F'QOXJ/^K\X/YZ;]QBQY@1T<IM<$W?\
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M#KVJ2OUX_P V6M?E^=G_ )!1110 4444 %%%% !1110 4444 %%%% !1110
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MVWW7OZM]3^A>WN"UU+!)" ,G$JG=OY^\3_".V..OUK5R/\/_ *WK^%?C2/\
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M]X>UCQ_^TG\3_B3H40\.ZLY_X1;Q+K4MYI%S<#["1F2!PQ/48Z=:^,?V7?\
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M9ZYX2\3?M?Q^/O >@_"[Q)%X>\,R-X(TF&"?[,UQIRLDVG-:B6*.VE+;I@K
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M'*\>V/K6=*/^T8>$5>\6]==7%MIKRU^ZRV.F<4HIM[N,GZJ2:^^R_'<_S4?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML['GY9_$]R<GWP./?%*F^95$]HR2TT_E[^HINVV]_P!/^"C]:OVFOVP?A_\
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M[IK7]/F?Z#&@_P#(O:$H&W&D:=CV MHP!CZ5T2=/Q_H*Y_0CG0=%/_4'T_\
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MEY.,?EIHGZ?CN$7>*MV18 QP**1<X&>M+6(Q@Y3\_P!#FH6&0<G& 3^(!_\
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MKW[ [0L42_LQ,8+R/@I-&P*CH*FKKG3?O===+=+='I;Y$ZWWT['LD0PP"_=
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M9\!?"^B6]G>1W 71(+32HKU47:#.+:!%<$<;&&#UQT%/E_X)5_L.SWMO??\
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M-2C?:ZZ>?H@,6U2X1[YG;S$,4IB3)W)((V^1!W!4_P!>U?Y'_P"U3I&@ZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC=+KQ/XJ%N]O)?-')EE!$TV,L2Q.X@-FOU*BXX4$J/O C&UN^W_#V^E?F/\
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MLP;3+;!A1P&5.P##-=]7*]WZO\S4****0!1110 4444 %%%% !1110 4444
M%%%% !2'I^(_F*6D/3\1_,4 +1110 @Z#Z#^5+2#H/H/Y4M !1110 4444 %
M%%% !1110 4444 %%%% !1110 4UNW^\*=10 S;DMD<'!'UY_P :_@&_X./[
M%+'_ (+A_P#!,J[10K7MKH4KL!]YH/&&EP;C_P!\D?K7]_;' S]/YBOX$O\
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M?7GI/"7_  \,:QBN?$/C+_@H<TEY:7LK1V?C"Z5A-$Q%H2#"/E\O!;U/XT/
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M/[=TS)'4@_Z5QQZ9S7^6XG_!*#_@XY*^:-(^/OF2G)_XJMN"?7YOT]JM6_\
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M)5-KR?M+6ER7/RF+PAXC,D0;^&1OL?7'.1V_"I/^(A[_ ()*NZ*/VF;=&3^
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M%OL55PSQJI5>,US4W-U%:3LU9K7;K_P;>H]-?ZZKIZ=]]3A_V\=:_P""-O[
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M_!/KX[_"+X-_%K7?%/Q-\6>'+O3_  _X?T_P1XJBDO))K>=&W%[#:5'F(.>
M=QXJE/6$=X\R<DG9;6U7;;T^1-.,FY)NZMI?OIJNMD?8?[(_[&W[,GC3_@BU
M\(?'M]\ /AC>>/\ 6?V3'U:?7+CPKH\VJW&L?V7J3R74M_):M*TY:,OYN[S
M0OS<8KS;_@U4OYC^P+XRT41E8_#WQB\<Z?:6A&(;:&/6[I?*A'W0B;?E   V
M@ =J\2_9-_X+5_\ !/SX2_\ !)/X3?!'Q3\5M6@^+/A#]F5O".K>#7\#^*CJ
M$?B,Z;J5M]A8_P!G;-S27"X.[H>E>[_\&K>B^)HOV!O%7B76M#U/1-%\;_%O
MQIXA\,RZC9SZ?=W>FWNLW4\<@@N8XIE5EE0H2N"IX.*YJDWR/5ZU++T36WEM
M\S1?$MMDM/3=Z>OZV/Z>XQ^["@$ @')'?CC\_>EPK-MP1@'<#D<'I4,:[T Q
M*@'R<GL/XL\=>PJ1AN8,255!G=GEL=?_ *_^-<\KNH]7IK;[M/N_KJ:]$C^1
MG_@Y3T?0O$?[2G_!*[0_$=K;ZKH]_P#M "WO]%O8$GL=0A>6S#07,<BM')&R
ML0RNI!!(QUS^C7_!6+]E/]G2P_X)J_&W5]!^#'PN\,ZMX?\ A3)JFF:MI?@K
M0+&^M)+?387VQ7MM8QSB5RP <R%V(SNZY_,K_@Z#\27'PX^*W_!-KXP:MX>U
MK4_ ?PZ^.8UCQ1J>BZ5?:J^F64<EI))<7,=C!.Z1JB,P+!<XP,FK7_!3#_@O
M%^P#\;/^"?7QE^#_ ,*O%WBWQA\1/&7PT&@:3H5IX)\302PZC+I\*,6=[#&V
M"0,C;N#C/-=48R:@XORDD[6TT;[F4II;QU[6U>J7Y/J?L9_P3Z_93_9E\>?L
M$_LD:SXL^ GPKUK4;_X'^![N\O[KP3X?>[NKB2PBFDN+N<V7FW,\DA,DDLS/
M(Q)!.W 'V!K7['/[*MXD5N/V?_@^)!<VUS#$O@'PXA#6X"IG%C\P Z@_>.:_
MG[_84_X.!O\ @GG\&OV)_P!F7X:>._&?BZR\;^!?A!X3\,>)M(_X0GQ(SV>K
MZ58+:W<3-_9Y#'>F[CH#V%?4+_\ !R1_P3)F*:@OC7Q<SV["(E?!?B1L%^@(
M2Q &"3U&>.>U.&'Q,IN2>C?NNZZ<JNWS+?6VG5=A1JQTU2T3TON[=;=/Z9\*
M?\%ROVU/A'_P2MU3X0?#WX:_L+_ WXCZA\5]7OQIFLZUX9T/3?)UV^B\J&*,
M1V!WI%<21[ V(LXW,@^:OTW^#7PJ^"/P4_8:\._M8?M[_LZ?!WPSX]\,_#J[
M\6_$B#PIX*\/ZO8Z-H.HI'J5M!###:A;B>"QN(UE^?<L@8,,@BO@[]HO_@L7
M_P $.OVI];\#7?Q[\*W7Q0U;P#JB:WX0N=<^'OB.YBTB^A99$FCWV*XDC*[N
M,\_E7KOC3_@XE_X)<>+?!FH^ O%-IXB\9> M6TD:!J'ABY\!>(Y](U#0UC6W
M:PN+>73FC>(11K&J$<(H'O6SPU96;L]5?57?P[/FLT[[Z6*;3VEH[>:M>.RM
M;:_<P/VT_P!I7]@3P1_P2\\9?\%+?V:OV:OA7\1=*V^&[/P=!KO@31=$AN9)
MM22 ?:(4LW,"J =V [N<8!/RGE_^"#GC35/^"AWA#Q_^T[\:OV1/V?\ P?\
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M H_>+N_LX$EB.I)QVQ5"Z_X.7_VO!<)#9:M\&+J)I9-UU'\-/%H2-<?+%AK
MYDC_ (SR#C@5M]1Q$K6KX?Y.V]M[[W,_;Q[2^Y>7][^OD?W>23MT1]^>,H ?
M+/J_^&.OTI$G8?*3YR'(+!LL6)QC'H?0<8]J_@Z3_@Y>_; 26&"YU_X,1F7,
M*2CX8>*2K3.QV7!']FG$,0XD'!)!Q0?^#E7]L]+VSM9M?^"$<=S)+!+/_P *
MQ\6&. 1@F.[_ .0=DQW+82-22 >HJUE^(Y4O:49*][J5ET\MW?35_D4JT'W7
MD[+Y[G]Y<+#YHN5=1R,<#)X^;N3G\OPJ4-@[2XRH^;) Y/3GU.1_]?-?P;#_
M (.1/VSRVUO'O[/\)9'E,3_"SQ<9K?8Q"QSD:=L+2*-R[1G'6I3_ ,'&W[:A
MF\M/B?\ LZ")XHY4EE^%/C#AG^_$0NF@?(.>>?<T?V;B';6C_P"!^FVG]:=M
M5[6'=_U_7]69_>&9@H+,4"*N7;=]TXZ8]_TJ">09@D64[>6\L*3YH;&.0"0
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M$IRQ$4DM$YK2WJ_/_ANE/)Z4N1T\%B9U(WE*2H5/>V:^Q96TOOWT/KSX.?\
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M#7A>Q\-^(K&Q=/*L]4M5 =3''Q'A47(P#UZU_F(>*8191OKNHQ)/I5J4$TK
M +++U(0@/@DY[^]?V_?\&O'P\^*MI\#O'GQ*U>\FLOAAK^MO!X8TF<R*+R8A
MB-1@1^/+*X4,IZFO@N Y?\+>(=)*,,10YIU(>ZTXPC*-VOY7II:ZZ(_N'Z;F
M3975\.L/6S;B*%3/L@QE"&4*HIK$UJ&(O3KTYR?QRK1O:5E[W31GZM_MB?\
M!'C]EG]M3XR>&OV@OB';>)M ^*WA>RDTNS\4>&-<OM%ODL9$,3P1S63QRJKJ
M2&PV&ZD&O I?^#?G]E.X!A;X@_&^.$R>=L3XF>)SE\D$X:] P23D9/H:_>0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,\X]L_K2TF.
M<^V*  G&/<@5P7Q.+O\ #3XCI&OFR?\ ""^+A&F=OF.V@:AA P^[EL+D<C.>
MU=XW\/\ O"N(^(ZN?AYX_3!^;P3XJP4X.6T._&%]&ST)[@>E%/7D??E?WV _
M@G_X-";K4(_VI?VV[40VWV&7QQXE:Y)U!DNH;A=0O @BT\';<Q'&U[@@F/'7
MBO\ 0)=G5\;CA26/'13TS]/7J*_RFO\ @B=_P5R^'/\ P2W_ &C/VIKOX@?
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MBB@!!T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^NR^XX9/AY\/H<-#X!\%QD8^YX6T1"!_P&R!]*D'@?P2H(7P1X1&0<@>&M)
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M)]^4GE_LA_!1@A(P_A*UD9<]PTC,2".1R,=@.*Z'PG^P'^Q3\-=?LO%'@/\
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MGI\NW]?TRD_[U=LD,3@X)5X]ZYXY(/!(QP>U2#Y06D4X7/') !QP!D\<#BK
M^F,]?\]Z#R#C&>G(XS04<!\0O!>B_$SP!XQ^'_BBT2ZT'QGX=UCPQJMN\2R
M:?K=C-833+&P(,D*7!D5<<L@Q7\F7B_]A?\ X*!?L">']:^ 7@OX)>!_^"CO
M["UUJ]SXK\&>"?B-JB:3KWPLU:YO9;ZUTW2=.5G>:VL[J93&50(?++(3DFO[
M!?F )\LDG@C(R?0@^@XXI?G120"3U(X(Z#[OZ_E5*IK:SU?G9/1;[>KZ]7H5
M&W6WHVU^.W]?,_FO_9!_8$_:>_:E_:(\#?ML_P#!1S1-)\#:9\(M(M]$_9N_
M9/\ #\XU/P?X L(+=8;'5+Z1B\;WL,:HT:2H&C*J%P!Q_2I&-J@<8'15P%0=
MD '&%& ,<>G%0+YQ4G(+'^(CY HZKCU/>ITQM&!C/./0]Q4N[UOVUTO]WX?U
M8D1DR<\<$$>Q'<<<&I*0$'IS0"#T/\Z5GW?W+^N_]+4%IN[_ &6_*G9Z^W6F
M[U/?H<=#_A0KKK<!0<]F_$4T[\X!_3C^5*'5L8.<].M&]<$YX7@\'C]*8%6Z
ME9"JH'WE693DK&".F\]#D] >#BOYM?\ @I)\9OAM_P $Z/VYO __  4!_:+^
M.?Q3T'X4:CX/M? MC\)O#$&HZEX;UK6;949YGLXI&M_M,B+RBQ[B#R<$U_27
M.=[)'@D-R6_AXZ CU.>OO[5^3'_!:?5/A_X5_8&^,WQ4\4?!OP%\<O$OPHT_
M2/$'@[P3XVT-/$R?VM=^(-*TQKF#2(Q)=R2""Y>1?*B883>1M7-:PEHK:WNM
M+.R;_6Q$J:DTVWW^[\GZGX_?\%COVK?A;_P4:_X):?LY_&?X.6WBK2_ ?C_]
MKSX-6>C3^+M(DTC4F1=:"?:X+&7=YH/FYMVY)&\J<$@?U3_"/1#X<^&'P^\/
M?:+BX.C>$M$L6EG4I+<""Q@3?*N,@GOTZ]Z_F#_X*Y26ES_P2L_X)]:AI?@W
M2/A['KO[1W[,.OR>%?#]A_9.D:'<ZE-#>36T%@5C-M'&\NSRG167;AAD8K^J
M;PZ&.A>'Y,EY'T/2MS@_)_QXVY+ #C:QYI\VBBU9*[2EIJO^'8K.[=[[7T]'
MIW_K0Z*BF[EZ$\CKUZTH8'H?YUC<T%HSTX/^?6BD.>PS^E #6!P^WEB.!Z''
M%>(?%_X,^"/V@?AQXR^$'Q<\-6_BOX=^,-/ET_6]#NV*1WT,H8!2^"4*M\R.
M!E6 ;'%>Y5%()#@1[1D_/N'&/Z]ZN,N7IU3]-O\ +0#\(M*_X-[OV"-#T6WT
M'0](^)>B:7%>274&D:7\3O%-KIVF6\LAD>&S2"[1$12WRQHJJ!P!P*^B/@'_
M ,$>?V"_V>[GQ)J6@?"IO&VO^*8!::IX@^(]]<^.KP641 M[.T?7_M8M%B7:
MN(N>1R!Q7ZJA"N-O3G*=LGN,]O;^M-6/!<K@;C@C^#W('7<> 3^-.=23V;LO
M^!Y='ZW)Y4VVUU]-/\^_WGPO'_P3J_8VBG0VO[._PR(E8R332>%=$$D+%N53
M-B"<CD 'O5Z'_@G1^Q45G2?]G'X6R"1MS,_@_0R23GG/V$G=SWSZU]M8"L$
MX.&9SS[8^IP*D.!\H&XD]_KWZ=CFIYI=;J_DA\J73^OZ1\1P_P#!.K]B&%3$
MO[-?PLVD$_/X.T,Y_%;('(QQVIZ_\$\OV+()87C_ &;?A3M7S/,+>#= /RL#
MY8.;#_/X5]DW\TEOMG !BB1WES@!(HU+NYSQA0"3TX%?E)XV_P""VO\ P2_\
M!^)M?\&^*?VMO >E^(_"NJW.D>(=,D>X>:PU*UD:&YLYL1!1);OE9 K/@],U
M47-WM&4MM>G;^OO[B<K=/QL?45K^P1^Q?:R03Q?LX?"7S%PA#>"O#[X.?XE-
MASG.,#''H<Y_FH^%G[,/P&N/^#E3]HGP1'\(_ 4'P^T?X%^ =4@\(Q^#M%N-
M!.K7NCP2W5S)9-9FWLS+,6961 SD_>R<G^HS]GG]IKX"?M;>$%^)'[.OQ+T/
MXE>$=/U)+"[UC0)VEMH;XJ9!;W"LJ.DC(&;:RC(&1GK7\_GP>O/L_P#P<U?M
M4VN&3[;^S_\ "\F0'"RF/1H"L>."=O ;'I6R@VVM;QBVU;5?"[O3L]/+7;=<
M^UTE=VO?^O\ A_N/W6'[#/[(R:NEX?V>_A+&D0F+1-X%\.M'*=K_ +Q\Z?V&
M6&3V%?R5?L6_ 3X):E_P<?\ [7?@36OASX$OO!VC>#[.XT'PA/X:TBZ\/6LD
ML&_=!IDMJUG"P.,F.)<\YK^X@"9[AR53R-CJ8G \QVY^8-CE2,C;GH:_BX_9
M+MUM/^#IW]J>V.^4M\.H9?,LF\FRC/V(D)/"3N>13\N1GFDIVC)-V:2TNM[Z
M\O9[?IU)6K5E]K6RTMIY']4D/[$_[*"W=Q*_[/WPBYN1L7_A /#6WRMP80!?
M[.P5)ZD#(6OY_OV4?V7?@1KG_!>K_@H?IM_\)/AI/X;\-_#;X4'1/#LG@[09
M=)TJXO-)MFNYK?3&LC:P/>.Q=VCB3);K7]4DP'VJ$B0*X8?)U#*6P>.S>A/?
MVQ7\ZG['RRVO_!?O_@I;Y<.Z.\^%_P &7E<GIC1K0\>_8#UQFLZ5KONHNSOV
MMTW?J)JUK[7LW9KM_P $_9D?L=_LMQQ&.X_9\^#DZEF61S\/_#"E8LYW #3O
ME_3TIMM^Q[^R0AQ:_L\?!XL#E3_PK_PRRDCW;3SD<<YKBOVM_P!NO]E']BS2
MM"U?]I[XP:/\)[7Q=<G3-$.J^=,]_<-P%B@MU>3'N1CGJ:^9?A#_ ,%G?^":
MOQD\>^'?A5\-?VHO"_B+QQX@NX[7P_H:V5Y;7.J7$K[!% ]P$5BS\?-@YZ U
MK[THW?-TV3Y7L][6?];])3OI=7>GGNNF_P"'<^X?^&2?V6UN2[?L\?!P22QA
M5_XMWX7(]QC^S2 >V1@U.O[+7[-<$D=Q:?L_?"""Z@#1AD^'7A=2$?&?F735
M/09YR>U?0LC 88@':0<]P,<<=3S2YRR@,0&4G/<D=,GIQ6'.U*+VVT;=G_7S
M^\W4;;+YGSE<?LR?L^W1N5N?@'\'OW\ MQ(/ASX7W\<ABW]F[B>1@]?Z^J^$
M/!^A^"="T_PSX<TG3= TBQ9C!INAZ9;:5IL()!_=6=G'%!'G@-M4%N":[D(<
M)N!8J<9R,<?Q$?Y_"G!@<KG/8DD=_P#ZYP*SNW%IW=ZG-\KK_*_:Q/+[U^E[
M_EZ?+?;4AC)."&?!<C!7MC\L?Y[4K#,HR"1CWQTZ^].W?-Y?( '#$\DYQCZ5
M*,]\?AFJ;NV]MM]WHDOO_3T+.'\8^!O!GCRV_LKQCX4\-^*;(?/%;>)=#L-;
MMH9,9+PPZA!/'&S!0-R@$YQ]/+[;]F#]G*(RRO\  ;X1"64&%FB^'/A>-BA&
M#RNFY7=CD@J<U]#MZX'U(_PYIN?O$Y4G'U7MGW[=*4:[5XZV=DK.UONVZ&<J
M7-KY]K]KV75W_/R/GI_V8?V:?W:M\ OA'B,%8"?AUX78AB"&9V.FY;(Z%B6]
M^]0V'[+7[,FE1W'V/X!?".-+N7=,K_#SPO(&D)^_^\TQMBCG[N*^B&Y( ((Q
M\Q9<DXZ8K!\12):Z?->7$PMX+:&22]N&D$4-K81JSW%S([$*HBC4MDL.G45O
M"5YKWIJ[M>\G;X>WZOS9,J227=;NUK^=M5^&QXG>?LP_LT3&T,_P%^$C.)66
M!D^'7AA!O(PV]ETX$IUY)_K5VU_9]_9Q4KI$7P'^$B)!(%9?^%;^$]HD(R"K
MG2BY7^\2Y /;@5^/7CC_ (.)?^"67PN\8>(O FN?'E[S5_!>O:AX>UTVMA?W
M=O8:CI\CPW >:#?&\:R(RAE8K\IK],/V+OVV?V</VZO!&H?%']F[Q[:>.O#.
MEWHT[5[RWCDBDLK^5'>.WEBD)DBD**2%< X4FMW"R<G*?,D];M=DK>2>ZMN^
MVRA:ZN[Z=E;1+RLE;\.O4_G;_9O^$/PGTO\ X.1_VL/!I^%GP^GT!?@;X3N[
M71)_!^AS:/9RRK 6N+73);-[.&8Y!,BP@D_>SR*_J'C_ &=?V>?M\\J?!#X1
MFZ=9(G?_ (5SX49D4ABQYTLJH+9'R!.N 17\Y7P106__  <Z?M2I(61I_P!G
M7P3)"O)WADM^21P..>?7VK^H^*#R]4EE!8EQ*VT-PW4 $?4\9Z<'I4U*LY.]
MY+]V]G9=-;;6OZ"4(IQZKFUZ]$GK\_P/XE?@;^S9\%OBK_P<=_M0>!/&W@;P
M]J7@[0OAEHDNFZ#IVFVNDZ9:S,JX,=G911Q1Y. [1JI92?F%?U'Z'_P36_8A
M\/ZO::Q8? #P8;O3IGO+<WNGV]W")UW$R/;3QLDQZE3+N[5_.K^Q_J::C_P<
MO?M7SQVWV=5^&^C6[#&"S*$ )[XSCM]>*_L,A6;^T9R75HB#\I&2OH%] 3R?
M7GVK*4G%WU35G?;JDK;:]OUN="<4E:SZ=DG?YW;1_&/_ ,$</"/A;5_^"WG_
M  4WTW6-$\,:UI6DV&EVFEZ=K&A:;>0VEDEVJP6>F:?<P206L=NF /)C50!@
M@BOZ][?X3?"B"_/V?X5?#FWRLDC2)X(\.),9&5@S"5=.&%9&9"NT9!;L<5_)
MO_P1_P##]O9_\%YO^"GDRR^;MTW2[J JP*HT]TOFQL 3R!E0.H]J_L)AW?:Y
M<ON!#X!!RO7OC[O?\NM:XB=ZM3=::ZV^^WVK^6_K8RI7:;Z7OMY1\^FWZG\O
MO_!#70/ ^H?M._\ !271!X/\*R:9I?Q8OYK;3+GP[I<D-G))JT@E^SB:V=(X
M9MQ+(@5>%K^D.3P'\-Y4<MX \ P(JF(W4OA30OE!XQ&/L6X\],-C/Z?SK?\
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MS>&*WNY5M8DN+Z":9(XT0;$#A4 V@;>*_IW'[(O[+^\,OP&^&.Y#\I_X0W1
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M"REMFV4LLB?QM,2<9Q]S/7KUK[MGGUR0S0Q:!XAFN8( 6D3P[JWFK)N.5/\
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MGE_\1P^AWAJBCAN'*?LYIJ2>73=KI:/F@G;;WG?HG;0_CAM/V<_@+H6FL?\
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MU/\ .@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[+^\W1NQZX%>M\G!P02,$9Z#U^M&.O)_/T[CZ]Z.?K9_^!/H+D\_P7EY>O\
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MS;:791:Q)+O74WMFM9XGEPH1I'A#$-(%53M>NVT+]HW_ (*$6O\ P57\3_\
M!3ZQ_P""7WQ@N? 7C7X=Z-X$A^'UQJ]JOBBS_L>P2QCOS<FU$(DG">81Y2Q[
MSPFWY1/L)\TFI1U@H_$EK_+MLEUTTV+E%6C==;Z=-M-?GN?WHVTDK7%PDH),
M<LI1\8*)M8 #USGC/]:_C!_9H.W_ (.L_P!I<0;)()/AE"999F\FY\P:><!(
M!@.N>_)[U]TM_P %OOVXFVO!_P $@?CXUVP+"$^(;7(!_@?%L%9\$?-MX'
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MR1[E4?,4Y7!YS7G'_!<__@FO^SE^Q1JO[%/[6O[+7PUTGX02^ OVD?A_X?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSG>C6 PV><Y.>]?9U9S=I^KDE\V@"BBB@ HHHH **** "BBB@ HHHH ****
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M8CF_TO\ :E^*=S;3!4,$6BVI0R+P'W1R,&P?F(9L ],#FOZ$O^"77[>GA/\
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M_=Q/;12JJ=]NY2%]<#'TJ&>ULS;+ +.U1'<$1FWB1%"MU"!=N??CBOY X/\
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MX*=?\')K2N\/_!/#28S$NV;S(K1XR%R<A/LI (!)X Z]3S7QW_P4#_X*'_\
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MJ*YSQ@6'A+Q1L7>W_"/:UA?4G3KD>_Y=^E..LHKNU^8'\7?B.6VE_P""-?\
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MF-XZC]ZY[=P<\DY[>@K]%X\DX RJX&3CD<8)SWQSQ^-?G;_P2?AM[3_@GO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI@I4-^SUX'(4]0#:R<'WK])ZB7QO_M[\T 4444 %%%% !1110 4444 %%%%
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MM?MC?\%(?VC?%O[)'_!,S5+'X>_ WX;W4^@?'?\ :HUBP>ZTO^UDD:._\/\
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M"\:33R)9:YKD-DB65FUO!+# VI7#(H1<R.SEF;;T7X?_  1_8H_:*_X*1_\
M!2S]H'XL_"GQ)\-OVB/!']C_  TT+PQXAT;59/%,<VFW.W0X]#L+B6:_O?$4
MJQ60"*0'G)=ABMG"')":5^;H[-[+_AWJ[>J(C*\I)[JWI\C]_?V8/V@/AY^U
M1\$?A[^T#\)]8FUCP#\2="@UW1_M>U;RR,CM'/:7L2X,-U;7$<D4L3JK+@97
MFOHD'(S7X ?\&\/PF^+_ ( _9&\?^._B3H6J>!O"?QU^+.N?%'X,_#35'D#?
M#_X<:K->+IVBV]I(JFQAF;_2UM\#;Y@-?O\ J, "N*7Q/^NAH+1114@%%%%
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M R,OSDL0PR2<FOU'"MU).2@!/H?;_/-<TY<S;[Z_>ET_KS+6B2[ _P##^/\
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M** "BBB@ HHHH *YCQJ6_P"$0\5XQ_R+&OX]=W]F7&/PKIZY?QGG_A$?%I/
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MNV[^[N/3S_X/7K\OZL?V<%0?,*DCG)*]<@?,OZ8QV_&OX=_^#C[PYXP\<_\
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MK37=G"K&Z?-G)5L].WMV&>_Z54N8&>Y@^?"QAGQT#[5)PW.,=>HK^0CXA_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=0/3KZ>W-?W7'[K_ .\?YBOX5_\ @[5B2_\ VE?^"?6ELID-WXHLU\H<%O\
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MDGQ1\9_\$@_BM\./!7P^DM=5\4^*9XM;T^,Z19-&EVEU=P2I*(F!W%-YC .
MN*^]O@E\#?V?/@3_ ,%B/^"='Q+_ &6O#&H_#3P%^TQ\+K+QGJ7A.77M9O+9
MUU?28KA1-:WMU)%N5C@?N^O/K7]*O_!9JZ$'_!,3]L)BV$F^$6NP,S <"3RB
M&&.ZL@([Y%?SM?!>*!/V\_\ @AN;HB[N?^&9_"PMY)#MRAT)<8##YF3(;IU%
M-OFHN=DG=K3?2VVGGY[]3)1Y96\UY=NA_:MM)GX()5R3]"Q*C\,X-7,'<#V
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MZOJ/PVCU"^;4#X-L?%EO=RZ,99I;:)I%U.&8.P*><%4S#:N ,U^"7_!IC<^
M]-_:$_X*&>&OA'=7=S\+(_B?(_@TI<%]-71HIYDM#;@$Q&/[.D/V8H2K1;/+
M.W;3@H^QNTUJ]7;7;;R\]'WT9K)-S5[M6LG\X_?I?:_^7]T,<IV N".=I..
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MK"_9"_91_P""VG[8O[-GPM_:@TO_ (*6^&O!C?$_PY9^)+?PH_@>:Y^P1WT
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M_ :#_@Y3^(WC#]H+XG^#/A7X9^!GP3OO!&FZCXSU"UBT[4M6\V2:&WM;AS+
MLC8'*$L.N,X%?I;HW_!N9^P+X-\2W?C#P1K7[0WA+Q#XCDW>)_$'AGXM:OIF
ML^)'4ALZSJ$!2:]*/\W[W=M(SR17FGQ2_P"#93_@E]\0==2\\2>&_BWK'C#5
M[J.\U7QGXC\<W^O:MJ:@ %;J_N%6:1B,@EP<9Y)K>$*7,WS.*<4E:+335T[2
MLTN]G?5);&<KN%.VJ5K^=EU5U?5=_1GYY_\ !Q;^T;^QG^TSX=_8Y^*?P-_:
M8^%/Q#^)'P&_:(\':A:>$_"VO?:?$-Y8:OK=BD_V01K$WE$PXD0_)A0V<.:_
ML5\$^,M$U_P)X(\07FM:=I1UOPGH-\]M-JFGQ^3+=:7:7,D+%K@ NCRE<+D@
M !@IXK\#M*_X-:/^"1_A]8;J+X5>-[G4+/RY+34(_&5Q'=PWZD&WOH2804EM
MI@LR ,NQ@"&R,CW1?^" W['+Z3;Z5/\ $3]J<1Q%665/CGX@BA4J L44$2JZ
MPQ1H%145BNU1\PZ#&4:+LE*22ZM-MWM;:,;M77V>RN]076^M]7K9?9TW?7K?
MK?H?M5!K^@ %_P#A(M%F#G:'&JZ>5.WI@_:3\QQR!D_2I_\ A)/#H\QO^$@T
M39""96&JV&(B.SDW/RG_ 'MHK^-7_@L__P $I_@[^Q1^Q#XF^.7P9^-?[4>F
M^,5^*WPJ\+0SWGQFU^ZMK+1/$VO+IVJQI#Y@4O+ #MF# J7^[WKN_P!O3_@E
M%\#/@Y_P26^+_P"U!\-?BS^T]I/Q;\$_ "V^(&E:W=?&SQ!=VD^JFUL9)OM&
MGJRK(LC7;MO6Y9\(%"J3E"5&EH^92YGRJT;:]=[6MYJWJ-2>VMTE*UWMIVT^
M7;TU_K]TK5]/UJU6\TV[@O;=F9!-;3PW$>Y>O[R!WC/X&M(,#T(.*_FW_P"#
M6#QYXX^(?_!+#P7K_CSQAKOC;5U\<>,+4:MXCU&YU75!#!J,B16TM]>/+<3)
M;(JQ1F21V(&69FR:_I%*E@=ORY4 'T).3Q]*YY0A>VGV;/ML[/T7X:7W-4VU
MJOZ0K#Y>>2/\17Q#_P %'WV_L-_M*G;>-_Q;35!ML(UENS\]O_JHW!5L8RV0
M<(">HK[?(.W'4X'XD8S7@O[4/PUOOB]^S[\6/AMI1*ZEXM\':KI=B _EF6[:
M$RP0%^B^?)&L);' ?/:M*+7M*7-LJB^6L2*D6U\K??V7?_@'\!?[!T3:A_P1
MZ_X+!1+<0-:>5;2JT4R&(-'9KNC D82&<$8N4485\A1BO[._^".?_*+C]ALG
MEQ\!O"P4D$8&^\&,'L  .1T'O7\3%I_P3<_X*8V'PX^)7P$^'G[*OBGP)!\6
MOBK:P_%>2+Q=(?#^O^#K#43"NIPVB+Y"B[L4$\T>/G+$'G-?Z O[)OPP'P2_
M9I^!_P )ET]=(/P^^'^B>&&TQ"&2UDL[<"5%8<';+YC<8'S5IBJR<7&Z_P!X
MGZWM%;>CO_P":5)I][K3\'^%CZ,,6%D"!%+#A@>=WJ!QR./R]Z_FB_X*X^%-
M&_9\_P""DO\ P3 _;7CUVZT6/Q;\8G^"GQ1FE=;70[7P=!I]A=6-SJ%PC*6$
MEW=-"HN"4&T <<#^F$Q\%P3G&0./3_#FOY__ /@XT_9*^*/[6?[ >KV7P9TB
M]U_XA_#;7K?QEH^C:5(\6KW'V66W>Y73)(U,T-W)!;,D<L8W!BI'2L(*[6EU
MMMU_3U-7JK7MYG[N#QGX4:&&>+Q'H+)<0PW<7_$VL-SVUTHEAG&;G.R=&#HW
M0JPJK-\1/!4$L4#>)M#,LS%0BZK8$@J 6W8N.V>:_P P;1_V]?!OPM\.:7X(
M^-O[ W[?[^-](T_2-,OM3M/B7XX@MM3N])MX[2XE@9XHD$$\D;/%%;F541E
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MZGJ =1]1_.IZ[XN\8OR7Y'QS=[/RC_Z2@HHHIB"BBB@ HHHH **** "BBB@
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M+C(!Q7Z!7W[4'[-6R*YU#XR_#XD.'MY1X@T\&WQR)#BYSY>,$_SK^/K]@?\
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MT[\YQ5VBD!3$=R!@MNYW [R",=!D$9_'CUI?+N"5_>XP<D<G(/8\YX_I5DL
M>3S^-&Y?7^?^%%V.Y7*R%P2[X"XV@D9/]XXZ]^N:S]5#II.K[6.?[,OR-Q8G
M?]FD.>3QWQ@CKSZULY&>V?UK-UDC^R=5' /]F7V3Z#[+)_C33:_KSN(_AT_9
M^BN-1_X)Z?\ !R/;1SR1/'\9_$\N\$9?99WDC[B>S"'!]<8/>OX)O@G/'#:^
M)R]N+G,$"",C@EF(!]>._M7]]'[-*B?]@/\ X.2XE8(1\7O%V7''RKI>JOG/
M;.UA_6OX%O@;Y+RZ]%+%(SO;Q&-P2(TP3G>>@[]:]"A[^*BI;246UW;5)_B_
M\A44W4J)_#]737^+EK*7X*/D?9/[(LTD?Q?U")(8);O^R9HK:"4YC@E.\@)G
M/.,@#_"OJSQ]%#/'JC@2+J+B]74(2<-"(5?+D9'[ML?+U[=N*^._V7XKO_A=
M1:&%HS&&=W63YI(AN'FC'4<G/'MWK[ ^()B.I>*EDS-<"*41NCB,1K(K;RY'
M$Q Y(.2!^=?SYXFJ/^ND--J=EZ\T+^KV>GZ'^Z7T&FX_1JK)-.2QG)%Z74I4
MIO1.VOIW71'^F;_P1\>"3_@G#^S$(&9HO^$"M_+<]=RS/T]\D\?_ *J_2]
M,G))/S>N1P?H:_,__@CU$L7_  3F_9EB21)84\!VQ!1=N?WKDXQT(Y'X5^EZ
M'M^0[]^I_P#KU^Q92W_9N7J_QX>DIW6Z5.%EZ6?^?8_QD\24UQYQHI:N/$F;
MMWO?_?JO-?SZ/3<F_B ]#C]:FJ+NOOM)^I-2UZ"TT6RT/B0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNY:+6<;:V=K.[VT;[:$RNU9=7;;^OT/PW_X(%_MR?\$\?'UG^T-\5O'7P_\
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M^%]SXLO? B^-?">L:%)XFL;E;*;2C?6<T*2/=-)#Y*G?DN)%( !!&!7X*?\
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M/;O):):M*;AG:.$C>LJYW#C@[CZK7DU:,[>ZOO:]Y^B?Y6"\5HG>^N_W*_\
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MJW@8> ?$&C1?#1(;G4/#4-K#;-9"Z$>Y':&W1-^.>1WXU/V?/^"2_P#P4O\
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MBIA.,<?$[Q F/SN/S_E6<FN=M2WE?K_=TZ:K;IY;&C5XK35)>7K_ %W1F_\
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MX]..@_E7Y1_\$6(I5_X)R?LYK),Y)\'03@L&!!^T2=CR1]>N/:OU;0\K_/\
M#^M?L.4.^6Y8^^'I_P#IJGUZ]3_'WQ:I^Q\3>/::U4>(\VLUW^NU;_._;2RT
MW+?9#[@?E4E1_P *?[P_K4E>B?GL;\JOO97];!1110,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1K9(X^I^F*1<[1C'?KTZT\\@CUI , "J J7"LR_(!Y>,.,<G^O'^>U?PV?\
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M^=^8@\'Z+%;R31R@(S%OF4?(O(QT./YYJ<^"?#US;FZMI1'ED5TQPTIX#?\
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M1X_U7P9^UI\8/ASX9U^[FFE$7A7PI>V4.C0V\B2DLA2Y?=M;G"\G-?M1I?\
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M3)?-^R%\*HYUP@9K35MNU5 & =3;\B&'KQQ7Z2;<@9_AY!'RY/T'2HW)(PV
M6.,%=PY&,Y]:I8BJOYMEJG+?W7M?Y=_NT;UTLK=O^']#\*OVPO\ @B+^S/\
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M-KT7K^'_  /P-92OMM_7^2/YP/V"SL_X+U?\%8#*\J^7\*OA"YSP-GVBR))
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M0,GD=/S-3U%$HV@D<]1_/^=2UZW?^ON/SE_Y?D%%%% @HHHH **** "BBB@
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MVFB^)M2\0Z;H.EQRW4@FO=1MHIQID<JQ"V1'Q%;AUWF.)&=?ZM?^#;+]KO\
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M7TR>:Z(8S$4DDIRIQ2TY;/MKK&6Z\UKM:UC.=*,F^;7UOZ6T:6F^Q_/FO_!
MOP/):017G[;O[6]\(2_E22:_I@9 >8P%%JQ'D\8.>>I '1UM_P $#/!%L,M^
MW#^UW,"0V#XDTS!8='V_9&/&.O3\:_H(,(+%B?X2H4#"C/L*!$$4A3T7 R,X
M[_YZ>V*O^U,7M&O4;V7P*W7^1-;+Y>1G]6I-J\5IMK/3[IG\_LG_  0,\"SW
M3WTO[:_[6,]T8MJ3R^(=*8PH!C@BW4#CKG!&.<5B+_P;V_"62[.J2_MA_M2W
M-Q@I>3RZ_IQ:XCZ;.(!MY/4"3/IP:_H9$6$V8;;G)Z\GJ3_]:EV'.<'O@!<
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M;6/G)R0O?KD\?H:_KUTK_@U8CM-<L+VZ_:BU:[TZWN%GU"%M"0M=QJ03'CG
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M_P S[7=?#SQ1J7AI+MQ_KQI\VPW+CUDR#@].G%>7>)[-9_AA?$0"222X03R
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M[9(X3RXU1 R*H(7.,[LN<::C/E3O&V^UFDU;1;;=U;[M4[[']CMNSL$W;?,
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M/$.GS/=:1H46L:3]FMI;B[B4J@9F4/N Q@@ ]*_=:Y_X*A?\$_X;L0-^U/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^)?Q-_:9UJ+Q=\0)/!5]!J'@72[F2XGO4A\/7]GFTE1)+^X61(3^[3RTZ(
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MG%VT:O?37S_7M_P;)NRN]D6<)ZG_ #^%)\G^U^E0'SANPN>5VC^(C^+VS_\
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M<KY;@*7Y[^G;!SW--Q:W0KWERK?3TZ(T:*A#2;06XSUZ'FI1T'T%*X"T444
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M"SX^^)/ 4][X?\6_8M(>UUKP'JJ&6V9$EABM7L[VVG4B!M[[BNXG&5K\#_\
M@@Y^SG^U9\<OVH/VA_VW?VQ? ]]X UZ235="N_!'C?PC$+S5?&"6+Z;<:[H6
MH:E"UQ;VDD2 H+5Q&^/D+ @G[]_X(8?LK?$7X!_M&_\ !2;XB>.? $O@G1/C
M-\9++6_ 3W&G"P;4=*LY-16YGLX]BCR7DFCD=HP QPS5A.R5^:3=EUM;162M
M9>;2WZE.D]UL_5VV7W]OP\I?$'_!)S]L?]BO5M0^(/\ P3*_:;U^\M# T]S\
M$OCKJMSXA\$E(Y3(]CH-O^\$+/ #%;APA#,%YP">IT#_ (+)?&O]GO18+/\
MX*-_L>_%+X*FQGCL;CXS:)8RW_PZUAT(2YU33[&PMI;N.S5@T@#8.Q@.V:_H
M>-O#(,C<C$E@5=E(8^G/2N,\1^#O#WBZRDT;QGH/A_Q=X??>TNF^*-(LM?L]
MC*%<_9]1AGBY3 )*GCV&*SISCS+FCI&U]+2MIL[ZN5M=$GMYD6JP:=-IRNO=
MGK&^B2>TK??YNUSQ']G_ /:G_9]_:J\$Z9X_^!GQ,\,>/M$U)5>-[+4+:#4(
MI60LT,VC7$RZC#.I#(Z26X.1W.:^@+R*1[&^BBC\F=K*Y\J!D9%D?RVP=K 8
M[\'.?I7X(_%O_@@Q\,%^)>M?M ?L3?&'QW^QW\7KS5KS7X9O"MY<:CX+O]9D
M!E1F\)R3P:5:65Q,%C:.WMW$<;.50X /A_@C_@I/_P %%/V O%L'PO\ ^"GO
M[/NL_%#X87?VV+P[^TM\$M+F\5:K>0PL\5I-XGT#36-OI:7*(LMPS@&%G8Y'
M(-R]G*%9TVE&SYF]'%>Y=V2::6KT2M:U[LZL'#$U,5A(4HSJU?K%)QV]FY.<
M/<7-*-^:3Y/>:5WJU='\;?[<%O<I^U_^U?;'2XI-0N?BAXE1S*FTQ*MR29$+
M 9W#N,\ #/.*^/O''V;3_@7J3V<)-W]OBCO),<IG;G'4]S@_RK[#_:_^*7@;
MXS?M8_&_Q]X)U:670/%?BK5M;TQ-2B&G:I;174N]+6^M/E:.9!PZMR&X/.:^
M5_'5HLOP*\3ZB?E2VU:*$P*N6E8A<,0.GMGTK\*RVG6PV?X2I3E>,\XE%M7O
M9N+N[:6:UL][WOH?[H9CB\KQ7T?>(L72KX?%XZCX<<E3#1:;P^(C3H*2BT[K
MD;<6G_*KWLV?!#WPBM4@"F:S,:R12GEQ<L22H/J#D]OPKUO]F^^U6S_:Z_96
MU&Q6=]6@^)WAR2TAMF O6=+Z$)Y#<[20<#(^]C'.:\EM8FAM;)IK>.91,9!;
ML_.'X!(]O?&/:O;_ -FR$#]M/]E'[#*]K>GXH>&@DJ#S4A8WT3*X[$QMC(S]
MT$]!7]#XVT:<'#5OV=_6\;;[Z]>OY_X6U':>(FZCA*=24I4UWO=]^[MY_,_T
MN?\ @VON+F[_ &-OCM=WRRI?77[9GQVFO$GYN$N'O])WK.>AE#?>P!S7]$5?
MSR_\&W7F+^R!\?UFE,]PO[:?QZ^T3$;?.E-_I&^7'0!CR,>F*_H:KPJC]^7J
M9Q=XQ>NRWWV"BBBH&%%%% !1110 4UMH&7Q@<Y/:G5'( VT$'KP>PQSD_EW_
M !XI+9>B A+!1(PV[PH9F .&7!P![_3OFO,]8^*?@/PYJT>E>(O''A'0+F6+
MS8[/5?$6D:;=K&>[V]Y>0S Y[[:]0P"P# 9[CKP.F>PSTQ7\9O@?]A'X3?\
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MM(U;4;R:YU&X\/>%-7DL=/$US*[S3-';1J"68[N]?UD?\$$M%_L7_@G7\+$
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M.:_J#^/&J:1X?^"7Q=US6GTA=*LO!6N7M^->:+^PXX8K.89U,S@PK9%@//\
M-!C"@ENU?P>_L)_#GXC_  F_X+#? SXH_M9>'M&\*_#3XK:QJ^H_LPZW\*IX
M_P#A -8>Z.]/[6N],*64@>#RV2&4%5=B!73"G=-V;Y7I=?W8M:]-_P C*/\
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M2^[74,(( ^6-0A )ZD!B,GK6)+_P6$_X)DPM+(?VSOA0DD9.%&M9(/.X;?+
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M;OSW&GRZ._S^2^[YZ)%23_@YE_X)&>6LA_:&T:20K@Q!7^7GIR-N![#-?/\
M^UK_ ,'%7_!*GXE_LL_M"?#SPC^T!HU_XI\=_!CXA>&-!L%CDW7.L:YX;O\
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M=7R7/(7YM-//(]37[:2?L3_LHRB-/^&>_A,!&L*)_P 43X?'R08V;O\ 0N2
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MM5W_ &OOV8T3+?&KP(5. "NNV1+<\!<2\D=\?CBOX<[C_@A1_P %2+B)A/\
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M_9^^-/B_0[?P_P"*/%O@31[O6+2SLX]-L9+PP*)[ZQLH56&"VN"088XE" 9
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M./Y+>[RN*:MR+H^1VE_>::LD[62M8RH0J1GN[.W76Z;VVTU=GWNKZW?\6?\
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M,PM?)$A)R6!S7\\/['<9_P"(B+_@I0Y$8V_!'X18,;;MP>RM<!N?ED ^^O\
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M4U._O9;33OMUW'#YNH-:/Y,S?:&8MY7/6O[BO^"4'PT_;U\&?#'Q/XH_;O\
MBWX>\7ZOXWO+6^^'7PO\,Z586.B?![P^%;R_#UK+9*$O!%'(L8D?YE$(VXS7
M?C?X<=]8QOOVCMV=M_2_D94E^]V=EY]7R_JV_N1^MI&V-T1>,_4*3W7N!_\
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MU7UVC/\ Y<)-/NM;V6O6_;?=$^RDDWS[=/NTW\^ES_/HO/VM?CIXVT:Z\4_
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M)U#2HIRML5W6UXLRW=M*H>TD21<RI)&05(DY&"/UK^0&/_@O%_P4/^Q7-^?
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M]T[]I;]GF>"Y>T>U^(>C2VFHHP!4B[C.Y7_$@<]#7S'J&K_VI:V\D-A86-S
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MS;\*39^+_#EW?VFK7485-5MYKD(3M>8"%Y">02^6!&.>M?J__P $ KNZOO\
M@G3\+KB9)O)8_P"A73Q>7'>VHAB*SV[8Q)"23B0=:UJSYL)&+5G>+:UT][;6
M[TOY[;''"GRXM5$]T]+=;;WO^GWG[7Q@@_GRO [=0><\_A4B_P 7^\:81R6&
M/EP%QV!QG(Z=<]:5 <]#T]/I7EM75MMOP_7^K'H7W\TE]UO\B2BBBF(****
M"BBB@ J.0%AM'&0>>_3U]^]25'*<(?FV#'+>GM^--;KU ^=_VF/A5X?^.?P
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MR/MAB<O'"Y8>9R=JAG&T:/M*:E)<W=M.VT5JTM+IWWU^\ARE%VB[;65KI_\
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MXX]<X_S_ "I,XZYZ9SC'X?6E=]E]_P#P '44TL!D'Z?7/I2_H <<T]>W]?<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %,/WQ]/\ &GT4 %07(#07"D\-!(#[ HP)_6IZCQE6XW$AP-PP
M#GJI]B:7VH/S_3OL!_FA?".0Z=_P=->.HX/G,OQ U*,*>A,D.D\'V QU]S7]
M\G[<W["_[/O[??PCU7X+_'SP7!XAL+Z*:3PYXHMHHU\1> ]9\N,P:QH%\VV2
MSN4= S.C ,K$$9P1_ SHADTO_@ZL\9Q1*MJ?^%FRQ&.W/FHRR6VD9&[KALY9
MOX<5_8E_P6?_ ."KFC?\$Q_A#X4D\.^&F\9_M ?'#Q#!X'^#'AF;<FC3:]=O
M#:I<:U>!E6TMHGE1@S8!)X;BO3FI2]@H[\LTM;+^(G=K^7OIKM9['-HO:;MR
MY$^OV-+:>METM?H?D]X$_P"#5;P?K?BV'2_C[^UG\;/BE\&_"VL6]]I'PUO?
M$EY-IMS;6$OF6%E>PS2>7)%'#'%"Z$D87'-?UC?#;X:>$/A/X \%?#3P3IJ:
M)X1\#:%8^'O#^DPJJQ0Z=IT"06\<JJ I=50.6[N6/<U_'+X[_;U_X.&?V5?
M.H_M1?&WX4? SQ3\&_"=A9>+O$WA/3/%ULVIOX<OH(K\1A8;HS>;%:W"(!][
M<OK7]6W[&?[3VB?MA?LR?"#]HK0;'^QK7XE^%-,UR[T9':8:/J=W;J]YIJ2N
M2TD=M+N596)++@DDY)RQ<*D%SRM:U]'UTWNK[I]=-+ZCH0LXR3^'W;]]O2^U
M[VNV?SL?\')W_!-;Q-^U#K7[/_[4GPB\:Z%9?&_X*W$6C^%/A[J6L6&F:IXW
MAFU--26WT47L\/\ IINH8U24*RQLB[B.!7S!^R3_ ,$R_P!M7]M__@H;\./V
MZ/\ @H'\*M0^#WA7X$?#'PQX=\$_#+QI<PZN?&_B'PQ9E-)U#3V@_P!%"M<,
MEU=OR)5BCVD\U^[?_!5+_@EGX-_X**Z1X:U\_$KQ=\-/BG\&XY=4\#:SH^N7
MVBZ-=7,!>\2PUI[:>&-+::<?/='+PAAT0,1^,_PL_P""MO[5W[#_ ,1/$'[.
M'QGOOAK\?_AQ\$]$TZ^\6_%K6/%Y2Z%LR"WM_"OPZNEG9O%NOZ2H\N^MB9)8
M@O->E1E"IEM)TW'VL%>HI1E%V=N5QDM&_AC>S3M9V:N<]1SA7DW=P=K6L[:)
MM6NO-V^:.3O/^"6W_!0+]N7_ (*MZ%^UO^US8)\-?AY^R]\1=-O?A3)))'+H
M7B/P-HVH+>6MEHMI& UJLIMK=I(SC=(6/2O[2K.\BU"'[3 I^SR8\N3H'4X
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MQ:?\<_VZ?C5I+S_$_6;2^AU2'P]:7%S]HGL;*X7?EMZJC2HRY4!< 8 _;/\
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MH]QX[^(5S^T=;W5MX]U#Q[JZZK>Q1732E_[+DPXMG7S&"/AB!@?P@5]ES?\
M!3K_ ()YP;A<?MD? <.G$NWQYI1R.I4A)'XXZ DXS[U4'_!4O_@G0V'C_;-^
M P!^4G_A.-/.[G &21R#[9]:E.JDK<Z;=[J$NJ2:U3W_ !V$^5N[L_FOD]]U
MY_IKP^N_\$F/V*O%WA'1O"'BOX3Z-XB3PU\-+7X4>'/$>I6L<WB'1O"5G>KJ
M5LFGW[#?!?Q72J1<(H;8H^E=;X@_X)F_LL^*M*M-.\1>$3K3V9\)[[[4#'<7
MM[;^"8XXM$LKN9P6EMTBB5)D)_>+D9[U0/\ P5J_X)M+<RVK_MD_ \2PR;#,
MOC&R,>?]X<?H>].E_P""M'_!-IL1?\-F_ Y7Y9&/C&S"S;>H#;<$-Z<<?2KC
M+$*RM)6[+\].K\U;LC-PB]7JU_P-NS^5GJ]7M\C:_P#\&_\ ^PAXC_:.C_:+
MU#0_$@A754\3/\%UU%8_A+?>)XXT0:K>^&SF":1C$A(*K\V6W<8KZK\=_P#!
M,7]ESQ_I?B<Q?#[2_ACXI\2^%]3\*:EXR^&]K!H?B.31+^W:V%LMZ@R3;0-Y
M=K@#8 !1<_\ !6__ ()I.RPR?MD?!$Y3]Z4\8VF(0.G(7KG],5FS?\%A/^":
M$;.)?VO_ (,M%;A%@>/Q;:L\YQA@%XR 1U)]3CFJE4Q$HI2YK7<M5;EU6BV3
MVV=[[VV14>6*U:LDE^6OE;:W]/N/^">/_!.WX%?\$VO@?=_!+X!2^(IO#NN>
M)KSQ?K>J^*K[[?KNJZW?L[W%U=W/.Z1MVSJ<* .@K[]B("A3P1P0>N?ZDC&?
M>OS#?_@LI_P31CG6)OVN?@\LK1A@&\56?EKN/&YAD*>F?RQFOI;]GW]LW]FC
M]JJ?7+/X _%SP=\4+KPP81KX\*ZM#J2:8+@$Q-*T)R XPRY45RSC)>])/7S3
M_*^VB\]^AJFNG^1]4AE/0YQUI0P(R#D9Q^-5HBQ)5A\F2H']XYY8^@_STIS%
M?FV_.\?\/0%NV?IT_P FL[[^7_#C)2Z@A>K$X _SP/K36?!VG"GW.#^>0*_'
MS]N?_@MY^PY_P3R^+^E_ O\ :.\5>)-*\?ZMX;M/%EO9Z+HK:E FE7['[(9)
MDE1D>0*Q"[3PK$'L/B*Z_P"#JK_@DZ\J1S^-?B0&VL%*^$)U#R#(6-29UWN^
M.,<_[)K6G!RUMI\OENUY_<!_2UYH#E0P)QS\PR"/?/T_I1]H4\@@\@8!SSZ8
M!S@]SC%?S&/_ ,'5?_!)B'SX)?&'Q<C<*)) ?!-R60$]%(DZ?GGUZ9R;O_@[
M#_X)-Z2RW<?B#XTWIF7RT2+P)=.N#QOV[\YZ88LWL,UO[!-/W7S=$TDNFM[J
MVR]+&4ISBVM+=M?+LOZ^1_45YQ&6(( )[^N.W7CM0KEG"[N",XW<[?4\U_+4
MG_!VI_P2:DV;]?\ C=!*=Q$9\!7?)QW^;!S] /3-8)_X.Y/^"5VGO=S";XYW
MJO+Y7_(CW+!48X+ +$-H .>IZ_0T/"JSLEIK]G?R]_YWOKL3[2:MHK=;7^YZ
M/RLK75C^J2:^;S)+=0"H&"P(/R\8^8'&?;K45LRK(,S?,YP(V)!//! )Z=:_
ME&D_X.\/^"7,.H);1V/QR.F.?-:Z_P"$*N<M*3D* 8"VT'((W?4YK6@_X.Z?
M^"5%]>/*]M\=_,L;=C"?^$"NC!,XY$0VK'F1L?*22#TP<'%_5GT@WHN;X=--
MM>ODG][+IU%-.W3\5W_JQ_5P94"L&;!C(#]<#/\ /''TJM&Y,C*#N/7'4>O7
M.,X[9S7YA?\ !.W_ (*O?LN_\%1O"GBOQ-^S7J^NK_P@DT2^+M!\76*Z1J.F
M6\Q AGN+=R'2-MRL'<!0I!SC!KZL^(O[4/[./P8M[W5OBE\>?A[X%T:UD$<L
MWB#Q#964"W(&3'%(\C&5ARNR,,V<\=ZYO9/FMLK7:5Y/HM.6_76U]NME<)R<
M7?IIY7U5_P"NWK9_38EP0AP&]#U_GBJK21B9LN-Q(X Z'CK_ (_7\/Q^^+'_
M  7%_P"";/PAL(=:OOVD/"'C=;AC&FF^ -037[X'/RO+;PJK*2<[0& /'7I7
ME]__ ,' _P"P;I_AR+Q?%'\7-8TZ]BWVJZ7X*N+V[NR?NPPVZ.C.QW9&&SCU
M&15O#R723TZ6UT3Z[?,UBG)7MT_'3]#]X1@ ?IGJ<_\ ZZA\YN?E'RG!Y[YQ
MQZ_A7\[4G_!QQ^S?X@C@A^%G[-W[6?Q U&0LLB6/PGU&.VLP@.!),'FW,>!@
M!-O<D5K6?_!>S1KJWEGG_8@_:Z@:W.^XD_X5CJ)5(!RY@S$?,?&2 >_KVE4)
M_:7+ZM7Z=->[UO\ +HT?T)!RV0 ,C&1Z9_'WIC2#H2.&V\9/S<\=Z_G@LO\
M@Y(_8_CUA-#\6?!']JGP,XD6&ZO/$WPGO[*UM;@G:%GE,B?+NX\S@'KMKL]0
M_P"#BS_@GKX>N"OB*^^)6A6TI!2_OO"-R(G9@-H4&1?E)PH;)^8@<\4O8RUT
M:^<6[:=GOY6OZV)<EM?7\/Z_IG[TM.L(RWW20I([,?NCVR3WJG-J1MY0DT4@
M!&X%(GDR,G^X#V'^>:_G0^('_!<7XE_%W1;B'_@G?^QM\3/C?KUQ=6L.F>(/
MB)H&I>&/ 6HQR/A[F/5HV!$2(5<$RMG&X8KD[&;_ (.&/VAA>:AJ_ASX)_LN
MZ5J,(M[6;0/$RZMJ6EQRJ%,T=M=3%G>%3WZNN#S5*G;IO:S=NMMUY7:T[7'%
MW5S^E5];LTWLUS;VR1J7EDO76SBC5?XC).57'7/IWZ&L23XA>"D!W^-O!*N!
MDA_$^CK@#J3FYR,'\/>OY\(/^"/'[=WQ$\*KHGQW_P""K7QDUI]5$L^NZ/H7
MARSL;&W2YR6M++4(;N%VCCR55]X^7D'/%=5X=_X-Y_V?+'1(M-\5?&?XR>-[
MQ8\7>LWWB_7K*XNI&),C[+749(UW$DX5^/:JY8:*ZTT?NW?W]5V&?MIXD_:$
M^"?A&W^T^)?BU\-M,42+$$;QGX?DF\R0@*I@_M 2C/KLQGO7#:C^V;^S%I,:
M/J7QJ\ PI(P5&3Q%I4W)QC_4W<A'XCIWK\OO"_\ P;K_ /!.#1;A+_Q#X5^(
M?B^^$BS22ZU\2/%3P/*I# F-KUUQD'C(/;BO=;+_ ((E?\$X; M'%\#KB3S#
MYF^?QCXCN#C@?+YFH-@=. ,^AIVPBM><V^ME9;VTOO\ ?KT[ ?87_#;G[*#M
M$/\ A>7P^WR<H#KUBI[==TH _.MW1_VM_P!FSQ!?_P!FZ=\:OAR\[*-@G\6:
M';(S$X $D]\@YR!@@'GG YKXQN/^"*W_  3HN]OF? K=L'&WQ3X@0KG_ +?\
M@_0UYKXO_P"""7_!-;QGIEU83?!G7-%GR3#J&D>/O%%K=02Y&&5H[XD@'G;U
M]",8HY<*U[LZE^EU&VO+TOYO9/;8#]:K?XA^![LH8/''@B>.7#HUOXKT:8-G
M_5[-ETVX,,$%<@YXSQ760WUO<Q^=97-M>1E1)NLYH[H,&X#(8BV\'L1VK\!O
M$/\ P;S?LQ2>"=2\(^ ?B5\7_A[>3,LFDZ]8>-O$.H7VD-&!M$2W>I()5R 2
M&88Y&*\]MO\ @CO^W;\*-"M8O@'_ ,%5OC/8:KX9"/HNB^(?#]I>:?>P1N,:
M?>W,]W,7B>+,9=RV03DYQNATZ;T4XOTB[7TWO\]=>X'](/F3\?NS@C/(Q@>^
M1P?8\_C3A/\ -L/WPH8C!.,^XX/X5_-'XC\;_P#!P=^S3J=T-'^&OP=_:M\%
MQ6*RR:IK_B/^R=<:6WB'FK':6<X*-<E20BX +$=!6Q\,/^"]VO\ P]T6>#_@
MH!^R-\6?V?\ 78+R>Q;7_!WAG4_$G@=7M@QF#ZM/(2G3<&\S &[*-V2H\J;7
M+)7V7RN]K-KM=:=[V$VEN?TD[SR3C QGVS^-/W# )/!QC\>G2OY\A_P<<?L0
MZKH]SK7P^^'G[1_Q0TR!I%DO/ _PNO\ 6+/?&2'5IX[G"R!AC:4R">H[\WX,
M_P""[/CWXDC5[GPE^P+^TI:Z2SR2>$]2UKP/JEK%JEJN3$UYD 02R*.50)@]
M!VI.A.7V;)Z:M);+;5M]_P#@IBYU_P -_P &Q_1<9!G:IR1C/H,\\_7_ #TJ
MN2LF0#NVGYAZ?4-U_P \U_-U??\ !:?]K*RN!O\ ^">_Q16*ZD8V<3Z+JJR3
M11DJS2_-E6)'R\YYQVK4M?\ @MA^T-;:=G5_^"?'QK&ORRRLMEIOAC5)XDL8
MQO$GF9W,Y4< G!)&.U5'#3C";M=6;?ELNJ7Z;>1#E=JS?I9=U_7_  &?:7_!
M;NU:;_@F'^U4(0!Y?PZUF1LLH^46S[CG."0 , &O\>KX5M_Q*-6AD.V.3[A/
M.6W$8'IR/UXK_1F_X*)_\%OOA'\<_P!A#]H?X-^.OV9OVG?A3\1?%'@'6M.T
MZ/Q/\.M0T[PI'?&'RUGN-:E&Q;=3O!5DR<JWF ?*?\X+X=ZI9V$$UI=7,<)G
M#.I8_NP#G[QQPW?%:4(R2P_35].G-3T7K;?];&B2:6E]%NM].I[Y\"W6S^+]
M@]^?*A*&!"!_K8W)!7\?7ISZ]/TA\,^(+_X;_%WP9XVT) ;_ $;Q9H]WID,B
M^8LY>^A+Q&,9+;\;5!!Y.*_-;X4:IIDGQ0\.R&Z@EMQ,MNS[E\H;F8_.Y'"]
M/FSCOGO7ZO?!6PTW7_VC_A/I=_;0:S;S>/O#D<6G!U:.^0:M:[5AYVR"+.YN
M,'G/:OQCQ$P]>MG>!E2J1Y57AS+_ +>BV[:IMK;T[W9_KW]"K-LKH?1\XO\
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M#@ 'K7X(1?\ !QQ_P3EG<BU\0^/IW0?OE7PL<PKUPP^UDAO]CCZ\4S_B(_\
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M!R6Q^%4KS_@Y<_8 L"1+X=_:!9V.UUB^&\\GE8RKAB+L8:,Y4C!/OS3]A/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?P=X2U+P[J=[HT&NV@%M?7BVL1FM3PP#'+>9M^Z%%?='_!?;QMX=A_X*&?\
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M8?CCJWQS^/G_  4^\5V]]%+\/9_B5IMQX#AL=/@T[3+/1&U?54T];&VM8HH
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M7'_!=[]G*T5Y)/@!^U:%4 AE^$UZ5<D9VQ'[8 9 >"H .:?L*FGNMW[<K_\
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M2]N9OL]/338P3G+I9Z7>]K-*Z5OZ39^@_P"RU_P;V_L1^.O^"<7@+XTZC?\
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MJ06GPY\00S1W,<OGMJK,CQJX,B;#*,%AU;/7^&OUC?\ X*8_\$^86\A_VO\
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M$V.H^'O$5HE_I>IH=,U*9?M-K)\D@7RR$!Z;R>V:^J?^#AO]B#]DGX5? ?\
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MM2VQ#<V5P6N4E 4^40D95/F# MG7EJ+1JHNB?-T[W4K?*VEE?RR<DTUH_O\
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M$=M0S:3?M0:0\3?O61M,N@0PYSQ*.,CKGJ>U?Y-]M\-M#EMH"+V=KA&(GW(
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M X(Z5_F>P_#_ $"4&001@*2NQV*Y!_C]25/3M5%O!6B6Z2$V\,A5G$(+<RD
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M8[L\':?H*_K!A_X)4_L!PA?+_9P\"[0.ALVVGV;YP":T#_P2[_8-)4?\,X^
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MUC\:Y)(/WEQ>Q^(]=66\4')267^R][@@8(\O&#7]4L?_  3*_85BD!7]F_P
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M^O\ 3-?@=_P;9<_\$J_@9CO8 ^O_ "RCK]\P,#%8SUJ>BO;L]-?Z[%"T444
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M&'?\-:<E&]U=.R:NUI?NO/5]K7UU1G*#DT[[.Z_#1JW2WS/Y9OVC_P#@L?\
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M"7X>_$#Q)X4DO!=:;HNJ75I9ZE#N-OJULDA$=U&P&UE=<,".O;';C["UM/\
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MM[JMZ;G]#JY&W<0S<Y8<9QV/7/\ ]:I*8@P/4'G\^OY4^O+B_>DO-O\ )?\
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M3]DF/]B/QQ_P3F\3^#]%\;2^'= N_'-EH^K#4IH-)*VJ2W8N$5(8R&9[N4C
M!+$R%54NG4JN,6J[[M2O=VT:4E=)Z65[*SO?H2V[N[7D[[7Y6NVGG;S/W/\
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MF+4[*4W \V6-;)MR-G_4_=SN/]<XQ7W;J'@/PY?WUM=/IUM&UEA/*B VR.F
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M'XCWH"L,?>. 0,\]>O;O5BBBR[+[A\W]V/W$&&&." /X<?+@>HQ4B@\DY&0
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MNP'\$7_!VS>2:=^U3\ )(?E+_LF_%>(E?E)4ZY<KMX_AX QTK^O'_@EX[O\
M\$\/V,V<?,_[/WP]8Y[?\22 KC\#Q[5_(=_P=RVCW/[4'[/10X"_LF_%J0D$
M9POB&[_3H?\ (K^O#_@EVY_X=V_L8AA\Q_9]^'?&.2%T. 9 ]Q@_0UM4JJ5.
M$;:Q2Z=HM?/OT(7QOT_^1/O-6S]?2G5""-WR]"0/Y9Z^]35S1UNW>]_/^O\
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M>;++*\=VQ/\ JU'W9%'?<<=<]L<UY!%-)IVJ7"%8_*F;*OD&5%QP1GIUX_\
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M[[_15<\']&+*\7@:SHU%2JXU.4=92]E>UW?=JZ5FONUN? 'P=\0?V@OB=:^
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MN?#K^)]=L5BCU77(=/O%24Q7DC+(LH&),9!.#7^=W\*=.\4Q?M-ZA^V1H_\
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M^O0_<K_@C ]J?^":W[+CVSEXSX!TA3UYE^PP!Q^.[G/7%?J<O  ^O\Z_*_\
MX(P6\,'_  33_9>CB965OA]I$H*]0\EC!E?J""./>OU+@5@B[CS@Y&>^<\]L
MXKAH75.-^NIV5;^TG)JW-)M^MOZ_0GHHHK4S"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ /0]O?TJ-B.%)QE<!O_ *_^)H<].">O []/UJK<QM-L0?*#
MQGN#Z$^_0?A515]^GI^3Z";:V5_Z_K4)FC+JBY:3A_EY+ 9^0D= 1U[ 5\C?
MM"?MU?LG?LR%+;XU?&;P9X:UAY/*'AJVUK3]2\1Q,3M'FZ';7#:A&S,=H1[<
M-G 52""?SE_X*E_\%,?&?P'\3^$OV(OV-O"M]\5/VW_CS;MI_AR+2XC?:/\
M";1+PRVMYXO\630"1;&73D(NK59GB"[0[ L%*4?V/_\ @A7^SO\ ##0]-^*7
M[75C-^U;^U;KUW'XI\=_$?X@:EJ%_:V/B"Z(NKC2= LQ>R6@TO3YRJ6NZ,>9
MY8(&S#-JHTTDV_1:7D]&WV4>UW=^C=YO/31?C^/]?DS^:3_@X3^(OC'_ (*)
M_M ?";Q9^Q;\(OB9\5?"O@[X,>*OAQK7B=_".N:19?VKXGU%[NU%JEQ:C[1;
M[9>95PCX+ #(K^W?_@GGX.U_X>?L/?LH>!?%=A/IWB;PK\$/ ^DZ[ITZM'/8
M:G::1!'=VLJL RM!,'B*D _*.*^H- \.^'-'M+/2-&\+Z/I&E6EK%!8VMGI5
MG;Q6L-N@CBC*1Q*H*!<(<;F'S-EB2>I4?NB(0AV@("JA0<'D!5 4#'8#'..U
M8O=K=?>-)WNUTU_#S>FFA*!EO3&#QSTQZ5+2 8&  /I2U.W3[NA04444P"D)
M Z\4M,89QT[]: ''D'-<9XTM7U#PMXOL+=/.NI_"^N6<$#KF*:6[TZ=(D8'A
MBTA11UQFNS)&#GT_'\*I2YR0JB4+C<IP< ^G3.1U!R.E$*C4DK>ZVK.V[TOY
M^6JL3*[6G]?UY'^45^V;XKL_ .E>.?V>?&&F>)]"^(5G^WKIOQ#6PUWP[?Z=
MH-WX;&J1#R]/U"ZB2UOPQP5,!;-?ZAOP"F-S\!/@K-$1"DWPM\"3P1(F$3'A
MW3W7'90J%0H)XQFOY ?^#PO2-&LOAS^RK<Z?H^C:=JEU\7]$-QJ>G6%I;:Y<
MJ;N!?GGAACGN K'Y/-D?#JH Q7]=_P"S>=_[.?[/\8DDPWP?^'89@!ND(\):
M0#YG^TQ!$G^T3S7HU_X=!V^.*G=N^DD[+UTU?G;N94M7)/6S:MVLT_Z1^('_
M  5\_8_^(_@[XG?#[_@JK^R-!<I\;_V<S;/\5/ WAJ![.Z^+_P -(+J*35M(
MU9+1"^J&*-I9095;*)R6PS5\F_'/]JW5O^"\/Q"^!G['?[*-Q<R?LQ6#^&_&
MO[>/B-K.6SN_!WB+3O+U"#X<12N&>6,W9:QOHE9%<?>C!%?IE_P6,_;;U+X'
M^!?"G[(_P(NH+_\ ;!_;!F3X:?"W2[=%O1X2T[59A9WOB_6[94D^SZ;#"\\:
MS7'EJS_,&(VFOQ^_9U^ GQ(_X-T/CKX%U?Q!+=?$S]G#]LBXT:3]IGXJ:I!M
MT_X3_%*; E>*[@#>78:IJ<DODF9O+,+#G:B@91::6JNKJ*;MVZ7L_)]ET*<7
M?K9VOIOM?7\;]]#^O[X>>!/"WPN\&>$/AMX"TNWT/P=X&TFQ\-Z'I5G$L%M9
M6-C&L<<<<:@(<E6D8K@&21VZMD_@I^U\W_'0?_P3.4@X_P"%&?'0CGC/]E7^
M./KZU_0%X5UO1O$FBZ9XD\.:S::]X=\0VMOJVA:M:2K-:7=E=1J\+VTJ$J\3
M@Y4YX'!YXK^?O]L+/_$09_P3+PR@GX(?'+@]2!IE]D?4@<?_ %^,'R*>Z;ZW
MZOI=/9[W6FMS2-[6?1[=OZ5NYRG_  7[('QX_P""1X;*C_ALJQ_><L%_T&SX
M\K^(^^.^*_I+A(>"V?)=1!!SS&-H'7:?PZ].1TK^;/\ X+Z+O_:!_P""1T>5
M$H_;&L7WG.0OV6UZ9P./?FOZ3P,6T)*B1?L\(R.,D+ENG8Y[_J:)-QC%VTY=
M_):.WG_EL,_F&^.MZD7_  <L? BU;<OG?LUZ:I;.Q2?MK$)S]_UP/I7]0@R6
M?+;OF&U1\I0#W]S^>>*_EM_:-"M_P<H?LWD!&DB_9_TU^ =X4WAX8CMU8 ]N
MU?U('B0YRRN0-I'0KT*?CG=]/SJOK"CU]R/RMRO\OPMN%UW18IK$ ?-TS3J8
MXW#''7OQ6 :]+7\]OF19/?UX^AQC_/2I#A1Z[NGY=?U]J@9XTZNN<[<;P>?H
M3Q^.*%=6R R%O[JR(6YZ< \$] .#5.$G&+M9KHG:[TT?1OU_6PDG&;;::DHZ
M17:RU]=W_P ..9@.O&!_DY_IGBJ\VYAA' R"<;><X[GO_7IFI%()('1?O+E3
M\W3'7/H>M38X.TD'C:,=!W_#/?WYK.+JQW:4E?E3^7]/IMW*3BFYJG)M-7O9
MJ2LM-VK^NY\@_MK:-!XC_9<^-.C7@,D4O@K5Y)U6,G(BL;ATXQC 91V..O-?
MY0&KV)GU3Q18Q+&[1^(]<!(98\"'4;B)>"?1>!_A7^NU\?4LV^"OQ46^19;>
M;P-XE2X4@'.W1[PKP1Z_RR!Z_P"2I=V$$OC+QOF"*-6\8>*=DDQ*QI'_ &U=
MX#8Z8';O7Y#XFU:F'Q&1XE2CS5/K$))=DX]-]7+KHVGMJS_57]G-3_M#">(6
M&E2C&C&IE;]^/6K%QDHV5DXJ'P]$T^I\?_&RPN=-OM#$H5(72(D*02QR#@-_
M]?V)ZUY(B/>ZNS;% B:-$1Y%!92N>A/Z?XU]3?M0V-M!;>#OLJ6TDLC;2\3%
MHY HR I/?\>.W7CY7CL"=2%Y=%H9%0/&D9(4LJ\;@/I7Z_PA.=;(<'4FFG]6
MBW9::*+7E_5]S^+_ *6N"AA/'3B.A2C91Q-5^J4TKWT?^1^TO_!L;KNIZ3_P
M6'^'NF6NGK);:Q;ZY:ZC)YRQM911VF8I%0G,H<LQ*KG@<XS7]C'_  <#EU^-
MO_!*QF0%1^VG\/\ RRI^8K]J <,O4C<".XK^0#_@UT\.G6_^"NGA76YH#(^@
M:;K,ZNI.V(SVOEEB,\\*IZ'\.M?V!?\ !P'&;GXS?\$M/+!C:+]M/X?(UUV1
M3<J2BYXSDG\3]*])OFQ%.SWA)+Y71_/#2?NW=X[VZ/6VOIK^I_39_P MCGG@
M8]A@Y!_'G\:FJ G]ZY&,@+D9ZY'7'K@_E4I;'_?0'X8S7G-J_P E^2_S15GV
MWV\_3ON.HIN[D>Y;].E132,L;$*6(3<%7J3Z"DFGL_Z_K]>S"S[?UM^9+N7U
M_G_A1D'HV._3M^-?+_Q!_:]_9B^$NNMX5^)_QQ\!>!?%$<0GF\.Z_K,=OJT,
M3?=DDM%#RJC#E7*A2#P:XT_\%!/V)A;)<']I_P"%:VTLBHLYUY1&7=A&JLYC
MPNYF5?GVC-:*G-ZJ$O\ P&7Z+S_K03TWT]=#[2##IN!(QFHW8J0/E) +9; X
MZ #WS7(Z+XAT7Q%I=IKV@:I;ZQH>H6UM=Z9K-A,EQ8:C;7:!H9K2>,LLB,IR
M"":Z1G!*QL/,V_,P)^;D?<X/4=<>E2]'9IIVV^Y_K^(;*_3^O\QXE5<Y(.[)
MZX;CJ5CZD*>I /UKC/'7Q!\#?#+PU?\ BWXD>*M"\&^&M/1I9]9\0:I9Z59!
M54R;(Y;N6)'G8 ;8D+2-_=QDU\E_M\_MT?!3]@;X.WGQ<^+^IR+J4[2:;X!\
M)Z3^^\0^+O$LD;+I>BZ=9*'>>.ZN_)AN6$;*B.<D9K^#CXA?'S]N_P#X*U?&
MW5OB1^U[X^T+]EK]A?P5XN_L>Q\)_$+5[WPWX#O_ !+)+Y-AX9NKJUE@G?Q-
M<HUO(UNYV 2$%26&W2G3O1:M\G'?5;)*UM'>[?H]#.<XKW7)7T=GY[)Z>G;U
MM<_5;_@Y,_;T_9C_ &O_ -BJ^_9W_9PUOQ?\9?BQ)XXT"]L-)\!^#-;U[2);
M>RN%-S*^LZ?;SVK>6!D&-I <<8XS^L/_  ;=_!CXD_!C_@G;H&D_%#PMJO@_
M6?$7B6Z\0VNC:Q%-;ZE#87-K"L;3P3JDT+Y4#:Z@C'/3C\^/@?\ $;X@?\$7
M/B/\*O 'Q^^!WPA\0?L1_'>\TJT\ ?'_ .'EG!K^H^%-9\0",>'8M;U2_AN7
M2QU19X98B\VV6&2.9-P*/7]<7A<VEUI=EJ>FW\5_INJP0ZE97-I%##:-:7$:
MRP+ D"K$(FC96&U03ZUM4E%4(072*OJM[WVM==E=WLMB%?VD96Z-.RM:]DNO
MDK/M\D=,N[<<D;>RC&5^IZG-/J- 22^1\W! ]N!^/K4E<4$TM>YN1Q]_P_K4
ME-52N<]\4ZJ **** "BBB@ HHHH *",\&BB@!B#C/?./Y5^(G_!P["LO_!)[
M]I6/(B+0^'\,_P PWC4TV]>,,>/H37[?5^(7_!PV#)_P25_:B)DC22/2]+D@
M.3L,J7X,:'_:SG_@0%:4TW)6ERNZM_G\B9[;?.WFOS/H/_@DLEX/^"8O[+:W
M&Q)A\&X5(B7"'Y;Y8V0# ZC.1WR*^%/^#<[S8_V7OVG+?RF@N+?]M/XZ,YVE
MC(LNOML;_;.T'@#*G'K7\_/[ G[<_P#P<$^"_P!CSX3^$?@A^R)X;^('P<3P
MK-I7@/QCJ-M</</H9AF47DS@$".',SHV0,@XKQ3_ ()J?M>_\%S/A=\&/C/I
M_P"RQ^S'X8\?>#[SXZ?$#5O&>L7$$TEUIWQ!O=0=O$.FV6T',5G=$B//3'-=
MZPWNR;Q$/>:;ZWLT[2TW[7ZVU,W-JUD]M_.R5M=+?\/IJ?Z1EN7PP='# ##-
MGYL\\\?*?8]*GR<@;3\W4@\#'J>W'3_&OX45_;Q_X.=EM[2[_P"&1=)A@N)_
M-DF%I<&289('FCD!@#QQC;5.X_;D_P"#GB:Z9D_90TM;;;)(MT;681C.2$SV
M;'0=*YUA(U-77BO2]KK7HX_)[M>ERHRFU\#>MKIW[?CK^I_=RV[(QT!'J<^Y
M/;\\TPJS,Q(Q@?>!Z^P'Z_6OX4I?VN/^#GO4+&VU*#]G31M/2&!C+;+!/YK!
M6_UA&1U [5A3_M-_\'1.IV\EROP.L(86C+?N[>;*@#^(;N#CI5++H],1=]-U
MK[O>7DM-/N'J[^Z]-6GMT7;6SU_'4_O&(V@'8S8 VH5+9/J3C /)_P :_C:_
MX.&-/G;_ (*>?\$F)(#)$]WX^N<$$L7*ZA@J .P/'IU%?+6C?'C_ (.C)OLT
MD7PZL+"W<B9Q)%*-O.TQOEL@'G-?DU_P4J\=?\%B?$W[5/[&T_[57AKP]H/Q
MJMM?D/P'-@9-M[J;W $GVK>QPPEP?EQSTR:TH47&4H\Z;4;*][N_+:^MDE9]
MWKVU(G&-N7\K73[NZ?X6NNW7^W;_ (+D?\%*O&/_  2^_98\"_%[P?\ #2\^
M)&N^,_&=OX"%I%YJVNB3-H[WL6IZ@$1@8_.B\B.-Q^\E*H.3Q1_X)=?M&?M>
M?$C]B;QM^VO^UQJMEK&G>(?">N>/? OPUT?PY+I.L>&_#OAVQGU%[>:3RUDO
M9+J"%UA9<\JQ'0FOYL_VBO '_!Q3^T)X:T[X;_'3X1>#_B3X2LFL=4TK3-3M
MC<62:G!%$UK='>'VW"JJDX S@@G%7/"'A_\ X.:=!\-1> ]*TG0-!^&D&E?\
M(Y'X,FM_*T"TT:>(6MQ9)&F%,<D.4<%3D9!Z5"IV;C[1.6[2NWRWO[MNZ:6]
MDMF4H)W=K+=]'T5W\^O7JK']%?P%_P""O'@W]IK_ ()U?M/?MV?"OX1Z[H4W
MP-/B2S3PWJ=C<1ZQK^J:$;?!C,B>=(DB7<,KJN0@WJV,<? '_!!W_@HY^WG_
M ,%7_CW\2OBU\4K^Q^'_ .SM\%HCHT7PX7PU<VC>*-4\0V[-ITPU9X4@FN=*
M7YKA4=^8R-Q-?D9H?[+7_!PMX&\#>,OA5X \-^"?"/PL\<7MU+XE^'FCVRQ:
M5XI?4&#WES) H5)!<-C>2A^Z.>@&K\$OV8/^#C7]G'3+KPM\!--\'_"KP_XF
MWWE[IFA6Z6]FMU&,&>61=CR3Y/(D) )P,=*''2SFK[J]W96CKWO=2NO/L%MK
M6;TO9VM^/7;Y>9_H:0Q-&1$D6R%"?)&/N\$Y;T[C'T]:\7_:+LIY/@#\>%AC
M8SW/PJ\=B/:"[9'A?5"6&,D[>7]@.>AK^(^V^&G_  =5PR^=!\8[&%KC][<*
M)7_>L^>6S+@'D9QP,<"LCQ=\)_\ @Z9F\)^.F\5?&G3&\'VGA+69O$EA/,?L
M-_H+64W]IH&,F2_V1I%([#/KQG*C9J7M%K;79-W5^KN^WR\RDVK<RM?KW>G;
MU/V?_P"#6VPN+#]A?XI)<EWD?]I#XB$R.C+O877S8SUV[AG'J,]<5XC_ ,$V
MX;^U_P"#@?\ X*@074#JXB\/-*9)?GPUE+L;:<$X'Y#'O7\]'_!-7X<?\%]?
M$_P;\3+^P[\5-,\+_#1/BCKUEXCCL9]L,GC&.1QJTLQ+8\DR;LG'5EYZ"OU.
M_P"#=GP_^T?X4_X*C?MS^'_VO=?M_%7[1EE;:2?B!XB28RM=3-:/]GCC; !C
MP"%') /WCUK5PM[22DO>2]W1M**6CUW?2RMY] ;3DK6T\WN^W]:7/[BHE8*1
MNR-Q82-DY]@/X<?TJ; ).,,"IYQ\JD#&=O\ AT-,!D))Z!B<)C^#L?9SWSC^
MM&T!0J.1L)8OW'?:WL>]>>E+F]/P>GK_ %ZZO==[V6GG;]#^)/\ X*FPSK_P
M<^_\$SIK5HTFFT;1(=_V<QN/+AE($EUC$X(=O+CR3%AU&/-K]5O^#DC=_P ,
MD_LZXB9@/VVOV?F:0-L2/&M7G+OT4L,[<D9VG'2OPW_X./=.^,TG_!8O]AF\
M_9HOO)_:#_L*Q7X=1:EB/1AJ<31N"\J$2^9)M1&!.-K,!7QY_P %7?%O_!=K
MQ%\&OATG[8VC>$M&^&VF_'7P GA>+3'E'VOXD6MRO_",_:"6SY,MPQ=B.?G.
M#Z]T8KEI3YOA6J\G%+3M:U_ZUE*5W9;RWOVE_2/](#PU$\WA?PPN3M&A:4S;
MANW'[! 1SW'8'TY[UOHHWEQ"5V@Q@%-N_P!^F,>G!&.:_A(>_P#^#H:70O#<
MND:IX5L=$&B:>^F6UO+*=MDUO&+=5)?)'E",<Y]^HK/OK;_@Z2F&EAO%.B6K
M7-S&%D6201+N(YE/F# '/7TSCU2PO-[W,K-W6FEKKK?L[=D_P4XU4[\C5W>]
M^R5NG35_@];(_N_>*1Y%#QEX3N &T@QL>^,9*C ]CVJN+:;9)&X^8MO!2!@K
M(,_)N"X#\#\>E?PN3>&?^#IZ"]BB3Q]X>A\V1U<0RR&)E9<"0YDR&.0??&/K
M1NOAW_P=3ZY<0Z$/BWHVAK;[KT:JLS* 5).QG\SH>?PXQUK?ZG)Z\Z:MV_X/
MG\S&\MN7\5_D?W920S-M<QLZX ""%E=,]<MMYY],]Z98VLJ7!G<2_*'"AT9#
MRI^7+ $C).#R._%?PE:K\$_^#JF*%98_VA= +QNCR2V%V3+/YC@#?N=@0.<A
M0.,<@\&OHOP3_P"#JC4O$(TJW_:,TNUOUD#?/<E;=OW3-OF;S !$%R&()YZ"
MM'0<:37,K.%KN-DKM7B_?T:WYM-%<I^UTDX3LFMF[.UM]&M_7NS\+?\ @X&O
MDA_X*1?MD60M3YU[X;T$.X!C-N8KL$QM%@%CG@DCT[=/Q>\&7D9\(:=$'A,W
ME>7Y+[3Y:]"[>^>>HZU]W_MRV/QZT+XF_M->'/VP[N#7?VH=,2S3QAXGW;H[
MVQ%SM@.F-D^8A;&3G@=,BORRTG3-9-G'<VJ7BV+1A&FAR5DSZ=LCO^1]NFN^
M3$X=\ONRA"*;V>D;+>^_D9TY5/?C"*DY0J*7/JE!Q]Z3]/O^5T?HC^R%J"6F
MM>,5N98(X/)B\X23I&K+QAEW,.GXXS7M_B:2U-WJVI6]W;7CV-Q93VD<DR2B
M4K?V_P F[)[9_#H<5^>GP?\ #'C?Q'<ZS:>&K?4;N[BAC$R69;?Y1Z--M(Y
MP6Y_E7K,_@[QQHI0:@^I+;V]W!'?VRE_/ES*@"QC<=VYR%7U8CK7\^<4X#"2
MXBQ\J^(C2K<SY(2?O.]2*Z=.UMM.C/\ 87Z/WB=Q1E/@=@,DP?"F*S/*H8*K
M2I8ZA13I.?L&I17,U>T6WV6EKZW_ -AW]D7QMX3D_95_9W^U>+O"MM=-\'_
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M_P _]_\ @G5_P5B:WMK9OA_XC C>1[I#J>L;)W<968G[63OSDD#([#%+>_\
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M@-MXZ$XZU(OQ)^'3 N/B#X'>$#:[#Q3H)7>.NYA?E0?4$YSVK^':W_X)[_\
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MAC 13VS7ZP1@#.T'K\V[[P/7&>XST]*:T3,01(RX7:0,#_@7'<=J>BLIY.X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY5;7Y_\ #O5[MB$@=3_.E!STIC*2<C'2G*, "LB@/;C//Y5_,/\ \';<8?\
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M8S]&!S^&:_7B'A   .>@Z"N&E_"A_A1W5OCG_C?Y+7^N_P!TM%%%:&(4444
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M# ZC\OSIVP8 .3CCGO\ 6@(H& .Y(]B?2DE9;M^H#-P4$'AL$DD9^GU/0TH
M*G;A=PSP,<GJ3ZYQC_&G%<KM)/3&>_UI-G"C)^7]>,<TP'_3I12 8& .!2T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "F'[X^G^-/IA^^/I_C0 ^JI#&4 ,  P.W'8-Z_ATS[5:J#&7S_M#]&R*
M:W_K]?TU&NOI^J1_F6?\%!]0M9?^#J?PC&+;['+:?&OX9V\TQ_>?:F:!V23
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MG]JCX7;G;8JKJ[C8V?O-.L+Q[3]1Q^--0;_X9^7E_7Y-Z:?Y_J?=E%?$S?\
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MC_M4?\%D=;OH[1_V5_AYHRSLPEU'4(KL1Q6ZH78EFDVD*H)._(P*^</V(O\
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M+-[?@M>G_!_#S/&/C@UN/A3\39)3 5'@CQ,EP;N-5@V?V/=[5+/A<G/X&O\
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MOIS]IF"W^R>!KJ8R"199(EFX$CA5.R.08QO3C/'YU\W:;=L+Q#=(YN7!BA)
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M]AG78=S.JICYLYX/]X>YZ5YQ\7? 6@_%'X;>+?AMXIM1?>%_'>CWGAKQ';L
MQ?2-3B,-W\I'),9.,^HKHIR;G&\G?FC\EHG:VWNOSW]"91BU9*VFMM-=-=//
MIY'X%?L"?\%0?V7H/^"0?PUN_$_Q[\#Z-\0_!7[-E]X9N-#OO&&GP>*!K>E>
M%[^RT[9')<BZ%Y'(D/EM@21F-"O.,>#_ /!IUX(UR/\ 90^/WQM\4:W=>)M:
M^.WQPUSQ./$&JW4FHZQ?:?97FI6EH;G4KAY)[N,QM'(A9RBD@(%4*HO>(_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %,/WQ]/\ &GT>^.: "H. WMN _P#'AC]<
M5,P)'!QS[U'M((S@_,/YY'\J:=FGY@?YF'_!3QUB_P"#HSX5M(0%/QL^%>/J
MTC*,^FYBH'UK_3.?[Q_#^5?YHW_!6*""U_X.</@5.L2JUS\:/A69F[R,=3MT
M4MT^[OXYK_2\_C8$9Z'IZ8_QKHQ$N94U_+%+_P ITOQO?\".5J5_.+^YS?\
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M .#L%FB_X(V_%C:"^_XI_"96X^Z&UF\!/MCKGW-?THR%0N6_#US[?UK^;/\
MX.O5F;_@CA\7-JC ^)WPJ=B.T:ZM>'/Y#!_K3I_'+7HOG9/_ (?\ .+_ .#3
M.VM[;_@EGI+6LWG--X^U:64 YV.88"4/H1DY'6OZ?X\]7^][_CT]>U?RY_\
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M9MT5P<JH"CCG[ _X)U_L4?L[?MDZ9X-_:[^)W[2/C;]N*U\'Z\\GPYMOB'J
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M[!_[+?PJ_:&^(WP,\!_&C7X-/\>W/PZU#[!J<]G(\"^8C$J"Q\PC@]Q7(_\
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MUXA<7DK%8-0G+.6,. ."1N(/2OSY\%SM+X/@MXD7[3(C1K)TC/.0Q[ C_.>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !FBHU^^WX_SJ2@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ J-B3C'0.,\CU _J>.M24P\D@C"Y5@?5@P./S IK=7VN!
M_FF?\%?'6'_@Y>_9Z<8)/QF^$X;'8R:WIR 'W&\'^E?Z68SO)QQC_"O\U3_@
MLA:0VG_!R?\ LV7(;#7OQE^$\DO/1AXCTE$'X[@/>O\ 2NK6L_A\DE_Y3IBU
MOY:??K?]!C]/Q_H:<.@^@_E37Z?C_0TX=!]!_*L1BT444 %%%% !36) R!GD
M?EGFG4UR0.%W'/2DMEZ+\@*TN=P.?XU.WCIUZ_3FOY1]5@V?\'05M.(W E^!
M>DJ[[#L)30H<?-TR/Y5_5I<9#9CP6XX[@$@$@?G]/QK^73Q+HFJ:;_P<J>'M
M=N@W]F:W\&K.VTV1641B:VT6);A) 3N9CC"XSC'0 "NNA]K7[$KK7O'MY=N_
MR(Q:OA;I[2I^FE2F_P!=._HS^HJ-COD4?NR)SA2,[^?O?C_GUJZ<[#D 'VY'
M6JD8(;>V6?>PY[_,1\GTSCG_ /7<;[I_#^8KFG\:_P .O_DO]=2H_!'T_2(U
M#A23Z_X5)3$Y4@^O]!3Z0]?D%%%% #7R5. ,^_;WK^</_@ZIA!_X(X_&D.V=
MOCSX;R+UQE=0O"!],C/XU_1Z<8P1D$X_.OYS_P#@Z@B$G_!'3XXYZ)XQ\ 2#
MZK>WY&./:G3^.7HOR_RN!XS_ ,&D#L__  2TM24*%?B5K:CC[VV*#!]\_P"1
M7]2PS@9]*_E=_P"#1*:6;_@EL!)G$7Q3\01Q_P"XB18_E]:_JCHK_P 5>J_*
M(!1112 **** "BBB@ HHHH **** "BBB@ HHHH *0]/Q'\Q2TAZ?B/YB@!:*
M** $'0?0?RI:0=!]!_*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@!"0.O%?R%?\ !Y7_ ,HW/AP0VT'X[^'\)C.[-L.<]1C'?UK^O-ADJ/K7
M\B?_  >5"/\ X=J_#LM_K!\>/#?E_3[,0WZ>G^%52=[OJX5?_2)6_7_AC.IM
M%]JE/\:D5_7^=C]3O^"!<?E?\$N/V=P!Y>[1WV$'=P8K, ]^V?\ (K]GT!"*
M&.X@<MC&??';Z=J_%3_@W]F>;_@EK^SYD[S%IEQ&,_[,5H/7UK]JH]VQ=W7'
M/^?I7-1^&"Z*"M^!U5]:M26BO-Z?)6_X?T'T445N8A1110 4444 %%%% !11
M10 4444 ,<$XP/7^E- <=/Z5+10-.W],C_>?YQ1^\_SBI**5EV7W#OY+\?\
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MV+0?BGI7C+7-&NM2OU:QT9](TZ2^T2UL6&%MH9IUCBG21E+1Y')XI_4'O?\
M!^71NZ'&I-Z.*^36[MU7]>FQ_HS37<D =Y(2(H\%G[8X!P<X)SQC^M6+>?ST
M$@7", RD]2#ZCM7\R7_!$_\ :8_;P_;"^.7[2GBC]JCQWX,'A#]F3Q5J_P #
M8/ 7@\E5U[4A/=FS\6:A#_RUE6&W7-QRNY@-V6 K^FV#;M!080J-H ^7';\>
M>G;D5SRH^S=[O1+?NTKJW>SO\_)VW5K:[_\ #:?F3UFM:XF>4D?OOE="-VX<
M=!T!]<>O3BM*J<LNP,1&99%8#8N,X;(+*#Z \]:48WE?7^FON[M^I,M8OT_+
M4_B]_P"#T)K1?V0OV?8T!^WQ_%R)855R%,/]GR-\Z#@_-@!B,CM7]6?[)$3R
M?LH?LRRS/Y:)\"OA49X5&X.?^$)T0H0W8J>?S[@5_*7_ ,'GD<?_  R5^SY-
M)Y:I'\78/-?8ZW#0_8F#*KD;3MY?@]OR_JR_928O^R7^S9Y0:/S/@5\*EBB.
M=[*?!.B 9X.69-K?[S5T5=(47KHE^;;:NM[W^>^IG'7FLMF[6[WC;RTMWV/S
MX_X*V?L$>*?VF/"?A/\ :)_9HOH?"'[9?[-M_!XU^%'BE,0MKUOIDBW-SX7U
M.7Y3/97<$4JQ0NVTO($P25S^-'PY_:'^+'_!P[\0? '[/C6Q\!_LU_LK:WHT
MW[;6G,_DW7COXL>%)WBMK'383AKC2+G6[&]=[>,20F$SM]S<1^H'_!8?]M?Q
MWX7D^'O_  3R_97U:ZL/VM/VJFMO#6F^+-+;[0/A5X3OKE8=0\3ZR;99I+%3
M;F6**2<1*58$,0V3^;?BW]B[QQ_P;]Z_\+?VR?V?=<USQU\(?%\NB:#^WIX?
MOW>\_MCQ)JXC_M'XA:5!$KM!:P:E+=:A-)( 5"F4NI;"CLX6TTO9.[=K6W73
M73K;3H@C)W::ZK\;?YV:[G]=WA7P_H_A;0M(\)Z#I5GHGA[P_IUIH_A[3-/B
MCM;2WTJR@C@@CBMH52*$;8U;:%&2222Q)/\ /9^V_)(O_!?#_@EM'%($>7X;
M?%Y'D:,,0BV]V/*7.<>9SR/45^[_ ,*?B+X/^,_@[P=\6_AWKL'B7X?^._#]
MGXB\.:QIT\<]K<07JAQ&KH64-')OB=.J/&R\XR?P=_;F:/\ X?W?\$L6D65&
M7X>?%D(<\%C%=8!_'K^/K6=/523VY7KUWC=+UT'.RJ0:^U9/Y)?*^Z??4T?^
M#@2"&XUO_@F+'<$*O_#:^BXD/.UAIME@B,Y$F<?=(/YXK^@ZQ\L:1HJJ?F33
M+%4R"!M^SHN63'R@ 9YZ$#'2OY[_ /@X'>--4_X)EF4D?\9J:+M8<2AQI]CM
M,9S@-SU)P17]!>DH6T72T=_,"Z1IY+G/VAE^S)\K,."Q!.".^[UK6K9X/#I_
M\_*FBWUDN^G3\04%.<[_ &4ONLI???\ X)_.I_P66^!7Q^TW]J+]CW]N7]GZ
MT^''B+6?@%XM674_!7Q*\:VG@;3?$ENJ*!!9ZI=R1K+*!SY:L3W[US-__P %
M;O\ @IFL<T\'[*/[)5C&W[R-I_VEM(=O*(RH):\PYC! 8^OIT/D__!;_ .'H
M_:1_X*/_ /!-C]E/QQXHUW2?@]X^\?QOX@T;1+RXM+N[(@3>V;>6/.7!!,C;
M<=*^V+__ (-U_P!@^\OHA/+\17@\MU6U/B"\>-%_BRXN5P3V^3],"NESPRA3
MYE=J"T:NM+=U=-Z7Z-W2\^E1II;.[5^G^6]W;S^;/EJ#_@KK_P %/&(0_LY?
ML>^9*V4W?M(:&.,]_P#2^,9[Y[=:Z'3O^"JO_!3^<W-S<?LZ_L<F-5\N.$_M
M*Z$O[T_<;_C\Z#'/ZU[[%_P;>_\ !/..>.X6P\?,T?W5D\2WS+U/4><O_P!<
M>U:H_P"#=C]@ !P=.\:X=AC&NWZD'M@_:FS^0_6E[?"_\^XK2S7)NM-'9:W7
MR5KH2C3[ST]7O9WVOWM]Q\UZ3_P51_X*A3C4S=? 7]C8_98W>-#^TCX?4HP)
MX!^UY; Z#\*XMO\ @JG_ ,%5YKP2V_P<_8S2T;>XMI/VC/#V?+3ACDW78]!7
MV,/^#=/_ ()[_P .D^-0>DO_ !4-^?,XZ$?:!]>II+;_ (-S_P#@G?#</.WA
M[Q=*61HU277K\!0P^8C_ $D[LC.3C\N*?UC"K:E!?]N?\#Y%6I]5+SW_ ,O7
M[ON^.IO^"G7_  5/NK4F/X>_L9VK7$KA%'[17ATF$$$ Y-WT&<YK*TO_ (*3
M_P#!61+>\M#X+_8QF>T8D7C?M$^'2Y#'( _TO)[#'..F,5]K_P#$.=_P3JCD
M1U\*^*'P^2IUK4''O_R]@#Z\_E2M_P &YW_!.UIC+!X9\31*Y!>(ZUJ#!L=<
MYNU/7U!],XJOK=!<L>2')*5I^[=J/5KK=:]/0F48Z.$IP:=[:N,K6TFK7MN]
M?6_0^$O$O_!2K_@I_J'@OQEIOBSX?_L<7NCS>%]:M]1BM?V@/#KSFUN=.GAE
MEAVW.Z6:-69HHLYD8*HSG%?Q W7BOXBZ?XI\37@C\+H^K:UX@O)X$UF":WM9
M[C4;B:9;.?<0T<<C,L+J?WJ ..O/^B#\3O\ @WZ_X)Z>'/AKX_U>T\(>(?M>
MF>$M=O[4_P!K:@P%SI^FW-S 2OVL[U$L:EAGD9ZYK_/6E^%7A6YUWQ59S6,M
MK9:=XF\0V-H29 5M]/U2YMK94R=P A0!]V<G/I7YCXAU<#S9/3LG"4L3I)M.
M_N.Z:72Z\O*Z:/\ 0'Z%.4\39MAN-_\ 5O'5<#BJ-3*746%=2BIJ3;5^6+YK
MV=]M/P^9_CCXE^(.J:5H4FK7.A30"ZGC@$-]#).@ (S(-Q9!Z,>I^O/S0NO:
M_8QQ+'%ISR1RY\][Q)"W4[=I)X].,8&.*^R/VD/AOX.T;PQX,&C65[#JNH:A
M-'J%U*[&WEME!V" ;CB0?Q'CK7R[:?#S0VO!;S/+EX_-!+-PP!Z?-CWSZ"OK
MN%G#^QZ$Z#]U.--J]]$D^U[[ZV7<_GOZ3.3YKE'B]FM'/:]3$8ZO0EB:DZDG
M*7,ZD8O5I::=K'ZL_P#!O19R>,?^"T7[*HO9([:1=6UB]W6I#)NL='NI0GR\
M#>0RGIC*GZ_W&_\ !P\&_P"$T_X)D,I_YO5^'H*ACNQ]I7Y@H/4?J/S'\1W_
M  ;B:+;V/_!;#]FFQCDECCL[OQ/<Q%3S*R:/)A'))S&RE@PR<[17]N/_  <,
MD0>/O^"8EY(0D%O^VE\/VD."=^+H<$<C&2/R[X->US.-6D[VNY]5IS-+6]NF
MR]$?SVK23M?WFE?OLM/D^I_3"H_?^9_"8PN>Y/!SCJ/3ZU:JNFV3:ZD%)%#*
M0,94C*GD=35BO.LU-OI9?DM/EL6%%%%4 4445+;^SK]UOSW *8X8GY>..O'O
M^/\ 2GT4[_?=:?-=AKTOZF>;5@\DC$.I "1D#"9(W,3_ !>P-1"U!$EO.5NK
M:5"AMY$#1%6/(>(Y5T)/S*P(/>M6JCY\QAV&.A^;IV_V?:FI<K7GIO;\>_87
M](_EZ_X.JOAO\/M%_P""3?Q.U[2/ '@;2]?'Q&\ LVN:;X1T:SU5MU_,T@&H
MVUI'= R9_>,\CERBD;<'-K_@T_@ _P"":U^3*JB7XI:M+Y"0K!'9D6L!\E%
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MS2?'/[&46N-\5[KQ#I6B79T+P_+XAU"+2)+2W6XE.G1 OB-F;<^#M.!7)?\
M!'N3]JB[_P"">OBO]IW]H[Q?XE\7?M$_$?P/XI\1KX)\0V\VE7&B:UX>TJYN
M=$LK?3IG\VWDU"\CAS&D84[U ))('S_K7_! 3X_^)GCN=9_X*?\ [4VKZ?\
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M%?U59K^5;_@T-7R_^"6KDY.[XL>)7ZYQN$73TK^J=#Q].OYFE42E[^[TM?\
MPIK_ (/?R =1114J_4 HHHH **** "BBB@ HHHH **** "BBB@ I#T_$?S%+
M2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &?Q#ZG_T$5_(E_P>5P-)_P $V/AW<AP%@^._AT%">6,M
MO@$#OMQR:_KN/WE_'^5?R,_\'D^[_AV?X"^YM_X7UX6!# ^9G[.Y&P] !CYO
M4$44%:_G&JW_ . 2?Z&=7X5_U\I?^G8+\F?I7_P;WPO#_P $K_V?]SNYFL+I
MP2/NDQVAX_$ &OVYB),:ENN.>,=Z_$;_ (-\G=_^"5_[/K,)"19W2]?[L=H#
MCVR>?7(K]NT^ZO7IWZUA1V6FCC=?-HZJVLI_]?&OP_X ZBBBMS$**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"-Q_%ZGI^'_ -:FR9*J.Q [=,<Y
M_I3WZ?C_ $--;HOT_H*25K[ZO^OZ] /X6_\ @[2LVN_C'\%O(MEN+B']FKXD
M]3ADA_MNX+..O0D_CBOZH/\ @EA([_\ !.3]C$LI$G_"B/ \18#)14T[;CW^
M4 <]_>OY=_\ @ZWDNHOC;\'VLHTFG?\ 9A^)J&-L;A$=:N=S@'GCGD#^=?T\
M_P#!*"Z)_P"";O['LMRVTQ_!+P<AQR1LLN^,]0?Q^M>C6C#ZG0DM9]=[[6[:
M:_)I+J<]*+]O5?>R^=HK]+_,Z_\ X*"_L3^'?V^OV=]>_9\\5>*+OPIH^N7]
MM?3:I80K+<*+<./+"$C;G<2''(/(K^>BV_X-0/AY<Z=X7\*^(?VNOB7K/@+P
M7J,FM^%_#ETDL]WI^J.QDW'5[BX%X^GI(24TXC[.B?(HQ7]=_GPOMD21/N%<
ME3@@]^1U_P#KU']IA(5I&3)+(."/E&0,8X]OR]*YH8BK3A[FW33II?UV[ZOY
M6W27-KO^6EMFT?R:>(/^#3S]G7Q7>:MXBU3XZ^+U\6:TJ#4-0L+"*WTJX,*"
M"&6;14F2SDG6) K3.A=FRQ.3FI_ 7_!K)\.?@5XBTOQK^SK^U)XT^%_Q#MXF
MBN_%T6DQ:E>RQ3Y%[':1R3;+-;E"4(CD7 / K^LA'B&1R!]T=!UZ?IS^-,CV
MG>6&,DJC8Z 'L?PQQ36+J2UYGVV7E][WOW8TNR^Y'XS_ /!.3_@D5)_P3Q^+
M'Q)^)FB_M!>*OB18_%F&2]\;^&-;TZ*VM-5\53$D^)#*LTA%R"S$1E<8/WNQ
M_:6,[(U^7&>V>.W3KCZ5$70K@N2![^E)Y\> HS\O'K6$ZDIRU3?GK;_(KDEV
M_KYEGS/;]?\ ZU<]K#M96NI:BJDM;Z7?7IP^"ALX&D4 9YWD9Q^=:WVA P&"
M>G;WK$\6M_Q2?BB5<C'A_5]I3B0$6,YQGT8@<>@JJ;]Y>;2^^2)DK73TT_ _
MRX/^"V?[3O[67[:7PS^.'Q$^+7Q1M[_X(_!+]KZ;X-_#KX86VCV]M]CN(;:9
MVU>[U"+]Y),;>)D*2'<2<GI7]Z?CK]M3X>_L%_\ !,#X)_''XC74,VKZ?\ ?
MA7HW@GPM#)'+JOBSQIJG@G2+;P[I6F61<378FNQ$)S$K".)P6*Y4'_/X_;DL
M87_8#_;*NYY0XF_X*C7/VF>,X2SA>PNHV\T'DL%<]._-?TA?L6>%_&/_  6N
M^/W[)?QDUG3DT/\ 8!_83^%G@K0?#GA?7;>Y6?XO_%72M M-.EU38Z"WNK31
M+JQB9)'WQ(D2#(=UW>A6IJT'I%1A%OO]O\V[::7\]#&DW>2Z<S_*/Y;+[]F?
MH]_P1T_8G^(=AKWQ#_X*-_ME:<^J_M4?M/7\FI^$M*UIGOG^%'PSO)WN]*\,
MZ9;W0D&FW#0M;RR/"4=4)4 ;@1^X'Q7^$O@?XV?#[QM\)_B;I5OXC\&>/?#^
MH^'-?T>Z1989+'5+5[6650X*I/%'(6AFP6B?!4BN^M9(\!/+L[>VM46WM85E
MA!C\H!(A"B,%BC2-54)\N .% J:\A62V>+SDBFE&6E\Y%*J>VXD @C.,=A7&
MDV[-V;=GK\.VN]DE?7N_5)MIJW6UG^*7;=]-=D?RP_L,?%SQQ_P2'_;%B_X)
MC_M W^I:A^S?\9/%MU_PQ=XSN?-N=/T.QO[E[BU\'7NI2G;'Y;2A C8V-CY<
MJ!7MW[=)B?\ X+T_\$MRZ'%OX ^*8D9R5SYD=R8S#_ST!SSCH<U]^_\ !3K]
MA"R_;I_9QN_#?AW4;3PS\=?AG<)XQ^!OQ$CDB2^\/>+M)9+FV5;J,^>D-TEN
M(' ;8&8,0!N-?S7_ +.'[7WB?]JW_@KS_P $V_A1\:;&YT']I3]ESP+\3? W
MQ6L;E6$FJ2:3:RV]GK\;;5$BZP@-X) ""'.3P35QIZ5+VNKIKNW9W3O9)K?\
M]+A)WE3\W?\ S5OU/U8_X.& 3-_P34^4D#]L_1-RC[Q7[!IXP&QE">.1TK^A
M[P_'M\/Z"%4"/^Q-,(0G)W?9(R 7ZM@'OZ&OYZ/^#AB0PV/_  3LG5<O#^V-
MH3C=U&+2P'7UZ=NU?T*>&9"?"_AN>4GYO#NE.1ZL=/@8\8ZG('\JSKW6$P[6
MG[V7SM+MV[EP^*K?RMZ\J[G\S?\ P5(F:Q_X+2?\$GIK&21+G4/B,+/4,VXG
MC-H+<$!68'R6(P2R\_G7]0Q4@X #;I-W7!7!!(SW[\=AQ7\P'_!3U(I/^"TG
M_!*H2?:MP\?JT!BD40;O(7F5#R>I_+Z5_4%M.X-W!;ITPWJ/[V,?I16<5"EK
M]A)W]%\_+T7J4+Y8R6!(8YY],^WK1MX'.2#]X@$T^BN:"5DUK^ETKA<88U/7
M\<#&?2EV\ +\N.AQDX].:=15@1"+:S,#RW7CC\NU*J(%VXP#D8[\^_ZU)4)!
M$F2>/Q]<_P N/_K4=W>UE<.]VE97U_(X7QY!'+X&\<VSH)4F\*>(D\M^5;S-
M+N5VD'L=V/\ (K_*;^+5DNC?&#XTZ.+%+9;/QCXCS"RA([=9M4NWS;< 2%N&
M( '(^F/]6;Q^"? WC@ E0_A/Q"N]3\RYTJZ7<G^TN<J1WQ7^4U\3V2'XY_%*
MRNYKJ]^S^-?$3)-J#;Y[MSJUV5$C'JB?= / '''-?D7B93?U?):ZE;EKXI7_
M /!75:^>VWJF?ZF_LS8MYSXBMRYH_5\@=GK%_O<9LMKJVN^A\2?M-379\-^
MXY6.U;Z?[/A<2/D'!9>P[9_'H:^48)Y;MY(3$T,]M$5DFYR">@ /7(_KFOLS
M]KK3+C3_  [X*U>109;O49TBAC96BB7_ )9^7MR 1Z'GC&..?D*SA"BWO)EF
M!=E-Z,@;E(!_3V]^F*_3^ %&?"]";U;K1O?J^2/GH[+[C^</IPT*O_$P.9\[
M^+!2<;;<OMEHEMINS])?^#?WQ!-X1_X+2?LL7UX0XNM:U2PF9SMS#?:7<QAN
MO#90'MU/:O[DO^#ADR'QE_P3,C4A8Y_VT_AX#(R!HP3=*,9.1D@ C%?P0?\
M!'N=[3_@KK^S%-;F7?\ \)G"82QY"/#, ..BA-P(]37]]/\ P<$2$^*O^"79
M55=F_;7^&S'S.;<J9D)W+U/0D$=.*]JJKU*3_P"GDON7+_G^5K;G\?VY8WV]
MY?>G']=?GL?TK1' $>2=BJN=NT<#&0/0_P ZD)[8/UQD56C\PSRD JH(4!LX
M.%'*_P"R>"/K5K/7KP2/R]*Y9*SZ:I/1WMHG^O0H44A. 2>@I:B>0!3@X]R,
MC\>_/3\:ANUD^NP$!NP-QV[PA D\OYF7) ' ^OY4Y+I9&("L O!# A\X/(7T
MXQFOYU?^"Q?[>_[;O[//[0/[.?[.7[#D'PYL?%7Q-\,?$+QMXUU_XE6+7^E6
M>B^"=,N-5D$"(CLLDD$.U<=&R*_#_P +_P#!=C_@K9XJ^(7P-^#"_$G]DNS\
M9?M$6.H7/@+66\,WD>F65SI[W43VFIRF(1O*\EI(H7=NY!Q733H.4;I=/-::
M>5M+]]?P _OH^UX**RX=RQ7'**J]3(W\)ZD ]?:IU.XJP'RD<$<\8_QK\3/^
M"*?[<G[0G[;_ ,!_B-K_ .T_;>$+?XH_"_XF>*?AYK:^!K5K/1=17PYJ#V4>
MHVT#A6$=T(S(#C!R.37[8PE1&N.%P,=<=,\#J.O(/>L:M/E>VJDEUZV>E]_/
MMH!/5?:"[!@0,YST[<<_B?:IMR^O\_\ "H6)+\9Z]6^[C_)Z5F]X^OZ/7Y ?
MSA_\'52H/^"07Q8FWA9+;Q]\/I8LL<,ZW]V0"IXDYVD@]NW->:?\&GT\=U_P
M3A\07_FLTUW\5]4DN 008R+>)0!;]( 03P ,XW?PUZ%_P=7R%/\ @D'\4U_<
M$R?$3X>1[6SN?=?W0Q$>SGU/M7$_\&I=JMM_P3L\2*GEPN_Q4U(NG5T(LX\>
M<P^5F;/&..OK7K+_ )%[U>E2&Z?_ #\\^EOZU1E)>^O.,OR2/Z>8H@JJ%)"\
MD$DEFSW(//'^%6AP /2J4)! 8%G(P-_\&0!D?KC'XU;5L]>O]*\>/QR^?YFB
MV7HOR'4445H,**** "BBB@ HHHH **** "OQ/_X.#Y_*_P""37[4S,HS_8FF
MJ" &53_:$;AF/11@$$]B1ZU^V%?*W[8_[+/@K]M+]G?XD_LV?$.\OM/\&?$G
M3%TS5;[2W$5_;A9!*'@<XVR!U&#U_2J@DY*[LKW;\KZ_AJ3*[MH_E\O^'OY>
M9\G_ /!%N!V_X)8_LD$1E#>_":*5 #N$GFW-_$'C/\(+(5 7C(/N:^ ?^#>!
M+V"T_;FM#;&.Q@_:E^(^Q@=RFXEUJ5B%E)Y=@K$J2-N/:L7X>?\ !$#]IKX'
M>%=*^$_PI_;[^*WAGX3^%(9-*\!^&TUVYCDTW2)WD9K&Y7 60_O&"&,LH#8Z
M\&M\)_\ @@!\4?V<XM??X"?MQ_&'PA>^/=9O/$GC^,ZW<BPU+6]2D,U[?6\2
M*SK-+*2Q=@,UU^S@H2_?Q]Y:7TTNKWUU\O.W8%';I;SWT7W+I^)_3<L)**C0
MC"DXR4)'N<$\\D]:DV/@?(O4\ +QZ'&<'/?G/8U_/);_ /!'S]K"YEN(]8_X
M*-_'I[:9G>Y:W\37*NPV%E6#@>6@<*"'"@*#7\]?P!\#?\%Q_P!L#XE_'O0O
MV9_VU[S2/#'[.GCW6_ QTSQGJ4]QKFM6VF7CV=O=W1"G?YZ .K8^;G!-9K#Q
MGK[:/2_Q)7\_>6_?1VZ+1%<JOKOY)/L][K^MF?Z%&QHXW<P%Y,9(41DOCMC=
M^0&>A]:7RW"*YBW,PRX 1G4=54!F R. <$]Z_P ]+QMX-_X+*_LS?MB?LI?L
MY?M7?MS^)]7T7]J+Q[IV@76G?#K69;37M TR\?RIKN%VQLMHI,JQ^Z"#S7V-
M_P %2?@5^UK^QS^T+^Q%\&O@K^WI^T%-IG[3_CS6?#'BJY\2>*GEDTJPTUK=
MEGT[).R=XK@*6R 74\]*?U:/N_OHMO5).>JTOK>VGXWTV#EA_45_G_70_MF9
M)2%V0X)^;YBG!YX;YB<X/7GTS7\6O_!TU#<1_M:_\$E+^,2PH/CCIMLKQ1"=
M_.;Q%$V(X5+!_E;#$\J&#<#%?KS:_P#!'WXK_P!GZ,%_X*%_M4R3_9+6?5;F
M7QD[&:\DB1IS;$,2L>\L(R<#;BOY:_\ @X8_8L\=?LZ_M+?\$\=#U?\ :<^,
M_P 6]-^(GQ4T;1]$U'QMKQO_ !!X,NKGQ!:V-WJ&B7+';;SJ\_GQ.",%3BJH
MJ*:O..EU:VK=X]6[6V;T6C=NP25^7KMKVMWN]--.B]#_ $6=/MIO[/TX2+MF
MCL;%)'8 .SK:Q"3<F?E(?<I7MSQQS=:)V(+0Y .<*R@=><#=R3[_ $[U^)EK
M_P $B=?_ +-T\WO[?O[76U=,L!*L?C4AUA^RPB381(1O$NXHP_@VX]*_'7_@
MIW^S%^T#^Q]\6?V1O!OP:_;T_:KO-)^.WCRW\.^,#XG\<&[DAT\WD<9?32,>
M5(8W&5.>V2214JC&3TJ)/5Q?+);:MI\R6G3O;96L$WRQC=Z;^EW^.ZOVN?V=
M.LPCQ';D-G;#RA$8(Y=\MQGD8[4B6@0Y$; H,[@RG>2#OVJ&/WCV.!7\5/\
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M<?\ !/3]H2*0*# &\'ZY&90>$EV')\MSC!!'U].L/[?W_!3B^OM5@M?@C^S
MUJ@"M,9_"&Y_. >65-TFY@#GS,Y)-69O^"@'_!1B'3'NKWX6?LHW<EK%Y$S
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIR@VSW$:-N(V8!52">>#^==52+DHVV22[Z\D-/Z=P/[^\L<_)@]N1^N#0"^
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M7[_BG]KZVL;?P+\/M/TV62:*VU*X:1YW+RM,1AGRV3R02%_D*^(8#>R&.'S
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M.!P:@D\5=[73Y;O397??9Z7]2;X__GU34=-[/^3=V7]*Z/Z-/^"#'[)_Q_\
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MPG5[!)6D*B(74!<MZ%?,)'3D8XK^#/3OV*/V[WM1)=? W_@J!%J@:;[))/\
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MZ'TK]V>'()4@KZXIP ZE<=L<$?7ZT_K%6UO:5/12LM+>6FWX IR7VG_P-/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IA'O\ Q@_J./K3
MZ:>WRY&0?QSUQ[=::W7J@/\ /%_X.,8&'_!<+_@G\8R0TOBGP65]=Q\;>'<_
MK_.O]"'3VF33=*1MV[^S;(.<DDO]GB#DG/7/<\]3FO\ /R_X./XVB_X+9_\
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M?Z\AJZ6JO;IO^OW:E"]++87_ ,S8%G=;2&;</]'D.=V<[N,@YR.N<BOYZO\
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M %%%% !1110 4444 %(3@9I:0C((H7GL#OT$)R4/U_E7\C'_  >3"0_\$T/
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M_H:BF^['['_V7']:F<$CZ'/Z&HGP0G?'7\O\:6B?2[U]123<7I_EOW/X4?\
M@[*\0P6?[0'P2T&\A66VO?V6_BA=J2BL1+!KERJ\G.,D5_5K_P $N%4?\$Y?
MV-$&75_@)X#(QG*K)I8;CN-N[;[8Q7\K'_!UOHUEK?[2/P2MIBL=S#^RA\5Y
MX92.FS7;H[,]MQ_3\*_JM_X)<((O^"=G[&J1L&5/@)X#C))&#MTQ0W_CP(_R
M37?5NL+AV^]UIN[/YV_K35G/!KVM2VO+I9=-8=._9GW-!8PHH5G>1MQ(+LS
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M$R6A4PL(].C5<LO G/'F#&=QY[9^]D/[E/\ /K7P%_P32\2>!_$7[$7P&OO
MZ9T.U\#:#ILZ*ACD.LVEC#%J)?=G<?.R=V<'J*^_EXA0>G7]3_6OW/*7_P )
MV#6]L-0U[KV<;?@K='W1_B+X@24N-N*[P=.?^L&;<T9*TDWC:S;:6GO.\O*^
M['Q]_P /ZU)3$!&??%/KT3XX**** "BBB@ HHHH *0C/<CZ4M% #=O\ M-^?
M_P!:C;[M^?\ ]:G44K+MM_P/\D W;[M^?_UJ<../2BBCE7;^M/\ +^KL J J
MOF[]H+$  [L\@@XQVZ9SWJ>HPH(QM*X;KWX_BSWSTI@?SB?\%0OV8?CI^S=^
MTQX3_P""L?[&'A^?Q+XS\ ^'[OPW^T)\)M,,T;_$OP5.7%_JW]GVY5=4UFQL
MF*6ID6616 "$ @#]1_V&OV^_@!^WK\,]-^(/PD\1VUIXN%DD7C3X6ZO<PVGC
M7P1K%ML34-/UC1)9$NX!%*Q"3-%M90=QR"3]P7%JVZY)C2XM[KY+JWN%66.6
M(J4:,(P92C@G<I4J0>0>E?BS^U?_ ,$8?A?\6/B!=?M"_LP^.?$?[)7[1L=K
MOAUOX9WLFA>#/$]_$^^.?QMH6G(D>JM.ZQBXD6/<X!#(<LYT@N;W6^5?S=%?
MR[75Q]/F_P!#]M %49S@D$F-OX6&06)!/ )_(TTR*&0&54R>03\LG?Y2><^O
MZ5_+[\4/BQ_P7B_84^&?BSQO\1;WX*_M&?#7X6>$-3\3ZWXC\/\ AW[#K#Z-
MHT)F9KJ6YA$LMP+90\IR#N#9KVG_ ((N_P#!7'XP_P#!13Q_\6OAO\;OAKI_
M@+Q)X&^'7A'XG:"UC$D5MJ'A[Q?<10Z>50*I\Y%E#2,=Q(7KBK>'Y8N<;2BD
M[RB[VT37,K:76NY*??37;KTV/Z(U.0#Q^!R*=5*UFC<M&K9:/(=?[K$YQ^57
M<Y_/%8?H,**** "BBB@ HHHH A93D\9SSP*S8[*.U=G@C4,[%F(15.2<\D8)
MR3GFMBF]3RH^O!K+V,7/G\T[:>73KM\@$0L5!;K],=A3Z:0<@@X QQ3JU **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IAPH  Z
ML/7N>3WI])CUYYR/;VIIV:?F!_GU_P#!S #8?\%F/^";E\H!)U/PO,!TR4\<
M^'.I^O%?WWZ!<&Y\-Z!<E1^_T73'.&SRUK"<?SYZYK^"3_@YJMTD_P""QW_!
M,I6*[9]1\,HV1P ?'GAL<_G7][.CVSKX=T*"+Y4CT?3(UV(0V5M8AZ94$ -D
MC&>?4UM*/-&&MM%_Z1'^O0(WYT^EK?-O^O78WV)/3(PHX([X[5Y1\=B#\$/C
M3(H))^$GQ&!QG)*^$=8XP#U)Z?6O27L9<ADN)<DKD')  QG@]?3L/Z><?&6&
M8_!3XP6^QW>3X7?$)$PI8N7\*ZJJJJ@$EF+ *HR6[9-0HJR=TW=?FG?7KLOZ
MUF%^:I9=KW\K:J_IL?EI_P &_3[_ /@E-^S<V,9N/B%^GQ \1BOVE1NBX]?Z
MFOQ6_P"#?995_P""5G[/D,L<D<MOJ?Q'B>*2-DDC*^/]?.UT8!E(#YY X(K]
MJ$'.>01V*D=NQ/!Z]LU->+NXI;2=UV5H[W\[$PWOY=O,:>)1E>2" 1R< $\C
MWQBOYB/^"&\Z-^VQ_P %-[9 =T7Q)N&(;CY7UN/9QUZ=Z_IX(/FY ;.#\QY3
MH<8]"#@8]*_EU_X(<17W_#>__!4HW*,(%\?11+^[:(B3^VAD;64%6(!ZCL36
ML+JG+RA33UVUWW^[6_H:7_K^OO/ZC$ ,:YZ8S6+X@8'2-:5UW6ZZ)J9D7 8.
MOV63?'[ADRI'/!]ZUR64;,-C& P5C^H_^M69K".=%UE<%BVE:@JY!Y+6DH Q
M]?KFL8I^UD[::6;7G'OY O/3;^OZ9_-E_P &Z*V_]O?\%3FM(UM[:7]MK49+
M>U4!!;1'3-44#:  N75GQC%?TPQMOPV<X8KG'7 Z\>OOTK^9[_@W5CDB\1?\
M%5B5+./VW]3&X*VQ@NEZD2B<<[<D$+G!8<=J_I<B+,/EC>+#$A65E'7KR .0
M?S[8K2K_ !)+;;>^_+'[M;>E]0D[/1-[[>7^?0@U#:+&^#<M]BN^!Z>0^?\
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M1L@1!9[AAA:PAQZ,(QN'YYXJ]7#)WD_6WW$1^%>B_(****3=OO7XNPPHHHH
M****3V^:_- %(._.>?R]J6BIGM\_T8'\Z'_!TQS_ ,$?_B[E$;_BXGPR^65M
ML;#^U+__ %C?PH>A/:O#?^#3@^=_P3]^(X"I&/\ A=FK?)"V^!,6<9(AD/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:<E*3:VTWWV2U^[N+1115$!1110 4444 %%%% !1110 4444 %%%% !1110
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M/@?X(^ KBX4Z[XB\5^)/#5K96.H:9IJGSKN'1;B>&]NI OEQ1J-YR17\5?\
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M!UP>3CZ?3U]?Z5GV\CAV$D9$K9;RQT*@\."!@$XX_P :BO+S[/-%P9'?_50
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M=<F\3_"7XKW\,TVK6]OK]\MM+I6EW,H*"QM8I=UN(I#&JH0J#<"OZ^_\%(_
MNN>.?V+OCE;^%M6\8:/XK\.>"=8\3^'6\#ZC<Z?XCNM6TFW>YMK&SGM<SA[M
MU\M509)8<5_/)^P#_P %3OVY-,^*_P"QE\"_VB?V0-5^&GA/X^0O\/=/^(6I
MYNO%VK#PS;JRZUXJO#&MR6O,;MUV<EAGDUVQM[.>MKZ62TTU3OU;YH^B5FK
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M_3M^5!0M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO_!,C]BNY(D7S/@AX=\Q6&V8@RWHY4=&XR1US@]>*XC_ (*I?M4?$_\ 9?\
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M-793L)*DBOV8_P""PBA_^"<O[3Q ,WF> -9>(!0P)-C,5QGH!_,G':OY2?\
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MZ8@[4)..,K@<],^U?P*?LQ?\%P/V_P#XW?"Z/Q;\6/VN?"7P%\?7=]<VO_"
M:A^S;>:F\%C;S&--1%XUB-AFB'G)&0'YQC->WWW_  50_:RTZ\MY1_P5!\(W
M-JP'GA?V6=09$R1G"_8NJYQZX^E"P%5J]XZV:UMH[;IJ]]7]WWA_;XK7AY*1
M_0Y'^%.+3\;E4#MC/49ZY/'X]?Y_Q6/_ ,%2/VE;P&YA_P""J?@F*WM(U-Q%
M#^RA?&1YI%S$HVV.YP"0'QG'.>E?*_[6_P#P64_X* ?!3X1KXR^!W[>&@?M
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M@U$LN5"/-*I%15FVY/[7*E?W5NW;LNOEC=M..KOW6O3STZ_UMJ_\'"^KV/\
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M9Z^"=[XO^'&I:L-)C\3WDB6,,=T&5+N9/M!5GCM@^]GC5P5 QN)VC^@/P?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1112EJK>:_- %12<+D DA@PQZDX/Z=:EJ
M%FVXYVY;IC=GGU]2>,>QI;.*UTO^7Y_\$#_/,_X.^0D?[=G["4K*54:7$"[<
M*<^)]-/)/IQGL,&O[I?V4E1_V9_@*&.5/PP\*-A<$%3I=N0?ITP?>OX3_P#@
M\5:1?VS?V(&1,.NAN4^8?,P\26&!G^'GC/XU_<[^QH\TG[*'[.TLJ&.8_"3P
M=O&\2X/]DVX(W#[V<9S^ -=];7!Q\IQ_],Q7^??7TL<]635>FO[BUUZU:/\
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M: %08'UY_05_)=_P>.DK_P $N?"Z^O[0/@;]([TBOZTAT'T'\J_DN_X/'_\
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MQ"^*.JS:]+X/L P>T@T6V%]=V"R6\9B6.62-F58\%23Q^)7_  75_P""-7[
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M<=#GO6C&P\M,_,=HYX.>.,GUQU]ZXZEW+W?P=NB-5.*>NO\ PZ_K^F)DDJV
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M\,_!$>_P3"8]T >ZWS7*@D11J"#$4'//4#^7%:8>#A5C+DY[-:=_=C+;7O\
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M*&Q>8USJ?_!4*8G,D1.B0G"$8"G]Z>?:O]$S+Y*D\E3C '! _'/X]*:/-VH
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MGOVYK6+23O;IH_\ AF!_*!\??#W_  46_P""B'[1/[$DOCK]G%/@Y\._V?\
MX[^'?BQXCUZ^BN(YIX])>,R6Y:1C@,$X4':,\*#U_J^:=W>(Q %#(5R<Y8#J
M0.NT\8/O^%,Q<&';/( P4K(0JE95/&0 /E]#[&GQ6^Q@XY(55!!^7:!\JA>
M",#)ZGO[*4KVTM:]M>_;8"]2#IP"/8TM%2 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%1[R"?K_+\.]'F>WZ__ %J !U+%>@ _
MB[C_ /7Q7\WO_!PY/XQMI/\ @FM<_#BUTB\^(EK^W!X(N/!]MK[%-%GU9(X/
M(CU!E^80$_>P:_I!9@V%;(W$;3UY!_#Z5_//_P %XE4>/?\ @E)(K?Z0O[?W
MP_4*>C1M%!NR/KFKAO\ +_(#Z.O?B#_P6/;7;[3+?X1?LT26-JY5;I]:U9XI
MXS]V2)FN"&R/FP<C!%?S[?\ !R]XT_X*$R_\$YX[3]HGP#\'-#\!WGQ0\.03
M7?@2]O;O6H[F.ZA-N[QW#ND5K)YC[B@3=MRVXA<?W%;0DTS0M(TN[?(C,2IW
M(N F1@ #& .A)]\?S"?\':,SQ?\ !+B\+HC+)\2/#:2^9@F,FYA*R*#_ !(0
M>G(K;#R7MXZ);>5FHO5/S=_OZC;O;2UOQ/U+_P"".MM]D_X)Q?LO1"/R(S\/
M=$>%<;68-8P98\#[Q!QZBOTXC?<QR,-V!ZE?7'O_ )XK\KO^"+VJ7NK_ /!-
M/]F&XO;U+N:'P'I5O',L6SRX8;2W$:%2,$A2W/?/TK]3X2O;DDDALYW?X=>E
M<U1MXFIVM?\ %$V=[W^7]>I8HHHH&%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ***0!1110 4444 %%%%*R_KY?Y( HHHHLOZOT_K\^[ ****++M_6B_)+^F
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M_P"%3>#2O^Z-'MAS[DY-?858R;NUY_\  ^\U3=E]_P [" 8& .!2T45"26R
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MG5+L:@Y"XFU$3@SSCOER#R>OK7YZZ4TJ+<P!)&D:"5%10.0(VYSSC\*^J?\
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M2T5"26R$(1D8Y_K2;%]/YTZBJNUM= 1>4, $DD$E6.,C/44>7M!"8&YLG/\
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MMZ7C_P $_MXB'SR#  5L@#IZ_KG)J<<Y!Z9(_"H8O]9*>Q9OT//OUJ9?XO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI/;YK\T 4
MUC@$\\<]L]>@_I3J8W1OHO\ ,TG\4?G^0'^>!_P>B7D.C?M%?L6ZV\;2G3O"
M^K7LD79TL]<6X*#H"S"(#]*^Z/V>O^#M7]BCX2_L_?!_X<Z]\!OVA=1\2>"_
MA_X<\.:F-+\/QKIUS>Z78Q6D\UA<SP8FMI6C,B/R/FVJ6QFOB?\ X/-X[>X_
M:3_8>@NXUGM)=#U"*Y@R!YL$GB*-9(R<\"2,LISV-?V$?L=?LQ?LV:M^R/\
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M]W#S?\'@?[-MPTLFF?LA_M+31Q @.?#LDB[O]LQ6951U^\%(]*K6_P#P=[?
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M^],E9B=@7< <NWW=@X*@?WO3\Z?@,NXMG;ZC'(&?6N1W7+OJ]?2W;\;/?3U
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M;5[V/;^QI\*[>)7)5=4L'6W;C)68JN_:%/WC@CC&#S7]H>TL \4TN%?# LS
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ML?,2!2C-RFU)I-RLDUKK*UFN9/1*WS7RT4+I-MW:5_6R_K_AC^6>[_X(A_\
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MJ^QY_#I[U_'G_P &9:'_ (=Y_&-T@17_ .%[ZD3<&3<6VZ7&57R?X"@W$/\
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M:TT;2_"_;?U,Y2O'5W;WW;O=7NWK]Y_:[_P;M3ZE>?MA_&"ZU2*>-[?]ASX
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M_AWT_7?_ (.:'6+_ ()4_$%YMJA/BU\)LLRDHV[6KH X'5<,%/7E3Z5\A_\
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MP]9)_ VB^-Y[_4;S3;V,;A-_:%^TLNU'&!&C[1V&"37VG_P<1FZG_P"":7B
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MOKQZ5H_\'<<>_P#X);7&#C;\4_#C?E<9/Y8_"O!_@Q\9_!7[7'_!PWHGQL^
M@UOQ?\,-#^$T.EZWXM739$TNQU%=(2)K>>=2\<3>:"JHS,1P"QQFOH#_ (.V
M8_,_X);7Q5'<)\3=!)V@G&;CJ2.B[N_I3BN2O34KJW)TZJ+_ !3T)6B;ZO\
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MGY5*!RV3Z8'?GBJ]G/M\EK;M>U[?/OJ"U5UJNYWV>W>FL5'WL8/K7G%Q\1O
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M?N(A[8Z>O7&>E<E5IU*K6SD[/R<D_P"O^ :4U:"]$_P7]?UI)1116184444
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M[G52N[& ??'3/:N/$X^K4GIRV5M'%WZ.[UUO^2*[6^7H?Q<_\0^O[=C2!O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_BI_X,OHT;]DGX]?NH49_B9*LMR+UC<&/[(G[LV&[:B _,)PN3C'O7]JJ*&
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MS#<>@!!V\?X<\X_.KL^S^[]0N2T5"-Z@+GS&/)/10/K],8'?FG!B7(YPISG
MP?\ 9I 245$2^#CDY&TC'//?T'O32[\C!#8^;'('^Z>YR0"/\*/E_6G^8$]%
M5@92Q!W!@0>GR%?8^N/UXI_[W.<<?W>.A[]?O#\NU'R8$U%0MYH "<D-\Q?
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M;RVO9]1F#,O^I_U<;%4X&X-@U_3.+.0. 6)3:%9AM^=?[I!.0<\YQ^.*FVD
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MMRBXJRIQ=E;=[MZ?A]V^HN5)6LET_+?\S^Q,*% "-QG;@]EQ]U>P/(/TJI=
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MO@;\!OV*O"5WXSL-%U[Q%87'B7QG?:5ILFD:5--'#<2SO<*H>ZCC29%R V[
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MP@T/X*_ 'P3IWA3PIIMJ1<3Q)'+K>L7LBI]KU'5]6,8O=0N;J8-.6N97*%V
MQDU;IPH)<LXR<K?"W:-E;=VU[>G>Q35TKW5_^!_D>A?L_P#P*^'_ .S5\(?
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M8(R*53C6M9^;:>2S="?I7ZJER(V/S*_.]&;:0IX,@=L*@[AF( QDGK7Y+_\
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M%>;433\W;==K=+G3%W6S\K[M=Q:***@84UR0 1Z_XTZB@!!Z^H'^?UK^5O\
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M-M0?Q64M%IVM?OZZO74PE]86T$[O1MQWT?R5]>VVI^W>H>)OVD;;P]+J,?\
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M?A#^T3X>_:LE_P""P7PY\9_&?0+>2VT+Q?X_T3Q+?7TT<B!'MO,O;B4>0A
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M JF>@]LU_H#CX?> E''@CP> /3PSHP^N,6?%/'@+P+@8\%^$P/3_ (1S1_\
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MG3;73_/_ (!Z)15?[H&S)W$*V#DJ<9S]>V*L51F%%%% !1110 4444 %%%%
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MM84"M=?L]?!*_.!@;KFZL'8_F>O>OZ#3^\E1I%.W&U2.S9SUK^?W]E&:*?\
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M 4444 %%%% !1110 4AZ?B/YBEI#T_$?S% "T444 (.@^@_E2T@Z#Z#^5+0
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M8O?KWKGK>+>*@TX955M97O3?=;:_??\ S1O#Z V$M:IQ;EB;_P"HJ.BTZ?\
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MB8KNV\/Z#!?$^8K74 A=XCD[8U\D!G4<>M:6G>'? T,[W4&EV0@3]W,MQ9@
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MLAGNRTC2%OXS&K$$D=1^5<5+Q4PM.$DLOS&?,[WE!-_9V=];_+KU/KY?L_\
MB.M2C+_6_(^:5F^?$2<DE9..BLEI==$]M-_QW^'OB#6/$FL7,NN6R?V?9::^
MZ-5$8EN!&V"=V-S;E!_6N,/BKQ?]JN+6/='8MJ;1*\B$FQMS*0JDXY&WD;>H
MK]J]5^#7PIN;.*;1/ MK96SE2\GF-&\H)QN4 #=T).<\4VP^"7POADNM/O\
MP1'J4^J0B:SNK-=\4$RJ-B,P4_O,\<_Q9/T<?%+"SU_LS'WWO[.*NM+==-U^
M/RYW^SZXFC2O_K=D#>UU7E:VFVBMH]=;6OZGXR3>+-3DM[33S<QPW$6K212W
M?D/M6U4C9*Q"XVMTP3[U4O\ 4O$,?B:..2^<:3)-! \UN&6 B1?]8R8)(/K^
M'%?KX?@C\)=+ADT&^\'275Y-<O<W<Z6X+6Z$DI"&"DAEXSSQGOVH/\&?AP9R
MTWA2TCR1<1QR-\PLX!ABJD<D@<\<'-5/Q+PDEI@ZR>]G#W[^ZK2UW?D<-3Z
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M3?%[Q9).T[B2022:SJ#(&8?PXR$'\(..PIW_  7Z1?\ A+OV"I-[ GXI_$!
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M2X+C8"$4J4W'V\K37N/XN1K[*5^3[5NNRL^Y479I::23:5_)/??_ (;L<_\
M\%%_^&)F_P""^?B2+]O'5CHOPQ?X!>!FT2[6QOKM9-1_L^W*P3&PCEFB1I?E
M:413&,$N(G("GZ$/A;_@W!E%UY7C.)$O('C64Z;XG)@#$MOC=M*0[^,C"_=(
M!Q7C?[?OQH_9X^"?_!?;Q-XD_:<^$'BGXP^"9/V?O \>B>'O"_A9?%5Q!J/]
MG6X>ZN+%D9C&L@\Q55XC(O"R(3N'TK=_\%*O^"3MQ9^?'^P!\;I;=7,-NB_
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M\G*JNVP48 ],KS[YK^4W_@]0@A?X6?LSW+?Z]+Z[C0=]K:C*6R.W!:OZLO\
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M[^YY(F?&O%]10C/B;/G&"48+^UL=:,5\*5J]_=ULVV]7J?);_L._LGS3F<_
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M^U"/4I_A1IJSIG<L5K$D;==H*[<$#WJ"\_X),?L57K!Y?A;80N%"[K:*&)B
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MLJ/)R1@^W:OU["XSW!Q]??-1O'GIG'ZC].E/^R<LW^H83_P1#_(3\7?$N_\
MR6W$-O\ L8UD]NC35GYKLMT?E+J__!'3]B+5['^SS\.ETZ)D$<\VE^3:W-T
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MK_EUB72>J7Q."7-Y-ZGX1:7_ ,&^/["^FWC7 C\?7D!8M'97>O&:WA)[1(5
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M!T C![)A]#W,P/4[L'TJ\_\ P6,^#9=4L/\ @GE\2;MV*HNSPI;HH#<#&=#
M4?3&1QVQ7]';>%?"P0*OA;PXRLQPHT73MG&/F;_1L9Y)Y%6%\+>&D!V>'?#\
M8QG*:/8 #'? @'3MS4?6J7,ER2;O>WMI66STLV]/Z>UNGDT2TZ7T6ME9?<OS
M[:'\X'_#W_X9&\,'_#N#XD"2&/S7E;PS9!0B\E@QT( ;5Y8MU[FOB+]D/]L+
MX;?MF_\ !P7\+?$OPU^$R_!^'X?_ +*'C;0O$.A7/V&'4-3U*>]NIA=7=M9Q
M6RI-: B%08$<(B[PSDLW]A]SX6T6>.XB71M#;[7!+;F;^QK -&LD;1DD^5EP
MH.0C9!Z8/2OS;_9]_P""1O[+_P"SE^U;XK_;*\%:;>W'QH\6V.I:;?:I<E8K
M6.RU5V>ZA@@B?9&I+<*JA<+ZFKEB*?)+W9*4H<NM2<]'RMV4K+=:/M?L[IP3
MM>VC3TC;;S1^"W[;G[1NG_LP_P#!P!K/B^^^!^M?M"3:_P# +P7I^F>#M#2.
MXNM/G33H$ENVADAN$&WB2(RPO$2 "CKE3]M3?\%AM/M@ G_!,3XI%C*Q-O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1112?ZK\T 5&V0-V> 22/4'M4E,;A3GG)XXZ=\?I2>\?5_EI_76X'\+W_!Z
M?;AOA/\ LW7(SA=2N5"_7490,>AVG'6OZHO^"74WG_\ !/']D5C&\;#X*^$$
M^8\G;9GD>@YP/<5_+W_P>DVF_P" G[/M[C_4Z^8@?3?J$A_P_P ]/Z>O^"5L
MDMQ_P3H_9#=U0,WP7\)$KGC!M&YSQ\_J/ZUV5K?47;65J=_).59+SULU8R27
M/&RM?F?X4W\MNGX'Z#9!13^1(.<#COS5/503I.I<<_V=>@?C;2<U94G;ALY.
M,$CKC@@]N.WKQ4.I#=IFH)W:PNA_WU;R"N&BO=A?=-:_))FI_,)_P;\1/%^T
MQ_P5K(!*C]INT&">2S0Z@<C\-WXU_4$,L%SD$LW!YYQTK^8C_@@4[P?M4_\
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M;=H8XR![=A[\=:N\]O7GZ?XT4 5HD=6RP&[UXR1T).._^/>K-'//IV_^O10
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M_@EA\7$:,R!)+>7.,[2B2?U/Z5UX'_?*#[>TUV^PWO\ (YL=_NC?_3_#:_\
M<Q2/*?\ @U!C1?\ @C_\.,9^?XD_$-VY/7[=9GCTY!%?TO0OO0,,X/3/H*_F
M;_X--IUE_P""0'P^RP_=?%#XDQ'/;9?VH _''%?TQVX(B (QR?U.:\ZAM/\
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MT_X(\J\/_!2?_@LK%&A,2?'C0OF XRUI*=H]3U/>OZ1XR2(R#D<AOJ!@Y_\
MK5KCOXT'W5._SY4[_+H94]%;=ZZO_MWR_7UZ,>6'G"/')PX(..G'([C@_P"3
M7\X6GW]MH?\ P<2>/([^XM;9O%7P!\"6FD17%G]NFO;BRTZW:X6TD&3I3Q@
MO,V!-VS7]';1@RDD_,5.UL_,@R. /3DGZ<U_-'XZ@N;7_@XN\(73DV]IJ/P7
MT.&)]- DGNY8-)@+1ZR'SY-LA&(6BPS #-:X;^)+;^%/I?:-^O73?IN7+IWY
ME^:^_P#0_I;1MQE(_A=AQ[$#\^IX[U'(=C0'!(,R*3GNQ &?4<]/:G1+M$XZ
M[I7SCH/F/Y=:8[$36\90LA?=G'W67[K9]B!Q_C7'#XI=?WO;_"5#^&G;5M_U
M?\#^;C]C33V\+?\ !=#]M#28[633[?Q-X8NO$>V=_MG]HR;RAN;249%C  3F
MV)RQ'2OZ1+=B[,F%^4 LH4#D]3GN<G!K^>G]G.#[!_P70^/\+LZ/J/PAOK](
ME&Y9$%TRB29F^96YP ORY K^AA4!.]&QCANP+'^(=^<FNZK_ !$M%^[AJUY=
MEU=^^E[&,.G^*?Z>O3^NI<3#=>2I(^G&,>_>OY?OV%;AI/\ @X*_X*91QPYB
M_P"$%^'0<JP!'[J/+E0.BX)/T]*_I_7$;*F[+-DD=^%Z^O6OYC/V(;,6W_!P
MK_P4NV_NP?AY\.I%(ZR>9;H2''0Y!.#]/2EA)I+&6ZQTM_AC;TU:+FKK7OKU
M_ D_;(_X.3_V;/V6_P!HCQE^SK/X UKQS<?#/Q!!H7Q5U^VUF/2K?PI'-<16
M[W M)6#W_E22KE(N6Q[\_IO^V]XY\/\ Q3_X)??';XA^&)9+[PSXV_9R\0>*
M=!=HF#+IVL>%)+VU\U3DML60#/3Y<]Z_A&_X*:?$W]GGX=_M?_\ !0*W_:/_
M &79M3\6>.?C"NA_"WXF:5$SZ%<:BEW!<16^M2QDE71$,TBL ,*>K<'^W#XH
MIKD?_!%KQ7%J^FZ;I%W_ ,,=.+33]'/F65M8-X!CDLU4G('^C%"^.A/(!S79
M6@H1P=E\7O25];M)W:3TT72R=ET1QT6^:2UT5M?)J^ME?IWWM:YYG_P;HR[_
M /@E'^SMF0.PT_4UW!@^#_:UYA>/NXQ@+_":_=+G'H>.:_"#_@W(5&_X)3?
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M2OZ<XN$'N2?UKSJ.G/YRD_E=G9/>W6]_DXK\R2BBBMR HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ II YW<\D_2G5#(44,6RJXZG[NX^GO22]^ZTOIIW;
MU8'\@'_!Y+]E'_!/;P-N4?:V^+?ACR6[K$+J'>,_YZGWK]VO^"/;?\:T/V.S
MCI\&?"W_ *2CV]Z_#3_@\@M(7_X)Q>"+MU8W$'Q?\+1(P!*['N[?=D^O\]WT
MK]Q/^"/$@;_@F9^Q\PSA?@WX84_46R]/4<]:VK:TN5.\N2"2[VE4U[=NO43T
MUZI/]/\ @'Z8E@!GM_\ 6S3<C<#CEAS^F/Y4X?='T_I2#.,G SCZ8SQ^//\
M*L5LEU5OZ_K<+^>^UNVGW]#^:K_@DO%<:7_P56_X+,Z=O86T7QNT*1XLX!8V
M$K A>Y&?3TK^DN)BZ^8 44KN4#C!8C.0/8BOYM_^"6K3#_@L+_P6:B++Y?\
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MW_@I,6\P,_PM^%7EA<88M9Q;]W^R!DGV]*RPF^)[--I]_@_RM\RZGE;XM/\
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M<]OEU]!Q]<?GFO\ 1,Q@<#_/O3JWN_\ "K?^ _YAM_7R%HHHK-;+T0!1113
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M(!]:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,#.>](54G) )]:=10
M  8Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBD.>V/QS0 M%&:* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J%E),F[# K]PX/3HW\_QJ:HG4 ,PSNQU]O3Z4UNO5 ?R;?\
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MM-=;W[==]=^G^4M% Z"BI&%-;^'_ 'A3J8^<<>N?YT M=.X*>6^O]37XP?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M<^G>H979"-HR#U]N>M344 (.F<=>?SI:** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ J-QA']\G\ZDJ.0_*X_V1_,_X4)VU[:@?RJ_\'@\ ?\
MX),-<'K!\>OA<@^DVH7 /_HL5^L7_!&!YIO^"8_[)!8."OPKT!$)!&42V105
MR!D9R,C(Z\U^4G_!X&3_ ,.D+H=C\??A/G\-1O<?UK\IO^"=O[&/_!?[XD_L
M8?"?5?V?_P!KOP+\./@SK7AC3YO VE:Q<3)K&E:5Y6ZVCC"D*J[652,8Z=^G
M11BJRE[\::BH_%L[S<DMTNJZF%9M.#2;^--)V;NEMO\ E8_OW"R@D@DG(Z\<
M<=\X_#O3S&6*%F.4;=P !WX/.?3UK^+)_P#@F?\ \'-\T<GF_P#!1+P'$9)D
M$>R_GW",<98@XY&"1U'TXJU9?\$P/^#F(3Q)/_P4D\$11F0-)/\ :[MY(E#9
M4J$RS*".@!...3Q6RPD-_K="/_;R7K]J^FSL3&K**_A5'L[+5]/[JW7?KY79
M]^?\$PK"]M?^"Q?_  6-FEB/D77Q2\.7$;;C(%C.G$*QXQ&&++A>.6Q7](21
MS(C+U/ '3GMSZ9K_ #A_V8/^">'_  69\2?MP?MB>&/@Q^WIX4\-_'KPCXBL
MK;X_>)TN[H0^(->EMF>QE &7<^3D="5R2PX./TIC_P""4/\ P<G7 ?[1_P %
M-/#<1#,51;Z[;<1T.5R /Y=Z*V#BDKXFCK%67-9M7T>KO;Y/9ZB>)=[*C5ET
MT76R;6V^I_:@8Y/E R#U)R N.,K@'KUY_I7\U?[>$5S;?\%Y_P#@EM<I;S""
M^L?B)%).(VA4^5H94;Y0 +J/<I"*20A&!C!KX!7_ ()*_P#!R5<N))_^"H?A
MZV*_(8EO+]MZ@\'*(0&Z<$CH.]?E[^TM_P $\?\ @LCX?_X*&?L@?#'XL_M]
MZ/K_ .T!X\_MYO@C\0([NXQX6.G6OF:HZJP%PC30KAEQE\?*.>:PN%C+FMB*
M5U"2:<E=)_:WU2OK9!]9=TG1JQOI=Q>^ZCMN]^UM3_2/,4\;3-&%R\A9>G1C
MGGZ=\]:7R[A\K(01E3D'!&""1GOCGCC-?Q37O_!''_@XMO[F:1O^"J-A"#+D
M,EYJ'S+SSA5)7/H0#[553_@C=_P<6VUYY_\ P]1L)8U50'>^OU(.1G <*1VQ
MFHCA(<ZE];H;JWO+3;I??374MUFU_"J*^FJMY=G_ $F?KOJJ73_\'%G@]H[:
M06<'[!VNO-*(C&JS2:_)&I8@;9 VY5!R=K,!U S^],<%PDSR2L)5VXCP3D<=
M-N/SX[\5_G+WW_!-/_@M;;?\%,]'^#+_ /!0VU3]I[4?V>M2\8Z;\3Y[RY96
M^&<&H/8WGAY2NZ;:UX&4IMX/S<*"U??\O_!%C_@XBG>$M_P5:MA&ZKYX2\U+
M*-_<^[A@A)"[3C]*UKX:"@O]JH_PX)133<DMFFWHM;W2L[/<S5:S7[FI.S=U
M&,GRNRT>FZT6^E[M)']MX^T 1C:.74L<_= (R3[XXZ&OYJ_V4E$/_!Q?_P %
M#Q-#('N?@C\'FMV ;#(FD6S,YX^[CD]@.?6OSPA_X(K?\'"T+Q_\;7$=$D"Y
M%YJ?R)W897/![=?:OS$^%_\ P3(_X*[>)?\ @I[^T9\&?"O_  4%M=)_:6\&
M> _"6O?$/XMB[NO.\1^']9M([C1K*0+_ *0YMH75?+V%X_XE!4XPAAN9-K$4
MERJ[U;M%6U;7]?<S=5XO65&:;T2MRZZ6WZ^EMGKL?Z2*+>*\BO$LBLY1F.06
M4Y_>#(/';WZ5\M_MS6C2_L6?M5VZ@>4_P&^*#*')&&C\):G(?HHV?+SU%?RA
M'_@B1_P<"D(TO_!5XB5I2'=+[45B6(M]TJ0&8=]JY/XUYW\=_P#@C%_P7$\-
M? [XS>(_B!_P5,;Q#X*T/X:^+=<\0^'VOM00:WH6CZ'=W^L:0S2A(BFH6EO)
M JLX+LZQC+NJFEAGS6^LT9*3BDD[KFNK;;W>FG=W[BCB(6?[FI&UF[QW6E^]
MM-->UC]S/^#;TY_X)3? T,V)%?6F8RG"$C7+[ 4G'#!2!CZ5^\KW,,:*7GMX
M2W4M(JCG&,9^OM]2*_SB_P#@EI_P2E_X*R_M(_L>>!/B3^SU_P %!;_X,?";
M4I=1L] \$1WMX@LY+/4)X;FXB2WR(XY9@\J^9M+F0E-Q#$?I'%_P0<_X+77"
M@:I_P5:UV;Y<9AO]44*?5L@9'LO/XUG*@H2M*I%NZ3\MGK?IK_5["5=2:M3F
MD^MM.E_6S3_K;^SR^UK2K*.2[N-7TV.*V3?*]S>PP0PIWDDEW;5 '/S$8KY-
M_:@^*7PIN?V:OV@=,?XJ?#Y9KSX/_$6".-_%FC&=Y9O#&I(J"#[5YS,9"L,:
M1QMEW7=MZC^43Q-_P0C_ ."I!NM,\&^,?^"M.IVU]XI=K2TT.\\17%O?:Z<$
ME+6V>YCN)8VY7;'&23QR:\*^)O\ P:[_ +9^@>!/B-\0/&G[<>J:];^%_!7B
M;Q!<Z1%J^M@:Q%HVE76I363A[A8<7L=N\+(^-[.JA23BM(4H)ZU$K\K6JM-W
M322MKUV6EU?74I5'S<O+)[7:VU5U_3^5SRO_ (,T%2#]KO\ ;.MHY4FBC\+;
M8Y8R&CF1/$\JK(A'!5E4,"."&&*_T5!E50>X!_6O\Z;_ (,Q-/;2?VK?VP]+
MG0I<Z9X-M[&17SO5K7Q!]G;=GG):(D^IS7^BT"=JXYSC)Z]>M<U=7GZ6:MMI
MT_3^K&@ZBBBLP"BBB@ HHHH **** "BBB@ HHHH **** "D/3\1_,4M(>GXC
M^8H 6BBB@!!T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@#\^O^"I_C#X
M8^!/V!_VD?$_Q@T:[\0> +#P)<QZQH]EJDFC7-]+>W-O9Z;!'J43));;M1GM
MMS*P++E/XL5_*'_P2T_9O_X*,_!75?@C\7_C7^TQ\.OV</V<?'7BJUN_@?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA[5DF,'V75;:ZM[^T9Y05V0M+;*DS$A1&QW$"OX:_A5_P2&^*_PG_;@_9?\
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MC5\0I0">@FU6Y8\?50?PK^KV(Y7/N:PBE[2I:]U+E_7]5Z6LM"YJRB]-4O\
MTB&_SN24445H9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK#X8?%R2&\TOQ6ND3W+ZCJ<5LT>XZ9YR>3 Y+ ;9SY>Y=SOM(;];F_X.C_\
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MUX"E=S7:5O+9>2_+H>A:T(>FOK97_P APZ#Z"EHHJELA!36_A_WA3J:W\/\
MO"@!%ZM]?\:_/'_@K*PB_P"":G[:\C<J/V?_ !PWIR+'D?AQS7Z'9P7/L/Y5
M^<__  5L?'_!,S]MMSC_ )-_\;J002 #9J,X'.,-D_3-:4M*]'=^]#?_ !0#
M7V<WTN_S?_ /Q!_X,[K9E_X)DZQ<%P5E^,'CE4C!.5*ZI=Y./?'XU_6I#_JU
M/KDX].:_DW_X,]X8HO\ @E[=S"YA9IOC'X^$D* ^;#MU2\P6QG[W8^W3K7]9
M,)!C7&2,<$]>IKGC\=9]ZG_MJ-)[0_PK_P!)B24445H9A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-R=P'8C_&@
M!U,;HW=L$],<>F:?41)RY]%;'X5$_L^O^77H!_+[_P ';MA!=_\ !([Q2)8M
MP@^+OP[U"/GB*:#4)I(R,=>1^6<U]1?\&XFM2:[_ ,$KO@5*RK%]DAN+)=H'
MS"!(0&;'=L\Y[#WKYT_X.Q%:;_@D9XY)&?*^)/@AL^R75T0?Y#]:]:_X-CKY
M+S_@E%\'Y!G$>JZQ#_W[-MTKNE_ =[WT7_E25K_+YW]7?.=N>G?^\_*R7Y]O
MGN?T&KYFU3]SGD#O@G\N_M2%%.X8^5A]T= ?7W]?_P!53L,@ #WQQT_EWI%3
MN1^%<,-GZO\ )?<: J8  8X ( (_#/KG^E)Y0)!+'C/<]_QJ6BCD7=_U_3_K
M<(A'C'.2.A*C/TS3?)Y+%OFR2I   ![8Z'BIZ*.3S?\ 5O\ +\NVH53%E2#T
M8Y8XY/;'M^'IZXJ-P5V[0/E&$_'KD^_].*M@[@0>O]/6H'X)!['C()!&,_3-
M#5JL=7K963\UMT_X.XI7TMIKKI?YZG\HW[:-S:^'_P#@Y2_8EN9(T*Z]^SAJ
M5I(&F*,9DUNYAC=%[E415P,YQS7]7;*?-+':5&,#'S9QSSUQS7\E?_!0!X(/
M^#DW_@GTUS);!9?@%JHA2527>7_A(KY1#&>@D<C*GMD=*_K3W*6DP?F5\$=P
M,<?R./:NBI#W8.[]Z*;?;X;>6[OI^9,9/G<9+2ZM;:VM_._ZCUZG'R_KZ>M/
MV*V"><9Y' Z^WO2*F1DY_P#K4\# Q7/R_P!Y_?Z?U]W;71VZ)_U_7<C:/>1E
MOE'\(&/\\<9I#"" H8J!VP#D=P2>QJ:BCDOU;_I?I^G;56M\R+R@&W#CC&,9
M'U'H?IZT[9DL2<AAC;C@>]/HHY/-_P!6_K[NVH1;-H4;C@# 'IZ$=R<D5YI\
M38C_ ,*Z^(QRR3-X-\0JTRKYF =-N2-L'(8@ G'?I[5Z:^T@!CC)X/<'V/UQ
MUKA_B!;)/X#\;1L962Z\+ZU#)Y;@28;3[B,^6Q/RL58X)[\U='F55QNVO<^>
ML5M^7EIKT::ZJ_\ 6I_!-_P:YO)%_P %;?\ @HG;J6EC_L[4RTSH(F+#Q3J/
M6,8"$E0",8Q7^@FI) )&#W'H:_S^O^#96)=/_P""R'_!2#3(1)Y,%EJRKYS;
MY3M\3ZD!YC#AF^7)(]3[5_H!)N(4G'<D#/?/45OB%[][6W^?O2U_#].FB)**
M**P **** "BBB@ HHHH **** "BBB@ HHHH *0]/Q'\Q2TAZ?B/YB@!:***
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOB:\_P"";/[44/@YYHO$H\$1RZ1)#'YICNHM4L75Y4/!MT +3Y^7R@V>,U^
M_P#P3M\;?MY1?#G]FK4?%_B#]@O6/A_=:YX?TW5M0FU'PG;^/)8T,,2VUK%'
M;?;$\1HJ[$A0B5I]W.:_HC_X*Q:;XDUC_@GQ^TUIOA.3R];NO -PEO\ OEMV
MDA6\M9+N".9_E26>V66*,GJS 5_G3?\ !)Z;X<>!_P#@HAX)U?X\?"/XNW?P
MFN_'>@:1\,O#\WB*6'PSX9^(5Q*D4>O:W%)(EO(&U%?M5O$QW21M\BL,5[F7
M3DL-5BMDV]KW5M5TMK;76WD<5>A3J5%.4DI62LWV?;7\;?JO]5,2B5D8*RX*
MAE(Q\VP?=./F7K@^F*U$ZG/H:SV<F9$)1FX*!1P4*@@CUP"!FM%5X)[D$8],
MUXCU<G_>_!1C8[DE&$4G?KIKV\_ZV)![=**0< #T%+4K9>B$%%%%,!F,,ON6
M)_*OSP_X*O1^=_P3<_;5ARH9O@'XU(R<=++<.??!%?HE7YW?\%6B4_X)Q?MI
M.%R?^%!^,QC!YQ9$'\LG_'%717[ZDMO?7_I468U6THO_ !:VV]R7]=ON/PT_
MX,[YX3_P3,UJ%)$-S%\7_&SR1EN1&VI714E>PP<CUK^MI""BD8QCMT_I7\@G
M_!G)Y;?\$]?&+AE++\3/$ZO$,Y&-1G&[O]X>W)/%?U]1@*BJO0#C'3_.:PC\
M=;_KY_[:CLKN\H6V5*FK]?AB/HHHK0Q"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ****3_ %7YH IC@8R?X03^E/J*
M;[C^Z@#W.3Q^-/JN_1]OGT _ /\ X.3+..^_X)0_&KS"1Y,UA,.V=GVC@@?A
MVKP[_@TTE9_^"2O@L,#NB^(OC$)G^Z+B#81Z\ FOH?\ X.-[-[K_ ()6?&U%
MP/+BMW<%@O19ST/7IT]Z^6?^#1?6/[4_X)+Z*6'.F?%[X@Z9CU6RO88U/OGD
M5V2:=%+=IO2VO\2"UZ6=[J_<SJ;P[KF_]);OZK]-S^HOG#$]R"/Q&?;WIT??
M\/ZTF"54=QU'UZ4*0,YX_P FN&/7_$_T-%TZ[+;]/T):***:V7HOR ****8#
M">6'HI_.HBP5&+#/' []ZD(.6./X?\/QJNV64Y&/3OZC^M3'^)]WZ$3OH[=^
MFG0_CA_X*ZWLFF_\'$7_  2CN%5MMSX:DL2RY&?,\0WAQGN!GIS7]CSR;))C
MM.5"_,.VY1S^ 'Z5_'-_P6):,?\ !P-_P25WD!Q:KL&.6_XG]WQ],\=>/QK^
MQ>[9=DYP7>.%Y/*5MK2!5R%S_MGY<]!WK:I=J"6_+%:=-O\ @_\ #BNTIM=]
M/5-_TQK7$87<+B-<'+R[AM"C.XN3A5V]SG P>M>9^-OBK\./A_HH\3^.?'OA
M?PKX4\XPIKVJZK;VNFF\5L?9WNG;RP^\$,N0<C&,FOY:/V[O^#B_P5X:TG]K
MG]E_P9\!?B3:?$_P79ZY\/M&\8:-JEL]M%XCGB>.WU&V2"!KLF(KYBK%+N!Q
MD,N0?S3OM;^+'B[_ (-R?AI-\9O"?Q+^-7Q.\:?$SX@3:7KEGXP2TU+PQ=7=
M\YTAO$,DTBRW:(Y)@LL^:FX)M)%=]'+N:*E5<J<IRY5=+563YUVM?6]G9/1Z
MVR==WT<>C?2WD[_GIN?W->#?VD_@'\1]9A\/^"_C+X \1>(+FV:=M"T+7[*^
MO9H1D^=# LGG.@5<Y537!^*?VY/V/O _C)_A_P"+/VFOA!X<\8Q7<>G-X8U;
MQ;IUIKD5],_E1VDEE)()$GDD^2-& 9FX -?P"?\ !LQ<77P^_;H@\)_$#X+_
M !<\8_&N\T.ZTZ?Q+J'BX3^%_ &ESF<QZGJ>BRR>88X8Y$1E,:D@;NAKY>_X
M+;_L&?M4_"[_ (*87O[0OQ,U+X;V?AGXC_&SP>OP^\7:5J=A-ITES'XABDTN
M75?#T$WVZUCLYDB;41/&HE0,I')%5]349RIQES-6=DX72;LVKI\W*O>V6C2;
MZJ?:\UF[;;ZN[LK+1V7-TUUW/]"C]IK_ (*B?L;_ +&_Q1^%/PC^._Q1L?#/
MB7XVS6TW@_R9HYK$:/>;?LWB#6)W.+'2I0X*W?*;>@/6ON'X;_%?X<_%[PQ8
M>,?A7XST/XB>#]1DEBL_%?A;4(M4TB>6W;9-%#>6S-%(\+<2!2=I(W'J!_ 3
M_P '$7P]OM;^(7['=QX]^$4?QJ^)6@?LSZ-)X\^(W@/4;?2=!U?P^MHI@TSP
MGH32+=_;(P(I(I+>-R5<;21C/]&W_!LEIZ:1_P $D/@_9Q>'==\*6\7CCXC/
M!I/B2"Y@UB"VFUA'@^TI=(DQ)1UVMM"D9"X XYJU)Q2;5D]FTTG=1VTM?_#I
M*^V]MJ<EM=?>M_)?\/ZG]!@(^49,NXX+C@*.?3T-5-C3.\+XW!2N_:&5XGZJ
MRGY6SW#9SSP:M+E1A<$X&5' ;U !Z'KDXZ5% ABF;YMXER0/^>9 R0?7T%<J
M;C+3L_NM=7^7W[&I_")_P0>T]=(_X.&O^"IFF(T;I9WGBR$-"H6)@FOW_**N
M%"\\ #%?WCXR![,3^IK^#_\ X(5PBR_X.)_^"J-F7+F.^\7QAVR2Y3Q!>9.?
MQ_*O[OD).X]1N./^^C_]:KJ;W_Q=/^GD@)****R **** "BBB@ HHHH ****
M "BBB@ HHHH *0]/Q'\Q2TAZ?B/YB@!:*** $'0?0?RI:0=!]!_*EH ****
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M9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ5I[R!6TFX\H-Y\2,V23][)K\X/^"TWB?Q)<?\%B_&?C#6? 7Q"B\!Z1\6_
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M S0 T<MG&,=<]3D<<4^BB@ HHHH **** "BBB@ HHHH **** "BBBB_Z?CH
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M\_CWK^YD * /08SW-<[5J]9=JDU]S1Z<G=0?>$/_ $E"T4451 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQJI=D%NYV$,,!&R=S#D#!SUK\E?^#-[4HY?^";OCK2U_U]M\9O%%R!Z"62X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBD) Z\4 +12 @]*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J)\,C;MRC('N<'C\
M\^O:I:KN0-N?G?)VXSMZ<;L<<>] 'YO_ /!7.T&H_P#!-C]K]%61_(^#OBN9
M0GWOW5EU?_9&>>W(K^<?_@S&%S_PRK\9\21O;/XSOP8>?,#BZ( 4=/F."?\
M9-?TL?\ !4F$M_P3F_;*RXC,GP+\;R-GH0FGEBJ^YQ@8')P*_F;_ .#,#4H7
M_9D^.6E[R;B'Q;<W 01_<22\ #;^Y)SQ]!73?W));I37XT7^C^: ^XO^"O'Q
M@;X#?\%/O^"=_CSQ1\1-6^'OPP.AZM8>+K^1[Q?"K.^L3JBZN+<-"6\L?+YH
MSC&.*^F? W_!;C]F_P 0_P#!1/XV_L]:S\:_AE9_ +P1\%/ OC+P-\0D;41'
MK_CK69;3_A(M"6^^Q!9#I<,L[[ AP\>S'1Z\>_X+6_M8? GX*_M!_LE_!_\
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MOB.^EM+R/6-5\,"RF"O^X5?M"&?:QPK\=<\U^NW[-/[1'BV?_@W_ /VM-?\
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MWX(YK_0:4!54#H !Z]*FRYIM?S2OZOE_*QO.ZY.WLXV^Y6\^XZBBBF0%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M._"NT5V3D][=.NE^563;6J=M'I;.3;;7DK_>MEWU/](#X/ZAX5U7X9_#O4O
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M>GV=[>NG_ 'T4459F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(3V'7KC\:6DP=V>V,?K0!\/?\ !2>,3_\
M!/S]L-,[=W[/?Q-);T*>&[YOKP5K^3G_ (,LY8U^$O[1:N$R-2B(.TEB!>Q,
MV3W^7/'I[FOZR_\ @I(2G[ /[8I89 _9X^*&!_W*^H=Q[U_)3_P982R-\-/V
MCX"08EN[>0@J."VH1+P?S)'OZ5I'X7[W);F=^CUAIZO]$3+I_B1^]'_!4C]I
MCP)X1^,W[)O[)_Q9^!?A3XS_  [_ &D_%UA:ZDGC73UU+3-$U$7K6MM):0[&
M*7R_>A?  /7IFO7M1_9$_P""3%E\9+3]G:]_9\^"7_"U[W1K+4X/!_\ 8EV=
M3?198TEM[PJD_EI;[&!R65<=,=*XK_@JG_P36^(7[<FK_ [XE_!'XRR_!OXN
M_ ;Q+:^(O"NMMIZ:E:R-:77VE6E@F!C#I(2J@D%L5\$C_@DS_P %1'_:3?\
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M5AB>.6(SAR%(.XYKVLK?+&L[-^[TMK:]EKWV5]M=4K&,U>:W;73HM/O\]/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML^NA"O";=^:[2UT6RU^?5]EK;K^\&A?#?X=^%=>UC7_#O@'PWHOB/Q?=K?\
MBC6-,TJSM=0UBZ0$+=ZG=)")+F7:3S(Q8 UZ"D8!(3*JA(7(^8=C@_W>. *R
MY=5T^&Y\BZU33875UB6V>[A2[EN&Y6,1&0.7/9%4D] ,9KY/_;=_;;^%/[ G
MP1U;]H+XTV'BO4/ NC74%IJ \(Z2=7O;&2<A8C);JZ$"1L*#GJ,8[UA4<^:C
M%<TM[MR;Z>>FO9/2R-5WLM5ZZ/[[?Y_,^"/^#@C2?"+?\$Z_B/XU\074-CXJ
M^&,T?C;X6ZO]J@L]1T[QUIZ%=-N-(FG9?].$3RB,(&D.,*IKRS_@V+\2^$?&
M/_!+?P%XGT+4[[5O$FO>-?%^I?$*\U683ZM/XOGN(#J<MXY.YV>X,Q63:%?D
MKD=/DO\ X+S?&[PY^W!_P1[\&_'#X.>#]3UCP+XC\?Z#XB_XJYKGPW/HFDVZ
M;I-4OXH)>5C\Y08)2T3EB&4XS7O?_!K@][?_ /!.73=4?X:Z?\/[&;QCKEI8
M7]A</(GBI;:5 ^JK$3Y:QOPZRQK^]$F2377.#6 FW9/G?NVU?O*W6W>_?1^;
MR@_?E'^7E3?R73RU.+_X.;))(/"?_!/*=!S%^VCX(8'OGS+/IW_^OBOZ6O!#
MF;P9X2G;AY/#>C9'UL("?U/2OYI_^#GE1:?#+]@?6@Q:73_VTO @CM_^>OF2
M69.!WQCG\/4U_2A\/I6N? G@BX*^69O"NA2M"?X&DTRV8GUZL<^E85=,%AVE
MS-SE9;+2RVUL[Z[=+(%+WY*VL4E;NG;R\]3L64@?4?KZ?_7KP']I/X+_  5_
M: ^#_B;X7?M#Z)H'B'X4^(A"VN:=XCD@@TP26CF6TNII[EXX8I+:4>9$[N-K
M#O7T+G_&OQ9_X.!?C;'\ _\ @E9^TAX\?0CXCDFL-)\+V]FE_<Z8]K=^);MM
M-M]1BO;-EN(I+&1UG4HP)YS6-+^/!M[O5Z:;*ZT:[=.AJ?RW?\%*O^">G['_
M /P2:_:1_8S_ &P_V,/C ++6?&/[2/AWPQXD^'^@^,=(UB.T\/7LT$<T]K9:
M;>7,L.GDSE&!11N1><KD_?G_  4R_P"#D?XR_L#_ +;I_9UN?AII=U\*I?!?
MPY\4Z7XRO+$M<W5GXET];O5I3,P_TH0H"O[DOY3NOF%21G\2_P#@WO\ @?\
M\$V_VHH]!U?]LOXFP6GQZ\!_%BW?X>^%_'OCG5+I/%\3.][8C3K#4I)XFFCD
M*PJT8#$Q_,=W-?87_!X!X7\-Q^+OV?4MOA=X8T>RL=(%G%\35N1'KESX<LE
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M.HH'Y^]%0 4444 %%%% !1110 4444 %%%% !1110 4AZ?B/YBEI#T_$?S%
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M_83+_P!)C_7Y&DG^[HZ;TU^$G_F/HHHI&04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %(2!UXI::S!>O^?K0 ZBD#!NE+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]C/]ESXG:II6D^'-2\>?![PGXAO=#T:V2TTG3)[S3H"UEIML@"6]I$!MCB0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ II4-U'_U_K3J* &JN
MTY'3IC'2G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK_IY+]"Y/W8^7^2^?7^M"U12 YS[$BEJ2 HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML2^M?A+I6F^+-=F_M54MM0D@\&V[W>KJ@;:@DGC3R[<'&^1E7&2%KY7\#_\
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M\/!O[!'PH\*_$CQ%X-\3>/M7\>^.](^&G@OP3X1@%SKNO^*=;9DL(+.!@WF
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MCMU]J6@ HHS10 449I 0>AS2OZ_<_P#(!:*,T9QUHOZ_<_U0!1113 **,T4
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M#L9[8+$%^Q2'HX&#BOZ3]._X*(?L.:G<"VL?VI?A+=2G $2^)HE+ XV[&=5
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ME-*H_P",Q?A>@+&,%M5(R4^BGK[U3_X?L?\ !*(M(J_M@_#-O*!+$:HV.#C
MXY/M^M#HU5IR2^X?MJ"^*I9NS5NS=ET;W/U\#J>_^?PS2[E]?Y_X5^1P_P""
MYW_!*8(''[8GPP^95<K_ &L2P!Z C'!Z]:S[C_@O#_P2CMQD_M??#>09_P"6
M>IY_GCG_ #FE[&I_)+[A>WP__/W\&WT[>O\ 6E_V +*>I_G2%T4=3C/O_6OQ
M];_@O-_P2FCMQ<#]KCX<NA/3^T 6Z9QU/;DUG'_@OM_P2C;)/[6GP\10<9:^
M Y/^?K5>PK?\^Y?AU^9/MZ723?:T9:[>5NJZG[)^8G'S=?J,?7%.W+Z^_?\
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M0_\ !*@+O'[2/A4#.W)NP.OYXSS_ ).*4?\ !P]_P2J:9XE_:1\* A"_F&]
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M@G?/9VH4D'& 0W7K^55&E4DKJ#:7R[=_5"^L4W\,T_\ MV?Z+S1_4<"#T/\
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MB*Y18+9H%@5LGRR$+L^,\$D>PP,+V<^B3_[>7EY^=O4CVGDWV]R7EY/77O\
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MACUP=V/Z_A4"?\'GWP,)D<_LY^/=A_U<GEY!';)7.?Q--4I/M_X$NZW>N]]
M<9=NOE_F?V_@Y.<=NN<_AQ3-V 2S*<D# QWXP2._-?PRS_\ !Z#\)UE86_[.
M_BTQDG;N3!'H""03CC_Z]<MJG_!Y]H#H!HO[-NL[E<DO=I<,"O4'$>0"?H/6
MJ]C+R]%)7Z:[/O\ B3:5OA:?I==.S/[Q3@C# *,?WAD?U'UI1QQCY0!\V?\
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M?3VI<DOY7_P^WWDVETC)_+_-_(_TE<'N<CH1MZ_E0%QC!P ,8K_-;_XC(/\
M@H2SE%_9>^%K-@G8NF^*6?MR1]E/ Y_2J_\ Q&)?\%('CE9/V8?A8#N^0_V1
MXG(5?0_Z%R<>H/\ O4<DO3U^7^8*,GM%]]C_ $JP!D@9 !Y'/)//Z?C3B >"
M.*_S4I/^#P[_ (*2RF!+;]F/X5QL5S*9-'\3'?C&2F;+ Y^GY4ZY_P"#P_\
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M6T49_B"'3^H/T]N*IS?\':'_  5:,\"']GKP*C1,?-5/#VND39[9_L\J,?\
M AU'2GR>?X/^OZV'R3_EE]S/],3;N^9E(/\ =W<''3IQS3@!C[O/IU_6O\T3
M_B+(_P""L%PSK:?LZ^"",\%O#NMG;D9Q_P @X#]?IBH!_P '6_\ P5KDEVM^
MSMX-9LCA/#FN+C/N+ K[\8_K2<6NC?HA\D_Y9?<_\C_3#]L<8_\ K8I-B^G\
M_P#&O\TH?\'5?_!6WS,K^S5X28XYQH&N$>I.1IQ'YGGI4L/_  =0_P#!7NX=
MI;;]FGPI(HR"J>'=:?;V[6&1COQ^-+EEV?;87)/^67_@+/\ 2O8'&$X)/6E
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M9/B;"5*;1:Z)+&\C'& 5^;=GN"5YZGFFL*F_B7_@N7_ UZVOV[ARU/Y'^/\
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M.N=UP#FO\WMO^"8G_!RSJ[L;_P#:)^)VY^KW'B @G(YR5ME]LU%!_P $>O\
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MX! /8>,/#H_'/]H_2O\ .4;_ (-M/^"X\Q!?]H_1UPF,CQIJB_AP>_KFAO\
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MS0!-10#GFB@ I#T_$?S%+2'I^(_F* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH
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M'UFK_+2_\ C^7+_PQ_"(O_!E#X'25G7]KW4=F,!6\(1, .,D@\9]\]:L6_\
MP91?#I#*;C]KC5)2^-N/"$0"9Z]9!CV^OX5_=EA&!!S]3_@*7:GKZ?Y_ST]J
M3KU';;3;1;_\'_A[D_6:O\E+H_@CO_X#OW];W/X3V_X,HOAP<X_:TU0<<?\
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M%?VBE,@@A<$'UI/+& "JD+]WKU]ZKZW5[T__  73\O[O]7!5=O=7_@*72/\
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MDCC\<=,\]J/K>(_FI?\ @N'EY>?Y=Q^TG:WLX/O[B\O[O2WS['\K1_X-&/\
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M:>,B2<C?XNO'8#KC+#GH>O\ ]>KK?\&JW_!(XV_D-\+/%88+Q*/%=T'7WW!
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M!77W6XD>3GQ/<?+OY_YY'!_Q_/1A_P"#8S_@DG!Q'\$]9(\@P@R>)9V(/)W
MF(<].,=.]?T*D(>IX   QTX]._X=.:0QQ'!;!(;(^H_SUZ=*7UB;W;^22Z^G
MZ^7F)XFJ_L0_\!I]_P#KW?TWL?SX'_@V1_X)'^8\G_"C]8+E%CPOB:8+D#&<
M>3CD^O3GG%3:A_P;)_\ !(G4+(6$OP%U9#$RMYZ>)KD2''//[@ Y]2>^:_H)
M$<0Z8Y.3]1W^OUZTNU.?FZCGW_S_ '>M+ZQ.WQ.ZV^&W3?371/[R?K$_^?</
ME&FNW]S;?1WU]-?Y\9O^#8S_ ()'S6T%LGP/UB&.';@+XGN,OLZ;OW SSS_G
M-=!%_P &UG_!)&*"&W_X9^OW\E0!(_B6<L<8 R?(QVZ?K7[UF*,DG=[?3Z8Q
M^-*$7;M+9'3D=?\ ZW^<T>WG_,]NRW\[6O\ ?O<AUZK?P0MZ07;M%>?J?@J?
M^#:__@DJ8'A/P"O C$-D>(IL@KZ'[.>G;I@U=T__ (-O/^"35A()8/@#=.S*
M%^?Q#,PQ_P!^.O\ GM7[NB./H",'M_CZ?D* D8  . .<#_/7V.33]O.WQR^Y
M>7^5^F[UZB]M6ZPA\E'R_N^7EN?A7<_\&Y'_  2:N9O-D_9\GRF,A=?F"]_^
MG;/UJ4?\&Y__  2<*)Y?[/DR!6!W#7Y^H_O V_KWYK]S^WW1S['M_GFDV@+M
MV#'4C!Y'O[5/MIZ>]+3^]Z>77KO^"'[2M_,NGW?=K\_Q/Q 7_@W@_P""4$4B
M2_\ #.ZS.HP"VLRR9X[_ .C?U]JTX?\ @WV_X)5QX$?[.ULH.25.INI ]R;<
M'''J:_:Q5"Y"H%]@#QG_ !_SUI<9_A!XV]#^N._K2]K.WQ2_\"]-=ON_'H+V
ME7^9?>_\C\5H?^#?;_@E;$93'^SQ;'SSE_\ B;/_  XX&;<?UIH_X-\?^"59
MW$?L\6^6 S_Q-Y,#C&<?9\;OUK]J0BC&% QG'!_&EP!_"!D>A_/_ #Q1[6I_
M//\ \"_X >TK?S+\3\;=._X('?\ !+O3$"6_[.NFLF<CSKP2?JT'_P!;D\4^
M7_@@M_P2\E+Y_9UTQ=S%F N_EW9R3CR,=>*_8\J,8*C@@]#]1GTIP5.O3@#'
M^'^?Z4>UD]Y2^^_];:_/RM2JU%9O79/5:;7WB^WJ?CDO_!!G_@F G*_L[:;C
M:4 ^V< 'C@>1_G\J;;?\$&O^"7UG,TT7[.FEF4#=C[6#STX'DXZ\8R,>N:_9
M#:O3=QD<=O\ #\>W>DV1YR,9/4\9..>N/7D'O_)^U:^U+IVZ6^[5:V]>UA5I
M[<NFG5=+6U4;Z6]>GK^/X_X(5?\ !,8S&?\ X9STE73^].A&".@40MZ]<"M.
M'_@B#_P3/(PO[.6AXC./WC)V_P"V&<5^MX ['YCR2.I /0__ %Z?CV^O'7ZU
M+JR[R_/MV7]7^X]I)^7DG?\ E\EV/R>'_!%3_@FJH$:_LX>&?EP 0D;?KY+?
MT^E(W_!$W_@FL^<_LX^&^?\ IG$/U-M7ZPJBIG8H7)R<=S3J7MI=Y_CVMUBQ
M<S\_O?E_P?O\C\H4_P""*/\ P392,1?\,X>%V4'()BA)_P#2?^E-N/\ @BC_
M ,$U[ID9_P!G'PN##C&V&'MTSFW/I_GBOU? QW)[<_YZTC+N!'W<]QQ3]I+O
M+[_3=6_X:X_:2M;F?W^GEZ_?Y'Y1P_\ !%G_ ()M1/YJ_LZ>&">^^W@/3_MV
MS^1YJ>7_ ((O_P#!-V[ADAD_9M\*;'^\5MK>-\^SB'</_KU^JQ&>O8YH*@]L
M?04_:RZ-Z>?IV2_I^@_:3_F?]>EOZU/RDL?^"*G_  39T]C)%^S=X6))ZS0P
MN,^V8>3QCGWK5/\ P1S_ ."<Q /_  S=X/"1 DC[#:X;@\_ZC.>>..3Q7ZC8
M'3 Q]*0H#].ZXX;TS]*/;5/YI??Z?CIOYW[![2?\S_K^OQ/RWF_X(Y_\$Y+I
M(R_[.'@\1+&0H^P6HZ'J3Y!^;VJTG_!'C_@G7 B+'^S=X- 51M<Z?:.",=<&
M 9_+GW'3]/=B[=I *YR >@^E-(P>F0  ,YX'X8]?P[4_;3_FEITYGW7EZ[]_
M07M*FC4G=;?KT_KK<_,"?_@CO_P3HO5$<G[-_@ML#.8]-M(VP"#R1 ,XX_\
MKUJ1_P#!(G_@GK&GD+^SCX&PJ*HSI=F3M (&3Y/)QW/\Z_2D #H@'/8'K^?6
MDVCDA!DYR>><?C1[>I_,_P /+R\G]_D'MJ^GO+^K>6G]=C\UD_X)%_\ !/6)
M&3_AFWP+B0XW'2;(XX]?(P.OIS5A?^"27_!/==KC]F_P%^Z'_0'L>P_Z]^?P
MS7Z.,R<1L02>!Q^ [YX_SWJ7 V[=HQCT/?\ 'O\ _JI>UF]V^G56Z7Z=;#]I
MB%O)+;L^BVT\NQ^<$O\ P27_ .">]\ 7_9M\ _N_NG^QK%>G(Q^X.?I4Z_\
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M[^RI&I5/V<O@WCT_X5_X:/;MFQ-?2X0 $>O7_'IUI-@]3_G\*.=^?_@3\O\
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M[8/\JDV\;><?_7S1CC'ICGOQ3O._V;>GWO\ X?MIYE_3[E_D19;^_GVP.?\
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M !1110 4444 8^L6MI-%'=7;SHFFF6] @<J["&,R.H0<RY5#A.YX[U_FZ_\
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M'4_SI<=\<^N*3 /4#\J(II:N[_X" 3<OK_/_  IU)@>@_*EI@%%%% !1110
M4444 %%%% !1110 4444 %%%%  >01ZU$4/;G_/3K^-2T4 1;#^HY_F>O:C8
M?U//\CU[U+10 Q5QG/?C'^?6G8'3'H/RZ4M% "8'ZY_&C ZX[D_GUI:* $W#
MU%)N7UI<#T'Y48'H/RH -P]10"#TYHP/0?E2XQT&/PH 3:/3MCOTHVCTZX]>
MW2EHH 3 ].^?QHP/RS^O6EHH 3 ].V/PHP#GCKC/X=*6B@!"!W]<\^O^>U-^
M3V[_ .?\,_A3^O44F!Z#\J &_)[=/T_Q_6CY.>G;_(_KC\:=@>@_*C ]!^5
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M8'Y9_7K2T4>]Y?C\_P"O\] 3 ].V/PHVCTZX]>W2EHHU\OQ\OTO^'H ?Y_\
MKTGXG]/\.]+119=E]P!^)ZY_^MT_^O[T444<J[+^O^&_J[ ****++LON *:5
M!Y]^??VIU%%DMD@&;!^OOT].M&P?S_'T[]J?13U[?U]WK_3T!FP?7CISU]:-
MI]!G^O;C&./3H>]/HI-7[KT;7^0$>T^B_P#U_7I^G2EVGT&/Z=^<9Y]>H[4^
MBER^<OO?]?\ #^EBXS"@<@#_ /7Q[_4]Z/D]NH_SZ?7MZT[ /4#\J,#T'Y50
M#?D]NI_SZ?3MZ4?)[=_\^N?3OZ4[ ]!^5&!Z#\J &_)[=O\ /KGU[^M'R>W7
M_/X?I3L#T'Y48'H/RH ;\GMU/^?3Z=O2E 4]![?Y]_UI<#T'Y4O3H* &[5]/
M\_Y_.EVCT'K_ )_PI:* $VCT'^?\_A1M'I[?Y]_?K2T4 -VKZ?Y_S^=+M'IW
MS_G_  Z4M% #<*.H'^?Y_K2?)[=/T_Q_6GXSU&?PI,#T'Y4 -^3GIVS_ /6_
MKC\:/D]NOZ_X?I3L#T'Y48'H/RH 3/7YAU&/IW_/_/L9_P!H=?;IZ4N!Z#\J
M,#T'Y4!;U^]^O]?=L-R?[P[^GX?Y_G1D_P!Y>GMU_P __JIV!Z#\J,#T'Y4"
MMZ_>_P#,3/\ M+V_^OWHS_M#K[=/3_/_ .M<#T'Y48'H/RH"WK][]>_];;"9
MZ?,.^>G-+@'G&:,#T'Y4M Q-H]*-H]*6B@!  .0*6BB@ HHHH **** "BBB@
M HHHH *0GGJ!UR#^E+28'H/RH 3/^T,X]NOK_GZX[4A)[,O;K_GO3L#T'Y48
M'H/RH_K85O7[WT_K^F1E$+!B5X/' _+K3\_[2]__ *W?_/OUHVKUQ[TN!Z#\
MJ LO/[WY>?E_5Q,_[0SCVZ^O^?KCM1G_ &AV_P#K]^_^?6EP/0?E1@>@_*@+
M>OWOT[_UON)G_:'7VZ>E)D_WAW]/P_S_ #IV!Z#\J,#T'Y4#MZ_>_P"NG]78
MW)_O+T]NO^?_ -5+G_:7M_\ 7[TN!Z#\J,#T'Y4?UL*WK][_ ,Q,_P"T.OMT
M]/\ /_ZS/^T.A].O;O\ Y_DN!Z#\J,#T'Y4#MZ_>_P"NG]78W)_O#IQTZ_Y_
M_51G_:7J/R[]_P#/X\.P/0?E1@>@_*G?^K?U_7JQ6]?O?^8F?]H=3GIT_P _
MY..3/^T.A].O;O\ Y_DN!Z#\J,#T'Y4AV]?O?]=/ZNQ,_P"T.@].O?O_ )_F
M9_VEZ_IZ?Y_KPN!Z#\J,#T'Y4?UL*WK][_S&Y_VEZG\NW?\ S^')D_WEZ>W7
M_/\ ^JG8'H/RHP/0?E0%O7[W_GY?U=B9_P!H=!Z=>_?_ #_,S_M#K[=/3_/_
M .I<#T'Y48'H/RH"WK][_P Q,_[2]_\ ZW>DR?[R]/;K_G_]5.P/0?E1@>@_
M*@+>OWO_ #\OZNQN3_>';T_'_/\ *ES_ +0QGVZ>G6EP/0?E1@>@_*C^MOZ_
MKYA;U^]_YB9_VAW_ /K=^W^?6E!]P3[48'H/RHP!T _*@?\ 77^OZ\Q:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0
MD#J?YTFY?7^?^%+@'J!^5&!Z#\J $W+Z_P _\*-R^O\ /_"EP/0?E1@>@_*@
M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****7JE?^O\
MW_3L A)[+G\0*7-%%#2>Z3]4 9HHHI<D>UMMFUMZ %%%%-*RLK_-M_F 4444
MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBDSR1Z8_6EH *0]/Q'\Q2TAZ?B/YB@!:*** $'0?0?RI:0=!]!_*EH ****
M"BBB@ HHHH **** *]PK,H*KDKDYSC;@=<?Q?3O7\"?_  5-^ /_  4&_;)_
M;X^.?PU^"GPK\7?$CP.8[;P[82ZT^H^ ?"Z6U]&Z3QR:Y;/%%K-H.L@F+IMX
M/%?WW3Q^8N"[1@')*G!(^O8YJNEO%&"5C02N,NPCC$T^T=9'"@L?0YR?6NS"
MXF6&4W&UY+E=[WM^OFEY7-*=65.5TENM='Z]ONOYGP/_ ,$VO@5X_P#V:_V/
M_@U\%OB;96.B>,O!OARPT_4]&TB\_M'2],>&,[[.TO066>%"<!\\D9-?H+SQ
MQGU/_P!:J45HJMYASN;G#<E 3DI^N/\ .*O5S5&IMO\ FWW2Z;?UU"I/GFY:
M:]E;R_0****@S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH *0]/Q'\Q2TAZ?B/YB@!:*** $'0?0?RI:0=!]!_*EH **** "BBB@
MHHHH **** $(!ZTM%% !2$ ]:6B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#T_$?S%+2'I^(_
MF* %HHHH 0=!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0$'..W6ESSCOU
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "D/3\1_,4M(>GXC^8H 6BBB@!!T'T'\J6
MD'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "D)QR:6FE<]_PQGUYZ]>: &APV2'#8)^48)^G7
M/'>G@ #@8[UG6%C]C,Y\QI/,D9ANR=N3D@9K1P>Y/7/I^% "T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %(>GXC^8I:0]/Q'\Q0 M%%% "#H/H/Y4M(.@^@_E2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>GXC^8I:0]/Q'\
MQ0 M%%% "#H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(>GXC^8I:0]/Q'\Q0 M%%% "#H/H/Y4M(.@^@_E2T %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>GXC^8I:0]/Q
M'\Q0 M%%% "#H/H/Y4M(.@^@I: "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "D/3\1_,4M(>GXC^8H 6BBB@!,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
M48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y48'H/RHHH ,#T'Y
..48'H/RHHH 6BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g3puwq45lgum000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3puwq45lgum000002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" F(!V # 2(  A$! Q$!_\0
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M0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH
M3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6
MB@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/
MRI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@
M>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^
M5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#
MT'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:*
M$P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*E
MHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#
M\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48
M'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?
ME1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3
M]!^5&!Z#\J6B@!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@
M!,#T'Y48'H/RI:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y48'H/RI
M:* $P/0?E1@>@_*EHH 3 ]!^5&!Z#\J6B@!,#T'Y4=", #@]OI2TG<?0_P Q
M0 #H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4G<?0_P Q2TG<?0_S%  .
M@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2=Q]#_,4M)W'T/\ ,4  Z#Z#
M^5+2#H/H/Y4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)W'T/\ ,4M)W'T/\Q0 #H/H/Y4M
M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4G<?0_S%+2=Q]#_ #%  .@^@_E2T@Z#
MZ#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4G<?0_P Q2TG<?0_S%  .@^@_
ME2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?SB_\
M%T8A%^TE_P $)"""9?\ @K)\)]G[N-1"TND211,JJ-KM:E4DCW@[V11)D5_1
MU7\Y7_!=7_DY'_@@]_VEE^$'_IMEH _HT'3\3_,TM(.GXG^9I: "OYQ/VYT+
M_P#!Q9_P1-VOY;#X&_MVL6"(Y*I\,;IFC_> A1(NZ,NN'179D(;!K^CNOYR/
MVX_^5BW_ ((G_P#9"OV\?_57W5 ']%EO$!(\H.W*A"BJH4[3\C9 W91?W8&<
M;>3EN:MU!!T;ZC^53T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3N/H?Y
MBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $;D@YSA<<CU.?3//H?
MK6?=7,$+0+.2/M#%(CN15,@&4B 8AFDD&XQH@8D(Q( %796'*$C)&<'(QCJ>
MG3%8VIV;7ALFB=$,<GS2E59@DJF(B-7P.=V6<$2(57R^&>J;<(\UG>Z2MIU6
MK?3S?DB)JI;EH5(4JTYQDYU7[L*5XJ=2S=[6NDE[KE[N[)VU&T@=;<EO/=&?
MR=R94*&;+Y<! P!&YR(P2BNRM(BM$-4M96FCA6>2:-8B42%P"98GDC2.24)
MS%8W5BLA6-]HE=-RD_PC_'WXY?''_@HC^V!\3?#/C']HWX>?LO>'?@]<^.-#
M^'%MXW\=:YX(^'NBZ=X7\6KX4U&*SUW2YH+S6_'/C$VT6J7-WJT#/&MG'86=
MH+:S^T3?1?P$^(7[=7[&G[!/[7_B?3O'&E:Q\+[C5= _X5%\;-!^,OA?XTS>
M&O'>M>,M)\$^+-,\%VECK6KW.C7.K:/J\^O7&JZO,&T+5;;37CT[[0)8&\W^
MTTO:2C3JU:495;XN/+*F_80]I4BX1O.&L>2FZO*JDI06_-[/^],W^@?Q'EG#
MO#:QWB;P9@?$SB?,/#W X3PUS7ZWE^8<OB'CL/@\KQ.#SF45@<UKT*&)CB\R
MP.61Q-; 4(U)5)27U=8K^R6+5[61G6-R1Y1=%='&X1R>7(#(P"L^[($:DLR_
M,H9?FI[:W!;W=I9NK^;<J[>6A5C%M .2@8NW!5RJ*Q",'(V$$_YZ>J>"/VTM
M&_9^\,?\%,Q\=?$T^B:A\;]8TVXN+?QYXE@\>:3XYTO6(])TWQAJ&G7TD>@:
MU#J^JJMH;#3;)[-8FEN-0MK6T9Y5]Z_;%_:'^,O[2>N?\$\OV@_$=UXD\*W'
MBOP_X;\'7NH>"=8\2:'X#U'Q7X0^-UU::I-)'87,%G<:G?6'DZEJ-ION=,AM
M-0AM]/O=0L(HW,PS.->3?U>O3C&A3Q')).,IT:U6G0IUXRC&<+*I4BIP?O<W
MNJ?Q<GV>*_9U9U1S[#X'*?%K@[/,MI8OC[A+/<7A,-B\-A\@X]\/\GQV:XKA
M?$4L=4PU?$8K%4LOJT\/BX.$';VCHNG.C[;^\=V:/<1SRQSV "@CU]3@]:S#
MJ-K;E8IC.)I8)KE49XB6$+JGE#]YL620MF(%@, [RF*O2W$0W9*AI2HCC()=
MF\LNZ!3]Y@N>!]!SQ7\F'_!1_P#X)H?M 7_QJ_:-_:LU/]J3P7\,_@!XDU__
M (32_MM9^(WQ6T270=*72=$T6#2KVST6UDT^PO[;58$DT;3=!:4:G?W]M9NC
M7%R$/;4Q4:$(J-/VTVW[50JTJ3@HI2YISJODBELD][2:346S^./!;P^X;\3^
M,JG"G$GB)E_AW#$X"IBLLS+'Y1C\ZAFN90J87#8;(L'A,LOB9XW%5JLG24%+
MFG#V-O:58']7JZU9N@G\R)K,LZM=1SQ$0A /GD*R%F0O^ZWQ*XWYY"@L$;7=
M-E+P_:TB2(MYKR[DB"(-V_S7PA1@."&)_O!>:_A._P""7G[+W[0'[5_B[XU>
M+/"_C_Q%_P (1X&^$_Q%\ :QXC\7?$#Q=<65WXJ^)7@C7-#\%K8Z';WLFH12
M6UFSZY)?&U4:;9PDO+#JYMX&_/&+PK^TAJ/P9^(/Q^B\3_$2?X;> _%VG_#S
MQWXNC^*&M[++QQJRN-/CAT]]<2^N[#5MB307=C:7%G:JX@GGC=0IY5FR=*A7
M6!Q,H555G%0LW&G0C"4ZTK4I6AJY-M024)SYG&TC^X\M_9OY!F/&_&'AWC/I
M,<'X'..$_P#5&CF$,RRBK@O99QQO2QE?)^&ZJKYE0]EG%2&#@H8'GGB:DL;2
MI>QIUHNE/_2_CDD:XD: M<02-#(FQ5:-K>X7<)DE8A&B5?O[6+@895*D&M:S
MX>55:+RU"[$3&0"6 =A@'#%6 ;D,5.#Q7\SGQI_X*A_"/X6_\$^=#^"/@CXU
M>*_"O[8-K^RS\&SX<BTWPQXJ.L:5XK\2^%?"VNPW<WBNYTNYTR.\O-*N+J22
M6XEFCM&<&\>&63RZSO\ @E!_P5V^'^C?#"7X<_MF?M!^.O&/QN\7?&F;1/!-
M]XE\-ZYXFO+G1/$K:%I7A32)]>\.:+)I%K"-7EO((_M4D*P!Y)IW2/+5TQS.
MC6J?5JDZ5/$<C;IRG34DZ<U3=.2O>-?2Z@USN'-+HTOYLK_0W\<WX;\3^*E#
M@O.L7D/#O$4LAHT:?#.<T\XS?)TIU8\695A5@9_6N&HT:,)8G-Z5:6%IR=N9
MQO./]0E%5H[N&0$J2=K.C?*<*\;!74M]T$$C SDCD<58# XP>O(_STK;6U[:
M;7Z?>?RFTUNK:N/_ &\MUZKL+1110(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HJE+?V\(9I"ZJBEF)C;"@==W'!^O6I8[J&79L?/F1B53V*$X!_'
MMC.>HXII-QYDFX]TM-KF<:U*=25*%2$JD(>TE!23G&',X\\H[J/,G&[TNFMT
M6**0'-+2- HHHH **** "BBB@ I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "FN2%)'7%.IDAPC'&<#.,9
MSC^M-;KU&MUZHSPWS1ED59,R;6X&T #<?3GU[CD5^&?_  6 \(>'_%?QU_X(
M]W6KQW(N?"7_  4/\)>)-!-MG:NIZ=H5RULTY7(\CS3#(YS]Q&/ !K]QK@[P
M#D(WD/)AF"E0#\[')& O\;$ +D9(R*_"'_@M-\2=$^#NI?\ !/GXJ:U;ZC-X
M:^%_[7-OX[\21:01/=QZ1H/ABYGOH;.U=D^U2N<&.PA;/E[F7]W\QPQ>(CAN
M3WH*TH-QE>44O:TU)RY=HJ,FV[VBDVTU<_:?HY<*/CCQDX9X8EE:SO\ M=<6
M8'!9+.C[>.)Q]'@K/<1E"IT/MU%F]&E/#R6U=4W?W;'[PV^I6%PJNE];2A]P
MWH_RO)&H\S9GKMW*=O8$8SS5]6&X*<'M[]3T/U]_<5^!/_!-S]NKX_?M7_$?
M]H/XU_&G6OAQ\//V;M;O-'TG]G3X;:OKOA7P]XFTN_T2]NTUS4Y;JYOH=<OO
MMVGM:?VMJFJ2-I]IXD%_I^D626$,8/[1Z=\8_A8;2W:^^*/PWCN!''YI/CSP
MK(OG!0)D$B:D%?;(&7< H;&0HS@=<H/EA/5QJ4J=2#<'#GC-7C.$9:R@])1=
ME>$E*RT1\IQUX9\7>'O%&+X1SW)L;_;.!4(YE2P6'K8VA@<>Z%&MB,!5Q%"E
M*BL1A:M26&Q%.$IQIXBC6I*<W3YCU=,<D#&3_G_/ZU_.7^W'_P K%O\ P1/_
M .R%?MX_^JONJ_>U?C)\( #_ ,75^&W7_H>?#!]/^HI7\]?[:WC;P7J7_!P=
M_P $9?%>G^,/"M]X6T'X(?MS6^N>);3Q%H]QH&BW&H_#2Z@TZWU;6(KQ]/TZ
M?4;C%OI\-Y<0R7MP?(MEEE^6LW=6WULE==79)+SOHE\D?*1R//&E?)\T<K:V
MR_%]%K_RYZ)?+T/Z5X.C?4?RJ>O,8_C)\($9HF^*WPU\S:LGE_\ "=>%]XC<
M?(Y7^U,A'_A;&&[&I?\ A<OP@_Z*M\-O_"Y\,?\ RTHL^S^YA_8>=?\ 0GS3
M_P -^+_^4GI-%>;?\+E^$'_15?AM_P"%SX8_^6E'_"Y?A!_T57X;?^%SX8_^
M6E%GV?W!_8>=?]"?-/\ PWXO_P"4GI-%>;?\+E^$'_15OAM_X7/AC_Y:4?\
M"Y?A!_T5;X;?^%SX8_\ EI19]G]P?V'G7_0GS3_PWXO_ .4GI-%>;?\ "Y?A
M!_T57X;?^%SX8_\ EI1_PN7X0?\ 15?AM_X7/AC_ .6E%GV?W!_8>=?]"?-/
M_#?B_P#Y2>DT5YM_PN7X0?\ 15?AM_X7/AC_ .6E'_"Y?A!_T5;X;?\ A<^&
M/_EI19]G]P?V'G7_ $)\T_\ #?B__E)Z317FW_"Y?A!_T57X;?\ A<^&/_EI
M1_PN7X0?]%5^&W_A<^&/_EI19]G]P?V'G7_0GS3_ ,-^+_\ E)Z317FW_"Y?
MA!_T57X;?^%SX8_^6E'_  N7X0?]%5^&W_A<^&/_ ):46?9_<']AYU_T)\T_
M\-^+_P#E)Z317FW_  N7X0?]%6^&W_A<^&/_ ):4?\+E^$'_ $57X;?^%SX8
M_P#EI19]G]P?V'G7_0GS3_PWXO\ ^4GI-%>;?\+E^$'_ $57X;?^%SX8_P#E
MI1_PN7X0?]%5^&W_ (7/AC_Y:46?9_<']AYU_P!"?-/_  WXO_Y2>DT5YM_P
MN7X0?]%6^&W_ (7/AC_Y:4?\+E^$'_15OAM_X7/AC_Y:46?9_<']AYU_T)\T
M_P##?B__ )2>DT5YM_PN7X0?]%5^&W_A<^&/_EI1_P +E^$'_15?AM_X7/AC
M_P"6E%GV?W!_8>=?]"?-/_#?B_\ Y2>DT5YM_P +E^$'_15?AM_X7/AC_P"6
ME'_"Y?A!_P!%6^&W_A<^&/\ Y:46?9_<']AYU_T)\T_\-^+_ /E)Z317FW_"
MY?A!_P!%6^&W_A<^&/\ Y:4?\+E^$'_15?AM_P"%SX8_^6E%GV?W!_8>=?\
M0GS3_P -^+_^4GI-%>;?\+E^$'_15?AM_P"%SX8_^6E'_"Y?A!_T5;X;?^%S
MX8_^6E%GV?W!_8>=?]"?-/\ PWXO_P"4GI-%>;?\+E^$'_15?AM_X7/AC_Y:
M4?\ "Y?A!_T5;X;?^%SX8_\ EI19]G]P?V'G7_0GS3_PWXO_ .4GI-%>;?\
M"Y?A!_T57X;?^%SX8_\ EI1_PN7X0?\ 15?AM_X7/AC_ .6E%GV?W!_8>=?]
M"?-/_#?B_P#Y2>DT5YM_PN7X0?\ 15OAM_X7/AC_ .6E'_"Y?A!_T5;X;?\
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M;?\ A<^&/_EI19]G]P?V'G7_ $)\T_\ #?B__E)Z317FW_"Y?A!_T57X;?\
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M\,?_ "THL^S^X/[#SK_H3YI_X;\7_P#*3TFBO-O^%R_"#_HJOPV_\+GPQ_\
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M?V'G7_0GS3_PWXO_ .4GI-%>;?\ "Y?A!_T57X;?^%SX8_\ EI1_PN7X0?\
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MW_A<^&/_ ):4?\+E^$'_ $57X;?^%SX8_P#EI19]G]P?V'G7_0GS3_PWXO\
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M^O\ GJ?\.3O^"8?_ $;!H/\ X67Q _\ FL_#_.:_5'>G_/,_]\"C?'_SS/\
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M/_\ $^XI_P#GM_7W'Y7_ /#D[_@F'_T;!H'_ (67Q ]?^QL_S^E)_P .3O\
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M?$#T_P"QL]?\]Z/^')W_  3#_P"C8- _\++X@>__ %-GT_ST_5'?'_SS/_?
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MXI_^>W]?<?E=_P .3O\ @F'_ -&P:!_X67Q ]/\ L;/7_/>E_P"')W_!,/\
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MY_2D_P"')W_!,/\ Z-@T#_PL?B![?]39]?\ /7]4=\?_ #S/_? HWI_SS/\
MWP*?U7"_\^Z.ZM^[H^7_ $[\UW7WL/\ B/OCY_T>+Q/_ /$_XI\O^IM_6OD?
ME=_PY._X)A_]&P:!_P"%E\0/?_J;/I_GH?\ #D[_ ()A_P#1L&@?^%E\0/\
MYK*_5'>G_/,_]\"C>G_/,_\ ? H^JX7;DI=_X='K;^YZ#_XC[X^?]'B\3_\
MQ/N*?_GM_7W'Y7?\.3O^"8>/^38- S_V.7Q ]/\ L;/PZ_IS1_PY._X)A_\
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M[A_Q'WQ[_P"CQ>)__B?\4^7;-_+7_AC\K_\ AR=_P3#_ .C8- _\++X@>O\
MV-G^?TI/^')W_!,/_HV#0/\ PL?B![?]39]?\]?U1WQ_\\S_ -\"C>G_ #S/
M_? I_5<+_P ^Z.ZM^[H^7_3OS7=?>P_XC[X^?]'B\3__ !/^*?+_ *FW]:^1
M^5W_  Y._P""8?\ T;!H'_A9?$#W_P"IL^G^>A_PY._X)A_]&P:!_P"%E\0/
M_FLK]4=Z?\\S_P!\#_/<T;T_YYG_ +X%'U7"[<E+O_#H];?W/0?_ !'WQ\_Z
M/%XG_P#B?<4__/;^ON/RN_X<G?\ !,/'_)L&@9_['+X@>G_8V?AU_3FC_AR=
M_P $P_\ HV#0/_"R^('_ ,UE?JCOC_YY'_O@4;T_YYG_ +X%'U;"_P E+HOX
M='RMI[/T_4/^(^^/G_1XO$__ ,3[BG_Y[?U]Q^5W_#D[_@F'_P!&P:!_X67Q
M ]O^IL^O^>I_PY._X)A_]&P:!_X67Q ]_P#J;/I_GI^J.]/^>9_[X%&]/^>9
M_P"^!1]5PO\ )2TU_AT?+^YYK^KA_P 1]\?/^CQ>)_\ XGW%/_SV_K[C\KO^
M')W_  3#_P"C8- _\++X@?\ S64?\.3O^"8?_1L&@_\ A9?$#_YK/P_SFOU1
MWI_SS/\ WP*-\?\ SS/_ 'P*/JN%_DI=/^7='RZ>S]+^OF'_ !'WQ\_Z/%XG
M_P#B?<4__/;^ON/RN_X<G?\ !,/_ *-@T#_PLOB#[_\ 4V?3_/0_X<G?\$P_
M^C8- _\ "R^('M_U-GU_SU_5'>G_ #S/_? HWI_SS/\ WP*/JN$_Y]TO_!='
MR_N:[K^KA_Q'WQ\_Z/%XG_\ B?\ %/E_U-OZ^ZWY7?\ #D[_ ()A_P#1L&@?
M^%E\0/?_ *FSZ?YZ+_PY._X)A_\ 1L&@?^%E\0/7_L;/\_I7ZH;T_P">9_[X
M%&^/_GF?^^!2^JX3^2EK;_EW1\O^G>CU7W^H?\1]\?/^CQ>)_P#XG_%/E_U-
MOZ^ZWY7?\.3O^"8?_1L&@_\ A9?$#_YK/P_SFC_AR=_P3#_Z-@T#_P ++X@^
M_P#U-GT_ST_5'?'_ ,\S_P!\"C>G_/,_]\"G]5PO\E'_ ,%T?+_IWKT[[^8?
M\1]\?/\ H\7B?_XG_%/_ ,]OZ^X_*[_AR=_P3#_Z-@T#_P +'X@>W_4V?7_/
M4_X<G?\ !,/_ *-@T#_PLOB![_\ 4V?Y_4?JCO3_ )YG_O@4;X_^>9_[X%+Z
MKA/^?=+7_IW1\O[FFZ#_ (C[X^?]'B\3_P#Q/N*?_GM_7W'Y7_\ #D[_ ()A
M_P#1L&@_^%E\0/\ YK/Q_P#KTG_#D[_@F'_T;!H'_A9?$#V_ZFS_ #^I_5'>
MG_/,_P#? HWQ_P#/,_\ ? I_5<+_ "4M'_S[H];?].]>@?\ $??'S_H\7B?_
M .)]Q3_\]OZ^X_*[_AR=_P $P_\ HV#0/_"R^('O_P!39]/\]#_AR=_P3#_Z
M-@T#_P ++X@>W_4V?7_/7]4=Z?\ /,_]\"C>G_/,_P#? H^JX7^2EK_T[H^7
M]ST#_B/OCY_T>+Q/_P#$^XI_^>W]?<?E=_PY._X)A_\ 1L&@?^%E\0/?_J;/
M\_J%_P"')W_!,/\ Z-@T#_PLOB!Z_P#8V?Y_2OU0WQ_\\S_WP*-\?_/,_P#?
M I?5L+_S[H]/^7='R_Z=^:_7J+_B/OCY_P!'B\3_ /Q/^*?+_J;?UKY'Y7?\
M.3O^"8?_ $;!H'_A9?$#V_ZFSZ_YZG_#D[_@F'_T;!H'_A9?$#W_ .IL^G^>
MGZH[T_YYG_O@4;T_YYG_ +X%/ZKA/^?=+_P71\O[FNZ_JX_^(^^/G_1XO$__
M ,3[BG_Y[?U]Q^5W_#D[_@F'_P!&P:!_X67Q!]O^IL^O^>I_PY._X)A_]&P:
M#_X67Q _^:S\/\YK]4=Z?\\S_P!\"C?'_P \S_WP*7U7"_\ /NEK;_EW1\O^
MG?FNS_$7_$??'S_H\7B?_P")_P 4_P#SV_K[C\K_ /AR=_P3#_Z-@T#_ ,++
MX@>O_8V?Y_2D_P"')W_!,3_HV#0/_"Q^('M_U-GU_P ]?U1WQ_\ /,_]\"C>
MG_/,_P#? I_5<+_S[H[JW[NCY?\ 3OS7=?>P_P"(^^/G_1XO$_\ \3_BGR_Z
MFW]:^1^5W_#D[_@F'_T;!H'_ (67Q ]_^IL^G^>A_P .3O\ @F'_ -&P:!_X
M67Q _P#FLK]4=Z?\\S_WP/\ /<T;T_YYG_O@4?5<+MR4N_\ #H];?W/0?_$?
M?'S_ */%XG_^)]Q3_P#/;^ON/RN_X<G?\$P\?\FP:!G_ +'+X@>G_8V?AU_3
MFC_AR=_P3#_Z-@T#_P ++X@?_-97ZH[X_P#GD?\ O@4;T_YYG_O@4?5L+_)2
MZ+^'1\K:>S]/U#_B/OCY_P!'B\3_ /Q/N*?_ )[?U]Q^5W_#D[_@F'_T;!H'
M_A9?$#V_ZFSZ_P">I_PY._X)A_\ 1L&@?^%E\0/?_J;/I_GI^J.]/^>9_P"^
M!1O3_GF?^^!1]5PO\E+37^'1\O[GFOZN'_$??'S_ */%XG_^)]Q3_P#/;^ON
M/RN_X<G?\$P_^C8- _\ "R^('_S64?\ #D[_ ()A_P#1L&@?^%E\0/3_ +&S
M_/ZU^J.]/^>9_P"^!1OC_P">9_[X%+ZKA?Y*6MO^7='R_P"G?I]X?\1]\?/^
MCQ>)_P#XGW%/_P ]OZ^X_*[_ (<G?\$P_P#HV#0/_"R^(/O_ -39]/\ /0_X
M<G?\$P_^C8- _P#"R^('M_U-GU_SU_5'>G_/,_\ ? HWI_SS/_? I_5<)_S[
MI?\ @NCY?W-=U_5P_P"(^^/G_1XO$_\ \3_BGR_ZFW]?=;\KO^')W_!,/_HV
M#0/_  LOB![_ /4V?3_/1?\ AR=_P3#_ .C8- _\++X@>O\ V-G^?TK]4-Z?
M\\S_ -\"C?'_ ,\S_P!\"E]5PG\E+6W_ "[H^7_3O1ZK[_4/^(^^/G_1XO$_
M_P 3_BGR_P"IM_7W6_*[_AR=_P $P_\ HV#0?_"R^('_ ,UGX?YS1_PY._X)
MA_\ 1L&@?^%E\0??_J;/I_GI^J.^/_GF?^^!1O3_ )YG_O@4_JN%_DH_^"Z/
ME_T[UZ=]_,/^(^^/G_1XO$__ ,3_ (I_^>W]?<?E=_PY._X)A_\ 1L&@?^%C
M\0/;_J;/K_GJ?\.3O^"8?_1L&@?^%E\0/?\ ZFS_ #^H_5'>G_/,_P#? HWQ
M_P#/,_\ ? I?5<)_S[I:_P#3NCY?W--T'_$??'S_ */%XG_^)]Q3_P#/;^ON
M/RO_ .')W_!,/_HV#0?_  LOB!_\UGX__7I/^')W_!,/_HV#0/\ PLOB![?]
M39_G]3^J.]/^>9_[X%&^/_GF?^^!3^JX7^2EH_\ GW1ZV_Z=Z] _XC[X^?\
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M*[_AR=_P3#_Z-@T#_P ++X@>W_4V?7_/4_X<G?\ !,/_ *-@T#_PLOB![_\
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M_P":S\/\YH_X<G?\$P_^C8- _P#"R^(/O_U-GT_ST_5'?'_SS/\ WP*-Z?\
M/,_]\"G]5PO\E+=?\NZ/E_T[UZ=]P_XC[X^?]'B\3_\ Q/\ BG_Y[?U]Q^5W
M_#D[_@F'_P!&P:!_X6/Q ]O^IL^O^>I_PY._X)A_]&P:!_X67Q ]_P#J;/\
M/ZC]4=Z?\\S_ -\"C?'_ ,\S_P!\"E]5PG_/NEK_ -.Z/E_<TW0?\1]\?/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M $4;X?\ _A7^'O\ Y:T6MLOP#DA_)'_P%?Y'H/EI_=%'EI_=%>??\+6^&_\
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MD?\ P%?Y'H/EI_=%'EI_=%>??\+6^&__ $4;X?\ _A7^'O\ Y:T?\+6^&_\
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M%'EI_=%>??\ "UOAO_T4;X?_ /A7^'O_ ):T?\+6^&__ $4;X?\ _A7^'O\
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M>_\ EK1;R_#^NR^X.2'\D?\ P%?Y'H/EI_=%'EI_='Z_Y_S[UY]_PM;X;_\
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MX6M\-_\ HHWP_P#_  K_  ]_\M:/D')#^2/_ ("O\CT'RT_NBCRT_NBO/O\
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M+6^&_P#T4;X?_P#A7^'O_EK2LNR^X.2'\D?_  %?Y'H/EI_=%'EI_=%>??\
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M\CT'RT_NBCRT_NC]?\_Y]Z\^_P"%K?#?_HHWP_\ _"O\/?\ RUH_X6M\-_\
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M'H/EI_=%'EI_=%>??\+6^&__ $4;X?\ _A7^'O\ Y:T?\+6^&_\ T4;X?_\
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M^BC?#_\ \*_P]_\ +6BWE^ <D/Y(_P#@*_R/0?+3^Z*/+3^Z*\^_X6M\-_\
MHHWP_P#_  K_  ]_\M:/^%K?#?\ Z*-\/_\ PK_#W_RUHMY?A_79?<')#^2/
M_@*_R/0?+3^Z*/+3^Z*\^_X6M\-_^BC?#_\ \*_P]_\ +6C_ (6M\-_^BC?#
M_P#\*_P]_P#+6BWE^']=E]P<D/Y(_P#@*_R/0?+3^Z*/+3^Z*\^_X6M\-_\
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MK_#W_P M:+>7X!R0_DC_ . K_(]!\M/[HH\M/[HKS[_A:WPW_P"BC?#_ /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *:6.<#KW)Z 4ZJY#%V.XX'13C'OCGG\?2FE?K;_ATOU)
MDVE=1<N]FE9=6[N[MV2;\C,OM3^PNIFGMHH2I8^8LAE^7<2%"9^0C!:4C9 %
M)DSO2OCC]L_]L74?V1?A1HGQG@^#GC+XM^"5\9:/H?C^3P8\*:GX#\(:DTD5
MQ\09M/F@N;C6=/M+O[-8PZ7;QVDEU-=K/+?V-G%-<)N?M7?!;]H_XRZ#X>TG
M]G[]IU_V:+VPU:2_\1^(K;X<:7X[UC7=/1$^RZ#92:KJUE9Z1IT\X+ZO_H5[
M<7\:01Q269B+2?G]/^P'_P %*]0T74]&UC_@K%K6K6>KQ:G9ZI%<?LX^!Y8+
MZPOXU@.FSPW&J36XT]+1[BU^RO;S+<0W$J2,%XK9TU&+G%\SBD[)4VE)I:-5
M:M.ZC>[]U)V:YEI)?LOAEPEX?YGBLKSSC;Q+X)RC*\-CZ,<RX3SG ^(U#&YG
M@GB*5*K1IYOPOP9Q%0P5:M1E.6'KQG4=*HH2K4*BYZ+_ %M^$GQD\#_'#X?^
M%OB?\,_$FD>*_!/C/2EUC0-=TNX6:&X@)19+.>!6,EIJEE(S6VIZ?,PN+&[B
MDMY4W8:O4 \S*"K1\J#RC#WZ%L].OIGH#7\*_C_1?VT_^"97QV^*W[/_ ,%/
MVD?B3<_"WPAI7@/XW_'CQQ\.OA_H4MEX/\/^/;J/3;OQC9_#/6;G6+>WET^Y
MO$BU&31;_2=-U*5X[W77L8+<7L'[<_!_]G']O7XZ>!/#?Q,^&'_!9'Q)XN\#
M^,-,AUC0/$>C_ 3P#<Z?<VL^&6VN#-=0W.GZI IVZAI<]O%<6,X:VN$2964>
M;AL2Y>U52G-3C+EDI.CR1DI.F_9R==2J4^:,H^T45%33IN3DM?V#Q'^BSD7!
M-'+N)GXX<"4/#_BS#8/-N#LZS#)?$7$8ROE^=T*>8Y1@,[H\/\$9O'(\[EE6
M(HXOZAF3PE6OAG''T*?U>HHT_P![=]Q_>C_[X>D,DX!):(  DDHY  &2>.N/
M;D]J_&7_ (8-_P""FO\ TEQ\:?\ B/\ X!_^3/;^?O3)?V#O^"F_ER&/_@KI
MXRCD".4D?]GOP#,B,%)5FB^W+YB*2"R;E++P&'!KI5:+M[JZ=:'7E_ZB7W\^
MFFJ/R*KX5\!4Z52I3^D+X<XBI"$YPH4LF\6U4KRC'FC2INKX:TZ2J56N2+JS
MA34I)SG&-VOV+N;J2:)# //0[D>:&)BD<O!$[Y<$6\8!$J!3(3C!X-?Q;_\
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MS^E'R_[/Z4 )N_Z:/^9_PHW?]-'_ #/^%+\O^S^E'R_[/Z4 )N_Z:/\ F?\
M"C=_TT?\S_A2_+_L_I1\O^S^E ";O^FC_F?\*-W_ $T?\S_A2_+_ +/Z4?+_
M +/Z4 )N_P"FC_F?\*-W_31_S/\ A2_+_L_I1\O^S^E ";O^FC_F?\*-W_31
M_P S_A2_+_L_I1\O^S^E ";O^FC_ )G_  HW?]-'_,_X4OR_[/Z4?+_L_I0
MF[_IH_YG_"C=_P!-'_,_X4OR_P"S^E'R_P"S^E ";O\ IH_YG_"C=_TT?\S_
M (4OR_[/Z4?+_L_I0 F[_IH_YG_"C=_TT?\ ,_X4OR_[/Z4?+_L_I0 F[_IH
M_P"9_P *-W_31_S/^%+\O^S^E'R_[/Z4 )N_Z:/^9_PHW?\ 31_S/^%+\O\
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MS^E'R_[/Z4 )N_Z:/^9_PHW?]-'_ #/^%+\O^S^E'R_[/Z4 )N_Z:/\ F?\
M"C=_TT?\S_A2_+_L_I1\O^S^E ";O^FC_F?\*-W_ $T?\S_A2_+_ +/Z4?+_
M +/Z4 )N_P"FC_F?\*-W_31_S/\ A2_+_L_I1\O^S^E ";O^FC_F?\*-W_31
M_P S_A2_+_L_I1\O^S^E ";O^FC_ )G_  HW?]-'_,_X4OR_[/Z4?+_L_I0
MF[_IH_YG_"C=_P!-'_,_X4OR_P"S^E'R_P"S^E ";O\ IH_YG_"C=_TT?\S_
M (4OR_[/Z4?+_L_I0 F[_IH_YG_"C=_TT?\ ,_X4OR_[/Z4?+_L_I0 F[_IH
M_P"9_P *-W_31_S/^%+\O^S^E'R_[/Z4 )N_Z:/^9_PHW?\ 31_S/^%+\O\
ML_I1\O\ L_I0 F[_ *:/^9_PHW?]-'_,_P"%+\O^S^E'R_[/Z4 )N_Z:/^9_
MPHW?]-'_ #/^%+\O^S^E'R_[/Z4 )N_Z:/\ F?\ "C=_TT?\S_A2_+_L_I1\
MO^S^E ";O^FC_F?\*-W_ $T?\S_A2_+_ +/Z4?+_ +/Z4 )N_P"FC_F?\*-W
M_31_S/\ A2_+_L_I1\O^S^E ";O^FC_F?\*-W_31_P S_A2_+_L_I1\O^S^E
M ";O^FC_ )G_  HW?]-'_,_X4OR_[/Z4?+_L_I0 F[_IH_YG_"C=_P!-'_,_
MX4OR_P"S^E'R_P"S^E ";O\ IH_YG_"C=_TT?\S_ (4OR_[/Z4?+_L_I0 F[
M_IH_YG_"C=_TT?\ ,_X4OR_[/Z4?+_L_I0 F[_IH_P"9_P *-W_31_S/^%+\
MO^S^E'R_[/Z4 )N_Z:/^9_PHW?\ 31_S/^%+\O\ L_I1\O\ L_I0 F[_ *:/
M^9_PHW?]-'_,_P"%+\O^S^E'R_[/Z4 )N_Z:/^9_PHW?]-'_ #/^%+\O^S^E
M'R_[/Z4 )N_Z:/\ F?\ "C=_TT?\S_A2_+_L_I1\O^S^E ";O^FC_F?\*-W_
M $T?\S_A2_+_ +/Z4?+_ +/Z4 )N_P"FC_F?\*-W_31_S/\ A2_+_L_I1\O^
MS^E ";O^FC_F?\*-W_31_P S_A2_+_L_I1\O^S^E ";O^FC_ )G_  HW?]-'
M_,_X4OR_[/Z4?+_L_I0 F[_IH_YG_"C=_P!-'_,_X4OR_P"S^E'R_P"S^E "
M;O\ IH_YG_"C=_TT?\S_ (4OR_[/Z4?+_L_I0 F[_IH_YG_"C=_TT?\ ,_X4
MOR_[/Z4?+_L_I0 F[_IH_P"9_P *-W_31_S/^%+\O^S^E'R_[/Z4 )N_Z:/^
M9_PHW?\ 31_S/^%+\O\ L_I1\O\ L_I0 F[_ *:/^9_PHW?]-'_,_P"%+\O^
MS^E'R_[/Z4 )N_Z:/^9_PI0W(_>/U'\1]?7M]:/E_P!G]*4;20!MR2 .G4]*
M!J]U:][JUM'>_3S[&[.9%\R:*25WN86BNI)+AW>9)-N_>0Y)SM&1GU!'-?U/
M_P#!K[\"_P!NWXX^*OVP+?\ 82_;<T']C+6?#/A[X*S_ !1E\2_ OP]\;[?X
M@:9J&M_$?_A$K+3E\22K'X73P_<VVN&X>U$EWJ']K[I9&AM56/\ E5:-X &>
M)5W 8VR$$G'&%'&3W[COVK^M?_@U4^ 7[57QT^*/[6TG[-_[9FK_ +(5EX(\
M.?!'4/BA9:%\+O#?Q%/Q@TO4[[XD6_AW2[NX\07MDWA4>%YK/4YUO=+\ZYU
M:U/&ZQK"'//2DXI15ZG-**3@X<_1-IRFOA6KU3LK13:2/4H8/!8O'83+\RQL
M\BAB)PC7Q>:_7,;1IPKU(QJ5:L,NP>*Q[A%2=2<*>"JU&DU"$FU&7]7\?[!/
M_!PC<J9X?^"ZWPS\N1W*A/V!OA.43#L"B&1]Y6,@HI<EB%RQ)R3)_P ,!?\
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MC_\ !>#XJ>#?#7Q"^'G_  7\^#GB[P3XPTF#7/#7B/1/V$_A#>6&K:;<<I+
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MB^G\_P#&F7%N,U.]VNDM5]S+T6GM+NDD=+>!#%Y]Q)YCQP+<9,3.(0[D.?E
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MM?"3_P";2O\ 3M^QP_WX_P#OR?\ /84OV.'^^G_?D_Y[G\Z/^(<Y5_T$8O\
M\"CY?].?+\?6Y_Q.IX@?]$CP_P#?B?+_ *F/]7]#_,1_XAQ?^"O?_1KMM_X=
MKX2?_-I1_P 0XO\ P5[_ .C7;;_P[7PD_P#FTK_3N^QP_P!]/^_1_P ]A2?8
MX?[\?_?D_3^5'_$.<J_Z",7_ .!1\O\ ISY?CZW/^)U/$#_HD>'_ +\3Y?\
M4Q_J_H?YB7_$.+_P5[_Z-=MO_#M?"3_YM*/^(<7_ (*]_P#1KMM_X=KX2?\
MS:5_IW?8X?[Z?]^C]?YT?8X?[Z?]^3_GL/RH_P"(<Y5_T$8O_P "CY?].?+\
M?6Y_Q.IX@?\ 1(\/_?B?+_J8_P!7]#_,1_XAQ?\ @KW_ -&NVW_AVOA)_P#-
MI1_Q#B_\%>_^C7;;_P .U\)/_FTK_3N^QP_WT_[\G_/<_G1]CA_OI_WY-'_$
M.<J_Z",7_P"!1\O^G/E^/K<_XG4\0/\ HD>'_OQ/E_U,?ZOZ'^8C_P 0XO\
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MX=KX2?\ S:5_IW?8X?[Z?]^C]?YTGV.'^_'_ -^3]/Y4_P#B'.5?]!&+_P#
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M.'^^G_?H_7^='_$.<J_Z",7_ .!1\O\ ISY?CZW/^)U/$#_HD>'_ +\3Y?\
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M7_@KW_T:[;?^':^$G_S:4?\ $.+_ ,%>_P#HUVV_\.U\)/\ YM*_T[OL</\
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M/#N.PU?A7@_/L0ZSQSJ/$<19;A\9B:=)T\3",:=*K7<:<6IRC""E.4N>T?\
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M<Y5_T$8O_P "CY?].?+\?6Y_Q.IX@?\ 1(\/_?B?+_J8_P!7]#_,1_XAQ?\
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ME_U,?ZOZ'^8C_P 0XO\ P5[_ .C7;;_P[7PD_P#FTH_XAQ?^"O?_ $:[;?\
MAVOA)_\ -I7^G=]CA_OI_P!^3_GN?SH^QP_WT_[\G_/8?E1_Q#G*O^@C%_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 51O>B?[R_^A"KU4;WHG^\O_H0JH_:_P +
M(GO2_P"O]#_T[ _&[X4?\ISOVL_^S*/@Q_ZE.GU^S(_A_P![_P")K\9OA1_R
MG._:S_[,H^#'_J4Z?7[,C^'_ 'O_ (FN.AO_ .#O_4BH?M?CC_R-_#O_ +,K
MX2?^L5EA-37^XW^ZW\C3J:_W&_W6_D:ZC\7/\JO_ (/!/^4P$O\ V:S\%/\
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M**7//3WOP7EY>0<E'_GP_P#P9/R_O^7_  ^MU\EO[Y_,_P"'I_C[4GE-_?\
MU/M_G\OQ**.>?\W;HNEO+R#DH_\ /A_^#)^7]_R_K6YY3?W_ -3[_P"?P/X'
ME-_?_4^W^?Q'XE%/VD_YOP7EY>0<E#_GP_\ P;/R_O\ E_6MSRF_O_J??_/Y
M_@OE-_?/YGU^GX?7\J2BESS_ )NW1=+>7D@Y*/\ SX?_ (,GY?W_ "_K6YY3
M?W_U/M_G\1^)Y3?W_P!3[_Y_ _@44^>?\WX+^[;IY!R4?^?#_P#!D_+^_P"7
M]:W/*;^_^I]O;_.1^)Y3?W_U/^?\_C112YZFGO=NBZ<OEY!R4?\ GP__  9/
MR_O^7]:W7RF_OG\SZ_3\/K^5)Y3?W_U/M_G\1^)13]I/^;M;1=+>7D@Y*/\
MSX?_ (,GY?W_ "_K6YY3?W_U/O\ Y_ _@>4W]_\ 4T44N>>GO?@O+R\@Y*/_
M #X?_@R?E_??;^M;GE-C[_XY..G^3]/SH\IO[_ZFBBCGG_-VZ+I;R\@Y*/\
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M2BESS_F[=%TMY>2#DH_\^'_X,GY?W_+^M;GE-_?_ %/M_G\1^)Y3?W_U/O\
MY_ _@44^>?\ -^"_NVZ>0<E'_GP__!D_+^_Y?UK<\IO[_P"I]O;_ #D?B>4W
M]_\ 4_Y_S^-%%+GJ:>]VZ+IR^7D')1_Y\/\ \&3\O[_E_6MU\IO[Y_,^OT_#
MZ_E2>4W]_P#4^W^?Q'XE%/VD_P";M;1=+>7D@Y*/_/A_^#)^7]_R_K6YY3?W
M_P!3[_Y_ _@>4W]_]3112YYZ>]^"\O+R#DH?\^'_ .#9^7]_R_K6YY38^_\
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M')1_Y\/_ ,&3\O[_ )?\/K=?);^^?S/^'I_C[4GE-_?_ %/M_G\OQ**.>?\
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M ()?^E0_I%3_ (-/?_>Z.Z?9^7],FMO^0IH?_84M?_0GK^'K_@F-_P GP?\
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M+5D_M;K='\I__!<S_D\'1/\ M#K_ ,%"/_4<\3U^_?\ P3Z_Y1_?L/?]FI?
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M?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL****
M^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL*
M*** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>
M7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON
M?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL****
M^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL*
M*** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>
M7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON
M?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL**** ^<ON?EY>7XL****
M^<ON?EY>7XL**** ^<ON?EY>7XL_A^_X*1?\GQ_\%3O^SC?^"-7_ */NJ_N/
MU#<-0U/H/]/N_O9'\9K^'+_@I"B']N7_ (*E;CC/[1__  1IR,^L]XA'H/D
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M^'_>_P#B:_&?X3_\ISOVL_\ LRCX,?\ J4Z?7[,#^'_>_P#B:XZ&_P#X._\
M4BH?M?CC_P C?P[_ .S*^$G_ *Q66$U-?[C?[K?R-.IK_<;_ '6_D:ZC\7/\
MJO\ X/!/^4P$O_9K/P4_]+/'E?RQ[O\ 9;\J_J<_X/!/^4P$O_9K/P4_]+/'
ME?RQ;Q[_ .?QH T;7[MU_P!>=Q_Z)%?[!O[$AQ^Q5^Q[P3_QB_\  GH/^J9^
M&J_Q\K7[MU_UYW'_ *)%?[!G[$C ?L5?L>@Y_P"37_@3_P"JS\-5^E>&W_(S
MQO\ V!Q_]+@?Q7]-G_DD^!?^QUB__4>F?3[GDG![<8YZ5^%_[7)S_P %T_\
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M<=_V 8+_ -*1^J>!W_)SN%_^QMFW_J)C?RV.V_X.(O\ E$7^UO\ ]??PB_\
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M[P'X 3Q7X64F'Q-X6TC5!:^';6*VMQE?!7CI9-5U75Y+;2S&^^6.3].?V?\
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MD,:HHB*P1K:PJD=O$EO!]FMXH8(PL44-O;8@ACB1(XHAM1  *E&W*G9G8I5
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M:Q_.?9?\$W_VY/\ @GO?7.N_\$I/VE1XP^#-KKLNH:C^PQ^U!J<FI^!(M/\
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MKD)M++[,\MI<W4,\9@CEDE<R2NUJIQ:X'J'Q-_X(1?\ !*GXL^.]4^(WB?\
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M>/\ 5O/S_+OH4444!=]X_P!6\_/\N^A1110%WWC_ %;S\_R[Z%%%% 7?>/\
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MR@I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JC>]$_WE_P#0A5ZJ-[T3_>7_ -"%5'[7^%D3WI?]?Z'_ *=@?C=\*/\
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M/K_T3/PU7Z5X;?\ (SQO_8''_P!+@?Q7]-G_ ))/@7_L=8O_ -1Z9]/.!DC
MQQV]J_##]KG_ )3I_P#!(KC_ )HO^VA_ZA4]?N>ZC)&../7TK\+_ -KD ?\
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M U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\
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M/^8>C^<OR/\ 4WZ'/_)I5I_S4^:Z?]N8(BV_[3?G_P#6K^[O_@Q[_P"2H?\
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MY7\L?S_[/ZU_4Y_P>"?\I@)?^S6?@I_Z6>/*_ECRW]W]10!H6OW;K_KSN/\
MT2*_V#?V)-W_  Q5^Q[C'_)K_P ">N?^B9^&J_Q\K7[MU_UYW'_HD5_L&_L2
M$_\ #%7['N!G_C%_X$]\?\TS\-5^E>&W_(SQO_8''_TN!_%?TV?^23X%_P"Q
MUB__ %'IGT\^[)Z9X]<=*_"_]KG/_#]/_@D5G'_)%_VT.F?^A*G_ /K5^Z#D
MY/'/'&?;UK\+_P!KG/\ P_3_ ."161C_ (LO^VA[_P#,E3U^A9]_NF$_[&&5
M?^K3"'\4^$'_ "4?$.__ ";KQ&[_ /1)YG_7J?N5%]V+_KD/_0C4M11?=B_Z
MY#_T(U+7LTOX&'_Z\4O_ $A'Y;B?][Q>_P#O-79/^9=EY?<%%%%68_.7W/R\
MO+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7
MW/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%%
M ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6
M%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\
MO+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7
MW/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%%
M ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6
M%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\
MO+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7
MW/R\O+\6%%%% ?.7W/R\O+\6%.7.1CK[_2FTY<Y&!G].U)[/T?Y#CO'66ZZ/
MNO+R_%D2[OM$_3[B>O3 _6OPO_X+W_\ )"_V)/\ M)W^R/\ ^E_BNOW04G[1
M/Q_ G?M@<_\ UJ_"_P#X+W_\D+_8D_[2=_LC_P#I?XKKP\__ .13CO\ L P7
M_I2/U3P._P"3G<+_ /8US7_U$QO]([;_ (.(O^41?[6__7W\(O\ U>'@>OUT
M\"D_\(!X$QC_ )$CP?\ 7/\ PC6F?T_6OR+_ .#B+_E$7^UO_P!??PB_]7AX
M'K]<_ N?^%?^!>/^9(\'_P#J-:9_^NJP_P#R4%?_ + ,-^=<[N(?^3)\)?\
M9>\;?^J[A<ZOG SZ=OJ?ZTE+S@<8X_J:2O=G\3^7Y(_&ULOBV71]EY>7XL**
M**D?SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R
M_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S
M\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'
MSE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1
M110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R
M_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S
M\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'
MSE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1
M110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R
M_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S
M\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'
MSE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1110'SE]S\O+R_%A1
M110'SE]S\O+R_%A3T^\/JO\ Z$*93T^\/JO_ *$*:W7JOS-*/\:E\7\2&Z?\
MT?+R_%GXL_\ !P7_ ,HC/VQ?^O;X/?\ JXO"%?Y=K;MO;[WOZG/]<?A7^HE_
MP<%_\HC/VQ?^O;X/?^KB\(5_EVL3MZ?Q>ON?Y?TK\6\0_P#D?X??_=Z/YR_I
MG^IOT.?^32K?_DI\U]?@P7XD7S_[/ZU_=W_P8]_\E0_X*+_]D^_9L_\ 3[\8
MJ_A$RW]W]17]W?\ P8]_\E0_X*+_ /9/OV;/_3[\8J_/S^L3_0TC_P!7'_N+
M_P"@BGTR/_5Q_P"XO_H(I] %*Z^\GU3_ -"-?C)^R[_RF:_X*5?]D9_9B_\
M3--7[-W7WD^J?^A&OQD_9=_Y3-?\%*O^R,_LQ?\ IFFJ,1\-/U_]P5S]K\(O
M^22^D'_V:*/_ *]+PJ/VC7JOU;^0J6HEZK]6_D*EJELO1?D?B4/A7S_-A111
M3*"D[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "J-[T3_>7_T(5>JC>]$_WE_]"%5'[7^%D3WI?]?Z'_IV!^-_PG./^"YW
M[6?_ &91\&/U\4Z>*_9@?P_[W_Q-?C-\*/\ E.=^UG_V91\&/_4IT^OV9'\/
M^]_\37'0W_\ !W_J14/VOQQ_Y&_AW_V97PD_]8K+":FO]QO]UOY&G4U_N-_N
MM_(UU'XN?Y5?_!X)_P I@)?^S6?@I_Z6>/*_EBW'^Z?\_A7]3O\ P>"?\I@)
M?^S6?@I_Z6>/*_ECW?[+?E0!H6OW;K_KSN/_ $2*_P!@S]B0D?L5?L>X4G_C
M%_X$_P#JL_#7M7^/G:_=NO\ KSN/_1(K_8-_8D./V*OV/>"?^,7_ ($]!_U3
M/PU7Z5X;?\C/&_\ 8''_ -+@?Q7]-G_DD^!?^QUB_P#U'IGTZY.<[3GT_#Z5
M^&'[7))_X+I_\$BN,?\ %E_VT/\ U"Y_\_C7[H.>2<'MQCGI7X7_ +7)S_P7
M3_X)%<$?\67_ &T.H_ZDJ>OT+/O]TPG_ &,,J_\ 5IA#^*?"'_DH^(=?^;=^
M(VG_ ':>9_Y7/W*B^[%_UR'_ *$:EJ*+[L7_ %R'_H1J6O9I?P,/_P!>*7_I
M"/RW$_[WB];?[35Z?WE_G_5@HHHJS'_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/D
MPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#
M_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z
M>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/D
MPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#
M_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z
M>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/D
MPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#
M_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z
M>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/D
MPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#
M_MY_=Z>7G^/DPI5.".,^U)3E.".#^'TI/9^C_(<=X^]U73SCY>?X^3(5)^T3
M?*?N(/T'/2OPP_X+W_\ )"_V)/\ M)W^R/\ ^E_BNOW04_Z1/P?N(.GL.?I7
MX7_\%[_^2%_L2?\ :3O]D?\ ]+_%=>'G_P#R*<=_V 8+_P!*1^J>!W_)SN%_
M^QMFW_J)C?RV.V_X.(O^41?[6_\ U]_"+_U>'@>OUS\"DCP!X$XS_P 41X/^
MG_(MZ8/_ *]?D9_P<1?\HB_VM_\ K[^$7_J\/ ]?KGX%/_%O_ O!_P"1(\']
MN/\ D6M,'^?:JP__ "4%?_L PWYUCNXA_P"3)\)?]E[QM_ZKN%SJLY XQQ_4
M_P#ZJ*7/ X/3O]325[L_B?R_)'XVME[SV73RCY>?X^04445(_P#MY_=Z>7G^
M/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHH
MH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_
M=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^
M/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHH
MH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_
M=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^
M/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHH
MH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_
M=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^
M/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHH
MH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_
M=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^
M/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPHHH
MH#_MY_=Z>7G^/DPHHHH#_MY_=Z>7G^/DPIZ?>'U7_P!"%,IZ?>'U7_T(4UNO
M5?F:4?XU+WF_WD.G]Z/EY_CY'XL_\'!?_*(S]L;_ *]O@]_ZN+PA7^78Q./N
MG[W\R?;MG]*_U$_^#@O_ )1&?MB_]>WP>_\ 5Q>$*_R[6/R]#][T]2?\G\:_
M%?$/_D?X?_L'H_G+\S_4SZ'/_)I5_P!E-FNO_</!:D.X_P!T_P"?PK^[S_@Q
M[_Y*A_P47_[)]^S9_P"GWXQ5_")N_P!EORK^[O\ X,>_^2H?\%%_^R??LV?^
MGWXQ5\ ?UD?Z&D?^KC_W%_\ 013Z9'_JX_\ <7_T$4^@"E=?>3ZI_P"A&OQD
M_9=_Y3-?\%*O^R,_LQ?^F::OV;NOO)]4_P#0C7XR?LN_\IFO^"E7_9&?V8O_
M $S35&(^&GZ_^X*Y^U^$7_))?2#_ .S1+_UZ7A4?M&O5?JW\A4M1+U7ZM_(5
M+5+9>B_(_$H?"OG^;"BBBF4%)W'T/\Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %4;WHG^\O\ Z$*O51O>B?[R_P#H0JH_:_PL
MB>]+_K_0_P#3L#\;_A/_ ,ISOVL\_P#1E'P8_P#4IT_'ZU^S _A_WO\ XFOQ
MF^%'_*<[]K/_ +,H^#'_ *E.GU^S(_A_WO\ XFN.AO\ ^#O_ %(J'[7XX_\
M(W\._P#LROA)_P"L5EA-37^XW^ZW\C3J:_W&_P!UOY&NH_%S_*K_ .#P3_E,
M!+_V:S\%/_2SQY7\L>Y?7^?^%?U.?\'@G_*8"7_LUGX*?^EGCROY9-P]1^=
M%^U^[=?]>=Q_Z)%?[!O[$A _8J_8]R?^;7_@3Z_]$S\-5_CY6OW;K_KSN/\
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M@5^%_P#P7O\ ^2%_L2?]I._V1_\ TO\ %=?N@I'VB?D?ZM1^@K\+_P#@O?\
M\D+_ &)/^TG?[(__ *7^*Z\//_\ D4X[_L P7_I2/U/P._Y.=PO_ -C7-?\
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MYP,D8&..WM7X8?M<_P#*=/\ X)%<?\T7_;0_]0J>OW/=1DC'''KZ5^%_[7(
M_P""Z?\ P2*Q_P!$7_;0_P#4*G_QK]"S[_=,)_V,,J_]6F$/XJ\(/^2CXAT_
MYMUXC?\ K)YEY'[E1?=B_P"N0_\ 0C4M11?=B_ZY#_T(U+7LTOX&'_Z\4O\
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MRT6RZ^2\O+\$%%%%2/7LOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\
MM?)?<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<%%%% :]E]_\ ]KY+[@HH
MHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]_
M_P!KY+[@HHHH#7LOO_\ M?)?<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<
M%%%% :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7L
MOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\ M?)?<%%%% :]E]__ -KY
M+[@HHHH#7LOO_P#M?)?<%%%% :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%%
M:]E]_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 51O.B?[R_^A"KU4;WHG^\O_H0JH_:_PLB>]+_K
M_0_].P/QN^$_/_!<[]K/_LRCX,?IXIT\U^S(_A_WO_B:_&;X4?\ *<[]K/\
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M7^UO_P!??PB_]7AX'K]=/ N?^%?^!.?^9(\'\>__  C6F<_TJL/_ ,E!7_[
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M1?D?B4/A7S_-A1113*"D[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH ****
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MA<ZOG SZ=OJ?ZTE'.!GT_J?ZYHKW9_$_E^2/QM/1?%LNCMM'^OO"BBBI'?\
MQ_<_+^OO[H**** O_C^Y^7]??W04444!?_']S\OZ^_N@HHHH"_\ C^Y^7]??
MW04444!?_']S\OZ^_N@HHHH"_P#C^Y^7]??W04444!?_ !_<_+^OO[H****
MO_C^Y^7]??W04444!?\ Q_<_+^OO[H**** O_C^Y^7]??W04444!?_']S\OZ
M^_N@HHHH"_\ C^Y^7]??W04444!?_']S\OZ^_N@HHHH"_P#C^Y^7]??W0444
M4!?_ !_<_+^OO[H**** O_C^Y^7]??W04444!?\ Q_<_+^OO[H**** O_C^Y
M^7]??W04444!?_']S\OZ^_N@HHHH"_\ C^Y^7]??W04444!?_']S\OZ^_N@H
MHHH"_P#C^Y^7]??W04444!?_ !_<_+^OO[H**** O_C^Y^7]??W04444!?\
MQ_<_+^OO[H**** O_C^Y^7]??W04444!?_']S\OZ^_N@HHHH"_\ C^Y^7]??
MW04444!?_']S\OZ^_N@HHHH"_P#C^Y^7]??W04444!?_ !_<_+^OO[H****
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M?^KC_P!Q?_013Z9'_JX_]Q?_ $$4^@"E=?>3ZI_Z$:_&3]EW_E,U_P %*O\
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M_P!.P/QN^%'_ "G._:S_ .S*/@Q_ZE.GU^S(_A_WO_B:_&?X3_\ *<[]K/\
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M+R\T%%%% 7_O/[EY>7F@HHHH"_\ >?W+R\O-!1110%_[S^Y>7EYH**** O\
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M ,"CO_PA'@__ -1K3!_.OR,_X.(O^41?[6__ %]_"+_U>'@>OUT\"$?\*_\
M @)Q_P 41X/_ /4:TRJP_P#R4%?_ + ,-^=8[N(?^3)\)?\ 9>\;?^J[A<ZK
M.0,>G]324I/ ^G]325[L_B?R_)'XXKV6JV73R7GY_B@HHHJ1W?=?=_P?-?>%
M%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?
M-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?
M=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%%
M7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%
M%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?
M-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?
M=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%%
M7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%
M%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?
M-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?
M=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%%
M7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%%%% 7?=?=_P?-?>%
M/3[P^J_^A"F4]/O#ZK_Z$M-;KU7YFE&_M:6J_B0Z?WEYGXL_\'!?_*(S]L7_
M *]O@]_ZN+PA7^7:Q&WK_%[]R<?S%?ZB7_!P7_RB,_;%_P"O;X/?^KC\(5_E
MVL1MZC[Q_F:_%O$/_D?X?_L'H_G(_P!3/H<_\FF7_93YK_Z1@B+<OK_/_"O[
MN_\ @Q[_ .2H?\%%_P#LGW[-G_I]^,5?PB[AZC\Z_NZ_X,>_^2H?\%%_^R??
MLV?^GWXQ5^?G]8G^AI'_ *N/_<7_ -!%/ID?^KC_ -Q?_013Z *5U]Y/JG_H
M1K\9/V7?^4S7_!2K_LC/[,7_ *9IJ_9NZ^\GU3_T,U^,G[+O_*9K_@I5_P!D
M9_9B_P#3--48CX:?K_[@KG[7X1?\DE](/_LT4?\ UZ7A4?M&O5?JW\A4M1+U
M7ZM_(5+5+9>B_(_$H?"OG^;"BBBF4%)W'T/\Q2TG<?0_S%  .@^@_E2T@Z#Z
M#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %4;SHG^\O_H0J]5&]Z)_O+_Z$*J/V
MO\+(GO2_Z_T/_3L#\;OA1_RG._:S_P"S*/@Q_P"I3I]?LR/X?][_ .)K\9_A
M/S_P7._:S_[,H^#'Z>*=/-?LP/X?][_XFN.AO_X._P#4BH?M?CC_ ,C?P[_[
M,KX2?^L5EA-37^XW^ZW\C3J:_P!QO]UOY&NH_%S_ "J_^#P3_E,!+_V:S\%/
M_2SQY7\LF!Z#\J_J;_X/!/\ E,!+_P!FL_!3_P!+/'E?RQ[%]/Y_XT :%K]V
MZ_Z\[C_T2*_V#?V) #^Q5^Q[D#_DU_X$]O\ JF?AJO\ 'RM?NW7_ %YW'_HD
M5_L&_L2*#^Q5^Q[D?\VO_ GU_P"B9^&J_2O#;_D9XW_L#C_Z7 _BOZ;/_))\
M"_\ 8ZQ?_J/3/IYP,D8&..WM7X8?M<_\IT_^"17'_-%_VT/_ %"IZ_<]U&2,
M<<>OI7X7_M<@#_@NG_P2*Q_T1?\ ;0_]0J?_ !K]"S[_ '3"?]C#*O\ U:80
M_BKP@_Y*/B'3_FW7B-_ZR>9>1^Y47W8O^N0_]"-2U%%]V+_KD/\ T(U+7LTO
MX&'_ .O%+_TA'Y9B;_6L7HG_ +35W]5Y,****LRU[+[_ /[7R7W!1110&O9?
M?_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\ [7R7
MW!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\ _:^2^X**** U
M[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:
M^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!111
M0&O9??\ _:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__
M +7R7W!1110&O9??_P#:^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^2^X*
M*** U[+[_P#[7R7W!1110&O9??\ _:^2^X**** U[+[_ /[7R7W!1110&O9?
M?_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\ [7R7
MW!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\ _:^2^X**** U
M[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:
M^2^X*<OWA^/\J;3E&2 ?\\4GL_1_D.-[K1;K\UY>2^XB4#[1/P/]6IZ>PK\+
M_P#@O?\ \D+_ &)/^TG?[(__ *7^*Z_=!5'VB?C^!#WZX%?A?_P7O_Y(7^Q)
M_P!I._V1_P#TO\5UX>?_ /(IQW_8!@O_ $I'ZGX'?\G.X7_[&N:_^H>-.V_X
M.(O^41?[6_\ U]_"+_U>'@>OUT\"_P#)/_ O'_,D>#__ %&M,K\B_P#@XB_Y
M1%_M;_\ 7W\(O_5X>!Z_73P(,^ / G')\$>#QGG_ *%K3#_.JP__ "4%?_L
MPWYUSNXA_P"3)\)?]E[QM_ZKN%SJCT'T_J:2EQ@#'I_4C^E)7NS^)_+\D?CB
MO9:+9=?)>7E^""BBBI'KV7W_ /VODON"BBB@->R^_P#^U\E]P4444!KV7W__
M &ODON"BBB@->R^__P"U\E]P4444!KV7W_\ VODON"BBB@->R^__ .U\E]P4
M444!KV7W_P#VODON"BBB@->R^_\ ^U\E]P4444!KV7W_ /VODON"BBB@->R^
M_P#^U\E]P4444!KV7W__ &ODON"BBB@->R^__P"U\E]P4444!KV7W_\ VODO
MN"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\ ^U\E]P4444!K
MV7W_ /VODON"BBB@->R^_P#^U\E]P4444!KV7W__ &ODON"BBB@->R^__P"U
M\E]P4444!KV7W_\ VODON"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB
M@->R^_\ ^U\E]P4444!KV7W_ /VODON"BBB@->R^_P#^U\E]P4444!KV7W__
M &ODON"BBB@->R^__P"U\E]P4444!KV7W_\ VODON"BBB@->R^__ .U\E]P4
M444!KV7W_P#VODON"BBB@->R^_\ ^U\E]P4444!KV7W_ /VODON"BBB@->R^
M_P#^U\E]P4444!KV7W__ &ODON"BBB@->R^__P"U\E]P4444!KV7W_\ VODO
MN"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\ ^U\E]P4444!K
MV7W_ /VODON"BBB@->R^_P#^U\E]P4444!KV7W__ &ODON"BBB@->R^__P"U
M\E]P4444!KV7W_\ VODON"BBB@->R^__ .U\E]P4]/O#ZK_Z$M,IZ?>'U7_T
M(4UNO5?F:4;^UI:+^)#K_>7D?BS_ ,'!?_*(S]L7_KV^#W_JX_"%?Y=K ;>@
M^\>WN:_U$O\ @X+_ .41G[8O_7M\'O\ U<7A"O\ +M91MZ?Q>_8G'\A7XMXA
M_P#(_P /_P!@]'\Y'^IGT.?^33+_ +*?-?\ TC!?UL1X'H/RK^[K_@Q[_P"2
MH?\ !1?_ +)]^S9_Z??C%7\(FQ?3^?\ C7]W?_!CW_R5#_@HO_V3[]FS_P!/
MOQBK\_/ZQ/\ 0TC_ -7'_N+_ .@BGTR/_5Q_[B_^@BGT 4KK[R?5/_0S7XR?
MLN_\IFO^"E7_ &1G]F+_ -,TU?LW=?>3ZI_Z$:_&3]ET_P#&YK_@I2/^J,_L
MQ_\ IGF_QJ,1\-/U_P#<%<_:_"+_ ))+Z0?_ &:)?^O2\*C]HUZK]6_D*EJ)
M>J_5OY"I:I;+T7Y'XE#X5\_S84444R@I.X^A_F*6D[CZ'^8H !T'T'\J6D'0
M?0?RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ JC>]$_WE_\ 0A5ZJ-[T3_>7_P!"
M%5'[7^%D3WI?]?Z'_IV!^-WPH_Y3G?M9_P#9E'P8_P#4IT^OV9'\/^]_\37X
MS?"C_E.=^UG_ -F4?!C_ -2G3Z_9D?P_[W_Q-<=#?_P=_P"I%0_:_''_ )&_
MAW_V97PD_P#6*RPFIK_<;_=;^1IU-?[C?[K?R-=1^+G^57_P>"?\I@)?^S6?
M@I_Z6>/*_ECV_P"TWY__ %J_J<_X/!/^4P$O_9K/P4_]+/'E?RQ;3_>/^?QH
M T;7[MU_UYW'_HD5_L&_L2#/[%7['O)'_&+_ ,">A_ZIGX:K_'RM?NW7_7G<
M?^B17^P9^Q("?V*OV/<,1_QB_P# G_U6?AKWK]*\-O\ D9XW_L#C_P"EP/XK
M^FS_ ,DGP+_V.L7_ .H],^GW')&3VYSSTK\+_P!KD8_X+I_\$BN2?^++_MH=
M?^Q*GK]SW!SC<<^OX?6OPP_:Y!'_  73_P""17.?^++_ +:'_J%S_P"/Z5^A
M9]_NF$_[&&5?^K3"'\4^$/\ R4?$.G_-N_$;_P!9/,_^&/W*B^[%_P!<A_Z$
M:EJ*+[L7_7(?^A&I:]FE_ P__7BE_P"D(_+<3_O>+TO_ +35Z_WE_P .%%%%
M68_]NO[_ $\_+\/-A1110'_;K^_T\_+\/-A1110'_;K^_P!//R_#S84444!_
MVZ_O]//R_#S84444!_VZ_O\ 3S\OP\V%%%% ?]NO[_3S\OP\V%%%% ?]NO[_
M $\_+\/-A1110'_;K^_T\_+\/-A1110'_;K^_P!//R_#S84444!_VZ_O]//R
M_#S84444!_VZ_O\ 3S\OP\V%%%% ?]NO[_3S\OP\V%%%% ?]NO[_ $\_+\/-
MA1110'_;K^_T\_+\/-A1110'_;K^_P!//R_#S84444!_VZ_O]//R_#S84444
M!_VZ_O\ 3S\OP\V%%%% ?]NO[_3S\OP\V%%%% ?]NO[_ $\_+\/-A1110'_;
MK^_T\_+\/-A1110'_;K^_P!//R_#S84444!_VZ_O]//R_#S84444!_VZ_O\
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MK^_T\_+\/-A1110'_;K^_P!//R_#S84444!_VZ_O]//R_#S84444!_VZ_O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_ P__7BE_P"D(_+<3_O>+W_WFKM?^9?UZ7[!1115F-O\?WOR_P _S[(****
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M04444!;_ !_>_+_/\^R"BBB@+?X_O?E_G^?9!1110%O\?WOR_P _S[(****
MM_C^]^7^?Y]D%%%% 6_Q_>_+_/\ /L@HHHH"W^/[WY?Y_GV04444!;_'][\O
M\_S[(**** M_C^]^7^?Y]D%%%% 6_P ?WOR_S_/L@HHHH"W^/[WY?Y_GV044
M44!;_'][\O\ /\^R"GIG</JN?^^A3*>GWA]5_P#0A36Z]5^9I17[ZE\7\2&[
M?\T?Z^\_%G_@X+S_ ,.C/VQO^O;X/8_\/%X0K_+L;=CJ/O?U.>WUK_43_P"#
M@O\ Y1&?MB_]>WP>_P#5Q>$*_P NUMVWM][W]3G^N/PK\5\0_P#D?X??_=Z/
MIO+^G\C_ %,^AS_R:5;_ /)39KMO_#P7XD.']1_G\*_N\_X,>_\ DJ'_  47
M_P"R??LV?^GWXQ5_")\_^S^M?W=_\&/?_)4/^"B__9/OV;/_ $^_&*O@#^LC
M_0TC_P!7'_N+_P"@BGTR/_5Q_P"XO_H(I] %*Z^\GU3_ -"-?C)^R[_RF:_X
M*5?]D9_9B_\ 3--7[-W7WD^J?^A&OQD_9=_Y3-?\%*O^R,_LQ?\ IFFJ,1\-
M/U_]P5S]K\(O^22^D'_V:*/_ *]+PJ/VC7JOU;^0J6HEZK]6_D*EJELO1?D?
MB4/A7S_-A1113*"D[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "J-[T3_>7_T(5>JC>]$_WE_]"%5'[7^%D3WI?]?Z'_IV
M!^-_PG./^"YW[6?_ &91\&/U\4Z>*_9@?P_[W_Q-?C-\*/\ E.=^UG_V91\&
M/_4IT^OV9'\/^]_\37'0W_\ !W_J14/VOQQ_Y&_AW_V97PD_]8K+":FO]QO]
MUOY&G4U_N-_NM_(UU'XN?Y5?_!X)_P I@)?^S6?@I_Z6>/*_ECRW]W]17]3G
M_!X)_P I@)?^S6?@I_Z6>/*_ECW?[+?E0!H6OW;K_KSN/_1(K_8-_8D)_P"&
M*OV/<#/_ !B_\">^/^:9^&J_Q\K7[MU_UYW'_HD5_L&_L2''[%7['O!/_&+_
M ,">@_ZIGX:K]*\-O^1GC?\ L#C_ .EP/XK^FS_R2? O_8ZQ?_J/3/IYR<GC
MGCC/MZU^%_[7.?\ A^G_ ,$BLC'_ !9?]M#W_P"9*GK]T'/).#VXQSTK\+_V
MN3G_ (+I_P#!(K@C_BR_[:'4?]25/7Z%GW^Z83_L895_ZM,(?Q3X0?\ )1\0
MZ_\ -NO$;_UD\S_RN?N5%]V+_KD/_0C4M11?=B_ZY#_T(U+7LTOX&'_Z\4O_
M $A'Y;B?][Q>K7^TU?\ TI+L^X44459C?^\_N7EY>:"BBB@+_P!Y_<O+R\T%
M%%% 7_O/[EY>7F@HHHH"_P#>?W+R\O-!1110%_[S^Y>7EYH**** O_>?W+R\
MO-!1110%_P"\_N7EY>:"BBB@+_WG]R\O+S04444!?^\_N7EY>:"BBB@+_P!Y
M_<O+R\T%%%% 7_O/[EY>7F@HHHH"_P#>?W+R\O-!1110%_[S^Y>7EYH****
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M_N7EY>:"BBB@+_WG]R\O+S04444!?^\_N7EY>:"BBB@+_P!Y_<O+R\T%%%%
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M*GK]T'(R3D8X_E7X8?M<G_C>G_P2*_[(O^VA_P"H5/7Z%GW^Z83_ +&&5?\
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M_P 7OW)Q_,5_J)?\'!?_ "B,_;%_Z]O@]_ZN/PA7^7:Q&WJ/O'^9K\6\0_\
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M7H[:A?8%O?:FUU T.EI!-J%\T5S8V<3S@2#\SOVP/^"H_P 4?V4?^"6WP?\
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M#PE^TO\ ##]KWQ+XU^'/C;P=\6O ][I U:W^'L^E-IL>N?#^Z$MR]IXDC2&
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M"8?!PQ&(E4AA\+#DPU*,KRBJ2FG549)\\?:3;DFZC47/DB4445L>7KV7W_\
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M'KV7W_\ VODON"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\
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MZ=',(XZM6AAZ$\)7ISP[G#%1G).5)? _[)?[<?\ P6A_:F\1?$ZU\&?L]_\
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MK\9/V7?^4S7_  4J_P"R,_LQ?^F::HQ'PT_7_P!P5S]K\(O^22^D'_V:*/\
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MB^[%_P!<A_Z$:EJ*+[L7_7(?^A&I:]FE_ P__7BE_P"D(_+,2O\ :\7[M_\
M::O;^9?U^'5A1115F-O[GXKR\_Z^;"BBB@+?W/Q7EY_U\V%%%% 6_N?BO+S_
M *^;"BBB@+?W/Q7EY_U\V%%%% 6_N?BO+S_KYL**** M_<_%>7G_ %\V%%%%
M 6_N?BO+S_KYL**** M_<_%>7G_7S84444!;^Y^*\O/^OFPHHHH"W]S\5Y>?
M]?-A_GT_G0=RR1>2P0AP^\\JI4@KN SQQV]>>:**'JK/5:Z=/7U70TA-P34:
M:3<Z4N>_OI4Y*;A%\RY8U&DIM6DU%6DGJ?E9^S;_ ,$I?@O^S7^WK^TO^W7X
M<UG7/%/C+]H"*]UO0M \5V\9_P"%6^)O&&LRZK\2TT?QG:ZG)?ZAI?B^ZDEC
MFTB]\-2K8:']DM;;59+B)S7HG[$'_!/7P#^PUKW[4/C[PGJTWCGXD?M4_'?Q
M=\6O%?BJ]TE/#=_HGAS7=9O=:T#X8^=I^KWD.K>'/!^JZMXAUK3->>SM=8U&
M\\0WL%[:0V\<03]#Z*\RGE&!I3C.G2<)1G4J:2D[RJVYW)2NI*T8I)I\JC%1
MLHI'Z%F7BIQKFV$S#!8W,Y3HYGE>69+BU"G2A*>69-.E4RW"J<4IJGA:E-SY
M>;EKSG.6)59U)-_#6N_L%_![7?VP-=_;#U.+4-3\7^._V7O%_P"RE\4_!MY;
MZ?/X0^(OPZ\3ZWI&J"?4[FWBTW5;?7$TRTU?P[JKO]K.NZ;JME'-?V":':I+
M^5Z_\&^LFBVGQ&^%'@'_ (*"?M+^"?V,_B9XZ\.Z_P"+?V2K.PL[C3[WP'HE
M^]\OPUTOXCW'BJ;5-+M+:WNK[3=.N;31;?39(;B'^V])U4VS//\ T:T5G7R+
M+<0K5*'64FXSE!MS<7--P<7*,^5<\7>,WK).[OV9/XS^(^17CE^?U(47@\!E
M\<-6PF Q6&IX7+(5(X!4:.)P]6G1Q&$=63HXVE&&-BE"'M_9I17YJ?!O_@E[
M\%O@9^T)\ ?COX)\8_$N/3_V:_V:-0_9S^$?PSO=<TZZ\.>&M(U9I;36==N[
MC3M(\/W6KZ[XFTN>2Y\4R709]7\4/+KTU^V1:CM?V[?V%?#O[;WA3X0:3J_B
M_5/A]XX^"'QB\)_%/X??%/1H+_5?$7A:#0M4M;OQ!H'AL#7M%:P7QOINGV6D
M:O?/*UQ8VL""$WB1B*3[VHJJ62972PT\)'!TO959*=32TIRCR6?/&TH_!%6@
MXV27+RM)GF5?$[C:KG6!XCEG>-_MS*^7^S<P=><Y8*TI3FJ>&J3G@ZL:LJM=
MUH8C#UH5?;5%4C+FT^%_V-OV(=,_8^T3]H71=,\?WGQ&TS]H3]IKXK_M'ZIH
MNO:!I^C:1X:?XI&"74?!]IIL$NJVFL06DMNEI!>W@@AO=/?_ $FQ@VBV/)_L
M=?\ !/#X;_L/?%C]KCQ[\']3:R\-?M8>/O!GCG_A7&A>%['P[X2^$Z^&;+6;
M>[\/:'MUN_N-=T_5;WQ%J&K-+)%I*Z?<1+'9V?D'R3^BE%=,<OP<9X::H13P
MCDZ%M.1S7++;XDUK:7-'FM.W.HR6&/\ $7C#,'Q/*IFM:G4XSE@GQ-.DJ:_M
M2&!E3GAZ=2G)2I4+2IIRJX6G0KR3G!U>2I.+^0O@!^R/X2_9T^,?[6WQ;\&Z
MSX@O9/VMOBGX=^+'BO0]::VN$T+Q?HWAZ^T/7+K2-4B87%SX?\22WJ:AI^B7
MEO')X<:W:UBNKV*8&+Z[C+%3O!''3/7IG^I_^L*=171AJ5/"4W2HQM%U*E35
MNZE4FYRMZR<GKUD]MCY_.<]S3/LVGG.85W/%SPN"P;4(TXTE1P& PV78=<O+
M>4EA\-34I3E*4I7NVK)8^N:)8:_IFHZ-JUI#J6D:UIFH:+K&EW6XVFI:5JUI
M-8ZC8W(C=)/(O+.XFMI@C(_E2-L8'D?A#9?\$5OB]\+;'XD_#S]D?_@IM^TM
M^RQ^SEXRUKQ%J'AS]G[0/"7AKQ]H'@BQ\8:9:V/B32=&\3:[XBTK6DT^[NVO
M)[-K"+1[K2]/*Q1R76IQOJ5U^^U%88_ X?,8P6)C.\(RIQG3J5*,U";BY1YJ
M4HR:;BKIMKR/;X5X]XFX,EF*R#$X:AALUQ&"Q>88#%Y=EV:8"OB,!S?5ZRPN
M9X;%TJ56'/-*K1C3J)2<5-1;BOEK]D#]DWX3?L4_ KPE^SW\'=%U.#PGX>NM
M6U75M8U75&O=>\=^,]>M5_X2SQOXYU2X,[WUUXLNH(4FLK:T$%C9QVEK''(8
M3.?/OV#_ -BO3_V%OV?+7X"Z1XWOOB+&GQ)^)'Q''B^;1[;PY?Q7?Q)\4S:[
M>Z)<Z1]OUFQ;2]-AG-G-<0RF35+57=K2VE<0K]S45-++L'2>$<**7U+#U,-0
MLVE&E5Y>=<J]WWN2/V=+:6O*ZQG'W%F8X?.</C\TJXN&?YGA<WS2=6%'VN(Q
M^#=5X6O[:,8U(.A[>LH0IRA!J:<XR<*;I_@?\7_^"%MAJ'CSXZ>*_P!DS]M7
M]H+]CS0?VGK75[_X[?#GP=I?A_Q)X'\5>*M:\1:AK3W.@M!J/A*^^'VA:=!=
MQ:;9Z;X;M)M2CL+>."'78[9C9I].Z;_P2?\ @WX/_P""<OQ8_P""?7P[\8^+
M?#=O\<]#N$^*WQHUQ%\9^,/&7Q,UNZ\-W7BSXKZOIFH:G907E[J__",V5A9Z
M:-4@EM-&CLK>XO;R\M'O)_U3HKSJ7#F6T93:A4G&<)TI4YU)NFJ51-3A"*:5
M-2YI-NGR2;E)MMRDW]-C/&OQ$QV&P&&KYO"V78G+<;0K4\#@*>(JXO*(THY;
MB,=6A04\QJ8.-&E&D\>\0G"E3A-2A%)?,OB_]E_X6?$K]E=_V1?C!X<E^(WP
MOU'X3^#_ (1^*8[-4\-W_B*V\)Z+X=T/2_%\,EIJ)_LS7M.N-!LO$=GM:6&V
MU"T@WQWJV\<4OYS_ +)/_!%3P3^R=^T[\$OVD?\ AI_XX?&6]_9T^!H^#/P8
M\&>,VT[3?#G@NWU"#7-'U6>R_LN=A#X:'AK7KVQMO",5EEM:FD\2:EKVJS^5
M81?ME17?5RO 5JM.K/#0<Z2C&#UM%0LX:=>62YDG>-];7O?S<#XK\?Y;EN?9
M5@L]JX;"<25*M7-8T<-@J;JSQ,)T\9.ERT$L/5Q=.?)7K8=4ZTX4Z<?:))GQ
M9^V5^QAH_P"V%-^SUJ6J_$_XA_"_Q7^S3\:=%^.OPW\8?#S4K6'6[/Q!IOEV
MFKZ<O]K6EW8PW6M:*LFGZ3K$EO<MX?N)%OEMKL!K1_SZ^.G_  1&L=6_:B\=
M_M:_L<?M@?&?]B#Q[\8]!U73_C!I?P[T&P\70>,=<\4/>0^+_%-S<ZQXGTQK
M74/$L4_]JZU$5U!V\1W&H>(='OM&O+QX%_=BBN3$</Y7BJCJUL-&527(Y2BY
M4Y-TU*,6G3<'!J+Y;PY6U&/,VTF=&1>+_'_#6'IX7)\[KX>C0AB*.%IXA4\R
MI8?#XJI0KU\.J&9+%4*]*6)HO%06*I5W1Q%6K4H.G*=X_BMX0_X(=_LW?"S]
MB+]H_P#8^^%?BWQ?H/B#]J[0_#.F?&3]H?Q)M\>>/?$>HZ'J^E:^UW+H-_>:
M+IEEHBZU8:IJ%CI27UY?V5SXDU*ZDUC4)75(^>T'_@EK_P % /#6C>&?"^B_
M\%O_ -IJS\/>&-'TS0],TZ/X)_#86.E:1I-M#8Z1IFF&XUJ[FFBTRSM+:$?:
MD0M&B!7)W5^Y5%9QX;RNG4IU*5*=!TX\D8X>K4P\7%2E.TE1E!2?-.3;>K;=
M[GI4_'+Q"C'&QQ&.P.9+,<9/'XUYQE66YS*KC*M+#T*M:$LTP^+E04J6%H05
M+#NE1@J--4Z<;:>3?!WP'XU^''PL^'W@OQU\4M?^,WC;PQX8LM(\4_%#7M'T
MOP[KOCK7=,N)99?%FMZ1IES<:?!JVL0F*U\BVN'MQ$FZ9PS''J=O')%!%'++
MYTB(!)+L$?F/_$_EJ65,G^$,0.QQ4U%>Y"*A&,%=J*44Y-RE:*LKR=Y2LNLF
MVW=MMMM_EV9YA6S7&5L;7HT*56O4G5G3PM*GAL.JE62G4E3PU+EHTDYN34:4
M(0A%JG",:480@44451P6_N?BO+S_ *^;"BBB@+?W/Q7EY_U\V%%%% 6_N?BO
M+S_KYL**** M_<_%>7G_ %\V%%%% 6_N?BO+S_KYL**** M_<_%>7G_7S844
M44!;^Y^*\O/^OFPHHHH"W]S\5Y>?]?-A1110%O[GXKR\_P"OFPHHHH"W]S\5
MY>?]?-A1110%O[GXKR\_Z^;"BBB@+?W/Q7EY_P!?-A1110%O[GXKR\_Z^;"E
M49(%)2KR0,X]Z3V?H_R'%>]'W.JZKNOZ_P"'9$J@7$PYX1#^@K\,/^"]_P#R
M0O\ 8D_[2=_LC_\ I?XKK]SU!^T3?,?N(?T''6OPP_X+W_\ )"_V)/\ M)W^
MR/\ ^E_BNO#S_P#Y%.._[ ,%_P"E(_5? [_DYW"^G_,VS;_U$QOY[G;?\'$7
M_*(O]K?_ *^_A%_ZO#P/7ZY^!1GP!X$]?^$(\'C_ ,MO3#_.OR,_X.(O^41?
M[6__ %]_"+_U>'@>OUS\"@_\(!X%.?\ F2/!_'_<MZ8?_K56&_Y*"O\ ]@&&
M_.L=W$/_ "9/A+_LO>-O_5=PN=5C 'T_J1_2BCH!SGC^I'_UZ*]V?Q/Y?DC\
M;2T7N]%V[+S_ *MYL****D+?W/Q7EY_U\V%%%% 6_N?BO+S_ *^;"BBG$9#,
MK@E)/+;D9$F 0C#.02&! ./4=*:M]IV7W%1I3G&3ITG)PLY))R?+ULE?73K^
MK0;3ZCIG'.<>O3_Z_KBD W#<.G/Z5#'.)&"@DDGANQYQQZXY'\ZD.]9-N24Q
MU^O4?_6_E5NF]DTG:_O;->5K:ZJPI5,-+EG0A5E#2E/F<>:->5K7LO@]UWVU
MZ[D?FIDC))!QT/6I<TS?"DL<+2(LLJ2R1(Q59)4@V&9E!SN$>]/,_NAU)ZU&
M+JV8!EE$BDD!D8%#@D, >02#U /7/IFGRK[,92DK7C'=MVVO;3KOWU-)8=48
MJ5?%X12GK3I)5.>23C=-I2UBFKZ===)$]%0BXA9@H)+') # D@#<> .P!/T!
M]Z5)X)!$RN-DX<Q/N&V3RU+.$(QDJH)(SD &IY7UI5(KN^7M?^;71-[=]--,
MU%2^&5*3T24?:N[O%=::6[2U:U:N]7>6G;6ZX]^U(0GFF#S1YP0RF+@N(PYC
M+E>2%\Q63/\ >!';%*WRCEF( S^'Y_TJ=':UVOO^ZR*=-PTG'E?FFM--7?\
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MX?NM)TSQ'-K>C:I=ZJ'\*:A=+J]I#]F$MW/;1Q,T,32))\3? _\ X(N_M?\
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M\4^$'_)1\0[_ /)NO$;O_P!$GF?]>I^Y47W8O^N0_P#0C4M11?=B_P"N0_\
M0C4M>S2_@8?_ *\4O_2$?EN)_P![Q>_^\U=F_P"9=GY_<%%%%68_*7WOR\_/
M\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WO
MR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?
M*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%
M%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/
M\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WO
MR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?
M*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%
M%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/
M\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WOR\_/\&%%%% ?*7WO
MR\_/\&%%%% ?*7WOR\_/\&%.7.1CCW_"FTY<Y&.OO]*3V?H_R''>.DMUU?=>
M?G^#(ES]HGY_@3MVP.*_"_\ X+W_ /)"_P!B3_M)W^R/_P"E_BNOW07=]HGZ
M?<3UZ8'ZU^%__!>__DA?[$G_ &D[_9'_ /2_Q77AY_\ \BG'?]@&"_\ 2D?J
MG@=_R<[A?_L:YK_ZB8W^D=M_P<1?\HB_VM_^OOX1?^KP\#U^N?@7/_"O_ O/
M_,D>#^,?]2UIG_ZJ_(S_ (.(O^41?[6__7W\(O\ U>'@>OUT\"Y_X0#P)C'_
M ")'@_ZY_P"$:TS^GZU6'_Y*"O\ ]@&&_.L=W$/_ "9/A+_LO>-O_5=PN=5S
M@=^/ZG_]=)2\X&?3M]3_ %I*]V?Q/Y?DC\;6R^+9=7V7GY_@PHHHJ1_*7WOR
M\_/\&%'4X'7T[TH!)Q3=I1BWYY],?_6[>F.*J,;IZZ]%]Q,N96DHRY$USRO+
MW5IK:^N_YCB".O'^?T_&OSW_ ."@?_!07X-?\$W_ ($7WQY^+OA76O%VHZ[X
MRT+P%X0\#^%M5TBUUOX@ZOJEO?7/DMJ6L>;'X9T70=!M-:U&]O;JWN-.$T<&
MEMLN=8ML_H*TAE^1#DD@?*"3SQV.<^@K_.1_X.5?VM]-_:#_ &]1\)/#7BF7
M5_AS^S!X*C\ 0VL-MHM[H6E?%77Y_P"TOB7>:%K.G>:WB#3[ZQ'A:UD:6=9+
M36=%N;2."TD@E=_FN*\XI9'EOM6V\36J*G0IQ:C*UDZDM4_A35ERN[Y=DV?T
M#]&_PY7B1XD4,%5YJG#N4X.IC\[JN%1PJT;QC2PW-%KV<JM6+@ZBJTIJE[7D
M?,['^A;\+?B-X,^,GPU^'WQ<^'&NV/B7P/\ $7PGH_B_PKK6F7(OK&_TC5K2
M.YC:WNU2,7*VDAEL99DCCC,UK)Y:*FT#T;&X!MP((/Z>X.!_DU_-A_P;3?M?
M^)/C_P#L/W_P,\3ZA'-KW[)&N6?@KPYK"ZMX>N=8UCX=>(K:XU7PMI4'A.UL
M-/U.QT/P+8Q7&BW?B+4KO4(=0U._LK6YF>6.-&_I$LY#):Q3#8JSJ)U1&9E5
M)!D(-T<3+@<E'0,N=ISUKOR;,7F6 PN,C9>UH_O%UA47+S1[;[6TL^CT/C/%
M'@V7A_QMG^0NG>A/%5Z^%33Y?J56?-@,1"I]IUJ+DY*4:<XR37*[-GD?Q]^+
MG@_X"_!_X@_&7XBIK\G@?X:^'9O%/B>/PMX=F\7Z_/HT5Y9Z==6NE^&;3%]J
M5R\M_;2F.V;?Y,3LV$C9J_&.\_X.4?\ @E=X2N)-#U'Q+\>=#O\ 3BEK<:7?
M_L[>)-&N;<J@DW7%A>:@)[>:7S-_ER0PMM*L!M<5^^5S'<8>2VCMVN2J>4UT
M2T+%'+>5'N8"WE*ALSQJ9"3"Q.8(\_P[_P#!V1\&?AGX6^)7[)'QN\*> -#\
M/?$3XNZ;\4]#^(^M6"X?Q79^!D\%GPV_B58@IU;Q!IZ:[K:WGBBZ']L7^GS:
M?;7<HBTNQV>-Q/C<RRG"5LSPV*IJG14+TJE#F3YZD87;51)ZR3473M[LFYW4
M8GZ']'_A'PWX\S>APMQ7D^:O-,=#&5<+G6!S58:=&&$PT\9[)866"J1M*%"I
M"=;ZPY.52C3AAN13K+]AYO\ @YM_X)0W#0>9\0_C9:(CF8,WP-\1HDK(I"KB
MVOP9"CLLBAPT:R(A8' KV7X,_P#!?7_@E?\ &/Q1K>DV7[2\7PW@L]!M=;EO
M?CEX+O?AKX;UB]%W%;,GA_5=1WR:OXJMVECFN-,F"QK9K)+;;VB?'YY?\&VG
M[*/[,7Q%_8'U[XL_$W]GGX._$;XF>,OC]X[\/7GB7XB>#/#/C^[DT?P!8>'(
M=)TGP_HWBO2M4T[PS;:;::YJ4EQ'I<,;ZW/*MYJ<TTME9^7Y;_P6%_X-_P#]
MFGP]^SAXW_:;_8Q\-VWP>UWX*^'/%7Q%^(_@V_\ $?B/4O#GQ%\$03R:QKLF
MG3>)+C6[SPUXX\/1+-<>'DT]K3P]J6G)_8$]C:7<D.K0^32S3BR>3T\Y4L)B
M,,U&K/#TJ#A45%-.3;Y^B3D^5)^[ISNR/TK%\(?1RP/B%FGAMB:G'F4YMALQ
M_L?!9O7Q^&Q>75L;4C!475I+!Q="-2I.-%.;G",:TJU:I0I*4X_UE_#[X@?#
M_P"*/A[0O'OPX\:^'O'OA7Q?9QZIH/B+PUK::[H^K6%Q:1:NM]!/83-;Z;*T
M-U'*NG7PCG$; FW!''2>*=?LO"7ASQ'XKU9;Q]*\*:#K/B/5ET^REU#4#IN@
MZ9=:O?+9:?;JUQ>WIM+286EE"K37<YC@B5GD4'_-M_X-[?VW?&?[*W[<GP^^
M%]QXJOH_@-^TOXA3X;>-/!6I^*K'1/ ECXPUB%++PU\2-8GUFVN[/2[GPQ<Q
M1(;VP>PU;6+&6#2)=4%M B#_ $G[:6YMY9(08[>%)S$8;B5I[^+4BK2Q74MX
M'_TBQDM]LEJ ,RQE,9S@?0<-Y]3S["8BI24:.+H2<)T>9SA%VM&:DDFUHURN
M*;E&2;Y;7_)_''P@GX4<49=EV*Q>(S'*,PPE#'X+&.A]4KXNE.<95J%1*5>-
M&JU=0JQ=6+A.$U3<E4@OP7UC_@Y9_P""7_AVZ2P\0Z_^T%H%^]O'=K8ZU^SU
MXETR\-M-N$5PMO>W$,K02,K+',JF)RK;6.TUDG_@YX_X)0@ GQW\:P&SM)^!
M>L@''7!^W<XSSBOG'_@ZM\!_#ZZ_8<^'?Q8/@/P]_P +#E_:$\!^"I_B&_AW
M2(_'#>%4\'?$:_B\--XK,4FL#P\=45=1BT:21HE?:X6,C-?C1_P:Y_"OX6?%
M[]L']H#1_BS\)/AG\4M&T3]FV74]*T?XD^%]%\8:#I.O2?$GP;I7]NZ;IGB#
M3M3M+6^>UO+BV,J0(5CFD(/* ?*XG/>)Z&>K)%7P<YRG!1K?45%6G'F7-255
MM/1Q=I6O>UU<_;^'O"CP5SGPDQWBOB<LXMP.!R_ZW[;+X<4T*[FL)B,/AW*&
M+EDU%QC4=93AS8?FY5JKRT_HD3_@YX_X)/ L3X[^-A)YPOP-UENG;#:@!C_]
M5)<_\'-W_!*&6-+BT^(?QNCEB99)8&^!WB*1)HHS)YML\9OWM(/.4)F2/!V@
M%WSOQ^K;?L-_L5QE53]B[]EM;9E_=A_@+\,[D@ _Q3GPXAG.<_O J[LCY1BO
MPL_X+Z_\$BO@;\1OV0=9_:$_9I^!?@WX8_'']GVUM[BXT?X3>'+'P1I/Q(^%
M=Y>O+XDTZ^\"^$M"N(O%7C'1[Z]AG\+7%G;6.K7*RWMGJ.HW.FV-I:P>UCZO
M%N P*QKQ>!K26CHT\%R2Y%HY.4<1+F:2;=.2Z;\R/@^",/\ 1KXOS^CPK0RS
MC_)*V.QDL)#,,;GF&6'YG'FHUU5_LU<M*M4Y(4YR44N:+G>,G!_TI_#KQEI?
MQ(^'_@CXDZ"]T_AWXB>$?#/COP[)?VKV%\^@>+]$L=?T9[NRD9FM)VTZ_MB]
MN68Q,=F3BNS )Z?7_)KYW_9#M[FW_9(_99L;RRU'2[[3?V<?@AIU_I>LV<NG
MZQIM[I_PS\,VMS9:I9S)#+;W<,D+!K>6"":W4I#/#'+&XKZ&$GE@*2..F>O\
M_7W_ "KZW!?6*V$PU3$V>)G2C*LHQY8J3C?W5=M)+;RLS^9.(,%@,LX@S; 8
M.I7658/'XK#83$8C$?6J\Z-&K*G3E5K1C1C4G)1O*7)%WNFKIMY>KX:U,,UB
MNI6DAQ?6)N?LOVBT',Z>;RC*$W%[=P4N4#0G[V1^<WP'_P""I7[-/[17[<OQ
MZ_85\""^M/B!\";.]AMO%FJZII$>F?%#6= N&3X@>'/ V@6,3WDUKX </=7>
MN/>OIFK6D,E_8Q[9(VKJ/^"HG[5^G?L8_L-_'_XWR>(YO#'B^W\#ZOX1^$VH
M:>FE7VN1_%?QG:2^'O MUI6AZJVS6HM,UV_M=4UR.WCN&T_0[6^U*:WG@MI$
M/^;/_P $X/VP?%'[&/[;'P3_ &C]!DEU"?2_%D.D?$+PXMQHVB2^,?!GCN\3
M3_&_AU]=U/3=1LM%CUE;X[=0-F;C2K>#[3#/;[0H^.XDXFI93FN78&DW4G*=
M.>*46O<A-J,4XM/I)SNG%WC&S=W;^G? 3P3EQ]X?>(7$.8TFX2PU3+^%:=13
MIJOFE*,9SG[79P;A&A[-^TIIUJDI*$XQD?ZS<.8U*[@ >4/9@"0=I.=PZ\C/
MI3ZY_3[Y;]=.GMM1L]2L=4LH=8L+O3KJTO=&E@N(8[N2;0M7L0]EK.F7#7.+
M*_M?L]E?62V]S9;O,<CH*^TIRYX\ZUC.THR5[23C%WUU/Y5Q^"J99C,1EE55
M.;+ZLL,W*+IM5(2M6@XJ35Z=7GC=2DFEO>Z11115G'\I?>_+S\_P85!=,R0.
MXY4;0S#H@/ #-T4DX !(SD#WJ>LJ_EM]\<#S(ET\T<\4%W%+<6LX5EBM\V%K
M/!+>NT[.L F+!WCEP<6_RU&3C)24>9+66NT5J]+.^UO*]WH;4:=*OSX:KB)8
M6.*A["-;D]I:K.<%1C:4XI<]5PIN7-IS/?9_#'_!0[_@H!\&O^"='P D^-?Q
MD\,^(O'B:]KVF>"/!/P_\)WNDZ;K7BWQ!J$5W>W<4^KZ@2GA_2=+TRRN;ZXU
M.]MKRVFO$T_2HEBFU!!)]:?"+XE^$?C+\,O OQ=\!ZWIWB+P5\2?"F@^,O#6
MN:3?QZCI5SIFN6,<L=G:ZA#'#:7DFESI-I=W=6L44-Q>VLVR,;<5_ ;_ ,'.
M7[9.A?'+]LGPS^SYX*O-(UKP[^Q_I6KZ7JFN)"C2W_Q-\>C1=6\7Z3IM_9:Q
MJND^(/#NAV.F>%FTF:.*QU"UU)O$NF:ND_\ 9T"I^S?_  :]_MA^%/B;^S%X
MH_9(\3>(;ZZ\?_L^^(M:\7^'[7Q)KNL:O=Z_\+/&%Q9RVJ^&] :)K'PIX>^'
M.OPVVF_9);R>TFN/$,<NF6UB@N$?\]P/%-/%<4XG .;AA[U:6';E%PJ3IKFE
M+9<O->2WE?EAK&]C^P.*_ >MDOT?.'>**V"E2XKPN(H8C.L/R252AEF-E3HT
M)5?>E=TU*A5NH1FHU\1&S47?^J @CJ".<<@]?3ZTE45 2X8M(\L\T3,T[W1?
M[0$EVR2)9QDV\(63">:@#G[K=:O[CC''3GKT]A]?;]:_0()RCS;+[[][;?\
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MYR_IG^IOT.?^32K?_DI\U]?@P7XD6&_O?H*_N[_X,>_^2H?\%%_^R??LV?\
MI]^,5?PB?/\ [/ZU_=W_ ,&/?_)4/^"B_P#V3[]FS_T^_&*OS\_K$_T-(_\
M5Q_[B_\ H(I],C_U<?\ N+_Z"*?0!2NOO)]4_P#0C7XR?LN_\IFO^"E7_9&?
MV8O_ $S35^S=U]Y/JG_H1K\9/V7?^4S7_!2K_LC/[,7_ *9IJC$?#3]?_<%<
M_:_"+_DDOI!_]FBC_P"O2\*C]HUZK]6_D*EJ)>J_5OY"I:I;+T7Y'XE#X5\_
MS84444R@I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JC>]$_WE_]"%7JHWG1/]Y?_0A51^U_A9$]Z7_7^A_Z=@?C=\*/
M^4YW[6?_ &91\&/_ %*=/K]F1_#_ +W_ ,37XS_"?_E.=^UG_P!F4?!C_P!2
MG3Z_9@?P_P"]_P#$UQT-_P#P=_ZD5#]K\<?^1OX=_P#9E?"3_P!8K+":FO\
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M\VZ\1O\ UD\S_P KG[E1?=B_ZY#_ -"-2U%%]V+_ *Y#_P!"-2U[-+^!A_\
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M7O\ ^2%_L2?]I._V1_\ TO\ %=>'G_\ R*<=_P!@&"_]*1^J>!W_ "<[A?\
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M9A,NS]YM+AG)J=;^T,'*C*E*G0QTY07)4<J*LJ5.O[>DJL*#A5M,]Q_X)/\
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M_N7EY>:"BBB@+_WG]R\O+S04444!?^\_N7EY>:"BBB@+_P!Y_<O+R\T%%%%
M7_O/[EY>7F@HHHH"_P#>?W+R\O-!1110%_[S^Y>7EYH*>GWA]5_]"%,IZ?>'
MU7_T(4UNO5?F:4?XU+5_Q(=%_-%]O-'XL_\ !P7_ ,HC/VQ?^O;X/?\ JXO"
M%?Y=K$[>G\7K[G^7]*_U$O\ @X+_ .41G[8O_7M\'O\ U<7A"O\ +M8_+T/W
MO3U)_P G\:_%O$/_ )'^'_[!Z/YR_,_U-^AS_P FE7_93YKK_P!N8(BRW]W]
M17]W?_!CW_R5#_@HO_V3[]FS_P!/OQBK^$3=_LM^5?W=_P#!CW_R5#_@HO\
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M%WW7W?\ !\U]X4444!=]U]W_  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\
M!\U]X4444!=]U]W_  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\ !\U]X4Y3
M@C/^>*;3E/S#\?Y4GL_1_D.+=UJMUT\UY^:^\B4C[1/S_ @[]<"OPO\ ^"]_
M_)"_V)/^TG?[(_\ Z7^*Z_=!2/M$_(_U:C]!7X7_ /!>_P#Y(7^Q)_VD[_9'
M_P#2_P 5UX>?_P#(IQW_ & 8+_TI'ZGX'?\ )SN%_P#L:YK_ .H>-.V_X.(O
M^41?[6__ %]_"+_U>'@>OUS\"D?\*_\  H[_ /"$>#__ %&M,'\Z_(S_ (.(
MO^41?[6__7W\(O\ U>'@>OUT\"8_X5_X$R?^9(\'_7'_  C6F<U6'_Y*"O\
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M#VI?#GXJW]G?ZQ:OJ/PYU/1V*K86FBZ9H_B34[/4E2XBMO&&BM&6+S8_(?\
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M$9^V+_U[?![_ -7'X0K_ "[6(V]1]X_S-?BWB'_R/\/_ -@]'\Y'^IGT.?\
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MZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J
M-[T3_>7_ -"%7JHWO1/]Y?\ T(54?M?X61/>E_U_H?\ IV!^-WPH_P"4YW[6
M?_9E'P8_]2G3Z_9D?P_[W_Q-?C/\)^?^"YW[6?\ V91\&/T\4Z>:_9@?P_[W
M_P 37'0W_P#!W_J14/VOQQ_Y&_AW_P!F5\)/_6*RPFIK_<;_ '6_D:=37^XW
M^ZW\C74?BY_E5_\ !X)_RF E_P"S6?@I_P"EGCROY8_E_P!G]*_J<_X/!/\
ME,!+_P!FL_!3_P!+/'E?RQ[%]/Y_XT :%K]VZ_Z\[C_T2*_V#?V),?\ #%7[
M'N<?\FO_  )ZX_Z)GX:]:_Q\K7[MU_UYW'_HD5_L&_L2*#^Q5^Q[D?\ -K_P
M)]?^B9^&J_2O#;_D9XW_ + X_P#I<#^*_IL_\DGP+_V.L7_ZCTSZ>?&3TQQZ
M8Z?E7X7_ +7./^'Z?_!(K&/^2+_MH=/^Q*G_ /KU^Z#J,D8XX]?2OPO_ &N0
M!_P73_X)%8_Z(O\ MH?^H5/_ (U^A9]_NF$_[&&5?^K3"'\4^$%_]8^(=O\
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M]<"OPO\ ^"]__)"_V)/^TG?[(_\ Z7^*Z\//_P#D4X[_ + ,%_Z4C]4\#O\
MDYW"_P#V-<U_]1,;_3.V_P"#B+_E$7^UO_U]_"+_ -7AX'K]<_ N/^%?^!>F
M?^$(\'_7_D6M,_K^M?D9_P '$7_*(O\ :W_Z^_A%_P"KP\#U^NG@4 ^ / GK
M_P (1X/&?^Y:TP_SJL/_ ,E!7_[ ,-^=8[N(?^3)\)?]E[QM_P"J[A<ZKL,>
MG;ZG^E)2XP!CT_J1_2DKW9_$_E^2/QM7LM([+\EY>7Y=@HI0,@GTJF;R)=Q=
M9@BD LD,LQ^8[0=D*NY&?O$*0HRS$*"01A*5W%7MOM^N_P B9349TH2Y5.M+
MEI12DW.2Y;I6B]M-]%IV)Y8DGC>&0,4D4JVQWB;!])(V1T.<?,C*P[&H@LD
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M*<S/&"8Q*T:H%^8[']MG]C>YE@A_X:Z_9?>6X-V(HQ\>OA:&Q8OY=P7'_"4
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M*<44'#,:.09G652%.K3G@\MQ-?#O2#C6A*A0=.?.ES2M?F?-S7?,?3T=]JD
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M=?>3ZI_Z$:_&3]EW_E,U_P %*O\ LC/[,7_IFFK]F[K[R?5/_0C7XR?LN_\
M*9K_ (*5?]D9_9B_],TU1B/AI^O_ +@KG[7X1?\ ))?2#_[-$O\ UZ7A4?M&
MO5?JW\A4M1+U7ZM_(5+5+9>B_(_$H?"OG^;"BBBF4%)W'T/\Q2TG<?0_S%
M.@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4;WHG^\O_H0J]5&]
MZ)_O+_Z$*J/VO\+(GO2_Z_T/_3L#\;OA1_RG._:S_P"S*/@Q_P"I3I]?LR/X
M?][_ .)K\9OA1_RG._:S_P"S*/@Q_P"I3I]?LR/X?][_ .)KCH;_ /@[_P!2
M*A^U^./_ "-_#O\ [,KX2?\ K%9834U_N-_NM_(TZFO]QO\ =;^1KJ/Q<_RJ
M_P#@\$_Y3 2_]FL_!3_TL\>5_+%L'O\ Y_"OZG?^#P3_ )3 2_\ 9K/P4_\
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MHHH"W]W^M/\ @_=YA1110%O[O]:?\'[O,**** M_=_K3_@_=YA1110%O[O\
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MX%/_ %)'@_\ 3PWIAK\C/^#B+_E$7^UO_P!??PB_]7AX'K]<_ HSX \"=?\
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M,^!-6T/Q2_AV[LO ]\S-?VWAK6GB.IV>B7L2CP]&QTVU>6!AL_5O_@C_ /\
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M !2M[O0(H)XKKP]_PB_B"'1+"UN;J5[>>WU^*\::V>VD$L$J7#,GXJ?\$_\
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MHHH"W]W^M/\ @_=YA1110%O[O]:?\'[O,**** M_=_K3_@_=YA1110%O[O\
M6G_!^[S"BBB@+?W?ZT_X/W>84444!;^[_6G_  ?N\PIZ?>'L5_\ 0@/ZTRGI
M]X?5?_0A36Z]5^9I17[ZE[MOWD//[4?Z^5^I^+/_  <%_P#*(S]L;WMO@]_Z
MN+P@/Z5_EV,HQGG[W\B?\*_U$_\ @X+_ .41G[8O_7M\'O\ U<7A"O\ +M8?
M+U/WO7T)_GCG\:_%?$/_ )'^'T_YAZ/YR_(_U,^AS_R:5:?\U-FNFW_+O!:$
M.P>_^?PK^[S_ (,>_P#DJ'_!1?\ [)]^S9_Z??C%7\(FW_:;\_\ ZU?W=_\
M!CW_ ,E0_P""B_\ V3[]FS_T^_&*O@#^LC_0TC_U<?\ N+_Z"*?3(_\ 5Q_[
MB_\ H(I] %*Z^\GU3_T(U^,G[+O_ "F:_P""E7_9&?V8O_3--7[-W7WD^J?^
MA&OQD_9=_P"4S7_!2K_LC/[,7_IFFJ,1\-/U_P#<%<_:_"+_ ))+Z0?_ &:*
M/_KTO"H_:->J_5OY"I:B7JOU;^0J6J6R]%^1^)0^%?/\V%%%%,H*3N/H?YBE
MI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@
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M^R/_ .E_BNO#S_\ Y%.._P"P#!?^E(_5/ [_ ).=PO\ ]C7-?_43&_TCMO\
M@XB_Y1%_M;_]??PB_P#5X>!Z_7/P+G_A / G./\ BB/!_;_J6M,__57Y&?\
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M9AL&I\LIQITH1C7<VG!2IPE)M*2_LV\.?%:7]F__ (-C?!_C'7O"FIZE>O\
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M\(=3'B'X5^+M(N/B-\$_B5::SX<M]3-I>VVH:CX7OX]-O+/5]-L-?L_DDO\
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M*M$M?$WASQ%H%W!?Z7?Z7?Q^=8:AI5]:E[+4HKVU(N)8M.9I;"]+Z9=_Z>C
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M&/+!VE0'#[=K \U-_P $NOAQ_P %^=<_84^$FM_L._&3X"^!OV6=5U_QU=>
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M^?X,*>GWA]5_]"%,IZ?>'U7_ -"%-;KU7YFE'^-2^+^)#=O^:/GY_@S\6?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO^1GC?\ L#C_ .EP/XK^FS_R2? O_8ZQ?_J/3/IYR<GCGCC/MZU^%_[7.?\
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M_<O+R\T%%%% 7_O/[EY>7F@HHHH"_P#>?W+R\O-!1110%_[S^Y>7EYH****
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M_LF_"/XN?'_4O 5]!^U;\>-6U:^^"WPPT3XN>*]"\.ZOXVUW4+*T\5>+M/\
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M- TG6[JS\0OX>_X1R+XNP>'+6\'@VUFL]3@U+Q-K4NF6.I7=CJ%R_P#2\O\
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MW^FZ9J/A+0/!]KH-O:QZ[XA-DTD%MK&I:K9:;IFFQWMU_7G_ ,$_/V9O _\
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M;^QN]/DANH)HY?+F61)E;GGH!AT&U %#9'3 (!&0/7!(![ D#@UA:'X9\/\
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M'^'_ .P>C^<OS/\ 4WZ'/_)I5_V4^:Z_]N8(BRW]W]17]W?_  8]_P#)4/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *HWO1/]Y?_0A5ZJ-[T3_>7_T(54?M?X61
M/>E_U_H?^G8'XW_"?_E.=^UG_P!F4?!C_P!2G3Z_9@?P_P"]_P#$U^,WPH_Y
M3G?M9_\ 9E'P8_\ 4IT^OV9'\/\ O?\ Q-<=#?\ \'?^I%0_:_''_D;^'?\
MV97PD_\ 6*RPFIK_ '&_W6_D:=37^XW^ZW\C74?BY_E5_P#!X)_RF E_[-9^
M"G_I9X\K^6/<OK_/_"OZG/\ @\$_Y3 2_P#9K/P4_P#2SQY7\L>Y?7^?^% &
MA:_=NO\ KSN/_1(K_8-_8D('[%7['N3_ ,VO_ GU_P"B9^&J_P ?*U^[=?\
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M]I._V1__ $O\5U^Z"D?:)^?X$'?K@5^%_P#P7O\ ^2%_L2?]I._V1_\ TO\
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M**** O\ WH_=_P#;!1110%_[T?N_^V"BBB@+_P!Z/W?_ &P4444!?^]'[O\
M[8**** O_>C]W_VP4444!?\ O1^[_P"V"BBB@+_WH_=_]L%%%% 7_O1^[_[8
M**** O\ WH_=_P#;!1110%_[T?N_^V"BBB@+_P!Z/W?_ &P4444!?^]'[O\
M[8**** O_>C]W_VP4444!?\ O1^[_P"V"BBB@+_WH_=_]L%%%% 7_O1^[_[8
M**** O\ WH_=_P#;!1110%_[T?N_^V"BBB@+_P!Z/W?_ &P4444!?^]'[O\
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ML2*#^Q5^Q[D?\VO_  )]?^B9^&J_2O#;_D9XW_L#C_Z7 _BOZ;/_ "2? O\
MV.L7_P"H],^GGQD],<>F.GY5^%_[7./^'Z?_  2*QC_DB_[:'3_L2I__ *]?
MN@ZC)&../7TK\+_VN0!_P73_ ."16/\ HB_[:'_J%3_XU^A9]_NF$_[&&5?^
MK3"'\4^$%_\ 6/B';_DW7B-_ZR>9_P!>GJ?N5%]V+_KD/_0C4M11?=B_ZY#_
M -"-2U[-+^!A_P#KQ2_](1^6XF_UO%V2_P!YJ[_XEY?T_0****LQU[1_JWEY
M?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1_JWEY?EV"BBB@->T
M?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HH
MHH#7M'^K>7E^78**** U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E
M^78**** U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1
M_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1_JWEY?EV"BB
MB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1_JWEY?EV"BBB@->T?ZMY>7
MY=@HHHH#7M'^K>7E^78**** U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'
M^K>7E^78**** U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78***
M* U[1_JWEY?EV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78**** U[1_JWEY?
MEV"BBB@->T?ZMY>7Y=@HHHH#7M'^K>7E^78*<O49Z>_TIM.49(!_SQ2>S]'^
M0XWO'2.Z_->7E^78B7'VB?I]Q/3K@?K7X7_\%[_^2%_L2?\ :3O]D?\ ]+_%
M=?N@JC[1/Q_ A[]<"OPO_P""]_\ R0O]B3_M)W^R/_Z7^*Z\//\ _D4X[_L
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M=[J<QL8?$7AQ-:\22S>$O$NGM:30^*([^6SL]52;3M1&G!K2ZU'[I_X->O\
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M9TO5/#5O=ZA>62:;,/#&MWFJ:;8Q-/J^JZII]MX=TJTN[B_;9_%'_P $D/\
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M\4Z>:_9D?P_[W_Q-?C-\*/\ E.=^UG_V91\&/_4IT^OV9'\/^]_\37'0W_\
M!W_J14/VOQQ_Y&_AW_V97PD_]8K+":FO]QO]UOY&G4U_N-_NM_(UU'XN?Y5?
M_!X)_P I@)?^S6?@I_Z6>/*_ECV+Z?S_ ,:_J<_X/!/^4P$O_9K/P4_]+/'E
M?RQ[?]IOS_\ K4 :%K]VZ_Z\[C_T2*_V#?V)%!_8J_8]R/\ FU_X$^O_ $3/
MPU7^/E:_=NO^O.X_]$BO]@W]B09_8J_8]Y(_XQ?^!/0_]4S\-5^E>&W_ ",\
M;_V!Q_\ 2X'\5_39_P"23X%_['6+_P#4>F?3SJ,D8XX]?2OPO_:Y '_!=/\
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M\O\ @_=YA1110%O[J_#R_P"#]WF%%%% 6_NK\/+_ (/W>84444!;^ZOP\O\
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M"R.#PG\'O#.GV=SI?P]^(]YX,\0)!X:^&VJO/)_;NOV>BZ'J5SXJ\>S""/\
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MGE.:RQ6'KUJN'G0JQE]9K.M5YY2H."YG"\E:$N;GFVFH\JLY'\X<5^-\./\
MP^>09]E>4Y?CLOXDPV9X+#Y'E6'RS U(+!8W#5Y8BE3J?[PJE:A[-TJ-/F@J
MOM:LFH17KQZG'3/%)117TY_/*2=O=73MY?\ !^[S"BBB@+?W5^'E_P '[O,*
M*** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,****
MM_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7
MX>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_
M  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N
M\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHH
MHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W
M]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?A
MY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\
M!^[S"BBB@+?W5^'E_P '[O,*>GWA]5_]"%,IZ?>'U7_T(4UNO5?F:45^^I>Z
ME^\AV_FC_P '[O,_%G_@X+_Y1&?MB_\ 7M\'O_5Q>$*_R[64;>G\7OV)Q_(5
M_J)?\'!?_*(S]L7_ *]O@]_ZN+PA7^7:P^7J?O>OH3_/'/XU^+>(?_(_P^G_
M ##T?SE^1_J;]#G_ )-*M/\ FI\UT_[<P6A%L7T_G_C7]W?_  8]_P#)4/\
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M?LVZ]X-\!)X"_9_B?4? 7C;P5>WNH3>*[&7Q4GAZ%]4DGN9[!M3NX&:\\S2
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MWOR\_/\ !A1110'RE][\O/S_  84444!\I?>_+S\_P &%%%% ?*7WOR\_/\
M!A1110'RE][\O/S_  84444!\I?>_+S\_P &%%%% ?*7WOR\_/\ !A1110'R
ME][\O/S_  84444!\I?>_+S\_P &%%%% ?*7WOR\_/\ !A1110'RE][\O/S_
M  84444!\I?>_+S\_P &%%%% ?*7WOR\_/\ !A1110'RE][\O/S_  84444!
M\I?>_+S\_P &%%%% ?*7WOR\_/\ !A1110'RE][\O/S_  84444!\I?>_+S\
M_P &%%%% ?*7WOR\_/\ !A1110'RE][\O/S_  84444!\I?>_+S\_P &%%%%
M ?*7WOR\_/\ !A1110'RE][\O/S_  84444!\I?>_+S\_P &%%%% ?*7WOR\
M_/\ !A3ESD8X]_PIM.7.1CK[_2D]GZ/\AQWCI+==7W7GY_@R)<_:)^?X$[=L
M#BOPO_X+W_\ )"_V)/\ M)W^R/\ ^E_BNOW07=]HGZ?<3UZ8'ZU^%_\ P7O_
M .2%_L2?]I._V1__ $O\5UX>?_\ (IQW_8!@O_2D?JG@=_R<[A?_ +&N:_\
MJ)C?Z1VW_!Q%_P HB_VM_P#K[^$7_J\/ ]?KGX%S_P (!X$Y_P"9(\'\8_ZE
MK3/_ -5?D9_P<1?\HB_VM_\ K[^$7_J\/ ]?KIX%S_P@'@3&/^1(\'_7/_"-
M:9_3]:K#_P#)05_^P##?G6.[B'_DR?"7_9>\;?\ JNX7.JYP._']3_\ KI*7
MG SZ=OJ?ZTE>[/XG\OR1^-K9?%LNK[+S\_P8A4N,!MO<GIQZ?K2K!C'S'\>3
M_+_/ZT44N9VLN7YQN^C[^0E"GS<TH2;=MY2T^'S]/N9^?G_!6&01_P#!,O\
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M0:MK>IV?B"^L(K^_M7OK35$@T*-M'OTO;B.YB:ZTW DE_O73]GC]GZ4K!%\
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MX_"OQ;Q#_P"1_A]_]WH_G+^F?ZF_0Y_Y-*M_^2GS7U^#!?B18;^]^@K^[O\
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M6_D:ZC\7/\JO_@\$_P"4P$O_ &:S\%/_ $L\>5_+'EO[OZBOZG/^#P3_ )3
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M_N7EY>:"BBB@+_WG]R\O+S04444!?^\_N7EY>:"BBB@+_P!Y_<O+R\T%%%%
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M>[/XG\OR1^-K9:O9=%V7EYK[PHHHJ1W_ +S^Y>7EYH0E0"7QM'7=TQ[YXI'
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M)=W!DO7CNYT?]&F@A;RPT:$12>;&,?<DY^=?1OF;YNO)YYJ4X9=C %=_F%2
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M^UKV_P HO-E;/[LXST;D=??.<>]*ID&0L(7=DG:-H+-C+-@#)/4L<DG!;-3
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M+R\T%%%% 7_O/[EY>7F@HHHH"_\ >?W+R\O-!1110%_[S^Y>7EYH**** O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM.O_ "2>9?\ #G[E1?=B_P"N0_\ 0C4M11?=B_ZY#_T(U+7LTOX&'_Z\4O\
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M444!?^^ON_X/]7] HHHH"_\ ?7W?\'^K^@4444!?^^ON_P"#_5_0**** O\
MWU]W_!_J_H%%%% 7_OK[O^#_ %?T"BBB@+_WU]W_  ?ZOZ!1110%_P"^ON_X
M/]7] HHHH"_]]?=_P?ZOZ!1110%_[Z^[_@_U?T"BBB@+_P!]?=_P?ZOZ!111
M0%_[Z^[_ (/]7] HHHH"_P#?7W?\'^K^@4444!?^^ON_X/\ 5_0**** O_?7
MW?\ !_J_H%*IP0:2G*<$9_SQ2>S]'^0XOWH^\MUT\UY_U?T(58&XF//W$'Z"
MOPP_X+W_ /)"_P!B3_M)W^R/_P"E_BNOW04C[1/S_ @[]<"OPO\ ^"]__)"_
MV)/^TG?[(_\ Z7^*Z\//_P#D4X[_ + ,%_Z4C]4\#O\ DYW"_P#V-<U_]1,;
M^6QVW_!Q%_RB+_:W_P"OOX1?^KP\#U^N?@4_\4!X%'_4D>#_ -?#>F"OR,_X
M.(O^41?[6_\ U]_"+_U>'@>OUT\"D?\ " >! ?\ H2/!_P"7_"-:8*K#?\E!
M7_[ ,-^=8[N(?^3)\)?]E[QM_P"J[A<ZG.0/I_4G^M%+G(&/3^II*]V?Q/Y?
MDC\;3T7O+9=/)>?]7] HHHJ1W_OK[O\ @_U?T"BBB@+_ -]?=_P?ZOZ!1110
M%_[Z^[_@_P!7] HHHH"_]]?=_P '^K^@4444!?\ OK[O^#_5_0**** O_?7W
M?\'^K^@4444!?^^ON_X/]7] HHHH"_\ ?7W?\'^K^@4444!?^^ON_P"#_5_0
M**** O\ WU]W_!_J_H%%%% 7_OK[O^#_ %?T"BBB@+_WU]W_  ?ZOZ!1110%
M_P"^ON_X/]7] HHHH"_]]?=_P?ZOZ!1110%_[Z^[_@_U?T"BBB@+_P!]?=_P
M?ZOZ!1110%_[Z^[_ (/]7] HHHH"_P#?7W?\'^K^@4444!?^^ON_X/\ 5_0*
M*** O_?7W?\ !_J_H%%%% 7_ +Z^[_@_U?T"BBB@+_WU]W_!_J_H%%%% 7_O
MK[O^#_5_0**** O_ 'U]W_!_J_H%%%% 7_OK[O\ @_U?T"BBB@+_ -]?=_P?
MZOZ!1110%_[Z^[_@_P!7] HHHH"_]]?=_P '^K^@4444!?\ OK[O^#_5_0**
M** O_?7W?\'^K^@4444!?^^ON_X/]7] HHHH"_\ ?7W?\'^K^@4444!?^^ON
M_P"#_5_0**** O\ WU]W_!_J_H%%%% 7_OK[O^#_ %?T"BBB@+_WU]W_  ?Z
MOZ!1110%_P"^ON_X/]7] HHHH"_]]?=_P?ZOZ!1110%_[Z^[_@_U?T"BBB@+
M_P!]?=_P?ZOZ!1110%_[Z^[_ (/]7] HHHH"_P#?7W?\'^K^@4444!?^^ON_
MX/\ 5_0**** O_?7W?\ !_J_H%%%% 7_ +Z^[_@_U?T"BBB@+_WU]W_!_J_H
M%/0_,/<K_P"A TRGI]X?5?\ T(4UNO5?F:47^^I>\G^\AT_O1\_ZN?BS_P '
M!9_XU&?MC>UM\'O_ %<7A U_EV,PQCG[W\R?\:_U$_\ @X+_ .41G[8O_7M\
M'O\ U<7A"O\ +M8C;U_B]^Y./YBOQ7Q#_P"1_A]?^8>C^<OSV/\ 4SZ'/_)I
M5K_S4V:Z_P#</!:D.\>_^?QK^[S_ (,>_P#DJ'_!1?\ [)]^S9_Z??C%7\(F
MY?7^?^%?W>?\&/7_ "5'_@HOGI_PK_\ 9L_]/OQBKX _K(_NG\<?LY?L_?$?
MQM:^._B#\&?AIXY\<Z;;Z/%I7B;Q-X-T#6?$MO\ \(W>C6-%BL]<OK.>^LSH
M6I,-4T58YHGL=0)NK4QSL)!_.-_P<#_&GXK_  C^+_[--IX"^*GQ&\ V6K^
M_'DMU8>"/'VM>"X=7O8?%'ARULSJ)T^Z4WFHK!<RI!J+D31V_P!I@BD2*:4-
MWO\ P59_:1_X*,_"W]MOPEX-_9,U/XIVO@"Z\#?#35KCPYX>^&(\4^"/%OBV
M_P#$FMV=Q9:QXA30;Z:T@O!%I>G>((H]6TU[6VN;2>6ZL+<R72_M-\(/"&J_
M'GX+_!OQM^UQ\"/AA-\;$\(F_P#&WA?7/!/AS7'\%^)?.N1=Z-X=M]8G\11:
M8C>79WC,-<U&-YS&H<!]\<>VG)UXQ<H\JC0]KRVIP?/1JIPJ*2YFU%PE%N#A
M?:459_V3P%@\?]'R?A)XX<<XCASQ-X3XGR#BFCE7 F#S_+L9G>4X?%Y-C,#0
M6:Y-F6"QN'RNEA\9BO;4IPH55-T8IRI5ZL7'Z,^'S?VIX&\(W%\LTT__  C7
MAPW$T[;Q/=7.C63W$\,X.997=F>>;Y7:?<_WBQK\KOV7@(O^"RG_  4I8 DG
MX/?LS$LQ+L-FB",*K,240J%+(I"E\N1N.:_7FS\JW\G3+:W0%2H>.!4MELTM
MXPL*K9 *BVZH%B62W'DM@;.@K\A_V8 &_P""Q7_!2,E&$C_"#]FG,FX>6RQZ
M7)$X5,;P1(AY)&0.@XHQ,U.5.\>1NJW&._+&5#%2LI62:]YV:23U['Y;X6XJ
MMB^&_I)XOZK4PM*KX)4L1A:,[-THUO%OPSFX2Y59/FULER_RW5K_ +2JV2ON
MN<?GS4E54#"8#^$(![]#SU^E6JOEY5%?W5Y]-OEU\S\)M91ZMPBWZM:_B%%%
M% @I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ JC>]$_WE_\ 0A5ZJ-[T3_>7_P!"%5'[7^%D3WI?]?Z'_IV!^-WPH_Y3
MG?M9_P#9E'P8_P#4IT^OV9'\/^]_\37XS_"?G_@N=^UG_P!F4?!C]/%.GFOV
M8'\/^]_\37'0W_\ !W_J14/VOQQ_Y&_AW_V97PD_]8K+":FO]QO]UOY&G4U_
MN-_NM_(UU'XN?Y5?_!X)_P I@)?^S6?@I_Z6>/*_EDW#U'YU_4W_ ,'@G_*8
M"7_LUGX*?^EGCROY9,#T'Y4 7[7[MU_UYW'_ *)%?[!O[$A _8J_8]R1_P F
MO_ G_P!5GX:K_'RM?NW7_7G<?^B17^P;^Q( ?V*OV/<@?\FO_ GM_P!4S\-5
M^E>&W_(SQO\ V!Q_]+@?Q7]-G_DD^!?^QUB__4>F?3SD9)R,<?RK\,/VN3_Q
MO3_X)%?]D7_;0_\ 4*GK]SW R1@8X[>U?AA^US_RG3_X)%<?\T7_ &T/_4*G
MK]"S[_=,)_V,,J_]6F$/XJ\(/^2CXA_[-UXC?^LGF9^Y,7W8O^N0_P#0C4M1
M1?=B_P"N0_\ 0C4M>S2_@8?_ *\4O_2$?EN)O]:Q?_835_\ 2E^E_P  HHHJ
MS'7R_'R_X/X!1110&OE^/E_P?P"BBB@-?+\?+_@_@%%%% :^7X^7_!_ ****
M U\OQ\O^#^ 4444!KY?CY?\ !_ **** U\OQ\O\ @_@%%%% :^7X^7_!_ **
M** U\OQ\O^#^ 4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P?P"BB
MB@-?+\?+_@_@%%%% :^7X^7_  ?P"BBB@-?+\?+_ (/X!1110&OE^/E_P?P"
MBBB@-?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\'\ H
MHHH#7R_'R_X/X!1110&OE^/E_P '\ HHHH#7R_'R_P"#^ 4444!KY?CY?\'\
M HHHH#7R_'R_X/X!1110&OE^/E_P?P"BBB@-?+\?+_@_@%%%% :^7X^7_!_
M**** U\OQ\O^#^ 4444!KY?CY?\ !_ **** U\OQ\O\ @_@%%%% :^7X^7_!
M_ **** U\OQ\O^#^ 4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P?
MP"G*?F'X_P J;3E^\/Q_E2>S]'^0XWNMMUW[K_@_@1*1]HGY'^K4?H*_"_\
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M?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ ****
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M*** U\OQ\O\ @_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\'\
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MY?\ !^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\
M!^[S"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S
M"BBB@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB
M@+?W5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W
M5^'E_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E
M_P '[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '
M[O,**** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,*
M*** M_=7X>7_  ?N\PHHHH"W]U?AY?\ !^[S"BBB@+?W5^'E_P '[O,****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P '@G_*8"7_ +-9^"G_ *6>/*_ECPW][]!7]3G_  >"?\I@)?\ LUGX*?\
MI9X\K^6/Y_\ 9_6@#0M?NW7_ %YW'_HD5_L&_L29_P"&*OV/<''_ !B_\">V
M?^:9^&J_Q\K7[MU_UYW'_HD5_L&_L2;O^&*OV/<8_P"37_@3US_T3/PU7Z5X
M;?\ (SQO_8''_P!+@?Q7]-G_ ))/@7_L=8O_ -1Z9]//G)YYXYQ[>E?A?^US
MG_A^G_P2*R<_\67_ &T.W_4E3_Y_"OW0?=D],\>N.E?A?^USG_A^G_P2*SC_
M )(O^VATS_T)4_\ ]:OT+/O]TPG_ &,,J_\ 5IA#^*?"#_DH^(=_^3=>(W?_
M *)/,_Z]3]RHONQ?]<A_Z$:EJ*+[L7_7(?\ H1J6O9I?P,/_ ->*7_I"/RW$
M_P"]XO?_ 'FKLW_,NS\_N"BBBK,?E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/
ME+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"B
MBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G
M^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[W
MY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/
ME+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"B
MBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G
M^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[W
MY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/
ME+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"BBB@/E+[WY>?G^#"G
M+G(QQ[_A3:<N<C'7W^E)[/T?Y#CO'26ZZONO/S_!D2Y^T3\_P)V[8'%?A?\
M\%[_ /DA?[$G_:3O]D?_ -+_ !77[H+N^T39Q]Q?7&,#I[U^%_\ P7O_ .2%
M_L2?]I._V1__ $O\5UX>?_\ (IQW_8!@OPDK_=U/U3P._P"3G<+]/^%7-=_^
MP3&K\]CMO^#B+_E$7^UO_P!??PB_]7AX'K]<_ N?^$ \"<X_XHCP?V_ZEK3/
M_P!5?D9_P<1?\HB_VMQZ7?PC_P#5X>!S_*OUS\"Y_P"$ \"8QSX(\'_7_D6M
M,_I^M5A_^2@K_P#8!AOSKG=Q#_R9/A+_ ++[C9?/^SN%]/7R.KYP._']3_\
MKI*,\#.,X[?4_P#U_P **]V?Q/Y?DC\;5K+XMDMWY+O_ %9A1114C^4OO?EY
M^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4O
MO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,****
M ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,
M**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY
M^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4O
MO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,****
M ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,
M**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY
M^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4O
MO?EY^?X,**** ^4OO?EY^?X,***3(/0BC7L&FGQ:[:OR\_/\Q:***=GV?W?U
MW7WAI_>^]^7GYH**7!]#^5&#UP<?2EKV"W=27JY>7GY_@Q**** ^4OO?EY^?
MX,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,**** ^4OO?
MEY^?X,**** ^4OO?EY^?X,**** ^4OO?EY^?X,*>GWA]5_\ 0A3*>GWA]5_]
M"%-;KU7YFE'^-2^+^)#=O^:/GY_@S\6?^#@O_E$9^V+_ ->WP>_]7%X0K_+M
M;.WK_%Z>Y_G_ %K_ %$O^#@O_E$9^V+_ ->WP>_]7%X0K_+M;=M[?>]_4Y_K
MC\*_%O$/_D?X??\ W>C^<OZ9_J;]#G_DTJW_ .2GS7U^#!?B18;^]^@K^[O_
M (,>_P#DJ'_!1?\ [)]^S9_Z??C%7\(GS_[/ZU_=W_P8]_\ )4/^"B__ &3[
M]FS_ -/OQBK\_/ZQ/]#2/_5Q_P"XO_H(I],C_P!7'_N+_P"@BGT 4KK[R?5/
M_0C7XR?LN_\ *9K_ (*5?]D9_9B_],TU?LW=?>3ZI_Z$:_&3]EW_ )3-?\%*
MO^R,_LQ?^F::HQ'PT_7_ -P5S]K\(O\ DDOI!_\ 9HH_^O2\*C]HUZK]6_D*
MEJ)>J_5OY"I:I;+T7Y'XE#X5\_S84444R@I.X^A_F*6D[CZ'^8H !T'T'\J6
MD'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "OP$_X*D_\%8OB;^PE\</#WPQ\!?!;
MPM\2M-\0_#JS\<ZMJ_BC7O$=G-;7P\1WNAV^CZ?8Z+#,LMF1:0WC1Q(]\UP]
MQ)M\MHZ_?NOYK/\ @L'^P9^UA\??VF/A?\>OV=;WP+X9T[P1\.1X2O\ QUXK
M^*6F?#R^\+^(FU_5M5M[G2KF]MUNK*0V.H*JWEG>HMV9'M9(7VY/'CZF)IX?
MGPD9RKJK145"G&I+D=1*JU"=DW&FY-7<=5\2/Z4^B=E7A3G7C+D^6^,M;)Z'
M!F(RK/.:>?YGC\HR=YQ#+ZD\FACL=EE2GCJ=&6.5-6P[<V[-0E:Q[I_P1Q^
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MA1110%U_-+[O3R]/O\PHHHH"Z_FE]WIY>GW^84444!=?S2^[T\O3[_,****
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M7XR?LN_\IFO^"E7_ &1G]F+_ -,TU?LW=?>3ZI_Z$:_&3]EW_E,U_P %*O\
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M O\ WE^'E_P?O\@HHHH"_P#>7X>7_!^_R"BBB@+_ -Y?AY?\'[_(**** O\
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MD('[%7['N2/^37_@3_ZK/PU7^/E:_=NO^O.X_P#1(K_8-_8D /[%7['N0/\
MDU_X$]O^J9^&J_2O#;_D9XW_ + X_P#I<#^*_IL_\DGP+_V.L7_ZCTCZ><C)
M.1CC^5?AA^UR?^-Z?_!(K_LB_P"VA_ZA4]?N>X&2,#'';VK\,/VN?^4Z?_!(
MKC_FB_[:'_J%3U^A9]_NF$_[&&5?^K3"'\5>$'_)1\0_]FZ\1O\ UD\S/W)B
M^[%_UR'_ *$:EJ*+[L7_ %R'_H1J6O9I?P,/_P!>*7_I"/RW$W^M8O\ [":O
M_I2_2_X!1115F.OE^/E_P?P"BBB@-?+\?+_@_@%%%% :^7X^7_!_ **** U\
MOQ\O^#^ 4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P '\ HHHH#7
MR_'R_P"#^ 4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P?P"BBB@-
M?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ ****
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M?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ ****
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M*** U\OQ\O\ @_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\'\
MHHHH#7R_'R_X/X!1110&OE^/E_P?P"GK@@Y.">/\_C_+WIE&>&XYQQ]?\_KB
MFMUZK\RH2C&5ZD5*"4KQU5WRV7_DWZ>9BZ\'N/#7B>&((S#P[XA7#.(R5&B:
M@3L+<-(=H"IGYLD=B1_.M_P0D_;-_8]^#7_!+_X%?#WXL_M1? KX:^.=&\6_
M&UM6\)^./B9X5\->(-/.L?&'Q?J&E&]TC5-1M[ZT@O+"X@U".YGB2$V<\,@<
MA\U_1I+:&>WNH,A3/%*B^9N-N_F(T;PW<0P+BSFC9H[JT;*7$3-$_P IKX@N
M?^"6_P#P3@N6=KC]A_\ 9:NF>09+?!CPG;J8O.DE/F1P0D2W!600-.V&DBB1
MI2S%@?"S3"X]YA1Q6 ]DYTX3@O:\Z5INBVO<C+_GW9[;Z-VL?KW 7$W!N&X"
MSSACBVCF5LTSG+,Q=3+/J\JZ66TL?2I6CB:E."FHX^<J<ES1O&TXOFNN@_X>
M._\ !/K_ */@_91_\/M\/O\ Y=^Q_*D_X>.?\$^NW[<'[*&>W_%]OA[U[?\
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M:6^G6L5KI5BL%A9:;I-LR+:6%OIL"V\-EI]O"J6UO:PVL<*0V\$<:1(@15P
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M^1KI/Q$_RJ_^#P3_ )3 2_\ 9K/P4_\ 2SQY7\L>Q?3^?^-?U.?\'@G_ "F
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M G^ZWAS3-JY] .W&,_A7Y)_\'$7_ "B+_:W_ .OOX1?^KP\#U^N?@4?\6_\
M IR?^1(\'_3_ )%K3#_];Z4\-IGU>.]L!A-7J_=5>/Y/5G7GMJ?@QP9545^Y
MX^X[Y8-S]G+VV"X4JS4XJ2NDX)16RC==7?IDB\MI&R3YC;N3TXQC\Q]:DI>@
M'7IW^II*]Z;;DV]=OP21^-1C%)\L(Q3E*=ELN>7.U&]VHIR=E=V2L%%%%05;
M^ZOP\O\ @_=YA1110%O[J_#R_P"#]WF%%%% 6_NK\/+_ (/W>84444!;^ZOP
M\O\ @_=YA1110%O[J_#R_P"#]WF%%%% 6_NK\/+_ (/W>84444!;^ZOP\O\
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M%%% 6_NK\/+_ (/W>84444!;^ZOP\O\ @_=YA1110%O[J_#R_P"#]WF%%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/E/[W_\ )?U\F%%%% ?*?WO_ .2_KY,**** ^4_O?_R7]?)A1110'RG][_\
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M/E/[W_\ )?U\F%%%% ?*?WO_ .2_KY,**** ^4_O?_R7]?)A1110'RG][_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5\M?M,_LN? K]JWPVO@/X\?#[3/&NBVL5_+I&KW*S6/B/P=/JL5O:W6H^"?%
M%@T6I^%]7G6SB2;4M/GANW@40HX4FOJ6FE$8AF120002H)!'0_4=CU':DXPG
MI.*DMTFKJ_FGHUW333ZIGH93FV:Y#F6"SG(\SS#)<XRW$4\7EV:Y5BZ^!S#
M8JE*\*^%Q6'G3JTJB7-'FA)/EDS\31_P0K_X)NM+>6T_PO\ B"(YY4B6X;XR
M>/VDNY@N)C$IU<RQL^U7N)5V+//)*Y_>,[-^@?[.?[)?[/O[)/ANZ\,_ ?X;
M^'O -AJ3Z<-=O8($NO$>LK8"6/36UWQ!/YFI:Q+ )IS ]Y<2O$LD@SDL3]5Q
MP0Q9$421@DDA%"C+'<QP.,DDDGJ3SUJI>1QA%4(FTLAQM'7>.1Z'W%.%'#0Y
MO8T84FZ<HN484XRL[7UC&.BZ*]GUTT?WG&/C5XP\?Y=3R+CGQ8\1N+<@^LT)
MQRKB#BK-<TPT)QK0G"<*.+Q56DI0G""B^1N,'+5R46OQO^%,@3_@N=^UF&.
MG[$WP9D8_P"R?%%B%Q]&B?H.I-?LS$X8@@Y#*&4CI@X_7^IK\9_A0%/_  7.
M_:TR <_L3?!A#GNO_"4V.!] 68X]S7[,H NT* ,' XZ#C@>GX5SX9Q2DK-MN
ML[]/]XJOUW?S21[?CBZD\U\.O:-<\?!CPD4>56C[&/!66J$9+K4Y;7E_-=]=
M9Z:_W&_W6_D:=37^XW^ZW\C70?C!_E5_\'@G_*8"7_LUGX*?^EGCROY8LOZ#
M_/XU_4[_ ,'@G_*8"7_LUGX*?^EGCROY8\M_=_44 :%K]VZ_Z\[C_P!$BO\
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MU=A1110'SG]S_P O+^KL**** ^<_N?\ EY?U=A1110'SG]S_ ,O+^KL****
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MBBB@/G/[G_EY?U=A1110'SG]S_R\OZNPHHHH#YS^Y_Y>7]784444!\Y_<_\
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M2'+^@_S^-?W>?\&/?_)4/^"B_P#V3[]FS_T^_&*OX1,M_=_45_=W_P &/?\
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M3Z_9D?P_[W_Q-?C/\)_^4YW[6>?^C*/@Q_ZE.GX_6OV8'\/^]_\ $UQT-_\
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M)S_P73_X)%<$?\67_;0ZC_J2IZ_=!R,DYXX]?2OPO_:Y(/\ P73_ ."16/\
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M\O\ @_?Y!1110%_[R_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\
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M>3ZI_P"A&OQD_9=_Y3-?\%*O^R,_LQ?^F::HQ'PT_7_W!7/VOPB_Y)+Z0?\
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M?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\'\ IRGYA^/\
M*FTY?O#\?Y4GL_1_D.-[K;==^Z_X/X$2D?:)^1_JU'Z"OPO_ ."]_P#R0O\
M8D_[2=_LC_\ I?XKK]T% ^T3\#_5J>GL*_"__@O?_P D+_8D_P"TG?[(_P#Z
M7^*Z\//_ /D4X[_L P7_ *4C]3\#O^3G<+_]C7-?_4/&G;?\'$7_ "B+_:W_
M .OOX1?^KP\#U^NG@4_\6_\  O\ V)'@_P#]1K3*_(O_ (.(O^41?[6__7W\
M(O\ U>'@>OUT\"#/@#P)_P!B1X/Y_P"Y:TS_ /758?\ Y*#$?]@&&_.L=W$/
M_)D^$O\ LO>-O_5=PN=43P/I_4TE*>@^G]325[L_B?R_)'XXKV6VR[^7_!_
M****D>OE^/E_P?P"BBB@-?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^
M4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P '\ HHHH#7R_'R_P"#
M^ 4444!KY?CY?\'\ HHHH#7R_'R_X/X!1110&OE^/E_P?P"BBB@-?+\?+_@_
M@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ **** U\OQ\O\
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MRQ[%]/Y_XU_4Y_P>"?\ *8"7_LUGX*?^EGCROY8]O^TWY_\ UJ -"U^[=?\
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M'_>_^)KCH;_^#O\ U(J'[7XX_P#(W\._^S*^$G_K%9834U_N-_NM_(TZFO\
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M\M"GI]X?5?\ T(4RGIG</JN?^^A36Z]5^9K1M[:E[LOXD.O]Z/GZ?TC\6?\
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ME^+/Q9_X."_^41G[8O\ U[?![_U<7A"O\NUMVWM][W]3G^N/PK_42_X."_\
ME$9^V+_U[?![_P!7%X0K_+M8G;T_B]?<_P OZ5^+>(?_ "/\/O\ [O1_.7],
M_P!3?H<_\FE6_P#R4^:^OP8+\2+Y_P#9_6O[N_\ @Q[_ .2H?\%%_P#LGW[-
MG_I]^,5?PB9;^[^HK^[O_@Q[_P"2H?\ !1?_ +)]^S9_Z??C%7Y^?UB?Z&D?
M^KC_ -Q?_013Z9'_ *N/_<7_ -!%/H I77WD^J?^A&OQD_9=_P"4S7_!2K_L
MC/[,7_IFFK]F[K[R?5/_ $(U^,G[+O\ RF:_X*5?]D9_9B_],TU1B/AI^O\
M[@KG[7X1?\DE](/_ +-%'_UZ7A4?M&O5?JW\A4M1+U7ZM_(5+5+9>B_(_$H?
M"OG^;"BBBF4%)W'T/\Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %4;WHG^\O\ Z$*O51O.B?[R_P#H0JH_:_PLB>]+_K_0_P#3
ML#\;_A/_ ,ISOVL_^S*/@Q_ZE.GU^S _A_WO_B:_&;X4?\ISOVL_^S*/@Q_Z
ME.GU^S(_A_WO_B:XZ&__ (._]2*A^U^./_(W\._^S*^$G_K%9834U_N-_NM_
M(TZFO]QO]UOY&NH_%S_*K_X/!/\ E,!+_P!FL_!3_P!+/'E?RQ[O]EORK^IS
M_@\$_P"4P$O_ &:S\%/_ $L\>5_+'N7U_G_A0!H6OW;K_KSN/_1(K_8-_8D.
M/V*OV/>"?^,7_@3T'_5,_#5?X^5K]VZ_Z\[C_P!$BO\ 8-_8D('[%7['N3_S
M:_\  GU_Z)GX:K]*\-O^1GC?^P./_I<#^*_IL_\ ))\"_P#8ZQ?_ *CTSZ><
M\DX/;C'/2OPO_:Y.?^"Z?_!(K@C_ (LO^VAU'_4E3U^Z#D9)SQQZ^E?A?^UR
M0?\ @NG_ ,$BL?\ 1%_VT/\ U"IZ_0L^_P!TPG_8PRK_ -6F$/XI\('_ ,9'
MQ#K_ ,VZ\1M/^[3S/_AS]RHONQ?]<A_Z$:EJ*+[L7_7(?^A&I:]FE_ P_P#U
MXI?^D(_+<2_]KQ>J7^TU?_2E_P %?,****LQO_>7X>7_  ?O\@HHHH"_]Y?A
MY?\ !^_R"BBB@+_WE^'E_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\
M!^_R"BBB@+_WE^'E_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R
M"BBB@+_WE^'E_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB
M@+_WE^'E_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB@+_W
ME^'E_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB@+_WE^'E
M_P '[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB@+_WE^'E_P '
M[_(**** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB@+_WE^'E_P '[_(*
M*** O_>7X>7_  ?O\@HHHH"_]Y?AY?\ !^_R"BBB@+_WE^'E_P '[_(****
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M7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ **** U\OQ\O\ @_@%%%%
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M?+\?+_@_@%%%% :^7X^7_!_ **** U\OQ\O^#^ 4444!KY?CY?\ !_ ****
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MV%%%%,H*3N/H?YBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *HWO1/]Y?\ T(5>JC>]$_WE_P#0A51^U_A9$]Z7_7^A_P"G8'XW
M_"?G_@N=^UG_ -F4?!C]/%.GFOV8'\/^]_\ $U^,WPH_Y3G?M9_]F4?!C_U*
M=/K]F1_#_O?_ !-<=#?_ ,'?^I%0_:_''_D;^'?_ &97PD_]8K+":FO]QO\
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M\OZMZ7**** M_<7]?+^K>ERBBB@+?W%_7R_JWI<HHHH"W]Q?U\OZMZ7****
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M_P!I._V1_P#TO\5U^Z"Y^T3\_P "=NV!Q7X7_P#!>_\ Y(7^Q)_VD[_9'_\
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MOO\ _MO)?<%%%% 6_NR^_P#^V\E]P4444!;^[+[_ /[;R7W!1110%O[LOO\
M_MO)?<%%%% 6_NR^_P#^V\E]P4444!;^[+[_ /[;R7W!1110%O[LOO\ _MO)
M?<%%%% 6_NR^_P#^V\E]P4444!;^[+[_ /[;R7W!1110%O[LOO\ _MO)?<%%
M%% 6_NR^_P#^V\E]P4444!;^[+[_ /[;R7W!3T^\/JO_ *$*93T^\/JO_H0I
MK=>J_,THK]]2]U_Q(=?[T?[WD?BS_P '!?\ RB,_;&_Z]O@]_P"KB\(5_EV,
M#C[Q^]_(GW[X_6O]1/\ X."_^41G[8O_ %[?![_U<7A"O\NUL[>O\7I[G^?]
M:_%?$/\ Y'^'T_YAZ/YR_+^KG^IGT.?^32K3_FILUT_[AX+^MR':?[Q_S^-?
MW>?\&/?_ "5#_@HO_P!D^_9L_P#3[\8J_A$PW][]!7]W?_!CW_R5#_@HO_V3
M[]FS_P!/OQBKX _K(_T-(_\ 5Q_[B_\ H(I],C_U<?\ N+_Z"*?0!2NOO)]4
M_P#0C7XR?LN_\IFO^"E7_9&?V8O_ $S35^S=U]Y/JG_H1K\9/V7?^4S7_!2K
M_LC/[,7_ *9IJC$?#3]?_<%<_:_"+_DDOI!_]FB7_KTO"H_:->J_5OY"I:B7
MJOU;^0J6J6R]%^1^)0^%?/\ -A1113*"D[CZ'^8I:3N/H?YB@ '0?0?RI:0=
M!]!_*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "J-[T3_ 'E_]"%7JHWG1/\ >7_T
M(54?M?X61/>E_P!?Z'_IV!^-WPH_Y3G?M9_]F4?!C_U*=/K]F1_#_O?_ !-?
MC/\ "<X_X+G?M9_]F4?!C]?%.GBOV8'\/^]_\37'0W_\'?\ J14/VOQQ_P"1
MOX=_]F5\)/\ UBLL)J:_W&_W6_D:=37^XW^ZW\C74?BY_E5_\'@G_*8"7_LU
MGX*?^EGCROY8_G_V?UK^IS_@\$_Y3 2_]FL_!3_TL\>5_+'EO[OZB@#0M?NW
M7_7G<?\ HD5_L&_L2;O^&*OV/<8_Y-?^!/7/_1,_#5?X^5K]VZ_Z\[C_ -$B
MO]@W]B0G_ABK]CW S_QB_P# GOC_ )IGX:K]*\-O^1GC?^P./_I<#^*_IL_\
MDGP+_P!CK%_^H],^GGW9/3/'KCI7X7_M<Y_X?I_\$BLX_P"2+_MH=,_]"5/_
M /6K]T')R>.>.,^WK7X7_M<Y_P"'Z?\ P2*R,?\ %E_VT/?_ )DJ>OT+/O\
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M]<?A7^HE_P '!?\ RB,_;%_Z]O@]_P"KB\(5_EVL3MZ?Q>ON?Y?TK\6\0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *HWG1/]Y?\ T(5>JC>=$_WE_P#0A51^U_A9$]Z7
M_7^A_P"G8'XW?"C_ )3G?M9_]F4?!C_U*=/K]F1_#_O?_$U^,WPG_P"4YW[6
M?_9E'P8_]2G3\?K7[,C^'_>_^)KCH;_^#O\ U(J'[7XX_P#(W\._^S*^$G_K
M%9834U_N-_NM_(TZFO\ <;_=;^1KJ/Q<_P JO_@\$_Y3 2_]FL_!3_TL\>5_
M+'N_V6_*OZG/^#P3_E,!+_V:S\%/_2SQY7\L>Y?7^?\ A0!H6OW;K_KSN/\
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M O\ WE^'E_P?O\@HHHH"_P#>7X>7_!^_R"BBB@+_ -Y?AY?\'[_(**** O\
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M\O\ @_?Y!1110%_[R_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\
M@_?Y!1110%_[R_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y
M!1110%_[R_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!111
M0%_[R_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!1110%_[
MR_#R_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!1110%_[R_#R
M_P"#]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!1110%_[R_#R_P"#
M]_D%%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!1110%_[R_#R_P"#]_D%
M%%% 7_O+\/+_ (/W^04444!?^\OP\O\ @_?Y!1110%_[R_#R_P"#]_D%%%%
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M *O#P/7ZZ>!<?\(!X$SC_D2/!_UQ_P (UIG]?UJL/_R4&(_[ ,-^=8[N(?\
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MG_H1K\9/V7?^4S7_  4J_P"R,_LQ?^F::OV;NOO)]4_]"-?C)^R[_P IFO\
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M[=?]>=Q_Z)%?[!O[$B@_L5?L>Y'_ #:_\"?7_HF?AJOTKPV_Y&>-_P"P./\
MZ7 _BOZ;/_))\"_]CK%_^H],^GG49(QQQZ^E?A?^UR /^"Z?_!(K'_1%_P!M
M#_U"I_\ &OW0=1DC'''KZ5^%_P"UR /^"Z?_  2*Q_T1?]M#_P!0J?\ QK]"
MS[_<\'_V,,J_]6F#/XI\(/\ DI.(=%_R;KQ&UZ_\DGF7E^NQ^Y47W8O^N0_]
M"-2U%%]V+_KD/_0C4M>S2_@8?_KQ2_\ 2$?EN)_WO%Z)_P"TU=_7T844459C
M;^['^O\ MT**** M_=C_ %_VZ%%%% 6_NQ_K_MT**** M_=C_7_;H4444!;^
M['^O^W0HHHH"W]V/]?\ ;H4444!;^['^O^W0HHHH"W]V/]?]NA1110%O[L?Z
M_P"W0HHHH"W]V/\ 7_;H4444!;^['^O^W0HHHH"W]V/]?]NA1110%O[L?Z_[
M="BBB@+?W8_U_P!NA1110%O[L?Z_[="BBB@+?W8_U_VZ%%%% 6_NQ_K_ +="
MBBB@+?W8_P!?]NA1110%O[L?Z_[="BBB@+?W8_U_VZ%%%% 6_NQ_K_MT****
M M_=C_7_ &Z%%%% 6_NQ_K_MT**** M_=C_7_;H4444!;^['^O\ MT**** M
M_=C_ %_VZ%%%% 6_NQ_K_MT**** M_=C_7_;H4444!;^['^O^W0HHHH"W]V/
M]?\ ;H4444!;^['^O^W0HHHH"W]V/]?]NA1110%O[L?Z_P"W0HHHH"W]V/\
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MK_MT**** M_=C_7_ &Z%%%% 6_NQ_K_MT**** M_=C_7_;H4444!;^['^O\
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M,H*3N/H?YBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH
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M/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%%
M?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%
M%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O
M+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W
M/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%%
M?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%
M%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O
M+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W/R\O+\6%%%% ?.7W
M/R\O+\6%.7.1CK[_ $IM.7.1@9_3M2>S]'^0X[QUENNC[KR\OQ9$N[[1/T^X
MGKTP/UK\+_\ @O?_ ,D+_8D_[2=_LC_^E_BNOW04G[1/Q_ G?M@<_P#UJ_"_
M_@O?_P D+_8D_P"TG?[(_P#Z7^*Z\//_ /D4X[_L P7_ *4C]4\#O^3G<+_]
MC7-?_43&_P!([;_@XB_Y1%_M;_\ 7W\(O_5X>!Z_73P+G_A / F,?\B1X/\
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MCC_R-_#O_LROA)_ZQ66$U-?[C?[K?R-.IK_<;_=;^1KJ/Q<_RJ_^#P3_ )3
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M(?\ H1J6HHONQ?\ 7(?^A&I:]FE_ P__ %XI?^D(_+<2[8O%ZV_VFK_Z4O\
MAOQZ!1115F/-_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!11
M10'-_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#
MT_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#T_X/W^04
M444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#T_X/W^04444!S?WO
MP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#T_X/W^04444!S?WOP]/^#]_D
M%%%% <W][\/3_@_?Y!1110'-_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W]
M[\/3_@_?Y!1110'-_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?
MY!1110'-_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-
M_>_#T_X/W^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#T_X/
MW^04444!S?WOP]/^#]_D%%%% <W][\/3_@_?Y!1110'-_>_#T_X/W^04444!
MS?WOP]/^#]_D%%%% <W][\/3_@_?Y!3E.".#^'TIM*IP0:3V?H_R'%ZQ][JN
MGG'_ (/W^1&I_P!(GX/W$'3V'/TK\+_^"]__ "0O]B3_ +2=_LC_ /I?XKK]
MSU8&XF//W$'Z"OPP_P""]_\ R0O]B3_M)W^R/_Z7^*Z\//\ _D4X[_L P7_I
M2/U3P._Y.=PO_P!C;-O_ %$QOY;';?\ !Q%_RB+_ &M_^OOX1?\ J\/ ]?KI
MX$./ '@3@G_BB/!Y]O\ D6M,X_Q]J_(O_@XB_P"41?[6_P#U]_"+_P!7AX'K
M]<_ I_XH#P*/^I(\'_KX;TP56'_Y*"O_ -@&&_.N=W$/_)D^$O\ LO>-O_5=
MPN=7G@<'IW^II*,Y ^G]2?ZT5[L_B?R_)'XVGHO>Z+IY1_KY^04445(^;^]^
M'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P
M?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\
M(**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (***
M* YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO
M[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>
MG_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^
M_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @
MHHHH#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH
M#F_O?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O
M?AZ?\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?
M\'[_ ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_
M ""BBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""B
MBB@.;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.
M;^]^'I_P?O\ (**** YO[WX>G_!^_P @HHHH#F_O?AZ?\'[_ ""BBB@.;^]^
M'I_P?O\ (*>GWA]5_P#0A3*>A^8>Y7_T(&FMUZK\S2B_WU+WK_O(=+?:C_7S
MMT/Q9_X."_\ E$9^V+_U[?![_P!7%X0K_+M8_+T/WO3U)_R?QK_42_X."S_Q
MJ,_;&]K;X/?^KB\(&O\ +L9AC'/WOYD_XU^*^(;_ .%_#_\ 8/1_.7YG^IGT
M.7_QJ5?]E-FNO_</!:D>[_9;\J_N[_X,>_\ DJ'_  47_P"R??LV?^GWXQ5_
M"'O'O_G\:_N\_P"#'O\ Y*A_P47_ .R??LV?^GWXQ5\ ?UD?Z&D?^KC_ -Q?
M_013Z9'_ *N/_<7_ -!%/H I77WD^J?^A&OQD_9=_P"4S7_!2G_LC/[,?_IG
MFK]F[K[R?5/_ $(U^,G[+O\ RF:_X*5?]D9_9B_],TU1B/AI^O\ [@KG[7X1
M?\DE](/_ +-$O_7I>%1^T:]5^K?R%2U$O5?JW\A4M4MEZ+\C\2A\*^?YL***
M*904G<?0_P Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %4;WHG^\O_ *$*O51O>B?[R_\ H0JH_:_PLB>]+_K_ $/_ $[ _&_X
M3_\ *<[]K//_ $91\&/_ %*=/Q^M?LP/X?\ >_\ B:_&;X4?\ISOVL_^S*/@
MQ_ZE.GU^S(_A_P![_P")KCH;_P#@[_U(J'[7XX_\C?P[_P"S*^$G_K%9834U
M_N-_NM_(TZFO]QO]UOY&NH_%S_*K_P"#P3_E,!+_ -FL_!3_ -+/'E?RQ[E]
M?Y_X5_4Y_P '@G_*8"7_ +-9^"G_ *6>/*_EC^7_ &?TH T+7[MU_P!>=Q_Z
M)%?[!O[$A _8J_8]R?\ FU_X$^O_ $3/PU7^/E:_=NO^O.X_]$BO]@W]B3'_
M  Q5^Q[G'_)K_P ">N/^B9^&O6OTKPV_Y&>-_P"P./\ Z7 _BOZ;/_))\"_]
MCK%_^H],^GG(R3GCCU]*_"_]KD@_\%T_^"16/^B+_MH?^H5/7[H/C)Z8X],=
M/RK\+_VN<?\ #]/_ ()%8Q_R1?\ ;0Z?]B5/_P#7K]"S[_=,)_V,,J_]6F$/
MXI\(+_ZQ\0[?\FZ\1O\ UD\S_KT/W*B^[%_UR'_H1J6HHONQ?]<A_P"A&I:]
MFE_ P_\ UXI?^D(_+<3?ZWB[6_WFKO\ XEY_T_4****LQN^\?ZMY^?Y=]"BB
MB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K
M>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0H
MHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_
MJWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT
M**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\
M?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=
M]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+O
MO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^
M7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"
M[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY
M_EWT*<IP1G_/%-IR]1GI[_2D]GZ/\AQ;O'6.Z_->?G^7?2)2/M$_/\"#OUP*
M_"__ (+W_P#)"_V)/^TG?[(__I?XKK]T%Q]HGZ?<3TZX'ZU^%_\ P7O_ .2%
M_L2?]I._V1__ $O\5UX>?_\ (IQW_8!@O_2D?JG@=_R<[A?_ +&N:_\ J)C?
MZ9VW_!Q%_P HB_VM_P#K[^$7_J\/ ]?KIX%(_P"$ \" _P#0D>#_ ,O^$:TP
M5^1?_!Q%_P HB_VM_P#K[^$7_J\/ ]?KGX%Q_P *_P# O3/_  A'@_Z_\BUI
MG]?UJL/_ ,E!7_[ ,-^=8[N(?^3)\)?]E[QM_P"J[A<ZO.0,>G]324O88].W
MU/\ 2DKW9_$_E^2/QM-V6L=E^2\_/\NX4445([OO'^K>?G^7?0HHHH"[[Q_J
MWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT*
M*** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?
MZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]
M"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO
M'^K>?G^7?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7
M?0HHHH"[[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[
M[Q_JWGY_EWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_
MEWT**** N^\?ZMY^?Y=]"BBB@+OO'^K>?G^7?0HHHH"[[Q_JWGY_EWT****
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M^'_>_P#B:_&;X4?\ISOVL_\ LRCX,?\ J4Z?7[,C^'_>_P#B:XZ&_P#X._\
M4BH?M?CC_P C?P[_ .S*^$G_ *Q66$U-?[C?[K?R-.IK_<;_ '6_D:ZC\7/\
MJO\ X/!/^4P$O_9K/P4_]+/'E?RR8'H/RK^IO_@\$_Y3 2_]FL_!3_TL\>5_
M+'L7T_G_ (T :%K]VZ_Z\[C_ -$BO]@W]B0 _L5?L>Y _P"37_@3V_ZIGX:K
M_'RM?NW7_7G<?^B17^P;^Q(H/[%7['N1_P VO_ GU_Z)GX:K]*\-O^1GC?\
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M  47_P"R??LV?^GWXQ5^?G]8G^AI'_JX_P#<7_T$4^F1_P"KC_W%_P#013Z
M*5U]Y/JG_H1K\9/V7?\ E,U_P4J_[(S^S%_Z9IJ_9NZ^\GU3_P!"-?C)^R[_
M ,IFO^"E7_9&?V8O_3--48CX:?K_ .X*Y^U^$7_))?2#_P"S1+_UZ7A4?M&O
M5?JW\A4M1+U7ZM_(5+5+9>B_(_$H?"OG^;"BBBF4%)W'T/\ ,4M)W'T/\Q0
M#H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5&\Z)_O+_P"A"KU4
M;WHG^\O_ *$*J/VO\+(GO2_Z_P!#_P!.P/QN^%'_ "G._:S_ .S*/@Q_ZE.G
MU^S(_A_WO_B:_&;X4?\ *<[]K/\ [,H^#'_J4Z?7[,C^'_>_^)KCH;_^#O\
MU(J'[7XX_P#(W\._^S*^$G_K%9834U_N-_NM_(TZFO\ <;_=;^1KJ/Q<_P J
MO_@\$_Y3 2_]FL_!3_TL\>5_+'M_VF_/_P"M7]3G_!X)_P I@)?^S6?@I_Z6
M>/*_ECPW][]!0!H6OW;K_KSN/_1(K_8-_8D&?V*OV/>2/^,7_@3T/_5,_#5?
MX^5K]VZ_Z\[C_P!$BO\ 8-_8DS_PQ5^Q[@X_XQ?^!/;/_-,_#5?I7AM_R,\;
M_P!@<?\ TN!_%?TV?^23X%_['6+_ /4>F?3SCDC)[<YYZ5^%_P"UR,?\%T_^
M"17)/_%E_P!M#K_V)4]?N@^<GGGCG'MZ5^%_[7.?^'Z?_!(K)S_Q9?\ ;0[?
M]25/_G\*_0L^_P!TPG_8PRK_ -6F$/XI\(/^2CXAT_YMUXC?^LGF9^Y47W8O
M^N0_]"-2U%%]V+_KD/\ T(U+7LTOX&'_ .O%+_TA'Y;B?][Q>C?^TU?_ $I>
M:[!1115F-O[K^]>7GY+[@HHHH"W]U_>O+S\E]P4444!;^Z_O7EY^2^X****
MM_=?WKR\_)?<%%%% 6_NO[UY>?DON"BBB@+?W7]Z\O/R7W!1110%O[K^]>7G
MY+[@HHHH"W]U_>O+S\E]P4444!;^Z_O7EY^2^X**** M_=?WKR\_)?<%%%%
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M8(BV_P"TWY__ %J_N[_X,>_^2H?\%%_^R??LV?\ I]^,5?PB8;^]^@K^[O\
MX,>_^2H?\%%_^R??LV?^GWXQ5^?G]8G^AI'_ *N/_<7_ -!%/ID?^KC_ -Q?
M_013Z *5U]Y/JG_H9K\9/V7?^4S7_!2K_LC/[,7_ *9IJ_9NZ^\GU3_T(U^,
MG[+O_*9K_@I5_P!D9_9B_P#3--48CX:?K_[@KG[7X1?\DE](/_LT2_\ 7I>%
M1^T:]5^K?R%2U$O5?JW\A4M4MEZ+\C\2A\*^?YL****904G<?0_S%+2=Q]#_
M #%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4;WHG^\O_H0
MJ]5&]Z)_O+_Z$*J/VO\ "R)[TO\ K_0_].P/QN^%'_*<[]K/_LRCX,?^I3I]
M?LR/X?\ >_\ B:_&;X3G_C>=^UG_ -F4?!C]?%.GBOV9'\/^]_\ $UQT-_\
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M+U]S_+^E?BWB'_R/\/O_ +O1_.7],_U-^AS_ ,FE6_\ R4^:^OP8+\2+Y_\
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M%WW7W?\ !\U]X4444!=]U]W_  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\
M!\U]X4444!=]U]W_  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\ !\U]X444
M4!=]U]W_  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\ !\U]X4444!=]U]W_
M  ?-?>%%%% 7?=?=_P 'S7WA1110%WW7W?\ !\U]X4444!=]U]W_  ?-?>%%
M%% 7?=?=_P 'S7WA3E.",_YXIM.4_,/Q_E2>S]'^0XMW6JW73S7GYK[R)2/M
M$_/\"#OUP*_"_P#X+W_\D+_8D_[2=_LC_P#I?XKK]T%(^T3\C_5J/T%?A?\
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MEW_E,U_P4J_[(S^S%_Z9IJ_9NZ^\GU3_ -"-?C)^R[_RF:_X*5?]D9_9B_\
M3--48CX:?K_[@KG[7X1?\DE](/\ [-%'_P!>EX5'[1KU7ZM_(5+42]5^K?R%
M2U2V7HOR/Q*'PKY_FPHHHIE!2=Q]#_,4M)W'T/\ ,4  Z#Z#^5+2#H/H/Y4M
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\
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M[;_@XB_Y1%_M;_\ 7W\(O_5X>!Z_73P+_P D_P# O'_,D>#_ /U&M,K\B_\
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M!KV7W_\ VODON"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\
M^U\E]P4444!KV7W_ /VODON"BBB@->R^_P#^U\E]P4444!KV7W__ &ODON"B
MBB@->R^__P"U\E]P4444!KV7W_\ VODON"BBB@->R^__ .U\E]P4444!KV7W
M_P#VODON"BBB@->R^_\ ^U\E]P4444!KV7W_ /VODON"BBB@->R^_P#^U\E]
MP4444!KV7W__ &ODON"BBB@->R^__P"U\E]P4444!KV7W_\ VODON"BBB@->
MR^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\ ^U\E]P4444!KV7W_ /VO
MDON"BBB@->R^_P#^U\E]P4444!KV7W__ &ODON"BBB@->R^__P"U\E]P4444
M!KV7W_\ VODON"BBB@->R^__ .U\E]P4444!KV7W_P#VODON"BBB@->R^_\
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MA3_\UE'_  V1^Q]_T=E^S)_X?SX4_P#S64?7L%_T&87_ ,**7_R8?ZK<3?\
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M ->WP>_]7%X0K_+M8?+U/WO7T)_GCG\:_P!*;_@O#^TM^S=X[_X)5_M:>%/
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M?^S6?@I_Z6>/*_EBR_H/\_C0!HVOW;K_ *\[C_T2*_V#?V)-W_#%7['N,?\
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M)/\ M)W^R/\ ^E_BNOW/7=]HFR!]Q/RP/>OPP_X+W_\ )"_V)/\ M)W^R/\
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M]T%%%% 7_P ?W/R_K[^Z"BBB@+_X_N?E_7W]T%%%% 7_ ,?W/R_K[^Z"FO\
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MT'^?QH"[\_Z_X9?<)L/HO_CW^-&P^B_^/?XTN7]!_G\:,OZ#_/XT!=^?]?\
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M?8IHQ%&(P-FQ<;6&WD>^,=\Y]?>G^<!T!_,>V.A_SUK\38?^"5G[1TL2RO\
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MG.HE*5-U_;\CLM%TA_A22ZA2=Q]#_,4M)W'T/\Q618#H/H/Y4M(.@^@_E2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !5&]Z)_O+_Z$*O51O>B?[R_^A"JC]K_  LB
M>]+_ *_T/_3L#\;_ (3G'_!<[]K/_LRCX,?KXIT\5^S _A_WO_B:_&;X4?\
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M *^_A%_ZO#P/7ZY^!21X \"<9_XHCP?]/^1;TP?_ %Z_(S_@XB_Y1%_M;_\
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M/\?)A37^Z?P_F*=37^Z?P_F*!QWC[W5=/./EY_CY,_R\_P#@X8_Y2^_M@_\
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M5_T OV;?_#XQ?_,O7^K-10!_E,_\0@?_  6*_P"@%^S;_P"'QB_^9>C_ (A
M_P#@L5_T OV;?_#XQ?\ S+U_JS44 ?Y3/_$('_P6*_Z 7[-O_A\8O_F7H_XA
M _\ @L5_T OV;?\ P^,7_P R]?ZLU% '^4S_ ,0@?_!8K_H!?LV_^'QB_P#F
M7H_XA _^"Q7_ $ OV;?_  ^,7_S+U_JS44 ?Y3/_ !"!_P#!8K_H!?LV_P#A
M\8O_ )EZ/^(0/_@L5_T OV;?_#XQ?_,O7^K-10!_E,_\0@?_  6*_P"@%^S;
M_P"'QB_^9>C_ (A _P#@L5_T OV;?_#XQ?\ S+U_JS44 ?Y3/_$('_P6*_Z
M7[-O_A\8O_F7H_XA _\ @L5_T OV;?\ P^,7_P R]?ZLU% '^4S_ ,0@?_!8
MK_H!?LV_^'QB_P#F7IDO_!H1_P %A8(Y)I]&_9JBAA1I9I9/CI!'''%&I:22
M21_# 5$1 6=V(55!)X%?ZM-8/BHD>&/$9'4:#K!'U&GW&*:5VEW:7WLUH0]K
M7HTF[*I5IT[VO;GFHWMUM<_R<_A?_P &N7_!2_XY^%;7QW\'?$'[)GQ#\(7%
M_J6F6WB/P[\?[>XLKFYT2^ETS48@6\)Q,1;7]M-;2/M.^1&Z]:_J\_X-KO\
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MO[$A _8J_8]R1_R:_P# G_U6?AJOTKPV_P"1GC?^P./_ *7 _BOZ;/\ R2?
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M"[[K[O\ @^:^\**** N^Z^[_ (/FOO"BBB@+ONON_P"#YK[PHHHH"[[K[O\
M@^:^\**** N^Z^[_ (/FOO"BBB@+ONON_P"#YK[PIK_=/X?S%.IK_=/X?S%
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M6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH ****
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M?]<A_P"A&I:]FE_ P_\ UXI?^D(_+,3?ZUB]$_\ ::N_JO)A1115F6O9??\
M_:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1
M110&O9??_P#:^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[
M_P#[7R7W!1110&O9??\ _:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^
MX**** U[+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\ [7R7W!1110&O
M9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\ _:^2^X**** U[+[_ /[7
MR7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:^2^X****
M U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\
M_:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1
M110&O9??_P#:^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[
M_P#[7R7W!1110&O9??\ _:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^
MX**** U[+[__ +7R7W!3E^\/Q_E3:<HR0#_GBD]GZ/\ (<;W6BW7YKR\E]Q$
MH'VB?@?ZM3T]A7X7_P#!>_\ Y(7^Q)_VD[_9'_\ 2_Q77[H*H^T3\?P(>_7
MK\+_ /@O?_R0O]B3_M)W^R/_ .E_BNO#S_\ Y%.._P"P#!?^E(_4_ [_ ).=
MPO\ ]C7-?_4/&G;?\'$7_*(O]K?_ *^_A%_ZO#P/7ZZ>!!GP!X$_[$CP?S_W
M+6F?_KK\B_\ @XB_Y1%_M;_]??PB_P#5X>!Z_7/P*!_PK_P*>_\ PA'@_P#]
M1K3#_.JP_P#R4%?_ + ,-^=8[N(?^3)\)?\ 9>\;?^J[A<ZL]!]/ZFDI<8 Q
MZ?U(_I25[L_B?R_)'XXKV6BV77R7EY?@@HHHJ1Z]E]__ -KY+[@HHHH#7LOO
M_P#M?)?<%%%% :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[
M@HHHH#7LOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\ M?)?<%%%% :]
ME]__ -KY+[@HHHH#7LOO_P#M?)?<%%%% :]E]_\ ]KY+[@HHHH#7LOO_ /M?
M)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH
M#7LOO_\ M?)?<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<%%%% :]E]_\
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M?^Q;T/\ ]-EK7&?3G24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6%XH_Y%GQ%_V M7_P#3?<5NUA>*/^19\1?]@+5__3?<54/CC_BC^:.G!_[Y
MA/\ L)H?^G8GY#?\$*/^4<GPS_[*9\:O_5H>):_8A^_^\E?CO_P0H_Y1R?#/
M_LIGQJ_]6AXEK]B'[_[R5CA_X"_Z]T/_ $S3/USZ1G_)_P#Q8_[.7QG_ .KK
M&%N/[H^K?^A&GTR/[H^K?^A&GU:V7HOR/QB'P1_PQ_)%*Z^\GU3_ -#-?C)^
MR[_RF:_X*4_]D9_9C_\ 3/-7[-W7WD^J?^AFOQD_9=_Y3-?\%*O^R,_LQ?\
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M\_A7Z%GW^Z83_L895_ZM,(?Q3X0?\E'Q#I_S;KQ&_P#63S,_<J+[L7_7(?\
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M*** _P# _P ?+_@_CY!1110'_@?X^7_!_'R"BBB@/_ _Q\O^#^/D%%%% ?\
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M#_'R_P"#^/D%%%% ?^!_CY?\'\?(**** _\  _Q\O^#^/D%%%% ?^!_CY?\
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M1_R+/B+_ + 6K_\ ION*J'QQ_P 4?S1TX/\ WS"?]A-#_P!.Q/R&_P""%/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %4;WHG^\O_H0J]5&]Z)_O+_Z$*J/VO\+(
MGO2_Z_T/_3L#\;OA1_RG._:S_P"S*/@Q_P"I3I]?LR/X?][_ .)K\9_A/_RG
M._:S_P"S*/@Q_P"I3I]?LP/X?][_ .)KCH;_ /@[_P!2*A^U^./_ "-_#O\
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M4]?N@YY)P>W&.>E?A?\ M<G/_!=/_@D5P1_Q9?\ ;0ZC_J2IZ_0L^_W3"?\
M8PRK_P!6F$/XI\(/^2CXAU_YMUXC?^LGF?\ E<_<J+[L7_7(?^A&I:BB^[%_
MUR'_ *$:EKV:7\##_P#7BE_Z0C\MQ/\ O>+U:_VFK_Z4EV?<****LQO_ 'G]
MR\O+S04444!?^\_N7EY>:"BBB@+_ -Y_<O+R\T%%%% 7_O/[EY>7F@HHHH"_
M]Y_<O+R\T%%%% 7_ +S^Y>7EYH**** O_>?W+R\O-!1110%_[S^Y>7EYH***
M* O_ 'G]R\O+S04444!?^\_N7EY>:"BBB@+_ -Y_<O+R\T%%%% 7_O/[EY>7
MF@HHHH"_]Y_<O+R\T%%%% 7_ +S^Y>7EYH**** O_>?W+R\O-!1110%_[S^Y
M>7EYH**** O_ 'G]R\O+S04444!?^\_N7EY>:"BBB@+_ -Y_<O+R\T%%%% 7
M_O/[EY>7F@HHHH"_]Y_<O+R\T%%%% 7_ +S^Y>7EYH**** O_>?W+R\O-!11
M10%_[S^Y>7EYH**** O_ 'G]R\O+S04444!?^\_N7EY>:"BBB@+_ -Y_<O+R
M\T%%%% 7_O/[EY>7F@HHHH"_]Y_<O+R\T%%%% 7_ +S^Y>7EYH**** O_>?W
M+R\O-!1110%_[S^Y>7EYH**** O_ 'G]R\O+S04444!?^\_N7EY>:"BBB@+_
M -Y_<O+R\T%%%% 7_O/[EY>7F@IRYR,#/Z=J;3E.".#^'TI/9^C_ "'%ZQ]Y
M[KHNZ\O-$2D_:)^/X$[]L#G_ .M7X7_\%[_^2%_L2?\ :3O]D?\ ]+_%=?N@
MI_TB?@_<0=/8<_2OPO\ ^"]__)"_V)/^TG?[(_\ Z7^*Z\//_P#D4X[_ + ,
M%_Z4C]4\#O\ DYW"_P#V-<U_]1,:=M_P<1?\HB_VM_\ K[^$7_J\/ ]?KGX%
MS_PK_P "\?\ ,D>#_P#U&M,__77Y&?\ !Q%_RB+_ &M_^OOX1?\ J\/ ]?KI
MX%/_ !0'@3@G_BB/!_T_Y%K3._\ GBJP_P#R4%?_ + ,-^=8[N(?^3)\)?\
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MGR,)(9HV3YHHR=IY;&3^)W_!$OPIJWQ6_P""B'C[XX_!CP?-\*?@?H&D^/\
M5/$7@%=:U>73O#.E?$!I[;P/\/[.]6UDM]8O/#L[C6K%-:F$T6E))<6MG"R+
M)7[5_LJ"&+_@L1_P4G6)51%^$?[,:N& \XR'0W+,Q+;R@_@) +IL9RSDL>JC
M5J5L)@9U.5U*GMN:5--0J-1Q<(U(J5K*<8V^&.VD8QDDOR'QE\*>#?!CC[Z2
MW"O!=+%9?E=?Z.G#6>U<@S/'4LRS;A'$9QXD^%..Q'"V=8VE*I"MF.65*MW.
ME7KP^JUZ$'7Q-2%3$5/VF0DE#G/RG/UR?_KU-56%75@&.0"^._!QM)_#/;O5
MJN]QY;*Z>BV]#_.;:51+93=GT>D7=>6OYA1112&%)W'T/\Q2TG<?0_S%  .@
M^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %4;SHG^\O\ Z$*O51O.
MB?[R_P#H0JH_:_PLB>]+_K_0_P#3L#\;OA1_RG._:S_[,H^#'_J4Z?7[,C^'
M_>_^)K\9OA/_ ,ISOVL_^S*/@Q_ZE.GX_6OV9'\/^]_\37'0W_\ !W_J14/V
MOQQ_Y&_AW_V97PD_]8K+":FO]QO]UOY&G4U_N-_NM_(UU'XN?Y5?_!X)_P I
M@)?^S6?@I_Z6>/*_ECW+Z_S_ ,*_J<_X/!/^4P$O_9K/P4_]+/'E?RR;AZC\
MZ +]K]VZ_P"O.X_]$BO]@W]B0@?L5?L>Y/\ S:_\"?7_ *)GX:K_ !\K7[MU
M_P!>=Q_Z)%?[!O[$A _8J_8]R1_R:_\  G_U6?AJOTKPV_Y&>-_[ X_^EP/X
MK^FS_P DGP+_ -CK%_\ J/3/IYR,DYXX]?2OPO\ VN2#_P %T_\ @D5C_HB_
M[:'_ *A4]?N@Y&2<C''\J_##]KD_\;T_^"17_9%_VT/_ %"IZ_0L^_W3"?\
M8PRK_P!6F$/XJ\(/^2CXA_[-UXC?^LGF7F?N3%]V+_KD/_0C4M11?=B_ZY#_
M -"-2U[-+^!A_P#KQ2_](1^68F_UK%ZI?[35W7FO-!1115F5WW7W?\'S7WA1
M110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S
M7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W
M?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%
MWW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1
M110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S
M7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W
M?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%
MWW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1
M110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S7WA1110%WW7W?\'S
M7WA1110%WW7W?\'S7WA3E.",_P">*;3E/S#\?Y4GL_1_D.+=UJMUT\UY^:^\
MB4C[1/S_  (._7 K\+_^"]__ "0O]B3_ +2=_LC_ /I?XKK]T%(^T3\C_5J/
MT%?A?_P7O_Y(7^Q)_P!I._V1_P#TO\5UX>?_ /(IQW_8!@O_ $I'ZGX'?\G.
MX7_[&N:_^H>-.V_X.(O^41?[6_\ U]_"+_U>'@>OUS\"D?\ "O\ P*.__"$>
M#_\ U&M,'\Z_(S_@XB_Y1%_M;_\ 7W\(O_5X>!Z_73P(1_P@'@0'_H2/!_Y?
M\(UIE5A_^2@K_P#8!AOSK'=Q#_R9/A+_ ++WC;_U7<+G59R!CT_J:2E)X'T_
MJ:2O=G\3^7Y(_'%>RU6RZ>2\_/\ %!1114CN^Z^[_@^:^\**** N^Z^[_@^:
M^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[
M_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N
M^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**
M** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:
M^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[
M_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N
M^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**
M** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:
M^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[_@^:^\**** N^Z^[
M_@^:^\*:_P!T_A_,4ZFO]T_A_,4#BW=:K==/->?FOO/\O/\ X.&/^4OO[8/_
M &'OAI_ZJ+P17XN@C9U_B)[],FOVB_X.&/\ E+[^V#_V'OAI_P"JB\$5^+H(
MV=1]\G^=?S'F_P#R,L?_ -A6(_\ 3Q_NSX<?\D3PS_V2F4?^JO!^9?LO^/S2
M_P#K]TW_ -'BO][7P;_R*'A7_L6]#_\ 39:U_@E67_'YI?\ U^Z;_P"CQ7^]
MKX-_Y%#PK_V+>A_^FRUKC/ISI**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K"\4?\BSXB_[ 6K_ /ION*W:PO%'_(L^(O\ L!:O_P"F^XJH?''_
M !1_-'3@_P#?,)_V$T/_ $[$_(;_ ((4?\HY/AG_ -E,^-7_ *M#Q+7[$/W_
M -Y*_'?_ ((4?\HY/AG_ -E,^-7_ *M#Q+7[$/W_ -Y*QP_\!?\ 7NA_Z9IG
MZY](S_D_WBQ_V<OC/_U=8PX[Q-X9\/>+(IM-\3:'HWB32UEBG?1?$6G:=K.E
M-/!(DJ:@^EZK;7-J;FU*1FUNT0R1%I0N=QK^9#_@OS^T'\:?A'XX^"/P^\"_
M$CQ;X0^'GQ'^%7Q&TGQOX*\)7FG:=X;\>:7)K&B>'X].U:WNH4:5TTN_NK&V
M-E+;B*TGN$5"2KI] _\ !4C]H;_@J;\)/VC[?0/V0/A]XEU/X(R_#KPOX@U#
MQ9H?P;TOXA6(\6F\\3)KUA?ZY?G?IMRD5EH,-K:#; IO?/G=(R[K]J?!+X<?
M#S]J[]F[]G7X@?MY?"+X1^-/CW%X(AO=?C^(6B^%K>]\(>([_4YI+RP72)+I
MHM(O+A8;">73K?\ =)<Q H=Q6J]RI1J1I2GSN$*2J.$XQIS4Z3FJ552M*22G
M2G&-DE*2>BE%?K/@]E6$\#\3X=^._'$^'/$O@G.)YUEV&X#R3/<OS#B[*<XQ
M>0XREEN8X[*,12GA,DE@<?+"XM5L0WB)5\%@YI1DZ=1?8W[/OPH^&GPS^%'@
M+PW\-O!>D^!]&L?"/AB*WM-#TZ/33"TV@VB$R7B1^;JDT<4LD$=W>W%_/#&[
MPB< XK\Z/V7P!_P6._X*5V@"<_"+]F2Z>5AF8YT5T13)P?*C1,(F, *!DXK]
M>=.2QM;>RTVR3[+IRF*#3XH,16L"6,:+#:P0=$A:-1Y1A_=M&H(/ )_(+]E\
M^=_P62_X*:2'S%V_"#]EVSBQ$ZHR#0+AFD$K?([>:63:AX53NY!QE5O[2%[Q
M<:S5FW)P7LL7R1>FMHO96BN6RLK(_//#_,\3FV4_23S#&XS'9AB,S\*ZKS/$
M9C6J8G&T_K/BSX98IO$5JLJE2K6G5J\TY.<W)U.;FDFF?M.F04&<_)R>N?3G
M\*GJA92;D56^\-P7_=7 S[GG^=7ZZIIJ5GV6O?S^9^"R482=.+O[*U-O?5)/
M6W6S384445 @I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ JC>=$_WE_]"%7JHWO1/]Y?_0A51^U_A9$]Z7_7^A_Z=@?C
M=\*/^4YW[6?_ &91\&/_ %*=/K]F1_#_ +W_ ,37XS_"?G_@N=^UG_V91\&/
MT\4Z>:_9@?P_[W_Q-<=#?_P=_P"I%0_:_''_ )&_AW_V97PD_P#6*RPFIK_<
M;_=;^1IU-?[C?[K?R-=1^+G^57_P>"?\I@)?^S6?@I_Z6>/*_EDP/0?E7]3?
M_!X)_P I@)?^S6?@I_Z6>/*_ECV+Z?S_ ,: -"U^[=?]>=Q_Z)%?[!O[$@!_
M8J_8]R!_R:_\">W_ %3/PU7^/E:_=NO^O.X_]$BO]@W]B10?V*OV/<C_ )M?
M^!/K_P!$S\-5^E>&W_(SQO\ V!Q_]+@?Q7]-G_DD^!?^QUB__4>F?3S@9(P,
M<=O:OPP_:Y_Y3I_\$BN/^:+_ +:'_J%3U^Y[J,D8XX]?2OPO_:Y '_!=/_@D
M5C_HB_[:'_J%3_XU^A9]_NF$_P"QAE7_ *M,(?Q5X0?\E'Q#I_S;KQ&_]9/,
MO(_<J+[L7_7(?^A&I:BB^[%_UR'_ *$:EKV:7\##_P#7BE_Z0C\LQ-_K6+T3
M_P!IJ[^J\F%%%%69:]E]_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]__P!K
MY+[@HHHH#7LOO_\ M?)?<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<%%%%
M :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\
M_M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\ M?)?<%%%% :]E]__ -KY+[@H
MHHH#7LOO_P#M?)?<%%%% :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]
M_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]__P!KY+[@HHHH#7LOO_\ M?)?
M<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<%%%% :]E]_\ ]KY+[@HHHH#7
MLOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\ _M?)?<%%%% :]E]__P!K
MY+[@HHHH#7LOO_\ M?)?<%%%% :]E]__ -KY+[@HHHH#7LOO_P#M?)?<%%%%
M :]E]_\ ]KY+[@HHHH#7LOO_ /M?)?<%%%% :]E]_P#]KY+[@HHHH#7LOO\
M_M?)?<%%%% :]E]__P!KY+[@HHIK-M!."<>@S0)OE3;44EJW=Z?^2^2^X=3E
M^\/Q_E4*R;OX6'X5,JDGE3CJ<C'^?\YI2T3OV_-?\$5.49M.-FKK57\N\5V_
M#R(E ^T3\#_5J>GL*_"__@O?_P D+_8D_P"TG?[(_P#Z7^*Z_=':J23.2H4J
MHZ\A@,>O;'_UJ_#+_@O<F?@7^Q'@@Y_X*=_LC'CG .H>*0#QGKN'Y&O#S_\
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M&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\
M[7R7W!1110&O9??_ /:^2^X**** U[+[_P#[7R7W!1110&O9??\ _:^2^X**
M** U[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??
M_P#:^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^2^X**** U[+[_P#[7R7W
M!1110&O9??\ _:^2^X**** U[+[_ /[7R7W!1110&O9??_\ :^2^X**** U[
M+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\ [7R7W!1110&O9??_ /:^
M2^X**** U[+[_P#[7R7W!1110&O9??\ _:^2^X**** U[+[_ /[7R7W!1110
M&O9??_\ :^2^X**** U[+[__ +7R7W!1110&O9??_P#:^2^X**** U[+[_\
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MJ6D'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\'#[V\7_  24_:X2*53+]M^$D05LJ2Q^-G@@NOS;?G14+LN<A2K$;64G]=O
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M46?9_<%UV_\ )EY>?E^'FPHHHHL^S^X+KM_Y,O+S\OP\V%%%%%GV?W!==O\
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M"N98FZBU5]A)7B^5QC:5I+E5E9I-::+I^WF?]I?R_P#LJ,_[2_E_]E7XA_\
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M8D_Z)/\ MQ?^(A^./_EO1_P_\_8D_P"B3_MQ?^(A^./_ );T?ZT9-_T%TO\
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M_P"RHS_M+^7_ -E7XA_\/_/V)/\ HD_[<7_B(?CC_P"6]'_#_P _8D_Z)/\
MMQ?^(A^./_EO1_K3DW_073_\#C_G_5O0/^(&^*^G_&'9GT_Y<_X?Z^:\K?MY
MG_:7\O\ [*C/^TOY?_95^(?_  _\_8D_Z)/^W%_XB'XX_P#EO1_P_P#/V)/^
MB3_MQ?\ B(?CC_Y;T?ZTY-_T%T__  ./^?\ 5O0/^(&^*^G_ !AV9]/^7/\
MA_KYKRM^WF?]I?R_^RHS_M+^7_V5?B'_ ,/_ #]B3_HD_P"W%_XB'XX_^6]'
M_#_S]B3_ *)/^W%_XB'XX_\ EO1_K3DW_073_P# X_Y_U;T#_B!OBOI_QAV9
M]/\ ES_A_KYKRM^WF?\ :7\O_LJ,_P"TOY?_ &5?B'_P_P#/V)/^B3_MQ?\
MB(?CC_Y;T?\ #_S]B3_HD_[<7_B(?CC_ .6]'^M.3?\ 073_ / X_P"?]6]
M_P"(&^*^G_&'9GT_Y<_X?Z^:\K?MYG_:7\O_ +*C/^TOY?\ V5?B'_P_\_8D
M_P"B3_MQ?^(A^./_ );T?\/_ #]B3_HD_P"W%_XB'XX_^6]'^M.3?]!=/_P.
M/^?]6] _X@;XKZ?\8=F?3:C_ (?Z^[RM^WF?]I?R_P#LJ,_[2_E_]E7XA_\
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MRM^WF?\ :7\O_LJ,_P"TOY?_ &5?B'_P_P#/V)/^B3_MQ?\ B(?CC_Y;T?\
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M] _X@;XKZ?\ &'9GT_Y<_P"'^OFO*W[>9_VE_+_[*C/^TOY?_95^(?\ P_\
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M7_B(?CC_ .6]'_#_ ,_8D_Z)/^W%_P"(A^./_EO7K?ZTY-_T%T__  ./^?\
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MX_\ EO1_K3DW_073_P# X_Y_U;T#_B!OBOI_QAV9]/\ ES_A_KYKRM^WF?\
M:7\O_LJ,_P"TOY?_ &5?B'_P_P#/V)/^B3_MQ?\ B(?CC_Y;T?\ #_S]B3_H
MD_[<7_B(?CC_ .6]'^M&3?\ 072_\#CY>?G^##_B!OBOI_QAV9]/^7/^'^OF
MO*W[>9_VE_+_ .RHS_M+^7_V5?B'_P /_/V)/^B3_MQ?^(A^./\ Y;T?\/\
MS]B3_HD_[<7_ (B'XX_^6]'^M&3?]!=+_P #CY>?G^##_B!OBOI_QAV9]/\
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MB3_HD_[<7_B(?CC_ .6]'_#_ ,_8D_Z)/^W%_P"(A^./_EO1_K3DW_073_\
M X_Y_P!6] _X@;XKZ?\ &'9GT_Y<_P"'^OFO*W[>9_VE_+_[*C/^TOY?_95^
M(?\ P_\ /V)/^B3_ +<7_B(?CC_Y;T?\/_/V)/\ HD_[<7_B(?CC_P"6]'^M
M.3?]!=/_ ,#C_G_5O0/^(&^*^G_&'9GT_P"7/^'^OFO*W[>9_P!I?R_^RHS_
M +2_E_\ 95^(?_#_ ,_8D_Z)/^W%_P"(A^./_EO1_P /_/V)/^B3_MQ?^(A^
M./\ Y;T?ZTY-_P!!=/\ \#C_ )_U;T%_Q [Q7T_XP[,^G_+G_#_7S7R_;S/^
MTOY?_949_P!I?R_^RK\0_P#A_P"?L2?]$G_;B_\ $0_''_RWH_X?^?L2?]$G
M_;B_\1#\<?\ RWH_UIR;_H+I_P#@<?\ /^K>@_\ B!OBOI_QAV9=/^7/^'^E
M\O(_;S/^TOY?_949_P!I?R_^RK\0_P#A_P"?L2?]$G_;B_\ $0_''_RWH_X?
M^?L2?]$G_;B_\1#\<?\ RWH_UIR;_H+I_P#@<?\ /^K>@+P-\5]/^,.S/I_R
MY_P_U]WD?MYG_:7\O_LJ,_[2_E_]E7XA_P##_P _8D_Z)/\ MQ?^(A^./_EO
M1_P_\_8D_P"B3_MQ?^(A^./_ );T?ZTY-_T%T_\ P./^?]6] 7@;XKZ?\8=F
M?3_ES_A_K3NOE^WF?]I?R_\ LJ,_[2_E_P#95^(?_#_S]B3_ *)/^W%_XB'X
MX_\ EO1_P_\ /V)/^B3_ +<7_B(?CC_Y;T?ZTY-_T%T__ X_Y_U;T#_B!OBO
MI_QAV9]/^7/^'^OFO*W[>9_VE_+_ .RHS_M+^7_V5?B'_P /_/V)/^B3_MQ?
M^(A^./\ Y;T?\/\ S]B3_HD_[<7_ (B'XX_^6]'^M.3?]!=/_P #C_G_ %;T
M#_B!OBOI_P 8=F?3_ES_ (?Z^:\K?MYG_:7\O_LJ,_[2_E_]E7XA_P##_P _
M8D_Z)/\ MQ?^(A^./_EO1_P_\_8D_P"B3_MQ?^(A^./_ );T?ZTY-_T%T_\
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MQ7T_XP[,^G_+G_#_ %\UY6_;S/\ M+^7_P!E1G_:7\O_ +*OQ#_X?^?L2?\
M1)_VXO\ Q$/QQ_\ +>C_ (?^?L2?]$G_ &XO_$0_''_RWH_UIR;_ *"Z?_@<
M?\_ZMZ!_Q WQ7T_XP[,^G_+G_#_7S7E;]O,_[2_E_P#949_VE_+_ .RK\0_^
M'_G[$G_1)_VXO_$0_''_ ,MZ/^'_ )^Q)_T2?]N+_P 1#\<?_+>C_6G)O^@N
MG_X''_/^K>@?\0-\5]/^,.S/I_RY_P /]?->5OV\S_M+^7_V5&?]I?R_^RK\
M0_\ A_Y^Q)_T2?\ ;B_\1#\<?_+>C_A_Y^Q)_P!$G_;B_P#$0_''_P MZ/\
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M[R/V\S_M+^7_ -E1G_:7\O\ [*OQ#_X?^?L2?]$G_;B_\1#\<?\ RWH_X?\
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M'_/^K>@?\0-\5]/^,.S/I_RY_P /]?->5OV\S_M+^7_V5&?]I?R_^RK\0_\
MA_Y^Q)_T2?\ ;B_\1#\<?_+>C_A_Y^Q)_P!$G_;B_P#$0_''_P MZ/\ 6G)O
M^@NG_P"!Q_S_ *MZ!_Q WQ7T_P",.S/I_P N?\/]?->5OV\S_M+^7_V5&?\
M:7\O_LJ_$/\ X?\ G[$G_1)_VXO_ !$/QQ_\MZ/^'_G[$G_1)_VXO_$0_''_
M ,MZ/]:,F_Z"Z7_@<?+S\_P8?\0-\5]/^,.S/I_RY_P_U\UY6_;S/^TOY?\
MV5&?]I?R_P#LJ_$/_A_Y^Q)_T2?]N+_Q$/QQ_P#+>C_A_P"?L2?]$G_;B_\
M$0_''_RWH_UHR;_H+I?^!Q\O/S_!A_Q WQ7T_P",.S/I_P N?\/]?->5OV\S
M_M+^7_V5&?\ :7\O_LJ_$/\ X?\ G[$G_1)_VXO_ !$/QQ_\MZ/^'_G[$G_1
M)_VXO_$0_''_ ,MZ/]:,F_Z"Z7_@<?\ /S_#T#_B!OBOI_QAV9]/^7/^'^OF
MO*W[>9_VE_+_ .RIK2^64;[Q#@@*,\CUP<X-?B+_ ,/_ #]B3_HD_P"W%_XB
M'XX_^6]*?^"_'[$TL-Q"GPM_;HMFE18UO8?V0?&[-:22.$CE(.K-G+L$0!26
M<@*"Q I?ZT9.T[8JFW9M+GC=NVV_]6>J6I5/P-\6>9<O">94)=*OL7[KM'L^
MOPK_ !+R-7X!;G_X+Y_\%$6QC_C!G]E0G((Q_P 330UP?<@G'T]1FOVFE)&P
M9R#(HQST&,C!]SC^E?SJ?\$Y/VA-"_:J_P""OG[;O[0_@#P+\8O#7PU\5?L?
M_ CP5H^K_%[X=^)?AOJNJ>(/ ?B+3-/UD#2]5C>UE:18&FCC6[E9(P9%"N6!
M_HK;YE5\#&0PQU]\#VP*Y>%:BQ&7XVI'WH5,QQM2FULXSK3G%IJRV:\NFQ[?
MCE0J8/.^'LLKPG3S/ >'O"6&QU.:<:E*MA\)@Z=:E4B_AJ1E&2<7JNI_EY_\
M'#&?^'OO[8/_ &'OAI_ZJ+P17XNC.SK_ !'MWR>:_:+_ (.&/^4OO[8/_8>^
M&G_JHO!%?BZ-VSM]X^O7)_2OP?-_^1EC_P#L*Q'_ *>/]:/#G_DB>&-_^24R
MCO\ ]"O!LOV7_'YI?_7[IO\ Z/%?ZPW_  6*/_&3_P#P;O\ _:0_P-_ZA>C5
M_D\V.?MNE>OVW3.GKYX]:_U1O^"]'Q @^#/C+_@B7\?]<\"_$OQKX%^ 7[9N
MB_$_XA6_PK\%:SX[\467A3P_\/-(N[J^M=%T>%C*S2(L,$-U<V:7<L+P1S@[
MRO&?3G]26X>H_.C</4?G7\YB?\'-_P"P.5!'P(_X*#ON^<NO['7BXAB_S%A_
MQ.CP2<CD\=SUIW_$3?\ L$?]$&_X*$?^(<^+O_ES0!_1CN'J/SHW#U'YU_.=
M_P 1-_[!'_1!O^"A'_B'/B[_ .7-'_$3?^P1_P!$&_X*$?\ B'/B[_Y<T ?T
M8[AZC\Z-P]1^=?SG?\1-_P"P1_T0;_@H1_XASXN_^7-'_$3?^P1_T0;_ (*$
M?^(<^+O_ )<T ?T8[AZC\Z-P]1^=?SG?\1-_[!'_ $0;_@H1_P"(<^+O_ES1
M_P 1-_[!'_1!O^"A'_B'/B[_ .7- ']&.X>H_.C</4?G7\YW_$3?^P1_T0;_
M (*$?^(<^+O_ )<T?\1-_P"P1_T0;_@H1_XASXN_^7- ']&.X>H_.C</4?G7
M\YW_ !$W_L$?]$&_X*$?^(<^+O\ Y<T?\1-_[!'_ $0;_@H1_P"(<^+O_ES0
M!_1CN'J/SHW#U'YU_.=_Q$W_ +!'_1!O^"A'_B'/B[_Y<T?\1-_[!'_1!O\
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M@\U^Q#D<\C[R5_';_P $[_\ @MG^R;^QA^S!X0_9_P#BC\+_ -K[Q1XQ\/\
MBKXA>([VZ^$'[-/B;Q[X4>P\9>+-2\3:39VWBZPU6WAU#5M)L=0MD\2^4I>W
MUL7EG(2\#&ONIO\ @YH_8('RGX$?\%"E((!4_L<^+P5*<%2#K/4=#UP0:QPS
MO0C_ ->Z/_DM.G%_<U8_7?I%I_\ $?O%G^[XE<9-ZZZYYC$E;OWUM?KV_HSC
M(VCD=6_]"-/W#U'YU_.:O_!S=^P0!C_A0W_!0@\GG_ACGQ=W)/\ T&?PI?\
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MPZ[>H^]Z?7VZTM?*/[*W[3?AK]K3X-^"_CEX-\ _%3X=>$/&MS-)X<TKXV>
M)?AOX[UFQB8B'Q-'X8N]4U>?3]#UB&,R:3>:A/'?:G"DK+;0!H&E^KJ904G<
M?0_S%+2=Q]#_ #%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/,4DEF..25DDL5622TLDN;3=&A_:VI_]!"\_\")?_BJ/[6U/_H(7G_@1+_\
M%5GT4>RI?\^J?_@$?\A_VIF7_0RQ_P#X55_+^_YHT/[6U/\ Z"%Y_P"!$O\
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M")?_ (JL^BCV5+_GU3_\ C_D']J9E_T,L?\ ^%5?R_O^:-#^UM3_ .@A>?\
M@1+_ /%4?VMJ?_00O/\ P(E_^*K/HH]E2_Y]4_\ P"/^0?VIF7_0RQ__ (55
M_+^_YHT/[6U/_H(7G_@1+_\ %4?VMJ?_ $$+S_P(E_\ BJSZ*/94O^?5/_P"
M/^0?VIF7_0RQ_P#X55_+^_YHT/[6U/\ Z"%Y_P"!$O\ \51_:VI_]!"\_P#
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M")?_ (JL^BCV5+_GU3_\ C_D']J9E_T,L?\ ^%5?R_O^:-#^UM3_ .@A>?\
M@1+_ /%4?VMJ?_00O/\ P(E_^*K/HH]E2_Y]4_\ P"/^0?VIF7_0RQ__ (55
M_+^_YHT/[6U/_H(7G_@1+_\ %4?VMJ?_ $$+S_P(E_\ BJSZ*/94O^?5/_P"
M/^0?VIF7_0RQ_P#X55_+^_YHT/[6U/\ Z"%Y_P"!$O\ \51_:VI_]!"\_P#
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M_GU3_P# (_Y!_:F9?]#+'_\ A57\O[_FC0_M;4_^@A>?^!$O_P 51_:VI_\
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M C_D']J9E_T,L?\ ^%5?R_O^:-#^UM3_ .@A>?\ @1+_ /%4?VMJ?_00O/\
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MTND[;;];:/R=[=KH<DYCW[6XD1HW!!/RNNT@'L<=\>]?O)\._P#@Y)_X*?\
MPN^'O@/X8>$O&7P;@\*?#?P;X8\!^%X+WX+>%KV]A\/>$=&L]!T:*\O91YMY
M=II]A;K<WDO[ZYF5YY29'8G\&-P]1^=&X>H_.NG"X[&8&<JF#Q-?#3DN64J-
M25-RC>Z3Y6KI-*W8^?S[ACAWB>G0P_$6299G=#"5)5,+1S3!T<93H3EI*=*-
M:,U"4DDFXV;6G8_H8/\ P=!?\%73R?&WP2)]3\#O"G^-)_Q%!?\ !5S_ *';
MX(_^&.\*?XU_/1N'J/SHW#U'YUW?ZP9Y_P!#;,/_  JK?_)'RW_$(?"UZOP^
MX1\_^$+ ?_*?ZOZ6_H7_ .(H+_@JY_T.WP1_\,=X4_QH_P"(H+_@JY_T.WP1
M_P##'>%/\:_GHW#U'YT;AZC\Z/\ 6#//^AMF'_A56_\ D@_XA#X6_P#1O>$?
M_#%@/_E/]7]+?T+_ /$4%_P5<_Z';X(_^&.\*?XT?\107_!5S_H=O@C_ .&.
M\*?XU_/1N'J/SHW#U'YT?ZP9Y_T-LP_\*JW_ ,D'_$(?"W_HWO"/_ABP'_RG
M^K^EOZ%_^(H+_@JY_P!#M\$?_#'>%/\ &C_B*"_X*N?]#M\$?_#'>%/\:_GH
MW#U'YT;AZC\Z/]8,\_Z&V8?^%5;_ .2#_B$/A;_T;WA'_P ,6 _^4_U?TM_0
MO_Q%!?\ !5S_ *';X(_^&.\*?XT?\107_!5S_H=O@C_X8[PI_C7\]&X>H_.C
M</4?G1_K!GG_ $-LP_\ "JM_\D'_ !"'PM_Z-[PC_P"&+ ?_ "G^K^EOZ%_^
M(H+_ (*N?]#M\$?_  QWA3_&C_B*"_X*N?\ 0[?!'_PQWA3_ !K^>C</4?G1
MN'J/SH_U@SS_ *&V8?\ A56_^2#_ (A#X6_]&]X1_P##%@/_ )3_ %?TM_0O
M_P 107_!5S_H=O@C_P"&.\*?XT?\107_  5<_P"AV^"/_ACO"G^-?ST;AZC\
MZ-P]1^='^L&>?]#;,/\ PJK?_)!_Q"'PM_Z-[PC_ .&+ ?\ RG^K^EOZ%_\
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M_P :/^(H+_@JY_T.WP1_\,=X4_QK^>C</4?G1N'J/SH_U@SS_H;9A_X55O\
MY(/^(0^%O_1O>$?_  Q8#_Y3_5_2W]"__$4%_P %7/\ H=O@C_X8[PI_C1_Q
M%!?\%7/^AV^"/_ACO"G^-?ST;AZC\Z-P]1^='^L&>?\ 0VS#_P *JW_R0?\
M$(?"W_HWO"/_ (8L!_\ *?ZOZ6_H7_XB@O\ @JY_T.WP1_\ #'>%/\:/^(H+
M_@JY_P!#M\$?_#'>%/\ &OYZ-P]1^=&X>H_.C_6#//\ H;9A_P"%5;_Y(/\
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M/^AV^"/_ (8[PI_C7\]&X>H_.C</4?G1_K!GG_0VS#_PJK?_ "0?\0A\+?\
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MY_T.WP1_\,=X4_QH_P"(H+_@JY_T.WP1_P##'>%/\:_GHW#U'YT;AZC\Z/\
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MX1_\,6 _^4_U?TM_0O\ \107_!5S_H=O@C_X8[PI_C1_Q%!?\%7/^AV^"/\
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M?G1N'J/SH_U@SS_H;9A_X55O_D@_XA#X6_\ 1O>$?_#%@/\ Y3_5_2W]"_\
MQ%!?\%7/^AV^"/\ X8[PI_C1_P 107_!5S_H=O@C_P"&.\*?XU_/1N'J/SHW
M#U'YT?ZP9Y_T-LP_\*JW_P D'_$(?"W_ *-[PC_X8L!_\I_J_I;^A?\ XB@O
M^"KG_0[?!'_PQWA3_&C_ (B@O^"KG_0[?!'_ ,,=X4_QK^>C</4?G1N'J/SH
M_P!8,\_Z&V8?^%5;_P"2#_B$/A;_ -&]X1_\,6 _^4_U?TM_0O\ \107_!5S
M_H=O@C_X8[PI_C1_Q%!?\%7/^AV^"/\ X8[PI_C7\]&X>H_.C</4?G1_K!GG
M_0VS#_PJK?\ R0?\0A\+?^C>\(_^&+ ?_*?ZOZ6_H7_XB@O^"KG_ $.WP1_\
M,=X4_P :/^(H+_@JY_T.WP1_\,=X4_QK^>C</4?G1N'J/SH_U@SS_H;9A_X5
M5O\ Y(/^(0^%O_1O>$?_  Q8#_Y3_5_2W]"__$4%_P %7/\ H=O@C_X8[PI_
MC1_Q%!?\%7/^AV^"/_ACO"G^-?ST;AZC\Z-P]1^='^L&>?\ 0VS#_P *JW_R
M0?\ $(?"W_HWO"/_ (8L!_\ *?ZOZ6_H7_XB@O\ @JY_T.WP1_\ #'>%/\:/
M^(H+_@JY_P!#M\$?_#'>%/\ &OYZ-P]1^=&X>H_.C_6#//\ H;9A_P"%5;_Y
M(/\ B$/A;_T;WA'_ ,,6 _\ E/\ 5_2W]"__ !%!?\%7/^AV^"/_ (8[PI_C
M1_Q%!?\ !5S_ *';X(_^&.\*?XU_/1N'J/SHW#U'YT?ZP9Y_T-LP_P#"JM_\
MD'_$(?"W_HWO"/\ X8L!_P#*?ZOZ6_H7_P"(H+_@JY_T.WP1_P##'>%/\:/^
M(H+_ (*N?]#M\$?_  QWA3_&OYZ-P]1^=&X>H_.C_6#//^AMF'_A56_^2#_B
M$/A;_P!&]X1_\,6 _P#E/]7]+?T+_P#$4%_P5<_Z';X(_P#ACO"G^-'_ !%!
M?\%7/^AV^"/_ (8[PI_C7\]&X>H_.C</4?G1_K!GG_0VS#_PJK?_ "0?\0A\
M+?\ HWO"/_ABP'_RG^K^EOZ%_P#B*"_X*N?]#M\$?_#'>%/\:/\ B*"_X*N?
M]#M\$?\ PQWA3_&OYZ-P]1^=&X>H_.C_ %@SS_H;9A_X55O_ )(/^(0^%O\
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M /*2@#^B^BOYT/\ A]7^WG_TK_\ _!0O_P &_@__ .4E'_#ZO]O/_I7_ /\
M@H7_ .#?P?\ _*2@#^B^L+Q1_P BSXB_[ 6K_P#ION*_GM_X?5_MY_\ 2O\
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MB@I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@
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M'_#%7[&W_1I7[,O_ (8;X6?_ #*T ?X4_P O^S^E'R_[/Z5_NL?\,5?L;?\
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M_1I7[,O_ (8;X6?_ #*T ?X4_P O^S^E'R_[/Z5_NL?\,5?L;?\ 1I7[,O\
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M5^QM_P!&E?LR_P#AAOA9_P#,K1_PQ5^QM_T:5^S+_P"&&^%G_P RM '^%/\
M+_L_I1\O^S^E?[K'_#%7[&W_ $:5^S+_ .&&^%G_ ,RM'_#%7[&W_1I7[,O_
M (8;X6?_ #*T ?X4_P O^S^E'R_[/Z5_NL?\,5?L;?\ 1I7[,O\ X8;X6?\
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M^S^E'R_[/Z5_NL?\,5?L;?\ 1I7[,O\ X8;X6?\ S*T?\,5?L;?]&E?LR_\
MAAOA9_\ ,K0!_A3_ "_[/Z4]%B8-N95('R].3Z5_NJ_\,5?L;?\ 1I7[,O\
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M]C;_ *-*_9E_\,-\+/\ YE:/^&*OV-O^C2OV9?\ PPWPL_\ F5H+/\*?Y?\
M9_2CY?\ 9_2O]UC_ (8J_8V_Z-*_9E_\,-\+/_F5H_X8J_8V_P"C2OV9?_##
M?"S_ .96@#_"G^7_ &?TH^7_ &?TK_=8_P"&*OV-O^C2OV9?_##?"S_YE:/^
M&*OV-O\ HTK]F7_PPWPL_P#F5H _PI_E_P!G]*/E_P!G]*_W6/\ ABK]C;_H
MTK]F7_PPWPL_^96C_ABK]C;_ *-*_9E_\,-\+/\ YE: /\*?Y?\ 9_2CY?\
M9_2O]UC_ (8J_8V_Z-*_9E_\,-\+/_F5H_X8J_8V_P"C2OV9?_##?"S_ .96
M@#_"G^7_ &?TH^7_ &?TK_=8_P"&*OV-O^C2OV9?_##?"S_YE:/^&*OV-O\
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M_P!G]*_W6/\ ABK]C;_HTK]F7_PPWPL_^96C_ABK]C;_ *-*_9E_\,-\+/\
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M#^\2>*9'#X.PG!7ZC@ACMH(;>%%CB@C2**-%54CCC4(B(J*JJB* JJJJH4
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MG?KZGF2:<*-5NI14JOL%1G"U:57E;:K0=W3BE%NZ45>ROJB_B7UC_P"^6_\
MBZ,2^L?_ 'RW_P 74E%0:$>)?6/_ +Y;_P"+K#\3^:/#7B([E'_$BU?!56#
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M,P5%)!%ZBB@\D*3N/H?YBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *8^[C&?P_S^5/HH B&_W_ !SZ'_/UQ3P6[C\<_P!*=10
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M+_C1R?WOP_X/FOO"Z_F73I4_N_W/,M_YZ'_/^?2DS]?R/^'^?K57YO4_DO\
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MQH_X8X_9+_Z-G^!__AJ?!?\ \I?<?G1;#]Z_3_EV_P"[_P!1'K_3U/;>"O\
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MHCU_IZGMO!7_ *%GBG_X?.%/*_\ S(_4^=/^'N/_  33_P"CQ?@Q_P"#^?\
M^0?Q_P#K4O\ P]R_X)I_]'B?!?\ \'\__P @_A_]>OHG_ACC]DO_ *-G^!W_
M (:GP7]?^@+Z4O\ PQQ^R7_T;/\  _\ \-3X+^G_ $!?6BV'[U^G_+M_W?\
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ML?RHMA^]?I_R[?\ =_ZB/7^GJ>V\%?\ H6>*?_A\X4\K_P#,C]3YU_X>Y?\
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MYT_X>X_\$T_^CQ?@Q_X/Y_\ Y!_'_P"M2_\ #W'_ ()I_P#1XGP8_P#!_/\
M_(/^<?7/T3_PQQ^R7_T;/\#O_#4^"_K_ - 7TI?^&./V2_\ HV?X'_\ AJ?!
M?_RE]C^5%L/WK]/^7;_N_P#41Z_T]3VW@K_T+/%/_P /G"GE?_F1^I\Z_P##
MW'_@FG_T>)\&/_!_/_\ (/\ G/TP?\/<?^":?_1XGP8_\'\__P @U]%?\,<?
MLE_]&S_ _P#\-3X+_P#E+[C\Z/\ ACC]DO\ Z-G^!_\ X:GP7_\ *6BV'[U^
MG_+M_P!W_J(]?Z>I[;P5_P"A9XI_^'SA3RO_ ,R/U/G7_A[C_P $T_\ H\3X
M,?\ @_G_ /D'\/\ Z_-4;W_@K?\ \$V9T-K!^V+\&0\T4\DK?V]=-Y=I;IYE
MW,J+9*KR0H48*6W;#(T2EEQ7TQ_PQQ^R7_T;/\#_ /PU/@OZ?] 7UXI/^&./
MV2_^C9O@=V/_ "2CP7VY'_,$[9S^1HMA^KK/R=-OHK/_ 'CH]?EYW!5O!3KE
MGBI=)N+CGW"L&II)PDI1R--<LUS:-7M:ZO=?E$/C7_P0&UCQ5XF^(5_XP_8V
MUW7O%T%E#J]SJ.FV>I:#J5Y'>:GJ/]L2:-J.DRZ?:Z_JM]?W@UC7UM?[1U2!
M;&'4IYX[*V$?U;H__!5/_@FKHD.E:3I_[77P173](TZWTBRTK3=0BTZVT'3X
M@([:SA2QTRWMX-.V106:6\:&(1VT&%7S)*^L/^&-_P!DOJ?V9O@=GN?^%4>"
M_?\ Z@OL?UH_X8W_ &2O^C9O@=_X:CP7_P#*3W'YU5)X:FYMJK+GBTU[*RNX
MM<UO;O6\I2;33;OK[S3]G-.*O#GB"6!_UCQOC=GM++:#P^"H9EQID^,P^%IO
M#K#6PU#%Y?B*.'2IPI)>SIJ48TH0C)022^"?AY^W%_P1H^$6M:WXI^%_Q;_9
M6^'/B#Q%;RV^O:[X0ATW0]:U^TFU$:E)%J]_INC07-Y#+JF+N2*X=]T_[TY(
MS7L<O_!6[_@FT(S-'^V+\%&E="OV?^WYP2QXW,_]GC(7/?'Y5])_\,;_ +)7
M_1LWP._\-1X+_P#E)Z9H_P"&-_V2O^C9O@=[_P#%J/!?K_V!/7]:AQPUXO\
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M ()I_P#1XGP7_P#!_/\ _(/X?_7KZ)_X8X_9+_Z-G^!W_AJ?!?\ \I?8TO\
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M>O\ 3U/;>"O_ $+/%/\ \/G"GE?_ )D?J?.W_#W+_@FG_P!'B?!?_P '\_\
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M /#YPIY7_P"9'ZGSK_P]Q_X)I_\ 1XGP8_\ !_/_ /(/^<_3!_P]Q_X)I_\
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M/[K_ .A'ZGSM_P /<?\ @FG_ -'B?!C_ ,'\_P#\@_YQ]<G_  ]Q_P"":?\
MT>)\&/\ P?S_ /R#7T5_PQQ^R7_T;/\  _\ \-3X+_\ E+['\J/^&./V2_\
MHV?X'_\ AJ?!?_REHMA^]?I_R[?]W_J(]?Z>K]MX*_\ 0L\4_P#P^<*>5_\
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M_P#PU/@O_P"4OL:/^&./V2_^C9_@?_X:GP7_ /*7W'YT6P_>OT_Y=O\ N_\
M41Z_T]3VW@K_ -"SQ3_\/G"GE?\ YD?J?.G_  ]Q_P"":?\ T>+\&/\ P?S_
M /R#_G'URO\ P]R_X)I_]'B?!?\ \'\__P @_A_]>OHG_ACC]DO_ *-G^!W_
M (:GP7_\I?8TO_#''[)?_1L_P/\ _#4^"_I_T!?6BV'[U^G_ "[?]W_J(]?Z
M>I[;P5_Z%GBG_P"'SA3RO_S(_4^=/^'N/_!-/_H\7X,?^#^?_P"0?Q_^M2_\
M/<O^":?_ $>)\%__  ?S_P#R#_G'US]$_P##''[)?_1L_P #O_#4^"_K_P!
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M;Q!,H QR2QL<#UR< '\J^B_^&./V2_\ HV?X'_\ AJ?!?T_Z OKQ4%S^QO\
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M9;[+?5[=]/R/Y;CS*,5-Q<TDI.$>6#E;7EC=VC?97=EH%%%%!04444 %%%%
M!2=Q]#_,4M)W'T/\Q0 #H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %-?.TXZXIU% (RXXD+R$+#B3+/%L49D((9G&,-D<,6SD=<U
MB:WX2\,^(9M'EU_P]X?UF;0=0AU?0+C5='TW49=#UF%"D6J:/)>6TS:9?K'E
M$OK%K>Z125651D5U0AC#LX0!F&&..O:G>6G]T=OTZ?EDU2Y>;F:N[+6RO>RZ
MW\OGN]114J$U4PDYTIQFZL)\S4HRDG&5)-.ZHN,IKE3^UHBL ^!NQG SRWI[
M4N&]OS;_ !JU@>G3^G2EQ[?I_GT'Y4^=]ODOEY>3^_R!Q3;;A3NW=^Z^OS7Y
M(J8;V_-O\:,-[?FW^-6\>WZ?Y]3^=&/;]*.=_P!?+R\G]_D+EC_)3_\  7_\
MD5,-[?FW^-&&]OS;_&K>/;]/P_EQ1CV_2CG?]?+R\G]_D'+'^2G_ . O_P"2
M*F&]OS;_ !HPWM^;?XU;Q[?I_GT'Y48]OT_SZG\Z.=_U\O+R?W^0<L?Y*?\
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M&]OS;_&C#>WYM_C5O\/\_P"2:,>WZ?Y]!^5'._Z^7EY/[_(.6/\ )3_\!?\
M\D5,-[?FW^-&&]OS;_&K6!Z#\O\ /J:7\/\ /7^='._Z^7EY/[_(.6/\E/\
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MT8;V_-O\:MX]OT_#^7%&/;]*.=_U\O+R?W^0<L?Y*?\ X"__ )(J8;V_-O\
M&C#>WYM_C5O'M^G^?0?E1CV_3_/J?SHYW_7R\O)_?Y!RQ_DI_P#@+_\ DBIA
MO;\V_P :,-[?FW^-6\>WZ4F!Z#\OP_E1SO\ KY>7D_O\@Y8_R4__  !__)%7
M#>WYM_C1AO;\V_QJW^'^?\DT8]OT_P ^@_*CG?\ 7R\O)_?Y!RQ_DI_^ O\
M^2*F&]OS;_&C#>WYM_C5K ]!^7^?4TOX?YZ_SHYW_7R\O)_?Y!RQ_DI_^ /_
M .2*F&]OS;_&C#>WYM_C5K ]!^7X?RI?P_S_ ))HYW_7R\O)_?Y!RQ_DI_\
M@#_^2*F&]OS;_&C#>WYM_C5O'M^G^?0?E1CV_2CG?]?+R\G]_D'+'^2G_P"
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MLMK[ZVW"BBB@ HHHH **** "D[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^.+>Q\0ZCX8T^V\-^(O#0M(M+\:77B.&P&M#5=533'LX7U)D@5: /JM?@_\
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M/!'_ ,BT?\*>_P"#@7_I,[_P3\_\1@\$?_(M>H_\0L__  1!_P"C1-4_\/\
M?M#_ /ST:/\ B%G_ ."(/_1HFJ?^'^_:'_\ GHT >7?\*>_X.!?^DSO_  3\
M_P#$8/!'_P BT?\ "GO^#@7_ *3._P#!/S_Q&#P1_P#(M>H_\0L__!$'_HT3
M5/\ P_W[0_\ \]&C_B%G_P""(/\ T:)JG_A_OVA__GHT >7?\*>_X.!?^DSO
M_!/S_P 1@\$?_(M'_"GO^#@7_I,[_P $_/\ Q&#P1_\ (M>H_P#$+/\ \$0?
M^C1-4_\ #_?M#_\ ST:/^(6?_@B#_P!&B:I_X?[]H?\ ^>C0!Y=_PI[_ (.!
M?^DSO_!/S_Q&#P1_\BT?\*>_X.!?^DSO_!/S_P 1@\$?_(M>H_\ $+/_ ,$0
M?^C1-4_\/]^T/_\ /1H_XA9_^"(/_1HFJ?\ A_OVA_\ YZ- 'EG_  J#_@X(
M#!A_P6:_X)\,B8)#?LR>"E#<])-MEE5[91U)]C6C:_ ?_@X@O[.XU>U_X+!_
ML(W&DV[2"ZU#3/V3_"^H:78LD:RLMW?QZ6\%I'''(C-)=W*;4>-F)\Q<]JW_
M  :X_P#!$2.X:(_LB:HJAH<!?V@/V@G:5?\ 6',<GQ+)4;QY;A9<NG(YX'X\
MQ_\ !'7_ (+(?L[?L_?\%&/V /V0_A%^Q8_[$O[8GQB^)VO>!M1^(OQI\=S_
M !9^'WPSU^73-'\(Z1HMXH_LR*YMO"?A[1#<1^(;+7[A=3FOYI;J3S@0 ?I[
M%\(_^#@*0R!/^"T/_!/B3RW,;B/]F7P-(8W !*2!;0;'P0Q5N1D=B*E_X4]_
MP<"_])G?^"?G_B,'@C_Y%JK\"/\ @UL_X)'I\&?A)IOQN_9.;4/C5I_PM\ 0
M?%W4=%^/_P =Y=%U'XEV_AJPLO'5_I=UI?Q!TO3Y+2]\4VNK74$=E865I%#+
M&+>RM8BL0];_ .(6?_@B#_T:)JG_ (?[]H?_ .>C0!Y=_P *>_X.!?\ I,[_
M ,$_/_$8/!'_ ,BT?\*>_P"#@7_I,[_P3\_\1@\$?_(M>H_\0L__  1!_P"C
M1-4_\/\ ?M#_ /ST:/\ B%G_ ."(/_1HFJ?^'^_:'_\ GHT >7?\*>_X.!?^
MDSO_  3\_P#$8/!'_P BT?\ "GO^#@7_ *3._P#!/S_Q&#P1_P#(M>H_\0L_
M_!$'_HT35/\ P_W[0_\ \]&C_B%G_P""(/\ T:)JG_A_OVA__GHT >7?\*>_
MX.!?^DSO_!/S_P 1@\$?_(M'_"GO^#@7_I,[_P $_/\ Q&#P1_\ (M>H_P#$
M+/\ \$0?^C1-4_\ #_?M#_\ ST:/^(6?_@B#_P!&B:I_X?[]H?\ ^>C0!Y=_
MPI[_ (.!?^DSO_!/S_Q&#P1_\BT?\*>_X.!?^DSO_!/S_P 1@\$?_(M>H_\
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MS_RF;_X)^-U)'_#,'@GA0"6;BV!^49;J!QR<9KN7_P"#7C_@B/#(YG_8\O\
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MB!;*\MS^Q_J\5NB!O.'Q[_:.EPP_U@D2/XDEHHT/_+9\(RY;  - 'GD7P?\
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MO0 4444 %%%% !1110 4444 %%%% !1110 4444 %)W'T/\ ,4M)W'T/\Q0
M#H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[Q%DM+J-P&22
MWG1@0""K1,K @@@@@D$$$'N"*L5#<?\ 'O/_ -<9?_0&H _SJ/V-E1OV3/\
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MW%_?:18VWVJ9KS6+_4+Q[V>]UO5+RYOF>;?%<7U])%#9V=O'';Q_P9^*KO\
MX//U\;>)?^$;3]H<>%QXA\0)H!@L_P!CJXMH] FU>[.D-;G4"TUVD6G_ &5X
M)-0E%]Y689I@V7/]R7[?/C+Q)\*?V(?VQ/B;X+\17/A/Q[X%_9B^./C7PGXM
ML(;477ASQ7X9^&WB34O#FOZ>][!<VJW^E:S#97]K#<PW:R3VZ+':RGY&_P Z
MC]@?_@KC\=/CKX,^(NL_MS_\'"?[1_[%_BG0?$>BZ;X#\*Z%^SJWQI;QQH%W
MI,EYJFN/J/A3P[;Q:$VG:@J::MM=[&N/,6Y61D.R@#]2?V9_AY_P=3+\!_\
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M^"LO[#LL@^SPA)%/B#Q7 $GB*M'<?(B;_.5U<*(RGE*J+^$7B2&.V_X-F?\
M@M;;1#"6_P#P4Z^/L"X"J-L7[5'[/J+M1%5$&Q5&Q0%&#M & /WJ_P"#C_\
MY-D_8?\ ^TKW[#?_ *DWBVOP:\5_\JT/_!;7_M*#^T%_ZU5^S]0!_=3\"_\
MDB?P?_[);\/O_41T>O5*\K^!?_)$_@__ -DM^'W_ *B.CUZI0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %)W'T/\Q2TG<?0_S%  .@^@_E2T@Z#Z#^
M5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5#<?\>\__7&7_P! :IJAN/\ CWG_
M .N,O_H#4 ?YU/[&?_)IO_!O1_VG@^,7_JS-:K_1<K_.C_8S_P"33?\ @WH_
M[3P?&+_U9FM5_HN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3M4UD+H$EK/:+"Q2-1!_0I_P41_;8_8__:U_X*0_\$'=%_9=_:8^"?[0&J>
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M>O5*\K^!?_)$_@__ -DM^'W_ *B.CUZI0 4444 %%%% !1110 4444 %%%%
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M$$OB[PG)_P 5#JNG#3Y/$D+&26&QF)Z+]H+_ (+[?M__ +%7A_P7\4OVX_\
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M(!D\D$R( 9NOE9+8\S /R?>XZ5(S*@+,RJ "26(4 #DDD\  <GTK\2OV8_\
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M[)WQ?^,GC'_@EEIWPP_:#\%>)-+'PG_9C\5?M2>#=0'QK\$MHEEJVJ:UX?\
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M!]EN+=KNZ5/-7E?V7O\ @XC_ ."C_P"VG!\2V_94_P""*%W\7?\ A2WB^T\
M?%%M._;%\%:,WA/Q.K7TJZ'-:^)_!>BS3RR)I6H!+W2Y-1T_S;4>;/,QBB<
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M3>'M1A@TLZ-H.LZG9^(IGDTRQO0#^A RQ@[3(@; .TLH.&(53@G.&8A0>Y(
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MW1[*?4KO6M;UN^DCL](TS3X;9[B[U&Z)MK6*-I;C$*N: .D$B$E0Z%EV[E#
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M/X?>YEU+[3),T*:>8+-8/,BEE"K,WQC_ ,%4_P#@KS^VI_P35\:^)_$.D?\
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M?BO0/&FO+K@UB+0/$ZS0:;-X;>V_LR*PC-Y]K5Y+VW6U02_C-^T;_P ''?\
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MVW>'569B66/!(6-3D(G&T<%0>* +5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M#<?\>\__ %QE_P#0&J:H;C_CWG_ZXR_^@-0!_G4_L9_\FF_\&]'_ &G@^,7_
M *LS6J_T7*_SH_V,_P#DTW_@WH_[3P?&+_U9FM5_HN4 %%%% !1110 4444
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M7TL%G8V=O$K23W-S-%##&I>1U4$UXH_[5/[,#1L5_:0^ A  8D?&'X>;0H8
MDM_PD6  >,DXSQUJM^UK\"/"G[47[,OQV_9R\<2:[%X4^-_PO\8_#/6W\,75
MO8^(%L_%FBW>E,=(OKRSO[*SOMTZ^1<WMG/:1/AKA#'NK^-C_@WZ_P""6/\
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M]H+]LZV8M$L=_;^*/A#_ *(4E1X;>.3_ (5.\T,S7!CD6=8WVE2HECC9E/\
M3I^Q5D_L=_LD]P/V9O@/].?A1X3_ )U]0T ?QO3_ /!E[_P3<9O);]H/]LR"
MX>1D2ZF\2?".?[3.^X[3Y?PF*,% .01"Q;EY3DBID_X,L_\ @FT44G]H']LQ
M20"5?Q1\'E<'T8#X0X##N!TK^QNB@#_/;_X*$?\ !NQ^QU_P2XLOV+_VDO@9
M\6/VA/&WC&]_X*+?LA_"Z[T+XHZSX"U/PO\ V'XG\<76JZG<BV\-> ?#&H'4
M;>;0M.2WD.HR6OE75RC6\KL9(.F\41I#_P &S7_!:R&,GRH?^"G7Q_BCB+!_
ML\<?[5?P 5(0ZJB/@ /N1(U8N2$7)%?O-_P<?_\ )LG[#_\ VE?_ &&OS_X2
M;Q;^O6OP:\5_\JT/_!;7_M*#^T%_ZU5^S]0!_=3\"_\ DB?P?_[);\/O_41T
M>O5*\K^!?_)$_@__ -DM^'W_ *B.CUZI0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %)W'T/\Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !2
M, P*L RL"K*PR&!&""#P01P0>"*6B@#&UY%70=;VJJ_\2G4S\J@<FSFR>!U/
M>OXU/^#,'_DU']N0<X'[8@( X_YICHGW>P/ P>@.,\"O[+?$'_(!UO\ [!&I
M?^D<U?QI?\&8//[*/[<@/0_MA@'W!^&.B C\10!]E?\ !U3^R;IO[2'_  3
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M%SJWQ._8Z^/=AILFFQ_#NT\1^%SH6MZMI7C7POXX^*'B$&&XL_#GA7QI\/\
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MT"[L_%WPN^-/A675=1GOH?$6F_V!HVC7J7=Q!-%9=!_P<4ZAXP_;]_X*H?\
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MX&U;X=>.+30O%'AN9;>&RU+2+^;3M1CM[VQ:47)AD>[(N@XK\QO^"[7_ "L
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MK>_GT/7M*N[-KC2=1N;._@TG4]-DN([K1=9AL+B\T+5(+*]M"M[;6\@_D?\
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M)?ZMK&IZQ\,/$=M8:7X?TM")=9O]4O)H;.S@C&;^\>*TCPT9!_@U_P""%?\
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M?'%'>6LX)@;RC+;R*6(.QRQ_HW% !1110!\'?\%,O'WC#X4?L _MN?$SX?\
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MM?Q;?\&<*(_PN_X*3*ZAA%^U]I,L0(^Y)_PC'B)-Z]\[>.<@#H >: )/ O\
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MQ?LAVF??_C&GPSU]?QK^T*7[H_WE_G7\7>C;O^(T/Q7L^_\ \,@6VS()&_\
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M^R8>)?\ U./@#G]:_M(C^XOTH _D6_X._P#XS^+O#'[&'P _9D\*V:C_ (;
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M'_!S=,T7_!%+]M1/,4FZTSX.6\,#0AC+(_QW^&RLJMC)*J?/5C_JY(4 X<X
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MF_WU_P#125+0 4A. 3Z#/ ST]J6@\\>OI0!_-K_P<\?M4>)/V<_^"4/Q6A\
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MJ^HV]Y+>3W5_97=K<7WE7C30IZS_ ,'36/\ AQ3_ ,$[,8^;XE_LSDX_B/\
MPRO\0 "<=3C !/; Z5\^ZIX5TSQM_P &OG_!&3POK?AY?%6A:Y_P4-^">E^(
M?#\^FR:KINK>'M1_:#_:0L-<L-;L8XY#/HUYI=Q<VM^C;$DCF6%W"R8/W9_P
M>4Z#H_AG_@EO^SKX=\.Z;::/H'A_]KCX?Z%HNB64:0:?HVC:+\&?BWI>E:=I
M5K&!':6=E8VMM!;V\058[<;% 0 4 ?4W_!QQ_P J]WC$]SI_[%63W/\ Q=7X
M3=:_0O\ X+*C_C2Y^W<<<_\ #&'C[G'//@^+/\A^0]*^&/\ @OMX'\9?$?\
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MGOK31-,U?QEXS^'OB'PMH%M-KUZ%AT>&\U+4(+&_DN_W.GI,US/F-5)_F_\
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MPO;&VD2\7S9[=;G<U?GO_P $#?\ @CK\6/\ @D!X/_:7TWXQ?'+P1\8=5_:
M\2?##4]-U3P/I_BRSM?#\/@'1?%VEQV^KOXLBAFNI+IO$T$=@P0+%%;1P$XE
M11_1';-*T$33QM%*4'F1LZ2,K=""\9*,3URAV\X% $H 484!1Z 8'Y"EHHH
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MR =;R<?\2C4N3G _T*;DXYXK_.4_X-N/VROVW/V9/@=^UEX:_9:_X)C?$?\
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M6GC+Q!;:39?$I/AK\*;K1;W5+R3PI<7/B/3[3^W)M9TJVLI;;7[R;P\+FSD
M.B_8S_9DMOV?/^#1/]KCQEJ/@#5_ OQ!_:/^!'QE^,/C236KNYG;Q?H]WJZ:
M!\*/%]CITMS/8:5IVK_";3?"-U8KIT-JM^LG]M7D1U*^N9#^Y/\ P;)*J_\
M!$7]B7:B*6TCXP,Q5%4NQ^/OQ2^9RH!=\87<Y9MJJF=JJ!ZQ_P %L?#VA^$O
M^"+W[?'A?PSH5AX9\.>'OV5/%&CZ%H&D:=::1H^D:5I]EI%K8Z;I.EZ>L5AI
M]C8V\4=M#9V4$%M L8CBCVKN/E'_  ;*?\H1?V)/^P/\7_\ U?OQ2H _2S_@
MH$H;]@S]MH'./^&1_P!I \$@\?!SQD1R,'J/Z5^$_P#P:%%I/^".GAL.[E8?
MVB/CQY:[FVJ/M7AL[<9P4WRR2;3QYC;\;L&OW9_X* _\F&_MM?\ 9HW[2/\
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MJ37?#4]JLL]C/#$/] F:&)U=GPORG+D_*N$==Q!.T@*[9#?*>]?PE_\ !O\
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MM:71M)U.36QXA\+WESJ'BH2:+*FCF+58X=GF"\QY\LJK_<?/_JKG\/\ T8*
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M4&OXPO\ @T$1);G_ (*YQ2(KQR?M;>&4=' 975G^+8*LIX((Z@U_:37\7/\
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M:GXI\0>&OVA/"GAG3K+4/LSI=ZSJ'BGQ1X3\-Q*K2M'?ZKHB7C6T4@E'8?\
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MHVBM%IEAI&DZ/!;6D-AH^F6MM#;V,-I"EC% L<-G%%;QQK7\D7_!Z1_RC.^
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M/_DTW_@WH_[3P?&+_P!69K5?Z+E !1110 4444 %%%% !1110 4444 %%%%
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M2ZC1RU\_P4^*-W)#OP\\T5HOAF",_O D;^8^PK<2M*LS." #]>=-_P"#H?\
MX+0:'8V.FZ%^TUX&TG2-)LM/TC2-&T_]G;X$6&C:1I%E''8V%A8:?;^ #9Z?
MIVGVD5K!;1B&-HK<11+A1AO0S_P<Q?\ !;?3_ K>/I_VV/A$ZGQS'X0/@=O@
M[\"[KX@S+>:)<ZX/&%CX77X;YF\ 1FU&C#6QJ$#1:Y/#IPTY4D,U>#?L&?\
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M/EH/LXRY8)_UT+_O.0) D7FB1HPQ?;C;<,N2VV64;FY9L10#<QX!8]3@ 9Z
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M.Z D0N2%BDF:Q@\N/=U61SD1LN7#<J,T ?P[?\'(.A_$S]E3_@L#_P $J?\
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M?Z59W-KX;\/QRJ1-K6MS6.FQ%=DER&55/]#0NX[B6_@"R". ,))0I=M\;;I
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MEEM;U2+B%AY<P9,JGF.%5SG'.1_GE?\ !7BT^)G[%?\ P5?_ &_/V7K:_P#
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M3KF]DU_6-9N$:TL;JZMH$LYK:-5N)B49I"U?8=(<X....N,X]\=_I0!_%O\
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M\,_\$LU,DDI?]KWQ!(6E;<07L? A*IP D8.=D8R%' -?TB?\%2/@):?M.?\
M!/?]L#X(W^MZOX:L_&OP,\=M<ZYH&GPZMK5JOA6U_P"$VAM=/TRYDAM[Y]7N
M_#=MH\T#312F"^D>!A*@P ?SN?\ !*[X[Z+^TQ_P6G_9O^-?AV3Q*-)\9_\
M!OK\*5"^,VMKGQ7>ZCX7_:$M?!6M:IK=Y:7^KI+=ZAK/AJ_O_-EU*6YNX;V&
MXO(XKQIXHO[**_S-_P#@SU^(7CSQY_P4[\4Z?XW\2ZSXCMOAG_P3_P#&_P -
MO UMJ\CLG@[P5IOQP^&OB"W\(:3$43[+I5IX@\1^(=2CMFW,M[J5[*3ND85_
MID4 %(Q(5BHW, 2%Z9(' SVR>,TM,E(6.1F8(H1RS$@!5"DEB3P !SD\#'-
M'\5O_!0V,W'_  =Q_P#!)YG9(&C^ FD?(Q9F9XH/VH)VB 52=^)SM<@0,$;$
MI=9$3^U*,L8T+J%<HI9020K$#<H) ) .0"0,]<5_"?\ \'5/@3P!\,?VZ?\
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MBW\;^'?#'B_QC\37\1Z187,][;PV.M3Z3\.-2TD7H-C(99;>\EM\N@$S,Q%
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M+<?P.&5L$&OX_OC[_P $!/\ @K)^TK^TS\#?VN/BK_P5M^%&O_'#]F35%O\
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M_7?"?B?5YX+.*..#2M3_ +8\.ZKHNI(TEMJ5I>W$<#L=*G=_A7_@NG-'<?\
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M+J-Y'#=^,_'=S\4?"'BL>'?#%F SZCXCGT#0-<U0Z3:AKI[#1KZ^8,(2*O\
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MM97%SK>IZ;X!O=>EM)(;/5/"NF:7-8M*#$8(%,+ 'W-_P<:? 71_VB/^"/\
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MT^KZ-\(]2;Q'J7AFQCL,?9=8U.4)96=_<J^GVWEE[L+$1(GS[^P!_P $=/\
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MPGY-IX?TG3+&WU2;26UEA;#[3>M.&N7^TA^P=_P<.#G_ (?@_"3\?V!_A?\
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MT>YL+?2?$GBSQ]K_ ,3-'@TN\DS#K%E+X2\8Z%=SWEMM6UOI;S39D$UD[/\
MKO\ MJ_!7]M3XO\ P6T7X>_L??M,> ?V:/B->W5G!XY^,'C/X/?\+8U.Z\-_
M8@FKZ=X2\+WVL6GAG1=4\0ZD)1J>IZMI^IFRT6X%MI*6-[&E]#^47_!%O_@B
MW^V9_P $G?&OB[2M9_;H\"?%K]FSQ[J?C'QWXV^"OAWX$1>%M3UWXL:WHNBZ
M#H/CB+QOJFMZWJVGQZ3I^A6\<_AS3Y;71[@^6SVTDJI<4 ?TH6E[;WJ.]NQ9
M4=HVRC+AT8J00P'4 .IZ,C*PX:K54;)F97)MY+8 _P"KF7Y]SCSF*R!B)(P9
M-O0%)!(G*JIJ]0!7N94AA:65@D<>'D<YPB#JS8R< <G -?Q@Z-B+_@]"\4RR
M%51/V/[:60DC,2+^S7X;5O,'\# C)7KM*MT-?UY?'+P]\3?%OP<^)_A?X+>.
M[#X7?%[Q!X%\3Z/\,OB3JGAZU\6Z;X"\=:AI%U:^&/%]_P"&+T-9Z_:>']7E
MM=3N-(N5,%_%;-;2@I(0?Y/(_P#@@#_P5JA_;6NO^"A<?_!7GX7I^US=^#?^
M$$N_B<G[&V@"WD\+GPO!X,&F#PFNM#P5(RZ%:VUHEV- %\AA6]\S[03+0!_8
M.^IVD4ZVSNZS,9%53&^"8U#8W8VY=23'DC=M8=14CW]JB[_,W+U)0%L=#CCG
M.S=)M&3Y:2-C"FO,?A3H/Q%\+?"WX:>%?BKXNB^)7Q2T+X?^%-"^(7Q*T_0K
M?P[I7C/QY9:%::?XL\7V_AJUD,.B67B+6[6\UI-+@=X=+CO8;2(LB5XK^V+X
M!_:S^)?P3U+P?^QG\9O 7[/'QMU;5](BM?B]\2OAK=?$^Q\)>&M/=VUN;PUX
M2.K6NB_\)=J>(K/3[_7[35]%31[C58IM*:^EL;NS /Y=_P#@E22O_!U'_P %
MGSL=@?AGXE3**6"D^-O@*ZER/NJPC*@GK(R)]YA7ZE_\',7QD\=_!3_@C9^U
MKKO@#4+/3K_QG:^!?@UKQO+*"_CF\&_%WQMIG@/QO;6HE^6'4[[PSK-W;6]R
MH\_3)&%W!^]"FOSN^$__  0#_P""L_P2_:O^-G[:_P ,_P#@KG\*_#?[27[0
M^EWFB_%SX@#]CG1M1A\3:?<7_AS47A3PKJOB*[\'::9+SPMHDOF:5HUFZ&WE
M:-G,DI/=?M8?\$3?^"T'[<'P7\2_L]?M,?\ !8[X5?$+X2>,-1\.ZOK7A@?L
M5^$?#OVS4?"FI6VLZ+=+JGAG4]&U;2I+/4K.VG L-0MUN]A6=74M&P!^>'_!
M6O\ 9J^)_P 3O^#>7_@D!^TO\,+$Z_8?L2?!CX ?%'QWX-32-3U"^OO"FN_"
MKP!ILGB*\O+!UBTO0?"G_"///XFO;L?/9W\;02Q.IW_UG_L9_M\?"C]JO]@7
MX:_M_P >H6.B^#=0^$&H>-/B='!;:C#9^#=9\ 6&H6WQ7T+1=*U*>355M=(\
M3Z!KVFZ!)J BO?$6CVVEZE#&T>I6C26O _[!G@Z3_@G/X!_X)U_&V5_B5X$T
MK]E_PO\ LV_$76='FOO",?C&P\/^#],\-7VN:8EO=2:AHEQ?7^GC5]+*W<D]
ME*%$TLT;R*W\YFK_ /!KE^U#X0^#GQ _8H_9^_X*@>(O O\ P3R^)'Q4\._%
M'Q?\%_$GP>T6[^+/B74(M#\,Z/XOMO$?Q0\)7?AR+6;>^70/-T;0GTI/!CM9
M^'I=8\.7U_IKW\X!X[_P:Z?#+QC^TQ^W9_P4H_X*I^(_$WQ9\5:+XJ\<>(/A
M#\+_ !=XOM(_[#^*GACQOXQ;Q7?QZCK6K--K$?BKX4^#_!_PHLVT&-UCTG2/
M$MAI\Y8I:QI^U_\ P<@?LIZS^TW_ ,$E?VDK#PC\/?"/C?XG_":VTOX[>#[[
M74MA?>$+7P#J]KK/Q.\0^";J\26XM_%LGPFM_%^D:;9V0-]K3:A)H]@INKZ(
M5^H_[%?['_P)_84_9Y\$_LW?L[^"$\$_#_P5 WF>>L,NO^,/$EW#;?VWX[\8
MZK&JR:]XM\220P2ZMJESEHQ;VVDV26^DZ7IUG;?3NI6[W5K) JQ/YL<T6)XS
M/"&EB:-&EM\A9HU9@9$;(V X&[! !_/5_P &V/[7.E_M.?\ !)GX&6FJ:KX-
MT_QM^S/I4GP*\=Z5IFK7VIZQX?T+X=0W%KX(U[QG;:C)--8:_P")?"=JOBK[
M/,[V!@F-W9I%$X@A_(S_ ()JK\*?^"HG_!R=^V]_P4!\(VOA[Q!\$_V7?#_A
MWPKX E\11+XXT[Q7XKTO2+3X0>$/C!\)?$5E%_86BV-RGP[O?'6D2MMU:WT;
MQC$!%]KDOKB/ZBU3_@W _:L^ WQ%_:D/_!-+_@IEXH_8X_9R_:ML;N/Q;\$=
M4^'FN_$+4M ?6V$VLQ^'_&B>+M,U'1;VSE:XTWPWXOTU;/X@:?X:N&T6]\3:
MA'OFE_9W_@D]_P $MOAA_P $I?V6[']GOX;:[JWC3Q-KVK0^/?C+\2M7BN+>
M7X@?%.\TRPL-8UO2-%:[GM/#GA>QTJPL?#WAGP];%Y8;&Q6YUJ]U76KF_P!3
MN@#Z]_;+O+?_ (9!_:L <L!^S7\=7+*"5"Q_"[Q4TASW" *'(!VM)&IY<5_.
M_P#\&=L@@_X)$:@)%<"Y_:Y^,@B8+E2?^$9^%:#+ X7<Z.JAL%F4@9XS^R'_
M  4>_9V_;9_:C^$-M\(_V._VDOAM^RT/&,/B?2?C-XU\>_""Z^*WB/7O 7B3
M0KC09/!/@VVO-<MM"\.0:G#>WC^*+N>PGUAG@T:;P]JNCR6]ZUW^7/\ P24_
MX(R_\%!_^"7>K>!OAO'_ ,%$OA]\1?V,=,\;>-/'OQ%_9VT3]FG3=#USQGXB
M\8>$GT&WN=.^)FJZ[K7BK0QIVOV/A3Q!*8-1:$0>'Y+-+1!?22  _+?_ (.[
MO^%S? 7]HK_@E]^WQ\/?[$T_1_@3XRU/1/#VNWT]CJ]W:_%O3?%>D_%7P_;S
M^%;A3-JFDKI/@Z\N+B[\M[1KE4T^8I-<0[_UO_X-]_VT_&?[<_\ P\R^->J?
M%'XJ?%CX1:G^V_K,G[.[?$,ZK_Q2WPEU3PQ:ZQI7ACPGX9U1Y%\)Z!ILUS)$
MFB6$GV:PDC2V*B>WD>3Z8_X+3?\ !(Y?^"N/[-7A#X)6/Q;N_@KXP^$GQ-T_
MXG> /%%_H,WBSPOJ6JSZ7?>'-8LO%5@FH6&OWUNOAO5]3;2[G1]8TR>T\0+8
M7%VM_I\<UE)[-_P2'_X)\^(O^"8G[#G@']D+6_B)H_Q>U7P=XK^(_B)_'NE^
M';WPI87\?C[Q;J?B:&)=!U#5=:N[%])@ODL)A_:,JWLJ&X06_F-&H!^H&G,K
M6D923S0#(OFF3S3(4D93(7P.7(W%?X2=O.,U=JM9AUMH5D$GF(H20RY+,Z?*
M[Y).5=@60]T(.!TJS0!5NID@\EG#G,NQ0BEV9RK;551R2?0=LGH#7\8/_!%F
M1;?_ (.1O^"[WFY4_;/&,N,=(F^.'A\^83T"*LJ.Q)&U"6/0X_JG_; ^'G[1
M7Q/^!?BWP?\ LG_&[2?V<OC[JKZ / OQFU_P!IWQ1T7P<MCXDTG4_$@OO!.L
MR+I>I-X@\+V>K^&K:ZG21M-N-62]2.0PB-OYLOV8?^"#W_!5+]E#]L+XI_MN
M>!?^"G7P'\4?%K]H/Q)9ZS^T98^+_P!DR5/#/Q@T63Q1:>)_$/AG4]-TGQ?
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MV7P[_P""A?PML-*N?%GB2+4_"/A_X0^'?&.C:=H6F6-SJETEOH.H>.]3\=_
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MWP3T3Q;X/\4Z?H]WH/AV]/\ PF/C*35B9/[4UKP)XG\$:%KWP[U2#208I/\
MA-+.WOIELKUEE_0K_@BW^R79?L&_\$V?V7O@)JNACPSX[D\#6GC[XI:;;>))
M?&-A)\3_ !Q:V^O>,M0TW65>:T&FW]]+'):66G,--LF<VMGO1?-?\FOAA_P;
MA_%OXH_M2_!'X\_\%4_VT[/]O#X=?LW> -#\%_!SX#:5\*E^%_P^L'\,R:3#
MX9LO%'ANRUJ]T'5/"%M%IMOJ'BG3+33;74?'>HZ5H4'C&_UC0[*ZTN[_ *HM
M/B%G:6&GVVC-IMMI\<.GVEI90V\%G86=H$L(4MTAV0_9H[=4%K!%#&D-FHVJ
M"BB@#^-[_@\/=9/#/_!+1D.XQ?M=ZXCH/]8';3/ DH79UW;"I/IO4?Q"O[)K
MR:%W16F1XQ<?9YK(C)DN9PLUO%< <[$AD:9[=LB;*+@L *_E1_X*7?\ !!__
M (*1?\%)?B9#JWQ,_P""FOPUM_@[\-OC9XY^*_[.'PYN?V7K3^U_@_I_B'4X
M9/#.@7/B7P]X@T:_\<3^'=#L=)TR6[UV2YCNKJSDO7@83O;C^E/X >&/C7X2
M^$'P[T+]HWQ=X(^*_P ;]$T*/2?'WQ*^'WA"\\!>&_&>M:?)/#9>*8/"6H:O
MKC:!J.LZ>MO=^(DL[XZ;'KMQ?G1K/3](>TT^T /X7O\ @WP^#7C[]GO_ (.0
M/^"C7PD^)=IHVE^,-!^%7[0>K:GI7AR]MM0T*VL_&WQU^$?C[P^NG7%E_HB0
MCP_XJTR3['&L;:=+/-I\T<=S;3(O^@Y7X]?"W_@E/H?PF_X+!?&#_@J-X*\5
MZ5HFD?'3]FA_A-\0_A0VFZW?:YJWQ9N?&/A35M0^)_\ PD][K5QIMII<_A;P
M3X=\.)X;T[2+6!9K$ZE'(K7$R-^PM !3)%WHZDL R,N5^\,@C*_[0SQ[T^D(
MW J<X((."0<$8X(P0?0@Y':@#^8#_@ZK_9)TK]I#_@EIXT^(MO:>&8_B)^R#
MXN\-_%>RU[5/"]]JGBN;P%K$K^#_ !;X3\%ZG;1O>:;)XOU#5O"&JZS<2;])
MN?\ A"72]C1K:VN;?]%O^"*G[5]A^V9_P34_9;^,MG)X);Q):> ]+^''CSP[
MX'U2?4+'PIXM^'-O8^$KG1M8DU!GNK7Q*GA>ST'7-3TZ4[K==;@6!GMI;:1_
MTH\7^"K3Q]X3\6_#_P 9V_\ :_A#QMX<U?P;XATZ*6>V35/#/B/3-1TC6K![
MFVEAU"SGO-,O)+*6_ANEEB$BSVIAN565?Y*] _X-Q_V_/V<?#?[0'P*_8*_X
M*V>*_P!F3]DOXS_$#3O&VF_"N3X<Z]KOC_P,UA/;75E!H7Q4\/\ B[P_KFD7
M\LD%MI?B'5_!K>')_%&@Z;I-OXLDU:2Q>>4 ];_8H\1:#_P47_X+I?M3_MS:
M1)K7B[]G/]@'X>P?LS?LY^([7XBMJWA.W^-7B5+CP_\ $+6_AUX1TQET_5/"
MWQ%\*2^)8IYKDW(T[Q)9V<]Y_P 3+["UI_5G:QB*+:IFP69\3NSNAD.\H"W1
M$)VHH^50-J\"OA7]@;]AOX:_\$Z_V9?!?[,7P;U;Q+KVF^'KC4?$WB?Q;XPU
M-M4\3?$#XB>)K^WO/&_CG79YFE@LY?$NI[[J32=.BM[2S@1([,1RM-++]SV(
M86T?F3+/*VYI94W[&D9B7V*[,T:@\+'G"#Y0 !B@"W1110 4444 %%%-?.UM
MI ;:<$C(!P<$CN >2._2@#G-6\9>$]!>!-=\2:%HAN3-]G_MC5].TK[0+8H+
MEK<:A<VS7 MFDA6X, D\EIX0^-XK+_X6?\-MP4?$#P068[8U'BSP_F5MI;9&
M/[1R6 !."!QST!(_ER_X+F?LU_"']KW_ (*R?\$*?V;OV@O#%SXS^#WQ-O?V
MW;+QOX:M?$7B'PO/JRZ%\-?!?BS24BUKPUJ6F:[IXMM>T+3;X&PU&WE>W@>T
M:18))$;QW_@HO_P2D_X-MO\ @ES\,? WQC_:B_9$^+?_  A7Q ^(UO\ #;P[
MJ?PX^*OQ_P#%^L/XJN_#.O\ B^(:CI__  MW0X[2T?3_  UJ$<%S'<3N]P$"
MPKF5T /Z[_\ A9_PU'!^(7@<$=0?%F@9!]#_ ,3#K1_PL_X:_P#10_ W_A6Z
M!_\ +"O\XO\ X77_ ,&8'\7[*/[6J-_$C:C^T &4]U;;^T,5R.^"1[T?\+K_
M .#+[_HU/]K/_P &/[07_P!$+0!_HZ?\+/\ AK_T4/P-_P"%;H'_ ,L*/^%G
M_#7_ **'X&_\*W0/_EA7^<7_ ,+K_P"#+[_HU/\ :S_\&/[07_T0M.7XT?\
M!F"P)7]E#]K5@,Y*ZA^T&0,*6.2/VA>,*K,<]%!/0&@#_1R_X6?\-?\ HH?@
M;_PK= _^6%'_  L_X:_]%#\#?^%;H'_RPK_/3\,S?\&COC73!K?@W_@G]^WW
MXMT8W$UJ-7\,^&/VJ=>TPW5N5%Q;"_TKXXW=J;B LHFA$OF1%E#JN170_P#"
M,?\ !J/_ -(U_P#@HY_X;[]KK_Y]% '^@7_PL_X:_P#10_ W_A6Z!_\ +"C_
M (6?\-?^BA^!O_"MT#_Y85_GZ?\ ",?\&H__ $C7_P""CG_AOOVNO_GT4?\
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M]7_"S_AMDY^('@@#C#'Q9X?PV1GY<:B3QT.0/;(YH_X6?\-?^BA^!O\ PK=
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M_0+E_P!8OUB_]'+7^?I=_P#*L'_P6:_[25?'#_UIW]GB@#^\#X%_\D3^#_\
MV2WX??\ J(Z/7JE>5_ O_DB?P?\ ^R6_#[_U$='KU2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *3N/H?YBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HH
MHH **** "J=^I>U<* 7#1-$")2OFI*C1;A"R/M\P+N^;;C.\%,@W*KW2"2!E
M^7.49-Q(!D1U>-<AT.6=5 &[!)P0PR" ?SK_ /!Q'_P53_:%_P""3_[._P
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M_P $/^^/'7_S94 ?Q#_\1F__  51_P"B6?L;?^&R^*'_ ,^:C_B,W_X*H_\
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M/^(S?_@JC_T2S]C;_P -E\4/_GS5_;Q_Q#X_\$9_^D?_ ,$/^^/'7_S94?\
M$/C_ ,$9_P#I'_\ !#_OCQU_\V5 '\0__$9O_P %4?\ HEG[&W_ALOBA_P#/
MFH_XC-_^"J/_ $2S]C;_ ,-E\4/_ )\U?V\?\0^/_!&?_I'_ /!#_OCQU_\
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M51_Z)9^QM_X;+XH?_/FH_P"(S?\ X*H_]$L_8V_\-E\4/_GS5_;Q_P 0^/\
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MO_#9?%#_ .?-7]O'_$/C_P $9_\ I'_\$/\ OCQU_P#-E1_Q#X_\$9_^D?\
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M_P $9_\ I'_\$/\ OCQU_P#-E1_Q#X_\$9_^D?\ \$/^^/'7_P V5 '\0_\
MQ&;_ /!5'_HEG[&W_ALOBA_\^:C_ (C-_P#@JC_T2S]C;_PV7Q0_^?-7]O'_
M !#X_P#!&?\ Z1__  0_[X\=?_-E1_Q#X_\ !&?_ *1__!#_ +X\=?\ S94
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M_P $/^^/'7_S94 ?Q#_\1F__  51_P"B6?L;?^&R^*'_ ,^:C_B,W_X*H_\
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M/^(S?_@JC_T2S]C;_P -E\4/_GS5_;Q_Q#X_\$9_^D?_ ,$/^^/'7_S94?\
M$/C_ ,$9_P#I'_\ !#_OCQU_\V5 '\0__$9O_P %4?\ HEG[&W_ALOBA_P#/
MFH_XC-_^"J/_ $2S]C;_ ,-E\4/_ )\U?V\?\0^/_!&?_I'_ /!#_OCQU_\
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M51_Z)9^QM_X;+XH?_/FH_P"(S?\ X*H_]$L_8V_\-E\4/_GS5_;Q_P 0^/\
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MO_#9?%#_ .?-7]O'_$/C_P $9_\ I'_\$/\ OCQU_P#-E1_Q#X_\$9_^D?\
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M  2P_P"BH_ME?^'.^&/_ ,YBOD;_ ((P_P#!(7X$_P#!0O\ 8?T[]IW]H?\
M:'_;ET;XC^(/CE\>_"M]-X"_:T\7^&O#ESI'A#XE:KH&@P)IU]::R(+J*VB6
MV9DN$>^E@>X8*)45?UG'_!LQ^Q$XWS_M*_\ !2%)G)>16_;-\2NVYB22SGPT
M"S-U8X^\3R>I /E'_B#&_P""6'_14?VRO_#G?#'_ .<Q7@O[4W_!I)_P39^
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M_P""V_\ V=IX1_\ 4S_:/H _LZW2_P#/*Z_-?_C]&Z7_ )Y77YK_ /'ZT**
M,_=+_P \KK\U_P#C]&Z7_GE=?FO_ ,?K0HH S]TO_/*Z_-?_ (_1NE_YY77Y
MK_\ 'ZT** ,_=+_SRNOS7_X_1NE_YY77YK_\?K0HH S]TO\ SRNOS7_X_37D
ME1'8I=* C98G.T;3EODDD8$#)!6-R" 0IQBM*B@#^8_PU_P;)_LK^!;?4M&^
M'_[;W_!4OX8>%;S7-9\41>$_A]^U!:^#O"=GJ.KWDNIZKJ=GH?A_X?V]DDE_
M?W+S-,+5=1GD8M<-(Y:>OT[_ ."='_!-?X1?\$R_!/Q0^'GP6\<?&[XD?\+H
M^+%S\9/B)XO^.?BS3?&WB74/%UYH&EZ#J5RWB"PT'0+R635+#2K*]N9M276-
M0EU"2XEGU*5WPOZ:T4 ,B $<84$*$0*"68[0HQEG^<G'4M\QZMSFGT44 %%%
M% !1110 4AZ'Z'^5+2'H?H?Y4 ?Q3?\ !Y1I=AKGP[_X)CZ)JULM[I6L_M1^
M+=*U.S=I$2[T_4=$\&6=[:L\3QRJMQ;32Q,T<D<BAR4=& 8?LDW_  ;>?\$2
MU8@?L"^"& [K\1OCE@_3/Q3S[5^/O_!XC_R*/_!+/_L[37__ $V^!Z_M*H _
M#7_B&]_X(E_]&">"?_#B_'+_ .>G1_Q#>_\ !$O_ *,$\$_^'%^.7_STZ_<J
MB@#\*)_^#;O_ ((K&0-!^P'X',:O;JRR_%#XX6ZE#*#<2($^)$\KM'#G$9DC
M69OW:F)OWU?RC?\ !?;_ ()0_!3_ ()C67[,'A3]DWXN_M._#SX1_MP_M+>-
M?!_Q:^!+_&O5G^#NF>%9[SP2]IIOAWPK;6MH+R.UT_7FTYKKQW?>,[E[73=-
MBN)9/LK-+_I(5_(?_P '6_P"^.7QS3_@F!_PI;X._%#XL_\ "%_M0>)=8\8/
M\-? ?B7QPOA+1[A?AMY.K^)1X=TS4ET73'^Q7A74-4%M8XM+C?.!&^ "TO\
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MV7 IR=L:_ SX^1^3&.(H&^S_  UEAD,$86+S(Y&1P@96*D4 ?#UQ_P &:/\
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MF@#[K/\ P<6?\$3P"5_;Z^%ZL.5/_"!?%XX;L<+\-P3@\X!!]".M>V_M%?\
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M\,;36J2"9+>5E!>%955!((VRH<(H;&0HZ5_-[^S]_P &NG_!,3]FCXX?"/\
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M76T;NWR+%%<OJ<QCA$D;W/VJ&:*6VA$LB":7+(D<JQ%?.C97<^0_[J1U7<.
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M%8O/LJIY5*E2QU3'Y72IRQ6&IX:M4E2Q$YPMAW3O5Y>9)?J)17A?C3XN> O
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M.:;XMD@\)_#_ %/Q/I;:%K4EPNG2/J=O.B13%[20-"H#@CD%37@)_P""_O\
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MX2^<2$_M"?'ICC<9(3_;>B_NKQCA?M3AA,-GRF%T/W@]?U 4 %%%% !1110
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M?]^(?_B*,W'_ #UN/^_$/_Q% &A16?FX_P">MQ_WXA_^(HS<?\];C_OQ#_\
M$4 :%%9^;C_GK<?]^(?_ (BC-Q_SUN/^_$/_ ,10!H45GYN/^>MQ_P!^(?\
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M  'H!@=,=O8 ?04M96E"[6*1;IUD'F.8&4RG,(D=%8F<M*QD">8K[C&R.IC
M&16K0 4444 %%%% !1110!S7B;0+7Q-HNM>'M0ED.E^(--U'1=72.5H9TTO5
MM-GTV^2SGC!:UN)+>X=XIB#LEQ(!\M?P4^)O^#?#_@FQI'_!<3X6?L&67@OX
MKM^SYXK_ .">OC#]HC4=&F^,>M2^)KCXI:3\7-0\)V&JV_B2WM_M]GH\OARV
MB@;1@K6LUV'O02=T%?W[&"%O,)B0^<09<J/WA">6-_\ >P@VC/\ #Q7\XOCN
M..W_ .#IGX'1P(L49_X(]^.4*1J%4I'^T+K:1K@=D2.-5'0*B@=* .#_ .(2
M;_@C.URH?X??'>:565)2WQ^\5LC&0)&L+R^2DI,<:[41"C&-V4EL)LZ[_@UC
M\-Z1X+_X)N>/?!^AI-#H_AC]MO\ :M\/:#;7<K7%Y!HN@>*M"TBRBGNG >\F
MBM[6V%Q=. TDK?, >*_I#ABB0KLC1=IE(PH&"2@)^I Y/6OYVO\ @V,_Y,$^
M,G_9_O[8G_J;Z50!_1?4<O\ JV_#_P!"%25'+_JV_#_T(4 ?YS'_  <_?\I^
M_P#@G1_V(G[)W_K57Q"K_1KK_.4_X.?O^4_?_!.C_L1/V3O_ %JKXA5_HUT
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MH **** "BBB@ HHHH *3N/H?YBEI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH
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M=.JZ698O/,7BU7C[+%3G#"3IUZ?LJD%_#K_P5'_X)MVO[ ?C;X=ZQX-\>_\
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MRAE/@7^RM%'(Z0O\8?%3M%'*R1O'!X E4+*8V^9ED960AAM^9LYK\*OV-/\
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M@9'T:/9#JWB2_P!3C\>WVBZD$6ZU(1+INBIJ]I>7,MO9W5QIFU$EN"Y^4_\
M@FQXI_X3G_@K!\%_'5OI/]AGQS\>?''C6Y\/QM]G&AV?B31?&>L6<$RQLL$L
M\$5]%#=+DEKV>>5E7<$7^B3_ (*TC_@FU\5[7PG\./VI_P!H72OA/\6/"G_"
M5R> ]=\#7LOB7Q?X7NKBPA.I>'/'>DZ1IGB%H?#LFH7.@ZY?:!K+Z%?:Q-:6
M)T^]MHH9)ZZL+06,R?,84:Z3KX^KR5*E3V=.=-?5YP]I-M<BDE%J,U>%3EB[
MZ'XGXK<:8?P)^FY]&7.>).%L[XNI9)]&G)<@SG!Y#E,\^SG)*BQ/$. KYWEN
M"PM*I[3%Y7.G4C/ZFZ4EA,3CITZLN6<*WY ?L0?!+_@C9\1O@+H.B_M ?&36
M?#W[2OQ6M+7PJF@^,==U'PW<_#OQPR3Z-::MX"ATNT?PV_AS7M1N+/4]-O/B
M#=WZ2W<!CE2QM6:*OFOP;_P3S_;Y^#_QV\/>-_@%\)O&/Q5MOAO\81<> _C5
MX=M_!=[X9\2VFA>)ETVT\>Z/<S^)]6@O;:70OM%W+8W#22V$YED93<C:/6_B
M/_P0D_;(\'^']7\4_#B]^''QP\/I=Z+=^$K'PQ?GPWXY\5>']0>VDL_$6I^%
M_$D-OH>G16-O>)K&J65SXJU%HXX#;VOFS.$7XV^#?[1_[6W_  3O^+$WA^V\
M<>(_A':^$?%^AVOCOX5^*H+G4O!=QHUMJZ:IXAMH?#\K7%H\6NF>ZNKW4/!]
MWI\&I *VEZO<1X1IA0P^$6"68X>6'K4YSBL5A*E)0C4A"*C3G)J4)N4XRES.
MHJO*_<27N+])RO%9GQC@?&//?HX?2<RCQYK<99-FCS[P?\8)XC.EP_@L?0Q=
M6G0X?P\,5E>.R&.6X/&_4%1GEV*P.(K*E#,4ZT/:P_<K_@Y+@,'A[]D-@S^:
MNJ_%']Z'VB2:3P_X=$Y94PK.[C<Q(Y+<8SFM[PA^U=-^RC_P0@^ 'BK2UN$\
M?^.O#VN?"GX?_9+:_DC?Q1XG\;^.0+BZOM,N+2?19-+TA-=U2PU..XC>+6[7
M2E#;9I@WG'_!POXRT?XA_"_]B#Q]X=OXM2\.^,H/''B;0[Z&.6&*\TG6_"OA
MC4;"]CMYU2>!;FWN8Y%CE19$#;70,"!\]_M+WMG#_P $#/V&;*[LTOI+WXH0
M6=NDMUJ%E'%>/XA^*<L-[+<V$<GEBV2.8 W310OYCDOYD<8/HR=-8_,JD*C=
M;#9/.M&S:C"I".'<)1<>9M*5G'EO=\K4917++^7_  _X-P'%?T4OH3\+\48+
MZW@L7]+'/,!FF!JRK4Z-)TH\5/$87$0E&4X*3A4HU/J\*4HT:E:*Y:TO:Q^
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MD\5>/])_8L_9O\'Z'+>6O@SQAXO\-6WQ&MX]#_M&QN(?#O@ZRU?PK;3:JO\
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MVO/^"4/Q.\/?&OQ!IG[%GA;Q/^TE\&=2L_[<M[[X:ZOX4UG4?AY)XDNKIYO
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M36,HOI?#OBB?36UVW4MYR0Z;XFT&[M%6ZLYH[B2UD28RP(WF_P"C#^Q+\?\
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M[B/A_!Y;_K##,^ \T=.OE<L'1IQQ6$G6RYXKVV"2PKQ%6%#GJU\/5]G\6_\
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MEI'@[0=5U=K274M4TK1K<06=]>264,%H\\\161WMX(HF!4HH4@#V.>:1;J.
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ML"_M&?G^T3_]$G1_Q#0_\%8?^E@7]HS\_P!HG_Z).O[8\?7\S_C1CZ_F?\:
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M_P!IR9 T9^YN#*T?F_,@E5@T1(;(R'"E2,,& *D-@C^2OQ-\6?BC_P $*/\
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M>#;>\N_B4GAJ]N[;P,+IC!)%H<S^3;F_V331QW;2+&S;?VX3X?>"% QX+\(
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M4UA?!;%^$E3AF7&4)5,?SYWB,T6;PQL>'4H<SJ15+">R@W%WEBX2]V'\-/\
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M>''%7A+2XW^CUX@9KF&;8'PTQ6<QQM;A/%8S$83$N>"S7%9=3^LX>E.F_JV
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ME&2E)P=.+<73BFTHN3C'WOB.'OI]YCPKX3^#'AKDWAZZ>(\(/%*CXG8?/O\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ'Z'^5+2'H?H?Y4
M?S;?\%._^4ZW_!O;_P!A[]O#_P!49HU:_P#P1R&?^"CW_!P8^YP3^VW\)$^5
ML?=\ >)<'.,]\$9P4)7WK(_X*=_\IUO^#>W_ +#W[>'_ *HS1JU?^".Q=/\
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M$PZ?J&B>#["[@_L[7+\O+/K&J2ZC>2WMS//,J0M(<?Z&%?Q:_P#!XC_R*/\
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MDDD+2S.TO+NSD _S^_\ B. ^-G;_ ()Y?#;';_B_7BT_K_PK*OTS_P""1/\
MP="_$W_@IG^W-\-OV0_$O['W@KX1Z1X[\.?$C7+CQQHWQ8\0>*=1TR7P+X&U
MKQ;:VT6C:CX&T.RN%U:[TN+3&>34X6MQ<F55E=8XI/ZW!\-OAW@;O /@G=@9
MQX5T/&<<X_T#IGI7!^+M6^"_P7T#QE\5_&</P^^&?@?X9^'M4\1^+OB%K&FZ
M!X:T?PKHFFVTMQK.I3Z^+:WEAMXM,2;[8%E^9L6:J\LJQL =5X]^*G@WX7>$
M_%7Q#^)'B'0_ 7P[\#>&M0\6^,?&GB[4X-$T3P[H>F6QN;V]U&ZO&C2&"TC&
MZ>8MY9+Q6\+274BQ5_)=_P $[OVNO$__  5@_P""[GQ#_P""@WP2^!/C7P_^
MQ9^S?^R)XQ_8_P#"_P :/$4%S9Q?$SQ#JGQ#A\:Z)K$.EW,44L6H:W-J.N70
M\-Z)_:FH>&/",/AK4_&2Z)J>N+8CY0^)/Q6_:;_X.G/VG-5^ WP!NO&7[/O_
M  1W^"7CRS'Q3^+4MC/I'B3X\>(-*1IK%197007^LZI ([OPIX$G$UKX*T2X
MM?%_C6WBUF6.RB_LQ_9V_9P^"_[)7P:\#_L__L[^"/#?P^^%/PRTN#3O#'A[
M2XI%D$L4?E:MXF\0W[@W.N>(]2G2XOM9\0W\D^H:MJEQ=3W\SR-N ![_ &>H
M&ZF BAQ$IFCE$C!;B.59-I^3F-HU*,'P_F#?"P0I("?YZ?\ @V+5Q^P#\8V<
M*&/[?G[860K!U!_X3C3 V&'! 9" ?XAAAP17VO\ \%._^"G?P@_X)J?"30O$
M&M65[\5OVB?C!JW_  BO[,W[./@LS7_C[XU_$#41:Z7I<5KI%@LU]:>#=.NM
M1L7\2:VT"K]IFL='TLW6N:II=E/Y]_P0D_8\^.7[%/["-C\/?VB].\/:!\6O
MB7\7OBE^T)XK\(>';JYOH/ =U\8=2T_7H? U_?3,\%YK/AR&'[-J<EA)+912
M216B33W-M=RL ?LG,[1Q.Z!2P&5#$JF?]M@#M4=2V, 55CO(KQ0UJ4N;=TR+
MF&6-XV? =8EP<EBNUMQ 0*P)89Q5F>/SD\LA2K,HD5LX:/(WK@==RY&#QSS7
M\:'[&W[./[;O_!2[X\_\%0/$]Y_P5Y_;M_9R\/\ [.O_  49_:$_9^\ ?#KX
M3^++2?PCI7@7P_J\.K>'[738=2NX'TRWTF#5_P"Q+33;.&.V@TO3+$"229I&
M4 _,C_@YZWM_P7U_X)U2LOEX\ _LG.JL"2?^,J?'V4) (W*SMD@E<+PQ;Y1_
MHV5_ED_\%F/V6OB5^R/_ ,%G/V!_AM\5/VO_ ([_ +9_B/6;+]E[Q1:_$OX^
MS:?<>*=#T^[_ &EO$&E0>"]/DL;FY0^&[)]#N=;@W&.X_M76K_S%=<SR_P"I
MM0 4444 ?Y]O_!S3^U5JG[$G_!<K_@G5^UAHW@S3/B#JWP*_9VT7Q?8>"]6U
MNXT'3O$$D?Q/^,>GQP7^KZ?9:I>Z5;[M7D=9TTZZ8R6@'D/%(2.53_@]O^.$
M8VC_ ()[?"LJB2.Q7]H3Q-\JP2K;.NUOAPTC2!MC"% \QB=9 A4,1_87^WM_
MP2I_81_X*1Q6*?M6_ _0?&GBK08-%T#1?B5HFJ3^$?BIH/AO2[_4=?@\-Z;X
MXTG9K=KX>N-4UK4KFZT&.46EY)>S33*&<,/Y[OV_?^""_P#P;[_\$\OV7?B/
M^TK\:/!GQ&TJR\,:-J$'@#P]KG[1GQ(2Z^)/Q&N+.\D\*> -(L-)GEUJ\GUG
M5XD@U5]'M+JXT?0HM3UZZ\JWT^XG0 \>^%'_  =1_P#!3+X\^%/^$\^!W_!$
MWQQ\8?!(U2^T-_%GPQUSXT^.?#L6MZ6(&U/19M9\.?!34-/35=/6ZMFO+$SB
MXMUN8#(BB12?2_\ B([_ ."R?_2OQ\?/_!5^T1_\X:OC+]@S_@LK\.O^#?G]
MEGX8?LD?M(?LP?&?Q!XM^.MC??MK^'M,\#7^EZ7;?#?P/\?&2+PC\+/$#_$:
M[T[7-6\3^&]/\&PWNHZTBR6MWINO:/<%Y+LW8/V.?^#V#]D*-KF*X_8S_:<@
MN84+)"_BOX5 2-&R^=&TC:ROER)&Q>) LC3N!"@$CH& ,'QA_P '-W_!6+X=
M^%]=\<_$+_@A)\5_ O@GPMIMQK/B?QAXQN?CIX7\+>'=(LT\RZU37?$.N? ^
MRTC2-.MD^:>]U"Z@MXQC?("1G[,_X(J_\'*6I?\ !4W]IGQ9^S#\1OV6+;X)
M^)[7X6:M\5O!_B3PA\0+CQMH-YI/A.YL[?Q3IWB:'7?#_A;4-.O)!KF@OX?G
MTJ'5;6Z(U:/4'L?)M'N/6/VH_P!OGP5_P4L_X-R/VU/VOOAWX*\7?#;PIX^_
M9Y^/^A67A3QI?:1?>(+&X\#>)-1\&7KW=SH,]QI\D&J7.E33VZ1.2MK.L=P
MQ(K^17_@T1NA%_P5FG:^D\G3(_V._C5*([V7RK&.T_X2+X?G_3[N8K&+.6X>
M60RRNL,<LL4&0T:B@#_0\_X*:_MLZK^P-^PA^T!^V1X7\":5\4;_ ."VA>#]
M:L?!&L:]=^&+'Q!'XG\?^$O!CBZU>TTS5KO3X[>#Q,VH6[IIUP;B6S%LRQ+(
M94_FCL?^#DG_ (+":EI-AKVF_P#! CXVZEHVJ6L%_INHZ?;_ !_O+6^L+JWC
MN[6_M9K;X%RK/87=M-'/:WD>ZVGB=9(I74@GIO\ @I/^VQIG_!8[]L7X5?\
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MO_41T>O5*\K^!?\ R1/X/_\ 9+?A]_ZB.CUZI0 4444 %%%% !1110 4444
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M/^'-_@T9&?\ AH'X[9&1D8UK2"<CJ.&4\]F4]"*_J H **** "BBB@ HHHH
M**** "BBB@ K^+7_ (-+_P#DNW_!;?\ [.T\(_\ J9_M'U_:57\6O_!I?_R7
M;_@MO_V=IX1_]3/]H^@#^TJBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D/0_0_P J6D/0_0_RH _BV_X/$?\ D4?^"6?_ &=IK_\ Z;?
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M+]IU/2-/GDU+4_&&M>(_Z"K2V>%WD8[-^_?&@C"2RDIF[EV(N;B4)\Y&% X
MZ4ZSBDC5L[DB/,4$A:22(M)(\A>9Y)&D+LP*KD+$NU%^4"KM !7\V_\ P;[_
M /)1/^"W_P#VF,_:8_\ 0=#K^DBOYM_^#??_ )*)_P %O_\ M,9^TQ_Z#H=
M'\[G_!S]_P I^_\ @G1_V(G[)W_K57Q"K_1KK_.4_P"#G[_E/W_P3H_[$3]D
M[_UJKXA5_HUT %%1>?#WD5<R^2-QV;I<XV+NQO8GH%SN[9J-KRV6:"W,H,UP
M91$BAGW&!=TNYD4K'L Y\QDRWRC+<4 ?S"?\%B_^"I/[>/P(_;]_9H_X)C_L
M,>%O@=IGQ'_;*^%.D:KX1^-GQ.@U*_UOX;>,M8\=^-= O=3L=/O;BZ\%7FEZ
M;X:\"R74-AK?AS69;[4+J>-4+BSC;S;7O^"(OB?]HO\ :5^&OQE_X+:_\%*/
M"7[5B?!BWT6[^$?P!\-Z/X._9\^%-[IT]QKUUX@D\>^"I=3A:]M_$NIQ^&_M
M5[X4LM&NO$MKX;ET3Q7?:OI,<5C'\=_\%Q_C'\,OV>/^#DO_ ()'_'#XU^+K
M#X>?"?X=?!K0=?\ &OC?6K?49=)T#2(/B/\ '.UDO;E=-LKZ]EB2YOK.!OLE
MI<,DEPF]54.R_A3_ ,'&'[9W["7[8W_!4KX._&GX?^.;W]IG]FSP]^S'X&\%
M_$"3X,>()?AUXGO]>T?QI\6KZ;PUH?BGQ]\/]<MM+U.P.O\ A[6+BZF\):Q9
M2Z5<3VELZ7EP\EN ?W]_M.?L0_\ !+S]N37OA!J?[1.@_ GXGZ]\(_"'C+X4
M_"GPS=?$_2[3P]X?\,_%*QTWPOK>CZ'X6\->*;:PNM>ATS3=,7P#J,MI<ZGX
M,URWTO4?"TEC?VP:OSA_: _X-V/^"#/[,7P4^+O[1WQ2_9@^(7_"O_@Q\/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=Y+IT7AZ#6=>6&/34LHHUN(]1DAN#(YC2-%2-/T]HHH **** "BBB@ HHHH
M**** "BBB@ K^+7_ (-+_P#DNW_!;?\ [.T\(_\ J9_M'U_:57\6O_!I=_R7
M;_@MO_V=IX1_]3+]H^@#^TJBBB@ HHHH ***,T %%%% !1110 4444 %%%%
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MV7PW81W0D46P7_0U_P"6A_ZZ+_Z7+U]/\FOXR/\ @TR_Y+Y_P6Z_[.U\+?\
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M\40:98V]OJMP;Q;*_OX+E#PWZ _\$P8?^#E;_@H?^SC9_M+Z]_P4F\"_LQ^
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M+N)5BU+2=7TZ]ATF\N8[+^W-#_L[Q#:6L5CJ]J& /N&BORL_X*/?!3_@IO\
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M.0V$^E>"_'GA_P 6&35[K4H+V[O&ACC'U_\ $&P_X.>?V*OA_;?M$?\ "_\
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M4O=#N$-M>)&;:7Y)#0![317^<=_P5R_X*.?\' '_  21^-7@?X3?$'_@H?\
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M2_\ 4O\ VC:_M#?_ %D?T;_T*.OXO/\ @TK_ .2X?\%M/^SM/"7_ *E_[1M
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MU_X.-O\ I SXB_\ "/\ CW_\FU_:110!_%O_ ,/M?^#C;_I SXB_\(_X]_\
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M7C2TU5=0N8=12V\(^+O$6F^%;@7\9O(KH1PS0F4EJ_&G]C__ ((N_P#!6/\
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M-.LKF^OKNSL+.UB::YO-0GCMK*VA3EY;FXF>.*&)5R6DD=57J2!7\X?[(?\
MP5SA_:,_X+E_ML?L3VGQRLM3^!?PQ^%6B>&O@G\.Y?#F@65_KGQP^'ES:Q?'
M/5?"GBO2[.XUGQ3HUC96.NZFDFHZX^FOID9O-*L8C""_'?\ !V3XU\4>'_\
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MN58",M%(LSW/S1S[I$0'>"/[:&Y5AC/RG@\9XZ9]^E '\%7_  >5_L+^"SX
M^ 7[?'@3P-X(\,^(%\=7?P2^.'C"Q:2P\7?$(^)M-EU/X3W-]9VN[2-3?PV_
MACQS#JFM26Z:\]KJNDV=Q>7EA9V=MIW] W_!O?\ MCZM^V)_P2@_9]\>^)]8
M\2>(_B#\*SK7P$^(.MZQI^E:<VO>)_APMJMG<Z?'HMJ+2;1;?PEKGA>QM;V.
MSM9YKC3Y3=PF<32S?GI_P>*PBY_X)4> )X;:TB$7[7/PJB\LW86ZMS+X/^*4
M/E6]K$3'<1W4D)DN)1F: VT.P?O[G;U?_!H),(?^"1 EENKBVAM/VM/C?YD
MM@\:H=#\!XT^)T5I)K;S)1=FYP6%PDEN2$C6@#V__@ZN>0?\$1?VCYWCCBN#
MX]_9U>1$(F1)/^%Y^!/XGC02G!Y9HE))P1\HK\W?^#)]!<_L5?MCF<O(1^U#
MX;()=P?W7PG\,+&I*L"T:+A5C;,84!=NT 5^D/\ P=9#'_!$/]I$8 _XK[]G
M@@ N0 WQU\!L,%_G/!S\PSDX[5_-%_P;'^'_ /@KIJ_[+G[1ES_P3E^*'[$O
M@+X?6WQUTF'XA6'[5'A?XAZSKVH^-7^'VBRPWGAO4O!5I=V]OH\6@QV$3V-]
M&)/M@N;F*7;)(B@'^CK>%(Q%)Y=S=21NL20P3^6EFHGGABOKA44RRQA,Q.95
MNHR8XO\ 1S\[K_E1?\%3H@W_  =">,[>54ADG_;N_9%=9;F9XX/+_L[X%30'
MSD6YF@>0DK\H:/R[B,^3%MC*?V<7_P ,?^#H[6M&U6UMOVD?^"2VE7&IZ7/;
M6.O:+\/OC<NHV4>K6\\1U'2+Z;0[ZW@N-.,BW>F3W.G7UO-=HCW$$\*LLGF7
M_!/#_@V1^%_[-/[36B?MP_M9_M+^/_VNOVL=+\16'Q-2ZU/3--TGP+IGQ)UC
M1_$MEXRU+78M:;Q+K/Q'@N-1UV&_\*ZG>Q^#9] N= TZZM=/$B1PV8!_3W<W
M*P7AMYOLTBS>;>JDHS)%%;$>;))$B?O(6*E(92LCPSO"")#(NW_+)^%$'AK_
M (+G_P#!Q_>WWQ,\1:EJ'P7\0?&'QQXKTKP_XS\-&*^O/@7^SMI^I:]X8^$N
MIVW@W4/#U_8IJN@Z,_AJ75K;59]9L+>Z2]GN[Z\C4'_5$GL4#QS*KRX@>UFA
M8Q_OX9!DEW<!P5D"R,4=<@$A&8)M_P K3_@VE,L?_!?7PAJ$LTDXGL?VQ;F>
M2/RIIIL>#O',;7#VNG-,\4LLQ0E%C2-T5&M]\05B ?ZG1 B7*2NWEB'3UM)7
MGF1_G,D.]AOGCDGMS&HDN'<84>;DLSG\)_\ @XF_8ETW]M7_ ()D?&GP_I/A
M#4/%_P 8?@K;GXU?!>/0K?0++7E\2>%HF'BO11J^LVTT5CX0O? TVKWNO:59
MZEH)U;4/"NBD75[=VEM:O^[+OY-BT;[IY%%I;/=/^Z%U.$0M=/+$2T1B!P[3
M!5C==I^7&?G_ /:RC"_LO_M*RSJ"ME^SI\;C:3WC[Q>1?\*T\2&XN+F>W9(8
MX3YR!_/0DKODC5&)>@#^,'_@RV_:>%QX8_:^_8^UWXCV=Q<VVH>"?C_\(?A3
M/IR03Q:7=2WGA+XU^,K/58]$ =HIXOA3INIVNIZS,D4\NG?V%;0HVK3K]T_\
M'BGP5^+/Q1_X)U_";Q9\-OAUXH\8Z)\&OVCV^(OQ1O\ 0X7U1? W@A_A?XU\
M.R^,+ZWM6>]3PS;:GJUB+_4(XS;Z1YSWNI+!IT<L\7\_O_!F6ZQ_\%,/C2T\
MUX7/[&/CB&-A;L]G';?\+*^$ES,\DS +!);;+>.",CR[@S7+E]RH)/\ 3'NM
M)L];@U+2=2M=/US0]8L=1TS5M+U.UBU'3K_3=2M6LM0L=0TZ=+FRU/2]3CE\
MJZTN[1(UMWEBECE@D=* /XY_^")__!Q]_P $Z/"G[&/[/7[*7[3'C?4/V8OB
M1^SI\%/!WPQN?$_CK2-3\2?#WQY:^%OL?AG3M0\+>*?"=GJ&JVFJZ[IBV^NZ
MGI&MZ#IVG>'D::*/7M86W>1?ZX? 'Q2^'OQETB\UGX:_$'X=_$SPGITK:9JN
ML^ /&'ASQW:Z=K=C%!J'V:_UOPCJ6JZ=!JTFEWFGW+Z61'=V@ECN(C<VEW Q
M_D__ ."C'_!H_P#LO?'OQ'XC^+?[%WC[1?V1-?MO"+0VOP)O- NM?^"OB7X@
M6<#_ -BWNIZV=</B#X;Z-KD02V\3)I.E>+89"6U33K*!F:U;^>[XE_\ !!C_
M (+Q_P#!+F]M/BQ^S%K.M_$C3/!5A;_%V]\7?L@_$C5[F#PQXGM;B\TBXTT?
M!_Q##X9\0_$'Q,-)2RN-FC?#SQ?;W&B7-M;1%VMKFU@ /[.OVK/^"2^H?%W_
M (*^_L!?\%1_@W/X4\/K\&_^$ETG]IZ#7+J/P[JGB[PUI7A'Q!I/PRU_PKI.
MF^%;FX\1^.)IO%VL:#XLO_%FNZ>W_"(Z?X2L-.:,:0EN?WF@@-P9EO;>-H[C
M"_9I2MS!]GE1\Q[7 0QNJ)F-K=?+;>@>53D?Q0_\$)O^#C?]H#]J#]I;P;_P
M3_\ V\? _A"P^+.MV/C#PMX/^,MI8>(_#'BSQ'\1OA_HV@6J?#'XC_#-='O;
M;3_&MTFB>-=?\3^-+Z^\/VT.J6)T:/PW99A9O[7M/9?M%V@AD1_M,4LLQ+-#
M/+) R.(M^'C,31%7@V@(K1N!^\- '^5/\4C)_P 19\S1J)93_P %7_ D6U@6
M*PO\2O#L<TZL3\C6<),T3$[8V16*E4*G_28_;V_:OL_V'?V2/VCOVJM1TK2=
M7C^"WPT\1>+-"\-Z_KEIX7L_&OB:TM)WT3PK::M<W,BR7^MZP\,,%O;6#ZE>
MG-C80W%Q-&5_S(/VM?"?BCQ[_P '-_Q5\"^!OB3K?P8\<^,O^"EF@>&O!?QB
M\-65MJ?B#X7>*M7\?:'::'XTTG2KZ6"RU*[T;4)(+Q+6[FC@80$/N!*-^W__
M  6;_P"#?O\ :@TK]EO]I#]M3XF?\%5/BY^UGXM^$?@Q/'OB_P !_&+P#<>!
M/"'B?PG\.-/2QNCIUKX4\<:_X?B\4Z)IRJWAM&\+6MKJ&H!I;W5+4S2W4H!_
M3+^PY^T3KG_!7'_@DGX3^,WC[X=^ O#WB']I#X-_%SP9KG@/657Q'X"?QSI6
MJ>+OALNJ :O9W M_">I>)]#M_$UEH=Y8:Q>^'[>:SMQJ&J76E)>3^N?\$DOV
M3_BA^P__ ,$\?V8/V3?C+?>"=3^*GP<\+^(]'\53^!]6O];\+3?VU\0_&'B2
MVETRYU+3="OM2A72=7TZ&:6ZT;3_ ";^.X:/S<%YOA[_ (-C9H!_P1-_8Q*[
M[QXV^.\1M6B+.)C\=?B)(8T(WB-0I216=<,DZR;HB54_OLD4URZM&+,M$((;
MJT9@]Q#*'CNFMKB]A9I($MT:*>" [VG:13(JQL< '\?/_!ZC^Z_X)W_LOI'D
M(_[9&B!@26W ?!WXM$;MV=V-J@9Z !1A>*^N?^#2J-)O^",/PH209 ^,W[0*
MJ02CJK>.VW!70K(N=S9VL"<^PQ\C_P#!ZK_RCQ_9=_[/)T7K_P!D;^+E?77_
M  :2_P#*&/X5?]EG_: _]3N@#]]/VA/@A\/_ -I7X+_%;]GWXEZ/::CX&^+_
M (,\2^ /%NDW U%%O]+U_3Y88I/M.C7^EWT*1W;P7\B1WULUR\;0F93(['_,
MN_X-]OB5XD_88_X+U3?LM0ZCJ7Q#T3QAXX^-G['FM:EI.JZAX&T76M0\!:UX
M@;0/BSK7A&4W]IK.HZ4W@W5O[*TO66N+O2X_$^IFSU+[4CF\_P!3 HJ:I&&O
M3$[R.(+:5@KSK&!/.;<8S<@K*B2]K:%$ &X$U_E+?\$]IE7_ (.D/#5ND2,R
M_P#!1_\ :?,?D2_;4>TDUCXRA)(;QR6:VBABMI5#AI#&OG>9N9@0#_5YT]Y9
M+999LB27#,A _=LJ+$Z;U5/.'F1NRS;$\Q65MBC"B]5#35E6U43L&EWON ;<
M8P3E$8X!$ACVO(I Q([8 7 J_0 4444 %1R^9Y4GE*&D\M_+4ML#/M.P%]K[
M 6P"VQMO7:V,%)F*1LP(4@J 3C'+*.=Q4<YQU[\ G /Y^_\ !3O]LZ;]@/\
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MN[1/@OG81]PC<2I7!0X9<%5(_O)/0_0_RK^#7_@^'_Y)_P#\$X_^QQ_:3_\
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MZ9'J$NO^!)[..T^Q>-/'>B$6=]\/1JEWI][!9+KNDQ:E=RW&CZ90!_3-X/\
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MKA8-;\/:O9WFEZYI%P1/I6K6UU9W"QW<,T:_IQ>@M:7"A=Q:%P!P,$J0&RV
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M'AV]\3V^I:*++4[.T:XM_$.@Z1J\'VZVNTCO+"%E0(&1@#^MI0 ,+C ) QC
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M#?Q=_P""C_PH^%WQ+\=_#3XJWWP:UBQ^'7BSPEXSLO%%Q<^.K:ZMK+2+;3;
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ML(K*U>&SM[>"$ ^B$;<B-UW*K9P1U /0\CZ'D=#3J** "BBB@ HHHH @NO\
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M)=>\;:=JOC'2EL8X+VW\17MFCY@6"ZACE'EMXW9_\&\/_!;"Q^$GB;X61?\
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M>:&7]=/[(M%CC@A\VWMX4"6]O!*R6]KY:+'!]DA.Z.V6V10EO# L=O$O A-
M'\@GQC_X-P_BO\$OV6/V1K__ ()O?&_PQX3_ ."C/[)GCC6_'^J_M$>*X&\"
M77QLN/'NKRZW\0_".K:EX?L=1MD\(6/B2\NKOPOH7C7P[XPCNM!7_A$-6UF'
M2[V>2/\ (C_@M)_P5Z^-O[6'_!+SQ?\ LF_M>?L'?'_]EG]I[P/^T%\+K#QA
MXLN?!6NW7[.GBG5OAQ;:I:^-]5TGQW?6FGV7A_4->\7'5(O"_@_2KGQII4^D
MQPWEEXXU&)E(_P!'9=.MXTMTA,D"VP18_*8;V16W&.2217D=)#Q(&;+Y)R#S
M7)>.OAAX!^*'A_4_"/Q)\)Z#X^\'ZPCQZGX2\8Z1IWB3PY=J]O\ 9AOTG5[6
M[MD>%#(UO+"L<UO+-*\,B%N #_.W_:3_ &*OV5/@Q^QW_P $N_CE\,O^"BGQ
MW^/WQ5\6?M*_\$Z_^$D_9Q\>?M=^%/BM\/?AZOBC2[+6?%$FD_"+2E75O#H\
M#:M#%X>T R[#X2TBYGT:Z,DLP>O](2ORO^$W_!$7_@E#\#?B-X1^+7PK_8=^
M"_A3XA^!-476_"7B2*T\0ZM/HFKI;SVT.HV]CKVOZII<MW;QW$CVDMU8SM:7
M(BO+;RKNW@GC_5"@ HHHH _AH_X.H_\ @DA^WG^V_P#M1?LY_'S]DOX(2?'?
MPEH'P2F^%GBO0]!USP]8^(_#&O:3XX\3>*$U/4],\3:KX>LKC0-6T[Q19P:9
M<Z?J-]J#:CINJP7]G;6,5E)-_%]XU_X)4?MW_#7]H.W_ &8?B-\!?^%>_'2]
M^')^,EEX(^(OQ&^#/@&#4OAI<Z\_A:/Q#8^*?$GQ$L/ <KG7(;VSCT2V\0-K
M<4EG=3P:9+:VSR1?[9TEG!+*9G3,C1K$QR2&B5F?RV1MR;69B7PH9N 6(4 ?
MYFW_  =U:EH/A?\ X+$_LW^(_$7A'3/'WA?PS^S'\%->U[X?:M>WVF:/XK\/
M>'?C1\5-6U?PK?WMFJR6-CXJTVUN?#UQ<V,@O(8K_P R/;,EON /DC]ENY_X
M.(/V(/A:OP0_92^*7ACX2?"J+Q+K?BN/PEI?[0'_  3TURU;Q#KJV<6KZPU[
MXO\ B+XCU;SM1%A;"2W%['9)]F26"UBDEF+?0P_;!_X.LPFS_AJ/3\8(R?CC
M_P $TR_+[_\ 6'Q47SG@'=D)\@PGRU];_LX_""T_;!^#_ACX]_LS_P#!K#^R
M'\5_A+XK.H+I7B+1?V^-"L;V"^L+B6WU'1-=T;6-2TK7?#VO:=*L$EWH>M:=
M:WUO;7-M(ENL5[$X]SN/V!OC-;(TLG_!HY^S"\4<1FDDB_;ZT%E$:1-+*W_(
M4W*8 I5X2IFD<;($E)% 'Y&_&GXW?\','QU^$/Q(^$'QS^/6D^,_@WX\\&:Y
MX?\ B7X6/QK_ ."=6_7?!D]F\FN:>I\,^,;'Q%))<64,BA-(NX]1EY2!F=]K
M/_X)YZE_P=(1?L??"*+_ ()Y6_QF_P"&0$M?&(^#A\/V'[+UUH8L)/'OB1_$
MPTV?XA0-XLD9/&[>*/M+:KA/M?VA;2,6H@S[S\)_&7_!*/\ X*$_\$Z?^"KO
MB3P/_P $HOA-^R7^TE^R)^SMJ_Q)\%^)_!WC_P 9?$'28[74#-H^F:YI^KZM
M/X=GLO$^D>(+&^W:=<:#?Z5+I[V5RM[+*;FTC_K5_P"#8V%?^')G[$SY(VV?
MQI)C&WRW=_CW\2\2.I4DRQ[<1.&!16=>0<  _E^_M?\ X/9_^??]H#_P3_L2
M_P#R'1_:_P#P>S_\^_[0'_@G_8E_^0Z_T?** /\ .#_M?_@]G_Y]_P!H#_P3
M_L2__(=']K_\'L__ #[_ +0'_@G_ &)?_D.O]'RB@#_-D\5:?_P>C^.?"WB;
MP3XIT;X_:MX;\7Z#J_A?Q'I<NF?L8VL6IZ#K^GW.E:OI[7-I':W$"7VGWES;
M2SV<T%S"KAX9XI0LB[_[//AG7?!/_!GQ_P %&_!?BC3)]%\3^#_VO]=\+>)-
M'N7BDN-)U_0/C/\ LNZ7J^F326[RP/-87]M/:RO#++$TD3M'(Z%6/^C>8DCG
M:4+EY6A+,V6QAA$ G]T!68@#^)V/>O\ /WN1M_X-@?\ @LPN6;'_  4I^-PW
M,<LV/VG?V=QN8\98]2<#)H _O!^!?_)$_@__ -DM^'W_ *B.CUZI7E?P+_Y(
MG\'_ /LEOP^_]1'1Z]4H **** "BBB@ HHHH **** "BBB@ HHHH **** "D
M[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH **** "BBB@ J&XF%O!+.PRL2%
MV!(7Y5Y;EN,XSC/4X'>IJK7=M'=P/!(B.&VL@D7<JS1L)(9-O<Q2JDB]PR@C
MF@#\Y/\ @KC>W!_X)8?\%!VCD@MKMOV._C\%>3S!&C2?#G78=T60&E:3S0MF
M%!^T7&R-0V<5_%;_ ,&4LB0_M)?MOF-9E+_L[?"][>W$$<ES>2P_$34_M4]G
M Q+W!@NX[A5VH1N&7VE%)_HI_P""S?\ P2-_X*+?\%0[^]^%W@?]OKX?_!_]
MCN4>#=:'P+U3X9:S-J^N>--!LR-4U'QEXO\ #-[I]_XET"?6=FN:+X9OYY]&
MTB^M[*XM[".[LH+H?B;\$?\ @T2_X*$?LU>/-,^*?[/W_!4+P-\'_B7I,5Y:
MV?CCP!X*^)WAGQ(+#4DC74=+N-2TWQ)%)>Z5>B,176GW:36MW TD5Q$\,LD+
M ']]/]HKY$<PC=Y'$A\B*0/(/*D6-R4SO 7=NE7&^$9$@# BG+IL;233-*\B
M3[95MRV^VBF*KNFC4\DL55E.1CYL??->(?L^_#WXX>!_A!\/_#7[0'QLM_CG
M\8M.T97^)OQ-T_P%X:^'6E>,/%%ZFZ]?2?"/ABTM--T;P]HI;^S?#]F4EOKO
M3;:VG\07-]J33W$GT!$@BBCB&,1HD8PH4810HPJX51QPJ@ =!Q0!DI*--B^R
MJ!L166V>:4X:0L0!/._R)YUQ+%%"N2PW<@!17\2G_!ZWXS\-3?LR_L7^ [C6
M])MOB'-\=O%?C&#P'_:EE<>(Y?"$/PUUK1;OQ,VC)(TESH5IKES::3<:PH^S
MVUS=QVB.T\Y5?[,OBKX8\?ZW\-/B;I'PD\5:1X(^*.N^$?$L/PW\7:_I#Z_X
M=\+_ !!NM$O+?PIXA\1>'%DB7Q!HFDZZVGZAJVC;X_[8LK>:RE?$BD?Q+_M8
M_P#!K-_P4\_;D^*,GQ>_:G_X*G?#?XM^+8IM7DT2+Q!\,O'+^&?"%EK6H?VK
M>^'/!/A&#6(/#OA#PJU]MECT#0-/LM,A**ZVA<$D _7/_@UAEF7_ ((H?LN2
M'SFBM_&W[0:W%[/+$D%M;O\ &KQH^V!ICOF4A_LL36N1;W2312X>%D'S#_P=
ME_L9>.OBY^QK\+/VS_AAKUQI7C3]@_QIJ'CC49+9O#/A^^A\%>*[WP[!)XN;
MQ%J,UMKEWXA\#>+?#?A:/POX>T9[K^TKG7]0U$6PGA)/4_\ !*K_ ((D?\%3
M?^":7COP!X>L/^"F/@/QQ^R3IFO0OX\_9SE^&OBB\T>Y\+W6N:IXC\1P?#4^
M(=1OK/X;^*==UG6+R^O?$OAY;"]OI61=2DO+:-+8?TF?'GX!^!/VCO@]\4_@
M=\4-)TSQ'X$^+?@K4_!/B;3M8TJQUN!K2^M62SU%;'58;FPEO]%U(PZ[I:SV
M\D%OJ]E9W83S$+4 ?R7?LL_\'3'AGXG?LO\ [(6DZ/X(\,ZW^V9XF_:J_9W_
M &2_CG\)O'WB[5-.U+4/!?Q'BU31M2_:4^&]]9Z=)<>+89]1TS2I?%.GW\=H
M^A>(M;>/5MEC>Z#<ZG_5E^U1\#=)_:L_9N^//[-_B"_?P[H?QM^%WQ ^$]WX
MC32]/UK4/#C^+_#VI^'X_$^EZ7JJ/IMU>:*]X-3TXSM&T-]:Q2"6!XA+'_(K
M^PC_ ,&>FD_LY_MA^"OCO^T!^T]IGQD^$7PA\7M\1?AQ\.?"/A?6_!OBG6_&
MWACQ%::M\,[CQ]XEEU&>%=&T9[6WUSQ'IWAR.W.NZWINGZ>TBZ%+J$-S_;%+
MIDDO_+],$DD#7<#)%/;W$+*1<6WES*WE13DY)CVNF#M(W-D _P OW_@@#^TW
M8?\ !''_ (*S_&O]DS]KW5/#7PVT;QUJFO\ [./Q#\7^(/$UW_PC_P ._B#X
M$UU[GP?J+WFE/=>&7TGQGK<.FZ+J?BO4)(=&L-)N5O%U6&W$R/\ Z?L.JR7<
M2RV?V2Y@EMQ=1W4,XDC2WGC2XLIFC4EY$NK:161H2Z;U9BPB97K\G?\ @H?_
M ,$/_P!@3_@I3I>NW_QO^$^F>&_C#?V<D>D?M _#6"#PM\5K#4X- DT'0K_7
M]5M8A;>.]/\ #L)AFT_PQXQ@U;P\9(0[V0E/F#\S-+_X(2?\%*O!?A]/V4?A
MY_P6@^-NC?L R:OX59M"O='=_P!J70O"&B^!['POJ/@'P?\ %FT,=EX=\%SW
M-M+%9^$=.CM/"KZ5)&^J:+?:D;N:\ /P<_X.L?VYOA7^W7^U+^S-^P7^RCK6
MJ?$7QU\$?B+XE\%^/]6TG4K:W^&.O_&3XKWO@WPSH7@C3KE[B.QUC7/!%QII
MAUGQ*K2Z)HUWXDU#2(KU;S2M:6/^V/\ X)4_LI>+?V(O^"?7[,O[*?Q /@N7
MQS\*_ #Z9\1M1\*P-_PCNJ^-]9US5M9NK6"_DAMI-9OM/CU*#2M6UG:XN[S2
M1]F=K*2#;\2_\$V?^#;O]@;_ ()P?$6R^-VAP>,/C]\>_#]]K=QX)^+'QDN[
M&ZN?!-KK5AIEBT.@>"]"M=.\%6^MV!L]2GLO&TNDS>+8QXDUFT&I):R1(O[\
M?8[F19//N(S(1<)%.D6&@650$=(FW0F9'W$NRG<, ]\@'\YO_!U#]GD_X(D_
MM+V7DRQ);^./V>5BBLTWB*5_CCX)^RHQE.'A:=$61H6=@LH9,_*#^;'_  96
MS6</[%W[9,<?VB;;^U+X>,<<=NEQ?Q1R?"CP\B3W=JF\6]L8Q+$UU(%M_,$Z
MK*=I ^K_ /@JK_P1(_X*H_\ !33Q]X^T#7/^"F_@3P5^R1J'B34KCX>?LYVG
MPR\4:;H>F^%$UVS\0>%K#XB6_AG5=,T[XC>)/#.H:?97&F^)?$(O[W3KB!9=
M+:S0^2OP-^R-_P &MO\ P5#_ &$_B+#\4?V5/^"JGP^^$'B9KO1[G7;;P_\
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MOAO=Z'<_$WPM'>^%M#U[P^/'S:IJ>A:M?:[;V;QV+VU '\Q'_!EU);K_ ,%
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M_8#\/_LD?!KQ7H$GQ-TOPQXNU75?C1+X+TS3T\2_&WQ597CP?$#Q'H%B(_\
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MK48P8=0L;L36NH0,\-W \4CQD _OSM+W[1<7=O\ NV-J8E=XMY17DB60POO
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M^&=0@CBDATGQ)9B#QM\/_$VBS1?;-#\1^"]4L+IS<WEIJ/FPO;R6P!_G$?\
M!8 VUS_P<V_$&X:ZMWAB_;)_9!2\EMIX6BMX[;0/@19LAFD<1+>0NDRWD$C+
M]FEMYQ)M6)]O^KC)JHCF:**+[1*Y9<HX6.'#,\+S[\.(Y+7S;H2(&22.%A$6
M+Q!O\]WQ+_P9>?M?>,_%&M^,_&'_  4+^$WBKQ5XFUN^\2^)?$FO_#_XH:EK
MGB+7]4NI=0U35M9U*?Q2U[>:AJ=[,\U[>M<_:9'Q,KK*TF[]@M/_ ."4/_!P
M5I/[..B?LNZ/_P %H_AKH?P^\.^&]'\(Z/XHT;X':S9?&.PT#0]1AO\ 3+.#
MXR0W$?Q%$EI#;PZ-'>?\)"+XZ!$ND&Z%HSHP!U/_  =A_M-0_";_ ()D:=\*
M(K3QAHOCC]ICXZ_#/P+X*\1^'==BT&/PI>> ?%ND?$[6M5UO4K>^M-2_LC5/
M#_AB^TBTDTDO(E_J-M->&&UAFS]<_P#!;_\ ;*MOV.O^"9GC^Y\.^)_$6@?'
MCXZ>#=$^!G[.]IX8\0:=HWC*+XD_$#0[70+77?"/]I3)+JUMX2COAJWB]M&6
M]U*RTF1KF-(W=)5_ /XZ_P#!J+_P4S_:CUWPCKG[2_\ P5JTGX_7?@1'M?"=
MW\6=#^+WC2YT&PN;RVO-0M=*&M^+;S["M_+:PO>>1,KW+11&64E59?O;_@HE
M_P $,/\ @J[^WA^T!X3^*<O_  5 ^'G@/P/\"/&NM>(?V4_!N@_"KQ+X8U+X
M-6%S>K)H>H?VMX3U&P.L_$'2=,M['2I/'-V9]:GM[.,0W5O"?LZ@'8_LQ_\
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MO;:S\,]>?61!JT6MZ'<V&IHRR&&ZM7<JP!\<?\$&+V&V^,7_  7)+K/([_\
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M3;:YBLU8K"#0!_GH?\'-/_!&J_\ V//BYX4_X*6_L)^#?&OACP5KGC.?QO\
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MV<2/^V)K*'?+'()HS\'/A8D2S6ZLTLL#2F9;?]VL=S+N6)V:&39_5O8?LZ_
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MS3KM8YK>05_,%^UA_P &LO\ P4[_ &X/BA<_&#]J3_@JA\.OB]XS,NL'1O\
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M^)/%.H1:3H7A[0M)BDNM1UK5[NZ*0Z=:V%M!+=-=W#)&(%$NX(2P_'C]E?\
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M/^^?AK_\S='_ !!;_LF_]'R_M@?]\_#7_P"9N@#^QW_A)-%_Z#>B?^#2Q_\
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M!MY&C92&P0 ?WJI._F,/(?S"B/*H9"L3$8$18':S[<,=I(P1CWF\V3_G@_\
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M5)['0? FJ^&D\6:M-;VUS:^()M.L_!,J&7Q/;Q2_!7_!LCH_PY_8:^,OQ_\
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MI.X^A_F*  =!]!_*EI!T'T'\J6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#T/T/\ *EI#T/T/\J /YMO^
M"G?_ "G6_P"#>W_L/?MX?^J,T:MC_@CE_P I&_\ @X+_ .SWOA-_Z@'B2L?_
M (*=_P#*=;_@WM_[#W[>'_JC-&K8_P"".7_*1O\ X."_^SWOA-_Z@'B2@#^C
M*BBB@")_]9']&_\ 0HZ_B\_X-*_^2X?\%M/^SM/"7_J7_M&U_:&_^LC^C?\
MH4=?Q>?\&E?_ "7#_@MI_P!G:>$O_4O_ &C: /[2**** "BBB@ HHJE-J%I
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M -G<G_U3?PTK]^/^"SW_ "B,_P""C'_9G7QJ_P#4&U.OP'_X,G?^3!_VM?\
ML[D_^J;^&E ']H]%%5;B]M;7;]HF2'<5"E\A2SRQPJNX KN:6:-%4G<2P(&
M2 "U15)M1LUED@:=1+%C>I5^"RE@%;;M<X4@A"Q5RJ-AV5386>%E1UEC*.H=
M&WKAE/1E.>0?44 2T57EN[:!/,DF0*"H^4[V)8A0 B!G8DD=%..IP 34VY<[
M<_-SQT/&"2 >H&X<CCF@"*Z_X]KC_KA+_P"BVK^;K_@Z[_Y0F?M$_P#92/V>
M?_5T>#J_I%NO^/:X_P"N$O\ Z+:OYNO^#KO_ )0F?M$_]E(_9Y_]71X.H _2
MK_@D#_RBR_X)U_\ 9F?[.G_JL= K](J_-W_@D#_RBR_X)U_]F9_LZ?\ JL=
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M$.K.MC-K7A"SO8[&\U#Q)9:=H][K!TJ\N;9_QF\ ?&3_ (-G/BSHA\5?"O\
MX(4_MZ_%+PO<:K>:9;^*/AQ\#_BEXR\.S:G;!)[S2XM4\/\ [1USIRZA8B=1
M<:;#(TMK$82PVNIKMI]6_P"#>J&&>5?^#=[_ (*8[H8W=O/_ &9/C?#"BJI+
MF:7_ (:#D\A%4,6E,;>6 7QQ0!\P^ ?VUM,_X*#>$/\ @X,_:EBTR;1?%?Q
M_P""1?[-ME\5=)CT=M"T73OC#X,\)V7A+XFVGAJPFU#5;E_"Z>*M*OO^$<O[
MV_GO+_32M[/Y3W'DQ?U._P#!L9_RA)_8I_Z\_C-_ZOOXFU^ O@_]HO\ X(P?
M&O\ X)M?\%G=&_X)<?L@?$;]FOQMX=_8?U:\^*VN^.;+4+./Q3X3N=8NK;P]
MIEBE]\6_B4WGV.LQW\UU_HVE/M6-S/<;C;VW[]?\&QG_ "A)_8I_Z\_C-_ZO
MOXFT ?OM111GZ_D?\_X]J "BBFLZHI9C@#J<'ZX  RQ/8*"2>!S0!!+_ *Q?
MK%_Z.6O\_2[_ .58/_@LU_VDJ^.'_K3O[/%?Z!4C!FC8=#Y)&00<&9>H."#Z
M@@$=",U_GZW?_*L'_P %FO\ M)5\</\ UIW]GB@#^\#X%_\ )$_@_P#]DM^'
MW_J(Z/7JE>5_ O\ Y(G\'_\ LEOP^_\ 41T>O5* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ I.X^A_F*6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT_[.T\)?^I?^T;7]H;_ZR/Z-_P"A1U_%Y_P:5_\ )</^"VG_ &=IX2_]2_\
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MS0!GM;C<"K_S'_\ $)?_ ,%D/^DCOPB_\/-^U'_\P=?Z+M% '^=%_P 0E_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML]W,YN+N>'3[<_:+F,4 ?GS_ ,%GO^41G_!1C_LSKXU?^H-J=?@/_P &3O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJA;3TF\/Z9J]]J4\9>P$,@!^M_\ P5'_ ."5WB+_ ()I:7J'_!3W_@C8FL_
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M ,]^@#^T"]4M;2*%9R=@V(,L_P"\3*CYX\;AP6WJ$!+G(&#_ "$:7X5\3_\
M!Q3^W)\4-.\?^)KG0O\ @CK^P;\7(/#.@?#?PC!XP\/VG[;WQFTR8W$U]XRU
MW4=,\/QW?@?PMJ6E30ZOHECYUYHT9L].LS!J'BF+Q)I/FW_"S?\ @]%'_-!/
MV36]OMO[.W_SX!TZ]:_7?_@@%^RE^T_^QM^PGJOPR_;#\$V/P[^-7B']H_XV
M?%G6?#>@:]X9\3Z2]K\2=4TK5;6[MIO".J:WI5K;/<VFHFVTY+UWM(?*#888
M !_/[_P6/_9-_9N_8Q_::TGX/_LM_!SP9\%OAU:?\$7?^"HOB0>'?"=A)NO-
M>U;PSXCEOM4U?6=5GU'7]=N2RK':'6M4U!--ME2STY+6T181]'?\&3O_ "8/
M^UK_ -G<G_U3?PTKU?\ X.$_^"?O_!3;]JW]I;X2?$W_ ()__"/PG\1= N/V
M-OCS^R[\5=3\5^,OAMX<%GX<^.M_>V'B?3M,L?'7B;0)X-7G\*W\@TO7K2*Y
M.FW9$T:>>B _D]_P3M_86_X.H_\ @EY\+_&_PA_95_9T^ >G>#?B#X]?XC^(
MHO'?CG]GKQEJ4GB5_#VB^&6>UU&?XH64MO8_V7H&GJMD5DC2X%Q.A5KB0$ _
MT4:*_BU_X6;_ ,'HO_1!OV3?_ W]G;_Y[]'_  LW_@]%_P"B#?LF_P#@;^SM
M_P#/?H _M*KS_P"**@_#WQX2,E?!'BPK[$^'-6!('8D$@GN/I7\>O_"S?^#T
M7_H@W[)O_@;^SM_\]^L[5O'G_!YUK.FZEHU]\ /V3I;/5M/N].NR+S]G4-]E
MOK>:TN$1F^+S)N>&:1?FCD S]W!(8 ^)/^#:_P#X)A_L8?\ !2C_ ()=?M*>
M$?VJOA+;>*]2\-?M;^,--\$?$?PU<1>&_BGX @U;X0?!^ZOF\*^*H[6ZCE,D
MMH!:Z;XDL-=T6VGN[N>VL+>YO)IVU_C!_P %&OVZO^"%M]^T!_P1Y\'2>,/C
MQXW\5^(?A1I__!*7XL?$P^&VU7PA\&_C5=:[X=U./7KP^()XM:NO!?C&VA\#
M_#+2?$Z:9:6/B*RUOQ#J0TWP=;Z'X8K^@;_@W0_X)L_%_P#X)K_L'ZE\-/CT
M+GPW\;OBW\8O&'Q<\?\ @C[?X;UO2?!%W!!I?@?P]H>B>(?#6J:KI?BW3=7\
M%^$M$\5ZA>I=)]@U+7+G21O.G+))]7_M;_\ !/>/]J/]OO\ X)[_ +6E[K_@
M_2_#7[$)^-_B/4O!TWA>VU[QG\3/$GQ)TCPSX?\ !>F7LUY;"PT[PKX=BTO7
MM<BU:\NKFYTO6YK*?2;*&:XN;R, _(<_\$&OV3?V1_V OVQ/VG_C+I'B/]I/
M]N_6_P!C+]HCXC^._C?\=[N+Q%J?ACXP:C\!OB%'XMN/!?A\7-WHUB\4^NSV
M@O-5NO&4RW^C6NM^'-6TE5@B3Y!_;X'E_P#!FQ^SA*O#GX-_L6Q$]04?XG^%
M@PVG*Y(=L-C<I(*D$*1_6]^VI\.?%OQC_8V_:M^$W@FUMM3^(GQ5_9R^-'PV
M\+Z9+<P:39:MXR\<_#CQ)X:\.V$NJ7KI906WV[5(+:XN&E6&$GSG<9 K^%'X
MF_\ !/[_ (.COC%^P!X8_P""9WB_]F[X&S?LP^!]!^'GA+1;"P\;? '2/&JZ
M9\*=9TW7?";OXPF^)8GNY?[0TNTDO[R.S#ZC!]HAE,1GE) /[3O^"0/_ "BQ
M_P""=?\ V9G^SI_ZK'0*_2*OAG_@G7\*/B3^S[^P?^QO\$?BAH5IH_Q%^$'[
M-'P<^&WC[PY8ZOIVL'1_&GA#P7I&BZY9P:S83S:/J%E;W%K,(KNUN9([E0LD
M#.K#/W-0 4444 %%%% !1110 4444 %%%% '\5'_  2ZF^S?\'4W_!9R9R T
M'PG\5W(6/S)%D2+Q9\ &V.B(US+\C*[P6T,DAF0",LJ#S.R3X:^*/^#F;]IS
MXXQ_$GXH>,_A[_P2&_9+^(FJ> ?A;X-^%:^)?"GB']K/XJ6L-[;Q?%/6/$_C
M+PE!ILGASPS?17!.CKIFIW/AZ[2TT V%G?:A+XAMOFOXT_L%_P#!?/\ 9N_X
M+!_MS?MX?\$X_@;\*/$&@?M)ZGJ_AW0O%?Q!\8?"+5;'4_ -W)\/]3N#'X?\
M5>-M O\ 0-5;7O!]OY4]PL,KV45W;@/%*V?WQ_X(#?LF?M+?L;?\$\]%^!O[
M5_A.S^'_ ,:E^-'QM\=ZYX>TSQ'X>\16T>F>//& URSU&PU;PKJ&L:.J2O<7
M$MO;VMY*D3LHDP1@@'YA>/?V6OV??V-O^"V7['7P6_9L^$7A/X,?#;1O^"4?
M[:VNW'A_PQ9S1_:-8UO5?'MYK6IZAJFH7FJ:[K=])?%C$^L:M?"QLFCL].EA
ML8(+=/G;X,17(_X,J_&<<L4\1D^!GQANO/(B5GB3]K?69(%?YWE=)[;Y(G91
MMM80A\N,6^[[2_X+/_LF_P#!6[QE^W_^SM^U_P#\$SOA3\-_'.J^!?V1OB/^
MS_XQUCXB>(_AWI^F+-\1?%7B:?7]%MO#7C_Q1X9OKV>;PYJ%K<V.IVL<EE:2
MW$\,DIV31'^<ZQ_X(!?\%1[+]EJ_^!-S_P $VO%$WQ1GTC6=,7XPP_\ !2_P
MQIG@&VFO_$<NO6MPW[/T.L_\(!<6%AI<T6E3:9_;OV+4K^-]9>5+[SK6( _T
M3_V*,']CK]DQUD+*_P"S%\ ]J9!0*/A;X7(D48#_ +P, 2W!"# !!KZ>KP#]
ME;PEKO@']FO]GWP)XIMK>S\3^!/@;\(_ OB6TM;JVU""T\1^$/ 6A:%KUE#J
M5G))9:A%9:Q9WMJEW9/):3B+S()75N/?Z "BBB@ HHHH **** "OX:_^#RK]
MB'X*?\*2\"?\%$A/XYD_:#L?&WPE_9DCM/\ A([-/AW;?#>6S^,OCD7I\,-H
MIOY?$[:U+)!_:,7B".#[&\:2Z<_D"0_W*5_G\_\ !Y=^WQXC&L?#_P#X)JCX
M9Z%)X7GT/X7_ +5G_"UU\2:@/$T6K)>?&?P,_@Y?"7V%=,ETDV]E%J<FN?VC
M+=P-YEN+6&,F28 ^D_\ @G!\<_B?_P $3_VV/@M^PA^T-\0/%U__ ,$\?V]O
MA?X%\4?L!:GXIU6+XBWW@;XT^)M+^'0U;P3J^MV]OI.M^#M!UOQ;XMO-(OM$
MT_PQJGARWUWQ5X$OM-NX(/\ A,=3'Z@_\%QOVZ_B'I&F_#;_ ()>_L;>)/#&
MK_MJ_M^:[=_!6Z9=2\;V_B/]F[X0>,+2YTGQ3\<-8C\ :9>:WX>L]/TV:Y&E
MZ_=W>ERZ-I@N?']I;:OI&D3"O+_^"VB?L=V/_!#+POXX_:H\'?VYXK\'_!3X
M&M^RY?\ A[Q!H_A;XM^'OV@]8\#^&K/P)K?PNUV[OM.UB5= OYCKGQ!T33'N
M;G4?A_HWB68:?-/!:2P_FQ_P:GW_ (%\8_M#?MM>-_VB_$?Q^\1?\%7GTJRM
M?BSI7[06FS:4-.^%QU?1[>RU+0KV^2;6U\2+>_V/9>)(=871M1L]+G@L]'TN
M\T.XNKP@'QGIO[#/@G_@G$G_  <;?LD>!/%WB7Q]8_#[_@E=\ ]2U_QQXI6.
M'4?%?C?QCH%MXL\9ZY%8PKLTS2[_ ,1:Q?R:/I?VG4I-/T[R;:XU74;A9;R;
M^G__ (-C/^4)/[%/_7G\9O\ U??Q-K\9/^"ADT!_:Z_X.C66=9HX_P#@EO\
MLQ6XE,H9!(_@'1D6/S?XI9)65BG\4[/&.U?L9_P;,W0B_P""(G[%I25XW6P^
M,P7;"LI#/\?_ (EQ+,Q8K&J1.QW*S#<I7<5;B@#^@6BLR.X?[1%$TYEWQ9_=
MVV8V:'Y)7DN%)BB>1F5D@W;@!A<\XTZ "BBB@"M+_K%^L7_HY:_S]+O_ )5@
M_P#@LU_VDJ^.'_K3O[/%?Z!<O^L7ZQ?^CEK_ #]+O_E6#_X+-?\ :2KXX?\
MK3O[/% ']X'P+_Y(G\'_ /LEOP^_]1'1Z]4KROX%_P#)$_@__P!DM^'W_J(Z
M/7JE !1110 4444 %%%% !1110 4444 %%%% !1110 4G<?0_P Q2TG<?0_S
M%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !5.ZNUM6C,F=DBRA56.1Y99E7S$AA"Y#2NBR%8S\T
MA7Y.AJY5.ZLQ<F-Q-/!)&1M>&1E^7S(Y&4IGRV+^6$+.K%49PA7<: /XY?\
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M6O\ C?QS#IFNWNH:MHAU_6IY)X] -]]BT2WQI]A;VL4?EU^C"!E&&8N<DY(
MQDY"C: ,+T'? &23S0 ZBBJTUP8I88P@?S!(3A\.!&N[Y$VGS">F-R]N3TH
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M>SUK2X=9TOQ#XI\0>*+Z'2]$\,7]A<V\EMK\TLVGL\J1B0NP%='X[_X.@?\
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MB-;_ !"N;OP[/H_@_P 1>"[G4;^32(DT.]\0MK_VGR+S2M8TNTLOWHGF\O\
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M^3$?F>7:#\I!K^-K_@T^_P""E?B[]H'X+^(/V%/VC_'OBCQ!\5_@QHEMXZ^
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MM2U[P\J6GAO3)[O4I[:T\.+'9QP1D1M7]X>E[#:Q2 *LLMO9O.NU4E63[)"
MLRC+*X0+A9&9E7"@E M &E115:ZGD@BWQ0^>^X#:9!$JH/FD=Y&#;0D89@ K
M%F 0 ;L@ DF=T3<AC7#)N,I(4)N <Y&,$+D@GC(YXS7X*?L0?\%M?#_[8/\
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MX^FJ^]:$'D+_ 'I?^_C?XT>0O]Z7_OXW^-2LQ&, G/I5=YY%?:(6(_O?Y_\
MK4ON^;2_-CBN=N*W6KNU%??*R?R;'F#'*22JP(P2Q88R,C:W!R,CU&<CD"JC
M:7;/''!(HFMDZQ3J)B[ L49I7S)E"QV\]..E7?,.Y1M/.<GL/\]Z7S/;]?\
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MVUOX6ZCX:7;X>^)6J16LSV]MHWB.WEO?%'AB*[\(:>UQ>W]I"?Y7O!G[4?\
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M+R_UKX?Q6-OJD\:M9V-S<3V5XEMY[V[W\EA<FVC(+JH!_8[_ ,$^_P#@K/\
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MW_J">%J^D/\ @WC_ .4A7_!2#_LRW_@C=_ZQYI- ']@,?W%^E/ID?W%^E/H
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MJ&#_ $1;9E:"(H_F+MQYF"-Y!(9\$ _,P+=,<_+D8)_EE_X-B/\ @DE\0OV
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M7OB3=V\/@[]J3Q%HNO>%+C4O 5Q\.O!'BSPU;>&?"?V%-%BU%UOGBL=,U/\
MM7P]I']VU !60MPCWTRJLI:.XCC/[J10S"V+-L=E5&5 /F<-MS\JDMQ6O6/<
M07VV0Q;566XE\](6(N);=@%B>&65]D,\8^9AMVMT&#S0!_F0?&S]K'P/^R/^
MU;X[^/VL)H_C*Z^"G_!R5^U;\6]3^&J>*]/T7Q#?^#;3X=>%+*3Q1Y<4&J:K
M::+:W(E,&K#2KS3+^]L7TV(R3ET'^EWX$^(/A#XA^ /!WQ,\"ZU%XK\%?$'P
M=X<^(/@_7M,M[F&W\0>$?%FCV6NZ#KNGV5]';7T5IJNDW]MJ4,%Q#'=1Q3JD
MT*3'RZ_AD_X.8_\ @CG^U%XJ^)WQ+_;*_8C^&%OXV^&7Q;^'V@:W^V9\._#!
M\*7OB/3?$_P11KOPMXVT/P?+H=IXAGTN_P#"\=K>ZSI_P^U34_$WB#Q>NM:K
MKFGW>FS0L_\ -U_P2W_X+,?M\_L6^)IO#7PM_:,T"3X=1V?]NZ/\"OVBKGQ#
MXG^&WCSQ/<ZIX'\)P>#?!VM+'<3_  [\276C:=#;^&M=US7_  ]\.O"&DZ?K
MEWJLBW#6JW8!_L'+?Q2-"(XYI%G42"4!%5(F3<LLB/(DRHQQ&/W6X2':R@YJ
MQ#-YR[O*EBR,A9@JL1DCHKMZ=\=1^'\GGP8_X.BOACIMSY'[>'[*7Q6_9HTJ
MR^+6K?"C7_VCOA#JFG?M/?L;>'M17P3IWC;1M(/Q_P#AQ%=VGBKQQ?K++!>^
M$/ VB>(FTFW>*_FNB$U);/\ H#_92_;G_9 _;'\.:=XG_9F_:(^%/Q:35_"[
M^.;KPWX6\564_CO2-!DU)-+?6?%/@'4+F#QQX-MTOF@L9;7Q)H&ER17EQ#$R
M(\T2R 'UU?.\<*LBNP$T7F>6VUECWC>_ +-M'\"%78X"L#S7\6G[(O[!7Q,_
M97_X.MOCA\1;7X<?%M_@1\:_@Y\9?C)X4^+OB329-2\,:SXA^*6F>%=:\:Z5
M-XIT2RAT739-+^(C>+] TO1=>:VU^:VTRSO'BU"*ZL]6N_[0M0>VF6*TEN3
MTT@<1%O)>\BA)>:VC+[2_FH"'6-@XC.\$ 9K*TE9X)A&FYM/G NX8I)9I;I)
M;B>20;IYF17M[>V^SKY$0D,!VQDR;-[ '54444 %%%% !1110 4444 %%%%
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MT5]SEQ..P>#7-B\30PZY9SO6J1IKDIJ,JDO>:]V$9P<GLE)-[G^IM_Q$8_\
M!%$9_P",^_AESP/^*0^+Y'KD_P#%NNO8<CVK[(^$W_!2_P#X)\?'7P#H_P 3
M?AE^V;^SOJ_@S7I-2ATV^UCXH>&?!&I22:1J=WI%^EUX:\=7WAKQ/IICO[*X
MCB_M/1K07< BO;3S[*XM[F;_ "NKC_@WG_X*\^=($_90D,:LPC,?Q@^"]W&!
MT^6Y'C[;,O7$B!AC@9Q7]!G["G_!L3^S5XG_ &7?A]KG[=/@[XV^"?VH+V]\
M6K\0/#'A#XO>%E\/Z=8V_B?4K?PB]D-$T3Q-IHDNO#$>FW5WY&MWF;J63S1
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MRL?!G'X ^/A6+RG,I*-2A@,;7IR;Y:E'"UITY*-KRIRC3:DNNE]+7>YZ-3Q
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MD=-_X.'_ /@C!K.I:;HNG?M]?"Y]0U>]L].L$E\,?%6S@DO+ZX2SMHY[V\\
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M[#4((KFVF1;[3;J[T^X0)-;W4L$L,CY'_$1C_P $4<@?\-^?#3_PCOC!_/\
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MG))I.I^)!K5KX6UK3]6BUZ!K>1DD6*  _P!0?X=?'#X+?&"35H?A+\7OA?\
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MPK_^:NC_ (;9_8S_ .CM_P!F/_P_7PK_ /FKK^>__B#J_P""0_\ S]?M6?\
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MXY?$BX^-/QU\+Q_$;4/$_P 3_"E[XB\+>$?&,6E>&[G^R/"7C?P]IT$$>FM
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MT+XY^$OAY\,]70:!I/P^^!?B+P[IWA2UU/PU#!:P2:O&VE@:8MC%; '[,?\
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M\'BNQTKPO\4O#6M/XFLI=4\+6]KX@LO&C6AT/78)3/X6OK^Y2U,G]=O[(_\
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MENMN6>SU72-6M;@)J-KK.CZU#>:3KVA:G!;:GX;UBRNM'U.W@NK62-?X0?\
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M8I=[AHY!^U?XSDWPJI 201I)&SD@.DK _,B5_HT5_G(?\'+G_*Q#_P $[/\
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M V!-(I+E9UCC#Q&-=I\O- 'X(_\ $+W_ ,$0_P#HS<_^'T_:%_\ GG57NO\
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MEXJTOX@>(O#WCO3-/NDD;1/^$;\->#=&TK59K>\BM[V&]U.>5;J[MI_LEO\
MV,6+M)!N> V[%V!BYVKM.U0H/ PH"N% 42AP,CD_Y8?@7X&_M]^._P#@O1_P
M48_:"_X)]^!=(^(/Q*_8U_:P_:0^.OB;PSKGBB\\/:5XMT*R^*'B2"/X83V>
MGW^G7OB:_P#B@+74='T/P^MS#IE_>Z9(-=N;>V2V6X_OF_X)^_\ !6+]E[_@
MH)\)_ OBCP7X[\.?"[XRZGXAO? /CS]E7XF^,-%\)_&WP#\4?"=@B^-/ /\
MPB6LS6OB+QBFF2QS:C8:OI.EVGVW1MLM_;Z5J]GK.C:< ?K%15"S#++=JQ \
MN1(XXUG,RK$$#HS(RK)!*[/(61BX,8B=7(; 74)DB@P]P;82GRA+&P6=6<84
MPYCE7*M@NS(R1QAY'&U20 >>?&[PWX8\8_![XG^%?&?AO0_&/A?7O 7BS3M;
M\+>)='L]?T#7[&70K]IM,U;1=1CEL-3LKE4VRVEVA@F&%;!P1_ C_P &Z6HV
M-U^V5_P2.L;?5=%N+[3?^"=W[>JZEH.E:M8W]WX8^W_MA?%/4K'3-7M(Y9-0
MTJYFLKF&]@T[5%2^-M)'?)OLKB*0_P!7G_!8_P#X*+^$_P#@G%^Q/\;OB8_B
M'PC<?&NZ\&/X?^ WPPUBYT;5]9\4^*_%EU'X6T+5KOP/<^*="\1>)O!NEZO?
MH?&.H:/YDFD6$<SK!=OMC;\BO^#5G_@E!\0/V./@GXT_:_\ VEOA]+X-_:'_
M &FKK3O^$/\ #?B5+*3Q+X)^"*+)?:9>ZGH<_AZ+6_ 7C#QMK-YJ^HZCIJ:[
M)%=^$3X7@UO3M+U:WNK*W /Z^**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q[XP
M_$WPI\$?AG\4OC?X]>ZM? _P=\">+_B-XTBTRS35;YO"O@S0KSQ3J^I6%CFT
M^T:O'8Z5.;:S-Q^]:)8O,625&7^;&+_@\%_X(_Q((E;]JDI'E(S_ ,*6T[_5
M@_+DM\1BSMR<NVTGCY%Q7]!G[87PHU_X_?LM?M-_ CPE=:/I_BWXM? GXM?#
MCPQJ>NWKC0=(\3^// FN>'O#.HZ^MO!=7<&E0ZK?03WGEV5XWV>)S%:W1)2O
MSX_X)]_\$F?V:_V1OV ?A!\$?BA^S7^S!XR^,G@GX4W3_%OQNOP]\-_$J/Q3
M\49;">X\4>(K/Q9X^\+?\)'=V=_?A9[2UN+33;;3X1':6>F6=O$D5 'Y_?\
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MXI^&'B/P3X/\%>%+2RU'6AK@\7V/C35_$.IP77]DCPW;V:3PZ<RP@'YSW_\
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MX<T*+4;R.5M,L?MFL^+H;%-1NX8I!:Q(?.NO*EEB0(C%/YJ?V1O@SX2^.?\
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MDL5!8%]!UF0#=C(!W#(_V%ZX!/\ ;I_P:: #_@BG\"" !O\ BA^T(S8'4_\
M"W/$JY..IVJHR>P Z 5_.W%>+EC>(<RJR2BZ=7V'*G?W:'[B#;LMXP3MK9O<
M_P!G?H_\/0X>\'^#:-.M*K'-:5;B=RE3]FU//8_6ZE*-I3YJ=&K6J4XRO'FY
M.9TT]3^DVBBBOGS]E"D/0_0_RI:BG9DAE9%9V6-RJH%+L=IP%#O&I/IN=1ZD
M4 ?QA>#O^5TKXK?]FBZ=_P"LV?#:O[0J_P Z'_@H-^V]/_P3V_X.RK[]H#4-
M'36O"C^&O@!\,OB%96>DOKWB2?X?_$GX/> ] UR?PK82:SH%LWBR*![8:3)<
MWKV-O FRX@NIB0?]#V3$>RUO);A1/-]GAN Y::9KJ;SXH;8P!=L=HN(Y+B:$
M$(GS,02S@'#^(OA[X"\97U_K7B;P9X5UW6CX7\5_#Y[OQ!X?T;Q%>P>!?%SZ
M;)XV\+K)J=A-)-X6\9?V5H8\5^'O,DTS5(=-LQ<12RVR;/%O#'[%7[&/@/2-
M.T[P/^R7^SCX<TS1/%VB_$K0+#P]\%_A[X=M]*^(_A2*YB\/?$"SN;;P_&^F
M^*M%%Y-;:)XJAVZYH]O/+!93QQR.&_AK^(W_  <G?\%U9_C%\<O#OP _9!^&
M_P 4?AW\-/CE\6/A7I/BCP?^RG\=/B!;E/ OC34]#@TS5O$7A#Q]=Z3<:XFE
MVVE7&JBW^Q[[BZ\Y+6&%X47F7_X.0?\ @XWD#JO_  3T\.M$S'*G]B']J&9&
M(.&)9?'&R3YA]X#' Y.,T ?Z-FFI,EN1/=RW<K32NS2B+,)=MWV6-H885DBM
M\^7%*R&210'=W8DU^3?_  7I_P"4/'_!0K_LV_Q=_P"END5_'S_Q$B?\''W_
M $CWT'_Q!_\ :D_^;JOF3]L__@NS_P %T?VC?V4OCW\#_P!H_P#8JT;X>_!#
MXE?#K5_#/Q'\:0?LC?M#^"Y?#WAR[DM7N;^/Q7XG\6:CX?T%DDAB4:CJ]I+9
MPEAN <H: /[/?^#:+_E"-^PS_P!BS\5O_5]?%.OW8K\'O^#9K'_#DC]B#Y]Q
M_L#XLY7:R[/^+\?$_P"7YB=^  =Z83YMNW<K$_O#0 4444 %%%% !1110 44
M44 %%%% !4<O^K;\/_0A4E1R_P"K;\/_ $(4 ?YS'_!S]_RG[_X)T?\ 8B?L
MG?\ K57Q"K_1KK_.4_X.?O\ E/W_ ,$Z/^Q$_9._]:J^(5?Z-= !1110 5_G
M)?\ !RTK/_P<1_\ !.M$5G=_#7[&BJJ@LS,W[5'CH*JJ,EF8D   DDX%?Z-M
M?YG?_!VEX.\6?$7_ (+6_LL> / >JIX?\;^./V?OV?/!W@_Q ]_=Z3'HGBKQ
M3\=_BCH7AW5YM6L!+?Z9'INKW]G=_P!HV47VNR,8GMMTZ1@ '^F",[W.."%_
MK3Z_SC&_X-IO^#AV5W,7_!0[PD45C'\G[9G[5!^:,[6W!O TA60XRZ;SL8E0
M  !7YS_\%*/^";'_  6Q_P""6?P?\,_'#X__ +9WQ%\;> _$_B[_ (0IKSX+
M?M*_M)>,9/"VIS:5>:E8ZEXQDUC3/"=AH&AWLMJ-,LM1GOYA/K-S96(MV>X7
M(!_K%T5_C>ZU\//^"FVB^%_%?BN\_;;^*Z67A/X<_L9_$R\M[3]IWXW7ER_A
M_P#;BCT^7X21Z89-9MXWU/2SJ4,?CNRNRD.AHLC:;=:SM$K^F?'3]F;_ (*M
M_L_?&/\ :"^!/C3]M[XI7?C?]F;XK?LG?!OXAZAX6_:@^.&I>&]3\5_MAVNJ
M:M\,KWPY>:E>:/J%S8:386(A\4-=:592V-S'(MM!=#$K '^OM17^;MXG_P"#
M;_\ X.)-#T'Q#J^D_M\Z=XLN]!TO6-2M/#NA_MG_ +2::]XFO+"UN+NTT72(
MM7\+Z9I%OK>M&&+3[%-5UBPT\7UQ"M[J5K:B6ZC_  B_;MO?^"GO[%GQK;P!
M\<_%W[<_[+I\2>'['Q3X.\%^//VK?'7Q'U&\T5[.WM))H_B#X8\3:?X6\4NN
MNVUW<ZN-#MUF\/07UA8:A9PW$:3W8!_LS45_F7_ 3_@A=_P6U_:>^%/@;X[_
M  &_X*??#WXF?"3XD:!;>)?"GB;3OVUOVH'LWM;F.)KG2]7MX/#/V[2M;T6X
ME-EK.DW*KJ&E:O;S6&JPVL\;PCUT_P#!M'_P</DDI_P40\*NA.5?_ALK]J4%
ME[$@>!& )] S#W- '^C7*&+J0"1F+D GI*I/Y#D^@YK_ #]+U63_ (-A?^"S
M:LI5E_X*5_'%65@596'[3W[/ *L#@@@C!!&0>#7C:_\ !M1_P<.,S0G_ (*'
M>$PZ.F3_ ,-F_M2,VUN4(4>!]P(*N5#QIDY*NW\&U\)/"_B3P-_P:0?\%0/!
M'C+44UGQAX-_;>\:^%?%FLQ7]UJD>K^)?#_QW_9DTK7-434[Y4O=12^U.UN;
MA+Z[1+J\607%PHED<4 ?Z!/P+_Y(G\'_ /LEOP^_]1'1Z]4KROX%_P#)$_@_
M_P!DM^'W_J(Z/7JE !1110 4444 %%%% !1110 4444 %%%% !1110 4G<?0
M_P Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 4]0.+*Y8(\A6)F"1C+
ML1R  60<D<Y90!DD@9K^>GQ'_P $2-%\3?\ !<;PE_P5I_X3"P@\!6'P[T_Q
M#K'@U?&/B ^,[[]I?0]#_P"%;Z)KUO"GAZ7PS!\+[?X9I8:/>: GB6.]NM<M
MI;KR9+68VX_HA(!!!&0000>A!X(/UJJUG"1$J[XHX0HCAB;RX0%.5!C VG'3
MD=* 'Q6EM#YGEPHGF\2 #(8<_+@Y 7DX084 \"IP   !@ 8 '8#H*6B@ K\Y
M/^"A_@__ (*7^,O#/@+3?^";7Q7_ &9?A3XHFN?%MG\4-2_:,\,^+/$!N-%O
MM+L(O"E_X F\,V&J)IVMZ!J0UF\O?[1T^YM[C[1I4FR2.TGMYOT;JE-8PS-,
MQ>=#<1K%((I6C'!^^H7[LK)B)Y!AFB 0\4 ?Y\%W_P &M/\ P5^?Q1;_ !+L
M?VT_V5K'XWGXC>(OBSKO[0^C>)/COI?QT\6>+O$G_"-7[:7XU\;P^#@VJ>']
M U?P^FH>%='BM?L%K?ZAJ,MY')9W%G;6'[<_#?\ 9T_X.C?AOX$\.>#)?VW/
M^";/CZ?P]8/9S>-_B5\/_BYX@^(?B(FYN;R"3Q9K5EX,TG3]0NX#=IIJW=K8
M6_EV<4)?SYDDN)OZ8QIEHL)A19(P2A+I*ZR[8Y%>./S =WEJ%6(+G'DJ(_NB
MIDLXU!R\TC_O<2R2L\J"5MS*CGE54@!!_".!Q0!S6BMXC&CZ19^(;RSF\1BR
MT6/6[G2(#;V$FIQV%N^M364=VPF%C>WZ7IM(PKSVMFT)D4N&KXW_ &V?#O[>
MGC#P!IEO^P'\:/@1\+OC'H>ORW6LZ9^T3\.=5\7_  \\:^%KAE@FL?MWAZ[;
MQ+X5O_#Y$EU8:I;:-J-KXBEVVES_ &?!B\3[L^PVY:1F0N)6#E78LBOM*LR
M_<,@/[PC[_?O36L("2<R %(XPBN0B1QJ5\M!U6-U.)$!VOQD<4 ?P#_MB_\
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MLUK!/";>:,/"=@9#D!@A5E!(()Y5<\\XYI([2"-2BIE=Q8!B6";L?*F3\J#
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MT%2TUU\Q&3<Z[@1N1BKC/=6'(/H10!_/]_P4L_9K_P""Z7[2'C;Q[X*_8O\
MVTOV5OV9_P!G#7K?PO-X6DO=&^(VC?M#:>^F^';.U\8Z=J7C;2?"'BC23H^O
M^(GU*^B.FP6U_%HT]A:>9!);SRW/\^G[/'_!L'_P5?\ V;?B3XZ^)5I\??\
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MB;UM5V*%!)P,98Y8^['J2>YJ"2UCEF6:1I&VQM'Y.\^0P8\LT70R#H'Z@<4
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MP1X5\5:U/KZ?"^SO8]7O[36-!T;Q)=WFK64TMEI]_P"=<L;B-T(:O)_VS?\
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M/A7\0/CA_P '=/Q7^%/PM^.OC#]FCX@>,?CA?V?AKXX> =+TS6O%O@.XT_\
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MU#X3:OX'^*OC6PGUJ?PW-&VDZOX8D\+>*]:U'Q3!I3P^*;DZ+H5KIR72-LA
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MD[.2=KINUT_.]T_7R"BBBD._]Y?AY?\ !^_R"BBB@+_WE^'E_P '[_(****
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M+QXR%@4N?V/95VL P=?AS\,F!5F.$.XD@Y"@G)K^Y3_@KM_P54^$?[,7P_\
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M>&GOK-H/#[ZQ<?\ "):QJUE9Z=<NC:?%/,\""UN,?BY=?\$>_A7:W$MO=?\
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M-?NU7X3_ /!M%_RA&_89_P"Q9^*W_J^OBE7[L4 %%%% !1110 4444 %%%%
M!1110 5'+_JV_#_T(5)4<O\ JV_#_P!"% '^<Q_P<_?\I^_^"='_ &(G[)W_
M *U5\0J_T:Z_SE/^#G[_ )3]_P#!.C_L1/V3O_6JOB%7^C70 4444 %?YR'_
M  <M\?\ !Q#_ ,$[B,@MX7_8T#8SR!^U1XZ(!]0#S]<'M7^B_)=,9Y(H7CQ
MA$A+(X\]E$HA>)29U9(-LP*C:XD /2O\Z7_@[!^%/[36D?\ !47]EG]JGX3?
M!WXAZWH'A[X=_LZ>"/AG\3K7P3?ZWX$U#]H2R^+_ ,3?&'@KX>07+P2:3K?C
M&]N(+">U\'2,9]4BNE@>)XVP #_1E155Y-J@9VDX&,DEV)QZDDDGJ2>:_%O_
M (+L_L%?M4_\%*?V.;/]DS]FCXD_!GX;V/CCXA^&=6^+MW\7HO$ZG5O"'@^^
MMO%.AVGA&_\ #&C:[=66J6OB_2='O=46;3S'>Z'%>VB3)(^R7^).U_X.0/\
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M#\0)[&[_ &>?%'CF+2HTL_%B>.M-71]'\!:K?QQMJ_AVUTW3K 26D<+/ZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGBCXM?LL_ME^,/A1X%L= U'Q5\;OA%\*/"GC7X7Z7;>(5"PE[^7XD:1XE/\
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M9&WRFXL?L_V7SI6"%[E(EG.P#?@FK\VHI&\L,*?:+F&#[2ULDBK*T08 B,.
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M-Q;!\[+J2(>;71RZ@L<B1A4<><+>4F9(VCFE17MD02A%G,X;.(G+*.0'.5H
MK+X>T5)5N%TO3ENDE$\=W'I]E#<I,!#^\2>*!)%=F@B+,&#,(T1B44+7D_AC
M]F?]GOP5X'\8_#7P?\%/A;X9\ _$/4O&&K^/?!VC>!?#EGX;\::E\08VA\>7
MOBC2(]/%GKEUXRMW>W\27&H1SS:M WE7CR( !^,W_!1__@Y"_8*_X)^ZYX@^
M$>E7^M_M._M0Z/J-UX<;X%?!QTN(]#\96[^'?)\,>/\ Q[):7NE>&;_4H=?<
M:?:Z#I?C75_[1TG4M'U#1].OX6C7Y%T[_@YG^+_@2W^%'Q#_ &J_^"/'[7OP
M#_9S^*6@^,O%5M\9-#UP_%2]T?PSX)LYFUC6]1\!V_PW\'7>DVEGJ1L;>_'B
M_7?",MMI=U-KT"7MC9R!P#]^?AA_P3K_ &#?@CXSTKXC_!O]CC]F;X6?$'0E
MO$T3QMX"^"?P\\,>*-(34K.73M173M:TK0+:^M!?6$\]E<^3,GFVTTD395C7
MUXE@4<-]JN'"HB(LS"8*4<L)09 S&5E_=M(26*@'.[FOYVOV,?\ @X\^!?[>
M_P 9/CKX _9G_94_:=^)'A/X+_!OPM\5+2_T+2_!C_%OQ]=Z_P"/?#G@74M"
MT'X2ZGXETG1K/3?#S>(H]<N_$E]\4<W6E6%X8-%6<VT4_/\ Q _X.EOV"OA9
M\7M8_9^\?_L__M]^&/CEH7B:[\':C\)]0_9ST9O''_"1V\KPP:;I^BV?Q,NY
MM9;4642:7<:,=0M-5M)(=0TN>^L)[>YF /Z3X($MT9(RY5I99?WCM(P::1I7
M 9R6V[W;:N=J+A% 50*FK^<J[_X.;/V--/M;N]U']DW_ (*<Z=9V-M<W=W=W
MW[&>L6UM;6UG&TUU-<3R^,UAMX;>)6EGFG>*&"-6>61%!-?I-_P3@_X*=_LQ
M_P#!4OX2^*OC+^S%=^+H_#?@SQQ=^ =>T/XBZ7HOAGQQ9:M:Z1I&M1ZE-X7T
MOQ%XCG@\-:G:ZS%#HNN7%S##JE_IVNV5O'YNCW6 #]#Z*** "FN"R,HZLK =
M1R01U'(_#GTIU!]Z 1_+/_P5VAM+;_@L=_P0046L4P/B#]MRX%M)IEG&MW>V
M_P ,O#*6]Q<V@@V3O9W$T=U:R2 M$JRW>X3R&0^;_P#!,<E_V\/^"YV[&]/V
MR_AEN']YO^%;:VA./]Y"1Z9/3%?Q?_MU_P#!7_\ X*(>+OV[=2^(?BG]H74-
M;\7_ +%_Q\_:2T#]F;5YO _PVMO^%::1KWB+6O!&MVL5M9>#[:#Q E[X9T72
MM,)\3IK$@6S25G>5I'?^Q7_@D/JEYK'[5_\ P6*UW4YC=:IX@_:'_9SU[4[H
MI'$;S5=>^!#ZMJ=T8H52&(W5]>3W!BA1(8S)MBC2-50?>\$U<.\QP-'D_P!H
M^M3G*IKK#ZI7AR_%NFG?3JM6[V_D[Z3V48F'#'%^=U<3?+\3P=@,MPV'NTJ>
M/P?&> Q.+Q'*HJ+=:&,P5/64I)46G&*^+]TE.57C' XI:1?NCZ#^5+7[8]&U
MV9_E>^9-J33E?WGW=U=^K;?WH:TL2$*[ -U[],GIV]/_ *QKSCXL_%OX;_ S
MP#KWQ7^,'CKPY\-?AEX72T/B/QOXJDG@T313J=Y!IFEO?RP*[PP76IW=M9B3
M80)9XTR"P->BM';LRM)MW =^HYX^O'M7SO\ M<?LO_#O]M#]G;XC_LR_$_5O
M%6A^ OBC9Z'8>(M2\#7FF:?XFBM=!\2Z3XILX]/O-7TS6+"$2:GHUGYYETZ=
MGA#QJ5#FL<=[:.$E+"+_ &CD?)S64'.RY4VM4F]WNEL>SPY2RO%9WEU+B7%0
MP>0_6J$<=6RY.ICEA'5A[>7(Y^]65-S<8+E<K12<;W7S<?\ @K]_P2Y*L1^W
MS^S,C8$J1R^,[W?)!(56#.W2@([AGW"6W'F/!&R3-N4$-T/A/_@J7_P3M\>7
M7B&T\'?MF_ +Q!-X7\*Z]XVU^+3?%EU<R:/X4\*67]H>)M?G4Z5%]KTO1+,-
M=W\]OL:"W5F*DJU?DE+_ ,&I'_!.V21YIOB[^U<)'DB?]SXM^'$2IM;]]@#X
M=D+))$-D;@8B<[]C\K7TM\ /^#?/]B+]G;P?^T-X1\,>+?C3XG?]HSX-:G\#
M]?\ $GB_5/!=WXA\#>%=8OUN]3U'X<ZCIG@_3IM"UW5;>.+3M8GN6O[+4[1/
M*N;)HG>-OC_K'&$)VI8/#UZ5[NI-I=/A2]I?>RO:75[7M_1>99']%U8>#P_%
M?&-/$J$'*G&A!*<I.$9.7-@I*T(SE448RI<RA;FBW%GU;_P]_P#^"88BCE?]
MO;]F-%9$!'_":7[;I(II4O&21=***3%]GDMK20><=TI:5T"DRQ_\%A/^"6A7
M_D_;]FZ64C"11^,+P-(Y^ZB@Z0?F9L*.O)Z'@'\M)_\ @U+_ .">5V7,_P 8
M?VKW#9;8GB[X=IO8'$;S#_A7AB>18@J/(L4;.P+D@G C@_X-1?\ @GA;G=%\
M6_VKD;^'_BL?AX #S@GR_AW'(O/4HR,, JZMAAFL7QOSI?V;A7'W7*\H)-W5
MTG[;FBO2+M?K=&W]@?14=.-7_6SCJ52%-QM2P\)4925VI5+X**<[/I[-223Y
M(MZ?T3?#OXO?#CXO^"_#/Q&^%'C/P_\ $+P%XUT=-9\(>+_"US+J&A^(+)KJ
MYL&O-/G:*%Y[>/4K<V#A%\U94GD<(L#(?25)*@D8) R/0XY'X'BO)_@Q\)M)
M^"7P>^''P7T;59M>\/\ PQ\-6G@_0=6U/1O#>BZLVB6<4L<0:S\&Z1X<T"QU
M"8NGVVZTK1[$7C1"ZFC;4)9[N7U@ * HSA0 ,DDX P,DDDGU)))/))-?8X6>
M+G0IO&4(4:W+'GY&G'GY5SK2]M=4N:2[-G\U9]'*(9SCX9!7J5\HC6J+ RQ$
M6L0\/[1^RE6>D74=.VL:=.^C<5)N,%HHHKH/*N_+^K?YO[T%?(W_  4"_P"3
M#?VU_P#LT[]H'_U6>OU]<U\C?\% ?^3#?VU_^S3OV@?_ %6>OUY^;_\ (IS3
M_L7XO_TS(^JX%;_USX5V_P"2@RG;_L-H?U]Q^87_  ;0?\HD/@U_V5+X\?\
MJP;JOWX8]/\ =']:_ ?_ (-H/^42'P:_[*E\>/\ U8-U7[[G'&,?=&<?CUKE
MX;_Y$>1?]B^&_P#U[B?7^.;_ .-P^)FW_)3XO_TNG_2\Q****]H_)KOR_JW^
M;^]!1110%WY?U;_-_>AK[Q]P*>>Y.,?A7R)\=_V\_P!CK]F/QE9?#O\ :!_:
M=^#7P;\<ZCH$'B.R\+>/_$%UI.JS:-J#WMOI>LQQ1V5Q')I]S=Z=>6^P2)*[
M0MLE5L(?KV66., \'G&,=<?YSUK\=OV_?^")?[*O_!2#XR:1\<_C9XZ^-OA?
MQ9I/@/0_A[#I_P //$'AJPT&?1] U'6=3L[N:TU_PQKEQ#J9N=:E#365W:P>
M5"@^SEW=SYF8ULXA1O@,!1G)R2YISBW;[6C<5Z=5NE+K]_P!@?#K&9_4P_'^
M;YW@<N6'E./]BTE5FJJBI03O2K-IM--<MG>S</BC['%_P6"_X)?G9O\ V]OV
M9G^4RL8_&5ZBO"HCCV,7TS-E.]RYVK.LN(1N"OG</<S^W1^R'_PH6#]II?VE
M?@P/@'+XDN?"C_&6;Q4+;P&_B&TU.#2IM TJ:YCAU#7M6CO;B."6/3H72'Y[
MB58[>.1Q_,I^VI_P;Y?\$O?V(/V:OBG^T_\ $'XB_MG>(?"_PRT.UO[K0?#?
MBWX:3:SXC\0:WJ]CX?\ "^AQRW'P\AATNRU;Q'J6F6^I:[*-3_L33C<:DVF7
MS6XA?\L_V7OCQ^P/\8T^&?\ P3'\.> /VR]<^#/[5WQ.^"<6I7GCGXN_"35-
M0_9]^+^J^*;5/$?B#X*V5Q\&+B>T9[.5_#OBC5='OO#\'Q"T2>Z%WI5G,8<_
M%U^)LUP-?ZOG%.G@L1-+ZI3I0E)5N:7+3<W"=5-3:<>7W7)^]>,?>/ZHR'P&
M\)>,\AQ&>\#9EQ?F>4Y?CN3-<7C<+AE4HX7#TJ=?'4J'MOJLE7I4JM.I&?+4
MLG[*-*I6J02_M&'_  6'_P""6[+E_P!O#]G"V*SW$+>9XRNY4<02E$DC>+2,
M%9XPDX +>6) C,S FMK1/^"M7_!,7Q)JVE>'?#_[=7[.^K^(?$&HV6B:!I5E
MXLO9;G4]<U6YBLM*TV)#I,>'OKV:&UC8MQ)*HZD"OR/;_@U"_P"">AECLKGX
MQ_M87)M8&9O^*I^'$"032SLTD7DR?#Z9[=V^^]NSN5<LY<EB*[;P%_P:Y_L
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M_P""J?BI(2 #\!/@:K HKAE71=3N".1QET49[\@Y!Q7]NW_!IN4/_!%3X#[
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MI;Y]D; @'*^8H< <  'S[_Q%Z_\ !5C_ *1S_![_ ,(+]I#_ .:JOT3\,?\
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M:U*9V-O:J$TG0;-8=.T"RTZSB6*ON-/^#X3P*BJB_P#!.CQ0%10JC_AIW0>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX6O?BM\/M(ETK2SX3TRR\*ZUXU\9^!K?PU%IB7/A*P@.AW$:ZAILLD?Z4_\
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M2WZ ]DO9P5KZI)-WM\3MK;I\^Z"BBB@5O[B_KY?U;TN5\C?\% ?^3#?VU_\
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M]*2@A67W!P>?;K^N/2KA\7_#A9N,E%)2:]W:^EF[:;I)_,_S=/\ @YZ5I/\
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M5MI-G<36GCW1X)G?2OAQH4DD5M'!#-)H\>E2&ZTZXU#6];U*;PN >_?L"?\
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M^K>(=$O[V#3X+FYNIX[5)?*625W1%:60GE/^&-_V0_\ HU;]F_\ \,=\,?\
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M\&_^"4?[ '[(7[.ME^WY^TI\1?!?AGQ9XB\(^$]/N;O]GSX5ZC%/K>N:A?\
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M7RO_ !%5_#E$@@0O_P $<_$4DMQ$"TERC_M%W<:K(['_ %<1A'DA%& S,?\
M6,1^&EV G_!L!_P650#_ %?_  4F^-Z;@SLK[?VH/V>L.H?YD7&%"M\QVEV^
M9S0!_=_\"_\ DB?P?_[);\/O_41T>O5*\K^!?_)$_@__ -DM^'W_ *B.CUZI
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %)W'T/\Q2TG<?0_S%  .@
M^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#['Y.\//;1,8'A18]@LO*-JELRJBM#;0P%75Y 2[%J /\]C_ (+6_MT^+/\
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M1QFQ@TVWB(DCE8Z<L9-S%_HZ36T*HL4:F7>) 8_W@(V%0"66"RM;:8^0LEE
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MY+[@HHHH"W]U_>O+S\E]P4444!;^Z_O7EY^2^X**** M_=?WKR\_)?<%%%%
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M>-HKB32=3L)7B>RU73[?X47=QH>H%4$SZ5J#+=VP?9)O*[V -K_@[RY\4?\
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M%G:+&+;=<[R9;DCS)6.99&<9 !_.UK#M)_P=3_#*1E*-)_P1FUMV1MNY6?\
M:0U!BK>7^[R"<'R_DR#M^7%?AU>_\JP7_!9?_M)1\</_ %J#]GJOW(UQF?\
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M?&?0M'?4-:U!-.T]K_7=5\"VF@:-I4=W<6\U]JVL:A8V>G6337-]<P10S&(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=_ZS9\-J_M"K^+WP=_RNE?%;_LT73O\ UFSX;5_:%0 4444 %?D7_P %Z?\
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M4,\4MAJ%FT4,MI?V36^H6LL$,UM<PW$,<B@%'X)_M ?!_P#:+\#Z/\2/V?\
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M//@'XV^)/[9WB[XJGX=_$7PKXF\(Z_IVE>/_ (__ +.&NVLD5CXLTG1-7O\
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M*FDGM?$\^L;+!M7$A/TY^S1\>=+_ &C/^#PSXH^+/!7@^_TK1/A7\,OB_P#
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M.H+S]CB]_;H_X)Z>&_A-JGAO_AJCP;XM\':/\9/A]X-%C_87A'X8ZUX_\/\
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MR->^!W[$?PF_9N\-WOCCPUXI_:C^(^N76J>(/!NL0:?X?U?X7_"/3;"[\4^
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M^3G-:]8OAU#'H>E1LKI)'I]E'.LL8BG6X2TA2X6YB'$=PLRNLT?\#J5[5M4
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MOV<DQ%?E9=WW_F')$AYD!R'/+9-6J "HVAB8$-&I#,';('+ 8#?[P'?K4E%
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M[Q=\/+*Q\FX\1VT7AC1M5\:WMAX;T[QMJ/B33]+N8[WQ3_@NK_P6*_X*T?\
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M<'Q5/8^$[2+P[I>N32ZWJ-J\D<6DI=ZG;?7GQC_X+H_\%6_^"4?[2?@SX?\
M_!7?]EO]G[X@_ ;XO6FAP^&/C'^QS'XOTCP[9R_VA:#Q3=Z3J?Q!O-3B\8Z[
MX8TB6X^W^ -?@\#WDTJQZIIFNW&CJ[D ^-_^"7O_  1?_P"#A#_@E#\7/'OQ
M9_9\M?V%_%?_  M'PHGA7Q[X-^)7Q5\0:OX5\10V-_/JOA_5G?1/"FA:[8ZG
MX>U*ZNKO3I--UBTMIOM4T.HVUY"RQI]V^/O^"%__  4H_P""H'[4'PU_:E_X
M*W_M,?!WP!X"^#_CO2/^$7_9"_9WT;5_'/PZ7X=Z#::'JVH)X=UKQ3>KI^F7
MGC_Q1;RV/C,^*/#OC76M1T6U>R?5(M,&@Z?I7]2/QD_:V^ O[/7P!U[]J'XM
M?$WPEX=^ /ASP;:^,9OB7'K-CJ.D:[97]H+W2+?P@--FO4\4W?B"%X(O#MKH
M=Q?3ZU=7$,6GK/&3,/Y/_ /_  6R_P""W'_!2B;XI?&/_@D[^PI\$;/]F?X:
M_P#"7>&_[3^/?B"+Q;XW^(?C_P -:II5S:^%M+33_'OP^M_"_C?6_ 'BSPEX
MB_X0O4-.N?">G16>M22?$F[N+RPAD /Z<OVJOV(OV>/VV_V;O%G[)_Q[^'FC
M:G\*-6\/VNFZ#I6@+!I5_P#"W4M(A%OX.USX<7-O#':^&_$GA**"TD\."PM8
M;6TT^.3P[J5K?Z)JFHV-Y_,O\,?^"-'_  6T_86^$&I?L3_L2?\ !0/X$ZE^
MR3\9-6\4Z7XH\9^,OAY%\//BO^S@/&OB[0?^$C\;?#BXLAJ_B'QSX]UCP<NI
M:<['Q-HMO83M/%X9@T#5Y],UO3/TF_X(]?\ !>KX3?\ !1KQ9XW_ &7?CAX(
MTS]F']N#X9ZCJ6@>(?@[=^)+/6M!^(M_X-BBTCQOK?PT\0^1:I<ZQHGB33-7
M&L>!WDU/4=(T6VL-3TS6O%.G1:MJ.G_GA_P6]_X*O_\ !;O_ ()1?$&3QOI7
M@7]BWQ!^QW\4OB+K?A'X">,IO"_CGQ+X\T%;#2&UK1O#WQ423Q]X8M8O'.JZ
M78ZWJUK<:'I6K>'YK;29_/O+6[*6LX!^G'_!&#_@AO\ #+_@D9X9^*6NWWQ+
MU#XY?M(?' 7.E^-OB9!9ZIX0\-P>"K/57UC0O"OA[PS>:WXCELD>Z":CK/B3
M6-3U?5=1U=Y1;W=EIZI95\\?M:?\$'_CW\9?^"BWQA_X*@_L\?M_ZW^R?\?-
M;'P@L?@\-$^%T'B_1/"FC^#? 6F_#_XB:1\2;._U];'XDZ/XW@TC3=0\/:7]
MEL=&MU,G]MV&MLMHMG]C_P#!&3]IO_@H1^U[^Q@W[37[;?@OX _#[Q!\8Q:>
M)?V5='^&-EK>CPZU\/\ 6?#WG:-XD\?V%WXH\6^3%XO\02PZMI%G:ZJ+R+PW
M,K:CING7H,"_E!\&OV\O^#C[XC_\%"/B?_P3^M_ G_!-2]\5?LY:7\-O'?Q[
M^)6F:)\6(?AOH7@'XCV>E>(O#ND^']7D\6KXCO?&.K:)?7]MI5O_ ,(6;&VU
MK3-1CU5[2SMX[NZ .Y^(G[$/_!R'^UQ\-]:_9$^.W[;'[+OP,^"J:#\3/#/C
MS]I7X0>%9]?^-'[2VGZWXITV#PMIWQ&\(:7%X<@^'$-[X8BN;*1OAMJ_AC[!
MH;W7AKQ$GBA;O[1'^_G[ 7[%WPU_X)[?LA_"G]E3X;+#J6A_#?1F_MWQ1=:)
MHNBZ_P"-_%]Q(+_Q#XW\16NE6=I:WVN:I>($L]0O?,N8-$T[0=/NKNX.GB9_
MD_\ X*__ /!8+X#_ /!(_P"!7ASXG>-?#6H?%'XE_%'5]4T#X'_";09[CPXW
MCR\\*RV'_"<:GK7C5=-U'3O#?A[P7#K<$FL73:?J.HW.I^(-!L].T>ZCNKR^
MT_\ )SPO_P %!?\ @XJ^*G[/.H_M^_"[]B/]E#1/V3HI[#X@^&/V3/%]S\2]
M;_;%\<_ C2I]'N?$<V@:PT^F^';^Y\0Z*=<UKP]?W_ANS\1SV$9ETKP)K<W]
MBVNN@'R/_P %M/\ @BU_P6=_X*B_MFZC\4-'OOV3]/\ @1\*WU7P3^S!X>N?
MB5>>&O$&G> 9-5M-:_M_Q):_\(9K%TWC3Q!J5I9W^NK_ &I/8VDEO%8:;;6U
MAY@G_I*_X)4^&_\ @I]X)^!7B#PI_P %3?%'PG\??&#PSXRNQX \<?"+4+74
MY_$?P]O])@NIK/QM::/H/A'P[:ZMHU^\FFZ#]AT&S$^F1P37QN[WS+N?X[_X
M(,?\%<OC#_P5E\._MD?$SXI?##X??"?0/A!\7?"7A+X0^#/#IU"Y\1Z-H?B;
MPWK.K7FC>,?%&J300^)?$L%UI]E9IJFG^&O"RH&GBDTAY5.?Q6_X*@?\%WO^
M"Y7_  3B_:RE^!WQ!^ W[%EEI/Q38>*O@ OA[3/&OQ&M?$7A'7]5_L;P_9WG
MC27Q=X$N]=UOPOJ+Q^%M9NM1\&^#(;K6T-S90W6E26UXX!_1/_P5_P#^".WP
M-_X*J_"OP]-K&K_\*._:6^%EQ:S? W]I#0]%:;Q+X,6WU&*^_P"$8\266GZC
MI][XE\%S:F'U#3]+BU2QO_#^N$:KX?OM+N;C5SJ'XZ?'W_@D!_P7K_;$\ 7/
M["'[3_\ P42^"VI?L=^#A_;5E^T'8^";_P#X6]\<DTO2/!&F^#/AW\6? /AS
M4/"]_)H/AC4%\3:[_:&I>--8GUWQ'8KK'BNY\1W5SH9TK]%_BK\=O^"^/P\_
MX)QVWQ>@_9Y_8?N?VU_"D>I?$CXI^%(/''C/4?#2_"+3M)B\10V/A[X>7+:3
M;VWQ9L4O]3T'Q-92_%F;PC9R^"[O6=$\1:]-XDBTG3?S#_X(7_\ !:[_ (*]
M?\%8OVK&\-^(OAK^RC:?LF_"6"WU7]I3QMIO@WQ9X9\2:=I_B;3=:M? 'AOP
M;/??$+Q#'<^+M=\2V#7]E:76AS:9_P (YH?B:2^U"SOO[*CN@#^AO]CW]A/1
M/^":'[ 5U^S!^Q3I]IXW\>>&?!_C_P 5^&;_ .+NH7J^&OB;^T%JWA_;!K/Q
M"N;.2-O#_AG7_$]CH=O=:;X9CLH]-T.U$=H3>"XNI_P$_87_ &!O^#C/X._\
M%/M-_;D_:3\=?LH?$'2OB_:>"/A/^U!#:>+-'BN=?^ V@WL9BM_".A>&_A]X
M;%MXG\ VG_$Q\+W<5W#/J.H65O:>()]:T^YO%E_LCMK5YX/*CNYMD%Q,CI<P
M*LT3QAFA$9B,4(:*22.3>J2PR(J($5M[&VUC*'C>.:$-%Y $LEJDDVU3BX <
M,@0SQ9BS&J! <D/TH ^2?VX/V2OAE^WA^S!\6_V8?BD'L_#'Q=\*W>D6?B6'
M1]%U?7O!.N1>8=&\9^$[+Q!8:A:6?B;PY<O]KLM5C@34+9)IDL[BW=U=? _^
M"0W['GQ%_P""?_\ P3[^"_[)WQ#U[PSXH\9?!B^^+VF7FL^$Y[JYT#Q)I.L?
M%OQYXH\*:Q;177EW.DWNK>'=6TF_U/1YGG?1M3O+W2VN[U;9+N;]-Y[:68@^
M;&NV(A?W)++,3DN'\P.L3@!7B0JS ?ZP9K/FAMM*MIY9HX%MIKE9+@P1I9Q1
M"4!YI[AC.H8R789VER7;S8X6^0&0 #TU"X-DEP[64<EUY8LP[2"'S6M][PSR
M9(1XYDF7=N"L%$8_>$9DEO9E_=[(VD+F.49*O /))C<0;]]PD\^V&,H\:XD#
M%_E(/\-W_!4;_@MK_P %Q/\ @DS\?O"/A;]H7X2?L2^,O@C\4_$_B#Q/\(]=
M\":#XXNKCQM\+?"OC*S36_ ,VKW7B^UN= ^).G>%]6\.-K^J7/@^]T#3[GQ!
M:7^CC7O*EBC_ +/?@[\1=%^*?PM^'WQ/\,:AH>K>'?'7A?0/%=AJ/A_6[+Q-
MI*:9K.CVFLW-CIWB2S,L6NV>D37$UBE_:JYN[FW:.2*TD20( ?D+_P %M/V>
M/^"G'[6'[-_B']F_]@SQ#^SSIO@;XV:#K7@C]H*+XOW^I:!\18/"&I3ROJ$/
M@+QA'#K_ (8A\-^,-+630M8L;SPE)X@T]+IK[2-;LTFVP_F)_P $ _\ @ES_
M ,%E?^"7/CW7OAA\3_$'[($W[&OQ$\2I\1/B7IUGXBUOX@^/-)\5:;H5GHZ7
M_P .)-,T7P:^GZYXCTRPT;3+Z\\2WVN^'=/L=+%Y:Z$U_<R2W/QOH'_!PW_P
M5+_:X_X*7?$']BC_ ()H^%OV,?B=X'O/BE\0/#_P/^(?Q#\ ^/\ 2([GX2^"
M[B<CXC_$#7&\?Z/?_P!E:5X?A?5-2?2O!\.LWL,4B:?X=FN7CM&_MT^%47Q,
MD^%G@)OV@F\'P_'"+P+X-'Q3G^&ZZO'X!N_B'!H-A/XTF\ 6^JO-K=UX4BUZ
MXOHM)?5+<ZB-,%M%?1F1 X /25=Y+<)'.D1G+-(TR&6W%BR#[1';/#+%<0*(
M5#(5(2TN',<A?:!7YS?\%2O^":GPI_X*H?LJ:W^SC\4-4U?PY=VFJV/CSX->
M-M),QU+X=_$W0M.U72]&\4WVG?:5L_$&AWNE:KJ/AW6M+U2&Z$ND:S>3V+V>
MK+I]_9_FM\-O^"Y%QXY_X+T^._\ @F#?3?"/PY^SMX5\!W?@3P!XZTLZCXT\
M8_%C]I*UTGPGXWN- TKQ;H%S-X8\,Z?;:'KGB;P[K'A34].O)[+6O 5XM_XC
MM=3U(:1!_0SXS^(7@KX9>"/&WQ'\9:XGAWP-\-?#7B#QCXU\5ZC;W;6WAKPC
MX3TN]\1>)=2:WM[:?4[NRT_3]/FD:"SLKFXE4>591W4RB, '\DFF_P#!)+_@
MO#X7^ %K_P $NM(_;Y_9O_X8,U+X>W'P[N?CH_P;TI?BSI/PVOO 7B/PKJ_P
M"L/ADZR7FJ>$=9U/5+7[1XV?QG#XTMN-5M?$-K8V\NBW/[A_\$E/^"7/PI_X
M)4_LP:=\"_AYXEU+QSXX\2:M8^._C9\3-12XB7XD>.X-,MM*FU/1/#=Q=7D'
M@W0M'T^U@T;PUH45Q+/;:=:PR:O?ZOJ3SWTOXM?##_@LG_P5V_X*F?%74X?^
M"0_[(GP7\*?LK^!_$OC/PM??M1_MH1^)9_"WBV^T^*:^\/W]G8^#]4T/5O#5
M_?6%G<:=+X=\.:+\1TL+_4],3Q'KF@B5XE\P_:O_ ."]7_!4[]@/PKIOP1_;
M,_8L^&OP_P#VJ_%/Q,\*:#\&_P!H7P?;ZIXO_9+^.G@YOB3-HWCAM+T%?%MA
MXC\%WUAX0EMK[PM/K'B>_P#$.JSO'JNK^#/#^G3PK0![AHW_  ;V_MO_ +/?
M[17[3W[97[#W_!3K_A1?Q[_:.^,OQV^(>L:-<?!BT\0_"G6_AY\0]<F\:^!O
MA]KOA;Q%K>MZ;>^*_"GB;4];BF^).I66J6EK8:M"_A[PSIEY%JK:KC_&G_@F
M%_P74_X*F>#K;X-?\%#/VPO@#^S!^SMI0^#^G>+_ (8?LRZ-=^/KO]H6X\-7
M^K/XP\7>*O$%Q_8-YX6U^[ @O[;1))=4^'-UXD_LF]7P-9_\(W&]Q^C7_!6W
M_@L_H'_!-WQ#\)/V:/@]\'/%G[5?[</[0"P2?#+X#^&X-4TFQMM(U:XU72-+
M\8ZIJ5KHFK"ZM[CQ/9RV.C^%M%AO)KVTT/73K&I>&[2QCU.Y^&],_:U_X.E?
MA!\-/!'[2/QI_8K_ &,OC'X&MYM9U/XI?LL?!_5/%/A#]J?3O#FFZ;XJ%SJM
MWJ=]XJ\8?#ZV2Q?1=-U**+P9-\0=<U:'4=$TK3M#N+K4;LZ: ?TT_"3X6>!O
M@5\+? 7P6^'OA_1-#\"?"KPKIGA/PUIUAI^D:'I]CIFBZ:+.!396%M:Z?:WV
MK*)[S5KFULK>*[N[W4KU8U,C"OX#?VV_^"!__!?;]M']LOQK^V[XT\5?LI>#
M/BC=^)M&U+P-K?@/XVZSX03X9>'_  *7M_A]IGAFZM/!$FKV$GA[3EM535;W
M5[W5+B</=7UU/<%'3^D/_@BS_P %:?'?_!5_QM^WCKFH> ]#\%?";X&_$7X4
M^'?A/HVI^&+O0?B5I^B^,?#/B&Y\1^'?B<TVL:[9ZKK.C>(_#E_I5G?6.G:.
M7T\S-<V%K/(T2_4/_!:7_@HCJ_\ P3)_8)^)?[1W@O2_ _BOXJV&H>&?!GPS
M\(>.=:73['4_%OC+5[;1;37$T2VGM]4\:VW@Z.['BK5O"6C7&G7MYH>G7$DV
MJ:/;?Z?& ?1_[!.G_MIZ=^RW\*--_P""@>J?#[4?VJ=$M=5T3X@:S\*=12^\
M)>+8;/6+FR\,>*&86&DV$>NZWX:@L+OQ1;Z?H]GI<.MRW<FDV-G"PB7[HK\\
MO^"9G[7&G_MS_L-?LV_M2V_B+PUXC\0?$CX;Z'/\3+GPMHVK:3X4T#XP:+;C
M3_BWH>D:?KZ+JEM::!XYMM:T:V/VR_M&-KNL[^^MWCNI-S_@H;_P4%^#7_!-
M[]EKQG^U)\:X-:N]!T6YM?#/@KPGHEG-<>(?B/\ $?7[:]F\(>"=%VQ26VGR
M:U_9NHW5YJVJ206>DZ5IU[>.MS<+;V-R ?;O]H!UF>-@R1O*J@P.'E** 1"C
MR(TIB<$RD* 5X3U/PC_P4!M_V\M6_9W\56__  3DU_X$Z-^T+J>ZSLY_CO:Z
M\=&AT/6K5M";7?"&J6$QTCPYXZ\,7FH1>)M$_P"$O\/^*- U@Z4^C:AI$QO4
MNH/YR_A7_P %+/\ @Y,_;D^$WC+]L3]CK]B?]C7PK^SGJ5CHFO\ P'\ _%/5
M=5\8?%KXL:%)JMUX7UN#P+XDT_XC>#]"UK4/#FOZ)K&HZS/XVTGX600V$L%O
MI,.JW,:?:/J#_@F9_P %J_VCO^"A'[9W[1?[/L?[.WA[X5ZU\!?V,+?Q_P"(
M/A'\3H?$/@7Q7H_[9FE^,M&\)>*O!.M_$ 7>OR_\*@U*?5X9-(U27X=-KNEV
MUP+M-/U&.SA2_ /S/_X(O?\ !%/_ (+6_P#!,K]LS2?B]?:C^RG+\&_BK>V'
MA']J&QM_B1-XEUS5_AC=Z^^L7OB/PI8)X(T^6+QKX7OKFZUWPH8M0M=.O;Y(
M=-UFSN=->2&OJ?\ X.%_^" /[0O_  4N_:;^#'[1/[*>L? ?PKJ;> H/A9\:
MK3QFS>"M8UFZT77[^ZT[XCW&M:?I6I/\0=0MO#.HP^%(=$U2&"_TG3O"NF0V
MNKRV<MK!IOP'\>_^"^?_  <(? 7]NV'_ ()Y^(?@5^Q/J/[0^O>.O#_@_P !
M^&?#G@_QAJV@>-T\?SK_ ,(!J6B>)[_XOZ';_P!BZ]9317NG76NVGAK5#;J\
MFK:182YM%_9/_@IK^UW_ ,%Y?V-OV4_"O[4'@/X<?L"ZWI?PL^%ME>_MD>&K
M34/B)\1=2\,>/;/Q!JNEZA\1?AJM_=_#6%/A?-X9BT#6M7\.ZDVH^+/#VL:K
MJ>GZ>_B2SM'U.0 _6?QW_P $^/@/\>OV#/ '[ ?[1NA>&OBK\-/"WP5^'GPO
MO-?CT[^P=7TW7_AKX&TCPOIOQ0\!WDDE_/X1\0Z9J-I<ZGI$\5W+,EMJ-QI5
MY<:EID^K0:C_ #CZ7_P1H_X+^?L=?#SPQ^R-^P?_ ,%0/!VK_LD>*]:\9Z1J
M\7C/POHGAOQ_\"O 'BV_L=*=O FN:SH7C#Q-J\]MX8U#4->MX? ?B/X?6VC>
M*M/NKKPS;Z-?:R+^+V__ ((8_P#!3K_@L)_P5/T7XW_%WXB_#/\ 9(\(?L[>
M!_!GC;X>^ ?$^A^%O&'AG7/$'[3,>C:5J7A+1;FPO/'?BX7GP[\-074$WQ+6
MXL-$NH[+7=%3P[?7MS#?PV_Y\_'/_@MG_P '#GP%_;T\%?\ !.#QW\%OV%+K
M]H3XBZKX$TGP3=>!_AU\5O$G@;Q#X6^(5Z--TSQ[I6MV7Q#N=?T_P+IQM-=N
MO%E]J_A>RU'P]I/AO6M0FTM;>TAN)@#]^_\ @BY_P1:\.?\ !(GP%\6;?6?B
M98_M!_'3XTZ^FM^*_B]+X2MO!<=IH&A">70O"&CR3WNO>*Y+#5M5D35_&-CJ
M'BC4+/6=7CM=4^R126863\AOA/\ L$?\'&GPZ_X*7?$K_@I?K/AG_@G;XM^)
M?Q@L[;P1XD\'>*_&-S=Z!X7^&5M!;Z'X?T?P)JFF^$-.\8^'SX8T"V@TFWU&
MR\5#5O$RVB1^+W\1)+*A_I"^)2?\%+(?V#_"\WP]D_9!B_X*.:=H?A!_$4_B
MUO'MO^RS;>(5UNU7X@S>&;>TSXRETR7PW]KA\(KJ")<+J\D+7\L40D4?D9_P
M1*_;L_X+4?\ !1NTG^/GQR\%?L7^$OV/8F^+O@73=0\)Z%XTT+XC^.?B3X1M
M;_1M&UCP[:3>+_&&FMX"TKX@6<ND>)Y]6CT+5KE8+B72K*]MF6XH H?\'%'_
M  3;_P""G/\ P5 B^"_P7_9>T3]F.#]G[P%93>._$7B?XE>(TT7XL2?%74-0
MN[4Z-H^LW'A;Q'?>'_".F^&K;1VE7P[<Z7)XFU"\O(_$)N[/2]&MX/GC]FW]
M@K_@X-_9[_X)/_%/_@GIX;N_V,U\0W6IVWP]^"OC*[^(-QJ&J^%/V>OB##XU
MU#X[>%WO?^$'_L+4=2;7[S3[7P9>Z]H6HZKI]AXV\>M)=M)I7A@V7QE\7?\
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M".W\-^(;'Q!I#IJ^D^*+NQN8'D^=?!'_  5/_P"#AS]I7XI?MPS_ ++WP/\
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M7_!T'_RE3\3_ /9!O@E_Z8-:K^WG_@TT_P"4*7P&_P"RG?M"?^K=\35_+O\
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MOA'KWCSP;:^,/B/X'U/PU-KFF36,5HFM:=IGPNT2\O+$-<%I(+?4K.1O^>^
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M-]1\2VD6C:W]CC\8S_%*R\:7&V]L=0BM?:]1@N[3_@V%_P""S-I?PF"\M/\
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M6D[CZ'^8H !T'T'\J6D'0?0?RI: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\EO\ @N/M;_@DG_P4;B\AF#?LI_$>=Y?*E_UL
M6EKL4.D2JZ1JJ2G,S[")-ZB)6%?K37Y)_P#!<JYCM?\ @DI_P43\V_L;"6[_
M &6OB=:6:W$L4$E\\N@QF6SA\]T^T7,L22Q10P!Y<3)A2VP$ _AC_P"#=GX@
M^/?^"<G_  6)^'/[,GCOQ1J&O>&_VS?@7\*[6ZTCX;SP7G@W4/$OQ/\ AAH'
MQL^#6M^)&U^+2[B:#X:^'?$6O^']3DT5KF6T\2ZC>V]@-3L$><>8?\'!.MZI
M^W1\8_VUOV^;/6Y[OX._LN?M#? [_@G]\"];L/A;J_A;0OB39OX2^+_C?XH6
M>M^*=<N+:XU7QG\)/B%H^I:>T5MI@\_1?%&E7KK;Z>=+FU'Z&_X+Y?L[^)/"
MG[%__!%3_@H9\(KSQIHU_P"&_P!BK]GCX#^//$?@."QATCX:ZYX"^'G@WX@_
M#'7-=\;:(RWVE_$/Q/JOBC5M.T^UU"=7:/P5#':M'/;W$;]#_P %0?A'IG[+
M_P#P;9_L=_#7XG^-;%/VK_VKOVO-._;3^*OA'7?B;9>-O%_CKQ'X]\$_$F[U
MSXE:1917,S6]C<^#_$WPEO/%,-DH@L/$/BB-+UFU.^NF< _T)?V=K=KG]G3X
M!0SR7,HNO@C\+89Y(&:*8Y^'/ATS+NC&WRKDA2V\H4D!"2C>JC^ W_@OS\)?
MC!_P5/\ VT_VV?$GP=U[P?'^SS_P1V_9IU-O''B+7/"'CSP['JGC+0/,\2?&
M+X/Z5XFM_#^I6'B+Q_\ VW;RWNBPW5QINDC1H;BZMM1NX7>ZN/[8? 7[5_P9
M\"_\$UO"_P"U-HWBOP]\3/AI\,/V2M.^*,DO@CQ/X?NI_$]M\,/A+%K6H:/X
M9O[J^CTT^(6O?"^HZ;9VMY)'MU6V:UGC$D;H/Y9O^"27[&7_  6^\5?L\_$3
M]JCX'?MH?LH> =(_X*%>*M1_:0\<>%_VAOAW'\>/B1XET7Q39/8^%_$GBW5=
M,TK7--MGUGPU=PM<^&KA(VLI6>WU*RCF:>U0 _3_ /X-5_VM]3_:D_X)@^&O
M!GBK6/%^O^-?V6O'6N_ /6M:\2)IC:?<>%[2W@\3?"_0/!S64_VZR\)^#?AM
MJGAWPC!_;-E;ZB+W2[J".:YA2"=_RA_X/?(HXO __!.5-BK"?$?[2<:IYC>7
M#_Q(?@XBN"$WD1$K(<EC*4VL/F)/RK_P;N>(O&/_  2R_P""TO[2/_!/3]H;
M5/!&BO\ %6P\0?#Z'QMK^N7WA31/$NO_  ^U/4-?^&>N?"S3-5FAMM7L?C58
MZQ'J?AE]52+4]1T'[$UBRSK+9O\ 4'_![WJ.FW_@O_@G7:V&IZ;?7EOXB_:,
MGGLK._M;F\AM;K0?@Y):W<EK#*\R6EU''(UM<L@BG"/Y+/M. #Z2MO\ @Z,^
M"_[(?[,_P$\'?$W_ ()[_MZ?#KQ59? 3PKI?PRU+XJ> /#/PR^'?Q<U_P7\+
M]%T&WU70-?USQ6;_ %;X>75R^DW-SKVAZ9J%]8:7J^F7L&CW=S<I:R0?\&MO
M_!-C]J#X#^.OVG/^"@'[1_PPUGX0_P##2W@BPM/@W\*M??19;[6_"7CWQ\?B
MKJ/B>]6?5CXJ\&MX9O=*T;2[/1O%>@:;J&KV>L#6DV?9X$N/L;_@H;^R=\(_
M^"H/_! 7P#>^!/B!X+\3ZC\!/V6OA[\?/A3XUT34YO$.D6GC'X,_":.R\?:3
M>3>'EO-6NHK_ ,+Z+X^\&IX=D"6Y\>C1[_68'G\.QQ1^"?\ !"7_ (+Z?";]
MI'1OV!O^">FMZ)\</&?[6NH?#+QSX;^+/Q*\37VC'0K"Y^#O@[5?$6D:QX@U
M.^N5O?%EIXL\-Z?=6NC6NG13:KH-SIUK%KT:M,+@@'Y6_P#!1EVC_P"#P[]E
M,!Y)-_Q>_861',QP4G\->'QL;"X:-GE^^,%(]P56:0D?Z&8LUL'E5;=4ADG>
M81PJ6;SY;B2:74EF^:X-S.'V2V\49"NC-EHV%?YX'_!1>^L+C_@\!_94U2#4
M=.GTZ'XP?L*RRW\5]9M:K':>']!%W.\\<S6\<=JUM,MR3(%@= K?>7/]=?\
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MX)M_\$\OC9)^SO\ M1?%CQAX0^*5OX1\/^-I='T'X3_$'QG8KH'B=KT:-/\
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M2[/2;6YNI;>""&]UFYAT^"YO+];:T$M_-=WCQ2S3,Q^!?A+_ ,$QOA3\%O\
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MEC;WNHV4$MW)%\//$JCR&FGC^T'9);%UC+M ;F!)0A>@#^+;_@Q\BDN/#_\
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MJU)\O2,XH_I,J.23RUW%25&2[#'R*%+%B"02.,84%B2,"I*\9_:*UGQWX<^
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M_IWV34)5OM(2VO1=Z_&_AN-KBXO]7OA/Y:720L ?1\?_  55_P"#5]Y'C/\
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MPMX:\3>#]&N#J2>,(]2@TS3]$\8ZY'/HD,\.CWL\\5_=6,UY9P2)](?L3_\
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MXDLH-5T'7M.U*UDMM5TKQ+IUY%+;ZYI.I6\S6>IZ=>130W=J6@<&-V%?GO\
M\%*_^"K'[)7_  2Z^%W_  L7]H+QA<S>/O$7AWQ3K_P3^#&EQZ@OBWXQZGX>
M;0+*^T3PY-!92:-IMC;7OB70H]5USQ+,D>BV5Y<:G#::A):"PN.!_P""&O\
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M<LBJOL6H21P*ES,\J0P+.\I15,?EF,J1*=K2+U_=F(;B_!^7D?@O_P %U_\
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MN'B-JK92)IK6)[@B-X1YC(RH1.LIVDD*H(8BOYM/VM/^"[TWPK_X*^_LH_\
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M IF2..X\^3SDBCE5)-R*PN!*=[*5 MZDD<EJZSRM#;@^9<,GG"0P0JTTB1M
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M !4EC>WT6D^)O#^H6VIZ+= 2V5U!<6D;Q_R>_P#!QU^UIXW_ &X?C_\ !?\
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M=!N?#GPECCO-$NY_%^EV5])>7_B?6([O0;6:)-/M](U6.Y:^A /V_P#V,O\
M@G%^QO\ L!>%+GPO^R?\ ?"'PI;5(KFV\2>*[:6Y\3_$GQ-#/K5YKWV/Q?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK T5PUQ:W$]NPGD8H%1V<I=P+$H-U;,OE[PI(;<*WHD$:*BA0%SPB[5R222
M.!DDDX[DT^B@ K\B_P#@O3_RAX_X*%?]FW^+O_2W2*_72OR+_P""]/\ RAX_
MX*%?]FW^+O\ TMTB@#QO_@VB_P"4(W[#/_8L_%;_ -7U\4J_=BOPG_X-HO\
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M ^LRS:]:7T/ACQ=HVA>/_#^DW%EXCUK^T['4-.C6RE^M?V]O^#3[2_''A?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML=/@L;2:YGNKMH;96N9[F=Y)3Z93=B;M^Q=^ -VT;L D@;L9P"20,\$DBG4
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MOB'Q%JMIH_A_2)M3_99\+Z'9PWVL7DL>GP-J.J:C8:;9&6X3?K-]:Z>0LDN
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MX@T[3I;[Q.NOVVL7 N;6 VQT^XM(/,\R(@?S(?\ !PW^UI\6?VSOVQ_V9?\
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M:+?_ )_U_P#!C;__ !5'VBW_ .?]?_!C;_\ Q5 &Y16']HM_^?\ 7_P8V_\
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M\"_^2)_!_P#[);\/O_41T>O5*\K^!?\ R1/X/_\ 9+?A]_ZB.CUZI0 4444
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MDN9TE!5]X E1UD SP5#8*_*1MXJT%"C"@*,DX P,DY)X[DDD^] 'Y!_MT?\
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M^'6L6\-W\,_"$7BBW1M:;3;WP_\ 8O'NKZ!K$D6HZ'XQ\5Z_I>HQ/<6(>OZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR_LJS,H7]D7]H:+N-_C?X:8/L/FCZ\?WOYU^4'_$(+_P6 _Z!/[,W_A](O\
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M_$4?8[/_ )]+;_OQ%_\ $4 ?YU^?^#27_GV_X*&_^;D__':,_P#!I+_S[?\
M!0W_ ,W)_P#CM?Z*'V.S_P"?2V_[\1?_ !%'V.S_ .?2V_[\1?\ Q% '^=?G
M_@TE_P"?;_@H;_YN3_\ ':,_\&DO_/M_P4-_\W)_^.U_HH?8[/\ Y]+;_OQ%
M_P#$4?8[/_GTMO\ OQ%_\10!_G7Y_P"#27_GV_X*&_\ FY/_ ,=HS_P:2_\
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M5I<W*E5^T?9I$ /U1N;B:&W%W=7?EZ?912RW\V39S*L+$SW<CEMBV=K!NFD
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MQ+DJH"*/[][@XA;]V\OW?D3[S?.O3) X^\<]@: /XL?@O_P2\O/CI_P<F_\
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M5[G2]+TO39KQ8DDDLM-LX7W>5N;\J+UB?^#8#_@LHI)*Q_\ !2;XX(@[*O\
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M>*2NW/0 *26P.^:9]K<72PL(1&PV+F1DN7N =S+'%+&B21+"&D:1)2PVD;*
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M*0.6'6KC!S5U+E<&WKHG\*LWT3TOH]$;TVH/"^ZJCQF)>"FE?W(U8TW&LO\
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M#;L9;?\ X5OXN$=QP%D\O]CWX,Q%=N=RR+L^<8V@G )P:_KR@Z'_ '8__0:
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M @?.[K]P?XEWPB^%!^-WQRT/X>^"?!?Q8\6Z1KVO7M]/X6^"W@ZX^+OQ4M/
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M7%I'/HD4<>E2O-)9M-)_7I_P6L\$_P#!1GQY^QU):_\ !+SXAW_@#]IGPO\
M$GPQXI>UTG6_#6AZ[\0?A_%8^)=-\1^!O#=SXLL[O0!KLE]J.B>)D369M(L)
MM+\-ZK&FJ"]:UM;D _6F:9;8'SE*IYD<:W"?:I8V,ZOY1\N+>XVRA4?G: P8
MNJG-0_:%;R)%CO6:,MYD, ^6Z!D6W)$<\R2^5'(PF63:H4+DL?NG_.UB^$/_
M  >FLY+^+?CX(0LY2+_A;G[(ZW!D-L6B9II-4$1B^T&,-&R+)M\Q$"LIE7^F
M#_@@]X5_X*\>%?A7^T+;?\%<-;\8:A\2KSQ_X1D^#[^-_$GPT\5W5MX(_P"$
M:NHO$(LIOAA=7&E1VG]N-9F>*\N(9C=9E<J@!8 _,OP!_P $R_\ @N?^Q%_P
M4%_X*(_MF_L4:=^P%XJ\._MA_$_Q[XIM]&^.WC'XE7VOVO@N7Q[XA\=>%+2U
MT[PII/ARTTKQ'J"ZP+.[CNO$6HZ=+.MN;B:S"FY7[C_X)[_\%UO''Q&^.'A[
M_@G5_P %,_V>O$_[(?\ P4>UJXU!M&\.:=X>N)O@_P#$G0[K1K;Q7X6G\(ZM
M'XG\27NF^(M9T.;4K.WL4U3Q#X6DNO#.J7$_C2QU!W\.V?TQ\7?^#@G_ ()!
M? WXD_$#X*?%?]L+3_"_Q&^&/B[7?!/C70;;X6_&;7/[ \1^'KZ33=2TF+5M
M$^'6JZ/?_8I[9[:>>SO-0LY65TBG(4-7X#_\%S/^"KO_  1Q_;-_9S\/?%7]
MFW]K30IOVY?V5/&?AGXJ_LR:_I_P0^-FF>+-=N-)UJ*;7_A)/XPU'PKX.MM)
M\'>+%GM]4U'[?K"VUH-!DM+.%6UF\:0 _H _X+>_L>_MM_MN?LD^$OA/^P-\
M:5^"OQC\._'7PSXNU?Q>/BQX]^#,4_@K3_"/C'3-4T8^,/ %M?Z]J%S)J&L:
M'=2Z;+:3:;=E#,Y2>R@>/^4S_B'M_P"#F7:Z-_P44MI%D6)'#_M\?M2Y>.(D
MK&S+X15]K9(<@[F'&ZO[]/V>/%^M?%#]GC]G[XF>)[6R7Q7\0/A%\+_B'X@B
MTB)]/TB'Q-XS\$Z1XBUZ2PM99;F2WLEO]3OQ:6TD]P\-NT4!DD8!Z]WPWK^H
M_P#B: /XQ_\ @CO_ ,$?/^"TW[''[=_@'XX?MK_M:6'QC^ &F>&/B5I/BKP0
MW[5GQL^*C:EK?BCPA?Z)X<U%O!7CWP[I^@:G/:ZQ/:3"ZN)S=6@C\V >8JX_
MLU@F6>&*95=%EC215D0QR*&4$!T/*,,X*GD'BJ8LI0LBK+%@8^R!X!(+;:."
MQ9R\[!_G#%XR#TQ@&KR+L544 *H"@;F/ &!R02?J23ZF@#^;WQ'_ ,K67P[_
M .T-WB'_ -:4U*OPRO?^58+_ (++_P#:2CXX?^M0?L]5^YGB5D3_ (.L?AON
M=0\O_!'+Q'$D;!E9F3]I#4I?D+ +(&02$>66(\F7>%VU^&EYS_P:_?\ !9*0
M!MLO_!23XWR*Q \N13^U%^SXH>%QD2Q?+M\P<>8LBC[M ']WOP+_ .2)_!__
M +);\/O_ %$='KU2O*_@7_R1/X/_ /9+?A]_ZB.CUZI0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %)W'T/\Q2TG<?0_P Q0 #H/H/Y4M(.@^@_E2T
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M!_:PL/V39O'O@OX)^$/%7[8P^%>@Z]_PS=??$.TMOA]+\8[K1?#=WXN^&_\
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MM\.?@9\1K^;7O@SX*T;Q5>L]CJ6G>'=)TCQ)8ZK#:%?[/U:YGO!%'_;,;/\
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M/ 4>1)5 9&;("K]]9!CS(IAC:P')!& #_/@\5_\ !YE^UI\,O'FM?#_XM?\
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MG'W36Y5&^A>54*)*[1NLBI'<?9MS(<JLCCEXVS\T9^1L<CI0!_-]_P %5?\
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MA\97.J>'4_M.UTWP]I^I:E<W[OIUO;-,D:2?;'[&W@/PS\._V3_V:_"'P_\
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M!/&\>C>)M&:[-E<7>GIJFG6CWFG"+4(E-K<VTDO\3/AO]G7X,_$'_@Y1U/\
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MH.OX]?Q]Z*!G SR>Y]?>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR1?'+P%)%;&4E( \BZL4)E=9$ # IY>YN&6F?\/+O^"=W_1\G[*?_A\O /\
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M8##X_$Y_Q1D5?$N-.>68C^P\37P4VW[U2I152%114$W.,I4;R24M#_6UN?\
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M\_\ 2G-\4?\ Q'KX'_\ S%4?VO\ L\_]*<OQ1_\ $>O@?_\ ,57*>V?T@?\
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M1=>?\%?/^"5TS.]O_P %%?V)2X4O;RW/[1/PQ0P7(C\M)!CQ"PN%P2#D@QG
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M&U_M37?B]\$=2O3:6TA:VM#<WNL74YM[>.258D\XJC.SH%+/7Y>_&S_@HO\
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MFU&_N+NXD6VM=/M"^^.VBCV(A /K3X:?\$^?B[\*?^#EKXP_MM:+X,\>ZO\
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M>(_AUI&G74=S8:I:WEA<R(LGG6D=W;36_P!KC@DD0^6I7^&BYMOC!_P;^_\
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M7'K'@Z&XS?:HQD^DO^#@\_\ %<_\$35_B_X?)_LO<=_EMM>W<=>,C/ID9ZT
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M.?@'_P"J\T.OXR/^#WG_ )."_8)_[(Q\8_\ U./"U?U4_P#!(K]L7]D7P?\
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M )-N_9]_[(;\(_\ U - KW-OO1_5O_030!_E#_"#_E;/?_M+3\2O_5K^,O\
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M\'9NP<?Z(?\ P5P^'_C'XR?\$Q/VY?AE\,O#&H>.O'WCK]F7XFZ3X.\):5#
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M_P#*<'_@WG_['7]N?_U27A>OZ1:_FZ_X*E_\IP?^#>?_ +'7]N?_ -4EX7H
M_H=OR-UXT>RXFA'FRH6;[5#&"KP)$J9F$33HDR>7%,&$3+&L[-L/^4C_ ,'
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M?Z5)&%6&_BMY)%9-RL <3_P0[_X*<7__  5,_8E\*_&OQ6OAS3/C9X$U*_\
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M^(UA'K&OZC>:A'965Q=:7I>I7$ECX9TB[:XFT'3X8=/6YFV;Z_;;3V+I*Q4
MB9XV/DO TCP_NI)FB?A%FD5I(]F4:-E<,P;<?S+_ .")ZK_PZ._X)S':N?\
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M^&;S3)8EO/L%KK7AWQ!X>MTMT\N[TJP,D1_?H2 ?ZHW[%YS^R!^REZ?\,S_
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MK6N:@\'B:W@-[J=]-+=W/DPQ0F:5S#%%$4B3\&?^#WK_ )."_8)_[(Q\9/\
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M4*36MQ)%'<);#;&ZIYL:;7*! _\ K?CC@=!Q7^3[^S9S_P '8L0/(_X>J_'
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MH **** "BBB@ HHHH **** "D[CZ'^8I:3N/H?YB@ '0?0?RI:0=!]!_*EH
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MQ8-M+\&_ XM+B*RD5V56+D;6D?Y-S%C\JH ?;$G6/_KH/_0'K_&-_P""[?\
MRF7_ ."@O_9R6N?^B=%K_5O_ &SO^"F_[&/_  3STG1]3_:\^.'A_P"&=WXK
M\/\ C+Q+\//#KV.MZKXG^)$'@&ULV\1Z?X2T?2M*NH6U1+K5-)TRPMM4U'3X
M-0U/5+:);R"$2R1_Y#__  4P_:/^%W[7_P#P4%_:V_:=^%$GB"U^'_QC^+>M
M>/\ P0OC72[71M<.CSV%C)!:ZQI-EJFH1V&H/<V3P1QPZA>IY;(#(\L@V@'^
MUGX%1)/!7A".15='\*>'E9&&58?V)I_# \$>QKJ_L5H9Q<FVA^T*YD$WEKY@
M=HE@+!\;@QA1(R<YV*J] *_!_P#X)#_\%O/V3/\ @H/\*/V=?A[_ ,+:\):)
M^VGXB\ RP?$/]G6TT?7M&U"S\2> =#_XKB]\+K=IK.GS^$+>RT^X\0Z'<S>)
MIKZ^T>,M)#!=17%E!^]- !7Y'?\ !9G]E[QW^W+_ ,$ROVN?V>OAM/8Q^/?&
M'@:T\2?#_3[;1KO7=2\5Z_\ "7Q/I/Q)D\*Z19Q7-F[ZUXZ7PHO@WP[(TT*V
M&K:M#<W@N+5'B?\ 7&H$MX8YI9T4K),%$A#-M;;G#;,[ Y!PSJH9@%W$[10!
M_GD_\&;/[4O@'X<_$#]JW]A[Q7#)H_Q5^*,]A\6_!K7][;6TVN:E\+]!U;0?
M%WP[T#0#%]HO_%&F:5?:OXEN;P7/]GPZ1HE]YD"M&DC?Z#J^?"S_ "SI!(6/
ME&1&CBF9OM$EU/<H1+!"$_=B'/E_*0HR<U_G?_\ !9S_ ()D_M/_ /!+S_@I
M'X4_X*L?\$\_AYXY\=_"Y/B#:_'?QUX=\%^%I++P7\(O&<OC#2=-UGX7ZMI?
MPSO-%UO4_A;\3(;Z2SU/1-*T)?L7A^YU2P\07]U:7(NE_?\ ^&O_  =$_P#!
M*OQ]^RM9_'OXA_&,_"GXI0>!M5U/Q?\ LK3:?K6N?$]O&.D0SQ7?@[PWJ-CH
MT7AO7X=3U*V7_A#O$,FIZ3!?:?>6UYK%MI)-QI]L ? __!Y'^U[\-O#/[(OP
M<_8NBNUU;XK?%_XEZ)\=%0:G;17G@OP#\/&UO2M+U[4](FMWO;G1?&VN:QK.
MC^&M1MIHHXKSPIK<%QO4(A^Z/^#47]D"P_9W_P""6GA7XG:QI_A6Y\:?M5>,
M]?\ B[>:M:^$I=!\8V/@K3;L>#O!W@?QCJ-\BWNOKX>U3PWXH\2Z%<K'!IEO
M;>,Y4TZ&13)>W7\N7P7_ &,_VWO^#CK_ (*:6_[:/[0W[/WQ&^&'[#_BCQGI
MD/B;6IO$&L^&/#WA;X-^#_#>AWF@_#CX6ZAXQAU#4=<U;Q3I>L>'M?U._P#"
M>A6GA+7M6USQ7KVDW&A7=RL5M_I:^"_#.B> ?"/AOP+X,T^30_!O@?PSH'@;
MPMIMM))<C1]"\,6-EHF@:=&=2^T:C>?V;I<-G9/<WE[</,D#SR2/+(SL >B,
M 'CP,9=R?<E&R?T%?XP?_!9'_E-!^WI_V>;XZ_\ 4TCK_5I_;9_X*A_L7_\
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M;&/0],U.\EEO[72=4NA,MJ#:0:1>/<[47>P!_FY?\'DW_*6WPO\ ]F=_!O\
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MK2]URVTCP[X4T#P-IU]K/V2S2V@N]9LO#EMK]WIL,LJZ+)?RZ5]NU%K7[9(
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M+9[L2R6\-U<QPN@F?/I$,7DQ+'O>3:.9)2IDD/=I&54#.>YVC/?FOCCX6_\
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M%_P-X#\4G1=5,AL-8CT7Q-K.G7TNFW,,%S-#=QPO%*+:9$9G1E'EY_X*P?\
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M<M>7%S=7$WA9I)[B>\=[J::0M)+<LT[LTK,YV=+_ &D?@AK_ (X\-_##P_\
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M%X'>Z7:TENENZBY^2-TE+F,+MFBP3\^WXGUK_@J'_P $Y?#NO:KX5UW]NO\
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MEH#W,=]!XN\+O:P6GQ-CLK1]'%YJ^A:O:W,=SK=YI6E@']0-%9MKJ*7=P8X
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M4-YJFJQSWL_BSQ'X@F?P=X+BUB6T\'"5]<^QZ@UOJNIV^I/8I?V\-BEU);*
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MSX/?_-G7^=__ ,'8O[$/[)7[%OQ^_8C\+_LJ_ +X>? W0/B%\._B-J7C73/
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MI:7"^J:=%I]_=RWVFPRWT$9MPSI_,W_P29_X-</V0/V=?V>(-1_;[^$_P_\
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M_=Z;XD\.^(OCK\+]&\1^&KW3HC)J-KK_ (?U+Q3;:QIM[9,!'<6=S917%NS
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M/VT=9^&W[<W_  =Y?LT_!7Q[\/\ 6&\*?L[3^"?AGXEMY?$<UI_PE'B#X:^
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M/KI\.>/A&M_X=OKS7GM?$N@7?AJ5);"6/S[@S7;"*+]X_P#@Z,_Y0A_MA?\
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M6?PSJNI>*/$?P\T+4+32G&L^(O#FJ^(-*@*6$UV6B^#_ ,"=3^"/_!W'\?\
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MNH[G2ULH2+)(+BWG,2^3" ?B]_P=D?LI? ;]F/\ X*1^$]3^!'PYT?X63?M
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M'P#XW\6^$O#MWLTK1HYK#3K/5X/#EL8M(_MY]1OP(O[2FC3_ $$/CM_P2O\
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M#^/[:2ROU>TTVXNO"NKZM#HNJQ@7&F7C026Y2X\HC\'O^#+[]E7X#^+?A_\
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M7BB_T+3QFWL/$.IKI2:5+XAA']IKH-YJ6DQ2I::A>1S?VT?M^?\ )BG[;?\
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MTBVBCL;GQ,NG^)+C1[_Q00=7O]*LM+T^YF>#3;;'^B77\''_  ?$_P#)/_\
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M*'Q;X-\0WO@26^\<W/PZU:'Q5%++J'@[Q-?Z9)8ZO]IA-RMC=S);1Q,5,?\
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MI?*6YWP2)(IM7$FRXB921,CO&43RR=^Y77*$&KZG< PS@@'D8/(SS[U^7?\
MP22_:!T+]JS_ ()R?L@_&C0-&3PO::K\%?!_@9_#7_"067B'5]+OOAO;MX!N
M8_$M_INRUFGUBV\,6WB"RTRXM+74-/TG7!#=C[0=Y_4-1M55P!M4#"C"C QA
M1V [#L* /XM_VG?V\E_X)E_\'-?BOQ-\<_ #:9^SQ^W/\"?V<_@PWQ>\3:I_
MPC&@^$]-\/C1;.\^(6GZI?NFCZGX9\)>,4.E^.89G2>UM$NQ9DWJK#<?V5:5
MX@T[5+2VOK&]LM1T^^2XGT[4M-O;34;'4((;B2(R6=S8R303HJJ'9DD8H,I(
M?,5P/R)_X+!_\$;?@=_P5K^"DO@_QHVG^!/CAX,M+NY^!OQ\L=,%UK_@75+F
MY:YN/#OB*SBDMW\4_#?66)_MKPV]S!.ES*^KZ/=:?K*1WZ?QBW7[.G_!R9_P
M05_X3C1/@%XB\<_%C]E[PO;7NNOK?@/2;7XU?!G2? 6D^.-7GCU"/P!XQM]7
MO_A)XF\9&Z;7_%VD>$M,&NQ6&NQ75UKU_+;"YA /]*Z]9;V86LVFW-S:N/,F
M$ZL(4^S2J(C$@.5N))7,@#=8(ED/RNE?G!_P5V_93N/VT/\ @G#^V!^SWI\?
MB.[\0>+/A9J_BSP=:>$-&LO$?B/6O'/PPDMOB-X*\)^'+35$=3>>,/$?A73?
M"+Q6#0ZDEMK5\EC.CW!%?RY?LM_\'ET&E^)8?A_^WM^R#JOPPUB3Q9):ZUXP
M^#<NO./!7@R3P]9W>G2ZC\,?B&^H^,M<\376K&5YY1XFL;1]$O-*EM[ -:S-
M=?U@?L(_\%+?V-/^"D'@N[\4_LG?&#2/%MUX?T^SU+QG\/;Z&/1?BAX&MM9N
M-7TZP'C3P9<L\VE2ZC>Z5=SP-;R:A8&*.V:2Z1[V*&@#D_\ @C=\,?'WP;_X
M)C?L.?"_XJ^!?$'PZ^)/@/\ 9V\(>'/&/@_Q9IEQI'B7PUK=I)=?;M'UC3;I
M5N-/O8V\N>:VG59?WB953&P'Z;OT7_?7^=9FF,AP(KC[5%]F@\MQ&B;  P)/
ME*L69CEML8 7RSD#(K3?HO\ OK_.@#_.;_:,_P"5U/X<_P#9:_@!_P"LJ^%J
M_P!&8D $G@ $D^@')-?YF'_!1;X\>"OV8/\ @[D?X_\ Q&L/%^I^"/A9\2/@
M)XF\1Z?X"\-7?C'QC=V,?[,'@RR$.@>&;&2*[UB]:XO(";6W<2" 33#<(BI_
MJ@;_ (.>O^">95@OPN_;O5B#M/\ PR%XZ.#C@X-\ <'G&1GIF@#]5_V:/VZ/
MAE^TW\7_ -L3X'>&-$\2Z!X^_8K^-&G_  @^)EGK,$,NG:C%XA\-#Q/X3\::
M)JMFTEFVC:_96VLP&PN)$U72KK2634;>);ZQ>;\Q?^#D/]E/Q3^UG_P37\1^
M%O@_\"/$7QR^-W@CXR_!;Q;\+=#\$>')_$GC[1Y4^(>AZ-X[UKPW:P*UQ#$/
M 4VK66J7F1:_V3/*UPR1PF1/FW_@W\^//@W]I?\ ;*_X+F?M _#[3_&^B^!O
MB9^TQ\ _$VAZ+\2?#5YX2\56&GW'PZ\<07+^)/"]X\U_HUX6TZY$5E.TC);/
M9E4PVT?U$KI1>,I'.UM$YCNE-MPWV[S%F^U[I SR[L /%<>8C@#*XX !-H$+
MVVA:+;20-;26^DZ= ]LV"UN\5G#&T#;?EW1%3&<<97CBOQS_ .#@ZS0?\$;?
M^"A=UNE9I?@G9(0TTCHOD^.O"#@1Q-\D2YVM\F"S&0MU%?L]$ABBCC+%RB*I
M<JJER!@L50*@+=2%4+GH *_&W_@X/_Y0Q?\ !0;_ +(O!_ZFW@Z@#^#3X@:?
MX<_X)!_\%O\ ]@?]HS0-!^&FD?"?XD?"K]DOXVZ7H][9:SX9\"_#7P?\<OA#
M9_!GXH:GKVIPQQQ?VSX8G;Q?\3]2U#29I[(2ZKIL=\ACN-0MC_J?>%[K3-4T
MJSU[1;^#4]'U[3]/U32=0L9TETS4=+O;<7FFZGIZP_Z.(-0L;FWG$\1)N5,<
MC$@+7\+G_!RO^R!KOQ:_X([_ /!.?]J_PI;^,M9O_P!F+X._!WPUXTT?0;'2
M9_#6D?##XN_"CP -:\<>+;N9(]7LTTOQ;X.\#^'M+>UGN+3[3XF=+BQ)F%W;
M_P!&G_!"+]LV7]M'_@F%^S?\5M?US5?$WC[POX9D^$?Q.U:]\-V?AM=1^(/P
MPAM-+UN;2+33O*TR[TI=/NM!M+34K2*U34+J.X=K:.?S@H!^M'C#5[3PYHNH
M>)KLRF/PYI6LZT8?MT&G6=Q'IVFSW4UO>WEY)#I]M'+'$8X[F_ECMK:5EF=U
M5":_Q^?^"C7PNT/XF_LS1_\ !4ZY\':WX8U;_@H3_P %%?VQ_$?PF76?&MMX
MCN[3]GKPW/I)TKP]K.B:=-/8Z'XG\._$:3QCI-[=.8I]1TRVL'LX8]&^Q;O]
M#?\ X.1?VF#\%/\ @F1\5?A9X9?0=0^*G[7=]I7[+O@'P7JUIK]_KWBB#XHW
M5EH'C:Y\#Z5X?>*[U3Q5X3\*ZO/XBLK::0V;&U*SVU]D6<W\T7_!TG^S)H?[
M&7_!,K_@CS^R_H<?A.0?!]_B'X1UK6?!?AP>$M#\6>+-)^&GPZA\8>-TT(22
MR6^H^./$KZEXJUN:_FN=3NM7U2[N;RYEN9YW< _N5_X)]?\ )AO[#O\ V:!^
MS=_ZIGP17U^_W&_W6_D:^0/^"?7_ "8;^P[_ -F@?LW?^J9\$5]?O]QO]UOY
M&@#_ #L_^#V/_DYW_@GC_P!DM^*7_JP?!M?Z%GA#_D4_"_\ V+NB?^FVVK_/
M/_X/:95@_:7_ .">\[ABD'PH^*TSA%+N4B\?>#Y&"(.6;:IVJ.6. .M?T&:!
M_P '.'_!/2PT'1+!_AA^W;(]EI&FVC.G[(GC@J[6UG#"SJ4OW0JQ0D%7=2""
MK,,$@'ZD?!/]O_P;\;/VZ/VS?V%]*^'OBO0_%W[&.@?!+Q!XH\=ZEJ&C3^&?
M&MO\;O"R^*=(A\.V%I,^K64FBP,;/46U2.,3W$;O;CR?+>3QC_@MI^S]\7_V
MJ/\ @E_^V5^S_P# OPFWC;XH>/?AWI,OA'PL+^VM;K7;_P ->./"/BV^TS3)
M+IEB_M&[T+P]JIT:Q#(^HZU#9:5&RRZK&P_)7_@B]^T[\.?VQ?\ @LI_P6:_
M:1^$^E_$#2? GQ"^&7[$?]B:/\2_!E]X"\>VY\+>"=5\*:J^K>$=2FEN["!]
M6T:^?3IGG87NG?9[W;"9O(3^JN]TA;UA<VIC-R9GO(+Z=G<V\J6[0VT44>0'
MA28B?RI<P!@\GEF4HZ@'YI?\$1OA9\2?@E_P2E_8D^%'Q@\#>)OAK\2_ _PB
M_L;Q?X%\9:9<Z-XG\.:FOBOQ)<BRUC2[M4N;&Y>UN+:Z6WG1)$@N(MR+G:/T
MP\4?\B]XB_[%[5__ $AN*U[-9TA5;G:TXVB65=N)W"('FVJ (P[9 CYVJ!S6
M1XH_Y%[Q%_V+VK_^D-Q0!_C=?\$]_P#@G@W[>_P0_P""G&I>#=&U_7/CK^S)
M\,/!'QE^$^DZ"NLZG<^(-/@\<>([?XD>$K/PMH\<K:_X@\2>'+.VM_#DMW%)
M;Z1?6TET5'G%T_KB_P"#1W_@JAHWC/X:ZA_P3%^+$NMI\2O@U%XN\<?L^W$V
MD6\>GW'P@FN['4?&7@34]2W+J;^-/"OCO7=1U*WCU;>U[H7B'3] T**WL?"D
MD;?$W_!E9*T?[47_  4/96E##X2_#AE^SQ++<?+\2/$HW11R Q/MW?,K@YR,
M#@U\^?\ !>;]D/XQ_P#!&/\ X*C> /\ @IA^RS?^'+3P'\7?BWXB^-7P^TR:
MSU?Q-_P@OQECM[.X^+FB>/+37CJ-E/I/Q$U'Q#K6OZ!=I?V48L]=U3P_X=L;
M!O!EO>T ?Z:D5XDVT(I#&1DD1F57AV#)\Q2<AL%#LQG#@]*_G,_;F_Y6(/\
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M3RJL6KZ1=NI O[3=;^8PBW"5)8T_<^6S>X,$\4DD+P;6 1]J70&3Y,P&#L#
M#J<@\8%7+5)U$GG;@-^R*,LD@6*(;%<,J(?WP'FE'W&,L5!P* +=%%% !111
M0 4444 ?R'_\'GG_ "BU^$?_ &>9\.O_ %5OQJK]:_\ @@K>+#_P1O\ ^">8
M$;R._P"SYH06)<"1EBU?7!.R@\$1JI=1G,F551N8"OR4_P"#SS_E%K\(_P#L
M\SX=?^JM^-5>M_L8?\%$_P!GK_@FM_P;_?L _&SXVZU?ZMK.J?L_:5X=^#OP
M1\'-%+\0?C?\3I]=UQ-(\(^#--"3W#3O=W42^)=9NK2YT?1M/EDO[JVO[I;'
M2[T ^W/^"R/_  6.^#__  2S^$=C-<6$7Q/_ &J_B5IUQIWP*_9QTVZ-YJ.N
M:Q?N-,LO%'C:'2O-U'3_  +I.JRQJ\]ND>H^(-0,>@^'G.H7#30>8?\ !'K_
M ()F^+/A[:R?\%'/VXM7U?XO?\%)_P!JGP]I'B[QSXJ^(N@W.EZC^S7X.\0:
M/!=:9\ OAMX6U/SD\#'P?9SP:%XA%C%:Q[]/70].6/1M/M9+C^8;_@W3^+WP
M3_;;_P""L?QY^/O_  43U;4O&O\ P4!<S>*OV<[GXR:MI5CX;T/7='OYK34/
M#'A#X87.EZ?]C^)'P_T>-CX1TZU:VTSPGI&F-+X<\/VGB&.._C_T<[*2.7[0
MT<J2@3NC!)9)#&T?[LK()"=CY4DJH"D$,-V=Q %L[**T#L%C-Q/Y37=RL:QO
M=S1PI%Y\JI\H=@G(7Y5& .!5F7_5M^'_ *$*DJ.7_5M^'_H0H _SL?\ @]D_
MY.3_ .">?_9,?B[_ .K#\&U_H3^#/^16\+_]BYH?_IHL:_SU_P#@]F8)^T?_
M ,$^)""1%\+/C%,552SN(O'_ (/D*1H.7E<+MCC'+N54<FOZ#/#O_!S1_P $
M^-.T/1;!_A;^WC)<6&D:=:S(G[(7CEB%L].MH9;CY+]X_)4Q'++*^,Y&Z/#D
M _4GX*_M^^#OC9^W3^V9^PII7P^\6:'XO_8T\-?!7Q)XH\>:A?Z/<>&_&EO\
M:_"B>*M)@\-Z?9ROJ]I-HL#-97YU..,7%U&[6RF$QO)\V_\ !>+X1_%G]H/_
M ()+_MD_"/X,^"_%WQ"^)?BSPCX)@\'^ _ VES:YXM\7-9?$WP%JE[IUOH]J
MCW4Y2QM;[4)[>!6N%CTYV"GA3^8/_!%K]J3X;_MC?\%HO^"R_P"T9\*]*^(.
MA> O'OPI_8D_L?3OBGX,O?A_XTMW\-^!]4\*:DNK^%M1GN;S3HI=6T>\?3I9
M9#]NTQK6_"1+<")?ZM/L-S;F:2WDEE\TJT<+S*JVK']V1#N1H]J++))M*8D:
M)$/#< 'FO[.FCZMX>_9\^!.@:]IM[HVN:'\&_AAH^LZ/J4)M]1TK5=,\$Z'9
M:CIM_ <F"]L;R":UNH228YXI$/W:],NM)2>Z-VLC!V20-$[,8P[0F%982IW6
MTH4D221?-(IPWK6L@*JJDEBJA2Q !8@ %B% 4$]<  #L *=0!_"U_P ':/\
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MMQ9#[)8V<&J0RZ=H]A9,;6VM[(W$9D:[FED_'#_@DE\-/%W_  4P_;Z^//\
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MN(K;3I+M?]*4V,D;>=#Y=E;I]N>>TMT4)<M*S;)7*A5WR(%>0[2ZM@*P^8D
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MF2%H"&B,9*D,7'1]PWDDDJ^Y3DY!!4XQ@?YU_P#P9Q_\I%_^"B'_ &1^[_\
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MIT^SL[2Q2Q%NKM_H/5_G'?\ !%D_\=7_ .W,_P#"/'O_  4%8M_"%_X6I/\
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MR>$O%]O_ &#JND37D^COJVIPR6-[+/I4PN)8KRPOHR"/X3/V9?!?_!3#7O\
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M^P_X/ABH3_@G'OZ?\91 <%OF*?!,)QN7^,KSD@=2K@%3X-_P0N_Y6G?V^_\
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M)S_]B+^TG_Z>_@S70?\ !CI_R&O^"CW_ &!_V9?_ $K^.%<__P 'Q'_)1O\
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M)HU[?:UKFM7<B.EOINEZ?!)>7\TBLJ6ZNY4]#_"C_P &77PF\73_ !2_;O\
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MW@$]CH-M=W$<LL@BNYYXXW:)48_F5_P=D?\ *%#X_P#_ &4K]GK_ -7'X4H
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MQS:V&EZ5IMM%9:?IUC;0[8K>TLK2&&VMH(E6.&&)(T4*H%:/_$6W_P $9/\
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M^@?]C'_@IO\ \$WKS]GO]D3X;Q_MN_LK:E\2$^!WP*\#6_@*Q^-7@74?&?\
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MTX#_ (*Y_P#!*CC/_!1/]B<],G_AH[X7#<>YP/$^!N.3@<#/%?F;_P %E/\
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MBYO9(6E/[(1W,\L#2OCRGG(!$N^5K&90,JL"PFWN$+Q,%DW/$,Y8MEJ_"?\
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M:6T-OK>M^'[[X[>"]3L]99K33=)T^[L[Z6\N'LKW3+&+3[F *]NTHW2-E?\
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M_C+X:^(;C3O&?A;59?!E[<W4^C?\(_*6T35]0MYP#V']@WQK9?&[_@O_ /\
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M4EI?G9B-S,223DYF\B#_ )XQ?]^T_P * /Y^?^(8'_@B-_T9L?\ P^GQ[_\
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M&\B'_GC%_P!^T_PH\B'_ )XQ?]^T_P * /Y^?^(8'_@B-_T9N?\ P^GQZ_\
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M[]I_A0!_/S_Q# _\$1O^C-C_ .'T^/?_ ,\VC_B&!_X(C?\ 1FY_\/I\>_\
MYYF:_H&\B'_GC%_W[3_"CR(?^>,7_?M/\* /Y^?^(8'_ ((C?]&;'_P^GQ[_
M /GFT?\ $,#_ ,$1O^C-C_X?3X]__/-K^@;R(?\ GC%_W[3_  H\B'_GC%_W
M[3_"@#^?G_B&!_X(C?\ 1F[?^'T^/7UQ_P E,]_K[T?\0P/_  1&_P"C-C_X
M?3X]_P#SS:_H&\B'_GC%_P!^T_PH\B'_ )XQ?]^T_P * /Y^?^(8'_@B-_T9
MN?\ P^GQ[_\ GFT?\0P7_!$8\G]C=B2<DGXZ?'O))_[J;7] WD0_\\8O^_:?
MX4>1#_SQB_[]I_A0!_/S_P 0P/\ P1&_Z,V/_A]/CW_\\VC_ (A@?^"(W_1F
MQ_\ #Z?'O_YYM?T#>1#_ ,\8O^_:?X4>1#_SQB_[]I_A0!_/S_Q# _\ !$;_
M *,V/_A]/CW_ //-H_XA@?\ @B-_T9L?_#Z?'O\ ^>;7] WD0_\ /&+_ +]I
M_A1Y$/\ SQB_[]I_A0!_/S_Q# _\$1O^C-C_ .'T^/?_ ,\VG+_P;"?\$25#
MA?V.7"R *X'QU^/0#J&5PK ?$SD!U5@.S*I'(!'] GD0_P#/&+_OVG^%'D0_
M\\8O^_:?X4 ?S\_\0P/_  1&_P"C-C_X?3X]_P#SS:/^(8'_ ((C?]&;M_X?
M3X]?U^)G^>U?T#>1#_SQB_[]I_A1Y$/_ #QB_P"_:?X4 ?S]'_@V#_X(CDDG
M]CAB226)^.GQ[)8DYR3_ ,+,]>>,9[TG_$,#_P $1O\ HS8_^'T^/?\ \\VO
MZ!O(A_YXQ?\ ?M/\*/(A_P">,7_?M/\ "@#^?G_B&!_X(C?]&;G_ ,/I\>_Z
M_$RC_B&!_P""(W_1F['_ +KI\>OZ?$P5_0-Y$/\ SQB_[]I_A1Y$/_/&+_OV
MG^% '\_/_$,#_P $1O\ HS8_^'T^/?\ \\VC_B&!_P""(W_1FQ_\/I\>_P#Y
MYM?T#>1#_P \8O\ OVG^%'D0_P#/&+_OVG^% '\_/_$,#_P1&_Z,V/\ X?3X
M]_\ SS:/^(8'_@B-_P!&;'_P^GQ[_P#GFU_0-Y$/_/&+_OVG^%'D0_\ /&+_
M +]I_A0!_/S_ ,0P/_!$;_HS8_\ A]/CW_\ /-H_XA@?^"(W_1FQ_P##Z?'O
M_P">;7] WD0_\\8O^_:?X4>1#_SQB_[]I_A0!_/Q_P 0P/\ P1&_Z,W;_P /
MI\>O_GF9I?\ B&"_X(C?]&;'_P /I\>__GFU_0-Y$/\ SQB_[]I_A1Y$/_/&
M+_OVG^% '\_:?\&PG_!$F-@\?['+HZ_=9?CK\>P0>F0?^%F9Y!(^AIO_ !#
M_P#!$;_HS<G_ +KI\>OYCXF U_0-Y$/_ #QB_P"_:?X4>1#_ ,\8O^_:?X4
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M\*/(A_YXQ?\ ?M/\* /Y^?\ B&!_X(C?]&;G_P /I\>_Z?$RC_B&!_X(C?\
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M,_\ K4?\0P/_  1&_P"C-S_X?3X]_P!?B817] WD0_\ /&+_ +]I_A1Y$/\
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M0;6#$!BK##@;'&.49@"#@AGV2/ &Z0;9O.4A@"C'J%PH^4C*G.20S9/-6:*
M*(L0+9;87-V FP";SA]H.PY^:79SO/W^/F&>E/FM%FD61IKA-J2IY<<NR)A,
MJ*V]-OS%=F4.?E9G/?BW10!3DLDD&!+/%@1!3$ZJR+$Y8*K%&.U@2C@D@H2!
M@G- L+<3M<A7\Z3B5B[,)4P0(W5MR[%X(5 O*J3G%7** &A !SD^Y))/UJ V
MR,S,S2,&DCD5&8%8FC7:!$-N5#'+L,G+DD$=*LT4 11P1Q($1<*,X'H"2<<8
MX&<#.3@ 9.*BN;."[C$4Z%D5Q(N&92LB@A7&#R5R2 P9,\E35JB@"%8 'WEY
M'^18PK,"HV]6 "@AGXWG.#@<#%+)"DJ,C [6&#CT_'/\JEHH J06-M; >7'S
MP2S$L6<$GS"/N!R222JKR> *MT44 %%%% %7['#YDTJADDN'1YW5CF4QIY<8
M8-N ")@ *%Z G)SF!=+M0BQMYLB+#Y($DA8\DEI2V S3/\H=R3E45< #G1HH
M 9&@C1$!)"*J@MC)"@ 9P ,X'8 >@%0S6RS,7,DL;^1+ K1E59!-MS*C%"PE
M3:#&<E5/)1B 19HH I/80OM):0,N&W@KN:4?=F8LAW3+U1R/W9Y0*:F-NI=I
M"SDE=J@D;8LKM9HAMRK/U<DG<>H[5/10!GC3;951%\Q0L31'#*=^X[ED<,K+
MYD3YDA*A1&[,57& )DLXD7AI&DVJIN&(:<A552?,V\%]NY\ !F9SCYJM44 5
M/L-KM""", ;<$*-XV/YJ8?&["R_O%!) ?G':A+*&./RT,H4JB-^\8LRHI4 L
MV3@@G=@C<>35NB@"G'9)%('26<*L8B6'S,P*@E:483;U&[R\Y_U05/X0:!9@
M1S1_:+H^>\KEVFS)'YJE2D+;?D1,YC4 [6 .3BKE% %06:!-GFW#'8(_,:4F
M38!&"-V.K^4"QQDLSD$;JD-M =W[I 63RRRHH?:.@#@;AM/*\\-\PYYJ>B@"
ML;2)HY(I-\BRH(Y=[L6=0NWYF&#G'4@@DTQ+"!-^0S^9DMNVCEHUB=OW:IN>
M0*&=WW.7)8,. +E% &='IEM$AA1I_LW[L"V:9WA0)NX7?NDPS-O?,ARRJ1C&
M#.]G#(%#F1MF "9&S@21R!3C 8!HU&"#E2RG(8U:HH SUTNR1!''&T:B)X/D
MEE!\F23S9(R2Y)#OR6)W@':K*N!4BV,*?,N]9=FQIP5$[CU>0*"Q)RQS\K,2
MY4L2:N44 5OLD(#J-RI(2S(K$+O+!BX[ABPR2",\^M1+81*25DGVD*!&9 Z(
MPF:8N@=6(=V;:Q+$;%55"[<U>HH JM:1,6.9%9@59D<J6#,C/GMF38JNV-VT
M84KDFEM[5+>,QAY9?G9]\S[W^8YV[@%RJCY5R"P4 $GK5FB@"O/;17"!) VT
M.KD*[)NV'(5BI!*$_>4$;L#-*L"K*\F^0[T1"A(V?(6(? 4,7PVPEF/R(@ &
M,F>B@! H'('\Z;(GF(Z;G3>K+OC.UTW#&Y&P<,.JG!P>U/HH SSIT6T*)KE<
M$E2LQ!7J8\9!'[DG=%D$@_>+CBM"BB@" V\9<.=_WS(4W'RV<JJ LO0[0HVC
MH#S@GFI5544*JA5&<!0% R<G   ')SP*=10!2N+))V9Q+<6\C! 9+=PC_NV#
M @LC@,5S$S 9,3NF1G-2?98@$5=R*G!56^61>?DE#;MZY)//.>^.*LT4 5/L
M4'R@AF5!A4=BRC#%DQNR08\D(P(95^7)%+':+&\<AEFE>-9DW2LK,ZS2"3YS
ML!/EX"1[2H"<,&(!%JB@ I& 8%6&01@CD<'Z<TM% %5[2-W1RT@*L[,J/L68
MLH4>?M :3RP!Y>6^7IR.*L;%]/Y_XTZB@"I)9Q/()0TD4N]6:2(JKR(N?W#N
M59C Q.YHP5RP!R"!3I+59&D;S)4,D83,;!"I'W95(7=YJ_PLY8#^[5FB@"F+
M-!(L@EFR&D=E#JJRM(,9F"(ID,8XBW'Y?>IXX50-\SR%G=RSD%OF8L%RH7*H
M#LC!R50*N3BI:* *\]LDZA2\L15E97AD:-P58-C(R"&V[6!!RI(X)S37M(W,
M?S2(J,Y\N-@D;K(I5HW4+S'N/F8&UA* ^[J#:HH J1V<<:0IND<1,S$N59IV
M8'+3ML!D8-M</\K;T1B25ID>GVT4WG1JROC!^8L&/3>=V6+;?E^\% Z*#S5Z
MB@!NU?3^=0"UB# _,P"NHC8[HQYC%G;8P(W,6()_N_+TR#9HH 0    8
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M<Q,JK(=LP,9C*29!;9SOVQLG[P!O:KU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MG<?0_P Q2TG<?0_S%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2=Q]
M#_,4M)W'T/\ ,4  Z#Z#^5+2#H/H/Y4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)W'T/\
M,4M)W'T/\Q0 #H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4G<?0_S%+2=
MQ]#_ #%  .@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2=Q]#_ #%+2=Q]
M#_,4  Z#Z#^5+2#H/H/Y4M !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)W'T/\Q2TG<?0_P Q
M0 #H/H/Y4M(.@^@_E2T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4G<?0_P Q2TG<?0_S%  .
M@^@_E2T@Z#Z#^5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2=Q]#_,4M)W'T/\ ,4 (",#D
M=!W%+N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH
M -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.
MBB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZ
MC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1
MN'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1
M^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W
M#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z**
M #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/S
MHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>
MH_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT
M;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4
M?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -
MP]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB
M@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\
MZ** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'
MJ/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=
M&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U
M'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #
M</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHH
MH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_
M.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;A
MZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G
M1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]
M1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@
MW#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z*
M* #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/
MSHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X
M>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'Y
MT;AZC\Z** #</4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</
M4?G1N'J/SHHH -P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1N'J/SHHH
I-P]1^=&X>H_.BB@ W#U'YT;AZC\Z** #</4?G1G)&,'@_P!*** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g1ow311dygir000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g1ow311dygir000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (K RT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG@@C@J>"*QQX*U34KZQF\3^)6U6VL95GAM(;)+:-Y5^ZTF"Q?'7' SVKM**
M.,G\%:I:ZAJ4WA[Q-)I5MJ<QN+FW:S6?;*PPSQ,2-A/4YW<\U-IG@.ST;4M
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M1YGWN^.@KI/#6I3:SX5TC5+A8UGO;*&XD6,$*&= Q R2<9/J:TV.U2V"<#.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG*8QR22>.IJ6YL+.\BBBNK2">.%UDC66,,$=?NL >A'8CI0!XWJ^B7GAV_\
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MBSM+ QNXX. 02",CBJMAXTM[SP_)KTVDZE9:6MK]JCN+CR3YR$9&U4D9LD=
M0.M96@S?VY<:CJ5_;ZM'JUS9-$EM]@GMUM8,Y$223(J-*2P)8GD@8^5:YV71
M[V?2;NP\.P^(&TN/24$MOJOG*S7$<B-&L0FQ@E5D#"/$?*@=J /2=&UR/61=
M)]DN;*ZM)!'/;703S$)4,I^1F4@A@003W'4$5J5R_A@27FNZ_K/V>Z@M;R2"
M.!;J!X781QX9MC@,!EB.0,[?3!KJ* "BFNI8<.R?[N/ZBF>4_P#S\2?DO^%
M$M%1>4__ #\2?DO^%'E/_P _$GY+_A0!+147E/\ \_$GY+_A1Y3_ //Q)^2_
MX4 2T5%Y3_\ /Q)^2_X4>4__ #\2?DO^% $M%1>4_P#S\2?DO^%'E/\ \_$G
MY+_A0!+147E/_P _$GY+_A1Y3_\ /Q)^2_X4 2T5%Y3_ //Q)^2_X4>4_P#S
M\2?DO^% $M%1>4__ #\2?DO^%'E/_P _$GY+_A0!+147E/\ \_$GY+_A1Y3_
M //Q)^2_X4 2T5%Y3_\ /Q)^2_X4>4__ #\2?DO^% $M%1>4_P#S\2?DO^%'
ME/\ \_$GY+_A0!+147E/_P _$GY+_A1Y3_\ /Q)^2_X4 2T5%Y3_ //Q)^2_
MX4>4_P#S\2?DO^% $M%1>4__ #\2?DO^%'E/_P _$GY+_A0!+147E/\ \_$G
MY+_A1Y3_ //Q)^2_X4 2T5%Y3_\ /Q)^2_X4>4__ #\2?DO^% $M%1>4_P#S
M\2?DO^%'E/\ \_$GY+_A0!+147E/_P _$GY+_A1Y3_\ /Q)^2_X4 2T5%Y3_
M //Q)^2_X4>4_P#S\2?DO^% $M%1>4__ #\2?DO^%'E/_P _$GY+_A0!+147
ME/\ \_$GY+_A1Y3_ //Q)^2_X4 2T5%Y3_\ /Q)^2_X4>4__ #\2?DO^% $M
M%1>4_P#S\2?DO^%'E/\ \_$GY+_A0!+147E/_P _$GY+_A1Y3_\ /Q)^2_X4
M 2T5%Y3_ //Q)^2_X4>4_P#S\2?DO^% $M%1>4__ #\2?DO^%'E/_P _$GY+
M_A0!+147E/\ \_$GY+_A1Y3_ //Q)^2_X4 2T5%Y3_\ /Q)^2_X4>4__ #\2
M?DO^% $M%1>4_P#S\2?DO^%'E/\ \_$GY+_A0!+147E/_P _$GY+_A1Y3_\
M/Q)^2_X4 2T5%Y3_ //Q)^2_X4>4_P#S\2?DO^% $M%1>4__ #\2?DO^%'E/
M_P _$GY+_A0!+147E/\ \_$GY+_A1Y3_ //Q)^2_X4 2T5%Y3_\ /Q)^2_X4
M>4__ #\2?DO^% $M%1>4_P#S\2?DO^%'E/\ \_$GY+_A0!+147E/_P _$GY+
M_A1Y3_\ /Q)^2_X4 2T5%Y3_ //Q)^2_X4>4_P#S\2?DO^% $M%1>4__ #\2
M?DO^%'E/_P _$GY+_A0!+147E/\ \_$GY+_A1Y3_ //Q)^2_X4 2T5%Y3_\
M/Q)^2_X4>4__ #\2?DO^% $M%1>4_P#S\2?DO^%'E/\ \_$GY+_A0!+147E/
M_P _$GY+_A1Y3_\ /Q)^2_X4 2T5%Y3_ //Q)^2_X4>4_P#S\2?DO^% $M%1
M>4__ #\2?DO^%'E/_P _$GY+_A0!+12 $  DGW-+0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12,RHI9B
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M%]I@_P">T?\ WV*/M,'_ #VC_P"^Q0!+147VF#_GM'_WV*/M,'_/:/\ [[%
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M 2T5%]I@_P">T?\ WV*/M,'_ #VC_P"^Q0!+147VF#_GM'_WV*/M,'_/:/\
M[[% $M%1?:8/^>T?_?8H^TP?\]H_^^Q0!+147VF#_GM'_P!]BC[3!_SVC_[[
M% $M%1?:8/\ GM'_ -]BC[3!_P ]H_\ OL4 2T5%]I@_Y[1_]]BC[3!_SVC_
M .^Q0!+147VF#_GM'_WV*9+?6<$9DFNH(T'5GD  H2OL)M)798HKDM0\?Z;
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M]BC[3!_SVC_[[% $M%1?:8/^>T?_ 'V*/M,'_/:/_OL4 2T5%]I@_P">T?\
MWV*/M,'_ #VC_P"^Q0!+147VF#_GM'_WV*/M,'_/:/\ [[% $M%(&# %2"#T
M(I: "BBB@ HHHH **** "N%A\#:NFK?:9?$(ECM$)TYY;<R3)+L>-'F8O^\V
M+(P[;C@GISW5% ',:!X9O]+TZ?3;^_L+NSGC<3&&QDBFFD?[TCR-,^XD9SQZ
M8P!BJ4/@*233;NUU+5S<O)I\>G6TT5N(FAB0DJQ!9@S[MI)X!VC"CFNTHH Q
MM"T:XTV:_O+^]CO+^^D5Y98H#"@"H%550LQ  !/+'EC[ ;-%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBH;FZM[*!I[F9(8EZN[8%-)MV0FTE=DU
M5-0U.RTNW,][<)#'VW'D^P'4GZ5RMSXQO=5N&L_#%D\[#AKJ1<(OO@_U_*I=
M/\$"6X%]X@NGU"Z/.PL?+7V]_P!![5U+#J"O7=O+K_P/F<+QDJKY<-'F\W\/
M_!^17D\2ZUXBD:W\.6;0P9PUY.,8^G8?J?I5_2O!%G:S?;-3D;4;UCN9YN5!
M^AZ_C^E=/'&D,:QQ(J(HPJJ, #Z4ZE+$M+EI+E7XOU8X8).7/7?/+\%Z(0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD^\B<8!_'/'O6M6A2]E[6G+?IU,:&)K.LZ%6&J7Q+9_U^9T5%%%<9Z 4444
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M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
M1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_
M (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#G
MG'_W\/\ A4M% $6Z?_GG'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A
M1NG_ .><?_?P_P"%2T4 1;I_^><?_?P_X4;I_P#GG'_W\/\ A4M% $6Z?_GG
M'_W\/^%&Z?\ YYQ_]_#_ (5+10!%NG_YYQ_]_#_A1NG_ .><?_?P_P"%2T4
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M[:T=T_\ SSC_ ._A_P *EHKFE*4G>3NSNA",(\L%9$6Z?_GG'_W\/^%&Z?\
MYYQ_]_#_ (5+14E$6Z?_ )YQ_P#?P_X4;I_^><?_ '\/^%2T4 1;I_\ GG'_
M -_#_A1NG_YYQ_\ ?P_X4EQ=VUG%YES<10Q_WI'"C\S7.7_Q!T"R)6.>2[D'
M\-NF?U.!4N48[LRJUZ5+^))(Z3=/_P \X_\ OX?\*KSZA':R1QW$UI#)(<(L
MEP%+?0$<UR?_  E/BC5N-'\/&&,])KH\8]1G:/YUS^L>"_%FJ7Z7=V;>YFE
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M$(UO_H<]0_)__CE9\TOY2?K&(_Y\O[X_YG9;I_\ GG'_ -_#_A1NG_YYQ_\
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M?\*-T_\ SSC_ ._A_P *EHH BW3_ //./_OX?\*-T_\ SSC_ ._A_P *EHH
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M,.!DD?Q<YZ]L5T,.EZYX[F6ZUAGT_1@0T=HAPT@['_ZY_ 5W=A86FF6B6ME
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MUM-G_GG*K?R-4;CPGH%SGS-)M1G_ )YIL_\ 0<5EW'PX\.S9V0SP?]<YB?\
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MD7W-4#_[EVX_F!62E#K?[E_F<SQN(6]!_>>HT5Y.^A>/X?NSWCC_ &+_ /\
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MC?XT>0G]Z3_OXW^- $M%1>0G]Z3_ +^-_C1Y"?WI/^_C?XT 2T5%Y"?WI/\
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M K$UOPGH^OJ3=VP6<CB>+Y7'X]_QS6W151E*+O%C3:U1Y_\ V=XN\)<Z;/\
MVQIR_P#+O(/WBCV'7\B?I6OHWCS2-4<6]PS6%X#@PW' SZ!NGYX/M74UD:SX
M8TG7D/VZU4RXP)D^60?CW^AR*V]K"?\ $7S1?,I?$C7HKS[^QO%?A/YM&N_[
M4T]?^76;[RCV'_Q)_"M71_'^EZA)]FO@VFWH.&BN.%SZ!O\ '%*5!VYH:K^N
M@G![K4ZRBD!! (((/((I:P("BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "J]]?VNFVCW5[.D$"=7<_YR?:L;Q)XOL/#R>4?](OW'[NUC/S
M$GIGT'ZU@V/A?5/$]XFJ>*I&2$',.GJ2 H]_3^?J16T*6G//1?GZ%J&EY;$4
MVK:YXYG>TT57L-(!*RWCC#2#T'^ _$BNMT#PUIWAVU\JSBS(PQ)._+O]3Z>P
MK3@@BMH$@@C2*)!M5$& H]A4E$ZMURQT7];A*=U9;!1116) 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !114-T5%G.7F$"B-LRDX$8Q][/MUH FHKQW1+#^RH==TNVTF%]>NK*
M6*SO+*YS%>L+6 G>S;<NQ8298$#>^'R3NNW$P\+>$O$^E6>@6.BZM;:*+D3Z
M<ZL)DVN@=G"(=ZD,<$'KD$Y- 'JM%<=X6LK71O%^NZ1I=O';Z9':6<Z10@*B
MR-YJL0!W98TSZXSWKL: "BFNX09(8Y_NJ3_*F>>G]V3_ +]M_A0!+147GI_=
MD_[]M_A1YZ?W9/\ OVW^% $M%1>>G]V3_OVW^%'GI_=D_P"_;?X4 2T5%YZ?
MW9/^_;?X4>>G]V3_ +]M_A0!+147GI_=D_[]M_A1YZ?W9/\ OVW^% $M%1>>
MG]V3_OVW^%'GI_=D_P"_;?X4 2T5%YZ?W9/^_;?X4>>G]V3_ +]M_A0!+147
MGI_=D_[]M_A1YZ?W9/\ OVW^% $M96L>'-*UV+;?VB.X&%E7Y77Z,/Y=*T//
M3^[)_P!^V_PH\]/[LG_?MO\ "G&3B[H:;6QPA\/^*/"A\S0+W^T+%>39W'4#
MV[?D1]*T=)^(&G7<WV34XWTN]4[62X&%S]3T_'%=5YZ?W9/^_;?X5G:MI.DZ
MW#Y>H69EP,*_E,'7Z,!D5O[6,_XB^:W+YU+XD:JLKJ&4AE(R"#P12UYVV@>(
M/##&7PW?RW5H#DV5S&?TXQ^(VFM'3/B'923?9-:MY=+O%X995.PGZXR/Q'XT
MG0;5X.Z_'[A.'6.IV=%4(=:TVXN/L\%Y%+,!N,:'<V/7 YJUYZ>DG_?MO\*Q
M::W():*I2ZM80?ZZY2/_ '\BJ<GBWP_%]_5[4'T#Y/Z4U&3V0[-FS17-R>/?
M#$?754/^[$[?R6J<OQ,\.1_=FN)?]R$_UQ5JA5>T65R2['845PI^*.F2'%KI
MVHS'_<4?R)H_X3_4YO\ CT\):A+Z$[OZ(:KZM5[#]G+L=U17!'Q5XPF_U'A1
MD_ZZ[O\ ZU-_M3XA7'33+.V'^Z3_ .S&CZO+JTOF'LWW1W]%<!]G^(5Q][5+
M.W!Z@0$G_P!%G^='_".^+)_^/CQ5-'GKY4+_ - */8Q6\U^/^0<BZL[^D9E4
M98@#U)K@?^$%O)O^/OQ3JLWK^[D'\V-*OPTT9CNN+W5)F]QC_P!DH]G2_G_
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M*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\
M?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_N
MR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+
MST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H
MEHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_
M  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_
MW[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3
M^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\
M*//3^[)_W[;_  H EHJ+ST_NR?\ ?MO\*//3^[)_W[;_  H EHJ+ST_NR?\
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MASD]V3=L0  8   ["EHHJ1!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45!?
M7MOINGW-]=R>5;6T3332$$[44$L<#G@ ]*YZU\;VLNEWU_=:3JMA%9IN(N84
M)E.=NU"CL-^[ VD@\CMS0!U%%9FC:U%K$=R!;7%I<VLWD7%K<[/,B;:&&=C,
MI!5E(()&#]:TZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJZR/HU\D5C'?NT#@6DD@19\
MJ?D+$$ 'ID\<UY1;6^I:AH^LVVCVVLOI,+K=?9[Z.02^='=)((XS+\[,8XV#
M DC.T#DFO9** .8\*QRW&K>(=8,%S!;7]W&;=;F%X798X40L4<!ERP8#(!(
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M @^8"P''S .U**_T_P 7:Y?Z=I\SX\/PQVOEQ'8\XEG(0$#&<LI/H#FNWHH
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MPO%]GD1=P5MTA,BGD;@%(P..?E .GHKS:Z^(>IP> ;/4TMK,ZU).8IHMC&)
MH+,V-V0"FTC)ZNM+J7CR_M+[7(X]8T!)]/NC#;:1+"QN[S"(P52)@=SEBH(C
M//8T >D45EV&I33:QJ.FW*(LMN(YHB@(W0R;@N1D_,&1U... >,X&I0 45B:
MCXNT+2KU[.]OA%<( 601.V,C(Y (Z51G^(7AN*!WCO7F=1D1I"X+>PR /S-2
MYQ6[.>6+H1;4IK3S1U-%<A8_$C0+F)FN99;1P<!9(V;/N"H/ZUH6OC7P]>74
M5M!J(::5PB*89!DGH,E<4E4@^HHXS#RM::U\S?HKSMOB%?Q:=XI,]K;1WFFR
M7+:?D-LN(8I/+)(W9W*V-V"/OJ>]=)JGBR#2-06"YTS4A:^?%;M?B)1 LDA
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M_P W9SG/&-GISGM6K10!PA^&ZG3-'M?[4/FZ5IHLX)1;_P#+59894E(W= T
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MQNWE2N<_,3][G-=O118:E9I^=SG+F>>TU#4=6>SNIX["R6*W@AB9GE=OG?:
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M"T/_ ,',W_R+0!T%%<_]L\8?] +0_P#P<S?_ "+1]L\8?] +0_\ P<S?_(M
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M"T/_ ,',W_R+0!T%%<_]L\8?] +0_P#P<S?_ "+1]L\8?] +0_\ P<S?_(M
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M"T/_ ,',W_R+0!T%%<_]L\8?] +0_P#P<S?_ "+1]L\8?] +0_\ P<S?_(M
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M^;#<,(P6&Z+: ?,&X,I S)D#RVVO^'ZOHO\ ;R7D6H@7NKO<V\D]K*6EC=8
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M=,BL=2\0V\MBS?8;@69$D$<OE[HOF@VE,R(3O!(P^2/+?:?U^?\ P _K\?\
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MXG02&V\WS#&#R 3M'.,9&.#QS7+W7A_P]K5MI-KJ<NN:A:69+K!>P3.L\CA
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M^VMY'VC[)L\B3S?.SCR_*V[]_P#L[<]ZN:1KNFZ['<R:;<&9;:<V\V8V0I(
M"5(8 Y&17!:=\.]7TVU6:$Z4MY;ZZVJP6\;NL!1D"M$3L)4C)PP4]!QSQJ?#
M7S]_BS[3Y8G_ +>GWB/.T'9'P,\GZ_RH6M_3_P"1_P V-Z?UZ_Y(Q;WXDZE:
MIK$RZCH#7%CJ4EG#H[1.+JY19 HPPE)R0>OED<5UR^*8K76-=35+ZPM['38K
M>0C$BR0^8#GS"1L.3C:$)/KSBL"X\(>(I-$\1:$L&CO::Q?3SBZDNY-\22,#
MGRO*P6 &1\XY[T:A\.[Z\GUPQWT"+=)8&T=PS'?;<_O%P."<=":2V5_+_@_=
M^/0;M=_/\]/P_P"";&J?$31=/T.[U*+[5<M:R1QR6WV:2.5#(<*61U#*I[$C
M!Q@9/%7I_&F@6MPL%Q>O%)MC:3?;R@0;\;/-.W$1.1PY4US&M>!=:\1+K-_>
M2V%OJ-Y!;0000RN\*K%+YF6<H#ECQPO'O46H?#_5+W5-6N62SDAU@Q/<12:G
M=HD#!0KKLBV"=<#C<4-->?\ 7]:^@CL;WQ;H>G:C]@NKW9.&1'(B=HXF?[@>
M0 JA/& Q&<UB:#X_MKO4=0L-5=+>>/6)M.M3';R^6^W[@:3!4.>>"1GL*EM=
M UW1=<U*;1WTU[/4IX9I'NVD,D&U%1@J@?/D*,$LN"><UFMX$U0V\D?GV>6\
M4#61\[?ZG<#M^[]_VZ>]*.ZO_6J_+4'MY_\  ?\ P#HD\;>'I-0^PK?/YWVQ
MK')MI0@N!UC+[=H;TR>>V:D/C'01JAT[^T!YXG^S%A$_E";_ )YF7&P/_L[L
M^U<RW@35#;R1^?9Y;Q0-9'SM_J=P.W[OW_;I[TU_ FKM9SZ%]HL?[&FU7^T3
M<[G^T*OFB3R]FW:3D8WENG\-$=;7_K;_ #?W#EUM_6__  /O-72_&T/EZY-K
M4L%M%9:N^G6_E(Q:7"J5 49+N<GA1SCI6D?&.@C2_P"T/MQ\G[0+78()#-YQ
MZ1^5MW[^^W;G'/2N9/@358[BXOX+FR-W'X@?5K:.1F\N1&C";'.W*MUY ;'O
M6;KFA3:$\?B?5+^PM]0EUN*[\IC*;11Y?E"-I0A*\<^8R@ ]A0ME?R_3_@_<
M#6KMY_K_ ,#[SMK+QKX?U"YAM[:_+2RW3V: P2+^^1=S(25 ! ]?IUK2TW5K
M+6+-KO3YQ/ LCQ;PI W(Q5@,@9Y!YZ5XU<R$> O$&L// E^_B,WNCR0DLMQ*
M"@ B[R X=>.HR:]:\+Z.N@^%=-TI1AK>W57/JY&6/XL2:&GRM]=/Q5_P_P A
M/?[_ ,'_ ,-^)A>'?B!:W?AG1KW6W6'4-3$QB@M+:63S/+8@[54,<XP<=^U:
MY\9:#]@T^]2^,L.H[OLHB@DD>3;]X[%4L N.20 .^*YOP_X$U32CX/\ /GLV
M_L47@N-CL=WG?=V949QWSC\:BT;P+K6A1Z!=6\NGSWNG?:XIHI)76-HYY"X9
M6V$AEXXV\\C(ZTY>7];_ / &:?AWQ];7GA/3]5UF2..YO99TBALX))6D$<C+
ME47<QP "3T&>U;+>+] 2/3I6U.(0ZEN^RS8;RW*C)!?&U3P>&(/!'6N(L_AM
MJ]GIV@.;BWFOM-^U)-%%?7%HDBS2%P5EC&]2..,$'\*MZE\.;S5?"FG>&7EL
MK2P\Y[F_D@,DK[R2RB/S2Q^\WS,6!.. ,D4GY?U_2U_ -+_U_7]7.ZTG5K/6
M]-AU'3Y&EM)AF.1HFCW#U 8 X]\<U;D#F-A&RK(0=K,N0#VR,C(_$5E^'+35
M+/PY:66KO:F]@C\II+3A&"\*P!4;3C&1C /3BK>GVD]E;F*?4;J_<MGS;E8P
MP'I^[11C\,\TVE=I$INVIS.CZGXFN_%FJ:5=7VD&WTWR&D:+3Y%:82*6(!,Y
M"D8ZX;Z5HV_C;P_=SF&VOFE8JYC*P2;9]@)81-MVR$8/"$GBDLM GA\3>(M0
MGDC^S:I' D8C8[UV(5;/&!UXP37/:9X&UB.#P]I=_<6/]G:#*TL,]N6\ZX^5
ME4,A7:F W.&;..V:G6Q6FYK:3\0='U/0K+4W2\@-XSK#;?9)9)7V]2JHI+@#
M!+*"HSC.:+CQ@LVM>%8M)DM[G3M::</,5;< D98;>1@Y&""/RKGK3P/XDM-'
MT337.EW5IIHGCDM)+R9(KD,<I(V(^2N3\A##WSTL>'? &IZ/%X0BFGLF&B37
MCSF-G_>+*&"[05Z_,,@XQVS5Z7_K^NQ.MOZ[&]XAUC5K;Q+H6C:7+90_VBMP
MTDUU;O-M\M5(PJR)UR>]5M&\;1_8-2DUZ6WCDL-2?3Q+:Q.5N6 !7RXP68MS
MRH+'(-6/$GA*+Q)XBT2ZO;>SN=.LDN5G@N%W%C(JA2HP1P1UR,=JYK_A76L)
MH5II8O+9XM'U+[3IF+B6%G@((\N1XP&1AN.'7=4KS_K7_(IVM_79_J=%J/Q!
MT:RMM.N(1<WB7M[]BQ!;R%X7'W@Z;=P8?W,;CZ5H?\)=H?EE_MWRC4/[,)\E
M_P#CYSC9]WU[]/>N6/@34H[*TN+>.Q34(=934WB:]N)$D"J5VM-)O9FQCY@H
M'&,=ZBE\"ZZ;IX8Y-.^Q-XC36O,:9_,VY!:/;LQD'.#GGT%-;V?]?#_P?N$]
MKK^M_P#@'32^._#D$>HRR7THATZ0Q7<OV28I$X8(5+;,9RPX!Z<].:T=+U_3
M=9FNX;&=VFM&"SQR0O$Z%AE3M< X(Y!'![5Q]WX$U2X\(>)M)2>S%QJFK/>P
M,7;:J&1'PQVY#84] 1[UT&DZ#=6'C/7M8EDA-OJ$5LD2JQWJ8U8-N&,=QC!-
M);:_UM_P0?6W]:_TR'_A+DCUGQ(MQY4>EZ'!&99<'>TA4NP],!=H ZY-5-/\
M6:OXB\'W][I6F1V>O6;E'TZ])<!@ P7(V_>0C!Z GOBHM#TV#_A,/&.E:C:P
MW$%W-;WZ1SH'61&3;T/!P\9_'%;7B'2;V?2=03P\ME9ZK?A8Y;QUVL%^[NRH
M)9E7.W/3UI:\OG;\1Z<VO?\ #^M3F-,^(.I:_I6N:YIUA%;Z3IM@S)]JC;S)
M;M4+LO# ;%X4\9)Z$4SP_P#$F[UUO"L?V6"&;4)+B#48F1@T3QQ;QLR> V0>
M<\'\:=:_#J]T&VU?2M"NH/[%U+3&A>&YD;>EULV"48!&&&-WOTZ8H@^'%U:^
M-O#FOV]Q J65F(;^'>W[R183&KH,8)YP<XX IOK;^M_Z^XG6WW_DK?UZE#1_
MB3J5[;Z%.VH:#>W.HW:V\VDVD;+<P*68%\^:WW0-QRH&.]:L?CO45$MS<06G
MV.#Q&^D2E48,(ONH^=Q^;<5SQ@CH!52V\$^(9/"6D^&+V/28[:RNHYWO8;N2
M27"2%_DC,2@$],[N 3UJ#6O#=[8Z3-I,CPR3:YXI6YA$3$E8BXE).0.0L9)Z
MCWJE;F^?ZQ_X(Y;.W]:2_P" >I4445(!5'6KZ73-$OKZ"W-S+;P/*D(SER!G
M'&:O56U"*ZGT^XBLKD6UTR$13% X1NQ*GJ/:D]AK<P/#FN:G?Z+<ZC.^GZM$
M'9;<Z0NTR%792,/(5[ AMX')R!C)JVGBC5KW0M.;[-:6VK7^HS62JP:2*#RV
MER3@@N0L1Z%<D]A4WA30]5L]5U'5=5@LK6:Y'E^3:2&3?B61][,57/W\ 8X
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M^6"W$*.BQ$ #?O\ E\J$#"<&-/[HQSNMO=0>.XSIFFZE:ZK(^!)"'DMKJ+=
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M>C_A'M4_Z'/7/^_-E_\ (]=!10!S_P#PCVJ?]#GKG_?FR_\ D>C_ (1[5/\
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>mnkd-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T09:24:21.9960684+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:mnkd="http://www.mannkindcorp.com/20221231" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mannkindcorp.com/20221231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.mannkindcorp.com/20221231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mnkd-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100010 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100020 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="Role_StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100040 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit" id="Role_StatementConsolidatedStatementsOfStockholdersDeficit">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders&apos; Deficit</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness" id="Role_DisclosureDescriptionOfBusiness">
        <link:definition>100070 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions" id="Role_DisclosureAcquisitions">
        <link:definition>100090 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments" id="Role_DisclosureInvestments">
        <link:definition>100100 - Disclosure - Investments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable" id="Role_DisclosureAccountsReceivable">
        <link:definition>100110 - Disclosure - Accounts Receivable</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories" id="Role_DisclosureInventories">
        <link:definition>100120 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100130 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset" id="Role_DisclosureGoodwillAndOtherIntangibleAsset">
        <link:definition>100140 - Disclosure - Goodwill and Other Intangible Asset</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>100150 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings" id="Role_DisclosureBorrowings">
        <link:definition>100160 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements" id="Role_DisclosureCollaborationLicensingAndOtherArrangements">
        <link:definition>100170 - Disclosure - Collaboration, Licensing and Other Arrangements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments" id="Role_DisclosureFairValueOfFinancialInstruments">
        <link:definition>100180 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock" id="Role_DisclosureCommonAndPreferredStock">
        <link:definition>100190 - Disclosure - Common and Preferred Stock</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS" id="Role_DisclosureEarningsPerCommonShareEPS">
        <link:definition>100200 - Disclosure - Earnings Per Common Share ("EPS")</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans" id="Role_DisclosureStockAwardPlans">
        <link:definition>100210 - Disclosure - Stock Award Plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100220 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans" id="Role_DisclosureEmployeeBenefitPlans">
        <link:definition>100230 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100240 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100260 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables" id="Role_DisclosureAcquisitionsTables">
        <link:definition>100270 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables" id="Role_DisclosureInvestmentsTables">
        <link:definition>100280 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables" id="Role_DisclosureAccountsReceivableTables">
        <link:definition>100290 - Disclosure - Accounts Receivable (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables" id="Role_DisclosureInventoriesTables">
        <link:definition>100300 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100310 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables" id="Role_DisclosureGoodwillAndOtherIntangibleAssetTables">
        <link:definition>100320 - Disclosure - Goodwill and Other Intangible Asset (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables">
        <link:definition>100330 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables" id="Role_DisclosureBorrowingsTables">
        <link:definition>100340 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsTables">
        <link:definition>100350 - Disclosure - Collaboration, Licensing and Other Arrangements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables" id="Role_DisclosureFairValueOfFinancialInstrumentsTables">
        <link:definition>100360 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables" id="Role_DisclosureEarningsPerCommonShareEPSTables">
        <link:definition>100370 - Disclosure - Earnings Per Common Share ("EPS") (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables" id="Role_DisclosureStockAwardPlansTables">
        <link:definition>100380 - Disclosure - Stock Award Plans (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100390 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100400 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" id="Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail">
        <link:definition>100410 - Disclosure - Description of Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100420 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
        <link:definition>100430 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default">
        <link:definition>100430 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail">
        <link:definition>100440 - Disclosure - Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" id="Role_DisclosureAcquisitionsAdditionalInformationDetail">
        <link:definition>100450 - Disclosure - Acquisitions - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" id="Role_DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail">
        <link:definition>100460 - Disclosure - Acquisitions - Schedule of Preliminary Purchase Consideration (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" id="Role_DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>100470 - Disclosure - Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails" id="Role_DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails">
        <link:definition>100480 - Disclosure - Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" id="Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail">
        <link:definition>100490 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail" id="Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail">
        <link:definition>100500 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail" id="Role_DisclosureInvestmentsAdditionalInformationDetail">
        <link:definition>100510 - Disclosure - Investments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail" id="Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail">
        <link:definition>100520 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail" id="Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail">
        <link:definition>100530 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" id="Role_DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail">
        <link:definition>100540 - Disclosure - Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail" id="Role_DisclosureScheduleOfAccountsReceivableNetDetail">
        <link:definition>100550 - Disclosure - Schedule of Accounts Receivable, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2" id="Role_DisclosureScheduleOfAccountsReceivableNetDetail2">
        <link:definition>100560 - Disclosure - Schedule of Accounts Receivable, Net (Detail)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail" id="Role_DisclosureAccountsReceivableAdditionalInformationDetail">
        <link:definition>100570 - Disclosure - Accounts Receivable - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail" id="Role_DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail">
        <link:definition>100580 - Disclosure - Schedule of Activities and Ending Reserve Balance (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail" id="Role_DisclosureInventoriesComponentsOfInventoryDetail">
        <link:definition>100590 - Disclosure - Inventories - Components of Inventory (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail" id="Role_DisclosureInventoriesAdditionalInformationDetail">
        <link:definition>100600 - Disclosure - Inventories - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail" id="Role_DisclosurePropertyAndEquipmentNetDetail">
        <link:definition>100610 - Disclosure - Property and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail" id="Role_DisclosurePropertyAndEquipmentNetParentheticalDetail">
        <link:definition>100620 - Disclosure - Property and Equipment, Net (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail">
        <link:definition>100630 - Disclosure - Property and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail" id="Role_DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail">
        <link:definition>100640 - Disclosure - Goodwill and Other Intangible Asset - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" id="Role_DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail">
        <link:definition>100650 - Disclosure - Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail">
        <link:definition>100660 - Disclosure - Accrued Expenses and Other Current Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail">
        <link:definition>100670 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" id="Role_DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail">
        <link:definition>100680 - Disclosure - Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail" id="Role_DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail">
        <link:definition>100690 - Disclosure - Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail" id="Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail">
        <link:definition>100700 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail" id="Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail">
        <link:definition>100710 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail" id="Role_DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail">
        <link:definition>100720 - Disclosure - Borrowings - Schedule of Maturities of the Company&apos;s Borrowings (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail" id="Role_DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail">
        <link:definition>100730 - Disclosure - Borrowings - Senior Convertible Notes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail" id="Role_DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail">
        <link:definition>100740 - Disclosure - Borrowings - MidCap Credit Facility - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail" id="Role_DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail">
        <link:definition>100750 - Disclosure - Borrowings - Mann Group Promissory Notes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail" id="Role_DisclosureBorrowingsPPPLoanAdditionalInformationDetail">
        <link:definition>100760 - Disclosure - Borrowings - PPP Loan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail" id="Role_DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail">
        <link:definition>100770 - Disclosure - Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail" id="Role_DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail">
        <link:definition>100780 - Disclosure - Borrowings - Milestone Rights - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail" id="Role_DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail">
        <link:definition>100790 - Disclosure - Schedule of Revenue from Collaborations and Services (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail" id="Role_DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail">
        <link:definition>100800 - Disclosure - Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail" id="Role_DisclosureSummaryOfUTRevenueDetail">
        <link:definition>100810 - Disclosure - Summary of UT Revenue (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail">
        <link:definition>100820 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail">
        <link:definition>100830 - Disclosure - Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail">
        <link:definition>100840 - Disclosure - Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1">
        <link:definition>100850 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1Default" id="Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1Default">
        <link:definition>100850 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" id="Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail">
        <link:definition>100860 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail" id="Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail">
        <link:definition>100870 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail" id="Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail">
        <link:definition>100880 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail" id="Role_DisclosureCommonAndPreferredStockAdditionalInformationDetail">
        <link:definition>100890 - Disclosure - Common and Preferred Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail" id="Role_DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail">
        <link:definition>100900 - Disclosure - Earnings Per Common Share ("EPS") - Components of Basic and Diluted EPS Computations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail" id="Role_DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail">
        <link:definition>100910 - Disclosure - Earnings Per Common Share ("EPS") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail" id="Role_DisclosureStockAwardPlansAdditionalInformationDetail">
        <link:definition>100920 - Disclosure - Stock Award Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail" id="Role_DisclosureStockAwardPlansStockBasedAwardPlansDetail">
        <link:definition>100930 - Disclosure - Stock Award Plans - Stock Based Award Plans (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail" id="Role_DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail">
        <link:definition>100940 - Disclosure - Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail" id="Role_DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail">
        <link:definition>100950 - Disclosure - Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail" id="Role_DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail">
        <link:definition>100960 - Disclosure - Stock Award Plans - Summary of Stock Options Outstanding (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail" id="Role_DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail">
        <link:definition>100970 - Disclosure - Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>100980 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail">
        <link:definition>100990 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail" id="Role_DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail">
        <link:definition>101000 - Disclosure - Commitments and Contingencies - Summary of Financing Liability Costs (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail">
        <link:definition>101010 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2">
        <link:definition>101020 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail" id="Role_DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail">
        <link:definition>101030 - Disclosure - Commitments and Contingencies - Remaining Purchase Requirements (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail">
        <link:definition>101040 - Disclosure - Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail">
        <link:definition>101050 - Disclosure - Commitments and Contingencies - Summary of Lease Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail">
        <link:definition>101060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2">
        <link:definition>101070 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail" id="Role_DisclosureEmployeeBenefitPlansAdditionalInformationDetail">
        <link:definition>101080 - Disclosure - Employee Benefit Plans - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail" id="Role_DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail">
        <link:definition>101090 - Disclosure - Loss from Continuing Operations Before Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail" id="Role_DisclosureProvisionForIncomeTaxesDetail">
        <link:definition>101100 - Disclosure - Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail" id="Role_DisclosureComponentsOfNetDeferredTaxAssetsDetail">
        <link:definition>101110 - Disclosure - Components of Net Deferred Tax Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail" id="Role_DisclosureEffectiveTaxRateDetail">
        <link:definition>101120 - Disclosure - Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>101130 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail">
        <link:definition>101140 - Disclosure - Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="mnkd_CashEquivalentsAndInvestments" name="CashEquivalentsAndInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" name="WholesalerDistributionFeesAndPromptPayDiscounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ReserveForReturns" name="ReserveForReturns" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" name="FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" name="FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" name="FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" name="FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" name="FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" name="FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" name="FinanceLeaseLiabilityDiscountedExcessAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" name="FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscounted" name="FinanceLeaseLiabilityDiscounted" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PurchaseObligationCurrent" name="PurchaseObligationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PromissoryNotesNoncurrent" name="PromissoryNotesNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AccruedInterestNoncurrent" name="AccruedInterestNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CreditFacilityNoncurrent" name="CreditFacilityNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PurchaseObligationNoncurrent" name="PurchaseObligationNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_MilestoneLiabilitiesNoncurrent" name="MilestoneLiabilitiesNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_GainLossOnPurchaseCommitments" name="GainLossOnPurchaseCommitments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_InterestExpenseOnFinancingLiability" name="InterestExpenseOnFinancingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" name="StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" name="StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" name="StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" name="StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" name="StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" name="StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" name="AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" name="IssuanceOfCommonStockPursuantToWarrantConversionShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" name="IssuanceOfCommonStockPursuantToWarrantConversion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CumulativeLossOnAvailableForSaleSecurities" name="CumulativeLossOnAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ConvertibleNotesMember" name="ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TwoThousandTwentyFourConvertibleNotesMember" name="TwoThousandTwentyFourConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" name="TwoThousandTwentyFourConvertibleNoteInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SeniorConvertibleNotesPrincipalMember" name="SeniorConvertibleNotesPrincipalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SeniorConvertibleNotesInterestMember" name="SeniorConvertibleNotesInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ConvertibleNotePrincipalMember" name="ConvertibleNotePrincipalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ConvertibleNoteInterestMember" name="ConvertibleNoteInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AtTheMarketOfferingMember" name="AtTheMarketOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TheMannGroupLLCMember" name="TheMannGroupLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_InterestOnMilestonePayment" name="InterestOnMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_InterestExpenseOnPromissoryNotes" name="InterestExpenseOnPromissoryNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" name="IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" name="IncreaseDecreaseInAccruedInterestOnPromissoryNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PurchaseOfAvailableForSaleSecurities" name="PurchaseOfAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_MilestonePayments" name="MilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" name="ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" name="ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_PaymentOnFinancingLiability" name="PaymentOnFinancingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ProceedsFromSaleLeasebackTransaction" name="ProceedsFromSaleLeasebackTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DepositForSaleLeasebackTransaction" name="DepositForSaleLeasebackTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" name="PaymentOfCreditFacilityPrepaymentPenalty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AtTheMarketIssuanceMember" name="AtTheMarketIssuanceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" name="ReclassificationOfInvestmentsFromLongTermToCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" name="ReclassificationOfConvertibleNotesAndInterestReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_PremiumOnConvertibleNote" name="PremiumOnConvertibleNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" name="PaymentsOnDebtAndInterestThroughCommonStockIssuance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AdditionOfRightOfUseAssets" name="AdditionOfRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_RightOfUseAssetsModification" name="RightOfUseAssetsModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" name="CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ContingentMilestoneLiability" name="ContingentMilestoneLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" name="CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" name="IssuanceOfWarrantsAssociatedWithCreditFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ReceivableFromCommonStockOffering" name="ReceivableFromCommonStockOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_BusinessPolicyTextBlock" name="BusinessPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_BasisOfPresentationPolicyTextBlock" name="BasisOfPresentationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" name="RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" name="RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_CostOfRevenuesPolicyTextBlock" name="CostOfRevenuesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PreLaunchInventoryPolicyTextBlock" name="PreLaunchInventoryPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" name="LossOnPurchaseCommitmentsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_MilestoneRightsLiabilityPolicyTextBlock" name="MilestoneRightsLiabilityPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ClinicalTrialExpensePolicyTextBlock" name="ClinicalTrialExpensePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" name="RecentlyIssuedAccountingStandardsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_VGoMember" name="VGoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" name="ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" name="ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" name="DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" name="ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_UnitedTherapeuticsCorporationMember" name="UnitedTherapeuticsCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ContractWithCustomerLiabilityTableTextBlock" name="ContractWithCustomerLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" name="ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" name="ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" name="ScheduleOfLeaseTermAndDiscountRateTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentMinimumCashCovenant" name="DebtInstrumentMinimumCashCovenant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_MidCapCreditFacilityMember" name="MidCapCreditFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TrancheTwoMember" name="TrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SalesReturnPeriod" name="SalesReturnPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ThironaBioIncMember" name="ThironaBioIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommitmentAssetMember" name="CommitmentAssetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_InsulinMember" name="InsulinMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_MilestoneRightsLiabilityMember" name="MilestoneRightsLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DeerfieldManagementCompanyLpMember" name="DeerfieldManagementCompanyLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ProductSalesMember" name="ProductSalesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommitmentAsset" name="CommitmentAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" name="LossOnPurchaseCommitmentsNumberOfContractsRecognized" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ContingentLiabilityRemainingPayableAmount" name="ContingentLiabilityRemainingPayableAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ContingentLiability" name="ContingentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_QrumPharmaIncorporatedMember" name="QrumPharmaIncorporatedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" name="GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" name="AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AssetAcquisitionMilestonePaymentPayable" name="AssetAcquisitionMilestonePaymentPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" name="AnnualRevenueMilestonesRangesForMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_GoodwillAmortizationPeriod" name="GoodwillAmortizationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_BusinessAcquisitionRepaymentOfDebt" name="BusinessAcquisitionRepaymentOfDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_BusinessCombinationAccumulatedCost" name="BusinessCombinationAccumulatedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PercentageOfRoyaltyPaymentOnNetSales" name="PercentageOfRoyaltyPaymentOnNetSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" name="GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DueInOneYearOrLessMember" name="DueInOneYearOrLessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_FairValueOfFinancialInstrumentsLineItems" name="FairValueOfFinancialInstrumentsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_FairValueOfFinancialInstrumentsTable" name="FairValueOfFinancialInstrumentsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AmortizedCostMember" name="AmortizedCostMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GrossUnrealizedHoldingLossesMember" name="GrossUnrealizedHoldingLossesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_EstimatedFairValueMember" name="EstimatedFairValueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AccruedInterestReceivable" name="AccruedInterestReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_AmountReceivableOnMaturedInvestment" name="AmountReceivableOnMaturedInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_NumberOfWholesaleDistributors" name="NumberOfWholesaleDistributors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" name="PercentageOfAccountsReceivableFromMajorCustomers" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PercentageOfSalesFromMajorCustomers" name="PercentageOfSalesFromMajorCustomers" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" name="PercentageOfCollaborationsAndServicesNetAccountsReceivables" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" name="PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" name="PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" name="PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" name="PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ReserveBalanceAbstract" name="ReserveBalanceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_PreLaunchInventoryMember" name="PreLaunchInventoryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AgreementWithRetailPharmacyMember" name="AgreementWithRetailPharmacyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_FurnitureFixturesAndOfficeEquipmentMember" name="FurnitureFixturesAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ComputerEquipmentAndSoftwareMember" name="ComputerEquipmentAndSoftwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_UTEquipmentMember" name="UTEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" name="ManufacturingEquipmentsAndComputerHardwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" name="ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CasperLLCMember" name="CasperLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" name="SaleLeasebackTransactionLeaseAgreementPeriods" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_CustomerDiscountsAndAllowances" name="CustomerDiscountsAndAllowances" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ReturnsReserveForAcquiredProduct" name="ReturnsReserveForAcquiredProduct" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CurrentPortionOfMilestoneRightLiability" name="CurrentPortionOfMilestoneRightLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_RetailInventoryPurchase" name="RetailInventoryPurchase" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSales" name="DiscountsAndAllowancesForCommercialProductSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" name="DiscountsAndAllowancesForCommercialProductSalesProvisions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" name="DiscountsAndAllowancesForCommercialProductSalesDeductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" name="DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" name="DiscountsAndAllowancesForCommercialProductSalesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" name="DebtPremiumRecognizedInAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PromissoryNotesMember" name="PromissoryNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DebtInstrumentMaturityMonthAndYear" name="DebtInstrumentMaturityMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_AccruedPaidInKindInterest" name="AccruedPaidInKindInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DebtInstrumentFloorRate" name="DebtInstrumentFloorRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentCapInterestRate" name="DebtInstrumentCapInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_NonConvertiblePromissoryNoteMember" name="NonConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_PriorToMidcapCreditFacilityAmendmentMember" name="PriorToMidcapCreditFacilityAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_PriorToFirstAmendmentMember" name="PriorToFirstAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_NumberOfTradingDays" name="NumberOfTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ConsecutiveTradingDays" name="ConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentConvertibleConversionPricePercentage" name="DebtInstrumentConvertibleConversionPricePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PrincipalAmountPerShare" name="PrincipalAmountPerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_MeasurementPeriodPercentage" name="MeasurementPeriodPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" name="DebtInstrumentInitialConversionPriceOfPremiumPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" name="DebtInstrumentOutstandingPrincipalAmountRedeemed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PrepaymentOfSecuredLinesOfCredit" name="PrepaymentOfSecuredLinesOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TrancheThreeMember" name="TrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DebtInstrumentAdvanceAvailableDate" name="DebtInstrumentAdvanceAvailableDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentExtendedInterestOnlyDate" name="DebtInstrumentExtendedInterestOnlyDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_MaximumValueOfAdditionalInvestmentLimit" name="MaximumValueOfAdditionalInvestmentLimit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" name="DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" name="DebtInstrumentUnamortizedPrepaymentPenalty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_EarlyTerminationFeesPercentage" name="EarlyTerminationFeesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" name="DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" name="LineOfCreditFacilityPrincipalPaymentStartDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" name="TermLoanAdvancePercentageOfAmountDrawdown" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PrivatelyNegotiatedExchangeAgreementMember" name="PrivatelyNegotiatedExchangeAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_LoanArrangementMember" name="LoanArrangementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_NonConvertibleNoteMember" name="NonConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_NewLoanArrangementMember" name="NewLoanArrangementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AccruedInterestMember" name="AccruedInterestMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" name="DebtInstrumentFairValueInExcessOfFaceAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CommonStockIssuedToPayInterest" name="CommonStockIssuedToPayInterest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PaycheckProtectionProgramCARESActMember" name="PaycheckProtectionProgramCARESActMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AmortizationOfDebtDiscount" name="AmortizationOfDebtDiscount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" name="MilestoneRightsLiabilitiesCurrentAndNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PaymentForMilestoneRightsLiabilities" name="PaymentForMilestoneRightsLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_MilestoneRightsLiabilityCurrent" name="MilestoneRightsLiabilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_BaringsGlobalMilestoneRightsMember" name="BaringsGlobalMilestoneRightsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_LicenseAgreementMember" name="LicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommercialSupplyAgreementMember" name="CommercialSupplyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CoPromotionAgreementMember" name="CoPromotionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CollaborationAndLicenseAgreementMember" name="CollaborationAndLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_LicenseAndDistributionAgreementMember" name="LicenseAndDistributionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_OtherAgreementMember" name="OtherAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ResearchAgreementMember" name="ResearchAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_VerticePharmaLLCMember" name="VerticePharmaLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ReceptorLifeScienceIncMember" name="ReceptorLifeScienceIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CiplaLtdMember" name="CiplaLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ContractWithCustomerLiabilityAdditions" name="ContractWithCustomerLiabilityAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" name="ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_RoyaltiesArrangementMember" name="RoyaltiesArrangementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" name="AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_UpfrontPaymentReceived" name="UpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_MilestonePaymentReceived" name="MilestonePaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ClinicalSuppliesMember" name="ClinicalSuppliesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TyvasoDPIMember" name="TyvasoDPIMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ManufacturingServicesMember" name="ManufacturingServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_NextGenResearchAndDevelopmentServicesMember" name="NextGenResearchAndDevelopmentServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TransactionPriceForTheContractualObligationsMember" name="TransactionPriceForTheContractualObligationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TransactionPriceForThePerformanceObligationsMember" name="TransactionPriceForThePerformanceObligationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommercializationAndContinuousImprovementActivitiesMember" name="CommercializationAndContinuousImprovementActivitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AmendmentToCoPromotionAgreementMember" name="AmendmentToCoPromotionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SupplyAndDistributionAgreementMember" name="SupplyAndDistributionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_BiommSAMember" name="BiommSAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" name="ResearchAndDevelopmentServicesAndLicenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_PreCommercialServicesMember" name="PreCommercialServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_FacilityExpansionServicesMember" name="FacilityExpansionServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" name="RevenueRemainingPerformanceObligationAnticipatedCashFlow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_AgreementAmendmentDescription" name="AgreementAmendmentDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_AllocatedTransactionPrice" name="AllocatedTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" name="PercentageOfModificationOfPreviouslyFixedConsideration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" name="DateOfAgreementInitiationForMarketingAndDistribution" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_MannGroupConvertibleNoteMember" name="MannGroupConvertibleNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ContingentMilestoneLiabilityMember" name="ContingentMilestoneLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_NotePayablePercentageOfInterestRateChange" name="NotePayablePercentageOfInterestRateChange" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtInstrumentMeasurementInputAfterChange" name="DebtInstrumentMeasurementInputAfterChange" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" name="SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_ContolledEquityOfferingSalesAgreementMember" name="ContolledEquityOfferingSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_AtMarketIssuanceSalesAgreementMember" name="AtMarketIssuanceSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CantorFitzgeraldMember" name="CantorFitzgeraldMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_JuneTwoThousandTwentyNoteMember" name="JuneTwoThousandTwentyNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DecemberTwoThousandTwentyNoteMember" name="DecemberTwoThousandTwentyNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_UnderwritingAgreementMember" name="UnderwritingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_RemainingWarrantsAvailableForPurchase" name="RemainingWarrantsAvailableForPurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" name="DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" name="DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_MarketPriceStockPurchasePlan" name="MarketPriceStockPurchasePlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_EarningPerShareBasicAndDilutedAbstract" name="EarningPerShareBasicAndDilutedAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_SeniorConvertibleNotesMember" name="SeniorConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" name="CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" name="WarrantsAssociatedWithMidcapCreditFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" name="RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_EquityIncentivePlanTwentyEighteenMember" name="EquityIncentivePlanTwentyEighteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_EquityIncentivePlanTwentyThirteenMember" name="EquityIncentivePlanTwentyThirteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GroupOneMember" name="GroupOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GroupTwoMember" name="GroupTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GroupThreeMember" name="GroupThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GroupFourMember" name="GroupFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_GroupFiveMember" name="GroupFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_RestrictedStockUnitsAndOptionsMember" name="RestrictedStockUnitsAndOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" name="EmployeeStockOptionsAndPerformanceBasedOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_EmployeeMember" name="EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" name="ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_PercentileRankOfShareholderReturnOfStock" name="PercentileRankOfShareholderReturnOfStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_TwoThousandFourEquityIncentivePlanMember" name="TwoThousandFourEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CostOfRevenueCollaborationsAndServicesMember" name="CostOfRevenueCollaborationsAndServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TransfersFromToParentAbstract" name="TransfersFromToParentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" name="DiscountOnPurchasePricePercentageOfFairMarketValue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_MilestoneRightLiability" name="MilestoneRightLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_MasterLeaseAgreementWithEnterpriseMember" name="MasterLeaseAgreementWithEnterpriseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_OfficeMember" name="OfficeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_RussellRanchRoadIILLCMember" name="RussellRanchRoadIILLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_MarlboroughLeaseMember" name="MarlboroughLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_LeaseRepurchaseDescription" name="LeaseRepurchaseDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" name="FinanceLeaseLiabilityDiscountedPaymentsDue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" name="PaymentOfLongTermPurchaseCommitmentAmendmentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_LongTermPurchaseCommitmentExpirationDate" name="LongTermPurchaseCommitmentExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" name="LongtermPurchaseCommitmentRenewalTimePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_NumberOfVehicleLeasesRetired" name="NumberOfVehicleLeasesRetired" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_NumberOfVehicleLeasesReplaced" name="NumberOfVehicleLeasesReplaced" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_NumberOfVehicleLeases" name="NumberOfVehicleLeases" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" name="OperatingLeasesAnnualIncreaseInRentExpense" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_LeaseExpirationMonthAndYear" name="LeaseExpirationMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_OfficeAndVehicleMember" name="OfficeAndVehicleMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_OneYearServiceMember" name="OneYearServiceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_TwoYearServiceMember" name="TwoYearServiceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" name="DeferredTaxAssetsCapitalizedResearchExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsMilestoneRights" name="DeferredTaxAssetsMilestoneRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" name="DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" name="DeferredTaxAssetsLossOnPurchaseCommitment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsCapitalizedCosts" name="DeferredTaxAssetsCapitalizedCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsInterestExpenseLimitation" name="DeferredTaxAssetsInterestExpenseLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxAssetsProductRevenueAndCosts" name="DeferredTaxAssetsProductRevenueAndCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" name="DeferredTaxLiabilitiesRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" name="EffectiveIncomeTaxRateReconciliationPermanentItems" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" name="EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" name="EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_IncomeTaxesLineItems" name="IncomeTaxesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_IncomeTaxesTable" name="IncomeTaxesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_ConnecticutTaxAuthorityMember" name="ConnecticutTaxAuthorityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_CaliforniaDivisionOfTaxationMember" name="CaliforniaDivisionOfTaxationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="mnkd_OperatingLossCarryforwardsSubjectToLimitation" name="OperatingLossCarryforwardsSubjectToLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_NetOperatingLossCarryforwardAnnualLimitation" name="NetOperatingLossCarryforwardAnnualLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" name="DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" name="ResearchAndDevelopmentCreditsBeginToExpire" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" name="DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>18
<FILENAME>mnkd-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T09:24:21.9960684+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="mnkd-20221231.xsd#TemplateLink" roleURI="http://www.mannkindcorp.com/20221231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationCurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneLiabilitiesNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CreditFacilityNoncurrent" xlink:type="locator" xlink:label="mnkd_CreditFacilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestNoncurrent" xlink:type="locator" xlink:label="mnkd_AccruedInterestNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesNoncurrent" xlink:type="locator" xlink:label="mnkd_PromissoryNotesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_PromissoryNotesNoncurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_AccruedInterestNoncurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_CreditFacilityNoncurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_PurchaseObligationNoncurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mnkd_MilestoneLiabilitiesNoncurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mnkd_PurchaseObligationCurrent" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="10270.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_LongTermInvestments" order="10280.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10290.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10300.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="10310.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10320.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="10330.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10340.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_GainLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingExpense" xlink:type="locator" xlink:label="us-gaap_SellingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnFinancingLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="mnkd_InterestExpenseOnFinancingLiability" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseDebt" order="10070.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="10120.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfRevenue" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingExpense" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AssetImpairmentCharges" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="10210.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnPromissoryNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestOnMilestonePayment" xlink:type="locator" xlink:label="mnkd_InterestOnMilestonePayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfCreditFacilityPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DepositForSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_DepositForSaleLeasebackTransaction" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_PaymentOnFinancingLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" xlink:type="locator" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePayments" xlink:type="locator" xlink:label="mnkd_MilestonePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_MilestonePayments" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_PaymentOnFinancingLiability" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="10140.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_ProceedsFromSaleLeasebackTransaction" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_DepositForSaleLeasebackTransaction" order="10170.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="10180.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="10190.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" order="10210.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="10230.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10240.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities" order="10250.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="10270.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10280.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10290.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="10300.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InterestExpense" order="10310.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mnkd_InterestOnMilestonePayment" order="10320.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="10330.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mnkd_InterestExpenseOnPromissoryNotes" order="10340.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="10350.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="10360.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10370.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetImpairmentCharges" order="10380.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10390.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10400.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10410.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10420.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="10430.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10440.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="10450.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10460.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="10470.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="10480.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" order="10490.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" order="10500.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" order="10510.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="10520.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_Goodwill" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" order="10090.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessAcquisitionRepaymentOfDebt" xlink:type="locator" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="mnkd_BusinessAcquisitionRepaymentOfDebt" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="10060.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CashEquivalentsAndInvestments" xlink:type="locator" xlink:label="mnkd_CashEquivalentsAndInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Investments" xlink:to="mnkd_CashEquivalentsAndInvestments" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Investments" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfAccountsReceivableNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveForReturns" xlink:type="locator" xlink:label="mnkd_ReserveForReturns" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" xlink:type="locator" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="mnkd_ReserveForReturns" order="10030.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfAccountsReceivableNetDetail2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventoriesComponentsOfInventoryDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrent" xlink:type="locator" xlink:label="us-gaap_ConstructionPayableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RetailInventoryPurchase" xlink:type="locator" xlink:label="mnkd_RetailInventoryPurchase" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CurrentPortionOfMilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:type="locator" xlink:label="us-gaap_DirectFinancingLeaseDeferredSellingProfit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReturnsReserveForAcquiredProduct" xlink:type="locator" xlink:label="mnkd_ReturnsReserveForAcquiredProduct" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CustomerDiscountsAndAllowances" xlink:type="locator" xlink:label="mnkd_CustomerDiscountsAndAllowances" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="mnkd_CustomerDiscountsAndAllowances" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="mnkd_ReturnsReserveForAcquiredProduct" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_DirectFinancingLeaseDeferredSellingProfit" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="mnkd_CurrentPortionOfMilestoneRightLiability" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="mnkd_RetailInventoryPurchase" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_ConstructionPayableCurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LineOfCredit" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DeferredFinanceCostsNet" order="10030.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscounted" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscounted" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10020.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10030.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10090.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureComponentsOfNetDeferredTaxAssetsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsProductRevenueAndCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsInterestExpenseLimitation" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsLeaseLiabilities" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsInterestExpenseLimitation" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mnkd_DeferredTaxAssetsProductRevenueAndCosts" order="10190.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEffectiveTaxRateDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>mnkd-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T09:24:21.9960684+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="mnkd-20221231.xsd#TemplateLink" roleURI="http://www.mannkindcorp.com/20221231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnFinancingLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_GainLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingExpense" xlink:type="locator" xlink:label="us-gaap_SellingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10220.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_2" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_SellingExpense" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="mnkd_InterestExpenseOnFinancingLiability" order="11710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="12010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="12070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="12310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="12370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="12430.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersDeficit" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CumulativeLossOnAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" xlink:type="locator" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketOfferingMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketOfferingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNoteInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotePrincipalMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotePrincipalMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesInterestMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesPrincipalMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNotesMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNotesMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_SeniorConvertibleNotesPrincipalMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_SeniorConvertibleNotesInterestMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNotePrincipalMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNoteInterestMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="mnkd_AtTheMarketOfferingMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_2" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" order="11840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="12120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="12260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="12400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="12420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" order="12680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="12700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" order="12820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" order="12960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" order="12980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" order="13100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="13240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" order="13380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" order="13400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CumulativeLossOnAvailableForSaleSecurities" order="16880.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceivableFromCommonStockOffering" xlink:type="locator" xlink:label="mnkd_ReceivableFromCommonStockOffering" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" xlink:type="locator" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiability" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" xlink:type="locator" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RightOfUseAssetsModification" xlink:type="locator" xlink:label="mnkd_RightOfUseAssetsModification" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionOfRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_AdditionOfRightOfUseAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" xlink:type="locator" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_PremiumOnConvertibleNote" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" xlink:type="locator" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" xlink:type="locator" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfCreditFacilityPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DepositForSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_DepositForSaleLeasebackTransaction" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_PaymentOnFinancingLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" xlink:type="locator" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePayments" xlink:type="locator" xlink:label="mnkd_MilestonePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnPromissoryNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestOnMilestonePayment" xlink:type="locator" xlink:label="mnkd_InterestOnMilestonePayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketIssuanceMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketIssuanceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10530.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="mnkd_AtTheMarketIssuanceMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="11080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestExpense" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_InterestOnMilestonePayment" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="11260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_InterestExpenseOnPromissoryNotes" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="11380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="11440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="11560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="11680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="12040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="12220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="12280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" order="12340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" order="12400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" order="12460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="12520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" order="12760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" order="12820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="12880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities" order="13000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="13060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="13120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="13180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="13360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_MilestonePayments" order="13420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="13480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" order="13540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" order="13600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_PaymentOnFinancingLiability" order="13660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="13720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="13780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="13840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="13900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="13960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromSaleLeasebackTransaction" order="14020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_DepositForSaleLeasebackTransaction" order="14140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="14200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="14260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" order="14320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="14380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="14440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="14500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="14770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="14830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" order="14950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" order="15010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_PremiumOnConvertibleNote" order="15070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" order="15130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness" order="15190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_AdditionOfRightOfUseAssets" order="15250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_RightOfUseAssetsModification" order="15310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="15370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" order="15430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ContingentMilestoneLiability" order="15490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" order="15550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" order="15610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReceivableFromCommonStockOffering" order="15670.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsTables" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionTableTextBlock" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="10330.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsTables" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityTableTextBlock" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ContractWithCustomerLiabilityTableTextBlock" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" order="10500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumCashCovenant" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_DebtInstrumentMinimumCashCovenant" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10230.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiability" xlink:type="locator" xlink:label="mnkd_ContingentLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiabilityRemainingPayableAmount" xlink:type="locator" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" xlink:type="locator" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation" xlink:type="locator" xlink:label="us-gaap_PurchaseObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:type="locator" xlink:label="us-gaap_OtherAssets" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAsset" xlink:type="locator" xlink:label="mnkd_CommitmentAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentMaturityDate" xlink:type="locator" xlink:label="us-gaap_InvestmentMaturityDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SalesReturnPeriod" xlink:type="locator" xlink:label="mnkd_SalesReturnPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:type="locator" xlink:label="mnkd_DeerfieldManagementCompanyLpMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain_2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InsulinMember" xlink:type="locator" xlink:label="mnkd_InsulinMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAssetMember" xlink:type="locator" xlink:label="mnkd_CommitmentAssetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ThironaBioIncMember" xlink:type="locator" xlink:label="mnkd_ThironaBioIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_ThironaBioIncMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:to="us-gaap_LongLivedAssetsHeldForSaleNameDomain_2" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:to="us-gaap_LongLivedAssetsHeldForSaleNameDomain" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:to="mnkd_CommitmentAssetMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_InsulinMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SalesReturnPeriod" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities" order="11240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentMaturityDate" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="11320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="11400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_CommitmentAsset" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherAssets" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="11510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="11580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" order="11690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ContingentLiabilityRemainingPayableAmount" order="11760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ContingentLiability" order="11780.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10200.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1Default">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10080.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:type="locator" xlink:label="us-gaap_ServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProductSalesMember" xlink:type="locator" xlink:label="mnkd_ProductSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ProductSalesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_OperatingExpenses" order="10510.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRoyaltyPaymentOnNetSales" xlink:type="locator" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationAccumulatedCost" xlink:type="locator" xlink:label="mnkd_BusinessCombinationAccumulatedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GoodwillAmortizationPeriod" xlink:type="locator" xlink:label="mnkd_GoodwillAmortizationPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" xlink:type="locator" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AssetAcquisitionMilestonePaymentPayable" xlink:type="locator" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" xlink:type="locator" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputEntityCreditRiskMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputEntityCreditRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_RangeAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_2" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_VGoMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_2" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputEntityCreditRiskMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_CreditFacilityAxis" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_AssetAcquisitionMilestonePaymentPayable" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_GoodwillAmortizationPeriod" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="11550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="11670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationAccumulatedCost" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_PercentageOfRoyaltyPaymentOnNetSales" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" order="11790.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="10220.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_VGoMember" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Goodwill" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessAcquisitionRepaymentOfDebt" xlink:type="locator" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10070.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessAcquisitionRepaymentOfDebt" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="10300.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="10140.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmountReceivableOnMaturedInvestment" xlink:type="locator" xlink:label="mnkd_AmountReceivableOnMaturedInvestment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestReceivable" xlink:type="locator" xlink:label="mnkd_AccruedInterestReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldtomaturitySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_HeldtomaturitySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ThironaBioIncMember" xlink:type="locator" xlink:label="mnkd_ThironaBioIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_ThironaBioIncMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_HeldtomaturitySecuritiesMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ShortTermInvestments" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_LongTermInvestments" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_Investments" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="mnkd_AccruedInterestReceivable" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="mnkd_AmountReceivableOnMaturedInvestment" order="10850.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DueInOneYearOrLessMember" xlink:type="locator" xlink:label="mnkd_DueInOneYearOrLessMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="mnkd_DueInOneYearOrLessMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CashEquivalentsAndInvestments" xlink:type="locator" xlink:label="mnkd_CashEquivalentsAndInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EstimatedFairValueMember" xlink:type="locator" xlink:label="mnkd_EstimatedFairValueMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GrossUnrealizedHoldingLossesMember" xlink:type="locator" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmortizedCostMember" xlink:type="locator" xlink:label="mnkd_AmortizedCostMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_AmortizedCostMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_GrossUnrealizedHoldingLossesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_EstimatedFairValueMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_CashEquivalentsAndInvestments" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_Investments" order="10980.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfAccountsReceivableNetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveForReturns" xlink:type="locator" xlink:label="mnkd_ReserveForReturns" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" xlink:type="locator" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="locator" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="srt_ProductOrServiceAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsReceivableGrossCurrent" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_ReserveForReturns" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccountsReceivableAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" xlink:type="locator" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" xlink:type="locator" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfSalesFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfAccountsReceivableFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfWholesaleDistributors" xlink:type="locator" xlink:label="mnkd_NumberOfWholesaleDistributors" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="locator" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_NumberOfWholesaleDistributors" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfSalesFromMajorCustomers" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" order="10370.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventoriesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementWithRetailPharmacyMember" xlink:type="locator" xlink:label="mnkd_AgreementWithRetailPharmacyMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreLaunchInventoryMember" xlink:type="locator" xlink:label="mnkd_PreLaunchInventoryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:type="locator" xlink:label="us-gaap_InventoryCurrentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:type="locator" xlink:label="us-gaap_InventoryLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryCurrentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="mnkd_PreLaunchInventoryMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="mnkd_AgreementWithRetailPharmacyMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryRawMaterials" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="10200.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:type="locator" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember" xlink:type="locator" xlink:label="us-gaap_BuildingImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:type="locator" xlink:label="us-gaap_LandMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingImprovementsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11110.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentNetParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UTEquipmentMember" xlink:type="locator" xlink:label="mnkd_UTEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_UTEquipmentMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ConstructionInProgressGross" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" xlink:type="locator" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstate" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CasperLLCMember" xlink:type="locator" xlink:label="mnkd_CasperLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentsAndComputerHardwareMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_CounterpartyNameAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CasperLLCMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ProceedsFromSaleOfRealEstate" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_SaleLeasebackTransactionDate" order="10470.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes" xlink:type="locator" xlink:label="us-gaap_SeniorNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SeniorNotes" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="10260.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesMember" xlink:type="locator" xlink:label="mnkd_PromissoryNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PromissoryNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentCapInterestRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentCapInterestRate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedPaidInKindInterest" xlink:type="locator" xlink:label="mnkd_AccruedPaidInKindInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_2" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_2" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_AccruedPaidInKindInterest" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentCapInterestRate" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMaturityMonthAndYear" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="11400.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentCapInterestRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentCapInterestRate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="locator" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToFirstAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToFirstAmendmentMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToMidcapCreditFacilityAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_NonConvertiblePromissoryNoteMember" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_PriorToMidcapCreditFacilityAmendmentMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_PriorToFirstAmendmentMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMaturityMonthAndYear" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentCapInterestRate" order="11000.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="locator" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" xlink:type="locator" xlink:label="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentSinkingFundPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentSinkingFundPayment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" xlink:type="locator" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodStartDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodStartDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MeasurementPeriodPercentage" xlink:type="locator" xlink:label="mnkd_MeasurementPeriodPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrincipalAmountPerShare" xlink:type="locator" xlink:label="mnkd_PrincipalAmountPerShare" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentConvertibleConversionPricePercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConsecutiveTradingDays" xlink:type="locator" xlink:label="mnkd_ConsecutiveTradingDays" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfTradingDays" xlink:type="locator" xlink:label="mnkd_NumberOfTradingDays" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_NumberOfTradingDays" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_ConsecutiveTradingDays" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentConvertibleConversionPricePercentage" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MeasurementPeriodPercentage" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="11000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" order="11020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="11040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodStartDate" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentSinkingFundPayment" order="11250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionDescription" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="11500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TermLoanAdvancePercentageOfAmountDrawdown" xlink:type="locator" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumCashCovenant" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EarlyTerminationFeesPercentage" xlink:type="locator" xlink:label="mnkd_EarlyTerminationFeesPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" xlink:type="locator" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MaximumValueOfAdditionalInvestmentLimit" xlink:type="locator" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentExtendedInterestOnlyDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentAdvanceAvailableDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrepaymentOfSecuredLinesOfCredit" xlink:type="locator" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSecuredLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheThreeMember" xlink:type="locator" xlink:label="mnkd_TrancheThreeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheOneMember" xlink:type="locator" xlink:label="mnkd_TrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheOneMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheThreeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain_2" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodOneMember" order="10710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromSecuredLinesOfCredit" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrepaymentOfSecuredLinesOfCredit" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentAdvanceAvailableDate" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentExtendedInterestOnlyDate" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MaximumValueOfAdditionalInvestmentLimit" order="11750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" order="11850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit" order="11950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts" order="12050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="12350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" order="12450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="12640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="12700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" order="12760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" order="12820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_EarlyTerminationFeesPercentage" order="13000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMinimumCashCovenant" order="13210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" order="13260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" order="13310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="13370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="13430.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedToPayInterest" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedToPayInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrincipalAmountPerShare" xlink:type="locator" xlink:label="mnkd_PrincipalAmountPerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestMember" xlink:type="locator" xlink:label="mnkd_AccruedInterestMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NewLoanArrangementMember" xlink:type="locator" xlink:label="mnkd_NewLoanArrangementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesMember" xlink:type="locator" xlink:label="mnkd_PromissoryNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LoanArrangementMember" xlink:type="locator" xlink:label="mnkd_LoanArrangementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrivatelyNegotiatedExchangeAgreementMember" xlink:type="locator" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_PrivatelyNegotiatedExchangeAgreementMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LoanArrangementMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_NonConvertibleNoteMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PromissoryNotesMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_NewLoanArrangementMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="11580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain_2" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="11610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="mnkd_AccruedInterestMember" order="11630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="11700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharePrice" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="11870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="12020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" order="12060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="12210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="12290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="12930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_CommonStockIssuedToPayInterest" order="13010.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsPPPLoanAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaycheckProtectionProgramCARESActMember" xlink:type="locator" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PaycheckProtectionProgramCARESActMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneLiabilitiesNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityCurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentForMilestoneRightsLiabilities" xlink:type="locator" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BaringsGlobalMilestoneRightsMember" xlink:type="locator" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_BaringsGlobalMilestoneRightsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PaymentForMilestoneRightsLiabilities" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneRightsLiabilityCurrent" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneLiabilitiesNoncurrent" order="10320.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceptorLifeScienceIncMember" xlink:type="locator" xlink:label="mnkd_ReceptorLifeScienceIncMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAgreementMember" xlink:type="locator" xlink:label="mnkd_ResearchAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OtherAgreementMember" xlink:type="locator" xlink:label="mnkd_OtherAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAgreementMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_OtherAgreementMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_ResearchAgreementMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_ReceptorLifeScienceIncMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfUTRevenueDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RoyaltiesArrangementMember" xlink:type="locator" xlink:label="mnkd_RoyaltiesArrangementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAgreementMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_RoyaltiesArrangementMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10280.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DateOfAgreementInitiationForMarketingAndDistribution" xlink:type="locator" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" xlink:type="locator" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCapitalImprovements" xlink:type="locator" xlink:label="us-gaap_PaymentsForCapitalImprovements" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AllocatedTransactionPrice" xlink:type="locator" xlink:label="mnkd_AllocatedTransactionPrice" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementAmendmentDescription" xlink:type="locator" xlink:label="mnkd_AgreementAmendmentDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:type="locator" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" xlink:type="locator" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePaymentReceived" xlink:type="locator" xlink:label="mnkd_MilestonePaymentReceived" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UpfrontPaymentReceived" xlink:type="locator" xlink:label="mnkd_UpfrontPaymentReceived" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BiommSAMember" xlink:type="locator" xlink:label="mnkd_BiommSAMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SupplyAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_SupplyAndDistributionAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmendmentToCoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercializationAndContinuousImprovementActivitiesMember" xlink:type="locator" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForThePerformanceObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForTheContractualObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingServicesMember" xlink:type="locator" xlink:label="mnkd_ManufacturingServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TyvasoDPIMember" xlink:type="locator" xlink:label="mnkd_TyvasoDPIMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalSuppliesMember" xlink:type="locator" xlink:label="mnkd_ClinicalSuppliesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain_2" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="mnkd_ClinicalSuppliesMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TyvasoDPIMember" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ManufacturingServicesMember" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_2" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="mnkd_TransactionPriceForTheContractualObligationsMember" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="mnkd_TransactionPriceForThePerformanceObligationsMember" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_CommercializationAndContinuousImprovementActivitiesMember" order="12030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="13010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_AmendmentToCoPromotionAgreementMember" order="13030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="13090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="13250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_SupplyAndDistributionAgreementMember" order="13310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="13370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="13380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="13410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_BiommSAMember" order="13430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="13490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="13550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_UpfrontPaymentReceived" order="13780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_MilestonePaymentReceived" order="13800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" order="13820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="13870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="13970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" order="14020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="14090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AgreementAmendmentDescription" order="14140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AllocatedTransactionPrice" order="14310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="14360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="14400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="14440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsForCapitalImprovements" order="14530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets" order="14550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" order="14850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" order="14900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CapitalizedContractCostImpairmentLoss" order="14920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="14970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" order="15060.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:type="locator" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FacilityExpansionServicesMember" xlink:type="locator" xlink:label="mnkd_FacilityExpansionServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreCommercialServicesMember" xlink:type="locator" xlink:label="mnkd_PreCommercialServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredOverTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalSuppliesMember" xlink:type="locator" xlink:label="mnkd_ClinicalSuppliesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="mnkd_ClinicalSuppliesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_2" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_PreCommercialServicesMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_FacilityExpansionServicesMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="10780.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:type="locator" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:type="locator" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredOverTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingServicesMember" xlink:type="locator" xlink:label="mnkd_ManufacturingServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TyvasoDPIMember" xlink:type="locator" xlink:label="mnkd_TyvasoDPIMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TyvasoDPIMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ManufacturingServicesMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" order="11340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" order="11500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="11580.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="10410.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1Default" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1Default" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1Default">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_DebtInstrumentMeasurementInputAfterChange" order="10370.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiabilityMember" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_SeniorNotesMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ContingentMilestoneLiabilityMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CreditFacilityAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10840.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NotePayablePercentageOfInterestRateChange" xlink:type="locator" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_SeniorNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CreditFacilityAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_RangeAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_DebtInstrumentMeasurementInputAfterChange" order="10620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_NotePayablePercentageOfInterestRateChange" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" order="11100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommonAndPreferredStockAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedToPayInterest" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedToPayInterest" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_MarketPriceStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RemainingWarrantsAvailableForPurchase" xlink:type="locator" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleOfStockTransactionDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheOneMember" xlink:type="locator" xlink:label="mnkd_TrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnderwritingAgreementMember" xlink:type="locator" xlink:label="mnkd_UnderwritingAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DecemberTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_JuneTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:type="locator" xlink:label="srt_WeightedAverageMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CantorFitzgeraldMember" xlink:type="locator" xlink:label="mnkd_CantorFitzgeraldMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtMarketIssuanceSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContolledEquityOfferingSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_ContolledEquityOfferingSalesAgreementMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_AtMarketIssuanceSalesAgreementMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_CantorFitzgeraldMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_JuneTwoThousandTwentyNoteMember" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_DecemberTwoThousandTwentyNoteMember" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_UnderwritingAgreementMember" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="11330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNotesMember" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_CreditFacilityAxis" order="11420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="11450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheOneMember" order="11570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="11900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="11940.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="12060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockValue" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="12370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_RemainingWarrantsAvailableForPurchase" order="12770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" order="12820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" order="12860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="13010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="13060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromStockPlans" order="13420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_MarketPriceStockPurchasePlan" order="13440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_CommonStockIssuedToPayInterest" order="13490.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" xlink:type="locator" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_SeniorConvertibleNotesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_ConvertibleNotesMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlanMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" xlink:type="locator" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentileRankOfShareholderReturnOfStock" xlink:type="locator" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" xlink:type="locator" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeMember" xlink:type="locator" xlink:label="mnkd_EmployeeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:type="locator" xlink:label="us-gaap_PerformanceSharesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndOptionsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFiveMember" xlink:type="locator" xlink:label="mnkd_GroupFiveMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFourMember" xlink:type="locator" xlink:label="mnkd_GroupFourMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupThreeMember" xlink:type="locator" xlink:label="mnkd_GroupThreeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupTwoMember" xlink:type="locator" xlink:label="mnkd_GroupTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupOneMember" xlink:type="locator" xlink:label="mnkd_GroupOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyEighteenMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_2" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupOneMember" order="10950.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupTwoMember" order="10990.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupThreeMember" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupFourMember" order="11070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupFiveMember" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_RestrictedStockUnitsAndOptionsMember" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlanMember" order="11210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="11460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_EmployeeMember" order="11510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="11560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="11590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="11610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="11640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" order="11810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="11900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" order="12050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="12090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="12130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="12170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="12210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentileRankOfShareholderReturnOfStock" order="12250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" order="12290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="12830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="12960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="13020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="13080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="13170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" order="13230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="13380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" order="13440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="13560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="13790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" order="13850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="13910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="14030.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansStockBasedAwardPlansDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:type="locator" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyEighteenMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10360.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CostOfRevenueCollaborationsAndServicesMember" xlink:type="locator" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_CostOfRevenueCollaborationsAndServicesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10200.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10260.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="mnkd_LeaseExpirationMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLeasesAnnualIncreaseInRentExpense" xlink:type="locator" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:type="locator" xlink:label="us-gaap_GainLossOnTerminationOfLease" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeases" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeases" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesReplaced" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesReplaced" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesRetired" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesRetired" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:type="locator" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:type="locator" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" xlink:type="locator" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseRepurchaseDescription" xlink:type="locator" xlink:label="mnkd_LeaseRepurchaseDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNetBookValue" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionNetBookValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionLeaseTerms" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionLeaseTerms" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstate" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_MilestoneRightLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiabilityRemainingPayableAmount" xlink:type="locator" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiability" xlink:type="locator" xlink:label="mnkd_ContingentLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarlboroughLeaseMember" xlink:type="locator" xlink:label="mnkd_MarlboroughLeaseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RussellRanchRoadIILLCMember" xlink:type="locator" xlink:label="mnkd_RussellRanchRoadIILLCMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeMember" xlink:type="locator" xlink:label="mnkd_OfficeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:type="locator" xlink:label="us-gaap_VehiclesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MasterLeaseAgreementWithEnterpriseMember" xlink:type="locator" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CasperLLCMember" xlink:type="locator" xlink:label="mnkd_CasperLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:type="locator" xlink:label="mnkd_DeerfieldManagementCompanyLpMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CasperLLCMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_MasterLeaseAgreementWithEnterpriseMember" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_OfficeMember" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="mnkd_RussellRanchRoadIILLCMember" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="11490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_MarlboroughLeaseMember" order="11570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="11660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="11690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="11710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiability" order="11740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiabilityRemainingPayableAmount" order="11780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="11820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_MilestoneRightLiability" order="11860.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_ProceedsFromSaleOfRealEstate" order="11930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="12000.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToExtend" order="12020.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" order="12040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="12060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SaleLeasebackTransactionLeaseTerms" order="12080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="12100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SaleLeasebackTransactionNetBookValue" order="12120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LeaseRepurchaseDescription" order="12140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiability" order="12190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="12230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="12270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" order="12340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate" order="12390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" order="12410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeasesRetired" order="12460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeasesReplaced" order="12480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeases" order="12500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="12520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="12540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="12560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="12580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="12610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" order="12680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LeaseExpirationMonthAndYear" order="12700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="12850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LeaseCost" order="12970.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:type="locator" xlink:label="us-gaap_OtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssets" order="12590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10290.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeAndVehicleMember" xlink:type="locator" xlink:label="mnkd_OfficeAndVehicleMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="10070.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_OfficeAndVehicleMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="10540.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEmployeeBenefitPlansAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoYearServiceMember" xlink:type="locator" xlink:label="mnkd_TwoYearServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OneYearServiceMember" xlink:type="locator" xlink:label="mnkd_OneYearServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="srt_StatementScenarioAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mnkd_OneYearServiceMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mnkd_TwoYearServiceMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer" order="10460.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:type="locator" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:type="locator" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CaliforniaDivisionOfTaxationMember" xlink:type="locator" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConnecticutTaxAuthorityMember" xlink:type="locator" xlink:label="mnkd_ConnecticutTaxAuthorityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="locator" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesTable" xlink:type="locator" xlink:label="mnkd_IncomeTaxesTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesLineItems" xlink:type="locator" xlink:label="mnkd_IncomeTaxesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="mnkd_ConnecticutTaxAuthorityMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="mnkd_CaliforniaDivisionOfTaxationMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" order="10590.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="10740.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>mnkd-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T09:24:21.9970685+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CashEquivalentsAndInvestments" xlink:type="locator" xlink:label="mnkd_CashEquivalentsAndInvestments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CashEquivalentsAndInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash equivalents and investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CashEquivalentsAndInvestments" xlink:to="mnkd_CashEquivalentsAndInvestments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" xlink:type="locator" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" />
    <link:label xml:lang="en-US" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Wholesaler distribution fees and prompt pay discounts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" xlink:to="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveForReturns" xlink:type="locator" xlink:label="mnkd_ReserveForReturns" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReserveForReturns_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserve for returns.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReserveForReturns" xlink:to="mnkd_ReserveForReturns_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due next twelve months.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due year two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due year three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due year four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due year five.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due after year five.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted excess amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted debt issuance costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscounted" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscounted" xlink:to="mnkd_FinanceLeaseLiabilityDiscounted_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorFirmId_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm Id</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AuditorLocation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationCurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationCurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase obligation current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PurchaseObligationCurrent" xlink:to="mnkd_PurchaseObligationCurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesNoncurrent" xlink:type="locator" xlink:label="mnkd_PromissoryNotesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Promissory notes noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PromissoryNotesNoncurrent" xlink:to="mnkd_PromissoryNotesNoncurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestNoncurrent" xlink:type="locator" xlink:label="mnkd_AccruedInterestNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedInterestNoncurrent" xlink:to="mnkd_AccruedInterestNoncurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CreditFacilityNoncurrent" xlink:type="locator" xlink:label="mnkd_CreditFacilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CreditFacilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Credit facility noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CreditFacilityNoncurrent" xlink:to="mnkd_CreditFacilityNoncurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase obligation noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PurchaseObligationNoncurrent" xlink:to="mnkd_PurchaseObligationNoncurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneLiabilitiesNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone liabilities non-current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneLiabilitiesNoncurrent" xlink:to="mnkd_MilestoneLiabilitiesNoncurrent_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other intangible asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Net Excluding Goodwill</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&apos; DEFICIT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing liability &#8212; current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue &#8212; current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized loss on purchase commitments &#8212; current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Promissory notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Promissory Notes Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest &#8212; promissory notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing liability &#8212; long term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CreditFacilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Midcap credit facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CreditFacilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Long Term Notes Payable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized loss on purchase commitments &#8212; long term</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseObligationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue &#8212; long term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Liabilities Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deposits from customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 16)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&apos; deficit:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undesignated preferred stock, $0.01 par value &#8212; 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2022 and 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.01 par value &#8212; 400,000,000 shares authorized, 263,793,305 and 251,477,562 shares issued and outstanding at December 31, 2022 and 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&apos; deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&apos; deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_GainLossOnPurchaseCommitments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (loss) on purchase commitments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GainLossOnPurchaseCommitments" xlink:to="mnkd_GainLossOnPurchaseCommitments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnFinancingLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest expense on financing liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InterestExpenseOnFinancingLiability" xlink:to="mnkd_InterestExpenseOnFinancingLiability_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Or Service [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Products And Services [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Commercial product sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicenseAndServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborations and services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseAndServiceMember" xlink:to="us-gaap_LicenseAndServiceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicenseAndServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License And Service [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty collaborations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Royalty [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Excluding Assessed Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of goods sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentInProcess" xlink:to="us-gaap_ResearchAndDevelopmentInProcess_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentInProcess_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development In Process</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Excluding Acquired In Process Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingExpense" xlink:type="locator" xlink:label="us-gaap_SellingExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingExpense" xlink:to="us-gaap_SellingExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset impairment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">(Gain) loss on foreign currency translation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain Loss Realized</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on purchase commitments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GainLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Purchase Commitments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other (expense) income:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense on financing liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense On Financing Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense on notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Gain Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on extinguishment of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gains Losses On Extinguishment Of Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other (expense) income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income tax expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Benefit from income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used to compute net loss per share - basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Basic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used to compute net loss per share - diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Diluted Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Income And Comprehensive Income [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative translation loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares stock options and restricted stock units net of forfeitures.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:to="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value stock options and restricted stock units net of forfeitures.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:to="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares exercise of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value exercise of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares market price stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" xlink:to="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value market price stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" xlink:to="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" xlink:type="locator" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital issuance of warrants pursuant to credit facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares payoff of convertible securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" xlink:to="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value payoff of convertible securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" xlink:to="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustment to additional paid in capital premium on convertible note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" xlink:to="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock pursuant to a warrant conversion shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock pursuant to a warrant conversion.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CumulativeLossOnAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative loss on available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CumulativeLossOnAvailableForSaleSecurities" xlink:to="mnkd_CumulativeLossOnAvailableForSaleSecurities_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertibleNotesMember" xlink:to="mnkd_ConvertibleNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty four convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Four Convertible Notes [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty four convertible note interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Convertible Note Interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Four Convertible Note Interest [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesPrincipalMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Senior convertible notes principal.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SeniorConvertibleNotesPrincipalMember" xlink:to="mnkd_SeniorConvertibleNotesPrincipalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Convertible Notes Principal</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Convertible Notes Principal [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesInterestMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesInterestMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Senior convertible notes interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SeniorConvertibleNotesInterestMember" xlink:to="mnkd_SeniorConvertibleNotesInterestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Convertible Notes Interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Convertible Notes Interest [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotePrincipalMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotePrincipalMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotePrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible note principal.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertibleNotePrincipalMember" xlink:to="mnkd_ConvertibleNotePrincipalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotePrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Note Principal</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNotePrincipalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Note Principal [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNoteInterestMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible note interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertibleNoteInterestMember" xlink:to="mnkd_ConvertibleNoteInterestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Note Interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertibleNoteInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Note Interest [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketOfferingMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketOfferingMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AtTheMarketOfferingMember" xlink:to="mnkd_AtTheMarketOfferingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At-the-market Offering</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketOfferingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">At The Market Offering [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions By Related Party [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TheMannGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The mann group llc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TheMannGroupLLCMember" xlink:to="mnkd_TheMannGroupLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TheMannGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The Mann Group L L C</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TheMannGroupLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">The Mann Group L L C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net issuance of common stock in association with stock options and restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net issuance of common stock associated with stock options and restricted stock units (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options And Restricted Stock Units Net Of Forfeitures</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to conversion notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to conversion notes (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to payoff of the 2024 convertible note interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Payoff Of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to payoff of the 2024 convertible note interest (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Payoff Of Convertible Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in at-the-market offering/placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in at-the-market offering/placement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance cost associated with at-the-market offering/placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Stock Issued Issuance Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Employee Stock Purchase Plan (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Acquisitions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Acquisitions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from the exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Exercise Of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from the exercise of warrants (in Share)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Exercise Of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Premium on Mann Group convertible note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment To Additional Paid In Capital Premium On Convertible Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from market price stock purchase</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Market Price Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Market Price Stock Purchase Plan (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Market Price Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants pursuant to Midcap Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cumulative translation loss</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to a warrant conversion</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Pursuant To Warrant Conversion</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock pursuant to a warrant conversion (shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Pursuant To Warrant Conversion Shares</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative loss on available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Loss On Available For Sale Securities</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestOnMilestonePayment" xlink:type="locator" xlink:label="mnkd_InterestOnMilestonePayment" />
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestOnMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest on milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InterestOnMilestonePayment" xlink:to="mnkd_InterestOnMilestonePayment_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnPromissoryNotes" />
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest expenses on promissory notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InterestExpenseOnPromissoryNotes" xlink:to="mnkd_InterestExpenseOnPromissoryNotes_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in recognized loss on purchase commitments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" xlink:to="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in accrued interest on promissory notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" xlink:to="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of available-for-sale securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PurchaseOfAvailableForSaleSecurities" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePayments" xlink:type="locator" xlink:label="mnkd_MilestonePayments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestonePayments" xlink:to="mnkd_MilestonePayments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" xlink:type="locator" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from net issuance of common stock associated with stock options and restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" xlink:to="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from market price stock purchase plan and from employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" xlink:to="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_PaymentOnFinancingLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment on financing liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentOnFinancingLiability" xlink:to="mnkd_PaymentOnFinancingLiability_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from the sale-leaseback transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProceedsFromSaleLeasebackTransaction" xlink:to="mnkd_ProceedsFromSaleLeasebackTransaction_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DepositForSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_DepositForSaleLeasebackTransaction" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DepositForSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deposit for the sale-leaseback transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DepositForSaleLeasebackTransaction" xlink:to="mnkd_DepositForSaleLeasebackTransaction_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfCreditFacilityPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of credit facility prepayment penalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" xlink:to="mnkd_PaymentOfCreditFacilityPrepaymentPenalty_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketIssuanceMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketIssuanceMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketIssuanceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AtTheMarketIssuanceMember" xlink:to="mnkd_AtTheMarketIssuanceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketIssuanceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At The Market Issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AtTheMarketIssuanceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">At The Market Issuance [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation, amortization and accretion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation And Amortization</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense on financing liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestOnMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest on milestone right</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestOnMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest On Milestone Payment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Write-off of inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Production Related Impairments Or Charges</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense on Mann Group promissory notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense On Promissory Notes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset Amortization Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on extinguishment of debt, net</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Asset impairment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Inventories</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities And Other Operating Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract With Customer Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized loss on purchase commitments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Recognized Loss On Purchase Commitments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accrued interest on Mann Group promissory notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Interest On Promissory Notes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deposits from customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Noncurrent Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of held-to-maturity debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Held To Maturity Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturity of debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Held To Maturity Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquisition of V-Go</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Businesses Net Of Cash Acquired</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Available For Sale Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of treasury bills</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Short Term Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquisition of in-process research and development, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire In Process Research And Development</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from public offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Milestone payment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance costs associated with the sale-leaseback transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net issuance of common stock associated with stock options and restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Net Issuance Of Common Stock Associated With Stock Options And Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from market price stock purchase plan and from employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment on financing liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment On Financing Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from the exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Warrant Exercises</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from MidCap credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Lines Of Credit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Long Term Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the Senior convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Convertible Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance costs associated with Senior convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Debt Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the sale-leaseback transaction</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Leaseback Transaction</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DepositForSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deposit for the sale-leaseback transaction</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DepositForSaleLeasebackTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deposit For Sale Leaseback Transaction</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Principal payments on Mann Group promissory notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Notes Payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of MidCap credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Lines Of Credit</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of MidCap credit facility prepayment penalty</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Credit Facility Prepayment Penalty</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" xlink:type="locator" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of investments from long-term to current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" xlink:to="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" xlink:type="locator" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of convertible notes and interest receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" xlink:to="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_PremiumOnConvertibleNote" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Premium on convertible note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PremiumOnConvertibleNote" xlink:to="mnkd_PremiumOnConvertibleNote_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" xlink:type="locator" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments on debt and interest through common stock issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" xlink:to="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionOfRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_AdditionOfRightOfUseAssets" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionOfRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Addition of right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdditionOfRightOfUseAssets" xlink:to="mnkd_AdditionOfRightOfUseAssets_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RightOfUseAssetsModification" xlink:type="locator" xlink:label="mnkd_RightOfUseAssetsModification" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RightOfUseAssetsModification_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-use assets modification.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RightOfUseAssetsModification" xlink:to="mnkd_RightOfUseAssetsModification_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" xlink:type="locator" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock issuance to settle employee stock purchase plan liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" xlink:to="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiability" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent milestone liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContingentMilestoneLiability" xlink:to="mnkd_ContingentMilestoneLiability_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock issued for acquisition of in-process research and development.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" xlink:to="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" xlink:type="locator" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of warrants associated with Credit Facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" xlink:to="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceivableFromCommonStockOffering" xlink:type="locator" xlink:label="mnkd_ReceivableFromCommonStockOffering" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceivableFromCommonStockOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Receivable from common stock offering.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReceivableFromCommonStockOffering" xlink:to="mnkd_ReceivableFromCommonStockOffering_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUPPLEMENTAL CASH FLOWS DISCLOSURES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest paid in cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NON-CASH INVESTING AND FINANCING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of investments from long-term to current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Investments From Long Term To Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of Thirona convertible notes and interest receivable from long-term to current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Convertible Notes And Interest Receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Premium on convertible note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PremiumOnConvertibleNote_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Premium On Convertible Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments on debt and interest through common stock issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments On Debt And Interest Through Common Stock Issuance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forgiveness of PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Decrease Forgiveness</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionOfRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Addition of right-of-use-asset</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionOfRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Addition Of Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RightOfUseAssetsModification_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use asset modification</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RightOfUseAssetsModification_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Assets Modification</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash construction in progress and property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred But Not Yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Issuance To Settle Employee Stock Purchase Plan Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent milestone liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Milestone Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for acquisition of in-process research and development</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Issued For Acquisition Of In Process Research And Development</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants associated with the MidCap Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Warrants Associated With Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceivableFromCommonStockOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivable from at-the-market offering</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceivableFromCommonStockOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivable From Common Stock Offering</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination And Asset Acquisition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivables [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancingReceivablesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesTextBlock" xlink:to="us-gaap_FinancingReceivablesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancingReceivablesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financing Receivables [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill and Other Intangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payables And Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses and Other Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable And Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Borrowings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration, Licensing and Other Arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common and Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Common Share ("EPS")</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Award Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation And Retirement Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefit Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pension And Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_BusinessPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessPolicyTextBlock" xlink:to="mnkd_BusinessPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BasisOfPresentationPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Basis of Presentation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BasisOfPresentationPolicyTextBlock" xlink:to="mnkd_BasisOfPresentationPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Presentation Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prior Period Reclassification Adjustment Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Statement Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue from contract with customer from commercial product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" xlink:to="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition - Net Revenue - Commercial Product Sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer From Commercial Product Sales Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue from contract with customer from collaborations and services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" xlink:to="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition- Net Revenue - Collaborations and Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer From Collaborations And Services Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Goods Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CostOfRevenuesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_CostOfRevenuesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenuesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost of revenues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CostOfRevenuesPolicyTextBlock" xlink:to="mnkd_CostOfRevenuesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenuesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenues</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenuesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Revenues Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Held-to-Maturity Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" xlink:to="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Purchased Options Price Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-Sale Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:to="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Purchased Options Price Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable and Allowance for Credit Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreLaunchInventoryPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_PreLaunchInventoryPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-launch inventory.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PreLaunchInventoryPolicyTextBlock" xlink:to="mnkd_PreLaunchInventoryPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Launch Inventory</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Launch Inventory Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquistitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill and Other Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Loss on purchase commitments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" xlink:to="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognized Loss on Purchase Commitments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss On Purchase Commitments Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone rights liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightsLiabilityPolicyTextBlock" xlink:to="mnkd_MilestoneRightsLiabilityPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Rights Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Rights Liability Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments Policy</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:type="locator" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical Trial Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:to="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical Trial Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Trial Expense Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Income or (Loss) Per Share of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Adopted Accounting Standards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Recently issued accounting standards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:to="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued Accounting Standards</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Recently Issued Accounting Standards Policy [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_VGoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">V-Go.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_VGoMember" xlink:to="mnkd_VGoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_VGoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">V-Go</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_VGoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">V Go [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Preliminary Purchase Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Supplemental Pro Forma Information (Unaudited)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Pro Forma Information [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Consideration Paid for IPR&amp;D</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Contractual Maturities of Held to Maturity Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of fair value of assets and financing liability on total investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" xlink:to="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Fair Value of Assets and Financing Liability on Total Investments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Of Assets And Financing Liability On Total Investments Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accounts Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of activities and ending reserve balance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" xlink:to="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Activities and Ending Reserve Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Activities And Ending Reserve Balance Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Inventory Current Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Intangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Finite Lived Intangible Assets Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses and Other Current Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Provision for Discounts and Allowances for Commercial Product Sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Carrying Amount of Borrowings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Debt Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Line of Credit Facility Debt and Key Terms</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Line Of Credit Facilities [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Maturities of the Company&apos;s Borrowings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Maturities Of Long Term Debt Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of amortization of debt issuance cost and debt discount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" xlink:to="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Amortization of Premium and Accretion of Debt Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Amortization Of Debt Issuance Cost And Debt Discount Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UnitedTherapeuticsCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">United Therapeutics Corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnitedTherapeuticsCorporationMember" xlink:to="mnkd_UnitedTherapeuticsCorporationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UnitedTherapeuticsCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United Therapeutics Corporation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_UnitedTherapeuticsCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">United Therapeutics Corporation [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revenue from Collaboration and Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityTableTextBlock" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContractWithCustomerLiabilityTableTextBlock" xlink:to="mnkd_ContractWithCustomerLiabilityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revenue Allocation, Remaining Performance Obligation, Expected Timing of Satisfaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Revised anticipated cash flows from transactions allocated performance obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" xlink:to="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Revised Anticipated Cash Flows From Transactions Allocated Performance Obligations Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of effect of modification on transaction price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" xlink:to="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Effect of Modification on Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effect Of Modification On Transaction Price Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Basic and Diluted EPS Computations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential Dilutive Securities Outstanding that are Considered Antidilutive</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Based Award Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assumptions Used to Calculate Fair Value of Employee Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Options Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Unit Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Lease Term and Discount Rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" xlink:to="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Lease Term and Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Lease Term And Discount Rate Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Lease Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financing Liability Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Maturity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining Purchase Requirements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:to="us-gaap_LongTermPurchaseCommitmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Purchase Commitment [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Office And Vehicle Lease Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Maturity Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from Continuing Operations Before Provision for Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of Net Deferred Tax Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Positions for which Significant Change in Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Text Block]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumCashCovenant" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument minimum cash covenant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentMinimumCashCovenant" xlink:to="mnkd_DebtInstrumentMinimumCashCovenant_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization, consolidation and presentation of financial statements disclosure.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MidCapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">MidCap Credit Facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MidCapCreditFacilityMember" xlink:to="mnkd_MidCapCreditFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MidCapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MidCap Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MidCapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mid Cap Credit Facility [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TrancheTwoMember" xlink:to="mnkd_TrancheTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche 2</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum cash covenant</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Minimum Cash Covenant</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SalesReturnPeriod" xlink:type="locator" xlink:label="mnkd_SalesReturnPeriod" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SalesReturnPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales return period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SalesReturnPeriod" xlink:to="mnkd_SalesReturnPeriod_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AFREZZA product sales</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConvertiblePromissoryNoteMember" xlink:to="mnkd_ConvertiblePromissoryNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ThironaBioIncMember" xlink:type="locator" xlink:label="mnkd_ThironaBioIncMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ThironaBioIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Thirona Bio, Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ThironaBioIncMember" xlink:to="mnkd_ThironaBioIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ThironaBioIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thirona Bio Inc</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ThironaBioIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Thirona Bio Inc [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Assets Held-for-sale by Asset Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:to="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Lived Assets Held For Sale By Asset Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Assets Held-for-sale, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:to="us-gaap_LongLivedAssetsHeldForSaleNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Lived Assets Held For Sale Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAssetMember" xlink:type="locator" xlink:label="mnkd_CommitmentAssetMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAssetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentAssetMember" xlink:to="mnkd_CommitmentAssetMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAssetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment Asset</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAssetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment Asset [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InsulinMember" xlink:type="locator" xlink:label="mnkd_InsulinMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_InsulinMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Insulin.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_InsulinMember" xlink:to="mnkd_InsulinMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_InsulinMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insulin</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InsulinMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Insulin [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone Rights Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightsLiabilityMember" xlink:to="mnkd_MilestoneRightsLiabilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Rights Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Rights Liability [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:type="locator" xlink:label="mnkd_DeerfieldManagementCompanyLpMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deerfield Management Company L.P.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeerfieldManagementCompanyLpMember" xlink:to="mnkd_DeerfieldManagementCompanyLpMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deerfield</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeerfieldManagementCompanyLpMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deerfield Management Company Lp [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SalesReturnPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Sales return right following product expiration in months</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SalesReturnPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Return Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining performance obligation, Expected timing of satisfaction, period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Table]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProductSalesMember" xlink:type="locator" xlink:label="mnkd_ProductSalesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ProductSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ProductSalesMember" xlink:to="mnkd_ProductSalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ProductSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ProductSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Sales [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:type="locator" xlink:label="us-gaap_ServiceMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceMember" xlink:to="us-gaap_ServiceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Service [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation Of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Total net revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Total cost of goods sold and cost of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion or amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for credit losses on held-to-maturity securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Held To Maturity Allowance For Credit Loss</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of available-for-sale securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentMaturityDate" xlink:type="locator" xlink:label="us-gaap_InvestmentMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentMaturityDate" xlink:to="us-gaap_InvestmentMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Maturity Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Interest Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-Sale Investment, credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Allowance For Credit Loss</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAsset" xlink:type="locator" xlink:label="mnkd_CommitmentAsset" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentAsset" xlink:to="mnkd_CommitmentAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment asset</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:type="locator" xlink:label="us-gaap_OtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Asset impairment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Long Lived Assets To Be Disposed Of</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairments of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill Impairment Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairments of other intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Intangible Assets Excluding Goodwill</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" xlink:type="locator" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Loss on purchase commitments number of contracts recognized.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" xlink:to="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation" xlink:type="locator" xlink:label="us-gaap_PurchaseObligation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on purchase commitments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on purchase commitments, number of new contracts recognized</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss On Purchase Commitments Number Of Contracts Recognized</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiabilityRemainingPayableAmount" xlink:type="locator" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent liability remaining payable amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContingentLiabilityRemainingPayableAmount" xlink:to="mnkd_ContingentLiabilityRemainingPayableAmount_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiability" xlink:type="locator" xlink:label="mnkd_ContingentLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContingentLiability" xlink:to="mnkd_ContingentLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Contingent liability remain payable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Liability Remaining Payable Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Contingent liability for milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Acquiree [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-Free Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend Yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Price Volatility [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Expected Term [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputEntityCreditRiskMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputEntityCreditRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputEntityCreditRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend Yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputEntityCreditRiskMember" xlink:to="us-gaap_MeasurementInputEntityCreditRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MeasurementInputEntityCreditRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Entity Credit Risk [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_QrumPharmaIncorporatedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">QrumPharma Incorporated.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_QrumPharmaIncorporatedMember" xlink:to="mnkd_QrumPharmaIncorporatedMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_QrumPharmaIncorporatedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">QrumPharma</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_QrumPharmaIncorporatedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Qrum Pharma Incorporated [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Global adjusted net sales of products exceeds fifty million.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Global Adjusted Net Sales Of Products Exceeds Fifty Million</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Global Adjusted Net Sales Of Products Exceeds Fifty Million [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" xlink:type="locator" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjusted net sales are greater than or equal to two hundred million.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" xlink:to="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjusted Net Sales Are Greater Than Or Equal To Two Hundred Million</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjusted Net Sales Are Greater Than Or Equal To Two Hundred Million [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset acquisition, date of acquisition agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" xlink:to="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Date Of Acquisition Agreement</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset acquisition, effective date of acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" xlink:to="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Effective Date Of Acquisition</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AssetAcquisitionMilestonePaymentPayable" xlink:type="locator" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset acquisition, milestone payment payable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AssetAcquisitionMilestonePaymentPayable" xlink:to="mnkd_AssetAcquisitionMilestonePaymentPayable_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" xlink:type="locator" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual revenue milestones ranges for milestone payments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" xlink:to="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset acquisition, up-front consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Productive Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales-based milestone payments payable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Milestone Payment Payable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual revenue milestones ranges for milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Annual Revenue Milestones Ranges For Milestone Payments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of consideration:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Consideration Transferred [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash consideration</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of contingent consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Consideration Transferred Contingent Consideration</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition Consideration Transferred</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GoodwillAmortizationPeriod" xlink:type="locator" xlink:label="mnkd_GoodwillAmortizationPeriod" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GoodwillAmortizationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Goodwill amortization period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GoodwillAmortizationPeriod" xlink:to="mnkd_GoodwillAmortizationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GoodwillAmortizationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill amortization period</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GoodwillAmortizationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill Amortization Period</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed current and noncurrent liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed operating lease liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible asset - Developed technology</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities assumed</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current And Noncurrent Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net assets acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental borrowing rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Discount Rate Percent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement inputs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Contingent Consideration Liability Measurement Input</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition-related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Acquisition Related Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Pro Forma Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisitions Pro Forma Revenue</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisitions Pro Forma Net Income Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Pro Forma Earnings Per Share Basic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Pro Forma Earnings Per Share Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Effective Date Of Acquisition1</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessAcquisitionRepaymentOfDebt" xlink:type="locator" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business acquisition, repayment of debt.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessAcquisitionRepaymentOfDebt" xlink:to="mnkd_BusinessAcquisitionRepaymentOfDebt_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Businesses Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock consideration (3,067,179 shares at $3.01 per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Consideration Transferred Equity Interests Issued And Issuable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForMergerRelatedCosts" xlink:to="us-gaap_PaymentsForMergerRelatedCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForMergerRelatedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Merger Related Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment of debt</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Repayment Of Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities assumed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Consideration Transferred Liabilities Incurred</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Acquired From Acquisition</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total consideration paid for IPR&amp;D</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Consideration Transferred1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition, share price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Share Price</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationAccumulatedCost" xlink:type="locator" xlink:label="mnkd_BusinessCombinationAccumulatedCost" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationAccumulatedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination accumulated cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BusinessCombinationAccumulatedCost" xlink:to="mnkd_BusinessCombinationAccumulatedCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationAccumulatedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition, total accumulated cost</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BusinessCombinationAccumulatedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Accumulated Cost</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRoyaltyPaymentOnNetSales" xlink:type="locator" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of royalty payment on net sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfRoyaltyPaymentOnNetSales" xlink:to="mnkd_PercentageOfRoyaltyPaymentOnNetSales_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Global adjusted net sales of products reference amount for royalty percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty payment in each of the calendar years</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Royalty Payment On Net Sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Global adjusted net sales of products, reference amount for royalty percentage.</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Global Adjusted Net Sales Of Products Reference Amount For Royalty Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Investments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_ScheduleOfInvestmentsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Investments [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Security Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Information By Category Of Debt Security [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldtomaturitySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_HeldtomaturitySecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldtomaturitySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Held-to-Maturity Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldtomaturitySecuritiesMember" xlink:to="us-gaap_HeldtomaturitySecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldtomaturitySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Heldtomaturity Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Investments [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Investments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Investments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost basis, due in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized cost basis due after one year through five years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized cost basis, total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate fair value, due in one year or less</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities Within One Year Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate fair value, due after one year through five years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Aggregate fair value, total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Held To Maturity Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Held To Maturity Securities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Debt Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Debt Type [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DueInOneYearOrLessMember" xlink:type="locator" xlink:label="mnkd_DueInOneYearOrLessMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DueInOneYearOrLessMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Due in one year or less.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DueInOneYearOrLessMember" xlink:to="mnkd_DueInOneYearOrLessMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DueInOneYearOrLessMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in One Year or Less</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DueInOneYearOrLessMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Due In One Year Or Less [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Held To Maturity Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Held To Maturity Securities [Line Items]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of financial instruments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value of Financial Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Of Financial Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments [Table]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmortizedCostMember" xlink:type="locator" xlink:label="mnkd_AmortizedCostMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizedCostMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortized cost.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmortizedCostMember" xlink:to="mnkd_AmortizedCostMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizedCostMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizedCostMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortized Cost [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GrossUnrealizedHoldingLossesMember" xlink:type="locator" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross unrealized holding losses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GrossUnrealizedHoldingLossesMember" xlink:to="mnkd_GrossUnrealizedHoldingLossesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Holding Losses</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gross Unrealized Holding Losses [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EstimatedFairValueMember" xlink:type="locator" xlink:label="mnkd_EstimatedFairValueMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EstimatedFairValueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated fair value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EstimatedFairValueMember" xlink:to="mnkd_EstimatedFairValueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EstimatedFairValueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EstimatedFairValueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Fair Value [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Bonds and Paper</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasuries</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Of Financial Instruments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Financial Instruments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CashEquivalentsAndInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash equivalents and investments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CashEquivalentsAndInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents And Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents At Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_Investments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Investments</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestReceivable" xlink:type="locator" xlink:label="mnkd_AccruedInterestReceivable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest receivable.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedInterestReceivable" xlink:to="mnkd_AccruedInterestReceivable_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmountReceivableOnMaturedInvestment" xlink:type="locator" xlink:label="mnkd_AmountReceivableOnMaturedInvestment" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmountReceivableOnMaturedInvestment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount receivable on matured investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmountReceivableOnMaturedInvestment" xlink:to="mnkd_AmountReceivableOnMaturedInvestment_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest Receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AmountReceivableOnMaturedInvestment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount receivable on matured investment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AmountReceivableOnMaturedInvestment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amount Receivable On Matured Investment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Accounts Notes Loans And Financing Receivable [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accounts Notes Loans And Financing Receivable [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="locator" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Notes And Loans Receivable [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableGrossCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGrossCurrent" xlink:to="us-gaap_AccountsReceivableGrossCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableGrossCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Gross Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Wholesaler distribution fees and prompt pay discounts</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Wholesaler Distribution Fees And Prompt Pay Discounts</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReserveForReturns_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Reserve for returns</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReserveForReturns_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reserve For Returns</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accounts receivable, net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Allowance for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allowance For Doubtful Accounts Receivable Current</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfWholesaleDistributors" xlink:type="locator" xlink:label="mnkd_NumberOfWholesaleDistributors" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfWholesaleDistributors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of wholesale distributors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfWholesaleDistributors" xlink:to="mnkd_NumberOfWholesaleDistributors_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfAccountsReceivableFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of accounts receivable from major customers.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" xlink:to="mnkd_PercentageOfAccountsReceivableFromMajorCustomers_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfSalesFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of sales from major customers.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfSalesFromMajorCustomers" xlink:to="mnkd_PercentageOfSalesFromMajorCustomers_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfWholesaleDistributors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of wholesale distributors</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfWholesaleDistributors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Wholesale Distributors</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of accounts receivable from major wholesale distributors</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Accounts Receivable From Major Customers</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of gross sales from major wholesale distributors</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Sales From Major Customers</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" xlink:type="locator" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of collaborations and services net accounts receivables.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" xlink:to="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" xlink:type="locator" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of revenue from major customers collaborations and services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" xlink:to="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for credit losses for accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of collaborations and services net accounts receivables</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Collaborations And Services Net Accounts Receivables</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of revenue from major customers collaborations and services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Revenue From Major Customers Collaborations And Services</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve provisions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve deductions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveBalanceAbstract" xlink:type="locator" xlink:label="mnkd_ReserveBalanceAbstract" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReserveBalanceAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserve balance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReserveBalanceAbstract" xlink:to="mnkd_ReserveBalanceAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReserveBalanceAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reserve Balance [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provisions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deductions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Raw Materials Net Of Reserves</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Work-in-process</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Work In Process Net Of Reserves</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Finished Goods Net Of Reserves</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventory</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:type="locator" xlink:label="us-gaap_InventoryCurrentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryCurrentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory Current [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryCurrentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryCurrentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Current [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PublicUtilitiesInventoryAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Public Utilities Inventory [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Public Utilities Inventory Type [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreLaunchInventoryMember" xlink:type="locator" xlink:label="mnkd_PreLaunchInventoryMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">pre-launch inventory.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PreLaunchInventoryMember" xlink:to="mnkd_PreLaunchInventoryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-launch Inventory</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PreLaunchInventoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Launch Inventory [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementWithRetailPharmacyMember" xlink:type="locator" xlink:label="mnkd_AgreementWithRetailPharmacyMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementWithRetailPharmacyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement with a retail pharmacy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AgreementWithRetailPharmacyMember" xlink:to="mnkd_AgreementWithRetailPharmacyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementWithRetailPharmacyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement With Retail Pharmacy</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementWithRetailPharmacyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement With Retail Pharmacy [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:type="locator" xlink:label="us-gaap_InventoryLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Raw materials inventory</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterials_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Raw Materials</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Inventory write-offs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:type="locator" xlink:label="us-gaap_LandMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LandMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Land</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LandMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Land [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Buildings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Building [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember" xlink:type="locator" xlink:label="us-gaap_BuildingImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Building Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingImprovementsMember" xlink:to="us-gaap_BuildingImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BuildingImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Building Improvements [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Machinery and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Machinery And Equipment [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:type="locator" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Furniture, fixtures and office equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture, fixtures and office equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture Fixtures And Office Equipment [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Computer equipment and software.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ComputerEquipmentAndSoftwareMember" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment and Software</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment And Software [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment - gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total property and equipment, net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life (Years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UTEquipmentMember" xlink:type="locator" xlink:label="mnkd_UTEquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UTEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">UT Equipment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UTEquipmentMember" xlink:to="mnkd_UTEquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UTEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U T Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_UTEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U T Equipment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressGross" xlink:to="us-gaap_ConstructionInProgressGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from related party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Related Party Debt</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentsAndComputerHardwareMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing equipments and computer hardware.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" xlink:to="mnkd_ManufacturingEquipmentsAndComputerHardwareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Equipment and Computer Hardware</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Equipments And Computer Hardware [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing Equipment, Computer Hardware and Software, Computer Equipment, Lab Equipment, and Building Improvements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" xlink:to="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Equipment, Computer Hardware and Software, Computer Equipment, Lab Equipment, and Building Improvements</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Equipment Computer Hardware And Software Computer Equipment Lab Equipment And Building Improvements [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CasperLLCMember" xlink:type="locator" xlink:label="mnkd_CasperLLCMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CasperLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">1 Casper, LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CasperLLCMember" xlink:to="mnkd_CasperLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CasperLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Casper L L C</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CasperLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Casper L L C [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of divestiture of long-lived</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisposals" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disposals</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" xlink:type="locator" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale leaseback transaction, lease agreement periods.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" xlink:to="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstate" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfRealEstate" xlink:to="us-gaap_ProceedsFromSaleOfRealEstate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale Of Real Estate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale leaseback transaction, lease agreement period.</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Leaseback Transaction Lease Agreement Periods</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale leaseback transaction, date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionDate" xlink:to="us-gaap_SaleLeasebackTransactionDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Leaseback Transaction Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">After 2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Amortization Expense After Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Major Class Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Developed Technology</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life (Years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Asset Useful Life</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Accumulated Amortization</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Book Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Net</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CustomerDiscountsAndAllowances" xlink:type="locator" xlink:label="mnkd_CustomerDiscountsAndAllowances" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CustomerDiscountsAndAllowances_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Customer Discounts And Allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CustomerDiscountsAndAllowances" xlink:to="mnkd_CustomerDiscountsAndAllowances_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReturnsReserveForAcquiredProduct" xlink:type="locator" xlink:label="mnkd_ReturnsReserveForAcquiredProduct" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReturnsReserveForAcquiredProduct_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Returns reserve for acquired product.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReturnsReserveForAcquiredProduct" xlink:to="mnkd_ReturnsReserveForAcquiredProduct_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CurrentPortionOfMilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Current portion of milestone right liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CurrentPortionOfMilestoneRightLiability" xlink:to="mnkd_CurrentPortionOfMilestoneRightLiability_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RetailInventoryPurchase" xlink:type="locator" xlink:label="mnkd_RetailInventoryPurchase" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RetailInventoryPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Retail inventory purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RetailInventoryPurchase" xlink:to="mnkd_RetailInventoryPurchase_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Salary and related expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Related Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CustomerDiscountsAndAllowances_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discounts and allowances for commercial product sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CustomerDiscountsAndAllowances_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer Discounts And Allowances</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReturnsReserveForAcquiredProduct_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Returns reserve for acquired product</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReturnsReserveForAcquiredProduct_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Returns Reserve For Acquired Product</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:type="locator" xlink:label="us-gaap_DirectFinancingLeaseDeferredSellingProfit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DirectFinancingLeaseDeferredSellingProfit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:to="us-gaap_DirectFinancingLeaseDeferredSellingProfit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DirectFinancingLeaseDeferredSellingProfit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Direct Financing Lease Deferred Selling Profit</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of milestone rights liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Portion Of Milestone Right Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable Current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RetailInventoryPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retail inventory purchase</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RetailInventoryPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retail Inventory Purchase</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrent" xlink:type="locator" xlink:label="us-gaap_ConstructionPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Danbury facility buildout</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionPayableCurrent" xlink:to="us-gaap_ConstructionPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction Payable Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued expenses and other current liabilities</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSales" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSales" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSales_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales provisions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales deductions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales balances from acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discounts and allowances for commercial product sales.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discounts and allowances for commercial product sales:</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provisions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales Provisions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deductions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales Deductions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">V-Go opening balance sheet</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discounts And Allowances For Commercial Product Sales Balances From Acquisition</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes" xlink:type="locator" xlink:label="us-gaap_SeniorNotes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior convertible notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotes" xlink:to="us-gaap_SeniorNotes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Notes</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Mann Group promissory notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable Related Parties Noncurrent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total debt &#8212; net carrying amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt premium recognized in additional paid-in capital.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:to="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesMember" xlink:type="locator" xlink:label="mnkd_PromissoryNotesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Promissory notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PromissoryNotesMember" xlink:to="mnkd_PromissoryNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Promissory Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PromissoryNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Promissory Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt premium recognized in additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Premium Recognized In Additional Paid In Capital</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument maturity month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentMaturityMonthAndYear" xlink:to="mnkd_DebtInstrumentMaturityMonthAndYear_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedPaidInKindInterest" xlink:type="locator" xlink:label="mnkd_AccruedPaidInKindInterest" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedPaidInKindInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued paid in kind interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedPaidInKindInterest" xlink:to="mnkd_AccruedPaidInKindInterest_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFloorRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument floor rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentFloorRate" xlink:to="mnkd_DebtInstrumentFloorRate_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentCapInterestRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentCapInterestRate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentCapInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument cap interest rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentCapInterestRate" xlink:to="mnkd_DebtInstrumentCapInterestRate_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SOFR</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Secured Overnight Financing Rate Sofr Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Term Debt, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Debt Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Convertible Notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeniorNotesMember" xlink:to="us-gaap_SeniorNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Notes [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Amount Due</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedPaidInKindInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest paid-in-kind</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedPaidInKindInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Paid In Kind Interest</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFloorRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate floor</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFloorRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Floor Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentCapInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate cap</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentCapInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Cap Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Month And Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Conversion Price1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIBOR</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">London Interbank Offered Rate L I B O R [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertiblePromissoryNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-convertible promissory note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NonConvertiblePromissoryNoteMember" xlink:to="mnkd_NonConvertiblePromissoryNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Convertible Promissory Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertiblePromissoryNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Convertible Promissory Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToMidcapCreditFacilityAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prior to midcap credit facility amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PriorToMidcapCreditFacilityAmendmentMember" xlink:to="mnkd_PriorToMidcapCreditFacilityAmendmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior To Midcap Credit Facility Amendment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prior To Midcap Credit Facility Amendment [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToFirstAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToFirstAmendmentMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToFirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">prior to the first amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PriorToFirstAmendmentMember" xlink:to="mnkd_PriorToFirstAmendmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToFirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior to First Amendment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PriorToFirstAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prior To First Amendment [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="locator" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment of principal balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Early Repayment Of Senior Debt</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total principal payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized Discount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Debt issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Finance Costs Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfTradingDays" xlink:type="locator" xlink:label="mnkd_NumberOfTradingDays" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of trading days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfTradingDays" xlink:to="mnkd_NumberOfTradingDays_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConsecutiveTradingDays" xlink:type="locator" xlink:label="mnkd_ConsecutiveTradingDays" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConsecutiveTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Consecutive trading days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConsecutiveTradingDays" xlink:to="mnkd_ConsecutiveTradingDays_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentConvertibleConversionPricePercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument convertible conversion price percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentConvertibleConversionPricePercentage" xlink:to="mnkd_DebtInstrumentConvertibleConversionPricePercentage_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrincipalAmountPerShare" xlink:type="locator" xlink:label="mnkd_PrincipalAmountPerShare" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Principal amount per share.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PrincipalAmountPerShare" xlink:to="mnkd_PrincipalAmountPerShare_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MeasurementPeriodPercentage" xlink:type="locator" xlink:label="mnkd_MeasurementPeriodPercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MeasurementPeriodPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement period percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MeasurementPeriodPercentage" xlink:to="mnkd_MeasurementPeriodPercentage_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of trading days</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConsecutiveTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consecutive trading days</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConsecutiveTradingDays_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Consecutive Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion price percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Conversion Price Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount per share</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PrincipalAmountPerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Principal Amount Per Share</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MeasurementPeriodPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement period percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MeasurementPeriodPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Period Percentage</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument initial conversion price of premium percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" xlink:to="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion price</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial conversion price of premium percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Initial Conversion Price Of Premium Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">No of convertible shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Conversion Ratio1</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" xlink:type="locator" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument outstanding principal amount redeemed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" xlink:to="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodStartDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodStartDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodStartDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redemption period start date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodStartDate" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodStartDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodStartDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period Start Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redemption price percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding principal amount redeemed</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Outstanding Principal Amount Redeemed</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentSinkingFundPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentSinkingFundPayment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentSinkingFundPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sinking fund</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentSinkingFundPayment" xlink:to="us-gaap_DebtInstrumentSinkingFundPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentSinkingFundPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Sinking Fund Payment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument redemption description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionDescription" xlink:to="us-gaap_DebtInstrumentRedemptionDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of repurchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Price Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" xlink:type="locator" xlink:label="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt default, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" xlink:to="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Default Longterm Debt Description Of Violation Or Event Of Default</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from offering after deducting initial purchasers discounts and commissions and estimated offering expenses payable</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="locator" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt issuance cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrepaymentOfSecuredLinesOfCredit" xlink:type="locator" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment of secured lines of credit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PrepaymentOfSecuredLinesOfCredit" xlink:to="mnkd_PrepaymentOfSecuredLinesOfCredit_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheOneMember" xlink:type="locator" xlink:label="mnkd_TrancheOneMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TrancheOneMember" xlink:to="mnkd_TrancheOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche 1</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheThreeMember" xlink:type="locator" xlink:label="mnkd_TrancheThreeMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche 3.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TrancheThreeMember" xlink:to="mnkd_TrancheThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche 3</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TrancheThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Three [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Redemption, Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Redemption, Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">On or After April 23, 2022 Through and Including April 22, 2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period Two [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">On or Prior to April 22, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period One [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">On or After April 23, 2023 Through Maturity Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Redemption Period Three [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSecuredLinesOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSecuredLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advance of borrowing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:to="us-gaap_ProceedsFromSecuredLinesOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSecuredLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Secured Lines Of Credit</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid of borrowing</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Of Secured Lines Of Credit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount available under credit facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Remaining Borrowing Capacity</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentAdvanceAvailableDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument advance available date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentAdvanceAvailableDate" xlink:to="mnkd_DebtInstrumentAdvanceAvailableDate_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentExtendedInterestOnlyDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument extended interest-only date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentExtendedInterestOnlyDate" xlink:to="mnkd_DebtInstrumentExtendedInterestOnlyDate_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MaximumValueOfAdditionalInvestmentLimit" xlink:type="locator" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum value of additional investment limit.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MaximumValueOfAdditionalInvestmentLimit" xlink:to="mnkd_MaximumValueOfAdditionalInvestmentLimit_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument minimum unrestricted cash and short-term investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" xlink:to="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument unamortized prepayment penalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" xlink:to="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument advance available date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Advance Available Date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument extended interest-only date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Extended Interest Only Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument payment term description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Frequency Of Periodic Payment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum value of additional investment limit</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Value Of Additional Investment Limit</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument minimum unrestricted cash and short-term investments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Minimum Unrestricted Cash And Short Term Investments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal prepayment against outstanding term loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Long Term Lines Of Credit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, prepayment penalty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Debt Extinguishment Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument unamortized prepayment penalty.</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized Prepayment Penalty</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EarlyTerminationFeesPercentage" xlink:type="locator" xlink:label="mnkd_EarlyTerminationFeesPercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EarlyTerminationFeesPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Early termination fees percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EarlyTerminationFeesPercentage" xlink:to="mnkd_EarlyTerminationFeesPercentage_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument payment number of equal monthly installments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" xlink:to="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" xlink:type="locator" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility principal payment start date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" xlink:to="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Effective Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Basis Spread On Variable Rate1</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument Payment Number of Equal Monthly Installments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Payment Number Of Equal Monthly Installments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line Of Credit Facility Principal Payment Start Date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Principal Payment Start Date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EarlyTerminationFeesPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Early Termination Fees Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EarlyTerminationFeesPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Early Termination Fees Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest on loans increased, percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Increase Decrease</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TermLoanAdvancePercentageOfAmountDrawdown" xlink:type="locator" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan advance percentage of amount drawdown.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" xlink:to="mnkd_TermLoanAdvancePercentageOfAmountDrawdown_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan advance percentage of amount drawdown</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Advance Percentage Of Amount Drawdown</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrivatelyNegotiatedExchangeAgreementMember" xlink:type="locator" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Privately-negotiated exchange agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PrivatelyNegotiatedExchangeAgreementMember" xlink:to="mnkd_PrivatelyNegotiatedExchangeAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Privately Negotiated Exchange Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Privately Negotiated Exchange Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LoanArrangementMember" xlink:type="locator" xlink:label="mnkd_LoanArrangementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LoanArrangementMember" xlink:to="mnkd_LoanArrangementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loan Arrangement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertibleNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non convertible note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NonConvertibleNoteMember" xlink:to="mnkd_NonConvertibleNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-Convertible Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NonConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Convertible Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NewLoanArrangementMember" xlink:type="locator" xlink:label="mnkd_NewLoanArrangementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NewLoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">New loan arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NewLoanArrangementMember" xlink:to="mnkd_NewLoanArrangementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NewLoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Loan Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NewLoanArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Loan Arrangement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Conversion Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion By Unique Description [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Conversion, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="us-gaap_DebtConversionNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestMember" xlink:type="locator" xlink:label="mnkd_AccruedInterestMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AccruedInterestMember" xlink:to="mnkd_AccruedInterestMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AccruedInterestMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Senior notes, effective interest rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, date of first required interest payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Date Of First Required Payment1</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument fair value in excess of face amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" xlink:to="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument fair value in excess of face amount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Fair Value In Excess Of Face Amount</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedToPayInterest" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedToPayInterest" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedToPayInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock issued to pay interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockIssuedToPayInterest" xlink:to="mnkd_CommonStockIssuedToPayInterest_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt issuance amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Amount1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of notes to common shares, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Shares Issued1</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Expense Debt</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedToPayInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued to pay interest</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockIssuedToPayInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Issued To Pay Interest</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaycheckProtectionProgramCARESActMember" xlink:type="locator" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Paycheck Protection Program, CARES Act.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaycheckProtectionProgramCARESActMember" xlink:to="mnkd_PaycheckProtectionProgramCARESActMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PPP Loan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Paycheck Protection Program C A R E S Act [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmortizationOfDebtDiscount" xlink:type="locator" xlink:label="mnkd_AmortizationOfDebtDiscount" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizationOfDebtDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of debt discount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmortizationOfDebtDiscount" xlink:to="mnkd_AmortizationOfDebtDiscount_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizationOfDebtDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AmortizationOfDebtDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Debt Discount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Financing Costs And Discounts</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone rights liabilities current and noncurrent.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" xlink:to="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentForMilestoneRightsLiabilities" xlink:type="locator" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment for milestone rights liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentForMilestoneRightsLiabilities" xlink:to="mnkd_PaymentForMilestoneRightsLiabilities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityCurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone rights liability current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightsLiabilityCurrent" xlink:to="mnkd_MilestoneRightsLiabilityCurrent_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BaringsGlobalMilestoneRightsMember" xlink:type="locator" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Barings Global milestone rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BaringsGlobalMilestoneRightsMember" xlink:to="mnkd_BaringsGlobalMilestoneRightsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Barings Global Milestone Rights</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Barings Global Milestone Rights [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining milestone rights liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Rights Liabilities Current And Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment for milestone liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment For Milestone Rights Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone rights liability, current</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightsLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Rights Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities And Other Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LicenseAgreementMember" xlink:to="mnkd_LicenseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercialSupplyAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">commercial supply agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommercialSupplyAgreementMember" xlink:to="mnkd_CommercialSupplyAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercialSupplyAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Supply Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercialSupplyAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Supply Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Co-promotion agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CoPromotionAgreementMember" xlink:to="mnkd_CoPromotionAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Co-Promotion Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Co Promotion Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration and license agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CollaborationAndLicenseAgreementMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration and License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CollaborationAndLicenseAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration And License Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LicenseAndDistributionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and Distribution Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LicenseAndDistributionAgreementMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LicenseAndDistributionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License And Distribution Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OtherAgreementMember" xlink:type="locator" xlink:label="mnkd_OtherAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OtherAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OtherAgreementMember" xlink:to="mnkd_OtherAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OtherAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OtherAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAgreementMember" xlink:type="locator" xlink:label="mnkd_ResearchAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ResearchAgreementMember" xlink:to="mnkd_ResearchAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_VerticePharmaLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Vertice Pharma LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_VerticePharmaLLCMember" xlink:to="mnkd_VerticePharmaLLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_VerticePharmaLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vertice Pharma LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_VerticePharmaLLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vertice Pharma L L C [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceptorLifeScienceIncMember" xlink:type="locator" xlink:label="mnkd_ReceptorLifeScienceIncMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceptorLifeScienceIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Receptor Life Science Inc.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ReceptorLifeScienceIncMember" xlink:to="mnkd_ReceptorLifeScienceIncMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceptorLifeScienceIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receptor CLA</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ReceptorLifeScienceIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receptor Life Science Inc [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CiplaLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cipla Ltd.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CiplaLtdMember" xlink:to="mnkd_CiplaLtdMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CiplaLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cipla Ltd</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CiplaLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cipla Ltd [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel">Total revenue from collaborations and services</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityAdditions" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityAdditions" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability additions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContractWithCustomerLiabilityAdditions" xlink:to="mnkd_ContractWithCustomerLiabilityAdditions_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability collaborations and services revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" xlink:to="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Additions</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue &#8212; collaborations and services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Collaborations And Services Revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RoyaltiesArrangementMember" xlink:type="locator" xlink:label="mnkd_RoyaltiesArrangementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RoyaltiesArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalties.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RoyaltiesArrangementMember" xlink:to="mnkd_RoyaltiesArrangementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RoyaltiesArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalties Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RoyaltiesArrangementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Royalties Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total revenue from UT</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" xlink:type="locator" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional option exercise and development milestone payments to be received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" xlink:to="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UpfrontPaymentReceived" xlink:type="locator" xlink:label="mnkd_UpfrontPaymentReceived" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UpfrontPaymentReceived" xlink:to="mnkd_UpfrontPaymentReceived_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePaymentReceived" xlink:type="locator" xlink:label="mnkd_MilestonePaymentReceived" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payment received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestonePaymentReceived" xlink:to="mnkd_MilestonePaymentReceived_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer, Duration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Duration [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer, Duration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="us-gaap_ContractWithCustomerDurationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Duration [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalSuppliesMember" xlink:type="locator" xlink:label="mnkd_ClinicalSuppliesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalSuppliesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical Supplies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ClinicalSuppliesMember" xlink:to="mnkd_ClinicalSuppliesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalSuppliesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical Supplies</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ClinicalSuppliesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Supplies [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TyvasoDPIMember" xlink:type="locator" xlink:label="mnkd_TyvasoDPIMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TyvasoDPIMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tyvaso DPI.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TyvasoDPIMember" xlink:to="mnkd_TyvasoDPIMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TyvasoDPIMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tyvaso DPI</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TyvasoDPIMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tyvaso D P I [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingServicesMember" xlink:type="locator" xlink:label="mnkd_ManufacturingServicesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ManufacturingServicesMember" xlink:to="mnkd_ManufacturingServicesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ManufacturingServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Services [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Next-gen research and development services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Next-Gen R&amp;D Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Next Gen Research And Development Services [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency Nature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies By Nature Of Contingency [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency, Nature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForTheContractualObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Transaction price for the contractual obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TransactionPriceForTheContractualObligationsMember" xlink:to="mnkd_TransactionPriceForTheContractualObligationsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Price For The Contractual Obligations</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Price For The Contractual Obligations [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForThePerformanceObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Transaction price for the performance obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TransactionPriceForThePerformanceObligationsMember" xlink:to="mnkd_TransactionPriceForThePerformanceObligationsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Price For The Performance Obligations</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Price For The Performance Obligations [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercializationAndContinuousImprovementActivitiesMember" xlink:type="locator" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercialization and continuous improvement activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommercializationAndContinuousImprovementActivitiesMember" xlink:to="mnkd_CommercializationAndContinuousImprovementActivitiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercialization And Continuous Improvement Activities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercialization And Continuous Improvement Activities [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmendmentToCoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amendment to co-promotion agreement..</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AmendmentToCoPromotionAgreementMember" xlink:to="mnkd_AmendmentToCoPromotionAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment to Co Promotion Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment To Co Promotion Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SupplyAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_SupplyAndDistributionAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SupplyAndDistributionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Supply and distribution agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SupplyAndDistributionAgreementMember" xlink:to="mnkd_SupplyAndDistributionAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SupplyAndDistributionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supply and Distribution Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SupplyAndDistributionAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supply And Distribution Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BiommSAMember" xlink:type="locator" xlink:label="mnkd_BiommSAMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BiommSAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Biomm S.A.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_BiommSAMember" xlink:to="mnkd_BiommSAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_BiommSAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Biomm</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_BiommSAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Biomm S A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_UpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment received</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_UpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestonePaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional option exercise and development milestone payments to be receive</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Option Exercise And Development Milestone Payments To Be Received</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total transaction price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development services and license.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:to="mnkd_ResearchAndDevelopmentServicesAndLicenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;D Services and License</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Services And License [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Timing of Transfer of Good or Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Timing Of Transfer Of Good Or Service [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Timing of Transfer of Good or Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Timing Of Transfer Of Good Or Service [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredOverTimeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over Time</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transferred Over Time [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreCommercialServicesMember" xlink:type="locator" xlink:label="mnkd_PreCommercialServicesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreCommercialServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-commercial services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PreCommercialServicesMember" xlink:to="mnkd_PreCommercialServicesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PreCommercialServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Commercial Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PreCommercialServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commercial Services [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FacilityExpansionServicesMember" xlink:type="locator" xlink:label="mnkd_FacilityExpansionServicesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FacilityExpansionServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Facility expansion services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FacilityExpansionServicesMember" xlink:to="mnkd_FacilityExpansionServicesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FacilityExpansionServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facility Expansion Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FacilityExpansionServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Facility Expansion Services [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Point In Time</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredAtPointInTimeMember" xlink:to="us-gaap_TransferredAtPointInTimeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transferred At Point In Time [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocation of Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:type="locator" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Progress Measure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Performance Obligation Satisfied Over Time Method Used Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:type="locator" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue remaining performance obligation anticipated cash flow.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:to="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total anticipated cash flows</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Remaining Performance Obligation Anticipated Cash Flow</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Anticipated Revenue Allocation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized during period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementAmendmentDescription" xlink:type="locator" xlink:label="mnkd_AgreementAmendmentDescription" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementAmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement amendment description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AgreementAmendmentDescription" xlink:to="mnkd_AgreementAmendmentDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementAmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment description</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AgreementAmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement Amendment Description</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AllocatedTransactionPrice" xlink:type="locator" xlink:label="mnkd_AllocatedTransactionPrice" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AllocatedTransactionPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Allocated transaction price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AllocatedTransactionPrice" xlink:to="mnkd_AllocatedTransactionPrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AllocatedTransactionPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocated transaction price</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AllocatedTransactionPrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue - non-current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCapitalImprovements" xlink:type="locator" xlink:label="us-gaap_PaymentsForCapitalImprovements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForCapitalImprovements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding for capital improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForCapitalImprovements" xlink:to="us-gaap_PaymentsForCapitalImprovements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsForCapitalImprovements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments For Capital Improvements</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding for development of alternative manufacturing processes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Other Productive Assets</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" xlink:type="locator" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of modification of previously fixed consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" xlink:to="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of modification of previously fixed consideration</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Modification Of Previously Fixed Consideration</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue recognition period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserve for allowance for doubtful accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" xlink:to="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Receivable Allowance For Credit Loss</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostImpairmentLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalizedContractCostImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment on contract assets related to variable consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostImpairmentLoss" xlink:to="us-gaap_CapitalizedContractCostImpairmentLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalizedContractCostImpairmentLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Contract Cost Impairment Loss</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DateOfAgreementInitiationForMarketingAndDistribution" xlink:type="locator" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Date of agreement initiation for marketing and distribution.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" xlink:to="mnkd_DateOfAgreementInitiationForMarketingAndDistribution_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketing and distribution agreement date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Date Of Agreement Initiation For Marketing And Distribution</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value By Balance Sheet Grouping [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Basis [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosure Item Amounts [Default]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Portion At Fair Value Fair Value Disclosure [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosure Item Amounts [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carrying Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Carrying Reported Amount Fair Value Disclosure [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimate of Fair Value Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Estimate Of Fair Value Fair Value Disclosure [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SeniorNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Senior convertible notes</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MannGroupConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Mann group convertible note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MannGroupConvertibleNoteMember" xlink:to="mnkd_MannGroupConvertibleNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MannGroupConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mann Group Convertible Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MannGroupConvertibleNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mann Group Convertible Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiabilityMember" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiabilityMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent milestone liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContingentMilestoneLiabilityMember" xlink:to="mnkd_ContingentMilestoneLiabilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Milestone Liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContingentMilestoneLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Milestone Liability [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total financial liabilities fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NotePayablePercentageOfInterestRateChange" xlink:type="locator" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Note payable, percentage of interest rate change.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NotePayablePercentageOfInterestRateChange" xlink:to="mnkd_NotePayablePercentageOfInterestRateChange_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument measurement input after change.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:to="mnkd_DebtInstrumentMeasurementInputAfterChange_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Substantial premium based on fair value post modification recognized as additional paid-in capital.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" xlink:to="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Note payable, percentage of hypothetical yield</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Measurement Input After Change</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Note payable, percentage of volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Note payable, percentage of interest rate increases (decreases)</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Note Payable Percentage Of Interest Rate Change</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Financial liabilities fair value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Substantial premium based on fair value post modification recognized as additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Substantial Premium Based On Fair Value Post Modification Recognized As Additional Paid In Capital</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing liability, long term</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing liability, short term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock By Class [Table]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContolledEquityOfferingSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contolled equity offering sales agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ContolledEquityOfferingSalesAgreementMember" xlink:to="mnkd_ContolledEquityOfferingSalesAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contolled Equity Offering Sales Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contolled Equity Offering Sales Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtMarketIssuanceSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">At market issuance sales agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_AtMarketIssuanceSalesAgreementMember" xlink:to="mnkd_AtMarketIssuanceSalesAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At Market Issuance Sales Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">At Market Issuance Sales Agreement [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CantorFitzgeraldMember" xlink:type="locator" xlink:label="mnkd_CantorFitzgeraldMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CantorFitzgeraldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cantor fitzgerald.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CantorFitzgeraldMember" xlink:to="mnkd_CantorFitzgeraldMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CantorFitzgeraldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cantor Fitzgerald</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CantorFitzgeraldMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cantor Fitzgerald [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:type="locator" xlink:label="srt_WeightedAverageMember" />
    <link:label xml:lang="en-US" xlink:label="srt_WeightedAverageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_WeightedAverageMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_JuneTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">June two thousand twenty note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_JuneTwoThousandTwentyNoteMember" xlink:to="mnkd_JuneTwoThousandTwentyNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">June 2020 Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">June Two Thousand Twenty Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DecemberTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">December two thousand twenty note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DecemberTwoThousandTwentyNoteMember" xlink:to="mnkd_DecemberTwoThousandTwentyNoteMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">December 2020 Note</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">December Two Thousand Twenty Note [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnderwritingAgreementMember" xlink:type="locator" xlink:label="mnkd_UnderwritingAgreementMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UnderwritingAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_UnderwritingAgreementMember" xlink:to="mnkd_UnderwritingAgreementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_UnderwritingAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting Agreement</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_UnderwritingAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Agreement [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Common stock, shares authorized</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amount of net proceeds from issuance of securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleOfStockTransactionDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock purchase agreements date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockTransactionDate" xlink:to="us-gaap_SaleOfStockTransactionDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Transaction Date</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Number of shares sold during the period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to note holders</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RemainingWarrantsAvailableForPurchase" xlink:type="locator" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining Warrants Available for Purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RemainingWarrantsAvailableForPurchase" xlink:to="mnkd_RemainingWarrantsAvailableForPurchase_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining Warrants Available for Purchase</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Remaining Warrants Available For Purchase</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt conversion converted instrument shares issued for accrued interest of notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" xlink:to="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt conversion converted instrument accrued interest of notes value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" xlink:to="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of notes accrued interest to common shares, value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Accrued Interest Of Notes Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of notes accrued interest to common shares</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Shares Issued For Accrued Interest Of Notes</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_MarketPriceStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Market price stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MarketPriceStockPurchasePlan" xlink:to="mnkd_MarketPriceStockPurchasePlan_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from stock purchase plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Plans</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market price stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MarketPriceStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Market Price Stock Purchase Plan</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:type="locator" xlink:label="mnkd_EarningPerShareBasicAndDilutedAbstract" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EarningPerShareBasicAndDilutedAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Earning per share basic and diluted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:to="mnkd_EarningPerShareBasicAndDilutedAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EarningPerShareBasicAndDilutedAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">EPS &#8212; basic and diluted:</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EarningPerShareBasicAndDilutedAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earning Per Share Basic And Diluted [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveVerboseLabel">Net loss (numerator)</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average common shares (denominator)</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share, Diluted</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Senior convertible notes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_SeniorConvertibleNotesMember" xlink:to="mnkd_SeniorConvertibleNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Convertible Notes</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_SeniorConvertibleNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Senior Convertible Notes [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" xlink:type="locator" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock options and performance based stock option awards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" xlink:to="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Options and PNQs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Options And Performance Based Stock Option Awards [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants associated with Midcap Credit Facility.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" xlink:to="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Associated with MidCap Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Associated With Midcap Credit Facility [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockPurchasePlanMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeStockPurchasePlanMember" xlink:to="mnkd_EmployeeStockPurchasePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted stock units and market restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" xlink:to="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs and Market RSUs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units And Market Restricted Stock Units [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities excluded from computation of earnings per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award number of shares available for grant increased by shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity incentive plan twenty eighteen.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:to="mnkd_EquityIncentivePlanTwentyEighteenMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan Twenty Eighteen [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity incentive plan twenty thirteen.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2013 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan Twenty Thirteen [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VestingDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche One [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupOneMember" xlink:type="locator" xlink:label="mnkd_GroupOneMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group One.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GroupOneMember" xlink:to="mnkd_GroupOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less than 25th Percentile</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group One [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupTwoMember" xlink:type="locator" xlink:label="mnkd_GroupTwoMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group Two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GroupTwoMember" xlink:to="mnkd_GroupTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">25th Percentile</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group Two [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupThreeMember" xlink:type="locator" xlink:label="mnkd_GroupThreeMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group Three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GroupThreeMember" xlink:to="mnkd_GroupThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">50th Percentile</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group Three [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFourMember" xlink:type="locator" xlink:label="mnkd_GroupFourMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group Four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GroupFourMember" xlink:to="mnkd_GroupFourMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">75th Percentile</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group Four [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFiveMember" xlink:type="locator" xlink:label="mnkd_GroupFiveMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group Five.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_GroupFiveMember" xlink:to="mnkd_GroupFiveMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">90th Percentile or Higher</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_GroupFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group Five [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndOptionsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted stock units and options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RestrictedStockUnitsAndOptionsMember" xlink:to="mnkd_RestrictedStockUnitsAndOptionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs and Options</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units And Options [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:type="locator" xlink:label="us-gaap_PerformanceSharesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance-based Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Performance Shares [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock options and performance based options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" xlink:to="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options and Performance-based Options</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Options And Performance Based Options [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeMember" xlink:type="locator" xlink:label="mnkd_EmployeeMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EmployeeMember" xlink:to="mnkd_EmployeeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity incentive plan, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity incentive plan, number of shares available for grant increased by shares</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increased By Shares</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" xlink:type="locator" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" xlink:to="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Or Strike Price Of Fair Market Value Of Underlying Common Stock On Date Of Grant Reacquired Or Withheld</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting rights percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award vesting date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentileRankOfShareholderReturnOfStock" xlink:type="locator" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentile rank of shareholder return of stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PercentileRankOfShareholderReturnOfStock" xlink:to="mnkd_PercentileRankOfShareholderReturnOfStock_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award target percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant date fair value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Vesting Date</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentile</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentile Rank Of Shareholder Return Of Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percent of target</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Target Percentage</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:type="locator" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Four Equity Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2004 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Four Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available for Future Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Goods Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CostOfRevenueCollaborationsAndServicesMember" xlink:type="locator" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost of revenue collaborations and services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CostOfRevenueCollaborationsAndServicesMember" xlink:to="mnkd_CostOfRevenueCollaborationsAndServicesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenue - Collaborations and Services</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Revenue Collaborations And Services [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling And Marketing Expense [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share based compensation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options issued or granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransfersFromToParentAbstract" xlink:type="locator" xlink:label="mnkd_TransfersFromToParentAbstract" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransfersFromToParentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Transfers From (To) Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TransfersFromToParentAbstract" xlink:to="mnkd_TransfersFromToParentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TransfersFromToParentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Transfers From To Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at January 1, 2022</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at December 31, 2022</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at January 1, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at December 31, 2022</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at December 31, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average grant date fair value of the stock options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average grant date fair value of the stock options vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash received from the exercise of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense related to options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at January 1, 2022</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at December 31, 2022</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at January 1, 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at December 31, 2022</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options in period grant date fair value outstanding.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of restricted stock units vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value of restricted stock units outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense related to non-option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrecognized compensation expense, weighted average period for recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" xlink:type="locator" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Discount on purchase price percentage of fair market value.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" xlink:to="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discount on purchase price percentage of fair market value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discount On Purchase Price Percentage Of Fair Market Value</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock available for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_MilestoneRightLiability" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone rights liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MilestoneRightLiability" xlink:to="mnkd_MilestoneRightLiability_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_CommitmentsAndContingenciesLineItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesTable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments and Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="mnkd_CommitmentsAndContingenciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MasterLeaseAgreementWithEnterpriseMember" xlink:type="locator" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Master lease agreement with enterprise.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MasterLeaseAgreementWithEnterpriseMember" xlink:to="mnkd_MasterLeaseAgreementWithEnterpriseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Master Lease Agreement with Enterprise</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Master Lease Agreement With Enterprise [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:type="locator" xlink:label="us-gaap_VehiclesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VehiclesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vehicle Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VehiclesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vehicles [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeMember" xlink:type="locator" xlink:label="mnkd_OfficeMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Office.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OfficeMember" xlink:to="mnkd_OfficeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Office [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RussellRanchRoadIILLCMember" xlink:type="locator" xlink:label="mnkd_RussellRanchRoadIILLCMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RussellRanchRoadIILLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Russell Ranch Road II LLC.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_RussellRanchRoadIILLCMember" xlink:to="mnkd_RussellRanchRoadIILLCMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_RussellRanchRoadIILLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Russell Ranch Road II LLC</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_RussellRanchRoadIILLCMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Russell Ranch Road I I L L C [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarlboroughLeaseMember" xlink:type="locator" xlink:label="mnkd_MarlboroughLeaseMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MarlboroughLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Marlborough lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_MarlboroughLeaseMember" xlink:to="mnkd_MarlboroughLeaseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_MarlboroughLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marlborough Lease</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MarlboroughLeaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marlborough Lease [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CommitmentsAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone rights liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_MilestoneRightLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Right Liability</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseRepurchaseDescription" xlink:type="locator" xlink:label="mnkd_LeaseRepurchaseDescription" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseRepurchaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease repurchase description.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LeaseRepurchaseDescription" xlink:to="mnkd_LeaseRepurchaseDescription_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease initial term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Term Of Contract</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease renewal option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease renewal options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingSubleaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Sublease Option To Extend</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee,option to extend [true false]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Sublease Existence Of Option To Extend</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionLeaseTerms" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionLeaseTerms" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionLeaseTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionLeaseTerms" xlink:to="us-gaap_SaleLeasebackTransactionLeaseTerms_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionLeaseTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Leaseback Transaction Lease Terms</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNetBookValue" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionNetBookValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionNetBookValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease repurchase, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionNetBookValue" xlink:to="us-gaap_SaleLeasebackTransactionNetBookValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleLeasebackTransactionNetBookValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Leaseback Transaction Net Book Value</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseRepurchaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease repurchase description</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseRepurchaseDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Repurchase Description</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Weighted Average Discount Rate Percent</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_InterestExpenseOnFinancingLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense on financing liability</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability discounted payments due.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liabilities Payments Due [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due Next Twelve Months</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due Year Two</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due Year Three</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due Year Four</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due Year Five</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due After Year Five</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Payments Due</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest payments</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Debt issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted Debt Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total financing liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Discounted</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" xlink:type="locator" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of long term purchase commitment amendment fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" xlink:to="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of long term purchase commitment, amendment fees</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Long Term Purchase Commitment Amendment Fee</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationFiscalYearMaturityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationFiscalYearMaturityAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInSecondYear" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInSecondYear" xlink:to="us-gaap_PurchaseObligationDueInSecondYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInSecondYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Second Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInThirdYear" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInThirdYear" xlink:to="us-gaap_PurchaseObligationDueInThirdYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInThirdYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Third Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInFourthYear" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInFourthYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInFourthYear" xlink:to="us-gaap_PurchaseObligationDueInFourthYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInFourthYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Fourth Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInFifthYear" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInFifthYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligationDueInFifthYear" xlink:to="us-gaap_PurchaseObligationDueInFifthYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PurchaseObligationDueInFifthYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Obligation Due In Fifth Year</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:type="locator" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Long Term Purchase Commitment, Expiration Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:type="locator" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Long-term purchase commitment, renewal time period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supply Agreement expiration period</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Purchase Commitment Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supply Agreement renewal period</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Longterm Purchase Commitment Renewal Time Period</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesRetired" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesRetired" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesRetired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of vehicle leases retired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfVehicleLeasesRetired" xlink:to="mnkd_NumberOfVehicleLeasesRetired_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesReplaced" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesReplaced" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesReplaced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of vehicle leases replaced.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfVehicleLeasesReplaced" xlink:to="mnkd_NumberOfVehicleLeasesReplaced_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeases" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeases" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of vehicle leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NumberOfVehicleLeases" xlink:to="mnkd_NumberOfVehicleLeases_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesRetired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of vehicle leases retired</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesRetired_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Vehicle Leases Retired</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesReplaced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of vehicle leases replaced</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeasesReplaced_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Vehicle Leases Replaced</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of vehicle leases</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NumberOfVehicleLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Vehicle Leases</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease rent expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Expense</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:type="locator" xlink:label="us-gaap_GainLossOnTerminationOfLease" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain or loss recorded for leases removed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnTerminationOfLease" xlink:to="us-gaap_GainLossOnTerminationOfLease_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GainLossOnTerminationOfLease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Termination Of Lease</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLeasesAnnualIncreaseInRentExpense" xlink:type="locator" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases annual increase in rent expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" xlink:to="mnkd_OperatingLeasesAnnualIncreaseInRentExpense_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="mnkd_LeaseExpirationMonthAndYear" />
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration month and year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_LeaseExpirationMonthAndYear" xlink:to="mnkd_LeaseExpirationMonthAndYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of annual increase in lease payment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Annual Increase In Rent Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Month And Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of right to extension of lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Option To Extend</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability-current (2)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current Statement Of Financial Position Extensible List</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:type="locator" xlink:label="us-gaap_VariableLeaseCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease Cost</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Payments</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeAndVehicleMember" xlink:type="locator" xlink:label="mnkd_OfficeAndVehicleMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeAndVehicleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Office and vehicle.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OfficeAndVehicleMember" xlink:to="mnkd_OfficeAndVehicleMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeAndVehicleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">office and vehicle</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OfficeAndVehicleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Office And Vehicle [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Next Twelve Months</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year 4</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Year 5</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Benefit Plans And Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Benefit Plans And Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementScenarioAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Scenario [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Unspecified [Domain]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OneYearServiceMember" xlink:type="locator" xlink:label="mnkd_OneYearServiceMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OneYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">One year service.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OneYearServiceMember" xlink:to="mnkd_OneYearServiceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OneYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One Year Service</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OneYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">One Year Service [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoYearServiceMember" xlink:type="locator" xlink:label="mnkd_TwoYearServiceMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two year service.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_TwoYearServiceMember" xlink:to="mnkd_TwoYearServiceMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Year Service</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_TwoYearServiceMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Year Service [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employer matching contribution deferral rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employer Matching Contribution Percent Of Match</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employer matching contribution, percent of employees&apos; compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employer Matching Contribution Percent</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employers matching contribution vesting percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total discretionary matching contributions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Benefit Plan Contributions By Employer</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Domestic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Foreign</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. state</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current State And Local Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. state</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State And Local Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Capitalized Research Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Milestone Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsMilestoneRights" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets, Tax Deferred Expense (Accrual Adjustment)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" xlink:to="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Loss on Purchase Commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Capitalized Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsLeaseLiabilities" xlink:to="mnkd_DeferredTaxAssetsLeaseLiabilities_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsInterestExpenseLimitation" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets interest expense limitation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsInterestExpenseLimitation" xlink:to="mnkd_DeferredTaxAssetsInterestExpenseLimitation_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsProductRevenueAndCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets product revenue and other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsProductRevenueAndCosts" xlink:to="mnkd_DeferredTaxAssetsProductRevenueAndCosts_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right of use asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="mnkd_DeferredTaxLiabilitiesRightOfUseAsset_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Components Of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized research costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Research Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone Rights</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Milestone Rights</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Accrual Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on purchase commitment</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Loss On Purchase Commitment</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-qualified stock option expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized patent costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Other</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense limitation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Interest Expense Limitation</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Product Revenue &amp; Costs</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Product Revenue And Costs</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Components Of Deferred Tax Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right of use asset</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Right Of Use Asset</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other prepaids</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Prepaid Expenses</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Net</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation Permanent Items</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation expirations of attribute.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" />
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation foreign withholding tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal tax benefit rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Permanent Items</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax attribute expirations</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Expirations Of Attribute</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign withholding tax</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Foreign Withholding Tax</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Other Adjustments</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Continuing Operations</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesLineItems" xlink:type="locator" xlink:label="mnkd_IncomeTaxesLineItems" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Taxes [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_IncomeTaxesLineItems_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesTable" xlink:type="locator" xlink:label="mnkd_IncomeTaxesTable" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Taxes [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_IncomeTaxesTable" xlink:to="mnkd_IncomeTaxesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Table]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">State And Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="locator" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Jersey</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewJerseyDivisionOfTaxationMember" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Jersey Division Of Taxation [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConnecticutTaxAuthorityMember" xlink:type="locator" xlink:label="mnkd_ConnecticutTaxAuthorityMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConnecticutTaxAuthorityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Connecticut tax authority.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ConnecticutTaxAuthorityMember" xlink:to="mnkd_ConnecticutTaxAuthorityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ConnecticutTaxAuthorityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Connecticut</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ConnecticutTaxAuthorityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Connecticut Tax Authority [Member]</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CaliforniaDivisionOfTaxationMember" xlink:type="locator" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">California division of taxation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_CaliforniaDivisionOfTaxationMember" xlink:to="mnkd_CaliforniaDivisionOfTaxationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">California Division Of Taxation [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Internal Revenue Service I R S [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_IncomeTaxesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance of deferred tax asset</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Change in the valuation allowance</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards Domestic</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards State And Local</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal operation loss carryforwards, not subject to expiration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:type="locator" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation" />
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Loss Carryforwards Subject To Limitation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:type="locator" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation" />
    <link:label xml:lang="en-US" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Operating Loss Carryforward Annual Limitation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, limitations on use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Limitations On Use</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Subject To Limitation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss and credit carryforwards, annual use limitation</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforward Annual Limitation</link:label>
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets tax credit carryforwards research not expire.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" />
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and Development Credits, Begin to Expire</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets tax credit carryforwards research expire.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire_lbl" />
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits not expire</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research Not Expire</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits begin to expire</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Credits Begin To Expire</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits expire</link:label>
    <link:label xml:lang="en-US" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research Expire</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning of Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross increases for tax positions of prior years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross decreases for tax positions of current year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lapse of statute of limitations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">End of Year</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized income tax interest and penalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Expense</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>mnkd-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-02-23T09:24:21.9980812+00:00 -->
<!-- Version            : 5.0.1.753 -->
<!-- Package ID         : c0466dbaf1b246c7b52d8570aa9c0ca8 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/role/TemplateLink" xlink:href="mnkd-20221231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mnkd-20221231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:type="locator" xlink:label="dei_AuditorLocation" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:type="locator" xlink:label="dei_AuditorName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:type="locator" xlink:label="dei_AuditorFirmId" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="11690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneLiabilitiesNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationNoncurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:type="locator" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CreditFacilityNoncurrent" xlink:type="locator" xlink:label="mnkd_CreditFacilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestNoncurrent" xlink:type="locator" xlink:label="mnkd_AccruedInterestNoncurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesNoncurrent" xlink:type="locator" xlink:label="mnkd_PromissoryNotesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseObligationCurrent" xlink:type="locator" xlink:label="mnkd_PurchaseObligationCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_LongTermInvestments" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mnkd_PurchaseObligationCurrent" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_PromissoryNotesNoncurrent" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_AccruedInterestNoncurrent" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_CreditFacilityNoncurrent" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleLongTermNotesPayable" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_PurchaseObligationNoncurrent" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mnkd_MilestoneLiabilitiesNoncurrent" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnFinancingLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GainLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_GainLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingExpense" xlink:type="locator" xlink:label="us-gaap_SellingExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_SellingExpense" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="mnkd_GainLossOnPurchaseCommitments" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="mnkd_InterestExpenseOnFinancingLiability" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="12300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="12420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersDeficit" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CumulativeLossOnAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_CumulativeLossOnAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" xlink:type="locator" xlink:label="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" xlink:type="locator" xlink:label="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" xlink:type="locator" xlink:label="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketOfferingMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketOfferingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNoteInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotePrincipalMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotePrincipalMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesInterestMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesPrincipalMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesPrincipalMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNotesMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNotesMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_SeniorConvertibleNotesPrincipalMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_SeniorConvertibleNotesInterestMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNotePrincipalMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertibleNoteInterestMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="mnkd_AtTheMarketOfferingMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="12270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="12390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="12410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants" order="12670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote" order="12810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan" order="12950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan" order="12970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility" order="13090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="13230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversion" order="13370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares" order="13390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="13510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="13650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="13670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_CumulativeLossOnAvailableForSaleSecurities" order="16870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="mnkd-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceivableFromCommonStockOffering" xlink:type="locator" xlink:label="mnkd_ReceivableFromCommonStockOffering" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" xlink:type="locator" xlink:label="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiability" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" xlink:type="locator" xlink:label="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RightOfUseAssetsModification" xlink:type="locator" xlink:label="mnkd_RightOfUseAssetsModification" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionOfRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_AdditionOfRightOfUseAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" xlink:type="locator" xlink:label="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PremiumOnConvertibleNote" xlink:type="locator" xlink:label="mnkd_PremiumOnConvertibleNote" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" xlink:type="locator" xlink:label="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" xlink:type="locator" xlink:label="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfCreditFacilityPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DepositForSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_DepositForSaleLeasebackTransaction" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromSaleLeasebackTransaction" xlink:type="locator" xlink:label="mnkd_ProceedsFromSaleLeasebackTransaction" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_PaymentOnFinancingLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" xlink:type="locator" xlink:label="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePayments" xlink:type="locator" xlink:label="mnkd_MilestonePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" xlink:type="locator" xlink:label="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentInProcess" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges" xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleGainLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnPromissoryNotes" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnPromissoryNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestOnMilestonePayment" xlink:type="locator" xlink:label="mnkd_InterestOnMilestonePayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtTheMarketIssuanceMember" xlink:type="locator" xlink:label="mnkd_AtTheMarketIssuanceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="mnkd_AtTheMarketIssuanceMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10550.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestExpense" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_InterestOnMilestonePayment" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mnkd_InterestExpenseOnPromissoryNotes" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleGainLoss" order="11430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentInProcess" order="11670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="12270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments" order="12330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInOperatingLeaseLiabilities" order="12390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes" order="12450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireHeldToMaturitySecurities" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" order="12810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="12870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="13170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="13350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_MilestonePayments" order="13410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="13470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits" order="13530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan" order="13590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_PaymentOnFinancingLiability" order="13650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="13710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="13770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="13830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="13890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="13950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_ProceedsFromSaleLeasebackTransaction" order="14010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_DepositForSaleLeasebackTransaction" order="14130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="14190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="14250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mnkd_PaymentOfCreditFacilityPrepaymentPenalty" order="14310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="14370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="14430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="14490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_li0l2" order="14550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="14760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="14820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent" order="14940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable" order="15000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_PremiumOnConvertibleNote" order="15060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance" order="15120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness" order="15180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_AdditionOfRightOfUseAssets" order="15240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_RightOfUseAssetsModification" order="15300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="15360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability" order="15420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ContingentMilestoneLiability" order="15480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment" order="15540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility" order="15600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="mnkd_ReceivableFromCommonStockOffering" order="15660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness" xlink:href="mnkd-20221231.xsd#Role_DisclosureDescriptionOfBusiness" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitions" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccountsReceivable" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_FinancingReceivablesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventories" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAsset" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowings" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstruments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommonAndPreferredStock" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS" xlink:href="mnkd-20221231.xsd#Role_DisclosureEarningsPerCommonShareEPS" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlans" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans" xlink:href="mnkd-20221231.xsd#Role_DisclosureEmployeeBenefitPlans" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="mnkd-20221231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalTrialExpensePolicyTextBlock" xlink:type="locator" xlink:label="mnkd_ClinicalTrialExpensePolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreLaunchInventoryPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_PreLaunchInventoryPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="locator" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CostOfRevenuesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_CostOfRevenuesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BasisOfPresentationPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_BasisOfPresentationPolicyTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessPolicyTextBlock" xlink:type="locator" xlink:label="mnkd_BusinessPolicyTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_BusinessPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_BasisOfPresentationPolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_CostOfRevenuesPolicyTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_PreLaunchInventoryPolicyTextBlock" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_MilestoneRightsLiabilityPolicyTextBlock" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_ClinicalTrialExpensePolicyTextBlock" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionTableTextBlock" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccountsReceivableTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventoriesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAssetTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityTableTextBlock" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ContractWithCustomerLiabilityTableTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureEarningsPerCommonShareEPSTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" xlink:type="locator" xlink:label="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LongTermPurchaseCommitmentTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="mnkd-20221231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="locator" xlink:label="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureDescriptionOfBusinessAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumCashCovenant" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="mnkd_DebtInstrumentMinimumCashCovenant" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiability" xlink:type="locator" xlink:label="mnkd_ContingentLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiabilityRemainingPayableAmount" xlink:type="locator" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" xlink:type="locator" xlink:label="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligation" xlink:type="locator" xlink:label="us-gaap_PurchaseObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:type="locator" xlink:label="us-gaap_OtherAssets" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAsset" xlink:type="locator" xlink:label="mnkd_CommitmentAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate" xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentMaturityDate" xlink:type="locator" xlink:label="us-gaap_InvestmentMaturityDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PurchaseOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="mnkd_PurchaseOfAvailableForSaleSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SalesReturnPeriod" xlink:type="locator" xlink:label="mnkd_SalesReturnPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:type="locator" xlink:label="mnkd_DeerfieldManagementCompanyLpMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InsulinMember" xlink:type="locator" xlink:label="mnkd_InsulinMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentAssetMember" xlink:type="locator" xlink:label="mnkd_CommitmentAssetMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ThironaBioIncMember" xlink:type="locator" xlink:label="mnkd_ThironaBioIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_ThironaBioIncMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis" xlink:to="us-gaap_LongLivedAssetsHeldForSaleNameDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongLivedAssetsHeldForSaleNameDomain" xlink:to="mnkd_CommitmentAssetMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_InsulinMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="dei_LegalEntityAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_SalesReturnPeriod" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_PurchaseOfAvailableForSaleSecurities" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentMaturityDate" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_CommitmentAsset" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherAssets" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PurchaseObligation" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ContingentLiabilityRemainingPayableAmount" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="mnkd_ContingentLiability" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="mnkd_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesTable" xlink:to="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember" xlink:type="locator" xlink:label="us-gaap_ServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ProductSalesMember" xlink:type="locator" xlink:label="mnkd_ProductSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ProductSalesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ServiceMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_OperatingExpenses" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRoyaltyPaymentOnNetSales" xlink:type="locator" xlink:label="mnkd_PercentageOfRoyaltyPaymentOnNetSales" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationAccumulatedCost" xlink:type="locator" xlink:label="mnkd_BusinessCombinationAccumulatedCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GoodwillAmortizationPeriod" xlink:type="locator" xlink:label="mnkd_GoodwillAmortizationPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" xlink:type="locator" xlink:label="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AssetAcquisitionMilestonePaymentPayable" xlink:type="locator" xlink:label="mnkd_AssetAcquisitionMilestonePaymentPayable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" xlink:type="locator" xlink:label="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" xlink:type="locator" xlink:label="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputEntityCreditRiskMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputEntityCreditRiskMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_VGoMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputEntityCreditRiskMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionDateOfAcquisitionAgreement" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionEffectiveDateOfAcquisition" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_AssetAcquisitionMilestonePaymentPayable" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_AnnualRevenueMilestonesRangesForMilestonePayments" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_GoodwillAmortizationPeriod" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationAccumulatedCost" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_PercentageOfRoyaltyPaymentOnNetSales" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredAbstract" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_VGoMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Goodwill" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:type="locator" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BusinessAcquisitionRepaymentOfDebt" xlink:type="locator" xlink:label="mnkd_BusinessAcquisitionRepaymentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForMergerRelatedCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsForMergerRelatedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsForMergerRelatedCosts" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mnkd_BusinessAcquisitionRepaymentOfDebt" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CashAcquiredFromAcquisition" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmountReceivableOnMaturedInvestment" xlink:type="locator" xlink:label="mnkd_AmountReceivableOnMaturedInvestment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestReceivable" xlink:type="locator" xlink:label="mnkd_AccruedInterestReceivable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldtomaturitySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_HeldtomaturitySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="locator" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="locator" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ThironaBioIncMember" xlink:type="locator" xlink:label="mnkd_ThironaBioIncMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_ThironaBioIncMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_HeldtomaturitySecuritiesMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsTable" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ShortTermInvestments" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_LongTermInvestments" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_Investments" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="mnkd_AccruedInterestReceivable" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="mnkd_AmountReceivableOnMaturedInvestment" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DueInOneYearOrLessMember" xlink:type="locator" xlink:label="mnkd_DueInOneYearOrLessMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract" xlink:to="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="mnkd_DueInOneYearOrLessMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesTable" xlink:to="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:type="locator" xlink:label="us-gaap_Investments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CashEquivalentsAndInvestments" xlink:type="locator" xlink:label="mnkd_CashEquivalentsAndInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EstimatedFairValueMember" xlink:type="locator" xlink:label="mnkd_EstimatedFairValueMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GrossUnrealizedHoldingLossesMember" xlink:type="locator" xlink:label="mnkd_GrossUnrealizedHoldingLossesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmortizedCostMember" xlink:type="locator" xlink:label="mnkd_AmortizedCostMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_AmortizedCostMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_GrossUnrealizedHoldingLossesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_EstimatedFairValueMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10050.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10050.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_CashEquivalentsAndInvestments" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_Investments" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfAccountsReceivableNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveForReturns" xlink:type="locator" xlink:label="mnkd_ReserveForReturns" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" xlink:type="locator" xlink:label="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableGrossCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="locator" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="srt_ProductOrServiceAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsReceivableGrossCurrent" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_WholesalerDistributionFeesAndPromptPayDiscounts" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_ReserveForReturns" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccountsReceivableAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" xlink:type="locator" xlink:label="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" xlink:type="locator" xlink:label="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfSalesFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfSalesFromMajorCustomers" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfAccountsReceivableFromMajorCustomers" xlink:type="locator" xlink:label="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfWholesaleDistributors" xlink:type="locator" xlink:label="mnkd_NumberOfWholesaleDistributors" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="locator" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_NumberOfWholesaleDistributors" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfAccountsReceivableFromMajorCustomers" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfSalesFromMajorCustomers" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_li0l2" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" xlink:type="locator" xlink:label="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReserveBalanceAbstract" xlink:type="locator" xlink:label="mnkd_ReserveBalanceAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ReserveBalanceAbstract" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ReserveBalanceAbstract" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ReserveBalanceAbstract" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ReserveBalanceAbstract" xlink:to="mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve_li0l2" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventoriesComponentsOfInventoryDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryNet" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureInventoriesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductionRelatedImpairmentsOrCharges" xlink:type="locator" xlink:label="us-gaap_ProductionRelatedImpairmentsOrCharges" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterials" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems" xlink:type="locator" xlink:label="us-gaap_InventoryLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementWithRetailPharmacyMember" xlink:type="locator" xlink:label="mnkd_AgreementWithRetailPharmacyMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreLaunchInventoryMember" xlink:type="locator" xlink:label="mnkd_PreLaunchInventoryMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilitiesInventoryAxis" xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesInventoryAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable" xlink:type="locator" xlink:label="us-gaap_InventoryCurrentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryCurrentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_PublicUtilitiesInventoryAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryAxis" xlink:to="us-gaap_PublicUtilitiesInventoryTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="mnkd_PreLaunchInventoryMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="mnkd_AgreementWithRetailPharmacyMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryCurrentTable" xlink:to="us-gaap_InventoryLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_InventoryRawMaterials" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryLineItems" xlink:to="us-gaap_ProductionRelatedImpairmentsOrCharges" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentNetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ComputerEquipmentAndSoftwareMember" xlink:type="locator" xlink:label="mnkd_ComputerEquipmentAndSoftwareMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FurnitureFixturesAndOfficeEquipmentMember" xlink:type="locator" xlink:label="mnkd_FurnitureFixturesAndOfficeEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember" xlink:type="locator" xlink:label="us-gaap_BuildingImprovementsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember" xlink:type="locator" xlink:label="us-gaap_LandMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingImprovementsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_FurnitureFixturesAndOfficeEquipmentMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ComputerEquipmentAndSoftwareMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="10050.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentNetParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UTEquipmentMember" xlink:type="locator" xlink:label="mnkd_UTEquipmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_UTEquipmentMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ConstructionInProgressGross" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" xlink:type="locator" xlink:label="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstate" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisposals" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CasperLLCMember" xlink:type="locator" xlink:label="mnkd_CasperLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingEquipmentsAndComputerHardwareMember" xlink:type="locator" xlink:label="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ManufacturingEquipmentsAndComputerHardwareMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_CounterpartyNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CasperLLCMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisposals" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ProceedsFromSaleOfRealEstate" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="mnkd_SaleLeasebackTransactionLeaseAgreementPeriods" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_SaleLeasebackTransactionDate" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_Goodwill" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:type="locator" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrent" xlink:type="locator" xlink:label="us-gaap_ConstructionPayableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RetailInventoryPurchase" xlink:type="locator" xlink:label="mnkd_RetailInventoryPurchase" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CurrentPortionOfMilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_CurrentPortionOfMilestoneRightLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectFinancingLeaseDeferredSellingProfit" xlink:type="locator" xlink:label="us-gaap_DirectFinancingLeaseDeferredSellingProfit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReturnsReserveForAcquiredProduct" xlink:type="locator" xlink:label="mnkd_ReturnsReserveForAcquiredProduct" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CustomerDiscountsAndAllowances" xlink:type="locator" xlink:label="mnkd_CustomerDiscountsAndAllowances" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_CustomerDiscountsAndAllowances" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_ReturnsReserveForAcquiredProduct" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_DirectFinancingLeaseDeferredSellingProfit" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_CurrentPortionOfMilestoneRightLiability" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_RetailInventoryPurchase" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ConstructionPayableCurrent" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSales" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales_li0l2" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSales" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSales" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:type="locator" xlink:label="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSales" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract" xlink:to="mnkd_DiscountsAndAllowancesForCommercialProductSales_li0l2" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit" xlink:type="locator" xlink:label="us-gaap_LineOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes" xlink:type="locator" xlink:label="us-gaap_SeniorNotes" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SeniorNotes" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesMember" xlink:type="locator" xlink:label="mnkd_PromissoryNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PromissoryNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentCapInterestRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentCapInterestRate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedPaidInKindInterest" xlink:type="locator" xlink:label="mnkd_AccruedPaidInKindInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_AccruedPaidInKindInterest" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentCapInterestRate" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMaturityMonthAndYear" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentCapInterestRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentCapInterestRate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMaturityMonthAndYear" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMaturityMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="locator" xlink:label="us-gaap_EarlyRepaymentOfSeniorDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToFirstAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToFirstAmendmentMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PriorToMidcapCreditFacilityAmendmentMember" xlink:type="locator" xlink:label="mnkd_PriorToMidcapCreditFacilityAmendmentMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="locator" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_NonConvertiblePromissoryNoteMember" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_PriorToMidcapCreditFacilityAmendmentMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mnkd_PriorToFirstAmendmentMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EarlyRepaymentOfSeniorDebt" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMaturityMonthAndYear" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentCapInterestRate" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DeferredFinanceCostsNet" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="locator" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" xlink:type="locator" xlink:label="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionDescription" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentSinkingFundPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentSinkingFundPayment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" xlink:type="locator" xlink:label="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodStartDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodStartDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MeasurementPeriodPercentage" xlink:type="locator" xlink:label="mnkd_MeasurementPeriodPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrincipalAmountPerShare" xlink:type="locator" xlink:label="mnkd_PrincipalAmountPerShare" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentConvertibleConversionPricePercentage" xlink:type="locator" xlink:label="mnkd_DebtInstrumentConvertibleConversionPricePercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConsecutiveTradingDays" xlink:type="locator" xlink:label="mnkd_ConsecutiveTradingDays" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfTradingDays" xlink:type="locator" xlink:label="mnkd_NumberOfTradingDays" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:type="locator" xlink:label="us-gaap_LongtermDebtTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_SeniorNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_NumberOfTradingDays" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_ConsecutiveTradingDays" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentConvertibleConversionPricePercentage" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MeasurementPeriodPercentage" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="11030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodStartDate" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentSinkingFundPayment" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionDescription" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TermLoanAdvancePercentageOfAmountDrawdown" xlink:type="locator" xlink:label="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumCashCovenant" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumCashCovenant" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EarlyTerminationFeesPercentage" xlink:type="locator" xlink:label="mnkd_EarlyTerminationFeesPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" xlink:type="locator" xlink:label="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFloorRate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFloorRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" xlink:type="locator" xlink:label="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtExtinguishmentCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MaximumValueOfAdditionalInvestmentLimit" xlink:type="locator" xlink:label="mnkd_MaximumValueOfAdditionalInvestmentLimit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentExtendedInterestOnlyDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentExtendedInterestOnlyDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentAdvanceAvailableDate" xlink:type="locator" xlink:label="mnkd_DebtInstrumentAdvanceAvailableDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrepaymentOfSecuredLinesOfCredit" xlink:type="locator" xlink:label="mnkd_PrepaymentOfSecuredLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSecuredLinesOfCredit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="locator" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:type="locator" xlink:label="us-gaap_VariableRateDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:type="locator" xlink:label="us-gaap_VariableRateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheThreeMember" xlink:type="locator" xlink:label="mnkd_TrancheThreeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheOneMember" xlink:type="locator" xlink:label="mnkd_TrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheOneMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheThreeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodTwoMember" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodOneMember" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodThreeMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromSecuredLinesOfCredit" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrepaymentOfSecuredLinesOfCredit" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentAdvanceAvailableDate" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentExtendedInterestOnlyDate" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MaximumValueOfAdditionalInvestmentLimit" order="11740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtExtinguishmentCosts" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="12340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentUnamortizedPrepaymentPenalty" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="12630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFloorRate" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments" order="12750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_LineOfCreditFacilityPrincipalPaymentStartDate" order="12810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_EarlyTerminationFeesPercentage" order="12990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentMinimumCashCovenant" order="13200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" order="13250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_TermLoanAdvancePercentageOfAmountDrawdown" order="13300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="13360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="13420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedToPayInterest" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedToPayInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrincipalAmountPerShare" xlink:type="locator" xlink:label="mnkd_PrincipalAmountPerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" xlink:type="locator" xlink:label="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AccruedInterestMember" xlink:type="locator" xlink:label="mnkd_AccruedInterestMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtConversionNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:type="locator" xlink:label="us-gaap_DebtConversionByUniqueDescriptionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NewLoanArrangementMember" xlink:type="locator" xlink:label="mnkd_NewLoanArrangementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PromissoryNotesMember" xlink:type="locator" xlink:label="mnkd_PromissoryNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NonConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_NonConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LoanArrangementMember" xlink:type="locator" xlink:label="mnkd_LoanArrangementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PrivatelyNegotiatedExchangeAgreementMember" xlink:type="locator" xlink:label="mnkd_PrivatelyNegotiatedExchangeAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_PrivatelyNegotiatedExchangeAgreementMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_LoanArrangementMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_NonConvertibleNoteMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PromissoryNotesMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_NewLoanArrangementMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtConversionByUniqueDescriptionAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionByUniqueDescriptionAxis" xlink:to="us-gaap_DebtConversionNameDomain" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionNameDomain" xlink:to="mnkd_AccruedInterestMember" order="11620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="11690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharePrice" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="11780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="11860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtInstrumentFairValueInExcessOfFaceAmount" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PrincipalAmountPerShare" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="12280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="12920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_CommonStockIssuedToPayInterest" order="13000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsPPPLoanAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaycheckProtectionProgramCARESActMember" xlink:type="locator" xlink:label="mnkd_PaycheckProtectionProgramCARESActMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_PaycheckProtectionProgramCARESActMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmortizationOfDebtDiscount" xlink:type="locator" xlink:label="mnkd_AmortizationOfDebtDiscount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mnkd_AmortizationOfDebtDiscount" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneLiabilitiesNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneLiabilitiesNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityCurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityCurrent" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentForMilestoneRightsLiabilities" xlink:type="locator" xlink:label="mnkd_PaymentForMilestoneRightsLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BaringsGlobalMilestoneRightsMember" xlink:type="locator" xlink:label="mnkd_BaringsGlobalMilestoneRightsMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_BaringsGlobalMilestoneRightsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_PaymentForMilestoneRightsLiabilities" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneRightsLiabilityCurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="mnkd_MilestoneLiabilitiesNoncurrent" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ReceptorLifeScienceIncMember" xlink:type="locator" xlink:label="mnkd_ReceptorLifeScienceIncMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAgreementMember" xlink:type="locator" xlink:label="mnkd_ResearchAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OtherAgreementMember" xlink:type="locator" xlink:label="mnkd_OtherAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAgreementMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_OtherAgreementMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_ResearchAgreementMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_ReceptorLifeScienceIncMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability_li0l2" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContractWithCustomerLiabilityAdditions" xlink:type="locator" xlink:label="mnkd_ContractWithCustomerLiabilityAdditions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiability" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="mnkd_ContractWithCustomerLiabilityAdditions" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ContractWithCustomerLiability_li0l2" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureSummaryOfUTRevenueDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RoyaltiesArrangementMember" xlink:type="locator" xlink:label="mnkd_RoyaltiesArrangementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAgreementMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_RoyaltiesArrangementMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DateOfAgreementInitiationForMarketingAndDistribution" xlink:type="locator" xlink:label="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="locator" xlink:label="us-gaap_CapitalizedContractCostImpairmentLoss" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" xlink:type="locator" xlink:label="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForCapitalImprovements" xlink:type="locator" xlink:label="us-gaap_PaymentsForCapitalImprovements" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AllocatedTransactionPrice" xlink:type="locator" xlink:label="mnkd_AllocatedTransactionPrice" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AgreementAmendmentDescription" xlink:type="locator" xlink:label="mnkd_AgreementAmendmentDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:type="locator" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="locator" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" xlink:type="locator" xlink:label="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestonePaymentReceived" xlink:type="locator" xlink:label="mnkd_MilestonePaymentReceived" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UpfrontPaymentReceived" xlink:type="locator" xlink:label="mnkd_UpfrontPaymentReceived" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_BiommSAMember" xlink:type="locator" xlink:label="mnkd_BiommSAMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SupplyAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_SupplyAndDistributionAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember" xlink:type="locator" xlink:label="us-gaap_LicenseAndServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AmendmentToCoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_AmendmentToCoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercializationAndContinuousImprovementActivitiesMember" xlink:type="locator" xlink:label="mnkd_CommercializationAndContinuousImprovementActivitiesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForThePerformanceObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForThePerformanceObligationsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransactionPriceForTheContractualObligationsMember" xlink:type="locator" xlink:label="mnkd_TransactionPriceForTheContractualObligationsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommercialSupplyAgreementMember" xlink:type="locator" xlink:label="mnkd_CommercialSupplyAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingServicesMember" xlink:type="locator" xlink:label="mnkd_ManufacturingServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TyvasoDPIMember" xlink:type="locator" xlink:label="mnkd_TyvasoDPIMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalSuppliesMember" xlink:type="locator" xlink:label="mnkd_ClinicalSuppliesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="mnkd_ClinicalSuppliesMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TyvasoDPIMember" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ManufacturingServicesMember" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CommercialSupplyAgreementMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="mnkd_TransactionPriceForTheContractualObligationsMember" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="mnkd_TransactionPriceForThePerformanceObligationsMember" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_CommercializationAndContinuousImprovementActivitiesMember" order="12020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="13000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_AmendmentToCoPromotionAgreementMember" order="13020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="13080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseAndServiceMember" order="13240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_SupplyAndDistributionAgreementMember" order="13300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="13360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="13400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_BiommSAMember" order="13420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="13480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="13540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="13760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_UpfrontPaymentReceived" order="13770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_MilestonePaymentReceived" order="13790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived" order="13810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="13860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="13960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" order="14010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="14080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AgreementAmendmentDescription" order="14130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_AllocatedTransactionPrice" order="14300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="14350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="14390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="14430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsForCapitalImprovements" order="14520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets" order="14540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_PercentageOfModificationOfPreviouslyFixedConsideration" order="14840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss" order="14890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CapitalizedContractCostImpairmentLoss" order="14910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="14960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_DateOfAgreementInitiationForMarketingAndDistribution" order="15050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:type="locator" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FacilityExpansionServicesMember" xlink:type="locator" xlink:label="mnkd_FacilityExpansionServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PreCommercialServicesMember" xlink:type="locator" xlink:label="mnkd_PreCommercialServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredOverTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ClinicalSuppliesMember" xlink:type="locator" xlink:label="mnkd_ClinicalSuppliesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="mnkd_ClinicalSuppliesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_PreCommercialServicesMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_FacilityExpansionServicesMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" xlink:type="locator" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" xlink:type="locator" xlink:label="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnitedTherapeuticsCorporationMember" xlink:type="locator" xlink:label="mnkd_UnitedTherapeuticsCorporationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:type="locator" xlink:label="us-gaap_TransferredOverTimeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="locator" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ManufacturingServicesMember" xlink:type="locator" xlink:label="mnkd_ManufacturingServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NextGenResearchAndDevelopmentServicesMember" xlink:type="locator" xlink:label="mnkd_NextGenResearchAndDevelopmentServicesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentServicesAndLicenseMember" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TyvasoDPIMember" xlink:type="locator" xlink:label="mnkd_TyvasoDPIMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CollaborationAndLicenseAgreementMember" xlink:type="locator" xlink:label="mnkd_CollaborationAndLicenseAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CollaborationAndLicenseAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TyvasoDPIMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ResearchAndDevelopmentServicesAndLicenseMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_NextGenResearchAndDevelopmentServicesMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="mnkd_ManufacturingServicesMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredOverTimeMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="us-gaap_TransferredAtPointInTimeMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_UnitedTherapeuticsCorporationMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1" xlink:href="mnkd-20221231.xsd#Role_DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CiplaLtdMember" xlink:type="locator" xlink:label="mnkd_CiplaLtdMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LicenseAndDistributionAgreementMember" xlink:type="locator" xlink:label="mnkd_LicenseAndDistributionAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VerticePharmaLLCMember" xlink:type="locator" xlink:label="mnkd_VerticePharmaLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CoPromotionAgreementMember" xlink:type="locator" xlink:label="mnkd_CoPromotionAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_CoPromotionAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_VerticePharmaLLCMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_LicenseAndDistributionAgreementMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CiplaLtdMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsTable" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="mnkd_FairValueOfFinancialInstrumentsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_DebtInstrumentMeasurementInputAfterChange" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember_li0l2" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentMilestoneLiabilityMember" xlink:type="locator" xlink:label="mnkd_ContingentMilestoneLiabilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="locator" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_SeniorNotesMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ContingentMilestoneLiabilityMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_SeniorNotesMember_li0l2" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" xlink:type="locator" xlink:label="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NotePayablePercentageOfInterestRateChange" xlink:type="locator" xlink:label="mnkd_NotePayablePercentageOfInterestRateChange" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtInstrumentMeasurementInputAfterChange" xlink:type="locator" xlink:label="mnkd_DebtInstrumentMeasurementInputAfterChange" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:type="locator" xlink:label="mnkd_FairValueOfFinancialInstrumentsLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember" xlink:type="locator" xlink:label="us-gaap_SeniorNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="locator" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_SeniorNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="mnkd_FairValueOfFinancialInstrumentsLineItems" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_DebtInstrumentMeasurementInputAfterChange" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_NotePayablePercentageOfInterestRateChange" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_FairValueOfFinancialInstrumentsLineItems" xlink:to="mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommonAndPreferredStockAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockIssuedToPayInterest" xlink:type="locator" xlink:label="mnkd_CommonStockIssuedToPayInterest" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarketPriceStockPurchasePlan" xlink:type="locator" xlink:label="mnkd_MarketPriceStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" xlink:type="locator" xlink:label="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RemainingWarrantsAvailableForPurchase" xlink:type="locator" xlink:label="mnkd_RemainingWarrantsAvailableForPurchase" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:type="locator" xlink:label="us-gaap_SaleOfStockTransactionDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheTwoMember" xlink:type="locator" xlink:label="mnkd_TrancheTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TrancheOneMember" xlink:type="locator" xlink:label="mnkd_TrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandTwentyFourConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_TwoThousandTwentyFourConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_QrumPharmaIncorporatedMember" xlink:type="locator" xlink:label="mnkd_QrumPharmaIncorporatedMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MidCapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_MidCapCreditFacilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TheMannGroupLLCMember" xlink:type="locator" xlink:label="mnkd_TheMannGroupLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertiblePromissoryNoteMember" xlink:type="locator" xlink:label="mnkd_ConvertiblePromissoryNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_UnderwritingAgreementMember" xlink:type="locator" xlink:label="mnkd_UnderwritingAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DecemberTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_DecemberTwoThousandTwentyNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_JuneTwoThousandTwentyNoteMember" xlink:type="locator" xlink:label="mnkd_JuneTwoThousandTwentyNoteMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember" xlink:type="locator" xlink:label="srt_WeightedAverageMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CantorFitzgeraldMember" xlink:type="locator" xlink:label="mnkd_CantorFitzgeraldMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_AtMarketIssuanceSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_AtMarketIssuanceSalesAgreementMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContolledEquityOfferingSalesAgreementMember" xlink:type="locator" xlink:label="mnkd_ContolledEquityOfferingSalesAgreementMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_ContolledEquityOfferingSalesAgreementMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_AtMarketIssuanceSalesAgreementMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mnkd_CantorFitzgeraldMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_JuneTwoThousandTwentyNoteMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_DecemberTwoThousandTwentyNoteMember" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_UnderwritingAgreementMember" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_ConvertiblePromissoryNoteMember" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_TheMannGroupLLCMember" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mnkd_QrumPharmaIncorporatedMember" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TwoThousandTwentyFourConvertibleNotesMember" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MidCapCreditFacilityMember" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheOneMember" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mnkd_TrancheTwoMember" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockValue" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_RemainingWarrantsAvailableForPurchase" order="12760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue" order="12810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes" order="12850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="12890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="13000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="13050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromStockPlans" order="13410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_MarketPriceStockPurchasePlan" order="13430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="mnkd_CommonStockIssuedToPayInterest" order="13480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:type="locator" xlink:label="mnkd_EarningPerShareBasicAndDilutedAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="mnkd_EarningPerShareBasicAndDilutedAbstract" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveVerboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_EarningPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_ConvertibleNotesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" xlink:type="locator" xlink:label="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MannGroupConvertibleNoteMember" xlink:type="locator" xlink:label="mnkd_MannGroupConvertibleNoteMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" xlink:type="locator" xlink:label="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_SeniorConvertibleNotesMember" xlink:type="locator" xlink:label="mnkd_SeniorConvertibleNotesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_SeniorConvertibleNotesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_MannGroupConvertibleNoteMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_ConvertibleNotesMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlanMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" xlink:type="locator" xlink:label="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PercentileRankOfShareholderReturnOfStock" xlink:type="locator" xlink:label="mnkd_PercentileRankOfShareholderReturnOfStock" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" xlink:type="locator" xlink:label="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeMember" xlink:type="locator" xlink:label="mnkd_EmployeeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember" xlink:type="locator" xlink:label="us-gaap_PerformanceSharesMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="mnkd_EmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RestrictedStockUnitsAndOptionsMember" xlink:type="locator" xlink:label="mnkd_RestrictedStockUnitsAndOptionsMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFiveMember" xlink:type="locator" xlink:label="mnkd_GroupFiveMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupFourMember" xlink:type="locator" xlink:label="mnkd_GroupFourMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupThreeMember" xlink:type="locator" xlink:label="mnkd_GroupThreeMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupTwoMember" xlink:type="locator" xlink:label="mnkd_GroupTwoMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_GroupOneMember" xlink:type="locator" xlink:label="mnkd_GroupOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:type="locator" xlink:label="us-gaap_VestingDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:type="locator" xlink:label="us-gaap_VestingAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyEighteenMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupOneMember" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupTwoMember" order="10980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupThreeMember" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupFourMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="mnkd_GroupFiveMember" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_RestrictedStockUnitsAndOptionsMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_EmployeeStockPurchasePlanMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="mnkd_EmployeeMember" order="11500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_PercentileRankOfShareholderReturnOfStock" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage" order="12280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="12670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="12820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="12950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="13010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="13070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="13160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" order="13220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="13370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding" order="13430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="13550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="13780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue" order="13840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="13900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="14020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansStockBasedAwardPlansDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyEighteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyEighteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EquityIncentivePlanTwentyThirteenMember" xlink:type="locator" xlink:label="mnkd_EquityIncentivePlanTwentyThirteenMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoThousandFourEquityIncentivePlanMember" xlink:type="locator" xlink:label="mnkd_TwoThousandFourEquityIncentivePlanMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_TwoThousandFourEquityIncentivePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyThirteenMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="mnkd_EquityIncentivePlanTwentyEighteenMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CostOfRevenueCollaborationsAndServicesMember" xlink:type="locator" xlink:label="mnkd_CostOfRevenueCollaborationsAndServicesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mnkd_CostOfRevenueCollaborationsAndServicesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TransfersFromToParentAbstract" xlink:type="locator" xlink:label="mnkd_TransfersFromToParentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_TransfersFromToParentAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="10790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:type="locator" xlink:label="us-gaap_LeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="mnkd_LeaseExpirationMonthAndYear" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLeasesAnnualIncreaseInRentExpense" xlink:type="locator" xlink:label="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease" xlink:type="locator" xlink:label="us-gaap_GainLossOnTerminationOfLease" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeases" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeases" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesReplaced" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesReplaced" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NumberOfVehicleLeasesRetired" xlink:type="locator" xlink:label="mnkd_NumberOfVehicleLeasesRetired" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" xlink:type="locator" xlink:label="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LongTermPurchaseCommitmentExpirationDate" xlink:type="locator" xlink:label="mnkd_LongTermPurchaseCommitmentExpirationDate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" xlink:type="locator" xlink:label="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_LeaseRepurchaseDescription" xlink:type="locator" xlink:label="mnkd_LeaseRepurchaseDescription" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionNetBookValue" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionNetBookValue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecurityDeposit" xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionLeaseTerms" xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionLeaseTerms" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingSubleaseOptionToExtend" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingSubleaseOptionToExtend" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfRealEstate" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfRealEstate" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightLiability" xlink:type="locator" xlink:label="mnkd_MilestoneRightLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiabilityRemainingPayableAmount" xlink:type="locator" xlink:label="mnkd_ContingentLiabilityRemainingPayableAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ContingentLiability" xlink:type="locator" xlink:label="mnkd_ContingentLiability" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_VGoMember" xlink:type="locator" xlink:label="mnkd_VGoMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MarlboroughLeaseMember" xlink:type="locator" xlink:label="mnkd_MarlboroughLeaseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember" xlink:type="locator" xlink:label="us-gaap_BuildingMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_RussellRanchRoadIILLCMember" xlink:type="locator" xlink:label="mnkd_RussellRanchRoadIILLCMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeMember" xlink:type="locator" xlink:label="mnkd_OfficeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:type="locator" xlink:label="us-gaap_VehiclesMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MasterLeaseAgreementWithEnterpriseMember" xlink:type="locator" xlink:label="mnkd_MasterLeaseAgreementWithEnterpriseMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CasperLLCMember" xlink:type="locator" xlink:label="mnkd_CasperLLCMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_MilestoneRightsLiabilityMember" xlink:type="locator" xlink:label="mnkd_MilestoneRightsLiabilityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:type="locator" xlink:label="us-gaap_CreditFacilityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:type="locator" xlink:label="us-gaap_CreditFacilityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeerfieldManagementCompanyLpMember" xlink:type="locator" xlink:label="mnkd_DeerfieldManagementCompanyLpMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_DeerfieldManagementCompanyLpMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_CreditFacilityAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mnkd_MilestoneRightsLiabilityMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mnkd_CasperLLCMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_MasterLeaseAgreementWithEnterpriseMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_OfficeMember" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="mnkd_RussellRanchRoadIILLCMember" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mnkd_MarlboroughLeaseMember" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mnkd_VGoMember" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="mnkd_CommitmentsAndContingenciesLineItems" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiability" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_ContingentLiabilityRemainingPayableAmount" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_MilestoneRightLiability" order="11850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_ProceedsFromSaleOfRealEstate" order="11920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="11990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseOptionToExtend" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend" order="12030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseCost" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SaleLeasebackTransactionLeaseTerms" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_SaleLeasebackTransactionNetBookValue" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LeaseRepurchaseDescription" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiability" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="12220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="12260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee" order="12330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongTermPurchaseCommitmentExpirationDate" order="12380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LongtermPurchaseCommitmentRenewalTimePeriod" order="12400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeasesRetired" order="12450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeasesReplaced" order="12470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_NumberOfVehicleLeases" order="12490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="12510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_GainLossOnTerminationOfLease" order="12530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="12550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="12570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="12600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_OperatingLeasesAnnualIncreaseInRentExpense" order="12670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="mnkd_LeaseExpirationMonthAndYear" order="12690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="12840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LeaseCost" order="12960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_InterestExpenseOnFinancingLiability" xlink:type="locator" xlink:label="mnkd_InterestExpenseOnFinancingLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="mnkd_InterestExpenseOnFinancingLiability" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail">
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscounted" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscounted" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedExcessAmount" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_FinanceLeaseLiabilityDiscounted" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInFifthYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInFourthYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInThirdYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInSecondYear" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationDueInNextTwelveMonths" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:type="locator" xlink:label="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationDueInNextTwelveMonths" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationDueInSecondYear" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationDueInThirdYear" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationDueInFourthYear" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="us-gaap_PurchaseObligationDueInFifthYear" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:type="locator" xlink:label="us-gaap_VariableLeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_VariableLeaseCost" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesLineItems" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OfficeAndVehicleMember" xlink:type="locator" xlink:label="mnkd_OfficeAndVehicleMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CommitmentsAndContingenciesTable" xlink:type="locator" xlink:label="mnkd_CommitmentsAndContingenciesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="mnkd_CommitmentsAndContingenciesTable" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mnkd_OfficeAndVehicleMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesTable" xlink:to="mnkd_CommitmentsAndContingenciesLineItems" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEmployeeBenefitPlansAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_TwoYearServiceMember" xlink:type="locator" xlink:label="mnkd_TwoYearServiceMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OneYearServiceMember" xlink:type="locator" xlink:label="mnkd_OneYearServiceMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:type="locator" xlink:label="srt_StatementScenarioAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="srt_StatementScenarioAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mnkd_OneYearServiceMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mnkd_TwoYearServiceMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="10700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureComponentsOfNetDeferredTaxAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="locator" xlink:label="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsProductRevenueAndCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsProductRevenueAndCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsInterestExpenseLimitation" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsInterestExpenseLimitation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLeaseLiabilities" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLeaseLiabilities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedCosts" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedCosts" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsMilestoneRights" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsMilestoneRights" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedResearchExpenses" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsMilestoneRights" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsLossOnPurchaseCommitment" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsCapitalizedCosts" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsLeaseLiabilities" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsInterestExpenseLimitation" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="mnkd_DeferredTaxAssetsProductRevenueAndCosts" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="mnkd_DeferredTaxLiabilitiesRightOfUseAsset" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureEffectiveTaxRateDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:type="locator" xlink:label="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ResearchAndDevelopmentCreditsBeginToExpire" xlink:type="locator" xlink:label="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" xlink:type="locator" xlink:label="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_NetOperatingLossCarryforwardAnnualLimitation" xlink:type="locator" xlink:label="mnkd_NetOperatingLossCarryforwardAnnualLimitation" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_OperatingLossCarryforwardsSubjectToLimitation" xlink:type="locator" xlink:label="mnkd_OperatingLossCarryforwardsSubjectToLimitation" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesLineItems" xlink:type="locator" xlink:label="mnkd_IncomeTaxesLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_CaliforniaDivisionOfTaxationMember" xlink:type="locator" xlink:label="mnkd_CaliforniaDivisionOfTaxationMember" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_ConnecticutTaxAuthorityMember" xlink:type="locator" xlink:label="mnkd_ConnecticutTaxAuthorityMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:type="locator" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="mnkd-20221231.xsd#mnkd_IncomeTaxesTable" xlink:type="locator" xlink:label="mnkd_IncomeTaxesTable" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mnkd_IncomeTaxesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="mnkd_ConnecticutTaxAuthorityMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="mnkd_CaliforniaDivisionOfTaxationMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesTable" xlink:to="mnkd_IncomeTaxesLineItems" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_OperatingLossCarryforwardsSubjectToLimitation" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_NetOperatingLossCarryforwardAnnualLimitation" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_ResearchAndDevelopmentCreditsBeginToExpire" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mnkd_IncomeTaxesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail" xlink:href="mnkd-20221231.xsd#Role_DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail">
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_li0l2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_li0l2" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458080272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 10, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNKD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MannKind Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3607736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Casper Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Danbury<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">661-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,923,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 910,286,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte&#160;& Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">
<p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Portions of the registrant&#8217;s definitive Proxy Statement (the &#8220;Proxy Statement&#8221;) for the 2023 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than May 1, 2023 are incorporated by reference into Part III of this Annual Report on Form 10-K.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460323872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Undesignated preferred stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Undesignated preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Undesignated preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Undesignated preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">263,793,305<span></span>
</td>
<td class="nump">251,477,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">263,793,305<span></span>
</td>
<td class="nump">251,477,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458725408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,767<span></span>
</td>
<td class="nump">$ 124,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">101,079<span></span>
</td>
<td class="nump">79,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">16,801<span></span>
</td>
<td class="nump">4,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">21,772<span></span>
</td>
<td class="nump">7,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">25,477<span></span>
</td>
<td class="nump">3,482<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">234,896<span></span>
</td>
<td class="nump">219,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">45,126<span></span>
</td>
<td class="nump">36,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible asset</a></td>
<td class="nump">1,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">56,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">9,718<span></span>
</td>
<td class="nump">8,441<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">295,282<span></span>
</td>
<td class="nump">321,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">11,052<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">35,553<span></span>
</td>
<td class="nump">27,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing liability &#8212; current</a></td>
<td class="nump">9,565<span></span>
</td>
<td class="nump">6,977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue &#8212; current</a></td>
<td class="nump">1,733<span></span>
</td>
<td class="nump">827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PurchaseObligationCurrent', window );">Recognized loss on purchase commitments &#8212; current</a></td>
<td class="nump">9,393<span></span>
</td>
<td class="nump">6,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">67,296<span></span>
</td>
<td class="nump">48,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PromissoryNotesNoncurrent', window );">Promissory notes</a></td>
<td class="nump">8,829<span></span>
</td>
<td class="nump">18,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AccruedInterestNoncurrent', window );">Accrued interest &#8212; promissory notes</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing liability &#8212; long term</a></td>
<td class="nump">94,512<span></span>
</td>
<td class="nump">93,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CreditFacilityNoncurrent', window );">Midcap credit facility</a></td>
<td class="nump">39,264<span></span>
</td>
<td class="nump">38,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Senior convertible notes</a></td>
<td class="nump">225,397<span></span>
</td>
<td class="nump">223,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PurchaseObligationNoncurrent', window );">Recognized loss on purchase commitments &#8212; long term</a></td>
<td class="nump">62,916<span></span>
</td>
<td class="nump">76,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">5,343<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue &#8212; long term</a></td>
<td class="nump">37,684<span></span>
</td>
<td class="nump">19,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneLiabilitiesNoncurrent', window );">Milestone liabilities</a></td>
<td class="nump">4,524<span></span>
</td>
<td class="nump">4,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Deposits from customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">545,820<span></span>
</td>
<td class="nump">530,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Undesignated preferred stock, $0.01 par value &#8212; 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2022 and 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8212; 400,000,000 shares authorized, 263,793,305 and 251,477,562 shares issued and outstanding at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">2,638<span></span>
</td>
<td class="nump">2,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,964,293<span></span>
</td>
<td class="nump">2,918,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(3,217,469)<span></span>
</td>
<td class="num">(3,130,069)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(250,538)<span></span>
</td>
<td class="num">(209,349)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
<td class="nump">$ 295,282<span></span>
</td>
<td class="nump">$ 321,161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CreditFacilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit facility noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CreditFacilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone liabilities non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PromissoryNotesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory notes noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PromissoryNotesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase obligation current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase obligation noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461140448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 99,770<span></span>
</td>
<td class="nump">$ 75,442<span></span>
</td>
<td class="nump">$ 65,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">16,003<span></span>
</td>
<td class="nump">16,833<span></span>
</td>
<td class="nump">15,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">19,721<span></span>
</td>
<td class="nump">12,312<span></span>
</td>
<td class="nump">6,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Selling</a></td>
<td class="nump">53,753<span></span>
</td>
<td class="nump">45,528<span></span>
</td>
<td class="nump">34,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">37,720<span></span>
</td>
<td class="nump">31,889<span></span>
</td>
<td class="nump">24,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">1,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">(Gain) loss on foreign currency translation</a></td>
<td class="num">(4,811)<span></span>
</td>
<td class="num">(6,567)<span></span>
</td>
<td class="nump">8,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_GainLossOnPurchaseCommitments', window );">Loss on purchase commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">163,880<span></span>
</td>
<td class="nump">122,464<span></span>
</td>
<td class="nump">113,057<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(64,110)<span></span>
</td>
<td class="num">(47,022)<span></span>
</td>
<td class="num">(47,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income, net</a></td>
<td class="nump">2,513<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_InterestExpenseOnFinancingLiability', window );">Interest expense on financing liability</a></td>
<td class="num">(9,758)<span></span>
</td>
<td class="num">(1,373)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes</a></td>
<td class="num">(15,011)<span></span>
</td>
<td class="num">(15,204)<span></span>
</td>
<td class="num">(9,471)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss', window );">Loss on available-for-sale securities</a></td>
<td class="num">(932)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,200)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense</a></td>
<td class="num">(23,290)<span></span>
</td>
<td class="num">(33,904)<span></span>
</td>
<td class="num">(9,545)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">(87,400)<span></span>
</td>
<td class="num">(80,926)<span></span>
</td>
<td class="num">(57,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute net loss per share - basic</a></td>
<td class="nump">257,092<span></span>
</td>
<td class="nump">249,244<span></span>
</td>
<td class="nump">222,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute net loss per share - diluted</a></td>
<td class="nump">257,092<span></span>
</td>
<td class="nump">249,244<span></span>
</td>
<td class="nump">222,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Commercial product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 56,247<span></span>
</td>
<td class="nump">$ 39,168<span></span>
</td>
<td class="nump">$ 32,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">27,924<span></span>
</td>
<td class="nump">36,274<span></span>
</td>
<td class="nump">32,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">41,494<span></span>
</td>
<td class="nump">$ 22,024<span></span>
</td>
<td class="nump">$ 9,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty collaborations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 15,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GainLossOnPurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GainLossOnPurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterestExpenseOnFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense on financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterestExpenseOnFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458434864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement Of Income And Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Cumulative translation loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,259)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818448094896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Deficit - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>At-the-market Offering</div></th>
<th class="th"><div>Convertible Notes</div></th>
<th class="th">
<div>Convertible Notes </div>
<div>The Mann Group L L C</div>
</th>
<th class="th"><div>2024 Convertible Notes</div></th>
<th class="th"><div>2024 Convertible Note Interest</div></th>
<th class="th"><div>Senior Convertible Notes Principal</div></th>
<th class="th"><div>Senior Convertible Notes Interest</div></th>
<th class="th">
<div>Convertible Note Principal </div>
<div>The Mann Group L L C</div>
</th>
<th class="th"><div>Convertible Note Interest</div></th>
<th class="th">
<div>Convertible Note Interest </div>
<div>The Mann Group L L C</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>At-the-market Offering</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Convertible Notes</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Convertible Notes </div>
<div>The Mann Group L L C</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>2024 Convertible Notes</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>2024 Convertible Note Interest</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Senior Convertible Notes Principal</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Senior Convertible Notes Interest</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Convertible Note Principal </div>
<div>The Mann Group L L C</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Convertible Note Interest</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Convertible Note Interest </div>
<div>The Mann Group L L C</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>At-the-market Offering</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Convertible Notes</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Convertible Notes </div>
<div>The Mann Group L L C</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>2024 Convertible Notes</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>2024 Convertible Note Interest</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Senior Convertible Notes Principal</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Senior Convertible Notes Interest</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Convertible Note Principal </div>
<div>The Mann Group L L C</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Convertible Note Interest</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Convertible Note Interest </div>
<div>The Mann Group L L C</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="num">$ (190,526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,799,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (2,991,903)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock in association with stock options and restricted stock units</a></td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock associated with stock options and restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,261<span></span>
</td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,235<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">$ 6,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,612<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering/placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering/placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance cost associated with at-the-market offering/placement</a></td>
<td class="num">(519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock from acquisition</a></td>
<td class="nump">9,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock from acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">6,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Issuance of common stock from the exercise of warrants</a></td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Issuance of common stock from the exercise of warrants (in Share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan', window );">Issuance of common stock from market price stock purchase</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan', window );">Issuance of common stock under Market Price Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility', window );">Issuance of warrants pursuant to Midcap Credit Facility</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Cumulative translation loss</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(57,240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,240)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="num">(180,419)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,866,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,049,143)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock in association with stock options and restricted stock units</a></td>
<td class="num">(498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(514)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock associated with stock options and restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,573<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,535<span></span>
</td>
<td class="nump">$ 4,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,830<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities', window );">Issuance of common stock pursuant to payoff of the 2024 convertible note interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities', window );">Issuance of common stock pursuant to payoff of the 2024 convertible note interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering/placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering/placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance cost associated with at-the-market offering/placement</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">1,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote', window );">Premium on Mann Group convertible note</a></td>
<td class="nump">22,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan', window );">Issuance of common stock from market price stock purchase</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan', window );">Issuance of common stock under Market Price Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IssuanceOfCommonStockPursuantToWarrantConversion', window );">Issuance of common stock pursuant to a warrant conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares', window );">Issuance of common stock pursuant to a warrant conversion (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(80,926)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,926)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="num">(209,349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,918,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,130,069)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock in association with stock options and restricted stock units</a></td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures', window );">Net issuance of common stock associated with stock options and restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock pursuant to conversion notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in at-the-market offering/placement</a></td>
<td class="nump">19,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in at-the-market offering/placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance cost associated with at-the-market offering/placement</a></td>
<td class="num">(381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">2,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">13,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan', window );">Issuance of common stock from market price stock purchase</a></td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan', window );">Issuance of common stock under Market Price Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(87,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87,400)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2022</a></td>
<td class="num">$ (250,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,964,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,217,469)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital premium on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital issuance of warrants pursuant to credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IssuanceOfCommonStockPursuantToWarrantConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock pursuant to a warrant conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IssuanceOfCommonStockPursuantToWarrantConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock pursuant to a warrant conversion shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares market price stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares payoff of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options and restricted stock units net of forfeitures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value market price stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value payoff of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options and restricted stock units net of forfeitures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444835040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">13,447<span></span>
</td>
<td class="nump">12,200<span></span>
</td>
<td class="nump">6,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, amortization and accretion</a></td>
<td class="nump">6,124<span></span>
</td>
<td class="nump">4,215<span></span>
</td>
<td class="nump">2,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense on financing liability</a></td>
<td class="nump">9,552<span></span>
</td>
<td class="nump">1,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_InterestOnMilestonePayment', window );">Interest on milestone right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Write-off of inventory</a></td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">1,902<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_InterestExpenseOnPromissoryNotes', window );">Interest expense on Mann Group promissory notes</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">5,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss', window );">Loss on available-for-sale securities</a></td>
<td class="nump">932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">1,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">(Gain) loss on foreign currency translation</a></td>
<td class="num">(4,811)<span></span>
</td>
<td class="num">(6,567)<span></span>
</td>
<td class="nump">8,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(11,807)<span></span>
</td>
<td class="num">(776)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(5,670)<span></span>
</td>
<td class="num">(4,081)<span></span>
</td>
<td class="num">(1,314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(15,552)<span></span>
</td>
<td class="num">(360)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">523<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4,096<span></span>
</td>
<td class="nump">1,374<span></span>
</td>
<td class="nump">793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(723)<span></span>
</td>
<td class="nump">8,814<span></span>
</td>
<td class="nump">3,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">19,047<span></span>
</td>
<td class="num">(14,567)<span></span>
</td>
<td class="num">(5,910)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments', window );">Recognized loss on purchase commitments</a></td>
<td class="num">(5,709)<span></span>
</td>
<td class="num">(5,892)<span></span>
</td>
<td class="num">(4,751)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(3,309)<span></span>
</td>
<td class="num">(2,135)<span></span>
</td>
<td class="num">(1,312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes', window );">Accrued interest on Mann Group promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,919)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Deposits from customer</a></td>
<td class="num">(4,950)<span></span>
</td>
<td class="nump">4,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(80,679)<span></span>
</td>
<td class="num">(61,709)<span></span>
</td>
<td class="num">(28,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of held-to-maturity debt securities</a></td>
<td class="num">(74,536)<span></span>
</td>
<td class="num">(196,131)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from maturity of debt securities</a></td>
<td class="nump">107,340<span></span>
</td>
<td class="nump">59,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of V-Go</a></td>
<td class="num">(15,341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(7,589)<span></span>
</td>
<td class="num">(11,466)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PurchaseOfAvailableForSaleSecurities', window );">Purchase of available-for-sale securities</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Acquisition of in-process research and development, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,983)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">4,874<span></span>
</td>
<td class="num">(151,537)<span></span>
</td>
<td class="nump">15,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestonePayments', window );">Milestone payment</a></td>
<td class="num">(1,088)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the sale-leaseback transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,120)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits', window );">Net issuance of common stock associated with stock options and restricted stock units</a></td>
<td class="nump">319<span></span>
</td>
<td class="num">(498)<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan', window );">Proceeds from market price stock purchase plan and from employee stock purchase plan</a></td>
<td class="nump">2,766<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PaymentOnFinancingLiability', window );">Payment on financing liability</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Issuance of common stock from the exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from MidCap credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from the Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Issuance costs associated with Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ProceedsFromSaleLeasebackTransaction', window );">Proceeds from the sale-leaseback transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DepositForSaleLeasebackTransaction', window );">Deposit for the sale-leaseback transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on Mann Group promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payment of MidCap credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PaymentOfCreditFacilityPrepaymentPenalty', window );">Payment of MidCap credit facility prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">21,388<span></span>
</td>
<td class="nump">270,267<span></span>
</td>
<td class="nump">49,853<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</a></td>
<td class="num">(54,417)<span></span>
</td>
<td class="nump">57,021<span></span>
</td>
<td class="nump">36,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD</a></td>
<td class="nump">124,184<span></span>
</td>
<td class="nump">67,163<span></span>
</td>
<td class="nump">30,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD</a></td>
<td class="nump">69,767<span></span>
</td>
<td class="nump">124,184<span></span>
</td>
<td class="nump">67,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOWS DISCLOSURES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid in cash</a></td>
<td class="nump">8,852<span></span>
</td>
<td class="nump">11,268<span></span>
</td>
<td class="nump">3,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent', window );">Reclassification of investments from long-term to current</a></td>
<td class="nump">82,850<span></span>
</td>
<td class="nump">32,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable', window );">Reclassification of Thirona convertible notes and interest receivable from long-term to current</a></td>
<td class="nump">7,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance', window );">Payments on debt and interest through common stock issuance</a></td>
<td class="nump">10,270<span></span>
</td>
<td class="nump">15,143<span></span>
</td>
<td class="nump">15,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Forgiveness of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AdditionOfRightOfUseAssets', window );">Addition of right-of-use-asset</a></td>
<td class="nump">1,812<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RightOfUseAssetsModification', window );">Right-of-use asset modification</a></td>
<td class="nump">3,793<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Non-cash construction in progress and property and equipment</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,090<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentMilestoneLiability', window );">Contingent milestone liability</a></td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment', window );">Issuance of common stock for acquisition of in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility', window );">Issuance of warrants associated with the MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReceivableFromCommonStockOffering', window );">Receivable from at-the-market offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PremiumOnConvertibleNote', window );">Premium on convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mnkd_AtTheMarketIssuanceMember', window );">At The Market Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from public offering</a></td>
<td class="nump">19,790<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">23,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs associated with the sale-leaseback transaction</a></td>
<td class="num">$ (381)<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
<td class="num">$ (518)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdditionOfRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Addition of right-of-use assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdditionOfRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issuance to settle employee stock purchase plan liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for acquisition of in-process research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentMilestoneLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent milestone liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentMilestoneLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DepositForSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deposit for the sale-leaseback transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DepositForSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued interest on promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in recognized loss on purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterestExpenseOnPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expenses on promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterestExpenseOnPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterestOnMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest on milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterestOnMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of warrants associated with Credit Facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentOfCreditFacilityPrepaymentPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of credit facility prepayment penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentOfCreditFacilityPrepaymentPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentOnFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment on financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentOnFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments on debt and interest through common stock issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PremiumOnConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premium on convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PremiumOnConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from market price stock purchase plan and from employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from net issuance of common stock associated with stock options and restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ProceedsFromSaleLeasebackTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from the sale-leaseback transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ProceedsFromSaleLeasebackTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReceivableFromCommonStockOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivable from common stock offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReceivableFromCommonStockOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of convertible notes and interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of investments from long-term to current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RightOfUseAssetsModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RightOfUseAssetsModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mnkd_AtTheMarketIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mnkd_AtTheMarketIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542378016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Description of Business</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Description of Business</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Business <span style="font-style:normal;">&#8212; MannKind Corporation and its subsidiaries (the &#8220;Company&#8221;) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company is currently commercializing Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The Company also collaborates with third parties to formulate their drugs on the Company&#8217;s Technosphere drug delivery platform. Tyvaso DPI (treprostinil) inhalation powder received FDA approval in May 2022, for the treatment of pulmonary arterial hypertension and for the treatment of pulmonary hypertension associated with interstitial lung disease. UT began commercializing Tyvaso DPI in June 2022 and is obligated to pay the Company a royalty on net sales of the product. The Company also receives a margin on supplies of Tyvaso DPI that it manufactures for UT.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation<span style="font-style:normal;"> &#8212; The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Principles of Consolidation<span style="font-style:normal;"> &#8212; The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications<span style="font-style:normal;"> &#8212; Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Segment Information<span style="font-style:normal;"> &#8212; Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. To date, the Company has viewed its operations and manages its business as one segment operating in the United States of America.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818556119600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> &#8212; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> The Company recognizes revenue when its customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to be entitled in exchange for those goods or services.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To determine revenue recognition for arrangements that are within the scope of Accounting Standards Codification (&#8220;<span style="color:#000000;">ASC&#8221;) </span>Topic 606, <span style="font-style:italic;font-family:Calibri;color:#000000;">Revenue from Contracts with Customers </span><span style="font-family:Calibri;color:#000000;">(&#8220;ASC 606&#8221;),</span> the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under ASC 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company has two types of contracts with customers: (i) contracts for commercial product sales with wholesale distributors, specialty and retail pharmacies and (ii) collaboration arrangements.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8211; Net Revenue &#8211; Commercial Product Sales &#8211;<span style="font-style:normal;"> The Company sells its products to a limited number of wholesale distributors, specialty and retail pharmacies, and durable medical equipment suppliers (&#8220;DME&#8221;) in the U.S. (collectively, its &#8220;Customers&#8221;). Wholesale distributors</span><span style="color:#000000;font-style:normal;"> subsequently resell the Company&#8217;s products to retail pharmacies and certain medical centers or hospitals. Specialty and retail pharmacies sell directly to patients. In addition to distribution agreements with Customers, the Company enters into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of the Company&#8217;s products.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue on product sales when the Customer obtains control of the Company's product, which occurs at delivery for wholesale distributors and </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generally </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delivery </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for specialty pharmacies. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> revenue on product sales to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> retail pharmac</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as the product is dispensed to patients. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenues are recorded net of applicable reserves</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including discounts, allowances, rebates, returns and other incentives</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. See </span><span style="font-style:italic;">Reserves for Variable Consideration</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> below.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Free Goods Program &#8211; <span style="font-style:normal;">From time to time, the Company offers programs to potential new patients that allow them to obtain free goods (prescription fills) from a pharmacy. The Company excludes such amounts related to these programs from both gross and net revenue.&#160;The cost of product associated with the free goods program is recognized as cost of goods sold in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reserves for Variable Consideration <span style="font-style:normal;">&#8212; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#8217;s sale of its products. These reserves, as further detailed below, are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. The Company&#8217;s analysis also contemplates application of the constraint in accordance with the guidance, under which it determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company will adjust these estimates, which would affect net revenue <span style="font-family:Calibri;">&#8212;</span> commercial product sales and earnings in the period such variances become known.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix, unbilled claims, claim submission time lags and inventory levels in the distribution channel.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances <span style="font-style:normal;">&#8212; The Company generally provides Customers with discounts which include incentives, such as prompt pay discounts, that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company compensates (through trade discounts and allowances) its Customers for sales order management, data, and distribution services. However, the Company has determined such services received to date are not distinct from the Company&#8217;s sale of products to the Customer and, therefore, these payments have been recorded as a reduction of revenue and as a reduction to accounts receivable, net. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Returns <span style="font-style:normal;">&#8212; Consistent with industry practice, the Company generally offers Customers a right of return for unopened product that has been purchased from the Company for a period beginning six months prior to and ending 12 months after its expiration date, which lapses upon shipment to a patient. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net. The Company currently estimates product returns using available industry data and its own sales information, including its visibility into the inventory remaining in the distribution channel. The Company&#8217;s current return reserve percentage is estimated to be in the single-</span><span style="font-family:Calibri;font-style:normal;">digits. </span><span style="font-family:Calibri;font-style:normal;color:#000000;">Adjustments to the returns reserve have been made in the past and may be necessary in the future based on revised estimates to the Company&#8217;s assumptions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Provider Chargebacks and Discounts <span style="font-style:normal;">&#8212; Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase products from the Company. Customers charge the Company for the difference between what they pay for products and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is recorded in accrued expenses and other current liabilities. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers, and the Company generally issues credits for such amounts within a few weeks of the Customer&#8217;s notification to the Company of the resale. Reserves for chargebacks consist of credits that the Company expects to issue for units that remain in the distribution channel inventories at each reporting period-end that the Company expects will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which the Company has not yet issued a credit.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Government Rebates <span style="font-style:normal;">&#8212; The Company is subject to discount obligations under Medicare and state Medicaid programs. These reserves are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities. Estimates around Medicaid have historically required significant </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">judg</span><span style="font-style:normal;">ment due to timing lags in receiving invoices for claims from states.</span><span style="font-style:normal;color:#000000;"> </span><span style="font-style:normal;">For </span><span style="font-style:normal;">Afrezza</span><span style="font-style:normal;">, the Company also estimates the number of patients in the prescription drug coverage gap for whom the Company will owe an additional liability under the Medicare Part D program. The Company&#8217;s liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product</span><span style="font-style:normal;">s</span><span style="font-style:normal;"> that ha</span><span style="font-style:normal;">ve</span><span style="font-style:normal;"> been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span><span style="font-style:normal;"> The Company&#8217;s estimates include consideration of historical claims expe</span><span style="font-style:normal;">rience, paye</span><span style="font-style:normal;">r channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Payer Rebates <span style="font-style:normal;">&#8212; The Company contracts with certain private payer organizations, primarily insurance companies and pharmacy benefit managers, for the payment of rebates with respect to utilization of its products. The Company estimates these rebates, including estimates for product that has been recognized as revenue, but which remains in the distribution channel, and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities. The Company&#8217;s estimates include consideration of historical claims experience, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Incentives <span style="font-style:normal;">&#8212; Other incentives which the Company offers include voluntary patient support programs, such as the Company's co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with co-payments required by payers. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with the products that have been recognized as revenue, but remains in the distribution channel inventories at the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Revenue &#8212; Collaborations and Services &#8212;<span style="font-style:normal;"> The Company enters into licensing, research or other agreements under which the Company licenses certain rights to its product candidates to third parties, conducts research or provides other services to third parties. The terms of these arrangements may include, but are not limited to payment to the Company of one or more of the following: up-front license fees; development, regulatory, and commercial milestone payments; payments for commercial manufacturing and clinical supply services the Company provides; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. </span><span style="color:#000000;font-style:normal;">With respect to our </span><span style="font-style:normal;">significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (&#8220;as amended, the CSA&#8221;), we have identified three distinct performance obligations: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&amp;D Services and License&#8217;), (2) development activities for the next generation of the product (&#8220;Next-Gen R&amp;D Services&#8221;), and (3) a material right associated with current and future manufacturing and supply of product (&#8220;Manufacturing Services&#8221;). Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#8217;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represents distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and the Company uses key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12 months. Amounts that the Company expects will not be recognized within the next 12 months are classified as long-term deferred revenue. For further information, see Note 11<span style="font-style:italic;"> &#8211; Collaboration, Licensing and Other Arrangements.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes upfront license payments as revenue upon delivery of the license only if the license is determined to be a separate unit of accounting from the other undelivered performance obligations.&#160;The undelivered performance obligations typically include manufacturing or development services or research and/or steering committee services. If the license is not considered as a distinct performance obligation, then the license and other undelivered performance obligations would be evaluated to determine if such should be accounted for as a single unit of accounting.&#160;If concluded to be a single performance obligation, the transaction price for the single performance obligation is recognized as revenue over the estimated period of when the performance obligation is satisfied. If the license is considered to be a distinct performance obligation, then the estimated revenue is included in the transaction price for the contract, which is then allocated to each performance obligation based on the respective standalone selling prices.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whenever the Company determines that an arrangement should be accounted for over time, the Company determines the period over which the performance obligations will be performed, and revenue will be recognized over the period the Company is expected to complete its performance obligations. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete its performance obligations under an arrangement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaboration agreements typically entitle the Company to additional payments upon the achievement of development, regulatory and sales milestones. If the achievement of a milestone is considered probable at the inception of the collaboration, the related milestone payment is included with other collaboration consideration, such as upfront fees and research funding, in the Company&#8217;s revenue </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">calculation. If these milestones are not considered probable at the inception of the collaboration, the milestones will typically be recognized in one of two ways depending on the timing of when the milestone is achieved.&#160;If the milestone is improbable at inception and subsequently deemed probable of achievement, such will be added to the transaction price, resulting in a cumulative adjustment to revenue.&#160;If the milestone is achieved after the performance period has</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> been</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> completed and all performance obligations have been delivered, the Company will recognize the milestone payment as revenue in its entirety in the period the milestone was achieved. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaborative agreements, for accounting purposes, represent contracts with customers and therefore are not subject to accounting literature on collaborative agreements. The Company grants licenses to its intellectual property, supplies raw materials, semi-finished goods or finished goods, provides research and development services and offers sales support for the co-promotion of products, all of which are outputs of the Company&#8217;s ongoing activities, in exchange for consideration. Accordingly, the Company concluded that its collaborative agreements must generally be accounted for pursuant to ASC 606.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For collaboration agreements that allow collaboration partners to select additional optioned products or services, the Company evaluates whether such options contain material rights (i.e., have exercise prices that are discounted compared to what the Company would charge for a similar product or service to a new collaboration partner). The exercise price of these options includes a combination of licensing fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, the Company concludes the option does not contain a material right, and therefore is not included in the transaction price at contract inception. The Company assessed the CSA agreement with UT and determined that a material right existed for the manufacturing services performance obligation. The transaction price is allocated to the material right as well as the remaining performance obligations in accordance with ASC 606. The Company also evaluates grants of additional licensing rights upon option exercises to determine whether such should be accounted for as separate contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Royalties &#8212;<span style="font-style:normal;"> The Company recognizes royalty revenue for a sales-based or usage-based royalty if it is promised in exchange for an intellectual property license. The royalty revenue is recognized as the latter of the subsequent sale of the product occurs or if the performance obligation to which the royalty has been allocated has been satisfied or partially satisfied. The Company&#8217;s collaborative agreement with UT entitles it to receive low double-digit royalties on net sales of Tyvaso DPI for the license of the Company&#8217;s IP that was considered to be interdependent with the development activities that supported the approval of Tyvaso DPI.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,073</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,435</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,324</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,098</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,820</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,770</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,442</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,144</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent revenue generated from the Company&#8217;s collaboration arrangements, including Next-Gen R&amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements</span><span style="font-size:9pt;color:#000000;">. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent royalties on UT&#8217;s net sales of Tyvaso DPI.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold and cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,071</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,084</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,557</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cost of goods sold and cost of revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,857</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows detailed accounting guidance in measuring revenue and certain judgments affect the application of its revenue policy. For example, in connection with its existing collaboration agreements, the Company has recorded on its consolidated balance sheets short-term and long-term deferred revenue based on its best estimate of when such revenue will be recognized. Short-term deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12&#160;months. Amounts that the Company expects will not be recognized within the next 12&#160;months are classified as long-term deferred revenue. However, this estimate is based on the Company&#8217;s current project development plan and, if the development plan should change in the future, the Company may recognize a different amount of deferred revenue over the next 12-month period. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Payments<span style="font-style:normal;"> &#8212; At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the customer, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as, or when, the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect license, collaboration, other revenue, and earnings in the period of adjustment</span><span style="font-family:Calibri;font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cost of Goods Sold<span style="font-style:normal;"> &#8212; Cost of goods sold includes material, labor costs and manufacturing overhead. Cost of goods sold also includes a component of current period manufacturing costs in excess of costs capitalized into inventory (&#8220;excess capacity costs&#8221;).&#160;These costs, in addition to the impact of the revaluation of inventory for standard costing, and write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of goods sold excludes the cost of insulin purchased under the Company&#8217;s Insulin Supply Agreement (the &#8220;Insulin Supply Agreement&#8221;) with Amphastar Pharmaceuticals, Inc. (&#8220;Amphastar&#8221;). All insulin inventory on hand was written off and the full purchase commitment contract to purchase future insulin was accrued as a recognized loss on purchase commitments as of the end of 2016.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cost of Revenues &#8211; Collaborations and Services<span style="font-style:normal;"> &#8212; Cost of revenues &#8211; collaborations and services includes material, labor costs, manufacturing overhead, and excess capacity costs.&#160;These costs, in addition to the write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of revenues &#8211; collaborations and services also includes the cost of product development.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents and Restricted Cash<span style="font-style:normal;"> &#8212; The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December 31, 2022 and 2021, cash equivalents were comprised of money market, corporate bonds and commercial paper accounts with original maturities less than 90 days from the date of purchase.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records restricted cash when cash and cash equivalents are restricted as to withdrawal or usage. The Company presents amounts of restricted cash that will be available for use within 12 months of the reporting date as restricted cash in current assets. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Held-to-Maturity Investments<span style="font-style:normal;"> &#8212; The Company&#8217;s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2022, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. The amortization or accretion of the Company&#8217;s investments is recognized as interest income in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Available-for-Sale Investment<span style="font-style:normal;"> &#8212; In June 2021, the Company purchased a $3.0 million convertible promissory note (the &#8220;Thirona convertible note&#8221;) issued by Thirona Bio, Inc. (&#8220;Thirona&#8221;). In January 2022, the Company purchased an additional $5.0 million convertible promissory note issued by Thirona. Unless earlier converted into conversion shares pursuant to the note purchase agreement, the principal and accrued interest shall be due and payable by Thirona on demand by the Company at any time after the maturity date of December 31, 2023. Interest accrues at a rate of 6% per annum. The Thirona convertible notes are general unsecured obligations of Thirona. The Thirona convertible notes are classified as an available-for-sale security and are included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company assesses whether it has any intention to sell the investment, determines fair value of its available-for-sale investments using level 3 inputs as well as assesses its allowance for credit losses associated with the available for sale investment. In June 2021, the Company and Thirona also entered into a collaboration agreement to develop a compound for the treatment of fibrotic lung diseases. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;"> for additional information. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk<span style="font-style:normal;"> &#8212; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Receivable and Allowance for Credit Losses<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> Accounts receivable are recorded at the invoiced amount and are not interest bearing. Accounts receivable are presented net of an allowance for credit losses if there are estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for credit losses. The allowance for expected credit losses is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. Accounts receivable are also presented net of an allowance for product returns and trade discounts and allowances because the Company&#8217;s customers have the right of setoff for these amounts against the related accounts receivable.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Pre-Launch Inventory <span style="font-style:normal;">&#8212; An improvement to the manufacturing process for the Company&#8217;s primary excipient fumaryl diketopiperazine (&#8220;FDKP&#8221;) was demonstrated to be viable and management expects to realize an economic benefit in the future as a result of such process improvement. Accordingly, the Company is required to assess whether to capitalize inventory costs related to such excipient prior to regulatory approval of the new supplier and the improved manufacturing process. In doing so, management must consider a number of factors in order to determine the amount of inventory to be capitalized, including the historical experience of achieving regulatory approvals for the Company&#8217;s manufacturing process, feedback from regulatory agencies on the changes being effected and the amount of inventory that is likely to be used in commercial production. The shelf life of the excipient will be determined as part of the regulatory approval process; in the interim, the Company must assess the available stability data to determine whether there is likely to be adequate shelf life to support anticipated future sales occurring beyond the expected approval date of the new raw material. If management is aware of any specific material risks or contingencies other than the normal regulatory review and approval process, or if the criteria for capitalizing inventory produced prior to regulatory approval are otherwise not met, the Company would not capitalize such inventory costs, choosing instead to recognize such costs as a research and development expense in the period incurred.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Inventories<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes inventory costs associated with the Company&#8217;s products based on management&#8217;s judgment that future economic benefits </span><span style="font-style:normal;">are</span><span style="color:#000000;font-style:normal;"> expected to be realized; otherwise, such costs are expensed as incurred as cost of goods sold. The Company uses a contract manufacturing organization outside of the U.S. for certain stages of V-Go inventory. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value and writes down such inventories, as appropriate. In addition, the Company&#8217;s products are subject to strict quality control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or may become obsolete or are forecasted to become obsolete due to expiration, the Company will record a charge to write down such unmarketable inventory to its estimated net realizable value. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company performs an assessment of projected sales and evaluates the lower of cost or net realizable value and the potential excess inventory on hand at the end of each reporting period.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Property and equipment<span style="font-style:normal;"> &#8212; Property and equipment is recorded at historical cost, net of accumulated depreciation. Depreciation expense is recorded over the assets&#8217; useful lives on a straight-line basis. See Note 7 &#8211; </span>Property and Equipment<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets<span style="font-style:normal;">&#160;&#8212; Long-lived assets include property and equipment, operating lease right-of-use assets and other intangible asset. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Assets are considered to be impaired if the carrying value is considered to be unrecoverable.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the asset exceeds the fair value of the asset. Fair value is determined using the market, income or cost approaches as appropriate for the asset. Any write-downs are treated as permanent reductions in the carrying amount of the asset and recognized as an operating loss.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In August 2019, the Company recorded a $1.5&#160;million&#160;commitment asset and a $0.4&#160;million other asset for deferred debt issuance costs related to the future funding commitments of the MidCap Credit Facility. A quarterly assessment was performed during the second quarter of 2020 to determine if the Company was on target to achieve certain required milestone conditions in order for the Company to access further borrowings under the MidCap Credit Facility.&#160;The Company determined that such milestone conditions related to Afrezza trailing net revenue were unlikely to be achieved.&#160;As a result, an asset impairment of $1.9&#160;million was recognized during the second quarter of 2020 and is reflected in&#160;the Company&#8217;s consolidated statement of operations. See Note 10 &#8211;&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Borrowings</span><span style="Background-color:#FFFFFF;">&#160;for further information on the MidCap Credit Facility.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded $0.1 million of asset impairments for the year ended December 31, 2021. There were no asset impairments for the year ended December 31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisitions &#8212; <span style="font-style:normal;">The Company first determines whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired do not constitute a business, the Company accounts for the transaction as an asset acquisition. Business combinations are accounted for by means of the acquisition method of accounting. Under the acquisition method, assets acquired, </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">including in-process research and development (&#8220;IPR&amp;D&#8221;) projects, and liabilities assumed are recorded at their respective fair values as of the acquisition date in the Company&#8217;s consolidated financial statements. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Contingent consideration obligations incurred in connection with a business combination (including the assumption of an acquiree&#8217;s liability arising from an acquisition it consummated prior to the Company&#8217;s acquisition) are recorded at their fair values on the acquisition date and remeasured at their fair values each subsequent reporting period until the related contingencies have been resolved. The resulting changes in fair values are recorded in earnings. In contrast, asset acquisitions are accounted for by using a cost accumulation and allocation model. Under this model, the cost of the acquisition is allocated to the assets acquired and liabilities assumed. IPR&amp;D projects with no alternative future use are recorded in R&amp;D expense upon acquisition, and contingent consideration obligations incurred in connection with an asset acquisition are recorded when it is probable that they will occur and they can be reasonably estimated. See Note 3 &#8211; </span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisition</span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">s</span><span style="font-style:normal;">.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Goodwill and Other Intangible Assets </span>&#8212; <span style="Background-color:#FFFFFF;font-style:normal;">The fair value of acquired intangible assets is determined using an income-based approach referred to as the excess earnings method utilizing Level 3 fair value inputs. Market participant valuations assume a global view considering all potential jurisdictions and indications based on discounted after-tax cash flow projections, risk adjusted for estimated probability of technical and regulatory success. </span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company tests for impairment annually on a reporting unit basis, at the beginning of the Company&#8217;s fourth fiscal quarter and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. To the extent the carrying amount of a reporting unit is less than its estimated fair value, an impairment charge will be recorded.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life. Estimated useful lives are determined considering the period assets are expected to contribute to future cash flows. Finite-lived intangible assets are tested for impairment when facts or circumstances suggest that the carrying value of the asset may not be recoverable.&#160;If the carrying value exceeds the projected undiscounted pretax cash flows of the intangible asset, an impairment loss equal to the excess of the carrying value over the estimated fair value (discounted after-tax cash flows) is recognized.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">No</span> impairments to goodwill or other intangible assets were recorded during the year ended December 31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recognized Loss on Purchase Commitments &#8212;<span style="font-style:normal;"> The Company assesses whether losses on long-term purchase commitments should be accrued. Losses that are expected to arise from firm, non-cancellable, commitments for the future purchases are recognized unless recoverable. When making the assessment, the Company also considers whether it is able to renegotiate with its vendors. The recognized loss on purchase commitments is reduced as inventory items are received. If, subsequent to an accrual, a purchase commitment is successfully renegotiated, the gain is recognized in the Company&#8217;s consolidated statements of operations. The liability balance of the recognized loss on insulin purchase commitments as of December 31, 2022 and 2021 was $72.3 million and $82.8 million, respectively. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">No</span>&#160;new contracts were identified in 2022 that required a new loss on purchase commitment accrual.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights Liability<span style="font-style:normal;">&#160;&#8212; </span><span style="font-style:normal;color:#000000;">In July 2013, in conjunction with the execution of a (now repaid) loan agreement with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (collectively, &#8220;Deerfield&#8221;), the Company entered into Milestone Rights Purchase Agreement (the &#8220;Milestone Rights Agreement&#8221;) pursuant to which the Company issued certain milestone rights to Deerfield Private Design Fund II, L.P. and Horizon Sant&#233; FLML S&#192;RL, (the &#8220;Original Milestone Purchasers&#8221;). The foregoing milestone rights provided the Original Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable upon achievement of such milestones (collectively, the &#8220;Milestone Rights&#8217;). In December 2021, the Milestone Rights were purchased by Barings Global Special Situations Credit Fund 4 (Delaware), L.P. and Barings Global Special Situations Credit 4 (LUX) S.ar.l. (together the &#8220;Milestone Purchasers&#8221;). As a result, the Milestone Purchasers have assumed the obligations of the Original Milestone Purchasers and is now entitled to all rights under the Milestone Rights Agreement. As of December 31, 2022, $60.0 million remained payable pursuant to the Milestone Rights Agreement upon achievement of Afrezza net sales milestones. The Milestone Rights liability is reported at fair value at the date of the agreement which is periodically offset against payments. See Note 12</span><span style="font-style:normal;"> &#8211; </span>Fair Value of Financial Instruments<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#8217;s consolidated statements of operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. See Note&#160;10 &#8211; <span style="font-style:italic;">Borrowings</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments<span style="font-style:normal;"> &#8212;The Company applies various valuation approaches in determining the fair value of its financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#160;&#8212;&#160;Quoted prices for identical instruments in active markets.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#160;&#8212;&#160;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#160;&#8212;&#160;Significant inputs to the valuation model are unobservable.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Income Taxes<span style="font-style:normal;">&#160;&#8212; The provisions for federal, foreign, state and local income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets to amounts that are more likely than not to be realized.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For uncertain tax positions, the Company determines whether it is &#8220;more likely than not&#8221; that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, no tax benefit is recognized. </span>Penalties, if probable and reasonably estimable, are recognized as a component of income tax expense.<span style="Background-color:#FFFFFF;"> The Company has reduced its deferred tax assets for uncertain tax positions but has not recorded liabilities for income tax expense, penalties, or interest.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingencies<span style="font-style:normal;"> &#8212; The Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals represent management&#8217;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation and may revise its estimates.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation<span style="font-style:normal;"> &#8212; Share-based payments to employees, including grants of RSUs, performance-based non-qualified stock options awards (&#8220;PNQs&#8221;), restricted stock units with market conditions (&#8220;Market RSUs&#8221;), options and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. RSUs are valued based on the market price on the grant date. Market RSUs are valued using a Monte Carlo valuation model and RSUs with performance conditions are evaluated for the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Trial Expenses<span style="font-style:normal;"> &#8212; Clinical trial expenses, which are primarily reflected in research and development expenses in the accompanying consolidated statements of operations, result from obligations under contracts with vendors, consultants and clinical site agreements in addition to internal costs associated with conducting clinical trials.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Income (Loss) Per Share of Common Stock<span style="font-style:normal;"> &#8212; Basic net income or loss per share excludes dilution for potentially dilutive securities and is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted net loss per share as they would be anti-dilutive.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards <span style="font-style:normal;">&#8212; </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued a new accounting standard to ease the financial reporting burdens caused by the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, commonly referred to as reference rate reform. The new standard provides temporary optional expedients and exceptions to current GAAP guidance on contract modifications and hedge accounting. In January 2021, the FASB issued a new accounting standard that expanded the scope of the original March 2020 standard to include derivative instruments on discounting transactions. In December 2022, the FASB deferred the sunset date to an alternative reference rate from December 31, 2022 to December 31, 2024. The Company adopted these standards in the third quarter of 2022 using the prospective method and determined there was no impact on the Company&#8217;s consolidated financial statements.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Standards<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">In November 2021, the FASB issued a new accounting standard around the recognition and measurement of contract assets and contract liabilities from revenue contracts with customers acquired in a business combination. The new standard clarifies that contract assets and contract liabilities acquired in a business combination from an acquiree should initially be recognized by applying revenue recognition principles and not at fair value. The standard is effective for interim and annual periods beginning on January 1, 2023, and early adoption is permitted. The impact of this standard will depend on the facts and circumstances of future transactions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial position or results of operations upon adoption.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818543346704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination And Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Acquisitions</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">V-Go</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_000622">May 2022</span>, the Company entered into an Asset Purchase Agreement (the &#8220;APA&#8221;) to purchase from Zealand Pharma A/S and Zealand Pharma US, Inc. (together &#8220;Zealand&#8221;) certain assets and assume certain liabilities associated with the V-Go wearable insulin delivery device. The transaction closed on May 31, 2022 (the &#8220;Acquisition Date&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the APA, the Company paid up-front consideration of $15.3 million for certain assets and assumed liabilities related to V-Go. In addition, the Company will be obligated to make one-time, sales-based milestone payments to Zealand totaling up to a maximum of $10.0 million upon the achievement of specified annual revenue milestones between $40 million and $100 million.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total preliminary purchase consideration for V-Go was as follows (in tho<span style="Background-color:#FFFFFF;color:#000000;">usands):</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair value of consideration:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,341</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of contingent consideration</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,951</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The transaction was accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and liabilities assumed to be recognized at their respective fair values as of the Acquisition Date. The excess of the purchase price over those fair values was recorded as goodwill, which will be amortized over a period of 15 years for tax purposes. The estimates and assumptions used include the projected timing and amount of future cash flows and discount rates to reflect the risk inherent in the future cash flows. The estimated fair values of assets acquired and liabilities assumed and resulting goodwill are subject to adjustment as the Company finalizes its purchase price accounting. The significant items for which a final fair value has not been determined include, but are not limited to the valuation of the intangible asset and assumed liabilities for rebates and return reserves. The Company does not expect its fair value determinations to materially change; however, there may be differences between the amounts recorded at the Acquisition Date and the final fair value analysis, which is expected to be complete no later than the second quarter of 2023.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands): </span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,921</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible asset - Developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,513</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,562</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net assets acquired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,951</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory of $11.2 million consisted of raw materials, semi-finished goods and finished goods. The fair value of the inventory was determined based on the estimated selling price to be generated from the finished goods, less costs to sell, including a reasonable margin, which are level 3 inputs not observable in the market. Property and equipment and assumed liabilities were recorded at their carrying amounts which were deemed to approximate their fair values based on level 3 unobservable inputs. The fair values of the right-of-use assets and lease liabilities for assumed operating leases were assessed in accordance with ASC Topic 842, Leases, based on discounted cash flow from lease payments, utilizing the Company&#8217;s incremental borrowing rate of 7.25%.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value of the intangible asset was determined by applying the income approach based on significant level 3 unobservable inputs. </span></p>
<p style="margin-top:12pt;margin-bottom:8pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value of the contingent milestone liability was estimated using the Monte Carlo simulation method for the calculation of the potential payment and the Geometric Brownian Motion forecasting model to estimate the underlying revenue. Market based inputs and other level 3 inputs were used to forecast future revenue. The key inputs used included a risk-free rate of 2.95%, dividend yield of 0%, volatility of 65%, period of 15 years and credit risk of 12%.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company incurred acquisition-related costs of approximately $0.4 million for the year ended December 31, 2022.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Net revenue and loss from operations for the year ended December 31, 2022 was $12.9 million and $0.3 million, respectively</span>, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):</p>
<p style="margin-top:18pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Supplemental Pro Forma Information (unaudited)</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.08%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,278</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(86,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,806</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">QrumPharma<span style="font-style:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_000660">December 2020</span>, the Company acquired QrumPharma, Inc., a privately held pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company&#8217;s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Consideration</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,574</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock consideration (3,067,179 shares at $3.01 per share)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transaction costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of debt</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash acquired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(155</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total consideration paid for IPR&amp;D</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The stock purchase of QrumPharma was accounted for under ASC 805, Business Combinations, as an asset acquisition since the transaction did not include the acquisition of inputs or processes and the fair value of the assets acquired were concentrated in a single identifiable asset, MNKD-101, which consisted of an in-process research and development asset (&#8220;IPR&amp;D&#8221;). Under ASC 805, an entity that acquires IPR&amp;D in an asset acquisition should follow the guidance in ASC 730, Research and Development, which requires that both tangible and intangible identifiable research and development assets with no alternative future use be allocated a portion of the consideration transferred and charged to expense at the acquisition date. Due to the stage of development of MNKD-101 at the date of acquisition, significant risk remained that the product would not obtain regulatory approval and it was not yet probable that there would be future economic benefit for the Company. Absent successful clinical results and regulatory approval, it was determined that there was no alternative future use associated with MNKD-101. Accordingly, the value of this asset was expensed at the time of acquisition and the total accumulated cost of $13.2 million, was allocated to the IPR&amp;D asset using a relative fair value basis and the total consideration was recognized as in-process research and development expense in the consolidated statement of operations. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The acquisition of QrumPharma also included a potential future royalty payment of 1.5% of net sales in each of the calendar years in which the total annual and global adjusted net sales of specified products exceeds $50 million and a royalty payment of 1.0% of net sales in each of the calendar years in which the total annual and global adjusted net sales of nebulized clofazimine are greater than or equal to $200 million. The contingent consideration in the form of royalty payments will be expensed as incurred since the probability of MNKD-101 obtaining FDA approval and generating net sales that exceed the specified thresholds could not be reasonably estimated on the date of acquisition.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818466124912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule Of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Investments</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash Equivalents <span style="font-style:normal;">&#8212; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $69.8 million and $124.2 million, respectively, of cash and cash equivalents.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Available-for-Sale Investment</span><span style="Background-color:#FFFFFF;font-style:normal;"> &#8212; The Thirona convertible note is classified as an available-for-sale security and is included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using level 3 inputs. As of December 31, 2022, the Company evaluated the fair value of its investment in Thirona using a Monte Carlo simulation which resulted in a fair value of $7.1 million. </span><span style="font-style:normal;color:#000000;">In addition, the Company determined that there was a related credit loss of $0.9 million on the investment which was recognized in the consolidated statements of operations for the year ended December 31, 2022.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Held-to-Maturity Investments <span style="font-style:normal;">&#8212; Investments consist of highly liquid investments that are intended to facilitate liquidity and capital preservation. As of December 31, 2022, the Company held $101.1 million of short-term investments and $2.0 million of long-term investments. As of December 31, 2021, the Company held $79.9 million of short-term investments and $56.6 million of long-term investments.</span> The amortization or accretion of the Company&#8217;s investments is recognized as interest income in the consolidated statements of operations and was approximately $0.7 million and $0.5 million for the years ended December 31, 2022 and 2021, respectively. No allowance for credit losses on held-to-maturity securities was required as of December 31, 2022 or 2021.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The contractual maturities of the Company&#8217;s held to maturity investments as of December 31, 2022 and 2021 are summarized below (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due in one year or less<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,733</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,669</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,961</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,948</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,433</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,823</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,924</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,352</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,102</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;font-size:9pt;">The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.</span><span style="color:#000000;"> </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the cash equivalents, long-term and short-term investments are disclosed below (in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, there was $0.6 million of accrued interest receivable and $5.1 million of amount receivable on matured investment recognized as prepaid expense and other current assets in our consolidated balance sheets. As of December 31, 2021, there was $0.3 million of accrued interest receivable recognized as other assets in our consolidated balance sheets.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461282016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">Accounts Receivable</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Accounts Receivable</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.34%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; commercial</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,359</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,939</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wholesaler distribution fees and prompt pay discounts</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,536</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,696</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for returns</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,108</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,797</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; commercial, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,715</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,446</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,086</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,060</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; collaborations and services, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,086</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,293</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,801</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022 and December 31, 2021, the allowance for credit losses was <span style="font-style:italic;">de minimis</span>. As of December 31, 2022 and December 31, 2021, the Company had three wholesale distributors representing approximately 74% and 80% of gross sales and 79% and 79% of accounts receivable, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, there was no allowance for credit losses for accounts receivable &#8211; collaborations and revenue. &#160;The Company had one collaboration partner, United Therapeutics, that comprised 100% of the collaboration and services net accounts receivable as of December 31, 2022 and approximately 98% of gross revenue from collaborations and services for the year ended December 31, 2022.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue net of gross-to-net adjustments<span style="color:#000000;">.</span> The activities and ending reserve balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prompt Pay Discount Reserve, Allowance for Wholesale Distribution Fees</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and Accounts Receivables Return Reserve:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,493</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,873</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,471</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,320</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,874</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,644</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,493</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196816<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464261056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Inventories</p>
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories consist of the following (in thousands): </p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,739</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work-in-process</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,815</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,522</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,927</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventory</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work-in-process and finished goods as of December 31, 2022 and 2021 include conversion costs and exclude the cost of insulin. All insulin inventory on hand was written off and the projected loss on the purchase commitment contract to purchase future insulin was accrued as of the end of 2016. Raw materials inventory included $0.8 million of pre-launch inventory as of December 31, 2022 and 2021, which consisted of FDKP received in November 2019 that will be used to manufacture Afrezza under an enhanced manufacturing process for FDKP. The Company expects to receive FDA approval of the new source of FDKP in 2024. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company analyzed its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company also performed an assessment of projected sales and evaluated the lower of cost or net realizable value and the potential excess inventory on hand at December 31, 2022 and 2021. Inventory that was forecasted to become obsolete due to expiration as well as inventory that does not meet acceptable standards is recorded in costs of goods sold in the accompanying consolidated statements of operations. <span style="font-family:Calibri;">T</span><span style="Background-color:#FFFFFF;color:#000000;">here was an inventory write-off of $2.2 million as a result of this assessment for the year ended December 31, 2022. </span>For the year ended December 31, 2021, there was an inventory write-off of $1.9 million as a result of this assessment, including $0.7 million related to the start of an agreement with a retail pharmacy. There was an inventory write-off of $0.5 million for the year ended December 31, 2020.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818465462192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Property and Equipment</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Land</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000802">39-40</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">5-40</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,952</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,651</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Machinery and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">3-15</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,334</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture, fixtures and office equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">5-10</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,969</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000810">3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,246</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,163</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,706</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,892</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,686</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,560</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,661</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,126</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,612</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">As of December 31, 2021 construction in progress included $4.7 million of equipment under construction for the manufacturing expansion for UT (the &#8220;UT Equipment&#8221;). There is no balance under construction for the UT Equipment as of December 31, 2022. The Company acts as agent on behalf of UT for the procurement of the UT Equipment. The Company has received $5.0 million in deposit for this service, which was recognized as deposits from customer in the consolidated balance sheet as of December 31, 2021. In April 2022, the Company and UT agreed that UT would hold title to the UT Equipment at all times. As such, there is no balance related to the UT Equipment included in construction in progress or deposits from customer in our consolidated balance sheet as of December 31, 2022. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 was $3.3 million, $2.0 million and $1.8&#160;million, respectively. During the years ended December 31, 2022 and 2021, the Company retired $2.4 million and $1.1 million, respectively of manufacturing equipment, computer hardware and software, computer equipment, lab equipment, and building improvements, as it was no longer in service. The net book value for the disposed assets was <span style="font-style:italic;">de minimis</span>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 8, 2021, the Company sold certain land, building and improvements located in Danbury, CT (the &#8220;Property&#8221;) to an affiliate of Creative Manufacturing Properties (the &#8220;Purchaser&#8221;) for a sales price of $102.3 million, subject to the terms and the conditions contained in a purchase and sale agreement. Effective with the closing of this transaction, the Company entered into a 20-year lease agreement with the Purchaser (the &#8220;Sale-Leaseback Transaction&#8221;). The sale of the Property and subsequent lease did not result in the transfer of control of the Property to the Purchaser; therefore, the Sale-Leaseback Transaction qualified as a failed sale leaseback transaction whereby the lease is accounted for as finance lease and the Property remains as a long-lived asset of the Company and is depreciated at its remaining useful life of 20 years or less. See Note 16 &#8211; <span style="font-style:italic;">Commitments and Contingencies</span><span style="font-family:Calibri;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818556117632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Asset<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Asset</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.<span style="Background-color:#FFFFFF;color:#000000;"> Goodwill and Other Intangible Asset&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill<span style="font-style:normal;"> &#8212; Goodwill represents the excess of the purchase price over the identifiable tangible and intangible assets acquired plus liabilities assumed arising from business combinations. The balance of goodwill was approximately $2.4 million as of December 31, 2022 as a result of our acquisition of V-Go in May 2022. Goodwill is tested at least annually for impairment by assessing qualitative factors in determining whether it is more likely than not that the fair value of net assets is below their carrying amounts. See Note 2 &#8211; </span>Summary of Significant Accounting Policies<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Intangible Asset <span style="font-style:normal;">&#8212; Other intangible asset consisted of the following (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">15</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,153</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization expense related to the other intangible asset was <span style="font-style:italic;">de minimis</span> for the year ended December 31, 2022. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The estimated annual amortization expense for the other intangible asset for the years ended December 31, 2023 through 2027 will be approximately $0.1 million per year and $0.7 million, thereafter.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its other intangible asset for potential impairment when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. <span style="font-style:italic;">See Note 2 &#8211; Summary of Significant Accounting Policies</span>.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464261056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Accrued Expenses and Other Current Liabilities</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities are comprised of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Salary and related expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,906</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,504</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Returns reserve for acquired product</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,013</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,136</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">895</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,380</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of milestone rights liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,088</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,166</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Retail inventory purchase</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Danbury facility buildout</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">846</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,719</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,980</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,553</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,419</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The provision for discounts and allowances for commercial product sales is reflected as a component of net revenues. The activities and ending balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,688</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,369</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,603</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,518</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go opening balance sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,511</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,504</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818448078240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10. Borrowings</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amount of the Company&#8217;s borrowings consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225,397</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223,944</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group promissory notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,829</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,425</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,264</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt &#8212; net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,490</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281,202</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The amendment to the Mann Group convertible note in the second quarter of 2021 resulted in a substantial premium of $22.1 million based on the fair value post modification, which contributed to the loss on extinguishment in the consolidated statement of operations for the year ended December 31, 2021 and was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of the Company&#8217;s debt and key terms: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.12%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount Due</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terms</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual&#160;Interest&#160;Rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maturity Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Conversion Price</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$230.0&#160;million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$230.0 million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5.21</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40.0&#160;million</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40.0 million</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">one-month</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SOFR (1% floor)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plus&#160;6.25%;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cap of 8.25%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.8 million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">$18.4 million (plus $0.4 million accrued interest paid-in-kind)</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.50</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. </span><span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The maturities of the Company&#8217;s borrowings as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.26%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amounts</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,667</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,163</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">278,830</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(235</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,105</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,490</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Senior convertible notes &#8211; <span style="font-style:normal;">In March 2021, the Company issued $200.0 million aggregate principal amount of Senior convertible notes in a private offering. Pursuant to an option to purchase additional senior convertible notes in the purchase agreement between the Company and the initial purchasers of the Senior convertible notes, the Company issued an additional $30.0 million aggregate principal amount of Senior convertible notes on March 15, 2021. The Senior convertible notes were issued pursuant to an indenture, dated March 4, 2021 (the &#8220;Indenture&#8221;), between the Company and U.S. Bank National Association, as trustee.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Senior convertible notes are general unsecured obligations of the Company and will mature on March 1, 2026, unless earlier converted, redeemed or repurchased. The Senior convertible notes will bear cash interest from March 4, 2021 at an annual rate of 2.50% payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2021. The Senior convertible notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the Company&#8217;s common stock, par value $0.01 per share, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Senior convertible notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Senior convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Senior convertible notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after December 1, 2025 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the common stock or a combination of cash and shares of common stock, at the Company&#8217;s election, in the manner and subject to the terms and conditions provided in the Indenture.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial conversion rate is 191.8281 shares of common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $5.21 per share of common stock). The initial conversion price of the Senior convertible notes represents a premium of approximately 30% to the last reported sale price of the common stock on the Nasdaq Global Market on March 1, 2021. The conversion rate for the Senior convertible notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date of the Senior convertible notes or if the Company delivers a notice of redemption in respect of the Senior convertible notes, the Company will, in certain circumstances, increase the conversion rate of the Senior convertible notes for a holder who elects to convert its Senior convertible notes in connection with such a corporate event or convert its Notes called for redemption during the related redemption period (as defined in the Indenture), as the case may be.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may not redeem the Senior convertible notes prior to March 6, 2024. The Company may redeem for cash all or any portion of the Senior convertible notes, at its option, on or after March 6, 2024 and prior to the 36th scheduled trading day immediately preceding the maturity date, if the last reported sale price of common stock has been at least 130% of the conversion price for the Senior convertible notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Senior convertible notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem less than all of the outstanding Senior convertible notes, at least $75.0 million aggregate principal amount of Senior convertible notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the Senior convertible notes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as described in the Indenture, holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Senior convertible notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Indenture includes customary covenants and sets forth certain events of default after which the Senior convertible notes may be declared immediately due and payable. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries) occur, 100% of the principal of and accrued and unpaid interest on the Senior convertible notes will automatically become due and payable. If an event of default with respect to the Senior convertible notes, other than certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries), occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Senior convertible notes by notice to the Company and the trustee, may, and the trustee at the request of such holders shall, declare 100% of the principal of and accrued and unpaid interest, if any, on all the Senior convertible notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the Senior convertible notes as set forth in the Indenture.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Indenture provides that the Company shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of the consolidated properties and assets of the Company and its subsidiaries, taken as a whole, to, another person (other than any such sale, conveyance, transfer or lease to one or more of the Company&#8217;s direct or indirect wholly owned subsidiaries), unless: (i) the resulting, surviving or transferee person (if not the Company) is a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and such corporation (if not the Company) expressly assumes by supplemental indenture all of the Company&#8217;s obligations under the Senior convertible notes and the Indenture; and (ii) immediately after giving effect to such transaction, no default or event of default has occurred and is continuing under the Indenture.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company&#8217;s net proceeds from the offering were approximately $222.7 million, after deducting the initial purchasers&#8217; discounts and commissions and the estimated offering expenses payable by the Company. As of December 31, 2022 and 2021, the unamortized debt issuance cost was $4.6 million and $6.1 million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility &#8212; In August 2019, the Company entered into the MidCap credit facility and borrowed the first advance of $40.0 million (&#8220;Tranche 1&#8221;) in August 2019 and the second advance of $10.0 million (&#8220;Tranche 2&#8221;) in December 2020. In April 2021, $10.0 million was prepaid. Under the terms of the MidCap credit facility, a third advance of $60.0 million (&#8220;Tranche 3&#8221;) became available to the Company after the Tyvaso DPI approval by the FDA through June 30, 2022 (see Note 11 &#8211; Collaboration, Licensing and Other Arrangements). The Company did not exercise its right to borrow Tranche 3.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mid Cap credit facility has been amended several times, including in April 2021, when the parties agreed to, among other things, (i) increase the amount available under the third advance from $25.0 million to $60.0 million and extend the date through which the third advance is available to June 30, 2022, (ii) amend the conditions to the third advance of $60.0 million being available to draw, including certain milestone conditions associated with Tyvaso DPI, (iii) remove the Company&#8217;s obligation to issue a warrant to purchase shares of the Company&#8217;s common stock upon drawing down the third advance, (iv) extend the interest-only period until September 1, 2023 and extend the maturity date until August 1, 2025, (v) amend the financial covenant relating to trailing 12 month minimum Afrezza net revenue, (vi) decrease the minimum cash covenant, (vii) decrease the interest rate on any amounts outstanding, now or in the future, under the MidCap credit facility, (viii) permit the Company to make certain acquisitions, subject to requirements, and (ix) permit the Company to make investments of up to an additional $9.0 million so long as the Company has $90.0 million or more of unrestricted cash and short-term investments following such investment. Concurrent with entering into this amendment, the Company made a $10.0 million principal prepayment against outstanding term loans under the MidCap credit facility and paid a related $1.0 million exit fee in lieu of the unaccrued portion of the original exit fee and prepayment penalties that would otherwise have been due with respect to the partial prepayment.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the prepayment penalty of $1.0 million related to the payment of $10.0 million was capitalized and will be amortized over the remaining life of the debt. As of December 31, 2022, the unamortized debt discount was $0.2 million and the unamortized prepayment penalty was $0.5 million. As of December 31, 2021, the unamortized debt discount was $0.4 million and the unamortized prepayment penalty was $0.8 million.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2022, the Company entered into the tenth amendment to the MidCap credit facility to change the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tranche 1 and Tranche 2 accrue interest at an annual rate equal to the lesser of (i) 8.25% and (ii) the one-month SOFR (subject to a one-month SOFR floor of 1.00%) plus 6.25%. Interest on each term loan advance is due and payable monthly in arrears. Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025. The Company has the option to prepay its existing term loans, in whole or in part, subject to early termination fees in an amount equal to 3.00% of principal prepaid if prepayment occurs on or prior to April 22, 2022; 2.00% of principal prepaid if prepayment occurs on or after April 23, 2022 through and including April 22, 2023; and 1.00% of principal prepaid if prepayment occurs on or after April 23, 2023 through the maturity date.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s obligations under the MidCap credit facility are secured by a security interest on substantially all of its assets, including intellectual property.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The MidCap credit facility, as amended, contains customary affirmative covenants and customary negative covenants limiting the Company&#8217;s ability and the ability of the Company&#8217;s subsidiaries to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock and make investments, in each case subject to certain exceptions. The Company must also comply with a financial covenant relating to trailing twelve month minimum Afrezza net revenue, tested on a monthly basis, unless the Company has $90.0 million or more of unrestricted cash and short-term investments. As of December 31, 2022, the Company was in compliance with the financial covenants.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The MidCap credit facility also contains customary events of default relating to, among other things, payment defaults, breaches of covenants, a material adverse change, listing of the Company&#8217;s common stock, bankruptcy and insolvency, cross defaults with certain material indebtedness and certain material contracts, judgments, and inaccuracies of representations and warranties. Upon an event of default, the agent and the lenders may declare all or a portion of the Company&#8217;s outstanding obligations to be immediately due and payable and exercise other rights and remedies provided for under the MidCap credit facility. During the existence of an event of default, interest on the term loans could be increased by 2.00%.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also agreed to issue warrants to purchase shares of the Company&#8217;s common stock (the &#8220;MidCap warrants&#8221;) upon the drawdown of Tranches 1 and 2 in an aggregate amount equal to 3.25% of the amount drawn, divided by the exercise price per share for that tranche. The exercise price per share is equal to the volume-weighted average closing price of the Company&#8217;s common stock for the ten business days immediately preceding the second business day before the issue date. As a result of Tranche 1, the Company issued warrants to purchase an aggregate of 1,171,614 shares of the Company&#8217;s common stock, at an exercise price equal to $1.11 per share. As a result of Tranche 2, the Company issued warrants to purchase an aggregate of 111,853 shares of the Company&#8217;s common stock, at an exercise price equal to $2.91 per share. The Company determined that these warrants met the criteria for equity classification and accounted for such warrants in additional paid-in capital. During the year ended December 31, 2021, the Tranche 1 and Tranche 2 MidCap warrants were exercised in full.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Mann Group promissory notes<span style="font-style:normal;"> &#8212; In August 2019, the Company issued a $35.0 million </span><span style="font-style:normal;color:#000000;">note that is convertible into shares of the Company&#8217;s common stock at $2.50 per share (the &#8220;Mann Group convertible note&#8221;)</span><span style="font-style:normal;"> and issued a non-convertible note to Mann Group in an aggregate principal amount of $35.1 million (the &#8220;Mann Group non-convertible note&#8221; and</span><span style="font-style:normal;color:#000000;">, together with the Mann Group convertible note, the &#8220;Mann Group promissory notes&#8221;)</span><span style="font-style:normal;"> as part of a restructuring of its then existing indebtedness to Mann Group.</span> </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Mann Group promissory notes originally accrued interest at the rate of 7.00% per year on the principal amount, payable quarterly in arrears on the first day of each calendar quarter beginning October 1, 2019. In April 2021, the Company repaid the entire principal amount of $35.1 million outstanding under the Mann Group non-convertible note, together with all accrued and unpaid interest thereon. On the same date, the Company and Mann Group amended the Mann Group convertible note, pursuant to which the parties agreed to (i) reduce the interest rate from 7.0% to 2.5% effective on April 22, 2021, and (ii) extend the maturity date from November 3, 2024 to December 31, 2025. </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendment to the Mann Group convertible note resulted in a debt extinguishment with a substantial premium based on the fair value post extinguishment. The fair value in excess of the face amount of $18.4 million contributed to a loss on extinguishment of $22.1 million in the consolidated statement of operations for the year ended December 31, 2021 and resulted in a corresponding debt premium of $22.1 million which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The Company wrote off a <span style="font-style:italic;">de minimis</span> amount of debt issuance cost.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The principal and any accrued and unpaid interest under the Mann Group convertible note may be converted, at the option of Mann Group, at any time on or prior to the close of business on the business day immediately preceding the stated maturity date, into shares of the Company&#8217;s common stock at a conversion rate of 400 shares per $1,000 of principal and/or accrued and unpaid interest, which is equal to a conversion price of $2.50 per share. The conversion rate will be subject to adjustment under certain circumstances described in the Mann Group convertible note. Interest on the convertible note will be payable in kind by adding the amount thereof to the principal amount; provided that with respect to interest accruing from and after January 1, 2021, the Company may, at its option, elect to pay any such interest on any interest payment date, if certain conditions are met, in shares of the Company&#8217;s common stock at a price per shall equal to the last reported sale price on the trading day immediately prior to the payment date.&#160;&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the Mann Group convertible note, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of accrued interest and $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal into </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares and </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million shares, respectively, of the Company&#8217;s common stock in the fourth quarter of 2020. During the year ended December 31, 2021, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of interest and $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.6</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal into 4,000,000 shares of common stock.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> During the year ended December 31, 2022, Mann Group converted $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.0</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of principal and capitalized interest into </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000,000</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of common stock. In addition, the Company paid $</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of interest by issuing the Mann Group </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,487</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of common stock</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the year ended December 31, 2022</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">PPP loan<span style="font-style:normal;"> &#8211; In April 2020, the Company received the proceeds from the PPP loan from JPMorgan Chase Bank, N.A., as lender, in the amount of approximately $4.9 million pursuant to the PPP of the CARES Act. In July 2021, the Company received notification from the U.S Small Business Administration that the full principal amount of the PPP loan was forgiven. The Company recognized a $4.9 million gain on extinguishment of debt for the forgiveness of the principal amount and accrued but unpaid interest for the year ended December 31, 2021. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to being forgiven, the PPP loan was evidenced by a promissory note dated April 9, 2020 that matured on April 9, 2022 and bore interest at a rate of 0.98% per annum (which was being deferred). The Company used all proceeds from the PPP loan to retain employees, maintain payroll and make lease, interest and utility payments. </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of the premium and accretion of debt issuance costs related to all borrowings for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights &#8212;<span style="font-style:normal;"> As of December 31, 2022 and 2021, the remaining Milestone Rights liability balance was $4.8 million and $5.9 million, respectively, which was based on initial fair value estimates calculated using the income approach and reduced by milestone achievement payments made. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">During the second quarter of 2022, the Company achieved an Afrezza net sales milestone specified by the Milestone Rights.</span><span style="font-style:normal;"> </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">The carrying value of the Milestone Rights liability related to the $5.0&#160;million payment, which was made in the third quarter of 2022, was approximately $1.1&#160;million and represented the fair value as determined in 2013 (the most recent measurement date).</span><span style="font-style:normal;"> As of December 31, 2022, the $4.8 million liability consisted of a $0.9 million current liability which was presented as accrued expenses and other current liabilities and a $3.9 million long-term liability which was presented in milestone liabilities in our consolidated balance sheets. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the first quarter of 2021, the Company achieved the second Afrezza net sales milestone specified by the Milestone Rights. <span style="color:#000000;">The milestone </span>carrying value of the Milestone Rights liability related to the $5.0 million payment, which was made in the second quarter of 2021, was approxim<span style="color:#000000;">ately $1.3 million, and represented the fair value as determined in 2013 (the most recent measurement date).</span> As of December 31, 2021, the $5.9 million liability consisted of a $1.1 million current liability which was presented as accrued expenses and other current liabilities and a $4.8 million long-term liability which was presented in milestone liabilities in our consolidated balance sheets.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Milestone Rights Agreement includes customary representations and warranties and covenants by the Company, including restrictions on transfers of intellectual property related to Afrezza. The Milestone Rights are subject to acceleration in the event the Company transfers its intellectual property related to Afrezza in violation of the terms of such agreement. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461527888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration, Licensing and Other Arrangements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. Collaboration, Licensing and Other Arrangements</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from collaborations and services for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (2)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,145</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vertice Pharma Co-Promotion Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cipla License and Distribution Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Receptor CLA</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">245</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT Research Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,820</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Next-Gen R&amp;D Services and R&amp;D Services and License for the periods presented.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The activity related to deferred revenue and the related revenue recognized for collaborations and services is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,370</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,937</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,971</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,707</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue &#8212; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,417</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,370</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">United Therapeutics License Agreement<span style="font-style:normal;"> &#8212; In September 2018, the Company and UT entered into an exclusive global license and collaboration agreement (the &#8220;UT License Agreement&#8221;), pursuant to which UT is responsible for global development, regulatory and commercial activities with respect to Tyvaso DPI. The Company is responsible for manufacturing clinical supplies and commercial supplies of Tyvaso DPI.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from UT for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UT Revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,826</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties &#8212; Collaborations <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from UT</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,851</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of royalties associated with the UT License Agreement. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:3.12%;text-indent:1.13%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The current portion of contract assets related to the royalties is included in prepaid expense and other current assets in the consolidated balance sheets.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the UT License Agreement, the Company received an upfront payment of $45.0 million in October 2018 and four $12.5 million milestone payments between April 2019 and November 2020. The Company will also be entitled to receive low double-digit royalties on net sales of Tyvaso DPI as well as a manufacturing margin on commercial supplies of the product. UT, at its option, may expand the scope of the products covered by the UT License Agreement to include products with certain other active ingredients for the treatment of pulmonary arterial hypertension. Each such optioned product would be subject to UT&#8217;s payment to the Company of up to $40.0 million in additional option exercise and development milestone payments, as well as a low double-digit royalty on net sales of any such product. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the inception of the agreement, the Company identified one distinct, performance obligation. The Company determined that the key deliverables include the license, supply of product to be used in clinical development, and certain research services upon achievement of specified development targets (&#8220;R&amp;D Services&#8221;). Due to the specialized and unique nature of these services and their direct relationship with the license, the Company has determined that these deliverables represent one distinct bundle and thus, one performance obligation. The Company also determined that UT&#8217;s option to expand the scope of the products to include products with other active ingredients is not a material right, and thus, not a performance obligation at the onset of the agreement. The consideration for the option will be accounted for upon exercise of the option.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expected to complete the activities specified in the initial development plan and to achieve the milestone events by December 31, 2021 for total consideration of approximately $105.8 million, which included an upfront payment, four milestone payments, various pass-through costs and payments for clinical supplies. Revenue was allocated as follows:&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sep 2018 - Dec 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Recognition period represents the estimated period to satisfy the performance obligation.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, UT and the Company updated the development plan under the UT License Agreement to provide for additional process-development and stability-testing activities as well as the expansion of the Company&#8217;s commercial manufacturing capacity. The activities and deliverables under the current development plan resulted in four distinct performance obligations which include: (1) the continued development and approval process for an NDA (&#8220;R&amp;D Services&#8221;); (2) certain pre-commercial services in preparation for commercial launch of Tyvaso DPI (&#8220;Pre-Commercial Services&#8221;); (3) development activities for the next generation of Tyvaso DPI (&#8220;Next-Gen R&amp;D Services&#8221;); and (4) certain design and construction activities in anticipation of expansion of the Company&#8217;s commercial manufacturing facility (&#8220;Facility Expansion Services&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">T</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he total consideration for the updated development plan of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$50.9</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million was allocated to the four distinct performance obligations based on management&#8217;s assessment of the stand-alone selling price of each performance obligation. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reve</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nue was allocated as follows:</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total transaction price</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-Commercial Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility Expansion Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
<tr>
<td colspan="16" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2021, the Company and UT entered into a commercial supply agreement (as amended, the &#8220;CSA&#8221;), pursuant to which the Company is responsible for manufacturing and supplying to UT, and UT is responsible for purchasing from the Company on a cost-plus basis, Tyvaso DPI and BluHale inhalation profiling devices, as required for commercial distribution and sale by UT. In addition, UT is responsible for supplying treprostinil at its expense in quantities necessary to enable the Company to manufacture Tyvaso DPI as required by the CSA. Also pursuant to the CSA, UT will remit a reimbursement of certain pre-production costs incurred by the Company to support the manufacturing and supply of Tyvaso DPI.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The activities and deliverables under the CSA and the current development plan resulted in three distinct performance obligations which include: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&amp;D Services and License&#8221;); (2) development activities for the next generation of Tyvaso DPI (&#8220;Next-Gen R&amp;D Services&#8221;); and (3) a material right associated with current and future commercial manufacturing and supply of product (&#8220;Manufacturing Services&#8221;). </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total revised anticipated cash flows of $221.5 million from the transaction was allocated to the three distinct performance obligations as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">221.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.</span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As amended , the term of the CSA continues until December 31, 2031 (unless earlier terminated) and is thereafter renewed automatically for additional, successive two-year terms unless (i) United Therapeutics provides notice to the Company at least 24 months in advance of such renewal that United Therapeutics does not wish to renew the CSA or (ii) the Company provides notice to United Therapeutics at least 48 months in advance of such renewal that the Company does not wish to renew the CSA. The Company and United Therapeutics each have normal and customary termination rights, including termination for material breach that is not cured within a specific timeframe or in the event of liquidation, bankruptcy or insolvency of the other party.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounted for the contract modification as if it were part of the existing contract since the amendment modified the scope and price of the CSA by extending the term and increasing the occupancy rate. The effect of the modification on the transaction price and on the measure of progress is recognized as an adjustment to revenue as of the date of the modification. The modification did not result in a change the activities and deliverables under the CSA. The total revised anticipated cash flows of $463.5 million from the transaction was allocated to the three distinct performance obligations as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.96%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">463.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(6)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(7)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">458.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(8)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&amp;D Services performance obligation was recognized.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The standalone selling price (&#8220;SSP&#8221;) for the Next-Gen R&amp;D Services performance obligation was based on industry ratios as well as the Company&#8217;s historical R&amp;D projects. The transaction price for the Next-Gen R&amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#8217;s Manufacturing Services performance obligation, given the nature of the Company&#8217;s contractual responsibilities and ASC 606 requirements.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(8)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received</span>.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2022,&#160;the Company and UT agreed to fund $2.3 million in capital improvements to support commercialization and continuous improvement activities and $0.7 million in the development of alternative manufacturing processes. The Company determined that the capital improvements and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&amp;D Services and as such no additional performance obligations were noted. <span style="color:#000000;">The total revised anticipated cash flows of $483.2 million from the transaction was allocated to the three distinct performance obligations as follows.</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">483.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Product Sales<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">477.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $71.5 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $411.7 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $150.2 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2022,&#160;the Company and UT agreed to fund an additional $39.5 million to support capital and continuous improvement activities and $2.3 million in the development of alternative manufacturing processes. The Company determined that the capital and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&amp;D Services. <span style="color:#000000;">The total revised anticipated cash flows of $722.3 million from the transaction was allocated to the three distinct performance obligations as follows.</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">722.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services and</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; Product Sales<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">712.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $120.0 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $602.3 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $220.8 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, deferred revenue consisted of $37.9 million, of which $1.6 million was classified as current and $36.3 million was classified as long-term on the consolidated balance sheet. As of December 31, 2021, deferred revenue consisted of $18.6 million, of which $0.6 million was classified as current and $18.0 million was classified as long-term on the consolidated balance sheet.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Vertice Pharma Co-Promotion Agreement<span style="font-style:normal;"> &#8212; In December 2020, the Company entered into a co-promotion agreement with Vertice Pharma pursuant to which the Company&#8217;s sales force promoted Thyquidity to healthcare providers who treat hypothyroidism. Vertice Pharma was obligated to pay fixed quarterly payments to the Company, as well as variable consideration based on gross profits resulting from all sales of Thyquidity. Vertice Pharma launched Thyquidity in collaboration with the Company in February 2021.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At inception of the agreement, the Company identified a single performance obligation that the Company will satisfy over time. The Company estimated the total transaction price was approximately $6.3 million, consisting of fixed consideration and the unconstrained amount of estimated variable consideration, which was based on gross profit applied to defined revenue benchmarks. The amount of variable consideration was constrained to the amount for which it was probable that a significant reversal of cumulative revenue recognized will not occur and the payments will be received. At the end of each subsequent reporting period, the Company re-evaluated the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusted its estimate of the overall transaction price. Any such adjustments were recorded on a cumulative catch-up basis in the period of adjustment. The total transaction price was recognized over a <span style="-sec-ix-hidden:F_001143">two-year</span> period during which the Company was required to satisfy its performance obligation, using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponded with, and thereby best depicts, the transfer of control to the customer. In July 2021, the Company and Vertice Pharma entered into an amendment to the Vertice Pharma Co-Promotion Agreement that modified the terms of payment where 50% of the previously fixed consideration was subject to certain promotional conditions, resulting in variable consideration.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2021, the Company and Vertice Pharma mutually agreed that the Company would cease promotional activities under the co-promotion agreement effective September 30, 2021, other than certain transitional activities that continued until October 15, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2021, the Company fully reserved $0.8 million of revenue from the co-promotion of Thyquidity, which was recognized as allowance for credit losses &#8211; collaborations and services, which is included in accounts receivable, net in the consolidated balance sheet. In addition, the Company recognized an impairment on contract assets of $0.1 million related to variable consideration from gross profits which was recognized during the year ended December 31, 2021. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2022, the Company and Vertice Pharma reached a final settlement of all obligations related to the termination of the co-promotion agreement of $0.3 million, which was recognized as revenue from collaboration and services in the Company&#8217;s consolidated statement of operations and the balance was written off against the reserve.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Thirona Collaboration Agreement<span style="font-style:normal;"> &#8212; In June 2021, the Company and Thirona entered into a collaboration agreement to evaluate the therapeutic potential of Thirona&#8217;s compound for the treatment of pulmonary fibrosis. If initial studies are promising, the Company can exercise certain rights to seek a full license to the compound for clinical development and commercialization. The parties will perform their respective obligations and provide reasonable support for research, clinical development and regulatory strategy. The collaboration agreement will be accounted for under ASC 808, Collaborative Agreements; however, no consideration will be exchanged between the parties. The Company will expense the costs incurred as research and development in the consolidated statements of operations. In December 2022, the Company and Thirona extended the collaboration agreement through February 28, 2023.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Biomm Supply and Distribution Agreement<span style="font-style:normal;"> &#8212; In May 2017, the Company and Biomm S.A. (&#8220;Biomm&#8221;) entered into a supply and distribution agreement for the commercialization of Afrezza in Brazil. Under this agreement, Biomm was responsible for pursuing regulatory approvals of Afrezza in Brazil, including from the ANVISA and, with respect to pricing matters, from the Camara de Regula&#231;&#227;o de Mercado de Medicamentos (&#8220;CMED&#8221;), both of which have&#160;&#160;been received. Biomm commenced product sales in January 2020. During the year ended December 31, 2020, the Company sold $0.2 million of product to Biomm. No shipments of product were made to Biomm during the years ended December 31, 2022 and 2021.</span><span style="font-size:12pt;font-style:normal;">&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cipla License and Distribution Agreement <span style="font-style:normal;">&#8212; In May 2018, the Company and Cipla Ltd. (&#8220;Cipla&#8221;) entered into an exclusive agreement for the marketing and distribution of Afrezza in India and the Company received a $2.2</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">million nonrefundable</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">license fee. Under the terms of the agreement, Cipla is responsible for obtaining regulatory approvals to distribute Afrezza in India and for all marketing and sales activities of Afrezza in India. The Company is responsible for supplying Afrezza to Cipla. The Company has the potential to receive an additional regulatory milestone payment,</span><span style="font-size:12pt;font-style:normal;">&#160;</span><span style="font-style:normal;">minimum purchase commitment revenue and royalties on Afrezza sales in India once cumulative gross sales have reached a specified threshold.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The nonrefundable licensing fee was recorded in deferred revenue and is being recognized in net revenue &#8211; collaborations over 15 years, representing the estimated period to satisfy the performance obligation. The additional milestone payments represent variable consideration for which the Company has not recognized any revenue because of the uncertainty of obtaining marketing approval. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, the deferred revenue balance was $1.5 million, of which $0.1 million is classified as current and $1.4 million is classified as long term in the consolidated balance sheets. As of December 31, 2021, the deferred revenue balance was $1.7 million, of which $0.1 million is classified as current and $1.6 million is classified as long term in the consolidated balance sheets.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458006576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12. Fair Value of Financial Instruments </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The availability of observable inputs can vary among the various types of financial assets and liabilities. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level input that is significant to the overall fair value measurement. The Company uses the exit price method for estimating the fair </p>
<p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">value of loans for disclosure purposes.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows:</span></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1 &#8212; Quoted prices for identical instruments in active markets.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 &#8212; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3 &#8212; Significant inputs to the valuation model are unobservable.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying amounts reported in the accompanying consolidated financial statements for cash, accounts receivable, accounts payable, and accrued expenses and other current liabilities (excluding the Milestone Rights liability) approximate their fair value due to their relatively short maturities. The fair value of the cash equivalents, long- and short-term investments, <span style="color:#000000;">MidCap credit facility, </span>Mann Group promissory notes, 2024 convertible notes, Senior convertible notes, <span style="color:#000000;">Milestone Rights liabilities</span> and Financing liability are disclosed below (amounts in millions).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash Equivalents <span style="font-style:normal;">&#8212; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $69.8 million and $124.2 million, respectively, of cash and cash equivalents.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Liabilities<span style="font-style:normal;"> &#8212; The following tables set forth the fair value of the Company&#8217;s financial instruments (Level 3 in the fair value hierarchy) (in millions):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">253.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">253.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone rights<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent milestone liability <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 13%, volatility of 75.8% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $245.0 million and $263.4 million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 12%. A change in yield of + or &#8211; 2% would result in a fair value of $40.0 million and $42.4 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:10pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of $22.1 million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2022 was determined by applying a discounted cash flow analysis with a hypothetical yield of 13% and volatility of 77.8% to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $20.5 million and $21.2 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 12%, volatility of 90% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $226.6 million and $249.4 million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 10%. A change in yield of + or &#8211; 2% would result in a fair value of $39.1 million and $42.7 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="text-decoration:none;Background-color:#auto;font-size:7pt;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of </span><span style="font-size:9pt;color:#000000;">$22.1</span><span style="font-size:9pt;color:#000000;"> million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the </span><span style="font-size:9pt;color:#000000;">$22.1</span><span style="font-size:9pt;color:#000000;"> million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2021 was determined by applying a discounted cash flow analysis with a hypothetical yield of </span><span style="font-size:9pt;color:#000000;">12%</span><span style="font-size:9pt;color:#000000;"> and volatility of </span><span style="font-size:9pt;color:#000000;">85%</span><span style="font-size:9pt;color:#000000;"> to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; </span><span style="font-size:9pt;color:#000000;">2%</span><span style="font-size:9pt;color:#000000;"> would result in a fair value of </span><span style="font-size:9pt;color:#000000;">$36.9</span><span style="font-size:9pt;color:#000000;"> million and </span><span style="font-size:9pt;color:#000000;">$38.8</span><span style="font-size:9pt;color:#000000;"> million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights Liability<span style="font-style:normal;"> &#8212; The fair value measurement of the Milestone Rights liability is sensitive to the discount rate and the timing of achievement of milestones. The Company utilized Monte-Carlo Simulation Method to simulate the Afrezza net sales under a neutral framework to estimate the payment. The Company then discounted the future expected payments at cost of debt with a term equal to the simulated time to payout based on cumulative sales.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingent milestone liability<span style="font-style:normal;"> &#8212; The acquisition of V-Go in May 2022 resulted in a contingent milestone liability which could result in obligations to the seller if certain revenue thresholds are met. The initial fair value of the contingent milestone liability was recorded as an adjustment to the purchase price. Subsequent changes in the fair value are reported in general and administrative expenses.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financing Liability<span style="font-style:normal;"> &#8212; The failed Sale Leaseback Transaction in November 2021 resulted in a financing liability which is included in the Company&#8217;s&#160;&#160;consolidated balance sheets as a current financing liability of $9.6 million and a long-term financing liability of $94.5 million. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">The fair value of $103.2 million was determined using level 3 inputs. As of December 31, 2022, the fair value was determined using a discounted cash flow analysis with a hypothetical yield of 10%. As December 31, 2021, the Company evaluated the fair value of its financing liability and determined that the fair value approximates the carrying value.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818628487680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common and Preferred Stock</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. Common and Preferred Stock </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is authorized to issue 400,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of undesignated preferred stock, par value $0.01 per share, issuable in one or more series as designated by the Company&#8217;s board of directors. No other class of capital stock is authorized. As of December&#160;31, 2022 and 2021, 263,793,305 and 251,477,562 shares of common stock, respectively, were issued and outstanding and no shares of preferred stock were outstanding. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In <span style="-sec-ix-hidden:F_001235">February 2018</span>, the Company entered into a controlled equity offering sales agreement (the &#8220;CF Sales Agreement&#8221;) with Cantor Fitzgerald &amp; Co. (&#8220;Cantor Fitzgerald&#8221;), as sales agent, pursuant to which the Company may offer and sell, from time to time, through Cantor Fitzgerald, shares of the Company&#8217;s common stock in such amount &#160;as may be permitted by the Sales Agreement. The original amount of common stock authorized for sale under the CF Sales Agreement was $50.0 million. Under the Sales Agreement, Cantor Fitzgerald may sell shares by any method deemed to be an <span style="color:#000000;">&#8220;</span>at-the-market offering<span style="color:#000000;">&#8221;</span> as defined in Rule 415 under the Securities Act of 1933, as amended. In February 2022, the Company filed a sales agreement prospectus under a registration statement on Form S-3 (File No. 333-262981) covering the sale of up to $50.0 million of common stock through Cantor Fitzgerald under the CF Sales Agreement. For the year ended December 31, 2022, the Company sold 5,059,856 shares of common stock at a weighted average purchase price of $3.91 per share for gross proceeds of approximately $19.8 million pursuant to the CF Sales Agreement. For the year ended December 31, 2021, the Company sold an aggregate of 578,063 shares of the Company&#8217;s common stock at a weighted average purchase price of $3.26 per share for aggregate gross proceeds of approximately $1.9 million pursuant to the Sales Agreement. <span style="color:#000000;">For the year ended December 31, 2020, the Company sold an aggregate of 11,851,566 shares of the Company&#8217;s common stock at a weighted average purchase price of $1.99 per share for&#160;&#160;aggregate gross proceeds of approximately $23.5 million pursuant to the CF Sales Agreement.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, the Company prepaid the June 2020 note with the issuance of&#160;1,235,094&#160;shares of the Company&#8217;s common stock, in accordance with the terms of the June 2020 note. In October 2020, the Company prepaid the December 2020 note with the issuance of&#160;1,377,356&#160;shares of the Company&#8217;s common stock, in accordance with the terms of the December 2020 note. The number of shares issued for the prepayments in June and October 2020 were determined based on the Company&#8217;s closing stock price on the day preceding the settlement date. See Note 10 &#8211;&#160;<span style="font-style:italic;">Borrowings</span>.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, 7,250,000 warrants were exercised at a price of $1.60 per share. The warrants were issued pursuant to an underwriting agreement with Leerink Partners LLC for a public offering of 26,666,667 shares of the Company&#8217;s common stock and warrants to purchase up to an aggregate of 26,666,667 shares of the Company&#8217;s common stock. There are no remaining warrants outstanding under this agreement.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the fourth quarter of 2020, the Mann Group converted $3.0 million of accrued interest and $7.0 million of principal under the Mann Group convertible note into 1.2 million shares and 2.8 million shares, respectively, of the Company&#8217;s common stock, in accordance with the terms of the convertible note. &#160;&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company issued 111,853 warrants to purchase shares of the Company&#8217;s common stock in connection with the third amendment to the Midcap Credit Facility. &#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company issued 3,067,179 shares of the Company&#8217;s common stock as consideration for the acquisition of QrumPharma. See Note 3 &#8211; <span style="font-style:italic;">Acquisitions</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">converted $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.0</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">principal amount of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024 convertible note</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> into </span>1,666,667<span style="color:#000000;"> shares of</span><span style="color:#000000;"> </span><span style="color:#000000;">the Company&#8217;s </span><span style="color:#000000;">common stock</span><span style="color:#000000;">. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2021, MidCap exercised 1,171,614 and 111,853 warrants issued in association with Tranches 1 and 2, respectively, under the MidCap credit facility, as amended, to purchase an aggregate of 1,283,467 shares of the Company&#8217;s common stock through a cashless exercise that resulted in the net issuance of 964,113 shares. See Note 10 &#8211; <span style="font-style:italic;">Borrowings</span>. </p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 31, 2021, the Mann Group converted $0.4 million of interest and $9.6 million of principal into 4.0 million shares of common stock.<span style="color:#000000;"> </span>See Note 10 &#8211;&#160;<span style="font-style:italic;">Borrowings</span>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2021, the Company received $0.1 million from the market price stock purchase plan (&#8220;MPSPP&#8221;) for 25,000 shares and a <span style="font-style:italic;">de minimis</span> amount during the year ended December 31, 2020.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2022, pursuant to the terms of the Mann Group convertible note, Mann Group converted $10.0 million of principal and capitalized interest into 4,000,000 shares of common stock. In addition, the Company paid quarterly interest payments on the Mann Group convertible note on April 1, 2022, July 1, 2022 and October 1, 2022 by issuing Mann Group an aggregate of 75,487 shares of common stock. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2022, the Company received&#160;$0.7 million from the market price stock purchase plan (&#8220;MPSPP&#8221;) for 252,176 shares.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818543630544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share ("EPS")<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Common Share ("EPS")</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14. Earnings per Common Share (&#8220;EPS&#8221;)</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic EPS excludes dilution for potentially dilutive securities and is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted EPS as they would be antidilutive.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EPS &#8212; basic and diluted:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss (numerator)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares (denominator)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">257,092</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">249,244</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,585</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.26</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common shares issuable represents incremental shares of common stock which consist of stock options, restricted stock units, warrants, and shares that could be issued upon conversion of the Senior convertible notes and the Mann Group convertible notes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potentially dilutive securities outstanding that are considered antidilutive are summarized as follows (in shares):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,120,463</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,120,463</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options and PNQs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,655,146</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,264,616</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,370,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,370,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,200,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants associated with MidCap credit facility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,283,467</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024 convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,666,667</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and Market RSUs<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,886,710</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,609,025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,037,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243,375</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">292,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,451,760</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,998,009</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,745,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.39%;"/>
<td style="width:95.61%;"/>
</tr>
<tr>
<td style="white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Market RSUs are included at the maximum share delivery percentage.</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818543368416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Award Plans</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15. Stock Award Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2018, the Company adopted the 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) as the successor to and continuation of the 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;). The 2018 Plan initially consisted of 12,000,000 new shares plus the number of unallocated shares remaining available for grant for new awards under the 2013 Plan. In May 2020, the 2018 Plan was amended to increase the number of shares of common stock that may be issued under the 2018 Plan by 12,500,000 shares. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective upon the approval of the 2018 Plan by the Company&#8217;s stockholders in May 2018, no additional awards have been or may be granted under the 2013 Plan. Any Prior Plans&#8217; (as defined below) returning shares will increase the number of shares issuable under the 2018 Plan. The Prior Plans&#8217; returning shares are shares subject to outstanding stock awards granted under the 2013 Plan or the 2004 Equity Incentive Plan (collectively, &#8220;Prior Plans&#8221;) that, from and after the effective date of the 2018 Plan, (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii) other than with respect to outstanding stock options and stock appreciation rights granted under the Prior Plans with an exercise or strike price of at least 100% of the fair market value of the underlying common stock on the date of grant, are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a stock award.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan provides for the granting of stock awards including stock options and restricted stock units to employees, directors and consultants. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s board of directors or its compensation committee determines eligibility, vesting schedules and criteria, and exercise prices for stock awards granted under the 2018 Plan. Options and restricted stock unit awards under the 2018 Plan, or the Prior Plans expire not more than ten years from the date of the grant and are exercisable upon vesting. Stock options that vest over time generally vest over four years. Current time-based vesting stock option grants vest and become exercisable at the rate of 25% after one year and ratably on a monthly basis over a period of 36 months thereafter. The Company also issues PNQ awards with performance conditions. For PNQs, the Company evaluates the probability that the performance conditions will be met and estimates the service period for recognition of the associated expense. RSUs with time-based vesting generally vest at a rate of 25%&#160;per year over four years with consideration satisfied by service to the Company. Certain RSUs issued to nonemployee directors vest immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service such as resignation, retirement or death. The Company also issued Market RSUs. The grant date fair value and the effect of the market conditions was estimated using a Monte Carlo valuation. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Market RSUs issued during the year ended December 31, 2022 had a grant date fair value of $6.10 per share and will vest on May 10, 2025 provided that the closing price of the Company&#8217;s common stock on such vesting date is not less than the closing price on May 10, 2022. The fair value of the Market RSUs was determined using a share price of $2.95, risk-free interest rate of 2.81%, volatility of 75%, and a dividend yield of 0%. The number of shares delivered on the vesting date is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025&#160;&#160;relative to the TSR of the Russell 3000 Pharmaceutical &amp; Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. The resulting stock-based compensation expense will be recognized over the service period regardless of whether the market conditions are achieved, as long as the service condition is satisfied.<span style="font-size:12pt;">&#160;</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about the Company&#8217;s stock-based award plans as of December&#160;31, 2022:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares&#160;Available</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Future</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2004 Equity Incentive Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,320</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2013 Equity Incentive Plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,240,690</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 Equity Incentive Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,832,577</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,802,796</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,802,796</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Share-based payment transactions are recognized as compensation cost based on the fair value of the instrument on the date of grant. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee stock options. The expected term of an option granted is based on combining historical exercise data with expected weighted time outstanding. Expected weighted time outstanding is calculated by assuming the settlement of outstanding awards is at the midpoint between the remaining weighted average vesting date and the expiration date. The Company recognizes forfeitures as they occur. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recorded RSU and option-based stock compensation expense of $12.8 million, $11.5 million and $6.2 million, respectively and employee stock purchase plan compensation of $0.6 million, $0.7 million and $0.3 million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense recognized in the accompanying consolidated statements of operations is included in the following categories (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">407</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">446</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue &#8212; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,425</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,708</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">626</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,044</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,194</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,578</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,158</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,455</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,893</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,943</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,447</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,511</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected volatility assumption used in the Company&#8217;s Black-Sholes option valuation model is based on an assessment of the historical volatility derived from an analysis of historical trade activity. The Company has selected risk-free interest rates based on U.S. Treasury securities with an equivalent expected term in effect on the date the options were granted. Additionally, the Company uses historical data and management judgment to estimate stock option exercise behavior and employee turnover rates to estimate the number of stock option awards that will eventually vest. There were no options issued in the years ended December 31, 2022 and 2021. The Company calculated the fair value of employee stock options granted during the year ended December&#160;31, 2020 using the following assumptions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001364">0.39% &#8212; 1.52%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected lives</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001366">5.67 &#8212; 7.0 years</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001368">93.83% &#8212; 94.25%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividends</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to stock options:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value ($000)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,732,513</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.01</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001382">5.49</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,543</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,196,391</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116,767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.82</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(344,768</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.31</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001383">5.10</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,512</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,776,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001384">5.15</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,315</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no options granted in the years ended December 31, 2022 and 2021. The weighted average grant date fair value of the stock options granted during the year ended December&#160;31, 2020 was $0.97. Total fair value of stock options vested during the years ended December 31, 2022, 2021 and 2020 was 3.2 million, $2.3 million and $4.5 million, respectively. The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $2.4 million, $1.7 million and $0.5 million, respectively. Intrinsic value is measured using the fair market value at the date of exercise for options exercised or at December&#160;31 for outstanding options, less the applicable exercise price. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash received from the exercise of options during the years ended December&#160;31, 2022, 2021 and 2020 was approximately $3.0 million, $1.0&#160;million and $0.6 million, respectively. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, 2021 and 2020, the Company recognized $0.1 million, $0.1 million and $0.2 million, respectively, of compensation costs related to the performance-based stock options. As of December 31, 2022 and 2021, there were $0.2 million and $0.3 million, respectively of unrecognized compensation costs related to performance-based stock options subject to performance conditions.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to restricted stock units: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,538,032</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.40</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,120,682</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.95</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,551,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,269,297</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.97</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.65</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total fair value of restricted stock units vested during the years ended December 31, 2022, 2021 and 2020 was $4.4 million $6.7 million and $2.5 million, respectively. Intrinsic value of restricted stock units vested is measured using the closing share price on the day prior to the vest date. The total grant date fair value of restricted stock units outstanding as of December 31, 2022, 2021 and 2020 was $43.2 million, $19.3 million and $13.3 million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, there was $0.6 million of unrecognized compensation expense related to options and PNQs and $25.0 million of unrecognized compensation expense related to restricted stock units and market based stock units, which are expected to be recognized over the weighted average period of <span style="-sec-ix-hidden:F_001423">2.08 to 2.22 years</span>. The Company evaluates stock awards with performance conditions as to the probability that </p>
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the performance conditions will be met and uses that information to estimate the date at which those performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.99%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#65279;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides all employees, including executive officers, the ability to purchase its common stock at a discount under the Company&#8217;s<span style="color:#000000;"> 2004 employee stock purchase plan (the &#8220;ESPP&#8221;). The ESPP is designed to comply with Section 423 of the Internal Revenue Code (&#8220;IRC&#8221;) and provides all employees with the opportunity to purchase up to $25,000 worth of common stock (based on the undiscounted fair market value at the commencement of the offering period) each year at a purchase price that is the lower of 85% of the fair market value of the common stock on either the date of purchase or the commencement of the offering period. An employee may not purchase more than 5,000 shares of common stock on any purchase date. The executives&#8217; rights under the ESPP are identical to those of all other employees.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#160;issued 0.7 million,&#160;0.5 million and 0.6 million shares&#160;of common stock pursuant to the ESPP for the years ended&#160;December 31, 2022, 2021 and 2020, respectively. There&#160;were&#160;approximately 0.4 million&#160;shares of common stock available for issuance under the&#160;ESPP as of December 31, 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461522320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16. Commitments and Contingencies</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Guarantees and Indemnifications <span style="font-style:normal;">&#8212; In the ordinary course of its business, the Company makes certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. The Company, as permitted under Delaware law and in accordance with its Bylaws, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The term of the indemnification period is for the officer&#8217;s or director&#8217;s lifetime. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company believes the fair value of these indemnification agreements is minimal. The Company has not recorded any liability for these indemnities in the accompanying consolidated balance sheets. However, the Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount can be reasonably estimated. No such losses have been recorded to date. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Litigation <span style="font-style:normal;">&#8212; The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. As of December 31, 2022, the Company believes that the final disposition of such matters will not have a material adverse effect on the financial position, results of operations or cash flows of the Company and no accrual has been recorded. The Company maintains liability insurance coverage to protect the Company&#8217;s assets from losses arising out of or involving activities associated with ongoing and normal business operations. The Company records a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company&#8217;s policy is to accrue for legal expenses in connection with legal proceedings and claims as they are incurred. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingencies <span style="font-style:normal;">&#8212; In July&#160;2013, the Company entered into the Milestone Rights Agreement with the Original Milestone Purchasers, pursuant to which the Company granted the Milestone Rights to receive payments up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable to the Original Purchasers upon achievement of such milestones (see Note 10 &#8212; </span>Borrowings<span style="font-style:normal;">). As of December 31, 2022, the initial fair value of the Milestone Rights is recorded in the consolidated balance sheet, including $0.9 million in</span><span style="font-size:12pt;font-style:normal;"> </span><span style="font-style:normal;">accrued expenses and other current liabilities and $3.9 million in milestone rights liability. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Sale-Leaseback Transaction <span style="font-style:normal;">&#8212; In November 2021, the Company sold the Property to the Purchaser for a sales price of $102.3 million, subject to terms and the conditions contained in a purchase and sale agreement. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser entered into a lease agreement (the &#8220;Lease&#8221;), pursuant to which the Company leased the Property from the Purchaser for an initial term of 20 years, with four renewal options of five years each. The total annual rent under the Lease starts at approximately $9.5 million per year, subject to a 50% rent abatement during the first year of the Lease, and will increase annually by (i) 2.5% in the second through fifth year of the Lease and (ii) 3% in the sixth and each subsequent year of the Lease, including any renewal term. The Company is responsible for payment of operating expenses, property taxes and insurance for the Property. The Purchaser will hold a security deposit of $2.0 million during the Lease term. Pursuant to the terms of the Lease, the Company has four options to repurchase the Property, in 2026, 2031, 2036 and 2041, for the greater of (i) $102.3 million and (ii) the fair market value of the Property.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser also entered into a right of first refusal agreement (the &#8220;ROFR&#8221;), pursuant to which the Company has a right to re-purchase the Property from the Purchaser in accordance with terms and conditions set forth in the ROFR. Specifically, if the Purchaser receives, and is willing to accept, a bona fide purchase offer for the Property from a third-party purchaser, the Company has certain rights of first refusal to purchase the Property on the same material terms as proposed in such bona fide purchase offer.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022, the related financing liability was $104.1 million, which was recognized in the Company&#8217;s  consolidated balance sheet as $94.5 million of financing liability &#8212; long-term and $9.6 million of financing liability &#8212; short-term. As of December 31, </p>
<p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021, the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.5</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which was recognized in our consolidated balance sheet as $</span>93.5<span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8212; long-term and $</span>7.0<span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financing liability</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8212; short-term. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability information is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001452">18.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001453">19.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,758</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,373</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability payments as of December 31, 2022 was as follows (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,774</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,269</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,533</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,849</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188,453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,896</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest payments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(132,936</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,883</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financing liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,077</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Commitments <span style="font-style:normal;">&#8212; In July&#160;2014, the Company entered into the Insulin Supply Agreement with Amphastar pursuant to which Amphastar manufactures for and supplies to the Company certain quantities of recombinant human insulin for use in Afrezza. Under the terms of the Insulin Supply Agreement, Amphastar is responsible for manufacturing the insulin in accordance with the Company&#8217;s specifications and agreed-upon quality standards.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( &#8364; in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the amendment, the term of the Insulin Supply Agreement expires on December&#160;31, 2027, unless terminated earlier, and can be renewed for additional, successive two-year terms upon 12 months&#8217; written notice given prior to the end of the initial term or any additional <span style="-sec-ix-hidden:F_001475">two-year</span> term. The Company and Amphastar each have normal and customary termination rights, including termination for a material breach that is not cured within a specific time frame or in the event of liquidation, bankruptcy or insolvency of the other party. In addition, the Company may terminate the Insulin Supply Agreement upon two years&#8217; prior written notice to Amphastar without cause or upon 30 days&#8217; prior written notice to Amphastar if a controlling regulatory authority withdraws approval for Afrezza, provided, however, in the event of a termination pursuant to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require the Company to pay the full amount of all unpaid purchase commitments due over the initial term within 60 calendar days of the effective date of such termination. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Vehicle Leases &#8211; <span style="font-style:normal;">During the second quarter of 2018, the Company entered into a lease agreement with Enterprise Fleet Management Inc. During 2021, 85 vehicles were retired and all of those vehicles were replaced, resulting in a fleet size of 89 vehicles. The Company received proceeds for the gain on the retired vehicles residual value in the amount of $0.5 million, which is included as a reduction to the Company&#8217;s lease expense. The revised monthly payment inclusive of maintenance fees, insurance and taxes is approximately $0.1 million. The lease expense is included in selling expenses in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Office Leases<span style="font-style:normal;"> &#8212; In May&#160;2017, the Company executed an office lease with Russell Ranch Road II LLC for offices in Westlake Village, California. The office lease commenced in August&#160;2017. The Company agreed to pay initial monthly lease payments of $40,951, subject to 3% annual increases, plus the estimated cost of maintaining the property and common areas by the landlord, with a five-month concession from </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">October 2017 through February 2018. </span><span style="font-style:normal;">The lease also provides for allowances for tenant alterations and maintenanc</span><span style="font-style:normal;">e.</span><span style="font-style:normal;"> The lease expense is included in general and administrative expenses in </span><span style="color:#000000;font-style:normal;">the accompanying consolidated statement of operations</span><span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2017, the Company executed an office lease with Russell Ranch Road II LLC to expand the office space for the Company&#8217;s corporate offices in Westlake Village, California which was renewed in April 2022. Pursuant to the renewal, the Company will pay initial monthly lease payments of $79,543, beginning in February 2023, subject to a 3% annual increase, plus the estimated operating cost of maintaining the property by the landlord. The Company will receive a six-month concession at the start of the lease extension period on July 31, 2023. The Company has no further right to extend the lease term beyond the extension period.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company assumed certain leased real property (the &#8220;Marlborough Lease&#8221;) pursuant to the APA entered into in May 2022. The Marlborough Lease pertains to certain premises in a building located in Marlborough, Massachusetts. The Company has paid initial monthly payments of $28,895, beginning in June 2022, subject to approximately 3% annual increases through February 28, 2026.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also acquired rights to a manufacturing service agreement where V-Go is manufactured using Company-owned equipment located at the manufacturing facility. The Company determined that this arrangement results in an embedded lease which grants the Company exclusive use of space within the manufacturing facility. The Company assessed the embedded lease cost to be $14,370 per month through February 28, 2026.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Lease information is as follows (in thousands):</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,714</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,284</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-current <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,380</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-long-term</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,040</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001504">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001505">2.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the consolidated balance sheets.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Operating lease liability &#8211; current are included in accrued expenses and other current liabilities in the consolidated balance sheets.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.12%;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,525</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">863</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,403</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">515</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">394</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,823</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,867</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,797</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.86%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,368</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,892</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,861</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,140</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,072</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">643</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,329</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464083056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Compensation And Retirement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17. Employee Benefit Plans</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company administers a defined contribution 401(k) savings retirement plan for its employees. The Company may make discretionary matching contributions. For the years ended December 31, 2022 and 2021, the Company matched each participant&#8217;s deferral at the rate of 50% of each participant&#8217;s deferral up to the first 10% of compensation. Participants hired after March 31, 2021 became vested in Company contributions at 100% after two years of service. For the year ended December 31, 2020, the Company matched each participant&#8217;s deferral at the rate of 50% of each participant&#8217;s deferral up to the first 6% of compensation. Participants are vested in Company contributions at 50% after one year of service and are 100% vested after two years of service. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s total discretionary matching contributions were $1.8 million, $1.5 million and $0.9 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464363136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">18. Income Taxes </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from continuing operations before provision for income taxes for the Company&#8217;s domestic and international operations was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,458</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before provision for income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,458</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2022, the Company has concluded that it is more likely than not that the Company may not realize the benefit of its deferred tax assets due to its history of losses. The Company has incurred operating losses since inception. Accordingly, the net deferred tax assets have been fully reserved. The provision for income taxes consists of the following (in thousands):&#160;  &#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,170</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,377</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,334</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,461</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(469</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,940</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,631</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,846</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,940</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,631</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,846</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes. A valuation allowance is established when uncertainty exists as to whether all or a portion of the net deferred tax assets will be realized. Components of the net deferred tax assets as of December&#160;31, 2022 and 2021, are approximately as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,537</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,800</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,804</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,804</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,369</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,440</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,675</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,591</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on purchase commitment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,117</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,845</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-qualified stock option expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,686</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,684</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized patent costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,204</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,568</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,624</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">588</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense limitation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,157</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,983</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred Product Revenue &amp; Costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">370</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">706,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">695,921</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(705,034</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(695,094</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,889</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">827</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,640</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(555</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other prepaids</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(249</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(272</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,889</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(827</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s effective tax rate differs from the statutory federal income tax rate as follows for the years ended December&#160;31, 2022, 2021 and 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal tax benefit rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-0.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax attribute expirations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign withholding tax</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2022 and 2021, management assessed the realizability of deferred tax assets. Management evaluated the need for an amount of any valuation allowance for deferred tax assets on a jurisdictional basis. This evaluation utilizes the framework contained in ASC 740, Income Taxes, wherein management analyzes all positive and negative evidence available at the balance sheet date to determine whether all or some portion of our deferred tax assets will not be realized. Under this guidance, a valuation allowance must be established for deferred tax assets when it is more likely than not (a probability level of more than 50 percent) that they will not be realized. In assessing the realization of the Company's deferred tax assets, the Company considers all available evidence, both positive and negative.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In concluding on the evaluation, management placed significant emphasis on guidance in ASC 740, which states that &#8220;a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome.&#8221; Based upon available evidence as of December 31, 2022, it was concluded on a more-likely-than-not basis that all deferred tax assets were not realizable. Accordingly, a valuation allowance of $705.0 million has been recorded to offset this deferred tax asset. During the years ended December&#160;31, 2022 and 2021, the change in valuation allowance was $9.9&#160;million and $19.6&#160;million, respectively.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December&#160;31, 2022, the Company had federal and state net operating loss carryforwards of approximately $2.2&#160;billion and $1.7&#160;billion available, respectively, to reduce future taxable income. $499.6 million of the federal losses do not expire and the remaining federal losses have started expiring, beginning in the current year through various future dates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to IRC Sections 382 and 383, annual use of the Company&#8217;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. As a result of the Company's initial public offering, an ownership change within the meaning of IRC Section 382 occurred in August 2004. As a result, federal net operating loss and credit carryforwards of approximately $105.8 million are subject to an annual use limitation of approximately $13.0 million. The annual limitation is cumulative and therefore, if not fully utilized in a year can be utilized in future years in addition to the Section 382 limitation for those years. We have completed a Section 382 analysis beginning from the date of our initial public offering through December 31, 2022, to determine whether additional limitations may be placed on the net operating loss carryforwards and other tax attributes, and no additional changes in ownership that met Section 382 study ownership change threshold has been identified through December 31, 2022. There is a risk that changes in ownership may occur in tax years after December 31, 2022. If a change in ownership were to occur, our net operating loss carryforwards and other tax attributes could be further limited or restricted. If limited, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, related to the Company&#8217;s operations in the U.S. will not impact the Company&#8217;s effective tax rate.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2022, the Company had $54.2 million of U.S. federal research and development credits which expire beginning in 2024, and $24.6&#160;million of state research and development credits. The California credits are indefinite and do not expire and $0.2 million of the available New Jersey credits expire at the end of 2023. The Company also had two types of credits in Connecticut of which $19.8 million do not expire and the $1.1 million of the R&amp;D credit expire at the end of 2023. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files U.S. federal and state income tax returns in jurisdictions with varying statutes of limitations. In the normal course of business the Company is subject to examination by taxing authorities throughout the country. These audits could include examining the timing and amount of deductions, the allocation of income among various tax jurisdictions and compliance with federal, state, and local tax laws. The Company's tax years since 2018 remain subject to examination by federal, state and foreign tax authorities.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of beginning and ending amounts of unrecognized tax benefits in 2022, 2021 and 2020, respectively, was as follows (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.86%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized Tax Benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning of Year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross increases for tax positions of prior years</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross decreases for tax positions of current year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute of limitations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">End of Year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December&#160;31, 2022, 2021 and 2020, the Company has not recognized a liability for unrecognized tax benefits. If any were recognized, it would affect the Company&#8217;s effective tax rate. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense. During the years ended December 31, 2022, 2021 and 2020, the Company did not recognize any interest and/or penalties.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461076288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessPolicyTextBlock', window );">Business</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Business <span style="font-style:normal;">&#8212; MannKind Corporation and its subsidiaries (the &#8220;Company&#8221;) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company is currently commercializing Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The Company also collaborates with third parties to formulate their drugs on the Company&#8217;s Technosphere drug delivery platform. Tyvaso DPI (treprostinil) inhalation powder received FDA approval in May 2022, for the treatment of pulmonary arterial hypertension and for the treatment of pulmonary hypertension associated with interstitial lung disease. UT began commercializing Tyvaso DPI in June 2022 and is obligated to pay the Company a royalty on net sales of the product. The Company also receives a margin on supplies of Tyvaso DPI that it manufactures for UT.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BasisOfPresentationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation<span style="font-style:normal;"> &#8212; The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Principles of Consolidation<span style="font-style:normal;"> &#8212; The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications<span style="font-style:normal;"> &#8212; Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Segment Information<span style="font-style:normal;"> &#8212; Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. To date, the Company has viewed its operations and manages its business as one segment operating in the United States of America.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Financial Statement Estimates</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> &#8212; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> The Company recognizes revenue when its customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to be entitled in exchange for those goods or services.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To determine revenue recognition for arrangements that are within the scope of Accounting Standards Codification (&#8220;<span style="color:#000000;">ASC&#8221;) </span>Topic 606, <span style="font-style:italic;font-family:Calibri;color:#000000;">Revenue from Contracts with Customers </span><span style="font-family:Calibri;color:#000000;">(&#8220;ASC 606&#8221;),</span> the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under ASC 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company has two types of contracts with customers: (i) contracts for commercial product sales with wholesale distributors, specialty and retail pharmacies and (ii) collaboration arrangements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock', window );">Revenue Recognition - Net Revenue - Commercial Product Sales</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8211; Net Revenue &#8211; Commercial Product Sales &#8211;<span style="font-style:normal;"> The Company sells its products to a limited number of wholesale distributors, specialty and retail pharmacies, and durable medical equipment suppliers (&#8220;DME&#8221;) in the U.S. (collectively, its &#8220;Customers&#8221;). Wholesale distributors</span><span style="color:#000000;font-style:normal;"> subsequently resell the Company&#8217;s products to retail pharmacies and certain medical centers or hospitals. Specialty and retail pharmacies sell directly to patients. In addition to distribution agreements with Customers, the Company enters into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of the Company&#8217;s products.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue on product sales when the Customer obtains control of the Company's product, which occurs at delivery for wholesale distributors and </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">generally </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delivery </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for specialty pharmacies. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> revenue on product sales to</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> retail pharmac</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as the product is dispensed to patients. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenues are recorded net of applicable reserves</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including discounts, allowances, rebates, returns and other incentives</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. See </span><span style="font-style:italic;">Reserves for Variable Consideration</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> below.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Free Goods Program &#8211; <span style="font-style:normal;">From time to time, the Company offers programs to potential new patients that allow them to obtain free goods (prescription fills) from a pharmacy. The Company excludes such amounts related to these programs from both gross and net revenue.&#160;The cost of product associated with the free goods program is recognized as cost of goods sold in the consolidated statements of operations.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reserves for Variable Consideration <span style="font-style:normal;">&#8212; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#8217;s sale of its products. These reserves, as further detailed below, are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to the Company&#8217;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. The Company&#8217;s analysis also contemplates application of the constraint in accordance with the guidance, under which it determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#8217;s estimates. If actual results in the future vary from the Company&#8217;s estimates, the Company will adjust these estimates, which would affect net revenue <span style="font-family:Calibri;">&#8212;</span> commercial product sales and earnings in the period such variances become known.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix, unbilled claims, claim submission time lags and inventory levels in the distribution channel.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances <span style="font-style:normal;">&#8212; The Company generally provides Customers with discounts which include incentives, such as prompt pay discounts, that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company compensates (through trade discounts and allowances) its Customers for sales order management, data, and distribution services. However, the Company has determined such services received to date are not distinct from the Company&#8217;s sale of products to the Customer and, therefore, these payments have been recorded as a reduction of revenue and as a reduction to accounts receivable, net. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Returns <span style="font-style:normal;">&#8212; Consistent with industry practice, the Company generally offers Customers a right of return for unopened product that has been purchased from the Company for a period beginning six months prior to and ending 12 months after its expiration date, which lapses upon shipment to a patient. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net. The Company currently estimates product returns using available industry data and its own sales information, including its visibility into the inventory remaining in the distribution channel. The Company&#8217;s current return reserve percentage is estimated to be in the single-</span><span style="font-family:Calibri;font-style:normal;">digits. </span><span style="font-family:Calibri;font-style:normal;color:#000000;">Adjustments to the returns reserve have been made in the past and may be necessary in the future based on revised estimates to the Company&#8217;s assumptions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Provider Chargebacks and Discounts <span style="font-style:normal;">&#8212; Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase products from the Company. Customers charge the Company for the difference between what they pay for products and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is recorded in accrued expenses and other current liabilities. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers, and the Company generally issues credits for such amounts within a few weeks of the Customer&#8217;s notification to the Company of the resale. Reserves for chargebacks consist of credits that the Company expects to issue for units that remain in the distribution channel inventories at each reporting period-end that the Company expects will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which the Company has not yet issued a credit.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Government Rebates <span style="font-style:normal;">&#8212; The Company is subject to discount obligations under Medicare and state Medicaid programs. These reserves are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities. Estimates around Medicaid have historically required significant </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">judg</span><span style="font-style:normal;">ment due to timing lags in receiving invoices for claims from states.</span><span style="font-style:normal;color:#000000;"> </span><span style="font-style:normal;">For </span><span style="font-style:normal;">Afrezza</span><span style="font-style:normal;">, the Company also estimates the number of patients in the prescription drug coverage gap for whom the Company will owe an additional liability under the Medicare Part D program. The Company&#8217;s liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product</span><span style="font-style:normal;">s</span><span style="font-style:normal;"> that ha</span><span style="font-style:normal;">ve</span><span style="font-style:normal;"> been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.</span><span style="font-style:normal;"> The Company&#8217;s estimates include consideration of historical claims expe</span><span style="font-style:normal;">rience, paye</span><span style="font-style:normal;">r channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Payer Rebates <span style="font-style:normal;">&#8212; The Company contracts with certain private payer organizations, primarily insurance companies and pharmacy benefit managers, for the payment of rebates with respect to utilization of its products. The Company estimates these rebates, including estimates for product that has been recognized as revenue, but which remains in the distribution channel, and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities. The Company&#8217;s estimates include consideration of historical claims experience, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Incentives <span style="font-style:normal;">&#8212; Other incentives which the Company offers include voluntary patient support programs, such as the Company's co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with co-payments required by payers. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with the products that have been recognized as revenue, but remains in the distribution channel inventories at the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock', window );">Revenue Recognition- Net Revenue - Collaborations and Services</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Revenue &#8212; Collaborations and Services &#8212;<span style="font-style:normal;"> The Company enters into licensing, research or other agreements under which the Company licenses certain rights to its product candidates to third parties, conducts research or provides other services to third parties. The terms of these arrangements may include, but are not limited to payment to the Company of one or more of the following: up-front license fees; development, regulatory, and commercial milestone payments; payments for commercial manufacturing and clinical supply services the Company provides; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. </span><span style="color:#000000;font-style:normal;">With respect to our </span><span style="font-style:normal;">significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (&#8220;as amended, the CSA&#8221;), we have identified three distinct performance obligations: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#8220;R&amp;D Services and License&#8217;), (2) development activities for the next generation of the product (&#8220;Next-Gen R&amp;D Services&#8221;), and (3) a material right associated with current and future manufacturing and supply of product (&#8220;Manufacturing Services&#8221;). Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#8217;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represents distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and the Company uses key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12 months. Amounts that the Company expects will not be recognized within the next 12 months are classified as long-term deferred revenue. For further information, see Note 11<span style="font-style:italic;"> &#8211; Collaboration, Licensing and Other Arrangements.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes upfront license payments as revenue upon delivery of the license only if the license is determined to be a separate unit of accounting from the other undelivered performance obligations.&#160;The undelivered performance obligations typically include manufacturing or development services or research and/or steering committee services. If the license is not considered as a distinct performance obligation, then the license and other undelivered performance obligations would be evaluated to determine if such should be accounted for as a single unit of accounting.&#160;If concluded to be a single performance obligation, the transaction price for the single performance obligation is recognized as revenue over the estimated period of when the performance obligation is satisfied. If the license is considered to be a distinct performance obligation, then the estimated revenue is included in the transaction price for the contract, which is then allocated to each performance obligation based on the respective standalone selling prices.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whenever the Company determines that an arrangement should be accounted for over time, the Company determines the period over which the performance obligations will be performed, and revenue will be recognized over the period the Company is expected to complete its performance obligations. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete its performance obligations under an arrangement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaboration agreements typically entitle the Company to additional payments upon the achievement of development, regulatory and sales milestones. If the achievement of a milestone is considered probable at the inception of the collaboration, the related milestone payment is included with other collaboration consideration, such as upfront fees and research funding, in the Company&#8217;s revenue </p>
<p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">calculation. If these milestones are not considered probable at the inception of the collaboration, the milestones will typically be recognized in one of two ways depending on the timing of when the milestone is achieved.&#160;If the milestone is improbable at inception and subsequently deemed probable of achievement, such will be added to the transaction price, resulting in a cumulative adjustment to revenue.&#160;If the milestone is achieved after the performance period has</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> been</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> completed and all performance obligations have been delivered, the Company will recognize the milestone payment as revenue in its entirety in the period the milestone was achieved. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s collaborative agreements, for accounting purposes, represent contracts with customers and therefore are not subject to accounting literature on collaborative agreements. The Company grants licenses to its intellectual property, supplies raw materials, semi-finished goods or finished goods, provides research and development services and offers sales support for the co-promotion of products, all of which are outputs of the Company&#8217;s ongoing activities, in exchange for consideration. Accordingly, the Company concluded that its collaborative agreements must generally be accounted for pursuant to ASC 606.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For collaboration agreements that allow collaboration partners to select additional optioned products or services, the Company evaluates whether such options contain material rights (i.e., have exercise prices that are discounted compared to what the Company would charge for a similar product or service to a new collaboration partner). The exercise price of these options includes a combination of licensing fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, the Company concludes the option does not contain a material right, and therefore is not included in the transaction price at contract inception. The Company assessed the CSA agreement with UT and determined that a material right existed for the manufacturing services performance obligation. The transaction price is allocated to the material right as well as the remaining performance obligations in accordance with ASC 606. The Company also evaluates grants of additional licensing rights upon option exercises to determine whether such should be accounted for as separate contracts.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition &#8212; Royalties &#8212;<span style="font-style:normal;"> The Company recognizes royalty revenue for a sales-based or usage-based royalty if it is promised in exchange for an intellectual property license. The royalty revenue is recognized as the latter of the subsequent sale of the product occurs or if the performance obligation to which the royalty has been allocated has been satisfied or partially satisfied. The Company&#8217;s collaborative agreement with UT entitles it to receive low double-digit royalties on net sales of Tyvaso DPI for the license of the Company&#8217;s IP that was considered to be interdependent with the development activities that supported the approval of Tyvaso DPI.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,073</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,435</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,324</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,098</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,820</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,770</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,442</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,144</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent revenue generated from the Company&#8217;s collaboration arrangements, including Next-Gen R&amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements</span><span style="font-size:9pt;color:#000000;">. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent royalties on UT&#8217;s net sales of Tyvaso DPI.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold and cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,071</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,084</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,557</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cost of goods sold and cost of revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,857</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows detailed accounting guidance in measuring revenue and certain judgments affect the application of its revenue policy. For example, in connection with its existing collaboration agreements, the Company has recorded on its consolidated balance sheets short-term and long-term deferred revenue based on its best estimate of when such revenue will be recognized. Short-term deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12&#160;months. Amounts that the Company expects will not be recognized within the next 12&#160;months are classified as long-term deferred revenue. However, this estimate is based on the Company&#8217;s current project development plan and, if the development plan should change in the future, the Company may recognize a different amount of deferred revenue over the next 12-month period. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Milestone Payments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Payments<span style="font-style:normal;"> &#8212; At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the customer, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as, or when, the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect license, collaboration, other revenue, and earnings in the period of adjustment</span><span style="font-family:Calibri;font-style:normal;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods Sold</a></td>
<td class="text">Cost of Goods Sold<span style="font-style:normal;"> &#8212; Cost of goods sold includes material, labor costs and manufacturing overhead. Cost of goods sold also includes a component of current period manufacturing costs in excess of costs capitalized into inventory (&#8220;excess capacity costs&#8221;).&#160;These costs, in addition to the impact of the revaluation of inventory for standard costing, and write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of goods sold excludes the cost of insulin purchased under the Company&#8217;s Insulin Supply Agreement (the &#8220;Insulin Supply Agreement&#8221;) with Amphastar Pharmaceuticals, Inc. (&#8220;Amphastar&#8221;). All insulin inventory on hand was written off and the full purchase commitment contract to purchase future insulin was accrued as a recognized loss on purchase commitments as of the end of 2016.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CostOfRevenuesPolicyTextBlock', window );">Cost of Revenues</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cost of Revenues &#8211; Collaborations and Services<span style="font-style:normal;"> &#8212; Cost of revenues &#8211; collaborations and services includes material, labor costs, manufacturing overhead, and excess capacity costs.&#160;These costs, in addition to the write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of revenues &#8211; collaborations and services also includes the cost of product development.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents and Restricted Cash<span style="font-style:normal;"> &#8212; The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December 31, 2022 and 2021, cash equivalents were comprised of money market, corporate bonds and commercial paper accounts with original maturities less than 90 days from the date of purchase.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records restricted cash when cash and cash equivalents are restricted as to withdrawal or usage. The Company presents amounts of restricted cash that will be available for use within 12 months of the reporting date as restricted cash in current assets. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy', window );">Held-to-Maturity Investments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Held-to-Maturity Investments<span style="font-style:normal;"> &#8212; The Company&#8217;s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2022, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. The amortization or accretion of the Company&#8217;s investments is recognized as interest income in the consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy', window );">Available-for-Sale Investment</a></td>
<td class="text">Available-for-Sale Investment<span style="font-style:normal;"> &#8212; In June 2021, the Company purchased a $3.0 million convertible promissory note (the &#8220;Thirona convertible note&#8221;) issued by Thirona Bio, Inc. (&#8220;Thirona&#8221;). In January 2022, the Company purchased an additional $5.0 million convertible promissory note issued by Thirona. Unless earlier converted into conversion shares pursuant to the note purchase agreement, the principal and accrued interest shall be due and payable by Thirona on demand by the Company at any time after the maturity date of December 31, 2023. Interest accrues at a rate of 6% per annum. The Thirona convertible notes are general unsecured obligations of Thirona. The Thirona convertible notes are classified as an available-for-sale security and are included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company assesses whether it has any intention to sell the investment, determines fair value of its available-for-sale investments using level 3 inputs as well as assesses its allowance for credit losses associated with the available for sale investment. In June 2021, the Company and Thirona also entered into a collaboration agreement to develop a compound for the treatment of fibrotic lung diseases. See Note 11 &#8211; </span>Collaboration, Licensing and Other Arrangements<span style="font-style:normal;"> for additional information. </span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit Risk<span style="font-style:normal;"> &#8212; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Loss</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Receivable and Allowance for Credit Losses<span style="font-style:normal;"> &#8212;</span><span style="color:#000000;font-style:normal;"> Accounts receivable are recorded at the invoiced amount and are not interest bearing. Accounts receivable are presented net of an allowance for credit losses if there are estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for credit losses. The allowance for expected credit losses is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. Accounts receivable are also presented net of an allowance for product returns and trade discounts and allowances because the Company&#8217;s customers have the right of setoff for these amounts against the related accounts receivable.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PreLaunchInventoryPolicyTextBlock', window );">Pre Launch Inventory</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Pre-Launch Inventory <span style="font-style:normal;">&#8212; An improvement to the manufacturing process for the Company&#8217;s primary excipient fumaryl diketopiperazine (&#8220;FDKP&#8221;) was demonstrated to be viable and management expects to realize an economic benefit in the future as a result of such process improvement. Accordingly, the Company is required to assess whether to capitalize inventory costs related to such excipient prior to regulatory approval of the new supplier and the improved manufacturing process. In doing so, management must consider a number of factors in order to determine the amount of inventory to be capitalized, including the historical experience of achieving regulatory approvals for the Company&#8217;s manufacturing process, feedback from regulatory agencies on the changes being effected and the amount of inventory that is likely to be used in commercial production. The shelf life of the excipient will be determined as part of the regulatory approval process; in the interim, the Company must assess the available stability data to determine whether there is likely to be adequate shelf life to support anticipated future sales occurring beyond the expected approval date of the new raw material. If management is aware of any specific material risks or contingencies other than the normal regulatory review and approval process, or if the criteria for capitalizing inventory produced prior to regulatory approval are otherwise not met, the Company would not capitalize such inventory costs, choosing instead to recognize such costs as a research and development expense in the period incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Inventories<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes inventory costs associated with the Company&#8217;s products based on management&#8217;s judgment that future economic benefits </span><span style="font-style:normal;">are</span><span style="color:#000000;font-style:normal;"> expected to be realized; otherwise, such costs are expensed as incurred as cost of goods sold. The Company uses a contract manufacturing organization outside of the U.S. for certain stages of V-Go inventory. </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value and writes down such inventories, as appropriate. In addition, the Company&#8217;s products are subject to strict quality control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or may become obsolete or are forecasted to become obsolete due to expiration, the Company will record a charge to write down such unmarketable inventory to its estimated net realizable value. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company performs an assessment of projected sales and evaluates the lower of cost or net realizable value and the potential excess inventory on hand at the end of each reporting period.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Property and equipment<span style="font-style:normal;"> &#8212; Property and equipment is recorded at historical cost, net of accumulated depreciation. Depreciation expense is recorded over the assets&#8217; useful lives on a straight-line basis. See Note 7 &#8211; </span>Property and Equipment<span style="font-style:normal;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets<span style="font-style:normal;">&#160;&#8212; Long-lived assets include property and equipment, operating lease right-of-use assets and other intangible asset. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Assets are considered to be impaired if the carrying value is considered to be unrecoverable.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the asset exceeds the fair value of the asset. Fair value is determined using the market, income or cost approaches as appropriate for the asset. Any write-downs are treated as permanent reductions in the carrying amount of the asset and recognized as an operating loss.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In August 2019, the Company recorded a $1.5&#160;million&#160;commitment asset and a $0.4&#160;million other asset for deferred debt issuance costs related to the future funding commitments of the MidCap Credit Facility. A quarterly assessment was performed during the second quarter of 2020 to determine if the Company was on target to achieve certain required milestone conditions in order for the Company to access further borrowings under the MidCap Credit Facility.&#160;The Company determined that such milestone conditions related to Afrezza trailing net revenue were unlikely to be achieved.&#160;As a result, an asset impairment of $1.9&#160;million was recognized during the second quarter of 2020 and is reflected in&#160;the Company&#8217;s consolidated statement of operations. See Note 10 &#8211;&#160;</span><span style="font-style:italic;Background-color:#FFFFFF;">Borrowings</span><span style="Background-color:#FFFFFF;">&#160;for further information on the MidCap Credit Facility.</span> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recorded $0.1 million of asset impairments for the year ended December 31, 2021. There were no asset impairments for the year ended December 31, 2022.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquistitions</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisitions &#8212; <span style="font-style:normal;">The Company first determines whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired do not constitute a business, the Company accounts for the transaction as an asset acquisition. Business combinations are accounted for by means of the acquisition method of accounting. Under the acquisition method, assets acquired, </span></p>
<p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">including in-process research and development (&#8220;IPR&amp;D&#8221;) projects, and liabilities assumed are recorded at their respective fair values as of the acquisition date in the Company&#8217;s consolidated financial statements. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Contingent consideration obligations incurred in connection with a business combination (including the assumption of an acquiree&#8217;s liability arising from an acquisition it consummated prior to the Company&#8217;s acquisition) are recorded at their fair values on the acquisition date and remeasured at their fair values each subsequent reporting period until the related contingencies have been resolved. The resulting changes in fair values are recorded in earnings. In contrast, asset acquisitions are accounted for by using a cost accumulation and allocation model. Under this model, the cost of the acquisition is allocated to the assets acquired and liabilities assumed. IPR&amp;D projects with no alternative future use are recorded in R&amp;D expense upon acquisition, and contingent consideration obligations incurred in connection with an asset acquisition are recorded when it is probable that they will occur and they can be reasonably estimated. See Note 3 &#8211; </span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acquisition</span><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">s</span><span style="font-style:normal;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Goodwill and Other Intangible Assets </span>&#8212; <span style="Background-color:#FFFFFF;font-style:normal;">The fair value of acquired intangible assets is determined using an income-based approach referred to as the excess earnings method utilizing Level 3 fair value inputs. Market participant valuations assume a global view considering all potential jurisdictions and indications based on discounted after-tax cash flow projections, risk adjusted for estimated probability of technical and regulatory success. </span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company tests for impairment annually on a reporting unit basis, at the beginning of the Company&#8217;s fourth fiscal quarter and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. To the extent the carrying amount of a reporting unit is less than its estimated fair value, an impairment charge will be recorded.</p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life. Estimated useful lives are determined considering the period assets are expected to contribute to future cash flows. Finite-lived intangible assets are tested for impairment when facts or circumstances suggest that the carrying value of the asset may not be recoverable.&#160;If the carrying value exceeds the projected undiscounted pretax cash flows of the intangible asset, an impairment loss equal to the excess of the carrying value over the estimated fair value (discounted after-tax cash flows) is recognized.</span></p>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">No</span> impairments to goodwill or other intangible assets were recorded during the year ended December 31, 2022.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock', window );">Recognized Loss on Purchase Commitments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recognized Loss on Purchase Commitments &#8212;<span style="font-style:normal;"> The Company assesses whether losses on long-term purchase commitments should be accrued. Losses that are expected to arise from firm, non-cancellable, commitments for the future purchases are recognized unless recoverable. When making the assessment, the Company also considers whether it is able to renegotiate with its vendors. The recognized loss on purchase commitments is reduced as inventory items are received. If, subsequent to an accrual, a purchase commitment is successfully renegotiated, the gain is recognized in the Company&#8217;s consolidated statements of operations. The liability balance of the recognized loss on insulin purchase commitments as of December 31, 2022 and 2021 was $72.3 million and $82.8 million, respectively. </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">No</span>&#160;new contracts were identified in 2022 that required a new loss on purchase commitment accrual.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneRightsLiabilityPolicyTextBlock', window );">Milestone Rights Liability</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Rights Liability<span style="font-style:normal;">&#160;&#8212; </span><span style="font-style:normal;color:#000000;">In July 2013, in conjunction with the execution of a (now repaid) loan agreement with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (collectively, &#8220;Deerfield&#8221;), the Company entered into Milestone Rights Purchase Agreement (the &#8220;Milestone Rights Agreement&#8221;) pursuant to which the Company issued certain milestone rights to Deerfield Private Design Fund II, L.P. and Horizon Sant&#233; FLML S&#192;RL, (the &#8220;Original Milestone Purchasers&#8221;). The foregoing milestone rights provided the Original Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable upon achievement of such milestones (collectively, the &#8220;Milestone Rights&#8217;). In December 2021, the Milestone Rights were purchased by Barings Global Special Situations Credit Fund 4 (Delaware), L.P. and Barings Global Special Situations Credit 4 (LUX) S.ar.l. (together the &#8220;Milestone Purchasers&#8221;). As a result, the Milestone Purchasers have assumed the obligations of the Original Milestone Purchasers and is now entitled to all rights under the Milestone Rights Agreement. As of December 31, 2022, $60.0 million remained payable pursuant to the Milestone Rights Agreement upon achievement of Afrezza net sales milestones. The Milestone Rights liability is reported at fair value at the date of the agreement which is periodically offset against payments. See Note 12</span><span style="font-style:normal;"> &#8211; </span>Fair Value of Financial Instruments<span style="font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#8217;s consolidated statements of operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. See Note&#160;10 &#8211; <span style="font-style:italic;">Borrowings</span>.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments<span style="font-style:normal;"> &#8212;The Company applies various valuation approaches in determining the fair value of its financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: </span></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#160;&#8212;&#160;Quoted prices for identical instruments in active markets.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#160;&#8212;&#160;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#160;&#8212;&#160;Significant inputs to the valuation model are unobservable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Income Taxes<span style="font-style:normal;">&#160;&#8212; The provisions for federal, foreign, state and local income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets to amounts that are more likely than not to be realized.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For uncertain tax positions, the Company determines whether it is &#8220;more likely than not&#8221; that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is &#8220;not more likely than not&#8221; that a tax benefit will be sustained, no tax benefit is recognized. </span>Penalties, if probable and reasonably estimable, are recognized as a component of income tax expense.<span style="Background-color:#FFFFFF;"> The Company has reduced its deferred tax assets for uncertain tax positions but has not recorded liabilities for income tax expense, penalties, or interest.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Contingencies<span style="font-style:normal;"> &#8212; The Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals represent management&#8217;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation and may revise its estimates.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation<span style="font-style:normal;"> &#8212; Share-based payments to employees, including grants of RSUs, performance-based non-qualified stock options awards (&#8220;PNQs&#8221;), restricted stock units with market conditions (&#8220;Market RSUs&#8221;), options and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. RSUs are valued based on the market price on the grant date. Market RSUs are valued using a Monte Carlo valuation model and RSUs with performance conditions are evaluated for the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ClinicalTrialExpensePolicyTextBlock', window );">Clinical Trial Expenses</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Trial Expenses<span style="font-style:normal;"> &#8212; Clinical trial expenses, which are primarily reflected in research and development expenses in the accompanying consolidated statements of operations, result from obligations under contracts with vendors, consultants and clinical site agreements in addition to internal costs associated with conducting clinical trials.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income or (Loss) Per Share of Common Stock</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Income (Loss) Per Share of Common Stock<span style="font-style:normal;"> &#8212; Basic net income or loss per share excludes dilution for potentially dilutive securities and is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted net loss per share as they would be anti-dilutive.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards <span style="font-style:normal;">&#8212; </span><span style="Background-color:#FFFFFF;color:#000000;font-style:normal;">In March 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued a new accounting standard to ease the financial reporting burdens caused by the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, commonly referred to as reference rate reform. The new standard provides temporary optional expedients and exceptions to current GAAP guidance on contract modifications and hedge accounting. In January 2021, the FASB issued a new accounting standard that expanded the scope of the original March 2020 standard to include derivative instruments on discounting transactions. In December 2022, the FASB deferred the sunset date to an alternative reference rate from December 31, 2022 to December 31, 2024. The Company adopted these standards in the third quarter of 2022 using the prospective method and determined there was no impact on the Company&#8217;s consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Standards<span style="font-style:normal;"> &#8212; </span><span style="color:#000000;font-style:normal;">In November 2021, the FASB issued a new accounting standard around the recognition and measurement of contract assets and contract liabilities from revenue contracts with customers acquired in a business combination. The new standard clarifies that contract assets and contract liabilities acquired in a business combination from an acquiree should initially be recognized by applying revenue recognition principles and not at fair value. The standard is effective for interim and annual periods beginning on January 1, 2023, and early adoption is permitted. The impact of this standard will depend on the facts and circumstances of future transactions.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial position or results of operations upon adoption.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BasisOfPresentationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BasisOfPresentationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ClinicalTrialExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Trial Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ClinicalTrialExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CostOfRevenuesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CostOfRevenuesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneRightsLiabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone rights liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneRightsLiabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PreLaunchInventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-launch inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PreLaunchInventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recently issued accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer from collaborations and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer from commercial product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=6435544&amp;loc=d3e41834-113960<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=6435544&amp;loc=d3e41834-113960<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464083056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,073</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,435</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,324</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,098</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,007</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,820</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,770</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,442</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,144</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent revenue generated from the Company&#8217;s collaboration arrangements, including Next-Gen R&amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements</span><span style="font-size:9pt;color:#000000;">. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.38%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amounts represent royalties on UT&#8217;s net sales of Tyvaso DPI.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold and cost of revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product sales</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,071</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,084</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,024</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,557</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cost of goods sold and cost of revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,497</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,857</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,641</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818454887760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Summary of Supplemental Pro Forma Information (Unaudited)</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Net revenue and loss from operations for the year ended December 31, 2022 was $12.9 million and $0.3 million, respectively</span>, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):</p>
<p style="margin-top:18pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Supplemental Pro Forma Information (unaudited)</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.08%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,278</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(86,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,806</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share - basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Consideration Paid for IPR&amp;D</a></td>
<td class="text">The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company&#8217;s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Consideration</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,574</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock consideration (3,067,179 shares at $3.01 per share)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transaction costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Repayment of debt</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash acquired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(155</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total consideration paid for IPR&amp;D</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,233</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember', window );">V-Go</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Schedule of Preliminary Purchase Consideration</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total preliminary purchase consideration for V-Go was as follows (in tho<span style="Background-color:#FFFFFF;color:#000000;">usands):</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair value of consideration:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash consideration</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,341</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value of contingent consideration</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,951</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands): </span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,921</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible asset - Developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,513</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities assumed</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,562</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net assets acquired</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,951</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818457980496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule Of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesTextBlock', window );">Schedule of Contractual Maturities of Held to Maturity Investments</a></td>
<td class="text">
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The contractual maturities of the Company&#8217;s held to maturity investments as of December 31, 2022 and 2021 are summarized below (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost Basis</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due in one year or less<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,862</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,733</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,669</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,961</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,948</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56,433</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,823</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,924</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,352</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,102</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">___________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="Background-color:#FFFFFF;color:#000000;font-size:9pt;">The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.</span><span style="color:#000000;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock', window );">Schedule of Fair Value of Assets and Financing Liability on Total Investments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the cash equivalents, long-term and short-term investments are disclosed below (in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">153.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investment Level</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Carrying Value)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding Losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial bonds and paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Treasuries</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents and investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less cash equivalents</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136.3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of fair value of assets and financing liability on total investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269820-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818457980496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable, Net</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.34%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; commercial</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,359</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,939</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wholesaler distribution fees and prompt pay discounts</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,536</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,696</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for returns</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,108</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,797</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; commercial, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,715</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,446</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable &#8211; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, gross</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,086</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,060</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable &#8211; collaborations and services, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,086</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,293</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,801</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock', window );">Schedule of Activities and Ending Reserve Balance</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue net of gross-to-net adjustments<span style="color:#000000;">.</span> The activities and ending reserve balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prompt Pay Discount Reserve, Allowance for Wholesale Distribution Fees</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and Accounts Receivables Return Reserve:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,493</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,873</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,471</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,320</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,874</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,644</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,493</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of activities and ending reserve balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464228576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Components of Inventory</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories consist of the following (in thousands): </p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,739</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,703</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work-in-process</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,815</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,522</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,927</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventory</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,152</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464308928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Land</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Buildings</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000802">39-40</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,389</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building improvements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">5-40</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,952</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,651</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Machinery and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">3-15</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,334</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture, fixtures and office equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">5-10</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,969</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000810">3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,246</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,163</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,706</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,892</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,686</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,560</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,661</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,126</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,612</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">As of December 31, 2021 construction in progress included $4.7 million of equipment under construction for the manufacturing expansion for UT (the &#8220;UT Equipment&#8221;). There is no balance under construction for the UT Equipment as of December 31, 2022. The Company acts as agent on behalf of UT for the procurement of the UT Equipment. The Company has received $5.0 million in deposit for this service, which was recognized as deposits from customer in the consolidated balance sheet as of December 31, 2021. In April 2022, the Company and UT agreed that UT would hold title to the UT Equipment at all times. As such, there is no balance related to the UT Equipment included in construction in progress or deposits from customer in our consolidated balance sheet as of December 31, 2022. See Note 11 &#8211; </span><span style="font-style:italic;font-size:9pt;color:#000000;">Collaboration, Licensing and Other Arrangements.</span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464183120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Asset (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Other Intangible Asset</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Other Intangible Asset <span style="font-style:normal;">&#8212; Other intangible asset consisted of the following (in thousands):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated Useful</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.26%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Life (Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">15</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,153</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818556119728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities are comprised of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Salary and related expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,906</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,504</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Returns reserve for acquired product</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,013</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Professional fees</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,136</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">895</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,380</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current portion of milestone rights liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,088</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,201</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,166</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Retail inventory purchase</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">875</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Danbury facility buildout</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">846</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">786</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,719</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,980</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,553</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,419</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock', window );">Schedule of Provision for Discounts and Allowances for Commercial Product Sales</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The provision for discounts and allowances for commercial product sales is reflected as a component of net revenues. The activities and ending balance consists of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounts and allowances for commercial product sales:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,688</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,369</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,057</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,603</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,518</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V-Go opening balance sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,511</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,504</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,227</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461486880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Carrying Amount of Borrowings</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amount of the Company&#8217;s borrowings consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225,397</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223,944</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group promissory notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,829</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,425</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,264</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,833</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt &#8212; net carrying amount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,490</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281,202</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facility Debt and Key Terms</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides a summary of the Company&#8217;s debt and key terms: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.12%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount Due</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terms</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual&#160;Interest&#160;Rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maturity Date</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Conversion Price</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$230.0&#160;million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$230.0 million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 2026</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5.21</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40.0&#160;million</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$40.0 million</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">one-month</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SOFR (1% floor)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plus&#160;6.25%;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cap of 8.25%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August&#160;2025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$8.8 million</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">$18.4 million (plus $0.4 million accrued interest paid-in-kind)</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.50%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$2.50</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">per share</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. </span><span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.</span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of the Company's Borrowings</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The maturities of the Company&#8217;s borrowings as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.26%; border-bottom:solid 0.75pt #000000;" valign="middle">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amounts</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,667</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,163</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total principal payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">278,830</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(235</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,105</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,490</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock', window );">Schedule of Amortization of Premium and Accretion of Debt Issuance Costs</a></td>
<td class="text">
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of the premium and accretion of debt issuance costs related to all borrowings for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">377</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,215</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of amortization of debt issuance cost and debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542271168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Schedule of Revenue from Collaboration and Services</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from collaborations and services for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,826</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement<sup style="font-size:85%;line-height:120%;vertical-align:top"> (2)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,145</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vertice Pharma Co-Promotion Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">325</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cipla License and Distribution Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Receptor CLA</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">245</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT Research Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">210</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,820</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Next-Gen R&amp;D Services and R&amp;D Services and License for the periods presented.</span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContractWithCustomerLiabilityTableTextBlock', window );">Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The activity related to deferred revenue and the related revenue recognized for collaborations and services is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning balance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,370</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,937</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,971</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,707</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue &#8212; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,924</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending balance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,417</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,370</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Revenue Allocation, Remaining Performance Obligation, Expected Timing of Satisfaction</a></td>
<td class="text">Revenue was allocated as follows:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Period</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sep 2018 - Dec 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Recognition period represents the estimated period to satisfy the performance obligation.</span></p></td></tr></table></div>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Transaction Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Price<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total transaction price</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-Commercial Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility Expansion Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
<tr>
<td colspan="16" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.</span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock', window );">Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations</a></td>
<td class="text">
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">221.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.</span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span> </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock', window );">Schedule of Effect of Modification on Transaction Price</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounted for the contract modification as if it were part of the existing contract since the amendment modified the scope and price of the CSA by extending the term and increasing the occupancy rate. The effect of the modification on the transaction price and on the measure of progress is recognized as an adjustment to revenue as of the date of the modification. The modification did not result in a change the activities and deliverables under the CSA. The total revised anticipated cash flows of $463.5 million from the transaction was allocated to the three distinct performance obligations as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.96%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Anticipated</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash Flow</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Allocation<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition Method</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Progress Measure</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recognition</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total anticipated cash flow<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">463.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Distinct Performance Obligation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Services and License<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ratably</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aug 2021 - Oct 2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Next-Gen R&amp;D Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over time</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Input</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% of completion of costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(6)</sup></p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Services<sup style="font-size:85%;line-height:120%;vertical-align:top">(7)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">458.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Point in time</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer of control</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">(8)</sup></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&amp;D Services performance obligation was recognized.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The standalone selling price (&#8220;SSP&#8221;) for the Next-Gen R&amp;D Services performance obligation was based on industry ratios as well as the Company&#8217;s historical R&amp;D projects. The transaction price for the Next-Gen R&amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#8217;s Manufacturing Services performance obligation, given the nature of the Company&#8217;s contractual responsibilities and ASC 606 requirements.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(8)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received</span>.</p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Schedule of Revenue from Collaboration and Services</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from UT for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UT Revenue</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT CSA Agreement</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,826</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UT License Agreement</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,145</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties &#8212; Collaborations <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,599</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue from UT</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,851</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,412</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of royalties associated with the UT License Agreement. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:2pt;margin-left:3.12%;text-indent:1.13%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The current portion of contract assets related to the royalties is included in prepaid expense and other current assets in the consolidated balance sheets.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContractWithCustomerLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContractWithCustomerLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of effect of modification on transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revised anticipated cash flows from transactions allocated performance obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464059008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">The following tables set forth the fair value of the Company&#8217;s financial instruments (Level 3 in the fair value hierarchy) (in millions):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Amount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">253.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">253.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone rights<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent milestone liability <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 13%, volatility of 75.8% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $245.0 million and $263.4 million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 12%. A change in yield of + or &#8211; 2% would result in a fair value of $40.0 million and $42.4 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:10pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of $22.1 million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2022 was determined by applying a discounted cash flow analysis with a hypothetical yield of 13% and volatility of 77.8% to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $20.5 million and $21.2 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation. </span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs&#160;(Level 3)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total Fair Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">237.5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MidCap credit facility <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible note<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">__________________________</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined</span> by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 12%, volatility of 90% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#8211; 2% would result in a fair value of $226.6 million and $249.4 million, respectively.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 10%. A change in yield of + or &#8211; 2% would result in a fair value of $39.1 million and $42.7 million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="text-decoration:none;Background-color:#auto;font-size:7pt;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of </span><span style="font-size:9pt;color:#000000;">$22.1</span><span style="font-size:9pt;color:#000000;"> million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the </span><span style="font-size:9pt;color:#000000;">$22.1</span><span style="font-size:9pt;color:#000000;"> million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2021 was determined by applying a discounted cash flow analysis with a hypothetical yield of </span><span style="font-size:9pt;color:#000000;">12%</span><span style="font-size:9pt;color:#000000;"> and volatility of </span><span style="font-size:9pt;color:#000000;">85%</span><span style="font-size:9pt;color:#000000;"> to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#8211; </span><span style="font-size:9pt;color:#000000;">2%</span><span style="font-size:9pt;color:#000000;"> would result in a fair value of </span><span style="font-size:9pt;color:#000000;">$36.9</span><span style="font-size:9pt;color:#000000;"> million and </span><span style="font-size:9pt;color:#000000;">$38.8</span><span style="font-size:9pt;color:#000000;"> million, respectively.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.25%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Fair value determined by applying a Monte Carlo simulation.</span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461715760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share ("EPS") (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Components of Basic and Diluted EPS Computations</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EPS &#8212; basic and diluted:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss (numerator)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares (denominator)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">257,092</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">249,244</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">222,585</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.34</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.26</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential Dilutive Securities Outstanding that are Considered Antidilutive</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potentially dilutive securities outstanding that are considered antidilutive are summarized as follows (in shares):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,120,463</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,120,463</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options and PNQs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,655,146</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,264,616</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mann Group convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,370,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,370,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,200,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants associated with MidCap credit facility</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,283,467</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024 convertible notes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,666,667</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and Market RSUs<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,886,710</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,609,025</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,037,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243,375</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">292,981</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75,451,760</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,998,009</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,745,273</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">_________________________</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:4.39%;"/>
<td style="width:95.61%;"/>
</tr>
<tr>
<td style="white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Market RSUs are included at the maximum share delivery percentage.</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818455070624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Stock Based Award Plans</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about the Company&#8217;s stock-based award plans as of December&#160;31, 2022:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Units</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares&#160;Available</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Future</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Issuance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2004 Equity Incentive Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,320</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2013 Equity Incentive Plan</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,240,690</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 Equity Incentive Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,832,577</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,802,796</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,802,796</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense recognized in the accompanying consolidated statements of operations is included in the following categories (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.94%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">407</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">446</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue &#8212; collaborations and services</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,425</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,708</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">626</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,044</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">614</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,194</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,578</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,158</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,455</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,893</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,943</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,447</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,511</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Assumptions Used to Calculate Fair Value of Employee Stock Options</a></td>
<td class="text">The Company calculated the fair value of employee stock options granted during the year ended December&#160;31, 2020 using the following assumptions:
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001364">0.39% &#8212; 1.52%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected lives</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001366">5.67 &#8212; 7.0 years</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001368">93.83% &#8212; 94.25%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividends</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Outstanding</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to stock options:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value ($000)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,732,513</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.01</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001382">5.49</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34,543</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,196,391</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.79</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116,767</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.82</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(344,768</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.31</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,074,587</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.06</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001383">5.10</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,512</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,776,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.23</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001384">5.15</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,315</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Unit Activity</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information relating to restricted stock units: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">per Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at January 1, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,538,032</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.40</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,120,682</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.95</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,551,088</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,269,297</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.97</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,838,329</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.65</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460331568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock', window );">Schedule of Lease Term and Discount Rate</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability information is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001452">18.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001453">19.8</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Lease information is as follows (in thousands):</span></p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,714</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,284</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-current <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,304</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,380</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liability-long-term</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,343</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,040</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,647</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average remaining lease term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001504">4.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001505">2.6</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average discount rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Information</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.14%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on financing liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,758</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,373</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.8%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,525</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">863</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,403</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">515</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">394</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,823</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,867</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,797</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Summary of Financing Liability Payments</a></td>
<td class="text">
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing liability payments as of December 31, 2022 was as follows (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.06%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,774</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,269</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,533</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,849</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188,453</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,896</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest payments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(132,936</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,883</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total financing liability</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,077</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentTextBlock', window );">Remaining Purchase Requirements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( &#8364; in millions):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.82%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.8</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Office And Vehicle Lease Payments</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.86%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,368</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,892</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,861</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2026</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,140</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2027</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,072</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">643</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,976</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,329</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Lease Term and Discount Rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818455034192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Loss from Continuing Operations Before Provision for Income Taxes</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from continuing operations before provision for income taxes for the Company&#8217;s domestic and international operations was as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,458</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before provision for income taxes</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(87,400</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,926</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,458</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes</a></td>
<td class="text">The provision for income taxes consists of the following (in thousands):&#160;  &#160;
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,606</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,170</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,377</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. state</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,334</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,461</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(469</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-U.S.</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,940</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,631</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,846</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,940</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,631</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,846</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Net Deferred Tax Assets</a></td>
<td class="text">Components of the net deferred tax assets as of December&#160;31, 2022 and 2021, are approximately as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,537</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">542,800</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,804</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,804</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,369</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Rights</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,331</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,440</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,675</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,591</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on purchase commitment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,117</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,845</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-qualified stock option expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,686</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,684</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized patent costs</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,204</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,568</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,624</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">588</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense limitation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,696</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,157</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,983</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred Product Revenue &amp; Costs</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">370</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">404</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">706,923</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">695,921</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(705,034</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(695,094</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,889</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">827</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,640</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(555</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other prepaids</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(249</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(272</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,889</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(827</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Effective Tax Rate</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s effective tax rate differs from the statutory federal income tax rate as follows for the years ended December&#160;31, 2022, 2021 and 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal tax benefit rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Permanent items</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-1.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6.1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-0.5</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax attribute expirations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5.9</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign withholding tax</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11.2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7.8</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective income tax rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.4</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Summary of Positions for which Significant Change in Unrecognized Tax Benefits</a></td>
<td class="text">
<p style="margin-top:2pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of beginning and ending amounts of unrecognized tax benefits in 2022, 2021 and 2020, respectively, was as follows (in thousands):</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.86%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized Tax Benefit</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning of Year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross increases for tax positions of prior years</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross decreases for tax positions of current year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lapse of statute of limitations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">End of Year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268,902</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460136304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMinimumCashCovenant', window );">Minimum cash covenant | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMinimumCashCovenant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument minimum cash covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMinimumCashCovenant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization, consolidation and presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459673488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Contract</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion or amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss', window );">Allowance for credit losses on held-to-maturity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PurchaseOfAvailableForSaleSecurities', window );">Purchase of available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairments of other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis=mnkd_CommitmentAssetMember', window );">Commitment Asset | Other Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentAsset', window );">Commitment asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember', window );">Milestone Rights Liability | Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiabilityRemainingPayableAmount', window );">Contingent liability remain payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note | Thirona Bio Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PurchaseOfAvailableForSaleSecurities', window );">Purchase of available-for-sale securities</a></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Investment securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Available-for-Sale Investment, credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_InsulinMember', window );">Insulin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Loss on purchase commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,300,000<span></span>
</td>
<td class="nump">$ 82,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized', window );">Loss on purchase commitments, number of new contracts recognized | Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | AFREZZA product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SalesReturnPeriod', window );">Sales return right following product expiration in months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Milestone Rights Liability | Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiabilityRemainingPayableAmount', window );">Contingent liability remain payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | AFREZZA product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SalesReturnPeriod', window );">Sales return right following product expiration in months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommitmentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommitmentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiabilityRemainingPayableAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent liability remaining payable amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiabilityRemainingPayableAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on purchase commitments number of contracts recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PurchaseOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PurchaseOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SalesReturnPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales return period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SalesReturnPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity date of investment, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis=mnkd_CommitmentAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis=mnkd_CommitmentAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_ThironaBioIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_ThironaBioIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_InsulinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_InsulinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542791920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail 1)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, Expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458263424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 99,770<span></span>
</td>
<td class="nump">$ 75,442<span></span>
</td>
<td class="nump">$ 65,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost of goods sold and cost of revenue</a></td>
<td class="nump">57,497<span></span>
</td>
<td class="nump">38,857<span></span>
</td>
<td class="nump">24,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_ProductSalesMember', window );">Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">81,073<span></span>
</td>
<td class="nump">39,435<span></span>
</td>
<td class="nump">32,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost of goods sold and cost of revenue</a></td>
<td class="nump">55,071<span></span>
</td>
<td class="nump">16,833<span></span>
</td>
<td class="nump">15,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">3,098<span></span>
</td>
<td class="nump">36,007<span></span>
</td>
<td class="nump">32,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total cost of goods sold and cost of revenue</a></td>
<td class="nump">2,426<span></span>
</td>
<td class="nump">$ 22,024<span></span>
</td>
<td class="nump">$ 9,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty collaborations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 15,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_ProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_ProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459806640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($) </div>
<div>Year</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Incremental borrowing rate</a></td>
<td class="nump">7.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">$ 11,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Risk-Free Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement inputs</a></td>
<td class="nump">2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement inputs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement inputs</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement inputs | Year</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Measurement inputs</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember', window );">QrumPharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessCombinationAccumulatedCost', window );">Business acquisition, total accumulated cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember', window );">QrumPharma | Global Adjusted Net Sales Of Products Exceeds Fifty Million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfRoyaltyPaymentOnNetSales', window );">Royalty payment in each of the calendar years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage', window );">Global adjusted net sales of products, reference amount for royalty percentage.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember', window );">QrumPharma | Adjusted Net Sales Are Greater Than Or Equal To Two Hundred Million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfRoyaltyPaymentOnNetSales', window );">Royalty payment in each of the calendar years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage', window );">Global adjusted net sales of products, reference amount for royalty percentage.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember', window );">V-Go</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionDateOfAcquisitionAgreement', window );">Asset acquisition, date of acquisition agreement</a></td>
<td class="text">May 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionEffectiveDateOfAcquisition', window );">Asset acquisition, effective date of acquisition</a></td>
<td class="text">May 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Asset acquisition, up-front consideration</a></td>
<td class="nump">$ 15,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_GoodwillAmortizationPeriod', window );">Goodwill amortization period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AssetAcquisitionMilestonePaymentPayable', window );">Sales-based milestone payments payable</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AnnualRevenueMilestonesRangesForMilestonePayments', window );">Annual revenue milestones ranges for milestone payments</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember', window );">V-Go | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AnnualRevenueMilestonesRangesForMilestonePayments', window );">Annual revenue milestones ranges for milestone payments</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AnnualRevenueMilestonesRangesForMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual revenue milestones ranges for milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AnnualRevenueMilestonesRangesForMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AssetAcquisitionMilestonePaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset acquisition, milestone payment payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AssetAcquisitionMilestonePaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessCombinationAccumulatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination accumulated cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessCombinationAccumulatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Global adjusted net sales of products reference amount for royalty percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_GoodwillAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_GoodwillAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfRoyaltyPaymentOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payment on net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfRoyaltyPaymentOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionDateOfAcquisitionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when asset acquisition agreement is executed, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionDateOfAcquisitionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionEffectiveDateOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when acquirer obtains control of acquired asset, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionEffectiveDateOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e848-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e845-128460<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEntityCreditRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEntityCreditRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542444368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Schedule of Preliminary Purchase Consideration (Detail) - V-Go<br> $ in Thousands</strong></div></th>
<th class="th">
<div>May 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredAbstract', window );"><strong>Fair value of consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash consideration</a></td>
<td class="nump">$ 15,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Fair value of contingent consideration</a></td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total</a></td>
<td class="nump">$ 15,951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458965424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember', window );">V-Go</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible asset - Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current and noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461383392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract', window );"><strong>Business Acquisition Pro Forma Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net revenue</a></td>
<td class="nump">$ 109,933<span></span>
</td>
<td class="nump">$ 98,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (86,967)<span></span>
</td>
<td class="num">$ (80,806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458915136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Detail) - QrumPharma<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="nump">$ 3,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Stock consideration (3,067,179 shares at $3.01 per share)</a></td>
<td class="nump">9,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForMergerRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_BusinessAcquisitionRepaymentOfDebt', window );">Repayment of debt</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Liabilities assumed</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="num">(155)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration paid for IPR&amp;D</a></td>
<td class="nump">$ 13,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_BusinessAcquisitionRepaymentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition, repayment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_BusinessAcquisitionRepaymentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the reporting period for charges associated with the mergers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464264672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Parenthetical) (Detail) - QrumPharma<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of common stock issued | shares</a></td>
<td class="nump">3,067,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition, share price | $ / shares</a></td>
<td class="nump">$ 3.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460116032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,767,000<span></span>
</td>
<td class="nump">$ 124,184,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">101,079,000<span></span>
</td>
<td class="nump">79,932,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,961,000<span></span>
</td>
<td class="nump">56,619,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion or amortization</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss', window );">Allowance for credit losses on held-to-maturity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AccruedInterestReceivable', window );">Accrued interest receivable</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AmountReceivableOnMaturedInvestment', window );">Amount receivable on matured investment</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-Maturity Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">101,100,000<span></span>
</td>
<td class="nump">79,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="nump">56,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note | Thirona Bio Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Investment securities</a></td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Available-for-Sale Investment, credit losses</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Schedule Of Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,800,000<span></span>
</td>
<td class="nump">$ 124,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedInterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedInterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AmountReceivableOnMaturedInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount receivable on matured investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AmountReceivableOnMaturedInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_ThironaBioIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_ThironaBioIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542268048">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract', window );"><strong>Held To Maturity Securities Debt Maturities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Amortized cost basis, due in one year or less</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 152,862<span></span>
</td>
<td class="nump">$ 103,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount', window );">Amortized cost basis due after one year through five years</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">56,619<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Amortized cost basis, total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">154,823<span></span>
</td>
<td class="nump">160,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Aggregate fair value, due in one year or less</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">156,976<span></span>
</td>
<td class="nump">103,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Aggregate fair value, due after one year through five years</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,948<span></span>
</td>
<td class="nump">56,433<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue', window );">Aggregate fair value, total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 158,924<span></span>
</td>
<td class="nump">$ 160,102<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL120269825-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458083216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule Of Held To Maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,767<span></span>
</td>
<td class="nump">$ 124,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=mnkd_DueInOneYearOrLessMember', window );">Due in One Year or Less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems', window );"><strong>Schedule Of Held To Maturity Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 51,800<span></span>
</td>
<td class="nump">$ 23,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=mnkd_DueInOneYearOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=mnkd_DueInOneYearOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459246608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">$ 154.9<span></span>
</td>
<td class="nump">$ 160.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Less cash equivalents</a></td>
<td class="num">(51.8)<span></span>
</td>
<td class="num">(23.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total Investments</a></td>
<td class="nump">103.1<span></span>
</td>
<td class="nump">136.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember', window );">Amortized Cost | Commercial Bonds and Paper | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">115.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember', window );">Amortized Cost | Money Market Funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">51.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember', window );">Amortized Cost | U.S. Treasuries | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">36.3<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_GrossUnrealizedHoldingLossesMember', window );">Gross Unrealized Holding Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total Investments</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_GrossUnrealizedHoldingLossesMember', window );">Gross Unrealized Holding Losses | Commercial Bonds and Paper | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_GrossUnrealizedHoldingLossesMember', window );">Gross Unrealized Holding Losses | U.S. Treasuries | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">153.7<span></span>
</td>
<td class="nump">160.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Less cash equivalents</a></td>
<td class="num">(51.8)<span></span>
</td>
<td class="num">(23.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total Investments</a></td>
<td class="nump">101.9<span></span>
</td>
<td class="nump">136.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember', window );">Estimated Fair Value | Commercial Bonds and Paper | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">66.2<span></span>
</td>
<td class="nump">115.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember', window );">Estimated Fair Value | Money Market Funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">51.8<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember', window );">Estimated Fair Value | U.S. Treasuries | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CashEquivalentsAndInvestments', window );">Total cash equivalents and investments</a></td>
<td class="nump">$ 35.7<span></span>
</td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CashEquivalentsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CashEquivalentsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FairValueOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FairValueOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mnkd_AmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mnkd_GrossUnrealizedHoldingLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mnkd_GrossUnrealizedHoldingLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mnkd_EstimatedFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460254864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Accounts Receivable, Net (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 16,801,000<span></span>
</td>
<td class="nump">$ 4,739,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Commercial product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">19,359,000<span></span>
</td>
<td class="nump">7,939,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_WholesalerDistributionFeesAndPromptPayDiscounts', window );">Wholesaler distribution fees and prompt pay discounts</a></td>
<td class="num">(2,536,000)<span></span>
</td>
<td class="num">(1,696,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReserveForReturns', window );">Reserve for returns</a></td>
<td class="num">(4,108,000)<span></span>
</td>
<td class="num">(2,797,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">12,715,000<span></span>
</td>
<td class="nump">3,446,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">4,086,000<span></span>
</td>
<td class="nump">2,060,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 4,086,000<span></span>
</td>
<td class="nump">1,293,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (767,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReserveForReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserve for returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReserveForReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_WholesalerDistributionFeesAndPromptPayDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Wholesaler distribution fees and prompt pay discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_WholesalerDistributionFeesAndPromptPayDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458166080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Distributor</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Distributor</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NumberOfWholesaleDistributors', window );">Number of wholesale distributors | Distributor</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfSalesFromMajorCustomers', window );">Percentage of gross sales from major wholesale distributors</a></td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses for accounts receivable | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices', window );">Percentage of revenue from major customers collaborations and services</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables', window );">Percentage of collaborations and services net accounts receivables</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Commercial product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfAccountsReceivableFromMajorCustomers', window );">Percentage of accounts receivable from major wholesale distributors</a></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfWholesaleDistributors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of wholesale distributors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfWholesaleDistributors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfAccountsReceivableFromMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of accounts receivable from major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfAccountsReceivableFromMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of collaborations and services net accounts receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from major customers collaborations and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfSalesFromMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sales from major customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfSalesFromMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458258416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Activities and Ending Reserve Balance (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReserveBalanceAbstract', window );"><strong>Reserve Balance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve', window );">Beginning balance</a></td>
<td class="nump">$ 4,493<span></span>
</td>
<td class="nump">$ 3,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions', window );">Provisions</a></td>
<td class="nump">17,471<span></span>
</td>
<td class="nump">11,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions', window );">Deductions</a></td>
<td class="num">(15,320)<span></span>
</td>
<td class="num">(10,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve', window );">Ending balance</a></td>
<td class="nump">$ 6,644<span></span>
</td>
<td class="nump">$ 4,493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReserveBalanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reserve balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReserveBalanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460287776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Components of Inventory (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 5,739<span></span>
</td>
<td class="nump">$ 2,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">13,815<span></span>
</td>
<td class="nump">2,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,218<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 21,772<span></span>
</td>
<td class="nump">$ 7,152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818454874624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Inventory write-offs</a></td>
<td class="nump">$ 2,202<span></span>
</td>
<td class="nump">$ 1,902<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=mnkd_PreLaunchInventoryMember', window );">Pre-launch Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials inventory</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=mnkd_AgreementWithRetailPharmacyMember', window );">Agreement With Retail Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductionRelatedImpairmentsOrCharges', window );">Inventory write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductionRelatedImpairmentsOrCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductionRelatedImpairmentsOrCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=mnkd_PreLaunchInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=mnkd_PreLaunchInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=mnkd_AgreementWithRetailPharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=mnkd_AgreementWithRetailPharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818455018912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 143,686<span></span>
</td>
<td class="nump">$ 134,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(98,560)<span></span>
</td>
<td class="num">(97,661)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">45,126<span></span>
</td>
<td class="nump">36,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 17,389<span></span>
</td>
<td class="nump">17,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 38,952<span></span>
</td>
<td class="nump">38,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 58,542<span></span>
</td>
<td class="nump">55,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 2,976<span></span>
</td>
<td class="nump">2,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 8,246<span></span>
</td>
<td class="nump">8,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment - gross</a></td>
<td class="nump">$ 16,706<span></span>
</td>
<td class="nump">$ 10,892<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_FurnitureFixturesAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461028528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Parenthetical) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_UTEquipmentMember', window );">U T Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_UTEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_UTEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459812192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 08, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mnkd_CasperLLCMember', window );">Casper L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstate', window );">Sale price</a></td>
<td class="nump">$ 102.3<span></span>
</td>
<td class="nump">$ 102.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SaleLeasebackTransactionLeaseAgreementPeriods', window );">Sale leaseback transaction, lease agreement period.</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionDate', window );">Sale leaseback transaction, date</a></td>
<td class="text">November 8, 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember', window );">Manufacturing Equipment, Computer Hardware and Software, Computer Equipment, Lab Equipment, and Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisposals', window );">Amount of divestiture of long-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SaleLeasebackTransactionLeaseAgreementPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale leaseback transaction, lease agreement periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SaleLeasebackTransactionLeaseAgreementPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the sale of real estate that is not part of an investing activity during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The date of the transaction involving the sale of the property to another party and the lease of the property back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123416376&amp;loc=d3e50796-112755<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919784-209982<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_CasperLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_CasperLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461323744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Asset - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">After 2027</a></td>
<td class="nump">$ 700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460334064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail) - Developed Technology<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Book Value</a></td>
<td class="nump">$ 1,153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458636928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables And Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salary and related expenses</a></td>
<td class="nump">$ 14,906<span></span>
</td>
<td class="nump">$ 14,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CustomerDiscountsAndAllowances', window );">Discounts and allowances for commercial product sales</a></td>
<td class="nump">8,504<span></span>
</td>
<td class="nump">4,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ReturnsReserveForAcquiredProduct', window );">Returns reserve for acquired product</a></td>
<td class="nump">1,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectFinancingLeaseDeferredSellingProfit', window );">Deferred lease liability</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">1,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CurrentPortionOfMilestoneRightLiability', window );">Current portion of milestone rights liability</a></td>
<td class="nump">924<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RetailInventoryPurchase', window );">Retail inventory purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionPayableCurrent', window );">Danbury facility buildout</a></td>
<td class="nump">846<span></span>
</td>
<td class="nump">786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,719<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 35,553<span></span>
</td>
<td class="nump">$ 27,419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CurrentPortionOfMilestoneRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of milestone right liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CurrentPortionOfMilestoneRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CustomerDiscountsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer Discounts And Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CustomerDiscountsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RetailInventoryPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retail inventory purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RetailInventoryPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ReturnsReserveForAcquiredProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Returns reserve for acquired product.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ReturnsReserveForAcquiredProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectFinancingLeaseDeferredSellingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred selling profit from direct financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectFinancingLeaseDeferredSellingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818445249648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract', window );"><strong>Discounts and allowances for commercial product sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSales', window );">Beginning balance</a></td>
<td class="nump">$ 4,227<span></span>
</td>
<td class="nump">$ 3,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions', window );">Provisions</a></td>
<td class="nump">23,369<span></span>
</td>
<td class="nump">13,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions', window );">Deductions</a></td>
<td class="num">(20,603)<span></span>
</td>
<td class="num">(12,518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition', window );">V-Go opening balance sheet</a></td>
<td class="nump">1,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountsAndAllowancesForCommercialProductSales', window );">Ending balance</a></td>
<td class="nump">$ 8,504<span></span>
</td>
<td class="nump">$ 4,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales balances from acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounts and allowances for commercial product sales provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458676144">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 225,397<span></span>
</td>
<td class="nump">$ 223,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Mann Group promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,829<span></span>
</td>
<td class="nump">18,425<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt &#8212; net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">273,490<span></span>
</td>
<td class="nump">281,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 39,264<span></span>
</td>
<td class="nump">$ 38,833<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The amendment to the Mann Group convertible note in the second quarter of 2021 resulted in a substantial premium of $22.1 million based on the fair value post modification, which contributed to the loss on extinguishment in the consolidated statement of operations for the year ended December 31, 2021 and was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company.</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444617552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">$ (17,200)<span></span>
</td>
<td class="num">$ (264)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_PromissoryNotesMember', window );">Promissory Notes | The Mann Group L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital', window );">Debt premium recognized in additional paid-in capital</a></td>
<td class="nump">22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">$ (22,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt premium recognized in additional paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459570000">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 04, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount Due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 230.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2026-03<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount Due</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025-08<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility | SOFR</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFloorRate', window );">Interest rate floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentCapInterestRate', window );">Interest rate cap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.25%<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Convertible Promissory Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount Due</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AccruedPaidInKindInterest', window );">Accrued interest paid-in-kind</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025-12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. </span><span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AccruedPaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued paid in kind interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AccruedPaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentCapInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument cap interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentCapInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument floor rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMaturityMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity month and year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMaturityMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461246288">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Prepayment of principal balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025-08<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility | Prior To Midcap Credit Facility Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024-08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | MidCap Credit Facility | Prior To Midcap Credit Facility Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFloorRate', window );">Interest rate floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember', window );">SOFR | MidCap Credit Facility</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFloorRate', window );">Interest rate floor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentCapInterestRate', window );">Interest rate cap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Non Convertible Promissory Note | Prior to First Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMaturityMonthAndYear', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024-11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. </span><span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#8220;SOFR&#8221;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentCapInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument cap interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentCapInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument floor rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMaturityMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument maturity month and year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMaturityMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_PriorToMidcapCreditFacilityAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_PriorToMidcapCreditFacilityAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_NonConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_NonConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mnkd_PriorToFirstAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mnkd_PriorToFirstAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444997152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Maturities of the Company's Borrowings (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">22,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal payments</a></td>
<td class="nump">278,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="num">(5,105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt &#8212; net carrying amount</a></td>
<td class="nump">$ 273,490<span></span>
</td>
<td class="nump">$ 281,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444844592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Senior Convertible Notes - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 22, 2021</div></th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 15, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  03,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from offering after deducting initial purchasers discounts and commissions and estimated offering expenses payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000.0<span></span>
</td>
<td class="nump">230,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NumberOfTradingDays', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ConsecutiveTradingDays', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentConvertibleConversionPricePercentage', window );">Conversion price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PrincipalAmountPerShare', window );">Principal amount per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MeasurementPeriodPercentage', window );">Measurement period percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage', window );">Initial conversion price of premium percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">No of convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191.8281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodStartDate', window );">Redemption period start date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  06,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Redemption price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentSinkingFundPayment', window );">Sinking fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionDescription', window );">Debt instrument redemption description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company may redeem for cash all or any portion of the Senior convertible notes, at its option, on or after March 6, 2024 and prior to the 36th scheduled trading day immediately preceding the maturity date, if the last reported sale price of common stock has been at least 130% of the conversion price for the Senior convertible notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Senior convertible notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem less than all of the outstanding Senior convertible notes, at least $75.0 million aggregate principal amount of Senior convertible notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the Senior convertible notes.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Percentage of repurchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault', window );">Debt default, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">If certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries) occur, 100% of the principal of and accrued and unpaid interest on the Senior convertible notes will automatically become due and payable. If an event of default with respect to the Senior convertible notes, other than certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries), occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Senior convertible notes by notice to the Company and the trustee, may, and the trustee at the request of such holders shall, declare 100% of the principal of and accrued and unpaid interest, if any, on all the Senior convertible notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the Senior convertible notes as set forth in the Indenture<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from offering after deducting initial purchasers discounts and commissions and estimated offering expenses payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed', window );">Outstanding principal amount redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consecutive trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentConvertibleConversionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument convertible conversion price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentConvertibleConversionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument initial conversion price of premium percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument outstanding principal amount redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MeasurementPeriodPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Measurement period percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MeasurementPeriodPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PrincipalAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PrincipalAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of debt redemption features under terms of the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Start date of debt instrument redemption period, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentSinkingFundPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount paid into a fund, which is used to retire the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentSinkingFundPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discussion of the facts and amounts pertaining to each failure to comply with an affirmative or negative covenant of a long-term debt instrument, including violating payment terms or an inability to meet certain minimum financial requirements or achieve or maintain certain financial ratios. The discussion would generally be expected to also include whether or not the failure can and will be overcome and a description of the terms of any waivers, including the amount of the waiver and the period of time covered by the waiver, and if reclassification of long-term debt to current has been made in the current balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=SL6230698-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453978896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - MidCap Credit Facility - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 22, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 06, 2019</div></th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  03,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument payment term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember', window );">On or After April 23, 2022 Through and Including April 22, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EarlyTerminationFeesPercentage', window );">Early Termination Fees Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">On or Prior to April 22, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EarlyTerminationFeesPercentage', window );">Early Termination Fees Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember', window );">On or After April 23, 2023 Through Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EarlyTerminationFeesPercentage', window );">Early Termination Fees Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PrepaymentOfSecuredLinesOfCredit', window );">Prepaid of borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Principal prepayment against outstanding term loans</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Debt instrument, prepayment penalty</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentUnamortizedPrepaymentPenalty', window );">Debt Instrument unamortized prepayment penalty.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMinimumCashCovenant', window );">Minimum cash covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Interest on loans increased, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_TermLoanAdvancePercentageOfAmountDrawdown', window );">Term loan advance percentage of amount drawdown</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember', window );">Tranche 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments', window );">Debt Instrument Payment Number of Equal Monthly Installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LineOfCreditFacilityPrincipalPaymentStartDate', window );">Line Of Credit Facility Principal Payment Start Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember', window );">Tranche 1 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFloorRate', window );">Interest rate floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember', window );">Tranche 1 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Advance of borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember', window );">Tranche 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments', window );">Debt Instrument Payment Number of Equal Monthly Installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LineOfCreditFacilityPrincipalPaymentStartDate', window );">Line Of Credit Facility Principal Payment Start Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember', window );">Tranche 2 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFloorRate', window );">Interest rate floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember', window );">Tranche 2 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Advance of borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheThreeMember', window );">Tranche 3 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Amount available under credit facility</a></td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentAdvanceAvailableDate', window );">Debt instrument advance available date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentExtendedInterestOnlyDate', window );">Debt instrument extended interest-only date</a></td>
<td class="text">Sep.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Aug.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument payment term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Mid Cap credit facility has been amended several times, including in April 2021, when the parties agreed to, among other things, (i) increase the amount available under the third advance from $25.0 million to $60.0 million and extend the date through which the third advance is available to June 30, 2022, (ii) amend the conditions to the third advance of $60.0 million being available to draw, including certain milestone conditions associated with Tyvaso DPI, (iii) remove the Company&#8217;s obligation to issue a warrant to purchase shares of the Company&#8217;s common stock upon drawing down the third advance, (iv) extend the interest-only period until September 1, 2023 and extend the maturity date until August 1, 2025, (v) amend the financial covenant relating to trailing 12 month minimum Afrezza net revenue, (vi) decrease the minimum cash covenant, (vii) decrease the interest rate on any amounts outstanding, now or in the future, under the MidCap credit facility, (viii) permit the Company to make certain acquisitions, subject to requirements, and (ix) permit the Company to make investments of up to an additional $9.0 million so long as the Company has $90.0 million or more of unrestricted cash and short-term investments following such investment.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MaximumValueOfAdditionalInvestmentLimit', window );">Maximum value of additional investment limit</a></td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments', window );">Debt instrument minimum unrestricted cash and short-term investments</a></td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentAdvanceAvailableDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument advance available date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentAdvanceAvailableDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentExtendedInterestOnlyDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument extended interest-only date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentExtendedInterestOnlyDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentFloorRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument floor rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentFloorRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMinimumCashCovenant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument minimum cash covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMinimumCashCovenant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument minimum unrestricted cash and short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument payment number of equal monthly installments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentUnamortizedPrepaymentPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument unamortized prepayment penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentUnamortizedPrepaymentPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EarlyTerminationFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Early termination fees percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EarlyTerminationFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LineOfCreditFacilityPrincipalPaymentStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility principal payment start date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LineOfCreditFacilityPrincipalPaymentStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MaximumValueOfAdditionalInvestmentLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum value of additional investment limit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MaximumValueOfAdditionalInvestmentLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PrepaymentOfSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment of secured lines of credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PrepaymentOfSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_TermLoanAdvancePercentageOfAmountDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term loan advance percentage of amount drawdown.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_TermLoanAdvancePercentageOfAmountDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453724048">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Mann Group Promissory Notes - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 22, 2021</div></th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument payment term description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">Nov.  03,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,200<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,011<span></span>
</td>
<td class="nump">15,204<span></span>
</td>
<td class="nump">$ 9,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Promissory Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentFairValueInExcessOfFaceAmount', window );">Debt instrument fair value in excess of face amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital', window );">Debt premium recognized in additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Convertible Promissory Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800<span></span>
</td>
<td class="nump">18,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt issuance amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Conversion of notes to common shares, shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense Debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommonStockIssuedToPayInterest', window );">Common stock issued to pay interest | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Convertible Promissory Note | Accrued Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt issuance amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Conversion of notes to common shares, shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Promissory Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital', window );">Debt premium recognized in additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | New Loan Arrangement | Convertible Promissory Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">No of convertible shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PrincipalAmountPerShare', window );">Principal amount per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | New Loan Arrangement | Promissory Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Senior notes, effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument payment term description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">quarterly<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1', window );">Debt instrument, date of first required interest payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Privately Negotiated Exchange Agreement | Loan Arrangement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Common stock price per share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Privately Negotiated Exchange Agreement | Loan Arrangement | Convertible Promissory Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember', window );">The Mann Group L L C | Privately Negotiated Exchange Agreement | Loan Arrangement | Non-Convertible Note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuedToPayInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to pay interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuedToPayInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentFairValueInExcessOfFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument fair value in excess of face amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentFairValueInExcessOfFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt premium recognized in additional paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PrincipalAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PrincipalAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the debt agreement requires the first payment to be made, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDateOfFirstRequiredPayment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionByUniqueDescriptionAxis=mnkd_AccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionByUniqueDescriptionAxis=mnkd_AccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_NewLoanArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_NewLoanArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_PrivatelyNegotiatedExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_PrivatelyNegotiatedExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_LoanArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_LoanArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_NonConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_NonConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459223904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - PPP Loan - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 22, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Issuance of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  03,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,200)<span></span>
</td>
<td class="num">$ (264)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_PaycheckProtectionProgramCARESActMember', window );">PPP Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Issuance of Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  09,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460319376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AmortizationOfDebtDiscount', window );">Amortization of debt discount</a></td>
<td class="nump">$ 431<span></span>
</td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">$ 1,453<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AmortizationOfDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AmortizationOfDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444613568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Milestone Rights - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent', window );">Remaining milestone rights liability</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PaymentForMilestoneRightsLiabilities', window );">Payment for milestone liability</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneRightsLiabilityCurrent', window );">Milestone rights liability, current</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneLiabilitiesNoncurrent', window );">Milestone liabilities</a></td>
<td class="nump">4,524<span></span>
</td>
<td class="nump">4,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_BaringsGlobalMilestoneRightsMember', window );">Barings Global Milestone Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneLiabilitiesNoncurrent', window );">Milestone liabilities</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone liabilities non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone rights liabilities current and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneRightsLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone rights liability current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneRightsLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentForMilestoneRightsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment for milestone rights liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentForMilestoneRightsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_BaringsGlobalMilestoneRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_BaringsGlobalMilestoneRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818454987632">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Revenue from Collaborations and Services (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 99,770<span></span>
</td>
<td class="nump">$ 75,442<span></span>
</td>
<td class="nump">$ 65,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,851<span></span>
</td>
<td class="nump">34,412<span></span>
</td>
<td class="nump">32,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAgreementMember', window );">License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,426<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
<td class="nump">32,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember', window );">Commercial Supply Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,826<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,924<span></span>
</td>
<td class="nump">36,274<span></span>
</td>
<td class="nump">32,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,426<span></span>
</td>
<td class="nump">34,145<span></span>
</td>
<td class="nump">32,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Commercial Supply Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">24,826<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Co-Promotion Agreement | Vertice Pharma LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">325<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Collaboration and License Agreement | Receptor CLA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | License and Distribution Agreement | Cipla Ltd</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">147<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services | Research Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Next-Gen R&amp;D Services and R&amp;D Services and License for the periods presented.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</span></p></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_VerticePharmaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_VerticePharmaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_ReceptorLifeScienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_ReceptorLifeScienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_CiplaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_CiplaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_OtherAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_OtherAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_ResearchAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_ResearchAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444605008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue From Contract With Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 20,370<span></span>
</td>
<td class="nump">$ 34,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContractWithCustomerLiabilityAdditions', window );">Additions</a></td>
<td class="nump">46,971<span></span>
</td>
<td class="nump">21,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue', window );">Revenue &#8212; collaborations and services</a></td>
<td class="num">(27,924)<span></span>
</td>
<td class="num">(36,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 39,417<span></span>
</td>
<td class="nump">$ 20,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContractWithCustomerLiabilityAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContractWithCustomerLiabilityAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability collaborations and services revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459620480">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Summary of UT Revenue (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 99,770<span></span>
</td>
<td class="nump">$ 75,442<span></span>
</td>
<td class="nump">$ 65,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,851<span></span>
</td>
<td class="nump">34,412<span></span>
</td>
<td class="nump">32,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation | Commercial Supply Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,826<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation | License Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,426<span></span>
</td>
<td class="nump">$ 34,145<span></span>
</td>
<td class="nump">$ 32,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation | Royalties Arrangement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 15,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of royalties associated with the UT License Agreement. </span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_RoyaltiesArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_RoyaltiesArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453314288">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">20 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 16, 2021</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,417,000<span></span>
</td>
<td class="nump">$ 20,370,000<span></span>
</td>
<td class="nump">$ 34,937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue &#8212; current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,733,000<span></span>
</td>
<td class="nump">827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue - non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,684,000<span></span>
</td>
<td class="nump">19,543,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,770,000<span></span>
</td>
<td class="nump">75,442,000<span></span>
</td>
<td class="nump">65,144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,924,000<span></span>
</td>
<td class="nump">36,274,000<span></span>
</td>
<td class="nump">32,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">AFREZZA product sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,247,000<span></span>
</td>
<td class="nump">39,168,000<span></span>
</td>
<td class="nump">32,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,851,000<span></span>
</td>
<td class="nump">34,412,000<span></span>
</td>
<td class="nump">32,213,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation | Manufacturing Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Funding for development of alternative manufacturing processes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember', window );">United Therapeutics Corporation | Commercialization And Continuous Improvement Activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForCapitalImprovements', window );">Funding for capital improvements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,500,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_UpfrontPaymentReceived', window );">Upfront payment received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestonePaymentReceived', window );">Milestone Payment Received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 463,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722,300,000<span></span>
</td>
<td class="nump">483,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
<td class="nump">37,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue &#8212; current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue - non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="nump">36,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Manufacturing Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized during period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AllocatedTransactionPrice', window );">Allocated transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722,300,000<span></span>
</td>
<td class="nump">483,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Manufacturing Services | Transaction Price For The Contractual Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000,000.0<span></span>
</td>
<td class="nump">71,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Next-Gen R&amp;D Services | Transaction Price For The Performance Obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602,300,000<span></span>
</td>
<td class="nump">$ 411,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Clinical Supplies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived', window );">Additional option exercise and development milestone payments to be receive</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Tyvaso DPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,500,000<span></span>
</td>
<td class="nump">$ 221,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember', window );">Commercial Supply Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_AgreementAmendmentDescription', window );">Amendment description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As amended , the term of the CSA continues until December 31, 2031 (unless earlier terminated) and is thereafter renewed automatically for additional, successive two-year terms unless (i) United Therapeutics provides notice to the Company at least 24 months in advance of such renewal that United Therapeutics does not wish to renew the CSA or (ii) the Company provides notice to United Therapeutics at least 48 months in advance of such renewal that the Company does not wish to renew the CSA.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember', window );">Commercial Supply Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,826,000<span></span>
</td>
<td class="nump">267,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember', window );">Commercial Supply Agreement | United Therapeutics Corporation | Collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,826,000<span></span>
</td>
<td class="nump">267,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember', window );">Co-Promotion Agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostImpairmentLoss', window );">Impairment on contract assets related to variable consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember', window );">Co-Promotion Agreement | Collaborations and services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss', window );">Reserve for allowance for doubtful accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember', window );">Co-Promotion Agreement | Vertice Pharma LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_AmendmentToCoPromotionAgreementMember', window );">Amendment to Co Promotion Agreement | Vertice Pharma LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentageOfModificationOfPreviouslyFixedConsideration', window );">Percentage of modification of previously fixed consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_SupplyAndDistributionAgreementMember', window );">Supply and Distribution Agreement | AFREZZA product sales | Biomm</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember', window );">License and Distribution Agreement | Cipla Ltd</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue &#8212; current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue - non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DateOfAgreementInitiationForMarketingAndDistribution', window );">Marketing and distribution agreement date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2018-05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember', window );">License and Distribution Agreement | Collaborations and services | Cipla Ltd</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue from UT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,000<span></span>
</td>
<td class="nump">$ 147,000<span></span>
</td>
<td class="nump">$ 147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</span></p></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional option exercise and development milestone payments to be received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AgreementAmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement amendment description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AgreementAmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_AllocatedTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocated transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_AllocatedTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DateOfAgreementInitiationForMarketingAndDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date of agreement initiation for marketing and distribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DateOfAgreementInitiationForMarketingAndDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestonePaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestonePaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentageOfModificationOfPreviouslyFixedConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of modification of previously fixed consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentageOfModificationOfPreviouslyFixedConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue remaining performance obligation anticipated cash flow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_UpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_UpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130534-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForCapitalImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForCapitalImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_ManufacturingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_ManufacturingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_CommercializationAndContinuousImprovementActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_CommercializationAndContinuousImprovementActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mnkd_TransactionPriceForTheContractualObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mnkd_TransactionPriceForTheContractualObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mnkd_TransactionPriceForThePerformanceObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mnkd_TransactionPriceForThePerformanceObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TyvasoDPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TyvasoDPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CommercialSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_VerticePharmaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_VerticePharmaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_AmendmentToCoPromotionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_AmendmentToCoPromotionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_SupplyAndDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_SupplyAndDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_BiommSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_BiommSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_CiplaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_CiplaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453802784">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Oct. 16, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember', window );">R&amp;D Services and License | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ratably<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">May 2021 - Oct 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_PreCommercialServicesMember', window );">Pre-Commercial Services | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Input<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember', window );">Next-Gen R&amp;D Services | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Input<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_FacilityExpansionServicesMember', window );">Facility Expansion Services | Point In Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="text">Transfer of control<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | R&amp;D Services and License | United Therapeutics Corporation | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6],[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Next-Gen R&amp;D Services | United Therapeutics Corporation | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Input<span></span>
</td>
<td class="text">Input<span></span>
</td>
<td class="text">Input<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8],[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember', window );">Clinical Supplies | Collaboration and License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember', window );">Clinical Supplies | Collaboration and License Agreement | R&amp;D Services and License | United Therapeutics Corporation | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total transaction price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Allocation of Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep 2018 - Dec 2021<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&amp;D Services performance obligation was recognized.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The standalone selling price (&#8220;SSP&#8221;) for the Next-Gen R&amp;D Services performance obligation was based on industry ratios as well as the Company&#8217;s historical R&amp;D projects. The transaction price for the Next-Gen R&amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Recognition period represents the estimated period to satisfy the performance obligation.</span></p></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of method used to recognize revenue for performance obligation that is satisfied over time. Includes, but not is limited to, output or input method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of when remaining performance obligation is expected to be recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_PreCommercialServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_PreCommercialServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_FacilityExpansionServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_FacilityExpansionServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=mnkd_ClinicalSuppliesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453177360">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th" colspan="2"><div>Oct. 16, 2021</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember', window );">R&amp;D Services and License | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Ratably<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">May 2021 - Oct 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember', window );">Next-Gen R&amp;D Services | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Input<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Tyvaso DPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 221,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 221,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Tyvaso DPI | R&amp;D Services and License | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Ratably<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Tyvaso DPI | Next-Gen R&amp;D Services | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Input<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | Tyvaso DPI | Manufacturing Services | Point In Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 206,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">Transfer of control<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow', window );">Total anticipated cash flows</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 463,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 483,200,000<span></span>
</td>
<td class="nump">$ 722,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | R&amp;D Services and License | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
<td class="text">Ratably<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8],[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="text">Aug 2021 - Oct 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Next-Gen R&amp;D Services | Over Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription', window );">Progress Measure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Input<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Input<span></span>
</td>
<td class="text">Input<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">% of completion of costs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember', window );">Collaboration and License Agreement | United Therapeutics Corporation | Manufacturing Services | Point In Time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 458,700,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 477,200<span></span>
</td>
<td class="nump">$ 712,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation', window );">Recognition Period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Transfer of control<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Transfer of control<span></span>
</td>
<td class="text">Transfer of control<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Allocation is based on management&#8217;s assessment of the stand-alone selling price of each performance obligation.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The license for the Company&#8217;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&amp;D Services performance obligation was recognized.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">The standalone selling price (&#8220;SSP&#8221;) for the Next-Gen R&amp;D Services performance obligation was based on industry ratios as well as the Company&#8217;s historical R&amp;D projects. The transaction price for the Next-Gen R&amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-size:9pt;color:#000000;">Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#8217;s Manufacturing Services performance obligation, given the nature of the Company&#8217;s contractual responsibilities and ASC 606 requirements.</span></p></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#8217;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#8217;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received</span>.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue remaining performance obligation anticipated cash flow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of method used to recognize revenue for performance obligation that is satisfied over time. Includes, but not is limited to, output or input method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of when remaining performance obligation is expected to be recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_ResearchAndDevelopmentServicesAndLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_NextGenResearchAndDevelopmentServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TyvasoDPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TyvasoDPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mnkd_ManufacturingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mnkd_ManufacturingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459217904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember', window );">Co-Promotion Agreement | Vertice Pharma LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember', window );">Co-Promotion Agreement | Vertice Pharma LLC | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue recognition period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember', window );">License and Distribution Agreement | Cipla Ltd | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2018-06-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Anticipated Revenue Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_CoPromotionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_VerticePharmaLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_VerticePharmaLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_LicenseAndDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_CiplaLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_CiplaLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2018-06-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2018-06-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459520720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,767<span></span>
</td>
<td class="nump">$ 124,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing liability, long term</a></td>
<td class="nump">94,512<span></span>
</td>
<td class="nump">93,525<span></span>
</td>
<td class="nump">$ 94,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing liability, short term</a></td>
<td class="nump">$ 9,565<span></span>
</td>
<td class="nump">6,977<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMeasurementInputAfterChange', window );">Note payable, percentage of hypothetical yield</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 69,800<span></span>
</td>
<td class="nump">$ 124,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMeasurementInputAfterChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument measurement input after change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMeasurementInputAfterChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FairValueOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FairValueOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818453922432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">$ 41.1<span></span>
</td>
<td class="nump">$ 40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_ContingentMilestoneLiabilityMember', window );">Contingent Milestone Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_MilestoneRightsLiabilityMember', window );">Milestone Rights Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">253.9<span></span>
</td>
<td class="nump">237.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">253.9<span></span>
</td>
<td class="nump">237.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount | Mann Group Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount | Contingent Milestone Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount | Milestone Rights Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount | Senior Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">225.4<span></span>
</td>
<td class="nump">223.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">225.4<span></span>
</td>
<td class="nump">223.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Fair Value, Inputs, Level 3 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="nump">40.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Mann Group Convertible Note | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">37.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Contingent Milestone Liability | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Milestone Rights Liability | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Senior Convertible Notes | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">253.9<span></span>
</td>
<td class="nump">237.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total financial liabilities fair value</a></td>
<td class="nump">$ 253.9<span></span>
</td>
<td class="nump">$ 237.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_MannGroupConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_MannGroupConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ContingentMilestoneLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ContingentMilestoneLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459644096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMeasurementInputAfterChange', window );">Note payable, percentage of hypothetical yield</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,200)<span></span>
</td>
<td class="num">$ (264)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMeasurementInputAfterChange', window );">Note payable, percentage of hypothetical yield</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NotePayablePercentageOfInterestRateChange', window );">Note payable, percentage of interest rate increases (decreases)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 41,100<span></span>
</td>
<td class="nump">$ 40,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">39,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 42,400<span></span>
</td>
<td class="nump">$ 42,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMeasurementInputAfterChange', window );">Note payable, percentage of hypothetical yield</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NotePayablePercentageOfInterestRateChange', window );">Note payable, percentage of interest rate increases (decreases)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="num">$ (22,100)<span></span>
</td>
<td class="num">$ (22,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital', window );">Substantial premium based on fair value post modification recognized as additional paid-in capital</a></td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Note payable, percentage of volatility</a></td>
<td class="nump">77.8<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="nump">$ 36,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 21,200<span></span>
</td>
<td class="nump">$ 38,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtInstrumentMeasurementInputAfterChange', window );">Note payable, percentage of hypothetical yield</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NotePayablePercentageOfInterestRateChange', window );">Note payable, percentage of interest rate increases (decreases)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 253,900<span></span>
</td>
<td class="nump">$ 237,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes | Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Note payable, percentage of volatility</a></td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 245,000<span></span>
</td>
<td class="nump">$ 226,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FairValueOfFinancialInstrumentsLineItems', window );"><strong>Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value</a></td>
<td class="nump">$ 263,400<span></span>
</td>
<td class="nump">$ 249,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtInstrumentMeasurementInputAfterChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument measurement input after change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtInstrumentMeasurementInputAfterChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FairValueOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FairValueOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NotePayablePercentageOfInterestRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note payable, percentage of interest rate change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NotePayablePercentageOfInterestRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Substantial premium based on fair value post modification recognized as additional paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MannGroupConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818446066896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common and Preferred Stock - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 09, 2020</div></th>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Undesignated preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Undesignated preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,793,305<span></span>
</td>
<td class="nump">251,477,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,793,305<span></span>
</td>
<td class="nump">251,477,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Undesignated preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,638<span></span>
</td>
<td class="nump">$ 2,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from stock purchase plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MarketPriceStockPurchasePlan', window );">Market price stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,176<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,283,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember', window );">QrumPharma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,067,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_MidCapCreditFacilityMember', window );">MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_UnderwritingAgreementMember', window );">Underwriting Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares sold during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_RemainingWarrantsAvailableForPurchase', window );">Remaining Warrants Available for Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note | The Mann Group L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Issuance of common stock to note holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue', window );">Conversion of notes accrued interest to common shares, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes', window );">Conversion of notes accrued interest to common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt issuance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommonStockIssuedToPayInterest', window );">Common stock issued to pay interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandTwentyFourConvertibleNotesMember', window );">2024 Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Issuance of common stock to note holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt issuance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember', window );">Tranche 1 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,171,614<span></span>
</td>
<td class="nump">1,171,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember', window );">Tranche 2 | MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="nump">111,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares sold during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | June 2020 Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Issuance of common stock to note holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | December 2020 Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Issuance of common stock to note holders</a></td>
<td class="nump">1,377,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_ContolledEquityOfferingSalesAgreementMember', window );">Contolled Equity Offering Sales Agreement | Cantor Fitzgerald</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockTransactionDate', window );">Stock purchase agreements date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_ContolledEquityOfferingSalesAgreementMember', window );">Contolled Equity Offering Sales Agreement | Cantor Fitzgerald | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_ContolledEquityOfferingSalesAgreementMember', window );">Contolled Equity Offering Sales Agreement | Cantor Fitzgerald | Common Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Amount of net proceeds from issuance of securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_AtMarketIssuanceSalesAgreementMember', window );">At Market Issuance Sales Agreement | Cantor Fitzgerald | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Amount of net proceeds from issuance of securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 23,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares sold during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,059,856<span></span>
</td>
<td class="nump">578,063<span></span>
</td>
<td class="nump">11,851,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_AtMarketIssuanceSalesAgreementMember', window );">At Market Issuance Sales Agreement | Cantor Fitzgerald | Common Stock | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Exchange price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.99<span></span>
</td>
<td class="nump">$ 3.91<span></span>
</td>
<td class="nump">$ 3.26<span></span>
</td>
<td class="nump">$ 1.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommonStockIssuedToPayInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to pay interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommonStockIssuedToPayInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt conversion converted instrument accrued interest of notes value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt conversion converted instrument shares issued for accrued interest of notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MarketPriceStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market price stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MarketPriceStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_RemainingWarrantsAvailableForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining Warrants Available for Purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_RemainingWarrantsAvailableForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mnkd_QrumPharmaIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_MidCapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_MidCapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_TheMannGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TwoThousandTwentyFourConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TwoThousandTwentyFourConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_JuneTwoThousandTwentyNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_JuneTwoThousandTwentyNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mnkd_DecemberTwoThousandTwentyNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mnkd_DecemberTwoThousandTwentyNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_ContolledEquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_ContolledEquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mnkd_CantorFitzgeraldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mnkd_CantorFitzgeraldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_AtMarketIssuanceSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_AtMarketIssuanceSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818455070464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share ("EPS") - Components of Basic and Diluted EPS Computations (Detail) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EarningPerShareBasicAndDilutedAbstract', window );"><strong>EPS &#8212; basic and diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss (numerator)</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,240)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares (denominator)</a></td>
<td class="nump">257,092<span></span>
</td>
<td class="nump">249,244<span></span>
</td>
<td class="nump">222,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, Basic</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, Diluted</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.26)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EarningPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earning per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EarningPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818445070128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Common Share ("EPS") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">75,451,760<span></span>
</td>
<td class="nump">69,998,009<span></span>
</td>
<td class="nump">32,745,273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_SeniorConvertibleNotesMember', window );">Senior Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">44,120,463<span></span>
</td>
<td class="nump">44,120,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember', window );">Common Stock Options and PNQs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">9,074,587<span></span>
</td>
<td class="nump">10,655,146<span></span>
</td>
<td class="nump">12,264,616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_MannGroupConvertibleNoteMember', window );">Mann Group Convertible Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">3,370,000<span></span>
</td>
<td class="nump">7,370,000<span></span>
</td>
<td class="nump">11,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember', window );">Warrants Associated with MidCap Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,283,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_ConvertibleNotesMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,375<span></span>
</td>
<td class="nump">292,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember', window );">RSUs and Market RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">18,886,710<span></span>
</td>
<td class="nump">7,609,025<span></span>
</td>
<td class="nump">6,037,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_SeniorConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_SeniorConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_MannGroupConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_MannGroupConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818447582144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 17, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 16, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,447,000<span></span>
</td>
<td class="nump">$ 12,200,000<span></span>
</td>
<td class="nump">$ 6,511,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options issued or granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of the stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of the stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from the exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding', window );">Total grant date fair value of restricted stock units outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,200,000<span></span>
</td>
<td class="nump">19,300,000<span></span>
</td>
<td class="nump">13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,082,000<span></span>
</td>
<td class="nump">1,090,000<span></span>
</td>
<td class="nump">684,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">686,000<span></span>
</td>
<td class="nump">527,000<span></span>
</td>
<td class="nump">627,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=mnkd_EmployeeMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=mnkd_EmployeeMember', window );">Employee | ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue', window );">Discount on purchase price percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8500.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Grant date fair value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate', window );">Vesting date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 10,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Common stock price per share</a></td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense related to non-option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Less than 25th Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentileRankOfShareholderReturnOfStock', window );">Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage', window );">Percent of target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 25th Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentileRankOfShareholderReturnOfStock', window );">Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage', window );">Percent of target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 50th Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentileRankOfShareholderReturnOfStock', window );">Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage', window );">Percent of target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 75th Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentileRankOfShareholderReturnOfStock', window );">Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage', window );">Percent of target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 90th Percentile or Higher</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PercentileRankOfShareholderReturnOfStock', window );">Percentile</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum | 90th Percentile or Higher</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage', window );">Percent of target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mnkd_RestrictedStockUnitsAndOptionsMember', window );">RSUs and Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="nump">$ 11,500,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mnkd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember', window );">Options and Performance-based Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember', window );">2018 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Equity incentive plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares', window );">Equity incentive plan, number of shares available for grant increased by shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld', window );">Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember', window );">2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Equity incentive plan, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount on purchase price percentage of fair market value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PercentileRankOfShareholderReturnOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentile rank of shareholder return of stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PercentileRankOfShareholderReturnOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options in period grant date fair value outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of shares available for grant increased by shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award target percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award vesting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=mnkd_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=mnkd_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=mnkd_GroupOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=mnkd_GroupOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=mnkd_GroupTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=mnkd_GroupTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=mnkd_GroupThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=mnkd_GroupThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=mnkd_GroupFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=mnkd_GroupFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=mnkd_GroupFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=mnkd_GroupFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mnkd_RestrictedStockUnitsAndOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mnkd_RestrictedStockUnitsAndOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mnkd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mnkd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458166704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Award Plans - Stock Based Award Plans (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">9,074,587<span></span>
</td>
<td class="nump">10,732,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding Restricted Stock Units</a></td>
<td class="nump">11,838,329<span></span>
</td>
<td class="nump">9,538,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Future Issuance</a></td>
<td class="nump">2,802,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember', window );">2004 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">1,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember', window );">2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">3,240,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember', window );">2018 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Options</a></td>
<td class="nump">5,832,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding Restricted Stock Units</a></td>
<td class="nump">11,838,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Future Issuance</a></td>
<td class="nump">2,802,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_TwoThousandFourEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mnkd_EquityIncentivePlanTwentyEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818459227296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 13,447<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="nump">$ 6,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=mnkd_CostOfRevenueCollaborationsAndServicesMember', window );">Cost of Revenue - Collaborations and Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="nump">$ 9,455<span></span>
</td>
<td class="nump">$ 6,893<span></span>
</td>
<td class="nump">$ 3,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mnkd_CostOfRevenueCollaborationsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mnkd_CostOfRevenueCollaborationsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458956640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">2.63%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">3.11%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="nump">92.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="nump">93.62%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected lives</a></td>
<td class="text">7 years 2 months 8 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818445048640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Summary of Stock Options Outstanding (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at January 1, 2022</a></td>
<td class="nump">10,732,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(1,196,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(116,767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="num">(344,768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31, 2022</a></td>
<td class="nump">9,074,587<span></span>
</td>
<td class="nump">10,732,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">7,776,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at January 1, 2022</a></td>
<td class="nump">$ 3.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">1.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">1.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired</a></td>
<td class="nump">6.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2022</a></td>
<td class="nump">3.06<span></span>
</td>
<td class="nump">$ 3.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">$ 3.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 5 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at December 31, 2022</a></td>
<td class="text">5 years 1 month 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 29,512<span></span>
</td>
<td class="nump">$ 34,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at December 31, 2022</a></td>
<td class="nump">$ 25,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461376240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at January 1, 2022 | shares</a></td>
<td class="nump">9,538,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">5,120,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(1,551,088)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited | shares</a></td>
<td class="num">(1,269,297)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at December 31, 2022 | shares</a></td>
<td class="nump">11,838,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at January 1, 2022 | $ / shares</a></td>
<td class="nump">$ 3.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">3.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested | $ / shares</a></td>
<td class="nump">2.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited | $ / shares</a></td>
<td class="nump">3.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at December 31, 2022 | $ / shares</a></td>
<td class="nump">$ 3.65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818446252000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 08, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Vehicle</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2013 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,000<span></span>
</td>
<td class="nump">863,000<span></span>
</td>
<td class="nump">$ 1,403,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,100,000<span></span>
</td>
<td class="nump">100,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing liability, long term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,512,000<span></span>
</td>
<td class="nump">93,525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing liability, short term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,565,000<span></span>
</td>
<td class="nump">6,977,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee', window );">Payment of long term purchase commitment, amendment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LongTermPurchaseCommitmentExpirationDate', window );">Supply Agreement expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LongtermPurchaseCommitmentRenewalTimePeriod', window );">Supply Agreement renewal period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,714,000<span></span>
</td>
<td class="nump">$ 2,284,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,647,000<span></span>
</td>
<td class="nump">$ 2,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Description of right to extension of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company will receive a six-month concession at the start of the lease extension period on July 31, 2023. The Company has no further right to extend the lease term beyond the extension period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | V-Go</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_MasterLeaseAgreementWithEnterpriseMember', window );">Master Lease Agreement with Enterprise | Vehicle Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NumberOfVehicleLeasesRetired', window );">Number of vehicle leases retired | Vehicle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NumberOfVehicleLeasesReplaced', window );">Number of vehicle leases replaced | Vehicle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NumberOfVehicleLeases', window );">Number of vehicle leases | Vehicle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain or loss recorded for leases removed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mnkd_MarlboroughLeaseMember', window );">Marlborough Lease | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,895,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_OperatingLeasesAnnualIncreaseInRentExpense', window );">Percentage of annual increase in lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mnkd_CasperLLCMember', window );">Casper L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstate', window );">Sale price</a></td>
<td class="nump">$ 102,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease initial term</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal option</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingSubleaseOptionToExtend', window );">Lease renewal options</a></td>
<td class="text">renewal options of five years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend', window );">Lessee,option to extend [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionLeaseTerms', window );">Lease, description</a></td>
<td class="text">The total annual rent under the Lease starts at approximately $9.5 million per year, subject to a 50% rent abatement during the first year of the Lease, and will increase annually by (i) 2.5% in the second through fifth year of the Lease and (ii) 3% in the sixth and each subsequent year of the Lease, including any renewal term.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LeaseRepurchaseDescription', window );">Lease repurchase description</a></td>
<td class="text">the Company has four options to repurchase the Property, in 2026, 2031, 2036 and 2041, for the greater of (i) $102.3 million and (ii) the fair market value of the Property.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Casper L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Lease repurchase, amount</a></td>
<td class="nump">$ 102,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiabilityRemainingPayableAmount', window );">Contingent liability remain payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_MilestoneRightLiability', window );">Milestone rights liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember', window );">Deerfield | Milestone Rights Liability | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiability', window );">Contingent liability for milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ContingentLiabilityRemainingPayableAmount', window );">Contingent liability remain payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mnkd_RussellRanchRoadIILLCMember', window );">Russell Ranch Road II LLC | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,543<span></span>
</td>
<td class="nump">$ 40,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_OperatingLeasesAnnualIncreaseInRentExpense', window );">Percentage of annual increase in lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_LeaseExpirationMonthAndYear', window );">Lease expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ContingentLiabilityRemainingPayableAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent liability remaining payable amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ContingentLiabilityRemainingPayableAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LeaseExpirationMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease expiration month and year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LeaseExpirationMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LeaseRepurchaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease repurchase description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LeaseRepurchaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LongTermPurchaseCommitmentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Purchase Commitment, Expiration Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LongTermPurchaseCommitmentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_LongtermPurchaseCommitmentRenewalTimePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term purchase commitment, renewal time period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_LongtermPurchaseCommitmentRenewalTimePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_MilestoneRightLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone rights liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_MilestoneRightLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfVehicleLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of vehicle leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfVehicleLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfVehicleLeasesReplaced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of vehicle leases replaced.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfVehicleLeasesReplaced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NumberOfVehicleLeasesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of vehicle leases retired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NumberOfVehicleLeasesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OperatingLeasesAnnualIncreaseInRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating leases annual increase in rent expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OperatingLeasesAnnualIncreaseInRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of long term purchase commitment amendment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether sublessee has option to extend operating sublease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingSubleaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend operating sublease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingSubleaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the sale of real estate that is not part of an investing activity during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123416376&amp;loc=d3e50796-112755<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 51<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51840-112757<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51843-112757<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 50<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51831-112757<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mnkd_VGoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mnkd_VGoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_MasterLeaseAgreementWithEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_MasterLeaseAgreementWithEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mnkd_MarlboroughLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mnkd_MarlboroughLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mnkd_CasperLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mnkd_CasperLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_DeerfieldManagementCompanyLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mnkd_MilestoneRightsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mnkd_RussellRanchRoadIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mnkd_RussellRanchRoadIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_OfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_OfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461478480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">18 years 9 months 18 days<span></span>
</td>
<td class="text">19 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464252304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary of Financing Liability Costs (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_InterestExpenseOnFinancingLiability', window );">Interest expense on financing liability</a></td>
<td class="nump">$ 9,758<span></span>
</td>
<td class="nump">$ 1,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_InterestExpenseOnFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense on financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_InterestExpenseOnFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461063456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Lease Liabilities Payments Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 9,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">10,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">10,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">10,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">10,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">188,453<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue', window );">Total</a></td>
<td class="nump">239,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedExcessAmount', window );">Interest payments</a></td>
<td class="num">(132,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(2,883)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_FinanceLeaseLiabilityDiscounted', window );">Total financing liability</a></td>
<td class="nump">$ 104,077<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted excess amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due after year five.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due year five.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due year three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance lease liability discounted payments due year two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818464072112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Remaining Purchase Requirements (Detail)<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase Obligation Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">2023</a></td>
<td class="nump">&#8364; 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">2024</a></td>
<td class="nump">14.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">2025</a></td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">2026</a></td>
<td class="nump">19.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">2027</a></td>
<td class="nump">&#8364; 9.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461000528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use asset</a></td>
<td class="nump">$ 6,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability-current (2)</a></td>
<td class="nump">$ 1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued expenses and other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accrued expenses and other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">$ 5,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Operating lease liability<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Operating lease liability<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 6,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Incremental borrowing rate</a></td>
<td class="nump">7.30%<span></span>
</td>
<td class="nump">7.25%<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461361952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary of Lease Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 1,525<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 1,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="nump">394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid</a></td>
<td class="nump">$ 1,823<span></span>
</td>
<td class="nump">$ 1,867<span></span>
</td>
<td class="nump">$ 1,797<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542510576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">$ 6,647<span></span>
</td>
<td class="nump">$ 2,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_OfficeAndVehicleMember', window );">office and vehicle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year 1</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Year 2</a></td>
<td class="nump">1,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Year 3</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Year 4</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Year 5</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">7,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Interest expense</a></td>
<td class="num">(1,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">$ 6,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_OfficeAndVehicleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mnkd_OfficeAndVehicleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818542493792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution deferral rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Total discretionary matching contributions</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=mnkd_OneYearServiceMember', window );">One Year Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage', window );">Employers matching contribution vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=mnkd_TwoYearServiceMember', window );">Two Year Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage', window );">Employers matching contribution vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employees' compensation</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mnkd_OneYearServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mnkd_OneYearServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mnkd_TwoYearServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mnkd_TwoYearServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818543395248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss from Continuing Operations Before Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,458)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax expense</a></td>
<td class="num">$ (87,400)<span></span>
</td>
<td class="num">$ (80,926)<span></span>
</td>
<td class="num">$ (57,458)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460364144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provision for Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (218)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">U.S. federal</a></td>
<td class="num">$ (5,606)<span></span>
</td>
<td class="num">$ (5,170)<span></span>
</td>
<td class="num">(4,377)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">U.S. state</a></td>
<td class="num">(4,334)<span></span>
</td>
<td class="num">(14,461)<span></span>
</td>
<td class="num">(469)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(9,940)<span></span>
</td>
<td class="num">(19,631)<span></span>
</td>
<td class="num">(4,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance</a></td>
<td class="nump">9,940<span></span>
</td>
<td class="nump">19,631<span></span>
</td>
<td class="nump">4,846<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818461097808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Components of Net Deferred Tax Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 542,537<span></span>
</td>
<td class="nump">$ 542,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">78,804<span></span>
</td>
<td class="nump">78,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsCapitalizedResearchExpenses', window );">Capitalized research costs</a></td>
<td class="nump">4,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsMilestoneRights', window );">Milestone Rights</a></td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment', window );">Accrued expenses</a></td>
<td class="nump">2,675<span></span>
</td>
<td class="nump">2,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsLossOnPurchaseCommitment', window );">Loss on purchase commitment</a></td>
<td class="nump">23,117<span></span>
</td>
<td class="nump">24,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Non-qualified stock option expense</a></td>
<td class="nump">7,686<span></span>
</td>
<td class="nump">5,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsCapitalizedCosts', window );">Capitalized patent costs</a></td>
<td class="nump">8,058<span></span>
</td>
<td class="nump">7,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">3,204<span></span>
</td>
<td class="nump">2,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">1,624<span></span>
</td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsInterestExpenseLimitation', window );">Interest expense limitation</a></td>
<td class="nump">10,991<span></span>
</td>
<td class="nump">5,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Depreciation</a></td>
<td class="nump">22,157<span></span>
</td>
<td class="nump">22,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsProductRevenueAndCosts', window );">Deferred Product Revenue &amp; Costs</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total net deferred tax assets</a></td>
<td class="nump">706,923<span></span>
</td>
<td class="nump">695,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(705,034)<span></span>
</td>
<td class="num">(695,094)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use asset</a></td>
<td class="num">(1,640)<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Other prepaids</a></td>
<td class="num">(249)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">$ (1,889)<span></span>
</td>
<td class="num">$ (827)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Capitalized Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsCapitalizedResearchExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Capitalized Research Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsCapitalizedResearchExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsInterestExpenseLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets interest expense limitation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsInterestExpenseLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsLossOnPurchaseCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Loss on Purchase Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsLossOnPurchaseCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsMilestoneRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Milestone Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsMilestoneRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsProductRevenueAndCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets product revenue and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsProductRevenueAndCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense (Accrual Adjustment)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818460105760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax benefit rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(4.40%)<span></span>
</td>
<td class="num">(6.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute', window );">Tax attribute expirations</a></td>
<td class="num">(13.20%)<span></span>
</td>
<td class="num">(5.90%)<span></span>
</td>
<td class="num">(6.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax', window );">Foreign withholding tax</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(7.20%)<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="num">(7.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation expirations of attribute.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation foreign withholding tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Permanent Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818444746720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2004</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance of deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 705,034,000<span></span>
</td>
<td class="nump">$ 695,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in the valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,940,000<span></span>
</td>
<td class="nump">19,631,000<span></span>
</td>
<td class="nump">$ 4,846,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Federal operation loss carryforwards, not subject to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards, limitations on use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant to IRC Sections 382 and 383, annual use of the Company&#8217;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_OperatingLossCarryforwardsSubjectToLimitation', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 105,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_NetOperatingLossCarryforwardAnnualLimitation', window );">Net operating loss and credit carryforwards, annual use limitation</a></td>
<td class="nump">$ 13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire', window );">Research and development credits begin to expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire', window );">Research and development credits expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized income tax interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire', window );">Research and development credits not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire', window );">Research and development credits begin to expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire', window );">Research and development credits not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_NewJerseyDivisionOfTaxationMember', window );">New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire', window );">Research and development credits begin to expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=mnkd_ConnecticutTaxAuthorityMember', window );">Connecticut</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire', window );">Research and development credits not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=mnkd_CaliforniaDivisionOfTaxationMember', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire', window );">Research and development credits not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets tax credit carryforwards research expire.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets tax credit carryforwards research not expire.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_NetOperatingLossCarryforwardAnnualLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Operating Loss Carryforward Annual Limitation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_NetOperatingLossCarryforwardAnnualLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_OperatingLossCarryforwardsSubjectToLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Subject To Limitation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_OperatingLossCarryforwardsSubjectToLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mnkd_ResearchAndDevelopmentCreditsBeginToExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits, Begin to Expire</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mnkd_ResearchAndDevelopmentCreditsBeginToExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mnkd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=mnkd_ConnecticutTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=mnkd_ConnecticutTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=mnkd_CaliforniaDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=mnkd_CaliforniaDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139818458907664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning of Year</a></td>
<td class="nump">$ 268,902<span></span>
</td>
<td class="nump">$ 268,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases for tax positions of prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 268,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">End of Year</a></td>
<td class="nump">$ 268,902<span></span>
</td>
<td class="nump">$ 268,902<span></span>
</td>
<td class="nump">$ 268,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>mnkd-10k_20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mnkd="http://www.mannkindcorp.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mnkd-20221231.xsd" xlink:type="simple"/>
    <context id="C_0000899460_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20230210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2023-02-10</instant>
        </period>
    </context>
    <context id="C_0000899460_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_0000899460_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesPrincipalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:SeniorConvertibleNotesInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotePrincipalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNoteInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertibleNoteInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnkd:AtTheMarketIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMinimumMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMaximumMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210601_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20220101_20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_us-gaapLongLivedAssetsHeldForSaleByAssetTypeAxis_mnkdCommitmentAssetMember_20200401_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongLivedAssetsHeldForSaleByAssetTypeAxis">mnkd:CommitmentAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:InsulinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-31</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputEntityCreditRiskMember_20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputEntityCreditRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201201_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201201_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnkd:QrumPharmaIncorporatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:ThironaBioIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">mnkd:DueInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">mnkd:DueInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:AmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:GrossUnrealizedHoldingLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:EstimatedFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:PreLaunchInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:PreLaunchInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdAgreementWithRetailPharmacyMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">mnkd:AgreementWithRetailPharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:UTEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210401_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_20210401_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToMidcapCreditFacilityAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToFirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210401_20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mnkd:PriorToFirstAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-15</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-04</startDate>
            <endDate>2021-03-04</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-22</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-22</startDate>
            <endDate>2021-04-22</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-22</startDate>
            <endDate>2021-04-22</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodOneMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodThreeMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190806_20190806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-06</startDate>
            <endDate>2019-08-06</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertibleNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:NonConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:LoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:PrivatelyNegotiatedExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-22</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20210422_20210422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2021-04-22</startDate>
            <endDate>2021-04-22</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:NewLoanArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">mnkd:AccruedInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TheMannGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:BaringsGlobalMilestoneRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:BaringsGlobalMilestoneRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:OtherAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:OtherAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:ReceptorLifeScienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:ReceptorLifeScienceIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdResearchAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ResearchAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdRoyaltiesArrangementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:RoyaltiesArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20190401_20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">mnkd:ClinicalSuppliesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:PreCommercialServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:FacilityExpansionServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:PreCommercialServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:FacilityExpansionServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20211031_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2021-10-31</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:TyvasoDPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CommercialSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-16</startDate>
            <endDate>2021-10-16</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-16</startDate>
            <endDate>2021-10-16</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-16</startDate>
            <endDate>2021-10-16</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-16</startDate>
            <endDate>2021-10-16</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:CommercializationAndContinuousImprovementActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221201_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:CommercializationAndContinuousImprovementActivitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ResearchAndDevelopmentServicesAndLicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:ManufacturingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForTheContractualObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mnkd:NextGenResearchAndDevelopmentServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mnkd:TransactionPriceForThePerformanceObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:UnitedTherapeuticsCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdAmendmentToCoPromotionAgreementMember_20210701_20210701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AmendmentToCoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:VerticePharmaLLCMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:CoPromotionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:BiommSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:SupplyAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180501_20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2018-06-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CiplaLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:LicenseAndDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:ContingentMilestoneLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20220201_20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180201_20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:ContolledEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mnkd:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdJuneTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200624_20200624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:JuneTwoThousandTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-24</startDate>
            <endDate>2020-06-24</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdDecemberTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201009_20201009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:DecemberTwoThousandTwentyNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-09</startDate>
            <endDate>2020-10-09</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdMidCapCreditFacilityMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TwoThousandTwentyFourConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnkd:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MidCapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:SeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:SeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:MannGroupConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdWarrantsAssociatedWithMidcapCreditFacilityMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:WarrantsAssociatedWithMidcapCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdConvertibleNotesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:RestrictedStockUnitsAndMarketRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20180516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-16</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-17</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-17</startDate>
            <endDate>2021-05-17</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">mnkd:GroupFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdTwoThousandFourEquityIncentivePlanMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnkd:EquityIncentivePlanTwentyEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:RestrictedStockUnitsAndOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mnkd:CostOfRevenueCollaborationsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMinimumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockOptionsAndPerformanceBasedOptionsMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnkd:EmployeeStockOptionsAndPerformanceBasedOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">mnkd:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20130701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mnkd:MilestoneRightsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:DeerfieldManagementCompanyLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-07-01</instant>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211101_20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-08</instant>
        </period>
    </context>
    <context id="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_srtRangeAxis_srtMinimumMember_20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mnkd:CasperLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-08</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:MasterLeaseAgreementWithEnterpriseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2017-11-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnkd:RussellRanchRoadIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnkd:MarlboroughLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20220601_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mnkd:VGoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mnkd:OfficeAndVehicleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_srtRangeAxis_srtMaximumMember_20210101_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtStatementScenarioAxis_mnkdOneYearServiceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:OneYearServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:TwoYearServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mnkd:TwoYearServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_20040831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <instant>2004-08-31</instant>
        </period>
    </context>
    <context id="C_0000899460_20040801_20040831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
        </entity>
        <period>
            <startDate>2004-08-01</startDate>
            <endDate>2004-08-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapNewJerseyDivisionOfTaxationMember_20220101_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdConnecticutTaxAuthorityMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnkd:ConnecticutTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdCaliforniaDivisionOfTaxationMember_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899460</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnkd:CaliforniaDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_mnkdSegment">
        <measure>mnkd:Segment</measure>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_mnkdContract">
        <measure>mnkd:Contract</measure>
    </unit>
    <unit id="U_mnkdYear">
        <measure>mnkd:Year</measure>
    </unit>
    <unit id="U_mnkdDistributor">
        <measure>mnkd:Distributor</measure>
    </unit>
    <unit id="U_utrD">
        <measure>utr:D</measure>
    </unit>
    <unit id="U_mnkdInstallment">
        <measure>mnkd:Installment</measure>
    </unit>
    <unit id="U_iso4217EUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="U_mnkdVehicle">
        <measure>mnkd:Vehicle</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0000899460_20220101_20221231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0000899460_20220101_20221231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0000899460_20220101_20221231" id="F_000007">0000899460</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0000899460_20220101_20221231" id="F_000008">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108"
      id="F_001438">P4Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingSubleaseExistenceOfOptionToExtend
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_001440">true</us-gaap:LesseeOperatingSubleaseExistenceOfOptionToExtend>
    <us-gaap:AssetAcquisitionDateOfAcquisitionAgreement
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      id="F_000622">2022-05-31</us-gaap:AssetAcquisitionDateOfAcquisitionAgreement>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      id="F_000660">2020-12-31</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2022-01-01_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231"
      id="F_001143">P2Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:SaleOfStockTransactionDate
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180201_20180228"
      id="F_001235">2018-02-28</us-gaap:SaleOfStockTransactionDate>
    <mnkd:LongtermPurchaseCommitmentRenewalTimePeriod contextRef="C_0000899460_20220101_20221231" id="F_001475">P2Y</mnkd:LongtermPurchaseCommitmentRenewalTimePeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231"
      id="F_001424">P2Y2M19D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231"
      id="F_001423">P2Y29D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0000899460_20221231"
      id="F_000107"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0000899460_20211231"
      id="F_000108"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0000899460_20221231"
      id="F_000109"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0000899460_20211231"
      id="F_000110"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000188"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_000189"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20200101_20201231"
      decimals="2"
      id="F_000190"
      unitRef="U_iso4217USD_xbrlishares">-0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000194"
      unitRef="U_xbrlishares">257092000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000195"
      unitRef="U_xbrlishares">249244000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000196"
      unitRef="U_xbrlishares">222585000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000658"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_000659"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231"
      id="F_000802">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231"
      id="F_000804">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231"
      id="F_000806">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231"
      id="F_000808">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20220101_20221231"
      id="F_000810">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20220101_20221231"
      id="F_000803">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20220101_20221231"
      id="F_000805">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20220101_20221231"
      id="F_000807">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20220101_20221231"
      id="F_000809">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20220101_20221231"
      id="F_000831">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20221231"
      decimals="INF"
      id="F_000883"
      unitRef="U_xbrlipure">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231"
      decimals="-5"
      id="F_000879"
      unitRef="U_iso4217USD">18400000</us-gaap:DebtInstrumentFaceAmount>
    <mnkd:AccruedPaidInKindInterest
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231"
      decimals="-5"
      id="F_000880"
      unitRef="U_iso4217USD">400000</mnkd:AccruedPaidInKindInterest>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="INF"
      id="F_000881"
      unitRef="U_xbrlipure">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231"
      decimals="INF"
      id="F_000882"
      unitRef="U_xbrlipure">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mnkd:DebtInstrumentFloorRate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231"
      decimals="2"
      id="F_000884"
      unitRef="U_xbrlipure">0.01</mnkd:DebtInstrumentFloorRate>
    <mnkd:DebtInstrumentCapInterestRate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220101_20221231"
      decimals="4"
      id="F_000885"
      unitRef="U_xbrlipure">0.0825</mnkd:DebtInstrumentCapInterestRate>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001283"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_001284"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0000899460_20200101_20201231"
      decimals="2"
      id="F_001285"
      unitRef="U_iso4217USD_xbrlishares">-0.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0000899460_20200101_20201231"
      decimals="4"
      id="F_001364"
      unitRef="U_xbrlipure">0.0263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_001366">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0000899460_20200101_20201231"
      decimals="4"
      id="F_001368"
      unitRef="U_xbrlipure">0.9268</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0000899460_20200101_20201231"
      decimals="4"
      id="F_001365"
      unitRef="U_xbrlipure">0.0311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_001367">P7Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0000899460_20200101_20201231"
      decimals="4"
      id="F_001369"
      unitRef="U_xbrlipure">0.9362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0000899460_20210101_20211231" id="F_001382">P5Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0000899460_20220101_20221231" id="F_001383">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="C_0000899460_20220101_20221231" id="F_001384">P5Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0000899460_20221231" id="F_001452">P18Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0000899460_20211231" id="F_001453">P19Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0000899460_20221231" id="F_001504">P4Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_0000899460_20211231" id="F_001505">P2Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20221231" id="F_001492">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20211231" id="F_001493">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20221231" id="F_001496">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20211231" id="F_001497">http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20221231" id="F_001500">http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="C_0000899460_20211231" id="F_001501">http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="C_0000899460_20220101_20221231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0000899460_20220101_20221231" id="F_000026">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_0000899460_20220101_20221231" id="F_000002">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0000899460_20220101_20221231" id="F_000003">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0000899460_20220101_20221231" id="F_000027">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0000899460_20220101_20221231" id="F_000016">000-50865</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0000899460_20220101_20221231" id="F_000006">MannKind Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000899460_20220101_20221231" id="F_000028">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000899460_20220101_20221231" id="F_000017">13-3607736</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000899460_20220101_20221231" id="F_000018">1 Casper Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0000899460_20220101_20221231" id="F_000019">Danbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000899460_20220101_20221231" id="F_000020">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000899460_20220101_20221231" id="F_000021">06810</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000899460_20220101_20221231" id="F_000022">(818)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000899460_20220101_20221231" id="F_000023">661-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0000899460_20220101_20221231" id="F_000029">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000899460_20220101_20221231" id="F_000005">MNKD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000899460_20220101_20221231" id="F_000030">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0000899460_20220101_20221231" id="F_000009">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="C_0000899460_20220101_20221231" id="F_000011">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="C_0000899460_20220101_20221231" id="F_000010">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0000899460_20220101_20221231" id="F_000031">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0000899460_20220101_20221231" id="F_000012">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0000899460_20220101_20221231" id="F_000013">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000899460_20220101_20221231" id="F_000014">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0000899460_20220101_20221231" id="F_000032">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0000899460_20220101_20221231" id="F_000015">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0000899460_20220630"
      decimals="0"
      id="F_000025"
      unitRef="U_iso4217USD">910286410</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0000899460_20230210"
      decimals="INF"
      id="F_000024"
      unitRef="U_xbrlishares">263923726</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000488">
&lt;p style="Background-color:#auto;margin-bottom:0pt;margin-top:3pt;text-indent:4.25%;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Portions of the registrant&#x2019;s definitive Proxy Statement (the &#x201c;Proxy Statement&#x201d;) for the 2023 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than May 1, 2023 are incorporated by reference into Part III of this Annual Report on Form 10-K.&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="C_0000899460_20220101_20221231" id="F_000033">34</dei:AuditorFirmId>
    <dei:AuditorName contextRef="C_0000899460_20220101_20221231" id="F_000034">Deloitte&#160;&amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="C_0000899460_20220101_20221231" id="F_000035">Los Angeles, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">69767000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">124184000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">101079000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">79932000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">16801000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">4739000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">21772000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">7152000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">25477000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">3482000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">234896000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">219489000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">45126000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">36612000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">2428000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">1153000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:LongTermInvestments
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000068"
      unitRef="U_iso4217USD">1961000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000069"
      unitRef="U_iso4217USD">56619000</us-gaap:LongTermInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">9718000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">8441000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">295282000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">321161000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">11052000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">6956000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000076"
      unitRef="U_iso4217USD">35553000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000077"
      unitRef="U_iso4217USD">27419000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000078"
      unitRef="U_iso4217USD">9565000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000079"
      unitRef="U_iso4217USD">6977000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">1733000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">827000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mnkd:PurchaseObligationCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000082"
      unitRef="U_iso4217USD">9393000</mnkd:PurchaseObligationCurrent>
    <mnkd:PurchaseObligationCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000083"
      unitRef="U_iso4217USD">6170000</mnkd:PurchaseObligationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000084"
      unitRef="U_iso4217USD">67296000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000085"
      unitRef="U_iso4217USD">48349000</us-gaap:LiabilitiesCurrent>
    <mnkd:PromissoryNotesNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000086"
      unitRef="U_iso4217USD">8829000</mnkd:PromissoryNotesNoncurrent>
    <mnkd:PromissoryNotesNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000087"
      unitRef="U_iso4217USD">18425000</mnkd:PromissoryNotesNoncurrent>
    <mnkd:AccruedInterestNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000088"
      unitRef="U_iso4217USD">55000</mnkd:AccruedInterestNoncurrent>
    <mnkd:AccruedInterestNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000089"
      unitRef="U_iso4217USD">404000</mnkd:AccruedInterestNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000090"
      unitRef="U_iso4217USD">94512000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">93525000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <mnkd:CreditFacilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">39264000</mnkd:CreditFacilityNoncurrent>
    <mnkd:CreditFacilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">38833000</mnkd:CreditFacilityNoncurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000094"
      unitRef="U_iso4217USD">225397000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000095"
      unitRef="U_iso4217USD">223944000</us-gaap:ConvertibleLongTermNotesPayable>
    <mnkd:PurchaseObligationNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000096"
      unitRef="U_iso4217USD">62916000</mnkd:PurchaseObligationNoncurrent>
    <mnkd:PurchaseObligationNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000097"
      unitRef="U_iso4217USD">76659000</mnkd:PurchaseObligationNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">5343000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">1040000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">37684000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">19543000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <mnkd:MilestoneLiabilitiesNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000102"
      unitRef="U_iso4217USD">4524000</mnkd:MilestoneLiabilitiesNoncurrent>
    <mnkd:MilestoneLiabilitiesNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000103"
      unitRef="U_iso4217USD">4838000</mnkd:MilestoneLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000104"
      unitRef="U_iso4217USD">4950000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000105"
      unitRef="U_iso4217USD">545820000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000106"
      unitRef="U_iso4217USD">530510000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000036"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000037"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000038"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000039"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000040"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000041"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000042"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000043"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000044"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000045"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000046"
      unitRef="U_xbrlishares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000047"
      unitRef="U_xbrlishares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000048"
      unitRef="U_xbrlishares">263793305</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000050"
      unitRef="U_xbrlishares">263793305</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000049"
      unitRef="U_xbrlishares">251477562</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000051"
      unitRef="U_xbrlishares">251477562</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000111"
      unitRef="U_iso4217USD">2638000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000112"
      unitRef="U_iso4217USD">2515000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000113"
      unitRef="U_iso4217USD">2964293000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000114"
      unitRef="U_iso4217USD">2918205000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000115"
      unitRef="U_iso4217USD">-3217469000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000116"
      unitRef="U_iso4217USD">-3130069000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000117"
      unitRef="U_iso4217USD">-250538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000118"
      unitRef="U_iso4217USD">-209349000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000119"
      unitRef="U_iso4217USD">295282000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000120"
      unitRef="U_iso4217USD">321161000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20220101_20221231"
      decimals="-3"
      id="F_000121"
      unitRef="U_iso4217USD">56247000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20210101_20211231"
      decimals="-3"
      id="F_000122"
      unitRef="U_iso4217USD">39168000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231"
      decimals="-3"
      id="F_000123"
      unitRef="U_iso4217USD">32324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">27924000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">36274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">32820000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">15599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">99770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000129"
      unitRef="U_iso4217USD">75442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000130"
      unitRef="U_iso4217USD">65144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000131"
      unitRef="U_iso4217USD">16003000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000132"
      unitRef="U_iso4217USD">16833000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">15084000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfRevenue
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">41494000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">22024000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">9557000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">13233000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">19721000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">12312000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">6248000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:SellingExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">53753000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">45528000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">34365000</us-gaap:SellingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">37720000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">31889000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">24675000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">106000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">1889000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">4811000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">6567000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">-8006000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <mnkd:GainLossOnPurchaseCommitments
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">-339000</mnkd:GainLossOnPurchaseCommitments>
    <us-gaap:CostsAndExpenses
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">163880000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">122464000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">113057000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">-64110000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">-47022000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">-47913000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000159"
      unitRef="U_iso4217USD">2513000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">112000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">167000</us-gaap:InvestmentIncomeInterest>
    <mnkd:InterestExpenseOnFinancingLiability
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000162"
      unitRef="U_iso4217USD">9758000</mnkd:InterestExpenseOnFinancingLiability>
    <mnkd:InterestExpenseOnFinancingLiability
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">1373000</mnkd:InterestExpenseOnFinancingLiability>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">15011000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000165"
      unitRef="U_iso4217USD">15204000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000166"
      unitRef="U_iso4217USD">9471000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleGainLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000167"
      unitRef="U_iso4217USD">-932000</us-gaap:DebtSecuritiesAvailableForSaleGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000168"
      unitRef="U_iso4217USD">-17200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000169"
      unitRef="U_iso4217USD">-264000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000170"
      unitRef="U_iso4217USD">-102000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000171"
      unitRef="U_iso4217USD">-239000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000172"
      unitRef="U_iso4217USD">23000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000173"
      unitRef="U_iso4217USD">-23290000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000174"
      unitRef="U_iso4217USD">-33904000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000175"
      unitRef="U_iso4217USD">-9545000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000176"
      unitRef="U_iso4217USD">-87400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000177"
      unitRef="U_iso4217USD">-80926000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000178"
      unitRef="U_iso4217USD">-57458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000179"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000180"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000181"
      unitRef="U_iso4217USD">-218000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">-87400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">-80926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">-57240000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000185"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_000186"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20200101_20201231"
      decimals="2"
      id="F_000187"
      unitRef="U_iso4217USD_xbrlishares">-0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000191"
      unitRef="U_xbrlishares">257092000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000192"
      unitRef="U_xbrlishares">249244000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000193"
      unitRef="U_xbrlishares">222585000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">-87400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000198"
      unitRef="U_iso4217USD">-80926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">-57240000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">-19000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">-87400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">-80926000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">-57259000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000204"
      unitRef="U_xbrlishares">211788000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">2118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">2799278000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">-19000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">-2991903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20191231"
      decimals="-3"
      id="F_000209"
      unitRef="U_iso4217USD">-190526000</us-gaap:StockholdersEquity>
    <mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000210"
      unitRef="U_xbrlishares">653000</mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">6000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000212"
      unitRef="U_iso4217USD">227000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000213"
      unitRef="U_iso4217USD">233000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000214"
      unitRef="U_xbrlishares">2612000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000215"
      unitRef="U_iso4217USD">26000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">5235000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesPrincipalMember_20200101_20201231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">5261000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000218"
      unitRef="U_xbrlishares">188000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">286000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdSeniorConvertibleNotesInterestMember_20200101_20201231"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">288000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000222"
      unitRef="U_xbrlishares">2800000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">28000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000224"
      unitRef="U_iso4217USD">6972000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotePrincipalMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231"
      decimals="-3"
      id="F_000225"
      unitRef="U_iso4217USD">7000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000226"
      unitRef="U_xbrlishares">1200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000227"
      unitRef="U_iso4217USD">12000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">2988000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">3000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231"
      decimals="-3"
      id="F_000230"
      unitRef="U_xbrlishares">11853000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231"
      decimals="-3"
      id="F_000231"
      unitRef="U_iso4217USD">118000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">23412000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20200101_20201231"
      decimals="-3"
      id="F_000233"
      unitRef="U_iso4217USD">23530000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000234"
      unitRef="U_iso4217USD">519000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000235"
      unitRef="U_iso4217USD">519000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000236"
      unitRef="U_xbrlishares">627000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000237"
      unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000238"
      unitRef="U_iso4217USD">678000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">684000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000240"
      unitRef="U_xbrlishares">3067000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000241"
      unitRef="U_iso4217USD">31000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000242"
      unitRef="U_iso4217USD">9219000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">9250000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000244"
      unitRef="U_iso4217USD">6511000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">6511000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <mnkd:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000246"
      unitRef="U_xbrlishares">7250000</mnkd:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">73000</mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">11527000</mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000249"
      unitRef="U_iso4217USD">11600000</mnkd:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000250"
      unitRef="U_xbrlishares">80000</mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000251"
      unitRef="U_iso4217USD">1000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000252"
      unitRef="U_iso4217USD">214000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000253"
      unitRef="U_iso4217USD">215000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000254"
      unitRef="U_iso4217USD">275000</mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility>
    <mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000255"
      unitRef="U_iso4217USD">275000</mnkd:AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000256"
      unitRef="U_iso4217USD">-19000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000257"
      unitRef="U_iso4217USD">-19000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000258"
      unitRef="U_iso4217USD">-57240000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000259"
      unitRef="U_iso4217USD">-57240000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000260"
      unitRef="U_xbrlishares">242118000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000261"
      unitRef="U_iso4217USD">2421000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000262"
      unitRef="U_iso4217USD">2866303000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000263"
      unitRef="U_iso4217USD">-3049143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_000264"
      unitRef="U_iso4217USD">-180419000</us-gaap:StockholdersEquity>
    <mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000265"
      unitRef="U_xbrlishares">1572000</mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000266"
      unitRef="U_iso4217USD">16000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000267"
      unitRef="U_iso4217USD">-514000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000268"
      unitRef="U_iso4217USD">-498000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000269"
      unitRef="U_xbrlishares">527000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000270"
      unitRef="U_iso4217USD">5000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000271"
      unitRef="U_iso4217USD">1085000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">1090000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">12200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">12200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000275"
      unitRef="U_xbrlishares">3830000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">38000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000277"
      unitRef="U_iso4217USD">9535000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">9573000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000279"
      unitRef="U_xbrlishares">170000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">425000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">427000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000283"
      unitRef="U_xbrlishares">1667000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">17000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">4983000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210101_20211231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">5000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <mnkd:StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000287"
      unitRef="U_xbrlishares">27000</mnkd:StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities>
    <mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">143000</mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities>
    <mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNoteInterestMember_20210101_20211231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">143000</mnkd:StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231"
      decimals="-3"
      id="F_000290"
      unitRef="U_xbrlishares">578000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">1880000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketOfferingMember_20210101_20211231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">1886000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">38000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">38000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000296"
      unitRef="U_iso4217USD">22107000</mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote>
    <mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000297"
      unitRef="U_iso4217USD">22107000</mnkd:AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote>
    <mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000298"
      unitRef="U_xbrlishares">25000</mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000299"
      unitRef="U_iso4217USD">106000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000300"
      unitRef="U_iso4217USD">106000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:IssuanceOfCommonStockPursuantToWarrantConversionShares
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000301"
      unitRef="U_xbrlishares">964000</mnkd:IssuanceOfCommonStockPursuantToWarrantConversionShares>
    <mnkd:IssuanceOfCommonStockPursuantToWarrantConversion
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">10000</mnkd:IssuanceOfCommonStockPursuantToWarrantConversion>
    <mnkd:IssuanceOfCommonStockPursuantToWarrantConversion
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20210101_20211231"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">-10000</mnkd:IssuanceOfCommonStockPursuantToWarrantConversion>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20210101_20211231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">-80926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">-80926000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="-3"
      id="F_000306"
      unitRef="U_xbrlishares">251478000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20211231"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">2515000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20211231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">2918205000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20211231"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">-3130069000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">-209349000</us-gaap:StockholdersEquity>
    <mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000311"
      unitRef="U_xbrlishares">2242000</mnkd:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">22000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">297000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000314"
      unitRef="U_iso4217USD">319000</mnkd:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000315"
      unitRef="U_xbrlishares">686000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000316"
      unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000317"
      unitRef="U_iso4217USD">2076000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000318"
      unitRef="U_iso4217USD">2082000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000319"
      unitRef="U_iso4217USD">13447000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">13447000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000321"
      unitRef="U_xbrlishares">3838000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">39000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">9557000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNotesMember_20220101_20221231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">9596000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000325"
      unitRef="U_xbrlishares">237000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">672000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertibleNoteInterestMember_20220101_20221231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">674000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000329"
      unitRef="U_xbrlishares">5060000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">51000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">19739000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">19790000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">381000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">381000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000335"
      unitRef="U_xbrlishares">252000</mnkd:StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">3000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20220101_20221231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">681000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">684000</mnkd:StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20220101_20221231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">-87400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">-87400000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231"
      decimals="-3"
      id="F_000341"
      unitRef="U_xbrlishares">263793000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20221231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">2638000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20221231"
      decimals="-3"
      id="F_000343"
      unitRef="U_iso4217USD">2964293000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20221231"
      decimals="-3"
      id="F_000344"
      unitRef="U_iso4217USD">-3217469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000345"
      unitRef="U_iso4217USD">-250538000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000346"
      unitRef="U_iso4217USD">-87400000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000347"
      unitRef="U_iso4217USD">-80926000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000348"
      unitRef="U_iso4217USD">-57240000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000349"
      unitRef="U_iso4217USD">13447000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000350"
      unitRef="U_iso4217USD">12200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000351"
      unitRef="U_iso4217USD">6511000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000352"
      unitRef="U_iso4217USD">6124000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000353"
      unitRef="U_iso4217USD">4215000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000354"
      unitRef="U_iso4217USD">2149000</us-gaap:DepreciationAndAmortization>
    <us-gaap:InterestExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000355"
      unitRef="U_iso4217USD">9552000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000356"
      unitRef="U_iso4217USD">1372000</us-gaap:InterestExpense>
    <mnkd:InterestOnMilestonePayment
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000357"
      unitRef="U_iso4217USD">3663000</mnkd:InterestOnMilestonePayment>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000358"
      unitRef="U_iso4217USD">2202000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000359"
      unitRef="U_iso4217USD">1902000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000360"
      unitRef="U_iso4217USD">496000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <mnkd:InterestExpenseOnPromissoryNotes
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000361"
      unitRef="U_iso4217USD">325000</mnkd:InterestExpenseOnPromissoryNotes>
    <mnkd:InterestExpenseOnPromissoryNotes
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000362"
      unitRef="U_iso4217USD">1598000</mnkd:InterestExpenseOnPromissoryNotes>
    <mnkd:InterestExpenseOnPromissoryNotes
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000363"
      unitRef="U_iso4217USD">5148000</mnkd:InterestExpenseOnPromissoryNotes>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000364"
      unitRef="U_iso4217USD">2987000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000365"
      unitRef="U_iso4217USD">1258000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000366"
      unitRef="U_iso4217USD">1177000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DebtSecuritiesAvailableForSaleGainLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000367"
      unitRef="U_iso4217USD">-932000</us-gaap:DebtSecuritiesAvailableForSaleGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000368"
      unitRef="U_iso4217USD">-17200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000369"
      unitRef="U_iso4217USD">-264000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000370"
      unitRef="U_iso4217USD">106000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000371"
      unitRef="U_iso4217USD">1889000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000372"
      unitRef="U_iso4217USD">4811000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000373"
      unitRef="U_iso4217USD">6567000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000374"
      unitRef="U_iso4217USD">-8006000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000375"
      unitRef="U_iso4217USD">13233000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000376"
      unitRef="U_iso4217USD">-17000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000377"
      unitRef="U_iso4217USD">-19000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000378"
      unitRef="U_iso4217USD">11807000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000379"
      unitRef="U_iso4217USD">776000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000380"
      unitRef="U_iso4217USD">705000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000381"
      unitRef="U_iso4217USD">5670000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000382"
      unitRef="U_iso4217USD">4081000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000383"
      unitRef="U_iso4217USD">1314000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000384"
      unitRef="U_iso4217USD">15552000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000385"
      unitRef="U_iso4217USD">360000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000386"
      unitRef="U_iso4217USD">154000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000387"
      unitRef="U_iso4217USD">-523000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000388"
      unitRef="U_iso4217USD">138000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000389"
      unitRef="U_iso4217USD">-227000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000390"
      unitRef="U_iso4217USD">4096000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000391"
      unitRef="U_iso4217USD">1374000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000392"
      unitRef="U_iso4217USD">793000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000393"
      unitRef="U_iso4217USD">-723000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000394"
      unitRef="U_iso4217USD">8814000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000395"
      unitRef="U_iso4217USD">3346000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000396"
      unitRef="U_iso4217USD">19047000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000397"
      unitRef="U_iso4217USD">-14567000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000398"
      unitRef="U_iso4217USD">-5910000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000399"
      unitRef="U_iso4217USD">-5709000</mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments>
    <mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000400"
      unitRef="U_iso4217USD">-5892000</mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments>
    <mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000401"
      unitRef="U_iso4217USD">-4751000</mnkd:IncreaseDecreaseInRecognizedLossOnPurchaseCommitments>
    <mnkd:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000402"
      unitRef="U_iso4217USD">-3309000</mnkd:IncreaseDecreaseInOperatingLeaseLiabilities>
    <mnkd:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000403"
      unitRef="U_iso4217USD">-2135000</mnkd:IncreaseDecreaseInOperatingLeaseLiabilities>
    <mnkd:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000404"
      unitRef="U_iso4217USD">-1312000</mnkd:IncreaseDecreaseInOperatingLeaseLiabilities>
    <mnkd:IncreaseDecreaseInAccruedInterestOnPromissoryNotes
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000405"
      unitRef="U_iso4217USD">4919000</mnkd:IncreaseDecreaseInAccruedInterestOnPromissoryNotes>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000406"
      unitRef="U_iso4217USD">-4950000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000407"
      unitRef="U_iso4217USD">4950000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000408"
      unitRef="U_iso4217USD">-80679000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000409"
      unitRef="U_iso4217USD">-61709000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000410"
      unitRef="U_iso4217USD">-28128000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000411"
      unitRef="U_iso4217USD">74536000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000412"
      unitRef="U_iso4217USD">196131000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000413"
      unitRef="U_iso4217USD">107340000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000414"
      unitRef="U_iso4217USD">59060000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000415"
      unitRef="U_iso4217USD">15341000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000416"
      unitRef="U_iso4217USD">7589000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000417"
      unitRef="U_iso4217USD">11466000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000418"
      unitRef="U_iso4217USD">801000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <mnkd:PurchaseOfAvailableForSaleSecurities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000419"
      unitRef="U_iso4217USD">5000000</mnkd:PurchaseOfAvailableForSaleSecurities>
    <mnkd:PurchaseOfAvailableForSaleSecurities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000420"
      unitRef="U_iso4217USD">3000000</mnkd:PurchaseOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000421"
      unitRef="U_iso4217USD">20000000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000422"
      unitRef="U_iso4217USD">3983000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000423"
      unitRef="U_iso4217USD">4874000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000424"
      unitRef="U_iso4217USD">-151537000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000425"
      unitRef="U_iso4217USD">15216000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231"
      decimals="-3"
      id="F_000426"
      unitRef="U_iso4217USD">19790000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231"
      decimals="-3"
      id="F_000427"
      unitRef="U_iso4217USD">1886000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231"
      decimals="-3"
      id="F_000428"
      unitRef="U_iso4217USD">23450000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <mnkd:MilestonePayments
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000429"
      unitRef="U_iso4217USD">1088000</mnkd:MilestonePayments>
    <mnkd:MilestonePayments
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000430"
      unitRef="U_iso4217USD">5000000</mnkd:MilestonePayments>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20220101_20221231"
      decimals="-3"
      id="F_000431"
      unitRef="U_iso4217USD">381000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20210101_20211231"
      decimals="-3"
      id="F_000432"
      unitRef="U_iso4217USD">38000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_mnkdAtTheMarketIssuanceMember_20200101_20201231"
      decimals="-3"
      id="F_000433"
      unitRef="U_iso4217USD">518000</us-gaap:PaymentsOfStockIssuanceCosts>
    <mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000434"
      unitRef="U_iso4217USD">319000</mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits>
    <mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000435"
      unitRef="U_iso4217USD">-498000</mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits>
    <mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000436"
      unitRef="U_iso4217USD">233000</mnkd:ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits>
    <mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000437"
      unitRef="U_iso4217USD">2766000</mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan>
    <mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000438"
      unitRef="U_iso4217USD">106000</mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan>
    <mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000439"
      unitRef="U_iso4217USD">215000</mnkd:ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan>
    <mnkd:PaymentOnFinancingLiability
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000440"
      unitRef="U_iso4217USD">18000</mnkd:PaymentOnFinancingLiability>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000441"
      unitRef="U_iso4217USD">11600000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000442"
      unitRef="U_iso4217USD">10000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000443"
      unitRef="U_iso4217USD">4873000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000444"
      unitRef="U_iso4217USD">230000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000445"
      unitRef="U_iso4217USD">7268000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <mnkd:ProceedsFromSaleLeasebackTransaction
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000446"
      unitRef="U_iso4217USD">102250000</mnkd:ProceedsFromSaleLeasebackTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000447"
      unitRef="U_iso4217USD">3120000</us-gaap:PaymentsOfStockIssuanceCosts>
    <mnkd:DepositForSaleLeasebackTransaction
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000448"
      unitRef="U_iso4217USD">2000000</mnkd:DepositForSaleLeasebackTransaction>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000449"
      unitRef="U_iso4217USD">35051000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000450"
      unitRef="U_iso4217USD">10000000</us-gaap:RepaymentsOfLinesOfCredit>
    <mnkd:PaymentOfCreditFacilityPrepaymentPenalty
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000451"
      unitRef="U_iso4217USD">1000000</mnkd:PaymentOfCreditFacilityPrepaymentPenalty>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000452"
      unitRef="U_iso4217USD">21388000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000453"
      unitRef="U_iso4217USD">270267000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000454"
      unitRef="U_iso4217USD">49853000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000455"
      unitRef="U_iso4217USD">-54417000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000456"
      unitRef="U_iso4217USD">57021000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000457"
      unitRef="U_iso4217USD">36941000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000458"
      unitRef="U_iso4217USD">124184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_000459"
      unitRef="U_iso4217USD">67163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20191231"
      decimals="-3"
      id="F_000460"
      unitRef="U_iso4217USD">30222000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000461"
      unitRef="U_iso4217USD">69767000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000462"
      unitRef="U_iso4217USD">124184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_000463"
      unitRef="U_iso4217USD">67163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000464"
      unitRef="U_iso4217USD">8852000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000465"
      unitRef="U_iso4217USD">11268000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000466"
      unitRef="U_iso4217USD">3558000</us-gaap:InterestPaidNet>
    <mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000467"
      unitRef="U_iso4217USD">82850000</mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent>
    <mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000468"
      unitRef="U_iso4217USD">32654000</mnkd:ReclassificationOfInvestmentsFromLongTermToCurrent>
    <mnkd:ReclassificationOfConvertibleNotesAndInterestReceivable
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000469"
      unitRef="U_iso4217USD">7375000</mnkd:ReclassificationOfConvertibleNotesAndInterestReceivable>
    <mnkd:PremiumOnConvertibleNote
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-3"
      id="F_000470"
      unitRef="U_iso4217USD">22107000</mnkd:PremiumOnConvertibleNote>
    <mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000471"
      unitRef="U_iso4217USD">10270000</mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance>
    <mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000472"
      unitRef="U_iso4217USD">15143000</mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance>
    <mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000473"
      unitRef="U_iso4217USD">15549000</mnkd:PaymentsOnDebtAndInterestThroughCommonStockIssuance>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000474"
      unitRef="U_iso4217USD">4873000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <mnkd:AdditionOfRightOfUseAssets
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000475"
      unitRef="U_iso4217USD">1812000</mnkd:AdditionOfRightOfUseAssets>
    <mnkd:AdditionOfRightOfUseAssets
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000476"
      unitRef="U_iso4217USD">1425000</mnkd:AdditionOfRightOfUseAssets>
    <mnkd:RightOfUseAssetsModification
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000477"
      unitRef="U_iso4217USD">3793000</mnkd:RightOfUseAssetsModification>
    <mnkd:RightOfUseAssetsModification
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000478"
      unitRef="U_iso4217USD">278000</mnkd:RightOfUseAssetsModification>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000479"
      unitRef="U_iso4217USD">1298000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000480"
      unitRef="U_iso4217USD">1264000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000481"
      unitRef="U_iso4217USD">92000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000482"
      unitRef="U_iso4217USD">1090000</mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability>
    <mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000483"
      unitRef="U_iso4217USD">684000</mnkd:CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability>
    <mnkd:ContingentMilestoneLiability
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000484"
      unitRef="U_iso4217USD">610000</mnkd:ContingentMilestoneLiability>
    <mnkd:CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000485"
      unitRef="U_iso4217USD">9250000</mnkd:CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment>
    <mnkd:IssuanceOfWarrantsAssociatedWithCreditFacility
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000486"
      unitRef="U_iso4217USD">275000</mnkd:IssuanceOfWarrantsAssociatedWithCreditFacility>
    <mnkd:ReceivableFromCommonStockOffering
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000487"
      unitRef="U_iso4217USD">226000</mnkd:ReceivableFromCommonStockOffering>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000489">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1. Description of Business&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Business &lt;span style="font-style:normal;"&gt;&#x2014; MannKind Corporation and its subsidiaries (the &#x201c;Company&#x201d;) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company is currently commercializing Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The Company also collaborates with third parties to formulate their drugs on the Company&#x2019;s Technosphere drug delivery platform. Tyvaso DPI (treprostinil) inhalation powder received FDA approval in May 2022, for the treatment of pulmonary arterial hypertension and for the treatment of pulmonary hypertension associated with interstitial lung disease. UT began commercializing Tyvaso DPI in June 2022 and is obligated to pay the Company a royalty on net sales of the product. The Company also receives a margin on supplies of Tyvaso DPI that it manufactures for UT.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;span style="font-style:normal;"&gt; &#x2014; The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;span style="font-style:normal;"&gt; &#x2014; The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Reclassifications&lt;span style="font-style:normal;"&gt; &#x2014; Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Segment Information&lt;span style="font-style:normal;"&gt; &#x2014; Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. To date, the Company has viewed its operations and manages its business as one segment operating in the United States of America.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <mnkd:BusinessPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000507">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Business &lt;span style="font-style:normal;"&gt;&#x2014; MannKind Corporation and its subsidiaries (the &#x201c;Company&#x201d;) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. The Company is currently commercializing Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. The Company also collaborates with third parties to formulate their drugs on the Company&#x2019;s Technosphere drug delivery platform. Tyvaso DPI (treprostinil) inhalation powder received FDA approval in May 2022, for the treatment of pulmonary arterial hypertension and for the treatment of pulmonary hypertension associated with interstitial lung disease. UT began commercializing Tyvaso DPI in June 2022 and is obligated to pay the Company a royalty on net sales of the product. The Company also receives a margin on supplies of Tyvaso DPI that it manufactures for UT.&lt;/span&gt;&lt;/p&gt;</mnkd:BusinessPolicyTextBlock>
    <mnkd:BasisOfPresentationPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000508">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation&lt;span style="font-style:normal;"&gt; &#x2014; The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). &lt;/span&gt;&lt;/p&gt;</mnkd:BasisOfPresentationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000509">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Principles of Consolidation&lt;span style="font-style:normal;"&gt; &#x2014; The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated. &lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="C_0000899460_20220101_20221231" id="F_000510">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Reclassifications&lt;span style="font-style:normal;"&gt; &#x2014; Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000511">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Segment Information&lt;span style="font-style:normal;"&gt; &#x2014; Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. To date, the Company has viewed its operations and manages its business as one segment operating in the United States of America.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_000582"
      unitRef="U_mnkdSegment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000490">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2. Summary of Significant Accounting Policies&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Financial Statement Estimates&lt;span style="font-style:normal;"&gt; &#x2014; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;span style="font-style:normal;"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; The Company recognizes revenue when its customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To determine revenue recognition for arrangements that are within the scope of Accounting Standards Codification (&#x201c;&lt;span style="color:#000000;"&gt;ASC&#x201d;) &lt;/span&gt;Topic 606, &lt;span style="font-style:italic;font-family:Calibri;color:#000000;"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="font-family:Calibri;color:#000000;"&gt;(&#x201c;ASC 606&#x201d;),&lt;/span&gt; the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under ASC 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company has two types of contracts with customers: (i) contracts for commercial product sales with wholesale distributors, specialty and retail pharmacies and (ii) collaboration arrangements.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2013; Net Revenue &#x2013; Commercial Product Sales &#x2013;&lt;span style="font-style:normal;"&gt; The Company sells its products to a limited number of wholesale distributors, specialty and retail pharmacies, and durable medical equipment suppliers (&#x201c;DME&#x201d;) in the U.S. (collectively, its &#x201c;Customers&#x201d;). Wholesale distributors&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; subsequently resell the Company&#x2019;s products to retail pharmacies and certain medical centers or hospitals. Specialty and retail pharmacies sell directly to patients. In addition to distribution agreements with Customers, the Company enters into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of the Company&#x2019;s products.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes revenue on product sales when the Customer obtains control of the Company's product, which occurs at delivery for wholesale distributors and &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;generally &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;delivery &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for specialty pharmacies. &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; recognize&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;s&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; revenue on product sales to&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; a&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; retail pharmac&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;y&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as the product is dispensed to patients. &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product revenues are recorded net of applicable reserves&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;including discounts, allowances, rebates, returns and other incentives&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. See &lt;/span&gt;&lt;span style="font-style:italic;"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; below.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Free Goods Program &#x2013; &lt;span style="font-style:normal;"&gt;From time to time, the Company offers programs to potential new patients that allow them to obtain free goods (prescription fills) from a pharmacy. The Company excludes such amounts related to these programs from both gross and net revenue.&#160;The cost of product associated with the free goods program is recognized as cost of goods sold in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Reserves for Variable Consideration &lt;span style="font-style:normal;"&gt;&#x2014; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#x2019;s sale of its products. These reserves, as further detailed below, are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. The Company&#x2019;s analysis also contemplates application of the constraint in accordance with the guidance, under which it determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#x2019;s estimates. If actual results in the future vary from the Company&#x2019;s estimates, the Company will adjust these estimates, which would affect net revenue &lt;span style="font-family:Calibri;"&gt;&#x2014;&lt;/span&gt; commercial product sales and earnings in the period such variances become known.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix, unbilled claims, claim submission time lags and inventory levels in the distribution channel.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Trade Discounts and Allowances &lt;span style="font-style:normal;"&gt;&#x2014; The Company generally provides Customers with discounts which include incentives, such as prompt pay discounts, that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company compensates (through trade discounts and allowances) its Customers for sales order management, data, and distribution services. However, the Company has determined such services received to date are not distinct from the Company&#x2019;s sale of products to the Customer and, therefore, these payments have been recorded as a reduction of revenue and as a reduction to accounts receivable, net. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Product Returns &lt;span style="font-style:normal;"&gt;&#x2014; Consistent with industry practice, the Company generally offers Customers a right of return for unopened product that has been purchased from the Company for a period beginning six months prior to and ending 12 months after its expiration date, which lapses upon shipment to a patient. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net. The Company currently estimates product returns using available industry data and its own sales information, including its visibility into the inventory remaining in the distribution channel. The Company&#x2019;s current return reserve percentage is estimated to be in the single-&lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;"&gt;digits. &lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;color:#000000;"&gt;Adjustments to the returns reserve have been made in the past and may be necessary in the future based on revised estimates to the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Provider Chargebacks and Discounts &lt;span style="font-style:normal;"&gt;&#x2014; Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase products from the Company. Customers charge the Company for the difference between what they pay for products and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is recorded in accrued expenses and other current liabilities. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers, and the Company generally issues credits for such amounts within a few weeks of the Customer&#x2019;s notification to the Company of the resale. Reserves for chargebacks consist of credits that the Company expects to issue for units that remain in the distribution channel inventories at each reporting period-end that the Company expects will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which the Company has not yet issued a credit.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Government Rebates &lt;span style="font-style:normal;"&gt;&#x2014; The Company is subject to discount obligations under Medicare and state Medicaid programs. These reserves are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities. Estimates around Medicaid have historically required significant &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-style:normal;"&gt;judg&lt;/span&gt;&lt;span style="font-style:normal;"&gt;ment due to timing lags in receiving invoices for claims from states.&lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-style:normal;"&gt;For &lt;/span&gt;&lt;span style="font-style:normal;"&gt;Afrezza&lt;/span&gt;&lt;span style="font-style:normal;"&gt;, the Company also estimates the number of patients in the prescription drug coverage gap for whom the Company will owe an additional liability under the Medicare Part D program. The Company&#x2019;s liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product&lt;/span&gt;&lt;span style="font-style:normal;"&gt;s&lt;/span&gt;&lt;span style="font-style:normal;"&gt; that ha&lt;/span&gt;&lt;span style="font-style:normal;"&gt;ve&lt;/span&gt;&lt;span style="font-style:normal;"&gt; been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.&lt;/span&gt;&lt;span style="font-style:normal;"&gt; The Company&#x2019;s estimates include consideration of historical claims expe&lt;/span&gt;&lt;span style="font-style:normal;"&gt;rience, paye&lt;/span&gt;&lt;span style="font-style:normal;"&gt;r channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Payer Rebates &lt;span style="font-style:normal;"&gt;&#x2014; The Company contracts with certain private payer organizations, primarily insurance companies and pharmacy benefit managers, for the payment of rebates with respect to utilization of its products. The Company estimates these rebates, including estimates for product that has been recognized as revenue, but which remains in the distribution channel, and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities. The Company&#x2019;s estimates include consideration of historical claims experience, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Other Incentives &lt;span style="font-style:normal;"&gt;&#x2014; Other incentives which the Company offers include voluntary patient support programs, such as the Company's co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with co-payments required by payers. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with the products that have been recognized as revenue, but remains in the distribution channel inventories at the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2014; Revenue &#x2014; Collaborations and Services &#x2014;&lt;span style="font-style:normal;"&gt; The Company enters into licensing, research or other agreements under which the Company licenses certain rights to its product candidates to third parties, conducts research or provides other services to third parties. The terms of these arrangements may include, but are not limited to payment to the Company of one or more of the following: up-front license fees; development, regulatory, and commercial milestone payments; payments for commercial manufacturing and clinical supply services the Company provides; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;With respect to our &lt;/span&gt;&lt;span style="font-style:normal;"&gt;significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (&#x201c;as amended, the CSA&#x201d;), we have identified three distinct performance obligations: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#x201c;R&amp;amp;D Services and License&#x2019;), (2) development activities for the next generation of the product (&#x201c;Next-Gen R&amp;amp;D Services&#x201d;), and (3) a material right associated with current and future manufacturing and supply of product (&#x201c;Manufacturing Services&#x201d;). Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#x2019;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represents distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. See Note 11 &#x2013; &lt;/span&gt;Collaboration, Licensing and Other Arrangements&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and the Company uses key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12 months. Amounts that the Company expects will not be recognized within the next 12 months are classified as long-term deferred revenue. For further information, see Note 11&lt;span style="font-style:italic;"&gt; &#x2013; Collaboration, Licensing and Other Arrangements.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes upfront license payments as revenue upon delivery of the license only if the license is determined to be a separate unit of accounting from the other undelivered performance obligations.&#160;The undelivered performance obligations typically include manufacturing or development services or research and/or steering committee services. If the license is not considered as a distinct performance obligation, then the license and other undelivered performance obligations would be evaluated to determine if such should be accounted for as a single unit of accounting.&#160;If concluded to be a single performance obligation, the transaction price for the single performance obligation is recognized as revenue over the estimated period of when the performance obligation is satisfied. If the license is considered to be a distinct performance obligation, then the estimated revenue is included in the transaction price for the contract, which is then allocated to each performance obligation based on the respective standalone selling prices.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Whenever the Company determines that an arrangement should be accounted for over time, the Company determines the period over which the performance obligations will be performed, and revenue will be recognized over the period the Company is expected to complete its performance obligations. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete its performance obligations under an arrangement. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s collaboration agreements typically entitle the Company to additional payments upon the achievement of development, regulatory and sales milestones. If the achievement of a milestone is considered probable at the inception of the collaboration, the related milestone payment is included with other collaboration consideration, such as upfront fees and research funding, in the Company&#x2019;s revenue &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;calculation. If these milestones are not considered probable at the inception of the collaboration, the milestones will typically be recognized in one of two ways depending on the timing of when the milestone is achieved.&#160;If the milestone is improbable at inception and subsequently deemed probable of achievement, such will be added to the transaction price, resulting in a cumulative adjustment to revenue.&#160;If the milestone is achieved after the performance period has&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; been&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; completed and all performance obligations have been delivered, the Company will recognize the milestone payment as revenue in its entirety in the period the milestone was achieved. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s collaborative agreements, for accounting purposes, represent contracts with customers and therefore are not subject to accounting literature on collaborative agreements. The Company grants licenses to its intellectual property, supplies raw materials, semi-finished goods or finished goods, provides research and development services and offers sales support for the co-promotion of products, all of which are outputs of the Company&#x2019;s ongoing activities, in exchange for consideration. Accordingly, the Company concluded that its collaborative agreements must generally be accounted for pursuant to ASC 606.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For collaboration agreements that allow collaboration partners to select additional optioned products or services, the Company evaluates whether such options contain material rights (i.e., have exercise prices that are discounted compared to what the Company would charge for a similar product or service to a new collaboration partner). The exercise price of these options includes a combination of licensing fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, the Company concludes the option does not contain a material right, and therefore is not included in the transaction price at contract inception. The Company assessed the CSA agreement with UT and determined that a material right existed for the manufacturing services performance obligation. The transaction price is allocated to the material right as well as the remaining performance obligations in accordance with ASC 606. The Company also evaluates grants of additional licensing rights upon option exercises to determine whether such should be accounted for as separate contracts.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2014; Royalties &#x2014;&lt;span style="font-style:normal;"&gt; The Company recognizes royalty revenue for a sales-based or usage-based royalty if it is promised in exchange for an intellectual property license. The royalty revenue is recognized as the latter of the subsequent sale of the product occurs or if the performance obligation to which the royalty has been allocated has been satisfied or partially satisfied. The Company&#x2019;s collaborative agreement with UT entitles it to receive low double-digit royalties on net sales of Tyvaso DPI for the license of the Company&#x2019;s IP that was considered to be interdependent with the development activities that supported the approval of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,073&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,435&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,324&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,098&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99,770&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,442&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,144&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent revenue generated from the Company&#x2019;s collaboration arrangements, including Next-Gen R&amp;amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;font-size:9pt;color:#000000;"&gt;Collaboration, Licensing and Other Arrangements&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent royalties on UT&#x2019;s net sales of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,071&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,084&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,557&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,857&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company follows detailed accounting guidance in measuring revenue and certain judgments affect the application of its revenue policy. For example, in connection with its existing collaboration agreements, the Company has recorded on its consolidated balance sheets short-term and long-term deferred revenue based on its best estimate of when such revenue will be recognized. Short-term deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12&#160;months. Amounts that the Company expects will not be recognized within the next 12&#160;months are classified as long-term deferred revenue. However, this estimate is based on the Company&#x2019;s current project development plan and, if the development plan should change in the future, the Company may recognize a different amount of deferred revenue over the next 12-month period. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Payments&lt;span style="font-style:normal;"&gt; &#x2014; At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the customer, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as, or when, the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect license, collaboration, other revenue, and earnings in the period of adjustment&lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cost of Goods Sold&lt;span style="font-style:normal;"&gt; &#x2014; Cost of goods sold includes material, labor costs and manufacturing overhead. Cost of goods sold also includes a component of current period manufacturing costs in excess of costs capitalized into inventory (&#x201c;excess capacity costs&#x201d;).&#160;These costs, in addition to the impact of the revaluation of inventory for standard costing, and write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of goods sold excludes the cost of insulin purchased under the Company&#x2019;s Insulin Supply Agreement (the &#x201c;Insulin Supply Agreement&#x201d;) with Amphastar Pharmaceuticals, Inc. (&#x201c;Amphastar&#x201d;). All insulin inventory on hand was written off and the full purchase commitment contract to purchase future insulin was accrued as a recognized loss on purchase commitments as of the end of 2016.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cost of Revenues &#x2013; Collaborations and Services&lt;span style="font-style:normal;"&gt; &#x2014; Cost of revenues &#x2013; collaborations and services includes material, labor costs, manufacturing overhead, and excess capacity costs.&#160;These costs, in addition to the write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of revenues &#x2013; collaborations and services also includes the cost of product development.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents and Restricted Cash&lt;span style="font-style:normal;"&gt; &#x2014; The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December 31, 2022 and 2021, cash equivalents were comprised of money market, corporate bonds and commercial paper accounts with original maturities less than 90 days from the date of purchase.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records restricted cash when cash and cash equivalents are restricted as to withdrawal or usage. The Company presents amounts of restricted cash that will be available for use within 12 months of the reporting date as restricted cash in current assets. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Held-to-Maturity Investments&lt;span style="font-style:normal;"&gt; &#x2014; The Company&#x2019;s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2022, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. The amortization or accretion of the Company&#x2019;s investments is recognized as interest income in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Available-for-Sale Investment&lt;span style="font-style:normal;"&gt; &#x2014; In June 2021, the Company purchased a $3.0 million convertible promissory note (the &#x201c;Thirona convertible note&#x201d;) issued by Thirona Bio, Inc. (&#x201c;Thirona&#x201d;). In January 2022, the Company purchased an additional $5.0 million convertible promissory note issued by Thirona. Unless earlier converted into conversion shares pursuant to the note purchase agreement, the principal and accrued interest shall be due and payable by Thirona on demand by the Company at any time after the maturity date of December 31, 2023. Interest accrues at a rate of 6% per annum. The Thirona convertible notes are general unsecured obligations of Thirona. The Thirona convertible notes are classified as an available-for-sale security and are included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company assesses whether it has any intention to sell the investment, determines fair value of its available-for-sale investments using level 3 inputs as well as assesses its allowance for credit losses associated with the available for sale investment. In June 2021, the Company and Thirona also entered into a collaboration agreement to develop a compound for the treatment of fibrotic lung diseases. See Note 11 &#x2013; &lt;/span&gt;Collaboration, Licensing and Other Arrangements&lt;span style="font-style:normal;"&gt; for additional information. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk&lt;span style="font-style:normal;"&gt; &#x2014; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounts Receivable and Allowance for Credit Losses&lt;span style="font-style:normal;"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; Accounts receivable are recorded at the invoiced amount and are not interest bearing. Accounts receivable are presented net of an allowance for credit losses if there are estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for credit losses. The allowance for expected credit losses is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. Accounts receivable are also presented net of an allowance for product returns and trade discounts and allowances because the Company&#x2019;s customers have the right of setoff for these amounts against the related accounts receivable.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Pre-Launch Inventory &lt;span style="font-style:normal;"&gt;&#x2014; An improvement to the manufacturing process for the Company&#x2019;s primary excipient fumaryl diketopiperazine (&#x201c;FDKP&#x201d;) was demonstrated to be viable and management expects to realize an economic benefit in the future as a result of such process improvement. Accordingly, the Company is required to assess whether to capitalize inventory costs related to such excipient prior to regulatory approval of the new supplier and the improved manufacturing process. In doing so, management must consider a number of factors in order to determine the amount of inventory to be capitalized, including the historical experience of achieving regulatory approvals for the Company&#x2019;s manufacturing process, feedback from regulatory agencies on the changes being effected and the amount of inventory that is likely to be used in commercial production. The shelf life of the excipient will be determined as part of the regulatory approval process; in the interim, the Company must assess the available stability data to determine whether there is likely to be adequate shelf life to support anticipated future sales occurring beyond the expected approval date of the new raw material. If management is aware of any specific material risks or contingencies other than the normal regulatory review and approval process, or if the criteria for capitalizing inventory produced prior to regulatory approval are otherwise not met, the Company would not capitalize such inventory costs, choosing instead to recognize such costs as a research and development expense in the period incurred.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Inventories&lt;span style="font-style:normal;"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes inventory costs associated with the Company&#x2019;s products based on management&#x2019;s judgment that future economic benefits &lt;/span&gt;&lt;span style="font-style:normal;"&gt;are&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; expected to be realized; otherwise, such costs are expensed as incurred as cost of goods sold. The Company uses a contract manufacturing organization outside of the U.S. for certain stages of V-Go inventory. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company periodically analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value and writes down such inventories, as appropriate. In addition, the Company&#x2019;s products are subject to strict quality control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or may become obsolete or are forecasted to become obsolete due to expiration, the Company will record a charge to write down such unmarketable inventory to its estimated net realizable value. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company performs an assessment of projected sales and evaluates the lower of cost or net realizable value and the potential excess inventory on hand at the end of each reporting period.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment&lt;span style="font-style:normal;"&gt; &#x2014; Property and equipment is recorded at historical cost, net of accumulated depreciation. Depreciation expense is recorded over the assets&#x2019; useful lives on a straight-line basis. See Note 7 &#x2013; &lt;/span&gt;Property and Equipment&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;span style="font-style:normal;"&gt;&#160;&#x2014; Long-lived assets include property and equipment, operating lease right-of-use assets and other intangible asset. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Assets are considered to be impaired if the carrying value is considered to be unrecoverable.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the asset exceeds the fair value of the asset. Fair value is determined using the market, income or cost approaches as appropriate for the asset. Any write-downs are treated as permanent reductions in the carrying amount of the asset and recognized as an operating loss.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In August 2019, the Company recorded a $1.5&#160;million&#160;commitment asset and a $0.4&#160;million other asset for deferred debt issuance costs related to the future funding commitments of the MidCap Credit Facility. A quarterly assessment was performed during the second quarter of 2020 to determine if the Company was on target to achieve certain required milestone conditions in order for the Company to access further borrowings under the MidCap Credit Facility.&#160;The Company determined that such milestone conditions related to Afrezza trailing net revenue were unlikely to be achieved.&#160;As a result, an asset impairment of $1.9&#160;million was recognized during the second quarter of 2020 and is reflected in&#160;the Company&#x2019;s consolidated statement of operations. See Note 10 &#x2013;&#160;&lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Borrowings&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;&#160;for further information on the MidCap Credit Facility.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded $0.1 million of asset impairments for the year ended December 31, 2021. There were no asset impairments for the year ended December 31, 2022.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Acquisitions &#x2014; &lt;span style="font-style:normal;"&gt;The Company first determines whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired do not constitute a business, the Company accounts for the transaction as an asset acquisition. Business combinations are accounted for by means of the acquisition method of accounting. Under the acquisition method, assets acquired, &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-style:normal;"&gt;including in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) projects, and liabilities assumed are recorded at their respective fair values as of the acquisition date in the Company&#x2019;s consolidated financial statements. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Contingent consideration obligations incurred in connection with a business combination (including the assumption of an acquiree&#x2019;s liability arising from an acquisition it consummated prior to the Company&#x2019;s acquisition) are recorded at their fair values on the acquisition date and remeasured at their fair values each subsequent reporting period until the related contingencies have been resolved. The resulting changes in fair values are recorded in earnings. In contrast, asset acquisitions are accounted for by using a cost accumulation and allocation model. Under this model, the cost of the acquisition is allocated to the assets acquired and liabilities assumed. IPR&amp;amp;D projects with no alternative future use are recorded in R&amp;amp;D expense upon acquisition, and contingent consideration obligations incurred in connection with an asset acquisition are recorded when it is probable that they will occur and they can be reasonably estimated. See Note 3 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Acquisition&lt;/span&gt;&lt;span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;s&lt;/span&gt;&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Goodwill and Other Intangible Assets &lt;/span&gt;&#x2014; &lt;span style="Background-color:#FFFFFF;font-style:normal;"&gt;The fair value of acquired intangible assets is determined using an income-based approach referred to as the excess earnings method utilizing Level 3 fair value inputs. Market participant valuations assume a global view considering all potential jurisdictions and indications based on discounted after-tax cash flow projections, risk adjusted for estimated probability of technical and regulatory success. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company tests for impairment annually on a reporting unit basis, at the beginning of the Company&#x2019;s fourth fiscal quarter and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. To the extent the carrying amount of a reporting unit is less than its estimated fair value, an impairment charge will be recorded.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life. Estimated useful lives are determined considering the period assets are expected to contribute to future cash flows. Finite-lived intangible assets are tested for impairment when facts or circumstances suggest that the carrying value of the asset may not be recoverable.&#160;If the carrying value exceeds the projected undiscounted pretax cash flows of the intangible asset, an impairment loss equal to the excess of the carrying value over the estimated fair value (discounted after-tax cash flows) is recognized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;No&lt;/span&gt; impairments to goodwill or other intangible assets were recorded during the year ended December 31, 2022.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recognized Loss on Purchase Commitments &#x2014;&lt;span style="font-style:normal;"&gt; The Company assesses whether losses on long-term purchase commitments should be accrued. Losses that are expected to arise from firm, non-cancellable, commitments for the future purchases are recognized unless recoverable. When making the assessment, the Company also considers whether it is able to renegotiate with its vendors. The recognized loss on purchase commitments is reduced as inventory items are received. If, subsequent to an accrual, a purchase commitment is successfully renegotiated, the gain is recognized in the Company&#x2019;s consolidated statements of operations. The liability balance of the recognized loss on insulin purchase commitments as of December 31, 2022 and 2021 was $72.3 million and $82.8 million, respectively. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;No&lt;/span&gt;&#160;new contracts were identified in 2022 that required a new loss on purchase commitment accrual.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights Liability&lt;span style="font-style:normal;"&gt;&#160;&#x2014; &lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt;In July 2013, in conjunction with the execution of a (now repaid) loan agreement with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (collectively, &#x201c;Deerfield&#x201d;), the Company entered into Milestone Rights Purchase Agreement (the &#x201c;Milestone Rights Agreement&#x201d;) pursuant to which the Company issued certain milestone rights to Deerfield Private Design Fund II, L.P. and Horizon Sant&#xe9; FLML S&#xc0;RL, (the &#x201c;Original Milestone Purchasers&#x201d;). The foregoing milestone rights provided the Original Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable upon achievement of such milestones (collectively, the &#x201c;Milestone Rights&#x2019;). In December 2021, the Milestone Rights were purchased by Barings Global Special Situations Credit Fund 4 (Delaware), L.P. and Barings Global Special Situations Credit 4 (LUX) S.ar.l. (together the &#x201c;Milestone Purchasers&#x201d;). As a result, the Milestone Purchasers have assumed the obligations of the Original Milestone Purchasers and is now entitled to all rights under the Milestone Rights Agreement. As of December 31, 2022, $60.0 million remained payable pursuant to the Milestone Rights Agreement upon achievement of Afrezza net sales milestones. The Milestone Rights liability is reported at fair value at the date of the agreement which is periodically offset against payments. See Note 12&lt;/span&gt;&lt;span style="font-style:normal;"&gt; &#x2013; &lt;/span&gt;Fair Value of Financial Instruments&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#x2019;s consolidated statements of operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. See Note&#160;10 &#x2013; &lt;span style="font-style:italic;"&gt;Borrowings&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;span style="font-style:normal;"&gt; &#x2014;The Company applies various valuation approaches in determining the fair value of its financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&#160;&#x2014;&#160;Quoted prices for identical instruments in active markets.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&#160;&#x2014;&#160;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&#160;&#x2014;&#160;Significant inputs to the valuation model are unobservable.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;span style="font-style:normal;"&gt;&#160;&#x2014; The provisions for federal, foreign, state and local income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets to amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;For uncertain tax positions, the Company determines whether it is &#x201c;more likely than not&#x201d; that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, no tax benefit is recognized. &lt;/span&gt;Penalties, if probable and reasonably estimable, are recognized as a component of income tax expense.&lt;span style="Background-color:#FFFFFF;"&gt; The Company has reduced its deferred tax assets for uncertain tax positions but has not recorded liabilities for income tax expense, penalties, or interest.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;span style="font-style:normal;"&gt; &#x2014; The Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals represent management&#x2019;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation and may revise its estimates.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;span style="font-style:normal;"&gt; &#x2014; Share-based payments to employees, including grants of RSUs, performance-based non-qualified stock options awards (&#x201c;PNQs&#x201d;), restricted stock units with market conditions (&#x201c;Market RSUs&#x201d;), options and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. RSUs are valued based on the market price on the grant date. Market RSUs are valued using a Monte Carlo valuation model and RSUs with performance conditions are evaluated for the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Clinical Trial Expenses&lt;span style="font-style:normal;"&gt; &#x2014; Clinical trial expenses, which are primarily reflected in research and development expenses in the accompanying consolidated statements of operations, result from obligations under contracts with vendors, consultants and clinical site agreements in addition to internal costs associated with conducting clinical trials.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Net Income (Loss) Per Share of Common Stock&lt;span style="font-style:normal;"&gt; &#x2014; Basic net income or loss per share excludes dilution for potentially dilutive securities and is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted net loss per share as they would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recently Adopted Accounting Standards &lt;span style="font-style:normal;"&gt;&#x2014; &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued a new accounting standard to ease the financial reporting burdens caused by the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, commonly referred to as reference rate reform. The new standard provides temporary optional expedients and exceptions to current GAAP guidance on contract modifications and hedge accounting. In January 2021, the FASB issued a new accounting standard that expanded the scope of the original March 2020 standard to include derivative instruments on discounting transactions. In December 2022, the FASB deferred the sunset date to an alternative reference rate from December 31, 2022 to December 31, 2024. The Company adopted these standards in the third quarter of 2022 using the prospective method and determined there was no impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Standards&lt;span style="font-style:normal;"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;In November 2021, the FASB issued a new accounting standard around the recognition and measurement of contract assets and contract liabilities from revenue contracts with customers acquired in a business combination. The new standard clarifies that contract assets and contract liabilities acquired in a business combination from an acquiree should initially be recognized by applying revenue recognition principles and not at fair value. The standard is effective for interim and annual periods beginning on January 1, 2023, and early adoption is permitted. The impact of this standard will depend on the facts and circumstances of future transactions.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial position or results of operations upon adoption.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_0000899460_20220101_20221231" id="F_000512">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Financial Statement Estimates&lt;span style="font-style:normal;"&gt; &#x2014; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000513">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;span style="font-style:normal;"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; The Company recognizes revenue when its customers obtain control of promised goods or services, in an amount that reflects the consideration which the Company expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;To determine revenue recognition for arrangements that are within the scope of Accounting Standards Codification (&#x201c;&lt;span style="color:#000000;"&gt;ASC&#x201d;) &lt;/span&gt;Topic 606, &lt;span style="font-style:italic;font-family:Calibri;color:#000000;"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="font-family:Calibri;color:#000000;"&gt;(&#x201c;ASC 606&#x201d;),&lt;/span&gt; the Company performs the following five steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to arrangements that meet the definition of a contract under ASC 606, including when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract, determines those that are performance obligations, and assesses whether each promised good or service is distinct. The Company has two types of contracts with customers: (i) contracts for commercial product sales with wholesale distributors, specialty and retail pharmacies and (ii) collaboration arrangements.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <mnkd:RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000514">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2013; Net Revenue &#x2013; Commercial Product Sales &#x2013;&lt;span style="font-style:normal;"&gt; The Company sells its products to a limited number of wholesale distributors, specialty and retail pharmacies, and durable medical equipment suppliers (&#x201c;DME&#x201d;) in the U.S. (collectively, its &#x201c;Customers&#x201d;). Wholesale distributors&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; subsequently resell the Company&#x2019;s products to retail pharmacies and certain medical centers or hospitals. Specialty and retail pharmacies sell directly to patients. In addition to distribution agreements with Customers, the Company enters into arrangements with payers that provide for government mandated and/or privately negotiated rebates, chargebacks, and discounts with respect to the purchase of the Company&#x2019;s products.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes revenue on product sales when the Customer obtains control of the Company's product, which occurs at delivery for wholesale distributors and &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;generally &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;delivery &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for specialty pharmacies. &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; recognize&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;s&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; revenue on product sales to&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; a&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; retail pharmac&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;y&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; as the product is dispensed to patients. &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product revenues are recorded net of applicable reserves&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;including discounts, allowances, rebates, returns and other incentives&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. See &lt;/span&gt;&lt;span style="font-style:italic;"&gt;Reserves for Variable Consideration&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; below.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Free Goods Program &#x2013; &lt;span style="font-style:normal;"&gt;From time to time, the Company offers programs to potential new patients that allow them to obtain free goods (prescription fills) from a pharmacy. The Company excludes such amounts related to these programs from both gross and net revenue.&#160;The cost of product associated with the free goods program is recognized as cost of goods sold in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Reserves for Variable Consideration &lt;span style="font-style:normal;"&gt;&#x2014; Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration for which reserves are established. Components of variable consideration include trade discounts and allowances, product returns, provider chargebacks and discounts, government rebates, payer rebates, and other incentives, such as voluntary patient assistance, and other allowances that are offered within contracts between the Company and its Customers, payers, and other indirect customers relating to the Company&#x2019;s sale of its products. These reserves, as further detailed below, are based on the amounts earned, or to be claimed on the related sales, and result in a reduction of accounts receivable or establishment of a current liability.&#160;Significant judgments are required in making these estimates.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Where appropriate, these estimates take into consideration a range of possible outcomes, which are probability-weighted in accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reduce recognized revenue to the Company&#x2019;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amount of variable consideration that is included in the transaction price may be constrained, and is included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized under the contract will not occur in a future period. The Company&#x2019;s analysis also contemplates application of the constraint in accordance with the guidance, under which it determined a material reversal of revenue would not occur in a future period for the estimates of gross-to-net adjustments as of December 31, 2022 and, therefore, the transaction price was not reduced further during the year ended December 31, 2022. Actual amounts of consideration ultimately received may differ from the Company&#x2019;s estimates. If actual results in the future vary from the Company&#x2019;s estimates, the Company will adjust these estimates, which would affect net revenue &lt;span style="font-family:Calibri;"&gt;&#x2014;&lt;/span&gt; commercial product sales and earnings in the period such variances become known.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant judgment is required in estimating gross-to-net adjustments, historical experience, payer channel mix, unbilled claims, claim submission time lags and inventory levels in the distribution channel.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Trade Discounts and Allowances &lt;span style="font-style:normal;"&gt;&#x2014; The Company generally provides Customers with discounts which include incentives, such as prompt pay discounts, that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized. In addition, the Company compensates (through trade discounts and allowances) its Customers for sales order management, data, and distribution services. However, the Company has determined such services received to date are not distinct from the Company&#x2019;s sale of products to the Customer and, therefore, these payments have been recorded as a reduction of revenue and as a reduction to accounts receivable, net. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Product Returns &lt;span style="font-style:normal;"&gt;&#x2014; Consistent with industry practice, the Company generally offers Customers a right of return for unopened product that has been purchased from the Company for a period beginning six months prior to and ending 12 months after its expiration date, which lapses upon shipment to a patient. The Company estimates the amount of its product sales that may be returned by its Customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized, as well as reductions to accounts receivable, net. The Company currently estimates product returns using available industry data and its own sales information, including its visibility into the inventory remaining in the distribution channel. The Company&#x2019;s current return reserve percentage is estimated to be in the single-&lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;"&gt;digits. &lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;color:#000000;"&gt;Adjustments to the returns reserve have been made in the past and may be necessary in the future based on revised estimates to the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Provider Chargebacks and Discounts &lt;span style="font-style:normal;"&gt;&#x2014; Chargebacks for fees and discounts to providers represent the estimated obligations resulting from contractual commitments to sell products to qualified healthcare providers at prices lower than the list prices charged to Customers who directly purchase products from the Company. Customers charge the Company for the difference between what they pay for products and the ultimate selling price to the qualified healthcare providers. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is recorded in accrued expenses and other current liabilities. Chargeback amounts are generally determined at the time of resale to the qualified healthcare provider by Customers, and the Company generally issues credits for such amounts within a few weeks of the Customer&#x2019;s notification to the Company of the resale. Reserves for chargebacks consist of credits that the Company expects to issue for units that remain in the distribution channel inventories at each reporting period-end that the Company expects will be sold to qualified healthcare providers, and chargebacks that Customers have claimed, but for which the Company has not yet issued a credit.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Government Rebates &lt;span style="font-style:normal;"&gt;&#x2014; The Company is subject to discount obligations under Medicare and state Medicaid programs. These reserves are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities. Estimates around Medicaid have historically required significant &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-style:normal;"&gt;judg&lt;/span&gt;&lt;span style="font-style:normal;"&gt;ment due to timing lags in receiving invoices for claims from states.&lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-style:normal;"&gt;For &lt;/span&gt;&lt;span style="font-style:normal;"&gt;Afrezza&lt;/span&gt;&lt;span style="font-style:normal;"&gt;, the Company also estimates the number of patients in the prescription drug coverage gap for whom the Company will owe an additional liability under the Medicare Part D program. The Company&#x2019;s liability for these rebates consists of invoices received for claims from prior quarters that have not been paid or for which an invoice has not yet been received, estimates of claims for the current quarter, and estimated future claims that will be made for product&lt;/span&gt;&lt;span style="font-style:normal;"&gt;s&lt;/span&gt;&lt;span style="font-style:normal;"&gt; that ha&lt;/span&gt;&lt;span style="font-style:normal;"&gt;ve&lt;/span&gt;&lt;span style="font-style:normal;"&gt; been recognized as revenue, but which remains in the distribution channel inventories at the end of each reporting period.&lt;/span&gt;&lt;span style="font-style:normal;"&gt; The Company&#x2019;s estimates include consideration of historical claims expe&lt;/span&gt;&lt;span style="font-style:normal;"&gt;rience, paye&lt;/span&gt;&lt;span style="font-style:normal;"&gt;r channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Payer Rebates &lt;span style="font-style:normal;"&gt;&#x2014; The Company contracts with certain private payer organizations, primarily insurance companies and pharmacy benefit managers, for the payment of rebates with respect to utilization of its products. The Company estimates these rebates, including estimates for product that has been recognized as revenue, but which remains in the distribution channel, and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability which is included in accrued expenses and other current liabilities. The Company&#x2019;s estimates include consideration of historical claims experience, payer channel mix, current contract prices, unbilled claims, claim submission time lags and inventory in the distribution channel. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Other Incentives &lt;span style="font-style:normal;"&gt;&#x2014; Other incentives which the Company offers include voluntary patient support programs, such as the Company's co-pay assistance program, which are intended to provide financial assistance to qualified commercially-insured patients with co-payments required by payers. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to receive associated with the products that have been recognized as revenue, but remains in the distribution channel inventories at the end of each reporting period. The adjustments are recorded in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of a current liability that is included in accrued expenses and other current liabilities.&lt;/span&gt;&lt;/p&gt;</mnkd:RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock>
    <mnkd:SalesReturnPeriod
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMinimumMember_20220101_20221231"
      id="F_000583">P6M</mnkd:SalesReturnPeriod>
    <mnkd:SalesReturnPeriod
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_srtRangeAxis_srtMaximumMember_20220101_20221231"
      id="F_000584">P12M</mnkd:SalesReturnPeriod>
    <mnkd:RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000515">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2014; Revenue &#x2014; Collaborations and Services &#x2014;&lt;span style="font-style:normal;"&gt; The Company enters into licensing, research or other agreements under which the Company licenses certain rights to its product candidates to third parties, conducts research or provides other services to third parties. The terms of these arrangements may include, but are not limited to payment to the Company of one or more of the following: up-front license fees; development, regulatory, and commercial milestone payments; payments for commercial manufacturing and clinical supply services the Company provides; and royalties on net sales of licensed products and sublicenses of the rights. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment such as determining the performance obligation in the contract and determining the stand-alone selling price for each performance obligation identified in the contract. &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;With respect to our &lt;/span&gt;&lt;span style="font-style:normal;"&gt;significant collaboration and service agreement with UT that includes a long-term commercial supply agreement (&#x201c;as amended, the CSA&#x201d;), we have identified three distinct performance obligations: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#x201c;R&amp;amp;D Services and License&#x2019;), (2) development activities for the next generation of the product (&#x201c;Next-Gen R&amp;amp;D Services&#x201d;), and (3) a material right associated with current and future manufacturing and supply of product (&#x201c;Manufacturing Services&#x201d;). Pre-production activities under the CSA, such as facility expansion services and other administrative services, were considered bundled services under the Manufacturing Services performance obligation as required by ASC 606. Following the FDA&#x2019;s approval of Tyvaso DPI, UT began issuing purchase orders for the supply of product, which represents distinct contracts and performance obligations under ASC 606. Revenue is recognized for the supply of product at a point in time, once control is transferred to UT. See Note 11 &#x2013; &lt;/span&gt;Collaboration, Licensing and Other Arrangements&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If an arrangement has multiple performance obligations, the allocation of the transaction price is determined from observable market inputs, and the Company uses key assumptions to determine the stand-alone selling price, which may include development timelines, reimbursement rates for personnel costs, discount rates, and probabilities of technical and regulatory success. Revenue is recognized based on the measurement of progress as the performance obligation is satisfied and consideration received that does not meet the requirements to satisfy the revenue recognition criteria is recorded as deferred revenue. Current deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12 months. Amounts that the Company expects will not be recognized within the next 12 months are classified as long-term deferred revenue. For further information, see Note 11&lt;span style="font-style:italic;"&gt; &#x2013; Collaboration, Licensing and Other Arrangements.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes upfront license payments as revenue upon delivery of the license only if the license is determined to be a separate unit of accounting from the other undelivered performance obligations.&#160;The undelivered performance obligations typically include manufacturing or development services or research and/or steering committee services. If the license is not considered as a distinct performance obligation, then the license and other undelivered performance obligations would be evaluated to determine if such should be accounted for as a single unit of accounting.&#160;If concluded to be a single performance obligation, the transaction price for the single performance obligation is recognized as revenue over the estimated period of when the performance obligation is satisfied. If the license is considered to be a distinct performance obligation, then the estimated revenue is included in the transaction price for the contract, which is then allocated to each performance obligation based on the respective standalone selling prices.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Whenever the Company determines that an arrangement should be accounted for over time, the Company determines the period over which the performance obligations will be performed, and revenue will be recognized over the period the Company is expected to complete its performance obligations. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which the Company is expected to complete its performance obligations under an arrangement. &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s collaboration agreements typically entitle the Company to additional payments upon the achievement of development, regulatory and sales milestones. If the achievement of a milestone is considered probable at the inception of the collaboration, the related milestone payment is included with other collaboration consideration, such as upfront fees and research funding, in the Company&#x2019;s revenue &lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;calculation. If these milestones are not considered probable at the inception of the collaboration, the milestones will typically be recognized in one of two ways depending on the timing of when the milestone is achieved.&#160;If the milestone is improbable at inception and subsequently deemed probable of achievement, such will be added to the transaction price, resulting in a cumulative adjustment to revenue.&#160;If the milestone is achieved after the performance period has&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; been&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; completed and all performance obligations have been delivered, the Company will recognize the milestone payment as revenue in its entirety in the period the milestone was achieved. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s collaborative agreements, for accounting purposes, represent contracts with customers and therefore are not subject to accounting literature on collaborative agreements. The Company grants licenses to its intellectual property, supplies raw materials, semi-finished goods or finished goods, provides research and development services and offers sales support for the co-promotion of products, all of which are outputs of the Company&#x2019;s ongoing activities, in exchange for consideration. Accordingly, the Company concluded that its collaborative agreements must generally be accounted for pursuant to ASC 606.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;For collaboration agreements that allow collaboration partners to select additional optioned products or services, the Company evaluates whether such options contain material rights (i.e., have exercise prices that are discounted compared to what the Company would charge for a similar product or service to a new collaboration partner). The exercise price of these options includes a combination of licensing fees, event-based milestone payments and royalties. When these amounts in aggregate are not offered at a discount that exceeds discounts available to other customers, the Company concludes the option does not contain a material right, and therefore is not included in the transaction price at contract inception. The Company assessed the CSA agreement with UT and determined that a material right existed for the manufacturing services performance obligation. The transaction price is allocated to the material right as well as the remaining performance obligations in accordance with ASC 606. The Company also evaluates grants of additional licensing rights upon option exercises to determine whether such should be accounted for as separate contracts.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &#x2014; Royalties &#x2014;&lt;span style="font-style:normal;"&gt; The Company recognizes royalty revenue for a sales-based or usage-based royalty if it is promised in exchange for an intellectual property license. The royalty revenue is recognized as the latter of the subsequent sale of the product occurs or if the performance obligation to which the royalty has been allocated has been satisfied or partially satisfied. The Company&#x2019;s collaborative agreement with UT entitles it to receive low double-digit royalties on net sales of Tyvaso DPI for the license of the Company&#x2019;s IP that was considered to be interdependent with the development activities that supported the approval of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,073&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,435&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,324&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,098&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99,770&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,442&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,144&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent revenue generated from the Company&#x2019;s collaboration arrangements, including Next-Gen R&amp;amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;font-size:9pt;color:#000000;"&gt;Collaboration, Licensing and Other Arrangements&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent royalties on UT&#x2019;s net sales of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,071&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,084&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,557&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,857&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company follows detailed accounting guidance in measuring revenue and certain judgments affect the application of its revenue policy. For example, in connection with its existing collaboration agreements, the Company has recorded on its consolidated balance sheets short-term and long-term deferred revenue based on its best estimate of when such revenue will be recognized. Short-term deferred revenue consists of amounts that are expected to be recognized as revenue in the next 12&#160;months. Amounts that the Company expects will not be recognized within the next 12&#160;months are classified as long-term deferred revenue. However, this estimate is based on the Company&#x2019;s current project development plan and, if the development plan should change in the future, the Company may recognize a different amount of deferred revenue over the next 12-month period. &lt;/p&gt;</mnkd:RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231"
      id="F_000585">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000540">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s net revenue and cost of revenue and goods sold as shown on the consolidated statement of operations is comprised of revenue generated from product sales, services and royalties as shown below (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.74%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.54%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81,073&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,435&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,324&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.86%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,098&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,007&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.86%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;99,770&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,442&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;65,144&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent the net sales of Afrezza and V-Go to wholesalers and specialty pharmacies and Tyvaso DPI to UT.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent revenue generated from the Company&#x2019;s collaboration arrangements, including Next-Gen R&amp;amp;D Services (as defined in Note 11) for UT as well as arrangements with other collaboration partners. See Note 11 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;font-size:9pt;color:#000000;"&gt;Collaboration, Licensing and Other Arrangements&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.38%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amounts represent royalties on UT&#x2019;s net sales of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product sales&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,071&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,084&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,557&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.76%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cost of goods sold and cost of revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;57,497&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,857&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,641&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231"
      decimals="-3"
      id="F_000586"
      unitRef="U_iso4217USD">81073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">39435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">32324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">3098000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">36007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">32820000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapRoyaltyMember_20220101_20221231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">15599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">99770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">75442000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">65144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20220101_20221231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">55071000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20210101_20211231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">16833000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdProductSalesMember_20200101_20201231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">15084000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20220101_20221231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">2426000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20210101_20211231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">22024000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapServiceMember_20200101_20201231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">9557000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">57497000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">38857000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">24641000</us-gaap:OperatingExpenses>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231"
      id="F_000605">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DebtPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000516">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Payments&lt;span style="font-style:normal;"&gt; &#x2014; At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the customer, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as, or when, the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company will re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect license, collaboration, other revenue, and earnings in the period of adjustment&lt;/span&gt;&lt;span style="font-family:Calibri;font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000517">Cost of Goods Sold&lt;span style="font-style:normal;"&gt; &#x2014; Cost of goods sold includes material, labor costs and manufacturing overhead. Cost of goods sold also includes a component of current period manufacturing costs in excess of costs capitalized into inventory (&#x201c;excess capacity costs&#x201d;).&#160;These costs, in addition to the impact of the revaluation of inventory for standard costing, and write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of goods sold excludes the cost of insulin purchased under the Company&#x2019;s Insulin Supply Agreement (the &#x201c;Insulin Supply Agreement&#x201d;) with Amphastar Pharmaceuticals, Inc. (&#x201c;Amphastar&#x201d;). All insulin inventory on hand was written off and the full purchase commitment contract to purchase future insulin was accrued as a recognized loss on purchase commitments as of the end of 2016.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <mnkd:CostOfRevenuesPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000518">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cost of Revenues &#x2013; Collaborations and Services&lt;span style="font-style:normal;"&gt; &#x2014; Cost of revenues &#x2013; collaborations and services includes material, labor costs, manufacturing overhead, and excess capacity costs.&#160;These costs, in addition to the write-offs of inventory are recorded as expenses in the period in which they are incurred, rather than as a portion of inventory costs. Cost of revenues &#x2013; collaborations and services also includes the cost of product development.&lt;/span&gt;&lt;/p&gt;</mnkd:CostOfRevenuesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="C_0000899460_20220101_20221231" id="F_000519">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cash and Cash Equivalents and Restricted Cash&lt;span style="font-style:normal;"&gt; &#x2014; The Company considers all highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase, that are readily convertible into cash to be cash equivalents. As of December 31, 2022 and 2021, cash equivalents were comprised of money market, corporate bonds and commercial paper accounts with original maturities less than 90 days from the date of purchase.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company records restricted cash when cash and cash equivalents are restricted as to withdrawal or usage. The Company presents amounts of restricted cash that will be available for use within 12 months of the reporting date as restricted cash in current assets. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:HeldToMaturitySecuritiesPurchasedOptionsPricePolicy contextRef="C_0000899460_20220101_20221231" id="F_000520">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Held-to-Maturity Investments&lt;span style="font-style:normal;"&gt; &#x2014; The Company&#x2019;s investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. For the year ended December 31, 2022, the Company held short-term and long-term investments of debt securities, including commercial paper and bonds. The Company assesses whether it has any intention to sell the investment before maturity, whether any declines in fair value are the result of credit losses, as well as whether there were other-than-temporary impairments associated with the available for sale investment. The Company intends to hold its investments until maturity; therefore, these investments are stated at amortized cost. The investments with maturities less than 12 months are included in short-term investments and investments with maturities in excess of twelve months are included in long-term investments in the consolidated balance sheets. The amortization or accretion of the Company&#x2019;s investments is recognized as interest income in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:HeldToMaturitySecuritiesPurchasedOptionsPricePolicy>
    <us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy contextRef="C_0000899460_20220101_20221231" id="F_000521">Available-for-Sale Investment&lt;span style="font-style:normal;"&gt; &#x2014; In June 2021, the Company purchased a $3.0 million convertible promissory note (the &#x201c;Thirona convertible note&#x201d;) issued by Thirona Bio, Inc. (&#x201c;Thirona&#x201d;). In January 2022, the Company purchased an additional $5.0 million convertible promissory note issued by Thirona. Unless earlier converted into conversion shares pursuant to the note purchase agreement, the principal and accrued interest shall be due and payable by Thirona on demand by the Company at any time after the maturity date of December 31, 2023. Interest accrues at a rate of 6% per annum. The Thirona convertible notes are general unsecured obligations of Thirona. The Thirona convertible notes are classified as an available-for-sale security and are included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company assesses whether it has any intention to sell the investment, determines fair value of its available-for-sale investments using level 3 inputs as well as assesses its allowance for credit losses associated with the available for sale investment. In June 2021, the Company and Thirona also entered into a collaboration agreement to develop a compound for the treatment of fibrotic lung diseases. See Note 11 &#x2013; &lt;/span&gt;Collaboration, Licensing and Other Arrangements&lt;span style="font-style:normal;"&gt; for additional information. &lt;/span&gt;</us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy>
    <mnkd:PurchaseOfAvailableForSaleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210601_20210630"
      decimals="-5"
      id="F_000606"
      unitRef="U_iso4217USD">3000000.0</mnkd:PurchaseOfAvailableForSaleSecurities>
    <mnkd:PurchaseOfAvailableForSaleSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20220101_20220101"
      decimals="-5"
      id="F_000607"
      unitRef="U_iso4217USD">5000000.0</mnkd:PurchaseOfAvailableForSaleSecurities>
    <us-gaap:InvestmentMaturityDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630"
      id="F_000608">2023-12-31</us-gaap:InvestmentMaturityDate>
    <us-gaap:InvestmentInterestRate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20210630"
      decimals="2"
      id="F_000609"
      unitRef="U_xbrlipure">0.06</us-gaap:InvestmentInterestRate>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0000899460_20220101_20221231" id="F_000522">Concentration of Credit Risk&lt;span style="font-style:normal;"&gt; &#x2014; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="C_0000899460_20220101_20221231" id="F_000523">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Accounts Receivable and Allowance for Credit Losses&lt;span style="font-style:normal;"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; Accounts receivable are recorded at the invoiced amount and are not interest bearing. Accounts receivable are presented net of an allowance for credit losses if there are estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectability of its accounts receivable in its calculation of the allowance for credit losses. The allowance for expected credit losses is based primarily on past collections experience relative to the length of time receivables are past due. However, when available evidence reasonably supports an assumption that future economic conditions will differ from current and historical payment collections, an adjustment is reflected in the allowance for expected credit losses. Accounts receivable are also presented net of an allowance for product returns and trade discounts and allowances because the Company&#x2019;s customers have the right of setoff for these amounts against the related accounts receivable.&lt;/span&gt;&lt;/p&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <mnkd:PreLaunchInventoryPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000524">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Pre-Launch Inventory &lt;span style="font-style:normal;"&gt;&#x2014; An improvement to the manufacturing process for the Company&#x2019;s primary excipient fumaryl diketopiperazine (&#x201c;FDKP&#x201d;) was demonstrated to be viable and management expects to realize an economic benefit in the future as a result of such process improvement. Accordingly, the Company is required to assess whether to capitalize inventory costs related to such excipient prior to regulatory approval of the new supplier and the improved manufacturing process. In doing so, management must consider a number of factors in order to determine the amount of inventory to be capitalized, including the historical experience of achieving regulatory approvals for the Company&#x2019;s manufacturing process, feedback from regulatory agencies on the changes being effected and the amount of inventory that is likely to be used in commercial production. The shelf life of the excipient will be determined as part of the regulatory approval process; in the interim, the Company must assess the available stability data to determine whether there is likely to be adequate shelf life to support anticipated future sales occurring beyond the expected approval date of the new raw material. If management is aware of any specific material risks or contingencies other than the normal regulatory review and approval process, or if the criteria for capitalizing inventory produced prior to regulatory approval are otherwise not met, the Company would not capitalize such inventory costs, choosing instead to recognize such costs as a research and development expense in the period incurred.&lt;/span&gt;&lt;/p&gt;</mnkd:PreLaunchInventoryPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000525">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Inventories&lt;span style="font-style:normal;"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out, or FIFO, method. The Company capitalizes inventory costs associated with the Company&#x2019;s products based on management&#x2019;s judgment that future economic benefits &lt;/span&gt;&lt;span style="font-style:normal;"&gt;are&lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt; expected to be realized; otherwise, such costs are expensed as incurred as cost of goods sold. The Company uses a contract manufacturing organization outside of the U.S. for certain stages of V-Go inventory. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company periodically analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value and writes down such inventories, as appropriate. In addition, the Company&#x2019;s products are subject to strict quality control and monitoring which the Company performs throughout the manufacturing process. If certain batches or units of product no longer meet quality specifications or may become obsolete or are forecasted to become obsolete due to expiration, the Company will record a charge to write down such unmarketable inventory to its estimated net realizable value. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company analyzes its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company performs an assessment of projected sales and evaluates the lower of cost or net realizable value and the potential excess inventory on hand at the end of each reporting period.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000526">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment&lt;span style="font-style:normal;"&gt; &#x2014; Property and equipment is recorded at historical cost, net of accumulated depreciation. Depreciation expense is recorded over the assets&#x2019; useful lives on a straight-line basis. See Note 7 &#x2013; &lt;/span&gt;Property and Equipment&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000527">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;span style="font-style:normal;"&gt;&#160;&#x2014; Long-lived assets include property and equipment, operating lease right-of-use assets and other intangible asset. The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Assets are considered to be impaired if the carrying value is considered to be unrecoverable.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company believes an asset to be impaired, the impairment recognized is the amount by which the carrying value of the asset exceeds the fair value of the asset. Fair value is determined using the market, income or cost approaches as appropriate for the asset. Any write-downs are treated as permanent reductions in the carrying amount of the asset and recognized as an operating loss.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;In August 2019, the Company recorded a $1.5&#160;million&#160;commitment asset and a $0.4&#160;million other asset for deferred debt issuance costs related to the future funding commitments of the MidCap Credit Facility. A quarterly assessment was performed during the second quarter of 2020 to determine if the Company was on target to achieve certain required milestone conditions in order for the Company to access further borrowings under the MidCap Credit Facility.&#160;The Company determined that such milestone conditions related to Afrezza trailing net revenue were unlikely to be achieved.&#160;As a result, an asset impairment of $1.9&#160;million was recognized during the second quarter of 2020 and is reflected in&#160;the Company&#x2019;s consolidated statement of operations. See Note 10 &#x2013;&#160;&lt;/span&gt;&lt;span style="font-style:italic;Background-color:#FFFFFF;"&gt;Borrowings&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;"&gt;&#160;for further information on the MidCap Credit Facility.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recorded $0.1 million of asset impairments for the year ended December 31, 2021. There were no asset impairments for the year ended December 31, 2022.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <mnkd:CommitmentAsset
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831"
      decimals="-5"
      id="F_000610"
      unitRef="U_iso4217USD">1500000</mnkd:CommitmentAsset>
    <us-gaap:OtherAssets
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831"
      decimals="-5"
      id="F_000611"
      unitRef="U_iso4217USD">400000</us-gaap:OtherAssets>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_us-gaapLongLivedAssetsHeldForSaleByAssetTypeAxis_mnkdCommitmentAssetMember_20200401_20200630"
      decimals="-5"
      id="F_000612"
      unitRef="U_iso4217USD">1900000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_000613"
      unitRef="U_iso4217USD">100000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:BusinessCombinationsPolicy contextRef="C_0000899460_20220101_20221231" id="F_000528">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Acquisitions &#x2014; &lt;span style="font-style:normal;"&gt;The Company first determines whether a set of assets acquired constitute a business and should be accounted for as a business combination. If the assets acquired do not constitute a business, the Company accounts for the transaction as an asset acquisition. Business combinations are accounted for by means of the acquisition method of accounting. Under the acquisition method, assets acquired, &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-style:normal;"&gt;including in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) projects, and liabilities assumed are recorded at their respective fair values as of the acquisition date in the Company&#x2019;s consolidated financial statements. The excess of the fair value of consideration transferred over the fair value of the net assets acquired is recorded as goodwill. Contingent consideration obligations incurred in connection with a business combination (including the assumption of an acquiree&#x2019;s liability arising from an acquisition it consummated prior to the Company&#x2019;s acquisition) are recorded at their fair values on the acquisition date and remeasured at their fair values each subsequent reporting period until the related contingencies have been resolved. The resulting changes in fair values are recorded in earnings. In contrast, asset acquisitions are accounted for by using a cost accumulation and allocation model. Under this model, the cost of the acquisition is allocated to the assets acquired and liabilities assumed. IPR&amp;amp;D projects with no alternative future use are recorded in R&amp;amp;D expense upon acquisition, and contingent consideration obligations incurred in connection with an asset acquisition are recorded when it is probable that they will occur and they can be reasonably estimated. See Note 3 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Acquisition&lt;/span&gt;&lt;span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;s&lt;/span&gt;&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000529">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Goodwill and Other Intangible Assets &lt;/span&gt;&#x2014; &lt;span style="Background-color:#FFFFFF;font-style:normal;"&gt;The fair value of acquired intangible assets is determined using an income-based approach referred to as the excess earnings method utilizing Level 3 fair value inputs. Market participant valuations assume a global view considering all potential jurisdictions and indications based on discounted after-tax cash flow projections, risk adjusted for estimated probability of technical and regulatory success. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company tests for impairment annually on a reporting unit basis, at the beginning of the Company&#x2019;s fourth fiscal quarter and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. To the extent the carrying amount of a reporting unit is less than its estimated fair value, an impairment charge will be recorded.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life. Estimated useful lives are determined considering the period assets are expected to contribute to future cash flows. Finite-lived intangible assets are tested for impairment when facts or circumstances suggest that the carrying value of the asset may not be recoverable.&#160;If the carrying value exceeds the projected undiscounted pretax cash flows of the intangible asset, an impairment loss equal to the excess of the carrying value over the estimated fair value (discounted after-tax cash flows) is recognized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;No&lt;/span&gt; impairments to goodwill or other intangible assets were recorded during the year ended December 31, 2022.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_000614"
      unitRef="U_iso4217USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_000615"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <mnkd:LossOnPurchaseCommitmentsPolicyPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000530">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recognized Loss on Purchase Commitments &#x2014;&lt;span style="font-style:normal;"&gt; The Company assesses whether losses on long-term purchase commitments should be accrued. Losses that are expected to arise from firm, non-cancellable, commitments for the future purchases are recognized unless recoverable. When making the assessment, the Company also considers whether it is able to renegotiate with its vendors. The recognized loss on purchase commitments is reduced as inventory items are received. If, subsequent to an accrual, a purchase commitment is successfully renegotiated, the gain is recognized in the Company&#x2019;s consolidated statements of operations. The liability balance of the recognized loss on insulin purchase commitments as of December 31, 2022 and 2021 was $72.3 million and $82.8 million, respectively. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;No&lt;/span&gt;&#160;new contracts were identified in 2022 that required a new loss on purchase commitment accrual.&lt;/p&gt;</mnkd:LossOnPurchaseCommitmentsPolicyPolicyTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20221231"
      decimals="-5"
      id="F_000616"
      unitRef="U_iso4217USD">72300000</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20211231"
      decimals="-5"
      id="F_000617"
      unitRef="U_iso4217USD">82800000</us-gaap:PurchaseObligation>
    <mnkd:LossOnPurchaseCommitmentsNumberOfContractsRecognized
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdInsulinMember_20220101_20221231"
      decimals="INF"
      id="F_000618"
      unitRef="U_mnkdContract">0</mnkd:LossOnPurchaseCommitmentsNumberOfContractsRecognized>
    <mnkd:MilestoneRightsLiabilityPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000531">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights Liability&lt;span style="font-style:normal;"&gt;&#160;&#x2014; &lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt;In July 2013, in conjunction with the execution of a (now repaid) loan agreement with Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P. (collectively, &#x201c;Deerfield&#x201d;), the Company entered into Milestone Rights Purchase Agreement (the &#x201c;Milestone Rights Agreement&#x201d;) pursuant to which the Company issued certain milestone rights to Deerfield Private Design Fund II, L.P. and Horizon Sant&#xe9; FLML S&#xc0;RL, (the &#x201c;Original Milestone Purchasers&#x201d;). The foregoing milestone rights provided the Original Milestone Purchasers certain rights to receive payments of up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable upon achievement of such milestones (collectively, the &#x201c;Milestone Rights&#x2019;). In December 2021, the Milestone Rights were purchased by Barings Global Special Situations Credit Fund 4 (Delaware), L.P. and Barings Global Special Situations Credit 4 (LUX) S.ar.l. (together the &#x201c;Milestone Purchasers&#x201d;). As a result, the Milestone Purchasers have assumed the obligations of the Original Milestone Purchasers and is now entitled to all rights under the Milestone Rights Agreement. As of December 31, 2022, $60.0 million remained payable pursuant to the Milestone Rights Agreement upon achievement of Afrezza net sales milestones. The Milestone Rights liability is reported at fair value at the date of the agreement which is periodically offset against payments. See Note 12&lt;/span&gt;&lt;span style="font-style:normal;"&gt; &#x2013; &lt;/span&gt;Fair Value of Financial Instruments&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The initial fair value estimate of the Milestone Rights was calculated using the income approach in which the cash flows associated with the specified contractual payments were adjusted for both the expected timing and the probability of achieving the milestones and discounted to present value using a selected market discount rate. The expected timing and probability of achieving the milestones was developed with consideration given to both internal data, such as progress made to date and assessment of criteria required for achievement, and external data, such as market research studies. The discount rate was selected based on an estimation of required rate of returns for similar investment opportunities using available market data. The Milestone Rights liability will be remeasured as the specified milestone events are achieved. Specifically, as each milestone event is achieved, the portion of the initially recorded Milestone Rights liability that pertains to the milestone event being achieved, will be remeasured to the amount of the specified related milestone payment. The resulting change in the balance of the Milestone Rights liability due to remeasurement will be recorded in the Company&#x2019;s consolidated statements of operations as interest expense. Furthermore, the Milestone Rights liability will be reduced upon the settlement of each milestone payment. As a result, each milestone payment would be effectively allocated between a reduction of the recorded Milestone Rights liability and an expense representing a return on a portion of the Milestone Rights liability paid to the investor for the achievement of the related milestone event. See Note&#160;10 &#x2013; &lt;span style="font-style:italic;"&gt;Borrowings&lt;/span&gt;.&lt;/p&gt;</mnkd:MilestoneRightsLiabilityPolicyTextBlock>
    <mnkd:ContingentLiability
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_000620"
      unitRef="U_iso4217USD">90000000.0</mnkd:ContingentLiability>
    <mnkd:ContingentLiabilityRemainingPayableAmount
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_000619"
      unitRef="U_iso4217USD">60000000.0</mnkd:ContingentLiabilityRemainingPayableAmount>
    <mnkd:ContingentLiabilityRemainingPayableAmount
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_000621"
      unitRef="U_iso4217USD">60000000.0</mnkd:ContingentLiabilityRemainingPayableAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="C_0000899460_20220101_20221231" id="F_000532">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Fair Value of Financial Instruments&lt;span style="font-style:normal;"&gt; &#x2014;The Company applies various valuation approaches in determining the fair value of its financial assets and liabilities within a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#x2019;s assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available in the circumstances. The fair value hierarchy is broken down into three levels based on the source of inputs as follows: &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&#160;&#x2014;&#160;Quoted prices for identical instruments in active markets.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&#160;&#x2014;&#160;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&#160;&#x2014;&#160;Significant inputs to the valuation model are unobservable.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000533">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes&lt;span style="font-style:normal;"&gt;&#160;&#x2014; The provisions for federal, foreign, state and local income taxes are calculated on pre-tax income based on current tax law and include the cumulative effect of any changes in tax rates from those used previously in determining deferred tax assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which the temporary differences are expected to be recovered or settled. A valuation allowance is recorded to reduce net deferred income tax assets to amounts that are more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;For uncertain tax positions, the Company determines whether it is &#x201c;more likely than not&#x201d; that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the financial statements. For those tax positions where it is &#x201c;not more likely than not&#x201d; that a tax benefit will be sustained, no tax benefit is recognized. &lt;/span&gt;Penalties, if probable and reasonably estimable, are recognized as a component of income tax expense.&lt;span style="Background-color:#FFFFFF;"&gt; The Company has reduced its deferred tax assets for uncertain tax positions but has not recorded liabilities for income tax expense, penalties, or interest.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000534">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Contingencies&lt;span style="font-style:normal;"&gt; &#x2014; The Company records a loss contingency for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These accruals represent management&#x2019;s best estimate of probable loss. Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. On a quarterly basis, the Company reviews the status of each significant matter and assesses its potential financial exposure. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Because of uncertainties related to these matters, accruals are based only on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability related to pending claims and litigation and may revise its estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000535">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;span style="font-style:normal;"&gt; &#x2014; Share-based payments to employees, including grants of RSUs, performance-based non-qualified stock options awards (&#x201c;PNQs&#x201d;), restricted stock units with market conditions (&#x201c;Market RSUs&#x201d;), options and the compensatory elements of employee stock purchase plans, are recognized in the consolidated statements of operations based upon the fair value of the awards at the grant date. RSUs are valued based on the market price on the grant date. Market RSUs are valued using a Monte Carlo valuation model and RSUs with performance conditions are evaluated for the probability that the performance conditions will be met and estimates the date at which the performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee options and the compensatory elements of employee stock purchase plans.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <mnkd:ClinicalTrialExpensePolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000536">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Clinical Trial Expenses&lt;span style="font-style:normal;"&gt; &#x2014; Clinical trial expenses, which are primarily reflected in research and development expenses in the accompanying consolidated statements of operations, result from obligations under contracts with vendors, consultants and clinical site agreements in addition to internal costs associated with conducting clinical trials.&lt;/span&gt;&lt;/p&gt;</mnkd:ClinicalTrialExpensePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000537">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Net Income (Loss) Per Share of Common Stock&lt;span style="font-style:normal;"&gt; &#x2014; Basic net income or loss per share excludes dilution for potentially dilutive securities and is computed by dividing net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per share reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted net loss per share as they would be anti-dilutive.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000538">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recently Adopted Accounting Standards &lt;span style="font-style:normal;"&gt;&#x2014; &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;In March 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued a new accounting standard to ease the financial reporting burdens caused by the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, commonly referred to as reference rate reform. The new standard provides temporary optional expedients and exceptions to current GAAP guidance on contract modifications and hedge accounting. In January 2021, the FASB issued a new accounting standard that expanded the scope of the original March 2020 standard to include derivative instruments on discounting transactions. In December 2022, the FASB deferred the sunset date to an alternative reference rate from December 31, 2022 to December 31, 2024. The Company adopted these standards in the third quarter of 2022 using the prospective method and determined there was no impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000539">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Recently Issued Accounting Standards&lt;span style="font-style:normal;"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;In November 2021, the FASB issued a new accounting standard around the recognition and measurement of contract assets and contract liabilities from revenue contracts with customers acquired in a business combination. The new standard clarifies that contract assets and contract liabilities acquired in a business combination from an acquiree should initially be recognized by applying revenue recognition principles and not at fair value. The standard is effective for interim and annual periods beginning on January 1, 2023, and early adoption is permitted. The impact of this standard will depend on the facts and circumstances of future transactions.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial position or results of operations upon adoption.&lt;/p&gt;</mnkd:RecentlyIssuedAccountingStandardsPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000491">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3. Acquisitions&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;V-Go&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In &lt;span style="-sec-ix-hidden:F_000622"&gt;May 2022&lt;/span&gt;, the Company entered into an Asset Purchase Agreement (the &#x201c;APA&#x201d;) to purchase from Zealand Pharma A/S and Zealand Pharma US, Inc. (together &#x201c;Zealand&#x201d;) certain assets and assume certain liabilities associated with the V-Go wearable insulin delivery device. The transaction closed on May 31, 2022 (the &#x201c;Acquisition Date&#x201d;).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the APA, the Company paid up-front consideration of $15.3 million for certain assets and assumed liabilities related to V-Go. In addition, the Company will be obligated to make one-time, sales-based milestone payments to Zealand totaling up to a maximum of $10.0 million upon the achievement of specified annual revenue milestones between $40 million and $100 million.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The total preliminary purchase consideration for V-Go was as follows (in tho&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;usands):&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of consideration:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,341&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of contingent consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,951&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The transaction was accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and liabilities assumed to be recognized at their respective fair values as of the Acquisition Date. The excess of the purchase price over those fair values was recorded as goodwill, which will be amortized over a period of 15 years for tax purposes. The estimates and assumptions used include the projected timing and amount of future cash flows and discount rates to reflect the risk inherent in the future cash flows. The estimated fair values of assets acquired and liabilities assumed and resulting goodwill are subject to adjustment as the Company finalizes its purchase price accounting. The significant items for which a final fair value has not been determined include, but are not limited to the valuation of the intangible asset and assumed liabilities for rebates and return reserves. The Company does not expect its fair value determinations to materially change; however, there may be differences between the amounts recorded at the Acquisition Date and the final fair value analysis, which is expected to be complete no later than the second quarter of 2023.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands): &lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventory&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,921&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible asset - Developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities assumed&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net assets acquired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,951&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventory of $11.2 million consisted of raw materials, semi-finished goods and finished goods. The fair value of the inventory was determined based on the estimated selling price to be generated from the finished goods, less costs to sell, including a reasonable margin, which are level 3 inputs not observable in the market. Property and equipment and assumed liabilities were recorded at their carrying amounts which were deemed to approximate their fair values based on level 3 unobservable inputs. The fair values of the right-of-use assets and lease liabilities for assumed operating leases were assessed in accordance with ASC Topic 842, Leases, based on discounted cash flow from lease payments, utilizing the Company&#x2019;s incremental borrowing rate of 7.25%.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The fair value of the intangible asset was determined by applying the income approach based on significant level 3 unobservable inputs. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The fair value of the contingent milestone liability was estimated using the Monte Carlo simulation method for the calculation of the potential payment and the Geometric Brownian Motion forecasting model to estimate the underlying revenue. Market based inputs and other level 3 inputs were used to forecast future revenue. The key inputs used included a risk-free rate of 2.95%, dividend yield of 0%, volatility of 65%, period of 15 years and credit risk of 12%.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The Company incurred acquisition-related costs of approximately $0.4 million for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Net revenue and loss from operations for the year ended December 31, 2022 was $12.9 million and $0.3 million, respectively&lt;/span&gt;, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Supplemental Pro Forma Information (unaudited)&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.08%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,278&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(86,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,806&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.32&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;QrumPharma&lt;span style="font-style:normal;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In &lt;span style="-sec-ix-hidden:F_000660"&gt;December 2020&lt;/span&gt;, the Company acquired QrumPharma, Inc., a privately held pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company&#x2019;s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,574&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock consideration (3,067,179 shares at $3.01 per share)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Repayment of debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities assumed&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash acquired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(155&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total consideration paid for IPR&amp;amp;D&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The stock purchase of QrumPharma was accounted for under ASC 805, Business Combinations, as an asset acquisition since the transaction did not include the acquisition of inputs or processes and the fair value of the assets acquired were concentrated in a single identifiable asset, MNKD-101, which consisted of an in-process research and development asset (&#x201c;IPR&amp;amp;D&#x201d;). Under ASC 805, an entity that acquires IPR&amp;amp;D in an asset acquisition should follow the guidance in ASC 730, Research and Development, which requires that both tangible and intangible identifiable research and development assets with no alternative future use be allocated a portion of the consideration transferred and charged to expense at the acquisition date. Due to the stage of development of MNKD-101 at the date of acquisition, significant risk remained that the product would not obtain regulatory approval and it was not yet probable that there would be future economic benefit for the Company. Absent successful clinical results and regulatory approval, it was determined that there was no alternative future use associated with MNKD-101. Accordingly, the value of this asset was expensed at the time of acquisition and the total accumulated cost of $13.2 million, was allocated to the IPR&amp;amp;D asset using a relative fair value basis and the total consideration was recognized as in-process research and development expense in the consolidated statement of operations. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The acquisition of QrumPharma also included a potential future royalty payment of 1.5% of net sales in each of the calendar years in which the total annual and global adjusted net sales of specified products exceeds $50 million and a royalty payment of 1.0% of net sales in each of the calendar years in which the total annual and global adjusted net sales of nebulized clofazimine are greater than or equal to $200 million. The contingent consideration in the form of royalty payments will be expensed as incurred since the probability of MNKD-101 obtaining FDA approval and generating net sales that exceed the specified thresholds could not be reasonably estimated on the date of acquisition.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:AssetAcquisitionEffectiveDateOfAcquisition
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      id="F_000623">2022-05-31</us-gaap:AssetAcquisitionEffectiveDateOfAcquisition>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-5"
      id="F_000624"
      unitRef="U_iso4217USD">15300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mnkd:AssetAcquisitionMilestonePaymentPayable
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-5"
      id="F_000625"
      unitRef="U_iso4217USD">10000000.0</mnkd:AssetAcquisitionMilestonePaymentPayable>
    <mnkd:AnnualRevenueMilestonesRangesForMilestonePayments
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-6"
      id="F_000626"
      unitRef="U_iso4217USD">40000000</mnkd:AnnualRevenueMilestonesRangesForMilestonePayments>
    <mnkd:AnnualRevenueMilestonesRangesForMilestonePayments
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-6"
      id="F_000627"
      unitRef="U_iso4217USD">100000000</mnkd:AnnualRevenueMilestonesRangesForMilestonePayments>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231"
      id="F_000541">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The total preliminary purchase consideration for V-Go was as follows (in tho&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;usands):&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of consideration:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,341&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value of contingent consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;610&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,951&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-3"
      id="F_000628"
      unitRef="U_iso4217USD">15341000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-3"
      id="F_000629"
      unitRef="U_iso4217USD">610000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      decimals="-3"
      id="F_000630"
      unitRef="U_iso4217USD">15951000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <mnkd:GoodwillAmortizationPeriod
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531"
      id="F_000631">P15Y</mnkd:GoodwillAmortizationPeriod>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220101_20221231"
      id="F_000542">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands): &lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventory&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,921&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible asset - Developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.76%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities assumed&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,562&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.76%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net assets acquired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,951&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000632"
      unitRef="U_iso4217USD">11152000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000633"
      unitRef="U_iso4217USD">2921000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000634"
      unitRef="U_iso4217USD">2428000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000635"
      unitRef="U_iso4217USD">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000636"
      unitRef="U_iso4217USD">1812000</mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000637"
      unitRef="U_iso4217USD">19513000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000638"
      unitRef="U_iso4217USD">1750000</mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities>
    <mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000639"
      unitRef="U_iso4217USD">1812000</mnkd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000640"
      unitRef="U_iso4217USD">3562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-3"
      id="F_000641"
      unitRef="U_iso4217USD">15951000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531"
      decimals="-5"
      id="F_000642"
      unitRef="U_iso4217USD">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0000899460_20220531"
      decimals="4"
      id="F_000643"
      unitRef="U_xbrlipure">0.0725</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputRiskFreeInterestRateMember_20220531"
      decimals="2"
      id="F_000644"
      unitRef="U_xbrlipure">2.95</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20220531"
      decimals="0"
      id="F_000645"
      unitRef="U_xbrlipure">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20220531"
      decimals="0"
      id="F_000646"
      unitRef="U_xbrlipure">65</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedTermMember_20220531"
      decimals="0"
      id="F_000647"
      unitRef="U_mnkdYear">15</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputEntityCreditRiskMember_20220531"
      decimals="0"
      id="F_000648"
      unitRef="U_xbrlipure">12</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220101_20221231"
      decimals="-5"
      id="F_000649"
      unitRef="U_iso4217USD">400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000543">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Net revenue and loss from operations for the year ended December 31, 2022 was $12.9 million and $0.3 million, respectively&lt;/span&gt;, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):&lt;/p&gt;
&lt;p style="margin-top:18pt;margin-bottom:8pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Supplemental Pro Forma Information (unaudited)&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.08%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;109,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;98,278&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(86,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,806&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share - basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.32&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_000650"
      unitRef="U_iso4217USD">12900000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_000651"
      unitRef="U_iso4217USD">300000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000652"
      unitRef="U_iso4217USD">109933000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000653"
      unitRef="U_iso4217USD">98278000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000654"
      unitRef="U_iso4217USD">-86967000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000655"
      unitRef="U_iso4217USD">-80806000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000656"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_000657"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000544">The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company&#x2019;s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash consideration&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,574&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock consideration (3,067,179 shares at $3.01 per share)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Repayment of debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities assumed&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash acquired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(155&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total consideration paid for IPR&amp;amp;D&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,233&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000661"
      unitRef="U_iso4217USD">3574000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="INF"
      id="F_000668"
      unitRef="U_xbrlishares">3067179</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201231"
      decimals="2"
      id="F_000669"
      unitRef="U_iso4217USD_xbrlishares">3.01</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000662"
      unitRef="U_iso4217USD">9250000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsForMergerRelatedCosts
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000663"
      unitRef="U_iso4217USD">531000</us-gaap:PaymentsForMergerRelatedCosts>
    <mnkd:BusinessAcquisitionRepaymentOfDebt
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000664"
      unitRef="U_iso4217USD">11000</mnkd:BusinessAcquisitionRepaymentOfDebt>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000665"
      unitRef="U_iso4217USD">22000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000666"
      unitRef="U_iso4217USD">155000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-3"
      id="F_000667"
      unitRef="U_iso4217USD">13233000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <mnkd:BusinessCombinationAccumulatedCost
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="-5"
      id="F_000670"
      unitRef="U_iso4217USD">13200000</mnkd:BusinessCombinationAccumulatedCost>
    <mnkd:PercentageOfRoyaltyPaymentOnNetSales
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201231"
      decimals="3"
      id="F_000671"
      unitRef="U_xbrlipure">0.015</mnkd:PercentageOfRoyaltyPaymentOnNetSales>
    <mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdGlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember_20201201_20201231"
      decimals="-6"
      id="F_000672"
      unitRef="U_iso4217USD">50000000</mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage>
    <mnkd:PercentageOfRoyaltyPaymentOnNetSales
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201231"
      decimals="3"
      id="F_000673"
      unitRef="U_xbrlipure">0.010</mnkd:PercentageOfRoyaltyPaymentOnNetSales>
    <mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_us-gaapCreditFacilityAxis_mnkdAdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember_20201201_20201231"
      decimals="-6"
      id="F_000674"
      unitRef="U_iso4217USD">200000000</mnkd:GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000492">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4. Investments&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cash Equivalents &lt;span style="font-style:normal;"&gt;&#x2014; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $69.8 million and $124.2 million, respectively, of cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Available-for-Sale Investment&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;font-style:normal;"&gt; &#x2014; The Thirona convertible note is classified as an available-for-sale security and is included in other assets in the consolidated balance sheet. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using level 3 inputs. As of December 31, 2022, the Company evaluated the fair value of its investment in Thirona using a Monte Carlo simulation which resulted in a fair value of $7.1 million. &lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt;In addition, the Company determined that there was a related credit loss of $0.9 million on the investment which was recognized in the consolidated statements of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Held-to-Maturity Investments &lt;span style="font-style:normal;"&gt;&#x2014; Investments consist of highly liquid investments that are intended to facilitate liquidity and capital preservation. As of December 31, 2022, the Company held $101.1 million of short-term investments and $2.0 million of long-term investments. As of December 31, 2021, the Company held $79.9 million of short-term investments and $56.6 million of long-term investments.&lt;/span&gt; The amortization or accretion of the Company&#x2019;s investments is recognized as interest income in the consolidated statements of operations and was approximately $0.7 million and $0.5 million for the years ended December 31, 2022 and 2021, respectively. No allowance for credit losses on held-to-maturity securities was required as of December 31, 2022 or 2021.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The contractual maturities of the Company&#x2019;s held to maturity investments as of December 31, 2022 and 2021 are summarized below (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost Basis&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost Basis&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due in one year or less&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,733&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,669&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,961&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,948&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,823&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;158,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,352&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,102&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;___________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-size:9pt;"&gt;The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.&lt;/span&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the cash equivalents, long-term and short-term investments are disclosed below (in millions):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Level&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Carrying Value)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial bonds and paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Treasuries&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;153.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;101.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Level&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Carrying Value)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial bonds and paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Treasuries&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, there was $0.6 million of accrued interest receivable and $5.1 million of amount receivable on matured investment recognized as prepaid expense and other current assets in our consolidated balance sheets. As of December 31, 2021, there was $0.3 million of accrued interest receivable recognized as other assets in our consolidated balance sheets.&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231"
      decimals="-5"
      id="F_000675"
      unitRef="U_iso4217USD">69800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-5"
      id="F_000676"
      unitRef="U_iso4217USD">124200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231"
      decimals="-5"
      id="F_000677"
      unitRef="U_iso4217USD">7100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdThironaBioIncMember_20221231"
      decimals="-5"
      id="F_000678"
      unitRef="U_iso4217USD">900000</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ShortTermInvestments
      contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231"
      decimals="-5"
      id="F_000679"
      unitRef="U_iso4217USD">101100000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20221231"
      decimals="-5"
      id="F_000681"
      unitRef="U_iso4217USD">2000000.0</us-gaap:LongTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231"
      decimals="-5"
      id="F_000680"
      unitRef="U_iso4217USD">79900000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="C_0000899460_us-gaapInformationByCategoryOfDebtSecurityAxis_us-gaapHeldtomaturitySecuritiesMember_20211231"
      decimals="-5"
      id="F_000682"
      unitRef="U_iso4217USD">56600000</us-gaap:LongTermInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_000683"
      unitRef="U_iso4217USD">700000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_000684"
      unitRef="U_iso4217USD">500000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000685"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_000686"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss>
    <us-gaap:HeldToMaturitySecuritiesTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000545">
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The contractual maturities of the Company&#x2019;s held to maturity investments as of December 31, 2022 and 2021 are summarized below (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost Basis&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost Basis&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due in one year or less&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;152,862&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;156,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,733&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103,669&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Due after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,961&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,948&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56,433&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154,823&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;158,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,352&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160,102&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;___________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-size:9pt;"&gt;The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.&lt;/span&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000687"
      unitRef="U_iso4217USD">152862000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000693"
      unitRef="U_iso4217USD">156976000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000688"
      unitRef="U_iso4217USD">103733000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000694"
      unitRef="U_iso4217USD">103669000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000689"
      unitRef="U_iso4217USD">1961000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000695"
      unitRef="U_iso4217USD">1948000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000690"
      unitRef="U_iso4217USD">56619000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000696"
      unitRef="U_iso4217USD">56433000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000691"
      unitRef="U_iso4217USD">154823000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000697"
      unitRef="U_iso4217USD">158924000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000692"
      unitRef="U_iso4217USD">160352000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000698"
      unitRef="U_iso4217USD">160102000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20221231"
      decimals="-5"
      id="F_000699"
      unitRef="U_iso4217USD">51800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20211231"
      decimals="-5"
      id="F_000700"
      unitRef="U_iso4217USD">23800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <mnkd:ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000546">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the cash equivalents, long-term and short-term investments are disclosed below (in millions):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Level&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Carrying Value)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial bonds and paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;66.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Treasuries&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;154.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;153.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(51.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;103.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;101.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="12" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Investment Level&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Carrying Value)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Holding Losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.42%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial bonds and paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Treasuries&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.62%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash equivalents and investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.42%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;160.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</mnkd:ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000701"
      unitRef="U_iso4217USD">66800000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231"
      decimals="-5"
      id="F_000702"
      unitRef="U_iso4217USD">600000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000703"
      unitRef="U_iso4217USD">66200000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000704"
      unitRef="U_iso4217USD">51800000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000705"
      unitRef="U_iso4217USD">51800000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000706"
      unitRef="U_iso4217USD">36300000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231"
      decimals="-5"
      id="F_000707"
      unitRef="U_iso4217USD">600000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000708"
      unitRef="U_iso4217USD">35700000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000709"
      unitRef="U_iso4217USD">154900000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231"
      decimals="-5"
      id="F_000710"
      unitRef="U_iso4217USD">1200000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000711"
      unitRef="U_iso4217USD">153700000</mnkd:CashEquivalentsAndInvestments>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000712"
      unitRef="U_iso4217USD">51800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000713"
      unitRef="U_iso4217USD">51800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231"
      decimals="-5"
      id="F_000714"
      unitRef="U_iso4217USD">103100000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20221231"
      decimals="-5"
      id="F_000715"
      unitRef="U_iso4217USD">1200000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20221231"
      decimals="-5"
      id="F_000716"
      unitRef="U_iso4217USD">101900000</us-gaap:Investments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000717"
      unitRef="U_iso4217USD">115200000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231"
      decimals="-5"
      id="F_000718"
      unitRef="U_iso4217USD">200000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000719"
      unitRef="U_iso4217USD">115000000.0</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000720"
      unitRef="U_iso4217USD">21300000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000721"
      unitRef="U_iso4217USD">21300000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000722"
      unitRef="U_iso4217USD">23900000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231"
      decimals="-5"
      id="F_000723"
      unitRef="U_iso4217USD">100000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapUSTreasurySecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000724"
      unitRef="U_iso4217USD">23800000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000725"
      unitRef="U_iso4217USD">160400000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231"
      decimals="-5"
      id="F_000726"
      unitRef="U_iso4217USD">300000</mnkd:CashEquivalentsAndInvestments>
    <mnkd:CashEquivalentsAndInvestments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000727"
      unitRef="U_iso4217USD">160100000</mnkd:CashEquivalentsAndInvestments>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000728"
      unitRef="U_iso4217USD">23800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000729"
      unitRef="U_iso4217USD">23800000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20211231"
      decimals="-5"
      id="F_000730"
      unitRef="U_iso4217USD">136600000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdGrossUnrealizedHoldingLossesMember_20211231"
      decimals="-5"
      id="F_000731"
      unitRef="U_iso4217USD">300000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdEstimatedFairValueMember_20211231"
      decimals="-5"
      id="F_000732"
      unitRef="U_iso4217USD">136300000</us-gaap:Investments>
    <mnkd:AccruedInterestReceivable
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000733"
      unitRef="U_iso4217USD">600000</mnkd:AccruedInterestReceivable>
    <mnkd:AmountReceivableOnMaturedInvestment
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000735"
      unitRef="U_iso4217USD">5100000</mnkd:AmountReceivableOnMaturedInvestment>
    <mnkd:AccruedInterestReceivable
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_000734"
      unitRef="U_iso4217USD">300000</mnkd:AccruedInterestReceivable>
    <us-gaap:FinancingReceivablesTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000493">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;5. Accounts Receivable&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, net consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable &#x2013; commercial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, gross&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,359&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,939&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Wholesaler distribution fees and prompt pay discounts&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,536&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserve for returns&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,108&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable &#x2013; commercial, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable &#x2013; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, gross&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,086&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for credit losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable &#x2013; collaborations and services, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,086&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,293&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,801&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022 and December 31, 2021, the allowance for credit losses was &lt;span style="font-style:italic;"&gt;de minimis&lt;/span&gt;. As of December 31, 2022 and December 31, 2021, the Company had three wholesale distributors representing approximately 74% and 80% of gross sales and 79% and 79% of accounts receivable, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, there was no allowance for credit losses for accounts receivable &#x2013; collaborations and revenue. &#160;The Company had one collaboration partner, United Therapeutics, that comprised 100% of the collaboration and services net accounts receivable as of December 31, 2022 and approximately 98% of gross revenue from collaborations and services for the year ended December 31, 2022.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes revenue net of gross-to-net adjustments&lt;span style="color:#000000;"&gt;.&lt;/span&gt; The activities and ending reserve balance consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prompt Pay Discount Reserve, Allowance for Wholesale Distribution Fees&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and Accounts Receivables Return Reserve:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,493&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,471&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deductions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,320&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10,874&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,644&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,493&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:FinancingReceivablesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000547">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, net consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable &#x2013; commercial&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, gross&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,359&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,939&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Wholesaler distribution fees and prompt pay discounts&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,536&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reserve for returns&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,108&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable &#x2013; commercial, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,715&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable &#x2013; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable, gross&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,086&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,060&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for credit losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable &#x2013; collaborations and services, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,086&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,293&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total accounts receivable, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,801&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231"
      decimals="-3"
      id="F_000736"
      unitRef="U_iso4217USD">19359000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231"
      decimals="-3"
      id="F_000737"
      unitRef="U_iso4217USD">7939000</us-gaap:AccountsReceivableGrossCurrent>
    <mnkd:WholesalerDistributionFeesAndPromptPayDiscounts
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231"
      decimals="-3"
      id="F_000738"
      unitRef="U_iso4217USD">2536000</mnkd:WholesalerDistributionFeesAndPromptPayDiscounts>
    <mnkd:WholesalerDistributionFeesAndPromptPayDiscounts
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231"
      decimals="-3"
      id="F_000739"
      unitRef="U_iso4217USD">1696000</mnkd:WholesalerDistributionFeesAndPromptPayDiscounts>
    <mnkd:ReserveForReturns
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231"
      decimals="-3"
      id="F_000740"
      unitRef="U_iso4217USD">4108000</mnkd:ReserveForReturns>
    <mnkd:ReserveForReturns
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231"
      decimals="-3"
      id="F_000741"
      unitRef="U_iso4217USD">2797000</mnkd:ReserveForReturns>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231"
      decimals="-3"
      id="F_000742"
      unitRef="U_iso4217USD">12715000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231"
      decimals="-3"
      id="F_000743"
      unitRef="U_iso4217USD">3446000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231"
      decimals="-3"
      id="F_000744"
      unitRef="U_iso4217USD">4086000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231"
      decimals="-3"
      id="F_000745"
      unitRef="U_iso4217USD">2060000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231"
      decimals="-3"
      id="F_000746"
      unitRef="U_iso4217USD">767000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20221231"
      decimals="-3"
      id="F_000747"
      unitRef="U_iso4217USD">4086000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20211231"
      decimals="-3"
      id="F_000748"
      unitRef="U_iso4217USD">1293000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000749"
      unitRef="U_iso4217USD">16801000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000750"
      unitRef="U_iso4217USD">4739000</us-gaap:AccountsReceivableNetCurrent>
    <mnkd:NumberOfWholesaleDistributors
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_000751"
      unitRef="U_mnkdDistributor">3</mnkd:NumberOfWholesaleDistributors>
    <mnkd:NumberOfWholesaleDistributors
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_000752"
      unitRef="U_mnkdDistributor">3</mnkd:NumberOfWholesaleDistributors>
    <mnkd:PercentageOfAccountsReceivableFromMajorCustomers
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231"
      decimals="2"
      id="F_000753"
      unitRef="U_xbrlipure">0.74</mnkd:PercentageOfAccountsReceivableFromMajorCustomers>
    <mnkd:PercentageOfAccountsReceivableFromMajorCustomers
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20211231"
      decimals="2"
      id="F_000754"
      unitRef="U_xbrlipure">0.80</mnkd:PercentageOfAccountsReceivableFromMajorCustomers>
    <mnkd:PercentageOfSalesFromMajorCustomers
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000755"
      unitRef="U_xbrlipure">0.79</mnkd:PercentageOfSalesFromMajorCustomers>
    <mnkd:PercentageOfSalesFromMajorCustomers
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_000756"
      unitRef="U_xbrlipure">0.79</mnkd:PercentageOfSalesFromMajorCustomers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_000757"
      unitRef="U_iso4217USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <mnkd:PercentageOfCollaborationsAndServicesNetAccountsReceivables
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231"
      decimals="2"
      id="F_000758"
      unitRef="U_xbrlipure">1</mnkd:PercentageOfCollaborationsAndServicesNetAccountsReceivables>
    <mnkd:PercentageOfRevenueFromMajorCustomersCollaborationsAndServices
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_000759"
      unitRef="U_xbrlipure">0.98</mnkd:PercentageOfRevenueFromMajorCustomersCollaborationsAndServices>
    <mnkd:ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000548">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes revenue net of gross-to-net adjustments&lt;span style="color:#000000;"&gt;.&lt;/span&gt; The activities and ending reserve balance consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prompt Pay Discount Reserve, Allowance for Wholesale Distribution Fees&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;and Accounts Receivables Return Reserve:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,493&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,471&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deductions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,320&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10,874&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,644&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,493&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</mnkd:ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000760"
      unitRef="U_iso4217USD">4493000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_000761"
      unitRef="U_iso4217USD">3873000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000762"
      unitRef="U_iso4217USD">17471000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000763"
      unitRef="U_iso4217USD">11494000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000764"
      unitRef="U_iso4217USD">-15320000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000765"
      unitRef="U_iso4217USD">-10874000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000766"
      unitRef="U_iso4217USD">6644000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve>
    <mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000767"
      unitRef="U_iso4217USD">4493000</mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve>
    <us-gaap:InventoryDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000494">
&lt;p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;6. Inventories&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories consist of the following (in thousands): &lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventory&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work-in-process and finished goods as of December 31, 2022 and 2021 include conversion costs and exclude the cost of insulin. All insulin inventory on hand was written off and the projected loss on the purchase commitment contract to purchase future insulin was accrued as of the end of 2016. Raw materials inventory included $0.8 million of pre-launch inventory as of December 31, 2022 and 2021, which consisted of FDKP received in November 2019 that will be used to manufacture Afrezza under an enhanced manufacturing process for FDKP. The Company expects to receive FDA approval of the new source of FDKP in 2024. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company analyzed its inventory levels to identify inventory that may expire or has a cost basis in excess of its estimated realizable value. The Company also performed an assessment of projected sales and evaluated the lower of cost or net realizable value and the potential excess inventory on hand at December 31, 2022 and 2021. Inventory that was forecasted to become obsolete due to expiration as well as inventory that does not meet acceptable standards is recorded in costs of goods sold in the accompanying consolidated statements of operations. &lt;span style="font-family:Calibri;"&gt;T&lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt;here was an inventory write-off of $2.2 million as a result of this assessment for the year ended December 31, 2022. &lt;/span&gt;For the year ended December 31, 2021, there was an inventory write-off of $1.9 million as a result of this assessment, including $0.7 million related to the start of an agreement with a retail pharmacy. There was an inventory write-off of $0.5 million for the year ended December 31, 2020.&#160;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000549">
&lt;p style="margin-top:6pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories consist of the following (in thousands): &lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,703&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,815&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,927&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventory&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,152&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000768"
      unitRef="U_iso4217USD">5739000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000769"
      unitRef="U_iso4217USD">2703000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000770"
      unitRef="U_iso4217USD">13815000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000771"
      unitRef="U_iso4217USD">2522000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000772"
      unitRef="U_iso4217USD">2218000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000773"
      unitRef="U_iso4217USD">1927000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000774"
      unitRef="U_iso4217USD">21772000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000775"
      unitRef="U_iso4217USD">7152000</us-gaap:InventoryNet>
    <us-gaap:InventoryRawMaterials
      contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20211231"
      decimals="-5"
      id="F_000777"
      unitRef="U_iso4217USD">800000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20221231"
      decimals="-5"
      id="F_000776"
      unitRef="U_iso4217USD">800000</us-gaap:InventoryRawMaterials>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_000778"
      unitRef="U_iso4217USD">2200000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_000779"
      unitRef="U_iso4217USD">1900000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdAgreementWithRetailPharmacyMember_20210101_20211231"
      decimals="-5"
      id="F_000781"
      unitRef="U_iso4217USD">700000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:ProductionRelatedImpairmentsOrCharges
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_000780"
      unitRef="U_iso4217USD">500000</us-gaap:ProductionRelatedImpairmentsOrCharges>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000495">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;7. Property and Equipment&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Useful&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Land&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000802"&gt;39-40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Building improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000804"&gt;5-40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,952&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,651&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Machinery and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;3-15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,334&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture, fixtures and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000808"&gt;5-10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000810"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,246&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,706&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,892&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;143,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;134,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(98,560&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(97,661&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45,126&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,612&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;As of December 31, 2021 construction in progress included $4.7 million of equipment under construction for the manufacturing expansion for UT (the &#x201c;UT Equipment&#x201d;). There is no balance under construction for the UT Equipment as of December 31, 2022. The Company acts as agent on behalf of UT for the procurement of the UT Equipment. The Company has received $5.0 million in deposit for this service, which was recognized as deposits from customer in the consolidated balance sheet as of December 31, 2021. In April 2022, the Company and UT agreed that UT would hold title to the UT Equipment at all times. As such, there is no balance related to the UT Equipment included in construction in progress or deposits from customer in our consolidated balance sheet as of December 31, 2022. See Note 11 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;font-size:9pt;color:#000000;"&gt;Collaboration, Licensing and Other Arrangements.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation expense related to property and equipment for the years ended December&#160;31, 2022, 2021 and 2020 was $3.3 million, $2.0 million and $1.8&#160;million, respectively. During the years ended December 31, 2022 and 2021, the Company retired $2.4 million and $1.1 million, respectively of manufacturing equipment, computer hardware and software, computer equipment, lab equipment, and building improvements, as it was no longer in service. The net book value for the disposed assets was &lt;span style="font-style:italic;"&gt;de minimis&lt;/span&gt;. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On November 8, 2021, the Company sold certain land, building and improvements located in Danbury, CT (the &#x201c;Property&#x201d;) to an affiliate of Creative Manufacturing Properties (the &#x201c;Purchaser&#x201d;) for a sales price of $102.3 million, subject to the terms and the conditions contained in a purchase and sale agreement. Effective with the closing of this transaction, the Company entered into a 20-year lease agreement with the Purchaser (the &#x201c;Sale-Leaseback Transaction&#x201d;). The sale of the Property and subsequent lease did not result in the transfer of control of the Property to the Purchaser; therefore, the Sale-Leaseback Transaction qualified as a failed sale leaseback transaction whereby the lease is accounted for as finance lease and the Property remains as a long-lived asset of the Company and is depreciated at its remaining useful life of 20 years or less. See Note 16 &#x2013; &lt;span style="font-style:italic;"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="font-family:Calibri;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000550">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Useful&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Land&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Buildings&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000802"&gt;39-40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,389&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Building improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000804"&gt;5-40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,952&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,651&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Machinery and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;3-15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;58,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;55,334&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture, fixtures and office equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000808"&gt;5-10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,969&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment and software&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000810"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,246&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction in progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,706&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,892&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;143,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;134,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(98,560&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(97,661&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.5%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;45,126&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,612&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;As of December 31, 2021 construction in progress included $4.7 million of equipment under construction for the manufacturing expansion for UT (the &#x201c;UT Equipment&#x201d;). There is no balance under construction for the UT Equipment as of December 31, 2022. The Company acts as agent on behalf of UT for the procurement of the UT Equipment. The Company has received $5.0 million in deposit for this service, which was recognized as deposits from customer in the consolidated balance sheet as of December 31, 2021. In April 2022, the Company and UT agreed that UT would hold title to the UT Equipment at all times. As such, there is no balance related to the UT Equipment included in construction in progress or deposits from customer in our consolidated balance sheet as of December 31, 2022. See Note 11 &#x2013; &lt;/span&gt;&lt;span style="font-style:italic;font-size:9pt;color:#000000;"&gt;Collaboration, Licensing and Other Arrangements.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20221231"
      decimals="-3"
      id="F_000782"
      unitRef="U_iso4217USD">875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLandMember_20211231"
      decimals="-3"
      id="F_000783"
      unitRef="U_iso4217USD">875000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20221231"
      decimals="-3"
      id="F_000784"
      unitRef="U_iso4217USD">17389000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_20211231"
      decimals="-3"
      id="F_000785"
      unitRef="U_iso4217USD">17389000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20221231"
      decimals="-3"
      id="F_000786"
      unitRef="U_iso4217USD">38952000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingImprovementsMember_20211231"
      decimals="-3"
      id="F_000787"
      unitRef="U_iso4217USD">38651000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20221231"
      decimals="-3"
      id="F_000788"
      unitRef="U_iso4217USD">58542000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapMachineryAndEquipmentMember_20211231"
      decimals="-3"
      id="F_000789"
      unitRef="U_iso4217USD">55334000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20221231"
      decimals="-3"
      id="F_000790"
      unitRef="U_iso4217USD">2976000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdFurnitureFixturesAndOfficeEquipmentMember_20211231"
      decimals="-3"
      id="F_000791"
      unitRef="U_iso4217USD">2969000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20221231"
      decimals="-3"
      id="F_000792"
      unitRef="U_iso4217USD">8246000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdComputerEquipmentAndSoftwareMember_20211231"
      decimals="-3"
      id="F_000793"
      unitRef="U_iso4217USD">8163000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20221231"
      decimals="-3"
      id="F_000794"
      unitRef="U_iso4217USD">16706000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20211231"
      decimals="-3"
      id="F_000795"
      unitRef="U_iso4217USD">10892000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000796"
      unitRef="U_iso4217USD">143686000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000797"
      unitRef="U_iso4217USD">134273000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000798"
      unitRef="U_iso4217USD">98560000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000799"
      unitRef="U_iso4217USD">97661000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000800"
      unitRef="U_iso4217USD">45126000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000801"
      unitRef="U_iso4217USD">36612000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ConstructionInProgressGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20211231"
      decimals="-5"
      id="F_000811"
      unitRef="U_iso4217USD">4700000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20221231"
      decimals="-6"
      id="F_000812"
      unitRef="U_iso4217USD">0</us-gaap:ConstructionInProgressGross>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20210101_20211231"
      decimals="-5"
      id="F_000813"
      unitRef="U_iso4217USD">5000000.0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20220101_20221231"
      decimals="-6"
      id="F_000814"
      unitRef="U_iso4217USD">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:Depreciation
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_000815"
      unitRef="U_iso4217USD">3300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_000816"
      unitRef="U_iso4217USD">2000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_000817"
      unitRef="U_iso4217USD">1800000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20220101_20221231"
      decimals="-5"
      id="F_000818"
      unitRef="U_iso4217USD">2400000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:PropertyPlantAndEquipmentDisposals
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember_20210101_20211231"
      decimals="-5"
      id="F_000819"
      unitRef="U_iso4217USD">1100000</us-gaap:PropertyPlantAndEquipmentDisposals>
    <us-gaap:SaleLeasebackTransactionDate
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_000823">November 8, 2021</us-gaap:SaleLeasebackTransactionDate>
    <us-gaap:ProceedsFromSaleOfRealEstate
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      decimals="-5"
      id="F_000820"
      unitRef="U_iso4217USD">102300000</us-gaap:ProceedsFromSaleOfRealEstate>
    <mnkd:SaleLeasebackTransactionLeaseAgreementPeriods
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_000821">P20Y</mnkd:SaleLeasebackTransactionLeaseAgreementPeriods>
    <mnkd:SaleLeasebackTransactionLeaseAgreementPeriods
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_000822">P20Y</mnkd:SaleLeasebackTransactionLeaseAgreementPeriods>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000496">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.&lt;span style="Background-color:#FFFFFF;color:#000000;"&gt; Goodwill and Other Intangible Asset&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;span style="font-style:normal;"&gt; &#x2014; Goodwill represents the excess of the purchase price over the identifiable tangible and intangible assets acquired plus liabilities assumed arising from business combinations. The balance of goodwill was approximately $2.4 million as of December 31, 2022 as a result of our acquisition of V-Go in May 2022. Goodwill is tested at least annually for impairment by assessing qualitative factors in determining whether it is more likely than not that the fair value of net assets is below their carrying amounts. See Note 2 &#x2013; &lt;/span&gt;Summary of Significant Accounting Policies&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Other Intangible Asset &lt;span style="font-style:normal;"&gt;&#x2014; Other intangible asset consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Useful&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Book Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000831"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,153&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization expense related to the other intangible asset was &lt;span style="font-style:italic;"&gt;de minimis&lt;/span&gt; for the year ended December 31, 2022. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The estimated annual amortization expense for the other intangible asset for the years ended December 31, 2023 through 2027 will be approximately $0.1 million per year and $0.7 million, thereafter.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company evaluates its other intangible asset for potential impairment when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. &lt;span style="font-style:italic;"&gt;See Note 2 &#x2013; Summary of Significant Accounting Policies&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000824"
      unitRef="U_iso4217USD">2400000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000551">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Other Intangible Asset &lt;span style="font-style:normal;"&gt;&#x2014; Other intangible asset consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Useful&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Life (Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accumulated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Book Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Developed technology&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000831"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,153&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231"
      decimals="-3"
      id="F_000832"
      unitRef="U_iso4217USD">1200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231"
      decimals="-3"
      id="F_000833"
      unitRef="U_iso4217USD">47000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231"
      decimals="-3"
      id="F_000834"
      unitRef="U_iso4217USD">1153000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000825"
      unitRef="U_iso4217USD">100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000826"
      unitRef="U_iso4217USD">100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000829"
      unitRef="U_iso4217USD">100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000827"
      unitRef="U_iso4217USD">100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000828"
      unitRef="U_iso4217USD">100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_000830"
      unitRef="U_iso4217USD">700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000497">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;9. Accrued Expenses and Other Current Liabilities&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities are comprised of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Salary and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,906&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discounts and allowances for commercial product sales&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,504&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Returns reserve for acquired product&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,013&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;895&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion of milestone rights liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,166&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Retail inventory purchase&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Danbury facility buildout&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,719&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,980&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,553&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,419&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The provision for discounts and allowances for commercial product sales is reflected as a component of net revenues. The activities and ending balance consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discounts and allowances for commercial product sales:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,688&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,369&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deductions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,603&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;V-Go opening balance sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,511&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,504&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000552">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities are comprised of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Salary and related expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,906&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14,022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discounts and allowances for commercial product sales&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,504&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Returns reserve for acquired product&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,013&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Professional fees&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;895&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current portion of milestone rights liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,201&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,166&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Retail inventory purchase&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;875&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Danbury facility buildout&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;786&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,719&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,980&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses and other current liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,553&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,419&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000835"
      unitRef="U_iso4217USD">14906000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000836"
      unitRef="U_iso4217USD">14022000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <mnkd:CustomerDiscountsAndAllowances
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000837"
      unitRef="U_iso4217USD">8504000</mnkd:CustomerDiscountsAndAllowances>
    <mnkd:CustomerDiscountsAndAllowances
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000838"
      unitRef="U_iso4217USD">4227000</mnkd:CustomerDiscountsAndAllowances>
    <mnkd:ReturnsReserveForAcquiredProduct
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000839"
      unitRef="U_iso4217USD">1013000</mnkd:ReturnsReserveForAcquiredProduct>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000840"
      unitRef="U_iso4217USD">1136000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000841"
      unitRef="U_iso4217USD">895000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:DirectFinancingLeaseDeferredSellingProfit
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000842"
      unitRef="U_iso4217USD">1304000</us-gaap:DirectFinancingLeaseDeferredSellingProfit>
    <us-gaap:DirectFinancingLeaseDeferredSellingProfit
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000843"
      unitRef="U_iso4217USD">1380000</us-gaap:DirectFinancingLeaseDeferredSellingProfit>
    <mnkd:CurrentPortionOfMilestoneRightLiability
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000844"
      unitRef="U_iso4217USD">924000</mnkd:CurrentPortionOfMilestoneRightLiability>
    <mnkd:CurrentPortionOfMilestoneRightLiability
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000845"
      unitRef="U_iso4217USD">1088000</mnkd:CurrentPortionOfMilestoneRightLiability>
    <us-gaap:InterestPayableCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000846"
      unitRef="U_iso4217USD">2201000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000847"
      unitRef="U_iso4217USD">2166000</us-gaap:InterestPayableCurrent>
    <mnkd:RetailInventoryPurchase
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000848"
      unitRef="U_iso4217USD">875000</mnkd:RetailInventoryPurchase>
    <us-gaap:ConstructionPayableCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000849"
      unitRef="U_iso4217USD">846000</us-gaap:ConstructionPayableCurrent>
    <us-gaap:ConstructionPayableCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000850"
      unitRef="U_iso4217USD">786000</us-gaap:ConstructionPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000851"
      unitRef="U_iso4217USD">4719000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000852"
      unitRef="U_iso4217USD">1980000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000853"
      unitRef="U_iso4217USD">35553000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000854"
      unitRef="U_iso4217USD">27419000</us-gaap:AccruedLiabilitiesCurrent>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000553">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The provision for discounts and allowances for commercial product sales is reflected as a component of net revenues. The activities and ending balance consists of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discounts and allowances for commercial product sales:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,688&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Provisions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,369&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,057&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deductions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,603&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;V-Go opening balance sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,511&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,504&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,227&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</mnkd:DiscountsAndAllowancesForCommercialProductSalesTableTextBlock>
    <mnkd:DiscountsAndAllowancesForCommercialProductSales
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000855"
      unitRef="U_iso4217USD">4227000</mnkd:DiscountsAndAllowancesForCommercialProductSales>
    <mnkd:DiscountsAndAllowancesForCommercialProductSales
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_000856"
      unitRef="U_iso4217USD">3688000</mnkd:DiscountsAndAllowancesForCommercialProductSales>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000857"
      unitRef="U_iso4217USD">23369000</mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000858"
      unitRef="U_iso4217USD">13057000</mnkd:DiscountsAndAllowancesForCommercialProductSalesProvisions>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000859"
      unitRef="U_iso4217USD">20603000</mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_000860"
      unitRef="U_iso4217USD">12518000</mnkd:DiscountsAndAllowancesForCommercialProductSalesDeductions>
    <mnkd:DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_000861"
      unitRef="U_iso4217USD">1511000</mnkd:DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition>
    <mnkd:DiscountsAndAllowancesForCommercialProductSales
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000862"
      unitRef="U_iso4217USD">8504000</mnkd:DiscountsAndAllowancesForCommercialProductSales>
    <mnkd:DiscountsAndAllowancesForCommercialProductSales
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000863"
      unitRef="U_iso4217USD">4227000</mnkd:DiscountsAndAllowancesForCommercialProductSales>
    <us-gaap:DebtDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000498">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;10. Borrowings&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying amount of the Company&#x2019;s borrowings consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;225,397&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223,944&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group promissory notes&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,829&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,425&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,264&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total debt &#x2014; net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281,202&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The amendment to the Mann Group convertible note in the second quarter of 2021 resulted in a substantial premium of $22.1 million based on the fair value post modification, which contributed to the loss on extinguishment in the consolidated statement of operations for the year ended December 31, 2021 and was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table provides a summary of the Company&#x2019;s debt and key terms: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount Due&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Terms&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Annual&#160;Interest&#160;Rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Maturity Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Conversion Price&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$230.0&#160;million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$230.0 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.50%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$5.21&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;per share&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$40.0&#160;million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$40.0 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;one-month&lt;/span&gt;&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;SOFR (1% floor)&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;plus&#160;6.25%;&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;cap of 8.25%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;August&#160;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$8.8 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000879"&gt;$18.4 million (plus $0.4 million accrued interest paid-in-kind)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.50%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$2.50&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;per share&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. &lt;/span&gt;&lt;span style="font-size:10pt;color:#000000;"&gt;In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The maturities of the Company&#x2019;s borrowings as of December 31, 2022 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.26%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total principal payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;278,830&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(235&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes &#x2013; &lt;span style="font-style:normal;"&gt;In March 2021, the Company issued $200.0 million aggregate principal amount of Senior convertible notes in a private offering. Pursuant to an option to purchase additional senior convertible notes in the purchase agreement between the Company and the initial purchasers of the Senior convertible notes, the Company issued an additional $30.0 million aggregate principal amount of Senior convertible notes on March 15, 2021. The Senior convertible notes were issued pursuant to an indenture, dated March 4, 2021 (the &#x201c;Indenture&#x201d;), between the Company and U.S. Bank National Association, as trustee.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Senior convertible notes are general unsecured obligations of the Company and will mature on March 1, 2026, unless earlier converted, redeemed or repurchased. The Senior convertible notes will bear cash interest from March 4, 2021 at an annual rate of 2.50% payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2021. The Senior convertible notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021 (and only during such calendar quarter), if the last reported sale price of the Company&#x2019;s common stock, par value $0.01 per share, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the Senior convertible notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Senior convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Senior convertible notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after December 1, 2025 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the common stock or a combination of cash and shares of common stock, at the Company&#x2019;s election, in the manner and subject to the terms and conditions provided in the Indenture.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The initial conversion rate is 191.8281 shares of common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $5.21 per share of common stock). The initial conversion price of the Senior convertible notes represents a premium of approximately 30% to the last reported sale price of the common stock on the Nasdaq Global Market on March 1, 2021. The conversion rate for the Senior convertible notes is subject to adjustment under certain circumstances in accordance with the terms of the Indenture, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date of the Senior convertible notes or if the Company delivers a notice of redemption in respect of the Senior convertible notes, the Company will, in certain circumstances, increase the conversion rate of the Senior convertible notes for a holder who elects to convert its Senior convertible notes in connection with such a corporate event or convert its Notes called for redemption during the related redemption period (as defined in the Indenture), as the case may be.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company may not redeem the Senior convertible notes prior to March 6, 2024. The Company may redeem for cash all or any portion of the Senior convertible notes, at its option, on or after March 6, 2024 and prior to the 36th scheduled trading day immediately preceding the maturity date, if the last reported sale price of common stock has been at least 130% of the conversion price for the Senior convertible notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Senior convertible notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem less than all of the outstanding Senior convertible notes, at least $75.0 million aggregate principal amount of Senior convertible notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the Senior convertible notes.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as described in the Indenture, holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Senior convertible notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Indenture includes customary covenants and sets forth certain events of default after which the Senior convertible notes may be declared immediately due and payable. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;If certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries) occur, 100% of the principal of and accrued and unpaid interest on the Senior convertible notes will automatically become due and payable. If an event of default with respect to the Senior convertible notes, other than certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries), occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Senior convertible notes by notice to the Company and the trustee, may, and the trustee at the request of such holders shall, declare 100% of the principal of and accrued and unpaid interest, if any, on all the Senior convertible notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the Senior convertible notes as set forth in the Indenture.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Indenture provides that the Company shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of the consolidated properties and assets of the Company and its subsidiaries, taken as a whole, to, another person (other than any such sale, conveyance, transfer or lease to one or more of the Company&#x2019;s direct or indirect wholly owned subsidiaries), unless: (i) the resulting, surviving or transferee person (if not the Company) is a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and such corporation (if not the Company) expressly assumes by supplemental indenture all of the Company&#x2019;s obligations under the Senior convertible notes and the Indenture; and (ii) immediately after giving effect to such transaction, no default or event of default has occurred and is continuing under the Indenture.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, the Company&#x2019;s net proceeds from the offering were approximately $222.7 million, after deducting the initial purchasers&#x2019; discounts and commissions and the estimated offering expenses payable by the Company. As of December 31, 2022 and 2021, the unamortized debt issuance cost was $4.6 million and $6.1 million, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility &#x2014; In August 2019, the Company entered into the MidCap credit facility and borrowed the first advance of $40.0 million (&#x201c;Tranche 1&#x201d;) in August 2019 and the second advance of $10.0 million (&#x201c;Tranche 2&#x201d;) in December 2020. In April 2021, $10.0 million was prepaid. Under the terms of the MidCap credit facility, a third advance of $60.0 million (&#x201c;Tranche 3&#x201d;) became available to the Company after the Tyvaso DPI approval by the FDA through June 30, 2022 (see Note 11 &#x2013; Collaboration, Licensing and Other Arrangements). The Company did not exercise its right to borrow Tranche 3.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Mid Cap credit facility has been amended several times, including in April 2021, when the parties agreed to, among other things, (i) increase the amount available under the third advance from $25.0 million to $60.0 million and extend the date through which the third advance is available to June 30, 2022, (ii) amend the conditions to the third advance of $60.0 million being available to draw, including certain milestone conditions associated with Tyvaso DPI, (iii) remove the Company&#x2019;s obligation to issue a warrant to purchase shares of the Company&#x2019;s common stock upon drawing down the third advance, (iv) extend the interest-only period until September 1, 2023 and extend the maturity date until August 1, 2025, (v) amend the financial covenant relating to trailing 12 month minimum Afrezza net revenue, (vi) decrease the minimum cash covenant, (vii) decrease the interest rate on any amounts outstanding, now or in the future, under the MidCap credit facility, (viii) permit the Company to make certain acquisitions, subject to requirements, and (ix) permit the Company to make investments of up to an additional $9.0 million so long as the Company has $90.0 million or more of unrestricted cash and short-term investments following such investment. Concurrent with entering into this amendment, the Company made a $10.0 million principal prepayment against outstanding term loans under the MidCap credit facility and paid a related $1.0 million exit fee in lieu of the unaccrued portion of the original exit fee and prepayment penalties that would otherwise have been due with respect to the partial prepayment.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, the prepayment penalty of $1.0 million related to the payment of $10.0 million was capitalized and will be amortized over the remaining life of the debt. As of December 31, 2022, the unamortized debt discount was $0.2 million and the unamortized prepayment penalty was $0.5 million. As of December 31, 2021, the unamortized debt discount was $0.4 million and the unamortized prepayment penalty was $0.8 million.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2022, the Company entered into the tenth amendment to the MidCap credit facility to change the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tranche 1 and Tranche 2 accrue interest at an annual rate equal to the lesser of (i) 8.25% and (ii) the one-month SOFR (subject to a one-month SOFR floor of 1.00%) plus 6.25%. Interest on each term loan advance is due and payable monthly in arrears. Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025. The Company has the option to prepay its existing term loans, in whole or in part, subject to early termination fees in an amount equal to 3.00% of principal prepaid if prepayment occurs on or prior to April 22, 2022; 2.00% of principal prepaid if prepayment occurs on or after April 23, 2022 through and including April 22, 2023; and 1.00% of principal prepaid if prepayment occurs on or after April 23, 2023 through the maturity date.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s obligations under the MidCap credit facility are secured by a security interest on substantially all of its assets, including intellectual property.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The MidCap credit facility, as amended, contains customary affirmative covenants and customary negative covenants limiting the Company&#x2019;s ability and the ability of the Company&#x2019;s subsidiaries to, among other things, dispose of assets, undergo a change in control, merge or consolidate, make acquisitions, incur debt, incur liens, pay dividends, repurchase stock and make investments, in each case subject to certain exceptions. The Company must also comply with a financial covenant relating to trailing twelve month minimum Afrezza net revenue, tested on a monthly basis, unless the Company has $90.0 million or more of unrestricted cash and short-term investments. As of December 31, 2022, the Company was in compliance with the financial covenants.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The MidCap credit facility also contains customary events of default relating to, among other things, payment defaults, breaches of covenants, a material adverse change, listing of the Company&#x2019;s common stock, bankruptcy and insolvency, cross defaults with certain material indebtedness and certain material contracts, judgments, and inaccuracies of representations and warranties. Upon an event of default, the agent and the lenders may declare all or a portion of the Company&#x2019;s outstanding obligations to be immediately due and payable and exercise other rights and remedies provided for under the MidCap credit facility. During the existence of an event of default, interest on the term loans could be increased by 2.00%.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also agreed to issue warrants to purchase shares of the Company&#x2019;s common stock (the &#x201c;MidCap warrants&#x201d;) upon the drawdown of Tranches 1 and 2 in an aggregate amount equal to 3.25% of the amount drawn, divided by the exercise price per share for that tranche. The exercise price per share is equal to the volume-weighted average closing price of the Company&#x2019;s common stock for the ten business days immediately preceding the second business day before the issue date. As a result of Tranche 1, the Company issued warrants to purchase an aggregate of 1,171,614 shares of the Company&#x2019;s common stock, at an exercise price equal to $1.11 per share. As a result of Tranche 2, the Company issued warrants to purchase an aggregate of 111,853 shares of the Company&#x2019;s common stock, at an exercise price equal to $2.91 per share. The Company determined that these warrants met the criteria for equity classification and accounted for such warrants in additional paid-in capital. During the year ended December 31, 2021, the Tranche 1 and Tranche 2 MidCap warrants were exercised in full.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Mann Group promissory notes&lt;span style="font-style:normal;"&gt; &#x2014; In August 2019, the Company issued a $35.0 million &lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt;note that is convertible into shares of the Company&#x2019;s common stock at $2.50 per share (the &#x201c;Mann Group convertible note&#x201d;)&lt;/span&gt;&lt;span style="font-style:normal;"&gt; and issued a non-convertible note to Mann Group in an aggregate principal amount of $35.1 million (the &#x201c;Mann Group non-convertible note&#x201d; and&lt;/span&gt;&lt;span style="font-style:normal;color:#000000;"&gt;, together with the Mann Group convertible note, the &#x201c;Mann Group promissory notes&#x201d;)&lt;/span&gt;&lt;span style="font-style:normal;"&gt; as part of a restructuring of its then existing indebtedness to Mann Group.&lt;/span&gt; &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Mann Group promissory notes originally accrued interest at the rate of 7.00% per year on the principal amount, payable quarterly in arrears on the first day of each calendar quarter beginning October 1, 2019. In April 2021, the Company repaid the entire principal amount of $35.1 million outstanding under the Mann Group non-convertible note, together with all accrued and unpaid interest thereon. On the same date, the Company and Mann Group amended the Mann Group convertible note, pursuant to which the parties agreed to (i) reduce the interest rate from 7.0% to 2.5% effective on April 22, 2021, and (ii) extend the maturity date from November 3, 2024 to December 31, 2025. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The amendment to the Mann Group convertible note resulted in a debt extinguishment with a substantial premium based on the fair value post extinguishment. The fair value in excess of the face amount of $18.4 million contributed to a loss on extinguishment of $22.1 million in the consolidated statement of operations for the year ended December 31, 2021 and resulted in a corresponding debt premium of $22.1 million which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The Company wrote off a &lt;span style="font-style:italic;"&gt;de minimis&lt;/span&gt; amount of debt issuance cost.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The principal and any accrued and unpaid interest under the Mann Group convertible note may be converted, at the option of Mann Group, at any time on or prior to the close of business on the business day immediately preceding the stated maturity date, into shares of the Company&#x2019;s common stock at a conversion rate of 400 shares per $1,000 of principal and/or accrued and unpaid interest, which is equal to a conversion price of $2.50 per share. The conversion rate will be subject to adjustment under certain circumstances described in the Mann Group convertible note. Interest on the convertible note will be payable in kind by adding the amount thereof to the principal amount; provided that with respect to interest accruing from and after January 1, 2021, the Company may, at its option, elect to pay any such interest on any interest payment date, if certain conditions are met, in shares of the Company&#x2019;s common stock at a price per shall equal to the last reported sale price on the trading day immediately prior to the payment date.&#160;&#160;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to the terms of the Mann Group convertible note, Mann Group converted $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of accrued interest and $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of principal into &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million shares and &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.8&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million shares, respectively, of the Company&#x2019;s common stock in the fourth quarter of 2020. During the year ended December 31, 2021, Mann Group converted $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of interest and $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.6&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of principal into 4,000,000 shares of common stock.&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; During the year ended December 31, 2022, Mann Group converted $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of principal and capitalized interest into &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,000,000&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of common stock. In addition, the Company paid $&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of interest by issuing the Mann Group &lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,487&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of common stock&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; during the year ended December 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;PPP loan&lt;span style="font-style:normal;"&gt; &#x2013; In April 2020, the Company received the proceeds from the PPP loan from JPMorgan Chase Bank, N.A., as lender, in the amount of approximately $4.9 million pursuant to the PPP of the CARES Act. In July 2021, the Company received notification from the U.S Small Business Administration that the full principal amount of the PPP loan was forgiven. The Company recognized a $4.9 million gain on extinguishment of debt for the forgiveness of the principal amount and accrued but unpaid interest for the year ended December 31, 2021. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior to being forgiven, the PPP loan was evidenced by a promissory note dated April 9, 2020 that matured on April 9, 2022 and bore interest at a rate of 0.98% per annum (which was being deferred). The Company used all proceeds from the PPP loan to retain employees, maintain payroll and make lease, interest and utility payments. &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of the premium and accretion of debt issuance costs related to all borrowings for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;431&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights &#x2014;&lt;span style="font-style:normal;"&gt; As of December 31, 2022 and 2021, the remaining Milestone Rights liability balance was $4.8 million and $5.9 million, respectively, which was based on initial fair value estimates calculated using the income approach and reduced by milestone achievement payments made. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;During the second quarter of 2022, the Company achieved an Afrezza net sales milestone specified by the Milestone Rights.&lt;/span&gt;&lt;span style="font-style:normal;"&gt; &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;The carrying value of the Milestone Rights liability related to the $5.0&#160;million payment, which was made in the third quarter of 2022, was approximately $1.1&#160;million and represented the fair value as determined in 2013 (the most recent measurement date).&lt;/span&gt;&lt;span style="font-style:normal;"&gt; As of December 31, 2022, the $4.8 million liability consisted of a $0.9 million current liability which was presented as accrued expenses and other current liabilities and a $3.9 million long-term liability which was presented in milestone liabilities in our consolidated balance sheets. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the first quarter of 2021, the Company achieved the second Afrezza net sales milestone specified by the Milestone Rights. &lt;span style="color:#000000;"&gt;The milestone &lt;/span&gt;carrying value of the Milestone Rights liability related to the $5.0 million payment, which was made in the second quarter of 2021, was approxim&lt;span style="color:#000000;"&gt;ately $1.3 million, and represented the fair value as determined in 2013 (the most recent measurement date).&lt;/span&gt; As of December 31, 2021, the $5.9 million liability consisted of a $1.1 million current liability which was presented as accrued expenses and other current liabilities and a $4.8 million long-term liability which was presented in milestone liabilities in our consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Milestone Rights Agreement includes customary representations and warranties and covenants by the Company, including restrictions on transfers of intellectual property related to Afrezza. The Milestone Rights are subject to acceleration in the event the Company transfers its intellectual property related to Afrezza in violation of the terms of such agreement. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000554">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying amount of the Company&#x2019;s borrowings consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;225,397&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223,944&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group promissory notes&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,829&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,425&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,264&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,833&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total debt &#x2014; net carrying amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;281,202&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000864"
      unitRef="U_iso4217USD">225397000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000865"
      unitRef="U_iso4217USD">223944000</us-gaap:SeniorNotes>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000866"
      unitRef="U_iso4217USD">8829000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000867"
      unitRef="U_iso4217USD">18425000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:LineOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-3"
      id="F_000868"
      unitRef="U_iso4217USD">39264000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-3"
      id="F_000869"
      unitRef="U_iso4217USD">38833000</us-gaap:LineOfCredit>
    <us-gaap:LongTermDebt
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000870"
      unitRef="U_iso4217USD">273490000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_000871"
      unitRef="U_iso4217USD">281202000</us-gaap:LongTermDebt>
    <mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20211231"
      decimals="-5"
      id="F_000872"
      unitRef="U_iso4217USD">22100000</mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_000873"
      unitRef="U_iso4217USD">-22100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000555">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table provides a summary of the Company&#x2019;s debt and key terms: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amount Due&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Terms&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Annual&#160;Interest&#160;Rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Maturity Date&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Conversion Price&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$230.0&#160;million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$230.0 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.50%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;March 2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$5.21&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;per share&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$40.0&#160;million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$40.0 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;one-month&lt;/span&gt;&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;SOFR (1% floor)&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;plus&#160;6.25%;&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;cap of 8.25%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;August&#160;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;N/A&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$8.8 million&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000879"&gt;$18.4 million (plus $0.4 million accrued interest paid-in-kind)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.50%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.44%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$2.50&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;per share&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. &lt;/span&gt;&lt;span style="font-size:10pt;color:#000000;"&gt;In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="-5"
      id="F_000874"
      unitRef="U_iso4217USD">230000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231"
      decimals="-5"
      id="F_000877"
      unitRef="U_iso4217USD">230000000.0</us-gaap:DebtInstrumentFaceAmount>
    <mnkd:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      id="F_000886">2026-03</mnkd:DebtInstrumentMaturityMonthAndYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_000875"
      unitRef="U_iso4217USD">40000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_000878"
      unitRef="U_iso4217USD">40000000.0</us-gaap:DebtInstrumentFaceAmount>
    <mnkd:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231"
      id="F_000887">2025-08</mnkd:DebtInstrumentMaturityMonthAndYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20221231"
      decimals="-5"
      id="F_000876"
      unitRef="U_iso4217USD">8800000</us-gaap:DebtInstrumentFaceAmount>
    <mnkd:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      id="F_000888">2025-12</mnkd:DebtInstrumentMaturityMonthAndYear>
    <us-gaap:EarlyRepaymentOfSeniorDebt
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430"
      decimals="-5"
      id="F_000889"
      unitRef="U_iso4217USD">10000000.0</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210430"
      decimals="2"
      id="F_000890"
      unitRef="U_xbrlipure">0.02</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mnkd:DebtInstrumentFloorRate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20210401_20210430"
      decimals="4"
      id="F_000891"
      unitRef="U_xbrlipure">0.0675</mnkd:DebtInstrumentFloorRate>
    <mnkd:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToMidcapCreditFacilityAmendmentMember_20210401_20210430"
      id="F_000892">2024-08</mnkd:DebtInstrumentMaturityMonthAndYear>
    <mnkd:DebtInstrumentFloorRate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831"
      decimals="2"
      id="F_000896"
      unitRef="U_xbrlipure">0.01</mnkd:DebtInstrumentFloorRate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220831"
      decimals="4"
      id="F_000895"
      unitRef="U_xbrlipure">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mnkd:DebtInstrumentCapInterestRate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapVariableRateAxis_us-gaapSecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_20220801_20220831"
      decimals="4"
      id="F_000897"
      unitRef="U_xbrlipure">0.0825</mnkd:DebtInstrumentCapInterestRate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210430"
      decimals="4"
      id="F_000893"
      unitRef="U_xbrlipure">0.0700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mnkd:DebtInstrumentMaturityMonthAndYear
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertiblePromissoryNoteMember_us-gaapLongtermDebtTypeAxis_mnkdPriorToFirstAmendmentMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210401_20210430"
      id="F_000894">2024-11</mnkd:DebtInstrumentMaturityMonthAndYear>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000556">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The maturities of the Company&#x2019;s borrowings as of December 31, 2022 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.26%; border-bottom:solid 0.75pt #000000;" valign="middle"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amounts&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;230,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total principal payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;278,830&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:81.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unamortized discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(235&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,105&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:81.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000898"
      unitRef="U_iso4217USD">6667000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000899"
      unitRef="U_iso4217USD">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000900"
      unitRef="U_iso4217USD">22163000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000901"
      unitRef="U_iso4217USD">230000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000902"
      unitRef="U_iso4217USD">278830000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000903"
      unitRef="U_iso4217USD">235000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000904"
      unitRef="U_iso4217USD">5105000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_000905"
      unitRef="U_iso4217USD">273490000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210331"
      decimals="-5"
      id="F_000906"
      unitRef="U_iso4217USD">200000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapPrivatePlacementMember_20210315"
      decimals="-5"
      id="F_000907"
      unitRef="U_iso4217USD">30000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      id="F_000908">2026-03-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="4"
      id="F_000909"
      unitRef="U_xbrlipure">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="2"
      id="F_000910"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <mnkd:NumberOfTradingDays
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="INF"
      id="F_000911"
      unitRef="U_utrD">20</mnkd:NumberOfTradingDays>
    <mnkd:ConsecutiveTradingDays
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="INF"
      id="F_000912"
      unitRef="U_utrD">30</mnkd:ConsecutiveTradingDays>
    <mnkd:DebtInstrumentConvertibleConversionPricePercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      decimals="2"
      id="F_000913"
      unitRef="U_xbrlipure">1.30</mnkd:DebtInstrumentConvertibleConversionPricePercentage>
    <mnkd:PrincipalAmountPerShare
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      decimals="0"
      id="F_000914"
      unitRef="U_iso4217USD_xbrlishares">1000</mnkd:PrincipalAmountPerShare>
    <mnkd:MeasurementPeriodPercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      decimals="2"
      id="F_000915"
      unitRef="U_xbrlipure">0.98</mnkd:MeasurementPeriodPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="4"
      id="F_000919"
      unitRef="U_xbrlipure">191.8281</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <mnkd:PrincipalAmountPerShare
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="0"
      id="F_000916"
      unitRef="U_iso4217USD_xbrlishares">1000</mnkd:PrincipalAmountPerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304"
      decimals="INF"
      id="F_000917"
      unitRef="U_iso4217USD_xbrlishares">5.21</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <mnkd:DebtInstrumentInitialConversionPriceOfPremiumPercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="2"
      id="F_000918"
      unitRef="U_xbrlipure">0.30</mnkd:DebtInstrumentInitialConversionPriceOfPremiumPercentage>
    <us-gaap:DebtInstrumentRedemptionDescription
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      id="F_000928">The Company may redeem for cash all or any portion of the Senior convertible notes, at its option, on or after March 6, 2024 and prior to the 36th scheduled trading day immediately preceding the maturity date, if the last reported sale price of common stock has been at least 130% of the conversion price for the Senior convertible notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Senior convertible notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem less than all of the outstanding Senior convertible notes, at least $75.0 million aggregate principal amount of Senior convertible notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the Senior convertible notes.</us-gaap:DebtInstrumentRedemptionDescription>
    <us-gaap:DebtInstrumentRedemptionPeriodStartDate
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      id="F_000923">2024-03-06</us-gaap:DebtInstrumentRedemptionPeriodStartDate>
    <us-gaap:DebtInstrumentRedemptionPeriodStartDate
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      id="F_000924">2024-03-06</us-gaap:DebtInstrumentRedemptionPeriodStartDate>
    <mnkd:DebtInstrumentConvertibleConversionPricePercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="2"
      id="F_000922"
      unitRef="U_xbrlipure">1.30</mnkd:DebtInstrumentConvertibleConversionPricePercentage>
    <mnkd:NumberOfTradingDays
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304"
      decimals="INF"
      id="F_000920"
      unitRef="U_utrD">20</mnkd:NumberOfTradingDays>
    <mnkd:ConsecutiveTradingDays
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304"
      decimals="INF"
      id="F_000921"
      unitRef="U_utrD">30</mnkd:ConsecutiveTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="INF"
      id="F_000925"
      unitRef="U_xbrlipure">1</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <mnkd:DebtInstrumentOutstandingPrincipalAmountRedeemed
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304"
      decimals="-5"
      id="F_000926"
      unitRef="U_iso4217USD">75000000.0</mnkd:DebtInstrumentOutstandingPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentSinkingFundPayment
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="INF"
      id="F_000927"
      unitRef="U_iso4217USD">0</us-gaap:DebtInstrumentSinkingFundPayment>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="INF"
      id="F_000929"
      unitRef="U_xbrlipure">1</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231"
      id="F_000932">If certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries) occur, 100% of the principal of and accrued and unpaid interest on the Senior convertible notes will automatically become due and payable. If an event of default with respect to the Senior convertible notes, other than certain bankruptcy and insolvency-related events of default involving the Company (and not just any of its significant subsidiaries), occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Senior convertible notes by notice to the Company and the trustee, may, and the trustee at the request of such holders shall, declare 100% of the principal of and accrued and unpaid interest, if any, on all the Senior convertible notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the Senior convertible notes as set forth in the Indenture</us-gaap:DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="INF"
      id="F_000930"
      unitRef="U_xbrlipure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210304_20210304"
      decimals="INF"
      id="F_000931"
      unitRef="U_xbrlipure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20210101_20211231"
      decimals="-5"
      id="F_000933"
      unitRef="U_iso4217USD">222700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231"
      decimals="-5"
      id="F_000935"
      unitRef="U_iso4217USD">4600000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20211231"
      decimals="-5"
      id="F_000934"
      unitRef="U_iso4217USD">6100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ProceedsFromSecuredLinesOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831"
      decimals="-5"
      id="F_000936"
      unitRef="U_iso4217USD">40000000.0</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <us-gaap:ProceedsFromSecuredLinesOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20200101_20201231"
      decimals="-5"
      id="F_000937"
      unitRef="U_iso4217USD">10000000.0</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <mnkd:PrepaymentOfSecuredLinesOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430"
      decimals="-5"
      id="F_000938"
      unitRef="U_iso4217USD">10000000.0</mnkd:PrepaymentOfSecuredLinesOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20190831"
      decimals="-5"
      id="F_000939"
      unitRef="U_iso4217USD">60000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20220101_20221231"
      id="F_000945">The Mid Cap credit facility has been amended several times, including in April 2021, when the parties agreed to, among other things, (i) increase the amount available under the third advance from $25.0 million to $60.0 million and extend the date through which the third advance is available to June 30, 2022, (ii) amend the conditions to the third advance of $60.0 million being available to draw, including certain milestone conditions associated with Tyvaso DPI, (iii) remove the Company&#x2019;s obligation to issue a warrant to purchase shares of the Company&#x2019;s common stock upon drawing down the third advance, (iv) extend the interest-only period until September 1, 2023 and extend the maturity date until August 1, 2025, (v) amend the financial covenant relating to trailing 12 month minimum Afrezza net revenue, (vi) decrease the minimum cash covenant, (vii) decrease the interest rate on any amounts outstanding, now or in the future, under the MidCap credit facility, (viii) permit the Company to make certain acquisitions, subject to requirements, and (ix) permit the Company to make investments of up to an additional $9.0 million so long as the Company has $90.0 million or more of unrestricted cash and short-term investments following such investment.</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210331"
      decimals="-5"
      id="F_000940"
      unitRef="U_iso4217USD">25000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422"
      decimals="-5"
      id="F_000941"
      unitRef="U_iso4217USD">60000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <mnkd:DebtInstrumentAdvanceAvailableDate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422"
      id="F_000942">2022-06-30</mnkd:DebtInstrumentAdvanceAvailableDate>
    <mnkd:DebtInstrumentExtendedInterestOnlyDate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422"
      id="F_000943">2023-09-01</mnkd:DebtInstrumentExtendedInterestOnlyDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422_20210422"
      id="F_000944">2025-08-01</us-gaap:DebtInstrumentMaturityDate>
    <mnkd:MaximumValueOfAdditionalInvestmentLimit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422"
      decimals="INF"
      id="F_000946"
      unitRef="U_iso4217USD">9000000.0</mnkd:MaximumValueOfAdditionalInvestmentLimit>
    <mnkd:DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheThreeMember_20210422"
      decimals="-5"
      id="F_000947"
      unitRef="U_iso4217USD">90000000.0</mnkd:DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422"
      decimals="-5"
      id="F_000948"
      unitRef="U_iso4217USD">10000000.0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210422_20210422"
      decimals="-5"
      id="F_000949"
      unitRef="U_iso4217USD">1000000.0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231"
      decimals="-5"
      id="F_000950"
      unitRef="U_iso4217USD">1000000.0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <mnkd:PrepaymentOfSecuredLinesOfCredit
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231"
      decimals="-5"
      id="F_000951"
      unitRef="U_iso4217USD">10000000.0</mnkd:PrepaymentOfSecuredLinesOfCredit>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_000953"
      unitRef="U_iso4217USD">200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <mnkd:DebtInstrumentUnamortizedPrepaymentPenalty
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_000955"
      unitRef="U_iso4217USD">500000</mnkd:DebtInstrumentUnamortizedPrepaymentPenalty>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_000952"
      unitRef="U_iso4217USD">400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <mnkd:DebtInstrumentUnamortizedPrepaymentPenalty
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_000954"
      unitRef="U_iso4217USD">800000</mnkd:DebtInstrumentUnamortizedPrepaymentPenalty>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831"
      decimals="4"
      id="F_000956"
      unitRef="U_xbrlipure">0.0825</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231"
      decimals="4"
      id="F_000957"
      unitRef="U_xbrlipure">0.0825</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <mnkd:DebtInstrumentFloorRate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831"
      decimals="4"
      id="F_000960"
      unitRef="U_xbrlipure">0.0100</mnkd:DebtInstrumentFloorRate>
    <mnkd:DebtInstrumentFloorRate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231"
      decimals="4"
      id="F_000961"
      unitRef="U_xbrlipure">0.0100</mnkd:DebtInstrumentFloorRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20190801_20190831"
      decimals="4"
      id="F_000958"
      unitRef="U_xbrlipure">0.0625</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_us-gaapVariableRateAxis_us-gaapLondonInterbankOfferedRateLIBORMember_20201201_20201231"
      decimals="4"
      id="F_000959"
      unitRef="U_xbrlipure">0.0625</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="C_0000899460_20220101_20221231" id="F_000968">Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025.</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831"
      decimals="INF"
      id="F_000962"
      unitRef="U_mnkdInstallment">24</mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments>
    <mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231"
      decimals="INF"
      id="F_000963"
      unitRef="U_mnkdInstallment">24</mnkd:DebtInstrumentPaymentNumberOfEqualMonthlyInstallments>
    <mnkd:LineOfCreditFacilityPrincipalPaymentStartDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831"
      id="F_000964">2023-09-01</mnkd:LineOfCreditFacilityPrincipalPaymentStartDate>
    <mnkd:LineOfCreditFacilityPrincipalPaymentStartDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231"
      id="F_000965">2023-09-01</mnkd:LineOfCreditFacilityPrincipalPaymentStartDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190801_20190831"
      id="F_000966">2025-08-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201201_20201231"
      id="F_000967">2025-08-01</us-gaap:DebtInstrumentMaturityDate>
    <mnkd:EarlyTerminationFeesPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodOneMember_20220101_20221231"
      decimals="4"
      id="F_000970"
      unitRef="U_xbrlipure">0.0300</mnkd:EarlyTerminationFeesPercentage>
    <mnkd:EarlyTerminationFeesPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20220101_20221231"
      decimals="4"
      id="F_000969"
      unitRef="U_xbrlipure">0.0200</mnkd:EarlyTerminationFeesPercentage>
    <mnkd:EarlyTerminationFeesPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodThreeMember_20220101_20221231"
      decimals="4"
      id="F_000971"
      unitRef="U_xbrlipure">0.0100</mnkd:EarlyTerminationFeesPercentage>
    <mnkd:DebtInstrumentMinimumCashCovenant
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190831"
      decimals="-5"
      id="F_000972"
      unitRef="U_iso4217USD">90000000.0</mnkd:DebtInstrumentMinimumCashCovenant>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190806_20190806"
      decimals="4"
      id="F_000973"
      unitRef="U_xbrlipure">0.0200</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <mnkd:TermLoanAdvancePercentageOfAmountDrawdown
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20190801_20190831"
      decimals="4"
      id="F_000974"
      unitRef="U_xbrlipure">0.0325</mnkd:TermLoanAdvancePercentageOfAmountDrawdown>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831"
      decimals="INF"
      id="F_000975"
      unitRef="U_xbrlishares">1171614</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20190831"
      decimals="2"
      id="F_000977"
      unitRef="U_iso4217USD_xbrlishares">1.11</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231"
      decimals="INF"
      id="F_000976"
      unitRef="U_xbrlishares">111853</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20201231"
      decimals="2"
      id="F_000978"
      unitRef="U_iso4217USD_xbrlishares">2.91</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831"
      decimals="-5"
      id="F_000979"
      unitRef="U_iso4217USD">35000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SharePrice
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831"
      decimals="2"
      id="F_000980"
      unitRef="U_iso4217USD_xbrlishares">2.50</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdNonConvertibleNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_us-gaapTypeOfArrangementAxis_mnkdPrivatelyNegotiatedExchangeAgreementMember_20190831"
      decimals="-5"
      id="F_000981"
      unitRef="U_iso4217USD">35100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831"
      decimals="INF"
      id="F_000982"
      unitRef="U_xbrlipure">0.0700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20200101_20201231"
      id="F_000984">quarterly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831"
      id="F_000985">2019-10-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210422"
      decimals="INF"
      id="F_000983"
      unitRef="U_xbrlipure">0.025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="C_0000899460_20190801_20190831" id="F_000986">2024-11-03</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="C_0000899460_20210422_20210422" id="F_000987">2025-12-31</us-gaap:DebtInstrumentMaturityDate>
    <mnkd:DebtInstrumentFairValueInExcessOfFaceAmount
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231"
      decimals="-5"
      id="F_000988"
      unitRef="U_iso4217USD">18400000</mnkd:DebtInstrumentFairValueInExcessOfFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_000989"
      unitRef="U_iso4217USD">-22100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231"
      decimals="-5"
      id="F_000991"
      unitRef="U_iso4217USD">22100000</mnkd:DebtPremiumRecognizedInAdditionalPaidInCapital>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_000990"
      unitRef="U_iso4217USD">-22100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831"
      decimals="0"
      id="F_000992"
      unitRef="U_xbrlipure">400</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <mnkd:PrincipalAmountPerShare
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190801_20190831"
      decimals="0"
      id="F_000993"
      unitRef="U_iso4217USD_xbrlishares">1000</mnkd:PrincipalAmountPerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionAxis_mnkdNewLoanArrangementMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20190831"
      decimals="2"
      id="F_000994"
      unitRef="U_iso4217USD_xbrlishares">2.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_000995"
      unitRef="U_iso4217USD">3000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_000996"
      unitRef="U_iso4217USD">7000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_000998"
      unitRef="U_xbrlishares">1200000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_000997"
      unitRef="U_xbrlishares">2800000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_000999"
      unitRef="U_iso4217USD">400000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_001001"
      unitRef="U_iso4217USD">9600000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtConversionByUniqueDescriptionAxis_mnkdAccruedInterestMember_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="-5"
      id="F_001000"
      unitRef="U_iso4217USD">10000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="0"
      id="F_001002"
      unitRef="U_xbrlishares">4000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="0"
      id="F_001003"
      unitRef="U_xbrlishares">4000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:InterestExpenseDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="-5"
      id="F_001004"
      unitRef="U_iso4217USD">300000</us-gaap:InterestExpenseDebt>
    <mnkd:CommonStockIssuedToPayInterest
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="INF"
      id="F_001005"
      unitRef="U_xbrlishares">75487</mnkd:CommonStockIssuedToPayInterest>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430"
      decimals="-5"
      id="F_001006"
      unitRef="U_iso4217USD">4900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20210101_20211231"
      decimals="-5"
      id="F_001009"
      unitRef="U_iso4217USD">4900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430"
      id="F_001007">2022-04-09</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200430"
      decimals="INF"
      id="F_001008"
      unitRef="U_xbrlipure">0.0098</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mnkd:ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000557">
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of the premium and accretion of debt issuance costs related to all borrowings for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;431&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortization of debt issuance cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,215&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;101&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</mnkd:ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock>
    <mnkd:AmortizationOfDebtDiscount
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001010"
      unitRef="U_iso4217USD">431000</mnkd:AmortizationOfDebtDiscount>
    <mnkd:AmortizationOfDebtDiscount
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001011"
      unitRef="U_iso4217USD">377000</mnkd:AmortizationOfDebtDiscount>
    <mnkd:AmortizationOfDebtDiscount
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001012"
      unitRef="U_iso4217USD">268000</mnkd:AmortizationOfDebtDiscount>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001013"
      unitRef="U_iso4217USD">1453000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001014"
      unitRef="U_iso4217USD">1215000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001015"
      unitRef="U_iso4217USD">101000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001016"
      unitRef="U_iso4217USD">4800000</mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent>
    <mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001017"
      unitRef="U_iso4217USD">5900000</mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent>
    <mnkd:PaymentForMilestoneRightsLiabilities
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001020"
      unitRef="U_iso4217USD">5000000.0</mnkd:PaymentForMilestoneRightsLiabilities>
    <mnkd:MilestoneRightsLiabilityCurrent
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001022"
      unitRef="U_iso4217USD">1100000</mnkd:MilestoneRightsLiabilityCurrent>
    <mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001018"
      unitRef="U_iso4217USD">4800000</mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001024"
      unitRef="U_iso4217USD">900000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <mnkd:MilestoneLiabilitiesNoncurrent
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20221231"
      decimals="-5"
      id="F_001026"
      unitRef="U_iso4217USD">3900000</mnkd:MilestoneLiabilitiesNoncurrent>
    <mnkd:PaymentForMilestoneRightsLiabilities
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001021"
      unitRef="U_iso4217USD">5000000.0</mnkd:PaymentForMilestoneRightsLiabilities>
    <mnkd:MilestoneRightsLiabilityCurrent
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001023"
      unitRef="U_iso4217USD">1300000</mnkd:MilestoneRightsLiabilityCurrent>
    <mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001019"
      unitRef="U_iso4217USD">5900000</mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001025"
      unitRef="U_iso4217USD">1100000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <mnkd:MilestoneLiabilitiesNoncurrent
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdBaringsGlobalMilestoneRightsMember_20211231"
      decimals="-5"
      id="F_001027"
      unitRef="U_iso4217USD">4800000</mnkd:MilestoneLiabilitiesNoncurrent>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000499">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;11. Collaboration, Licensing and Other Arrangements&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from collaborations and services for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT CSA Agreement&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt; (1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT License Agreement&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt; (2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vertice Pharma Co-Promotion Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cipla License and Distribution Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receptor CLA&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT Research Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue from collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of revenue recognized for Next-Gen R&amp;amp;D Services and R&amp;amp;D Services and License for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The activity related to deferred revenue and the related revenue recognized for collaborations and services is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,707&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue &#x2014; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(36,274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,417&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;United Therapeutics License Agreement&lt;span style="font-style:normal;"&gt; &#x2014; In September 2018, the Company and UT entered into an exclusive global license and collaboration agreement (the &#x201c;UT License Agreement&#x201d;), pursuant to which UT is responsible for global development, regulatory and commercial activities with respect to Tyvaso DPI. The Company is responsible for manufacturing clinical supplies and commercial supplies of Tyvaso DPI.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from UT for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT CSA Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT License Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties &#x2014; Collaborations &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue from UT&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,851&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of royalties associated with the UT License Agreement. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;margin-left:3.12%;text-indent:1.13%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The current portion of contract assets related to the royalties is included in prepaid expense and other current assets in the consolidated balance sheets.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the UT License Agreement, the Company received an upfront payment of $45.0 million in October 2018 and four $12.5 million milestone payments between April 2019 and November 2020. The Company will also be entitled to receive low double-digit royalties on net sales of Tyvaso DPI as well as a manufacturing margin on commercial supplies of the product. UT, at its option, may expand the scope of the products covered by the UT License Agreement to include products with certain other active ingredients for the treatment of pulmonary arterial hypertension. Each such optioned product would be subject to UT&#x2019;s payment to the Company of up to $40.0 million in additional option exercise and development milestone payments, as well as a low double-digit royalty on net sales of any such product. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the inception of the agreement, the Company identified one distinct, performance obligation. The Company determined that the key deliverables include the license, supply of product to be used in clinical development, and certain research services upon achievement of specified development targets (&#x201c;R&amp;amp;D Services&#x201d;). Due to the specialized and unique nature of these services and their direct relationship with the license, the Company has determined that these deliverables represent one distinct bundle and thus, one performance obligation. The Company also determined that UT&#x2019;s option to expand the scope of the products to include products with other active ingredients is not a material right, and thus, not a performance obligation at the onset of the agreement. The consideration for the option will be accounted for upon exercise of the option.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company expected to complete the activities specified in the initial development plan and to achieve the milestone events by December 31, 2021 for total consideration of approximately $105.8 million, which included an upfront payment, four milestone payments, various pass-through costs and payments for clinical supplies. Revenue was allocated as follows:&#160;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allocation of Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sep 2018 - Dec 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Recognition period represents the estimated period to satisfy the performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2021, UT and the Company updated the development plan under the UT License Agreement to provide for additional process-development and stability-testing activities as well as the expansion of the Company&#x2019;s commercial manufacturing capacity. The activities and deliverables under the current development plan resulted in four distinct performance obligations which include: (1) the continued development and approval process for an NDA (&#x201c;R&amp;amp;D Services&#x201d;); (2) certain pre-commercial services in preparation for commercial launch of Tyvaso DPI (&#x201c;Pre-Commercial Services&#x201d;); (3) development activities for the next generation of Tyvaso DPI (&#x201c;Next-Gen R&amp;amp;D Services&#x201d;); and (4) certain design and construction activities in anticipation of expansion of the Company&#x2019;s commercial manufacturing facility (&#x201c;Facility Expansion Services&#x201d;).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;T&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;he total consideration for the updated development plan of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$50.9&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million was allocated to the four distinct performance obligations based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reve&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;nue was allocated as follows:&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allocation of Price&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total transaction price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;May 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pre-Commercial Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Facility Expansion Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="16" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the estimated period when the R&amp;amp;D Services performance obligation will be substantially complete.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Pre-Commercial Services and Next-Gen R&amp;amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2021, the Company and UT entered into a commercial supply agreement (as amended, the &#x201c;CSA&#x201d;), pursuant to which the Company is responsible for manufacturing and supplying to UT, and UT is responsible for purchasing from the Company on a cost-plus basis, Tyvaso DPI and BluHale inhalation profiling devices, as required for commercial distribution and sale by UT. In addition, UT is responsible for supplying treprostinil at its expense in quantities necessary to enable the Company to manufacture Tyvaso DPI as required by the CSA. Also pursuant to the CSA, UT will remit a reimbursement of certain pre-production costs incurred by the Company to support the manufacturing and supply of Tyvaso DPI.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The activities and deliverables under the CSA and the current development plan resulted in three distinct performance obligations which include: (1) the license, supply of product to be used in clinical development, and continued development and approval support for Tyvaso DPI (&#x201c;R&amp;amp;D Services and License&#x201d;); (2) development activities for the next generation of Tyvaso DPI (&#x201c;Next-Gen R&amp;amp;D Services&#x201d;); and (3) a material right associated with current and future commercial manufacturing and supply of product (&#x201c;Manufacturing Services&#x201d;). &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The total revised anticipated cash flows of $221.5 million from the transaction was allocated to the three distinct performance obligations as follows. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;221.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;206.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the estimated period when the R&amp;amp;D Services performance obligation will be substantially complete.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Next-Gen R&amp;amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As amended , the term of the CSA continues until December 31, 2031 (unless earlier terminated) and is thereafter renewed automatically for additional, successive two-year terms unless (i) United Therapeutics provides notice to the Company at least 24 months in advance of such renewal that United Therapeutics does not wish to renew the CSA or (ii) the Company provides notice to United Therapeutics at least 48 months in advance of such renewal that the Company does not wish to renew the CSA. The Company and United Therapeutics each have normal and customary termination rights, including termination for material breach that is not cured within a specific timeframe or in the event of liquidation, bankruptcy or insolvency of the other party.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounted for the contract modification as if it were part of the existing contract since the amendment modified the scope and price of the CSA by extending the term and increasing the occupancy rate. The effect of the modification on the transaction price and on the measure of progress is recognized as an adjustment to revenue as of the date of the modification. The modification did not result in a change the activities and deliverables under the CSA. The total revised anticipated cash flows of $463.5 million from the transaction was allocated to the three distinct performance obligations as follows. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;463.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(6)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(7)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;458.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(8)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the period when the revenue for the R&amp;amp;D Services performance obligation was recognized.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The standalone selling price (&#x201c;SSP&#x201d;) for the Next-Gen R&amp;amp;D Services performance obligation was based on industry ratios as well as the Company&#x2019;s historical R&amp;amp;D projects. The transaction price for the Next-Gen R&amp;amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(6)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Next-Gen R&amp;amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(7)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#x2019;s Manufacturing Services performance obligation, given the nature of the Company&#x2019;s contractual responsibilities and ASC 606 requirements.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(8)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#x2019;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received&lt;/span&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2022,&#160;the Company and UT agreed to fund $2.3 million in capital improvements to support commercialization and continuous improvement activities and $0.7 million in the development of alternative manufacturing processes. The Company determined that the capital improvements and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&amp;amp;D Services and as such no additional performance obligations were noted. &lt;span style="color:#000000;"&gt;The total revised anticipated cash flows of $483.2 million from the transaction was allocated to the three distinct performance obligations as follows.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;483.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Product Sales&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;477.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.26%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.68%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.02%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The total anticipated cash flow includes a transaction price of $71.5 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;amp;D Services performance obligations and $411.7 million for future supply of Tyvaso DPI over the remaining term of the CSA.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#x2019;s estimated production of product in the amount of $150.2 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2022,&#160;the Company and UT agreed to fund an additional $39.5 million to support capital and continuous improvement activities and $2.3 million in the development of alternative manufacturing processes. The Company determined that the capital and continuous improvements should be combined with the manufacturing services performance obligation and the alternative manufacturing processes should be combined with the Next-Gen R&amp;amp;D Services. &lt;span style="color:#000000;"&gt;The total revised anticipated cash flows of $722.3 million from the transaction was allocated to the three distinct performance obligations as follows.&lt;/span&gt; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;722.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services and&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; Product Sales&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;712.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#160;&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;__________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The total anticipated cash flow includes a transaction price of $120.0 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;amp;D Services performance obligations and $602.3 million for future supply of Tyvaso DPI over the remaining term of the CSA.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to UT. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#x2019;s estimated production of product in the amount of $220.8 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The ultimate cash flows may vary as manufacturing purchase orders are received.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, deferred revenue consisted of $37.9 million, of which $1.6 million was classified as current and $36.3 million was classified as long-term on the consolidated balance sheet. As of December 31, 2021, deferred revenue consisted of $18.6 million, of which $0.6 million was classified as current and $18.0 million was classified as long-term on the consolidated balance sheet.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Vertice Pharma Co-Promotion Agreement&lt;span style="font-style:normal;"&gt; &#x2014; In December 2020, the Company entered into a co-promotion agreement with Vertice Pharma pursuant to which the Company&#x2019;s sales force promoted Thyquidity to healthcare providers who treat hypothyroidism. Vertice Pharma was obligated to pay fixed quarterly payments to the Company, as well as variable consideration based on gross profits resulting from all sales of Thyquidity. Vertice Pharma launched Thyquidity in collaboration with the Company in February 2021.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At inception of the agreement, the Company identified a single performance obligation that the Company will satisfy over time. The Company estimated the total transaction price was approximately $6.3 million, consisting of fixed consideration and the unconstrained amount of estimated variable consideration, which was based on gross profit applied to defined revenue benchmarks. The amount of variable consideration was constrained to the amount for which it was probable that a significant reversal of cumulative revenue recognized will not occur and the payments will be received. At the end of each subsequent reporting period, the Company re-evaluated the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusted its estimate of the overall transaction price. Any such adjustments were recorded on a cumulative catch-up basis in the period of adjustment. The total transaction price was recognized over a &lt;span style="-sec-ix-hidden:F_001143"&gt;two-year&lt;/span&gt; period during which the Company was required to satisfy its performance obligation, using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponded with, and thereby best depicts, the transfer of control to the customer. In July 2021, the Company and Vertice Pharma entered into an amendment to the Vertice Pharma Co-Promotion Agreement that modified the terms of payment where 50% of the previously fixed consideration was subject to certain promotional conditions, resulting in variable consideration.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In September 2021, the Company and Vertice Pharma mutually agreed that the Company would cease promotional activities under the co-promotion agreement effective September 30, 2021, other than certain transitional activities that continued until October 15, 2021. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2021, the Company fully reserved $0.8 million of revenue from the co-promotion of Thyquidity, which was recognized as allowance for credit losses &#x2013; collaborations and services, which is included in accounts receivable, net in the consolidated balance sheet. In addition, the Company recognized an impairment on contract assets of $0.1 million related to variable consideration from gross profits which was recognized during the year ended December 31, 2021. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2022, the Company and Vertice Pharma reached a final settlement of all obligations related to the termination of the co-promotion agreement of $0.3 million, which was recognized as revenue from collaboration and services in the Company&#x2019;s consolidated statement of operations and the balance was written off against the reserve.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Thirona Collaboration Agreement&lt;span style="font-style:normal;"&gt; &#x2014; In June 2021, the Company and Thirona entered into a collaboration agreement to evaluate the therapeutic potential of Thirona&#x2019;s compound for the treatment of pulmonary fibrosis. If initial studies are promising, the Company can exercise certain rights to seek a full license to the compound for clinical development and commercialization. The parties will perform their respective obligations and provide reasonable support for research, clinical development and regulatory strategy. The collaboration agreement will be accounted for under ASC 808, Collaborative Agreements; however, no consideration will be exchanged between the parties. The Company will expense the costs incurred as research and development in the consolidated statements of operations. In December 2022, the Company and Thirona extended the collaboration agreement through February 28, 2023.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Biomm Supply and Distribution Agreement&lt;span style="font-style:normal;"&gt; &#x2014; In May 2017, the Company and Biomm S.A. (&#x201c;Biomm&#x201d;) entered into a supply and distribution agreement for the commercialization of Afrezza in Brazil. Under this agreement, Biomm was responsible for pursuing regulatory approvals of Afrezza in Brazil, including from the ANVISA and, with respect to pricing matters, from the Camara de Regula&#xe7;&#xe3;o de Mercado de Medicamentos (&#x201c;CMED&#x201d;), both of which have&#160;&#160;been received. Biomm commenced product sales in January 2020. During the year ended December 31, 2020, the Company sold $0.2 million of product to Biomm. No shipments of product were made to Biomm during the years ended December 31, 2022 and 2021.&lt;/span&gt;&lt;span style="font-size:12pt;font-style:normal;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cipla License and Distribution Agreement &lt;span style="font-style:normal;"&gt;&#x2014; In May 2018, the Company and Cipla Ltd. (&#x201c;Cipla&#x201d;) entered into an exclusive agreement for the marketing and distribution of Afrezza in India and the Company received a $2.2&lt;/span&gt;&lt;span style="font-size:12pt;font-style:normal;"&gt; &lt;/span&gt;&lt;span style="font-style:normal;"&gt;million nonrefundable&lt;/span&gt;&lt;span style="font-size:12pt;font-style:normal;"&gt; &lt;/span&gt;&lt;span style="font-style:normal;"&gt;license fee. Under the terms of the agreement, Cipla is responsible for obtaining regulatory approvals to distribute Afrezza in India and for all marketing and sales activities of Afrezza in India. The Company is responsible for supplying Afrezza to Cipla. The Company has the potential to receive an additional regulatory milestone payment,&lt;/span&gt;&lt;span style="font-size:12pt;font-style:normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-style:normal;"&gt;minimum purchase commitment revenue and royalties on Afrezza sales in India once cumulative gross sales have reached a specified threshold.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The nonrefundable licensing fee was recorded in deferred revenue and is being recognized in net revenue &#x2013; collaborations over 15 years, representing the estimated period to satisfy the performance obligation. The additional milestone payments represent variable consideration for which the Company has not recognized any revenue because of the uncertainty of obtaining marketing approval. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, the deferred revenue balance was $1.5 million, of which $0.1 million is classified as current and $1.4 million is classified as long term in the consolidated balance sheets. As of December 31, 2021, the deferred revenue balance was $1.7 million, of which $0.1 million is classified as current and $1.6 million is classified as long term in the consolidated balance sheets.&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000558">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from collaborations and services for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands): &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT CSA Agreement&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt; (1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT License Agreement&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt; (2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vertice Pharma Co-Promotion Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;325&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cipla License and Distribution Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Receptor CLA&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT Research Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;210&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue from collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of revenue recognized for Next-Gen R&amp;amp;D Services and R&amp;amp;D Services and License for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001028"
      unitRef="U_iso4217USD">24826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001029"
      unitRef="U_iso4217USD">267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001030"
      unitRef="U_iso4217USD">2426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001031"
      unitRef="U_iso4217USD">34145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231"
      decimals="-3"
      id="F_001032"
      unitRef="U_iso4217USD">32213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001033"
      unitRef="U_iso4217USD">325000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdVerticePharmaLLCMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001034"
      unitRef="U_iso4217USD">1147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001035"
      unitRef="U_iso4217USD">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdOtherAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001036"
      unitRef="U_iso4217USD">323000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001037"
      unitRef="U_iso4217USD">147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001038"
      unitRef="U_iso4217USD">147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20200101_20201231"
      decimals="-3"
      id="F_001039"
      unitRef="U_iso4217USD">147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001040"
      unitRef="U_iso4217USD">245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdReceptorLifeScienceIncMember_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20200101_20201231"
      decimals="-3"
      id="F_001041"
      unitRef="U_iso4217USD">250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdResearchAgreementMember_20200101_20201231"
      decimals="-3"
      id="F_001042"
      unitRef="U_iso4217USD">210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20220101_20221231"
      decimals="-3"
      id="F_001043"
      unitRef="U_iso4217USD">27924000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20210101_20211231"
      decimals="-3"
      id="F_001044"
      unitRef="U_iso4217USD">36274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_20200101_20201231"
      decimals="-3"
      id="F_001045"
      unitRef="U_iso4217USD">32820000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mnkd:ContractWithCustomerLiabilityTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000559">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The activity related to deferred revenue and the related revenue recognized for collaborations and services is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,937&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46,971&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,707&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue &#x2014; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27,924&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(36,274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ending balance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,417&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</mnkd:ContractWithCustomerLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001046"
      unitRef="U_iso4217USD">20370000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_001047"
      unitRef="U_iso4217USD">34937000</us-gaap:ContractWithCustomerLiability>
    <mnkd:ContractWithCustomerLiabilityAdditions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001048"
      unitRef="U_iso4217USD">46971000</mnkd:ContractWithCustomerLiabilityAdditions>
    <mnkd:ContractWithCustomerLiabilityAdditions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001049"
      unitRef="U_iso4217USD">21707000</mnkd:ContractWithCustomerLiabilityAdditions>
    <mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001050"
      unitRef="U_iso4217USD">-27924000</mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue>
    <mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001051"
      unitRef="U_iso4217USD">-36274000</mnkd:ContractWithCustomerLiabilityCollaborationsAndServicesRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001052"
      unitRef="U_iso4217USD">39417000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001053"
      unitRef="U_iso4217USD">20370000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231"
      id="F_000560">
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from UT for the years ended December 31, 2022, 2021 and 2020 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT Revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT CSA Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,826&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;UT License Agreement&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,145&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties &#x2014; Collaborations &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,599&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue from UT&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42,851&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,412&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Amount consists of royalties associated with the UT License Agreement. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;margin-left:3.12%;text-indent:1.13%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The current portion of contract assets related to the royalties is included in prepaid expense and other current assets in the consolidated balance sheets.&lt;/p&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001054"
      unitRef="U_iso4217USD">24826000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001055"
      unitRef="U_iso4217USD">267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231"
      decimals="-3"
      id="F_001056"
      unitRef="U_iso4217USD">2426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20210101_20211231"
      decimals="-3"
      id="F_001057"
      unitRef="U_iso4217USD">34145000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20200101_20201231"
      decimals="-3"
      id="F_001058"
      unitRef="U_iso4217USD">32213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdRoyaltiesArrangementMember_20220101_20221231"
      decimals="-3"
      id="F_001059"
      unitRef="U_iso4217USD">15599000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220101_20221231"
      decimals="-3"
      id="F_001060"
      unitRef="U_iso4217USD">42851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20210101_20211231"
      decimals="-3"
      id="F_001061"
      unitRef="U_iso4217USD">34412000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20200101_20201231"
      decimals="-3"
      id="F_001062"
      unitRef="U_iso4217USD">32213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mnkd:UpfrontPaymentReceived
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20181031"
      decimals="-5"
      id="F_001063"
      unitRef="U_iso4217USD">45000000.0</mnkd:UpfrontPaymentReceived>
    <mnkd:MilestonePaymentReceived
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20190401_20201130"
      decimals="-5"
      id="F_001064"
      unitRef="U_iso4217USD">12500000</mnkd:MilestonePaymentReceived>
    <mnkd:AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="INF"
      id="F_001065"
      unitRef="U_iso4217USD">40000000.0</mnkd:AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001066"
      unitRef="U_iso4217USD">105800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000561">Revenue was allocated as follows:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allocation of Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Period&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;105.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Sep 2018 - Dec 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Recognition period represents the estimated period to satisfy the performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transaction Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allocation of Price&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total transaction price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;May 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pre-Commercial Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Facility Expansion Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td colspan="16" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the estimated period when the R&amp;amp;D Services performance obligation will be substantially complete.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Pre-Commercial Services and Next-Gen R&amp;amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001067"
      unitRef="U_iso4217USD">105800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="2"
      id="F_001068"
      unitRef="U_xbrlipure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001069">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapContractWithCustomerDurationAxis_mnkdClinicalSuppliesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001070">Sep 2018 - Dec 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001071"
      unitRef="U_iso4217USD">50900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_20211031"
      decimals="-5"
      id="F_001072"
      unitRef="U_iso4217USD">50900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031"
      decimals="-5"
      id="F_001073"
      unitRef="U_iso4217USD">18400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001077">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001080">May 2021 - Oct 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031"
      decimals="-5"
      id="F_001074"
      unitRef="U_iso4217USD">4600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001078">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001081">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031"
      decimals="-5"
      id="F_001075"
      unitRef="U_iso4217USD">7200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001079">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031_20211031"
      id="F_001082">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031"
      decimals="-5"
      id="F_001076"
      unitRef="U_iso4217USD">20700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdFacilityExpansionServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_20211031_20211031"
      id="F_001083">Transfer of control</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_0000899460_20211031_20211031"
      decimals="-5"
      id="F_001084"
      unitRef="U_iso4217USD">5000000.0</us-gaap:ProceedsFromRelatedPartyDebt>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210831"
      decimals="-5"
      id="F_001085"
      unitRef="U_iso4217USD">221500000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000562">
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:28%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.18%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;221.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.9%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;206.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.6%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.66%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the estimated period when the R&amp;amp;D Services performance obligation will be substantially complete.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Next-Gen R&amp;amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</mnkd:ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812"
      decimals="-5"
      id="F_001086"
      unitRef="U_iso4217USD">221500000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812"
      decimals="-5"
      id="F_001087"
      unitRef="U_iso4217USD">6000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812"
      id="F_001090">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812"
      id="F_001092">Aug 2021 - Oct 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812"
      decimals="-5"
      id="F_001088"
      unitRef="U_iso4217USD">8800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812"
      id="F_001091">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812"
      id="F_001093">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812"
      decimals="-5"
      id="F_001089"
      unitRef="U_iso4217USD">206700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812_20210812"
      id="F_001094">Transfer of control</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210101_20211231"
      decimals="INF"
      id="F_001095"
      unitRef="U_iso4217USD">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <mnkd:AgreementAmendmentDescription
      contextRef="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCommercialSupplyAgreementMember_20220101_20221231"
      id="F_001096">As amended , the term of the CSA continues until December 31, 2031 (unless earlier terminated) and is thereafter renewed automatically for additional, successive two-year terms unless (i) United Therapeutics provides notice to the Company at least 24 months in advance of such renewal that United Therapeutics does not wish to renew the CSA or (ii) the Company provides notice to United Therapeutics at least 48 months in advance of such renewal that the Company does not wish to renew the CSA.</mnkd:AgreementAmendmentDescription>
    <mnkd:ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000563">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounted for the contract modification as if it were part of the existing contract since the amendment modified the scope and price of the CSA by extending the term and increasing the occupancy rate. The effect of the modification on the transaction price and on the measure of progress is recognized as an adjustment to revenue as of the date of the modification. The modification did not result in a change the activities and deliverables under the CSA. The total revised anticipated cash flows of $463.5 million from the transaction was allocated to the three distinct performance obligations as follows. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:27.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Anticipated&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Description&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash Flow&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Allocation&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition Method&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Progress Measure&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.54%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recognition&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:4.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.16%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total anticipated cash flow&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;463.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Distinct Performance Obligation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;R&amp;amp;D Services and License&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Ratably&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aug 2021 - Oct 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Next-Gen R&amp;amp;D Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(5)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Over time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Input&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% of completion of costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(6)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.96%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Services&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(7)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.44%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;white-space:nowrap;" valign="top"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;458.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.58%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Point in time&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.46%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.64%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Transfer of control&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.08%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(8)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Represents the period when the revenue for the R&amp;amp;D Services performance obligation was recognized.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The standalone selling price (&#x201c;SSP&#x201d;) for the Next-Gen R&amp;amp;D Services performance obligation was based on industry ratios as well as the Company&#x2019;s historical R&amp;amp;D projects. The transaction price for the Next-Gen R&amp;amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(6)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Next-Gen R&amp;amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(7)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#x2019;s Manufacturing Services performance obligation, given the nature of the Company&#x2019;s contractual responsibilities and ASC 606 requirements.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(8)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#x2019;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received&lt;/span&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mnkd:ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001097"
      unitRef="U_iso4217USD">463500000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001098"
      unitRef="U_iso4217USD">463500000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      id="F_001101">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      id="F_001103">Aug 2021 - Oct 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001099"
      unitRef="U_iso4217USD">4800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      id="F_001102">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      id="F_001104">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001100"
      unitRef="U_iso4217USD">458700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      id="F_001105">Transfer of control</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001106"
      unitRef="U_iso4217USD">64300000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016"
      decimals="-5"
      id="F_001107"
      unitRef="U_iso4217USD">399200000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:AllocatedTransactionPrice
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211016_20211016"
      decimals="-5"
      id="F_001108"
      unitRef="U_iso4217USD">144500000</mnkd:AllocatedTransactionPrice>
    <us-gaap:PaymentsForCapitalImprovements
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430"
      decimals="-5"
      id="F_001116"
      unitRef="U_iso4217USD">2300000</us-gaap:PaymentsForCapitalImprovements>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20220401_20220430"
      decimals="-5"
      id="F_001117"
      unitRef="U_iso4217USD">700000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <mnkd:AllocatedTransactionPrice
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      decimals="-5"
      id="F_001115"
      unitRef="U_iso4217USD">483200000</mnkd:AllocatedTransactionPrice>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430"
      decimals="-5"
      id="F_001118"
      unitRef="U_iso4217USD">483200000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      id="F_001121">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      id="F_001123">Aug 2021 - Oct 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430"
      decimals="-5"
      id="F_001119"
      unitRef="U_iso4217USD">5900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      id="F_001122">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      id="F_001124">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430"
      decimals="-2"
      id="F_001120"
      unitRef="U_iso4217USD">477200</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220401_20220430"
      id="F_001125">Transfer of control</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430"
      decimals="-5"
      id="F_001126"
      unitRef="U_iso4217USD">71500000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220430"
      decimals="-5"
      id="F_001127"
      unitRef="U_iso4217USD">411700000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:PaymentsForCapitalImprovements
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdCommercializationAndContinuousImprovementActivitiesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231"
      decimals="-5"
      id="F_001129"
      unitRef="U_iso4217USD">39500000</us-gaap:PaymentsForCapitalImprovements>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231"
      decimals="-5"
      id="F_001130"
      unitRef="U_iso4217USD">2300000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <mnkd:AllocatedTransactionPrice
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221201_20221231"
      decimals="-5"
      id="F_001128"
      unitRef="U_iso4217USD">722300000</mnkd:AllocatedTransactionPrice>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001131"
      unitRef="U_iso4217USD">722300000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001134">Ratably</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001136">Aug 2021 - Oct 2021</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001132"
      unitRef="U_iso4217USD">10000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001135">Input</us-gaap:RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001137">% of completion of costs</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-2"
      id="F_001133"
      unitRef="U_iso4217USD">712300</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredAtPointInTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20220101_20221231"
      id="F_001138">Transfer of control</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForTheContractualObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001139"
      unitRef="U_iso4217USD">120000000.0</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow
      contextRef="C_0000899460_srtProductOrServiceAxis_mnkdNextGenResearchAndDevelopmentServicesMember_us-gaapLossContingenciesByNatureOfContingencyAxis_mnkdTransactionPriceForThePerformanceObligationsMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001140"
      unitRef="U_iso4217USD">602300000</mnkd:RevenueRemainingPerformanceObligationAnticipatedCashFlow>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231"
      decimals="-5"
      id="F_001110"
      unitRef="U_iso4217USD">37900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231"
      decimals="-5"
      id="F_001112"
      unitRef="U_iso4217USD">1600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20211231"
      decimals="-5"
      id="F_001114"
      unitRef="U_iso4217USD">36300000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001109"
      unitRef="U_iso4217USD">18600000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001111"
      unitRef="U_iso4217USD">600000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20221231"
      decimals="-5"
      id="F_001113"
      unitRef="U_iso4217USD">18000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20221231"
      decimals="-5"
      id="F_001141"
      unitRef="U_iso4217USD">6300000</us-gaap:RevenueRemainingPerformanceObligation>
    <mnkd:PercentageOfModificationOfPreviouslyFixedConsideration
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdVerticePharmaLLCMember_us-gaapTypeOfArrangementAxis_mnkdAmendmentToCoPromotionAgreementMember_20210701_20210701"
      decimals="2"
      id="F_001142"
      unitRef="U_xbrlipure">0.50</mnkd:PercentageOfModificationOfPreviouslyFixedConsideration>
    <us-gaap:ContractWithCustomerReceivableAllowanceForCreditLoss
      contextRef="C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20211231"
      decimals="-5"
      id="F_001144"
      unitRef="U_iso4217USD">800000</us-gaap:ContractWithCustomerReceivableAllowanceForCreditLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="C_0000899460_us-gaapTypeOfArrangementAxis_mnkdCoPromotionAgreementMember_20210101_20211231"
      decimals="-5"
      id="F_001145"
      unitRef="U_iso4217USD">100000</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_001148"
      unitRef="U_iso4217USD">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20210101_20211231"
      decimals="INF"
      id="F_001147"
      unitRef="U_iso4217USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdBiommSAMember_srtProductOrServiceAxis_us-gaapProductMember_us-gaapTypeOfArrangementAxis_mnkdSupplyAndDistributionAgreementMember_20220101_20221231"
      decimals="INF"
      id="F_001146"
      unitRef="U_iso4217USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mnkd:DateOfAgreementInitiationForMarketingAndDistribution
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180501_20180531"
      id="F_001149">2018-05</mnkd:DateOfAgreementInitiationForMarketingAndDistribution>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531"
      decimals="-5"
      id="F_001150"
      unitRef="U_iso4217USD">2200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531"
      id="F_001151">P15Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231"
      decimals="-5"
      id="F_001153"
      unitRef="U_iso4217USD">1500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231"
      decimals="-5"
      id="F_001155"
      unitRef="U_iso4217USD">100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20221231"
      decimals="-5"
      id="F_001157"
      unitRef="U_iso4217USD">1400000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231"
      decimals="-5"
      id="F_001152"
      unitRef="U_iso4217USD">1700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231"
      decimals="-5"
      id="F_001154"
      unitRef="U_iso4217USD">100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20211231"
      decimals="-5"
      id="F_001156"
      unitRef="U_iso4217USD">1600000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000500">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;12. Fair Value of Financial Instruments &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The availability of observable inputs can vary among the various types of financial assets and liabilities. To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for financial statement disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is categorized is based on the lowest level input that is significant to the overall fair value measurement. The Company uses the exit price method for estimating the fair &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;value of loans for disclosure purposes.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy, as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1 &#x2014; Quoted prices for identical instruments in active markets.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2 &#x2014; Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;margin-left:4.25%;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3 &#x2014; Significant inputs to the valuation model are unobservable.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The carrying amounts reported in the accompanying consolidated financial statements for cash, accounts receivable, accounts payable, and accrued expenses and other current liabilities (excluding the Milestone Rights liability) approximate their fair value due to their relatively short maturities. The fair value of the cash equivalents, long- and short-term investments, &lt;span style="color:#000000;"&gt;MidCap credit facility, &lt;/span&gt;Mann Group promissory notes, 2024 convertible notes, Senior convertible notes, &lt;span style="color:#000000;"&gt;Milestone Rights liabilities&lt;/span&gt; and Financing liability are disclosed below (amounts in millions).&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Cash Equivalents &lt;span style="font-style:normal;"&gt;&#x2014; Cash equivalents consist of highly liquid investments with original or remaining maturities of 90 days or less at the time of purchase that are readily convertible into cash. As of December 31, 2022 and 2021, the Company held $69.8 million and $124.2 million, respectively, of cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Financial Liabilities&lt;span style="font-style:normal;"&gt; &#x2014; The following tables set forth the fair value of the Company&#x2019;s financial instruments (Level 3 in the fair value hierarchy) (in millions):&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unobservable&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inputs&#160;(Level 3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;225.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;253.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;253.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone rights&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent milestone liability &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined&lt;/span&gt; by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 13%, volatility of 75.8% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $245.0 million and $263.4 million, respectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 12%. A change in yield of + or &#x2013; 2% would result in a fair value of $40.0 million and $42.4 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:10pt;color:#000000;"&gt;The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of $22.1 million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2022 was determined by applying a discounted cash flow analysis with a hypothetical yield of 13% and volatility of 77.8% to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $20.5 million and $21.2 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a Monte Carlo simulation. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unobservable&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inputs&#160;(Level 3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;237.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;237.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;__________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined&lt;/span&gt; by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 12%, volatility of 90% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $226.6 million and $249.4 million, respectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 10%. A change in yield of + or &#x2013; 2% would result in a fair value of $39.1 million and $42.7 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="text-decoration:none;Background-color:#auto;font-size:7pt;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$22.1&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$22.1&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2021 was determined by applying a discounted cash flow analysis with a hypothetical yield of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;12%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; and volatility of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;85%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#x2013; &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;2%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; would result in a fair value of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$36.9&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million and &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$38.8&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a Monte Carlo simulation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights Liability&lt;span style="font-style:normal;"&gt; &#x2014; The fair value measurement of the Milestone Rights liability is sensitive to the discount rate and the timing of achievement of milestones. The Company utilized Monte-Carlo Simulation Method to simulate the Afrezza net sales under a neutral framework to estimate the payment. The Company then discounted the future expected payments at cost of debt with a term equal to the simulated time to payout based on cumulative sales.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Contingent milestone liability&lt;span style="font-style:normal;"&gt; &#x2014; The acquisition of V-Go in May 2022 resulted in a contingent milestone liability which could result in obligations to the seller if certain revenue thresholds are met. The initial fair value of the contingent milestone liability was recorded as an adjustment to the purchase price. Subsequent changes in the fair value are reported in general and administrative expenses.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Financing Liability&lt;span style="font-style:normal;"&gt; &#x2014; The failed Sale Leaseback Transaction in November 2021 resulted in a financing liability which is included in the Company&#x2019;s&#160;&#160;consolidated balance sheets as a current financing liability of $9.6 million and a long-term financing liability of $94.5 million. &lt;/span&gt;&lt;span style="Background-color:#FFFFFF;color:#000000;font-style:normal;"&gt;The fair value of $103.2 million was determined using level 3 inputs. As of December 31, 2022, the fair value was determined using a discounted cash flow analysis with a hypothetical yield of 10%. As December 31, 2021, the Company evaluated the fair value of its financing liability and determined that the fair value approximates the carrying value.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20221231"
      decimals="-5"
      id="F_001158"
      unitRef="U_iso4217USD">69800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0000899460_us-gaapCashAndCashEquivalentsAxis_us-gaapMoneyMarketFundsMember_20211231"
      decimals="-5"
      id="F_001159"
      unitRef="U_iso4217USD">124200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000564">The following tables set forth the fair value of the Company&#x2019;s financial instruments (Level 3 in the fair value hierarchy) (in millions):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying Amount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unobservable&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inputs&#160;(Level 3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;225.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;253.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;253.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;41.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone rights&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contingent milestone liability &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined&lt;/span&gt; by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 13%, volatility of 75.8% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $245.0 million and $263.4 million, respectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 12%. A change in yield of + or &#x2013; 2% would result in a fair value of $40.0 million and $42.4 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:10pt;color:#000000;"&gt;The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of $22.1 million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2022 was determined by applying a discounted cash flow analysis with a hypothetical yield of 13% and volatility of 77.8% to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $20.5 million and $21.2 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a Monte Carlo simulation. &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Significant&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unobservable&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inputs&#160;(Level 3)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total Fair Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;237.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;237.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;MidCap credit facility &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible note&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(3)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;37.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(4)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;__________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined&lt;/span&gt; by applying a discounted cash flow analysis to the straight note with a hypothetical yield of 12%, volatility of 90% and a Monte Carlo simulation for the value of the conversion feature. A change in yield of + or &#x2013; 2% would result in a fair value of $226.6 million and $249.4 million, respectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a discounted cash flow analysis with a hypothetical yield of 10%. A change in yield of + or &#x2013; 2% would result in a fair value of $39.1 million and $42.7 million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="text-decoration:none;Background-color:#auto;font-size:7pt;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;The April 2021 amendment to the Mann Group convertible note resulted in a substantial premium of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$22.1&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million based on the fair value post modification which was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$22.1&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million loss on extinguishment did not result in a change in the financial position of the Company. The fair value assessed as of December 31, 2021 was determined by applying a discounted cash flow analysis with a hypothetical yield of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;12%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; and volatility of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;85%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; to the straight note and a binomial option pricing model for the value of the conversion feature. A change in yield of + or &#x2013; &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;2%&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; would result in a fair value of &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$36.9&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million and &lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;$38.8&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Fair value determined by applying a Monte Carlo simulation.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001160"
      unitRef="U_iso4217USD">225400000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001161"
      unitRef="U_iso4217USD">253900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231"
      decimals="-5"
      id="F_001162"
      unitRef="U_iso4217USD">253900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001163"
      unitRef="U_iso4217USD">39300000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001164"
      unitRef="U_iso4217USD">41100000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_001165"
      unitRef="U_iso4217USD">41100000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001166"
      unitRef="U_iso4217USD">8800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001167"
      unitRef="U_iso4217USD">20800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20221231"
      decimals="-5"
      id="F_001168"
      unitRef="U_iso4217USD">20800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001169"
      unitRef="U_iso4217USD">4800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001170"
      unitRef="U_iso4217USD">12600000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_001171"
      unitRef="U_iso4217USD">12600000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001172"
      unitRef="U_iso4217USD">600000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20221231"
      decimals="-5"
      id="F_001173"
      unitRef="U_iso4217USD">1000000.0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdContingentMilestoneLiabilityMember_20221231"
      decimals="-5"
      id="F_001174"
      unitRef="U_iso4217USD">1000000.0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231"
      decimals="INF"
      id="F_001175"
      unitRef="U_xbrlipure">13</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231"
      decimals="INF"
      id="F_001178"
      unitRef="U_xbrlipure">75.8</us-gaap:DebtInstrumentMeasurementInput>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20220101_20221231"
      decimals="INF"
      id="F_001180"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231"
      decimals="-5"
      id="F_001184"
      unitRef="U_iso4217USD">245000000.0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20221231"
      decimals="-5"
      id="F_001187"
      unitRef="U_iso4217USD">263400000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="INF"
      id="F_001176"
      unitRef="U_xbrlipure">12</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20220101_20221231"
      decimals="INF"
      id="F_001181"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_001185"
      unitRef="U_iso4217USD">40000000.0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231"
      decimals="-5"
      id="F_001188"
      unitRef="U_iso4217USD">42400000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231"
      decimals="-5"
      id="F_001183"
      unitRef="U_iso4217USD">-22100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231"
      decimals="-5"
      id="F_001190"
      unitRef="U_iso4217USD">22100000</mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231"
      decimals="INF"
      id="F_001177"
      unitRef="U_xbrlipure">13</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20221231"
      decimals="INF"
      id="F_001179"
      unitRef="U_xbrlipure">77.8</us-gaap:DebtInstrumentMeasurementInput>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231"
      decimals="INF"
      id="F_001182"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231"
      decimals="-5"
      id="F_001186"
      unitRef="U_iso4217USD">20500000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20221231"
      decimals="-5"
      id="F_001189"
      unitRef="U_iso4217USD">21200000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001191"
      unitRef="U_iso4217USD">223900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001192"
      unitRef="U_iso4217USD">237500000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231"
      decimals="-5"
      id="F_001193"
      unitRef="U_iso4217USD">237500000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001194"
      unitRef="U_iso4217USD">38800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001195"
      unitRef="U_iso4217USD">40800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_001196"
      unitRef="U_iso4217USD">40800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001197"
      unitRef="U_iso4217USD">18400000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001198"
      unitRef="U_iso4217USD">37800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMannGroupConvertibleNoteMember_20211231"
      decimals="-5"
      id="F_001199"
      unitRef="U_iso4217USD">37800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByMeasurementBasisAxis_us-gaapCarryingReportedAmountFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001200"
      unitRef="U_iso4217USD">5900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementBasisAxis_us-gaapEstimateOfFairValueFairValueDisclosureMember_20211231"
      decimals="-5"
      id="F_001201"
      unitRef="U_iso4217USD">18100000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdMilestoneRightsLiabilityMember_20211231"
      decimals="-5"
      id="F_001202"
      unitRef="U_iso4217USD">18100000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231"
      decimals="INF"
      id="F_001203"
      unitRef="U_xbrlipure">12</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231"
      decimals="INF"
      id="F_001206"
      unitRef="U_xbrlipure">90</us-gaap:DebtInstrumentMeasurementInput>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20210101_20211231"
      decimals="INF"
      id="F_001208"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231"
      decimals="-5"
      id="F_001212"
      unitRef="U_iso4217USD">226600000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_us-gaapSeniorNotesMember_20211231"
      decimals="-5"
      id="F_001215"
      unitRef="U_iso4217USD">249400000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="INF"
      id="F_001204"
      unitRef="U_xbrlipure">10</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210101_20211231"
      decimals="INF"
      id="F_001209"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_001213"
      unitRef="U_iso4217USD">39100000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211231"
      decimals="-5"
      id="F_001216"
      unitRef="U_iso4217USD">42700000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231"
      decimals="-5"
      id="F_001218"
      unitRef="U_iso4217USD">22100000</mnkd:SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231"
      decimals="-5"
      id="F_001211"
      unitRef="U_iso4217USD">-22100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231"
      decimals="INF"
      id="F_001205"
      unitRef="U_xbrlipure">12</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputPriceVolatilityMember_20211231"
      decimals="INF"
      id="F_001207"
      unitRef="U_xbrlipure">85</us-gaap:DebtInstrumentMeasurementInput>
    <mnkd:NotePayablePercentageOfInterestRateChange
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231"
      decimals="INF"
      id="F_001210"
      unitRef="U_xbrlipure">0.02</mnkd:NotePayablePercentageOfInterestRateChange>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231"
      decimals="-5"
      id="F_001214"
      unitRef="U_iso4217USD">36900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMannGroupConvertibleNoteMember_20211231"
      decimals="-5"
      id="F_001217"
      unitRef="U_iso4217USD">38800000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_0000899460_20211130"
      decimals="-5"
      id="F_001220"
      unitRef="U_iso4217USD">9600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20211130"
      decimals="-5"
      id="F_001219"
      unitRef="U_iso4217USD">94500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0000899460_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20211130"
      decimals="-5"
      id="F_001221"
      unitRef="U_iso4217USD">103200000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <mnkd:DebtInstrumentMeasurementInputAfterChange
      contextRef="C_0000899460_20221231"
      decimals="2"
      id="F_001222"
      unitRef="U_xbrlipure">0.10</mnkd:DebtInstrumentMeasurementInputAfterChange>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000501">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;13. Common and Preferred Stock &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company is authorized to issue 400,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of undesignated preferred stock, par value $0.01 per share, issuable in one or more series as designated by the Company&#x2019;s board of directors. No other class of capital stock is authorized. As of December&#160;31, 2022 and 2021, 263,793,305 and 251,477,562 shares of common stock, respectively, were issued and outstanding and no shares of preferred stock were outstanding. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In &lt;span style="-sec-ix-hidden:F_001235"&gt;February 2018&lt;/span&gt;, the Company entered into a controlled equity offering sales agreement (the &#x201c;CF Sales Agreement&#x201d;) with Cantor Fitzgerald &amp;amp; Co. (&#x201c;Cantor Fitzgerald&#x201d;), as sales agent, pursuant to which the Company may offer and sell, from time to time, through Cantor Fitzgerald, shares of the Company&#x2019;s common stock in such amount &#160;as may be permitted by the Sales Agreement. The original amount of common stock authorized for sale under the CF Sales Agreement was $50.0 million. Under the Sales Agreement, Cantor Fitzgerald may sell shares by any method deemed to be an &lt;span style="color:#000000;"&gt;&#x201c;&lt;/span&gt;at-the-market offering&lt;span style="color:#000000;"&gt;&#x201d;&lt;/span&gt; as defined in Rule 415 under the Securities Act of 1933, as amended. In February 2022, the Company filed a sales agreement prospectus under a registration statement on Form S-3 (File No. 333-262981) covering the sale of up to $50.0 million of common stock through Cantor Fitzgerald under the CF Sales Agreement. For the year ended December 31, 2022, the Company sold 5,059,856 shares of common stock at a weighted average purchase price of $3.91 per share for gross proceeds of approximately $19.8 million pursuant to the CF Sales Agreement. For the year ended December 31, 2021, the Company sold an aggregate of 578,063 shares of the Company&#x2019;s common stock at a weighted average purchase price of $3.26 per share for aggregate gross proceeds of approximately $1.9 million pursuant to the Sales Agreement. &lt;span style="color:#000000;"&gt;For the year ended December 31, 2020, the Company sold an aggregate of 11,851,566 shares of the Company&#x2019;s common stock at a weighted average purchase price of $1.99 per share for&#160;&#160;aggregate gross proceeds of approximately $23.5 million pursuant to the CF Sales Agreement.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2020, the Company prepaid the June 2020 note with the issuance of&#160;1,235,094&#160;shares of the Company&#x2019;s common stock, in accordance with the terms of the June 2020 note. In October 2020, the Company prepaid the December 2020 note with the issuance of&#160;1,377,356&#160;shares of the Company&#x2019;s common stock, in accordance with the terms of the December 2020 note. The number of shares issued for the prepayments in June and October 2020 were determined based on the Company&#x2019;s closing stock price on the day preceding the settlement date. See Note 10 &#x2013;&#160;&lt;span style="font-style:italic;"&gt;Borrowings&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2020, 7,250,000 warrants were exercised at a price of $1.60 per share. The warrants were issued pursuant to an underwriting agreement with Leerink Partners LLC for a public offering of 26,666,667 shares of the Company&#x2019;s common stock and warrants to purchase up to an aggregate of 26,666,667 shares of the Company&#x2019;s common stock. There are no remaining warrants outstanding under this agreement.&lt;/p&gt;
&lt;p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In the fourth quarter of 2020, the Mann Group converted $3.0 million of accrued interest and $7.0 million of principal under the Mann Group convertible note into 1.2 million shares and 2.8 million shares, respectively, of the Company&#x2019;s common stock, in accordance with the terms of the convertible note. &#160;&#160;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2020, the Company issued 111,853 warrants to purchase shares of the Company&#x2019;s common stock in connection with the third amendment to the Midcap Credit Facility. &#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2020, the Company issued 3,067,179 shares of the Company&#x2019;s common stock as consideration for the acquisition of QrumPharma. See Note 3 &#x2013; &lt;span style="font-style:italic;"&gt;Acquisitions&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2021, the Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;converted $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.0&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;principal amount of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024 convertible note&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;s&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; into &lt;/span&gt;1,666,667&lt;span style="color:#000000;"&gt; shares of&lt;/span&gt;&lt;span style="color:#000000;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;"&gt;common stock&lt;/span&gt;&lt;span style="color:#000000;"&gt;. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In October 2021, MidCap exercised 1,171,614 and 111,853 warrants issued in association with Tranches 1 and 2, respectively, under the MidCap credit facility, as amended, to purchase an aggregate of 1,283,467 shares of the Company&#x2019;s common stock through a cashless exercise that resulted in the net issuance of 964,113 shares. See Note 10 &#x2013; &lt;span style="font-style:italic;"&gt;Borrowings&lt;/span&gt;. &lt;/p&gt;
&lt;p style="margin-bottom:12pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 31, 2021, the Mann Group converted $0.4 million of interest and $9.6 million of principal into 4.0 million shares of common stock.&lt;span style="color:#000000;"&gt; &lt;/span&gt;See Note 10 &#x2013;&#160;&lt;span style="font-style:italic;"&gt;Borrowings&lt;/span&gt;. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2021, the Company received $0.1 million from the market price stock purchase plan (&#x201c;MPSPP&#x201d;) for 25,000 shares and a &lt;span style="font-style:italic;"&gt;de minimis&lt;/span&gt; amount during the year ended December 31, 2020.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2022, pursuant to the terms of the Mann Group convertible note, Mann Group converted $10.0 million of principal and capitalized interest into 4,000,000 shares of common stock. In addition, the Company paid quarterly interest payments on the Mann Group convertible note on April 1, 2022, July 1, 2022 and October 1, 2022 by issuing Mann Group an aggregate of 75,487 shares of common stock. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the year ended December 31, 2022, the Company received&#160;$0.7 million from the market price stock purchase plan (&#x201c;MPSPP&#x201d;) for 252,176 shares.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001223"
      unitRef="U_xbrlishares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001224"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001225"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001226"
      unitRef="U_iso4217USD_xbrlishares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001227"
      unitRef="U_xbrlishares">263793305</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001229"
      unitRef="U_xbrlishares">263793305</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_001228"
      unitRef="U_xbrlishares">251477562</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_001230"
      unitRef="U_xbrlishares">251477562</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_001232"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001231"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20180228"
      decimals="-5"
      id="F_001233"
      unitRef="U_iso4217USD">50000000.0</us-gaap:CommonStockValue>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdContolledEquityOfferingSalesAgreementMember_20220201_20220228"
      decimals="-5"
      id="F_001234"
      unitRef="U_iso4217USD">50000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231"
      decimals="INF"
      id="F_001236"
      unitRef="U_xbrlishares">5059856</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20221231"
      decimals="2"
      id="F_001241"
      unitRef="U_iso4217USD_xbrlishares">3.91</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20220101_20221231"
      decimals="-5"
      id="F_001242"
      unitRef="U_iso4217USD">19800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231"
      decimals="INF"
      id="F_001237"
      unitRef="U_xbrlishares">578063</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20211231"
      decimals="2"
      id="F_001239"
      unitRef="U_iso4217USD_xbrlishares">3.26</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20210101_20211231"
      decimals="-5"
      id="F_001243"
      unitRef="U_iso4217USD">1900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231"
      decimals="INF"
      id="F_001238"
      unitRef="U_xbrlishares">11851566</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_0000899460_srtRangeAxis_srtWeightedAverageMember_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20201231"
      decimals="2"
      id="F_001240"
      unitRef="U_iso4217USD_xbrlishares">1.99</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionAxis_mnkdCantorFitzgeraldMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_us-gaapTypeOfArrangementAxis_mnkdAtMarketIssuanceSalesAgreementMember_20200101_20201231"
      decimals="-5"
      id="F_001244"
      unitRef="U_iso4217USD">23500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdJuneTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200624_20200624"
      decimals="INF"
      id="F_001245"
      unitRef="U_xbrlishares">1235094</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdDecemberTwoThousandTwentyNoteMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201009_20201009"
      decimals="INF"
      id="F_001246"
      unitRef="U_xbrlishares">1377356</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630"
      decimals="INF"
      id="F_001247"
      unitRef="U_xbrlishares">7250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630"
      decimals="2"
      id="F_001248"
      unitRef="U_iso4217USD_xbrlishares">1.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630"
      decimals="INF"
      id="F_001249"
      unitRef="U_xbrlishares">26666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200630"
      decimals="INF"
      id="F_001250"
      unitRef="U_xbrlishares">26666667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mnkd:RemainingWarrantsAvailableForPurchase
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdUnderwritingAgreementMember_20200601_20200630"
      decimals="INF"
      id="F_001251"
      unitRef="U_xbrlishares">0</mnkd:RemainingWarrantsAvailableForPurchase>
    <mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_001252"
      unitRef="U_iso4217USD">3000000.0</mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_001255"
      unitRef="U_iso4217USD">7000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <mnkd:DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_001254"
      unitRef="U_xbrlishares">1200000</mnkd:DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20201001_20201231"
      decimals="-5"
      id="F_001257"
      unitRef="U_xbrlishares">2800000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdMidCapCreditFacilityMember_20201231"
      decimals="INF"
      id="F_001259"
      unitRef="U_xbrlishares">111853</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231"
      decimals="INF"
      id="F_001260"
      unitRef="U_xbrlishares">3067179</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228"
      decimals="-5"
      id="F_001261"
      unitRef="U_iso4217USD">5000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdTwoThousandTwentyFourConvertibleNotesMember_20210201_20210228"
      decimals="INF"
      id="F_001262"
      unitRef="U_xbrlishares">1666667</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheOneMember_20211031"
      decimals="INF"
      id="F_001263"
      unitRef="U_xbrlishares">1171614</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_us-gaapDebtInstrumentAxis_mnkdTrancheTwoMember_20211031"
      decimals="INF"
      id="F_001264"
      unitRef="U_xbrlishares">111853</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031"
      decimals="INF"
      id="F_001265"
      unitRef="U_xbrlishares">1283467</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20211031"
      decimals="INF"
      id="F_001266"
      unitRef="U_xbrlishares">964113</us-gaap:CommonStockSharesIssued>
    <mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_001253"
      unitRef="U_iso4217USD">400000</mnkd:DebtConversionConvertedInstrumentAccruedInterestOfNotesValue>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_001256"
      unitRef="U_iso4217USD">9600000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20210101_20211231"
      decimals="-5"
      id="F_001258"
      unitRef="U_xbrlishares">4000000.0</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001267"
      unitRef="U_iso4217USD">100000</us-gaap:ProceedsFromStockPlans>
    <mnkd:MarketPriceStockPurchasePlan
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001268"
      unitRef="U_xbrlishares">25000</mnkd:MarketPriceStockPurchasePlan>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="-5"
      id="F_001270"
      unitRef="U_iso4217USD">10000000.0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="INF"
      id="F_001271"
      unitRef="U_xbrlishares">4000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <mnkd:CommonStockIssuedToPayInterest
      contextRef="C_0000899460_us-gaapDebtInstrumentAxis_mnkdConvertiblePromissoryNoteMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTheMannGroupLLCMember_20220101_20221231"
      decimals="INF"
      id="F_001269"
      unitRef="U_xbrlishares">75487</mnkd:CommonStockIssuedToPayInterest>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001272"
      unitRef="U_iso4217USD">700000</us-gaap:ProceedsFromStockPlans>
    <mnkd:MarketPriceStockPurchasePlan
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001273"
      unitRef="U_xbrlishares">252176</mnkd:MarketPriceStockPurchasePlan>
    <us-gaap:EarningsPerShareTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000502">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;14. Earnings per Common Share (&#x201c;EPS&#x201d;)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic EPS excludes dilution for potentially dilutive securities and is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution under the treasury method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For periods where the Company has presented a net loss, potentially dilutive securities are excluded from the computation of diluted EPS as they would be antidilutive.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;EPS &#x2014; basic and diluted:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss (numerator)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average common shares (denominator)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;257,092&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;249,244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;222,585&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.32&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common shares issuable represents incremental shares of common stock which consist of stock options, restricted stock units, warrants, and shares that could be issued upon conversion of the Senior convertible notes and the Mann Group convertible notes.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Potentially dilutive securities outstanding that are considered antidilutive are summarized as follows (in shares):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,120,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,120,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock options and PNQs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,655,146&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,264,616&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,370,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,370,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants associated with MidCap credit facility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,283,467&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024 convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,666,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RSUs and Market RSUs&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,886,710&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,609,025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,037,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;243,375&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;292,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,451,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,998,009&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,745,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.39%;"/&gt;
&lt;td style="width:95.61%;"/&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Market RSUs are included at the maximum share delivery percentage.&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000565">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;EPS &#x2014; basic and diluted:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss (numerator)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average common shares (denominator)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;257,092&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;249,244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;222,585&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.32&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001274"
      unitRef="U_iso4217USD">-87400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001275"
      unitRef="U_iso4217USD">-80926000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001276"
      unitRef="U_iso4217USD">-57240000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001277"
      unitRef="U_xbrlishares">257092000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001278"
      unitRef="U_xbrlishares">249244000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001279"
      unitRef="U_xbrlishares">222585000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001280"
      unitRef="U_iso4217USD_xbrlishares">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_001281"
      unitRef="U_iso4217USD_xbrlishares">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0000899460_20200101_20201231"
      decimals="2"
      id="F_001282"
      unitRef="U_iso4217USD_xbrlishares">-0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000566">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Potentially dilutive securities outstanding that are considered antidilutive are summarized as follows (in shares):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Senior convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,120,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;44,120,463&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common stock options and PNQs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,655,146&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,264,616&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mann Group convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,370,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,370,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,200,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants associated with MidCap credit facility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,283,467&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024 convertible notes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,666,667&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;RSUs and Market RSUs&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,886,710&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,609,025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,037,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee stock purchase plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;243,375&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;292,981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;75,451,760&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;69,998,009&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,745,273&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;_________________________&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.39%;"/&gt;
&lt;td style="width:95.61%;"/&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1)&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Market RSUs are included at the maximum share delivery percentage.&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20220101_20221231"
      decimals="INF"
      id="F_001286"
      unitRef="U_xbrlishares">44120463</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdSeniorConvertibleNotesMember_20210101_20211231"
      decimals="INF"
      id="F_001287"
      unitRef="U_xbrlishares">44120463</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20220101_20221231"
      decimals="INF"
      id="F_001288"
      unitRef="U_xbrlishares">9074587</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20210101_20211231"
      decimals="INF"
      id="F_001289"
      unitRef="U_xbrlishares">10655146</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdCommonStockOptionsAndPerformanceBasedStockOptionAwardsMember_20200101_20201231"
      decimals="INF"
      id="F_001290"
      unitRef="U_xbrlishares">12264616</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20220101_20221231"
      decimals="INF"
      id="F_001291"
      unitRef="U_xbrlishares">3370000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20210101_20211231"
      decimals="INF"
      id="F_001292"
      unitRef="U_xbrlishares">7370000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdMannGroupConvertibleNoteMember_20200101_20201231"
      decimals="INF"
      id="F_001293"
      unitRef="U_xbrlishares">11200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdWarrantsAssociatedWithMidcapCreditFacilityMember_20200101_20201231"
      decimals="INF"
      id="F_001294"
      unitRef="U_xbrlishares">1283467</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdConvertibleNotesMember_20200101_20201231"
      decimals="INF"
      id="F_001295"
      unitRef="U_xbrlishares">1666667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20220101_20221231"
      decimals="INF"
      id="F_001296"
      unitRef="U_xbrlishares">18886710</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20210101_20211231"
      decimals="INF"
      id="F_001297"
      unitRef="U_xbrlishares">7609025</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdRestrictedStockUnitsAndMarketRestrictedStockUnitsMember_20200101_20201231"
      decimals="INF"
      id="F_001298"
      unitRef="U_xbrlishares">6037542</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="INF"
      id="F_001299"
      unitRef="U_xbrlishares">243375</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_001300"
      unitRef="U_xbrlishares">292981</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001301"
      unitRef="U_xbrlishares">75451760</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001302"
      unitRef="U_xbrlishares">69998009</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0000899460_20200101_20201231"
      decimals="INF"
      id="F_001303"
      unitRef="U_xbrlishares">32745273</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000503">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;15. Stock Award Plans&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2018, the Company adopted the 2018 Equity Incentive Plan (the &#x201c;2018 Plan&#x201d;) as the successor to and continuation of the 2013 Equity Incentive Plan (the &#x201c;2013 Plan&#x201d;). The 2018 Plan initially consisted of 12,000,000 new shares plus the number of unallocated shares remaining available for grant for new awards under the 2013 Plan. In May 2020, the 2018 Plan was amended to increase the number of shares of common stock that may be issued under the 2018 Plan by 12,500,000 shares. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective upon the approval of the 2018 Plan by the Company&#x2019;s stockholders in May 2018, no additional awards have been or may be granted under the 2013 Plan. Any Prior Plans&#x2019; (as defined below) returning shares will increase the number of shares issuable under the 2018 Plan. The Prior Plans&#x2019; returning shares are shares subject to outstanding stock awards granted under the 2013 Plan or the 2004 Equity Incentive Plan (collectively, &#x201c;Prior Plans&#x201d;) that, from and after the effective date of the 2018 Plan, (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii) other than with respect to outstanding stock options and stock appreciation rights granted under the Prior Plans with an exercise or strike price of at least 100% of the fair market value of the underlying common stock on the date of grant, are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a stock award.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The 2018 Plan provides for the granting of stock awards including stock options and restricted stock units to employees, directors and consultants. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s board of directors or its compensation committee determines eligibility, vesting schedules and criteria, and exercise prices for stock awards granted under the 2018 Plan. Options and restricted stock unit awards under the 2018 Plan, or the Prior Plans expire not more than ten years from the date of the grant and are exercisable upon vesting. Stock options that vest over time generally vest over four years. Current time-based vesting stock option grants vest and become exercisable at the rate of 25% after one year and ratably on a monthly basis over a period of 36 months thereafter. The Company also issues PNQ awards with performance conditions. For PNQs, the Company evaluates the probability that the performance conditions will be met and estimates the service period for recognition of the associated expense. RSUs with time-based vesting generally vest at a rate of 25%&#160;per year over four years with consideration satisfied by service to the Company. Certain RSUs issued to nonemployee directors vest immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service such as resignation, retirement or death. The Company also issued Market RSUs. The grant date fair value and the effect of the market conditions was estimated using a Monte Carlo valuation. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Market RSUs issued during the year ended December 31, 2022 had a grant date fair value of $6.10 per share and will vest on May 10, 2025 provided that the closing price of the Company&#x2019;s common stock on such vesting date is not less than the closing price on May 10, 2022. The fair value of the Market RSUs was determined using a share price of $2.95, risk-free interest rate of 2.81%, volatility of 75%, and a dividend yield of 0%. The number of shares delivered on the vesting date is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025&#160;&#160;relative to the TSR of the Russell 3000 Pharmaceutical &amp;amp; Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. The resulting stock-based compensation expense will be recognized over the service period regardless of whether the market conditions are achieved, as long as the service condition is satisfied.&lt;span style="font-size:12pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information about the Company&#x2019;s stock-based award plans as of December&#160;31, 2022:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&#160;Available&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;for Future&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2004 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,320&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,240,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,832,577&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,802,796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,802,796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Share-based payment transactions are recognized as compensation cost based on the fair value of the instrument on the date of grant. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of employee stock options. The expected term of an option granted is based on combining historical exercise data with expected weighted time outstanding. Expected weighted time outstanding is calculated by assuming the settlement of outstanding awards is at the midpoint between the remaining weighted average vesting date and the expiration date. The Company recognizes forfeitures as they occur. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recorded RSU and option-based stock compensation expense of $12.8 million, $11.5 million and $6.2 million, respectively and employee stock purchase plan compensation of $0.6 million, $0.7 million and $0.3 million, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense recognized in the accompanying consolidated statements of operations is included in the following categories (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of goods sold&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;407&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue &#x2014; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,425&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,708&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;338&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,194&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,578&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,158&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,455&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,893&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,943&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,447&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,511&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The expected volatility assumption used in the Company&#x2019;s Black-Sholes option valuation model is based on an assessment of the historical volatility derived from an analysis of historical trade activity. The Company has selected risk-free interest rates based on U.S. Treasury securities with an equivalent expected term in effect on the date the options were granted. Additionally, the Company uses historical data and management judgment to estimate stock option exercise behavior and employee turnover rates to estimate the number of stock option awards that will eventually vest. There were no options issued in the years ended December 31, 2022 and 2021. The Company calculated the fair value of employee stock options granted during the year ended December&#160;31, 2020 using the following assumptions:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001364"&gt;0.39% &#x2014; 1.52%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected lives&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001366"&gt;5.67 &#x2014; 7.0 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001368"&gt;93.83% &#x2014; 94.25%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividends&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information relating to stock options:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value ($000)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,732,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.01&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001382"&gt;5.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,543&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,196,391&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(116,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(344,768&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001383"&gt;5.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,512&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,776,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001384"&gt;5.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were no options granted in the years ended December 31, 2022 and 2021. The weighted average grant date fair value of the stock options granted during the year ended December&#160;31, 2020 was $0.97. Total fair value of stock options vested during the years ended December 31, 2022, 2021 and 2020 was 3.2 million, $2.3 million and $4.5 million, respectively. The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $2.4 million, $1.7 million and $0.5 million, respectively. Intrinsic value is measured using the fair market value at the date of exercise for options exercised or at December&#160;31 for outstanding options, less the applicable exercise price. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash received from the exercise of options during the years ended December&#160;31, 2022, 2021 and 2020 was approximately $3.0 million, $1.0&#160;million and $0.6 million, respectively. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, 2021 and 2020, the Company recognized $0.1 million, $0.1 million and $0.2 million, respectively, of compensation costs related to the performance-based stock options. As of December 31, 2022 and 2021, there were $0.2 million and $0.3 million, respectively of unrecognized compensation costs related to performance-based stock options subject to performance conditions.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information relating to restricted stock units: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,538,032&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.40&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,120,682&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,551,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,269,297&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.97&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.65&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total fair value of restricted stock units vested during the years ended December 31, 2022, 2021 and 2020 was $4.4 million $6.7 million and $2.5 million, respectively. Intrinsic value of restricted stock units vested is measured using the closing share price on the day prior to the vest date. The total grant date fair value of restricted stock units outstanding as of December 31, 2022, 2021 and 2020 was $43.2 million, $19.3 million and $13.3 million, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:12pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2022, there was $0.6 million of unrecognized compensation expense related to options and PNQs and $25.0 million of unrecognized compensation expense related to restricted stock units and market based stock units, which are expected to be recognized over the weighted average period of &lt;span style="-sec-ix-hidden:F_001423"&gt;2.08 to 2.22 years&lt;/span&gt;. The Company evaluates stock awards with performance conditions as to the probability that &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the performance conditions will be met and uses that information to estimate the date at which those performance conditions will be met in order to properly recognize stock-based compensation expense over the requisite service period.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.99%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#xfeff;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company provides all employees, including executive officers, the ability to purchase its common stock at a discount under the Company&#x2019;s&lt;span style="color:#000000;"&gt; 2004 employee stock purchase plan (the &#x201c;ESPP&#x201d;). The ESPP is designed to comply with Section 423 of the Internal Revenue Code (&#x201c;IRC&#x201d;) and provides all employees with the opportunity to purchase up to $25,000 worth of common stock (based on the undiscounted fair market value at the commencement of the offering period) each year at a purchase price that is the lower of 85% of the fair market value of the common stock on either the date of purchase or the commencement of the offering period. An employee may not purchase more than 5,000 shares of common stock on any purchase date. The executives&#x2019; rights under the ESPP are identical to those of all other employees.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#160;issued 0.7 million,&#160;0.5 million and 0.6 million shares&#160;of common stock pursuant to the ESPP for the years ended&#160;December 31, 2022, 2021 and 2020, respectively. There&#160;were&#160;approximately 0.4 million&#160;shares of common stock available for issuance under the&#160;ESPP as of December 31, 2022.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20180531"
      decimals="INF"
      id="F_001304"
      unitRef="U_xbrlishares">12000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531"
      decimals="INF"
      id="F_001305"
      unitRef="U_xbrlishares">12500000</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20180516"
      decimals="INF"
      id="F_001306"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mnkd:ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20200531"
      decimals="INF"
      id="F_001307"
      unitRef="U_xbrlipure">1</mnkd:ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231"
      id="F_001308">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0000899460_srtRangeAxis_srtMinimumMember_20220101_20221231"
      id="F_001309">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231"
      decimals="2"
      id="F_001310"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20220101_20221231"
      id="F_001311">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_us-gaapVestingAxis_us-gaapShareBasedCompensationAwardTrancheOneMember_20220101_20221231"
      decimals="2"
      id="F_001312"
      unitRef="U_xbrlipure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20220101_20221231"
      id="F_001313">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231"
      decimals="2"
      id="F_001314"
      unitRef="U_iso4217USD_xbrlishares">6.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20220101_20221231"
      id="F_001315">2025-05-10</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate>
    <us-gaap:SharePrice
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517"
      decimals="2"
      id="F_001316"
      unitRef="U_iso4217USD_xbrlishares">2.95</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517"
      decimals="4"
      id="F_001317"
      unitRef="U_xbrlipure">0.0281</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517"
      decimals="2"
      id="F_001318"
      unitRef="U_xbrlipure">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20210517_20210517"
      decimals="2"
      id="F_001319"
      unitRef="U_xbrlipure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <mnkd:PercentileRankOfShareholderReturnOfStock
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231"
      decimals="2"
      id="F_001320"
      unitRef="U_xbrlipure">0.25</mnkd:PercentileRankOfShareholderReturnOfStock>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupOneMember_20220101_20221231"
      decimals="2"
      id="F_001321"
      unitRef="U_xbrlipure">0</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage>
    <mnkd:PercentileRankOfShareholderReturnOfStock
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231"
      decimals="2"
      id="F_001322"
      unitRef="U_xbrlipure">0.25</mnkd:PercentileRankOfShareholderReturnOfStock>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupTwoMember_20220101_20221231"
      decimals="2"
      id="F_001323"
      unitRef="U_xbrlipure">0.50</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage>
    <mnkd:PercentileRankOfShareholderReturnOfStock
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231"
      decimals="2"
      id="F_001324"
      unitRef="U_xbrlipure">0.50</mnkd:PercentileRankOfShareholderReturnOfStock>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupThreeMember_20220101_20221231"
      decimals="2"
      id="F_001325"
      unitRef="U_xbrlipure">1</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage>
    <mnkd:PercentileRankOfShareholderReturnOfStock
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231"
      decimals="2"
      id="F_001326"
      unitRef="U_xbrlipure">0.75</mnkd:PercentileRankOfShareholderReturnOfStock>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFourMember_20220101_20221231"
      decimals="2"
      id="F_001327"
      unitRef="U_xbrlipure">2</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage>
    <mnkd:PercentileRankOfShareholderReturnOfStock
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231"
      decimals="2"
      id="F_001328"
      unitRef="U_xbrlipure">0.90</mnkd:PercentileRankOfShareholderReturnOfStock>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_us-gaapVestingAxis_mnkdGroupFiveMember_20220101_20221231"
      decimals="2"
      id="F_001329"
      unitRef="U_xbrlipure">3</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000567">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information about the Company&#x2019;s stock-based award plans as of December&#160;31, 2022:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Restricted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Units&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&#160;Available&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;for Future&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Issuance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2004 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,320&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,240,690&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.32%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018 Equity Incentive Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,832,577&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,802,796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.32%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,802,796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdTwoThousandFourEquityIncentivePlanMember_20221231"
      decimals="INF"
      id="F_001330"
      unitRef="U_xbrlishares">1320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyThirteenMember_20221231"
      decimals="INF"
      id="F_001331"
      unitRef="U_xbrlishares">3240690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231"
      decimals="INF"
      id="F_001332"
      unitRef="U_xbrlishares">5832577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231"
      decimals="INF"
      id="F_001334"
      unitRef="U_xbrlishares">11838329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0000899460_us-gaapPlanNameAxis_mnkdEquityIncentivePlanTwentyEighteenMember_20221231"
      decimals="INF"
      id="F_001336"
      unitRef="U_xbrlishares">2802796</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001333"
      unitRef="U_xbrlishares">9074587</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001335"
      unitRef="U_xbrlishares">11838329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001337"
      unitRef="U_xbrlishares">2802796</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20220101_20221231"
      decimals="-5"
      id="F_001340"
      unitRef="U_iso4217USD">12800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20210101_20211231"
      decimals="-5"
      id="F_001338"
      unitRef="U_iso4217USD">11500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdRestrictedStockUnitsAndOptionsMember_20200101_20201231"
      decimals="-5"
      id="F_001339"
      unitRef="U_iso4217USD">6200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20220101_20221231"
      decimals="-5"
      id="F_001343"
      unitRef="U_iso4217USD">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20210101_20211231"
      decimals="-5"
      id="F_001341"
      unitRef="U_iso4217USD">700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="-5"
      id="F_001342"
      unitRef="U_iso4217USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000568">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total stock-based compensation expense recognized in the accompanying consolidated statements of operations is included in the following categories (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:42.94%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of goods sold&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;407&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;446&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of revenue &#x2014; collaborations and services&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,425&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,708&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;626&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,044&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;614&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;338&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,194&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,578&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,158&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,455&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,893&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,943&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.66%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,447&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,511&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20220101_20221231"
      decimals="-3"
      id="F_001344"
      unitRef="U_iso4217USD">329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20210101_20211231"
      decimals="-3"
      id="F_001345"
      unitRef="U_iso4217USD">407000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231"
      decimals="-3"
      id="F_001346"
      unitRef="U_iso4217USD">446000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20220101_20221231"
      decimals="-3"
      id="F_001347"
      unitRef="U_iso4217USD">1425000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20210101_20211231"
      decimals="-3"
      id="F_001348"
      unitRef="U_iso4217USD">1708000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdCostOfRevenueCollaborationsAndServicesMember_20200101_20201231"
      decimals="-3"
      id="F_001349"
      unitRef="U_iso4217USD">626000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20220101_20221231"
      decimals="-3"
      id="F_001350"
      unitRef="U_iso4217USD">1044000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_001351"
      unitRef="U_iso4217USD">614000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_001352"
      unitRef="U_iso4217USD">338000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20220101_20221231"
      decimals="-3"
      id="F_001353"
      unitRef="U_iso4217USD">1194000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_001354"
      unitRef="U_iso4217USD">2578000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapSellingAndMarketingExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_001355"
      unitRef="U_iso4217USD">1158000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20220101_20221231"
      decimals="-3"
      id="F_001356"
      unitRef="U_iso4217USD">9455000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20210101_20211231"
      decimals="-3"
      id="F_001357"
      unitRef="U_iso4217USD">6893000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_001358"
      unitRef="U_iso4217USD">3943000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001359"
      unitRef="U_iso4217USD">13447000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001360"
      unitRef="U_iso4217USD">12200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001361"
      unitRef="U_iso4217USD">6511000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001362"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001363"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000569">The Company calculated the fair value of employee stock options granted during the year ended December&#160;31, 2020 using the following assumptions:
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:77.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.92%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001364"&gt;0.39% &#x2014; 1.52%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected lives&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001366"&gt;5.67 &#x2014; 7.0 years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.84%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001368"&gt;93.83% &#x2014; 94.25%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:77.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dividends&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.92%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000570">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information relating to stock options:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value ($000)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,732,513&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.01&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001382"&gt;5.49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34,543&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,196,391&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.79&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(116,767&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(344,768&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,074,587&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.06&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001383"&gt;5.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,512&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,776,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.23&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001384"&gt;5.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,315&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_001370"
      unitRef="U_xbrlishares">10732513</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0000899460_20211231"
      decimals="2"
      id="F_001376"
      unitRef="U_iso4217USD_xbrlishares">3.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001385"
      unitRef="U_iso4217USD">34543000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001371"
      unitRef="U_xbrlishares">1196391</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001377"
      unitRef="U_iso4217USD_xbrlishares">1.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001372"
      unitRef="U_xbrlishares">116767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001378"
      unitRef="U_iso4217USD_xbrlishares">1.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001373"
      unitRef="U_xbrlishares">344768</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001379"
      unitRef="U_iso4217USD_xbrlishares">6.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001374"
      unitRef="U_xbrlishares">9074587</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0000899460_20221231"
      decimals="2"
      id="F_001380"
      unitRef="U_iso4217USD_xbrlishares">3.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001386"
      unitRef="U_iso4217USD">29512000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001375"
      unitRef="U_xbrlishares">7776518</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0000899460_20221231"
      decimals="2"
      id="F_001381"
      unitRef="U_iso4217USD_xbrlishares">3.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001387"
      unitRef="U_iso4217USD">25315000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001388"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001389"
      unitRef="U_xbrlishares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20200101_20201231"
      decimals="-4"
      id="F_001390"
      unitRef="U_iso4217USD_xbrlishares">970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001392"
      unitRef="U_iso4217USD_xbrlishares">3200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001391"
      unitRef="U_iso4217USD_xbrlishares">2300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_001393"
      unitRef="U_iso4217USD_xbrlishares">4500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001395"
      unitRef="U_iso4217USD">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001394"
      unitRef="U_iso4217USD">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_001396"
      unitRef="U_iso4217USD">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001399"
      unitRef="U_iso4217USD">3000000.0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001397"
      unitRef="U_iso4217USD">1000000.0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_001398"
      unitRef="U_iso4217USD">600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20220101_20221231"
      decimals="-5"
      id="F_001402"
      unitRef="U_iso4217USD">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20210101_20211231"
      decimals="-5"
      id="F_001400"
      unitRef="U_iso4217USD">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20200101_20201231"
      decimals="-5"
      id="F_001401"
      unitRef="U_iso4217USD">200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20221231"
      decimals="-5"
      id="F_001404"
      unitRef="U_iso4217USD">200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapPerformanceSharesMember_20211231"
      decimals="-5"
      id="F_001403"
      unitRef="U_iso4217USD">300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000571">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information relating to restricted stock units: &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Grant Date&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;per Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at January 1, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,538,032&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.40&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,120,682&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.84%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,551,088&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,269,297&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.97&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.84%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,838,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.65&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0000899460_20211231"
      decimals="INF"
      id="F_001405"
      unitRef="U_xbrlishares">9538032</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20211231"
      decimals="2"
      id="F_001410"
      unitRef="U_iso4217USD_xbrlishares">3.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001406"
      unitRef="U_xbrlishares">5120682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001411"
      unitRef="U_iso4217USD_xbrlishares">3.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001407"
      unitRef="U_xbrlishares">1551088</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001412"
      unitRef="U_iso4217USD_xbrlishares">2.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001408"
      unitRef="U_xbrlishares">1269297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001413"
      unitRef="U_iso4217USD_xbrlishares">3.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0000899460_20221231"
      decimals="INF"
      id="F_001409"
      unitRef="U_xbrlishares">11838329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0000899460_20221231"
      decimals="2"
      id="F_001414"
      unitRef="U_iso4217USD_xbrlishares">3.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001417"
      unitRef="U_iso4217USD">4400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001415"
      unitRef="U_iso4217USD">6700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_001416"
      unitRef="U_iso4217USD">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001420"
      unitRef="U_iso4217USD">43200000</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001418"
      unitRef="U_iso4217USD">19300000</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding>
    <mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
      contextRef="C_0000899460_20201231"
      decimals="-5"
      id="F_001419"
      unitRef="U_iso4217USD">13300000</mnkd:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_0000899460_us-gaapAwardTypeAxis_mnkdEmployeeStockOptionsAndPerformanceBasedOptionsMember_20221231"
      decimals="-5"
      id="F_001421"
      unitRef="U_iso4217USD">600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_0000899460_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20221231"
      decimals="-5"
      id="F_001422"
      unitRef="U_iso4217USD">25000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231"
      decimals="0"
      id="F_001425"
      unitRef="U_iso4217USD">25000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <mnkd:DiscountOnPurchasePricePercentageOfFairMarketValue
      contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20220101_20221231"
      decimals="0"
      id="F_001426"
      unitRef="U_xbrlipure">85</mnkd:DiscountOnPurchasePricePercentageOfFairMarketValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_srtTitleOfIndividualAxis_mnkdEmployeeMember_20220101_20221231"
      decimals="INF"
      id="F_001427"
      unitRef="U_xbrlishares">5000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20220101_20221231"
      decimals="-5"
      id="F_001428"
      unitRef="U_xbrlishares">700000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20210101_20211231"
      decimals="-5"
      id="F_001430"
      unitRef="U_xbrlishares">500000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0000899460_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-5"
      id="F_001429"
      unitRef="U_xbrlishares">600000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0000899460_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20221231"
      decimals="-5"
      id="F_001431"
      unitRef="U_xbrlishares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000504">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;16. Commitments and Contingencies&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Guarantees and Indemnifications &lt;span style="font-style:normal;"&gt;&#x2014; In the ordinary course of its business, the Company makes certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. The Company, as permitted under Delaware law and in accordance with its Bylaws, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The term of the indemnification period is for the officer&#x2019;s or director&#x2019;s lifetime. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company believes the fair value of these indemnification agreements is minimal. The Company has not recorded any liability for these indemnities in the accompanying consolidated balance sheets. However, the Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount can be reasonably estimated. No such losses have been recorded to date. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Litigation &lt;span style="font-style:normal;"&gt;&#x2014; The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. As of December 31, 2022, the Company believes that the final disposition of such matters will not have a material adverse effect on the financial position, results of operations or cash flows of the Company and no accrual has been recorded. The Company maintains liability insurance coverage to protect the Company&#x2019;s assets from losses arising out of or involving activities associated with ongoing and normal business operations. The Company records a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company&#x2019;s policy is to accrue for legal expenses in connection with legal proceedings and claims as they are incurred. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Contingencies &lt;span style="font-style:normal;"&gt;&#x2014; In July&#160;2013, the Company entered into the Milestone Rights Agreement with the Original Milestone Purchasers, pursuant to which the Company granted the Milestone Rights to receive payments up to $90.0 million upon the occurrence of specified strategic and sales milestones, $60.0 million of which remains payable to the Original Purchasers upon achievement of such milestones (see Note 10 &#x2014; &lt;/span&gt;Borrowings&lt;span style="font-style:normal;"&gt;). As of December 31, 2022, the initial fair value of the Milestone Rights is recorded in the consolidated balance sheet, including $0.9 million in&lt;/span&gt;&lt;span style="font-size:12pt;font-style:normal;"&gt; &lt;/span&gt;&lt;span style="font-style:normal;"&gt;accrued expenses and other current liabilities and $3.9 million in milestone rights liability. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Sale-Leaseback Transaction &lt;span style="font-style:normal;"&gt;&#x2014; In November 2021, the Company sold the Property to the Purchaser for a sales price of $102.3 million, subject to terms and the conditions contained in a purchase and sale agreement. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser entered into a lease agreement (the &#x201c;Lease&#x201d;), pursuant to which the Company leased the Property from the Purchaser for an initial term of 20 years, with four renewal options of five years each. The total annual rent under the Lease starts at approximately $9.5 million per year, subject to a 50% rent abatement during the first year of the Lease, and will increase annually by (i) 2.5% in the second through fifth year of the Lease and (ii) 3% in the sixth and each subsequent year of the Lease, including any renewal term. The Company is responsible for payment of operating expenses, property taxes and insurance for the Property. The Purchaser will hold a security deposit of $2.0 million during the Lease term. Pursuant to the terms of the Lease, the Company has four options to repurchase the Property, in 2026, 2031, 2036 and 2041, for the greater of (i) $102.3 million and (ii) the fair market value of the Property.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective with the closing of the Sale-Leaseback Transaction, the Company and the Purchaser also entered into a right of first refusal agreement (the &#x201c;ROFR&#x201d;), pursuant to which the Company has a right to re-purchase the Property from the Purchaser in accordance with terms and conditions set forth in the ROFR. Specifically, if the Purchaser receives, and is willing to accept, a bona fide purchase offer for the Property from a third-party purchaser, the Company has certain rights of first refusal to purchase the Property on the same material terms as proposed in such bona fide purchase offer.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022, the related financing liability was $104.1 million, which was recognized in the Company&#x2019;s  consolidated balance sheet as $94.5 million of financing liability &#x2014; long-term and $9.6 million of financing liability &#x2014; short-term. As of December 31, &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021, the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;related &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;financing liability&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;100.5&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, which was recognized in our consolidated balance sheet as $&lt;/span&gt;93.5&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;financing liability&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &#x2014; long-term and $&lt;/span&gt;7.0&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;financing liability&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &#x2014; short-term. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing liability information is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001452"&gt;18.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001453"&gt;19.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense on financing liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,758&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,373&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing liability payments as of December 31, 2022 was as follows (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,774&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,533&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;188,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;239,896&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(132,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,883&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financing liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;104,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Commitments &lt;span style="font-style:normal;"&gt;&#x2014; In July&#160;2014, the Company entered into the Insulin Supply Agreement with Amphastar pursuant to which Amphastar manufactures for and supplies to the Company certain quantities of recombinant human insulin for use in Afrezza. Under the terms of the Insulin Supply Agreement, Amphastar is responsible for manufacturing the insulin in accordance with the Company&#x2019;s specifications and agreed-upon quality standards.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( &#x20ac; in millions):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to the amendment, the term of the Insulin Supply Agreement expires on December&#160;31, 2027, unless terminated earlier, and can be renewed for additional, successive two-year terms upon 12 months&#x2019; written notice given prior to the end of the initial term or any additional &lt;span style="-sec-ix-hidden:F_001475"&gt;two-year&lt;/span&gt; term. The Company and Amphastar each have normal and customary termination rights, including termination for a material breach that is not cured within a specific time frame or in the event of liquidation, bankruptcy or insolvency of the other party. In addition, the Company may terminate the Insulin Supply Agreement upon two years&#x2019; prior written notice to Amphastar without cause or upon 30 days&#x2019; prior written notice to Amphastar if a controlling regulatory authority withdraws approval for Afrezza, provided, however, in the event of a termination pursuant to either of the latter two scenarios, the provisions of the Insulin Supply Agreement require the Company to pay the full amount of all unpaid purchase commitments due over the initial term within 60 calendar days of the effective date of such termination. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Vehicle Leases &#x2013; &lt;span style="font-style:normal;"&gt;During the second quarter of 2018, the Company entered into a lease agreement with Enterprise Fleet Management Inc. During 2021, 85 vehicles were retired and all of those vehicles were replaced, resulting in a fleet size of 89 vehicles. The Company received proceeds for the gain on the retired vehicles residual value in the amount of $0.5 million, which is included as a reduction to the Company&#x2019;s lease expense. The revised monthly payment inclusive of maintenance fees, insurance and taxes is approximately $0.1 million. The lease expense is included in selling expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Office Leases&lt;span style="font-style:normal;"&gt; &#x2014; In May&#160;2017, the Company executed an office lease with Russell Ranch Road II LLC for offices in Westlake Village, California. The office lease commenced in August&#160;2017. The Company agreed to pay initial monthly lease payments of $40,951, subject to 3% annual increases, plus the estimated cost of maintaining the property and common areas by the landlord, with a five-month concession from &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-style:normal;"&gt;October 2017 through February 2018. &lt;/span&gt;&lt;span style="font-style:normal;"&gt;The lease also provides for allowances for tenant alterations and maintenanc&lt;/span&gt;&lt;span style="font-style:normal;"&gt;e.&lt;/span&gt;&lt;span style="font-style:normal;"&gt; The lease expense is included in general and administrative expenses in &lt;/span&gt;&lt;span style="color:#000000;font-style:normal;"&gt;the accompanying consolidated statement of operations&lt;/span&gt;&lt;span style="font-style:normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2017, the Company executed an office lease with Russell Ranch Road II LLC to expand the office space for the Company&#x2019;s corporate offices in Westlake Village, California which was renewed in April 2022. Pursuant to the renewal, the Company will pay initial monthly lease payments of $79,543, beginning in February 2023, subject to a 3% annual increase, plus the estimated operating cost of maintaining the property by the landlord. The Company will receive a six-month concession at the start of the lease extension period on July 31, 2023. The Company has no further right to extend the lease term beyond the extension period.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company assumed certain leased real property (the &#x201c;Marlborough Lease&#x201d;) pursuant to the APA entered into in May 2022. The Marlborough Lease pertains to certain premises in a building located in Marlborough, Massachusetts. The Company has paid initial monthly payments of $28,895, beginning in June 2022, subject to approximately 3% annual increases through February 28, 2026.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company also acquired rights to a manufacturing service agreement where V-Go is manufactured using Company-owned equipment located at the manufacturing facility. The Company determined that this arrangement results in an embedded lease which grants the Company exclusive use of space within the manufacturing facility. The Company assessed the embedded lease cost to be $14,370 per month through February 28, 2026.&lt;/p&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Lease information is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,714&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,284&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability-current &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability-long-term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,040&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,420&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001504"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001505"&gt;2.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;__________________________&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:4.25%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:7pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-size:9pt;color:#000000;"&gt;Operating lease liability &#x2013; current are included in accrued expenses and other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.12%;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;863&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,403&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Variable lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;515&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;394&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,823&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,867&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,368&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,892&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,861&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,140&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;643&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <mnkd:ContingentLiability
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_srtRangeAxis_srtMaximumMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20130701"
      decimals="INF"
      id="F_001432"
      unitRef="U_iso4217USD">90000000.0</mnkd:ContingentLiability>
    <mnkd:ContingentLiabilityRemainingPayableAmount
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_001433"
      unitRef="U_iso4217USD">60000000.0</mnkd:ContingentLiabilityRemainingPayableAmount>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_001434"
      unitRef="U_iso4217USD">900000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <mnkd:MilestoneRightLiability
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdDeerfieldManagementCompanyLpMember_us-gaapCreditFacilityAxis_mnkdMilestoneRightsLiabilityMember_20221231"
      decimals="-5"
      id="F_001435"
      unitRef="U_iso4217USD">3900000</mnkd:MilestoneRightLiability>
    <us-gaap:ProceedsFromSaleOfRealEstate
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211101_20211130"
      decimals="-5"
      id="F_001436"
      unitRef="U_iso4217USD">102300000</us-gaap:ProceedsFromSaleOfRealEstate>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108"
      id="F_001437">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingSubleaseOptionToExtend
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_001439">renewal options of five years</us-gaap:LesseeOperatingSubleaseOptionToExtend>
    <us-gaap:SaleLeasebackTransactionLeaseTerms
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_001442">The total annual rent under the Lease starts at approximately $9.5 million per year, subject to a 50% rent abatement during the first year of the Lease, and will increase annually by (i) 2.5% in the second through fifth year of the Lease and (ii) 3% in the sixth and each subsequent year of the Lease, including any renewal term.</us-gaap:SaleLeasebackTransactionLeaseTerms>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      decimals="-5"
      id="F_001441"
      unitRef="U_iso4217USD">9500000</us-gaap:OperatingLeaseCost>
    <us-gaap:SecurityDeposit
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108"
      decimals="-5"
      id="F_001443"
      unitRef="U_iso4217USD">2000000.0</us-gaap:SecurityDeposit>
    <mnkd:LeaseRepurchaseDescription
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_20211108_20211108"
      id="F_001445">the Company has four options to repurchase the Property, in 2026, 2031, 2036 and 2041, for the greater of (i) $102.3 million and (ii) the fair market value of the Property.</mnkd:LeaseRepurchaseDescription>
    <us-gaap:SaleLeasebackTransactionNetBookValue
      contextRef="C_0000899460_srtCounterpartyNameAxis_mnkdCasperLLCMember_srtRangeAxis_srtMinimumMember_20211108"
      decimals="-5"
      id="F_001444"
      unitRef="U_iso4217USD">102300000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001447"
      unitRef="U_iso4217USD">104100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001449"
      unitRef="U_iso4217USD">94500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001451"
      unitRef="U_iso4217USD">9600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001446"
      unitRef="U_iso4217USD">100500000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001448"
      unitRef="U_iso4217USD">93500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_0000899460_20211231"
      decimals="-5"
      id="F_001450"
      unitRef="U_iso4217USD">7000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000572">
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing liability information is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001452"&gt;18.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001453"&gt;19.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:12pt;margin-bottom:8pt;text-indent:4.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="Background-color:#FFFFFF;"&gt;Lease information is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,714&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,284&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability-current &lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;(2)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,304&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,380&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liability-long-term&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,343&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,040&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.06%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,420&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average remaining lease term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001504"&gt;4.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_001505"&gt;2.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.06%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average discount rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0000899460_20221231"
      decimals="3"
      id="F_001454"
      unitRef="U_xbrlipure">0.090</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0000899460_20211231"
      decimals="3"
      id="F_001455"
      unitRef="U_xbrlipure">0.090</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000573">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.24%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense on financing liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,758&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,373&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.36%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,525&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;863&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,403&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Variable lease costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;274&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;515&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;394&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash paid&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.26%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,823&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,867&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.36%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <mnkd:InterestExpenseOnFinancingLiability
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001456"
      unitRef="U_iso4217USD">9758000</mnkd:InterestExpenseOnFinancingLiability>
    <mnkd:InterestExpenseOnFinancingLiability
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001457"
      unitRef="U_iso4217USD">1373000</mnkd:InterestExpenseOnFinancingLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000574">
&lt;p style="margin-bottom:8pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financing liability payments as of December 31, 2022 was as follows (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,774&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,533&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,849&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;188,453&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;239,896&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:76.66%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(132,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Debt issuance costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,883&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:76.66%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total financing liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;104,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001458"
      unitRef="U_iso4217USD">9774000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001459"
      unitRef="U_iso4217USD">10018000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearThree
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001460"
      unitRef="U_iso4217USD">10269000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearThree>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFour
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001461"
      unitRef="U_iso4217USD">10533000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFour>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFive
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001462"
      unitRef="U_iso4217USD">10849000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueYearFive>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001463"
      unitRef="U_iso4217USD">188453000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive>
    <mnkd:FinanceLeaseLiabilityDiscountedPaymentsDue
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001464"
      unitRef="U_iso4217USD">239896000</mnkd:FinanceLeaseLiabilityDiscountedPaymentsDue>
    <mnkd:FinanceLeaseLiabilityDiscountedExcessAmount
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001465"
      unitRef="U_iso4217USD">132936000</mnkd:FinanceLeaseLiabilityDiscountedExcessAmount>
    <mnkd:FinanceLeaseLiabilityDiscountedDebtIssuanceCosts
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001466"
      unitRef="U_iso4217USD">2883000</mnkd:FinanceLeaseLiabilityDiscountedDebtIssuanceCosts>
    <mnkd:FinanceLeaseLiabilityDiscounted
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001467"
      unitRef="U_iso4217USD">104077000</mnkd:FinanceLeaseLiabilityDiscounted>
    <us-gaap:LongTermPurchaseCommitmentTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000575">
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2021, the Company and Amphastar amended the Insulin Supply Agreement to extend the term and restructure the annual purchase commitments. In connection with the amendment, the Company agreed to pay $2.0 million of amendment fees, which were recognized in cost of goods sold for the year ended December 31, 2021. The remaining purchase commitments as of December 31, 2022 were as follows ( &#x20ac; in millions):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="3" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.82%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermPurchaseCommitmentTextBlock>
    <mnkd:PaymentOfLongTermPurchaseCommitmentAmendmentFee
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001468"
      unitRef="U_iso4217USD">2000000.0</mnkd:PaymentOfLongTermPurchaseCommitmentAmendmentFee>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001469"
      unitRef="U_iso4217EUR">8800000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001470"
      unitRef="U_iso4217EUR">14600000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001471"
      unitRef="U_iso4217EUR">15500000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001472"
      unitRef="U_iso4217EUR">19400000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001473"
      unitRef="U_iso4217EUR">9200000</us-gaap:PurchaseObligationDueInFifthYear>
    <mnkd:LongTermPurchaseCommitmentExpirationDate contextRef="C_0000899460_20220101_20221231" id="F_001474">2027-12-31</mnkd:LongTermPurchaseCommitmentExpirationDate>
    <mnkd:NumberOfVehicleLeasesRetired
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231"
      decimals="INF"
      id="F_001476"
      unitRef="U_mnkdVehicle">85</mnkd:NumberOfVehicleLeasesRetired>
    <mnkd:NumberOfVehicleLeasesReplaced
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231"
      decimals="INF"
      id="F_001477"
      unitRef="U_mnkdVehicle">85</mnkd:NumberOfVehicleLeasesReplaced>
    <mnkd:NumberOfVehicleLeases
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231"
      decimals="INF"
      id="F_001478"
      unitRef="U_mnkdVehicle">89</mnkd:NumberOfVehicleLeases>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231"
      decimals="-5"
      id="F_001480"
      unitRef="U_iso4217USD">500000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapVehiclesMember_us-gaapTypeOfArrangementAxis_mnkdMasterLeaseAgreementWithEnterpriseMember_20220101_20221231"
      decimals="-5"
      id="F_001479"
      unitRef="U_iso4217USD">100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531"
      decimals="0"
      id="F_001481"
      unitRef="U_iso4217USD">40951</us-gaap:OperatingLeaseExpense>
    <mnkd:OperatingLeasesAnnualIncreaseInRentExpense
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20170501_20170531"
      decimals="2"
      id="F_001482"
      unitRef="U_xbrlipure">0.03</mnkd:OperatingLeasesAnnualIncreaseInRentExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130"
      decimals="0"
      id="F_001483"
      unitRef="U_iso4217USD">79543</us-gaap:OperatingLeaseExpense>
    <mnkd:OperatingLeasesAnnualIncreaseInRentExpense
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20171101_20171130"
      decimals="2"
      id="F_001484"
      unitRef="U_xbrlipure">0.03</mnkd:OperatingLeasesAnnualIncreaseInRentExpense>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="C_0000899460_20220101_20221231" id="F_001486">The Company will receive a six-month concession at the start of the lease extension period on July 31, 2023. The Company has no further right to extend the lease term beyond the extension period.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <mnkd:LeaseExpirationMonthAndYear
      contextRef="C_0000899460_deiLegalEntityAxis_mnkdRussellRanchRoadIILLCMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeMember_20220101_20221231"
      id="F_001485">2023-07</mnkd:LeaseExpirationMonthAndYear>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630"
      decimals="-3"
      id="F_001487"
      unitRef="U_iso4217USD">28895000</us-gaap:OperatingLeaseExpense>
    <mnkd:OperatingLeasesAnnualIncreaseInRentExpense
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapBuildingMember_us-gaapTypeOfArrangementAxis_mnkdMarlboroughLeaseMember_20220601_20220630"
      decimals="2"
      id="F_001488"
      unitRef="U_xbrlipure">0.03</mnkd:OperatingLeasesAnnualIncreaseInRentExpense>
    <us-gaap:LeaseCost
      contextRef="C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20220601_20220630"
      decimals="-3"
      id="F_001489"
      unitRef="U_iso4217USD">14370000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001490"
      unitRef="U_iso4217USD">6714000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001491"
      unitRef="U_iso4217USD">2284000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001494"
      unitRef="U_iso4217USD">1304000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001495"
      unitRef="U_iso4217USD">1380000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001498"
      unitRef="U_iso4217USD">5343000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001499"
      unitRef="U_iso4217USD">1040000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001502"
      unitRef="U_iso4217USD">6647000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001503"
      unitRef="U_iso4217USD">2420000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0000899460_20221231"
      decimals="3"
      id="F_001506"
      unitRef="U_xbrlipure">0.073</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_0000899460_20211231"
      decimals="3"
      id="F_001507"
      unitRef="U_xbrlipure">0.073</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001508"
      unitRef="U_iso4217USD">1525000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001509"
      unitRef="U_iso4217USD">863000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001510"
      unitRef="U_iso4217USD">1403000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001511"
      unitRef="U_iso4217USD">274000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001512"
      unitRef="U_iso4217USD">515000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001513"
      unitRef="U_iso4217USD">394000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001514"
      unitRef="U_iso4217USD">1823000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001515"
      unitRef="U_iso4217USD">1867000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001516"
      unitRef="U_iso4217USD">1797000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000576">
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum office and vehicle lease payments as of December 31, 2022 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,368&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,892&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2025&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,861&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2026&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,140&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2027&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,072&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;643&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.12%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,976&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,329&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.12%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total operating lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001517"
      unitRef="U_iso4217USD">1368000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001518"
      unitRef="U_iso4217USD">1892000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001519"
      unitRef="U_iso4217USD">1861000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001520"
      unitRef="U_iso4217USD">1140000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001521"
      unitRef="U_iso4217USD">1072000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001522"
      unitRef="U_iso4217USD">643000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001523"
      unitRef="U_iso4217USD">7976000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001524"
      unitRef="U_iso4217USD">1329000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231"
      decimals="-3"
      id="F_001525"
      unitRef="U_iso4217USD">6647000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000505">
&lt;p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;17. Employee Benefit Plans&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company administers a defined contribution 401(k) savings retirement plan for its employees. The Company may make discretionary matching contributions. For the years ended December 31, 2022 and 2021, the Company matched each participant&#x2019;s deferral at the rate of 50% of each participant&#x2019;s deferral up to the first 10% of compensation. Participants hired after March 31, 2021 became vested in Company contributions at 100% after two years of service. For the year ended December 31, 2020, the Company matched each participant&#x2019;s deferral at the rate of 50% of each participant&#x2019;s deferral up to the first 6% of compensation. Participants are vested in Company contributions at 50% after one year of service and are 100% vested after two years of service. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s total discretionary matching contributions were $1.8 million, $1.5 million and $0.9 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_0000899460_20220101_20221231"
      decimals="2"
      id="F_001526"
      unitRef="U_xbrlipure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_0000899460_20210101_20211231"
      decimals="2"
      id="F_001527"
      unitRef="U_xbrlipure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20210101_20211231"
      decimals="INF"
      id="F_001530"
      unitRef="U_xbrlipure">0.10</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20220101_20221231"
      decimals="INF"
      id="F_001529"
      unitRef="U_xbrlipure">0.10</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
      contextRef="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20220101_20221231"
      decimals="2"
      id="F_001533"
      unitRef="U_xbrlipure">1</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_0000899460_20200101_20201231"
      decimals="2"
      id="F_001528"
      unitRef="U_xbrlipure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_0000899460_srtRangeAxis_srtMaximumMember_20200101_20201231"
      decimals="INF"
      id="F_001531"
      unitRef="U_xbrlipure">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
      contextRef="C_0000899460_srtStatementScenarioAxis_mnkdOneYearServiceMember_20200101_20201231"
      decimals="2"
      id="F_001532"
      unitRef="U_xbrlipure">0.50</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
      contextRef="C_0000899460_srtStatementScenarioAxis_mnkdTwoYearServiceMember_20200101_20201231"
      decimals="2"
      id="F_001534"
      unitRef="U_xbrlipure">1</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001535"
      unitRef="U_iso4217USD">1800000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001536"
      unitRef="U_iso4217USD">1500000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="C_0000899460_20200101_20201231"
      decimals="-5"
      id="F_001537"
      unitRef="U_iso4217USD">900000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000506">
&lt;p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;18. Income Taxes &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss from continuing operations before provision for income taxes for the Company&#x2019;s domestic and international operations was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,458&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss before provision for income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,458&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December 31, 2022, the Company has concluded that it is more likely than not that the Company may not realize the benefit of its deferred tax assets due to its history of losses. The Company has incurred operating losses since inception. Accordingly, the net deferred tax assets have been fully reserved. The provision for income taxes consists of the following (in thousands):&#160;  &#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. state&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,170&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. state&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,334&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14,461&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(469&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9,940&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,631&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,940&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,631&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes. A valuation allowance is established when uncertainty exists as to whether all or a portion of the net deferred tax assets will be realized. Components of the net deferred tax assets as of December&#160;31, 2022 and 2021, are approximately as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;542,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;542,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,804&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,804&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized research costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,369&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,440&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,675&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,591&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss on purchase commitment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-qualified stock option expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,684&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized patent costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,568&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,624&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;588&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense limitation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,157&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred Product Revenue &amp;amp; Costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;706,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;695,921&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(705,034&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(695,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;827&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,640&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other prepaids&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(249&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(272&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(827&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s effective tax rate differs from the statutory federal income tax rate as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal tax benefit rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-4.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-6.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax attribute expirations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-13.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-5.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-6.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign withholding tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-7.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-11.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-7.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective income tax rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2022 and 2021, management assessed the realizability of deferred tax assets. Management evaluated the need for an amount of any valuation allowance for deferred tax assets on a jurisdictional basis. This evaluation utilizes the framework contained in ASC 740, Income Taxes, wherein management analyzes all positive and negative evidence available at the balance sheet date to determine whether all or some portion of our deferred tax assets will not be realized. Under this guidance, a valuation allowance must be established for deferred tax assets when it is more likely than not (a probability level of more than 50 percent) that they will not be realized. In assessing the realization of the Company's deferred tax assets, the Company considers all available evidence, both positive and negative.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In concluding on the evaluation, management placed significant emphasis on guidance in ASC 740, which states that &#x201c;a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome.&#x201d; Based upon available evidence as of December 31, 2022, it was concluded on a more-likely-than-not basis that all deferred tax assets were not realizable. Accordingly, a valuation allowance of $705.0 million has been recorded to offset this deferred tax asset. During the years ended December&#160;31, 2022 and 2021, the change in valuation allowance was $9.9&#160;million and $19.6&#160;million, respectively.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December&#160;31, 2022, the Company had federal and state net operating loss carryforwards of approximately $2.2&#160;billion and $1.7&#160;billion available, respectively, to reduce future taxable income. $499.6 million of the federal losses do not expire and the remaining federal losses have started expiring, beginning in the current year through various future dates.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pursuant to IRC Sections 382 and 383, annual use of the Company&#x2019;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period. As a result of the Company's initial public offering, an ownership change within the meaning of IRC Section 382 occurred in August 2004. As a result, federal net operating loss and credit carryforwards of approximately $105.8 million are subject to an annual use limitation of approximately $13.0 million. The annual limitation is cumulative and therefore, if not fully utilized in a year can be utilized in future years in addition to the Section 382 limitation for those years. We have completed a Section 382 analysis beginning from the date of our initial public offering through December 31, 2022, to determine whether additional limitations may be placed on the net operating loss carryforwards and other tax attributes, and no additional changes in ownership that met Section 382 study ownership change threshold has been identified through December 31, 2022. There is a risk that changes in ownership may occur in tax years after December 31, 2022. If a change in ownership were to occur, our net operating loss carryforwards and other tax attributes could be further limited or restricted. If limited, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, related to the Company&#x2019;s operations in the U.S. will not impact the Company&#x2019;s effective tax rate.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2022, the Company had $54.2 million of U.S. federal research and development credits which expire beginning in 2024, and $24.6&#160;million of state research and development credits. The California credits are indefinite and do not expire and $0.2 million of the available New Jersey credits expire at the end of 2023. The Company also had two types of credits in Connecticut of which $19.8 million do not expire and the $1.1 million of the R&amp;amp;D credit expire at the end of 2023. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company files U.S. federal and state income tax returns in jurisdictions with varying statutes of limitations. In the normal course of business the Company is subject to examination by taxing authorities throughout the country. These audits could include examining the timing and amount of deductions, the allocation of income among various tax jurisdictions and compliance with federal, state, and local tax laws. The Company's tax years since 2018 remain subject to examination by federal, state and foreign tax authorities.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-top:2pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of beginning and ending amounts of unrecognized tax benefits in 2022, 2021 and 2020, respectively, was as follows (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized Tax Benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning of Year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross increases for tax positions of prior years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross decreases for tax positions of current year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Settlements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lapse of statute of limitations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;End of Year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December&#160;31, 2022, 2021 and 2020, the Company has not recognized a liability for unrecognized tax benefits. If any were recognized, it would affect the Company&#x2019;s effective tax rate. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes interest and penalties accrued related to unrecognized tax benefits in income tax expense. During the years ended December 31, 2022, 2021 and 2020, the Company did not recognize any interest and/or penalties.&#160;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000577">
&lt;p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss from continuing operations before provision for income taxes for the Company&#x2019;s domestic and international operations was as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,458&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss before provision for income taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(87,400&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(80,926&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(57,458&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001538"
      unitRef="U_iso4217USD">-87400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001539"
      unitRef="U_iso4217USD">-80926000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001540"
      unitRef="U_iso4217USD">-57458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001541"
      unitRef="U_iso4217USD">-87400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001542"
      unitRef="U_iso4217USD">-80926000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001543"
      unitRef="U_iso4217USD">-57458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000578">The provision for income taxes consists of the following (in thousands):&#160;  &#160;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. state&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total current&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,606&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,170&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,377&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. state&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,334&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14,461&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(469&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-U.S.&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(9,940&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,631&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,940&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,631&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,846&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001544"
      unitRef="U_iso4217USD">-218000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001545"
      unitRef="U_iso4217USD">-218000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001546"
      unitRef="U_iso4217USD">-5606000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001547"
      unitRef="U_iso4217USD">-5170000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001548"
      unitRef="U_iso4217USD">-4377000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001549"
      unitRef="U_iso4217USD">-4334000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001550"
      unitRef="U_iso4217USD">-14461000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001551"
      unitRef="U_iso4217USD">-469000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001552"
      unitRef="U_iso4217USD">-9940000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001553"
      unitRef="U_iso4217USD">-19631000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001554"
      unitRef="U_iso4217USD">-4846000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001555"
      unitRef="U_iso4217USD">-9940000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001556"
      unitRef="U_iso4217USD">-19631000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001557"
      unitRef="U_iso4217USD">-4846000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001558"
      unitRef="U_iso4217USD">-218000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000579">Components of the net deferred tax assets as of December&#160;31, 2022 and 2021, are approximately as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;542,537&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;542,800&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,804&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;78,804&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized research costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,369&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Rights&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,331&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,440&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,675&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,591&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss on purchase commitment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,117&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-qualified stock option expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,686&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,684&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized patent costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,568&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease liability&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,624&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;588&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest expense limitation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,696&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,157&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,983&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred Product Revenue &amp;amp; Costs&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;370&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;404&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;706,923&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;695,921&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(705,034&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(695,094&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;827&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,640&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(555&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other prepaids&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(249&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(272&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,889&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(827&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001559"
      unitRef="U_iso4217USD">542537000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001560"
      unitRef="U_iso4217USD">542800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001561"
      unitRef="U_iso4217USD">78804000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001562"
      unitRef="U_iso4217USD">78804000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <mnkd:DeferredTaxAssetsCapitalizedResearchExpenses
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001563"
      unitRef="U_iso4217USD">4369000</mnkd:DeferredTaxAssetsCapitalizedResearchExpenses>
    <mnkd:DeferredTaxAssetsMilestoneRights
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001564"
      unitRef="U_iso4217USD">1331000</mnkd:DeferredTaxAssetsMilestoneRights>
    <mnkd:DeferredTaxAssetsMilestoneRights
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001565"
      unitRef="U_iso4217USD">1440000</mnkd:DeferredTaxAssetsMilestoneRights>
    <mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001566"
      unitRef="U_iso4217USD">2675000</mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment>
    <mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001567"
      unitRef="U_iso4217USD">2591000</mnkd:DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment>
    <mnkd:DeferredTaxAssetsLossOnPurchaseCommitment
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001568"
      unitRef="U_iso4217USD">23117000</mnkd:DeferredTaxAssetsLossOnPurchaseCommitment>
    <mnkd:DeferredTaxAssetsLossOnPurchaseCommitment
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001569"
      unitRef="U_iso4217USD">24845000</mnkd:DeferredTaxAssetsLossOnPurchaseCommitment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001570"
      unitRef="U_iso4217USD">7686000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001571"
      unitRef="U_iso4217USD">5684000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <mnkd:DeferredTaxAssetsCapitalizedCosts
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001572"
      unitRef="U_iso4217USD">8058000</mnkd:DeferredTaxAssetsCapitalizedCosts>
    <mnkd:DeferredTaxAssetsCapitalizedCosts
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001573"
      unitRef="U_iso4217USD">7518000</mnkd:DeferredTaxAssetsCapitalizedCosts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001574"
      unitRef="U_iso4217USD">3204000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001575"
      unitRef="U_iso4217USD">2568000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <mnkd:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001576"
      unitRef="U_iso4217USD">1624000</mnkd:DeferredTaxAssetsLeaseLiabilities>
    <mnkd:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001577"
      unitRef="U_iso4217USD">588000</mnkd:DeferredTaxAssetsLeaseLiabilities>
    <mnkd:DeferredTaxAssetsInterestExpenseLimitation
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001578"
      unitRef="U_iso4217USD">10991000</mnkd:DeferredTaxAssetsInterestExpenseLimitation>
    <mnkd:DeferredTaxAssetsInterestExpenseLimitation
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001579"
      unitRef="U_iso4217USD">5696000</mnkd:DeferredTaxAssetsInterestExpenseLimitation>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001580"
      unitRef="U_iso4217USD">22157000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001581"
      unitRef="U_iso4217USD">22983000</us-gaap:DeferredTaxAssetsOther>
    <mnkd:DeferredTaxAssetsProductRevenueAndCosts
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001582"
      unitRef="U_iso4217USD">370000</mnkd:DeferredTaxAssetsProductRevenueAndCosts>
    <mnkd:DeferredTaxAssetsProductRevenueAndCosts
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001583"
      unitRef="U_iso4217USD">404000</mnkd:DeferredTaxAssetsProductRevenueAndCosts>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001584"
      unitRef="U_iso4217USD">706923000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001585"
      unitRef="U_iso4217USD">695921000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001586"
      unitRef="U_iso4217USD">705034000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001587"
      unitRef="U_iso4217USD">695094000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001588"
      unitRef="U_iso4217USD">1889000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001589"
      unitRef="U_iso4217USD">827000</us-gaap:DeferredTaxAssetsNet>
    <mnkd:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001590"
      unitRef="U_iso4217USD">1640000</mnkd:DeferredTaxLiabilitiesRightOfUseAsset>
    <mnkd:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001591"
      unitRef="U_iso4217USD">555000</mnkd:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001592"
      unitRef="U_iso4217USD">249000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001593"
      unitRef="U_iso4217USD">272000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001594"
      unitRef="U_iso4217USD">1889000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001595"
      unitRef="U_iso4217USD">827000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000580">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s effective tax rate differs from the statutory federal income tax rate as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.25%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Federal tax benefit rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Permanent items&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-1.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-4.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-6.1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-0.5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax attribute expirations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-13.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-5.9&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-6.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign withholding tax&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-7.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-11.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-7.8&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective income tax rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001596"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001597"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0000899460_20200101_20201231"
      decimals="INF"
      id="F_001598"
      unitRef="U_xbrlipure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001599"
      unitRef="U_xbrlipure">-0.012</mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001600"
      unitRef="U_xbrlipure">-0.044</mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001601"
      unitRef="U_xbrlipure">-0.061</mnkd:EffectiveIncomeTaxRateReconciliationPermanentItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001602"
      unitRef="U_xbrlipure">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001603"
      unitRef="U_xbrlipure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001604"
      unitRef="U_xbrlipure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001605"
      unitRef="U_xbrlipure">-0.132</mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute>
    <mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001606"
      unitRef="U_xbrlipure">-0.059</mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute>
    <mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001607"
      unitRef="U_xbrlipure">-0.066</mnkd:EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute>
    <mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001608"
      unitRef="U_xbrlipure">0.000</mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax>
    <mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001609"
      unitRef="U_xbrlipure">0.000</mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax>
    <mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001610"
      unitRef="U_xbrlipure">0.004</mnkd:EffectiveIncomeTaxRateReconciliationForeignWithholdingTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001611"
      unitRef="U_xbrlipure">0.072</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001612"
      unitRef="U_xbrlipure">0.112</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001613"
      unitRef="U_xbrlipure">0.078</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001614"
      unitRef="U_xbrlipure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001615"
      unitRef="U_xbrlipure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001616"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0000899460_20220101_20221231"
      decimals="3"
      id="F_001617"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0000899460_20210101_20211231"
      decimals="3"
      id="F_001618"
      unitRef="U_xbrlipure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_0000899460_20200101_20201231"
      decimals="3"
      id="F_001619"
      unitRef="U_xbrlipure">0.004</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001620"
      unitRef="U_iso4217USD">705000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0000899460_20220101_20221231"
      decimals="-5"
      id="F_001621"
      unitRef="U_iso4217USD">-9900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0000899460_20210101_20211231"
      decimals="-5"
      id="F_001622"
      unitRef="U_iso4217USD">-19600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_0000899460_20221231"
      decimals="-8"
      id="F_001623"
      unitRef="U_iso4217USD">2200000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_0000899460_20221231"
      decimals="-8"
      id="F_001624"
      unitRef="U_iso4217USD">1700000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001625"
      unitRef="U_iso4217USD">499600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse contextRef="C_0000899460_20220101_20221231" id="F_001626">Pursuant to IRC Sections 382 and 383, annual use of the Company&#x2019;s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <mnkd:OperatingLossCarryforwardsSubjectToLimitation
      contextRef="C_0000899460_20040831"
      decimals="-5"
      id="F_001627"
      unitRef="U_iso4217USD">105800000</mnkd:OperatingLossCarryforwardsSubjectToLimitation>
    <mnkd:NetOperatingLossCarryforwardAnnualLimitation
      contextRef="C_0000899460_20040801_20040831"
      decimals="-5"
      id="F_001628"
      unitRef="U_iso4217USD">13000000.0</mnkd:NetOperatingLossCarryforwardAnnualLimitation>
    <mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20221231"
      decimals="-5"
      id="F_001629"
      unitRef="U_iso4217USD">54200000</mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire>
    <mnkd:ResearchAndDevelopmentCreditsBeginToExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20220101_20221231"
      id="F_001631">2024</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
    <mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20221231"
      decimals="-5"
      id="F_001630"
      unitRef="U_iso4217USD">24600000</mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire>
    <mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdCaliforniaDivisionOfTaxationMember_20221231"
      decimals="-5"
      id="F_001634"
      unitRef="U_iso4217USD">200000</mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire>
    <mnkd:ResearchAndDevelopmentCreditsBeginToExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_us-gaapNewJerseyDivisionOfTaxationMember_20220101_20221231"
      id="F_001632">2023</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
    <mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire
      contextRef="C_0000899460_us-gaapIncomeTaxAuthorityAxis_mnkdConnecticutTaxAuthorityMember_20221231"
      decimals="-5"
      id="F_001633"
      unitRef="U_iso4217USD">19800000</mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire>
    <mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire
      contextRef="C_0000899460_20221231"
      decimals="-5"
      id="F_001635"
      unitRef="U_iso4217USD">1100000</mnkd:DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire>
    <mnkd:ResearchAndDevelopmentCreditsBeginToExpire contextRef="C_0000899460_20220101_20221231" id="F_001636">2023</mnkd:ResearchAndDevelopmentCreditsBeginToExpire>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock contextRef="C_0000899460_20220101_20221231" id="F_000581">
&lt;p style="margin-top:2pt;margin-bottom:8pt;text-indent:4.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of beginning and ending amounts of unrecognized tax benefits in 2022, 2021 and 2020, respectively, was as follows (in thousands):&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&#160;31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.84%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrecognized Tax Benefit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Beginning of Year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross increases for tax positions of prior years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross decreases for tax positions of current year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Settlements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.66%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lapse of statute of limitations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;End of Year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.66%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268,902&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"&gt;&#160;&lt;/p&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001637"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_001638"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0000899460_20220101_20221231"
      decimals="-3"
      id="F_001639"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0000899460_20210101_20211231"
      decimals="-3"
      id="F_001640"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0000899460_20200101_20201231"
      decimals="-3"
      id="F_001641"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0000899460_20221231"
      decimals="-3"
      id="F_001642"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0000899460_20211231"
      decimals="-3"
      id="F_001643"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0000899460_20201231"
      decimals="-3"
      id="F_001644"
      unitRef="U_iso4217USD">268902000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0000899460_20210101_20211231"
      decimals="INF"
      id="F_001646"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0000899460_20200101_20201231"
      decimals="INF"
      id="F_001647"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0000899460_20220101_20221231"
      decimals="INF"
      id="F_001645"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_001092"
          xlink:label="F_001092"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001087"
          xlink:label="F_001087"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001090"
          xlink:label="F_001090"
          xlink:type="locator"/>
        <link:footnote id="FNT_000013" xlink:label="FNT_000013" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001092"
          xlink:to="FNT_000013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001087"
          xlink:to="FNT_000013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001090"
          xlink:to="FNT_000013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000693"
          xlink:label="F_000693"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000694"
          xlink:label="F_000694"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000687"
          xlink:label="F_000687"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000688"
          xlink:label="F_000688"
          xlink:type="locator"/>
        <link:footnote id="FNT_000000" xlink:label="FNT_000000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The investments due in one year or less include cash equivalents of $51.8 million as of December 31, 2022 and $23.8 million as of December 31, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000693"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000694"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000687"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000688"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000888"
          xlink:label="F_000888"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000882"
          xlink:label="F_000882"
          xlink:type="locator"/>
        <link:footnote id="FNT_000003" xlink:label="FNT_000003" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In April 2021, the Mann Group convertible note was amended. The interest rate prior to the amendment was 7.00% and the maturity date was in November 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000888"
          xlink:to="FNT_000003"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000882"
          xlink:to="FNT_000003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001105"
          xlink:label="F_001105"
          xlink:type="locator"/>
        <link:footnote id="FNT_000021" xlink:label="FNT_000021" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer. The modification did not result in a cumulative catch-up adjustment as a result of the revenue being deferred for the performance obligations that were affected by the modification. The allocation of the transaction price for the Manufacturing Services includes a material right related to the Company&#x2019;s estimated production of product in the amount of $144.5 million. The Company will sell product to UT under individual purchase orders, which represent distinct performance obligations. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001105"
          xlink:to="FNT_000021"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000878"
          xlink:label="F_000878"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000887"
          xlink:label="F_000887"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000884"
          xlink:label="F_000884"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000885"
          xlink:label="F_000885"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000875"
          xlink:label="F_000875"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000883"
          xlink:label="F_000883"
          xlink:type="locator"/>
        <link:footnote id="FNT_000002" xlink:label="FNT_000002" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">In April 2021, the Company prepaid $10.0 million principal balance and amended the MidCap credit facility. The interest rate prior to the amendment was one-month LIBOR (2% floor) plus 6.75% and the maturity date was in August 2024. </xhtml:span><xhtml:span style="font-size:10pt;color:#000000;">In August 2022, the Company amended the MidCap credit facility and transitioned to the benchmark interest rate from LIBOR to the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;). The interest rate prior to the amendment was one-month LIBOR (1% floor) plus 6.25% (cap of 8.25%).</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000878"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000887"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000884"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000885"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000875"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000883"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001029"
          xlink:label="F_001029"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001028"
          xlink:label="F_001028"
          xlink:type="locator"/>
        <link:footnote id="FNT_000004" xlink:label="FNT_000004" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Manufacturing Services and sales of product to UT for the periods presented.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001029"
          xlink:to="FNT_000004"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001028"
          xlink:to="FNT_000004"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001031"
          xlink:label="F_001031"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001030"
          xlink:label="F_001030"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001032"
          xlink:label="F_001032"
          xlink:type="locator"/>
        <link:footnote id="FNT_000005" xlink:label="FNT_000005" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Amount consists of revenue recognized for Next-Gen R&amp;D Services and R&amp;D Services and License for the periods presented.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001031"
          xlink:to="FNT_000005"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001030"
          xlink:to="FNT_000005"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001032"
          xlink:to="FNT_000005"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001059"
          xlink:label="F_001059"
          xlink:type="locator"/>
        <link:footnote id="FNT_000006" xlink:label="FNT_000006" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Amount consists of royalties associated with the UT License Agreement. </xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001059"
          xlink:to="FNT_000006"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001070"
          xlink:label="F_001070"
          xlink:type="locator"/>
        <link:footnote id="FNT_000007" xlink:label="FNT_000007" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Recognition period represents the estimated period to satisfy the performance obligation.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001070"
          xlink:to="FNT_000007"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001100"
          xlink:label="F_001100"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001120"
          xlink:label="F_001120"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001089"
          xlink:label="F_001089"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001076"
          xlink:label="F_001076"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001119"
          xlink:label="F_001119"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001133"
          xlink:label="F_001133"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001074"
          xlink:label="F_001074"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001073"
          xlink:label="F_001073"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001075"
          xlink:label="F_001075"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001132"
          xlink:label="F_001132"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001099"
          xlink:label="F_001099"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001088"
          xlink:label="F_001088"
          xlink:type="locator"/>
        <link:footnote id="FNT_000008" xlink:label="FNT_000008" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Allocation is based on management&#x2019;s assessment of the stand-alone selling price of each performance obligation.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001100"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001120"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001089"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001087"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001076"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001119"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001133"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001074"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001073"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001075"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001132"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001099"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001088"
          xlink:to="FNT_000008"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001080"
          xlink:label="F_001080"
          xlink:type="locator"/>
        <link:footnote id="FNT_000010" xlink:label="FNT_000010" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Represents the estimated period when the R&amp;D Services performance obligation will be substantially complete.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001080"
          xlink:to="FNT_000010"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001092"
          xlink:to="FNT_000010"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001081"
          xlink:label="F_001081"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001082"
          xlink:label="F_001082"
          xlink:type="locator"/>
        <link:footnote id="FNT_000011" xlink:label="FNT_000011" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Pre-Commercial Services and Next-Gen R&amp;D Services performance obligations will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001081"
          xlink:to="FNT_000011"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001082"
          xlink:to="FNT_000011"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001083"
          xlink:label="F_001083"
          xlink:type="locator"/>
        <link:footnote id="FNT_000009" xlink:label="FNT_000009" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The Company also acts as agent for the procurement of equipment for the manufacturing expansion for the UT Equipment. The Company received $5.0 million from UT for the UT Equipment, which was recognized as deposits from customer on the consolidated balance sheet and will be released as the title is transferred to UT.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001083"
          xlink:to="FNT_000009"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001076"
          xlink:to="FNT_000009"
          xlink:type="arc"/>
        <link:footnote id="FNT_000012" xlink:label="FNT_000012" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The Facility Expansion Services performance obligation would be recognized as control of manufactured products is transferred to the customer.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001083"
          xlink:to="FNT_000012"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001137"
          xlink:label="F_001137"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001104"
          xlink:label="F_001104"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001124"
          xlink:label="F_001124"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001093"
          xlink:label="F_001093"
          xlink:type="locator"/>
        <link:footnote id="FNT_000014" xlink:label="FNT_000014" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The Next-Gen R&amp;D Services performance obligation will be satisfied over time using the input method based on the costs incurred to date as a percentage of the total estimated costs to fulfill the contract. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001137"
          xlink:to="FNT_000014"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001104"
          xlink:to="FNT_000014"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001124"
          xlink:to="FNT_000014"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001093"
          xlink:to="FNT_000014"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001094"
          xlink:label="F_001094"
          xlink:type="locator"/>
        <link:footnote id="FNT_000015" xlink:label="FNT_000015" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The Manufacturing Services performance obligation will be recognized as control of manufactured products is transferred to the customer; therefore, no revenue associated with this obligation was recognized during the year ended December 31, 2021. The allocation of transaction price includes a material right related to manufacturing services. The total anticipated cash flow is based on the Company&#x2019;s estimated production and the ultimate cash flows may vary as manufacturing purchase orders are received.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001094"
          xlink:to="FNT_000015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001098"
          xlink:label="F_001098"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001131"
          xlink:label="F_001131"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001118"
          xlink:label="F_001118"
          xlink:type="locator"/>
        <link:footnote id="FNT_000016" xlink:label="FNT_000016" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The total anticipated cash flow includes a transaction price of $64.3 million for the contractual obligations under the CSA for the Manufacturing Services and the Next-Gen R&amp;D Services performance obligations and $399.2 million for future supply of Tyvaso DPI over the remaining term of the CSA.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001098"
          xlink:to="FNT_000016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001131"
          xlink:to="FNT_000016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001118"
          xlink:to="FNT_000016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001121"
          xlink:label="F_001121"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001101"
          xlink:label="F_001101"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001134"
          xlink:label="F_001134"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001103"
          xlink:label="F_001103"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001136"
          xlink:label="F_001136"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001123"
          xlink:label="F_001123"
          xlink:type="locator"/>
        <link:footnote id="FNT_000019" xlink:label="FNT_000019" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The license for the Company&#x2019;s IP was considered to be interdependent with the development activities to support approval of Tyvaso DPI. A sales-based royalty is promised in exchange for the IP license; therefore, the royalties associated with the license are excluded from the determination of the transaction price and the Company will recognize revenue as the sale of Tyvaso DPI to a patient occurs. </xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001121"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001101"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001134"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001103"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001136"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001123"
          xlink:to="FNT_000019"
          xlink:type="arc"/>
        <link:footnote id="FNT_000020" xlink:label="FNT_000020" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Represents the period when the revenue for the R&amp;D Services performance obligation was recognized.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001136"
          xlink:to="FNT_000020"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001123"
          xlink:to="FNT_000020"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001103"
          xlink:to="FNT_000020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_001102"
          xlink:label="F_001102"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001135"
          xlink:label="F_001135"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_001122"
          xlink:label="F_001122"
          xlink:type="locator"/>
        <link:footnote id="FNT_000017" xlink:label="FNT_000017" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The standalone selling price (&#x201c;SSP&#x201d;) for the Next-Gen R&amp;D Services performance obligation was based on industry ratios as well as the Company&#x2019;s historical R&amp;D projects. The transaction price for the Next-Gen R&amp;D Services was based on fixed consideration which was allocated between performance obligations as discussed in note (2) above.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001104"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001137"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001102"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001119"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001124"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001135"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001132"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001099"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001122"
          xlink:to="FNT_000017"
          xlink:type="arc"/>
        <link:footnote id="FNT_000018" xlink:label="FNT_000018" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">Pre-production activities under the CSA, such as facility expansion services and certain other administrative services, were considered bundled services that are part of the Company&#x2019;s Manufacturing Services performance obligation, given the nature of the Company&#x2019;s contractual responsibilities and ASC 606 requirements.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001100"
          xlink:to="FNT_000018"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_001105"
          xlink:to="FNT_000018"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000867"
          xlink:label="F_000867"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000866"
          xlink:label="F_000866"
          xlink:type="locator"/>
        <link:footnote id="FNT_000001" xlink:label="FNT_000001" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><xhtml:span style="Background-color:#auto;text-decoration:none;"/><xhtml:span style="color:#000000;"/><xhtml:span style="font-size:9pt;color:#000000;">The amendment to the Mann Group convertible note in the second quarter of 2021 resulted in a substantial premium of $22.1 million based on the fair value post modification, which contributed to the loss on extinguishment in the consolidated statement of operations for the year ended December 31, 2021 and was recognized as additional paid-in capital in the consolidated balance sheet as of December 31, 2021. The accounting for the $22.1 million loss on extinguishment did not result in a change in the financial position of the Company.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000867"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000866"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>135
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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ML[:NL,+)5/ =$B9:JYF&71N;K=T09A[C4@E]E^@\E<PYDYR2#"O(T"6FF*6
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MY0XY&C'L0WEPR/G,*>=!IN@..V5C]B$'GH&2^L<_(/TAG/SDQ![4[%X%Y%R
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MQN:#$MOZ\;Y;H93(Z[<;'B>\K 3Z_W="J/V'Z@<.CY0N_P502P,$%     @
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M=@EL#**)Q-M$,O:.,D807Y&.^XYXCN>U;&AR.MQM@4>GPYTCT72:O'0,7^<
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M*[RAS3#%I@N$-L#O<\[59J(=-&U<^!=02P,$%     @ <X%75A_[JPGN(@
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MSK;?%ZN=MG2>/#[U>\%+T^WB^_/[/]SUYH]/Z4_:M[7KKE\.;SX[LT=GNW^
M]_&G]=H]_>/>\W^NMW\>UOCR?U!+ P04    " !S@5=60W^Q2-0.  #&60
M&    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;+6<_W.;N!+ _Q4F[^;-W4S=
M((EO[FLSXQJGYYDVR8O3WL\$RS&O&'R D^;^^B<!MHRTR"&CS,U<;6=9V&6U
M^FBU\/$I+WZ6:THKZ]<FS<I/9^NJVGXX/R_C-=U$Y?M\2S/VEU5>;***?2T>
MSLMM0:-E?= F/<>V[9UOHB0[N_A8_W937'S,=U6:9/2FL,K=9A,5SY]IFC]]
M.D-G^Q]NDX=UQ7\XO_BXC1[H@E;?MS<%^W9^T+),-C0KDSRS"KKZ=#9!'\(
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MTP2INWI2;[=H>!/::UQF%,M= ,LQ,$K? LM=@>7NJ<)TPKAK&Z7[U5SYBMU
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M=^Q95.G*BGI-@U,7U!%\7 EL[7Z+5A!/H*^G1]_)<IE 3\N.ZD<10"\!Y=\
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MHH6Y8>(291GNWA(X0>C)\Q@8TVA;NH9DG.YH"6.2Z&L2H.U=T64EX.[#'01
M"\C![%OB@F"R'5  H_T-T$&>,[KA@M\&$<BZ<2*+8@$1LZLLJ:@0I5: T4.[
M;(]7B0E)+>4L*->H#BLV>E!^(1G WP=P"93X#7R'I59N77<%76O< LT&4+RP
MKS5\67Y2K!?MDLU1FA U&]FI-:M"U:JB&N=P<'J7 D(-'?,D:B0:4N B"JFU
M&LE,^4<_62KZI5XN>X!-AMH2C0VP&1 TTSQ >UV["E14": 9/A08)"!^9D_)
M@4T16\84E*!$5K.";F7A1P9/'I.3B@(9OR6YZ^T#M L )FC? C4CIXI#UR;6
MY/,(38.1T::! F!Y?5,Q0&J2U:B+*F39-@%N<"C%9%P$S5\R,-%PMNM(QR\P
M>G*:O 8B3[XC+0.K7S?9UHNPU^2%%&@[U?0W)OP:715"*CY%L-N!:P,+ 4ZM
MW*V'BZ@@W L.L,4[Q7A9X>RLX^ZA>[MLBAV; P6(S/NLJ#-%Q3[&*%@>:$*C
MP %J"DY921S##-"ZL$ :; $@8ZN: (@X$6SQX&BUBBU%J 3%6"^9!XF_R(\)
MJY;!D2:,39NU?AR^#9P%[UM$OH-Q%.%F, O$:C_](ARJ\?A>Z8VV&)-T1((9
M.["X:[[*'L,]4,)@67-4BWZZKTPJ?DIK'=$5V,&RGMAN9/;%QSQEX_3P*-Q<
MM!N7GQ+VP&>1'<\,I-X1K"MW1L21J6*88N<9CG@B51G;6#D9B\G4RE[/5"2G
MP]<IWDJ%SMKDIBYA) QL"(DCE13HD"V=?3:L-%AAQ#7!>@L&T,)UMTY%JIJ"
MZ(C#-:-Z6*'$*V3=9EP#X@'RV^M)J4_2%:!O31)UIA5S*>YTU3<T1TXB$99-
M4B.EG;!7)FZU<I_+&C!Y4]30;/8NRPPDA[]/N9.H+Q6%C1$0<E#@,ZY%7#F)
M31!G.=")2"8PKJ<FPB#>!SL'7PN^J,\&@N+#1/Q F8%B0,2/V^R3A#=LJ 4M
M&T"2#9FDPWO L?OD6.O'I N;('<(90A(F8)6W7?H@[;*5&2.-_5"5GMR2Y%>
M7A+NNLG)2O<"A[TON([^)QIX8-K3S>) B(]?NAO<KH9_E%P5.DIK&'9"P*/L
MZ<E5%Y!H9 %U*8 N^535MPBCYA/("Q0QPH$=#)>33YD#R<'S(,LR1B8LQ"VS
M%M>JY)@L^KW& 8!Z"6O -V UH9C[X88TNL+7RPVB!&>%JBKM&9I> &IB(17H
M4AP1@R481.0;Z7/OT$9$C9Z4'TD,*Y $25_!.*4&@IA_67N$Z68$&\F!PH=_
MO%(8"6  ^Y[X!QZ'BP5Q%<F#\<-#<5Y7;.<RZ71./7[>*Q->J9YA%)]"&#<M
M!LVJ ?A(<_7;'@7+S<B%1_P05&(_^!:T.,8[V=1C%E_U(*K)&RWJ/%+H'I59
ME95[$*@@0%MB+U"1NY*#=FP\V6B/AU WQS[KOLA9-O,:/>:-DVX"AAX(,(&/
MOU!H\=!6)/[A8AJ<B]\A7\+E5R#9R/?3# 2BF'BA<<A*Z0QQW,+CN!CFDCS(
MZ;[1<.T>1#'0-9+):!8??5:Q/>(/D,BT"?+@4/K",$B1<8!ZC#HC0]^@!(]B
MW!HF9[#=H *]>Z#8Z"2*8C@.);(*5T:5A.N-?>>MI2G5P 9<4 PRZN$0[ 9T
M?MVPK_T9J< 1D;$M@5&QRI7)MOB,= >2'N4+J4-TX_ O>LK;HJ5()=G99;9N
M)?JN4=02@_ >=)&#*C, #Y&5]"JRDJZ"[3$58@R>E%A,QLA@QC%^I34$)PTB
MC!/M4*KOK9WE;1X #J86T/LF>]<+KB'2@S5$AEYDN;9#\T#1JB%[YD)K9.QB
M=RPVTB/G/R8R'VD&J-SK-DW=KS=WF*+W8SN-?5(2R;C\QN2;4J,M(W2&8.F?
MZEL40?&B,+)FY!6!W@<%/8]B$ ,S/ @[%! :I9MG-+4%;30F<NLG)!)Z5:S)
M6TZW+-!R_0)<<:@QNHHN]]C02Y%S@T/]7GQ>)65R@UK2;$2LWA+9(?D4RX&K
M&JA=G-: *%@*VEZ\2)R$4-=76*-@2(AH&5% .]6H2CX"*\>QE1@7;EU4%0J1
MMOB<;#ES#1*<K6,$AN,DQ/F%7LU6'=KT:$I_WA4BC7.R0)D/RVR'<=I^AR2S
MD0 ?Q2W$&1DXR<%@C?2Y,?TU]H%;%*N#08'VT'Y V)K-P8 [Y>)T@M^>0\D#
MN<7@7=:&@=O#%&/W+H9O::$P\!B3GA)>V0VX-V0413:M=\#0#F8H%167K0SR
M='@3YIS8H&>_ #<:!#F8UV"CT+T'9?F46!0#7@A4;&2$)XIBD"N)P8/F&S37
M #.6[@1F6Q=HI5X9&T36J*#0<0-';[,\8"_#W&R5*XE4#E.PJ,-CM>XM:, I
MY0X,!4Y;[E%6^YTZ\-<#!SZH-R\$S!W(=BOG!KX^Q:1D0$K7XQ:K+C+3<IL,
M$5,%L42<;5VFD)>D<2FJ;(7F3W 3F!4PX,9E9;=9BI<GLU, F(0UZ PRE#.&
M&[BR_A)'+0B%1AUOZA"^]@%=/_50!)V:1WF\D8!B\J-(!!K*&GJXW7!\:$^:
M?$6Q:)E$$Z!J%PY2SH+9PR 81AB&L2%/LMG6" L)6:G$F)$4 6_C.,)0R.A>
MOB20X!TVK]S8QVAZI&S)>IM@S'  "D,'0O4&-VX]:"7KA_!VR1PD$4KZ^4O@
MB[+:!(ITEV,="!8GQ@J7 *1",F]1!%5"4^#?8 6<<Y^\#ZS#>]8%$R.D7&/V
M-GXS[& 0S[31N27K<O)!9$D>ZQ/I9UJ]*&E_+PO70Y+52V+*+76<W^0"'B)C
M(K<35^7SDY/O 9*/@KEW,CQCP&Z4!@Z\26)6PF-I JLUX=.AX8>FW-YUO'ET
M5AE2I\EW(9;YGH.7D^9^05FYOTEB2.5C)/G8-7Y+F;;&^0"1DY^*W ?2)_G8
M\L>8B?_W^=?&3'XI_X8ZM Q\ ;C7@X1P&-S TH?2\E$!4T*KS'O-IE"=#?I[
M1256#._^IB9-0%Q"SB(+>,(%K.4U_'ZU:MS//V?)H&X @R6QN1<2RSX7$PJ<
M0K(E;WJ,9&$D#I3%.MMI'BXV;8G^07=1(8DX3J 7 ZQ#!,B3T;NLZ9)72CK3
MYDT80'03T183LP@'DD >-M[;&0*)36O@RZ;S65="$?(/6^Z(-;05/*MEE0X<
M<9IZ-#11&@=U=$K1I$HS,B\S?C OQ"Z2AVA-*DG(OC)Z-O%K3JQ3%;)*P@(L
M+C33LJ6LZR^0?<0\2/*K:3$XC:9Q[5H<,H+13$!$MHLLEMC 2#*(C R#TV()
M_9J0R4'[^AT%9P[)RF'%BM0@2%I>HCMUL\X *UI" Q>W65.@<JW:OJ'P(Y<+
M:BF#IC !JY5;%9U$!%!/*!UI<)S4/J]OF-*'S90RZV3^9MKM"_QD799PBZ7
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M<S-,$]]4P^HX0.:[GN*>Q3 E6=@X6\MTB#='^2Q*KV  35[<\LO:9E\I%9P
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M4?GX<)(;C-W;=YR>X:0Q'';:[P**D+DMY261IM"YGU@=_H7T[#N[IQQ[(#D
M;LS69LB&>J87:)39(7P[,>@XR63^A/Y7< .?[9-"BJ:'4(JX6>5@$IX,X:G'
MC4$4_.$\&;@JD,)%>Q ('7JIH^/\ME(L'^PJ#/_'\_'IO3RLZO3_I6JE%DW!
MT<P*LY1_TH&4XL%^A;&_.^JB*>8S"41>':?['QP>.]#OAB40)SX<&9MJNZ/I
MOB!L3S#[;NKQHJ.O'8QYU*&,?G-W.T:<=EZC9[V]7.,^$AXGNSBY-=)W;8H\
MC'_^G+4_^M@-1I-VI#R GI-#'^E.!U]52P4\IV_'O$_E_ ?6[F[W>?K6?Y7M
M7_??MM_Q\8O%1+'$TNGD8G[D#R/"A3,;_D:+[N9,R3_72B(>] *>+PTJI;V@
M#;J/]C?_ U!+ P04    " !S@5=6'8 ;!\,&  !3$@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6S-6%MOV[@2?O>O(+S!(@$<61=;L=LD0))VMP5:
MG&*3[GDX6"QHB;:(4J*7I))Z?_U^0\FVG-A.]^WD(1+)F6_N,[0NG[3Y9@LA
M'/M>JLI>]0OGEF^&0YL5HN0VT$M1X62N3<D=EF8QM$LC>.Z92C6,PS =EEQ6
M_>M+O_?%7%_JVBE9B2^&V;HLN5G="J6?KOI1?[WQFUP4CC:&UY=+OA#WPGU=
M?C%8#3<HN2Q%9:6NF!'SJ_Y-].9V1/2>X'<IGFSGG9$E,ZV_T>)C?M4/22&A
M1.8(@>/Q*.Z$4@0$-?YJ,?L;D<38?5^C_^)MARTS;L6=5O^5N2NN^I,^R\6<
MU\K]II\^B-:>,>%E6EG_GSTUM,FXS[+:.EVVS-"@E%7SY-];/W08)N$!AKAE
MB+W>C2"OY3ON^/6ET4_,$#70Z,6;ZKFAG*PH*/?.X%2"SUU_K!Z%=?"RLY=#
M!T#:'F8M\VW#'!]@CF+V65>NL.Q]E8M\%V (33;JQ&MU;N.CB.]$%K D&K X
MC.,C>,G&O,3C)0?P[I'$>:T$^\^<=4QE_[N966>0$G_LL[K!'.W'I#)Y8Y<\
M$U=]U($5YE'TKW_^*4K#MT<T'FTT'AU#?RT@QYE'P8Z5=]P6[/U?M7SDRF_\
M_-,DCN*WS8'H'&0:968=TW-6((_5BBF)XYS)#MR3= 731BYDQ15>4)14]K):
M("-=;:23PA+$-&0Y7UDB4<):QAUSA6 .U4S'R]ID!2H)FSCA1C!J)Q)"H<:C
M,$[.$#%9.<TR*!JP&X^*W!#E3)A-?C!>Y?2")<'?Z7+)JQ4KA,K923H-)B@8
MI7SM@_ DBD=!O-X:0*9="M\3U&I ^"3+4V;/O ,%'KE4'%J=HPV>WV.[X^>-
M5Q^@Q$,AC:[XCB65=C '3E;<6CF7(F<<3H%:.["68*W(R)$KKPAX9)6I&K6%
M%Z9AI0&K%8X.O-$4.*UDSAUH9ESQ*@,(M8/G6GOX;CC)\;:>65B*-;Q?"FYK
M0]HY-N?2,-A?BX!]K1 ?)?_&2:%53O%>(.[6ZZ@T]&G Q/=6U[G1)1/<4&HT
M5$8LM7%=,S)$RXB"VOLCZ86U8'7EI&)K:8'WZ#JLN7#"H -"V%8YBILD6XZ;
M6EM26@G$FB4X6=8^JOO3:C>;!,GQWJ7=EY*W8LBV=?@;@=RW1V!QHS2SLJP5
M][/HJ9!901F(V=$XA3^#/KD(HG6N4E$SGN?2^<1U^YR2-\5$KA7LB=(+\,KK
MG2&DTOE >>0PF&X*0S=9U#&B48T0C,CTHO)AWY=LUN'1N!>HN"48;QNB@[(G
MZA4R@ D:#"]]'+ /J-)SI\\_-YUCM=.XUA75W?NA%K7I*.@>C6@TD3G/I)*D
M;LNRKJ^,+[&M6-O&O?X_F!9-DXG":!LFXK(%TOR<8K);:M1_XB#LDBI=+5Y0
M'I*^M\5=3+N1/"Y\G ;I#TA_:*+L1V,-S^SV]8X*/D(7;VVC"IQ<KN.X(_J5
MQMWV(+H/^CR;T261G?ITT[4%F3U[TWO!_V(GZMV4L-UCW&DDR2U'KO1N%@LC
M%A3W7ZBX?J?B^A>4[VKA^U75YO)ZG)U&9[UH' \F:8QG.IA>I+V37A0F@XLD
M:=_2=.KY^1Q.WD*XPNAZ4; Y-3W:L;UH,$TC^C^:] "61E-ZC(#TH)&<D# :
M3.($S\E@&H\(/PT'R3ANWZ(P[OUY^*]'VCX4N_TP/V!9.VU>3$#?-\91=Z(>
MB>Q)G+Q*&36YMMOT?(]Y)GK0254"/Y3D2*1<V@Q=;B>/6BWVIU%GAG^BV? \
M-T[1N,V*.KE/B+/>KX:::&<>?FCGX2<_!7OO+>XXOCMVT@@54PJ329333".C
MO1E+CH;9\U(913)-@PD>IV&0]LZ:==S#]! 8R]Q\PZ^S>0W>EB/J43!Z;9L$
MN5]^#>[A5>.G."IV@YZD0;)%3L;!19-:+\/L+QU;KU*&C4?!E!2+H,^9WTC
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M?6::3QC-PNFE_VPPT\[ITK\6^)DF#!'@?*[QLZ9=D(#-=Z3K?P!02P,$%
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M9;'-\,,E]G6@G0#NSY6RNXDSL.\4)W\#4$L#!!0    ( '.!5U:^740TM00
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M&_!2B<,*3T-RO 'KI85NN@]VL'UL3O\'4$L#!!0    ( '.!5U8Q^75AM 8
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MQ> 91_"!YTKNZ'&K&Y6S4N/BI%.".7V$;OPKA065L$.&1+--5GKTOT70B%
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M^1KTL@=-OP,Z2<6U-:'VXITIJ/@GP @9;M-,-VE>I@<1WU(^%-/)D4C':7H
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M,_^6<"S+B9@D#NQ3WN(OL5N?=[]9U_"N]MBLZ@A,G^!M0,L.G/\-U0)$*%F
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MT8EMIL>2"/(==W\UX2_:*,F=..37#;40 2+4UCKQA\6,8!1S@QW:(XQ.3[[
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M*,P*,(H=6@5L4%E(8D-9C18F,L ::</LT9^1%MSM.\0^'?O&Y;47@/A/M27
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MX]5=H^,]3=PVHWN?V+N(;"^T'PF:Y6R#TF>0N11N3TQ/0=!LE5Q;;NM65'_
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MQJJZ5P8$M9#=DSWT>1@IS,,7%&BO0!WNSI%#^9Y9MCS3:D<T2H,U7+A0G3:
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M:*T E_! ?8A,J&)"WB,@,(/P81#@E#"=P 'U8S M\%B[0PN#S[1Z3VIN2U7
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MML-:XH_MOI.Y;%U"SV9B2_R62HO6U)U=P="ARRM^J2L#YLWU2^__**_\>*1
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MQPR'A->#((1 1X3:0^24 , _6SLXREKK323>%4'LQ!_.0^_:"P?3N?>I/IW
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MY#^^L-JM?Y1ZR[?G%[HL]8:_KI4$ZS0 [Y=:E_4/6J#YYQ1O_P-02P,$%
M  @ <X%75GS!_HL_$    R\  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&ULM5IIC]LXMOWN7T'45 8)X'+9\MY9@$K2Z<F@,PG2/>D/@\$#+=$V7V31
M+4I5J?[U[]Q+4IOE2O5@7H"X9$N\O.NY"_7BSN1?[5ZI0GP[I)E]>;$OBN,/
MU]<VWJN#M"-S5!GN;$U^D 6^YKMK>\R53'C1(;V.QN/%]4'J[.+5"_[M4_[J
MA2F+5&?J4RYL>3C(_/ZU2LW=RXO)1?CAL][M"_KA^M6+H]RI7U3QS^.G'-^N
M*RJ)/JC,:I.)7&U?7MQ,?G@]H^?Y@2]:W=G&M2!)-L9\I2_ODY<78V)(I2HN
MB(+$GUOU1J4I$0(;OWN:%]66M+!Y':B_8]DART9:]<:DO^FDV+^\6%V(1&UE
MF1:?S=W?E)=G3O1BDUK^%'?NV7ET(>+2%N;@%X.#@\[<7_G-ZZ&Q8#4^LR#R
M"R+FVVW$7+Z5A7SU(C=W(J>G08TN6%1>#>9T1D;YI<AQ5V-=\>J-.1QT 2T7
M5L@L$6],5NALI[)8*_OBNL 6].!U[,F]=N2B,^0FD?@ "GLK?LP2E;0)7(.W
MBL$H,/@Z>I#B6Q6/Q'0R%-$XBAZ@-ZT$GC*]Z2,$OND*+-YJ&Z?&EKD2_[K9
MV"*'U_R[3PUNDUG_)A1)/]BCC-7+"X2*5?FMNGCUU[],%N/G#X@PJT28/43]
MS]OL87*3Q4@\2%+\5,I<9H52[N9[F/:0Z:V.)466%7_]RRJ:1,]Q0Q1[)4R>
MZ P1+F)3YA;?MT*#[J:TV-G:(3^$'8\RNX<O?P796.4%$$1H1[K KD,L;S.U
MJ]DH\5PN[O8ZWH,VB-R+C0)(_%[J7"6B,$Q7'.6]6ZX)05)FEVZ&[6#?S$K&
M!SL2O]9L#86TXJAR[%^ GMON+2C<2;@&_C!#FE EAK@RBQ4"M]BSH*_O\0#X
MUT%/8)A^-UNH3.5.F 2,QH7!-R!KQ9"Z97;QBXGC,L]A -*$+3?_BZ>;K*<:
MO.$6=) JIW9'GA8'XD(SK3L(0TX(BPI9--7/EEL^MZPZ90L2R990:BSAOKJX
M=UHIH DR(ZW4;>N3EK1):"<2I,%(1;O!4/5;JK>J +H[^@ T?2@/0AY,F16T
MT]$4T(26J=B6!85C=UM-3L!*4,ESL3=W4%W>=JT]Q):U+DCK04<Z0XRSU8XF
MU?$]UDGG1BJ3&RA4L[*QTH LJ!Q-SMN"-2+MF7+\PE.D3EK^ V],-3BRS-!6
MZES<RK147HGV5!ZYRY7RSFH)Z?5!IFV:)$]F"N8J![HR)ZF6&YW"4D']->V"
M'<_%)/DI4R$?B.'N$#N1Y-L;F;(B.(<@"O[6ITHLS^$?O ?PT?I+NO4U,W<9
MD72 4=0<403$:9G0EL7>6%5K6>8:7[>Y.9SZ4VYN->5\=FZ5!5W[6";MX)$-
M6XE,RM(YOXEEYF! 6D-FA#4MG(S$'(E_&.?9GOV]O%5X6&6U.F%P4LE(_ S5
M[1PW =J:=@ 'C8!,U0Y>"I9BI4A4%]YQ*O7!>H1RTNI'H>-(W!!2 &QB==C
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M2+UR?$8'0EN& [XR0)(#[(.Y^"! (_SO'J%D]KVOT7PM\!05->,=A&)7/H1
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MRN6OENR/JECSET*+HJJ*C&]72@+M: #>+XNB:G[0 KM/QU[]#U!+ P04
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M'7? F Y'NBSRK4+9'K;7^MM*ZNHV+=I;//D2L*H!"&UPP?B6(.3(!<OY(6D
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M.PFSJT!2PR&7'?Z[JN ]G'$A#W&B+2@PS4%;'2"Y3]?_Z(0Q+!+B2 =IP02
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M53KS(LS;R&78.3I92"T32*D63F1"T?HZ(]F6AHT RJV"-I@CH>F;*%"<:F]
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M^?Z>!*OQ2]+=('2NFB@;4%,+"^E-4_%MN,OH2K;KB)[I9)WX:N^F(O\)X&V
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M6)36=%>Y#<O]P^!QND+.D;L''B^TL!'IB<.>2KV.\Q(]M."0_Z)-+9I3-T?
MY9J-]QI-F"]IO%X%PC_:G(DW^>.:O^V04WPZGP&,[4PO+"?S$09]/4XN89_$
M):AH9;7;83 $ MPH$-Q[@KM&-\  YI6O2,,,Z:(DO6%A7:HC'#K2K/."XV:H
MIIFKF,D//F>^;*1XNQ$FNI8C ]8Y"*2:RM>;3O2]FPSM[RA48UC:-G-EGE:\
M?*EMC"4VL+4/&0^Z7O HRL-%IX4.)C<F<-Z76FR;P1W?:G%)B?TF,KPB<R5'
MYN<;OW>82LOB*@0C^&'DC&V#;H'<O=KV>BV5?^*BSN%M5E%YAZJ6>C'LFORB
M6HN.'?6XX\7==S4H]ZN4L6M-VEV[(^T=)#L2;X-W!\LJ'>A,L]@3\OQ.Y_/T
ML)HEU34^6P,)AW6<A3ZD5]+D:9QR_@'C^@BS]T0-,0V4I>#@$!G]\G6%W:>L
M>MS9U>M^U?&4*D>YMJK6LXI:WTD1P*"^A,CP90>,N40ULY/@FRA00,09RA-C
M(DAW^^[B]<\?XHH 6;U,RT\86)&I<YKM2BZ3AC(CN*@C/EX(;#*_\#D3\8L)
MM1.0\MQ4$4YW)PIJXTQIS)R%0:USB]='+5+X-B*%&"E_.CN[##UHJ]+0#84#
M5YB%*D5FZVV6^#S$N'R[Q#?A_=SC7A#]88EIJ5%DS0K8FDJ?5BPW@$ITIVI0
M)?,X'ZZWK[L4#B)K(5VS&81EG;AE!ZL0+@AKG(LD)&&PDW?)8#&,(*50OOB/
M3WI58@1G6"%M#.BU<>5U7O>3IT]<( U @"57"F5E*</EBU.>,=FNK.W;;\VO
MG*-#(>WI=#X_R>C%!4/)O<G0[Q_64Z&_8>''.#;O?K";UE0A7 TRVS(/>K<+
M3>!L4VEG&6SL]K?(>LB5"ZU)L1?:0JU2EZ$UF>P\H!&K D323:[!\?=>TMV3
MQ?FDZ,^3P/P0GQ(W.UZR2_O6M[CV)R@-%+0"$7G$XLK['Z\#CJ!L9#$08G^E
MDH@2Q$"I2\KK73)4(%K2(\%:7A:"CI)9B64ZL,&>J%>^92)&O.LRN+PN.8(3
M4Z=7HVE26&J3TPIBDO26! 8L%(RF*?AWT0<^P/.R0FM6*+@=VEL8Z)K49(M#
M;PGQN6IM($#RAI"=?IL)"\0,@3WAC%F%EQX:H7@ADMH.H*G7=]7JOYC&'4ZP
M5ER5302Z%_E#;[&FBTUO+;0YD#04??Q-5,U<*52/';6AOHV$0S@%($9)W[?4
M6.)-VJ8_?@\8NLW.LZ+ &>'6?GB(=GS[*S(,K.G_W=G)PV_AR_#ZC]_O04P'
M1K?%^*PBV\"G1X?/0>:BF%;]I:WV."0:4X$<T(_8,S"K\05XOJE 1)5?<(*;
MJOY$R_OQ?P-02P,$%     @ <X%75E0!'/Q$!   C0D  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&ULC59M;]LV$/ZN7W%0A\ &5%NO?DEL TZS=@76
MS(B=#L,P#+1$6T0E4B/I..FOWY&R9:5U@OB#>:*.SSWW2DWV0GY3.:4:'LN"
MJZF;:UU=]OLJS6E)5$]4E..;C9 ET?@HMWU524HR>Z@L^J'O#_HE8=R=3>S>
M0LXF8J<+QNE"@MJ5)9%/U[00^ZD;N,>-.[;-M=GHSR85V=(EU??50N)3OT')
M6$FY8H*#I)NI.P\NKV.C;Q6^,KI7+1F,)VLAOIF'S]G4]0TA6M!4&P2"RP/]
M0(O" "&-_PZ8;F/2'&S+1_2/UG?T94T4_2"*/UFF\ZD[<B&C&[(K])W8_T8/
M_B0&+Q6%LO^P/^CZ+J0[I45Y.(P,2L;KE3P>XO"6 ^'A0&AYUX8LRQNBR6PB
MQ1ZDT48T(UA7[6DDQ[A)RE)+?,OPG)XMZV2 V,"2;3G;L)1P#?,T%3NN&=_"
M0A0L951!9T76!57=25^C87.\GQZ,7-=&PA>,!"%\$5SG"G[E&<V> _21<4,[
M/-*^#E]%O*%I#Z+ @] /PU?PHB8,D<6+7L [Y^_?\[72$LOFGW,>UWCQ>3S3
M2I>J(BF=NM@KBLH'ZLXNW@4#_^H5MG'#-GX-O9VT._I ^8X"X1E\$$K_N/=)
MB$S!4A0H4DXET32#CU*4L) BVZ4:E@23ZL$2.;(4W3:G[L03*30&X9SGKW-;
MY12)E!7A3Q?O1F$PO%+ <;C(%JGT0+2]M[5$E2%*<,W%G@-VK4:X5'#<9YGE
MKC0N.!4L ,XF] B[6P%3J%=6DBE4:F%O&Z\WQNOJX+6JO59MK^71ZQ.#M9E:
MT&&&B-@IU%+=2^<O2F1=RH"%2,LUE:88'5.,YB\P?[YS>W+;6;3M0B?H.J/
M\X>1$XV].$J<*/2B,'::+'3"KA-Y_GCD1 //]X=&882836:@$W6=(/&2\=BQ
M@0ZOFG4E-"G:47=^<<9C;SCT41@F7AR'* P2+XACY]^7?HYA.2]-7R@$LG6,
M83<9,="U)QCI^4;2[]^)#>'7]Y\$: '[7.!;U)!U:%5%4X;$GZ#*"0Y3VV#F
MQ>KI@2@!-XO/YMC]JN<8SW^V^D(Z]9EJPY%8D+6H"P.(E(1O;<5@OAE/BUUF
MVOR6/NKWV!)P=T'*ZNKFU  =S#[.=:SK#/7A5F@*0= %O &1H*F-/5XB9FUC
MX]S6.0@D)']@4!&ID;3JH0EZA -+-[A"]BU=#WY'"GCC(4$3G3\LW+QM!@,4
MG0U04QAH\G[UK/>:5)VBW7MK$1^'2KL_?V[AY_6-Q94D6-T!"L' &T61$7!G
M=*IP)_3B<."$H>=CW8^])!D>ZC9]FT6T,?3B\1"%:.2-$B.$L3>(@W,3MM^Z
M(DLJM_9#P-0*AK&^+9O=YEMC7E^Q)_7Z0^4+D5N&$Z>@&SSJ]X:)"[*^_.L'
M+2I[X:Z%QNO;BCE^+U%I%/#]1F -'!Z,@>8+;/8_4$L#!!0    ( '.!5U9X
MQ+_?6@4   (.   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;+576V_;
M-A1^UZ\@W"!( "76Q;(M-S&02]L%:#<O2;N'80^T1%ML*5$EJ;C^]SN'DE6Y
M<86@V%YLB>+Y^)W;1_)B(]47G3%FR+=<%/IRD!E3SH9#G60LI_I<EJR +RNI
M<FK@5:V'NE2,IM8H%\/ \\;#G/)B,+^P8PLUOY"5$;Q@"T5TE>=4;:^9D)O+
M@3_8#=SS=69P8#B_*.F:/3#SL5PH>!NV*"G/6:&Y+(ABJ\O!E3^[CG&^G?")
MLXWN/!/T9"GE%WRY2R\''A)B@B4&$2C\/;$;)@0" 8VO#>:@71(-N\\[]+?6
M=_!E236[D>(OGIKL<C =D)2M:"7,O=S\QAI_(L1+I-#VEVR:N=Z ))4V,F^,
M@4'.B_J??FOB\!*#H#$(+.]Z(<OREAHZOU!R0Q3.!C1\L*Y::R#'"TS*@U'P
ME8.=F5\E7RNN.49(DY-'NA1,GUX,#4#CA&'2P%S7,,%/8/R ?)"%R31Y4Z0L
MW0<8 J>66+ C=AWT(MZRY)R$ODL"+PAZ\,+6T=#BA3_!NZXTC&A-.AZ3O]_#
M&+DS+-?_''*ZAAP=AL1^F>F2)NQR  VAF7IB@_GQ*W_LO>XA/&H)C_K0YP]U
MFQ"Y(@]560H&K6"H( LEB2U(<E?438F>G'PL:)5RP]*#V>M?ZG=H?L6>6%$Q
M0HN4" EQ6BF9$VA^1>OB@+6(R1C9,JH(PRP3R!'+ETRU>2(;JLF1'YS'4*M"
MV+8#O"/O/-P-N+"2+IEM1K%]D6M5ZYK37='!%?''=SH..$>.[\5N'(;P%$_=
M8#*UG]$GYV0Z=N/QQ#F%)\^=>F-XVGTDX"K1&56,G&&C\\1R3[FH8&D .P$O
M1F!0/P7.:4^2HS;)47^206332C#,\@U$F:=-O,F"\M3&_&YQ?TSS\O7MH;SV
MHS]"NFYD7M)B2\I*)1G(5TJH$+@<YA)46AOPDA=KDM"28Q) <I(O..%/5>4+
MB >D WDD>_3LFS9H"%,3JC,;+1L_O8-OUCY^-0W\R6L-1GD.MG8%%_:!Y6>H
M V(DH>EGD#JL@GHIA(.)&4"ZI"I*C 6'DEM")K")VT&C:*%I+?#L&^Q4FL%'
M9%) 6G%#Z+I&L8H%[$,@=;P BK+2,%>?SIR]X#LW2&#/8<AZZ$:3D?-@P[,?
MC)/0]<83UY_$NP!00X["<\__7E2G3NP&D><\=A@G4AOM1*'OW+.2;JW_$#KT
MT_%]YSVG2RY J1!0P[8)90@5;\E15#$% R=^%$%1/DIT<)]6^:R$L#E"-PC#
MGM(=MZ4[[BVN3V?OY*&2[+7Z1<V<M)PF_[W(3_X'PM.6\/3%_;]03'#8XE'T
M%TVW[HO"(?;]^*@ QI9&V4'?:<$/]8*E@EFU*OZ\5TC;+&\I5^2)BLKRW@.9
M.5>YK ISN(7\R U'_G-[U!$L_OWY8]^KZ[JVC"._)^)Q&_'XER)>T[;2=9<"
M%[[B>!@B5UHSTQ240O4$;>DVYE7=F(=2TT\$4\,[V]P2#\AXSL4#J[;ZV<T9
M_<Z/=_G1FA_M\A//A0/SV:ARMS?@S,B>:6&3P=KSF7-7P,9JI-IB&GS7CP('
M-FH0-K.UJS& *U&[G,"-83-^)V6Z@<T>7D?!%,QAAUGSEBOLKK>P50M  /UF
M259((==;QW?A(N'\41\X0+0%PPI5>*H^DZNS2N]\A9E3/V@4;S<4NY$?=A5S
M=E ^?7<2/5]D%Z_M'G0GBJC]X\ >%7Z(=V]I#COG\IRIM;U]X#8(X:V/Z.UH
M>\&YJL_UWZ?7MZ,/5*TYG,($6X&I=SZ!G5_5-X[ZQ<C2GO*7TL"=P3YF<$EC
M"B? ]Y649O>""[37OOF_4$L#!!0    ( '.!5U9Q<09N? 0  +4+   9
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M_8^21&G7MV/@;Z3@6(ZP3:,Z%DXXE"%L^3ZB4COI_4)RXL#O.#Y1)=%#F7'
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M\&IE"A? _%Q"\BH[**!Z!X__!5!+ P04    " !S@5=6[281K2@,   ;+@
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MHI&J/^J,SLZ>''W;<NSMRQW-<G[G=-2WQX*&?=^>;B-F+S_=U@JAMREI$]=
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MB7>S6'JG^.2>K4IN3J<C"_Z<UBCK;5]VMND;M@.*;Y6TA<$W,N?YCP9& '1
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M8@'O*Z[=!EA?*ZA=/W .AA?;_#M02P,$%     @ <X%75M/?) $E!@  5P\
M !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULG5=M;]LV$/[.7T&X:9$
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M3I3N7M3#D*AC2/1JAFS1_O('CCGX.).S"J*<0Y3I:98U047WGT,\9"%RU@0
M7DT^0#"O%UQ9/9I.EO0<?LVD6N[B73\\ZX4MXF2;('D+4FV!1.ZQ3:#9)E"]
M!52N@0KD<5;4^5K+FO)98X( 7NW;G[+6P$)]<$C^Y$PUA6V+PP0YC \/'R[!
M^H$[SJ3,(1=DD9,]@N'<(Z&;X#.,NT6*/_*JYK3E$5A0 )7E"BKL3+%6B(QK
MH&OH1_!,W)3$?DP@*P!1-K>K<E!4R 7:"TO<,"2Q%Y(@2,D=-#RP#&:]<4B0
MB2F.HY1\XA4XI;#R+(?>(K"\(7.!CV$4D=A)QP&P?AP&+4_WB!<X88AF>+X#
MN06#V(D\KX>B<4?1N)<#IY"R99/]] M2P$A@5)'56)?I1R84?6 %. O\=EDN
M"KGDO*T';='8Q;O^/>_7Y0M"W^Z5-YS #1]7&_+5AI:C0*<&YTRQ"@7R6MF"
M"7)+I E_1A,L=2ZM]6K9FG)L;7<OR5QR*_2W]U,%* 3L"K7/4(@7)^XP&+_M
M..0-(_\MP;RV%;. >&H2#>.D6Y$,70M3DP<)!HL"RA89!\,T6&L9AT,_>DLN
MQ*/(P1J]*G4]@4ZZ0"?]M:@Y_Z%;M\)'-VK^KE#V:_T/K4MAJ[>KY'8\#\D?
MM74Y0K/=A7RUQSKLJX^0+#,.!9.K3$ QNH&6Q"G4E6;I\Y6W' _%;06U!X<:
MLNV>JY+N8YSU 3F=S12?(;^O8(6 HV[6DGQ_SW7=@ZTVR S]G54UNJYMG<1S
MG02[BQ=@D1FZ'@0ZQ%(30#>!K/W4\/-9OUH9D9-]K NQ$XP]<D"\83(F<-B=
M<F'L/R]VDCBQ?U(?.244S@=A"/,IS,?#P/L9Y+,.O]'>+,H84'I8.OPQ0/=7
M:&S(=LHG3I)@F4FMO!^@?(3RD1-X40\ETXZ2Z6LIN?.P 0T1ZB*DR2Y>]JO^
MG[Q4:Q@-16L\\[R&H#;F].*GHKGFZ2\H!2&!\X<;^-;7H=MQ*'(\'TX_P(-@
M.([( P!L^!-%T'%29(./+-GDC^/'8\<?(X- */DU4S:./\$PWAG:T<9EI^1J
M9J]T&EIG79GFWM/-=K?&T^:RM%[>7#D_,S6#I*,%GX*H.TS@E**::USS8>3"
M7ITFTL!%S [G<//E"A? _ZF49O6!&W1WZ9-_ 5!+ P04    " !S@5=6X09,
M\UH%  !:#@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RM5TMOVS@0
MONM7$&ZW2 !%UON1)@:2M,4&:- @R;:'Q1YHB;:(2J1*4G&]OWZ'E"R[M:VF
MP!Y$D1+G_<T,>;'BXJLL"5'H>UTQ>3DIE6K.IU.9EZ3&TN$-8?!GP46-%2S%
M<BH;07!AB.IJZKMN/*TQ99/9A?EV+V87O%459>1>(-G6-1;K:U+QU>7$FVP^
M/-!EJ?2'Z>RBP4OR2-1?S;V U73@4M":,$DY0X(L+B=7WOEUJO>;#9\I6<F=
M.=*6S#G_JA>WQ>7$U0J1BN1*<\#P>B8WI*HT(U#C6\]S,HC4A+OS#?</QG:P
M98XEN>'5%UJH\G*23E!!%KBMU -?_4EZ>R+-+^>5-"-:=7MCD)BW4O&Z)X9U
M35GWQM][/^P0I.X1 K\G\(W>G2"CY3NL\.Q"\!42>C=PTQ-CJJ$&Y2C307E4
M OY2H%.S&U[75(&7E428%>B&,T79DK"<$HE.GO"\(O+T8JI EJ:8YCW?ZXZO
M?X2OYZ,[8%5*])X5I/B1P124'#3U-YI>^Z,<WY'<08%G(]_U_1%^P6!Y8/@%
M+[#\:L_R=U3F%9>M(.COJ[E4 N#SSR$W=$+"PT)T2IW+!N?D<@(Y(XEX)I/9
MFU=>[+X=,2$<3 C'N,\>(46+MB*(+]!' MA$3T34)HY:?]XRA1ZP(H?T'N?\
M@3(,CF!+5%$\IQ55:T195P-T,E% BT0+7D%2 TPH0ZKDK03)\O3<@E"1>D[$
M$*Z]+Y[UQ>0+*1!^)@+2'S)<UQ CTIBBM"F:\YI@(4\M+W52R\M@V",M-L8*
M,-;*'-?ZHQM[K_R_FG]J0*K:*BJT-F=\<=;" DM) % GWJGUVHKMQ OA[=M^
M&N[1#9X]RULA (?HQ-=4GAVX8?=.W1&JBK/EF?:2%=E!&,!^-W2M)ZYP963'
M86)DA[[[^]X.G=CRX?F%KQ,G %^;<03/T8#G:!S/76?8POEV&[A#&![GMALY
MR\32A.^6@:U$*D2^0V<#(0"*Q3[<P769G41I%X@DL(ZP@V$_2#F72AK*R(_@
MG<:!685N8'W&@NJJ^L-6/PFMR(NL( NM&RQ+U&!: $'JZ[BF<0)CDB4C/HX'
M'\<O]?$VR3\.27Z/UZ8D'G+W..-#):/IN>F4 X%[V856^#?3$8:@"PUX#!:A
MY;FVZZ5Z'NFY'V=Z'NMY% 1ZGNAY&F;64PF1QPN(/U23U ZCH$\7/\CL-(NW
MV-@H;IUX@6]G06R=@C)S!>5#MF#F)FXGOIVF ?PT?([@R'-#VTW&@I<,P4M&
M??PP9.U]*_)2X^>!?&LI9/.QH(TSO&7H#J]-7;/!\P2Z8-U@MC8]Y*IN0(3"
M F%@#UW<[+AEL@4VZ+%MFFJ-KI:"&.E(<4@I!1O--K7I1-J?HLV5;J7Z!V:L
M!5<U&P/R;1]V@#FL&>N/;"NJRHY&R]=;?E)2RRZT8(@7>NT[+AR1JDJ3 MH&
M(K0@1-IH5=*\1"L(,.B4\R6C_P(Q92:4FF#)>2&1Y%4!@!1&DJZ&J+-]KQ$X
M"/"T4T@/670<^%J-7>2C-Z_2( [?:H5Z(T8R0/?"#OVF4!OL1T[4(S]SP@[W
MF3-V4DH'U*4O/F9\:$T@[\#DNJW1I\6"0C+H\]-G OZ%35WE'JLCX])Z"74O
M@7<2-)*>>PE=X?QE;<$_>?BEM07*?;SQ+E0%OW<O5&&O]Z_M0:/M"@LDMK];
M5^)P4U,2.TOBO6X#!<4._&RH&/Q8>]^T\$/QF^Z<]VLBEN96(Y'IR]W1?_@Z
M7)RNNOO"=GMWZ[K#8DF9!.D+('6=!'JJZ&XRW4+QQMP>YES!7<1,2[C\$:$W
MP/\%YVJST *&Z^3L/U!+ P04    " !S@5=6=@L$Y_$&  "6$@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,2YX;6RM6&MOXS86_:Y?0;C=0090;$G6RS-)
M@#S:W0$ZTR#)=+%8[ =:HF-B]"I)3Y+^^IY+2H[3V)JVV"\B)5V>^SKWDM+)
M0ZN^Z+40ACW65:-/)VMCNG>SF2[6HN9ZVG:BP9M5JVIN<*ON9[I3@I=V45W-
MHB!(9S67S>3LQ#Z[5F<G[<94LA'7BNE-77/U="&J]N%T$DZ&!S?R?FWHP>SL
MI./WXE:8S]VUPMULBU+*6C1:M@U38G4Z.0_?7>0D;P5^D>)![\P9>;)LVR]T
M\Z$\G01DD*A$80B!8_@J+D55$1#,^+7'G&Q5TL+=^8#^H_4=OBRY%I=M]6]9
MFO7I))^P4JSXIC(W[<._1.]/0GA%6VE[90].-EM,6+'1IJW[Q;"@EHT;^6,?
MAYT%>7!@0=0OB*S=3I&U\HH;?G:BV@>F2!IH-+&NVM4P3C:4E%NC\%9BG3G[
MT!1M+=@=?Q2:'=WQ927TVY.9 30)S(H>YL+!1 =@PHA];!NSUNR'IA3E2X 9
M;-H:%@V&742CB%>BF+)YZ+,HB*(1O/G6T;G%FW_3478E=5&U>J,$^^_Y4AL%
M:OQOG\\.,=Z/2.7R3G>\$*<3U(,6ZJN8G+WY+DR#]R/VQEM[XS'TLY]:K=E*
MM36[1&!ELY'-/?NY$XH3FS6[$*A(P:Y5^U7:"L$MV\WF/H=&5>YWZ-F.XMF.
M]MF.I;.C>V&'='88RRIZ8-8"?M0=;Y[>?)='8?9>LQ(BVLB"\:;$"B-48S%Y
MM8O_P#7C!%*A?X"BL@%8N]%8I-^^\_XCN'*<8V",J)="$6L\8@U=0KH$WN=&
M&HC<&FZ$]K[WCO+,CX/ >VOG@;^(4C=/\#S),4?-HZ(;SYH;O7\UVKA\T_D_
MHXJ-L"79LB499<M?H\$HUGX:W*U'<PQN:*F-9NW*YMJEBZCR-Q-VN5%*-,;[
M/+V=LI4HP8<*01NBOV]F135E^&#2/K7-,8F]>G$4A93TN]: ?46O^X#0E5@)
M")0O;3M*_#2@S&(29I3NH]B?9QDF.X;1LWE,+\/8C]/0BJ4+# =-&T9G6SDH
M/UKXB]BJ"1=^.G=(?AZ3";_P:L/=ID=IX$TA/"?>RSI!BW@@J,[7,6JF6VJF
MH]2DLF\;Q-.2XQ/.&4, ;3,^UUJ8O2S]*[#$N0;00WB(EF@;!$W= Q*[9+-[
MBFT[1#B?<=0P[T#O1XE]7E1/8QWG &NO7FM^YY&W?2]#*534,@JNU!/JYX&K
MDMI#$D=^,L_Z68Y&<8.:XZI86P-+\14'IP['(,,*P$NCO2R'7#P,E[R3R*/\
M#;K5L+1H48Q(\QS<.O8^2NSJ!M%B]M"EO1 L#'&-08GSHE ;K!6/..AIM*S(
M3[,$UV01NBX''G4;H.+P ^"ZEH;,\:*Y'X:9%Q&9$LO?7S>P8R4!!FW%%[AN
M2=@C>YF?YJF'.LE?6MTAYN2>M3GW S3%S$_ OY^15N7-_0ANPIXT]WX29$0E
M^5)6TCS!A32*O23/O0^T@<#+01N$8*BM B]$UX4ST+Q(D2ATM4*Z-U'DATE&
MPR*?/^<0[;3<%(;=(/K-1K WO.[>8P,C ^<H[A@&N7H\0#HO"U)T^KF7+A*,
MX=Z2/,J"Q ]<.R"Y8$'33P<0OX>S>;[ F$?92[H-\9 "G+,I)L9O$ 2[ELH9
M@8K[/2A)$DQL;-'21<<EB'@4Q=2%CJ(LVO;!\H .0B-+($ZFC)G\JK6,-)1L
MVU"RT<K_8;42]BQO^\<-R+.O>XQCW.TYCX@M+KF FA6LE'BF^O,/]1CJXAO3
MJJ>A[^]L@V[)3N<8#CY/J$G O]KS;!NRUW!H1L&?WB!_[/63XJ5HQ$H::X 7
MA=/ ^\<?AFN!+QCJE@SGH%I[Q^$TPN/C>!K3D$Y##+>V:.D;IZ0ZIS)R51)8
MJ6 Z)]E@FF"@T'-CE%QNX#1J3O8'-D#/'78R73CL%$-_G,+7C5FOVZJD?@C3
M 1I8:'<E-?LJY3ASD&%O=C;-,;CV$-A'PY5PG@GRA^2\UC9"QWQ+QWR42K?N
M<Y8J[KK5TIU:*?4/:XE.? NOT1,+CMA?KGES3U:QSPUZ4(LWO_7;X(5+X=Z-
M<%S_.2.HID!QNK#!D*6XETU#,29>@7EV6K>;?KO<[*K?89 FV_:PTJ>=I7-!
MK9[\_]NA?'\0O(NM^;"5P- _HC3W%T'T8C9TEW\JVJ:0;$7;0U]XP.NV^0!.
MIR0>VUI\=;8:(!U0*4:!^N.AA3IX6KL5QE2"]LG7VK:?$+Q#BP:BZRIV^KQK
M'5Z'R'XC,/UL'[MG._\*:J'N[1\1.L"#&^ZWP?;I]J?+N?O7\"SN_MA\Y IY
MTJP2*RP-IAF^*Y3["^)N3-O9/P_+UIBVMM.UX.A;)(#WJ[8UPPTIV/Z*.OL=
M4$L#!!0    ( '.!5U:N&@X#[0(  !<)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;,U6WV_3,!#^5TYA0D.")4W7EHTV4G\P,8FR:M7@ ?'@)M?4
MFF,'VVDWQ!^/':>AE;K 4!]X2>SSW7?W?;9SZ6^$O%<K1 T/&>-JX*VTSB]]
M7\4KS(@Z$SERL[(4,B/:3&7JJUPB2<J@C/EA$'3]C%#N1?W2-I-17Q2:48XS
M":K(,B(?1\C$9N"UO*WAEJ8K;0U^U,])BG/4=_E,FIE?HR0T0ZZHX"!Q.?"&
MK<MQS_J7#I\I;M3.&"R3A1#W=G*=#+S %H0,8VT1B'FM<8R,62!3QO<*TZM3
MVL#=\1;]JN1NN"R(PK%@7VBB5P/OK0<)+DG!]*W8?,"*3\?BQ8*I\@F;RC?P
M("Z4%ED5;"K(*'=O\E#IL!,0AD\$A%5 ^+<![2J@71)UE96T)D23J"_%!J3U
M-FAV4&I31ALVE-M=G&MI5JF)T]$$52QI7DHJEC JE'%0"M[ ,$FH-1,&U]P=
M%^MT.D%-*'L%)T Y3"ECQJKZOC;%6$@_KA*/7.+PB<2M$*:"ZY6"]SS!9!_
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MP5G/'%;IVK";:)&7G6PAM.F+Y7!E_EQ06@>SOA1";R<V0?TO%/T"4$L#!!0
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M6#)<(L(Q)8"AU=RXL:\3.U !&O$71GM^<@R4E$=*?ZB33]G<L-03H0*E0E%
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M%<J=9=7PJ3H1=*/',8]4"%KJPS6"&6(*(*^O*!6'$W6#9@2X^!]02P,$%
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M9\H=MC]0_Y\)43]_:2M8O>EN^E]02P,$%     @ <X%75H<0\35$ @  0@4
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MY15TAJPJSNI&B[PLVAZ$AA*PO-Q!E4ZE>0&>;X303S>F#FSJ_N@_4$L#!!0
M   ( '.!5U;OZ!. WP(  .P'   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y
M+GAM;*U546_:,!#^*U963:W4DI!  AU$ KII?>B$RM@>ICV8Y"!6'3NU'>C^
M_6PG9)2&KI/VDMB7^SY_=Q??C79</,@,0*&GG#(Y=C*EBFO7E4D&.98=7@#3
M7]9<Y%CIK=BXLA" 4PO*J>M[7NCFF# G'EG;7,0C7BI*&,P%DF6>8_%K"I3O
MQD[7V1ONR293QN#&HP)O8 %J6<R%WKD-2TIR8))PA@2LQ\ZD>SV+C+]U^$9@
M)P_6R$2RXOS!;&[3L>,904 A488!Z]<69D"I(=(R'FM.ISG2  _7>_9/-G8=
MRPI+F''ZG:0J&SL#!Z6PQB55]WSW&>IX^H8OX53:)]K5OIZ#DE(JGM=@K2 G
MK'KCISH/!X!N> +@UP#_&- [ 0AJ0& #K939L&ZPPO%(\!T2QENSF87-C47K
M: @S55PHH;\2C5/Q)'DLB20FI1)=H4553,37>ED4%'3!%*9H+CBR:4.WK/IU
M3 W.EPR7*5&07J#S&U"84'FA69:+&W1^=H'.D(MDA@5(1!A:,J+DI3;J]=>,
MEQ*S5(Y<I:,P6MRD5CRM%/LG%'=]=,>9RB3ZR%)(GQ.X.OPF!_X^!U/_5<8;
M2#HHZ%XBW_/]%D&SM\.[K\@)FI($EB\XP3<MI;9(B0YJ<Z( /R8KJ82^"C_;
M\E@=TVL_QK2':UG@!,:.OO\2Q!:<^/V[;NA]:,O!?R)[EI%>DY'>:^SQ%]W-
M!&R!E= 69P4.+=ATK6W<]8;#(!BYV\,(7KH-!WXT:+R>2>LWTOI_E4:Y;/V/
M^R\.O!J$PS ZTM7FY@V\L%U8V @+WR0,%2"J2Z@OIFYX)&F36G%%AQJ\3M [
M4MKNY;<+C1JAT;\+30DMU?'EKJ1&;Y+:[G4LU3UHG#F(C9TG$B6\9*KJ'XVU
M&5D3VZF/[%,]RJK)\X>FFH-W6&R([JT4UIK2ZT2ZW**:+=5&\<*VYQ57NMG;
M9:;',0CCH+^O.5?[C3F@&?#Q;U!+ P04    " !S@5=6G[GJ?@0#  #M!P
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MLXG*'J#]E91FM[ !^H<X^0M02P,$%     @ <X%75JC/@H%Y!   WA,  !D
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M_A;S-9_*BJ0X<O3G*E$LT4D^?O C[\LV"W9$MF%(V!D2OL6>C(G,06\MI";
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M]J-B/]RMF[O5?FSK_T'D@G*%&,P-S#N+C3G9MM-VHD75=*29T*:_-</"_(%
MV@"S/Q=";R:VR?7_M/0O4$L#!!0    ( '.!5U:PO781(@,  )T-   9
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M?@*N U3[@C&Y+>@.JA=9\!=02P,$%     @ <X%75F$O<7)P!@  =#(  !D
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M:;;4S%4+36D$GA+KSR:58)--_-#W#MFD:M9D$]\GQ&MG$Z)ABL PU5&R,)W
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MP5 L-6<I3"51RR2A\F$,7*Q'CN=L!B[9?*'-@!L,,SJ'*]#7V51BSRU98I9
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M>F.C5S9%M.EH4;G"M1+:E$'7+,Q_!Z1=8.;70NB7CJV%_D^6_@502P,$%
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M?A"H70$]3Y6RVXD3:'XYT1]02P,$%     @ <X%75KG&O)7! P  * P  !D
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M9!&!@,S8$ PO!UB!$#82XOC2!@VZ/:WC^?TI^H^./)+9,@TK*?[@.[-?!&E
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MIO1\0F4=:'PNZ9ZH.W:"YD$6_0902P,$%     @ <X%75OE6V7%Y!@  'B@
M !D   !X;"]W;W)K<VAE971S+W-H965T-S N>&ULM5I;;]LV&/TKA'M! C2V
M2%_BI(F!Q(ZT8,T:).WV4.R!D6B;B$1J%)4TP'[\2$JQ+%>F[)5M@%H7GJ./
MYZ-('HIGSUP\9DM")/B>Q"P[[RRE3$][O2Q<D@1G79X2IN[,N4BP5*=BT<M2
M07!D0$G<0YXWZB68LL[DS%R[%9,SGLN8,G(K0)8G"18OER3FS^<=V'F]<$<7
M2ZDO]"9G*5Z0>R*_IK="G?56+!%-",LH9T"0^7GG IX&:*@!IL2?E#QG:\=
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MO=RT-D=E6'M,$AI\$90'>5"^*(+R-M#>N3:>-5?N=C4,/SM=L,8IX(R<Q?I
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MAT3H"NKY@JOXH+C1#90_AYC\!U!+ P04    " !S@5=6G.Y&FA$#  "*"@
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M84$%FW<$ZWK3ZM^!:C&3C9!@/=7>-*J]L:KVV$1F2%)6TJ62PH0M,&$^)BS
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M80R6G*G71,1Q*<='ADGX01-M(Q[TZ=8A]!G&'T++0NBW\F,8S78PG(#+!&-
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M/!&9[3T1@48-H#0*I8506H2BZ<)J/1YCL\=C^WQ12-V019KGHE<]4!\'E.9
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MVGU( 8T90&D42@NAM A%T_74.C FYB'^[6ZVO8J!VBJ@- =*<Z$T#TKSH;0
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M-Q ' L'1"X).$)P*HC."82<8OE<0=H+PO8)1)QB="L(S@J@31&KLV\%2(YU
M#N,9)3M 96U!DQ?*+J46 UQB.;.>.!5/2Z'C\2VA0E'B%0-78+%8@ <"L;B\
M*8I26@\K<(_;"2PGPL<$<5A6GT2-KT\)^/CA$_@ 2@Q^7Y.&05RPF<M%5)+M
MYET$=VT$P9D(?/!(,%\SD.("%1I]^H8^, !<T;E^3(+]F-P&1N+-A@Y $/P"
M B_P=1UZAWSH*;FGD2=OR)N5D/M2[D]UPV&6)RC?R[7!9^^7>X:Q'/;S:ZAX
MP[.\9RYF$..T$?L1!W\]B K@GJ.:_:V)[K:EA7J:W&:OV0;F:.Z(?90AND5.
M_/-/?N3]JO/))BRQ"4MMPC)+L"-_P][?T$2/%Y3D"!4,+"FIP3UC#<0Y F0I
M-A*\NN*(UD#. 9W71O*E7MN$)39AJ4U8UL(B!9.GAFT<3L;#F;O5>#CJ/1P9
M/7R$O*$E_PX*R)'.*+.\WS+DGC'2>6/47^J-.9C?R'8 @#=LHPEU?MB,)K,$
M._(MZGV+C'U]((P!\5)&+UR\P)N2K=46*]9><6;%&7F7KCB;L,0F+(U^6"17
M_EB<M?METGJGJ19$H7XMC7M/QN;]L#M"Z4;?J+QT]&W"$INPU"8LLP0[\G+2
M>SFQ>G:9V/37)BRQ"4MMPC)+L"-_I[V_T__M[&(D7^KU],>7^O1TMTILMIC:
MA&668$<>^M[K!ZSWWTXO9OVE7KT1C?KX ]ZT/7\$NL5H-9[4*BVS13OV\B 9
MX9M'#^,&5J#$8NTAQ@$]9ZD1<[&E+6UZL/Z\@>=-)R<KT&JKJ55:9HMV;%SP
M:EQ@^2AJ!EYLH4U:8I66=C3S]I[9:K,UT#W("-:(KE3NEH&<-)BWR9N^M,\/
MWZBLZ$GYG7^=^)KR5.:350;R%=\FHQ\A7968@0HM15/>8"P^D6B;WVUO.-FH
M?.0SX9S4ZG*-8(&HK"">+PGA^QO90)]EC_\%4$L#!!0    ( '.!5U8X=;UD
MN (  )P'   9    >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;*U576_3,!3]
M*U:8T)!@^6PWC392VX#8PZ1J9?" >'"3V\9:8@?;:0>_GFLG#6V73D/:2^*/
M>T[N.8[O'6V%?% Y@":/9<'5V,FUKJY=5Z4YE%1=B HX[JR$+*G&J5R[JI)
M,PLJ"S?PO*%;4L:=>&37YC(>B5H7C,-<$E67)96_IU"([=CQG=W"'5OGVBRX
M\:BB:UB OJ_F$F=NQY*Q$KAB@A,)J[$S\:^3@8FW =\8;-7>F!@E2R$>S.0F
M&SN>20@*2+5AH/C:P R*PA!A&K]:3J?[I 'NCW?LGZUVU+*D"F:B^,XRG8^=
M*X=DL*)UH>_$]@NT>FR"J2B4?9)M&^LY)*V5%F4+Q@Q*QILW?6Q]V /XPQ.
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M>T :$H(]O)CVPDVNC;7$[FRWA6^_LY-F"4D#D_JFC9V[OW]WL<\WV0KY6Z4
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MJ^HG5M^PK&XDS\J/-.ZYE#PI+Q<LF#)1"*CG,\[ETTW10?TET>A_4$L#!!0
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MP)2!?+^B5#P/5(#FPGSZ#5!+ P04    " !S@5=6:%:B.1D8   I<@$ &0
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MBVE=6Y*;S4)JBWR676?3[7>VZW_73=YE^;IL5J/+OC9KPS\7R%,W=W390:/
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M.2:7F& >)IB/!&9P>51S>824T3[9@>Z<5@J/7J9!YW@X?98&K=!]N<$$\Y'
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M:W-H965T<R]S:&5E=#@T+GAM;.V=ZV_;MAK&_Q4BZQE:(!=+ENTD30/D4EV
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MZF))&O"4FI/*P>-T"A)L$6C5"YM=1/WV9F@=]MF<1"$^I@%41+XD;GV56]*
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MX;ROX6#/\L#XDT@ )/J>TDRLC$3*_-8T191 BL4-RR%35[:,IUBJ(=^9(N>
MXS(II:9C6;Z98I(9P;(\]\"#)2LD)1D\<"2*-,7\^ XH.ZP,VW@^\9GL$JE/
MF,$RQSMX!/DE?^!J9#:4F*20"<(RQ&&[,M[:MZ'MZ(0RXBN!@V@=(RUEP]B3
M'MS'*\/2%0&%2&H$5C][6 .EFJ3J^%9#C>:>.K%]_$R_*\4K,1LL8,WH7R26
MR<J8&RB&+2ZH_,P.[Z$6Y&E>Q*@H_Z)#'6L9*"J$9&F=K"I(25;]XN^U$:T$
MQ[F0X-0)SDL3IG7"]*4);IW@ELY44DH?0BQQL.3L@+B.5C1]4)I99BOY)-/S
M_BBYNDI4G@SN,.'H*Z8%(+9%=R3#640P1?>9D+Q0$RP%^@V]C6.BIZF\4#UL
M>M)>AR QH6_0*T0R]&?""H&S6"Q-J2K3?#.JJWA75>%<J"*$Z 9-[0ER+,=!
M7QY#]/K5FQ[,^N48>P 3#F,^L;W"6$,84]G<>.TT7CLE=_K?7O]QR>N_/Z@D
M="\A%?_T^5C=P>V_@VX2MR+'$:P,U04$\#T8P:^_V+[U>Y^;8\+"D6 =9Z>-
ML],A>K#&(D'JT4.1/H!O!=ECJOWLL[!"^25*M\5]X"]F_FQI[MO>G$?9CFO/
MW6Y8.%C7_U3M-JK=0=7U$Y3M$"5X0RB1QPFB3(TE\+1/>L7S6J(6KF<[)])[
MHJ:>XYTH=\\,4BS+:J(ZDKQ&DG>]))$P+B]J\L[K\/R38M?>F20UYR=3'IX'
M+?Q+@OQ&D#\HZ!.3@')\Q!L*$Y0#C]1CJ3ZHNMLFQYS)!"2)5!,X$J!QG[Z*
M;UNMLJP;^T3?8!'7OLDCP3I^S1J_9L,/0-,C)ZHOYH44$_0!]D#1M,^<0=BU
M[7!,6#@2K&/BO#%Q_M,_-/,QG1T3%HX$ZSB[:)Q=O*0_*2^?^Q,!@;;:[[WV
MN\_)0>*U3HX)"Q?GWSAKZEQJ>;;U8TUI#;KTD65P1!\Q?U(;E[OBTI)P$'*M
M,:/2PK%H70-;BW+[I[_ ]2W&LG=,6C@6K6OOCW6X/;@8O6ZY6+.ZZ\5YZR6I
M#3H/4PM&YS0N'"[M6NEF:^>G]^GJG=N13" *6X6W;F9J-<.KK6\UD"PO-X,;
M)M76LCQ, ,? =8"ZOF5JP5(/]/ZR^0=$\"]02P,$%     @ <X%75BY1D6'1
M!P  D5   !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULM5SO;]LV$/U7
M"*\86J"S+5)4?BPQT)KK5J IBF;M/BLVG0B5)4^BG1;8'S]*5D73OM"6<NR'
MQG:.3]23CWGWCM+58UY\*Q^D5.3[,LW*Z\&#4JO+T:B</<AE7 [SE<ST;Q9Y
ML8R5?EO<C\I5(>-Y/6B9CNAX'(V6<9(-)E?U9Y^*R56^5FF2R4\%*=?+95S\
M>"O3_/%Z$ Q^?O YN7]0U0>CR=4JOI>W4GU9?2KTNU&+,D^6,BN3/".%7%P/
MW@27(N+5@#KB:R(?RYW7I#J5NSS_5KUY/[\>C*L9R53.5 41ZQ\;.95I6B'I
M>?S;@ [:8U8#=U__1']7G[P^F;NXE-,\_2>9JX?KP?F S.4B7J?J<_[XEVQ.
MJ)[@+$_+^G_RV,2.!V2V+E6^; ;K&2R3;/LS_MX0L3,@")\80)L!]-0!K!G
M3AT0-@/"FIGMJ=0\B%C%DZLB?R1%%:W1JA<UF?5H??I)5EWW6U7HWR9ZG)J\
MBY."?(W3M23Y@KQ+LCB;)7%*WF>E*M;Z JN2_$9.B7HII(J3])4._W(KR,L7
MK\@+DF3D)DE3?87+JY'2\ZV..IHU<WN[G1M]8FY"SH:$!:\)'5,*#)^>/CP
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M(OQD9'O.MQ,M:GOR/0J-YZ@=YG@U FD ^'PCA'Z:F!?TEZWX-U!+ P04
M" !S@5=6Y,-S\S@%  #F(@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,2YX
M;6S-6EUOXC@4_2M65EK-2CLE-OF +B"U=6=VI.V4+9J=A]4^N(D!JTG,VJ:T
M_W[M)"0$0E16K@8>( GW'M][KJ^3 QYMN'B22TH5>$F33(Z=I5*KRUY/1DN:
M$GG!5S33W\RY2(G2IV+1DRM!29P[I4D/N6[02PG+G,DHOS85DQ%?JX1E="J
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M&QJYR1^4 ?KS>YF*9W0O>13JW-8G2A<C(]:Y^Z4GL!;MH*$=O/'1$O19JI[
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MT*;!*8:I:2E!6@/S?2F$/DXL0=VD1G\ 4$L#!!0    ( '.!5U:IL]G:=P0
M  D5   9    >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;+5886^C.!#]*R-N
M=6JE;L F0-)+(C7IGFY/VMNJW>[J/KK@)*B <[;3M/_^;*"0$.*F*/V28.-Y
MGN>Q9QX>;1A_%$M*)3RG22;&UE+*U:5MBW!)4R)Z;$4S]6;.>$JD:O*%+5:<
MDB@W2A,;.XYOIR3.K,DH[[OADQ%;RR3.Z T'L4Y3PE^F-&&;L86LUX[;>+&4
MNL.>C%9D0>^HO%_=<-6R*Y0H3FDF8I8!I_.Q=84N9QAK@WS$SYANQ-8S:"H/
MC#WJQM=H;#G:(YK04&H(HOZ>Z(PFB492?OQ7@EK5G-IP^_D5_<^<O"+S0 2=
ML>17',GEV!I8$-$Y62?REFW^HB4A3^.%+!'Y+VS*L8X%X5I(EI;&RH,TSHI_
M\EPNQ)8![A\PP*4!;AIX!PS<TL#-B1:>Y;2NB223$6<;X'JT0M,/^=KDUHI-
MG.DPWDFNWL;*3D[N) L?X6I#> 0W"<D$?(:[(J3 YE"\_K[22R[@^UH*2;(H
MSA9P=DTEB9-S-?[^[AK./IW#)[!!+ FG N(,[K-8B@O5J9Y_+-E:*$,QLJ5R
M6D]MAZ6#T\)!?,!!A.$;R^12P)<LHM$N@*W85I3Q*^4I-B)>T[ '+KH [&#<
MXM#L>'-D<,>M(N#F>.X!O'_6Z0/E^6+G:]>V1 5"OQU!G_1+L2(A'5OJ* O*
MGZ@U^?TWY#M_M-$[$=@.V7Y%MF]"GVSO("+A;Y*M]4X['(QI@>?E>#HG/4V0
M$[C80^[(?MJF99RX(RVOHN49:7UYICR,17-[%@R\/0:?$1KZ[A U&!CGZ,C
MKQCX1@8J)\YI+-L9^&T,_, /&@2,4W0D$%0$@C="L(IYN_O!OOMNOQ_X@X;[
MQ@DZNC^HW!^\YV"H)$/SM&#(4]/!'J^A$_2]03,L^^/VCM".S\/*Y^$QNYX\
M)/1HGX=[O@1!X'NH&0OCS!UC@9RZ*#K&G/PKK_XT@JLGRI6:@=<##C<\#BFL
M%,L\6[?6,^>4V?I4:+LKL24/T(D3=@D8;(78[3G-7&>>MBLM7-/"W1-V::M7
MOCXQO6#8I&"<HBN%6C8@8Z$V9^S2MD%A@)L4/D(+H%H,(+,:,.3LTG*'@-]S
M][;11U1]5)=]9*[[7;)V";G#3!T0O\G,,Q^C78_K,H_,=;Y+SBXA=UW!3?UE
MGKAK*.KRCX+WI>Q;JK]B=61FZON!J^_%-4G@!^4IG/U+"1?GK5Q/) +*-?D(
M28%J38&.%A6M7,W6'KSH90($J?X  Q\B\M+V>3([$L@K@ 3@-JA=CK4&0:<7
M(6] -HGC_F'F'Z%3<*U3L%FG7"T6G"Z(I/!5;?$X$W$(/TFR;M4E^*2ZY%1H
MN\QK78+-NN0@\PMX8]>7P/Y6-L-##S5+8\LPM^_U#TAF7"L/?)3R>-=^+2%W
M7/9<Y#5=/JD@L;<NE5+*%_E=FX"0K3-97+94O=5]WE5^B]7HGZ++67$K5\,4
MEX3?"%^HT$%"YPK2Z06JYO'BWJUH2+;*KZX>F)0LS1^7E$24ZP'J_9PQ^=K0
M$U2WGY/_ 5!+ P04    " !S@5=6(,(5F30#  !,"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Y-RYX;6RU5FUOVC 0_BM6-DV;M)+8(1 ZB$3;=2]2MZJH
M[6<W.<!J8C/;@5;:CY_M0*!K"*VF?4ELQ_<\SUU\YQNNA+Q7<P"-'HJ<JY$W
MUWIQ[/LJG4-!54<L@)LO4R$+JLU4SGRUD$ S9U3D/@F"GE]0QKUDZ-8N93(4
MI<X9ATN)5%D45#Z>0"Y6(P][FX4K-IMKN^ GPP6=P03T]>)2FIE?HV2L *Z8
MX$C"=.2-\?$)[EH#M^.&P4KMC)%UY4Z(>SOYEHV\P"J"'%)M(:AY+>$4\MPB
M&1V_UJ!>S6D-=\<;]'/GO''FCBHX%?DMR_1\Y,4>RF!*RUQ?B=576#L46;Q4
MY,H]T:K:VS>,::FT*-;&9EXP7KWIPSH0.P8AV6- U@;$Z:Z(G,HSJFDRE&*%
MI-UMT.S N>JLC3C&[5^9:&F^,F.GDXD6Z3T:KZC,T&5.N4)':%+](22FZ J4
MEBS5D*%JYS5G&HUM*)E^1._/0%.6?QCZVFBQB'ZZYCVI>,D>7DS0A>!ZKM!G
MGD'V%, W3M2>D(TG)Z05\0S2#@KQ1T0"0M!;Y",UIQ+4^M7"$-:Q"AU#N(?A
M1UG<@;1AF31 5AHKA&XS@DVQ8[6@*8P\DT,*Y!*\Y-T;W L^M>CKUOJZ;>C)
MSU(K37G&^ Q1C;Y37MK?N G)[\9(5+(KX,@!VT1>)H,HC(.0#/UE@Z*H5A2U
M*OHB*;=GIXTZ>D8=81+TXCW4O9JZUTI]8T[N >;>,^8C'$4XB.-FZGY-W6^E
M-N5B"NP0>[^!G?0&9-!O9H]K]O@UI\"D!;AC&[[D',3/1&$<AW%(!LVB!K6H
M06OJW+KJ:"(R7H(TU1ZYDX%,R0)T3IE$-S0O 2V,3I=;3=H&_R&U<+"MD\&_
M)=>VXC16PPJ]OQ/9L--M#BK>*=[XA?EU@'U]"01/Z ?1'GZRY2<O2[(#].0Y
M/>GLRW"\K<>XM9P^2;0#"L+& .Q)-;RMN/A5);<IV0X(ZS:<B][?/\;?N> +
MD#/7QBB4BI+KZJZO5^M6:5PU"-OM59]U0>6,F6L^AZDQ#3I]D^RR:EVJB18+
MUR[<"6V:#S><FW8/I-U@OD^%T)N)):@;R.0/4$L#!!0    ( '.!5U::EZMC
M:0\  'JS   9    >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;+6=:V_;.!J%
M_PJ1G5UT@#31U4ZZ:8#4DB@)Z4S1[LQ^&.P'1:9C;67)HTLN0'_\DK)L61%#
M6SLG4V#B"_F0LLXK4CPD=?68%]_+)6,5>5JE6?GQ9%E5ZP_GYV6\9*NH/,O7
M+./?+/)B%57\;7%_7JX+%LV;3*OTW-"TR?DJ2K*3ZZOFLR_%]55>5VF2L2\%
M*>O5*BJ>/[$T?_QXHI]L/_B:W"\K\<'Y]=4ZNF??6/7;^DO!WYWO*/-DQ;(R
MR3-2L,7'DQO]0VA?B Q-BM\3]ECNO2;B4.[R_+MX$\P_GFBB1BQE<240$?_S
MP&8L306)U^//%GJR*U-DW'^]I7O-P?.#N8M*-LO3?R?S:OGQY.*$S-DBJM/J
M:_[HL_: ;,&+\[1L_D\>V[3:"8GKLLI7;69>@U62;?Y&3^T/<4P&H\U@O,A@
M&*]D,-L,YK$9K#:#=6P&N\U@O\R@OY)ATF:8''O0TS;#]-@J7;09+H[-<-EF
MN#PV@ZYMSYS6*&ASRAN].%$575\5^2,I1'K.$R\:T37YN4R23,3'MZK@WR8\
M7W4]RU>KI.*"KTH297,RR[,JR>Y9%B>L)._)S7R>""%'*0FR33@*6;]S6!4E
MZ<]7YQ6OA$"=QVV!LTV!QBL%ZN0S+V)9$C>;L[DD/SV0WU  SOG1[WX"8_L3
M?#*4Q%_RAS.B79P20S-T\MLWA[S[27I@:DQ89V?$U!J,H< X1]2FQ:AJXQZ-
MT:<*C*?&?(Z>B:D?I% UQ6'Q68OI?AKR.ULF<<HD./]XG.HG"H[': I,>.B\
MIUP^F]_(E&-ZLC1WD6DV7/.(R+P91.8?MSPY"2JV*O\CJ?.G#=N2LT6C^Z%<
M1S'[>,);U9(5#^SD^A]_TR?:/V7"1\(<),Q%PCPDC")A/A(6(&$A"-:+$&L7
M(9:*?GT3QT7-YH0]\=YBR38-6%XM6<';SJ+@D4/2)+I+4MZ"L5(6)4K^V"A!
MPAPDS$7"/"2,;F"3!B:Z\@_7EYKX[^K\85__PV2Z+DD7(.L6@F ]:=L[:=M*
M:?^Z9D4D+O<D9;SW3^*\K*0*5F+&*A@)<Y P%PGSD#"Z@=G[TK0->RCA8;J+
MB3E4L#U4NJ4-TX6@8^B)<[(3YT0I3B_)(MX+$>)L+Z_/,FDJ(6.EB80Y2)B+
MA'E(&)T,I:E9LNNF+TNIV;(K++*"(0C6$_%T)^+I6!&?DC3G[RM6K&1Z5O+&
MZAD)<Z;#5M22G3T76:J'A-'I0('\$'1C*%5)0E-VP0V0U0M!L)Y2+W9*O1BO
MU'*9%]6K4E4"QTH5"7,NAJ=O(E,JLE /":,7PV"S)Y(&?WBDD\OI=*A39.5"
M$*RGT\N=3B^5.OT2/8O1"I(ONNLH6==%O-ST8+?#&:<DXG_F3=H%D]^8*4L:
M*V DS$'"7"3,0\(H$N9?#D+!T&2="V2A(0C6"P5=ZX;5-64P?*O7Z_29W-P7
MC#5*9T_KI-@,GO-[NR27#7U_4D/'ZAY*<Z T%TKSH#1ZX-3NQHW%P/%4IG=H
M=0(H+431^G&Q9S?IX^*B8!E[C%)54"B)HX,"27.@-!=*\Z T>N"\&N29186L
M+?>A]0B@M!!%ZT>#T46#,6:8[Y04PLY_GR_>U[S+%)4EJZ01H:2.C@@DS8'2
M7"C-@])H2]N_$YA,=6MX)R!):!@7PX0!M'XABM;7=F=?ZDKO9T_;MQMM?]UJ
M^S>N[1NA[5/RK8HJMKUK:&]T>6/P)2^;60?D#_>I$I-Q[E)&W*Q>L4T72FIY
MJNLS.BJ@IB>4YD)I'I1&#ZFBL>>:*YN\L?A+V0/HL80H6C^".GM35_N;@]9!
M.=RNAHV6/]3-A-)<*,V#TJ@^M"HG$VLX[.-+$AJ6(;DIAM8O1-'ZDNYL35WM
M:SJLC(MDW5S;^16_Z>Z0*N=WQU4[YU*,'C66YVMCF^H21NL<ZGE":2Z4YD%I
M],!Y_M>2D5F^6D?9,WE,TI3?YL4L>>!]6E(F3^]78@8?B?,L9F5SUB.N IZE
MK**BZ0J(-QL9=,K8W"$2_BJLT^VT-,,\(_N%+:.29#E9U$734O0%-M_C-J.3
M=^PY;S]]6<Z9M'5"_H8!E!:B:/W([CQA76T*NW_6R;KIR?T@O[^GN31TH98P
ME.9 :2Z4YD%I%$KSH;0 2@M1M'Y(= ZSOK$%WV8&IP[UFZ$T!TISH30/2J-0
MF@^E!5!:B*+U@Z4SN76UR]T,$O 0*>4C7E!'6Q]ZN+IE3H>=;P=:K@NE>5 :
MA=)\*"V TD(4K2_TSB77U3;YYZCD?<_-H-B>#_*8\!ZQF_&OUD7"O_FQ71^Q
M22EUR=4EC8X*J$\.I;E0F@>E42C-A]("*"U$T?K+M#I/W=#>L#]E0+UU*,V!
MTEPHS8/2*)3F0VD!E!:B:/U@Z8QV0VW(_E*O[G@SDR_(0]N.-.,>)2E8E11L
MWC4PTF"!>NY0F@.EN5":!Z71EM9;-&"_&$>&EAA :2&*U@^!SETWU.ZZ(@36
M*2_V4 Q 778HS8'27"C-@])H2U/' ++$ $H+4;1^#'0NO*$V3%^- ;7TH58Z
ME.9 :2Z4YD%IM*7UI'_Y4OK0I<%06HBB]:7?V>?&*/N<%.TTW&:ML%3U4 <=
M2G.@-!=*\Z T:@R-<>F:-6BI 906HFA]Y7<NNZ%V7VF49"0O2)J7HK,3Y\6<
M=W86XI-M!VB5/TAW7_FD1H\. JB]#J6Y4)H'I5%CN%Q8MJ#/AY8:0&DABM8/
M@LZ0-M2&].>H2._R(J_OE^U@ZP_RJ4[2.6\1Y)=_J#L-I3E0F@NE>5 :A=)\
M*"V TD(4K1\?G3MMO*4[;4#=:2C-@=)<*,V#TBB4YD-I 906HFC]8.G<:4/M
M3H^_EX :UL;0L#8N+BZ'JXX=:+DNE.9!:11*\Z&T $H+4;2^]CO#VCBPKIL5
M,9=[=,_$,%*49764DB2+BR82^)W&)B36F^7?TF" ^M0M[6(O&+0SS7P9"%#_
M&4KSH#0*I?E06@"EA2A:?S_&SG\VU0M_9U&Y%C,W^+^93.;J[&-E#J4Y4)H+
MI7E0&H72?"@M@-)"%*T?#IW#;.IO> -A0AUF*,V!TEPHS8/2*)3F0VD!E!:B
M:/U@Z;QH4^U%?XM2WD4JDECJMYG#%<*Z9IB2$;^9NIS12C^Z8!=:L >E42C-
MA]("*"U$T?HRWMN36FTGW[9]_J02R[1?6Z)W &)HKVX6,5-G'2UO[&;3V-VF
ML=M-8_>;QFXXC=UQ^BU<9;-SE4VUJWR['?]I=JW)FZ6LTAA08RQ%"$"-8RC-
MA=(\*(U":3Z4%D!I(8K6#X'.7C;5]K(L!*2#H <X+PAB=&DAU@B_'AE0-QE*
M<Z$T#TJC4)H/I0506HBB]2.C\YQ-M>=\R\J2L=.-H/>6G?]1%34CBR@MF?QF
M6(T5N:7Q /68H3072O.@- JE^5!: *6%*%H_'CJ/V51OLGWT8PQ,R1;6L@DO
M,W6!HR4/=8JA- ]*HU":#Z4%4%J(HO4EWSG%YA'KF$_)O-OH1JIW-43L:%+E
M%>\;M79;XS?7V9P5S68EFQY8LUM**?9.B=;K(G]*5E'%TF?RT^69359)FK:[
MF30=JE-2UG?_97&S&TI$;.WO&VATM]V!;5X7(E(%?Y$49=5DVV[&TAZ6>,).
MLY_+SO_;5)"7>O=,WB4_$^/,_KLP!9OM7%B\V5YE,PMKD2RJY9#:0-\E/*_9
MY4R>>%+Q!8OBI:AZR?ZL12TEE>)U26LQK8N('6"VO4HQ."';Q&6F_NU'7T*@
MACN4YD%I%$KSH;0 2@M1M/XEI#/<3;7A_HW%/!2K9WX168N-$*47D,OAC!#9
MGMHS=5FCU0YUU:$T#TJC4)H/I0506HBB]9_AUKGJEMI5WXXF[)X4<*#I/("K
M7FP&MLCK8C?"P)N^O8)$TB]%SEM(\40-WO(8FC$1FXIMMA8S)TT#9&@6?RLF
MSXOT][S5JS8+JD1K]Y.N&6?FKK'=M61-(QHE!5E%Q7=6D8<HK=FVV=J6*6V=
MU(<W-EZA-!=*\Z T"J7Y4%H I84H6C]>.]O?4B\L_YQDR:I>D1_DT'P8-6BL
MQ0^E.5":"Z5Y4!J%TGPH+8#20A2M'QB=Q6\9;S@?QH*N-H?2'"C-A=(\*(U"
M:3Z4%D!I(8K6#Y9N(H%US$2"KC,F'@J5U_+IPRWJF-DQZE)'ZQXZ?0!*\Z T
M"J7Y4%H I84H6E_W>X^L5OO^#F/%(F&IV'OD<Y*RLLIYL] \&J$DMZK]W=7@
MT0T$=)(!E.9":1Z41J$T'TH+H+001>L'2C?)P++?LC<%7<4.I3E0F@NE>5 :
MA=)\*"V TD(4K1\LW;P#2SU!8!<<5?>,D&;(:K5K8MKE65+W54T?'2W060E0
MF@NE>5 :M89/X;[49&/Z/K3< $H+4;1^)'0S#BSUC -I)!1L)79$X2$0W<DW
MO%)31T< =)("E.9":1Z41JWAP[TGKT0 = ("E!:B:/T(Z"8@6.JY S=Q7-1L
MOEN=WI@2>?,TE+@NBOW(2.1KU]4%C X&J-T.I;E0F@>E44ORJ'1I*$"-="@M
M1-'ZH= 9Z=:!K=9WO9]B<X.M?(":&C9:]E#?'4ISH30/2J/6\&'AIESW4$L=
M2@M1M)[N[<Y2MP\]H?J802;Q9?0DO#Q9-*B+&!L-4)H#I;E0F@>E42C-A]("
M*"U$T?HAT[G:]ELN9K>A3C>4YD!I+I3F06D42O.AM !*"U&T?K!T3K>M7LS^
M%X>;U/31T0*UNJ$T%TKSH#0*I?E06@"EA?9PDX/!P%H_$CH;VU;;V/_G<).:
M.CH"H*8WE.9":1Z41NWAO()7AIN@Y0906HBB]2.@,[1MM:']M2Y+EJ;D:Y3%
M2_(UC^8D",CM[8S?7ORZ6"1QNTQ#&@902QM*<Z T%TKSH#0*I?E06@"EA2A:
M/U0Z2]M^2TO;AEK:4)H#I;E0F@>E42C-A]("*"U$T?K!TEG:MMK2'KWCKIHW
M.CZ@)C:4YK:T_7[+]-*V7NR ZDF26=JEK?>346C=?"@M@-)"%*VOZ,Z:MM76
M]%_?1U==P&B)0UUJ*,UM:>H]?KVC4E%HS7PH+8#20A2M+_#.>;:/>80WOT8G
MXLHM7[VG1HR6,-1;AM)<*,V#TNB!$VEHAOE>FTKE#W6;H;001=O(_[Q<,E8Y
M415=7ZU8<<]F_#:W)+%8I2#Z^'N?\L[)0CSX^\.-<7(^^'RF?_!TR>=4_Q T
MGY]W^.NK-6\?/D?%?9*5O$%8\**TLRGOBC4.]O9-E:\_GN@GY"ZOJGS5O%RR
M:,X*D8!_O\CS:OM&%/"8%]^;P[G^'U!+ P04    " !S@5=6N<)3LGP"  !6
M!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6RM56UKVS 0_BN'!Z.#
M+7:<M&L[Q] FE TZ*.VV?AC[H-B76%0OGJ0DS;_?279,RMPV@WV)==(]C^X>
MW5VRC38/MD)T\"B%LI.H<JX^CV-;5"B9'>@:%9TLM)',D6F6L:T-LC* I(C3
M)#F))>,JRK.P=V/R3*^<X IO#-B5E,QL+U'HS20:1KN-6[ZLG-^(\ZQF2[Q#
M][V^,63%'4O))2K+M0*#BTET,3R?CKU_</C!<6/WUN SF6O]X(TOY21*?$ H
ML'">@=%GC5,4PA-1&+];SJB[T@/WUSOVJY [Y3)G%J=:W//259/H-((2%VPE
MW*W>?,8VGV//5VAAPR]L6M\D@F)EG98MF"*07#5?]MCJL =(3YX!I"T@/10P
M:@&CD&@364AKQAS+,Z,W8+PWL?E%T":@*1NN_"O>.4.GG' NGVHIN:-G<1:8
M*F&JE>-JB:K@:.$#W%'9E"N!H!=PQ16C?;6$:\[F7'"WA6LD#>$;&AG@,VX+
MO5(.;IE#.)JA8UR\RV)'H?H+XZ(-Z[()*WTFK!D6 Q@-WT.:I&D/?'HX?/@4
M'I- G4IIIU(:^$8'J'3QETH^::'MRB#\O)A;9Z@V?_7EW%PR[K_$]^NYK5F!
MDX@:TJ)98Y2_?3,\23[U*?"?R)[H,>KT&+W$GM^'[L 2V!H--3OULY\8OC1$
M* CG"^*(*]@B,[:W %Z^87C:0.$,)(E=6:"=DFUMGQ2O4)T=1/5$B'$GQ/C?
MA"AW#6"H ?K2;OA. Y\?L>L\&21G6;S>3^@5IR;4>*_K_<3]RLR2*TLOL"!8
M,OAX'(%IIEAC.%V'03#7CL9*6%8T^-%X!SI?:.UVAI\MW5])_@=02P,$%
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M&L^H70#M+Y6R6\,=T W\]"]02P,$%     @ <X%75J$98/;O @  < @  !H
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M.)R#- OP_XD0>G-CIKE\W._^#U!+ P04    " !S@5=6EM+2]M4"  !!"
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&ULK59=;]HP%/TK5E9-K;0U
MGX2V@TA -JW2JJ&R=@_3'DQR(583.[,=Z/[];">D?*2,A[X0V[GG^)YS'5\&
M:\:?1 8@T7.14S&T,BG+&]L6208%%I>L!*K>+!@OL%13OK1%R0&G!E3DMN<X
MH5U@0JUH8-:F/!JP2N:$PI0C414%YG_'D+/UT'*MS<(]6692+]C1H,1+F(%\
M**=<S>R6)24%4$$811P60VODWL2ACC<!CP368FN,M)(Y8T]Z<IL.+4<G!#DD
M4C-@]5C!!/)<$ZDT_C2<5KNE!FZ/-^Q?C':E98X%3%C^DZ0R&UI7%DIA@:M<
MWK/U5VCT]#1?PG)A?M&ZB74LE%1"LJ(!JPP*0NLG?FY\V *XX2L KP%X^X#@
M%8#? /Q3 4$#"(PSM13C0XPEC@:<K1'7T8I-#XR9!JWD$ZK+/I-<O24*)Z,)
M*PHB51VE0)BF:,*H)'0)-"$@T$<TJX\#8@OT#92_Z);69TT7[3P&B4E^H>(>
M9C$Z/[M 9XA0]"-CE5!L8F!+E:/>R4Z:?,9U/MXK^;@>NE,I9 )]IBFDNP2V
M$M<J]#8*Q]Y1QAB22^2['Y#G>%Y'0I/3X6X'/#X=[AQ1X[?U\@V??T*]1@?U
MBHE(<B8J#NC7:"XD5Y_5[ZXBU)L$W9OHJ^9&E#B!H:7N$@%\!5;T_IT;.I^Z
M#'Q+LOB-R';,#5IS@V/LT?<2.-9VHMR<]80)V7F&:YK0T.B+=16Y/:\WL%?;
MMAP&787^;DS<010X+T$[*GJMBMY1%8^8$SS/X7\B:I;>UMY>/]C3<!C3<_=T
MQH<Q_G70+2%L)81')4RPR%")2=J5=WCHV96W9^RD*RCL[V7>$=2_[N^E;F]=
MK@7PI6E20ME:45G?0NUJVP='YOK?6Q^K_EBWLQ>:NKG>8;XD5*B"+12E<]E7
M9O*Z8=43R4ISA<^95 W!##/5XX'K /5^P9C<3/0&[;^&Z!]02P,$%     @
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MW!#I,/XVG$Z[I0'NCK?L7ZUVK65.)$YX_HNF*ALYUPZDN"!5KA[X^ALV>FR
M"<^E_<*Z\?4<2"JI>-& =00%9?6?;)H\[ #\P0% T ""UX#P *#7 'JG L(&
M$-K,U%)L'F*B2#04? W">&LV,[#)M&@MGS)S[#,E]"K5.!5]YU+"0O ")IPI
MRBK*EO"C1$',L4@8H[Y:"%/!5]0>M3;ACB6\0'@D&Y1P'J,B-/\ %_ TB^'\
M[ .< 67PF/%*$I;*H:MTH&8[-VF"&M=!!0>"\@.XU]%D$KZP%--] E<K;&4&
M6YGCX"ACC,DE]/R/$'A!T!'0Y'2XWP&/3X=[1]3TVD/K6;[> ;Z7_$-,99)S
M6>DS^GT[ETKHA_2G*^,U8]C-:(K+C2Q)@B-'5P^)8H5.]/Z=/_ ^=V7K+<GB
M-R+;RV389C(\QAX],:HPA9DB"CLO:@T?6+@IH:OHXOHJ]/0IKG83TN7F?0H&
M^VYQAUO_*NQ?MVY[(OJMB/Y1$?8-S^N'2NNKH?35P(WN#1*[5/5/4]7EUJ&J
MPZU+E;M3I0H42UOM)22\8JI^R>ULVU!N;1U]-3_6C:;N"R\T=9>Z)V))==7*
M<:$IO<LK'9JH*W]M*%[:6CCG2E=6.\QTLT1A'/3Z@G.U-<P&;?N-_@-02P,$
M%     @ <X%75OFC6KHX P  P P  !H   !X;"]W;W)K<VAE971S+W-H965T
M,3 X+GAM;*U7;6_:,!#^*U963:VTDE<"=!"ID$WKATZHM-UG-SD@:F(SVT#W
M[V<[(>7%I%3B2V([]SQW]YQM7?IKRE[Y'$"@MR(G?&#-A5C<V#9/YE!@WJ(+
M(/++E+(""SEE,YLO&.!4@XK<]APGM N<$2OJZ[4QB_IT*?*,P)@AOBP*S/X-
M(:?K@>5:FX6';#87:L&.^@L\@PF(I\68R9E=LZ19 81GE" &TX%UZ][$K@9H
MB^<,UGQKC%0J+Y2^JLE=.K <%1'DD A%@>5K!2/(<\4DX_A;D5JU3P7<'F_8
M?^KD93(OF,.(YG^R5,P'5M="*4SQ,A</=/T+JH3:BB^A.==/M"YM0^DQ67)!
MBPHLYT5&RC=^JX38 KCA$8!7 ;Q]0' $X%< _U1 4 $"K4R9BM8AQ@)'?4;7
MB"EKR:8&6DR-ENEG1-5](IC\FDF<B,:,KC)=1+F'T!U): 'H$;\!1Y<Q")SE
M5^@:/4UB='EQA2Y01M#CG"XY)BGOVT)&H'CLI/(V++UY1[RY'KJG1,PY^D%2
M2'<);!EZ';^WB7_H-3+&D+20[WY#GN-YAH!&I\-= SP^'>XT9./7U? UGW^$
M;[1D#(@P"5L" S-0W0XW?($3&%CR^'-@*["BKU_<T/EN$N6<9/&9R'8$"VK!
M@B;VZ#<EUT^M2<ND6"/RLXJ=DRPNR4)-IB[F573MN=V^O3(HT:Z5:#<J\4@%
MSN6-<70#-<(_*\<YR>*2K'V2'&$M1]AXDF*8@I0B-2D1GE.)<Y+%9R+;4:Q3
M*]9IW$#J&*$II,!P;E*M<[AIVZ$3UF4JY3!9N1UGURKN'%8\\#L=<\F[=0+=
MCQ/@ @LPA=\UN?2#O? -5FX0A.Y>_":RL&<.OU>'WSOA *<-^[9WZ+77"_:T
M'1FLW%[H[Z=@, NZ06C.P77>VPFG,8MGG"]QV='ELJ?$)#%6HV+9=F](Q6!E
M2L5@UI#*5F?D?EP08_#NP28_B/Q#D]A@8KCV[*W6K@ VTRTR1PE=$E%V2?5J
MW8;?ZN9S;WVHVG/=,K[3E+W]/6:SC'"4PU12.JV.%)*5[7(Y$72A&\@7*F0[
MJH=S^8L!3!G([U-*Q6:B'-0_+=%_4$L#!!0    ( '.!5U8F]+GGM 0  /41
M   :    >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6RMF&UOVS80Q[\*H15%
M"\R12#VGMH'4QK ";1<D:?>:D>F8B"2J%&4G^_0[RK;LB)26#GV36-;=Z7?4
MW?U)3W="/M8;QA1Z*O*RGCD;I:I+UZVS#2MH?2$J5L*=M9 %57 I']RZDHRN
M6J<B=XGG16Y!>>G,I^UWUW(^%8W*><FN):J;HJ#R^2/+Q6[F8.?XQ0U_V"C]
MA3N?5O2!W3+UK;J6<.5V45:\8&7-18DD6\^<*WRY($0[M!;?.=O59Y^13N5>
MB$=]\6DU<SQ-Q'*6*1V"PK\M6[ \UY& X\<AJ-,]4SN>?SY&_Z--'I*YIS5;
MB/QOOE*;F9,X:,76M,G5C=C]R0X)A3I>)O*Z_8MV>]N8."AK:B6*@S,0%+S<
M_Z=/AX4X<\#!@ ,Y.)#7.O@'![]-=$_6IK6DBLZG4NR0U-8037]HUZ;UAFQX
MJ5_CK9)PEX.?FB]$48F2E:I&8HV^0MTLV9I)R5;HCCZAJ[IF<.O=DBG*\_=H
M@K[=+M&[-^_1&\1+=+<134W+53UU%<#HD&YV>/#'_8/)P(.7++M /OX=$8\0
MB_OB]>[XI;L+2]"M ^G6@;3Q_,%XAZP59$W;K"]M2>VC!/8HNN<NZXIF;.9
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MG=HV/)RY/B9%H/G&4&BV!HT-QWY7VWP7=5(,:K!!T2)0M!@*S9:A\=UX!CA
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M80,  *X5   -    >&PO<W1Y;&5S+GAM;-U846_:,!#^*U&Z3JTT-82,0%9
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M1)$= <RN( @P!.Y&',$4@ 8,"8+R/;CW/O*V[RFO^0_M^"]02P,$%     @
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M&2_2YUV,8Z21\1YZ'8]Y]$XVI(VQL#9V)]0[,9%$QL(2@9EU<+<9PX$L88W
MS#K$1#X9"_OD*;/>>:*15L;B(U@@Q0XCB+0R%M8*3+%#3*25L;!6_CN!#5F1
M9<;2@UK/$]B=;1.Y9KR'#LNKF:PZXN/42#<3<=T\98N[8CA!OID(^^:5<57U
MLSI=+"SO0D^0;R;"OL%IXX1C(M],A'V#,6..":=.A'V#,1..B=PS$1\78TGX
M8X.D__O;.NV08R+W3(3=\PSSAG:Y:(M>1'/Z L=$[IGLLTOS'#/0S@1I9R*L
MG>>8K*FVZW403>2>R1YG4YY%<Q9.L,3(/;&P>R!F<-)C9*%8V$*\1_OR0N<C
MI#&R4+R'"9@GS&?GO.$WI!A9*!:V$,0,3SJR4"P^BO8:9I_-<TPXA2\]L,;
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M^6BZ[VKJ<+B38R(?3:7+%'9@;K:=Z=KP5CI%/II*ERD@S* G/$4^FDJ7*>S
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M]S6:Q-V2Y65;%#/:]K&Z<GJQ?3S1]M%*[_X!4$L#!!0    ( '.!5U:SZYZ
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MJ]X>H'=0O0- [Z!Z!X#>0?4. +U#MUD"T#NHW@&@=U"] T#OH'H'@-Y!]0X
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MF^K= 'HWU;L!]&ZJ=P/HW53O!M"[J=X-H'=3O1M [Z9Z-X#>3?5N +V;ZMT
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M4$L! A0#%     @ <X%75@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !S@5=6(R&,@NT    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" !S@5=6F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( '.!5U9OG5-24 @  $0S   8
M      " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" !S@5=6201<\.D"   5"@  &               @(&2$   >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ <X%75N*5QJ54!P  F2   !@
M             ("!L1,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( '.!5U:[V<@2K0<  %XJ   8              " @3L;  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !S@5=6C2M" .@"  #2
M"0  &               @($>(P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ <X%75A_[JPGN(@  &8@" !@              ("!/"8
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( '.!5U9#?[%(
MU X  ,99   8              " @6!)  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " !S@5=6WP8MM'P&  "-#@  &
M@(%J6   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ <X%7
M5A]%N=8,)P  *H<  !@              ("!'%\  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( '.!5U9E@16<9@P  , ?   9
M      " @5Z&  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ <X%75AV &P?#!@  4Q(  !D              ("!^Y(  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !S@5=62<<E[B $   U"@
M&0              @('UF0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( '.!5U:^740TM00  '@*   9              " @4R>  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ <X%75C'Y=6&T
M!@  \0\  !D              ("!.*,  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " !S@5=6'7M5K8H$   K"@  &0
M@($CJ@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( '.!
M5U;K.Z5'Y ,  /8(   9              " @>2N  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ <X%75N>ME!,Z'   _6(  !D
M         ("!_[(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " !S@5=6J9SB_V09  #A:0  &0              @(%PSP  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( '.!5U97?<43P@D  *,>
M   9              " @0OI  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ <X%75N3C*=7=!@  X!,  !D              ("!!/,
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !S@5=6]6GX
ML7@%  !.#   &0              @($8^@  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( '.!5U;.H#9MRQ   %HQ   9
M  " @<?_  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M<X%75GS!_HL_$    R\  !D              ("!R1 ! 'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " !S@5=6W$CD04P#  "&"   &0
M            @($_(0$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( '.!5U:N'#D;O T  $8F   9              " @<(D 0!X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ <X%75HLMGX_T/@
MQN8  !D              ("!M3(! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " !S@5=65 $<_$0$  "-"0  &0              @('@
M<0$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( '.!5U9X
MQ+_?6@4   (.   9              " @5MV 0!X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ <X%75G%Q!FY\!   M0L  !D
M     ("!['L! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '.!5U:>FA^M"P0  ) )   9              "
M@0J/ 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ <X%7
M5L 0:,G(!0  $P\  !D              ("!3),! 'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " !S@5=6[281K2@,   ;+@  &0
M        @(%+F0$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( '.!5U;G.=S]'@4  (80   9              " @:JE 0!X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ <X%75D,0!J)I!   O0D
M !D              ("!_ZH! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " !S@5=6T]\D 24&  !7#P  &0              @(&?KP$
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( '.!5U;A!DSS
M6@4  %H.   9              " @?NU 0!X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ <X%75G8+!.?Q!@  EA(  !D
M ("!C+L! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !S
M@5=6KAH. ^T"   7"0  &0              @(&TP@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( '.!5U;25*B"6 D  ))F   9
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M970T-RYX;6Q02P$"% ,4    " !S@5=6+(^@:K4#   #$   &0
M    @(&]X0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M '.!5U;OZ!. WP(  .P'   9              " @:GE 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ <X%75I^YZGX$ P  [0<  !D
M             ("!O^@! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " !S@5=61P!TH88"  "4!0  &0              @('ZZP$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( '.!5U:HSX*!>00
M -X3   9              " @;?N 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ <X%75HF?]/Z& P  #0L  !D              ("!
M9_,! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !S@5=6
M,<@LA*<"   6"   &0              @($D]P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( '.!5U8F WY3D 4  *XF   9
M      " @0+Z 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ <X%75B@_KE&- P  XPX  !D              ("!R?\! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !S@5=6H])GPI\#  !$#@
M&0              @(&- P( >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( '.!5U9JG\F<NP(  (D'   9              " @6,' @!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ <X%75KE[/XB2
M @  WP8  !D              ("!50H" 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " !S@5=6L+UV$2(#  "=#0  &0
M@($>#0( >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( '.!
M5U9A+W%R< 8  '0R   9              " @7<0 @!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ <X%75KGAS\G_ @  :@L  !D
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M=#8V+GAM;%!+ 0(4 Q0    ( '.!5U8)/%MR%0,  ,,(   9
M  " @4PH @!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
M<X%75F_]Q,8W!   8@P  !D              ("!F"L" 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " !S@5=6++_&)PL#  "<"0  &0
M            @($&, ( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( '.!5U;Y5MEQ>08  !XH   9              " @4@S @!X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ <X%75O1F:/CM!0
M&B$  !D              ("!^#D" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6Q02P$"% ,4    " !S@5=6G.Y&FA$#  "*"@  &0              @($<
M0 ( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( '.!5U9@
MW.Q! 0P  *)<   9              " @61# @!X;"]W;W)K<VAE971S+W-H
M965T-S,N>&UL4$L! A0#%     @ <X%75O1)_C4,$@  )-T  !D
M     ("!G$\" 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
M" !S@5=6_%LFSJX*  #O:   &0              @('?80( >&PO=V]R:W-H
M965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( '.!5U98-%ZO!P0  '$7   9
M              " @<1L @!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L!
M A0#%     @ <X%75CAUO62X @  G <  !D              ("! G$" 'AL
M+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " !S@5=687@DTST#
M   L"P  &0              @('Q<P( >&PO=V]R:W-H965T<R]S:&5E=#<X
M+GAM;%!+ 0(4 Q0    ( '.!5U;U&8?>H08  %4T   9              "
M@65W @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ <X%7
M5MEMI??T @  Z@<  !D              ("!/7X" 'AL+W=O<FMS:&5E=',O
M<VAE970X,"YX;6Q02P$"% ,4    " !S@5=6,X1VU4,$   \%P  &0
M        @(%H@0( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0
M   ( '.!5U9H5J(Y&1@  "ER 0 9              " @>*% @!X;"]W;W)K
M<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ <X%75E]4>*HA"P  7U4
M !D              ("!,IX" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q0
M2P$"% ,4    " !S@5=6A1*NPG\.   /@   &0              @(&*J0(
M>&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( '.!5U;&X4P5
M[P,  +@4   9              " @4"X @!X;"]W;W)K<VAE971S+W-H965T
M.#4N>&UL4$L! A0#%     @ <X%75ISLS>:K P  C!   !D
M ("!9KP" 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " !S
M@5=6+E&18=$'  "14   &0              @(%(P ( >&PO=V]R:W-H965T
M<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( '.!5U;Y3J9V$P<  (DX   9
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M970Y,BYX;6Q02P$"% ,4    " !S@5=6H,EW69 #  !F$0  &0
M    @($>_0( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    (
M '.!5U;25'M&> 0  .H8   9              " @>4  P!X;"]W;W)K<VAE
M971S+W-H965T.30N>&UL4$L! A0#%     @ <X%75MGIU;X4 P  L H  !D
M             ("!E 4# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"
M% ,4    " !S@5=6J;/9VG<$   )%0  &0              @('?" , >&PO
M=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( '.!5U8@PA69- ,
M $P*   9              " @8T- P!X;"]W;W)K<VAE971S+W-H965T.3<N
M>&UL4$L! A0#%     @ <X%75IJ7JV-I#P  >K,  !D              ("!
M^! # 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " !S@5=6
MN<)3LGP"  !6!@  &0              @(&8( , >&PO=V]R:W-H965T<R]S
M:&5E=#DY+GAM;%!+ 0(4 Q0    ( '.!5U8M1H@Q@P(  /P%   :
M      " @4LC P!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0
M   ( '.!5U:A&6#V[P(  ' (   :              " @08F P!X;"]W;W)K
M<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( '.!5U:.G:U6>0(  "4&
M   :              " @2TI P!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM
M;%!+ 0(4 Q0    ( '.!5U:1>'B+]P,  /H/   :              " @=XK
M P!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( '.!5U:6
MTM+VU0(  $$(   :              " @0TP P!X;"]W;W)K<VAE971S+W-H
M965T,3 T+GAM;%!+ 0(4 Q0    ( '.!5U9":F8P9 ,  !@.   :
M      " @1HS P!X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4 Q0
M   ( '.!5U:Z74S_T ,  $,3   :              " @;8V P!X;"]W;W)K
M<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( '.!5U::-IT\M@(  (H'
M   :              " @;XZ P!X;"]W;W)K<VAE971S+W-H965T,3 W+GAM
M;%!+ 0(4 Q0    ( '.!5U;YHUJZ. ,  , ,   :              " @:P]
M P!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( '.!5U8F
M]+GGM 0  /41   :              " @1Q! P!X;"]W;W)K<VAE971S+W-H
M965T,3 Y+GAM;%!+ 0(4 Q0    ( '.!5U9C_ZZK< ,  *,,   :
M      " @0A& P!X;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4 Q0
M   ( '.!5U81Z% %E 8  'HP   :              " @;!) P!X;"]W;W)K
M<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( '.!5U898Y3 XP(  )@(
M   :              " @7Q0 P!X;"]W;W)K<VAE971S+W-H965T,3$R+GAM
M;%!+ 0(4 Q0    ( '.!5U:X7*SN80,  *X5   -              "  9=3
M P!X;"]S='EL97,N>&UL4$L! A0#%     @ <X%75I>*NQS     $P(   L
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64$L%!@    !X '@ #"$  !YF P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>509</ContextCount>
  <ElementCount>672</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>173</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable</Role>
      <ShortName>Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Goodwill and Other Intangible Asset</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset</Role>
      <ShortName>Goodwill and Other Intangible Asset</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Collaboration, Licensing and Other Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Common and Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock</Role>
      <ShortName>Common and Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Earnings Per Common Share ("EPS")</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS</Role>
      <ShortName>Earnings Per Common Share ("EPS")</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Stock Award Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans</Role>
      <ShortName>Stock Award Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables</Role>
      <ShortName>Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Goodwill and Other Intangible Asset (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables</Role>
      <ShortName>Goodwill and Other Intangible Asset (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Collaboration, Licensing and Other Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Earnings Per Common Share ("EPS") (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables</Role>
      <ShortName>Earnings Per Common Share ("EPS") (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Stock Award Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables</Role>
      <ShortName>Stock Award Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Description of Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Acquisitions - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail</Role>
      <ShortName>Acquisitions - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Acquisitions - Schedule of Preliminary Purchase Consideration (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail</Role>
      <ShortName>Acquisitions - Schedule of Preliminary Purchase Consideration (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails</Role>
      <ShortName>Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail</Role>
      <ShortName>Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail</Role>
      <ShortName>Acquisitions - Schedule of Consideration Paid for IPR&amp;D (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Investments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail</Role>
      <ShortName>Investments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail</Role>
      <ShortName>Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail</Role>
      <ShortName>Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail</Role>
      <ShortName>Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Schedule of Accounts Receivable, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail</Role>
      <ShortName>Schedule of Accounts Receivable, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Accounts Receivable - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail</Role>
      <ShortName>Accounts Receivable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Schedule of Activities and Ending Reserve Balance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail</Role>
      <ShortName>Schedule of Activities and Ending Reserve Balance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Inventories - Components of Inventory (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail</Role>
      <ShortName>Inventories - Components of Inventory (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Inventories - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail</Role>
      <ShortName>Inventories - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Property and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail</Role>
      <ShortName>Property and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Property and Equipment, Net (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail</Role>
      <ShortName>Property and Equipment, Net (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Property and Equipment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Goodwill and Other Intangible Asset - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail</Role>
      <ShortName>Goodwill and Other Intangible Asset - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail</Role>
      <ShortName>Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Accrued Expenses and Other Current Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail</Role>
      <ShortName>Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail</Role>
      <ShortName>Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail</Role>
      <ShortName>Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail</Role>
      <ShortName>Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Borrowings - Schedule of Maturities of the Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail</Role>
      <ShortName>Borrowings - Schedule of Maturities of the Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Borrowings - Senior Convertible Notes - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail</Role>
      <ShortName>Borrowings - Senior Convertible Notes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>100740 - Disclosure - Borrowings - MidCap Credit Facility - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail</Role>
      <ShortName>Borrowings - MidCap Credit Facility - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>100750 - Disclosure - Borrowings - Mann Group Promissory Notes - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail</Role>
      <ShortName>Borrowings - Mann Group Promissory Notes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>100760 - Disclosure - Borrowings - PPP Loan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail</Role>
      <ShortName>Borrowings - PPP Loan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>100770 - Disclosure - Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail</Role>
      <ShortName>Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>100780 - Disclosure - Borrowings - Milestone Rights - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail</Role>
      <ShortName>Borrowings - Milestone Rights - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>100790 - Disclosure - Schedule of Revenue from Collaborations and Services (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail</Role>
      <ShortName>Schedule of Revenue from Collaborations and Services (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>100800 - Disclosure - Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail</Role>
      <ShortName>Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>100810 - Disclosure - Summary of UT Revenue (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail</Role>
      <ShortName>Summary of UT Revenue (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>100820 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>100830 - Disclosure - Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>100840 - Disclosure - Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>100850 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1</Role>
      <ShortName>Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>100860 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail</Role>
      <ShortName>Fair Value of Financial Instruments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>100870 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail</Role>
      <ShortName>Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>100880 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail</Role>
      <ShortName>Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>100890 - Disclosure - Common and Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail</Role>
      <ShortName>Common and Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>100900 - Disclosure - Earnings Per Common Share ("EPS") - Components of Basic and Diluted EPS Computations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail</Role>
      <ShortName>Earnings Per Common Share ("EPS") - Components of Basic and Diluted EPS Computations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>100910 - Disclosure - Earnings Per Common Share ("EPS") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail</Role>
      <ShortName>Earnings Per Common Share ("EPS") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>100920 - Disclosure - Stock Award Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail</Role>
      <ShortName>Stock Award Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>100930 - Disclosure - Stock Award Plans - Stock Based Award Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail</Role>
      <ShortName>Stock Award Plans - Stock Based Award Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>100940 - Disclosure - Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail</Role>
      <ShortName>Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>100950 - Disclosure - Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail</Role>
      <ShortName>Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>100960 - Disclosure - Stock Award Plans - Summary of Stock Options Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail</Role>
      <ShortName>Stock Award Plans - Summary of Stock Options Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>100970 - Disclosure - Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail</Role>
      <ShortName>Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>100980 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>100990 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>101000 - Disclosure - Commitments and Contingencies - Summary of Financing Liability Costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail</Role>
      <ShortName>Commitments and Contingencies - Summary of Financing Liability Costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>101010 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>101030 - Disclosure - Commitments and Contingencies - Remaining Purchase Requirements (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail</Role>
      <ShortName>Commitments and Contingencies - Remaining Purchase Requirements (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>101040 - Disclosure - Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>101050 - Disclosure - Commitments and Contingencies - Summary of Lease Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Summary of Lease Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>101060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>101080 - Disclosure - Employee Benefit Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail</Role>
      <ShortName>Employee Benefit Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>101090 - Disclosure - Loss from Continuing Operations Before Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail</Role>
      <ShortName>Loss from Continuing Operations Before Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>101100 - Disclosure - Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail</Role>
      <ShortName>Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>101110 - Disclosure - Components of Net Deferred Tax Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail</Role>
      <ShortName>Components of Net Deferred Tax Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>101120 - Disclosure - Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail</Role>
      <ShortName>Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>101130 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="mnkd-10k_20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>101140 - Disclosure - Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 51 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, mnkd:AccruedPaidInKindInterest, mnkd:DebtInstrumentCapInterestRate, mnkd:DebtInstrumentFloorRate, mnkd:LongtermPurchaseCommitmentRenewalTimePeriod, us-gaap:AssetAcquisitionDateOfAcquisitionAgreement, us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1, us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted, us-gaap:DebtInstrumentFaceAmount, us-gaap:DebtInstrumentInterestRateStatedPercentage, us-gaap:EarningsPerShareDiluted, us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1, us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:LesseeOperatingLeaseRenewalTerm, us-gaap:LesseeOperatingSubleaseExistenceOfOptionToExtend, us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:SaleOfStockTransactionDate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding -  mnkd-10k_20221231.htm 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Not-Referenced] WARN: 6 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList, us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList, us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList -  mnkd-10k_20221231.htm 76, 77, 78, 79, 80, 81</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="mnkd-10k_20221231.htm">mnkd-10k_20221231.htm</File>
    <File>mnkd-20221231.xsd</File>
    <File>mnkd-20221231_cal.xml</File>
    <File>mnkd-20221231_def.xml</File>
    <File>mnkd-20221231_lab.xml</File>
    <File>mnkd-20221231_pre.xml</File>
    <File>mnkd-ex1042_615.htm</File>
    <File>mnkd-ex1043_616.htm</File>
    <File>mnkd-ex1049_458.htm</File>
    <File>mnkd-ex1050_456.htm</File>
    <File>mnkd-ex1051_457.htm</File>
    <File>mnkd-ex1052_455.htm</File>
    <File>mnkd-ex1053_454.htm</File>
    <File>mnkd-ex231_9.htm</File>
    <File>mnkd-ex311_7.htm</File>
    <File>mnkd-ex312_8.htm</File>
    <File>mnkd-ex321_10.htm</File>
    <File>mnkd-ex322_6.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g1ow311dygir000001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1230">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>141
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mnkd-10k_20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 40,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1230,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 509,
   "dts": {
    "calculationLink": {
     "local": [
      "mnkd-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mnkd-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mnkd-10k_20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mnkd-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mnkd-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mnkd-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 1034,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 56,
    "http://www.mannkindcorp.com/20221231": 4,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 64
   },
   "keyCustom": 189,
   "keyStandard": 483,
   "memberCustom": 106,
   "memberStandard": 57,
   "nsprefix": "mnkd",
   "nsuri": "http://www.mannkindcorp.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Acquisitions",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:InterestExpenseOnFinancingLiability",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101000 - Disclosure - Commitments and Contingencies - Summary of Financing Liability Costs (Detail)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail",
     "shortName": "Commitments and Contingencies - Summary of Financing Liability Costs (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101010 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail",
     "shortName": "Commitments and Contingencies - Schedule of Financing Liability Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217EUR",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101030 - Disclosure - Commitments and Contingencies - Remaining Purchase Requirements (Detail)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail",
     "shortName": "Commitments and Contingencies - Remaining Purchase Requirements (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermPurchaseCommitmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217EUR",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101040 - Disclosure - Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail",
     "shortName": "Commitments and Contingencies - Schedule of Lease Term and Discount Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101050 - Disclosure - Commitments and Contingencies - Summary of Lease Information (Detail)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail",
     "shortName": "Commitments and Contingencies - Summary of Lease Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:VariableLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Office And Vehicle Lease Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdOfficeAndVehicleMember_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101080 - Disclosure - Employee Benefit Plans - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail",
     "shortName": "Employee Benefit Plans - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101090 - Disclosure - Loss from Continuing Operations Before Provision for Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail",
     "shortName": "Loss from Continuing Operations Before Provision for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101100 - Disclosure - Provision for Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail",
     "shortName": "Provision for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101110 - Disclosure - Components of Net Deferred Tax Assets (Detail)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail",
     "shortName": "Components of Net Deferred Tax Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101120 - Disclosure - Effective Tax Rate (Detail)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail",
     "shortName": "Effective Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101130 - Disclosure - Income Taxes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-8",
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101140 - Disclosure - Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Tax- Summary of Positions for which Significant Change in Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Accounts Receivable",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable",
     "shortName": "Accounts Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancingReceivablesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Property and Equipment",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Goodwill and Other Intangible Asset",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset",
     "shortName": "Goodwill and Other Intangible Asset",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Borrowings",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Collaboration, Licensing and Other Arrangements",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements",
     "shortName": "Collaboration, Licensing and Other Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Common and Preferred Stock",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock",
     "shortName": "Common and Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Earnings Per Common Share (\"EPS\")",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS",
     "shortName": "Earnings Per Common Share (\"EPS\")",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Stock Award Plans",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans",
     "shortName": "Stock Award Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Employee Benefit Plans",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans",
     "shortName": "Employee Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mnkd:BusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "26",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mnkd:BusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Accounts Receivable (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables",
     "shortName": "Accounts Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Property and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Goodwill and Other Intangible Asset (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables",
     "shortName": "Goodwill and Other Intangible Asset (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Borrowings (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Collaboration, Licensing and Other Arrangements (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
     "shortName": "Collaboration, Licensing and Other Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Earnings Per Common Share (\"EPS\") (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables",
     "shortName": "Earnings Per Common Share (\"EPS\") (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Stock Award Plans (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables",
     "shortName": "Stock Award Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_mnkdSegment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Description of Business - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
     "shortName": "Description of Business - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_mnkdSegment",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20210101_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "mnkd:RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail 1)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "mnkd:RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2021-01-01_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220531",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Acquisitions - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
     "shortName": "Acquisitions - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Acquisitions - Schedule of Preliminary Purchase Consideration (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
     "shortName": "Acquisitions - Schedule of Preliminary Purchase Consideration (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapAssetAcquisitionAxis_mnkdVGoMember_20220531_20220531",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "Acquisitions - Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdVGoMember_20220531",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails",
     "shortName": "Acquisitions - Summary of Supplemental Pro Forma Information (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&D (Detail)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
     "shortName": "Acquisitions - Schedule of Consideration Paid for IPR&D (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201201_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Acquisitions - Schedule of Consideration Paid for IPR&D (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
     "shortName": "Acquisitions - Schedule of Consideration Paid for IPR&D (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapBusinessAcquisitionAxis_mnkdQrumPharmaIncorporatedMember_20201231",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Investments - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
     "shortName": "Investments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "mnkd:AccruedInterestReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail",
     "shortName": "Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail",
     "shortName": "Investments - Schedule of Contractual Maturities of Held to Maturity Investments (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapShortTermDebtTypeAxis_mnkdDueInOneYearOrLessMember_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mnkd:CashEquivalentsAndInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail",
     "shortName": "Investments - Schedule of Fair Value of Assets and Financing Liability on Total Investments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapIncomeStatementLocationAxis_mnkdAmortizedCostMember_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mnkd:CashEquivalentsAndInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Schedule of Accounts Receivable, Net (Detail)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
     "shortName": "Schedule of Accounts Receivable, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_us-gaapProductMember_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "mnkd:NumberOfWholesaleDistributors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_mnkdDistributor",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Accounts Receivable - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
     "shortName": "Accounts Receivable - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "mnkd:NumberOfWholesaleDistributors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_mnkdDistributor",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock",
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Schedule of Activities and Ending Reserve Balance (Detail)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail",
     "shortName": "Schedule of Activities and Ending Reserve Balance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock",
       "us-gaap:FinancingReceivablesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "mnkd:PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Inventories - Components of Inventory (Detail)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail",
     "shortName": "Inventories - Components of Inventory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Stockholders' Deficit",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit",
     "shortName": "Consolidated Statements of Stockholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProductionRelatedImpairmentsOrCharges",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Inventories - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail",
     "shortName": "Inventories - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryRawMaterials",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapPublicUtilitiesInventoryAxis_mnkdPreLaunchInventoryMember_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Property and Equipment, Net (Detail)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
     "shortName": "Property and Equipment, Net (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "link:footnote",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211031_20211031",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Property and Equipment, Net (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail",
     "shortName": "Property and Equipment, Net (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapPropertyPlantAndEquipmentByTypeAxis_mnkdUTEquipmentMember_20221231",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ConstructionInProgressGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Property and Equipment - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
     "shortName": "Property and Equipment - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Goodwill and Other Intangible Asset - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail",
     "shortName": "Goodwill and Other Intangible Asset - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail",
     "shortName": "Goodwill and Other Intangible Asset - Summary of Other Intangible Asset (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapDevelopedTechnologyRightsMember_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Accrued Expenses and Other Current Liabilities (Detail)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail",
     "shortName": "Accrued Expenses and Other Current Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:DiscountsAndAllowancesForCommercialProductSalesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:DiscountsAndAllowancesForCommercialProductSales",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail",
     "shortName": "Accrued Expenses and Other Current Liabilities - Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:DiscountsAndAllowancesForCommercialProductSalesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "mnkd:DiscountsAndAllowancesForCommercialProductSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail",
     "shortName": "Borrowings - Summary of Carrying Amount of Principal Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeniorNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20210101_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
     "shortName": "Borrowings - Summary of Carrying Amount of Borrowings (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
     "shortName": "Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "mnkd:DebtInstrumentMaturityMonthAndYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "link:footnote",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:EarlyRepaymentOfSeniorDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
     "shortName": "Borrowings - Schedule of Line of Credit Facility Debt and Key Terms (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "link:footnote",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20210401_20210430",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:EarlyRepaymentOfSeniorDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Borrowings - Schedule of Maturities of the Company's Borrowings (Detail)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail",
     "shortName": "Borrowings - Schedule of Maturities of the Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20210422_20210422",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Borrowings - Senior Convertible Notes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
     "shortName": "Borrowings - Senior Convertible Notes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapLongtermDebtTypeAxis_us-gaapSeniorNotesMember_20220101_20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20210422_20210422",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100740 - Disclosure - Borrowings - MidCap Credit Facility - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
     "shortName": "Borrowings - MidCap Credit Facility - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20220101_20221231",
      "decimals": "4",
      "lang": null,
      "name": "mnkd:EarlyTerminationFeesPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFrequencyOfPeriodicPayment",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100750 - Disclosure - Borrowings - Mann Group Promissory Notes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
     "shortName": "Borrowings - Mann Group Promissory Notes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapDebtInstrumentAxis_mnkdPromissoryNotesMember_us-gaapRelatedPartyTransactionAxis_mnkdTheMannGroupLLCMember_20211231",
      "decimals": "-5",
      "lang": null,
      "name": "mnkd:DebtInstrumentFairValueInExcessOfFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100760 - Disclosure - Borrowings - PPP Loan - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
     "shortName": "Borrowings - PPP Loan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapDebtInstrumentAxis_mnkdPaycheckProtectionProgramCARESActMember_20200401_20200430",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:AmortizationOfDebtDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100770 - Disclosure - Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail",
     "shortName": "Borrowings - Schedule of Amortization of Premium and Accretion of Debt Issuance Costs (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "mnkd:AmortizationOfDebtDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100780 - Disclosure - Borrowings - Milestone Rights - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
     "shortName": "Borrowings - Milestone Rights - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "mnkd:MilestoneRightsLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100790 - Disclosure - Schedule of Revenue from Collaborations and Services (Detail)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
     "shortName": "Schedule of Revenue from Collaborations and Services (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_us-gaapLicenseAndServiceMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdLicenseAgreementMember_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100070 - Disclosure - Description of Business",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100800 - Disclosure - Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail",
     "shortName": "Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "mnkd:ContractWithCustomerLiabilityAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100810 - Disclosure - Summary of UT Revenue (Detail)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail",
     "shortName": "Summary of UT Revenue (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_us-gaapTypeOfArrangementAxis_mnkdRoyaltiesArrangementMember_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211031",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100820 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
     "shortName": "Collaboration, Licensing and Other Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_mnkdManufacturingServicesMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdUnitedTherapeuticsCorporationMember_20221201_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireOtherProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211031",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100830 - Disclosure - Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
     "shortName": "Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_mnkdPreCommercialServicesMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_20211031",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211031",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100840 - Disclosure - Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
     "shortName": "Collaboration, Licensing and Other Arrangements - Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtProductOrServiceAxis_mnkdResearchAndDevelopmentServicesAndLicenseMember_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_mnkdTyvasoDPIMember_us-gaapTimingOfTransferOfGoodOrServiceAxis_us-gaapTransferredOverTimeMember_us-gaapTypeOfArrangementAxis_mnkdCollaborationAndLicenseAgreementMember_20210812",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211031",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100850 - Disclosure - Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
     "shortName": "Collaboration, Licensing and Other Arrangements - Additional Information (Detail 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_srtCounterpartyNameAxis_mnkdCiplaLtdMember_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2018-06-01_us-gaapTypeOfArrangementAxis_mnkdLicenseAndDistributionAgreementMember_20180531",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100860 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
     "shortName": "Fair Value of Financial Instruments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100870 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
     "shortName": "Fair Value of Financial Instruments - Fair Value of Financial Instruments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "mnkd:DebtInstrumentMeasurementInputAfterChange",
      "reportCount": 1,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100880 - Disclosure - Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
     "shortName": "Fair Value of Financial Instruments - Fair Value of Financial Instruments (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapCreditFacilityAxis_mnkdMidCapCreditFacilityMember_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "mnkd:DebtInstrumentMeasurementInputAfterChange",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100890 - Disclosure - Common and Preferred Stock - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
     "shortName": "Common and Preferred Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromStockPlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100900 - Disclosure - Earnings Per Common Share (\"EPS\") - Components of Basic and Diluted EPS Computations (Detail)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail",
     "shortName": "Earnings Per Common Share (\"EPS\") - Components of Basic and Diluted EPS Computations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100910 - Disclosure - Earnings Per Common Share (\"EPS\") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail",
     "shortName": "Earnings Per Common Share (\"EPS\") - Potential Dilutive Securities Outstanding that are Considered Antidilutive (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100920 - Disclosure - Stock Award Plans - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
     "shortName": "Stock Award Plans - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100930 - Disclosure - Stock Award Plans - Stock Based Award Plans (Detail)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail",
     "shortName": "Stock Award Plans - Stock Based Award Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100940 - Disclosure - Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail",
     "shortName": "Stock Award Plans - Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20220101_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100950 - Disclosure - Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
     "shortName": "Stock Award Plans - Fair Value of Employee Stock Options Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100960 - Disclosure - Stock Award Plans - Summary of Stock Options Outstanding (Detail)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail",
     "shortName": "Stock Award Plans - Summary of Stock Options Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100970 - Disclosure - Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail",
     "shortName": "Stock Award Plans - Summary of Restricted Stock Unit Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20220101_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedLiabilitiesAndOtherLiabilities",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100980 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100990 - Disclosure - Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail",
     "shortName": "Commitments and Contingencies - Schedule of Financing Liability Lease Term and Discount Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "mnkd:ScheduleOfLeaseTermAndDiscountRateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mnkd-10k_20221231.htm",
      "contextRef": "C_0000899460_20221231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 173,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "verboseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r721",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mnkd_AccruedInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest.",
        "label": "Accrued Interest [Member]",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "AccruedInterestMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest noncurrent.",
        "label": "Accrued Interest Noncurrent",
        "terseLabel": "Accrued interest \u2014 promissory notes"
       }
      }
     },
     "localname": "AccruedInterestNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AccruedInterestReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest receivable.",
        "label": "Accrued Interest Receivable",
        "terseLabel": "Accrued interest receivable"
       }
      }
     },
     "localname": "AccruedInterestReceivable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AccruedPaidInKindInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued paid in kind interest.",
        "label": "Accrued Paid In Kind Interest",
        "terseLabel": "Accrued interest paid-in-kind"
       }
      }
     },
     "localname": "AccruedPaidInKindInterest",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AdditionOfRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition of right-of-use assets",
        "label": "Addition Of Right Of Use Assets",
        "terseLabel": "Addition of right-of-use-asset"
       }
      }
     },
     "localname": "AdditionOfRightOfUseAssets",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional option exercise and development milestone payments to be received.",
        "label": "Additional Option Exercise And Development Milestone Payments To Be Received",
        "terseLabel": "Additional option exercise and development milestone payments to be receive"
       }
      }
     },
     "localname": "AdditionalOptionExerciseAndDevelopmentMilestonePaymentsToBeReceived",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted net sales are greater than or equal to two hundred million.",
        "label": "Adjusted Net Sales Are Greater Than Or Equal To Two Hundred Million [Member]",
        "terseLabel": "Adjusted Net Sales Are Greater Than Or Equal To Two Hundred Million"
       }
      }
     },
     "localname": "AdjustedNetSalesAreGreaterThanOrEqualToTwoHundredMillionMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital premium on convertible note.",
        "label": "Adjustment To Additional Paid In Capital Premium On Convertible Note",
        "terseLabel": "Premium on Mann Group convertible note"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital issuance of warrants pursuant to credit facility.",
        "label": "Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility",
        "terseLabel": "Issuance of warrants pursuant to Midcap Credit Facility"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AgreementAmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement amendment description.",
        "label": "Agreement Amendment Description",
        "terseLabel": "Amendment description"
       }
      }
     },
     "localname": "AgreementAmendmentDescription",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_AgreementWithRetailPharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with a retail pharmacy.",
        "label": "Agreement With Retail Pharmacy [Member]",
        "terseLabel": "Agreement With Retail Pharmacy"
       }
      }
     },
     "localname": "AgreementWithRetailPharmacyMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AllocatedTransactionPrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated transaction price.",
        "label": "Allocated Transaction Price",
        "terseLabel": "Allocated transaction price"
       }
      }
     },
     "localname": "AllocatedTransactionPrice",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AmendmentToCoPromotionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to co-promotion agreement..",
        "label": "Amendment To Co Promotion Agreement [Member]",
        "terseLabel": "Amendment to Co Promotion Agreement"
       }
      }
     },
     "localname": "AmendmentToCoPromotionAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AmortizationOfDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of debt discount.",
        "label": "Amortization Of Debt Discount",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscount",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AmortizedCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost.",
        "label": "Amortized Cost [Member]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AmortizedCostMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AmountReceivableOnMaturedInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount receivable on matured investment.",
        "label": "Amount Receivable On Matured Investment",
        "terseLabel": "Amount receivable on matured investment"
       }
      }
     },
     "localname": "AmountReceivableOnMaturedInvestment",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AnnualRevenueMilestonesRangesForMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual revenue milestones ranges for milestone payments.",
        "label": "Annual Revenue Milestones Ranges For Milestone Payments",
        "terseLabel": "Annual revenue milestones ranges for milestone payments"
       }
      }
     },
     "localname": "AnnualRevenueMilestonesRangesForMilestonePayments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AssetAcquisitionMilestonePaymentPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition, milestone payment payable.",
        "label": "Asset Acquisition Milestone Payment Payable",
        "terseLabel": "Sales-based milestone payments payable"
       }
      }
     },
     "localname": "AssetAcquisitionMilestonePaymentPayable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_AtMarketIssuanceSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At market issuance sales agreement.",
        "label": "At Market Issuance Sales Agreement [Member]",
        "terseLabel": "At Market Issuance Sales Agreement"
       }
      }
     },
     "localname": "AtMarketIssuanceSalesAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AtTheMarketIssuanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-the-market issuance.",
        "label": "At The Market Issuance [Member]",
        "terseLabel": "At The Market Issuance"
       }
      }
     },
     "localname": "AtTheMarketIssuanceMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-the-market offering.",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At-the-market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_BaringsGlobalMilestoneRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barings Global milestone rights.",
        "label": "Barings Global Milestone Rights [Member]",
        "terseLabel": "Barings Global Milestone Rights"
       }
      }
     },
     "localname": "BaringsGlobalMilestoneRightsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_BasisOfPresentationPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis Of Presentation Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfPresentationPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_BiommSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biomm S.A.",
        "label": "Biomm S A [Member]",
        "terseLabel": "Biomm"
       }
      }
     },
     "localname": "BiommSAMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_BusinessAcquisitionRepaymentOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition, repayment of debt.",
        "label": "Business Acquisition Repayment Of Debt",
        "terseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "BusinessAcquisitionRepaymentOfDebt",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_BusinessCombinationAccumulatedCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination accumulated cost.",
        "label": "Business Combination Accumulated Cost",
        "terseLabel": "Business acquisition, total accumulated cost"
       }
      }
     },
     "localname": "BusinessCombinationAccumulatedCost",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10030.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current and noncurrent liabilities.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current And Noncurrent Liabilities",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAndNoncurrentLiabilities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10040.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed operating lease liability.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10090.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed operating lease right-of-use assets.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_BusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business.",
        "label": "Business Policy [Text Block]",
        "terseLabel": "Business"
       }
      }
     },
     "localname": "BusinessPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_CaliforniaDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "California division of taxation.",
        "label": "California Division Of Taxation [Member]",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CaliforniaDivisionOfTaxationMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CantorFitzgeraldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cantor fitzgerald.",
        "label": "Cantor Fitzgerald [Member]",
        "terseLabel": "Cantor Fitzgerald"
       }
      }
     },
     "localname": "CantorFitzgeraldMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CashEquivalentsAndInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and investments.",
        "label": "Cash Equivalents And Investments",
        "terseLabel": "Total cash equivalents and investments"
       }
      }
     },
     "localname": "CashEquivalentsAndInvestments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CasperLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1 Casper, LLC.",
        "label": "Casper L L C [Member]",
        "terseLabel": "Casper L L C"
       }
      }
     },
     "localname": "CasperLLCMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CiplaLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cipla Ltd.",
        "label": "Cipla Ltd [Member]",
        "terseLabel": "Cipla Ltd"
       }
      }
     },
     "localname": "CiplaLtdMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ClinicalSuppliesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Supplies.",
        "label": "Clinical Supplies [Member]",
        "terseLabel": "Clinical Supplies"
       }
      }
     },
     "localname": "ClinicalSuppliesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ClinicalTrialExpensePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Trial Expense",
        "label": "Clinical Trial Expense Policy [Text Block]",
        "terseLabel": "Clinical Trial Expenses"
       }
      }
     },
     "localname": "ClinicalTrialExpensePolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_CoPromotionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Co-promotion agreement.",
        "label": "Co Promotion Agreement [Member]",
        "terseLabel": "Co-Promotion Agreement"
       }
      }
     },
     "localname": "CoPromotionAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CollaborationAndLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreement.",
        "label": "Collaboration And License Agreement [Member]",
        "terseLabel": "Collaboration and License Agreement"
       }
      }
     },
     "localname": "CollaborationAndLicenseAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CommercialSupplyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "commercial supply agreement.",
        "label": "Commercial Supply Agreement [Member]",
        "terseLabel": "Commercial Supply Agreement"
       }
      }
     },
     "localname": "CommercialSupplyAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CommercializationAndContinuousImprovementActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercialization and continuous improvement activities.",
        "label": "Commercialization And Continuous Improvement Activities [Member]",
        "terseLabel": "Commercialization And Continuous Improvement Activities"
       }
      }
     },
     "localname": "CommercializationAndContinuousImprovementActivitiesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CommitmentAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment asset.",
        "label": "Commitment Asset",
        "terseLabel": "Commitment asset"
       }
      }
     },
     "localname": "CommitmentAsset",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CommitmentAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment asset.",
        "label": "Commitment Asset [Member]",
        "terseLabel": "Commitment Asset"
       }
      }
     },
     "localname": "CommitmentAssetMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies [Table]",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issuance to settle employee stock purchase plan liability",
        "label": "Common Stock Issuance To Settle Employee Stock Purchase Plan Liability",
        "terseLabel": "Issuance of common stock under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued for acquisition of in-process research and development.",
        "label": "Common Stock Issued For Acquisition Of In Process Research And Development",
        "terseLabel": "Issuance of common stock for acquisition of in-process research and development"
       }
      }
     },
     "localname": "CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CommonStockIssuedToPayInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued to pay interest.",
        "label": "Common Stock Issued To Pay Interest",
        "terseLabel": "Common stock issued to pay interest"
       }
      }
     },
     "localname": "CommonStockIssuedToPayInterest",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock options and performance based stock option awards.",
        "label": "Common Stock Options And Performance Based Stock Option Awards [Member]",
        "terseLabel": "Common Stock Options and PNQs"
       }
      }
     },
     "localname": "CommonStockOptionsAndPerformanceBasedStockOptionAwardsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment and software.",
        "label": "Computer Equipment And Software [Member]",
        "terseLabel": "Computer Equipment and Software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ConnecticutTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Connecticut tax authority.",
        "label": "Connecticut Tax Authority [Member]",
        "terseLabel": "Connecticut"
       }
      }
     },
     "localname": "ConnecticutTaxAuthorityMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consecutive trading days.",
        "label": "Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "ConsecutiveTradingDays",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_ContingentLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Liability",
        "label": "Contingent Liability",
        "verboseLabel": "Contingent liability for milestone payments"
       }
      }
     },
     "localname": "ContingentLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ContingentLiabilityRemainingPayableAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent liability remaining payable amount.",
        "label": "Contingent Liability Remaining Payable Amount",
        "verboseLabel": "Contingent liability remain payable"
       }
      }
     },
     "localname": "ContingentLiabilityRemainingPayableAmount",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ContingentMilestoneLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent milestone liability.",
        "label": "Contingent Milestone Liability",
        "terseLabel": "Contingent milestone liability"
       }
      }
     },
     "localname": "ContingentMilestoneLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ContingentMilestoneLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent milestone liability.",
        "label": "Contingent Milestone Liability [Member]",
        "terseLabel": "Contingent Milestone Liability"
       }
      }
     },
     "localname": "ContingentMilestoneLiabilityMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ContolledEquityOfferingSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contolled equity offering sales agreement.",
        "label": "Contolled Equity Offering Sales Agreement [Member]",
        "terseLabel": "Contolled Equity Offering Sales Agreement"
       }
      }
     },
     "localname": "ContolledEquityOfferingSalesAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ContractWithCustomerLiabilityAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability additions.",
        "label": "Contract With Customer Liability Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAdditions",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ContractWithCustomerLiabilityCollaborationsAndServicesRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability collaborations and services revenue.",
        "label": "Contract With Customer Liability Collaborations And Services Revenue",
        "terseLabel": "Revenue \u2014 collaborations and services"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCollaborationsAndServicesRevenue",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ContractWithCustomerLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability.",
        "label": "Contract With Customer Liability Table [Text Block]",
        "terseLabel": "Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ConvertibleNoteInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible note interest.",
        "label": "Convertible Note Interest [Member]",
        "terseLabel": "Convertible Note Interest"
       }
      }
     },
     "localname": "ConvertibleNoteInterestMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ConvertibleNotePrincipalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible note principal.",
        "label": "Convertible Note Principal [Member]",
        "terseLabel": "Convertible Note Principal"
       }
      }
     },
     "localname": "ConvertibleNotePrincipalMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible notes.",
        "label": "Convertible Notes [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ConvertiblePromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible promissory note.",
        "label": "Convertible Promissory Note [Member]",
        "terseLabel": "Convertible Promissory Note"
       }
      }
     },
     "localname": "ConvertiblePromissoryNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CostOfRevenueCollaborationsAndServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenue collaborations and services.",
        "label": "Cost Of Revenue Collaborations And Services [Member]",
        "terseLabel": "Cost of Revenue - Collaborations and Services"
       }
      }
     },
     "localname": "CostOfRevenueCollaborationsAndServicesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_CostOfRevenuesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenues.",
        "label": "Cost Of Revenues Policy [Text Block]",
        "terseLabel": "Cost of Revenues"
       }
      }
     },
     "localname": "CostOfRevenuesPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_CreditFacilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit facility noncurrent.",
        "label": "Credit Facility Noncurrent",
        "terseLabel": "Midcap credit facility"
       }
      }
     },
     "localname": "CreditFacilityNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CumulativeLossOnAvailableForSaleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative loss on available-for-sale securities",
        "label": "Cumulative Loss On Available For Sale Securities",
        "terseLabel": "Cumulative loss on available-for-sale securities"
       }
      }
     },
     "localname": "CumulativeLossOnAvailableForSaleSecurities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CurrentPortionOfMilestoneRightLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of milestone right liability.",
        "label": "Current Portion Of Milestone Right Liability",
        "terseLabel": "Current portion of milestone rights liability"
       }
      }
     },
     "localname": "CurrentPortionOfMilestoneRightLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_CustomerDiscountsAndAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Discounts And Allowances",
        "label": "Customer Discounts And Allowances",
        "terseLabel": "Discounts and allowances for commercial product sales"
       }
      }
     },
     "localname": "CustomerDiscountsAndAllowances",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DateOfAgreementInitiationForMarketingAndDistribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of agreement initiation for marketing and distribution.",
        "label": "Date Of Agreement Initiation For Marketing And Distribution",
        "terseLabel": "Marketing and distribution agreement date"
       }
      }
     },
     "localname": "DateOfAgreementInitiationForMarketingAndDistribution",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "mnkd_DebtConversionConvertedInstrumentAccruedInterestOfNotesValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt conversion converted instrument accrued interest of notes value.",
        "label": "Debt Conversion Converted Instrument Accrued Interest Of Notes Value",
        "terseLabel": "Conversion of notes accrued interest to common shares, value"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAccruedInterestOfNotesValue",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt conversion converted instrument shares issued for accrued interest of notes.",
        "label": "Debt Conversion Converted Instrument Shares Issued For Accrued Interest Of Notes",
        "terseLabel": "Conversion of notes accrued interest to common shares"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssuedForAccruedInterestOfNotes",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_DebtInstrumentAdvanceAvailableDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument advance available date.",
        "label": "Debt Instrument Advance Available Date",
        "terseLabel": "Debt instrument advance available date"
       }
      }
     },
     "localname": "DebtInstrumentAdvanceAvailableDate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "mnkd_DebtInstrumentCapInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument cap interest rate.",
        "label": "Debt Instrument Cap Interest Rate",
        "terseLabel": "Interest rate cap"
       }
      }
     },
     "localname": "DebtInstrumentCapInterestRate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_DebtInstrumentConvertibleConversionPricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument convertible conversion price percentage.",
        "label": "Debt Instrument Convertible Conversion Price Percentage",
        "terseLabel": "Conversion price percentage"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPricePercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_DebtInstrumentExtendedInterestOnlyDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument extended interest-only date.",
        "label": "Debt Instrument Extended Interest Only Date",
        "terseLabel": "Debt instrument extended interest-only date"
       }
      }
     },
     "localname": "DebtInstrumentExtendedInterestOnlyDate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "mnkd_DebtInstrumentFairValueInExcessOfFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument fair value in excess of face amount.",
        "label": "Debt Instrument Fair Value In Excess Of Face Amount",
        "terseLabel": "Debt instrument fair value in excess of face amount"
       }
      }
     },
     "localname": "DebtInstrumentFairValueInExcessOfFaceAmount",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtInstrumentFloorRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument floor rate.",
        "label": "Debt Instrument Floor Rate",
        "terseLabel": "Interest rate floor"
       }
      }
     },
     "localname": "DebtInstrumentFloorRate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_DebtInstrumentInitialConversionPriceOfPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument initial conversion price of premium percentage.",
        "label": "Debt Instrument Initial Conversion Price Of Premium Percentage",
        "terseLabel": "Initial conversion price of premium percentage"
       }
      }
     },
     "localname": "DebtInstrumentInitialConversionPriceOfPremiumPercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_DebtInstrumentMaturityMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument maturity month and year.",
        "label": "Debt Instrument Maturity Month And Year",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityMonthAndYear",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "mnkd_DebtInstrumentMeasurementInputAfterChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument measurement input after change.",
        "label": "Debt Instrument Measurement Input After Change",
        "terseLabel": "Note payable, percentage of hypothetical yield"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInputAfterChange",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "mnkd_DebtInstrumentMinimumCashCovenant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument minimum cash covenant.",
        "label": "Debt Instrument Minimum Cash Covenant",
        "terseLabel": "Minimum cash covenant"
       }
      }
     },
     "localname": "DebtInstrumentMinimumCashCovenant",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument minimum unrestricted cash and short-term investments.",
        "label": "Debt Instrument Minimum Unrestricted Cash And Short Term Investments",
        "terseLabel": "Debt instrument minimum unrestricted cash and short-term investments"
       }
      }
     },
     "localname": "DebtInstrumentMinimumUnrestrictedCashAndShortTermInvestments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtInstrumentOutstandingPrincipalAmountRedeemed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument outstanding principal amount redeemed.",
        "label": "Debt Instrument Outstanding Principal Amount Redeemed",
        "terseLabel": "Outstanding principal amount redeemed"
       }
      }
     },
     "localname": "DebtInstrumentOutstandingPrincipalAmountRedeemed",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtInstrumentPaymentNumberOfEqualMonthlyInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument payment number of equal monthly installments.",
        "label": "Debt Instrument Payment Number Of Equal Monthly Installments",
        "terseLabel": "Debt Instrument Payment Number of Equal Monthly Installments"
       }
      }
     },
     "localname": "DebtInstrumentPaymentNumberOfEqualMonthlyInstallments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_DebtInstrumentUnamortizedPrepaymentPenalty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument unamortized prepayment penalty.",
        "label": "Debt Instrument Unamortized Prepayment Penalty",
        "terseLabel": "Debt Instrument unamortized prepayment penalty."
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPrepaymentPenalty",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DebtPremiumRecognizedInAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt premium recognized in additional paid-in capital.",
        "label": "Debt Premium Recognized In Additional Paid In Capital",
        "terseLabel": "Debt premium recognized in additional paid-in capital"
       }
      }
     },
     "localname": "DebtPremiumRecognizedInAdditionalPaidInCapital",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DecemberTwoThousandTwentyNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December two thousand twenty note.",
        "label": "December Two Thousand Twenty Note [Member]",
        "terseLabel": "December 2020 Note"
       }
      }
     },
     "localname": "DecemberTwoThousandTwentyNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_DeerfieldManagementCompanyLpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deerfield Management Company L.P.",
        "label": "Deerfield Management Company Lp [Member]",
        "terseLabel": "Deerfield"
       }
      }
     },
     "localname": "DeerfieldManagementCompanyLpMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_DeferredTaxAssetsCapitalizedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10140.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Capitalized Costs",
        "label": "Deferred Tax Assets Capitalized Costs",
        "terseLabel": "Capitalized patent costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedCosts",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsCapitalizedResearchExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Capitalized Research Expenses",
        "label": "Deferred Tax Assets Capitalized Research Expenses",
        "terseLabel": "Capitalized research costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchExpenses",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsInterestExpenseLimitation": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10170.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets interest expense limitation.",
        "label": "Deferred Tax Assets Interest Expense Limitation",
        "terseLabel": "Interest expense limitation"
       }
      }
     },
     "localname": "DeferredTaxAssetsInterestExpenseLimitation",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10160.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liabilities.",
        "label": "Deferred Tax Assets Lease Liabilities",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsLossOnPurchaseCommitment": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10120.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Loss on Purchase Commitment",
        "label": "Deferred Tax Assets Loss On Purchase Commitment",
        "terseLabel": "Loss on purchase commitment"
       }
      }
     },
     "localname": "DeferredTaxAssetsLossOnPurchaseCommitment",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsMilestoneRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Milestone Rights",
        "label": "Deferred Tax Assets Milestone Rights",
        "terseLabel": "Milestone Rights"
       }
      }
     },
     "localname": "DeferredTaxAssetsMilestoneRights",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsProductRevenueAndCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10190.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets product revenue and other.",
        "label": "Deferred Tax Assets Product Revenue And Costs",
        "terseLabel": "Deferred Product Revenue &amp; Costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsProductRevenueAndCosts",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets tax credit carryforwards research expire.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research Expire",
        "terseLabel": "Research and development credits expire"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets tax credit carryforwards research not expire.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research Not Expire",
        "terseLabel": "Research and development credits not expire"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearchNotExpire",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10110.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense (Accrual Adjustment)",
        "label": "Deferred Tax Assets Tax Deferred Expense Accrual Adjustment",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DeferredTaxLiabilitiesRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use asset.",
        "label": "Deferred Tax Liabilities Right Of Use Asset",
        "negatedLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DepositForSaleLeasebackTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit for the sale-leaseback transaction.",
        "label": "Deposit For Sale Leaseback Transaction",
        "negatedLabel": "Deposit for the sale-leaseback transaction"
       }
      }
     },
     "localname": "DepositForSaleLeasebackTransaction",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DiscountOnPurchasePricePercentageOfFairMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount on purchase price percentage of fair market value.",
        "label": "Discount On Purchase Price Percentage Of Fair Market Value",
        "terseLabel": "Discount on purchase price percentage of fair market value"
       }
      }
     },
     "localname": "DiscountOnPurchasePricePercentageOfFairMarketValue",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales.",
        "label": "Discounts And Allowances For Commercial Product Sales",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSales",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSalesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales.",
        "label": "Discounts And Allowances For Commercial Product Sales [Abstract]",
        "terseLabel": "Discounts and allowances for commercial product sales:"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSalesAbstract",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales balances from acquisition.",
        "label": "Discounts And Allowances For Commercial Product Sales Balances From Acquisition",
        "terseLabel": "V-Go opening balance sheet"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSalesDeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales deductions.",
        "label": "Discounts And Allowances For Commercial Product Sales Deductions",
        "negatedLabel": "Deductions"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSalesDeductions",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSalesProvisions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales provisions.",
        "label": "Discounts And Allowances For Commercial Product Sales Provisions",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSalesProvisions",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfProvisionForDiscountsAndAllowancesForCommercialProductSalesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_DiscountsAndAllowancesForCommercialProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounts and allowances for commercial product sales.",
        "label": "Discounts And Allowances For Commercial Product Sales Table [Text Block]",
        "terseLabel": "Schedule of Provision for Discounts and Allowances for Commercial Product Sales"
       }
      }
     },
     "localname": "DiscountsAndAllowancesForCommercialProductSalesTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_DueInOneYearOrLessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due in one year or less.",
        "label": "Due In One Year Or Less [Member]",
        "terseLabel": "Due in One Year or Less"
       }
      }
     },
     "localname": "DueInOneYearOrLessMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EarlyTerminationFeesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Early termination fees percentage.",
        "label": "Early Termination Fees Percentage",
        "terseLabel": "Early Termination Fees Percentage"
       }
      }
     },
     "localname": "EarlyTerminationFeesPercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_EarningPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earning per share basic and diluted.",
        "label": "Earning Per Share Basic And Diluted [Abstract]",
        "terseLabel": "EPS \u2014 basic and diluted:"
       }
      }
     },
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation expirations of attribute.",
        "label": "Effective Income Tax Rate Reconciliation Expirations Of Attribute",
        "terseLabel": "Tax attribute expirations"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_EffectiveIncomeTaxRateReconciliationForeignWithholdingTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation foreign withholding tax.",
        "label": "Effective Income Tax Rate Reconciliation Foreign Withholding Tax",
        "terseLabel": "Foreign withholding tax"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignWithholdingTax",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_EffectiveIncomeTaxRateReconciliationPermanentItems": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation Permanent Items",
        "label": "Effective Income Tax Rate Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EmployeeStockOptionsAndPerformanceBasedOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock options and performance based options.",
        "label": "Employee Stock Options And Performance Based Options [Member]",
        "terseLabel": "Options and Performance-based Options"
       }
      }
     },
     "localname": "EmployeeStockOptionsAndPerformanceBasedOptionsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EquityIncentivePlanTwentyEighteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity incentive plan twenty eighteen.",
        "label": "Equity Incentive Plan Twenty Eighteen [Member]",
        "terseLabel": "2018 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanTwentyEighteenMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EquityIncentivePlanTwentyThirteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity incentive plan twenty thirteen.",
        "label": "Equity Incentive Plan Twenty Thirteen [Member]",
        "terseLabel": "2013 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanTwentyThirteenMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_EstimatedFairValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated fair value.",
        "label": "Estimated Fair Value [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimatedFairValueMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld.",
        "label": "Exercise Or Strike Price Of Fair Market Value Of Underlying Common Stock On Date Of Grant Reacquired Or Withheld",
        "terseLabel": "Exercise or strike price of fair market value of underlying common stock on date of grant reacquired or withheld"
       }
      }
     },
     "localname": "ExerciseOrStrikePriceOfFairMarketValueOfUnderlyingCommonStockOnDateOfGrantReacquiredOrWithheld",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_FacilityExpansionServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility expansion services.",
        "label": "Facility Expansion Services [Member]",
        "terseLabel": "Facility Expansion Services"
       }
      }
     },
     "localname": "FacilityExpansionServicesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_FairValueOfFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instruments.",
        "label": "Fair Value Of Financial Instruments [Line Items]",
        "terseLabel": "Fair Value Of Financial Instruments [Line Items]"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsLineItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_FairValueOfFinancialInstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value of Financial Instruments [Table]",
        "label": "Fair Value Of Financial Instruments [Table]",
        "terseLabel": "Fair Value Of Financial Instruments [Table]"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsTable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscounted": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2": {
       "order": 10030.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted.",
        "label": "Finance Lease Liability Discounted",
        "terseLabel": "Total financing liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscounted",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2": {
       "order": 10020.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted debt issuance costs.",
        "label": "Finance Lease Liability Discounted Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedDebtIssuanceCosts",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2": {
       "order": 10010.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted excess amount.",
        "label": "Finance Lease Liability Discounted Excess Amount",
        "negatedLabel": "Interest payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedExcessAmount",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due.",
        "label": "Finance Lease Liability Discounted Payments Due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDue",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10060.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due after year five.",
        "label": "Finance Lease Liability Discounted Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10010.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due next twelve months.",
        "label": "Finance Lease Liability Discounted Payments Due Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10050.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due year five.",
        "label": "Finance Lease Liability Discounted Payments Due Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueYearFive",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10040.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due year four.",
        "label": "Finance Lease Liability Discounted Payments Due Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueYearFour",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10030.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due year three.",
        "label": "Finance Lease Liability Discounted Payments Due Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueYearThree",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail": {
       "order": 10020.0,
       "parentTag": "mnkd_FinanceLeaseLiabilityDiscountedPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease liability discounted payments due year two.",
        "label": "Finance Lease Liability Discounted Payments Due Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_FurnitureFixturesAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture, fixtures and office equipment.",
        "label": "Furniture Fixtures And Office Equipment [Member]",
        "terseLabel": "Furniture, fixtures and office equipment"
       }
      }
     },
     "localname": "FurnitureFixturesAndOfficeEquipmentMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GainLossOnPurchaseCommitments": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10210.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on purchase commitments.",
        "label": "Gain Loss On Purchase Commitments",
        "negatedLabel": "Loss on purchase commitments"
       }
      }
     },
     "localname": "GainLossOnPurchaseCommitments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global adjusted net sales of products exceeds fifty million.",
        "label": "Global Adjusted Net Sales Of Products Exceeds Fifty Million [Member]",
        "terseLabel": "Global Adjusted Net Sales Of Products Exceeds Fifty Million"
       }
      }
     },
     "localname": "GlobalAdjustedNetSalesOfProductsExceedsFiftyMillionMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global adjusted net sales of products reference amount for royalty percentage.",
        "label": "Global Adjusted Net Sales Of Products Reference Amount For Royalty Percentage",
        "terseLabel": "Global adjusted net sales of products, reference amount for royalty percentage."
       }
      }
     },
     "localname": "GlobalAdjustedNetSalesOfProductsReferenceAmountForRoyaltyPercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_GoodwillAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill amortization period.",
        "label": "Goodwill Amortization Period",
        "terseLabel": "Goodwill amortization period"
       }
      }
     },
     "localname": "GoodwillAmortizationPeriod",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "mnkd_GrossUnrealizedHoldingLossesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross unrealized holding losses.",
        "label": "Gross Unrealized Holding Losses [Member]",
        "terseLabel": "Gross Unrealized Holding Losses"
       }
      }
     },
     "localname": "GrossUnrealizedHoldingLossesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GroupFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Five.",
        "label": "Group Five [Member]",
        "terseLabel": "90th Percentile or Higher"
       }
      }
     },
     "localname": "GroupFiveMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GroupFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Four.",
        "label": "Group Four [Member]",
        "terseLabel": "75th Percentile"
       }
      }
     },
     "localname": "GroupFourMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GroupOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group One.",
        "label": "Group One [Member]",
        "terseLabel": "Less than 25th Percentile"
       }
      }
     },
     "localname": "GroupOneMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GroupThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Three.",
        "label": "Group Three [Member]",
        "terseLabel": "50th Percentile"
       }
      }
     },
     "localname": "GroupThreeMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_GroupTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Two.",
        "label": "Group Two [Member]",
        "terseLabel": "25th Percentile"
       }
      }
     },
     "localname": "GroupTwoMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_IncreaseDecreaseInAccruedInterestOnPromissoryNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10510.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in accrued interest on promissory notes.",
        "label": "Increase Decrease In Accrued Interest On Promissory Notes",
        "negatedLabel": "Accrued interest on Mann Group promissory notes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestOnPromissoryNotes",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10500.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_IncreaseDecreaseInRecognizedLossOnPurchaseCommitments": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10490.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in recognized loss on purchase commitments.",
        "label": "Increase Decrease In Recognized Loss On Purchase Commitments",
        "terseLabel": "Recognized loss on purchase commitments"
       }
      }
     },
     "localname": "IncreaseDecreaseInRecognizedLossOnPurchaseCommitments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_InsulinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insulin.",
        "label": "Insulin [Member]",
        "terseLabel": "Insulin"
       }
      }
     },
     "localname": "InsulinMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_InterestExpenseOnFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10060.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense on financing liability.",
        "label": "Interest Expense On Financing Liability",
        "negatedLabel": "Interest expense on financing liability",
        "terseLabel": "Interest expense on financing liability"
       }
      }
     },
     "localname": "InterestExpenseOnFinancingLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFinancingLiabilityCostsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_InterestExpenseOnPromissoryNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10340.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expenses on promissory notes.",
        "label": "Interest Expense On Promissory Notes",
        "terseLabel": "Interest expense on Mann Group promissory notes"
       }
      }
     },
     "localname": "InterestExpenseOnPromissoryNotes",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_InterestOnMilestonePayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10320.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest on milestone payment.",
        "label": "Interest On Milestone Payment",
        "terseLabel": "Interest on milestone right"
       }
      }
     },
     "localname": "InterestOnMilestonePayment",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_IssuanceOfCommonStockPursuantToWarrantConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock pursuant to a warrant conversion.",
        "label": "Issuance Of Common Stock Pursuant To Warrant Conversion",
        "terseLabel": "Issuance of common stock pursuant to a warrant conversion"
       }
      }
     },
     "localname": "IssuanceOfCommonStockPursuantToWarrantConversion",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_IssuanceOfCommonStockPursuantToWarrantConversionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock pursuant to a warrant conversion shares.",
        "label": "Issuance Of Common Stock Pursuant To Warrant Conversion Shares",
        "terseLabel": "Issuance of common stock pursuant to a warrant conversion (shares)"
       }
      }
     },
     "localname": "IssuanceOfCommonStockPursuantToWarrantConversionShares",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_IssuanceOfWarrantsAssociatedWithCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of warrants associated with Credit Facility.",
        "label": "Issuance Of Warrants Associated With Credit Facility",
        "terseLabel": "Issuance of warrants associated with the MidCap Credit Facility"
       }
      }
     },
     "localname": "IssuanceOfWarrantsAssociatedWithCreditFacility",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_JuneTwoThousandTwentyNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June two thousand twenty note.",
        "label": "June Two Thousand Twenty Note [Member]",
        "terseLabel": "June 2020 Note"
       }
      }
     },
     "localname": "JuneTwoThousandTwentyNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_LeaseExpirationMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration month and year.",
        "label": "Lease Expiration Month And Year",
        "terseLabel": "Lease expiration"
       }
      }
     },
     "localname": "LeaseExpirationMonthAndYear",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "mnkd_LeaseRepurchaseDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease repurchase description.",
        "label": "Lease Repurchase Description",
        "terseLabel": "Lease repurchase description"
       }
      }
     },
     "localname": "LeaseRepurchaseDescription",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_LicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement.",
        "label": "License Agreement [Member]",
        "terseLabel": "License Agreement"
       }
      }
     },
     "localname": "LicenseAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_LicenseAndDistributionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "License And Distribution Agreement [Member]",
        "terseLabel": "License and Distribution Agreement"
       }
      }
     },
     "localname": "LicenseAndDistributionAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_LineOfCreditFacilityPrincipalPaymentStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility principal payment start date.",
        "label": "Line Of Credit Facility Principal Payment Start Date",
        "terseLabel": "Line Of Credit Facility Principal Payment Start Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityPrincipalPaymentStartDate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "mnkd_LoanArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan arrangement.",
        "label": "Loan Arrangement [Member]",
        "terseLabel": "Loan Arrangement"
       }
      }
     },
     "localname": "LoanArrangementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_LongTermPurchaseCommitmentExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Purchase Commitment, Expiration Date",
        "label": "Long Term Purchase Commitment Expiration Date",
        "terseLabel": "Supply Agreement expiration period"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentExpirationDate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "mnkd_LongtermPurchaseCommitmentRenewalTimePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term purchase commitment, renewal time period.",
        "label": "Longterm Purchase Commitment Renewal Time Period",
        "terseLabel": "Supply Agreement renewal period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentRenewalTimePeriod",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "mnkd_LossOnPurchaseCommitmentsNumberOfContractsRecognized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss on purchase commitments number of contracts recognized.",
        "label": "Loss On Purchase Commitments Number Of Contracts Recognized",
        "terseLabel": "Loss on purchase commitments, number of new contracts recognized"
       }
      }
     },
     "localname": "LossOnPurchaseCommitmentsNumberOfContractsRecognized",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_LossOnPurchaseCommitmentsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss on purchase commitments.",
        "label": "Loss On Purchase Commitments Policy Policy [Text Block]",
        "terseLabel": "Recognized Loss on Purchase Commitments"
       }
      }
     },
     "localname": "LossOnPurchaseCommitmentsPolicyPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_MannGroupConvertibleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mann group convertible note.",
        "label": "Mann Group Convertible Note [Member]",
        "terseLabel": "Mann Group Convertible Note"
       }
      }
     },
     "localname": "MannGroupConvertibleNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Equipment, Computer Hardware and Software, Computer Equipment, Lab Equipment, and Building Improvements.",
        "label": "Manufacturing Equipment Computer Hardware And Software Computer Equipment Lab Equipment And Building Improvements [Member]",
        "terseLabel": "Manufacturing Equipment, Computer Hardware and Software, Computer Equipment, Lab Equipment, and Building Improvements"
       }
      }
     },
     "localname": "ManufacturingEquipmentComputerHardwareAndSoftwareComputerEquipmentLabEquipmentAndBuildingImprovementsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ManufacturingEquipmentsAndComputerHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing equipments and computer hardware.",
        "label": "Manufacturing Equipments And Computer Hardware [Member]",
        "terseLabel": "Manufacturing Equipment and Computer Hardware"
       }
      }
     },
     "localname": "ManufacturingEquipmentsAndComputerHardwareMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ManufacturingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing services.",
        "label": "Manufacturing Services [Member]",
        "terseLabel": "Manufacturing Services"
       }
      }
     },
     "localname": "ManufacturingServicesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_MarketPriceStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market price stock purchase plan.",
        "label": "Market Price Stock Purchase Plan",
        "terseLabel": "Market price stock purchase plan"
       }
      }
     },
     "localname": "MarketPriceStockPurchasePlan",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_MarlboroughLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marlborough lease.",
        "label": "Marlborough Lease [Member]",
        "terseLabel": "Marlborough Lease"
       }
      }
     },
     "localname": "MarlboroughLeaseMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_MasterLeaseAgreementWithEnterpriseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Master lease agreement with enterprise.",
        "label": "Master Lease Agreement With Enterprise [Member]",
        "terseLabel": "Master Lease Agreement with Enterprise"
       }
      }
     },
     "localname": "MasterLeaseAgreementWithEnterpriseMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_MaximumValueOfAdditionalInvestmentLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum value of additional investment limit.",
        "label": "Maximum Value Of Additional Investment Limit",
        "terseLabel": "Maximum value of additional investment limit"
       }
      }
     },
     "localname": "MaximumValueOfAdditionalInvestmentLimit",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MeasurementPeriodPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement period percentage.",
        "label": "Measurement Period Percentage",
        "terseLabel": "Measurement period percentage"
       }
      }
     },
     "localname": "MeasurementPeriodPercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_MidCapCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MidCap Credit Facility.",
        "label": "Mid Cap Credit Facility [Member]",
        "terseLabel": "MidCap Credit Facility"
       }
      }
     },
     "localname": "MidCapCreditFacilityMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_MilestoneLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone liabilities non-current.",
        "label": "Milestone Liabilities Noncurrent",
        "terseLabel": "Milestone liabilities"
       }
      }
     },
     "localname": "MilestoneLiabilitiesNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestonePaymentReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payment received.",
        "label": "Milestone Payment Received",
        "terseLabel": "Milestone Payment Received"
       }
      }
     },
     "localname": "MilestonePaymentReceived",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestonePayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payments.",
        "label": "Milestone Payments",
        "negatedLabel": "Milestone payment"
       }
      }
     },
     "localname": "MilestonePayments",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestoneRightLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone rights liability.",
        "label": "Milestone Right Liability",
        "terseLabel": "Milestone rights liability"
       }
      }
     },
     "localname": "MilestoneRightLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestoneRightsLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone rights liabilities current and noncurrent.",
        "label": "Milestone Rights Liabilities Current And Noncurrent",
        "terseLabel": "Remaining milestone rights liability"
       }
      }
     },
     "localname": "MilestoneRightsLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestoneRightsLiabilityCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone rights liability current.",
        "label": "Milestone Rights Liability Current",
        "terseLabel": "Milestone rights liability, current"
       }
      }
     },
     "localname": "MilestoneRightsLiabilityCurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_MilestoneRightsLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Rights Liability",
        "label": "Milestone Rights Liability [Member]",
        "terseLabel": "Milestone Rights Liability"
       }
      }
     },
     "localname": "MilestoneRightsLiabilityMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_MilestoneRightsLiabilityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone rights liability.",
        "label": "Milestone Rights Liability Policy [Text Block]",
        "terseLabel": "Milestone Rights Liability"
       }
      }
     },
     "localname": "MilestoneRightsLiabilityPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_NetOperatingLossCarryforwardAnnualLimitation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryforward Annual Limitation",
        "label": "Net Operating Loss Carryforward Annual Limitation",
        "terseLabel": "Net operating loss and credit carryforwards, annual use limitation"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardAnnualLimitation",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_NewLoanArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New loan arrangement.",
        "label": "New Loan Arrangement [Member]",
        "terseLabel": "New Loan Arrangement"
       }
      }
     },
     "localname": "NewLoanArrangementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_NextGenResearchAndDevelopmentServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Next-gen research and development services.",
        "label": "Next Gen Research And Development Services [Member]",
        "terseLabel": "Next-Gen R&amp;D Services"
       }
      }
     },
     "localname": "NextGenResearchAndDevelopmentServicesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_NonConvertibleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non convertible note.",
        "label": "Non Convertible Note [Member]",
        "terseLabel": "Non-Convertible Note"
       }
      }
     },
     "localname": "NonConvertibleNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_NonConvertiblePromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-convertible promissory note.",
        "label": "Non Convertible Promissory Note [Member]",
        "terseLabel": "Non Convertible Promissory Note"
       }
      }
     },
     "localname": "NonConvertiblePromissoryNoteMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_NotePayablePercentageOfInterestRateChange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note payable, percentage of interest rate change.",
        "label": "Note Payable Percentage Of Interest Rate Change",
        "terseLabel": "Note payable, percentage of interest rate increases (decreases)"
       }
      }
     },
     "localname": "NotePayablePercentageOfInterestRateChange",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_NumberOfTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of trading days.",
        "label": "Number Of Trading Days",
        "terseLabel": "Number of trading days"
       }
      }
     },
     "localname": "NumberOfTradingDays",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_NumberOfVehicleLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of vehicle leases.",
        "label": "Number Of Vehicle Leases",
        "terseLabel": "Number of vehicle leases"
       }
      }
     },
     "localname": "NumberOfVehicleLeases",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_NumberOfVehicleLeasesReplaced": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of vehicle leases replaced.",
        "label": "Number Of Vehicle Leases Replaced",
        "terseLabel": "Number of vehicle leases replaced"
       }
      }
     },
     "localname": "NumberOfVehicleLeasesReplaced",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_NumberOfVehicleLeasesRetired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of vehicle leases retired.",
        "label": "Number Of Vehicle Leases Retired",
        "terseLabel": "Number of vehicle leases retired"
       }
      }
     },
     "localname": "NumberOfVehicleLeasesRetired",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_NumberOfWholesaleDistributors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of wholesale distributors.",
        "label": "Number Of Wholesale Distributors",
        "terseLabel": "Number of wholesale distributors"
       }
      }
     },
     "localname": "NumberOfWholesaleDistributors",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "mnkd_OfficeAndVehicleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office and vehicle.",
        "label": "Office And Vehicle [Member]",
        "terseLabel": "office and vehicle"
       }
      }
     },
     "localname": "OfficeAndVehicleMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_OfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office.",
        "label": "Office [Member]",
        "terseLabel": "Office Lease"
       }
      }
     },
     "localname": "OfficeMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_OneYearServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One year service.",
        "label": "One Year Service [Member]",
        "terseLabel": "One Year Service"
       }
      }
     },
     "localname": "OneYearServiceMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_OperatingLeasesAnnualIncreaseInRentExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases annual increase in rent expense.",
        "label": "Operating Leases Annual Increase In Rent Expense",
        "terseLabel": "Percentage of annual increase in lease payment"
       }
      }
     },
     "localname": "OperatingLeasesAnnualIncreaseInRentExpense",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_OperatingLossCarryforwardsSubjectToLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards Subject To Limitation",
        "label": "Operating Loss Carryforwards Subject To Limitation",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToLimitation",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, consolidation and presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_OtherAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other agreement.",
        "label": "Other Agreement [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PaycheckProtectionProgramCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program, CARES Act.",
        "label": "Paycheck Protection Program C A R E S Act [Member]",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "PaycheckProtectionProgramCARESActMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PaymentForMilestoneRightsLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment for milestone rights liabilities.",
        "label": "Payment For Milestone Rights Liabilities",
        "terseLabel": "Payment for milestone liability"
       }
      }
     },
     "localname": "PaymentForMilestoneRightsLiabilities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PaymentOfCreditFacilityPrepaymentPenalty": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of credit facility prepayment penalty.",
        "label": "Payment Of Credit Facility Prepayment Penalty",
        "negatedLabel": "Payment of MidCap credit facility prepayment penalty"
       }
      }
     },
     "localname": "PaymentOfCreditFacilityPrepaymentPenalty",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PaymentOfLongTermPurchaseCommitmentAmendmentFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of long term purchase commitment amendment fee.",
        "label": "Payment Of Long Term Purchase Commitment Amendment Fee",
        "terseLabel": "Payment of long term purchase commitment, amendment fees"
       }
      }
     },
     "localname": "PaymentOfLongTermPurchaseCommitmentAmendmentFee",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PaymentOnFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment on financing liability.",
        "label": "Payment On Financing Liability",
        "negatedLabel": "Payment on financing liability"
       }
      }
     },
     "localname": "PaymentOnFinancingLiability",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PaymentsOnDebtAndInterestThroughCommonStockIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments on debt and interest through common stock issuance.",
        "label": "Payments On Debt And Interest Through Common Stock Issuance",
        "terseLabel": "Payments on debt and interest through common stock issuance"
       }
      }
     },
     "localname": "PaymentsOnDebtAndInterestThroughCommonStockIssuance",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PercentageOfAccountsReceivableFromMajorCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of accounts receivable from major customers.",
        "label": "Percentage Of Accounts Receivable From Major Customers",
        "terseLabel": "Percentage of accounts receivable from major wholesale distributors"
       }
      }
     },
     "localname": "PercentageOfAccountsReceivableFromMajorCustomers",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentageOfCollaborationsAndServicesNetAccountsReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of collaborations and services net accounts receivables.",
        "label": "Percentage Of Collaborations And Services Net Accounts Receivables",
        "terseLabel": "Percentage of collaborations and services net accounts receivables"
       }
      }
     },
     "localname": "PercentageOfCollaborationsAndServicesNetAccountsReceivables",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentageOfModificationOfPreviouslyFixedConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of modification of previously fixed consideration.",
        "label": "Percentage Of Modification Of Previously Fixed Consideration",
        "terseLabel": "Percentage of modification of previously fixed consideration"
       }
      }
     },
     "localname": "PercentageOfModificationOfPreviouslyFixedConsideration",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentageOfRevenueFromMajorCustomersCollaborationsAndServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from major customers collaborations and services.",
        "label": "Percentage Of Revenue From Major Customers Collaborations And Services",
        "terseLabel": "Percentage of revenue from major customers collaborations and services"
       }
      }
     },
     "localname": "PercentageOfRevenueFromMajorCustomersCollaborationsAndServices",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentageOfRoyaltyPaymentOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty payment on net sales.",
        "label": "Percentage Of Royalty Payment On Net Sales",
        "terseLabel": "Royalty payment in each of the calendar years"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPaymentOnNetSales",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentageOfSalesFromMajorCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sales from major customers.",
        "label": "Percentage Of Sales From Major Customers",
        "terseLabel": "Percentage of gross sales from major wholesale distributors"
       }
      }
     },
     "localname": "PercentageOfSalesFromMajorCustomers",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PercentileRankOfShareholderReturnOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentile rank of shareholder return of stock.",
        "label": "Percentile Rank Of Shareholder Return Of Stock",
        "terseLabel": "Percentile"
       }
      }
     },
     "localname": "PercentileRankOfShareholderReturnOfStock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_PreCommercialServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-commercial services.",
        "label": "Pre Commercial Services [Member]",
        "terseLabel": "Pre-Commercial Services"
       }
      }
     },
     "localname": "PreCommercialServicesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PreLaunchInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "pre-launch inventory.",
        "label": "Pre Launch Inventory [Member]",
        "terseLabel": "Pre-launch Inventory"
       }
      }
     },
     "localname": "PreLaunchInventoryMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PreLaunchInventoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-launch inventory.",
        "label": "Pre Launch Inventory Policy [Text Block]",
        "terseLabel": "Pre Launch Inventory"
       }
      }
     },
     "localname": "PreLaunchInventoryPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_PremiumOnConvertibleNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premium on convertible note.",
        "label": "Premium On Convertible Note",
        "terseLabel": "Premium on convertible note"
       }
      }
     },
     "localname": "PremiumOnConvertibleNote",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PrepaymentOfSecuredLinesOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment of secured lines of credit.",
        "label": "Prepayment Of Secured Lines Of Credit",
        "terseLabel": "Prepaid of borrowing"
       }
      }
     },
     "localname": "PrepaymentOfSecuredLinesOfCredit",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PrincipalAmountPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount per share.",
        "label": "Principal Amount Per Share",
        "terseLabel": "Principal amount per share"
       }
      }
     },
     "localname": "PrincipalAmountPerShare",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "mnkd_PriorToFirstAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "prior to the first amendment.",
        "label": "Prior To First Amendment [Member]",
        "terseLabel": "Prior to First Amendment"
       }
      }
     },
     "localname": "PriorToFirstAmendmentMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PriorToMidcapCreditFacilityAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior to midcap credit facility amendment.",
        "label": "Prior To Midcap Credit Facility Amendment [Member]",
        "terseLabel": "Prior To Midcap Credit Facility Amendment"
       }
      }
     },
     "localname": "PriorToMidcapCreditFacilityAmendmentMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PrivatelyNegotiatedExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Privately-negotiated exchange agreement.",
        "label": "Privately Negotiated Exchange Agreement [Member]",
        "terseLabel": "Privately Negotiated Exchange Agreement"
       }
      }
     },
     "localname": "PrivatelyNegotiatedExchangeAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from market price stock purchase plan and from employee stock purchase plan.",
        "label": "Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan",
        "terseLabel": "Proceeds from market price stock purchase plan and from employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from net issuance of common stock associated with stock options and restricted stock units.",
        "label": "Proceeds From Net Issuance Of Common Stock Associated With Stock Options And Restricted Stock Units",
        "terseLabel": "Net issuance of common stock associated with stock options and restricted stock units"
       }
      }
     },
     "localname": "ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ProceedsFromSaleLeasebackTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from the sale-leaseback transaction.",
        "label": "Proceeds From Sale Leaseback Transaction",
        "terseLabel": "Proceeds from the sale-leaseback transaction"
       }
      }
     },
     "localname": "ProceedsFromSaleLeasebackTransaction",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ProductSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product sales.",
        "label": "Product Sales [Member]",
        "terseLabel": "Product Sales"
       }
      }
     },
     "localname": "ProductSalesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promissory notes.",
        "label": "Promissory Notes [Member]",
        "terseLabel": "Promissory Notes"
       }
      }
     },
     "localname": "PromissoryNotesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_PromissoryNotesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promissory notes noncurrent.",
        "label": "Promissory Notes Noncurrent",
        "terseLabel": "Promissory notes"
       }
      }
     },
     "localname": "PromissoryNotesNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve.",
        "label": "Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve deductions.",
        "label": "Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prompt pay discount reserve allowance for wholesale distribution fees and accounts receivables return reserve provisions.",
        "label": "Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfActivitiesAndEndingReserveBalanceDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PurchaseObligationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10230.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase obligation current.",
        "label": "Purchase Obligation Current",
        "terseLabel": "Recognized loss on purchase commitments \u2014 current"
       }
      }
     },
     "localname": "PurchaseObligationCurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PurchaseObligationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase obligation noncurrent.",
        "label": "Purchase Obligation Noncurrent",
        "terseLabel": "Recognized loss on purchase commitments \u2014 long term"
       }
      }
     },
     "localname": "PurchaseObligationNoncurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_PurchaseOfAvailableForSaleSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10250.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of available-for-sale securities.",
        "label": "Purchase Of Available For Sale Securities",
        "negatedLabel": "Purchase of available-for-sale securities",
        "terseLabel": "Purchase of available-for-sale securities"
       }
      }
     },
     "localname": "PurchaseOfAvailableForSaleSecurities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_QrumPharmaIncorporatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "QrumPharma Incorporated.",
        "label": "Qrum Pharma Incorporated [Member]",
        "terseLabel": "QrumPharma"
       }
      }
     },
     "localname": "QrumPharmaIncorporatedMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ReceivableFromCommonStockOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivable from common stock offering.",
        "label": "Receivable From Common Stock Offering",
        "terseLabel": "Receivable from at-the-market offering"
       }
      }
     },
     "localname": "ReceivableFromCommonStockOffering",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RecentlyIssuedAccountingStandardsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recently issued accounting standards.",
        "label": "Recently Issued Accounting Standards Policy [Text Block]",
        "terseLabel": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "RecentlyIssuedAccountingStandardsPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ReceptorLifeScienceIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receptor Life Science Inc.",
        "label": "Receptor Life Science Inc [Member]",
        "terseLabel": "Receptor CLA"
       }
      }
     },
     "localname": "ReceptorLifeScienceIncMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ReclassificationOfConvertibleNotesAndInterestReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of convertible notes and interest receivable.",
        "label": "Reclassification Of Convertible Notes And Interest Receivable",
        "terseLabel": "Reclassification of Thirona convertible notes and interest receivable from long-term to current"
       }
      }
     },
     "localname": "ReclassificationOfConvertibleNotesAndInterestReceivable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ReclassificationOfInvestmentsFromLongTermToCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of investments from long-term to current.",
        "label": "Reclassification Of Investments From Long Term To Current",
        "terseLabel": "Reclassification of investments from long-term to current"
       }
      }
     },
     "localname": "ReclassificationOfInvestmentsFromLongTermToCurrent",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RemainingWarrantsAvailableForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Warrants Available for Purchase.",
        "label": "Remaining Warrants Available For Purchase",
        "terseLabel": "Remaining Warrants Available for Purchase"
       }
      }
     },
     "localname": "RemainingWarrantsAvailableForPurchase",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_ResearchAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research agreement.",
        "label": "Research Agreement [Member]",
        "terseLabel": "Research Agreement"
       }
      }
     },
     "localname": "ResearchAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ResearchAndDevelopmentCreditsBeginToExpire": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Credits, Begin to Expire",
        "label": "Research And Development Credits Begin To Expire",
        "terseLabel": "Research and development credits begin to expire"
       }
      }
     },
     "localname": "ResearchAndDevelopmentCreditsBeginToExpire",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "mnkd_ResearchAndDevelopmentServicesAndLicenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development services and license.",
        "label": "Research And Development Services And License [Member]",
        "terseLabel": "R&amp;D Services and License"
       }
      }
     },
     "localname": "ResearchAndDevelopmentServicesAndLicenseMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ReserveBalanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve balance.",
        "label": "Reserve Balance [Abstract]"
       }
      }
     },
     "localname": "ReserveBalanceAbstract",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "mnkd_ReserveForReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserve for returns.",
        "label": "Reserve For Returns",
        "negatedLabel": "Reserve for returns"
       }
      }
     },
     "localname": "ReserveForReturns",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RestrictedStockUnitsAndMarketRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units and market restricted stock units.",
        "label": "Restricted Stock Units And Market Restricted Stock Units [Member]",
        "terseLabel": "RSUs and Market RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndMarketRestrictedStockUnitsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_RestrictedStockUnitsAndOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units and options.",
        "label": "Restricted Stock Units And Options [Member]",
        "terseLabel": "RSUs and Options"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndOptionsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_RetailInventoryPurchase": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail inventory purchase.",
        "label": "Retail Inventory Purchase",
        "terseLabel": "Retail inventory purchase"
       }
      }
     },
     "localname": "RetailInventoryPurchase",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ReturnsReserveForAcquiredProduct": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns reserve for acquired product.",
        "label": "Returns Reserve For Acquired Product",
        "terseLabel": "Returns reserve for acquired product"
       }
      }
     },
     "localname": "ReturnsReserveForAcquiredProduct",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from contract with customer from collaborations and services.",
        "label": "Revenue From Contract With Customer From Collaborations And Services Policy [Text Block]",
        "terseLabel": "Revenue Recognition- Net Revenue - Collaborations and Services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerFromCollaborationsAndServicesPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from contract with customer from commercial product sales.",
        "label": "Revenue From Contract With Customer From Commercial Product Sales Policy [Text Block]",
        "terseLabel": "Revenue Recognition - Net Revenue - Commercial Product Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerFromCommercialProductSalesPolicyTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_RevenueRemainingPerformanceObligationAnticipatedCashFlow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue remaining performance obligation anticipated cash flow.",
        "label": "Revenue Remaining Performance Obligation Anticipated Cash Flow",
        "terseLabel": "Total anticipated cash flows"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationAnticipatedCashFlow",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RightOfUseAssetsModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets modification.",
        "label": "Right Of Use Assets Modification",
        "terseLabel": "Right-of-use asset modification"
       }
      }
     },
     "localname": "RightOfUseAssetsModification",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_RoyaltiesArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties.",
        "label": "Royalties Arrangement [Member]",
        "terseLabel": "Royalties Arrangement"
       }
      }
     },
     "localname": "RoyaltiesArrangementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_RussellRanchRoadIILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Russell Ranch Road II LLC.",
        "label": "Russell Ranch Road I I L L C [Member]",
        "terseLabel": "Russell Ranch Road II LLC"
       }
      }
     },
     "localname": "RussellRanchRoadIILLCMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_SaleLeasebackTransactionLeaseAgreementPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale leaseback transaction, lease agreement periods.",
        "label": "Sale Leaseback Transaction Lease Agreement Periods",
        "terseLabel": "Sale leaseback transaction, lease agreement period."
       }
      }
     },
     "localname": "SaleLeasebackTransactionLeaseAgreementPeriods",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "mnkd_SalesReturnPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales return period.",
        "label": "Sales Return Period",
        "verboseLabel": "Sales return right following product expiration in months"
       }
      }
     },
     "localname": "SalesReturnPeriod",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "mnkd_ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of activities and ending reserve balance.",
        "label": "Schedule Of Activities And Ending Reserve Balance Table [Text Block]",
        "terseLabel": "Schedule of Activities and Ending Reserve Balance"
       }
      }
     },
     "localname": "ScheduleOfActivitiesAndEndingReserveBalanceTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of amortization of debt issuance cost and debt discount.",
        "label": "Schedule Of Amortization Of Debt Issuance Cost And Debt Discount Table [Text Block]",
        "terseLabel": "Schedule of Amortization of Premium and Accretion of Debt Issuance Costs"
       }
      }
     },
     "localname": "ScheduleOfAmortizationOfDebtIssuanceCostAndDebtDiscountTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of effect of modification on transaction price.",
        "label": "Schedule Of Effect Of Modification On Transaction Price Table [Text Block]",
        "terseLabel": "Schedule of Effect of Modification on Transaction Price"
       }
      }
     },
     "localname": "ScheduleOfEffectOfModificationOnTransactionPriceTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of fair value of assets and financing liability on total investments.",
        "label": "Schedule Of Fair Value Of Assets And Financing Liability On Total Investments Table [Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Financing Liability on Total Investments"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ScheduleOfLeaseTermAndDiscountRateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Lease Term and Discount Rate.",
        "label": "Schedule Of Lease Term And Discount Rate Table [Text Block]",
        "terseLabel": "Schedule of Lease Term and Discount Rate"
       }
      }
     },
     "localname": "ScheduleOfLeaseTermAndDiscountRateTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revised anticipated cash flows from transactions allocated performance obligations.",
        "label": "Schedule Of Revised Anticipated Cash Flows From Transactions Allocated Performance Obligations Table [Text Block]",
        "terseLabel": "Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations"
       }
      }
     },
     "localname": "ScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsTableTextBlock",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mnkd_SeniorConvertibleNotesInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior convertible notes interest.",
        "label": "Senior Convertible Notes Interest [Member]",
        "terseLabel": "Senior Convertible Notes Interest"
       }
      }
     },
     "localname": "SeniorConvertibleNotesInterestMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_SeniorConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior convertible notes.",
        "label": "Senior Convertible Notes [Member]",
        "terseLabel": "Senior Convertible Notes"
       }
      }
     },
     "localname": "SeniorConvertibleNotesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_SeniorConvertibleNotesPrincipalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior convertible notes principal.",
        "label": "Senior Convertible Notes Principal [Member]",
        "terseLabel": "Senior Convertible Notes Principal"
       }
      }
     },
     "localname": "SeniorConvertibleNotesPrincipalMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options in period grant date fair value outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding",
        "terseLabel": "Total grant date fair value of restricted stock units outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant increased by shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increased By Shares",
        "terseLabel": "Equity incentive plan, number of shares available for grant increased by shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award target percentage.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Target Percentage",
        "terseLabel": "Percent of target"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPercentage",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award vesting date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Vesting Date",
        "terseLabel": "Vesting date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "mnkd_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares exercise of warrants.",
        "label": "Stock Issued During Period Shares Exercise Of Warrants",
        "terseLabel": "Issuance of common stock from the exercise of warrants (in Share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares market price stock purchase plan.",
        "label": "Stock Issued During Period Shares Market Price Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under Market Price Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesMarketPriceStockPurchasePlan",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares payoff of convertible securities.",
        "label": "Stock Issued During Period Shares Payoff Of Convertible Securities",
        "terseLabel": "Issuance of common stock pursuant to payoff of the 2024 convertible note interest (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPayoffOfConvertibleSecurities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares stock options and restricted stock units net of forfeitures.",
        "label": "Stock Issued During Period Shares Stock Options And Restricted Stock Units Net Of Forfeitures",
        "terseLabel": "Net issuance of common stock associated with stock options and restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockUnitsNetOfForfeitures",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "mnkd_StockIssuedDuringPeriodValueExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value exercise of warrants.",
        "label": "Stock Issued During Period Value Exercise Of Warrants",
        "terseLabel": "Issuance of common stock from the exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value market price stock purchase plan.",
        "label": "Stock Issued During Period Value Market Price Stock Purchase Plan",
        "terseLabel": "Issuance of common stock from market price stock purchase"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value payoff of convertible securities.",
        "label": "Stock Issued During Period Value Payoff Of Convertible Securities",
        "terseLabel": "Issuance of common stock pursuant to payoff of the 2024 convertible note interest"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePayoffOfConvertibleSecurities",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value stock options and restricted stock units net of forfeitures.",
        "label": "Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures",
        "terseLabel": "Net issuance of common stock in association with stock options and restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Substantial premium based on fair value post modification recognized as additional paid-in capital.",
        "label": "Substantial Premium Based On Fair Value Post Modification Recognized As Additional Paid In Capital",
        "terseLabel": "Substantial premium based on fair value post modification recognized as additional paid-in capital"
       }
      }
     },
     "localname": "SubstantialPremiumBasedOnFairValuePostModificationRecognizedAsAdditionalPaidInCapital",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "mnkd_SupplyAndDistributionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply and distribution agreement.",
        "label": "Supply And Distribution Agreement [Member]",
        "terseLabel": "Supply and Distribution Agreement"
       }
      }
     },
     "localname": "SupplyAndDistributionAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TermLoanAdvancePercentageOfAmountDrawdown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan advance percentage of amount drawdown.",
        "label": "Term Loan Advance Percentage Of Amount Drawdown",
        "terseLabel": "Term loan advance percentage of amount drawdown"
       }
      }
     },
     "localname": "TermLoanAdvancePercentageOfAmountDrawdown",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "mnkd_TheMannGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The mann group llc.",
        "label": "The Mann Group L L C [Member]",
        "terseLabel": "The Mann Group L L C"
       }
      }
     },
     "localname": "TheMannGroupLLCMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_ThironaBioIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thirona Bio, Inc.",
        "label": "Thirona Bio Inc [Member]",
        "terseLabel": "Thirona Bio Inc"
       }
      }
     },
     "localname": "ThironaBioIncMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche one.",
        "label": "Tranche One [Member]",
        "terseLabel": "Tranche 1"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche 3.",
        "label": "Tranche Three [Member]",
        "terseLabel": "Tranche 3"
       }
      }
     },
     "localname": "TrancheThreeMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche 2",
        "label": "Tranche Two [Member]",
        "terseLabel": "Tranche 2"
       }
      }
     },
     "localname": "TrancheTwoMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TransactionPriceForTheContractualObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction price for the contractual obligations.",
        "label": "Transaction Price For The Contractual Obligations [Member]",
        "terseLabel": "Transaction Price For The Contractual Obligations"
       }
      }
     },
     "localname": "TransactionPriceForTheContractualObligationsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TransactionPriceForThePerformanceObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction price for the performance obligations.",
        "label": "Transaction Price For The Performance Obligations [Member]",
        "terseLabel": "Transaction Price For The Performance Obligations"
       }
      }
     },
     "localname": "TransactionPriceForThePerformanceObligationsMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TransfersFromToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers From (To) Parent [Abstract]",
        "label": "Transfers From To Parent [Abstract]"
       }
      }
     },
     "localname": "TransfersFromToParentAbstract",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "mnkd_TwoThousandFourEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Four Equity Incentive Plan [Member]",
        "label": "Two Thousand Four Equity Incentive Plan [Member]",
        "terseLabel": "2004 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFourEquityIncentivePlanMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TwoThousandTwentyFourConvertibleNoteInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty four convertible note interest.",
        "label": "Two Thousand Twenty Four Convertible Note Interest [Member]",
        "terseLabel": "2024 Convertible Note Interest"
       }
      }
     },
     "localname": "TwoThousandTwentyFourConvertibleNoteInterestMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TwoThousandTwentyFourConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty four convertible notes.",
        "label": "Two Thousand Twenty Four Convertible Notes [Member]",
        "terseLabel": "2024 Convertible Notes"
       }
      }
     },
     "localname": "TwoThousandTwentyFourConvertibleNotesMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TwoYearServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two year service.",
        "label": "Two Year Service [Member]",
        "terseLabel": "Two Year Service"
       }
      }
     },
     "localname": "TwoYearServiceMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_TyvasoDPIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tyvaso DPI.",
        "label": "Tyvaso D P I [Member]",
        "terseLabel": "Tyvaso DPI"
       }
      }
     },
     "localname": "TyvasoDPIMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_UTEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UT Equipment.",
        "label": "U T Equipment [Member]",
        "terseLabel": "U T Equipment"
       }
      }
     },
     "localname": "UTEquipmentMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_UnderwritingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting agreement.",
        "label": "Underwriting Agreement [Member]",
        "terseLabel": "Underwriting Agreement"
       }
      }
     },
     "localname": "UnderwritingAgreementMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_UnitedTherapeuticsCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United Therapeutics Corporation.",
        "label": "United Therapeutics Corporation [Member]",
        "terseLabel": "United Therapeutics Corporation"
       }
      }
     },
     "localname": "UnitedTherapeuticsCorporationMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_UpfrontPaymentReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment received.",
        "label": "Upfront Payment Received",
        "terseLabel": "Upfront payment received"
       }
      }
     },
     "localname": "UpfrontPaymentReceived",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mnkd_VGoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "V-Go.",
        "label": "V Go [Member]",
        "terseLabel": "V-Go"
       }
      }
     },
     "localname": "VGoMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_VerticePharmaLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertice Pharma LLC.",
        "label": "Vertice Pharma L L C [Member]",
        "terseLabel": "Vertice Pharma LLC"
       }
      }
     },
     "localname": "VerticePharmaLLCMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_WarrantsAssociatedWithMidcapCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants associated with Midcap Credit Facility.",
        "label": "Warrants Associated With Midcap Credit Facility [Member]",
        "terseLabel": "Warrants Associated with MidCap Credit Facility"
       }
      }
     },
     "localname": "WarrantsAssociatedWithMidcapCreditFacilityMember",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "mnkd_WholesalerDistributionFeesAndPromptPayDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wholesaler distribution fees and prompt pay discounts.",
        "label": "Wholesaler Distribution Fees And Prompt Pay Discounts",
        "negatedLabel": "Wholesaler distribution fees and prompt pay discounts"
       }
      }
     },
     "localname": "WholesalerDistributionFeesAndPromptPayDiscounts",
     "nsuri": "http://www.mannkindcorp.com/20221231",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r291",
      "r292",
      "r408",
      "r438",
      "r675",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r485",
      "r624",
      "r655",
      "r666",
      "r667",
      "r692",
      "r706",
      "r716",
      "r774",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r485",
      "r624",
      "r655",
      "r666",
      "r667",
      "r692",
      "r706",
      "r716",
      "r774",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r348",
      "r627",
      "r693",
      "r715",
      "r768",
      "r769",
      "r777",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Or Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r348",
      "r627",
      "r693",
      "r715",
      "r768",
      "r769",
      "r777",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products And Services [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r466",
      "r485",
      "r514",
      "r515",
      "r516",
      "r623",
      "r624",
      "r655",
      "r666",
      "r667",
      "r692",
      "r706",
      "r716",
      "r765",
      "r774",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r466",
      "r485",
      "r514",
      "r515",
      "r516",
      "r623",
      "r624",
      "r655",
      "r666",
      "r667",
      "r692",
      "r706",
      "r716",
      "r765",
      "r774",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r291",
      "r292",
      "r408",
      "r438",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase Agreement Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r307",
      "r486",
      "r728",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Unspecified [Domain]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r307",
      "r486",
      "r728",
      "r729",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Scenario [Axis]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r755",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r666",
      "r667",
      "r839",
      "r841",
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts Notes And Loans Receivable [Line Items]",
        "terseLabel": "Accounts Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable And Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r18",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r261",
      "r351",
      "r352",
      "r671"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Gross Current",
        "terseLabel": "Accounts receivable, gross"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10320.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Net Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "terseLabel": "Accretion or amortization"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities And Other Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r110",
      "r253"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r36",
      "r38",
      "r185",
      "r617",
      "r656",
      "r657",
      "r737",
      "r738",
      "r739",
      "r749",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r749",
      "r750",
      "r751",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r153",
      "r154",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r128",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments To Additional Paid In Capital Stock Issued Issuance Costs",
        "negatedLabel": "Issuance cost associated with at-the-market offering/placement"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Share based compensation",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r262",
      "r353",
      "r369"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail2": {
       "order": 10020.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance For Doubtful Accounts Receivable Current",
        "negatedLabel": "Allowance for credit losses",
        "terseLabel": "Allowance for credit losses for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r427",
      "r600",
      "r690",
      "r691",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization Of Financing Costs And Discounts",
        "terseLabel": "Amortization of debt issuance cost"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfAmortizationOfPremiumAndAccretionOfDebtIssuanceCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r710",
      "r818",
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition Consideration Transferred",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition Consideration Transferred [Abstract]",
        "terseLabel": "Fair value of consideration:"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "auth_ref": [
      "r818",
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition Consideration Transferred Contingent Consideration",
        "terseLabel": "Fair value of contingent consideration"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDateOfAcquisitionAgreement": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when asset acquisition agreement is executed, in YYYY-MM-DD format.",
        "label": "Asset Acquisition Date Of Acquisition Agreement",
        "terseLabel": "Asset acquisition, date of acquisition agreement"
       }
      }
     },
     "localname": "AssetAcquisitionDateOfAcquisitionAgreement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionEffectiveDateOfAcquisition": {
     "auth_ref": [
      "r817",
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when acquirer obtains control of acquired asset, in YYYY-MM-DD format.",
        "label": "Asset Acquisition Effective Date Of Acquisition",
        "terseLabel": "Asset acquisition, effective date of acquisition"
       }
      }
     },
     "localname": "AssetAcquisitionEffectiveDateOfAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisition.",
        "label": "Asset Acquisition Table [Text Block]",
        "terseLabel": "Schedule of Preliminary Purchase Consideration"
       }
      }
     },
     "localname": "AssetAcquisitionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r69",
      "r107"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10380.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10190.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairment",
        "verboseLabel": "Asset impairment"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r204",
      "r228",
      "r257",
      "r287",
      "r333",
      "r342",
      "r346",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r572",
      "r576",
      "r589",
      "r714",
      "r772",
      "r773",
      "r837"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r247",
      "r265",
      "r287",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r572",
      "r576",
      "r589",
      "r714",
      "r772",
      "r773",
      "r837"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10240.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r88",
      "r356",
      "r372",
      "r643"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Purchased Options Price Policy",
        "terseLabel": "Available-for-Sale Investment"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesPurchasedOptionsPricePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building Improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r564",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r172",
      "r173",
      "r564",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": {
     "auth_ref": [
      "r168",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.",
        "label": "Business Acquisition Effective Date Of Acquisition1",
        "terseLabel": "Acquisition date"
       }
      }
     },
     "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued",
        "terseLabel": "Number of common stock issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition Pro Forma Earnings Per Share Basic",
        "terseLabel": "Net loss per share - basic"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition Pro Forma Earnings Per Share Diluted",
        "terseLabel": "Net loss per share - diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition Pro Forma Information [Abstract]"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r815",
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition Pro Forma Information [Text Block]",
        "terseLabel": "Summary of Supplemental Pro Forma Information (Unaudited)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition Share Price",
        "terseLabel": "Business acquisition, share price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisitions Pro Forma Net Income Loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisitions Pro Forma Revenue",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsSummaryOfSupplementalProFormaInformationUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination And Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r179",
      "r180",
      "r181"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination Consideration Transferred1",
        "totalLabel": "Total consideration paid for IPR&amp;D"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination Consideration Transferred Equity Interests Issued And Issuable",
        "terseLabel": "Stock consideration (3,067,179 shares at $3.01 per share)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r567"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination Consideration Transferred Liabilities Incurred",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination Contingent Consideration Liability Measurement Input",
        "terseLabel": "Measurement inputs"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r183",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10010.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10080.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill",
        "terseLabel": "Intangible asset - Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10050.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10020.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10060.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy",
        "terseLabel": "Acquistitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred But Not Yet Paid",
        "terseLabel": "Non-cash construction in progress and property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostImpairmentLoss": {
     "auth_ref": [
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost Impairment Loss",
        "terseLabel": "Impairment on contract assets related to variable consideration"
       }
      }
     },
     "localname": "CapitalizedContractCostImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Carrying Reported Amount Fair Value Disclosure [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired From Acquisition",
        "negatedLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r71",
      "r250",
      "r669"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10300.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash And Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r72",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r65",
      "r71",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r65",
      "r194"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r731"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents At Carrying Value",
        "negatedLabel": "Less cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class Of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1",
        "terseLabel": "Exercise price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right",
        "terseLabel": "Warrants to purchase of common stock"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Outstanding",
        "terseLabel": "Class of Warrant or Right, Outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration, Licensing and Other Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Bonds and Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r30",
      "r212",
      "r233"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r389",
      "r390",
      "r661",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments And Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments And Contingencies Policy [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Common stock available for issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r749",
      "r750",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r9",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "positiveLabel": "Common stock, shares authorized",
        "terseLabel": "Common stock, $0.01 par value \u2014 400,000,000 shares authorized, 263,793,305 and 251,477,562 shares issued and outstanding at December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation And Retirement Disclosure [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs Policy [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components Of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components Of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r39",
      "r268",
      "r270",
      "r276",
      "r644",
      "r652"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r223",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r184",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation Policy [Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress Gross",
        "terseLabel": "Construction in Progress, Gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for the acquisition of merchandise, materials, supplies and services pertaining to construction projects such as a housing development or factory expansion not classified as trade payables. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Construction Payable Current",
        "terseLabel": "Danbury facility buildout"
       }
      }
     },
     "localname": "ConstructionPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r697",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract With Customer Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r697",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract With Customer Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r454",
      "r455",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract With Customer Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfDeferredRevenueRelatedToRevenueRecognizedForCollaborationsAndServicesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r454",
      "r455",
      "r463"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10220.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract With Customer Liability Current",
        "verboseLabel": "Deferred revenue \u2014 current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r454",
      "r455",
      "r463"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract With Customer Liability Noncurrent",
        "terseLabel": "Deferred revenue \u2014 long term",
        "verboseLabel": "Deferred revenue - non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract With Customer Liability Revenue Recognized",
        "terseLabel": "Revenue recognized during period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerReceivableAllowanceForCreditLoss": {
     "auth_ref": [
      "r369",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional.",
        "label": "Contract With Customer Receivable Allowance For Credit Loss",
        "terseLabel": "Reserve for allowance for doubtful accounts"
       }
      }
     },
     "localname": "ContractWithCustomerReceivableAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Long Term Notes Payable",
        "terseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r45",
      "r627"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10130.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r46",
      "r287",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r589",
      "r772"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10140.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost Of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost Of Sales [Member]",
        "terseLabel": "Cost of Goods Sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost Of Sales Policy [Text Block]",
        "terseLabel": "Cost of Goods Sold"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10120.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs And Expenses",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs And Expenses [Abstract]",
        "terseLabel": "Expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r747",
      "r811",
      "r813"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense Benefit",
        "terseLabel": "U.S. federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r747",
      "r811"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense Benefit",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r165",
      "r546",
      "r554",
      "r747"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense Benefit",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r747",
      "r811",
      "r813"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State And Local Tax Expense Benefit",
        "terseLabel": "U.S. state"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionByUniqueDescriptionAxis": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction.",
        "label": "Debt Conversion By Unique Description [Axis]",
        "terseLabel": "Debt Conversion Description"
       }
      }
     },
     "localname": "DebtConversionByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion Converted Instrument Amount1",
        "terseLabel": "Debt issuance amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion Converted Instrument Shares Issued1",
        "terseLabel": "Issuance of common stock to note holders",
        "verboseLabel": "Conversion of notes to common shares, shares"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionNameDomain": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion Name [Domain]",
        "terseLabel": "Debt Conversion, Name"
       }
      }
     },
     "localname": "DebtConversionNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r285",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r421",
      "r428",
      "r429",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r205",
      "r207",
      "r225",
      "r293",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r601",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Variable Rate1",
        "verboseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r5",
      "r207",
      "r225",
      "r432"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Debt Instrument Carrying Amount",
        "totalLabel": "Total principal payments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r121",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument Convertible Conversion Price1",
        "terseLabel": "Conversion price",
        "verboseLabel": "Conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r26",
      "r129",
      "r132",
      "r134",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument Convertible Conversion Ratio1",
        "terseLabel": "No of convertible shares"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentDateOfFirstRequiredPayment1": {
     "auth_ref": [
      "r27",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt agreement requires the first payment to be made, in YYYY-MM-DD format.",
        "label": "Debt Instrument Date Of First Required Payment1",
        "terseLabel": "Debt instrument, date of first required interest payment"
       }
      }
     },
     "localname": "DebtInstrumentDateOfFirstRequiredPayment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "auth_ref": [
      "r745"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument Decrease Forgiveness",
        "negatedLabel": "Forgiveness of PPP loan"
       }
      }
     },
     "localname": "DebtInstrumentDecreaseForgiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r196",
      "r198",
      "r405",
      "r601",
      "r688",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument Face Amount",
        "positiveLabel": "Amount Due",
        "terseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r27",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument Frequency Of Periodic Payment",
        "terseLabel": "Debt instrument payment term description"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r25",
      "r196",
      "r434",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument Interest Rate Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
        "label": "Debt Instrument Interest Rate Increase Decrease",
        "terseLabel": "Interest on loans increased, percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r25",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument Interest Rate Stated Percentage",
        "terseLabel": "Annual interest rate",
        "verboseLabel": "Senior notes, effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r266",
      "r687",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument Maturity Date",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument Measurement Input",
        "terseLabel": "Note payable, percentage of volatility"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r27",
      "r293",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r601",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionDescription": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Description",
        "terseLabel": "Debt instrument redemption description"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument Redemption Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Period One [Member]",
        "terseLabel": "On or Prior to April 22, 2022"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodStartDate": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of debt instrument redemption period, in YYYY-MM-DD format.",
        "label": "Debt Instrument Redemption Period Start Date",
        "terseLabel": "Redemption period start date"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodStartDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Period Three [Member]",
        "terseLabel": "On or After April 23, 2023 Through Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument Redemption Period Two [Member]",
        "terseLabel": "On or After April 23, 2022 Through and Including April 22, 2023"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument Redemption Price Percentage",
        "terseLabel": "Percentage of repurchase price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed",
        "terseLabel": "Redemption price percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentSinkingFundPayment": {
     "auth_ref": [
      "r129",
      "r771"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount paid into a fund, which is used to retire the debt instrument.",
        "label": "Debt Instrument Sinking Fund Payment",
        "terseLabel": "Sinking fund"
       }
      }
     },
     "localname": "DebtInstrumentSinkingFundPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r27",
      "r129",
      "r133",
      "r134",
      "r135",
      "r195",
      "r196",
      "r198",
      "r222",
      "r293",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r430",
      "r601",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Debt Instrument [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMilestoneRightsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r195",
      "r198",
      "r775"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument Unamortized Discount",
        "negatedLabel": "Unamortized discount",
        "terseLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt Policy [Text Block]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r357",
      "r372",
      "r373",
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Allowance For Credit Loss",
        "terseLabel": "Available-for-Sale Investment, credit losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10360.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10080.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Gain Loss",
        "negatedLabel": "Loss on available-for-sale securities",
        "terseLabel": "Loss on available-for-sale securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLoss": {
     "auth_ref": [
      "r358",
      "r369",
      "r370",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss for debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities Held To Maturity Allowance For Credit Loss",
        "terseLabel": "Allowance for credit losses on held-to-maturity securities"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault": {
     "auth_ref": [
      "r77",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discussion of the facts and amounts pertaining to each failure to comply with an affirmative or negative covenant of a long-term debt instrument, including violating payment terms or an inability to meet certain minimum financial requirements or achieve or maintain certain financial ratios. The discussion would generally be expected to also include whether or not the failure can and will be overcome and a description of the terms of any waivers, including the amount of the waiver and the period of time covered by the waiver, and if reclassification of long-term debt to current has been made in the current balance sheet.",
        "label": "Default Longterm Debt Description Of Violation Or Event Of Default",
        "terseLabel": "Debt default, description"
       }
      }
     },
     "localname": "DefaultLongtermDebtDescriptionOfViolationOrEventOfDefault",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r747",
      "r812",
      "r813"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense Benefit",
        "terseLabel": "U.S. federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r197",
      "r775"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Deferred Finance Costs Net",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r165",
      "r747",
      "r812"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense Benefit",
        "terseLabel": "Non-U.S."
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r69",
      "r165",
      "r547",
      "r553",
      "r554",
      "r747"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense Benefit",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r206",
      "r224",
      "r540"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Income Tax Liabilities",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r747",
      "r812",
      "r813"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State And Local Income Tax Expense Benefit",
        "terseLabel": "U.S. state"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r809"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets Liabilities Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r809"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards Domestic",
        "terseLabel": "Federal operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration",
        "terseLabel": "Federal operation loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local",
        "terseLabel": "State operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10180.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r162",
      "r163",
      "r810"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10130.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost",
        "terseLabel": "Non-qualified stock option expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r163",
      "r810"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10150.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "Deferred Tax Assets Tax Deferred Expense Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowance of deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities Prepaid Expenses",
        "negatedLabel": "Other prepaids"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureComponentsOfNetDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r465",
      "r468",
      "r481",
      "r700",
      "r701",
      "r702",
      "r703"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan Contributions By Employer",
        "terseLabel": "Total discretionary matching contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans And Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans And Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent",
        "terseLabel": "Employer matching contribution, percent of employees' compensation"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan Employer Matching Contribution Percent Of Match",
        "terseLabel": "Employer matching contribution deferral rate"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.",
        "label": "Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage",
        "terseLabel": "Employers matching contribution vesting percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r69",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation Expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r69",
      "r108"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10300.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation And Amortization",
        "terseLabel": "Depreciation, amortization and accretion"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DirectFinancingLeaseDeferredSellingProfit": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred selling profit from direct financing lease.",
        "label": "Direct Financing Lease Deferred Selling Profit",
        "terseLabel": "Deferred lease liability"
       }
      }
     },
     "localname": "DirectFinancingLeaseDeferredSellingProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation Of Revenue [Line Items]",
        "terseLabel": "Disaggregation Of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r462",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue [Table]",
        "terseLabel": "Disaggregation Of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation Of Revenue Table [Text Block]",
        "terseLabel": "Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r491",
      "r520",
      "r521",
      "r523",
      "r527",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]",
        "terseLabel": "Stock Award Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r143",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Text Block]",
        "terseLabel": "Stock Based Award Plans"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.",
        "label": "Early Repayment Of Senior Debt",
        "terseLabel": "Prepayment of principal balance"
       }
      }
     },
     "localname": "EarlyRepaymentOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r277",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r308",
      "r310",
      "r312",
      "r313",
      "r314",
      "r318",
      "r580",
      "r581",
      "r645",
      "r653",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share Basic",
        "terseLabel": "Net loss per share - basic",
        "verboseLabel": "Net loss per share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r277",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r310",
      "r312",
      "r313",
      "r314",
      "r318",
      "r580",
      "r581",
      "r645",
      "r653",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Diluted",
        "terseLabel": "Net loss per share - diluted",
        "verboseLabel": "Net loss per share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Income or (Loss) Per Share of Common Stock"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Common Share (\"EPS\")"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Continuing Operations",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r289",
      "r532",
      "r556"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate",
        "terseLabel": "Federal tax benefit rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r808",
      "r814"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r808",
      "r814"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r808",
      "r814"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation Other Adjustments",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Salary and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "verboseLabel": "Unrecognized compensation expense, weighted average period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r807"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options",
        "terseLabel": "Unrecognized compensation expense related to non-option"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r807"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options",
        "terseLabel": "Unrecognized compensation expense related to options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r128",
      "r245",
      "r272",
      "r273",
      "r274",
      "r294",
      "r295",
      "r296",
      "r298",
      "r304",
      "r306",
      "r321",
      "r368",
      "r453",
      "r524",
      "r525",
      "r526",
      "r549",
      "r550",
      "r579",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r617",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r419",
      "r588",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate Of Fair Value Fair Value Disclosure [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r188",
      "r192",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value By Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r419",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r583",
      "r620",
      "r621",
      "r622",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r188",
      "r189",
      "r419",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Fair Value By Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r419",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Disclosure Item Amounts [Domain]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r419",
      "r468",
      "r473",
      "r583",
      "r620",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r419",
      "r468",
      "r473",
      "r583",
      "r621",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r419",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r583",
      "r622",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Inputs Level3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r419",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r620",
      "r621",
      "r622",
      "r688",
      "r689",
      "r700",
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value Of Financial Instruments Policy",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r604",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease Liability",
        "terseLabel": "Financing liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease Liability Current",
        "terseLabel": "Financing liability \u2014 current",
        "verboseLabel": "Financing liability, short term"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease Liability Maturity Table [Text Block]",
        "terseLabel": "Summary of Financing Liability Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease Liability Noncurrent",
        "terseLabel": "Financing liability \u2014 long term",
        "verboseLabel": "Financing liability, long term"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r612",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease Weighted Average Discount Rate Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r611",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFinancingLiabilityLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "positiveLabel": "Financial liabilities fair value",
        "verboseLabel": "Total financial liabilities fair value"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure [Abstract]",
        "terseLabel": "Financial liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesTextBlock": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financing receivable.",
        "label": "Financing Receivables [Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "FinancingReceivablesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite Lived Intangible Asset Useful Life",
        "terseLabel": "Estimated Useful Life (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r255",
      "r385"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense After Year Five",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite Lived Intangible Assets Amortization Expense Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite Lived Intangible Assets By Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r101",
      "r629"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r97",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r101",
      "r628"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite Lived Intangible Assets Net",
        "totalLabel": "Net Book Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r827",
      "r828"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10390.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10200.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain Loss Realized",
        "negatedLabel": "(Gain) loss on foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain Loss On Termination Of Lease",
        "terseLabel": "Gain or loss recorded for leases removed"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r69",
      "r122",
      "r123"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10370.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10090.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gains Losses On Extinguishment Of Debt",
        "negatedLabel": "Loss on extinguishment of debt, net",
        "terseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10180.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r254",
      "r379",
      "r642",
      "r686",
      "r714",
      "r763",
      "r764"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "order": 10070.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10260.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill And Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill And Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Asset"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAsset"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r95",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill And Intangible Assets Policy [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r69",
      "r380",
      "r381",
      "r382",
      "r686"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill Impairment Loss",
        "terseLabel": "Impairments of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Held To Maturity Securities Debt Maturities [Abstract]"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r91",
      "r217",
      "r364",
      "r650"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value",
        "terseLabel": "Aggregate fair value, due after one year through five years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
     "auth_ref": [
      "r360",
      "r648"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount",
        "terseLabel": "Amortized cost basis due after one year through five years"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r758",
      "r846"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis",
        "totalLabel": "Amortized cost basis, total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue": {
     "auth_ref": [
      "r89",
      "r218",
      "r761",
      "r847"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.",
        "label": "Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value",
        "totalLabel": "Aggregate fair value, total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r90",
      "r216",
      "r363",
      "r649"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Held To Maturity Securities Debt Maturities Within One Year Fair Value",
        "terseLabel": "Aggregate fair value, due in one year or less"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
     "auth_ref": [
      "r359",
      "r647"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount",
        "terseLabel": "Amortized cost basis, due in one year or less"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesPurchasedOptionsPricePolicy": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Held To Maturity Securities Purchased Options Price Policy",
        "terseLabel": "Held-to-Maturity Investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesPurchasedOptionsPricePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesTextBlock": {
     "auth_ref": [
      "r759",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Held To Maturity Securities [Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Held to Maturity Investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HeldtomaturitySecuritiesMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as held-to-maturity.",
        "label": "Heldtomaturity Securities [Member]",
        "terseLabel": "Held-to-Maturity Investments"
       }
      }
     },
     "localname": "HeldtomaturitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r69",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment Of Intangible Assets Excluding Goodwill",
        "terseLabel": "Impairments of other intangible assets"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r69",
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment Of Long Lived Assets To Be Disposed Of",
        "verboseLabel": "Asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r288",
      "r555"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r200",
      "r213",
      "r237",
      "r333",
      "r341",
      "r345",
      "r347",
      "r646",
      "r685"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10010.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest",
        "totalLabel": "Loss before income tax expense"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r288",
      "r555"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureLossFromContinuingOperationsBeforeProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority Name [Axis]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority Name [Domain]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r289",
      "r533",
      "r538",
      "r545",
      "r551",
      "r557",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r290",
      "r305",
      "r306",
      "r332",
      "r531",
      "r552",
      "r558",
      "r654"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10020.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "negatedLabel": "Benefit from income taxes",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r271",
      "r529",
      "r530",
      "r538",
      "r539",
      "r544",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10460.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10420.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase Decrease In Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r741"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10470.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase Decrease In Accrued Liabilities And Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r625",
      "r741"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10480.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase Decrease In Contract With Customer Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10430.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase Decrease In Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10520.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase Decrease In Other Noncurrent Liabilities",
        "terseLabel": "Deposits from customer"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10450.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase Decrease In Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10440.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Information By Category Of Debt Security [Axis]",
        "terseLabel": "Debt Security Category"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r96",
      "r99"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10270.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets Net Excluding Goodwill",
        "terseLabel": "Other intangible asset"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r197",
      "r215",
      "r275",
      "r331",
      "r599"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10310.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense on financing liability"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r50",
      "r425",
      "r435",
      "r690",
      "r691"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10070.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense Debt",
        "negatedLabel": "Interest expense on notes",
        "terseLabel": "Interest Expense Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r279",
      "r282",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Interest paid in cash"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service I R S [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Current [Table]",
        "terseLabel": "Inventory Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r94",
      "r672"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory Finished Goods Net Of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r264",
      "r670",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10330.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r249",
      "r263",
      "r320",
      "r375",
      "r376",
      "r377",
      "r626",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory Policy [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Raw Materials",
        "verboseLabel": "Raw materials inventory"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r94",
      "r674"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory Raw Materials Net Of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r94",
      "r673"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory Work In Process Net Of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesComponentsOfInventoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r48",
      "r330"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10050.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income Interest",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentInterestRate": {
     "auth_ref": [
      "r757",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of interest on investment.",
        "label": "Investment Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "InvestmentInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentMaturityDate": {
     "auth_ref": [
      "r756",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity date of investment, in YYYY-MM-DD format.",
        "label": "Investment Maturity Date",
        "terseLabel": "Maturity date"
       }
      }
     },
     "localname": "InvestmentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "totalLabel": "Total Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r201",
      "r219",
      "r239",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r613",
      "r713"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease Cost",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease Cost Table [Text Block]",
        "terseLabel": "Summary of Lease Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee Operating Lease Liability Maturity Table [Text Block]",
        "terseLabel": "Schedule of Future Minimum Office And Vehicle Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee Operating Lease Liability Payments Due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months",
        "terseLabel": "Year 1"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Five",
        "terseLabel": "Year 5"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Four",
        "terseLabel": "Year 4"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Three",
        "terseLabel": "Year 3"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability Payments Due Year Two",
        "terseLabel": "Year 2"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2": {
       "order": 10010.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee Operating Lease Liability Undiscounted Excess Amount",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee Operating Lease Option To Extend",
        "terseLabel": "Description of right to extension of lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Lease renewal option"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Term Of Contract",
        "terseLabel": "Lease initial term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingSubleaseExistenceOfOptionToExtend": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether sublessee has option to extend operating sublease.",
        "label": "Lessee Operating Sublease Existence Of Option To Extend",
        "terseLabel": "Lessee,option to extend [true false]"
       }
      }
     },
     "localname": "LesseeOperatingSubleaseExistenceOfOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LesseeOperatingSubleaseOptionToExtend": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend operating sublease.",
        "label": "Lessee Operating Sublease Option To Extend",
        "terseLabel": "Lease renewal options"
       }
      }
     },
     "localname": "LesseeOperatingSubleaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r22",
      "r287",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r573",
      "r576",
      "r577",
      "r589",
      "r684",
      "r772",
      "r837",
      "r838"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r14",
      "r208",
      "r231",
      "r714",
      "r746",
      "r762",
      "r826"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders' deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r24",
      "r248",
      "r287",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r573",
      "r576",
      "r577",
      "r589",
      "r714",
      "r772",
      "r837",
      "r838"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseAndServiceMember": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License And Service [Member]",
        "terseLabel": "Collaborations and services"
       }
      }
     },
     "localname": "LicenseAndServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r5",
      "r207",
      "r225"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line Of Credit",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line Of Credit Facility Remaining Borrowing Capacity",
        "terseLabel": "Amount available under credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate L I B O R [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsHeldForSaleByAssetTypeAxis": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the assets held for sale.",
        "label": "Long Lived Assets Held For Sale By Asset Type [Axis]",
        "terseLabel": "Long-Lived Assets Held-for-sale by Asset Type"
       }
      }
     },
     "localname": "LongLivedAssetsHeldForSaleByAssetTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongLivedAssetsHeldForSaleNameDomain": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A name of the assets to be disposed.",
        "label": "Long Lived Assets Held For Sale Name [Domain]",
        "terseLabel": "Long-Lived Assets Held-for-sale, Name"
       }
      }
     },
     "localname": "LongLivedAssetsHeldForSaleNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r5",
      "r207",
      "r229",
      "r418",
      "r433",
      "r688",
      "r689"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long Term Debt",
        "totalLabel": "Total debt \u2014 net carrying amount"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r119",
      "r293",
      "r423"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r119",
      "r293",
      "r423"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r119",
      "r293",
      "r423"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r119",
      "r293",
      "r423"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfMaturitiesOfCompanySBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10280.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long Term Purchase Commitment [Text Block]",
        "terseLabel": "Remaining Purchase Requirements"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Longterm Debt Type [Axis]",
        "terseLabel": "Long-Term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r27",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Longterm Debt Type [Domain]",
        "terseLabel": "Long-Term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r391",
      "r392",
      "r393",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingencies By Nature Of Contingency [Axis]",
        "terseLabel": "Loss Contingency Nature"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r115",
      "r116",
      "r391",
      "r392",
      "r393",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery And Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputEntityCreditRiskMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using risk of default, credit spread risk and downgrade risk.",
        "label": "Measurement Input Entity Credit Risk [Member]",
        "terseLabel": "Dividend Yield"
       }
      }
     },
     "localname": "MeasurementInputEntityCreditRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input Expected Dividend Rate [Member]",
        "terseLabel": "Dividend Yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input Expected Term [Member]",
        "terseLabel": "Period"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input Price Volatility [Member]",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-Free Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r65",
      "r67",
      "r70"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r41",
      "r70",
      "r214",
      "r236",
      "r246",
      "r267",
      "r269",
      "r274",
      "r287",
      "r297",
      "r299",
      "r300",
      "r301",
      "r302",
      "r305",
      "r306",
      "r311",
      "r333",
      "r341",
      "r345",
      "r347",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r581",
      "r589",
      "r685",
      "r772"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "positiveVerboseLabel": "Net loss (numerator)",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New Jersey.",
        "label": "New Jersey Division Of Taxation [Member]",
        "terseLabel": "New Jersey"
       }
      }
     },
     "localname": "NewJerseyDivisionOfTaxationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "NON-CASH INVESTING AND FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10040.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income Expense",
        "totalLabel": "Total other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income Expense [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r28",
      "r199",
      "r748"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).",
        "label": "Notes Payable Related Parties Noncurrent",
        "positiveTerseLabel": "Mann Group promissory notes"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "positiveLabel": "Total cost of goods sold and cost of revenue"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r333",
      "r341",
      "r345",
      "r347",
      "r685"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10030.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r608",
      "r713"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r829"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease Expense",
        "terseLabel": "Operating lease rent expenses"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Liabilities Payments Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail2": {
       "order": 10020.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease Liability",
        "terseLabel": "Operating lease, liability",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "terseLabel": "Operating lease liability-current (2)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease Liability Current Statement Of Financial Position Extensible List",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r606",
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease Payments",
        "terseLabel": "Cash paid"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease, right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r742"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10350.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease Right Of Use Asset Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r612",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease Weighted Average Discount Rate Percent",
        "terseLabel": "Incremental borrowing rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r611",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseTermAndDiscountRateDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards Limitations On Use",
        "terseLabel": "Operating loss carryforwards, limitations on use"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r1",
      "r78",
      "r84",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure And Significant Accounting Policies [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureDescriptionOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r203",
      "r227",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other asset"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10290.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r35",
      "r37",
      "r590",
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax",
        "negatedLabel": "Cumulative translation loss",
        "terseLabel": "Cumulative translation loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Noncurrent",
        "terseLabel": "Deposits from customer"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10410.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income Expense",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10100.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income Expense",
        "terseLabel": "Other (expense) income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income Expense [Member]",
        "terseLabel": "Other Expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other Than Temporary Impairment Credit Losses Recognized In Earnings Categories Of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables And Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForCapitalImprovements": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.",
        "label": "Payments For Capital Improvements",
        "terseLabel": "Funding for capital improvements"
       }
      }
     },
     "localname": "PaymentsForCapitalImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForMergerRelatedCosts": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the reporting period for charges associated with the mergers.",
        "label": "Payments For Merger Related Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "PaymentsForMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payments Of Debt Extinguishment Costs",
        "terseLabel": "Debt instrument, prepayment penalty"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments Of Debt Issuance Costs",
        "negatedLabel": "Issuance costs associated with Senior convertible notes"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments Of Stock Issuance Costs",
        "negatedLabel": "Issuance costs associated with the sale-leaseback transaction"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r57",
      "r566"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments To Acquire Businesses Gross",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10230.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments To Acquire Businesses Net Of Cash Acquired",
        "negatedLabel": "Acquisition of V-Go"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r56",
      "r87"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments To Acquire Held To Maturity Securities",
        "negatedLabel": "Purchase of held-to-maturity debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10270.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.",
        "label": "Payments To Acquire In Process Research And Development",
        "negatedLabel": "Acquisition of in-process research and development, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments To Acquire Other Productive Assets",
        "terseLabel": "Funding for development of alternative manufacturing processes"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r278",
      "r818",
      "r819",
      "r820"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AssetAcquisitionConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments To Acquire Productive Assets",
        "terseLabel": "Asset acquisition, up-front consideration",
        "verboseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10240.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r466",
      "r467",
      "r473",
      "r474",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r483",
      "r484",
      "r487",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Pension And Other Postretirement Benefits Disclosure [Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEmployeeBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-based Stock Options"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion At Fair Value Fair Value Disclosure [Member]",
        "terseLabel": "Fair Value Disclosure Item Amounts [Default]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Undesignated preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Undesignated preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r8",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Undesignated preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Undesignated preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r8",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Undesignated preferred stock, $0.01 par value \u2014 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r736"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10340.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Prior Period Reclassification Adjustment Description",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds From Convertible Debt",
        "terseLabel": "Proceeds from the Senior convertible notes",
        "verboseLabel": "Proceeds from offering after deducting initial purchasers discounts and commissions and estimated offering expenses payable"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds From Issuance Initial Public Offering",
        "terseLabel": "Proceeds from public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "verboseLabel": "Amount of net proceeds from issuance of securities"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds From Issuance Of Long Term Debt",
        "positiveLabel": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from PPP loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsPPPLoanAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r60",
      "r745"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds From Lines Of Credit",
        "terseLabel": "Proceeds from MidCap credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds From Related Party Debt",
        "terseLabel": "Proceeds from related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r52",
      "r87"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds From Sale And Maturity Of Held To Maturity Securities",
        "terseLabel": "Proceeds from maturity of debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfRealEstate": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period.",
        "label": "Proceeds From Sale Of Real Estate",
        "terseLabel": "Sale price"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10260.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds From Sale Of Short Term Investments",
        "terseLabel": "Proceeds from sale of treasury bills"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSecuredLinesOfCredit": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).",
        "label": "Proceeds From Secured Lines Of Credit",
        "terseLabel": "Advance of borrowing"
       }
      }
     },
     "localname": "ProceedsFromSecuredLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r59",
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "verboseLabel": "Cash received from the exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds From Stock Plans",
        "terseLabel": "Proceeds from stock purchase plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r740"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds From Warrant Exercises",
        "terseLabel": "Issuance of common stock from the exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "AFREZZA product sales",
        "verboseLabel": "Commercial product sales"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductionRelatedImpairmentsOrCharges": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10330.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.",
        "label": "Production Related Impairments Or Charges",
        "terseLabel": "Write-off of inventory",
        "verboseLabel": "Inventory write-offs"
       }
      }
     },
     "localname": "ProductionRelatedImpairmentsOrCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r246",
      "r267",
      "r269",
      "r280",
      "r287",
      "r297",
      "r305",
      "r306",
      "r333",
      "r341",
      "r345",
      "r347",
      "r367",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r571",
      "r574",
      "r575",
      "r581",
      "r589",
      "r646",
      "r685",
      "r711",
      "r712",
      "r739",
      "r772"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10280.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r113",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Disposals",
        "terseLabel": "Amount of divestiture of long-lived"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r109",
      "r252"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property and equipment - gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r111",
      "r232",
      "r651",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10250.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumOfficeAndVehicleLeasePaymentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Estimated Useful Life (Years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Public Utilities Inventory [Axis]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Public Utilities Inventory Type [Domain]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Loss on purchase commitments"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Fifth Year",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Fourth Year",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Next Twelve Months",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Second Year",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation Due In Third Year",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesRemainingPurchaseRequirementsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "PurchaseObligationFiscalYearMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy",
        "terseLabel": "Accounts Receivable and Allowance for Credit Loss"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r475",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r240",
      "r618",
      "r619",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r475",
      "r618",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party Transactions By Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfBorrowingsParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r61",
      "r745"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments Of Lines Of Credit",
        "negatedLabel": "Payment of MidCap credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments Of Long Term Lines Of Credit",
        "terseLabel": "Principal prepayment against outstanding term loans"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments Of Notes Payable",
        "negatedLabel": "Principal payments on Mann Group promissory notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10160.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research And Development Expense Excluding Acquired In Process Cost",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10400.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10150.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research And Development In Process",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r731",
      "r743"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units R S U [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r136",
      "r230",
      "r659",
      "r660",
      "r714"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r245",
      "r294",
      "r295",
      "r296",
      "r298",
      "r304",
      "r306",
      "r368",
      "r524",
      "r525",
      "r526",
      "r549",
      "r550",
      "r579",
      "r656",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From Contract With Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r328",
      "r329",
      "r340",
      "r343",
      "r344",
      "r348",
      "r349",
      "r350",
      "r461",
      "r462",
      "r627"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10110.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Contract With Customer Excluding Assessed Tax",
        "positiveLabel": "Total net revenue",
        "positiveVerboseLabel": "Total revenue from collaborations and services",
        "terseLabel": "Total revenues",
        "verboseLabel": "Total revenue from UT"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of method used to recognize revenue for performance obligation that is satisfied over time. Includes, but not is limited to, output or input method.",
        "label": "Revenue Performance Obligation Satisfied Over Time Method Used Description",
        "terseLabel": "Progress Measure"
       }
      }
     },
     "localname": "RevenuePerformanceObligationSatisfiedOverTimeMethodUsedDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue Remaining Performance Obligation",
        "terseLabel": "Total transaction price",
        "verboseLabel": "Anticipated Revenue Allocation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of when remaining performance obligation is expected to be recognized as revenue.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation",
        "terseLabel": "Recognition Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1",
        "terseLabel": "Remaining performance obligation, Expected timing of satisfaction, period",
        "verboseLabel": "Deferred revenue recognition period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Table [Text Block]",
        "terseLabel": "Schedule of Revenue Allocation, Remaining Performance Obligation, Expected Timing of Satisfaction"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue Remaining Performance Obligation Percentage",
        "terseLabel": "Allocation of Price"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty collaborations"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleLeasebackTransactionDate": {
     "auth_ref": [
      "r241",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The date of the transaction involving the sale of the property to another party and the lease of the property back to the seller.",
        "label": "Sale Leaseback Transaction Date",
        "terseLabel": "Sale leaseback transaction, date"
       }
      }
     },
     "localname": "SaleLeasebackTransactionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleLeasebackTransactionLeaseTerms": {
     "auth_ref": [
      "r241",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.",
        "label": "Sale Leaseback Transaction Lease Terms",
        "terseLabel": "Lease, description"
       }
      }
     },
     "localname": "SaleLeasebackTransactionLeaseTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleLeasebackTransactionNetBookValue": {
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r834"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller.",
        "label": "Sale Leaseback Transaction Net Book Value",
        "terseLabel": "Lease repurchase, amount"
       }
      }
     },
     "localname": "SaleLeasebackTransactionNetBookValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockTransactionDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format.",
        "label": "Sale Of Stock Transaction Date",
        "terseLabel": "Stock purchase agreements date"
       }
      }
     },
     "localname": "SaleOfStockTransactionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Table]",
        "terseLabel": "Schedule Of Accounts Notes Loans And Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfAccountsReceivableNetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]",
        "terseLabel": "Schedule of Accounts Receivable, Net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccountsReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule Of Accrued Liabilities Table [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSPotentialDilutiveSecuritiesOutstandingThatAreConsideredAntidilutiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]",
        "terseLabel": "Potential Dilutive Securities Outstanding that are Considered Antidilutive"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r172",
      "r173",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule Of Business Acquisitions By Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfConsiderationPaidForIPRDParentheticalDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryAmountsOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsScheduleOfPreliminaryPurchaseConsiderationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule Of Business Acquisitions By Acquisition [Text Block]",
        "terseLabel": "Schedule of Consideration Paid for IPR&amp;D"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions Table [Text Block]",
        "terseLabel": "Schedule of Revenue from Collaboration and Services"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule Of Debt Table [Text Block]",
        "terseLabel": "Summary of Carrying Amount of Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Components of Net Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Components of Basic and Diluted EPS Computations"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Stock Based Compensation Expense Recognized in Accompanying Consolidated Statements of Operations by Category"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r97",
      "r100",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule Of Finite Lived Intangible Assets [Table]",
        "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetSummaryOfOtherIntangibleAssetDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r97",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule Of Finite Lived Intangible Assets Table [Text Block]",
        "terseLabel": "Summary of Other Intangible Asset"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Held To Maturity Securities [Line Items]",
        "terseLabel": "Schedule Of Held To Maturity Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": {
     "auth_ref": [
      "r361",
      "r362",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Schedule Of Held To Maturity Securities [Table]",
        "terseLabel": "Schedule Of Held To Maturity Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfHeldToMaturitySecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]",
        "terseLabel": "Loss from Continuing Operations Before Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r2",
      "r15",
      "r16",
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule Of Inventory Current Table [Text Block]",
        "terseLabel": "Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Investments [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Investments [Line Items]",
        "terseLabel": "Schedule Of Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsTable": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.",
        "label": "Schedule Of Investments [Table]",
        "terseLabel": "Schedule Of Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule Of Line Of Credit Facilities [Text Block]",
        "terseLabel": "Schedule of Line of Credit Facility Debt and Key Terms"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]",
        "terseLabel": "Schedule of Maturities of the Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosurePropertyAndEquipmentNetParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block]",
        "terseLabel": "Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r488",
      "r490",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Options Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block]",
        "terseLabel": "Assumptions Used to Calculate Fair Value of Employee Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]",
        "terseLabel": "Summary of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r135",
      "r136",
      "r258",
      "r259",
      "r260",
      "r322",
      "r436",
      "r437",
      "r438",
      "r440",
      "r444",
      "r449",
      "r451",
      "r692",
      "r727",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule Of Stock By Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate Sofr Overnight Index Swap Rate [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r732"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling And Marketing Expense [Member]",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 10170.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.",
        "label": "Selling Expense",
        "terseLabel": "Selling"
       }
      }
     },
     "localname": "SellingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r211",
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSummaryOfCarryingAmountOfPrincipalBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Convertible Notes",
        "verboseLabel": "Senior convertible notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRevenueAndCostOfRevenueAndGoodsSoldGeneratedFromProductSalesServicesAndRoyaltiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10290.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number",
        "periodEndLabel": "Outstanding at December 31, 2022",
        "periodStartLabel": "Outstanding at January 1, 2022",
        "terseLabel": "Outstanding Restricted Stock Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at December 31, 2022",
        "periodStartLabel": "Outstanding at January 1, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward",
        "terseLabel": "Weighted Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value",
        "terseLabel": "Total fair value of restricted stock units vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum",
        "terseLabel": "Volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum",
        "terseLabel": "Volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedCompensationExpenseRecognizedInAccompanyingConsolidatedStatementsOfOperationsByCategoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
        "terseLabel": "Equity incentive plan, shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "terseLabel": "Shares Available for Future Issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r510"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period",
        "negatedLabel": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period",
        "terseLabel": "Options issued or granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of the stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Outstanding at December 31, 2022",
        "periodStartLabel": "Outstanding at January 1, 2022",
        "terseLabel": "Outstanding Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansStockBasedAwardPlansDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at December 31, 2022",
        "periodStartLabel": "Outstanding at January 1, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward",
        "terseLabel": "Weighted Average Exercise Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "Grant date fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share Based Compensation Award Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Common stock price per share"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage",
        "terseLabel": "Vesting rights percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1",
        "terseLabel": "Compensation cost"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected lives"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansFairValueOfEmployeeStockOptionsAssumptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Exercisable at December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value of the stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued Price Per Share",
        "terseLabel": "Exchange price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short Term Debt Type [Axis]",
        "terseLabel": "Short-Term Debt, Type"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short Term Debt Type [Domain]",
        "terseLabel": "Short-Term Debt, Type"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfContractualMaturitiesOfHeldToMaturityInvestmentsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r209",
      "r210",
      "r226",
      "r735"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10310.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r78",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State And Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r33",
      "r128",
      "r245",
      "r272",
      "r273",
      "r274",
      "r294",
      "r295",
      "r296",
      "r298",
      "r304",
      "r306",
      "r321",
      "r368",
      "r453",
      "r524",
      "r525",
      "r526",
      "r549",
      "r550",
      "r579",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r617",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Income And Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r321",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsTables",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r8",
      "r9",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period Shares Acquisitions",
        "terseLabel": "Issuance of common stock from acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r32",
      "r128",
      "r129",
      "r136",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period Shares Conversion Of Convertible Securities",
        "terseLabel": "Issuance of common stock pursuant to conversion notes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r8",
      "r9",
      "r128",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period Shares Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under Employee Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r128",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "positiveLabel": "Number of shares sold during the period",
        "terseLabel": "Issuance of common stock in at-the-market offering/placement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r128",
      "r136",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansSummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r33",
      "r128",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period Value Acquisitions",
        "terseLabel": "Issuance of common stock from acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r33",
      "r128",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period Value Conversion Of Convertible Securities",
        "terseLabel": "Issuance of common stock pursuant to conversion notes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r8",
      "r9",
      "r128",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period Value Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r8",
      "r9",
      "r128",
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock in at-the-market offering/placement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r9",
      "r12",
      "r13",
      "r86",
      "r714",
      "r746",
      "r762",
      "r826"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders' deficit:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r286",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r453",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "Common and Preferred Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible [Text Block]",
        "terseLabel": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOWS DISCLOSURES:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r698",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing Of Transfer Of Good Or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r698",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing Of Transfer Of Good Or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred At Point In Time [Member]",
        "terseLabel": "Point In Time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred Over Time [Member]",
        "terseLabel": "Over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMannGroupPromissoryNotesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsAdditionalInformationDetail1",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsRevenueAllocationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCollaborationLicensingAndOtherArrangementsScheduleOfRevisedAnticipatedCashFlowsFromTransactionsAllocatedPerformanceObligationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommonAndPreferredStockAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureScheduleOfRevenueFromCollaborationsAndServicesDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfUTRevenueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r682",
      "r700",
      "r702",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "U S Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureInvestmentsScheduleOfFairValueOfAssetsAndFinancingLiabilityOnTotalInvestmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt issuance cost"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsSeniorConvertibleNotesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r528",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "End of Year",
        "periodStartLabel": "Beginning of Year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r159"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions",
        "terseLabel": "Gross decreases for tax positions of current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Expense",
        "terseLabel": "Unrecognized income tax interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions",
        "terseLabel": "Gross increases for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities",
        "terseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations",
        "terseLabel": "Lapse of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r323",
      "r324",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Financial Statement Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "negatedLabel": "Valuation allowance",
        "negatedTerseLabel": "Change in the valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureProvisionForIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r609",
      "r713"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfLeaseInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsMidcapCreditFacilityAdditionalInformationDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureBorrowingsScheduleOfLineOfCreditFacilityDebtAndKeyTermsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicle Leases"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureStockAwardPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r309",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number Of Diluted Shares Outstanding",
        "terseLabel": "Shares used to compute net loss per share - diluted",
        "verboseLabel": "Weighted average common shares (denominator)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/DisclosureEarningsPerCommonShareEPSComponentsOfBasicAndDilutedEPSComputationsDetail",
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r308",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number Of Shares Outstanding Basic",
        "terseLabel": "Shares used to compute net loss per share - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.mannkindcorp.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=6435544&loc=d3e41834-113960",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "50",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51831-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51840-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51843-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196816",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130534-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r718": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r719": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r726": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269825-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919784-209982",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>142
<FILENAME>0001564590-23-002309-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-23-002309-xbrl.zip
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MK:5MZJ#"_@,2T.*?^W-,=U<F*[>F8;([)YI?7#?#<7C,.304L?X\[O'M2X8
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MPMP?CR)L!^.B6DIV[@9(QFN[D(!$+A)H[P.49&0NOX%V:L%7OW,/7X+'K9#
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M*JQ@4'$8=VBRODKB<&VAX>7F^C7'2M;>MWFOJG$]V\Q:H</"XNXAR\8VJ?U
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M)UYN/1 QT(5BM2_039]5E*I.<]2V.*$G-;^F\\M-./HK)^W3>UG9U;3/]I$
MZN;SX"2=T? 4H?AK\"I\\*]W('[H<F;+?S3^$AFHH2[C7 ]M$8M7T$-_6/U_
M>, QE'\6[;893GZHBY./"S4AP7I<U8UWVH:]KYM?Z=B</^DT4[-_Z+;6 V2
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M/^^_3JS_UDZQ-C4I0CR:'"# ;3@/94"M6I$TLBQ(W);>H"LVB=:,BW!CAIM
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MW%.8ZC5U@"*8<"G^YR<4<A)M%D (YL8.CH?AI1F5V*MHX(K>(A89 TYLWGE
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M)4@PB(KR^+Y2<:0'@.#.H828>F?>=\W)C+$@9^:+8FE\M33*@%K5M@,E[:?
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M$UQNQ47W[,$@&7B$^UJJEE>#!CHZ^W$,-ZB/:=5K=YW[9GS6Z]1Q^390$-^
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M%T(K$BK 91"WB$BND?N:.03#0NS6VL\2:R>YX[.M2G!&AZH]-=CHZ+(1'E\
M]+!K<8#-<FD2DN?(FV5WQ9GGR9HC!UWQ[:.Q%P"W!>\X_N+^F+?Z:R3H(@L]
M<!DEG7]4NF]23V%8^Z'S AA62R)04>%V00,,N<-??)HWP#!0#CV0EWP>NGD
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MRSWRF@_GZUD^'?<=!!C5/&(*!"#1'#<6^5?!9QR%865F0ZU<&J:*O4<@BQ&
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MM.?.1_ PJPBYX/#TD65DEG;1 NIH'ZD>D ([[X)\I0B2BBQ4+(!/F<(50I0
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M_.(&J162D.AC [H?:Y(2.<Y?HH)]DZZ4L#:<Q,I[=G407 XYT,9)$/<^^SU
MBQ11+)G9HO&04/7_@PRE+:(AAY"*2R8?>Y>DZ^(=-/.-6KY-L1Q!9#D7Z%FR
M<VTE%E7F.:B?)JC<"6._"SNYTZ-U3K]_\HP&])9FC8056GOM=J1@0\3,/.2&
M.R%,FI U8X3!GANJ@^#AW:C\^K$VZ9C''*XTE:=>_#5.+JFBP-9%A2XDU\;]
M,$.Y4JV:5&8/X'EKHU!X=@=19+E@/62_31C%OP?,O)J^!\AQNY&-7I*@E;9"
M('_)[.X!OY(:<#?$@_[KEA#.=/'%9G");5*:44S!\.-L)]@>-S+OL*8J1,R%
MS,3I,2MFA=D;.E:RT;N:'H;31V/W@$-7D7O B_'S44K(&-Z[>T#[T-)MQ!LZ
M[/\WY?]-^?_E%!?4Z&U,&N_=5]Y[P"DH7^_&*E+F#W;./6!YTQ$M5]HXR$MI
MN(O4+SS7#LFV@&8M#:*1*?LG^FPC_L,]DN4I6Q[VKA_=S?L-=3>Y:]-57Z\)
M3G .,C6.%V1YU/UH<14_&L5XLXS1@VUN@VJ;%)+ZU-U@&.GN3S=V.EMZ>A>'
M=?-IBZ6([CD9@!!B$+BD5' 9;9?@S!LJ*7Q2*X_):>M"SI\0GWK#XYXPEV_5
MOH+7:,7KN.SXN&O=I-;#0MW@O/8,\[B,EX;5K^)RZ=1<7Z>YT9_\'L"<=20=
M5VAS#WC&4G7"!:GE<KO4/_,WKE7!Y3/-:2C8PL$*>IV!?\QE>VW_]$BB_;J.
MXM'F6>%B@K+N^U]+W[3^-*UG@%FF5<"Y=O!IC07#2V G!<5SVDXN5$1CC_=M
M'FK=GTP0)LV6M8H7UB2U,LL.9^EDWHDGCXS[6GN7S,S\-;S<<_$>,'UV!V:5
MUX8GH%LKQM;VH7LB<A-@8]+%6>ZS!63IT79L2J=$DUG_F\P>=_Z^+7SOBP%$
M;7HS^:XL;/H6>N*VI[QI??1]+>DM70(BF,4?O&!PZ:'=# U![G;0DV0M/OKP
M4<7W;]Q6^1C(20;7\999OW"&O!/]_."I7Q3#$! "@R>5W2VW6O3X[0HCM%M5
M_LG+UV,Y?<.F>P##-BU93T)KAPPAV*ZWSFZR ;'\W@9HRK/J"B]8%0Y2-^&L
MGH*L@H\X52;,KTI/&S_]5@[=;\J'R65?. U)'>F?S'@F;9L"8YY=NEL$(Q6[
MTO(BB:;W*X<KL-P%2\Q6+9I\N@\O0N40/Z,*J//29V7[-)<L^@$)W39[S#Y7
M\$M(5IZ+,O(8OH;6I_FL;?0/(!G^ 633TFV4_'^,U%'OC4;D\\F2_P$QSC\@
M=GP ,?/'_V6X]X+^8997;Q>P[L"A]UNMGS35V9XE$>W%8WYTC"U-DOMNX C.
MVC3@W$?RRSW@C1_A/>#Q">18R&+)TUAS<E]U)&=Y],G"_'.,I-6S/%,<V02;
MM%1EKJ(>E4\ADVM)-%'>+^:@3\[NA+CU N??Z';$73IN'P!M"H V,A3EA3%[
MKYM'PJ2Z>I14:DCXKG3&,-HP\]V69E#;32&'#]!AL T4?B=R'G$0Y4?6,A@K
M%:QZSD!",^[M*[6R!'URFR-SGI?>827AX9<L.BJ:/]1X<5MV#\"R%3"4\/>0
M/%B9M".O7YEE\5S7J]6+2I/K!/:P8946HO5%&!VNWC#>UF\V>U=R"T;Y=WAM
MU1SVAH V,O;3%,$OB?*D2^4J9** LVN$UYA_()<BZ?> N.)$1=02\H*U0W6Q
MY[_+ZJ?S.(J:N-]R%G^/0N\P3F5N:8;O 7V3]O\Q\E$,K8EKE]SJ:A$#.CZ;
MZ78L\/36VZQKC&;\90>3-XR(;HK7O;BM4>_0O@> Z@[S:P7Z2517=E,.6(+#
M^WXV1&[5X"Q\W4W[NWR8?P=]L"W+V3C=;F7-5M%'B9W>(>2IH\T&T E?63/)
M$Y2G5:?PB8'P=EZ$9ASUNYTN_6-_*)&S=NM9KG'%LD$N._SL(6\5GT9/,W&7
MT$05Q-OG%^[GSOJ>R;XRH!]7+J3\9 IF"2?TK_M'*Y1WFG#..W]?EI6;A0B"
M/C&9N(R''B,\M1FML@HQ,PXY/]:"O/;V07,=:$J^!3&?[R._;BS-(I,9+#I)
M OM/?Y?9^ZJ;V2<A_1D.]YJ;S)Z2BN=]+Y8*@+854G6#MQT';X,Y^D]WT9!-
MT$>]_P5Q-/\YU*D-D_Z_Q+=<E+[*$[>(?K!<6"DQN5V@0,C; /-U^ERZDMY"
MGSM'^2E?_7/(EXF#_5+NLK+S+U&EKH2953-;Q^?MTK_!%JL^NS;<Y;<R*[L1
M7H_I7X*5#'6]GX.<;*,*0X0DL%/M;VE6:"PRA969FLV)>7--$7%_;<62A1[R
MN5NXJ,-2#S*+2S!"W(KPAD,Y(R@/W.UDW?K(^8:F57%#9O^X9L2-&N=K_2MY
MS0VN^"G[<-@7'%I],X<&)) 2>G<SL__6NF%[[/<;LD(])=T&8S@,]53Y:XTV
MG;N#-D$=#[!O>%X?:%Z![$[A*XZ7,BQ:^7,/%6;8/3#/PKA1N&6D)D35;-Z%
M2VZ5\_=NA__9Y5!8/010"W\#+&.4#/X#SL;_3#;H597#IFU&?-5_@^GFO'>S
M?9/E5CW7YYDKS?12RL?=O X3)K#G7E\R"TW>[NT3&L2-O#XMX\[BNP?\E Y]
MX%6OUBOJW[;B//4EO]@*5XSQ%O.L..#B$7VDUU'(0C*!-#OYSR:(*=IGF7D+
M?^#Z!+#6C8KT0EN=UPJ1"K35S_]F9;QD/BE.,.SW66[&[-"F]OUTF:"'8(I>
M7<FE@M?24<U58/X\Z]\-\"-$$Y5]^HOW\+.>>'QKZ8G9Y&Z= PYJHP^-J]>D
M3^>6\&S%$WM1O$T4*WB_#RF&LHXR*\7QTS^L)J[!U1'&)_"?$XD'TV>(VXJ=
M+[O4K,VA70\/,BJM&7264*<1K$[2^@QOPVTF!;-/)AA%Z((*+N/R8'%-8BLU
MK$4O%J(+V;[TM<_X#QX?]=(5]_P'3^OL,<\G/Y6PF?AO6>4!R[Q6S)KA@__!
M2T7_.3J/([1BCKR,\*#;FSE,BBGLE&XN[6#.6NZ1&=][YS*RX"36=NN]3&NH
M)O:E;OH7=Z-&C#%"<RJ%K@L[\B5#"#KK;/[_3.Q5=U'EZ7V.A,%-_.=%).:O
M(=8ME]/CP+_UF#.?Y3^J7>Q>+UV?6=3UEP"OT:W,\='6DJI'N'B&]#UX?H2=
MB&&A/517<8U!0Z*Y 7A'A?YV"V9^Z+O6A7[MYZI2%3W8F698LGW.ROST/(D+
M3R!P_/&B=$L])EB2R8NN%T72AB;0ZV<? E;3L%?(F(^*";'&A AQ\ZP;;*/Q
M#Z/RELF(YQ9K05\GS?4QW[,D5MQ)M7(_^NAP;GS8*_N_OJ+/_M]\3%CE_W=I
M@4ZRY\#F.:(C^SDKHGRCM@F-A.INA;R-#/Y93<NW#J[X6/[,ATY&+[L;)?QK
M.HP,68'I  U.B8*=ZPYBF[3R&VQ=>M"'=Y'7(6KJ1R\=>]*"#Z+>Z_\XCLA\
M_383S,G$IXA&D [@K7R7K??"=^);>%-FIQY>PFE+-&^#U0_*AQ4^K\XLT,O%
MP7XG:/TZPZ5QNOQIMU[C86\PU/BY+?50E6V$=%GA/<!J_F=M(E'<;47*IF3)
MRAI60B#T6%H!-<A 8$.TA+>)E%27FH1AJNGEARBF,ID1&9"&"5>GDNXOQRPZ
MC/2B;)'-V4L5MQAZ[(7)VP]ZJ<(05E;T!ZE#CK*HG89?#%K8X(L'>&8D+AIF
ML*WC8O19G\3R/1$K%J>(.",043OBWKB^.JGX;EX;3E-R6-6!RT;*CY5(N_)1
MA?:PV=F%X>DE^-<B7'SI_-MT[!+/+_LTL22-JN(,KQ=\P@,8^-DG" ^.#47)
MES^O&&6+/$,D?@OQ%_=Z(D<W>R5*;?U/)=SC7JT+9/A>]2;=&"6WGIU#^B/^
M.?, W@/:&*R.!(VWXVA ++ 2GE*4LK[DW[BK<)'7R=:=6'BC+QLE31L(<2_C
MC8D(]*PJR5VVIP],=]A.WB7B>F#6.GFXW0/.=,3L5M0)\V/BR Z^8QWO<!;+
M>;#67%7.\T62T_Q"89P\7AYX,Y2*.0BJN/2O^'4/<&1=U_].T= X/]<O59J?
M'X4$E,\8_TA@[!.="^VCH;$N*[N!',L<RM\VW@.R;S$6::%U1\'EN25&MBAH
M?MND5= 4B">-%1;]4KCH&+V64!MO""S3G9+T$?IV/5X[07W<*8LKA)=43]2B
M'/*"!?4N\5-"?-9703IVE:2=514Z]2Y]<$N.P*BSG9TCBQ)+U,8&G+*IK_^$
MQ!UI%)-AG_!\R=/CS53Y 2N%^%ZM>%&8X]XO>")S T"^I-7-(B'L.;]F(<:%
M7^_<JW.5P2.$\>B0M['1/2#P<>&1-)!WKR0"A&\P8R.@'V8IDD[_/N,E]O.<
M=0=:8NGF8I5[0!B%N%;,]ZR;MQ]]<O$LK9F:%N-+U[$[?U!^&9%_LE;A#1X-
M\17Y#=PEOX%^_X5$3>5_KHG#,C).K.0QO5(825W(^')M[U?O+S16!E4E["*Q
M'MM)V/%&S3*%J-@P:S#'<YE4\R!@&FIK/=/;5>?([.E!])/D[+,[9J.35<YM
M8EOW!EBT:6NMBD<0GET<1SV)=!=&>#FB,>A)V\[3(JAQF,"?Y[;.MBB.B(]5
MT4\C-0RIOECG^P4.I6-HY-$ML7F;"1Y<RM]*%<GZ-GQ#+9RB4@+U5S=1G^-9
MWU&%:93:DM@I%[)8,5V05)WW/P[+%ZU/A:H3]?\V?O)YA]>1Q?75[[=A@<0_
M#89$7AHP9+N[2T_=08S\[@& /YH)W1,[R8M$C>%4IFE'!X_>@8HY@6***5$;
MI%?A3D]&)@KC!?@_NV6'>SA?.LHFZT2H&*IHDZC0C/IS@Y L]A8+L7OVF3EO
M[-?$ROQX.Z6IJ[,5TN9W%BT2NZ8YC/K'5%D[?E7%>KUYQFH$T&@T%CU>LA>6
M)A_G!KGUE8)YG\\-F@Z?TP1:OH]5X$UNX$TCR'_]@J2)F.^*>="O\.SJ88<0
M[AX]Z,3OP];O>TTZ*S-@N_?\><'CL76@\KP2P& G?O23'3Z[X$./R#-%7_X5
M&H8:X9(B.SQ/_W$/[_[:KJZH(:U^+%H?LYSR):6FJBI$V=^U=.TZ2LR1)GB=
M%V75NR1+-1EDN3=V9R0&37#[^*W$RIX(FFBI1J4T^Z\S'_2DC(7FP2'Q>J3>
MY""&C??7"+/K;M0JKO?I,-4O(]AJ0#ELZ7E/A0@^LL<M)^V: O.XH?U.H<X+
M :T<HRZ<F8?37=H3O@P_VR&".M19.:QK7JCR7XQ1Q&(IOL>59EEOBP"G?[$=
M9CW-WD!KQU<K&Z=!A95>^HO;(%HEF+N\F]_8'NI#_^2C1F"LF:]P9T<#=E9V
M[MSV=,-=64_6! UPW!;MI#=+E7C1\3G(XL.^0519O+ TX>[)PXZXC#I_5R[]
M4G_N$JAZ)')N7FU]HGQH-$C:OC@UF4BI\21.!=\!7_SK$MGT'Y'IAJPP.S](
M893TJALQC:/($/_7/JP]VC4JRN6C89<+(X;#<R@H#[7CLIL6G)_*4VG4_KKT
M6/0-/6A\/6X+'S^@508@/P>6E+A+_66MG2;5U% V7&M+S.QE]=)"?A;Z]+@7
MH)R;%0B4V5FR.[B#&*_S%/U9E^52IR'''?B<:%J8_58,9UXGVUK?E^_RI"MN
MN,CVP":_K+120;@,_()MW=(^)#8$AX[F10/HE1_>!Q@0Q*GJ0\EB@OY,;1!;
MOGE\Q<@(0!^]SDKQ71OT@_[54?RJ/PE6[,E#V)8\&HB?57Z._5FKC3^HZ4/]
MO&?G%CUP+]EOS.OUB]%5NN%):L/U-$9X)5*EMV#H IB9P2GP5(.]C_)EN^;E
M&J,6 <4J>?DB_CB8^VU/!W!/=>.XK8F_Y%7"+1Z-(K#RL\*R>>6PT423R,HN
M9Y1HKS1<*C/B /'7H2S_&*37@1_911/(QR!!URJCSGV.K#Y,B@"1I\#$6\.X
ML_J4Z/(BK+5RPQVY:A7<*.=223="-IB..P=!96?PLSM_(Y-W.)$L1SP5AS>:
MU7;I*H;RP':IBC2G;N8O(9@8 18LYC[+6JWT2[UVJTMX[5X>Q=T%@W1K!KV%
M2BZE-Q]QXQFO^G#8QUPUK=$TA_MI+0Q /?"O!LGX?FLV: (:&(PEQH\9N%61
M0^F;O="R$!'S-U/%:$(H5#Q^7K<TXM%=N-:[K2>!B_A>E(N9/7Q7-S'01F-U
MOMT[#RNF/,^5)IF5I-:ZU/*_#_9W99QEDE?8<CXR)$EG\-6CLL%'"P*O@-EA
M'JC@EL2[8,=":%<::AMNLN@5)ZSC=+RA)2;/T UG+I@_;<8)EA2%'6#G72]4
M]Q?QY-M43TW__23<GG(A%_QI"[]D'5_ZS<R-_7#NMG=TMA46JO![7GWX%>]*
M<]KLT.^7,S@$%$GA6 .XWW#YK@"YB10J5_[9$ T_T-;U V-@'CW_3O\NWZ6%
MB9I>>AP]9BRR?W.WA"PQ]%5L@HW?RI40/&:O&:](ZT7+5+'LL[SO,^9]>,SZ
M&>5!;.C#%AO>&8$W7,OQ_"8OY6[I&Z2LNUL:<GVV3)C2&"A*"6FL.A]!TQV>
M;087;S\V- ?NBBPYI$;EA6\S-_$&?-#5&F3SP(^45N^[^>QM?'T)N?G2:*QV
M#PAI/23(Q.RJV6G8K,I=G&'-7TPS-=LP\.I_H9C_8[UX^5"6\E;U"_MW*!FR
M"53TCFQAQ\:.(#/Q&U.V;Z,(2:4']XN@A8!3LJJ"WCQ]SZ\:2!/QU/HIX@46
M/?N-)SF/L-J.VXW/!C.R^/YI,5Q/'QM*].C?373ZW&67^*5MLMN)Z=CG?Z13
MY$Q<666)"SSY9Q.(0'A[T=2K<X?HEH>4E146?C_C?6+G+1(&I4FGT^S;$$H'
MV[F!7['H:&O\#!;3QJP^0=8;XUXB]*::7JY"J!=V'JDT"P_^/;_V%> +QBTX
M$,L5Q6JD_1H->-%,8D1M%>ZF,^' -O43UL#!>LS-&I7Y-/*OZ?AML6\WP5@
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MJQK?7!MM&=ZD&S 3B*GVSVE7]*U-A34LPO)<X-M,AQ 5JP@F3 N'/5+:Z>-
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M'D,^RJM<I<[K, S[([QW?+X6S;_>':/.+=/ OTKLJ6 4?: 1=CH(KYV 2OB
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M^?04"4R^ , I...#MUI<E6BOO7+'E;()0DTA9@*3R$/@S[N-M_5 DD&<OY6
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MG(1>]IACZ6/A=KS:K[+ .DEQ9'%F9</HULKV#!)'C'MO.>N! F?5;:R4'JJ
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MY^0<>G#G38<Y?CNH\\"E>&,MI:N.O05.WUS_MPL"9I:E(U@W\*DVAEY<S42
MQLRLIWW+,$0:JLL 70*GG+\5[=.SN.MI13,)W%O*>2.[^I6([C?)BCX>A+M@
M6#/MZ3*=+U).= B=G2%9P>6R#9QD)7!?(/MR8.B8V,5_4]_)Z#<F 3^Q_&NV
MSZ\PK3VQ]Z2GM<#ODF.Q"EXV"ZBVIL11N9DGB/KH9ZG7T^Q$;$NYMC8B[@^
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MU#W2S7\-$ ]=O[WRK_[%XC]_D5S,_ 502P,$%     @ <X%75J\[#L=,L00
M/9]/ !4   !M;FMD+3$P:U\R,#(R,3(S,2YH=&WLO7MSXSBR+_CWV8C]#ES/
MG7.K8\LN27Z[NNN&RI:K->W7D>3JTW=CPP&1D(0IBM2 I%V:3W\S 9(B]::L
M!T&A8V)*EO@ $K_\90+(3/SZOW[V;<-XI=QCKO/;0?FH=&!0QW0MYG1_.PC\
MSN'%P?_Z\G__7[_^/X>'QLUM_<&HFCY[I3?,,VW7"SC]T+S_Q:@[-G.H\=]?
M&W?&C6L&?>KXQJ'1\_W!U:=/;V]O1U:'.9YK!SZ\QSLRW?XGX_ P>O UIP1_
M,&Z(3PWQWY51*56.#TN5P\IQJWQ^=7)Y53H^*I^=7E;*I?^W5+HJE1(/^"X[
M8"3^NS).CTI'Y:/ST^/$A4_$_$&ZU*C?)"XT2R=G9U:;=,KMRLF9>=X^K5@7
MI^<E0B[-DDDNDBUU!T/.NCW?^&#^(IH(_74<:MMT:-PRAS@F([;1C'KZ$41C
M'AE5VS8:>)MG-*A'^2NUCL*G]GP8 1@%Q[OZV>8V^^T@(37\YLCEW4^54NGX
M$TC0AQ?0@\3UUNB&Y,5GG^2/T:5]YX>5>G*?.,X/YEBFRP=B.* OE7+EN!S=
M$7B'_G! O?BN#O':XO'1+^*6Q.5=0@93K\8?4A=[_H"GF^U1\ZCKOG["7U*7
M6CX?:T=*+O#S)_P9[RD=ELJ'E;@#'O=G]2#^*=TJ[D^]-'T1,V>TG)FI"QW"
M3&_ZI>*GU,7TI]F;?BW^DA8(9=.OA!]2%YH!YZ#*P^E71[^F;W$#Q^>S[I _
MIMOM!/W*- !62M!RGSH>:]OT$"^C7*BX=UA!C@D!#*SQ(S6P;\?B >7+R\M/
MXM<87SZ?J1F7G^#7Z,*)1Z9U"']N$R_6(>:Y)Y7R^3RMDU?$;?;8M!;#I>5/
M_WU_US1[M$\.QU65_9SUAC+J-;(GDF<,'N"4H+\ \G#1H1 L,^/[%M^4OH']
M]*??,&K3)Y\3Q^NXO"\&$)M\*GCY+/&00T!)ZD$1:A8]Y^(PIIS90$"./!!D
M28F%__:I3X1U.:3_"MCK;P?7K@-H\P];T,<#PY1__7;@ P@_B;N-3WB?SWR;
MP@>DP\-RZ<=+Q'I'<!'\_BFZX-=/T:N0]1^^ ?$[8"5]RHU7M"N5H_/(K+1=
M:_CE5XN]&IX_M.EO!Q;S!C89XB!2;/5__,I^7N'C*,>_Y)_,LJ@C_A1_P[4/
M<F0,!D1]^U+"_T R#NGC(RF[JH)1M="PWMJD&_;QI]^@'>B]N/SB\O+DK"2Z
M5"J7RG'?#KYTB.W17S^EWK/HW2?)=T<V_1;,/K&?X%K7NH7OO&SMN/TK8R/.
MDXVH.3 ZPVMH!B=VW;'HSS_H,%L#1K]F;,A%LB'7@CM#8?Q%":\Y%GHNV=IR
M>%BN /BS-*1\<APW)+2K5W?4\RA]' A^=;IW%,BM01WZ1NP6Y?TY;0+3=HV<
M3OF <'_X (^M_F3>"RK'-?'@B7=WU_>TWZ8<FUTNET$,7YY.,@UB^>2DM*#)
MS0!L!+2Z!B\'M37I8^=Q@!31<FMH0ZPU]R'1&9\'V?3B#&U?NC=5Z(Q?-8&'
M/(:M1B0\=A)?5+N<4M2>.?T('S;^K+@OW[^YHUY42J?'Y?C#P1?\=%@ZS0BF
MTMG9Q,A\#3Q@:\]+-*'6Z5#I\H_WJ[RX/U.>%W?IOWC0?^H1, ?@(H,7Z@(:
MJ#7J9:E<D?I2DOHB/+SL*@,Z,][+!GT%CP2TI$^8 P $/A-F":'7MEE7V*?:
MSP'TFUHMUH=+'CM-^-;K$!-_DP2X1/\;U,9./2$V6VC^Y/W>UV'RE]$H@X5A
M)I52&0$W?M@[F]WTX6TXC.*%$C5E^%_T C2>,,(<&MH5@!VIDOO$W;Z;0G,"
MCW* GBK9F*%R?#H^,DUB0PN:OFO^2(AK ;?.EW6"#AS?Y;?,_W<7B,>VTL*=
MUW>X#^9W5@TP[ \?01\XLA8TU9L41OFB)&&+'RH7"-ORA7"7+K+1YGDL'&S$
MU9WK=('E^D\!-WM EM=NO\]\?'5$]JQ/)2ZSF:&LHW92.1D?M5I_8+M#2ILP
ML07X-@&^]"NT$437'\ <0 #S 1THX'>K^D:XY;5<G]C)WZ]=SW]P_;\H--MT
MNP[[-XQEZ&CP\*M%K /6H('C)\8._K@G/UD_Z">9<Z+SE?ORY4U&"4PP2GXE
M $RQ4 +S^W_+I2(9 ;Q>O/'Y)9P3/3=O#D;VI#QRUR*YC%#J51VA2: Y8.(9
M7>0YADL1'KMRF V./!CJ@R]1,Z,FK=K."2=JY7:6-]K.R_%V/G$*[,.I)2CR
M.[&#14[G)MM7GO ?,K=O[?)[$8MH'BJ@EVSKQ<28UPA'*^J!B@E]O6%V ,J9
MB3T-BYJL#[.KWP[ +_18U_GMX!"F&4?')YOHPP0>5NI#.>I#>4$?*AOHP^4$
M9E;J0RGJ0VE^'RIGF?LPJ^$39N]/BBNZ0.>OX$]T*7 G<.QC)VR_Z(OW&/BX
M$(3+Z:L"Z_ 8G(C3\](E=+JTMMY,N%YK[<ULB(G>G%Q68%JXQMZ<;;0WL\$F
M>E.IG%Z<KM*;A=IR=CK!6E-F5.":W^(\0#E".SN=(+1U=V]-7#<Q=P;G?M+V
MN0.8OPV?;)AH@!>!TX4!NA3/'NT$]AWKS+.%\QVW\!TS7_%UB/,7<6\\\V8V
M(GN.YW=\F6TY[J(T08'Y['.]/^#NJYB7>7/Z?YJU^Q,LDZ_NWQ.S!\K#A\G+
MYHU_UOY/D%%.^H\3Y-L V,$/.+UE/_$?].-AJ@Z3L65$D14*TSS?]X@B8V=Q
MU@C<Q^/?X=JFV_%A7DG7.> 3\]PU#WAJ>KX1CCLI9>WSA&.4SSXOR7'9^S\Q
MA\]7_[.27#DSRT^9=.=" .]GN7)6,!R7QV5Q"QSMTSOV2JVZ \YS%_?WQ:Y%
M%IZ;_13OZ_">_-/EUS8!)S Q[C?TE=H@)*M%S9[CVFYW* -J5A_[F1., 4@V
MX:9>7$SPX UM^W7'\[G8%:WC_A/U8)Q]VO3%(C3E)OP ,X_%PKCFU&+^+3&9
MS1)[ ??,NA[_,0V:[X0S H)K1"OZX?=-:D('K$>8^C@HHC LR>F*]KD='O\B
M-E&;;V2 OXROYR=\Y?K#+3K)I;/*Z7J6CB[.)[0L+5+H,:WV<6=OL0#3=R;7
M[7'''J&%FQ?,\UP^?'#CCJZV1=/JT7OB.-^X&PS&MA;'YX:G!U_*%R=B^WA-
M4KLHI?8$JJ;) VP@ S7Z@SE6!$2E9;:BQ*9K[@2!K5-SHST9?.:XG6I2A[D<
M1><MH5B5TW5U>&):NLX.YP,U6Y#B24K/QJC)=EW>6&I+,H?4/F>Y!T587I,
M3^<($/J>A&&QQ'@BQ'CQ+D,Y?;FL7)GT0U1;\H,^3.X>*[:' 7V8F"/F<@\C
MK93EX[,)T4_?ITX$07P=CBYY(D/!^KAY?4L8%[M[X+0'?1&LY368]^.64YK4
M[7!)9U4Y2&6JG!UG6IR%GDZLU(ENM!?WM+U,3^,8&[#][]J,'^LYKD.52_>5
MD\S[\=/'>V*];JWC'4GANPO&6Y#OND;\LG)VL2;(3T88;1SR<G[_/L@?E^<;
MXBF0GUBWR0?DQR-P)B!__E?E_F)-@)^85&X#\&L8[\OCLVS[3^7C24=_Y?&6
MP;;)[="QW=,XXA #8[!Y@8PMKF2RT<ANI_>5LVS!5L>33D_N.CIE.Z%\G[F?
MTZWS._KY70:;.5:LO"Y^5?L),S[FH5^\9/?G*?RL[B\P8I-!=:<3@)9>.141
M[;-:*GY<IHW1DN#%7Y?WY?E\,Z5M$QA<9]LB]2A?KM"VT\E-V70NP+HD=_+7
M>59,GTYNIJRW;9'D*MG;=G(Y@;>Q' ILVF/GV9,+TV*Q!#7LL1.G>3ZY88A\
MG.EVQ^8NOHW$.2]+\F^/?H]RN1S^X#HR4\_/V+L)Q&ZE=^4M]6["OT_W[@YF
M_<) AYDZVQR\<%$V:@*CWO5*79SPY[;3Q65&<#U=/"U-;*+/Z.(()EO5PD6-
MR=C;B:7HK?5V*:U<I;?BNT0J(W9>1 !C%I<7"@0S;J\\D18+K3-$5N\5YJ+^
M=N"Q_L#&'%GQ78]CXT5J9IR6^=.SHI\)-[F+^95+Y_9F2"]>-FOXRZ^?TOT9
MR6&LXU(6GAOPD2C$K.4J'"J!C46^E+@ONI&*!,CPN^A+9N'7'4:Y(1I%IZ;A
M7M?_2&<_CM\<O>G3E%>%;QJ(7(2QUWM13M&743Y1])#1;^E[J$R7E'>$&5WI
M7]*-2;XX^BX48DJP.#\44DT'BJ9[T0=\P[SQ2]A$<4GTT.BWU)OPJ4N/WS%.
M>Q08-IF?[N,0B"(;Y=&SPU_>/02)+<SI(Q!>< 57K&\ *J6S8\4& +3F[/!X
MDP,P1QTL]@J=&6L</N1!EFQPHQYF'K[T $X\+O&J&^JX?3!P<UZV4%O3;YM\
M8O1KLK^K 4P18DX!+$6R[P/8/-F4U9-->2NR\;C_Q%TK,/U''N8()O<CP]]F
MAS)M6Z*Q=:==]#_36FE!$WX.;&:RL,6&Q?KHC&(%*>CIU;2N'GQ)A-.-.OOK
MIZE/'-?I=#N4=E+6AI'QY56-D?5AI)P9(^5<8F1\MT5C9'T8*67&2"D/&+F#
MOQV/8L: _'$_K,Z,;FO[LP;<%-D2Y0<WBMJD.;@ILG7*#VX4M5,-=TCL.*"S
MX-8IU5EMD^9%D>1^<4$)TLX!^Q:3U:((\VCK3A8-PP >U\%<S23%8=4AK,KF
MFC]&]<,N56.W.%QI7I='5#?1Z>W0W6C)KWRYE26_+$"H6I;8U"6VS.6Z)@/F
M$WM_0#%7 !H@@ZII!OU )$F)\!F\BM,>2ON58OG,/MTCL"PK# V<08/ZA#G4
MBA)4]@<ETWM>4$CL;CSS+YOW>F0[=Y2+[IH5SJ]?Y,[M#Z)RX->IA*X9^?6R
MED BRUZ4%7CBS#'9(,:5YKE-\5R&%DR.X,$7D0*_U!AJC=B91FC.7@=G:TU1
M4U,*@6^-J!TB*DJ!U\Z(LLY(>@BU/NQ*'[0KDF]71.O)YO2D$.C6>-H&GL;$
M.&/RMY:B@]J;R;,W,Q\(ZVO \E *&S853%J_U=9O[9WEQ3O3>J_U_MW%A-77
M5JT?>ZT?TQ<:M-N[;VYOIEFDUFZMW=KI+8#3J[5>:[UV>;5V%$,[5O0TH[N#
MML<L1OBP26SZV!&7Q.I0]<4@\!_4?^QTH,')<P/55XG=.ZHSQ1_JP,P!T'JP
M@2ACK1-Y<^FT?JQ//_8:U1I'N<V]+ *\E$S"+!SJ9B9N[@_$=IG!63@\35^?
M+SB"=EYK8AP(.4AQ7;R46W!0Y" G,=< F6-Y"HZ,?)0,V!(D%"K\E&MUF6I8
M=UVTK.@65HD::VNURGN#J!R89Y70M=R&8F3$<Q4=M#>0SD%TT'*^S#YL@6I]
MWD8\T-[H=L[B@;2>:SU?' &DOG9J?=A+?<A).*QV9W6PN];NHFJW=FYSZMQJ
MK==:KUU=K1V%UH[6F]OJN8%''/@(/PQOW6"B9(SV617P63.,I-:.'6N']OGR
MXO-IK=FMUA0"ZQI=.4/7NLO#J@]1Q1V7G1<MU+JBW1C%W1BM0]O2H4(@7V-M
MUU&:FR@]H#XN=^_)J)026P0]V'3I@;W1"5UZ0#G]V&M4:QSE)!6O %C*?TY>
MX? T?2FMX C:?1)X.7=)BXO7B0H.BAQDF>4:(',L3\&1D9,D\/Q!8JKQJ$1^
M2*7@L,A#HG,ELPM2R9T+LM#R[ VB<F""5$+72@E3FMARN<&<FX"+O<6\IN&\
M;!1K7=B$+A0"P1HS6\',NF/3U >>.J[#SL,:]ET#M".14T=":\8&-*,0>-8(
MRL5"NOI 4F!%O7!XFNYQ%AQ!N]_"K>1N.V:QXU5P4.1@_3S7 )EC>0J.C)QL
MX6X7$LO&)=8]+R".20OEB"P?EYCNOG9"UHBC L0D*H2CO,<CKHZC AQPI!".
M<GZXD:X#I>LP;19A5<^C?M4$C](3\XD82]^_N45RDJ;U,T1*W%/M#[V3?YX=
M!M^!YG$RH('/3._:Y0.7$[RI2&C*S$9+2&;_T!> 4 3TG@5ZFK)G8WCH4^(%
MG$HQAI=$#XU^2[T)G[H<R#WN/W'7"DS_D3<I?V4F32XAA+^%N(6+&\3IRBO@
MCWOFL'[0+P*JH3=7<=\.ON"?J=Z]?_L.'SE-U*-5BY2P]T\5-H11\K/(&$WV
M3F,TMQB]@[\=CU8=*_PQ'6C1H*_4"6B#]@G#!<LGRCLN[^.T\+%MLZXPD;6?
M VJB!65]N 3FE/"MUY%6MQG)0;QTY'(KB_/Y*)PASF45P!\.J#7/LUGG:!S$
MK_^/7S?SAB/+Q>>D9EJ;?5,LT$^3$E5].7V6)J/S%?Z :SJ%V,>?K6G"U9SL
MKF;\=^!$W14H%7"2UT6F[#A1=_E;!9SD=;E[@0>9]AL+:G7B[9,,7IVV.;,Q
M4D2+DQ>,J&9O9F&DB-8F+QC)JZU9.@(>Q-MGGN?R(<:#CR]:9-R89=QUR%?F
MUATS25%G(465SHY+*L$O2S3]-#F^?[GN'1O#$V.Q&P8]R\J@<,=Q:7^T8^3D
MX0>M'7ND':OXH*D[BJ\=VF3L@5*D2F*EZ/]]"\")G7?QQ2#@=,:^>_A@^+BF
M7?<HE8=3B_FWQ&0V2Z#]GEG7XS_&H"]?EB[4<M/C')Z)WH;0FMW?;2.L?'E8
MNMA:Q#XHDMNG<4K#G6N2./PLO.31[U'^X#HNO!-^=+KR'MRP<;PQ3KUSG>X=
M>Z66B//R?J>V=>MR7&S[.A1?M88#FB#J?I_Y@G[PM^1\\"2<#ZK*KDL+(B;=
M*:)8']7.&>;13'69@=[-!/8DZP1V&R[ZO$5U,*R!S9*Q=L59V!!X375PZT9X
M][NP$P-<H-7-' SP6@N/CL4W@G_K<W UYP4X1M>LR=?*1A4%W%39%:24V%&Q
M*+NC76+71*]B8-Q0RF%8;.N>.*0K[#;FFA)G>#=8*M!PD8=O4\]W'=I@W9[O
MW3'23GOYZN%O"2]_7I_?[V[!2%Z-#67XYL6#^?ZWOS,V4U4SO;KZ: 4ID(*H
M"M^,"6"GQ^7X@XK0RV\"V&EBK)=;Z3[=RD[Z8@N? 3LJ06;SN0;Y V6*?E(
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M;E: +9XI<77+]KO8.SWOB+(L%!IR&F695S!,QE_O!1AV''^]PSW@.3F@83W
M0B7 I?VF>2F:J=[O9C,GUWEK*Z.H .EFZJ HYUEBJZ.H<'.X/*,HYU.?213M
M1S;W% #E+T]5.3NV'QG32F!'.>NU!':*:;CRAYV<VRR8A+I]&A]S?N>:,NTA
M=;2[YS]VFL0NUME5<WJ>/-A]K.\:0>M"D/J.CS((RKGOLRJ"U'=_E$%0SCV@
M>0B2-7-1A WZ2IV 7KNV3=HN)]$Q(TW*7YFY1]8MK(2[O$RTU=LTX@IN#55
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MB"\\34(S-$+2!F4,+'SXXV9]H-OZF"P+NBEDJ!&7"7''I6ED&!FIS!&M$WL
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M<MHMP%690RYK3V&?][+$,\H)4DV\9=ICYU*0.%RL//G.'H]>.B!=>MCFE/P
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M_".]NZ HK#0M:UK6M)Q;6@ZO 7:6601RXSC,0YFVTL(P/\T.,(O EQE=82H
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MBF*1*GR].+X07R4;:7_/8M4//7;O4DJ8 ](DS-V\W+/Q^GCBG@UL*_#=[-D
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M%=AJ/%M,NUGGPHO%PQ,[2_'B&K;]9$&&B&2@@.E.GM((7AEO1^2M%22-1<?
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M-.[HZW_Y7Q)?] :/R/,HRZEES4(F!G.=X5X^M3]5Z[0->6P1R8RA^!P-%,G
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M,_B3+Y?5J@$+%HNQ2?+/49B-PFS?=_#8A-FW"A#UL.K*Q@A4R[7):M.F]69
MCOVV2@_\\T\N_GY3;0FOU9\-[/CF;,)VS52XH9_\(UFF "<U"LVZ(Y+9@*X\
M>4:N[\79^>?"?@A8'/>3A]5J9>HPCB#-#\^X'I-^]"#IRC8OW#-.DR?X_ ?
M]0((B/YVH5]9FN3GBFM>.K)%']6GLDMV<OSFE,S5U<*0D']:9J> @@=TVA+
M4#GJ;,"S;FJ@W=*7^P["MT4UI8%^G\]-MLD*3*Q,%\*48J>VJIH6:(GT-WK6
MCB<$L_[>I#/&KN)A,3+RYU\WR3=YU>2TZ6F=?&-!7G^D(>KT:=9G*(7"["<8
M/E[ME_\1@R$#>_#I:M59H"*:^S=UWK15<?)L@_*.ZU^Z?#K%:)B2R_( ?//L
MVM(  .V,EJ:L;@3S=2'CG^;5&@>%3(RN98])T9M/DV_,',BT](RA+=BUMO*U
M__ZO>U]\#8S1V00+$+^"MO0'KEFYI*6C/_!\KFG9JU_!6TG7/V^T;YP.!ZJF
MFE-Z%I]3AIY=FF(&O,Y<$-D8.C/S&[$%!4R/?_SL47+G&7WAU5T20H#]U1L"
M ";9\T?=%=T._:L;*[\9IR#'=(%HII/9)#.S $@;GW(&+ROI.W6C@,R,GH::
MKLPT)U=+.@ S4ZR7>4J[5!1&L!SU9=A2^>]'I_;6-$V:+3L:7-L,_2)<9_L:
MI9U&,$J>@IJAG^@'+:WF=;:L*@:!=,=0Z1;B<5^9LFPVQ4U:YFE8D_?'U-Y]
M%/G83S0D;Y6) R)Q*TRJ(I$9[T2>Z8V!Z$*-%F27?(<^OI<\J]W[=UT>WL!=
MK],S]12V7&EA?+^MJVZ-CZ[;>O/* %I;J@.5!-;BGNEUMU!IKHA^8^_[)!&2
M\;SDV&9*#S&G-+*\8J!I??QD8!;T"Q8'N="$-*;$;_!B.E3+?)W452&7D$0)
M72<P=3AH:W^+Y7,!P.P+6UD,HT\")&V U+TP*.VGFY59Y%VL/:C1OV)!2T-D
M\,PFN0,A>X+-(''XN*OIZ_C;V1?XVSG][;+)TZM4ZECQP7WZX.SSNX(4^<\4
MAP9_OH<_W[\;+ _D0AYMC'D-CA)<RQUKUBXA/':M%O3(\S*3+:)K3!-DB81+
MT0+%%9O+0+5VVV8&Q+Q<2=I-:>%RLK+XMC^[_FIK0:^U%3Q+'@5-$IC;.>:&
M]>G_Y&%'^H9$;!!2XQ^<X0?GND:[SNZ=\R^__!Q?/+OKKLE;IA<L&C=O %?8
M,5?JZLWU7+#<$^YA;+Y?0IPH\J&+&7,1/%.$^T:OC6!DVNO:+HWCM*3]H1%?
MQ$I0T<.-:/E'M&QYVYI$9/#+JLOH"]]_?]6_$&D':DXW+-96)!6 *LA_#;75
M1@XWG3.6=2=@YE2RFX 5AT?WQ6>GX1HY%962G*-CH<J)OGKI%P;KY*3_Y0P(
MS@P* &TK:J=;%J8D:VSA= X#NM#U3!Z:NA7NMRL&%; /3F.JA4/6$T%NYSW-
MYO>+1:M:>$Z6G5B^%Q=OUA[GO-4\L$!Y7-/?!A3(9=-4=/O:\.^#HZ##\;0D
M0<&_^O'ZDFUJ$HM3VI!*+8TDTB)PZ6CG>R8CK7PW3P'$GWM>6-R7=/:+X/.*
MR/MN0R<UG<(HY/<& M2]=A+,5&\;_1)[!7#W(:WR,%\7:?(]N=<LCAPG"43W
M) G%^[=TMM&E;:>&[[-4^H(^_(&<J(H44W*5UREML2X-/Q>R0*272#E:#;Q2
M&!0JONCXSMD)X)?OG@93<(<DM9LR$PD :7/%E8WL)#^JNX7;.%S'.U>/+N\Z
M7Z3EXN].B-?7;E?5)*"OZHH"+G@-H3:5P[2J;I10@PV]:ZPE+<;]<(A><I#E
M>*IK$PJ0V"(F&6]6.8.2L\CX_MFP07NY)&,CV.S0. TMYZ=ET^9M)^#6@1MV
MW9+<!)(\_9JFXH[,D8B:X83+;_'5WQ0N5@EBR9C9#9_( =SRDJ#4EAU-#1_1
MXS-&] ^:*[S1. F:4)@]HU2,&7%!;DT#UA$V\H3=!=09UM\]>Z#^[@-H5&\0
MV3NN1M[\#4JR[_O'KCHDHYA5.ZWK[WB>+^P\W7*Y]Q1F:#WX"8T@?6_0CY,Z
M/YK&::=(0N +F>)9;XJA6;##0!Z8S/8LWM(.=V&/;O_T[/Y=_$4-;L!_QU#[
MJX65>8;/_EDMRX:6X:&-&4"J\('>98_PE2<?I31%$3J>6-AGI]?9J7!%X3+H
M3ZR: @\"F90GS^L%N::_6CO[JME ;L..=([XMZ:BJY_&HN6E.[U'8JV\.=OQ
M?I)D*%;K"19<U-:ZO*3O\2\ZX!>!#@\M%Z8C8C1Z.@).6'P:1&F"JX0;4:2W
M0A+)I%9D3M<5,.3QYWE>KTZ3QVE=Y* 7*-G; CT/_%$7F=)5D-@@_,KV9%8A
M=$;OFAOT3=EXQXLJ>V7P)WJ:/X*GVX^JIMIYAQ?B%*/@9_B,\MG[=T?KV?2/
M=?24?_H?[0H<Z=1WG=(#AX"Y?RP0,/O4 YGDL__YY&EK5O][?OF_+YY>_^M_
MGUP^?/G\Q?4G_\!?E1[D<D JQ%O[=A6A0NZ3?[P $]*3%!>L^2WR]$W]E1]%
MG/Y_59<TRZHK9HS5G\.IAI"9=X62/_GNRWRKY=220S7 0<WJ? HZ(4-?GY!D
M7!C&]7=VO\#\AP\!NX8("8X,]7DSK#F_H3'.#/B$F 2CVX"(P'8(2X#_AFRO
M54!X%3+V,FT0C2HW-V;WB)FNP'_*C&OXD^,+H5>3F2:<"(S\JLPT0WP?E[-9
MKIK:TTUUI$1J#-D3]8%5CM[1E<IM,Z?7;23:/S5,8)>O\$0TCL_EU.G(YG.3
MM32@T^3I/$'L1D?E=TM?G+7"15=EI'0F4>_Y1"-).><_2AGR!'9?5RCEB?>:
M,8-YQZQSB[JZI3U=D\4#4*^&/%:<GR)_!<*PJ5\S91A,9Y#S3)7(PS8S9K\2
MLI,LK[-NU;2(:#63;7+D(0KFC-]'1Z*@>4@(#F<$:U=4X, @*ZNJN?7<K@O]
MV&SX6^LTG[ESU#\J!RL+_P'Y=YV\>/S]Y<O'CY*7SY/G/[Y(OOGQ^ND/CZ^O
M?U\3^.YI_4:1]9[]WTJCZ.\,[:WLG*-SI W$;I="7!*DQ?)?<1=P,D"/0]=A
MR6(@3<!UA["$6B7@'/)66M-EF8 S''+O_+7,@D1YM" .GKKU$6B_QCD(3Z<_
M0[HPTV:IA'4AXQY35SH)Z:@F>4O*EOPZ)J.I1;B5';T9'JYYG0(AFP7+/,T+
M2P4HJL:\7B.R' F JE4JUQV##<<TW0QD=14/"7)$XG.Y#44SYZ[/5BA'GW7U
M:&XE"]?P^(5OVSJ2X0+S4I"\NW&YR8V*SLGV#W$T%;()YSK-?NGRVG&FJL15
M' /[:V5;;>*W,I/?&^Z%%^#Q(#""J1EX5CK\I G_ N178%NUFY7265NWDI=@
M5A_/8S0!-"]@/EB^Y_7L!$_:T%\W 4@# J=%N\SL_44N:R,[X._H]LM4/V#I
MAH?K2A+<K"5GQ/1*?+Y5LT:<DJ$J=;@1^X^+]<6]?<!]^A/0?2[>7FXV4/QY
M>GZQ#^OS!ITPXF*-N%A_QLWYP+A8[[!#_9^D:^:P)S\BA;.&E%J1YA:[\%B
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M7GC73=9%1Z@*$$3"8+EMI+9"%]V]_-]VOWV7W$Q&H\<$.%4T.8@!Y%4YF<I
M:3+<V@"QB1:7+?+M7LIM??.$_^_M"G5;8,=JY".*[Z?O)CNB\M(AT<&;RU=X
MVN4% $)D466]N6V/?K^J(&4NY[7Y]5=!FOK/R;>5"+U916I!JI>:UD+X%-Q]
M#7=I!203SJ#XFEKNRGZ7X4.H.4D5G<=5QQA(_C!B^#.>+T]@X@M_)Y%ZQP<
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M_3;9=K8[E_[[ *D/'/O[P;%@?W^85_ZVP[;G>O1:N"\+M"7-K5**&+]F%0T
M=SP,:)IR 7$:PENC'ZFO:U]N;E(2$H^NGD[ZB:Z:[##2:;^"-6Z3%D($B6+'
MB*S(*DW%XF<DT;"8P F9;>3F#X60_.'S[,_B)6!X;(;;'BI'V=%FO*4-PJV0
MB(2D%5'G4@/#2'ZS8'8061F+4S2GV>Z0R8>%,TQ*JU.CY5%:3KN:3OU#1&E
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MPIT$#A )@]G8= T'-D+A(E]'@@4<\S0T4+RXD!DNM]3>6NX4<=M]_$>8G'9
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MB[+XUU!RD,+\DUD7G.^.GG7!K MF7? X=,&R99)N408W 14UNXW&]595#_7
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MLP003I(7>W#6=U@ZF#VTI6@_E7UFCH\\B(MGEU)TLD@(CA%)(V>A/T/]\VT
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M!3UI-?]<(%_&607@V"\ \&6C0O![SU=0OEHGZ,T(6D9K66U5JW7M !3"\@;
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MP1AT1!+)AU>G=*"1(PIK21,  T6X7(59#I.54E;ZVJ@*$>1CPX]D2.'V ;O
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MSAW3P[*<9//E04Q6?0;'NPD.G$FMN-A["8D$#<NXZ#03E=2M#\T.M!S+_<\
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M5)\47&UW"D_SI)&;^;Z3[<(CR(XYX_^!Y2WGC/^<\9\S_H\CXS_&TTVN4PP
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M9>]=F-LVLG71OX+RB<^Q=U&,2$F6;,^D2I&=C._$CVLIDYI[ZU8*))H2)B#
MX"%%\^OO>O4#($A1LFR"9.^J/;$D$NCNM7J]U[=(.BR3? 8>://-A]_8-" ?
M=H0%[EC,,EJIM&2A@V'SW7HJW%VY%ER"))MMBKAA,]NY+VXLTY7QY&UH%8Y1
MBYZI::N/ >1X -GQ.KQ6#W#7*R-806K\0%.B1K-49A7%(\RJ;,C<EJSI8@/W
MAAGT(V</325F:CGAOR:^*X6KR62O-J]:C]$B)S',;8BXW0-\IU/T[GKU*EUP
MIOD:IXA&$%%E31*._Y"I4^YP'<)GPM*R:W)U)F&<DW:8QD4][&-GW!LDS-8J
MI5K&K==6IX0LZP@+H[?:%$8CTF$.*+HFX=\ @\>ZZ9D1/QSKL*#9\IN>XX 3
MZ3BF<<,&D>@^<5\TFR6W<MO,Y=C\N,;]\[1T0'!'QW_HV=_"4+5(2,V$G83%
M%5&.VXHP2(Y* [03WQ=\J+%1;)Q+1F>PW3;)PZE"7=@2:FP$Z^?9\3[HZK;\
MO(FOSMS ,.K<B%VS%VB"[8S:LV2B3"1LHI'J6M9JT&%<2P,+Q7#L76&XEO5P
M3/4I/&^]T",4W'AMJ;OP2#[P@'NQ!LR-97F;24Y42AYKYH-I.J>L:D,W<]G9
M2($9/7&<B1MT$B,57J-)4=<=:(\Y!3<K9DU%K&",DBX!%@$$SW TAG)* S3F
M+_Y51<^)UAEPEUL5%"D$;E&N>N/A3KRS5 DRK7L"U0Q[UZ_ 3J$Q0<FMQ'CB
MY"[-6(^.IE3H1Q/_]!2]]J(!RRU2.)85,AY;%[*2OUI;9)9:J45KQ/5QJ6F^
M^)!Z/-.1!E;*"!ZSF=5IL\#<KTMMSJ.YO]/9F>7)-*=VOTUS2)JR6><J)8:.
M=1V"C\%)#VZ.-%%8\;.?-^L_Y@ID][1$Y 85^<+]RTKY>SH,N"CFJ -SD9@\
M6U9M=K UU69#?72[/<DD0K,[(S,)KW#%PX*:_$Q:UJGVYM%C-#<)T<BQN221
M\F)3ATI.HZ[H6FW\GRVXZCF!U"QO&UM5RX."$*H+H%?S55B\$S=0(49W-D,>
MIHC6(LEN90K53. 0U.L0C?%&#ONY?HD3#EB@A//ZO!7C=]3L$2W<>%O.0V7*
MX?+Y:_QMIW>'B ,,);T6VD)A2!DJ"TYO!>:4\.%1&MYJ><D$(]=K#*LP&0B<
MH5U(V.>N O2'E+1UJBZ457F;$2'\*YJ$1VHQ/HYK*]H<E 'THT'3GVG",>;8
M-'1/2WN*&4V@*]+CUE(HH]KK!G1-X]6'?+K5!:*"B]#$G5(G2"9-1+0VI]/S
M/I?\CAEU7,8Z?]\W?/C<;TJ2(O%,+OQ=3,#56=*,P_5-M\'9^W.W]&N^\KTV
MB7(E=J$ )5OJC16VSK5=^%AV]9PQVOQ7GB294.*&PT(<$9_1>,Q1+:=%O9T2
MZK'3B.LM4WJJ;0M&%4\8-_C9\ "*]DH,Q9GB_'VN8)>Q[GPN:RNF2(4[EUA'
MBDPK['*J<2R>-T9P6!1F)I.1#\Z.+M5#KT.$S"ZO!/[KSPK(H#"#!%^-C5/M
M'$&(%3;&R[,\HO.]LH]/9BA]W:R5Y7VO3Q@VFHSM5+Y<RC_47SU,)MV*H]P<
MOZO[LU!MD&K!?N5:_,CURI%Y:\*,M(4-M^L=F<XF$!6ES!2LK7^.7HXAT,.W
M@/5)I4-.J44=7$5JB%.94-@3;SR8Y.3B8(](/0@*JW\?YL $ R[5@O_]I&O%
M9$JZGEP-JST%;8R>%#!&,:Z ,9(P=8K$!G@P&>?*6'B:3A\.J-I2.\-GU&[+
M1 -:S7I.MJ]0)3K8B&A"@0#ZK(FGG[[_U*- !L5S<*8/:GP)FM#\=(P0(F[Z
MS/Y5L&Q'"H0IM=[4"]4.^[BS&<IE+CN3Q;#@YGB/CF_4"ODH',SM@);*Q&?D
MG4[JH5AN&B5KA<L/L-48KN9UQDP](0;B:X:=LBPU>(HPK"?,BT9RT)(73HF>
MFX27MBRCH*GQ"=_$P@SBXU;.A*TDC09,A-!%H.Q>FN@[S>F9R8PE#,_(YS2U
MYXNMBF8W6SB&(X4_(  @>,=3_7CX?5ZIVLX;M1[-X3@HMMPQ\Z-;=YA/(3G,
MBZN*\U@Y9TM'JCV3:F: RO1/J>*]I?#0A$%_;*Y9VJ:KW$AR1_:T&D<X"PKY
MC&<AX[#F2,H:X5\VOV$3!F0]X+L$6Z%>*,#3XC%B)(<HA;&$SD"G:%6,71F<
MQYEP+["2_JK4^L*13&<V0MDA@Z=[@>FY$MJ/Z"B2#_*.@SE  5U^)C7O__C'
MN6/=G(':R34$=",#,=^H/,HB5"!$$ZYU3*SPT1A;DPS\05<9MQ63D9JKJY4Y
M!Y.6.U5PQ2,)UG)EQ>AV'L5!JU>%\IB6/@*^DD'FNE#OQT^F6&ZB0WI.6FI!
MD&HU?X*29I04X8I[? %XP91^U@!CD75C0(D[A?OZI$PV6X]:1VT.@CZ_%%]O
MSD9KJ%&G!XS>4&JKYWMK\>@#^O&3B56SL#;6$+L:[F#UUIDPJ,/M^Z;A'\I)
MA+ME_1+F<\49[L-@:\R]S^G\=IIQ+2&:@VL<AF['.>"1\T14_,ND2B-;[8&-
M?<[!LH_M*-_0_6N]!YF&VS1#K\&-=@VY%H*J%5%-UA2MA+*_OE-7SPJ*)\'-
MZ:1(**G\_ART#Q,2;3>RE437$I>;#OT>ZBWM$QD*FAU;/ ZFECN&V\#M3P1P
M0C>59%4IL['9,-K@H?8?W>B6"1',Y3=8BJGT.LXSL=;!"<J(<LP7&CF!68^$
MU+.WYS\_1RXI]1C$6CQ$0XW(!S;<F;_0-F6]<IR5"YD=.IK'-Y(074RC1<^I
M JK5)ORAKH =\/P(JYG!J^!<S:D%O^E$/45%FVDT_#6-K!^+HD!!@?@QMPL0
MG;'6CA]]5\JKJC7IXZT\?WL&LJ&PJG8^3X]Y]S@5#"*=LW=&:$2D=G"#[=JM
M7F@"+S1^C>E_H*9F3 ^*_Y4!WUX10TI(A.H#,# Z3LB0,]D@1P?(YGM828="
MB@ J! "G)^*C;EHV?!JCJEFVZ[W8=B53[6/UB*N#2-3-L8R- M9X(U**IG*U
MYR5M"-UH-GRX0;N )X__8-.#V,EZDE%&S*.C$F@WNR( ^)=M C&%1U38+36&
M+ME, I<"D<W'(R:J@VRUY#72Q8(@<]1L;4^UKI#GSRU2%)9G!<F_UL%]#)9G
M*9_"?<O(NB;*\4 F61)G%GZ$SE\2OKJKH1YV8_0RX"D3S<*+3+!^NG'#>93D
M>,0R)?-GC*/D:B@WZ)3K+YQ)4LA Z!_:ICBZO2]>PV_@K]K8W7Q-(#*HI1#%
MC#_&$Z[%M>:::'6C"9O<3^9)\(3L=T+?EZ!)O7*#QN/BV*%63+];'>656XBR
M)*">A>2:X@^EL,#\BUG:,Y:<)'3:>8VW=*UT44N9X77&II(2\_T, ,7E9X[)
MZCR ;(NPN&*HR.>D7<0BG(5%2=!I"D,\#E(:>V0%#604D"_YBN@*YC:JP:#8
M 2XGF,9_P4FH@L["U5+@B"3H 9 1F!K0M]5?J-F['<!-,P.K%!3JO+NL8-*;
M0(NVS8Q;X-Y<ZVK47ND4*]FK.7?GI)_4@3"LZZRZ_AV'-"\IT%D]U?A[""Y]
M0A.0Z+J(B^&6<O9LO15)*>X TF D<]XW:$7]&=+1N9+Q4HZAI NRKR574,0.
M7!PY"JW'MJ*,8_>\"?Y=KTZ=M!&<HWVU#R;Q'ZB>;T1CL1RNU=K82!,^$4/7
M?$DMO!\%.J)&07XM\&'-C%&5@U@T964N\M>6U:$<;DT=RNI6Q>HG_7A%*>M8
MQ>=WY_\\#SZ__>7TXNV;X.)C\.[#Q=M??GE[=O'KZ2_!I\\?/[W]?/'OQT#'
M67\E04@Y=1U0E_9*7<0!5CJ'M!@\PA142M&^_A8*,%4Z5;=84IOEIKB$P8G@
MT_>L=>Z<L?6Q<JM==-,"V$Y8X$(!6W 7\DO.M/=T:,I%%1PQ\ -Y9(("@>HF
M213G%/#0%:%/VT97'1 RA;D:YLJIQF%W!],CO)@ HUEM@Y[$=A.OB:)BDL[X
ML\+0G6TR!]/HRH1H,NYV%!/"EKW;MH/V;0CJB#@_DU@ED?34E;A8A=,B**^&
M\>$26Y_+97QHCP#60:W#!*0Y'<6IA4,.2[8-2L*M*7!HM![]")8 !UG#I :W
MR9&-[ :CN;;]/LJF>"1C%S-)RA',2R0Z>8\OU<O'J31*XIWT+/@30QS6*V;D
MA>PR,T8CY<=4<)M53!DZ+/X8>Z[Z2<07-1!&,!YY>B8QAX2,>'QWC=-BIS[#
MH&14>:TGC;4_HH@K17TA;LS7M'HT98D%@$PG5.+/$!MO!3427/!*"<J WI.6
M/)=H<U1D3(415L&!XJ60N0BBF'QP*1N7\Z>LN]W4IJ>VYJ <*%B,YT#%<Y*%
M;F$XG5YM=C1'U1BCK@KA^^P7X\(00L6E@,6W=H2'HSP+H[X,,R>8'LJ(<L$V
MP:/C$QF+6BQ;COP16<FGT<4C6NY)ZZS(S"RMP4^C_9R*-2S &F(5-_IC:T?%
M^3(VH'4;B037"PMU;Y?*8<);IU5[^<NX],BZ"G1Z17.+?+CUG9+[+/J47%)5
M%QY8$W*FB^!+5+#6F<;A?<'-E>+>)RZ!Y=X$EBU8O\IE$6T2B*2#C691-RDL
MF^?T&'$*#^F9[IJ_> /R%XL*P\R"[].9>LT^>G52.2/?;"!SL[^DZQ.H;%7A
M!HH:&  VY7'9#'U=5VNY_HDK;FJ($49"4-9)"X^>NV(>H2#]IE2$BH-#*%*\
M\5*#3Q:AUWM64R0(*'^K:4=0XSI]8I23RR\<_V_B66.MFQTV.;;Q X*KCIQ,
M):7<VG$1ZJ.8S:7K-3JN@)%M49^T8L*#!B>Z=H;\+WJ'\T4G=A]GU(\2$9J"
MQM?GPF)C1E!I!DZH9/E54/,C-8UF6LUBTP=:N)6I/@,ZQ G6[H"U%>DZ$>=)
M/1%J8D#K_9JPBY(1#Y,X+TJ1<5ENHD!UP6E0YVYKQ&J[XSH*/_\.O'!QTBX9
M4.1B_L/*VGYP6DB"%A_!=)JO8! !*O--<ZI3Z+7K#B(&KH(*W-A_'1QAG=?@
MH%=?YU2'JZR.DW6AHL)_E8F#.D.+H,Q*HHS8;BD_G3^+5L6Y\!5P)L1NK1NP
MH;)?5'AUNW<^I2$'7*%'<>M4$-QTD/KTG0/<-G]>TTQR;6&32?3JN6./;IG<
M$GX./%@,>Z<D2XR">0 TVU=I(J-DYX')22.%[%@;BS&NU4X+*^GH<\TVS U(
MOU;J+(.,<2TH# \O\=[6TJ9Z)A1K$KCVTMIMIF4#L;HP\B@JOFY2:^4H=K^I
ML%5_S3!2"!)#@[E$;."<\I&".M< )MK.L_8 ?[E7?Z+6"$V]8>NCC&HF'/R"
M'#MG-$![Z$%#15*5'[>D2$RUV'S$N-.T?B.XS%0A$A:/,XO@FB;(YASKQ[1C
M2"4CII8= 1HYY:/K6Q4]R6WRZ0?_R&Z4X2;7^',Y2E(5.HO"S=8H3&@E5$%K
MZGW<V=:\-B-/@BLP5J>H5JQE1HEO2O68"D\"-764FW9_3YW^56ZHM0-F)$^T
M:#'N?MA"(%&HMSNRR$6NZ:DK +*9SI*0/:!QSFO=4F1(8M=M<)F+':J?4ZOF
M<YZ%*8@]]$\D@N$DW;&O"7BK36W:%@$TJF3:E]P0=,,;#^6J+9>P%)V_2>VY
M2C30AF T6*9S^L0?M[JMW9Q[Q,4=R&,W5V)=W%H3\$J1;B'"H$(T5$G8\":)
MSG:]GFW$4XQ$SZ7:WV +AAZKFP;Y:Y0;W/3+C@$P+M!@>*@JY5/'4S!1KT90
MB^>V[^&-6B&\Y:*B4,^D:E0%4?5=4H8Z@ 2Z-2XR+B'E0?"JYEK51K*FKCTF
MM<IP0:1=1"^$F^(IAIK:$)'ND)"*Q*MX)O&;ROK4]A':X^/>DR1Q8P&B ^PH
M-Z?:''M "'* :N[!E*H*UB6%+=ZIM*DBD4[GZR2:QID.:LOZV@J;.*5L37'7
M!14'VUJNG#1$,!F,>_)@JZ(N'CDZBLRAJ;"8TKJ(ELU=FCL[PEHY'(=KY;SQ
MUJ@N*$=-8<$S<'Y8CD3@XMNYR%T]"B"AQY;W:5!2$W<;-Y"!)4L(KV"@1]LX
M9:B(MQ,=&R[A89K:[D29B46OJ4?(^=F\*/U\MQUC89=!J <4F2.ZF?-E=30;
M@2H:!:2AVX"L,19(8#)F._FDEEBX(*G#TJ5<EK!U%&5=%&HCG%.:-87#G/7P
MG=HW8ATP(V5R$][>V6?10]VL#0$)*#MW:_&EUHT12]G2B=5,58C540A4UY+G
ML*]<+.Z,DEPDCVJ5O'C?4P<AE/I"&B.HM:OK8L +KHFSAK8E.%S'DS)I1S)4
M5,L 73\\4H;@)' HPN3R>$V"A0[!>U]2YVS5<7/PU;W#6EVJ0GOG3E>3V>,1
MI^%X&%TMF92W&34:%L7\.!%6=B49E=U@-H5*0185R #IX$VUY$A[L[MVFI7Q
M@2,C\[7!N.&ITC-74%$3'J=YONCH08)E'!:D5(1-'.&GFC?<115SJ41!DMJ7
M&9?%5""S8)SO3MBKM0'6NP:H<LUYI"5DSSA@U">FQM9TT;*!]UUH)XL]NRQG
MMZEI+G-%Y01%&*8*@/A.*(Z](B>;Q^$!(Y_"DCU*;8?P>.AB/G\HF05VKND>
M.<GG4V=#9);H78$NN4%HU8KB#=DMML'P:NSYL%V$RT37!><L99SNXRRH@SAI
M8L:BV?2W!703%Y*:^$^D=&=&;(=P.J \3K#)]>Y8+,X0++(^E[263"W-/("1
MXERWR0FP )>J2YSI0JZ+-%([3U\4%[./QO.6<]BV$7%'6U,LU3FWL2LP/N^0
M*R7A6[MA#L([A3'./UU\[&FY7(.&U5=8:E)UED9JRU.=K6S,6"$'0NUA='MA
MYB.S(>9ERF5^_ @^%:N "?0>NZ%I0(KTV6?2B#N1H,\>!WTD;..D3CDEQFJE
M=AP.$-L<:CD=:/ )^Q*+X#,_4^<(WKGS%&Q3F9:7*/HD<-A(MO !/<,#(Q %
M7#7L\7E/.FG0HM3% U? &QB%HEZWB:#R&,E'BB^J%.?V<U.G2I$]74^ <:Z\
MK%(])%7-0O#S6=V2>8NCG]B98!S4T-3,NN&K'H]]1@A [L1)P$W)+9(WNZGD
MU-N)),1HS>>6=E2) 7CX39<JXT@5*B4Q&$5!ZU0.35:G]=T6US2GL5O0"D3B
M(.U1RW8#*9N-35C1S!UK\,= Q\0+(A&EV76?;P'6#MQ8++NB1EKL5,TR @:B
M,;%13H-H,,[G=-W8+B[V5A3R#]LPKL;LS?-TSRB[MHL>IW7\4V..4PK"&0?+
MD.KZP#3XIOLHMG%T1<)\L9&42(?H2A&PJA--L*-@^X$DO-N2!YA<$I5OVHX;
MT0M30D5&/YGM[$Y.XX*ZL^ X:P#C;163]DKK)C@+^J\SL69,K.,^LC^@:Z5
MR%#=5MB.H?,P6*O.Z;):?<*H/O;>98)P2F .3I+>Z5]NB<>UER:ZK%Z:?DHV
MQ^:FW2^,RQB_FJ8_9< :?#>=V$+$P4 0]R"];F?T3/ORY@0F_6'NU-$' %_]
M TL*:E_MU93_&,= O?I?^_1_<)HZSJ,7R/4- 18?5!)[-9T$3BSA2A'Z+$)#
M9XV$!%U]4 +N5<UJ>3=.)-1::L+DMF!7S_;'Z:91N?KZ[1P>T6V%+ P93UN@
M"@PQ; ^=VY=1;SOC)CRU%9!OS:),V]-B&FU: K5X7!(F%0&XJ'K321#76:P6
M:#-$KU6$,GZK\T@#A""3^K2XUD6GD70H.["!S02T]L5OFF/;31OIXV;X.Q<^
M^3'.'+?=.*)8H:B'ADI;;\_ &_<:7('J+4R)>I)0UR4 L4GHLML%)AG<>D['
M"P"Z06)K3/RK#&WTHCA&P+9? K9*Q=61H_H.F+ D_T!(_)HPJHVVLZ4ID3(R
M=3> 2OTX=RT5KFYJV.9SZ]V-$KZ0W8%+3G&<,@!3%(_>Y+$9$G*CE:9Q>RAM
MPQEQ,M5UP1?57X5_4"B*@D(X*#5)I# TTZ#F!-(5)DHW8::BWDR-F4D-V4(Z
MI]@<WWN9<3=(E9<F-J7Q"%1Z&6J0=TZIF]$I_> <?^$('6%.4%,LZ27AHIES
MTTGV2:H'=8RZ->+(HD\&G]DXLBX-D&@RI4?G31<=<M39<AMT-,:Y#:>Y%16M
MM.6G\$P4;N(V84=G $Z#54S-0'U.CROUF\8SB?[YT:?SVS,!>*X=8"S'9A14
M:Y\)UQC@ GCPBW;?[6?G=OV,19Q^A 7RYUJEFD,: M/EJ;HMY"G@8%)-?$2G
M 1YO1.4MM? PHL$YPS4P.08&_O->K5!32F'<V+7N']*]'79^D[MSO"Y$++J-
MMKFX#M1+Y-/C>*WBY4I"!K2HEW#1BV6P%"W2=#";X'XHP6M=&;G$T>3^H[%.
MFT:DGF2G>G>V>E)DG.O$F;!'1J  :L8E^PRNB&EA*@[0+;X$W("Q)A,?=D8W
M\8F[$T^6[8A"WBVU:!H2.80_I'MNN%N4GS[4U*$$=5_@"#"[^)Y=_:9+.AO8
M,%-MP$V"+SCI'L-?<LL<]+)H<=VN1@3/<@Y8E:W#T4ZY?JM7C[5IPQ430=0/
MAV6N&D%K\)(PK\[Z>B ZAXD/#HZ?A<^?#9X_^_%Y\"S4;=SP:V%B Y[FH%*X
MS5]S4]2?E=+"C0&]BS.#1Q&<!O:I7T$WT-(NSAY)-TA?D$K_D\6IT?9,&#N;
MK7D5"BZBIR%1N$;NS%\P;9(01H-1ED:2:1/_O[8;&K%"\#2BK283_)Y;,U'K
M^;"24TM(S4XL(1P_W.*A2FB7\2 9&I:697QL1O+46*BEBUMAI9@C;M<G(7MU
M$8E^@1[!@_N#2TAZRB;C)/C%6;I;TZ7CGIDM0GDHN;U\O:?Q[P"P+ T&B4,D
M(T7IZDA<I"Z#+?XD2IZ(<IS%\C"3595Z!M >FR$B)N0]7.,;L+"-)Y/@ABO.
M>"Q?(YNO2P*%J9WV\[K=9R;#6ZDK[H?(ACBO.<^2ON!R 2>S7C.9PNL,/L+7
M#_$JN7IXDC5+#FR9E]30FO(ZJG.R]7_R5JE*=E[,3Q81CX7T&"DN3>BSW@[!
M WEJY=\BX2<4,)W'+FQI[[<2QKU$IH;"66EH6A/)$#4GSO(^'',M*=47S-,<
M]381C>6W^L/6 ^R-.,"H15@?KD;K'PH73\ VIPA[LG.JDP&E/@:2&TZ\B U<
MP],:B8 .WN0'.. LW>Z.+&7 ,Z?:0F^^8#F36S%<N)+/;6&)R]9<YYCV8DT=
MIYV&%HJ2EBJ!!4--1%N8LX%:\Z\F!N2'?">MD:^I_:E>,]96&2;522VU9*;(
M":-NG,C1TL*>HE5^[K%S]; 4FFE4QT>1MG7YX[,5FY.M\ D)G9#8JN*>%[ZX
M9_N+>]S)J:;W68=K&0 ?!!N[8]A$E&J'X ]UZ\Q(=$:]$ H@&A5%-9'1LO4B
MV9$6+84R4_NH[]4IMK!Q?'";!9LF%)>XUQ")]7I4QZ\HJD*ZL#64F1X%H?YJ
MVRV:&:YI N+7@%5H/4 M4+(]HPJ26RXDJCOI"XL8R4K[3Q71<#/R6>JP:U;J
M$<*#!1N7**$U.(Q%)06)4L>@O?6Z&<(C&R5!T/ -VHLRF@F_>O:N67#^128)
M0S3*"3]0%I,KN26Y82=\(%2G;@4\F!K(8F&Z*V99*88!]S6D<%\VO=C\-\5W
M#8\!.$V*J^SV.+GE2(-Y'U?GF&;Q3"%K\'2YTKI7-\X[,'(8+3UIKN9O.VI+
MB+DU('AV3F+D1FETIV8V@.JQ"*;?0="4<N?%[S.%61'7O_>##V[GDWB@"*R4
MVC8H.2NSS<))25SJD6"+ (%44BBJ<&(D.'R+\RU\1\]B/_ T8!(^(I/)#J+T
MKBZ?DLLN/:BT$HVB@7M(D"(3&B*9[E4%[="<Y24W+,MVBYX-'59V?/&"[:(M
M34MI#R/*_GEQLR0<;WPC:LVO65BVI^_+@DO MO)/;[A\%I.<U&TLDR@):!6G
MA*09]H$F#*&BP2GPDQAGK:'0VX*[>JD+BZ_@7<EAPRNI$)UAA:@LGWN]Z>+@
MDT1I,+XZ@6-DY(\A*FQHX(H%6X"#RO1(?!./'C%7U_'Z%#:V27,UL@P9)6W<
ML03 31^9'F\BX7P[HXS[6TIA?T&(7\R_&M6(4=5YAW93-ON:JI8O:Y>2L@OU
M"7N;BR\ZA^SY\=?/P=G']^\_?@C.+SZ>_7-CT3Q_:X7'8 "8LF9D$\(UH8SE
MUV@W"<B*%%BH$<AQ4UB%QE1<VA9RL9PI?,D%U8C)DTE(T-CHF&4M)MR3Z\[7
M0H;DAV ^"ZXPC2QP3$ Q8C?<'&F <Q)N43&^4E&5*#.5M=!8-0F% JD3& Z_
M=EYU0$^!T-1G1;8M6\8\ YS"/(R50NH^+IH@TBW8I8TD+,MMW=J=U2NZK</D
M0$F:K(RP2_LDX)Z./1- )(B@;"H0F:Y:-1Z [M7.3-[8[+M7+_V3,:0R^VVD
M;C/;BUSF6;),WFJSRD"QXC )V W)<+PEDR2[$1_)GK13..#<*AX3AQ!_=KJH
MM+&D6$:7T E,XVIJP4X,0B@*YBR=NX(&--Y9##M #(INW67.;=27@V.<FC?0
M[8FTEYC;-3AREM#@/'Z^,[BYX*(QC::?N=C>/8GP6[!2_8#:0&;%/S(A5;N\
MX;O@+/@N\IFN9F%-DD>U)OQP; P25K%..,%\W;%KJ"_&I>1421[97N&&3%OV
M9'X4VL8V52LE*DQ;06:DN^\"=@A('HTY&4N#NB&OY4;M)M=ZC'M+JG.3^,^*
M,SQP-^'49!(I@PDT&YKC8B:]4Q9PJX4#:L=$.S'*Q5S1)E%;<:2QH(&F37+/
M%K\_ME%?=G&=@Y 82*'3^7/?NM_*&-@JNC>:3)=" A_K0W90#5QCV1NZ?9NM
M5['> BU4SODOBOF8-BD2KV8&0J,6#MC.G H5<LA/TG'8Z.*B"O9:03.]JQ#8
M1U,()Z-8-9!*FW;6&0YV-'AN"69UE9Z/RB4G-!ZH-B]-ESC?&?0RU8J3A+#3
MI%*:D<GQ5!7O492F4Z'Y2O@CBJ\UAW!>(E$3#*K#G[B$9$3)\K\_V7\2H.M=
MS$*<T&A^GJ$ND)_E.?R-/6JQFA7JE?[':U#!47GU"FMFY TY_2^GN"_3OS\!
M7C2/X0\?]D\.GKX&VZ14>_AN9*:;/)P]6917H?7?R>PK\:OD'\$7RU;GW40A
M8N>>G-.KU7P<NF/#1C;C;]^7T9WG<] ?#+MP/DMDQ?]I[/G_?-%A+ID<L5SP
M1&"+LA+C%_X8CO]@4(0]=R/KVI2$IU=, \V]'AGG9#A\\=J)<R]@H&V].;6S
M6T#=5DYH/_UF]=,*%&I^I7TD!$MU$^FZ1F>X'BA>CCVN_:5)3#Z5;F2ERCT9
M]D@/7*D&?R' (47%F\P$_Y/C_Z!F@/^"\O ZI(,WP>L0KT.\#MD.'2)! QPT
M,^6,V\0D);")#^'AJ*J2,.=E5."L43UEW9.IPI%Q7KIO,(]ZZ>ZENY?NVR'=
M&QY"+=W22+%H: 8VVT<$I"^9A L*5A4S*KJE;'NDDIC*CV=)6.*I>H&_N6SK
M!;X7^%[@;X? E\Z?RUS'^9WB5T+-B5.3AC _%&45Q:J9P7=+&D-NP2 <-Q-5
M<KXF!42V'34P".PF"R@)B9_>G'IEL;DL[Y6%5Q9>66R'LI"A;J:*"H$ZL3UE
MS 4W.@=,26*WH(HP<[D+!1,!"MP(ZIZ'#=W@J%RL>ZEGO>4AA:(\L9?_F\O%
M7OY[^>_E_[;(_\P*?&KDPPI,F5)'Z=TJIWF,GZNBB,.]7__(0T13U."07HYO
M+C=Z.>[EN)?CVR''$^R72[B5VT6L\/)Y<[G,RV<OG[U\W@[Y',5%7DG-#+7Y
M4C <%K\W#2/%-QW[S;%Y&2QQ^'B(W>V,H<?01E<J3$I$2D\C-8W'W!@_B^T/
MG+\U)?[4#*9?R@@$7A%L)#M[1> 5@5<$VZ$(QE=A>JG,Y"6GGY7K\%G*CPF>
MDWN[@^(65,'4F_(;S(=>@GL)[B7X=DCP.L0H6/$XQ6ANXA\C536P AT(HEKE
MC1Y0B$@5B(5<Z#0K02"I2T2W2))8XTV9V5UC0F1-LVN-G9 JFA:L2W$<B X7
M.T, SA% EGJ8];>-#^$C2-MQ>;S:\6K'JYWM4#N$W\)#. RPQ#B/=7$- ZH4
M/,X7G L1X1J#M8[*6FO/I5J=N7I/+_8WEWF]V/=BWXO][1#[KBE.H&IQ,:M*
M5?,E4)P36!":\5?QC$<_.#">NH@G,PAA]>GD!.5@1G.Y0]/N5:FY+4,(CK=E
M",&COM*K^8X)*Z_FO9KW:GZWU+P9B9;7@,MYIIWWV3:7);TP]\+<"_/M$.:,
M>CZC88Z$I$<SE8LB&\<T,![=LYZ!8%6,CRZN&H[.G3+(/F.JQVE/Y@T10+.=
MWR ]V%[J;S#O>JGOI;Z7^MLA]5OJ IK6>]MXNBQOA_;V8GUSF=.+=2_6O5C?
M#K'N%.RV3'Y&@@V.7]?!4[VH7[LH\Z+>BWHOZCM]<[HGZ@GL&@4X3[<9)3*5
M9VXJCC/EAA&RT=S'#ZF_0$50$W:&4Z44U@%'<<Z81SP,&T@7PY]";.S 9UUE
M272_-+O7 1WC9*\#O [P.F [=$ I8^%8$11764Y3X!,OHC>:T;R(]B+:B^CM
M$-'.1(->(%/(9BH?JYD>/Q:GUZK@RE8VWLW'&X,[:9HKSBP/9[,$C'(4S8)6
MS6%\!#?57XB")"XH=M,V*!/^@9,_/X1%%/X9_)QDHS )WA/HJ<WUSK*BB/$E
M.#UA\;/BB9Z27:5ZGFV4!47F5=#F7B2O@KP*\BIH.U000W>$9<6C#]+;(%&7
MW&6-$\1AEP4/J#?E.M.P)#RG\#*,TX):,4!+9<DUZH"*/NTT;,S'D4B%F% 2
MPSG!K[PNV$B.]KK ZP*O"[9#%R".!H)CST\^[KG@'SI3;/\H "%L\L]R$/-Z
M0(Y-'E/*8!R#+X)) QJ^B0@@=: H]!VJ%'O":4A/FB!"M_:!S%\Q;:V1O<<X
MFB?/LFG1#][Q4.=X#*HJ[P5Q";KJ-AB!CQ*C[JF2$MV/:Y7'DUM2>N(:A:.L
M*E%U\9R?V4R%.7I!A#L8CDE[W:A1$6-6G#X#3MHTQJ^@/H-G\O")DM#$J08V
M!$K=3K.J2&[Q=("N"M1B &JEBO O?9Y/+>\ORSP>55A02U[==,8*%-9,G?"P
MBQ[-GH:U](*K$)5I'@.74PVN2@IU@]/L^O?L;5QZ=XA)W8Z[P_[P:*W-C*=L
M5 #'%.#:QL4?B#%3 &'0Z2T$[P6/B#!KQEF51 Q024PF0SM L%2JU5,EAJ-G
M.,41Z*W2G"D\W'NT*PY.9NW]BG(>HRR)W-.(2Y!IX_N<[CT.[AWYX),P3E8)
M&FAOW@T>].:/2]\L\OZ!"R=Y-@V6"J32Q!2$3YNA!; *X$XSX8C)X5EA!-<5
M2!C#G1B7>"GQ,4D,:XNTF!#2LMQI(>W]2/>B:WS_<2ZF4N@V:! N<OP2LUE*
M@!4._PHNTI\5\&+) -QXO/ S<(S\0G,'XG4@3@<(W98(#_.5N:_W658;^VF(
M0>[X;DQUR/)91J+W,@-606VC&KQ+US].XVDU#<9)5N#C1W$D#.-\UL3@]*>;
M0D,.VQ$0M6_?8YO,Y9$J49&D'!:CJS3/O<'I'3$V?I;<% 3-FDS MW*EGKTO
MK24 (.)R%=8%Y<+;U)M_4V,P:S8J0]16K/IAT1,Y5A>D2S]:RL@03=A.^-,$
M!V*16XHS.F*XC6,T!@P6&3!8/]A<L7P*A[%7AG\HY%LTIJ[C@LY!;_$*;!F$
M,,O&E=@)<$!L2;Q127B#=P[^(_2?PI-(8EK8-3PZA'3CNRT2>P2F"AL61"MM
MMDGQ1B^89KEK,+& O45[[9H,&S!ZI[/2U(FX7\8'YFJ6A,@Y&#.89FBJ.+ -
M<$3A)=V6#1?*O['(BU,C?PBK2-.E'YRIG&Y!N(C*+83$L];$AZ]3<4VI. V@
MWX-DQ<^%<(@1O%0N34DK&-W"8]@LLAH"GJCHGO:(D,PG 1>#RN4J\RQQ[CJ9
MGW4^Z-%('0SGFZ_"<_57;X@#[V0N+5[-CR("&E97/T"5M_#@N&!)N;_2"B'$
M7U[%(^'^U'U[@(8\?A@8]P9>!&8ZKK\@R4V05%5Y!6:U%9*C+,QI4JBM>X)-
MQ451X<O51.4X"91E,#;"H1-1>Z'TM7'2I*C0:0C_PZ^XSN:U'(I)&D8WB9&P
MO%SR:C!HA3_UM*IE76?GD#IG >L]5_1=#LT,]P^T&C;,]K/,RCMSF.J7\$9+
M"AFEE]R:XRP:=+RA1I#!T5,D*7&*IF55 B^F5$\F>^0#(OM0S]9C7VX4TU,(
MXJ4BL3>62S..<Y!Y^* QLL,%F?S.'I&/02>&M]P]+I*I5?9IMB4*.W\6:8@<
M )J%1KI:WH53+;*IV92[]P8]X+&W]*Q)7C'$97U)MX\F,!EE_P\\,71LZU)Z
MDBU^\%1-1\YMF^=J3?88S9EBAB>"=AP^$U@XBU,B(]D&]4<YTGR#]3 )F\72
ME/DN4NSXXRF<P=ZIR_7L"ADT-V8NN?3X@[EH.ELZ49&2:0C@ZB,\'3ZCT%_\
M-8WQA?1]^N4IW!00_G37N;,69%Z!!CAL!VX&$[P:X14I>7@ENG$&:V&DRAL%
MC%_)M.,Y+>_Z6DF,L8SF9W249]ZP"\&7O :Q@4SRGRKB*T/KHF691>B++=$A
MA]]L22E-W)PEV:V"B[[9)L%]^(C2]^S2) E\3K=.<UR)OV1, J#S?\B@S\2*
M!M81ZA3H*$L/1I&E0(?_@!(M@"8L U%UXG?@C( J*BV(:!0D@[-(8;D1ZLT(
ME%D:A<9;N@>'QT4;@QJ3?Y(E279#\N-V)N.U10\S\(=),C7L(<I)4;XI,_X'
M_.F5AW#J9C3;YX%\'LCG@;8C#X1F*XC"^%J"@&/=\V?E=3""1<)9HI-%5J6Z
M"I.)+^K:7#;T MP+<"_ MT> MTKML"@PL(C_"A $%GQ L,@G<52!$P>V=E1A
M^.N&_8\%L+MP:*K5F[-3-XQ+ASZ+]0!]E^!V,+Q7%5Y5>%6Q0ZIBG(3QU!3\
MSM7X/E@[P.D6C"C%J($X(38OL-X %0>^P03]5\]A9(TXW-)46K8T9N>5U.9>
M-:^DO)+R2FK+E13FX[%(=Y93;^)LEMSV I7" 7%&U2FP MV!Q'.KH%HE_UWJ
M8N$7[ZTRMF7(R$GWAXQX[=PQ&>.UL]?.7CM_L7:^#\GO1>9U^)NHS;DN915'
MCXJ"T:^L53Q(C<3J!0R^_W2SKX-7)%Z1>$6R=6[>/:*/JV:BL'PS+N9*I\E_
MQ,JY<#()8_ANE(W+G#O^OGH[9?T$UNC$75S%A1-LC3(L#\Q*=JE1JQ855H'K
MJ@_XA?:R0TD:YD$2ZUI1;"<J[1&__4M:!D['93_X"50SD 8KF'NZ5#T8#HV&
MMLU5IV/2X8.7!P?4TR!NMVG3JG^T)Z_E6042DJX9!UB4J"MQJ;"RY)9=+L7%
M6DDLHJ5F@L8J3#'^Z1CN FIP##0 J:_D(?@X_6AY(+4P-HT3<N^IBI9>0ZR-
M%>Z9J1F7@D[X+!QE?$DKI$]A@?P4A^K,DOIS"U-F7%[A">BP15I@NQK'Y:E3
M@^:K50F56P)IL'Q<T2GQBN&,IQE&X^GFZ,IX;LZ:#ZLWRULG3%9=YEK8>NF'
M%C_?Q$"-46L!-)$25B"H(R@-L&\%S@FK[EW900W INK49!RXVG2>B?K!;U=Q
MHNH6J$M0$U&*>(-,QJM,NN5X=4ZK GY_$HZY1IL"4'#,M381[!Y(@?9X? G.
M22J4^@/I/\I=^4>%U\ AV(E(!PVOQRZYK,!%(1BO;D)J.R^[(FI@H%6C.$7K
MF+I*N(4'9SUQI?%U?)GEW+_.YUF/H"$'B 1PIK@O?_/2L!MS$?9ZQ-S?(:TQ
M-9AAW7=!EZS CKCZ*"J');@EB(F./55T9*VW!@D,)PF,EF;XP"JG'E+#OLX&
M-$?*SKE*@MF##QZ)T?*J>S:/=UY78#O.$CHC^;BIH,;IIF;=:2EHX?%&2P'K
M[1+;2:/"Z3QX2*M!PR9P.R,1^P*^&EY2*QYK.\?DT%T4;<:&10ZPK0S8%JTY
MXP99#/:*.PA4S)]<='JZ 7"9J,5S4_.&E9#_#.XH'.N<=05/=MK\"93"W."$
MVOFH@\KTF>&IQ*A(C6A_X%7$2R246G 5>Z1X03RX;2D@=&(60%=A/N4J4SBR
M%$2D:YIM9M/1CXHU$YQSE)&E947OC-@1E2ARO.Y]!W,)% .SOO3!WV856 3
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MFXH6F4QY!'K$,S0M&M-Z"\J[C%02PRJX*:;Y),HK532KD!P3/!DWE5BE8&;
M0:%!.G^&5!Q;P)J+R2V-?,%U$ P+RLF<;(%(32E8 );$Z217__TOVX\7M]<A
M6-%O/KUC+S4;)1)0+9SV'BD&/6,G^B>]:BH$)>]3FC@DVZ@3.RUL[!B?V!'3
MENW9-+\E#3X 8>B^P&4!-X*O,RBL:/Y(YBA/$&UHR,5)+#FQ,^P_0_9Y7R.U
M%7W!,WP4]=[NO_XD11K4&3(<O'[.U>I21&&2"=\-]H?] W1G$AVD).N.NIUP
M$;#RO5N<V9F0[1M>YHI'IO"=A!>:-_7X=Q.^9G"Q@;^D5H614&'M^*@B0'#4
M/@@4!6<$FSNF10\&K_5FF!_>@N"SQ=STR<$+\U%4]G%IJY_/*#AT"3Y ;%,H
M*)+ 2XR([:T%[,PG-=(2OO$)O/G@W;M>@%HJ.#&O^LE\T1TL"N\\1Y.??D97
M\$U8AGU6;E\EBS;\QBPLFUB22WORPVG!@ ]CYO2#04\\9F!UXAAD=I+5\QIA
M>-@[/#YJ*@06CJ(%@"B_@9.:8 SN7\"C8+.#Q@/!#XM/P=>M01H*BY(25'_-
MXISYX/^J$G+C3_H/R\ET3K3,#:TJ,$YMU96<.X@+&C7/%\J5#>_#/!EEU&X<
M_((?-C*B6>Y_BL+8W/#@U-S^FI" =[X/.53"(N#_@5?C_?A$=4?!Z??G=%T:
MO_[U'&Y:.F8M.K<F#!*R&L5F MG:+%?3V!1J:&L@2+*Q;M!TGM.#'XH"1$T%
MFRBY[^/AS-IJO9@5B-&R CO:R!*KA1<L".]L.4./8",DX,9G/JWO<O#[+V]_
M/OT%/9BSMV_?O/OP\_GOOWYZ<WKQ]G?7E3EX3%?F%W4)Q_S)3N_9"H_&Z/KN
M\^\6\.WA[^_??7C[^_GI3V\O_OW[FW?G9[]\//_U<]T!/WQ,KGV/.)#GX42!
MJGD3%S@*&.S_[>#=#X+5P=V]VQ89'6Q09'3A47<^5OK#I]//%R"9OLST[(1P
M.?K]_>GG?[Z]^/VGCY]___SVYW?G%Y]//UR<4\3WXX??W_[?O[IBYNA1Q0PG
M]]&5_:PN*23CU)*=<77L6TK+]^ 37/5\[@""O,=Z,TGAOL-IL[FQ;LDXY.\Z
MP"6/(<'6R7=R)FY5^69+XX_-,FA3B4Z9P&8Y_<^<UQ/&L;&KXG8*=# >T8=_
MOA$G*"AB+$M KU$"U62G[Q^RGZ*'W#?B*'/%V<M6<0,K_NZH#Z90YO@#@WWR
M!PX<[!1"MQCL'U+FLF"/RQGPG"-X6-1>&RY5\>![H.FTN4;-#\RYGYR*D9_S
M<';UZ$DS9T,OEJB@>3"WG^C_[J>)#OHO!T]?STNXQT1VN#="F7/$EWC$V+<F
MM6 C++)5&&20"S.)$Q7I&S/AX1)8;.#.R X&)SJ^Z:*44=JZ-MQ]A! :!)=%
M(1\93R%LC1%0.\.T#<4L;WF%^@O3Y@'U980"+/07-= FV.A,*J2\HF'4/!5\
M7%L"EZWQJ^?NSN.PP''_9/ H1M'2MS8M"&:\S@"(7-3&V#+7Q4DBX[X+7>N>
MQX6-E8^K:95P))QC-2[@ET"Q/!->B+4\9$$]@R?#1[B!1T46>.)YJQ"E6-:S
M^+DKR4&? I_'X,F^@Q/]BX3UL[C^F1]K;4WT.58>O$&.U^'FOAOL[SN $SW4
M!XWPU."8ZI%P%<WU]?C%C08^R?/A>=Z][%6_WK:C+Y+ C@#LA$NPICZ5> J6
M1#[^^Y/+079S,!A$MY=Q3K=RT/_/[/))4,8E[O))$"8E_J<&N'L,#L)?KZ]X
M/8>'A_ #.FG=(,S2MW;)P'@C0B#XE($*OMULZ]AT\F%9/%6KASDW?A)&4PNH
M4=8"<H.)Z26 3*A0I9R>()#P,83I D]O #61;<!-DVZ;J4XU_@6^E6X.:O3W
MN&"@%J/)IK$10,C@4]ZYI<783=Q*),NN=Q+-X85].9Z2M6*XN%IC2[1FT@VL
MDM/9/\FSJ=!5ERDP]N>H,K"<SF%0.VIC/.0&.P.?%0KYX%QC&&$)F/&,7*=]
MD^_PK[; PD*.-"%%B#>0.S$A!?N7>TKMR *M9:"V)G%>H!](-C4-)AW# :91
MF.MOFW8[;L\E_#,N(%6),D"?BW$L^L$;KD; UU&Y ",LMN?:Z)G<*HUOPH>=
M@M&1!(._%=6L'O]!"IP /;#K9D]4W6 (/$BG ?L0Y4]HXD7YM^_A"3_T..G[
M6(^C6_81KC/NY/'6N(QRU2H\X&(X-3Z*Q2.7E]@ SL4CQT>]PY/C!3!#3BG&
M8-_D3.X,QOV8Y3D9[CI(MFVA\>$&A<8WK(:A*QW:8.CD]YQW\+67A 6!7/J?
M8LW@E#%Q2._G$O.FWTA[$H5/=,3EX%GX_-G+YQW;$9J?A[BR8?=6MCHP_D0"
M32[ &#G/+%,C!<9@/,(:DE%VK;XVC.XW3/B\^/WSV_.WG__U]HV;UWEQC[S.
M__M9,*[^OSN5RN)4T,*DT>:?\/'O[T\_G/[\EAHF*%__Z_GYNX\??H??_O+O
M\W?GO__D'OWQXZ;4YC 9,(&/O63BI9VF87);Q&0VV$**LUIG^V?;1/31-!%M
M1?:_'J*,[-&8^'1[KW]K6Q7B[PG\%1@1D;29_T<*RCG@R+;U754O^ H&^*-4
M$57AV3H80NDX35,$W_VLL-B84DVP)[#P]OZY\=75IPU"<+BWT(B][6<?K>2B
M#"3DS/[)'1_>M]G';!J7QD&_X_P#<-9UZ_P$$PFX<,FL4.72<3_XBO=2YVWD
MM):L4^N\9>>%K86)1J8G9?KVK);8'!X:WX^<3(=T<5'/!"$KPZIJ"2$"LN9N
MS,(-.^5*">D10D=<77BW.:X;-:*(-R*QWMST"S7N7V;7&QS]^'B-G>GJ9K,%
MZF\<TPH7 A,*M!@;P6VX[K9_)?ZO 2:*TS2[EK00L%$XHX>BE1Q58PU&I*X)
M, XSC%&4\T 8[A"OTJF".XD]S8C=J514"/=C"W42T[0%8G&X!MD8AUAQTTH^
MPUDQ2<7*@> _N&>&Q\80&H-.G8!]2=PY?'U!ORIFE.:/\MN]67:#'C^>7I6$
MMM7[#>B)Z2BCOJZKD/^B]R'/RG#44  [CB.-\7&M4NH8BL"9N)81C;0WPBX1
MN18I->.%W] RX'>WA#F"D*,EN1_<2(SEU=B"C9 7A /)!10%2"K$#HGSL2R9
M@IT4-3)G9. ]$(R4HC].9-DEI*(&+TVN5X'I1WH6IP4.5@JN*F#'Y_ *<PZ?
MZ-"PC3D *9>'? A[V$-.( OP0=*'_'VX #'7B:.VY,:IX#*Y'2N!0"'@.^KW
M(IE)U([B<*1*MU/\7WL_9["/,)?1'OQP<]),&RWKS,0FP2Y!5BNJT;@JPU3A
M#W$ZJ0K#PGJA>@E4P*%Q,.3/G$KDF)X<%^/M3[$UO310?_.,&<SBF6)H0-O@
M%3PK<P7/01C9.'GNLME,CC<'D1]CD]E/;TZY+/Z:,<A-U;_6$R7V*&E8_T^G
M_Z!#^_2/O7>_O.%+T;S*C+Q"H&@,I='30 D7]A+#X8_499C6^(4RE'87U.@!
M_$;+(73%0G>MV4AC11@@V6V8E#33(T6 1QU++GD>$9XG)4 (1T*V3L@G*%()
M: -KA@7!TEF!AOQVL$+H7'Z]V'@,#B<S@^?J3'EP,2H07*5PVQ/1RL&D#<TK
M4B87X> AN&?E-#K^B4T4!B64VR@=,5[K3BR;TW-H&4P],8F)M [TB_L\@A-&
M.,MP?$6-F*%9;J0NM8UA&R8%*]1( WX;7!J>]H:2(*\NZYVE!JFF1"P+Y[OJ
M$@4GP5[H6T53>PO6/<Y"42Y'Y \4#C9%@7=^3+6+/$^D<'"C-2BG'* @U6PZ
M+]9[>*3_PDTN7(41#UN2.A$B)#(6R:3O#OI#,#QLMV-MBE8AMF/M&\.C_?X1
MOTC:) 4P-2+YD60,K_K=R7'_L/:Q'OQNO_^RUESYW=$Q+$#_1I*2TA19,Z^;
M.R//!)^ 7@?-AL%A-2":DEL:<<C#=&XD_8LY6=4<"(%%,$#;&(=.7G&G%2ER
M >LFO>U 8S6&/M10)L7)42P?9W10U0Q^J\4Z> 1PKJFR&0WZ"LU?'F4&(XI^
M.3)Y!/F%$<EN2S*J7?D[2_!88'3JG<\TZ;%2_,%?+S""=X,#%D)9@4S%-A(?
MW[5'G5JC$,LV^1SJSVSON[^O6.^2)W&6"W(2IMDK:KOA\@=]J&_!')A2"=9F
M.QL7I-052+_0S=.OT%7$/894A4#17K(&0WM<TMB/G"KP>*1$L.S0CHI<.'_S
MF7C[/Y^>?M+=ES)9Y"&K%1.Q<!!66;W^ 8K D!()^Y\J8EAJUH4.9'Y._C_&
MKRU2/S?C]UR U)Z^8AK9^2]0/(4\70.-1Z8%B-6G-':5\D#ZK NZ2@4G,A15
MI+<^9[U\GLP7C#7GBA.S B4G6#W'\I04HWY@7 B Q5](+O'5:/:I'&9(,(2.
M': /SU3]\5/ML-?Z65.AGS3 4RDW.K4].6R.R[2#ZUF8LI6V"%8098NR]#(C
MNRLLXH(S[3C:BE+ *-QKB\,G2U>3RVLSD0(,3J'AKNQ7$3\X1O1S!EXSR)X]
M Y_G8$D*$AU>2_1U#,"#.15M,VL4#"YV >,N)>?*9L')R9PR0%M1/T(SVA"%
M <.1X?[)@H(+@ =BF9XA-QE>/,^I@(BF?SG<WF1.N2@YY=PI;(L:%(XNI.V2
M5A$8=L8NQN(E/?:,5L@S,,E+UXJS<.\E;]-RD7M"#'MIH"PWW'ISKSE)-GV;
M7<&J]1!?> [ :,%"16BLX;'[X3*UH<Y+\&$+V/<>6F5A])^*BVK)(T%\0#2S
MQQE/2V%9-4: 30,)*\_[KXK$IDOMI).Q;575T&[:RTW@UNTEY!YK:6FMGQQ/
MKK#3NYN^@)&>/39#]T;4A8YB"7YM"^6<XYE(]3Q8_F7XES+C!98>)07<T"/2
MI]^ %VS]#KX7OD<0F9,*U9O-<<8IUXL,3;G(>36=AAQI.G>>W&9@B.GU@=,7
M&8:LK8!K;=6]L\=W^#5[?)=<HW5 67^6"_#9N0":"A^ ]_7?W3YK\5X_B3?)
M!71+A@*M=/&Q%H7/'N[UBGG;MJ?0!#3CD3-V@OC@=HC2#;AHBGP54^^HQUQ2
M"P?%=#3*9 S/X]"R 7F,*@[8Z1"O1''@$=H6>_/^K0'"T/9;_[P?/$.O13M;
M/9VG.0/Y I<P+ZSY]EO[$A$8GU Q,>2)Y:<XC]>-0>C*6G?1-0 JO68NHB*E
M %*1\"+A_I^;[3M?I[<8/%F*?Y4Q&PM.02H!ZYKR4<(Q%80/"7^:7;(Y0=%?
M[M#)<TRY.1\%3P_71MI2PIXDK!P88\2:XDD#:?1]1N!8UPROD:K+3*!5<_#$
M>&0:97;0+=,DI#G2YH7B VM+T CK1LAH427&AA>G'?CBM.TO3NM:N92QD8P5
MQH5HI%0X;$/XM7@?M>@(LA'C^)C10I,EQ2EKV1>*BXXM20Y5!WL)C!^GI=A$
M$\K6)4K1"4HTOM2QG18MZJO?M47^IE;A?=!$'5MWV+4%U0V=CBWNMF/KP:AU
MQY;D9$DQ@(;C!-&!C3K(^V+Q=FQ51<?6TSE1JWU4'6:6H" &XA6GW!B<3_"8
M]/S<SMV4N&T]S=&[%-=8Y8-Q>KG*QZR/M,JG>]C*F=U(4-4X7MQ$[\XY04B4
M%!W@0M *5RHN;K[NLZ846B'_P@-#^IU)2(JC7:LL>Z1@T0\KL%_F:W0 B&.E
M$UIPZ'-!F<_Z NG$IV.IU.Z4M+/::AA&2WA&:Y8!)_2KY[;V@.)QA9L8F%"<
MGQ8\KBV8#57\FKFJ^'I% YMH8E>?\0E2)6FG!0\RY1PTO<1& RA2Z3#RS$@0
MXN.>F>3CAA3J$86>&Z8P%X%"&O;'MOO08ZB0D.:D5AQB%,6#\>!8SY1Q *[-
M2FUF@4KXI(:6:\)ACQ@:&JGRAF;XRFT$1\4)R7#(I;XPCOD$8_TI#IU3X7,V
ME^\W,1()(M<(Q+%H24+II" V=F,2"PN^."&7A/'4?DX'ZHF1W $C#-D*FW0
MXL="0*ZR(HIGN64,'6(/36[)!-(%9]F--#M)'F)N@<W'\!EG@1IIE\<4()T!
M5/F-*CFIF@AN+-6$-+--)2:%*897OUU8/8F8*3@<.0/.)6I4)68:3,T1GBQ.
M3A8JR,KYE)NY<LJU_C7C5E]*L@5355YE]&$G+7!>8E0PCQ"_+2)BTG)T5':I
M)C@]/S,A6R'G13:+Q\&+_1>]NSI87;IHE-UYE>64DYR9:UF/C<J;S9)A5;B
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MK3O3H/Q2FM)SCYE-)](WC3DI1 ^J87&J [G=;7YUU/?67*(9!((\GL)YU?K
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M' QZP7!_. S&V10E2!24&7UXEL?P-?Q*/[B G_5[8#F31(W+(@CQ.Z,XI3Y
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MYP7>AM(50RI>X'F!=]<5V&X*>$&V\73]+CB["M-+M79AUB6 V6Z0Q@N]3E+
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MP'F(0G3/P:ZR/2#*>PH.>E$ XPT^?-J(,^]W%>8L9;6=*"<M=V/_^:[RCIE
M>=QOA15)/JN=7/J<&\PG'H7>9[672X;'-!"?XC\^L_C8PXIJ_KQ0XCBWX_S(
MC>5:A<3Q847T#W'.[M]<?D'5L$E>QJ/3E%ZRF>M"7&C5AF_[*8-$#SU_] EJ
M.8QRH[E>TZ\U1>#U4P=T<^UY1.%Y>DH78U6UBGGYY=8JIB#4 1539WMH!3:T
MIGGMFN8M+:/6( 6A#JB.IM0@:_;MV:WV/,4@@M8T6M/LO*:Y' M?T):M5C2%
MDI"G4C25>R3@1<K(UEK>IXZ(:9U4$'F@[FO:<WIZ-?,R_097RH**VN]N7==
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MA4$BY+D8L9O6E\C*;90]_X<(44M&(C? ['024T.M"QD\W#$CAP0T"N2*2U[
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M$GT#3!0FW>%IA7)KB/ET41#*-!RCTVZEF@%N<?"//V$=QV!&TUA*##.R98:
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M4F=@=!"3C"9BTGI@=(<_IF%C$W=K2>CA-8#)FX6!:M'X3L/ \\% J])L-FL
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MBUE.@\6;$6H-%FN#A:'YJL 4VD926Z76,#*5G?769H?K]F!DON>@IE4MO !
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MPYXWW'VSW6GS" #-FE ]G3Q'Z]<7!O)<$9[+3$@NSG,['75WN^0Y-&OB43<
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MZ0XWGCC%U(.:H+XP,/4HDGKTGA\!/,:[0]_9;IO-%LX(<+H[N+N3[&C]^L)
MLBM"=OV2R6Z'WN)FHX4SFYONSO-N$ 1.Q:V0GN<:H?@N_+E($5G^R3-N-/_
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M]IMFL]'>P@*5@E< BLSI1B$H<GM7 2@V# (K"D7NCVNW+;/5[9KMCIU;?E7
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MZG/ )YS]H<8&RJH8.- =(&"@K%J$*C-3KO9/E24(L+9M-C@+&\_^4&,#88"
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M_CEO_4PWW'J,YJ:GU[<?^F%W0Z0X/0V?% <)2P&*Z]5SJC4]G11WI"M.BH.
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M;=-NMDG-8$X &IY(S;1];5%(:Z6UYN8=R]7H(?7V$+(#;5]3%'3?M9$90&"
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M7[!=B/Q"?B%,/ ,EMQPS#)#N0VXAMQ F<LNA-,1611IB#N6O:9575T[VW%>
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MTE:[/*F:[@XC5;-&>H?U3YQL1S6:M6(0W,?3LWJCP(UW_D$"O<P@@6P"DH3
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M#!2XI2^0L&S1BFPH?Y=ZP]^]^&XXC^0BB7"9H3SLOQ]UWVRTRKL6QB!0[R!
M1H2 @<Z @ (9L<AQ[Q;-L7:@Q#>Z@N2Z+VVUS':'W(AF<VQ:734"J %9+S]
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M\'W?J9M&.6AQ8W]<I[A/6*DUW<A3S#R. \KUG?]^X:RSJQ;0YS/3.&2D'LI
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M?\5U5N1!\ BLEQ^@HD >+,*#]IYXL(1N(U:_8UI-BT0(9F6(1$BI& $&O?P
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M#*PWKES376NXF^BXP:T1A\*)YN&#<>--I^RUB^<H&##H'JXP4.!^EJV34&#
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MTD6!DM#.4O^\][^Y:_6@5S)M_KS,FJ^?DN:]JZ!6PS;M-@M#T8P+U>\IAD+
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M)J' P,)/>-'3F(7+#,^8"=^9%M=!6<P#02T\LZDW"MS8\E03!09,#R%=0,!
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M<[%C4_*R'6"QCQ5N1$Z.5SI>^:QX9=_Q2NO 8FO UHBO;Y'"'*?\J6 <;*^
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MS1NI#3O[^T[6V89(6W0R/[ET5+N<S/:%6YQQ;0487CI#L@,*SL*V%C2.0&R
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M-$=@C5D(FY=.(<\Q??1).H.OIE&6)C[J<3<L*Z)QS."% O;A)]C+5'0VS5C
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M-$Y'?D[F(&Q 8#VL3)XIH$G$VC&@HK _%)(C3F=@R&@"(*IV1U;GC1_%'+\
MRQDHZ"7_VYCKL,$T8HK 4%-F081*=7?F?V=(%H#AW_4_("9>^QD1!*!P6F:
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M:2S/_6P!OPG_6:+60KJ:IA#A'E X I#:D/,$/L"QB=X7VB,'OE+>?$"]62G
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MJZ._KT]GNEM66E"($[$WA8V"2(DC^%1(N"859I(I:1;!98$9F:*.*[PU2'A
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M\Y"BO7Y?.=*%77!J1OIY3AOEF<!'S@EN)U4FTAI>"-R8IIQ$">>H\%//6Q+
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M/S4'[B7E[!8;@V-KN/OON%EOI$5TZGKRQQ_"[R"/]6@'^9JVS+!N_()'ZO1
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MJ JU&H[<V43W.+[KFK_)EJL7O/W]"7D_'^7R0>!^PW@UO0,_?/%_1+-R]G-
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M,V'OA]B,2M-/U<0AO128?!KH+B#O>KC\[+A[,2E(\=GVL@VCU_FS]$BO7?]
M;:UE;!TO<YZ*XELSU:&E6P=/>Q1!M[:+%D$W 0UC=>4)RLM<*,GD"V(_X'Y$
M>;:8<:ZW,(0ER--2 C&)<9QCAK1/M*?/,Y&#>511JNG_:B]U_T1.%R13XR;P
MQ!DSSTNC,]8[L]Q*X\B8T6H\898,J!:X0+%Q07W4HTE5C,N+R&JUMI066\MX
M%;VJ@4P3)H?-*-J1;KQU$<9(!9[Z588J&HQMW&NR',.\<<GG2.-E*@CI[(OT
MJ\9F.]Z\NA)Z@OLD-VKZ.VS4&FB9?"=)J**D6 -OM43_:3+<N)+U>U/KF,.A
MC8A)28-5HX$%#Y_H/N.J$)WB-68UNOXDHA+U)ZA&4C3F+.%/_).KJM6O^-PY
MGK.85V[>MED>9/+JH3ZU06IUZGV(\@#^5<I9>Y&6]J2=3=L($$@>Z2?$_4KN
MH<Y&FO_=KYO'UQ?CM5:FZUOI5SWO'!T[5:=(48E9&$#$>EL1X@$V6N;*>:];
M(W OL@K3&-=>U>56W!@HG*ZJY^GZNQJ7HH]%P]D,,G(II9.*@NFQ0HD$YD-^
MSK/J1.>I1'VZ=IN*K_:\]V*@(7FH!$<C-F6VYLR9.#(6KDH40IXLM4M>ZWJ'
MNT2;*<T#'ZV#V,7 B+QZL0XB=>4\4":OO*(:;?/HEJ(05.Q',ZE,%B+O14S&
MXV!'>U2K-\TW8[V-HBG<-G!X/E.=[^L4FY\ZOHN<]+* LW??$Q;I-[4^"[Z<
M AZ*BGV5$8#S16;S.%TP4C%43YSKS!<AP&^7?^0=V1P6%72Q!!;DT- 3D2X(
MV_-2Z7Z\]9'!R]Y'%U__;UXET:*TQD$NZBT^6H5B]<)#J?5>E6N(7@"XFVHI
M]3U!Y8&\&*R487$5QY1G%%]42>KSV*<YJZ;2)+V5:\5%^6VH8&9+5V]^&8*F
MZ6(IGZ!'AZ%OT_,U;ZITUJ*S2?Y.?UF[$'T-F6?Q!8G$._6S.&TZ/>"ZZ#VZ
M<PVT^L63%2>ZWX<J)*GS5B5BEJP@I=9,M'96#*-*;/(+S9I<8QE]8B1O_R\"
M_6+J'!$)O\9 (Q(5LU5UO21)<AR4D_-R"SGBI#FR"A]_'X-6W+T,IBF-&>2-
MHNK7BK0D50$36C6L4-BX'?S=C/\>F/F <43M*:YPI*'HV^L8+RF\XF8\NAI/
MW,T]5%^U0)$)+8<6Z C,YY/$Y:1K8\#S74,354]^;)-%&,N[@:_!MCIR1"VY
MI_0$5YZ9JA4!(8\0)8P=WMPL+GS5-T,>CFA))2AR%[K06FBTDDRT:A^FA^2.
M"1FD?^C7M2%R-\K</HK^,Q<L(SGH<!MQ]"NP5.&4?8T5;6\\N!^N*""ZH#&,
M52'(<];'=]!1 !@)<6LYG8(,#T ^+Y]R[R!Y4W,OC&)> T1CQJ6"&B_$'VZH
M!W<IO#TBJQI1O2QX!GH8@2TEV[#7/B=<2/QRT![$DM]KILTA#OCY:$\Y#1T$
MQ*;EM&IV*1<^X(Y8N/I@@GSK"K<Z9I7VC=,VP.)8R(9()$P#"L;RUFK11#^[
MJL.O"!.I"JN U#%(-%"*)_N!<X)S;BC"&W#R0I8JZ4]SKQ<_H?1TZ1;$E'(A
MY7AXGN*,)^[<#:L*RJ%T@3,!.F6HA=J5UBZ2)P\NJHPNG/G;E5_:C"DTND4#
M&9VH5KH769JD:-JYC@+-C@*P#P#T20@*"\"KNC3@#4 QI-^N/09^R[6\9PFJ
MPB DL3<_-X"K?)K6G;Y/X3_5>/B3R_>JZ$Z4U?&2UJK-LI>+ETG'0\7+]"-7
MK9G&):BG"7J82E$D8R17"Z6>[IW+1J*-SV?OS[^9,ZE8-O:3[YC2SV1"+X]R
M:*TDJ=T:E6[1GSN"MKD:H3=B,Q_$'^'VN*I+(]_EZ81O*M<".UQ%%7I+&*F&
M6>A $MHK,A41,OO]Y.3"NRY!^4BXU5)->TU#;2PFKC!EX37S]%[66#CJ)R5^
MMJI#0OBL 1=DG[!%/Y$5A7D VHZTP5)5KJ-0Q8"I#.]1 )Y?KA[%U_K"D5BH
M6G[GC?*I@;;MRB>.&RJ3G E[0+1H6 I+CA;-[@94UFG^<F2:++Z@4>Z+RA72
M"TVQF$99?:+%0"L^  Q0W86%9.+*IS8KA=K\D^>>VL9@_'/3!L,OM1WY\=-/
M.'UHOJA9#2IES!D1>L6V%==VHM@0Q?R>6N7;XX]T][ZF-_5RT?78M$\R7H4=
MKI.H\BYKE0N\LS@7'%IR@_J=$29$3BDG,-7,UJ $-7=&>5!5A].ELR$:XC"(
M 0"32/8H6GM+=W_,[!V.B8VB/U)5OC(V7))CGMM+!KX\K'Z#<[!7@F@N9P53
MBIE>3LA/ITX&9I0JD1"!5BQDFHD:!VJ3*<T"K?%F)9^Y[!F*^B:?QHF%PB_&
MRQ)G42'#:4I,H##&QD-R&^3:XQFQGO*?!JTM.>%=T=W)D+Y;S-_8H3SX1 92
M-"/% /_;J5/0W+!.>%XP)S:A8A+]*2M1W3#FVI!>FH8*C\F^$FJ">+OJ[]4L
M7JH0A3N>_^!-M.A#MQ@,0M6H!)((S?"3&J^I_,05&F22CXE#5'J*D26YP)&9
MZO.$+?AK7J"-@39&+K6-M!"5C9)FPA=6]^SS8E^!U6L6Q2R3=Z/CQHS"EEE%
M5;AX&X*NM=JCSZ7WT9$?#L*]H.N'HT%WM+<_Z?K'(,SWC@[[1_V#H^'^P;TD
M9;U;I50]!)&,TSB\-X%M2DW#GJ?/*;IWSFNKGK@3<?_W[N_I@[:_<\X&RH*A
M7F!'JF[THSN-0MC@6]&;8/#JMR\^&7VR/GU%KQU8C#IIWM5CY^3B1-GU&"Z2
M3Y/H_?\9UE:&WL74AYUZ)[]>DLRI_?J/RP[Z1_5>$V)Q\:#Z@,QQTE0#T9]<
M_J4V,Z)1NHVP]FY!E(K,2][[+F38PQ<3+!E&J;@XU4=.(;_@0<-EK.=@T,A2
MIOO3:.2CY+$?8$_G$^TO=X^'K*^EVCC\_?=4[UFV/^RK?QA-RMXB9Y[!5Z:A
MO\ <4VQ4AN@@K=XZUS6AK,VPP-VK9A]/7"6HYGJAY:W$,B"U21I40%K.NX#5
MS8$@F\P2'31RXBY$LL!5>L*U5=&J#O!EW1&[FR')TIF>^ZLZ(Z(ZNY0<S11#
M+?T%R8]\.3)J95ZS#$*+2!E_9^9_1R<7ZW*5C9I_B.ASHS:9W&22O10I"A+L
MY$XMJWQ>-%?.-H38OF%*U^]:51\+.(KV+JN[$=[='.D>(%T!R?6:5-6;'BG=
M5)@JTB+2&D'(6N\-KM.,C)_0)[[Q+ZB[S.F"\D]I5K_>5=30N%@L@'S Q;;?
M\(%^PZ,5][M9#]'!X<^[GP<BWAKWT]];?D$]Z0IK]6"-&AI]?6=72&?K:/+W
M/-GCS\[962<=XHP8<XRQ]PMZ&K2&HKIL0R[/529?+_C$N6Z8QK])=.G5;V4.
M))&_>6MZ%<+H!O]3D&(VIORCO[W: W"R.(;GL&)6_3Q'\2%^-J#PUB^+]!U_
M&W<1^_.<O97_> <")BRF<.=@<! 0BXS^EVH!H^OD;Z\XU-2JXV5G$CO@)7L(
M0OD+ZCWQ=J]WN*_]\@K=QN:OWE<:$M_4X7'O\."7=^+H$GW(IO;XNUYUA?=R
M5NO5A?BS:7KA+QI&Y,.J;#9VT"R?>OB6.P:*\&?#BP-GT!N,5L.&3CA'M;K8
M/GRL*7K28A<5+&!W2,A_>S5X90$=]0]ZQQO1T=)@UT^AK*/')"S>9'"W)-3_
MY=WM%,?E(#/'0]QF_GR'K.Q1+[Q))[\*47-O@7/ZZ=/>I]/'%SAXQ3]'VEC#
MS4ZQS9\A9C8ED4<#$A<\SQ<$K0)E]]?>7X,N?@8WLP9._VX?B/8-.;\YF#2Y
M3VV#MR'VK8';_?T.C?Q-&QR30].7G92S,"W$WY6?88@^R\YPU&^9OF$;\OX<
M9<@:--RB/K0=;70-:_ME6'0-F[MUZKFSOFV U<.4I<>SN->SME\XP[,#5/MK
M.T><WG0_O>GXKCC%J<Y0KV@7E+9>#8DPGO@Y6E6E.AWTFR&:G7N,UN7Y+YRW
M[,RYM$J9"M,20SF#WA8%='_8.[0;.%<86MN5O;%"77H,:#PY.K'%]KO3:;$*
M>"]2GWJZ_J>M@-+I6KJN50TLOZ^N99>KZGC?'E?5,I5KJ=S8*?O9N201&M>O
ME*X"O\7LE7H&[4.3A.PAT#4[5]:SIBEI*)##JJA-I2J!];6,8E$"2Q.G9"U.
M1XUG))\SMH^:I5@=5?!9A-AFI%.UT-?*P1H->N6,P;16[<7K9:),FX*MU7+E
M6IE./?U93M *J$2'/U-U"^*]I'@/).QTJJ]YZVM]=^'?UVD:8M:K/*[,@(7#
M9@7MDA;R19T8?FQI!GIMEO/O8ND3OA2QP@M:Y2>DF]-,[+#,,-,<>5TCNQS_
MP+N/4L/2,IO#58EI!54+*Y52+(K@J=Q?[Q(]S])_-L:85<T813&;/L]-FZ!6
MU?OK$Q^R*/\.W\ ";&ILS@OFZ@N9.PT-(",BKXF4O,6L'$PEL8%*L_)R_$_:
M4RJ&R?$IW[F1,8V55C$-]Z!^CR8.ZE7_5)BH-VPOV(S?OVB0Q)<R)D6(OK'4
M\%.K31?WWZ'FLK*(##,)JP:-6M<N-3&L\)-K:IK)9UXLRQ:?4*786(%?3'S"
M_BC9C<00U3,Y97R/O/<#GZE2G<#H1YGS9')>S1;+/N)\., TO65 9QU1=X\]
M&,?,:+<M,YVK9I\Z(1>M;$)U'&M<K0\_+ZC;IYHQ6>OEC4U<8M@^UO]C^GS&
M^Q]3T2##1DZU]@)#H\I_:39M8W[093!E81FS\\DWQ1G/U#!Z'N 3<;_P) D_
M5Y ZX<![BNFW3U*RFCU)8QKDKO=!TK)Y)8)B(VH!2U]1WCI<::GDDYF_,H?7
M>Y%)O';$$)^L:^591 5M331T";E/ &PN(7?G=&)M0NYSK>[@NN3&A1Q/+<76
M5KRWXLYMR:]U0/K)&;;/39#;"CHGV]MD.YQLAZ6=SSKOX2S!">EIMK NY\W)
M]YVDA+KT!!LR/5UFP?TR"QK^\9;^<4U'.;H[UW"5*QYYMY=<?G:#UB]K)R#T
M._W]@34YGXZ7;%F=L=A/8;\Z<T%CC\1H.TQ!H)$PUNGY3K=YMK:5-:1@*QB<
M@K.)@M/H4KE-!4=RS8L8M@E/?)2,TPJ%9] Y'MB3<.GXBW/?V ,$F2QHG?;O
M-!QG<=FMX3@7CET:3J.SLN1MEB@AH\&1<[K8AF;.Z6(!$,[J.>)=[P.?QXMI
MT2R8)K#3ZXTC3,X+\YS,_Q?/H.P @]-1-M%1]A\WS"39*'_X'(M:KJ9^8I4B
MU.\,6IK"VX?@+Y[/[,8;\[-++.S7CL[YS+3DVHMI.#+QT6XZZ9:YK.QQ!1E/
M7%UR/=J>C$KE>K3M&G[W5[O,F4/;U+D4<_Z,O)E@?S[Y(U^[0^Y/4;B.^O:D
M^[@6;T_!'?6SM;#!86^X;S=HJ,'; _6M1^SSYO0M6\S&^W8&<PJ9K;#<K-.;
MT]BVH+$=/J:CS";E[+BSWV^.6[6M&YS3SFSRD3UBL/"!(O]Q*\DU2M[97$ 7
M#+3HSFTI)[>80]D!)S>SZ0D#ST7"7$K0SP;"YV9W.NOL0R?Q75C>;IG@TG_L
M\FH</5H<ZK3,T!Z'OWU-DX#_H#UEAZ^C<[CO,G^L0V-;O!HN\^>NS!_9LG=G
MO79<_.D)&&LNO/1$0.7R?1Y+SSK^2?D^\N^6-/9QB3Y/!J=M<3*Y1)\EB3[:
M>(07G>UC#5AL]82XA)_G TN7\+,KE6W4&.VX3:W--D_8L+-_L#U-S27]/ 5-
M[3'=8X\QY/D):&I?<9R<.=K*0L^8F\!MC<?%3>"^/RRM;7'M)G#O0$WK;TE-
M4T-JV]0UX.M6J&E;'M7]6!XU-ZI[E9KVJ*.Z=TB[JJD\CNS\]_M3\C/H>+^O
MB/4 V]KWFB:5!Z"(\3Y@%WF4XYA=N*W,OU4#@?..E[-9U)U$291/X>\XBYE/
M(#9_Q0<0:[-\U8!C"0><\:V-2Q[[.+0ZY;-[JX'1.8,=)==B5#,?^GO-$@PK
MX#CI+)W)T<':QSM>C"/'@S0O:)PQ+M(1 YEQ,=_+F)^G"<U?Y8@K1PSCH.88
MNVEY0WAA7A9\<'(ZQKG*]+P8=0VO?6=%SVMO@;YT;O,M#DZN342&.PK\+%O0
MUL1,6C'G')\.&1.#V?WY/$M_T,V(]_1YVNH&Y?[+Q-@V'J8.%C7!MJ5-!I][
M:X32Y>1I>;+4#+F+X^'K.1]!3L.UL]!/ 'BW43'U3BY//6#24> =C08=C^)"
M "^U=SET''Y24\0YF/E.YOX"[Q=>*0O8T5_X;6W2]W_\VQ$0[[L<@9TQ?-*/
MD?]GZ2T^B5BC#8=OH_\?XRR.YF7&#/)O](,V(UO_($8%U'T#O[UF'\0AOL'G
M+E@6K&[MW$:L(T6KW<&KWPZ!>S:(]9>>F";\\F8\M[&56D^\.G=9(/'$"XDN
M@![IC'&"\H'0%/[IP]]7TI$^1WR%F-048G.HVQ(H[=6@M+=3J7FT)W!LFLD#
MS0&_NV/@G]^[_@3.\]:/;_U%_LK[]7ZZ4MLA5V:>T 6@GF1H+W#S2%A14O*1
MWXIF1\?]/\,@*?X\.O+#0;@7=/UP-.B.]O8G7?^8#;M[1X?]H_[!T7#_X-ZS
MTI\DU=1Q7@K97*<G0PS/,Y:C,%.D5K'D8LIEEY05P._B$(4S^S%G0<'EE134
M4F9.R@(8:\_[!PHUV;$R0JI(@$UK^P$1H]91W\SE,N:V@$T&9<RAC\K1M93;
M*+YT<B:A-<?G<KY]KA P;PJJ3@J$"WO(8%L)BD62YGZ6P'JH3J1@6R S\>!^
M;T&,X:DZ2EB)'Q$1LVA<DGK#V5 P!=P1R_'3>X7_@YZ'94'8PW93;#R7]\P1
M\8ZI,X\3]C6"&G8+Z %?JK+ZB,57BB('/;[V!06M=^IG,6A^T4SBQHP5TS0D
MW*+%-;01WYNG!:KM@ 9"RR"PX5]^9T Y -O >P_P3^"4\!5Z%99C@*&D \W2
M$.0%X+W<%;T+YV49ESP"NWK>%U(>!;%IZ$JH4-<_2:<J<TY2\GL2F]22>(7?
MV4*^5/*5"<%#5'BC_'MWDC&VN0[4Z!C=8@*=*I"=H@D1DI*4)BKSYPMH2R57
MS,YPH]LR>,3#]>6O%G-&3R_Y^S>XE4]P*6?(@P!JJ+"M,*% %1OTCEM4,60%
M-W!: .$B8G&XT?VNT^WRB=WOQ__'WKLOMZT<^\)/\+T#RLE*V544%\$[[<15
MLK2TXG-L2Y^EE5W[KU4@,!01@P"#BV3FZ4_W#  "!$&"X 5#HG/.3BR)!&;Z
M]NONZ>D.C?AM2)TM]&V]^9BM> ?BOCBHJ%SIRQ"V?WF$?<!P^%\Q63;3M+]6
M8B& ,9UMDHJ+_5_ P10]BW2;.#-Z1H+Z!!B_F9AJEIC* B@D##@$G8;I<VM;
M2E2'%TA:6*V_N.&$07N[A;S9K-0OM7>-PN0&XCG>53+$^:U@U)7++.X B6P7
M"%TB2V0MRN0Z1P6$,"$JW\4";O#]!TU@JBV5_T-M;\IDMIK=_$1FY.VAABH
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M$\M49\EPO)BR)&)#^6SKS8:BX>RL%]$,>(J]Z>?\SSH+?#[R0@\?$4[D,/D
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M)_C2Z;Q-9S\Y!S[]W$%_"87_#?[E+Z+9I-YGSPN8<>_B_V+JZEN "G\_X8=
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MMDZ!X*WQVQ\4_DV6^&:8CD(C,875@!&Q3/@SIFAB:HG@VW%-H C8+L WD:=
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MX[8]CGDH>)-1 22Z+"9'<TUI./-'\[&I/+E,\P+7+']7GN8FRX/E!^+%VI&
M578+E(8]%=\?(UV11U>*5*AMZE]0<R] #E;1C/%CA3'MTX8Q?SR&GLSBD>G@
MS_@F.W@H<Y)+9NW. 2<FT+CSRS5JY O(PPOR!2Z 5>0+',L7Z-3>%SC0[;3#
M32DFS^!R31QY!O+P@CR#"V 5>0;'\@RZM?<,]CGP[#2'Y!"<A684/P6%S9WG
M1;?VH-GIR<V%)\?7+$4'^Z"PI8'@G3/-I:&1KV2 RLADO !W>?@M*R-(_F4=
MS%XK$#_?H>L4ENP6EO0.&98<J1EEO]7L4KFC;+(FJRTG""4(E8!/!*'GR;?=
M(;1_2@@]T/$:71^03O!D->R$IX2G$O")\/0\^;8[GAYT7L,QFRWV#UFF0CA*
MU_ NO#[E"_.\S)D4E0[)P!HIRKCVN8Q'S"#%N#Q>4$W=!;"*:NJ*\>_M[J%"
M/ <F]/8ST8)_H[GN OC"7?NJ3K"H?.ULA/ =P:X,;)#5EA/LG@VK"'9/TMF1
MX.ARE8LP21Y>$"9= *L(DXX6"HY.'0K2=:8Z6))W!SE(VO=P;]-!DN$$8XLI
M[>8!D?AL;CA]KOXRTP8GZ1BLD5Q?JBVGV7201,P@Q:@M+_:J,]O$O%J&%^=;
MBW805EYTZ+%SY-%IK48>,MR9ZO2;?6EJT_)"C%P8J)4U(90F7A!*$TH32A\3
MI=6CHO3%7<LBR)87)@BRY>$%039!-D'V<2"[?53(WN?F%T37!-7EQ*YR= @/
M\7[U-: ._-8P7SY&O/P6S)AKZL6)H;;AY^3FN\UV[Y<JU>S:4YR)<LMT+LQ*
M1VTH(-#MAN)/F<N45\U3_KJ[*J;[FE_KNALPXS,.O0*%_ XO,U^0G!NT$A>Q
MS?W-9JP4H)F%2X0]:>*MBAF^5G'C]_+&AB6VE>Y^=#T#M4SLYM[^JOF!RQ(W
M3O?:8&_-=='4!OG[D]N"W\_$$A)M&_$#SK.-<88"W)R[;*X!(+&?<V9[@A0.
M,EO1 Q?U'3[D,=^#)RA.X.(&.(*AZ5/&FJ79.E.\*8./-)7UTJ/N*3W=0TA/
MB>"IJ/2D"2J(5YQHPKB4-""M%?O1^F6[M1"&!2UITKX5&DT7VZSLHM:MHAH3
M-FR'^YFZT8;FVC.[&D-X_>-*F\!^WFO6J[8 +^#7JDE]HE?^/25?2^7JCCJK
M7M*=:8-X@I.PU"SO"1;QR7+T'UL,6$MMJ0E+QD"_YBA/H#H[N C#G&V',C)V
M+&-G^2HK3#TP:KJ.AM53E@391-)>=[!*TD=]RHP $&$2/>N;XS/OBP,KN+:-
M-10_+<'[TGDA$<F75K:AV,SGAM3T? XS8&>5B6-9SBN03GD+IM:?.H$' .:]
M>[^7GB7V7TJ[T2=$+YZC@_"J__&F!:QDEH5^,ZPW_CGTR/G/J;6^UP+?^1#Z
MY. /6]K<8^^C?WQ00K^]U0K;ZU155M8?-%M#J8:@UC:;%&7V>OT*"^XSICHO
MEAL>TVZO902L!+9MH\,G06ZH SYGMU@Y]ZF4IG*V1:&#8!_$#Y5G14Z1[9"#
M]@?L?'/1R"(AHPADY&%$##)M&4!&[32'P]T/(.J-0AA0$?#4V)Z54A,R>&3P
MSI2OF!\G@W>.GO;1+AN'SO?E%HNLR3$JO)F%^@%,VFS&7-W4+/DN@7.@JDXQ
MCIMNE_7FO23MM&4U7W(PJ5T,^7>IH[HTH)>5=?5&?SEX4#&PU)+FA"MGP"3"
ME;-E7;UQ1;+1V?N'E&JG.3B[J+*A/./U+OGN)AP'\*5AA;PW>^A23K4<$(!.
M]VEV*\/NKY8U1K9N6;;([['>B+KQ#96+GNL_N(X1Z/Z]^\C<%U-G_%Y-^.#P
M;\O[--G"^,X;!7>H^?]X8_X$@@0SP_'#O\=EW9TW']51H],;27/7AHR"Y+:9
M()&DGR"1(+$@)&8J_4\&B=GK3$4A<= 8=0@1I1.^0T7O$A\(RQ^]_\_4L9@'
MFN(JANGYKCD.N"68,'@MWHR<N\YL[BMS;8$?$+HN7]:+O)@+3C82&\B5.4('
M_,XP=<MZ:0EO$X;P#NS@M6T\<"OXH"UN(QLH1;#?;O0ZA^M:27;BW&>B$4!*
M1O::";ZL;"" + 60(TD LGSHKS;Z(P)(Z62QT)"8XY[9'^#"Y86E KXS#W01
M.TRXBLO\P+4K'Q%3Z8U+:1@C[QD&S=$[$U:E"_KV8A<Y22DGJ=M*.4FA$;US
MW._"A$J1)^@VU-;A!N@=J_\F#=#;*WE H%L'2TZ@>S:L(M ]&NBJ)P/=\KF'
M=F,P&A#HGH4('B A(7$9PME,I]4*W5#GC3'ER^'1$4N=+Q02GTY_I_#R7*'=
M/:',S(]L0>8WYDMU0P$<([5'AS*RR9ZLAH-PE7"5^$2X>EI<S4R).!&NEL\W
M=!K=+M4Z2"=Z-6A2(#D'-O>]LRP-;"<?=2=N/'A"2ZE]0?6:(@?9:V^PY& #
M%7'*RQM2$2G80 !!TE]?-A! R,N;VJO(Q1TJRU_0?OC.=)3DOK#D:>W-DAQL
M(.0NDZ+NGJH7SQ?XV?;8M6V$?SQ,37IK2.EJZ<105A-! $G27U\V$$"6 <B>
M! "Y3_UXJ]\B@)1-#&4YSZ4+[)EXW[*<5\W6Q15VW66&Z2L6Z'=U9[ETI^X\
MDI-TI^Y,6$5WZHKR;PBA>=4CANFVF83*19@D#R\(DRZ 581)1[OGG9W $OGX
M=XY[ZP1C?Q)8V:C^Y %]HME\G^Y\GX<X2G#G^]0Q_(5<!,\MV:[T9CCY5>>0
M22]P58H<KS/A9<&K;^29'?YHI< <H$-<CZM!Y0$Y:?*:'H)T>7A!D%X'7A*D
M5P;IP\HA?9\^_^U1AR#]+"3S' HH#"? E$.[>4!T[ZK-UKDF7_9*K!SQP.H8
M?#H[]9'C%&1WU$XQKY9>F+1CD4_#2G+ 4@[8Z$ .V'[=^?J-84N5_@@KU_#7
MRGY(6TA"N"R-02=<)EPF7-X#EWNMP^%R^0Q'MS'HC B62XE8Y4@0)CA^]5%6
MX+>&^?(QXN6W8,9<4]^-&*F]_[)]=X(.2(CD\@J_LKWRRFZSW?NE2B6^]A1G
MHMR"_F'N4.FH#06]7EX,LOI;^&]_RA0M_W:(\JIYRM]!..V(&HG%F3XHE0[O
M-)@R,VUS9GI__Q4_^[&IE%C&C3.#[RZ4J68H&TP1SC6)QZPZ;LH>I8>?@/S
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MTRGV.S<2GP)SKT3:#.K/W]E4GD"F;YS97+,7H))S4!\/'QZN!3YTK6AS^!K
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M>8=_6PS_<6T;US/']<W_\M_GID..=6HP&C9Z_185-YZ%0+ZK&H#I&H/$5IT
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MF'WUQ^.I>;_/_K?J^A)]5YB?P\*U[(:OAB1./B%M@]9_9KF&$2QA]1M/4Z8
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M-"Z;:PO>:LAC,_-*$,1:</AR72!ETOYP47UD<U^T2U*19DR#OR"_T3Z RMH
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M\UQF^B.$"A,VWGIG$#-?*:>&2WKI\Y[VEOF[">N=-@*)GD8B!_ ]K*TXJ75
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MX$YGF%5-7-TL;" WUB.NAO"7< B;(VQIZ4*S$6?FL1,%YJBX*  1@1;/RY^
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MX+S4?>4:1@5C?@D-@ Y\:]DON<V_+T/06JCD@/"Z% 2]$X/@S[+_$"JP<P!
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M#*(E-0BA7"Z2U^(SJX_:]6;K=4X6-^O-]NO;_#9/&L<&J)B1C[J7@4$BC"P
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MW:TBCBT@*JI U(F&=93K%'*D"L3C-S="\<5LEZH0B?ZO,.RH(Q*([JFNKL+
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M\SB/F]=)#)$8TD,,=3810^7&4*? &"*A=1JAA49G:;>RM8(I+D]D7ESLRZ(
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MX@!D[ <"*D\AB3:;/68VT"\(#(&H&'4<A%R(%)7<&-C($OB;$<M1]3 NK</
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M'CE[G!CP#5C_M4??FWJ"WA) %QP<L\;KJU^9FB+$/KNI1 >\-&ZR!Q4F<B@
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M#V9Y!HNQZ//\(#31Q>$9]86%D6!V+P90@_R ^,$"7RQRE6A'$PWH?$*^H\:
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MW.Q(S)7"WU@VR&Q#!<@]WF5^=4+N6=<+.ET)X*(IBJ@V3 *X%/[&LD$"> 4
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MH-3,6H1UWX-% Y$#0B6.X6H%N<L5,'(&XS/:HKH%KL)*<YYZ;J4WX*<%0 U
M^9J7JPU[K=&DU^IU\_Y[7GXJFH#<G(M*K"@N@];*BEXN*JS.BKV7JPW45G\T
M:@V&>8=^=]Q)EZ5:RA,!E::8:U+FN<GJ*S*SESL[663/ZZ-2VR<&4NK)]4R?
M.)6XFO-M#UKR5AW++=EQ]V+H&@ Q)J8XU]G/0=R8N#J)A_C943*I "18V_K1
MGELF+/ -Y]K@Q;M/9.J%NH=)4'7, YNU((MV9&"."9Q+EAGU7!NS6H3&+$!/
MH"6*.TNAZP\>80G[5_@8A#*M^_;Z$TV"^<I5]&?Z!_7M:Q:_7L/Z 2 _6<'_
M'C"Y:,(7>^.WL(J.\BIZQOIGHD>T$$RCM\.C6YCG!/!E>4^6+DMO::'S55,-
MQ1QM2YEY[B+.K^/_1RIX;OA0L+962I2*4#MM+Q#]_1 6H--+<14&P+!>7,24
MH,.PL(*4"[!&)I85!C '8<.<*WO*FE%*AP#8%(2TX+4,NKX<\6FF8?^43F]3
MC$ ]JNVYFV^$UC+ %0M6J41HW(? J)T0.]N\0)TWW $+F)'RH 9.D+V/.%E4
M]MO8_W4SN_(\3%EDKGC"4@.5:O;<&R[3E&PQU>*<D3KN4LPMO;X8G,,-R;H_
M8LZLL:55H <H)RBBD<QA<1-EF)6T3/PBC?NF6#]3-M97N1YQ-=?!F,Q)&^S8
M=Q+$6KS] 6KT .;"SF@>!:3\6PA"UU<'*<&[(T;HT32?<F50J54GO1Y55]K9
MCOXIF*J4$8J28I&JSFC^7,_9EJ7G4A0.DYJ=1QYX(8*J!9<3+(]] K.HW+5[
MRJM/\#APH#M*K]=K:T-M,E9?@\0^,@-&*S:H.ABP+)&H%50D%TW>>JY!B.E_
M @N#7ABFB&]F*1D]M*'G$C0*Y%+C6:P#5"MG%TM-^$;KV$&)H7];$8A,J:"6
M96\C0?5=NY*SEXM8*9&9M_XA1(I!D&JY)G.AP&.@?_+/U<Y>@0BCO8D4H5P<
MLDG-W9W\0:L[F+3&@X*24+%'CX5X76'.%]H:, ;@1:R52G<O@91QNI_/_Z8"
M,]IYO$,Z8MT@_(LO^XJM^AP,P\XBD"\:O.MU)IN2+M3Y>?#PN,226UW:19(D
M].U5!9O>+XC(JMOTRV!.J7ZN5<\F!4VAL;E.N^D'F&*UP!1C^\,#/.4!&W9V
M*(05F.9<?DN:YAVZYC>9YM&XU1WV-AGFK>'4\QCK7BYC*(WU9J$H--9: 0AG
MC76BHT<PV[EHM?%F>\M1QL1L%YRI*+7:.9.],8;<P9YWCV//<TER:<]1%+J1
M3'3W+OVIX&>KK<%PHZ\MB$GOYRH/TJ1OEHL"DPYVH< P9$QZNNOPJ-:]UD3+
M97"L5)/7;C#H;>@EW,4IW]S=6W(YT7I[D A%DG^$#BE G*5'\"(%^KOX(ZD[
MC/'W%F<&R#*_46AO1.KG.C>PW^XZ/L#+3^(1,VG!2]LLM?)  ]S3_9-[/W=#
M7W?,^R?XXRI_?+JB/%-)'&K]^!][84I+ZPU:W4G^:E%&Y=UQI44[J WLB*=\
MBCF'S7_Q$[+LI>GH&R-P>3OV!KF(G98CR4;A7<_/(!O1OHXK'VJW.XG_L9]\
M]$:C5J\@O7<<^<BSF57D8%GX6_@4?R/O 8C.Y%-1X2=]+&YHL-J8%BY6=TX?
M7$M?!9-;N^W2?F#F-'&OB'W4U*EL&L2,RQ@D"&Q6 ,&>_XYR1[#P 4*J=J-#
M_UPT2PXT\+,6+]Z]=SW/?8('^]SL=R[*[E=0S7SC$W9BW<S^I2-X!S<>/?OV
ME4K(S2PI@EWK6 ]YO^*?\_D'=X@P2G25%A*?\.'.0Z$_,,QVMF]3KE%+&Y2T
M\CWQ-3.9)3^(9UCTGAATWNMRT?-M3$6$_<A?3GWV^(\Q-:N;OGW)21WB80&Q
M8H>8V8HL[;BA2+M9NL/J4?S=J3HG-4J_$RR=?5?0+77 _"N__W[-LB?PE"EH
M:=*#42DR[N>S735%QI4)S?W8?058&[:&0_R_@EL[]XE(P5#'3,/SEE$LRJK"
MA^<B!ODVN"))WZUCZGEM1#TDIHKAL;.%%<BG9DZI?",+W7)@?Y$IN'K4+1M[
M;S^YWBWGW>F%=9>N-<6+]I((8+JE,"I;6ZEFB#(\3N'OANM318!C>@#'#3VP
M=?\-P<@QQRKQO_.W'I(J5Q,/\H>;-CK45X;AA?@+=B?1S8Q.2-BQSZE$FE*W
MJ]QZ[@+ P/4*7.N21(3_?I7^2_Q44*;X_A8 AZRCO4M*H+>EJT)GI, N0$J+
MBI=##_:/>-DP^>J@+BC!1UL(#BZ58UA+W4YUJFRZ_).V9U:PI/FK[W>.,<&X
M%FO(I?%*W70 E&->M5[O0>%]><\0Y0M*:6U3MP CWWH#?FV1_KI*=91T*CNY
M-?R\V\(S^8QL=HL')A6D.'^^9K^ ^*-NS+.?K9RJ+Q/-S6, *I2^L/95T,I0
M&#;LURX..W<(HWTBJ7/+,PNN@[9,0U\J;%M*M*](<J6T%DGK,!=[O<>#]L3W
MKY([8EA&,\(U;FYOO,_\3%\LRKN=K>(O*GA/+)__! -]"T];Z)\=,%1+O#Z+
MF!D)K5BE[;6ZPU%+'144[O8)B7UZB;0%ODAV[-[:Q3K)/E(YQUYRS^BV;&.*
M-IE\8[1X?K#^DL9D#,]X3,:1KA(0SA:5W$EW"IN8/BVQUOFX^0*]9U]L.E87
M:V5[!Z[#7/?VT0/77 'NDQMZ:Y>S9D: <H!0MQR@* @\!>-.[/$+MJXD)D^.
MX0FV1.!_/Q?)"+9&7[#U\-P)7]3^_F3N=, SQ?"U&8CM-?>RC/_&3L_$O=SE
M\M="35K_4)&;NLOWTJ[L+I]/+E3;)X3:*;6>]JS*GYSV6D7-VJ=:&< /80%V
MJC)<09/RQXN/GT?8?VS@%JV$MQMS<N-D;D[O[IE>@'@-M$XM&+!<+=$XS%]R
M=+:D!;MW"&FW9FYX9@%SAK[O&I:>I&+X"GQ%95?GK"<C4[EZI@X&R\S,^#;3
M1Y];F131X37E8:ZV<O2VE(HC-_=6!FW<:_4/K.E'1X%U>H>B37P_ME7L%L#T
MQ:OX-+P5.M7(5X4CN1Z^_:_E>59*3X;]EJJ6'M J["+;GM+)-Y!MN5[E',"O
MY QB797J7N,JU;L>3>IV"D Q53@]M$*]?]_MF56H=R7TQEN5,Q7JJK7G7+O?
M918_=R5X?U-+0/'=!9V=0JHZ>W_/_68LULZXYXER;*T&#Z^*/1GF*OSI8TKL
M5DH;%K[E$K>=C>.&>>[LBBO8%K_RAW7M\G;R^+0=+":^<>O+[=WM;7Q1%U9\
M*CA!V6&P["03;=UEF^<O1B)4I<'V>_\V7D_*;HC?J@LF$ X'FUE^?/\1RP*:
M.XE4=TN;WH5HCM;*'2#+=%ELZ&%JU>4]C7(5WDO#\)VOW]AV6U(JI>V8T46R
M]!ZYV(^JB.ZC_2LF9XGNU6\JZN][YS4]G18->UX[F8;'TGCOK+U*F!>?0>(G
MA3:U$,)'V.CQ6)/_$<*STG<%1RF_Z'=3UH>!=B'UY!IR&9,,:*3"9B8=]^ZM
M'G=G7+ZDC :M_GAC^B,K)DU!FB(?C7FV%4!CXR5/NSIJNQKF;J> G:=UU$:]
MFARUZG*N#;26.BJ]3:*S[\B-'$L_ZAZ>K?"CFQ[J&+%QKA,R^ATE(@<]L,;'
M95"ZQ(+U\?8N$JOSGIGQ7O=!-F ["OE!IV;YBFG98=S*M@2S[^#D-4 \]@<<
MII?<7XKH9]&4\C+DM_6:UJ-%#^703+$#?P*ZV:[OOX[N\LU=:I*<&HX,-K?@
MJ2,^J7!B24_==90/N"!X#"[?(S.;& &;3!.O.ME,4H((/#JO)[XKEF:YV= Z
MUX"-X5BZU Z!"'RN % 0-<]/QHED,NEK)T!=+^6L4V<Q"T9XX0_;B*\\T4-?
M:;,-)@6/+ON$CC=BLQB1AJWM'*&KX!/08I/)&*1'[8AFBG(ZI=F*C^&F]^4&
M5O3D3M3I5FA)\K65.V-.S- F-[-UFT(E[<HQ.=/NL5_TF>V,<(A.YXFYMDUS
M20J=L>HK?KB 1<-Z8L:QVP.B4'%*598.;$IQ,<5@7WE%:S6L!P)$!L2!+(/4
M?30L0O=?OSFHCE^]=9*-I#YD_#1;UALZ6O> 4=1LH\E0Z[+1<'P%;9Q43.D0
M_8*6!-^ VS)(_?(>B<5^Q58P&'5ZVLNW?)\1>>GD085]4*$"L]1Q(-[;/60Z
M]6.\MBR3\!<G%/%4OVQ^*/0SD5_M]/LGI'[17$%Q> &KP[3=KR]4T*YG8TST
MJ_<)7?DH^&Y'VZ(J229_IV[W@Q4G[8:6\7)\3)_TWQCM?<Q$>_' HA-KULNW
M3W,K('1V.F[MR=.71[)?)V=#7GU^YH!RCK!RP?IR[IC3--;$$*2)@$"JVAF-
M$]8AA0OA1T)4ML%>DU#48 M724V.'_2(R2EI\,Z>K]AP(0V>-'@-5@%IVBZ3
MK]B5=7+3MJO;T&036#G]</WI4_?3]1'TC6<D3L>!XQ:'L=!".X6UM_DRS)NJ
M.G,T;C# NE1F'.82'(_H.\#-<Q@ML:L. O"INYMK('DE *^>)]21;#@)GDBR
M2T2Y"#Y)1#D?7DE$$8(-$E$DHD@^242Y %XU'E%.U@UUQ'2DVNN,Q.;#5WXR
M0'GE8'^^'KC>ZU-E[R7."T;VAMFDG\3C $/PK5Q(E1,]?%<=U41AV/)J_U.G
MN7OYP,Q]IF?)?@=;5_FP:0]D@$I$>].!R^A :N_%N_&HU2\XB2Z>G#5,TR7$
M28AKI.!+B!.2+14@+G=V=@^(VW#QU?X0UVU-M/SE N+)6<,T74*<A+A&"KZ$
M."'94@'B<I?&[@%QW0CB\K,1]X:XP:BE]644)YQ(O1:BF_6Y[V@0/Z?\K_4+
M>K+7\KR");L+RSDHUUP/U^35#J(7Q78Y6M$HHR<JJ[*UYH/8==%^4(4K!'.7
M74<&]HK9UVCX"+\;BUWX>I-<?G9(OGLG!TD##ZD[R8_S/K%Q%^L8D# 2>%H+
M(H%7'%Y(X+T 5DG@/1KPYD:IU J\F[/PNP%O?]+2^OG1/1)X191 ";R2%Q)X
M+X95$GB/!KR3HP+OYMK ;L"K::W!>""!]RPD4*!F\TW5 M,-\3IKK=.H:D'<
M@1Y?,"[2/4U'9,W9*8TH1<Y][V/*,*^1+I2P/1'/P\J+=J]V:ZPH<[7&N:E^
MA9,WJI80M*37XEVWTZLO4W&LF\)*#7VC[,7)F@<E!$L(ODQ>2@B6$%P"P;F9
MKA4@N+R8L ;!]57I)01+")80+"'X;'@I(5A"< D$;YUINP,$EY<5LA LT&DY
M"<'[GB_XF8Z<A-_B!,J(CWRTZ7Z$R.S[D%F8U5YY\NFEUYE# 3@1EP[S] @?
M7.OC]%^/X&QYW2X9RJZ /!ISU$K?\@/\*_NUNZ233%L*3K('SN!A!/87- OP
M^R?=@T7BO_ *;O[PU"C?*6$S>DTE7,++V"A>GX^_Q3&J=\2QDAF]..P>=A;P
MD<;X 9Q6K]!Q]?D/;1F+FSOWE(S%O4H-U[V+I_9^Y -[<:;Z=3+)-3]%]YXT
M>V+N[9;IQ^F)T50:<-PME2XPCGB@)45^^K=XVJZ)@Y#9,%XV0)?)E)R1>]**
MZLDGYC4Q:)$3#.40W8OCFQRB*P0;SJ231]HY"4'GQ1HY>.WL^2J'Z)Y>C<2<
M*2F'Z$J#=YD&3P[1E09OJPI<-@>D(3M[OLJ1N4*R9?=D ^SLDN;E"E.!+:NR
ME2C+B=@@+S8]]5GI4IAI5+^"J'S:L<FIV0U,^Y^2'N?Z! [L#KA:@#P$&UH#
M^'L.?,W[5?$#KGY8_E\+Y[O)K/YU8O2_HLW_0HLNFX\;??[Z:=,![G?]?DO5
MNJW^L"?,R>U-YDU:+P'84 #N%VV(1.6#1/OSX)-$^^.@?>X6T(:@??G))HGV
MYZL HEHOB?9B\$&B_7GP2:+]3LP;0Z@J(/<:#SK5$OI'JYY=?$+_.GUXAY_2
MH4=F;K_^LUI67XXK.\MROK1)@K.A*V>658G2<U>&7TB4S@SW'=KM&V:VKQP3
MODW#;\? \]'$3/WYZDGWS%IR]I-6=]1O#<8C84Y-2]LEN.V20;P8?)#J( 0;
M))17@O+<)>02R@],R*O=UG P:*E]<6Y D<9+<.,EL5P,/DAU$((-$LNK8/DD
M=\NUQ')O\YUE6[%<:VG#?FNH2BP73D'DP853<V#3[5_R\,+Y +DLO5XX&Z0_
M5<F?REU9?B'^%-IM:K;7^A'K*&3T6KU1MP5;DMV(HFF J-9))C_$X(-4!R'8
M(,&Z$ECG+C=O#%A7+U6,)%B+J@&B6B<)UF+P0:J#$&R08%T)K'N-!>L#:A%J
M"[XMT5I$%9!G+D[-@7_Q62>*[ONN8>DX#.7)"N;*%\N\UI>*X1'3"I29;EBV
M%:SD*8SS06]9,;UP-D@GZN#3DU)'+EQ'9-PM!A^D.@C!!@D9$C+$X8.8.B(A
M0PP^2'40@@T2,BJE:OL7FJJ-$D97<;[H7U8P_V*9AKZ\ILFB3SQ75$ORMJ6-
M>ZW^4)[O%DXG9!_YJ3D "M67'>2B:8$L)$DV2.=)7G G(!_$U!$9;XO!!ZD.
M0K!!0H:$#''X(*:.2,@0@P]2'81@@X2,2BG:P86F:,O'91R2B!T.A_!_]25B
MI55Z]D3LZ9+C%Y^+_7;W![NK_(ON?2>!@C__XH?Q7I.EC0<OW]J60]IS]G95
MZ[Y\2_75T&UNGC%9^^Z5^OJ7G^$191HFFVX%!'E97KIP-DA?JY*O=:GC2+\1
M/_ L(^ 7J?T!E,!;UA@*%/VQCLM"U'%K/!ZV1FI]1YJDW;IPNR53)F+P0:J#
M$&R0,%X)QB]USN@!,'[(-2+#[J35U082Q453#5'-ED1Q,?@@U4$(-D@4KX3B
MESJ'[  4KUX9&;:ZO5%KT-<DBHNF&J*TJ&=J(-$X9$[AS$1DNJTEB+H37#!;
M/BZ6MKLB1&&37I>A9\QUGRA+6W=.TKV>=JXD>T3M<MC,&SGX72!6=3.#WP]B
MUT7[;B?N<]Q)L=)&3RK7<_/F $RZ<,T1T_))D#H;5DF0.EJ"X5*GHT:1"\T@
MW/*XY1;"ECK* 5H?AX#45PR0WL'E6C7I'0C,'.D=7 "KI'=P).^@U[W4>:L[
M> ?5RPS:1&M-QJKT#LY"*T2YV'Q3Y<%T0[PT1NO4F-I6>YV1V)RY=P/=5IA5
M.LG!B@VNVS$X<G:*(DJE-.(-$K40]S<Q3[IR O$RZ\H=EY_2U\OZ>L\^"_:@
M@Q6C0:L_4%NCH3@'*\K\K%*LD";GN7ES )1?M+D0%0\DME\.+R6VGP[;GWUT
M[$'EE>&D-9F,6]WN1&+[64BDQ';)'(GM#>:EQ/;38?NS3YH]J#C2TUJC_J"E
MC7H2VRM)Y,DM#B^/_!SH0!WXK6D]9C;_OHQ!6ZF2(<++4A(,GYD$?Y7]#U(%
M=LX)0.G!1>C7%UU0(&+;*"0@;O'/7/SHSQEA>:.'@?N6"R#LW-:7/GD3_>.M
M$AG:+C]4&E>G^%/8W_N=W@0_D%*CS-\G@\Y037]@EUK7*<5]],R\IC=YE9::
MGFO7DV?>=>HF- 5,G&(Y#"L4'0S?G"@+_8>U"!>L%@?&W@9D\5;*DG@&[$5_
M()UM!B(R]E_#!?$L8S]"KMF%K91AAA(M9=9^99?P2^;'&%&[@SRB?K!\PW;]
MT",W,\1.XO@4/+\1&\?J7+M^X+/& ]TGYJV^6L!2_7M8]GO;-;[OEP,GOJ$O
MT<_Q0L*^:3DA,:^"9'U_F883_-4E(W4X,7IMTC4'[;XYUMO3WD!K][5!WX2H
M6^V;_3U$5M5*2,T%;>K:YMZN456)5 <=A39G*%=/NF<JV)OA<WN[VW:&:[OI
M=[3!RU.Z=I\=Y8N^4H#=XQ;5*I0DW5DINNDN<9@W_@[_JGS\;V@%*^6S@]H%
MJD9WK[S"O^,Q%*W[EGX,?TM_5M^^5G2??M\/#8/XONLI@4LO.>3R0\55<6?1
M2WJ[O:27>4E'N8^62#]L@7-JZ;:]PK?XEH^;@%=4\&%S([@2;4KKVQ4.M'H@
MJ%WO5SF%HY("ZCPEWLV,_M6_"H.YZP&[S>T]1[BEK["(I$F(4B@F$/[]_@G^
MO?J(,D%(TBRDCKN#/>\%TUJP /R_G!NL."""C$;*T@X97QVZ+:1NZ #%78..
M?^>?\LA"M]"'5_1'W;*I'P+O5AYP_!?]%SY21_+X\'WP,!(QP%UUE%@VM6XK
MD4/*Y">0+*"*@W  ,@70X!$\ II=%5\)_,MP%PM@.CLP&LP!01;PY"F BN^#
M&<N^G[]CNJHB-/&EP,BLVB0FHN GU_L-Z?>9;]CDW_>/*DD06>TO28,R26)$
MZRA%\%<24N,2B9?#A;RI+4**TQC6R8@#P]R+-K0$GZ0]!;Y];^LSV,\;W7[2
M5\"ZGT_B>0#E,W8X[6OL@>6;G &UAZ(SZ[4GPZ'1[H^)WIZ89-;6QSU]2"9F
M?SC0]G &A$//C[,9,2A.A4N@(-H/?;GT7'#/4["6V),4P-*CFZ.W/K-)<W!C
MB.>#(4O!<07KD[LF4VC(NI];7@ZRU.$F0]/VB8'&Y@EB4I\X+]XY;M["8#B+
M_P(N<'R9Z\"C*;Q* =SAII\"T;KMC[#G"ER@6\^"3U,GCW-+>06X P)L.?"]
M*;'=I]> <T%(<U41W#Q9MKT%D1!U*" 6X [S9PK>G7L1ACW\GWXX_0]((F*A
M&P9^ $X6_2#%.TZ##?M%JK!?=/ME/AA&_4S8[54K\L;6EDF=/H37EC+SW 7U
M]:BIHT\GL;:8X"CD%*2EO+)>*^3'TH)]X8*(M[ <_"0Z"^B3(D5!#Y;TI;!5
M\@-B/<NGG_9)$-A4HO$Y\""D#GQQ1BS8=$LQ= =3'>@, B?@Q=X3?I,1E7D1
M:?=W2@P]].-%S@!_(=#"3RT(!*4ZMWH/Q#%6^$3XD<D</!'HY\$39YRHC\3'
M3U+VA\:<LZR%WX*%PDKI:I!LX-=8P1R>X"]+F0E>.;R%W17.V0L6A^ H5?IV
MM&U%O$YQBKT%WI:A7^!9WPG2UJ"[!A?)!G('6ZW0$NB2L4&CC ?TD;_CQKNC
M;[C%%]S,/NF6QP+\/W4[A%_\@2NU5[#1:^JKT3CKQOD _+^949_G&]$-1MH;
M#V?&SHE]7 >ZQ.V!2!B1J@W(I1;X-R]3,H.VAB8Q'G&3T1_">*M9OY0C2*0<
ME(<M*L=>O'5DU1/?O/(*G6@WX$[LZS6$0?E!<^_/()I3 OT'^R(@#97&*7A6
M'/@=I*)#&'^9<*1-1V>O$#<7L9\<I;/Q(<*S9<(+(_VD=(X4-&TP6<*I6/6\
M^#8H_D=4"Y\:)7Z* S3<!(X9@>OY4=#KAW: PX^9\WOF)%UW9*8NYD2 B,FV
M@<)(%2/E>E"1MP)0-- K9N)AI02$T9K2L<^MV&#ZQIR8H4TX^3PPY+".%OTI
M-EW48#%F;D>["&%OMG&R,"Z-8,K-6U2.6JB,"Q=Q HUY22X/3&3N C7J94VW
MNVG3=3?M([Z8?O@67N)N,HB^%WS#QU%+"#]\8?G3\@O%U]TN,_1BMRL 5VI%
M=,]?C^ 8\*?M6*QCS!T ZG#F,0\('6?.\2B[%BD:#=3Q;XK[B&P H58 <8E'
MTSO)'\H)G3M(7MD?IO_YDZV3D5K=A]:64YW6,S?TBHG=4:Y##ZM_E#9M*AV)
M^J1HR1C@,YHA&\"_<1=93O"TNL?9MB_NJ[EC>96%.DUK6B?%,C!/ZN]P3 ^_
M?;]:,N+S7V;.UC'UW^4F?2T#]P4W[;[D_BW82LHB9E)TK#*L$-!UL =.,(<?
M8)>6S^15QR(%2%"*S'G957.M[\\DN[61L4"F*3%>O.L-<V:#_H6F%<'909*R
M."A.1]N^R_P<7[G]^L_(/E-G!8A)7P4N7>*' \9^0O/\]9]^-K%-T!<#&6<I
M3/ &ICH#'F9NZ"\+'\@".P@<%X3I$!)T$3_))]XC^LZ<M0A( (/N@V.EL]RZ
M[[OHJQ.$,.0AZ; *%]U)@1:OV3L=8X_**IKKN!1)1=<NV.1RQ?_(7Y7^?(DZ
MT$?#^L%YN'%(/4K.LF; 6:;CFT%'S57J!%#<8N+6!D1,?&G!!1PFYNBQV,/"
M3,DJUHYLF WX1;Q AP"$Z@!/QL-GT/>,;GE,W$FJ =9B04S4(% )ZCSP.&D:
M!NO154G^G^HQNFK3N&Q,'<7 LIG]@85@!$26NA>7J*(-T!!>Q_*&;STX],\M
MS"+ (I%MZ!R:1 _F9>8K,^&+?8@Y1]1=HC$C"Q;1PB19D\A^\'@R;95@,9$E
M@EWXM.*B?$$A4:YUSW859O#@PV<?=J1; C@U03YQQT@;JINL)O2!&%3"E9[:
MP@*2ILQU\#U+2 VT_6F#+;5\MP\ASA]W'\KRKFI]I4(>FJ#2$_/*00>?H-K>
MN_BKFR0?]"]*5O@,B"\8W2C/0O,K]1@)>L4QT#IE+/*F\]VP4S!&"%&0-V:@
M'%.-8_[ZAK!(K:EVQ@TFIHZ.1HARJ_D&I8MZ,Z:^0I%$RXE)?;5+17&0LYT\
M(V$F#@CV=:!4Q]FXHL+!>NZ(6J;(;: B#F8,S1Q$T#Z+2 N>S0H.?&T:,TA9
MU< OI17OB>; >>B>6!S&[7C%!RI4<2'CJ,*M=@?J:$VXM<XD[PZ O;?\[^V9
M1[ I"0B!@EW9)\N-1*DL]YA3I=G4*S"-"V9'OL%*/\%"/_-U?CNB4E "%E*R
MG_6P.@7WD+QL*8^N#5NEKG@50A8G5>HB9&2'_XP7>1I29IW5@NO>7K($F0Y^
M$UH5^.?*PF1Q%9+6ES[91-(/?*$B$+0@G\]L8JZ&EWB./&^_;GI3-I(GYGEK
MHF5CEL7YSG/.7W3'^7\6>GO)U2*L'LRK4\JK^[MOKWD.;)Y$F)AH2QMO[L*F
ML88%+NR_'O8%8O6-^^#PT,B\?PM]GP!$]X#:RBTL8*$;)*03996__ZTW?JN\
MM]R &'/'M=T'K V:Y$>R(!]DA*^JA;[QS+5M]\E_DT*>?45/ZV9\@=N8<M^
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MG/X'/IU>NFTMHNJ#3:)H Q^/7XX>CA$B_!=+?C3;QXZ0%>0Z*.FP:0*>[(=
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M^]OE?J[NF158/$UQM-V66N/)ILH\/)1R.F.4=670?<F(I4]Y83Q]Q'IF>7[
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MG>7+-5K1**/X%F(O.@_%FX1I<@F#-=H/^EJX69C4G[Y<_H@Z@72'\:-RZ)P
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M=B!7^,!ZN8PK+N=R/YG(0#]PW >#+[96T.437]5S&6P$7<]"\SW%4B T]8(
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MC%I[2+Q\'3IVPG3)V?*,80:E2B"@D'L0+Y'8+U]1=)T\*<;!BE,R 4%!S-6
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MOV]T?(ZA$TF@<@TN^HT1PA+7U[A 0G4.KFSE#*^DYT7OP-6\RI6AI*87*&#
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M \C5V0F6W0EJ(WTE4,5OCAT%%X4&%:M#@@@<%-68B),*QX(XJ010$2<1)Y4
M'!2<U"=.*AH+XJ020!6_#TV<M N_''WNNIM=E,*Z=A]L!\9E)?HFG:17W:HA
M7;MUNFYT1*F7[D9WX0.@E!'>!.7!]KC)M&)+4=(2_!JV&$]4^+A2/@\KEBDK
MCE' A'S/F2(.O-9'K(8'"V*U*F!)K$:L1M9W(5:CU'3A6!"K50'+E+4\B=7.
MD-SN[4ANWUF:/1/7E-LF3D:>VT9<OA2Y\-^)B0"KU/%M.]*MU8(WYJE*.6:<
M4J[7JQVU8 6O\I>:<,! %$,40S@1Q901/*(8%#!0906B&,+IV/PL40Q&\"I/
M,52)]2I[+5&EO9+M\E7>$>& H4F5]O+LD_8W]TFC/9D/@9O+M5_:CO9+VWOW
M2^5\N/>/%\8S3-^?Z;87?G!]*[57ZS?[:#93R0ULVS?%@0#Q'RE^=6$@_LO%
M?X-S\%\KXK_6*?BO-6@2_V%3-93\1]E>4ORJPD!U='/QW_ <_)?RO&PJ_NO6
M.H,!\1\V52OWN=DK244?U12,3C;1CAC!0 MQ)('(:%<@\DTZN1M+_VAK"-+1
M$(YTNFCJ5I$S.'8Y3BQ8,O=;,<7'"@.Q8!X6[#7/QX*G3$JWNK5NOT4TB$WC
M4-(@9:5)\:L* V6E<]%@ZWPTF+F60[<_(J+#IE-4DA@A*,<VJ:.ZC7@H\1(5
MKHXJ>$107;HLXU%PE3K"H:J+J,%!4761.*EP+(B32@ 5<1)Q4@G 0<%)5 FX
M<"R(DTH %36I(TXJ 3BGJ3!QFEY\E%?=;/6F%UPLEU:RU[#A2/T#RH-ERA*(
M%'><80>ZO6L'NO 3R*/:J'NZ"\'4.;>4Y[&(K*_!P1-9EP=+(NOBR+IS4K(^
MZ4'I4:W?P7-0FM@:-UM30AZQAR>V+@^6U)JO.+;NGI2M3UMK9-@]7:U)(FLZ
M 5ZQG8H_N.ESY0:X:=I/W-)RER>A@W=X>)C:'1.6E &Y&,#90ZI$M^.E([Z)
M_' 49$%X=>.ZPKN=<NN'N+-N9J =5[M]04="RNMIB,'Q8$$,7@4LB<$+8_!$
M'X[3,CCB/0VB\/*Z&MK8P(,%47@5L*2-C<(H/-%*Y+04CG>C@QB\ZO<R=-L?
MFX*U&]4A<W4IH_ #(P0%XD,&V7DX!EXEXZJ_XH,Q7U8D'Y2E#JF.O/YYKO,4
M.SUFI0RO6"=*A(8'"R(T(C0B-"*TJP<'!:$E,]]$:&@\(1%:*0@M7]*;".T4
MI_D3#40O4Y6]W1JB/ZA//+SKH/YO'@?)P&]UXS';Q&/S?+DV+PE$G&A .Z3*
M&5:P"7.F]^1^:K?1[KTL$IAH,XH9RF*9QY_A?8Z8F$(#?9VJWS QF<"/+K,G
MS!.SN>UP9\%T WX+JJS!%\;">Q+"4E_0N.,LP#H85QM:ZEM<;G2YC%LZ,PT^
M-DS#,^!K,#PV,2QN:08WX:WP9$]]TUH?$)O[SMQVA=M@-]*@-V\7,,-EPI7:
M9+A3F,K35$BGI0G'XX;E+9AX-ESY=I=YMOPKC-*17V?P>L[42^%Y<G(P?$MX
MRS)+ZNWAV)\,^,)8P"C!I?PI] 8+_>1G?R8<0UOZPV9OD.AC^$V#@?FFN)]L
M[OZYLI'%2B0/TB8> +^WIJW]S'8B5X!GG$MV<GP1?!/47N@WWFI<WS7+^]YZ
M\>;6!A0M$:*S;]I<?>*=T,1L+)Q Y3NM&I.O53C)\T0U!CZ-\?G<L9_!97O"
M7,@O3FP)D<M^,:1FV+X+GW=_?17Y[%!P;TYE0?M,)K"NUJ9_V' /,0PC6<'0
M0@^E'%;HW__QH@DR%J8I/3CH[/+GD!O4S[$)O>*^9[\.V0$\L\GGKG@5_>,U
MBQ;FS;!54F)K[T(<UN\W!GE/ZJP%1AK\53BGB(PJNV:)UH^#-CX\0B&/;5/?
M&68,TZ!U4FA@)" (P*;_ L&:I--L]%+6!*T,; DF*3Q@OT0@CD/VZ4^15)IJ
M$.)$K(,9FB7KM#&P3JO3&)WH]&=E8)6K&2*B"CNX7&9RUGT;Q$B1O[MV6&72
MAOP=PL#[O,5J=MI0$(B7=__A73*S^0K?O1W%2.4% >MUJ13D4:G-.JPXM5/Q
M/$&% *J*=2+'"@,1"A$*X71N0BGU:3"LV%6>88JY 'R^%23^PJ:?A<?LN7"X
M.J-DVJX;G'6"+SYQ1W?QG8FM,O_/#%TW14$GRBOEFW8=!B\0 <7LU2;N[*>X
M$Z<6$V<5[R/O]Q&<W^VZ[SMP4G';@>Y414IZW7:MUQFD/>9-1H_"]Q+E$>65
M6ON)\C"BDIGR^LVS4=[6&INI*6_83%T>FXS^VM;@>'=Q\:_!OPI7<$>;JJLG
MNG@4ICV?P3"9!D9K>+G7X)2#+R0@H?Q@R6&@J"1'5-(Z&)7 /VZ5PXM%))%S
M/-=B?#"$P*1[LL"$C!_%6IRHKV0^E[0?!0Q$?3FHKWU6ZLN_*"?JPZEAM"]>
M/ :W?&YX05$,YD3K<\UV\Z_&:7N M@<(!@I)4(0DG2@DF5D_]60\LN;]HB D
M+'IVMDWQ;JW3']'^ #;5HBUQ?&(G[:\Z#,1Y;^KX4*F\<=#6\:4Q^&28PO7@
M TQ)B;:*BS<"2ID1#$34QRQ.N_L7ITN?%[B\<RU(6[5.^F;09.DH+)UXKFH.
MEK0?!0S$<SEXKG="GLN_"]RJ=;NG.YA-EHYL=4V;P/DQN-$TQQ<Z$^'>!Z7!
M"S<"RO01#!1U'!-U]/=''?"/Z'?AEJ_R@MR\T?_CNYZ\EW*N%7>[UA_T: L8
MFXK1%C ^L9/V5QT&XKX<W#<X,_?E7X6W:[W1Z;+-9/W(5N&TQYT? UFD@(%Y
MSWU'FW)7@ 7.9H:R1MH&*-P>*#E(,%!0<DQ0,MP?E$CW=V]]"9W?[=+WG6T5
MWJFU6J<K3D8VCV(93HQ7,E=+VH\"!F*\'(PW.@?C';'V[M:&W=,EGLGFD2V^
M:0O\B/K@ME7_KP]BGAA"ASG:VD]FSY6=A[OBM#%0N%E0:I!@H(CDB(AD<+AF
M:G)O  (3^;]<ON+&TM\*2TP,S_TVY8YX"X&+OOZ!6]L]VXI]4.L/^[1W@$T+
M:=\<G]A)^ZL. ]%C#GI,5;SSO/1X1.UQH,?353DC!X%L=4];ZZ>I<C;GGJHY
M?DR-,]IE*%EZN_(^"0<,%+3D"%K:J6N<R>CC;/?(A[5F;TB;"]CTB;;3\8F=
MM+_J,!#1Y2"Z],4\4Q#=$>7$:[T6$1TZ?:)=].(QN/>FPJ&=@,(UGQ)]! /%
M&L?$&MT<.P'*^YUK>=VIM4_8PX2,'L7RFBBO9+Z6M!\%#$1Y.2BO=Q[*.^JN
M>/]T"VTR>F0+;=K0/N*NN) 7Q$V#CPW3\!:4WB_<!BCG1S!0_'%,_'&@8)MR
M>1]#CV><KT%7J]9O4[-0=/I$^]CXQ$[:7W48B.AR$-V!ZFS9B&[K\GKM4/B0
MMJK1J0QM51>/P1V8E"-<+[K>#8OIF>&I2QJ4S2_<'BBQ1S!0D'%,D'&@VEKD
M_L(\_L>E\SO;LKI9&U'E5WR:11O8^,1.VE]U&(CR<E#>@7)K.2GOJ O9(ZI7
M@DZQ:/^Z> S>B;D#!G/4<IMR^B5+)E?>#^& @6*/[+''\'!AM;.>#F^W:Q
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M14?)"H< J\>MF"5@A8&(+P?Q92]]E8/XTI^A)N)#IU)$?(5#@-7C5LP2L,)
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MB*W0_[6V;91:C=K=0^DHJ4M!*N:0$@7!S]H*)%(N&1Y*#S.184(0_B27KSE
MZ!8+@GSK:K;OC$?#E=<-)_!!G@F$;9?V-Y?_JW2_]+[_ K(1BZ6 (S$&-"$D
M54_V&&[[@H:[KJXP\F#@>V65--O.IMF&FA:R 4C45I3@/0'%+N9"K;4BV8 +
MN[4M2Q*EYJLU9.#K<NA;!X&^K::R_O?4JM8:[5O';4\JY9!4[QA)'113BFDV
M6@<MZNO?_M(9OGX7+=8SVE#_]#:46OFO/,A;M]V)8<*[8K'**O>_?CU40)@=
MA,CKQR."7)),4"YDN"*_IA8E]F0]7E?[[6K)J(8@ERQ.D$X;^RXL/UTW%EW"
M6FPMF2&>02I6L!R >!\&(]_$0\LSU*:P6MS9?J ZFMPU<A;*1\%;N*_<4+!,
M,H(-V/"AT9:@!T.5SX2)KXZ.Z-$R)MSKETL1;9E&"44#'X<O1OE9*:BX=%0R
M2J[MC6"S4 HKE',M$'(0 <E'F^K[)G]R8^[U?]VUM29("QX#6CH,4\U[)!5_
MCWK-)&@)%RSE5A+,MFK9/.G4S'W,25F6%AS+4\/>=<A1[ND+)V%5R6%N&U<Q
M1M9J=D.I3IUH1G/^0]3'L';]65=)@U?<?.(+]P7[K1#I;PA_Z5V;O6;_NZY9
MWO=>?]B>]'NB/NR.>_5N7^O6>7/<K[=ZP[ZNZ:/V0/0R'A8\W=BW\$*S-TQL
MK'_S9S"$Q?WDBSI] U;YP7;^+4.0;ZN3(=&6\^^6/%4 O_Y3L>5;84'0[+EW
MP(W<M2V(_Q;P&-> ./ !)O(6[/9GMIUX 20YE]KM^&*KZ*)C?7%)#K&1R(TZ
M?[&J\J&\^7+=*IV-"-)!@4=5E."O25?YH'$H7TDK099![N1'YR^:FWN1\JP%
M_&=BRZR0RWY1^1IPO/!Y]]=7H;G)4YSRS*V*U8,SL/]X <M%39BF/.4*8UK^
M')Z?53_'4'@%WM%^'9Z@U>!]?.Z*5]$_7K/HS'<S[)20J&=QH7.^O7YC=(HR
M4G$'>\Q1W\K># @ :3=:1=8,7Q?IV#;UG2>OAVFP.2D0,!*8-B A6]D6?U^C
M PNQ?KHB49>RFL)Q^S^YV_5^^\FXPN\S7.*> @X8DN:SJVI2<>83$D]E3 /I
MK;. ;JJ-PI)8VAAXI=5L#+LI[@%6!C,9UZ.SFXKS"0H,VHU^/[.AE!L4<F6H
M,9/)"71F1*ZL> S(E9$KNR[,9'H5G1E5W)7E7N6?K9+ZUE7^)1%(ET/."\'Z
M;H^\F\_"_1YT%>UIF8\!A8J[)Q08C!2/9RF01,9!QE$1#()E",F<]+Y:&! I
M( 6&C*-X#(@42.^KB &1 E)@*FX<Q71 NWB*#TW)U[?+0\GVA,D3;NC2W@>R
M>^6K\(QT%^]"C@D-#']%AT!VSBZ?<62_[)GH(+;C%LN!2HJ)&YV=%_+"V(Q[
M_WAA/,/D_)EN>^'?EY<].R_>M/O#VJAYNK[G9.#E]K/;5J2E-FFD.%3-'(CO
M,**2G>\2#;ER\5VBIP?QW;6K$E(_2WR' X>JF0/Q'4945/7 -EE'\3B<)C.+
M^/!EOS'LX0;AGT[0MT46])1ETE6!7/X<=LJ1%73L"9L[!OQ:%<!!MYE!N5L<
M.)#W0@$#$7R>!6VB@>6N,D21G_RJRN # A\<>_9%NL<OJGP_?'99Y2AW@Z"-
M9?"?PK%U[D[7(I<3K7O)&93;&="Z%P<.9 XH8"!NS,&-W43[P?-SXYZ><L2-
MUZ9Q2)T!<2,.',@<4,! W)B'&Q.U;L_/C<V(&_%LGY)O0)811WQ6^5HRXF V
M^S+BZUU"T6TD44H<!P[DOE# 0*$-[7GCP0&EB=!B& <.9 XH8"#&(,; @P-*
M$R'&P($#F0,*&(@QB#'PX$#G:@L'X9OP/%/('JAT9+9P,)#NN9%C0@$#<??1
MW$TF4FX3H=4>#AS('%# 0(Q!C($'!Y0F0HR! P<R!Q0P$&,08^#! <<IPU@R
M\ (-V_$G#3_RN2OD\4+7XY[OJ7^:QLR G^3!PV([@ =9PWPXE=ROH=R2:NT'
M*Q)<Q5T?"JA&L=Z(1Z%5<DLK=(<QE5VM.T&RK8MSU'H;6.(H). 01UT_5,11
MQ%$E (<XBL ACBHI5,11Q%$E  ?'\<U]Z5G=]L>F8.W&"=.SR&%Y;^G']J\Z
M#2);\[ I 2FY5T.Y];?FYZ10M]+1/C0K&6#DKIQ^YAW<RR!9:C/-7F6G?9)V
M(P?KK%Y-O9Q=\=-.$JB4ZRB6!O:L\8FCBP:'.)HXFCCZ+!S=*5D+3.+H\M(
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MK(9E!-T.,/G LJ%Y>$$H$62<PG_.L>S?R+IRH*]?3ZHMJLCB$'M3^G?Q]R;
M(4<B."2U3D':6KK(=V-_AX;%R)K;I;]F$JD(*N/3'5XXXACW/MV=VP][)YN
M;7 0$:XHTEE1(%@%>/';$?@/CC,Q_I-3^(;++0.I=5 6GA!ZA2GI(#,,$8D
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M9+Z+J\V@J4;F/[5G;A@7_Q=)Z=!NXK>WT G8-+'#:-$?1*ZFOJH.S742KSM
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M8&^^P@':8-Z[&UZP8)/:]N5EUPC4T@59=93)5TFU[#LUL5C"A0[S<PP)N3G
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M0_.!,&0:1[ NP*I3T=H[[(&WWE-SPJ3=D*S8HK[F="$*6F,/GC"$61U.*?9
M S<HET.:0FY**\9?_7=+S8,L!]XJP&H22E\L):(\M2;>HPC1R<JL7S8>.]20
MI4LU_HMM2\[5<\1-SR+@?TK];3.-S=#VT?D)/4/JUBQ;?^YV*N+Z;\FZ6$N,
MP6U92(TJ/2MRV<)+G#"M^0YY;>'>?\6""/+[2A4+&KP^'7'8PJSNOI,OG/ST
M-59C>>@N+8;$B2L4^%N09?J(&&(UZ]:8#FH@1E?Z2#@[OXH,-<)KZ6\!"/E^
MRWPP;MSO^;&O,D[<6*K7-D\-R)2T>ZZHD;PC=&QDW\8 *GO+$$TW[-+[(&$T
M7P;HR6-/^?U7AP;6ZCR7T"/GOK_]C)<L$O4VKY[=%>3@R2.!:OXIXQ:6FG)"
M:%!F=*F@K^&CI:24'< Z!_$ W,*?\5.K>)J_6TI0Y>5L)99<_=%24BK71-G;
MYAL*:>W"$,I@N97LCIV:#,D6JI5UGC.^R56O#W50I5M]<#*&%FP):,N/Y.[7
M6<!7B[2R"5L&:'TQN;NZG[C5_< 4W%*EKI>2RF(TI*?@C1#6.)(,CGT-69T)
M#E7IN/(#<,=60YK$J5DJ)QNL42GIN0&L-?I@0GY3FN\+(PTHP(8D\@\(8J?"
M)!E2A;+RPF8":>F:=DM<J*W:8,$W?;64F"(R[C[>;/QM U5:,&O)@[ -!H@:
M*6N&L)8H*4N R#[8II"FT)82FPU7%$'+'S)K)I\&V%)2I]$*!PV4J;]92@B\
MCD&!NVJ@I?&SI>3\#@=\%R?OD&NOV9J^6DH,O/G?1"RX)0M\[Q)(25BK?-,.
M8REA%V3CH]O(JZQ^E5]M'7Q; =;L7DR.ES*"'I2]W$I48V*<-)6.$6?T2*QA
MF$FR"Y$_%#(.-WGSVB LG0?%%?!T _^_>@:K,]G1N9!\ECRWKR:OG[,/.$EF
M4D3K](+*EL.7@3Y\V2P"EE^.5;G1]'5 !%9%526Q^?N0IO6%3RAQTW,6J3YS
M:?IJZ72>;Q]1R"YG-Y7 I.K/E@Z_E,,AVRQ:TCQ402PEZS-^CCYBFIOAI051
M36:G)I:2+25C$$&KURR8KW!F,<1\GRA*L=<#Z;JV'!039LIZ]"9,:&]I*1,*
M;U9Z\2 RVD#=L)C%H91@9<+)?13.YR9W6&<$EK(D?PPS9WJ?F2&PI:2F'DPC
MAY(9K*6$?B!<3>\G%<=[^4=+A]Z^T11>S ;'DF$K2XF?B610F;]=N1^W@EA*
M5A:W=O6\X3L)1Z<F30MF*7FI$Z$HKZG:&2=\CX"8O32$]]IG3X7R[MK>EC.<
M44&[;.W,]Y!+'+H!V:0"*">!5 /)]+Y(M@:3M^Z^SUP02]5,RFEJ!AC2\52.
MP_S$/%':/@G=X$O2(^'6C[^])L]038-/7@_G0ZDEP>[2NCKEK8GPA'#;Z2+7
MU^1U'."%2 84?,50 JQB/N316SNUE97%IF0/_""<]-<:,:F#LG1M+XH*YTZF
MAN+N)I"6$@ER2(NDRO-43NMP(2*1B_!7XP;V3N#R2YOB@>\-W<319,%)*1/=
MH8$\53WLDC7R7V1;;C_\/ @T(A62>++[ 878F](\>G0&99"DM;G((S0)-=F'
M#H1\2/8-S'_F^]B#U*W1=KI88.$9%/FFF@(T.C2Q=.V81,F.!7&XP*PV>LU@
M+27T D$:R&L2_7O)K1._>MO<\-528OXSIGC^Q.8K;G@AZLV?^%=%'APMF*7D
M76)7#-" 1"-02\G\0KFA_!0082ZJIUPKB*5DY0?A/Q!<7T=A_LB;V\?U+*U&
MP*63HR4O L"@*-)II'8QO%K);(S[9*#BA8-(.%QZU3)=B(1WLGG2![9!<DI-
MC# \C/G3BL.:D[I1 +K8986/0;R1R:;!C.,HSF-M,#8JP14*4N^8T&1N8!)7
M')+]F,NQFA'4%/K%74H&UQ28$LA<6CHG5WRE[3"6+NS2LZTD,@<\\Y*W4YP9
MI,^3)Q1XB@NXW7%8RIA\[PI#YHJWOQ#&ILK(5V9&]W:6,N!JO?'9%M>7HDH!
M6!V8I>3=Y>D[Q,B_4"(R%2=KL.IC[79KM^:6LB-;D;&H)H-IF-QP%+&*'[8%
M2!K3)>9QEO@A,65D2^\CS(,;RG=':).V+TISO%R'O>Z<_7A^$N\"'RO_E3R*
M^9(<<:[@T17&U4EF"FZI=C6.?[XB00=RJ^"6DBNZJB4QJ_YJ\^#YT5LQ>.E7
MJP=?S[Y6_]UF JY9'"C&+_]L]?#YG%4-7_K9TN$W[.JI56MD 51@+26T9+4U
M&^U*PG=K:SDCU"3:/OCT%<4TN.>J^!6GZ5_A@B<Q1--<?L+CZ&_Y05H^JM'D
MSEM837<8I:6SI@&<5U;8ST/Y#]U+_]>1/=W.[6JA_LY7!I$VNT@9U@^NTAVF
M%9G$TJMFXN,[1+^F1OF*^5P3DN)L_"=0@TK,B0&\M9?4.XMRCH(ECNI9!'M$
M:"W3I*L<L&(4!GXEOMT8WM*E^8*!NSH-(VQ\ZUCUHW5I8RGA(J)N@0-1_ IR
M0(G$.15/L ;(1@?PKI,T,Y"6RP O8<VF0%!(7+%K5AES\&Z^)=9FJT)V6Q2*
MO SS%:(I-V[H3(Q6&!^PA>:A+U*^^+U9W]<P>K[/.FA:Y30KV)3F'M]RL8R:
M>9A?^>W0TMI=35.A]9NHR JV/$F26>?OJI:8N@2'D <7ABVE0C"!M7 ):AGX
M'' :$)C"[4"<%[U?;4&GXP?!HD,^H0TC')2+7\,Y[ KNUS<!J3[A,8>WU!B9
M+A9\<:DD[RG]9NG [^(PQ+Y_!S4C[ACR;FYJJ6Y:02PEBR_K/K=I6;Q<":VJ
MJIOZJZ7$B#'>X4VZCRF>SK1!O/@J:+"?71,*&X,8=KY=93MV;O2$E\5VWJ7%
MD':]6594YY;1)60_SZR58@?(GT-=XYP=G9OUS).#OC9JINGJ>4.2CDMI\HWA
M[?-KP=@CY=CO,,5/R)^3-4ZL>IE<XR8EBM,AOS[5V=7Z[WA%7#^9U>$=CL!C
MF[\S:861Z;*FR$/#D#<^<K5T94##(:R5($L)F6[$ZT*Z3$8YH32&ND-)),<-
MO4O6#'@MGEMQ'5I8>WX48R\60U7)Z580698V/3],3&P^S%3W5 9X_:NE9MZ4
M8F!MZGZMD*+\9BDA\R?62(CZFZ6$7.(%#OAV,T?/$WX&BL+T<1J\7,NR3J23
M7PK%[]+&%E/5J,)9A;!*_NY&!M3@ADPT_R/[+96B>#J _(GWKSBIQ=;("*.V
M0V;.+0O#PM]:V*6-'&EN,&0V2#,>;MJ,EH84<,ADE\[FI&5%K ,.F>SLS5 Z
MI47IRE+ZBRXMALR(6<"\V(W2:V7AMFY3_B;P8;) 4F>QS4T77_CR#H0J&- &
M; OY1L4K%PLH3_0(><+9&G/*(/L#O.ZG\/)$Z/0,0ZA>>@K*M6&7EM:>KDR(
M*4Y6X70QB9+4+K@+.YHP#)HMURS 9$E%C![SX7J:@W7A2@,":YF2DZ*XU51_
ML_ 64QIHZ=:R_KO5MY07C%)0,#>.8%>*HQ4+5*E]VH L/;E><*MRP0)*T"5Y
M)/#H>;K@PT]<.Y7D%7I(2XDL7'/\&'&!@F#+"1%//N_CAW]QH<U9W1KKV,B6
M[=C &OF,HT;B$K=EG1O=VKS>)5+7,WKR +8DWLSY\IDEUT*X[9QNUGY RJ%.
MDIJ0&7[ 2T+GK,R6+BUJ_N'!:<5>*F&Q/OQZ MP)W15>H[__/U!+ P04
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M5D%'J,-R =[N%/9*@]?1FKO ZM6$W2I-VPNX7DUR6KQ'_PJD#Z\F#)=^A:'
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MUG#F^UC3A!X/--#JQH&OGU@VD;N6Z!2"I]?U;?6[(WTI6H-[V+74(1<VW#'
MKJ7S=*W!VB!OUS)R0N"U[@/4GQ0QO*\M==RK;->2*VZQXV?-0C'KU%MM'UKZ
MIM1V5\/(@]D%]RF;WJBOJ24LLY(%EZ<3\,'C #W,*(FGLRO\A/X7.31,KBM1
MNF0WDY(R6)' L/>A-0?(?/RR:Z$X (89EP;PZ1IO$*#< T,^RC]U 5%*U@@J
MC5;.G! +;9;Z''40 #5I^96#Z>^.'PMMH7L;<A#05!1<(QY-XPP"A$U5UHA$
MZV#;#^#Z0XSTI2-6[^BWB">'#;)ZBZ_!.ZKI;$V 8'6>8 @ "T2HREF'(>P.
M5XMS/,D.@@-O\]V^<?! (L?7LDOLAX-A[Q859=1_I%IZ!/ETI>C"$4D7):GS
MQ'6B@5=Y6(#S*+&#BN:X4)#CVJ]MWS[724'X\+4ZIFJ0FU?K;;ND7IBMS6Z0
MX :E++\0S<'8<CZN98P::]9*GUAKZ#L$H4? ;\AJOBEE5O^8@:PAJ"P%>2.*
M'V.&ZA5*VL>Q1DR+Z-99,BP2P;GY$Z:KNW?)QLPE![=9L;Z(->ZB9%P0%I/V
M(4:9SO:M+9><A']:K'8]O&#(+3V[[P@)85-C-J7VRML\WN-R1R<Z//.)G:[Y
M1'?',]\GS^QU95"K"Q(_1I/8WV1'QD:+$7YSH6\N],V%]@6&V-I3]Z%;2 -F
M#>S9TW(D2!]P7MW1D\[L\1,=C!?A9%M_<B@9[0H'.)RE]\C3YVJSJ$4X:=1)
MSD"^*^'A#T)_KIX@41>IC9PID>Z<YV].A"AV_!XD:J%F2B#!GAO5[VW?OM?*
M0<2@MMK!<0/0MGJL/IGE1J#-)"H?G1KVX_G5[O*M;MGT+!>MP7CM=FZU;R'B
M>9R4YI??HX6_^RC1^>K#M+UT"^QO3-U7J)I&%K] U4%I6X((^LIV.MLWG%QR
M$OYIL=J/BH+1W[*T;@]9ZG25M&98Z]=PS]"FR_&D[I=2#JJ_ 0?CQ7H02:\1
M9,%2A&[PTV8_CI+J5Y]AYS>-,M0U6_T6EH0=6#>M[0DCZ,2Z*&W?<G/*2D2F
MQVI7UBL@C<O1.K>5/3B5/4RY>B?O?*-7GV3+%RGJ@W%(HOSKM5_IFZ$;;QM*
MG-9T4=)LB-E]U(C&R8O5V0N6$D*T49&J_[E+)G&5&<F?C1*H0VKXOO:T9=I!
M0![*)@IRU:GIMV^9723!>/(-^T":!&F7+/'6[=ST-,-\@6%#$Q4URNE+=.E-
MZGODPU!3V-!,L!#R D3UGP0S<\!&0V&8N"A6)R-W%MQ*279QLAJ5HF@EOZ.>
M/1XELDH["$EJ??I4ZJJ6B.UU\W-3@:+L#C*:E> 27"Y9(I2UVE#S,AS$S.BT
MFAC<?G)+1_D=$A*A";$ZQN<"@VN967WVPP]#MRVT^O:<T.+H\EI6=]010D(@
M)K&Z4XZ(N> ,0:WN("VD)$U;!JO;0@M9SOJ]GM5-F(4TH&W_K=S^V!H4NE(I
M*R2.)=^V-YP0/".4DF<P\>'JN*5ZRYL]#HK!,2P<O_BL5':PCZ$&DRI4$D;O
M+@C$9^VYP'N+Y2:JW].\5?M.(A1F9B3;G]PZE"VEXND8$>;YZ&D6ZH8$TP=$
MY[PMGNN_MWV+6"L'$07;ZKUE%P35Q6+;!>>2]5K=(BHW\6.EX$ZPO._/XDL-
M,T1K+R:(.7M3L+-J#AN6?-!UD/1X(C&5-4P" Q@TLUQ</<# 0FT\9$<8G.#/
M1*_8C/Z0A/X.B__A&?E/Z!L)HIE0P8KB0+J/H[*,3)JG04E7;,$RED82VEE_
MC*Z3S2/#\4?@Y-VJ\G2LF!"=Q(R*(]\0M9W.6ZC:2YS6#O).AZ@<*\7N]@?=
M #38._6^!]L4F\O^D-[\FM4'(5JQ6D5 5A^+Z(<HC8VM/BO1#E*Z<5(^33&<
M1X!][QRG?>%. X^]" "H() +E5L_;K1YS)]ZD4HJ]#KF8#(,_4@E4\F4><?J
M ]%YB, 2>]D(,4HZPR;*BI_XRR2EZ4O59?&/IE$0LS)PYG2D21N0@3M!(T_;
MA!1\V199RIHED$F=* ^A628-,FPS&I&5GO0P4U9NE<T!5K,7L*B4T#!.ZQL"
MBVH-S2*UOBNP: =N&*@DVK)R'VX.J+7X6GE#;N-F4[0Y:+^#[M9VLZ.YJ%ST
MUE?(IB>V3/) [+W>/)_<%[LUA'7P?_G".E_QGU6)TWR+Z =D_*M3\Q;"<ZT[
M.P_%-.-D7W<X+A>7B,L2]?"17-@[)T+Z,M-\(]H5*'3(I+E-PB)YZ3J[N+12
M7;DR8@YBF@LS&CB0Z?K006D[@O0@P1 .!+ND(_SS8*5;[@^'^I)Q.^JH^;91
M<00?_88#/(_GX\D$NP@^_#N:8==/_:V!\U!)'NSR0\)2:JZQ@]@;H0:U5SE7
M51Q =VDA)U<Z)1ZFL*+5]\*T!R2L>,V]./$AB2M8:2]*>B"B*M772X\Q$.%U
M"#N$&$Y8?M+'I%H=]IJ S.XC9>-(67RH;!HKBX^5C4-E[\&R2:A>Q=&RX.Y2
MSU&S+!.[O9/7_<ZEN62FV>CV1^!)GPTK#O 6U-MI]9MG]-5&](U+V[9\]@T)
MPRN );7*,4B4B4:"\ Q-2/+RU!-F[1*O"+T.@"AZ<%XDV\7W--I@/)NJ/+K;
MAK/QNGDL\05<@DX*/6JB,HKVONG"K%W 7\((NYH1*(89'@27+Q%UP([AP*'+
M:S"?28\G^"8H/[ VS1M#:H:(GXWMNQ(3*).>%,YJGSU\H%>VS;9(H$\_;Y<7
MWZ:/SFI",JV!<;.G:,Y0@ 1?FN@DI?O1EW3\^\B)V-;]!ICU^Q"HBZ 9L:X0
M+.=^!&HF9:JC5*HB*UV7EXB7HB'!*JK2HWA\=$W-7JH^?<Y>!T7-@OWN^'$:
M1N0/-.2, 2_)>VSG,R>8@I<53U6)TS8TBSU.W[;F+3-G/4C21<G()DE) D[6
MMQ<S-TM'^.=A!_8.7#ATKBRK#^@%@! WG[9W6N.SSG4]YSJ<J-6'[PJX\,5.
M5I^WJVA-1^!L=0\US@!ATP$U[Y"L?GU&&H^N+;#5;]+(:TECID/Y=1KSU2@+
M$J1M K^SI^ZK/E;ZFH@ T<%DXSC9EKETOD$K>P7O#CVA($9)<8K(#7]N>H;V
ME"L^DC>+9+:2ZQ2D[O9O$,M3[-DRO<%S'"7Z)(]T"\E^>*X<[&.!!UXY*)E6
M!_A+_K,,+W4%::39#_SGS@(FU&?-JQ77Y":E[<//;!S\F?K9P,O\5G@_<R@Z
M VWQRA]@7/<\51+C][2J2!B.@_PQO:(P4&%U-5+LA^--\)*WX!S_U/N_.%1D
MGHMX/W)47[146$\;A'I?\.RU6@@@9QDD_:S]3:);, /IZU%),^D)H<\.]<*<
M+]45WDK:>/RQ*H^#U5GA22TH:2%K6L3-S)B2:'7D3(OTE0*L2E)D%,PQ7@JK
M;BE:.-@3,1J"!%4-78EV8CO'DQ]@\!EP,A:NC9KI,RS!.)F/CFGUEWQ;J?I]
MTTR7$%/E?YW4]C-#O-+6Y%6KLV+UN94""O4+R\YV9T+&AXC92ZOOD/("(NCM
M=N*\JM:XMYF++(+9B>,H8>'K@E"I ZC!&8N&&+<-C+;-AM6G4 J8=.TSK3Z'
MZL9%(LF@?!)E(R(;*:(5"H##JT&!*[E7(+,+D2DG,LTYVP(."^NJU RK>HJ^
M ,_B*%;!^JYW<S[>A<!518>R$[D"D%T(9GEMS,:I:P&#A:54LC"TG),7>+RN
M('9C5;RB6+6I0*4 PXZ"J<O)!+D1?F+I#NGN[>U$!E,0U<"FWD3S:M!55HD-
M?8=<$KA@41/ADX54!+-"J7\Y^IJSZSQ,Y?7N/1\(]CZTU&$5#Q=9U>4?.)K-
MB._A8 H?XS[ 4AA!FT3@&W%VG7L\.8TBBA_CB/_=&94A!J#0WPFS5^ 4\*./
MLC"AGT(D':-K4X);1,$TLSIDUB*@U\E?)SV 23_-2^Q997D,LBTK'^Y[ECN'
MVPHD=?T<U"6OI[K]D%$" ]+S+%M]#"N'G[21L/J&H7Y=$_4;5I_P:E:]IN#$
MZA-@S9@UQ*A6GQOK7[5".QBKKS[JQW)S=ZQ\*MV8Q,E^P?[O$>SKW_X?4$L#
M!!0    ( '.!5U;K\8UBEW<  ,7K"  5    ;6YK9"TR,#(R,3(S,5]D968N
M>&UL[;W;<N0XLB#XOF;[#[DU+S.V4Y6ZY+6M>\9"MVR=469H)&75]%,912(4
M/,D@5+PH%?WU Y!!@A%!@G 0($ &QW9/5TJ"P]T)./SN?_^?KZO@S0N*8A^'
M__CE^+>C7]Z@T,6>'S[]XY<T_M6)7=__Y7_^C__W__G[__?KKV\NKJZ_O9FY
MB?^"+OS8#7"<1NB_WG_];V_^S]G=S9L;/_SQZ,3HS05VTQ4*DS>_OEDFR?/?
MWK[]^?/G;]["#V,<I G9+/[-Q:NW;W[]M0!]'B&'_N+-A9.@-]G_^]N;DZ.3
MTU^/3GX].7TX^ORWDW=_.SG^[?/G#T<?/KW[_X^._G9T5 'P>T[%F\K_^]N;
M][\=_7;\V\?WIY4_O'7<'\X3>G-]4?E#]^C=AP_>H[,X?CQY]\']^/C^Q/OT
M_N.1XWQVCUSG4Q53_+R._*=E\N:_NO\M0Y'0&X8H"-#ZS94?.J'K.\&;^X+2
M__[F.G1_>S,+@C=W=%G\Y@[%*'I!WF\;J 'AV]^"@GGDDX1Q]L]__%+AWNMC
M%/R&HZ>W)T='IV^+O_YE\^?TMUY2+JC^\?NW^2_+/]T#_?,T^]OCSY\_O\U^
M6_YI[-?](0%Z_/;_?+VY=Y=HY?Q*OFI"B*:XQ/[?XNR'-]C-/J< "6\:_X+^
MZ]?BSWZE/_KU^.37T^/?7F/O%\*X-V]RUCF1&^$ W:'%FPS]OR7K9_2/7V)_
M]1Q0K+*?+2.T:,2FX!'=Y#T%_U^<(/CES0;P][OK?<[Z8?+6\U=O-W_S-EOP
M5C-69$,4TF/^JX<63AHD,!QKEO>(,5XY?BB-\&:U=GRS?7Y=H=4CBH#(;B_5
MC>F2@(C<]!']6G()AF\M@"K6HBBOPA\>P>ODY/@DOYS_Y0&1OR*"_"83)KL8
M4=I63AC^\$//Q=%S]A84Z]]FN&T#J$,*!C1Q7G&(5^L<^GU"0-,'ZAS3%\GW
MR#^]\H?Q?#$GG,GD5]Q&Z1V!]Z<$O&UN5@DD5],/??K'E/BM/T>O"0H]Y!5
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M1]&+[Z)8_"2T -"'[CS:["7Z\9O7:D#RJ_-*$T3$/W?-(AUHY7DK0+2V%VE
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MWG^2*X*\;RB7^_-%(67()T41"MU-=OD5CC8BY9;H$D2/<9[$8RM*]I(SVDH
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M8H.%'C5"U'VO.J@]$TCOP!5YBJLMY;H3R(/:,X%T1 #\&>%!&3@!LH-Q.Y(
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M[SX4$P3L>^=EB;@Q'.D5)*\VUKO_+0XNJMMXJ'?S%QMNGXTA7+1PTB"IIUQ
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MX2JU!OWE,D[\%<T_K8A/D/.[&8 4/MF@A^\A$0T!33C[)PX\JB=G>6A S$1
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M-]Y TI!W]=5Y]5?I2MS=4K-(!UI$X,'1VEZD :T[)WP"E-'O+=&%$B1;KK)
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MJ\D!:8BT"N=5D+4%KE>2[GTJ$9^NTM"[S356>7KJ8"G(6YZG29PXH4= EY/
M\_(RRD"T8@(?F- L MB.JU.9@0ZG7-U>IIB!B"KE$5,B2BX$T]?!('LEK;;*
MYHX*;]5MS@N@"J[A-=6ZG&"G+(B>EFRZ DS.=X-O_F/9UY/^*W*HPDJ!YX=;
MXH-P8<CF[E=%"8%WOW0B<8P:UZOHB=_X#3J?93'0LEU)8^2FB?^"'B*'OET7
MSEHH4XF[7"[O/J5F]7PA@TCM6MTIRGBUPN%]@MT?MTXTCW+OU.].D"+(R02!
MFTJE5!)8N)NZZ0';4 YNAD$<)17$R;\8TN0??W[U0W^5KL2S?VL6Z4#+>95
M:WN1!K3NG/ )4!.PMT072J()Q#L+M#M[_!=RZ6X#<H1A=7MM$'07BSBT\CF3
M]32&G;U;1;(D/.U<!)IN@M+'V/=\)UI7D(%FG7. 3,-5IBI/R2K/J0+A9JI
MF"H0 /E!PZ@U4)8?-(#* C5=XL967,#1%P969="N/F&8NC>D\@. ,HS;-7=K
MZ@]4G?8=DXIE8IM.^N*>['K+$=>8K"P+UW!J.>>H-IGFN-8OP"BR-Q6QC:)M
M!PRCR'YQHK;1Z)A3*[<=ERR[T/YZ%MW9I)_L%442+!"*+##:[15:T"3+VJ@0
M(W04LHP;AV.TVF_C2&;."L5&&1]&(=OXP6S617@44JP]EX 1/ K1)9'C,?XN
MRH!\'L8,T[9_W\>AR,]B'##MR=/( 4[Z74G_ +P?*N@73KEDC!G/.PC/PF6]
MUT?Q0(JG3S/"#^)>;.7!,]I'H0J#2QM*^L<V*T:ZCH4-(!B5&."6+C&:1U%"
M6OQI6]%92?9[Z\LI:XO[-1132NYC7RDEE!#-2<&!$\?SQ1].%#E$VD1WM"_4
MY2L1Q'Z,-C;+YI?QYK<Q*/-?<@/=N=!U6!7NMZR!%OD>*#YW@@!Y9^M+QUUN
M_VUG%L VDVMH2QZ8&^R$,^^%2I>JQIVKF!>1\]/#/X4RL: 0C65^7X=NA)R8
M/"#Y_\HG$?&AJIB;DD>MSIUX>8[):^^(Y46+0I+",&O@0;^S'V92Z JA6*(B
MI V,%&XW-:-W2JMI8S6 "N5DH"KX[AN@A0BX_"MU@JR%1+"F?T3D /VU>#6)
M)/0#GJISYL1^?/],KK(W#ZMM%3M4M?%@&I.&EXL%<FF<174I3"U@!2>JHAK?
M1D4?H5LBT8)D+7G(^"![_315Q9_HAMTJ86J!Z2YAR+D74[OTD>AQ"5%I4S]>
MYC[>6$QH 8!I;T?_7.) ;?),P2'O05P\"!!R!("I4QJ^A_0F$OTY01Y]]F>A
M=[\DIX%N>DVLZ#CI\H9 -Y$KVLW3D++ /E$@*S90 ?G&7XE] AB\?FO>(O17
MBD)W/5_DCG_?[=QK@@=SY!6)0G?D<F/ %P_6/ R$402!4X#KQI::O1!CGVH,
M'?"L!Z6[1J9&?;Y#U%M&I'GI]CAWGLGOQ)YP6<B2-?K59H59YVSP R (J,=6
M4K*4B,,RV@WE@>PB,8H* -0H>?-0.7$5D&:_W$^L_+LQD$9)ZSJGL G>"(GZ
M\\0P6=U&,]9#FR;539/J^IE4-\WW'/U\SZ:03D04_"4"ZC^-2SOA 'G)&Q9V
MV1^D)#4L[/4-FF893WT/IKX'4]\#\8+QNDLTL*X''"D"&_8S@*X'K>(>-SY$
MUO0\T$!FY;UGQ>Y#2V$4(+.J6#%"#9?X]#I$[W@0(DG)$#W3W1IZ':)GNOJB
MQRFO[TS7S_<SY?6]_?)7SY37]R.3QR*.2=8<PA[YO#T!A$<ZUW4KS GF=V;<
M,%U4)*% JV1&E17VOV:@,(4P)^ITTP]#4\%5,:/.'OEH_T.AZ634JO,?1U6Q
MWQ[E9Y79HZB_$DS48&7'IA],I9_[!IA/P]A@6BG657U=GS#%2D]-:PBZZ&Y.
M:&,%EZ.@723?D!5;CIAD7L9HR0#C&K'"!CRBN< E\1_'0WRW7.Z2(^-H. ;(
MSB\I_SPJR@7*+ K*3XY&1;E O4Q)^6@?>W[Y4TG_F!_\UL*UD@OO1Z'JUO\I
MKT"Q9(!Q'V&/@^E//HZU_9QP#3!CQ7@,_#H[EU/07;+@TRCZ[PF5WQ<TGXZV
M 6-M1X22[#%W4N.WK6 L&,^%![0E*<D_'=4)4-!BAG%F:,$@.&?:^P^5W!"?
MB6"L Q=9^R7"Z?,MX9$?QSA:9_-TM'3ADM_+PDY<$L3()*Q7^MG33F_(>\!$
M"RG$]#9_N,.+^6 TYRH7&VV:U.7]^=I1YR[O(;V:=1O>-!>D7N^RZ2CM0![G
MW 1W?H% -DUH_@RJ);&$V6N2_$ &TAL:_=X'LXNNW4J970"5;JBP::Q^AUS\
M%%)?UW7(Y/BMXY-_GSO/?N($PM\ "E;SI_E"M*+X!L<QBN?AMA<W]^Q"/HD
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MWR=KTM/U#49J4B18\NTH?*F0R('YY'SC(<.CXU%YCP&Q@R/Q:5#&.J+Z ?F
M.$1Y.U<MC5#!6]CG;@#0(&,TE>!O?.>1-F'W4?P-AVX:18(-N(3 Z*X2SS-B
M*IO/0F^>+%%4^1%$'Q8$*&6G[GS1 N#Z7);G37!DK>@L.HNC!OB"G 0 4\E%
MVC\[IS^OZY$^R()@I7 _<R)ZM;\$^-$)=G8$.BE$0 $N7XS<WY[PRUL/^?F]
M(__!KAOYQY^78;(_J)R#Y?X:I>C<H"<GR.&+.A=JETU>A<FK,'D5!+P*M;=G
M(.X$GL# =:)J"'Z#1J&, 4_$R%P$4D_YR'P%  6,E2^.(I%:3#NVIT)9J9-
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M"Y8)8BY?B1GHDZ>7/L;E+^/-;V.0D)#<P*[781=!C6_#_E:F7X:JW%/[/NQ
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M1HBNV:P7\CSWC9&M$FF'DDJ3TQ[$4O/FNF=([X_%DTHBZ:FTCS_N3R2^4@]
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MZ:'&F&E:W1R<J*UMV<?X^>F0^:F^863)V,^FH^V#.ZB*.IT67^!$I+!@5%]
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MP1H 2 FSHMSS=[3T77(8,_DC++<:5JO#Y X]!XZ+A)XC$2@J,4OH=-&NB&V
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MH6?$H;TOZM=K1IHV><NJ>N&]4O:6RLE))PH><833IV7V@@#/9=-RS6P[2_V
MMAF$<VUWI133[E)R5H+@CAB:RSOL>-?7-S?G0,YQ8<A%:!8+WX5^P.U%FC_;
MQ@LHT1AH=Z5^Q8;H5<F:UD\FY+TL[]H#P56BQ[H(.%,DG:TI%N!^["+@)"42
M,:"B3)K,GB*4A9+^\)/E)<TX>XY\"1DE"E#W"U7)5R8L^X9#A_VD8M)+W \P
M:,VDTC,P7U2P@IZO!@!R2I\3D[,*%]%[ZW04TY2NP?)LGE/]EIQ,AUPOV$P'
M($ -Y.QN!2D3JE][.*5>EA;&'50%FI W(2[M/^A+U )&=VO&"'E^<N6XV:9P
M-:9^?:](0Y^1NM52)^ "H6CAH\#[ZH3.TT:L9LUX;YZ!IT $%("I,7)_>\(O
M;SWDY_PD_\'82/[Q)U%T0-][?XU2=&[0DQ/D\$4_9^TR20=08]ZD<.&G("#5
M^-U BC !P'JML803B849/O*R2-CYQ0VW9B %CSQ!@>M$U!#J'AN%,08\#=:4
M0ZH_L+Q7VY[:,J&VGARUI9'0O:-\;&_!JY!.B07U7E:88K@>5OV1;BHW/S%=
MPZ>ZW/S4WE)FR>+L4WL;B4H6T)\:[@VJYWK5^XTD!O:8NFE<IQD&N_48Y?8^
M'W*N3]SDF"U)?C>Z!Z3%(5Y2_M[J8RX6%\ = AJ,$?:>^JZ!( R.:)5<^3#:
MBR$4B2SY\-%JJU<F6"O"BFJ<F;'"7D-9)@Z/F[,%&,GVRP8@R35)'"6UG^W]
MP*V>$&YZ3$'AL6D7B+XCO)NG5)+\SGZ2NS]O]4EE)0_>VWNP.W[VO:2^DN8/
MH[/=^(F7C/!!*+;<[%,.L;NO\O&' =QO?HIP<8TK.<LE=1_M]1)UB4S5)(8S
MDDUKG#V1W)2GSQAAVN6IF!' "HN2#Y_L;2@F?R :ZV48V:;EN*;/SR]>*LG_
M;*\WN1/Y(F5HC DC%0&ME84%!TZ.A <N#9H#3<6BC \C$X+R9<&,)2-3%'B%
MWXSHD;X*(N7ZC DC%8M['1=*BH]'*@;%>F0P-HQ,"K:V/&&4CU38-;2?873;
M:]ZKI[O:-ZCDP,E(%6%^!RA&OKV^2_DK#^[J5;+C=&1R -B;C?%A9'(!WE:O
M9(7I' XMK. W0F2TCTP=%NE.R8@?F1K,:Q9:$OU^I)IP0[M61O?(5-^";GZ3
M74;^R-Z]^L^^URF9T3\R02=$/Z0U-N/4R*1B/:?J;"73.6M:W@-(TWO&B9&=
M@?89!27I'T?Z/HJ,CRB9\,EP\H<^)NQ[A,6SUF2'T^R5H6<T(N2MWC(I?!FF
M*Y2?3"J02_3!9>T4>,PJH.DVOVQ]$)7#9.1(,S);0ZX_M0 PW5T\65"?[3I[
MC.$-//F >F\T*='UG .DOZ]PKN03[$'1W4R9)HAD6F$L>1/J ?2'MB2R_32"
MC&6.P^Y*&_+L]@G!#6QE%H.]OD0ITNK"",:KWP6(%)!1W#2RO>#!$ K"Q9['
M=CNP]J.?"--OS>!"-L3\*DW(GVYJ<_.2#?+'5;_@)HP2JYYKV!T']9JJ38PV
MHO\JT'J-=*PO=_\>>N2[9!6[WN6K2_Y4O-EWQPU,DEV>'=CT%'&8EA W6R0H
MHLZ8*_]%"Z4[&UA"MDZ*[206IY$V8C/8%A'[0/;4]FDWP&TB]R?61BP%;0FI
MWXBF\? 3!2\H<R*#+%/Y/3HT:6?JB%2[]OWE4S_TT?9#GSI6'D+'2H&@QP%T
MK)3KZ6$\F=R>GA[']B;7=F]PL?_L,;I'&R"5U4[LZ7]FF#6ELLHX,K)LB@ZV
M"FN<9EJ&6L"3W%IE+!EIAB+<6\%8,M*L14F7%>/+@<O8*BL.4;@V>ZI96\*1
M2I/6-,XC\53G?H-VEZOG *\1.D,AV3"A^F@\\SP_Q^DZ7.!HE9?JR(3C)*';
M$FB#HJ_767-!:4=>!9FLN83_F%(4XK/U!EV0(QL 5+,O:H-)=7N*3K%__-5)
MW"6Y8M4_R!.'?T<QO7NWQ XG-]=Y OFVE6YKED5UJ&ZP4\@1[B[6,F"^R'[9
M#Q_*S:1\B<1.H]K5/8I>X*-,ZQ?+>>E#)(]'_6(-8]#N"<,=\JA^#^-GY/H+
M'WFP68$< (-"]\\3/0@7Y3K%QI"1<PV+IW&&?+2F<8:B"/4RGWQ?1RJ;V]WB
M.(FR N;,B5WY"Z9%BD>H%&]H(ULRU!Z(KGY&\/FQ;U3IXD[COKV&T;2R#BL_
M0".?):?G?G/F'1EO;J9ZWI'%8^8DYQU9G%$O.>_HV/:A%UJO88,&RKACVB/)
MKB1:.&F0[']SO@:.!<P">R+CK0*H&['#"(:+V8&8:TDS.NT6P>)TUGLNAE3U
MTY-6U\4AQ8J(3,N](;/3IA&6UO,1YD%G^2FF=65K&"L2FY$(PO<;9[P.R9^A
M!^<5*0POPH#:$E44Q%JO\^9[&"$7/X7^OY%'4-F<L;C$[98\V\%FC,,UG:A'
MKFK9DD?<5]-I&ZFH!;DT*(JRW?+":?(?^7SF<R>*UH3+/YW(B^]03)0-=YFU
MWA%/'Y>$+D5) 82PY@*]H !G":+Y;O$9>O*S)CD@]"$@^^#^-YSH_0"5#:3H
M^882EMN!X[BZ2?Z&W?@K/\GNK3 -,*!RL;LF^/%]^OB?R$T>L 3B0*BZNW T
M8L.0B.?A=YC$@D#5[V#?/NO-N)%S7GX"UDT,Z%7ONID][,B\"$3(W1"2 TU<
MV-G#'N*)?4WU:E<3W0R\9I+IG(#L9,V" /^D;<5WL3Q?4G?H=0@ON8?#[OO[
M[F/8Z7O6@=-,4J;/$?7NCF@:88HVCIWKNWOQP+,P*.VD;/3569HL,[NJ9C"[
M$!T\.",@0C8)I3,9T%)5'A2Y"E G\(F(#'WGPG_QJ8][OB#@\ZZ>L-PI$5"2
M5:IA2%YMWTV3*N50]/A0-'_^;^CG?Z H1NLN; 8 TTS.EA;Q'VGDQY[ORA'3
M"JKWBZE"MA@3CNJ0-R(4NPO$#L*PXN*"E>?O+^RZ_[Z'%8##C:$\H78B<"/#
M1IZTPS]?N/U VYB-4Q?Z%[S:7(IK4@".3,?%A?H$="=Z&%E*PL\/!KSS0TAF
MDB%<0%NS)NM)$>DB"K<]V3TJ:1:P@:S)]='Y:#&SE)%KNM!:]N':,]1;*:_+
M83,MS24?,%GBAY4#)>1DP@#/'LNTL5>B"ZGK(-<LH]KT75=$-=SASC*!+._*
M(OWA16(LC NFQ5[_7-B)L#%6V"L&=;&B*>3*\KY&(ATAX??!=)X1\N0 DRL&
MTVM&B'A82@SKJC+PIZ%C2A/C@VFGC@H^0)+3&.4#?PNZ9!663/@P$MV@4[9H
MR8V/G5LM;7Y._\^C$Z/_\7\!4$L#!!0    ( '.!5U;RM6W^"/\  %EV#P 5
M    ;6YK9"TR,#(R,3(S,5]L86(N>&ULY+U[<^0VDB_Z_XTXWP'7>V+#CM-R
M/SR/M6=W3U3KX:E8M:J.)-MGUW%C@B)1$M<LHH9DJ5OSZ2\  B3(X@-/$I3/
M8ZR6JC*3^?ME(@$"B7_]WU_V"7B&61ZC]-^^>O_MNZ\ 3$,4Q>GCOWUUS,^"
M/(SCKT!>!&D4)"B%__;5"\R_^M___C_^GW_]?\_.P,75^@:LPB)^AA=Q'B8H
M/V;PZ[M/WX#_^_'V&ES'Z6\/00[!!0J/>Y@6X P\%<7AA[=O/W_^_&VTB],<
M)<<":\^_#='^+3@[XZ+/,QB0/X"+H(" _I\?P(=W'[X[>_?A[,-W]^^^_^'#
M'W[X\/[;[[__\[L__<L?_]>[=S^\>R<(^+E\+"#\GQ_ '[]]]^W[;__\Q^^$
M#VZ#\+?@$8+UA?#!\-T?_O2GZ"'8O7_X\(<_A7]^^..'Z%_^^.=W0?!]^"X,
M_D6T%!U>LOCQJ0!?A]]0$_'SIBE,$O@"KN(T2,,X2, =?](W8)V&WX)5DH!;
M\K4<W,(<9L\P^I9)3;#??DBX\S!&:4[_^6]?"=[[\I EWZ+L\>V'=^^^>\L_
M_17[^)>3SW_^CG[Z_????_^6_K7Z:!YW?1"+??_V_WZZO@N?X#XXPU!A%H1$
M01[_D--?7J.08B1A%^C]!/G7&?_8&?G5V?L/9]^]__9+'GV%O0% Z8\,)? 6
M[@#Y[T^WZUZ=W[\EGWB;PD=,G.@Z>( )MIF*>,K@KOM[298UOD;L^)[8\?Y/
MQ(Y_ZI)6O!QP/.3Q_I!@K[PU-O4&%G:M;0NT;? 69C&*+E/+3NX6Z\;XNR+(
M+'N]3[#M![C'^0W:-?U4I'6C41$DEHT^$6G1: UN%*=VFA)A%^0/5 T>DA^#
MX%"J2HC0M\&7.+^ N^"8%*=FYOC+U,83"7B8^O 6)D5.?D/$Y6?D5]3@#I']
M-E,KR$#//DED#8P'I>7EZ"-(AE\*F$:0)?Q*-@K['RF'X;>/Z/EM!./R:? /
M]3/@?_SM,BWBXN4<UQU9D*RQ^"__ 5^:>A,R@J&,_Y(^S+]]-?#EMTT#R>?)
M,(I_(B433,]^NI,5]K?DH<6)#.;HF-$Q5MJ711VS_UZJ 4P/H(H UO2O;VN#
M3NU?96'#BB +N0'XQQ$;V"?>A@C7!H?B+!&9OLO0?M";3"T:]=+;05[LT]\B
M"OW[#V7=\$_D-W\[#_*GR[\?X^<@P3+S51JMTV>8%Z02S65X("-%G1#C4NTP
M(V)%-RW1OOIWHA' 6B7 -3V(:Z7?SLL2!<20O ^U>//+$\F'6&B&)S5%%C_0
MNOT*0J)BBZT]%-O@A4QXT%&%2<IR-;FEJ,<)VVH;0"08 7;8"LJ\ [4#'((7
M\H'2$A\HJ L^,G&^%DW9K/$*9;>P.&:I/!$[OJE)M1-)3LC$M( =RD!6ZO&!
M*OT H&'W:,%=KB3 :XBGR==Q\! G>+#D/,+3CN"%YKV+([S!U=3]9Y@\PT\H
M+9[D>6&B0I- ^BJ=,(V9 Q)B#TBX056*@A')6-0D$!TA2+%1H*!6@3TURP=B
M6J *LH2/8ZK_)PRR^\_( <,KR<Z)S31YP><7; OF,UH6B]LL4"=O X,I.(ME
M05>L+65/PUNBRR/F$G,6R-T&&S396R,Q 7^O,+R.Z%N*GH2]1)4_Y-UAK<OC
M;H,)>M2M89B"N?&SJ\1;BIZ&N5B51\S%UBR0N2(3-)E;P>"8N:M= 3.']&W)
M=\[AACXOB!P0BY9*YVYZJ'.Z Q87Q+[\$L(\7^W)OVR1N2G3#8%%'7.1%E(;
M0$"-6 !+.[&69.:IOUVP\0(^%.L\/Y+/G*-<84%?7; ;7IXHFHN<$38$Q,P2
M$!)3%D#1?@)(\K3'_R[(:HN;KJ@X$_,6P#)54LEP2'%#Q#EZAMGJ(2^R()0:
M>#N^I+<!HB'$#D=*&/Z=2@:_<MG_W_Q[';J]C'H=815BOM/V'C^>+,+-[^@!
M+,JPO[&EVC],Q,^/<*>349\C?'%HHN1+,QJNL(:(:+E*@D=9'K:^I.>WAA#[
M3*S$ R)_?BIV.QKU^L(;IR9J_K23%:NMQ>10@6IZ;'W9+*P;PNQX% \L#^@T
M99:: %9%CU+,3]EA,-"HG[QS?#NQ2GO<#JFO<,D8).5">GB4FKT.?MW,ORUQ
M#FN!4A,@J@#5Y0^U^R!!$K[RT/UM@BMXWB;%R[@R('E#@ T_"P*=YG#F<)98
MO"1[%SB==#_QF9= ]%!>#@$STM]G 3F >?>R?T")+-%;7]+S:4.(_<S-Q(-2
M_OP$[G8TZO6%-TY-U/QIXQ3-+7PDVYF#M+@)]M*E<_=W3<[0-&6Y2+KL$$VM
M"!!-\[-U$ <TYB/??)[H.WO>\U9-PQ6.6ADNW1ZSK%'>*4YB^[^ON:#;(\_^
MJ,$T-8I.?R:SH[@@&7_YB$%BXGX;0\XO,$G^(T6?TSL8Y"B%$7G%!J6V'4H(
M,4F(/4*='>@D^LY^(PH!UPA*E?,'@!Q62-I]WN*2G$ "_D,-$BNGF<MPO(4'
ME!6DK"R"0GXZ/"S#Z&QSITQW1YQ95JKT@5*A+_$P A.2=9VOD"2&:-@(A9]1
M<DR+('NYBA/,$+48./FRB:=;PIRQOM(#2D6^L+T/"33J).^\GF@ZW :AJ8YS
M7%<]HDRQ3T7KJR9N;8AR1F6J!7 UOA"Y&P$TXA[/O)UH.=H&@>_V09)\/.9Q
M"G/%?-SZJHE+&Z*<$9AJ 5R-+P3N1@"-N,<S;R=:CK9!X,L]S!YQ_?)CACX7
M3^=H?PA2Q4S<(\+$Q9TBG1&;:P.E.L#T^<+P88B0I-\\A2,Q0\)*#G_",ULM
MYC>_:913!$GN$CA1XAN[.[V/AGWCEZ<3'2?;JIYOCOL'U15"\7NFE5PIQVG1
M#$H=OA"VP^LGY;+H%9\\?%HHCSK7!E'O@R_K".(?=W'9/E>'M;U"3!S<(]09
MG[$^T%3H&;O'H$+2WO,6EL04$1LAL8JBC)ST*_]SC2O]]VKAT"G Q.<= IV%
M 5/RAO] ^J9#L$D]>+TY#@^2\IJ74"1=*#1 >#\U[3^8TOZ#;5]_F)CV]Y^1
MO[3_($O[#RYH;PF*<=I_F(3VY_C'37://J=:I!>_;L'/M3CWA">Z ,H T>89
MV3M Z:)ZVUL> M!-<^KZS9CK+;*<O F%FVR;H><X#:7W:PW+L.#NEDSWI*<*
M">NY2L^8WP=4%_T[G><K*-V!4,*QD8'#8C1L45X$R7_%AW,4Z<5"2X(%IS<D
MNH^#4AW ^@!1Z%D4= /4%0,=;O,3C&[^2\-@N&^7/%H& Q6^-[^CN3=4D.%@
M3R[U)!;O"84[O8SZ/.&+1Q,U9YH1D=S5E6R?4*JX2'[Z/3WWM>78)R75 *@*
M;Y81>[V.AKSBDX<3=>=:V>>*]GN4WA4H_.WN*<"&;XX%O88P3J7[2<A(,MI@
M.2#9X<FD4BV@>G%9334#0?7\K%> $*DYU&^XDEZ<E&"R$3_;XT,2AU<)"J0;
M/75\T<3=@B!G176I U EOM"^R_-HT#%>>3G1<+"=0_ZK-#T&2;F'7):SW=\U
M.U$NRG+8OJ)4P_;,ST_>0130F(=\\WBBYVQ+O=>R(,UC\O)4C\RGWS=L(=:2
MY[(_6Z7*.V+WHM)NW-;I+1\1:)-<P?DV2HQU&J(,JZ';!.ARXCGI7)F]J*_M
MC8@R&2 '13LK3!I:A;5OIMN391,5')&B4SW'+.F'BZ$E!Y59(-W!\)AA ]Y_
M>+B/BT0Z:DZ_I^?NMAP'/5^(6(!VX/V'KQ^^ 5SA_-SO=3T:<HU/;F84%H0#
M*MTU62^_A$_X<:%*(YCN[YIY4Y1EG[A<"^!J/&D#,X@"&O.0;QY/])QMIWS!
M< =A$3_#BZ (V!EFU;JE6X;9X-<ETV&E4JDC/3T"?IA[?J9+P81D7><K).U"
M1!4-LU!8A[ML=8QB3/)54<"\[+BOTK1Y2(*>S_LEV@^"]?G5+6#*@*#-D^[.
M$O @.:?Y"04C/U&C@8)AB_)2WU6<[==2UVIT?$FSF[8HQ$&+<N9((A^L+^9G
M<;>G4:\SO/%JTN70R#$A5<KJQE>,W.:FB.:>\Z-T[G(PZO&")\Y,5/QHA7[D
M13^]=4>-@O77C#S'Q;BC(M?@#1U/'(X&/.*1<Q-5OP[1<Q?D#U3^,3][#()#
MR5&8%#G_34U6]HN_T64ZLO"]V957*<5!LD7E KC*)4=J\M014)%O=U;-%8+-
M#E0J =?IS:5)6H B'<<J7+6DP\@M%@/Q?"VB>SZV0;;)J&W1ST%RA%N8T5T@
M*IR4E:C/2CD-]O/Q3VD$\_@Q#>A-K-P(D)>[F@Y!!IZ) 7XP4Q%8I.?>98#(
MDDNEDFUPPDK):8)2+:!Z2;?\<N/3=(-"TQ/EKJO5L7A"6?P/N=L392790JLM
M>>I0R\N=:4%E@(\AUPMD;ZAUN]5OT'I"B^T=7$D@-$4XT3:WQJ'$I=A%I)0Z
M4PC%5+F_X=,";B1T1%?Z"])PR*Q'$)DB7!0WKDN+LHN)];W0RM&#?-G!K@KF
M2!Q9V,,^*7##$66\@5TGK(2=^S8F55+B]%&2$._@1%YYV,#/Z9,*?DC#D0O
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M9UR?D2)4ZF[<X>\;'$/ID.>@?0;1<H9_LP=QK<>/L!E$!,EXRD?O)X+C =$
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M^::Z.F57&L,NK Q?0$',2>AF+3_B20-JI._L!<#:NJ., <CU D$QH&>5B6K
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M'<PW&$#BZ6.</Y4;?(@#7#X>;.@C@1MAC6_(BK^5AZ/\J,=FJ\7 ,\P>4)V
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M\P+M8:;4-4U;M$T2#*IRL;&>36 R^ S3L7N^YXMW.7 'PUO"LPL#<BAXN7I
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MN[O.Z.8=_Y\E:3T&KC^H(O(#5@56$IO4_-A)U:@]3[91-791+>%Q$N%)FF"
M3U*/8O^8ZR$N@N3RRP&FF"Q'_%#KE!;CT<=C@<N@_X1TY4IE")*7:7),3TZ'
M@S4<E)[1:3\>'4C*HQW?R"+G(4./&1FD2(&%_W' Q>0+_0?\^S$>N0MXRC%+
M&7.DZ_>EX,O"DBD%HE; U0*LE\P+P'_"<KW5/-]XL"=0ZKZ+8QK!S/'-,1[X
M@K.@:S9 5G-*:P;]('-IB[Q'7&^[:]R@.[CG;@E/DYP\2'TGHE58?-B4)G=/
MC=:VM-?BHKYPQJF<M&\5#"H7<@&S"7"CRC/O-ATSQQZO/J;T;O B+7M9N[[6
M7J]E.B!I/3L&FRL_N83/^@-/M)VJM43?6&</BC,,Z1F[34_N7F6/'BTY>2IV
M88 0UN.7"P_-FW(8?ON(GM]&,"ZG3/B'>J:$__&W"[9;C=2@*#N@C##FX\LM
MQ&HAJ53@E^(CUO&;S#1)4:!Z#:VDP#[_*M5 U$T:*%;:YYT'Z2&*M!R["/22
M0> ^"L"!7XEJ0'5/N&]J%8;H2,NZ+4KB,(9:NTN&I.C/5/NEVEW+J]0 KD=Z
M:\%4"PL2,"%YQSG>$;O)'H,T_@==;\-SAAS;$)4;$M-H2VICMCEYLV,[.H+D
M#O^&;BK,25^A!.7'#.)/W\6/*5VZ2XO39U(:&N:S39__4]OJ8,"">9C%!SY%
M^GC,X_%7%E/%U&PT17-#_'NC)$OTHO&@83V=CXKVDZE,]02@?@10/P/]CO 4
MH',<F650MY\VW2>[N5+4W7&/YV\O)#V-@.E'UM+/-=-DB!GBVL\@Y(,=GDX_
MX$S"DB1])2DLD.E4VZJ2]<%4TV055*X:"+IIRJ7:&VN,OA7KFL@C,[\[+NH[
M3*K'0JTQ15:B5?IV:'"PR:7&R)-10Q&]82KV^G 92 TE&*&\FZET"Y]@=$Q@
M8P.^UAG284$& _R08+OC.M/4/@W@6[Z7PPPIN=!Q-A?TKOD&XD_T-09Y#T#Z
M/Q<O=S \9O32%OS'<Y@509S>9P%I!EUNK#+,_^YL,#E2Z,8F%R=!*TO]B +G
ME$)3P?1:Z9.<,(>\FZ\V[]>&@M)24)M*/\",!<Q:OKUR]C&S?H&I-5)V?MWD
M;L,3<8Y>U_HW$@XA@21<Y'C4JPZ0"@9H#5TC@O3),RC8Q42%KI;DTH?DIB*2
M'%)(R7%>H\*"NS[BW CS6=(J&2=2' ,OPKJ]1GH=%&,VU/:(M3Y:4CV-<<ZS
MO"L#%5+PW02SCY9^[1E$OQRKW')<R1-MWKQBD()GF$Y6*VJW4 S&^2R)=\M.
MN)!M[V0&<<D/N>BD7PEA^NB,"K=\HIR=_*'JZ)2D4NA=2I8'$2G[TW%Z[K7"
M,%VKR77 RDG2^58\GW;IU_DT+61E^.D@\T^/HDR:F7UP^!&AZ'.<)&7'!^Q%
MTE6CO7"D,U H"M8'5DF1562Y9MZK@NGN6LCR;#310QT9.=WQ*"-ED=8XHRK9
M,94=CC45H<E8LRF>8'9"ZP7Q=W#HT7'ULH!53U+SS$Z"EW+E-HU689@=@T1K
MU7U0C$'5T"_6=ONC<FV.;DEBFKP;-F2P0@K.<SPD\.5H9@<W T;\D'$,3<<&
M;17&QUA453I9[2=JRR8,.6LB6(X:K)TB$$SR@\&FE#@]%:.'PT+A3UKO>9@1
M==;"=!#LF']T(6^CS>8Q?1+,>GXYGIG0E_ >SS]&8$%RSG(\?#15:PT/O2)L
ML<=A>O^(L@Q]CM-'3U+W&!R]I+&6>IVZOB]R9TF;1N>R=+*L)84SG41SDL-M
M'"_S+>_;Y96M@X^3CBKG*,$.(B?VXV>X(MU-'J&%ER%*8@VZO<FK<='YJE*.
MTC>XT SQO(-L;JDG'H))G@Q;.G@C X<O"-OD!-9G*"(X_SAX%<39ST%RA+4E
M6L/;L!R#G60#<NUN),.* -4D@.+?^"*%%U+QG^LMI!T&Z&TA'19DEV(.<[Q
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M (^RG#C7:.P,['0[]1R0"KD$[341J'JM6AD&J&5"*Y8N7M6<(L,Z-[#^J.(
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MX":0?1W$"""B/6^ \W9;YVC_$*?ESF'UU:HA*?HH]DMUL9*$$VY>Q!XUXI"
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M-*GA!"=PTN/F1#6Y,;J&<_*]_?T^N0GV4'VOOYP\%QC6\B</R3> */<]%#L
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MD^A3D :/=$Y/;K$)TI?K@V+5(R-*N\GUF&A'7:Z96E#K!4PQN/YVZ\-D0P%
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MY?@ST\7@CPA%G^,DJ4U4G3?U2= 'J5NB@\6)2G[.=YH0M7[$TP@P2,Y=?H+
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M71!4[<I?6\R/,=K]^#]\$<$$?=.UGX-]Q$[7=6M66.W9;LDJ1_MS<D_>)$Y
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M]RE&((4]-+[DCQWM6J)V$/!UVJ<(AGC.7I[E;1@?&&[1CT;G<6Q-22 UWW&
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M4F+2(BR8,USKO7(O&=\GA8%VR5T'N!=#>[#YSW$[]\B#"@2,S= A[L0[8U%
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M5:"$9]TR+NAK7]-)WS[ %GZOS"+N2;3!=E?\0Q3<==].,<A5,N>#2D8PC'\
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MU,C[]Z'FICNM)KMMQ1>B=_7#:;"X.=/K J ;7J)<F: VTW8EP*YD@E5G@%2
M:@%)=\SECHS8/LHPW#XEPY#:[R8FVC3,M3>8]-5P="*YWJY8BP+KW:\Q)>*,
M=9U>O_+U]4Y]P\X?G9F,>O/JQC301+F5U"\@SHUC;8!Z4_MB\2Z=7-!$]>;<
MFB!\VU^*@M8I$L+POZJO>GDS>I_2#<;;[(8!K=U?<6%")"84[! W+#8O[7#*
M5^[1CJF V?OVM,GY[T6V2C%GI5E9U2)#;->,-O3 >THPS<C?<9;'!]'AL:2)
M?QQQDN&,EY&)V)"F"Y5Z.0D^?:A* ]=2()MX.$3)W0GZ*?N/;+4")6?U%V"$
M-T/<J)T686-$SN&1RX\"'L5M?&,%O7+VYL2V@'=Q@K/U3C9U,+ZN'B;D_&2N
MGW"@MW-Z!?9,LD6$\Q59(8(SA.MG8_RHE3J='M8]I<PR]WB=V#;Y.O^BHZTT
M"06Q#<4$T01$/F:GUFFO4D!I6)^1"O7V9.;,*RRIR\FH>VMSHVB*PJ5N/E3[
MZCB,-5)!_>C/@+RH3?-T0"W M-SF2P,-#.84M^%-@OX,K6?ZLT]6/V*KWADF
MU$)ERG#J@4Y *J87VN'7A<J5@;%9L #2.,>I4BE\T(PSFW[G/,%XV!4]1+&7
M"[DZO5" 2?I_\S,S.(T]35?K$J S]S;)%8R_/7VG]K45C4F&@JYD$2#9*4$T
M12MQX+DZIC%!/__Y G&M\C4)/;WLQ8'F;;(A)Y$=I#[TL_@0D Y1MI@;^V5#
M\0O!U]@[&5]P:TZK8Q1KDJ$0#'@P(#VT;+A9\[^?E^!_K4<T3FI="'K&_N=T
MAA)ZAK0[A'$@&BR*ACQ2Z)PG_US.DQ85AV X9L>ICZ.V%P.K^?0XTZ&,?@GN
M>CEE3FM,B>I^VOZ]<+5]%;> =(>>:9K2[VQ%"L/3C#&CMOJ#C@]II%)P;DBQ
M0X(?3Q*1''U4_9GB6O2L*W6\M; Y..,@VA"T_LV6V'CO&,<8%^.\B38Q89/F
M ^;G!$RUGPL=7T9']F_YFTVTLZ4\HJF8%:< D5 ^S8E>HYCP=")T2K9L:2)O
MZ-%.200C-CKB3<=I>UG8*D_EK"N71 5W5+)')7]4"."WE(.:8E>%89F^=S<F
MY:5<0QOI20HT1&H%4CD>?^P.X2K7 L;V&@S=.O50.__Z1XY9A-K>)BR*X2Q?
M)\2X3+ 5.2_FU45^$A/#BCG[F^3^B3+V0.UL$-=V6^M7L%M]\^A'?#@=?HW(
MB47OU9;%3Z9>WM/SE3'@3._B@T5FGS$]U[KG9O3#U$"7O-$K9\Y7ME')GEE=
MP1\1+@ $F[/%EKKHV$.4^\+F:,;O6\)M.HTW.=Y>1ME^E6P?]S3->0O8BK5Y
M4YEQ3+Q$1#NFD\3)@Q2)K7PKF="&"25NK#(NUB?QE*&R:!#-;+R83'M8=4')
M@]EKZ=K55O,>,T<SV[Y9D_1BTGTL)BF">M*RW(_5%OTH18!GJD8PMQOFL*Z!
M;POZWH^W[PE\5P@)-[:. _'BL+7DZ*F5PI1+[3[8>M;9RQID!WX%4U1P19SM
MK$6];E+\EQ-.-F_KG;QCB3>C*[KTT?1U)]7-([R9%M."6,H ?(-KB6_G!>.0
MCI>"98<WEFQ%_2S%>+@\#,C=9+WSD?E6<F'#)/41"J8<O8HMJOBB.S\CG'_;
MU1>,7/9<[T$G'4ZM1$&Z+(@+@Y@T2(B#N#R:G?2HP_?<^U LM+/UCK_KYY+<
MN282&!!SC]"#Q$.VIM&V7M%+Q(V]5H99F#.A40*D!+HYJM1:P> 15'Y8<>/Q
MF/.3;G8WUY7V?3EX'B+8RIM9SBG.]OR/ES0S.^NS(#8B*62(>/!)Y*+EL .&
M:YFC2*T5"AZQ(E=$<RP!7)TA$AR]U'KI/"&Z4K55)BC[491Q\;U&"7^VV/-Z
M:MS!(L3!=BR_=#BU'*?[H9AB=L9]':7DC4\K<2(.<&\PSAS:?@V1<3SX["<;
MY/Q:L!3K(<43[3 O: 2J3Y<A:M1"C1YN2%14+1JQ7O_E%)$O-,GWY(U_*")D
MS(V@,74OA^R&W":Y RQ</BD[YV(N#CI(><1'"X$@6.<XJVB_6['"P\F6[UH2
MXLK]DV)OU1S%A:JC[5IQ"6*S7(*J>E*9FZG5EB^LN.J> L%6W5"G[GJ?M+E/
M<2GRP-A?[W9XPQLH^RC;.TC8UT'V *,)'NF7%TM<A M4"F'<K'B>6PI3Z#NO
M*HPTORB8.Q;8-8 M\0WKOI^C+,X>V>8FVJZ37Z,TYA?47,H1S1S[:/I"LYM'
MB/JF9QXKV"/)'[$%?"&! !BBKQK@W.FF0[I>"J8=SEG#<MW TD,9N1E7_7V'
M&TH0]+5<\@M9D!(&Z=(L6@D=L#?&OPX[_AF6SSKX=QWO8:K;FT(=)AWK  ^:
MS#G>*<Z2=%3E09+&$'&.QJM&*$,BHT<SW1;G-F';SRC#5UC^OY_]S3G5$*O>
M)I<07=S5.I>!)ZYZ4:QX;B^ -T,T MEH)].NYN4 :K2'*5BC@O?HVK7\HIN9
MC,J6U1LWRC>Z5VGT?4N_&Q7YLZ7H6H/5E$.8 KA%0D69.'VL]092G1:W2@8(
M1V'V(%,W52\#T%JM73LT/53DG7:L1!LF9UNFQ=<[HJKW^%>#P_0]Y5^2*,O6
MN]^B-(V2?)T^Q"_[<H,B2CW$>8RS2[8EP-O/;]?19E__K,U*P ,S]_ED-'/_
MQJ_H9[PP6]G0C!_UT\.!+26RG&[^@+%H\&<FU#LBBS<)%2.$-#P8*!Z\2Y+@
MHNW5*Z&0E I]?D-<KK,OS1Q"KG^P^!9G6+1X*_\Q4_^:61VS.C+P;!=## /L
M<Q5'U56=!8;OBBG@H& ,_% @,-/W(D$>=/@2>=DAL?I(5GXFZSFB]>WA3VRD
M;'G$)7C!?"EN6]F_@X [>*T$_7O@)26,,4TC<6VEL1/O%?3?U_F>1>A\SU9X
MM2_!\-1^ *F17D&"52RO&0&QC-80F;I2O\8[6R7;KS2)JK_P1AU9M.$[V,R^
M.JHU:7>L+%G]S>6Z7,[5'.A(+!8&O7)@G;=X_%3GCG3VWOI&L<GU-<HQ>?N*
M7V@>\X:;US_8)HPQ7;VD6'"V["=E0]*YLY\IBT ]_A3[3TG)'V$E (H*"2 <
MNSG@2QV5O! L&R_8)&]4,4<%=U2R]U&K=-I!$JOQS5"@^0$3+LQ]E.9O6F"S
M753WDAGS%*^3K'\C5,R0X*9'>1B3N E2U$)U@%$A X!,OI[N&+%]RZL!0MXQ
M"=7D:IF^TMW3RD!]H+$9]AC;[E5=[R?X=56U&+9<DG9\V_4]1!NU,.\>Q*5@
MQ0K"BK(?"3JL(WA:KZ7+B0O*BH^'5+AP@I-VF;WM#MD.])(FKSC-XV>"O]+<
MMK=P-P%'*^@B&,3]&#.TJ;BAA,)X5C0("S72%D@(=%]DG#YIK!#G-=X?P\I/
M2M%14W1_;HF_CYL/NPFXVD0'P3!NB;^K=!E8,^,@+-1(6R AJ+DET[__:3*L
M_*1;])GZQ\GHD#&+_OSV+8G_<L)7565"E[;A!@3'9:(.,@CT<J7BBZX@%F\T
M1Y(Z*701J)%VP#Z_(<E4AVZ6#N*54%^C W;K&MY.PQ<^%<W@CG2!.#.(+M0"
M3J?7-!4&%8@.W^!LO!V0K#:;]%251[9<$'9\VW$ITDHMR%)0<2KK3T-8!O8C
M08=U!$_KM;9I2N4%G_$KOX""DW:99UCR/>ZC5*;4V4PZ^K?<HUM%)42N2I6G
MK9(TCSA%&6<)8WYIT3SMU@T<+2O;%61E$F2 FH'ZF[+'7%P7>'[B62^G\(@3
MWH6=GZ1E%PB7Y3"* ([2&6OK\Z? Z]U-G#)]X+^<XI1?GHBWPB-*8O02]?4T
ML(?)!,5(>;DEGIJ]X_Q1J@2H,#V:E&B?Y^VG">2=3S\'M;X8>/45JO;PD_/E
M.:6",RI8%P_HS;.OC0K\W41Q*@K$WR;7/S:8)Z;?1!LLGX49KV2M:'HIYM?+
M8Y(2?CLF@>H>$"<\$8T)(?PQXBUUA!P0%L8N<+?7ZS-0^5*@[6L58("K[_(L
M$XRX(]9PSJI!Q&V")',1>_A@5P.#-8LW<JWZR)>JMUG&-@1/E(6R8@ED'&*&
MR#B:7C_9((&DMGB/!5/Q#C-Z [6C-L2-6BAR@D*)U4F/N@CD6]RR%9DP:.ME
MI1E-7^=@W3Q"Q3X&E^P#9Q#<YCF?-,"R\[QR2)]+P:WC/+-D6VN!)QG/==;?
MH@JQH<YD9/#K@ W* >&L<0JQ3]=@90L.L5WG,T/Q*E^POU#_OQ W;<?=QEE;
MM+XLC&T<5[)'BK^7HZ=B"K[^<<0)KUWT'& 179[Q*BZB!<?X9?(4J[/.<]7V
MI=DR!D5JXQ&\E%&A)\J/$@QN$@S?LD5OFSW>_'&?LG ETH_93R]I=+A</5P_
MKC;6#]E,Z;F^?#*C'^8)F^*-*N9(<;] @C]B D!8_-NB2EVTNP0$:P_7[N]%
M'I.'EVE3#D'%@A[C0Y=HA1[0-1+V9W!/9S'],!8;C+?9#3.N6[73J%JM^9N-
MCC2+^:5&@95BB[A1HX(Q7U9QUK+78_\<99@!(!OY" >7C:Z*+E#F:0 ])%QO
MI3M)ADD(T-AQ%==:5$$(9P8H44/5 46DEBS0!X>'S(' 0R$MHRB:NET-CL)[
M=8W::&_BA,61.'D1[>162=GSS2IQU)SFB*(*ACPF,K_RD&E#A];0DQ7*L$66
MNFIW*2AV>%[)5C91%&4R2LYC)] O,6&[$)I@65SJ+HZ>>>EP7OWNE*;\$$U4
M!-G(7XPG55NRCF'=CDV0R;<4 :5"!D0J(9!B+$K8)*4<$*9D1]SI",4[]1!3
MU^XW-.UF:;.Y-2#FOB\:)!YJ6RMO3FF*#CW6",'LK."DUIIU,K$.HF^7?F)>
M1<=OD"OH3AO5WA#\(':&W$#4JFO2R88^1RF;H+-?"'V.2(.-Y0F<"2E'2QHF
M'<28%%LD^9[%* B69($?M50F<*STK4,#J"H(2+;C]ZY3#8H8C<?/2=ML"]%Z
MC1C^H(;O$3I7 #V-K2&/4D%YAIW&'"GN10%!Q=_+.?%$2[K:.7?K>LXCC-,-
MB]1'Q#B>.Z'&-)B%^ETKZ6!U+Y0ND#<[G&140X[V5KC9A(=_\@F39B',PT7Y
M5\O=GR7!$0=&)@S"O4_#\OH_$P<.5-3)+8X@B*F;37;^9P4N==+Q(H D=0SU
MB8U/:++<L5&4G*@47[9ZSO*4_6SC>L.TO!=]*VE/4_>-K2<+A@,KRIE+\YWC
M-UR=KZ'+P*G$CYL]WIX([Z:I5_@^KU2]Z?AG7?(GWMW6QE1#<!_QQ-*[-/[G
MGT)&T8.TJY![6>![TUGJO>Y-0E@@KA30(FEXK-^?]9$Y#<^P?&>\X8LQUY+R
M75]W+2792BY,!4_)"E91^ $TJ(&: &J^WO1:JMUC"?>0HI,.J;U5#.39M[R=
M4D0>3\<C>7-UQ$$Z(]Z^]= -XIJ;DB?*!%-83FH*&;51(61XFMGO"AO)T:<G
M3S(:,C@0C\Y]S\R&BGINSG[=3<+99KI(!GK*^NE8\(/FR(/P4$.= 86B[KF?
M2F9^G3;L&$I_12WB>W35<M7-QI%L1ZZ+3<DYVXT)^4#NK+$61[@$XDK:$D_J
MH-@%8-?1NTX!%V M/N7@2-NX5FWC\A8EBN&(K-H\C9]/8^9V0VHC=W2]U,-M
M\"*9 %PR-K6R2??99C@VM]T&&H6/67-GVPF7-^<1=T2NOM+^94<UMQ$+,EG*
M:S%0$V,O"G100> TKL<>P67\)!9.6*+)&<##'G"&F1WL79VL\_N.J'?0"^)J
M!2]8WC:$"#71%$3MU_/ZE.H]+B2#"D^ZY/;FB;_R]C(;?+^/TD-T=W=IZ8A=
M7W>TA'9R0=Q0L4*2%V+,(+CA !S40$\ 5:_[X+G>Q_M@2-E)N]CL/Y<>IT-N
M%#2]BW?X<1-C9B.WR<9Z3NPCXAR:NXD&FATE0\0Y(L42,9X0O-,()VJL.K"8
MU.=,!<CEW<K';!E:=M(0NVE'_@YBXR.)[O*M[8%KXVNNAW,U,F$.4#D+Q'A
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M%$TN_OQF>^AJ0]7]W,&<2X!Z1HPWTK@@R1G&09$#J-1=K<L!D+1BQ_>LGPL
M93'N"M:I3VKK*E'JL#^B[27C"[ :V? N=@'8Q]J!ZG2J%LT!!J7=;4J/\77>
MJCTGNT_9='A#TZ<]+DY[3Q%9/Y/X1>9*VAX).9!V/=>P9A7F8*D2 QVY'*(E
M6[[G7=1+41"M9(&P.AYA 72D^A>&=NV@2X-:""%ZU3$QD"8'T@3Q<!XVT[")
MXXC]G4FW#OP>I\R[#CS3V7>,ZB?MU6K[6$T<HXZ5*,N(4486T!^CAM6_,+3-
M8I0FQQ0Q*ORP!V-4QX@#] Z)_UH47);+MA,]9;>'8TI?10KXBDGW*MKR.7<5
ML>8PNJ&%)<= #W@;TH@SQTTI#XHK@5!42@0A?(TWCO/^)4Z0+-,0VGN>%%;
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MK5CQA[ +L@65NBAW"0#J4>GG?_[IWY""L&3O*R-@RD$5F0%M0RG:NA9\_:4
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M"C9!VMH#/D1QPN?L2YH(IJ>(B)J)Z$__A:,T^X?W$3[-+-%CT#0 ]EU;G?<
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MG"-/BBQX3K?N;AO_ T[P]XAPH<8Z4XV47Y0TTJ'<*)4L$*2W@:: #7C1F?:
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M1&RI%7TY'8_D36M-B*M0(C'T4'1@TM&I6:S_2L<J8(+TS5X0"U?TB>"DH]-
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MDE-$;I--RG^]31[D!;CI:8@U2<?3:',602X(&CZ1H4@(@&(E ?NA=I "X>+
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M:N^(\O>#75X,\Z%VNWB#5\E6O43[@OG3-//<IXZONV8YM)(+D],D6(D\$_6
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MT-U<OJ?F]0+L[O!*L_#M[^RY_%8CK T=RTG&5+AYKNHR28UV$5VXV)N#/=<
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M$<NX$*0[&\WWCYPE\<XCD0:\8Q^-I"K,J^VH/=H"HTNP$U6L *U,H!4*$*D
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MX@]N\2?\0_XC_ _IL/S/_P-02P,$%     @ <X%75FSPK6L8IP  ,G8- !4
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MLQ!PGC<2>&4A(XEL= %*XQ&%;<SJ]D\WCMS;10VCK%GH";$C(^. A <7:7)
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MUR;%D;->AVB=QXSF/()<7>*T=*]?NKD!):\;/M3,IK1+">1(:FJX4Y$+P"+
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MH34B=&+4?;)[CPGU(^\1'<EQM-LP$<*Q;_ L;P-LM[K5Y'^ZKVE$;6DY#5#
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MSJ91"2"7\IK B(['-2+(M\S5,NNV\H!<A%_8"5T$7YR8#NGQ,85OF$*TI"[
MEZX;)FFAF%2N\"'$>6NFH/D.PIXT'I&;A*DS_E_(]YY(B@L]J9>^3[XY@8MN
M27A-@<(Q-+%/AKKNMKH4:I2*U2T)8_SO=(LN5FP[IYU]+@-O&:(M3K9196-#
M)BT[@N:)2\[&)(OW)%@_H7 KR6KMY[H=%ANZQCUXKO_>Z*&_?*'BF0D;>A ?
M'1^I/O:B]'4?_",V.(.'[(*.NC!-S9-[H'N'VEWL==^)-GDA&\A,&@B82,T)
MTB&9;?Y"(60",KYVPG"/@_7OC@]+N!8D:,R+63G54N[Z+DJ:)\(T=DRO]YG&
MYOM9W+DO2DGS1,JB?4]HRSP1X?YNNW-PR/#D,@A%E5HN09'.>>W$:$VO+B@Z
M6 7XRX!&)K3;#J4U?[7/6=EG\3#Y4NZA+PS")*5,\J<-#NDUY J3N\ %/D75
M?JM=?J>A64LGC/?PC57WM4&&TT@*Q\T]6M6?0#<%A*K4OK@F].Q0HYRJ[&5(
MMCB*Z*[[2F($W".== Q8<'<!5=D)$P-?G:W$0V4S#:/,0_=(W=>:&?Y" K3_
MXH1_H?@V"3P)]==$P:A9>&H8U?\K?'K]QAG&R 1NNS8J0YB3/9Z_3ZD,,0&9
ME^X.0H/[T,4F6OO6?;HHTWO5;MS>Q]&P#>=P*D_8 A*-J!+.4WG@5J(J2;?&
MG][#M\BIKC/J#D_SA;5(M9C#C0A5K?6I)#IVWGF(Z.5L*@F-L#,(N7P?GLUW
MUB(HX>9H0/3DM%[8;=6U>+1(FZ-M*CV78&=3V%MZ># _6 L?U"--C+CAI]((
M2/]S2F6]NIZ.IM+\!R8QNEX..6H3O(?<MP4V"KXA<P#M+CL ![ AEH!WN+#;
M.P,'3#R,I,3PO=T*!HZA7,P1QW."NJ,5S_K -(Z7W05MX'C5!A^6<'VP.W<
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M/,N/1\U=NEF).UXMZRN*I2(/033'$TLHQK;FILF5BGB?2?(<KQ+_E!N)?L-
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M2;OOS7*[L/U-D6-G0.^:?D-G?;2^8=]G.>+Q!H5W=-!@C:EZO8PBI/ YO?]
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MTC4/,]Q#?)7]Z,]^6+/7'^F%LCW)7\DQD419:]KN+BVW]A@[83QEC*L*P/:
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MSY$=8703_T;T3IO1'].DOU*%]_0-^2\HM?C P?H]!IK#M_2';_5<HBE%E&@
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MO>PSBZ$'G_6D=*?BUIC/#XCED%!I7KH]KIT=_9F8"I>E+%G%J-I4+FU!#E8
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M%S*!ZE=FMQ=(EG73L+9"78.RN'3=,.&1<\#"*0U?&S6UY:NGU-,PROS5_K<
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MH65\6Q(=ZJ8H$[#WF%"AXP0QI;ZD=RN<;*^<"'F+H!Q_2:+X"_'PBH[$L'E
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M#8+/ \.64Q$/'. ,LWDVIFGL6H AQL+?\\2N:> .=$7BL\,9K':^>M0":[.
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MU4SVSN!;<CQZX>MR]X"C-,,^NL'AGWM_L__F$^!V_L8+BIM:!Y[C'B7(Y\#
M%PP2)SG)<P<)3QG^.OAO#F^51^D[1E]E;U\)\$1C)@=J!]T0A7+G/4=HN5L\
M/Q^("!X/*'O!37Y5,L,E3'[<\-- 1A9O2&O^5EG^AN+X@-+G;/1-)OE[\@\G
M?RRP(:WD@:>!Z0JU<7N9A/0(>T#DT*!_7>Q["?B 1S1I_3S04U0)+,#QI@%%
MPCQ=HM,$+U0[9<'BE1>RS<3G=-62(R&,IS:[Y:(&W*D,8CO=.'+!!9\.+'H\
MDYPT!6MWV#AA*-OI4Y.+\CA[V?9 K%RL3Q<S%N]2=))=!UM.IT?^+_1_'LE>
M^Y__!U!+ P04    " !S@5=69@V?EHLQ  !H^ ( $P   &UN:V0M97@Q,#0R
M7S8Q-2YH=&WM/6MOVTB2WQ?8_]#GP^[9@"*_\IHD&T"1E40[MN25Y<D-#@>!
MHEH6)Q2I)2E[?+_^NKI)BGI8*G:K]+"YP$YL2V1U55?7NZL^_<=%L]K^_;K&
MOK>O+MGU[9?+>I4=O#H^_G%>/3Z^:%^H#UZ73TY9.["\T(D<W[/<X^-:XX =
M#*)H].'X^.'AH?QP7O:#N^-VZW@0#=W7QZ[OA[S<BWH'G__ZET_P-_DOMWKP
M;^1$+A<_#+V?O5?\S].3UV>=MZ=ORN)[XM/CY.-/Q\D#__'J%6M\8U7?N^=!
MQ -V_Z9\4CXKOSMGKU[!%[I^[U'\^Y=/(Q9&CR[_Q\'0"NX<[U77CR)_^.%D
M%'V,_Q+Y(_EKQ/^,7CE>CWO1AY._?>S[7O2J;PT=]_%#VQGRD#7X VOY0\M3
MGX7.__$/IZ?BR8//?_>ZX>CCI^/1YWF(4^^W7.?.^Q X=X,4?F9%,TN(X<#;
M/GA^,+3<+.0S\8#\]8'#ZSYT?;>W=-7R[1%L6U^\3+S1X^K[]U;@6 (DBX$<
M?*[].7"Z3L1.3\JOS]:-UB(<EA%Z#C]%$2<24.V/Q-1?#CP'*KFHS^TQG*Q/
M\(4$(9='@M-?A2/+=KR[#Z].RHKWV*=C^-KGWW@0PC/39,C@;0O$>)!E^]/,
M,5BQ7U@FFSD:\QR<@PY3Z,OG>MSV PM(\V$LUA>XCGCZX'/EJM:X$/]OQZ1
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MNH\;--99;$ZSQ.!=A<L"4^)LH2FQ(](/KF91QT*U0\>[E4W3#QIC*V]>4PO
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M/BF_WU S"^U((TK1&KP_SC_1;@B^K;X)%"0:[_7=9_$N>N[%*E;M+0>Q@X-
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MV^6EQ#A,;,6L(,_>;]J4HYIC^*J1ZL(6,!OU\$RF(;-T7K%6RYG5TZ;RM>Q
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M2X1TW_F#]WQ&L:U$G7M2+/8)J3D80Y#2UO4]U^CK:A$=Q;9/-P9Q">5Q"7X
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MW)&.]:1GKS@<Q2FO2:IP].D=N+0\)I2-'MD;CT;J/I![^@#*QPWU9/R505&
M2M)DOE!/HC! =9.R$K*P]0,>QV)K,+TNK%BM:T?="!7GLUK"*.F'D:!LE&"R
M@<1^,6^$L].*G1/>8[X@?9PGR$[%&D%H$69R.8;D/%CN/OT\%D*!)DM&(*X1
M#H2U7&\6)A/#[C107B KO2J+ALJY+JXYR^1@BPK1T.G,&Y*[[]H/%OPY%.%%
M<9Y<LE0= O%>ZD(;F4.W$9-AK&HY)N1,D7-NE;J^+M#0X6%?0\FPV34O'#HW
M39WWYMO +)4SYIZRW/OM8&@J3(!H,SFK;#4W+HW3.8;LN6/(*G]B?O#6>.P-
MV*29?B"'Z5+P7F7E[GF>1C8"Q+E>CVT>6NPB=50_%;LJAT1-[W4+)AOLXAA,
M-C;&N<\@'TJSZU8CKN7).BC,?6^*?!B0\VN_@0''P.1WG;BP!: 6V1;30@E\
MH?D@H]DHK2H;(ZJH#\+3\$G:3D7.EX5$!SGT?>ZECO<I0SE-LY"Q<TJRT0 *
M>T%TZ8!X&'Z[&,U\[?/REFQ&(JHME]BE/:,5]GN @OPSN-J$NI FKI'4T?>0
MGA2/R+B/+LD=3FK4N-B5?%T]"-!#ZQS'"\+6Z%EPDR26PWCAJ#4RH&RJ0>$>
MO"Q5; ,5N^=.Q99-GN3-AYPK2.<GM_P.@CXJ[R3C6#1+3H&>3PF1LQI3-;LB
MUDW.V T=^8E[KE6_2Y.K,XCJ<K)?/$Z(3!&2'#5EP8LZB(CU3CZS?-&;B&=1
M;R.I%F :L<%P$^ETW0>Y\^G [\M1Y/6G!J>7',"  [!M1("EY%1!WCQ'LB)4
M EB\1*\R(4*8^,B]A3T!W/65H?%&X@WX@G\+,S@M07%=]!FQ?X^63#K?M/_#
M-@4NS:,G8-H3?'+U&@;NEEG(VNSQ72&RD"_#.-FO^6$,BD0;"I\CI3&AX,R^
M;8OE;:#6"2F>C7M1JB&0IS)84P$O+:P--+CC,=R_2)B7>Z^.7@JP#S')DV'G
M[.P]T.Y ;LGNCNJCC),3P6O3A4 O5%!E0U\\GB>GO72=*:/7.,HRR.@:2&I$
MNXYE(;M7;"13U$*;<+Q-4T%2]_(1&R0U5B7<Q_ZPG:0M1+KG+:E 6>-&:19E
MF:\&7_)GH3]J3% W=T45I!^.U0 SH5KP&%=/;-,E3H;%G1?&8JL!S"'DR@T2
MD/&YC*)X1+&7T6)Z&78.N?N2)HNA&M)%Y/A$SAEZLJY%4;P6#S:&@RX@MZ@R
MPTY%=-]IP1A"/.K&";ZIJ<VL%CW'BL6H>P_"A]@FO39UY*&RE0Y(?3+W-K,)
M5==T90?>4.Z/(@;.<B\<#/V'S%D"+L2Q]3L1+Q!6UR(<\";V5>J5>><\1CW3
M8]RU/,<:;)9>K:Q-NGO=EP\&K,>E]>T^H1I\0^ 4]HB,#CDW3;+84^FJTW;5
MO2^$JR[-]\2<MNOQ((U SB_@ M4TH>)F-N":3=V1CKBT<& ^V=%]\.4FK_F[
M#4,U6N&.^B/9VVIJ#954"'B,#Q76\>CFAGL<>MS"<E1."<]=C1.319Q7JXW+
M2>Y"?R0V,1(7I$(  ?%J^'$4Y#7PT(]3+H!'$;L+/9#U%27G\D09^)C]@J28
M=+I24@%YYW@9 %502Y<)R7$#>\J3F(F?I+/6]]._3.:U#&FD(GB@'W'!G",N
M@W;B9'RN G@#-N@*XA(_T(#>PD^.5R%V35Q8L7-A)!'S\I_E.F+(Q4E_D;5
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M8E_3%I'3:>*5M(]B]NFXNFO!!\(R7_!7'F1_1<;LS$/GY#Z,5)^_F(M[0X6
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M%-2O!LA:O=.K-IJDUFI>-2[KS5ZC^I4TFE>MSG6UUVBI&]B@?@E72>]+HTN
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M"I)M %CFSFZ9%4DVWX]ZS4N$M6_8.,QIMR']WA4;IXGN"/$%!UZ@SN3@6W!
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MFA+?;3!MS8A/Y%,O,QPR%;Q1!7]\U2KXK&#Z]A@U<6$H70>^_#]02P,$%
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M'I@LPX!RH>%_E*Z>S$2UF?\$M(;']1@>J,EXFR-;%[74LMFC3,\$KR1,5W3
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MXO[\-S?NO]S$B^?I&SSI-UG\/1C7WNCAQ9K)N.]8 -MJ-C#L!GBLK!SU,%_
ML"//HJ+-Y/1B*9M$2;G==F[=,=&S/G"@UY3*/( HX=\BB:'V?Q=040=[K;)!
MWP!E4;_,J7JOG,:,&L=(M/V79 90(8BB.4ZU&JUSNAE6Q^7S]6 &@LU]Z774
M"G?QU$M8=B+21/].TV/80*4=L*$@C6.U"S(@L6M70/FX.H5*)N(XGI6GM)$U
M7[8A</!4]['9[WYU+B\&H/\'#W0?GUU$ZM+JAS;L>2_VI:-C-6Q3MW+HWDN?
M!,LV\V6?J&=0G5]+K<.%)F/"?EFN TEXC-0J,&4ODK@S-^ F>Y>F#W+^7T3!
M<OJ)9]@N^R&V;5<6>W!OJ\7N$IHAU[U@Y>\6*)\<H!5EHIE)J>;A?^?!##]<
M0^\I"MC( )$H1;O"I<$7X&A!R8>R\AV4>1&D!=2++,W0S<RIND&SC[F ").!
MDTUU CD\LKIC4XQQ3]RR?#V/C')\)(/1/ VH59CA/&[,=GR1AE6=?RB.)T:D
MJPQG37J06[G(G%TR,P,211]JNY:K(1-[NS<:K<>QJ+,2;?^&J"_6<9DB5[::
M69ZMT;_!#V<ZD'AOJ>A_38F>U4'CP0H2(JK+:]L<K8HR,RX#3N<)&1(!6>4"
MM(.3U/PQT:G>%=VBNH2/KM(9@RIFY%?NS*:EZ<<:%EJ.R,:Q2J!S[ 78_)[E
M1('M5*H;Q!C082(O7WU-T2V!O"PPD5;#[ZG;*,5@!GK.W/&-J.Q DDL5%$<K
MK]=>=JKU^(6F6E^2-?%<,I#[]<-7E5%UNLW>6?>B?R;$Q\#Y_:+_W_4?D0W]
MZ287&EE/LT![5F2; HVJ@P4MC4*M-BEZX:8*[<;Z01;,%7W\Q+\-X BV+"PT
MCC&HHC3] (GEA@W6U*XEP73$&R'Y+"'Y++G2IVV'-8D>^,/A#.T4^0BTYK-*
MQ%]@H>[%XSF'-;8HEI[=Q.Q9@_&'VF'&SF6K>;9=6DAL:/8@8M^U[!S<9'P3
M9 JAC Z%U8_H6-+V)V*B8/P(UTB^]\2H/K7-SWQ?I&-$(-+Y!'0QH:AY/KP8
MVNM35[LEGM&<48C'PZ%)PLK>-G1_+K PP_"QB+5=8\EX-.5(,W48W\K A[[S
M<6XHZ6*;^G$9'W/4DW.6N%A])V.%VVHTKPE>)0*#I@46L FJT9VT;<;ME2EW
MB@ U.)[X#74)R^KR\"PT03'UR>\QKH/G%[Y5(\_:.$*@AQCCK @ *Q<FG21-
M7US.B)]6EIG,HZA.7_7Q><*@L9)/<FNS,3T6_20F#86YF+?L%DD,[>1%7(Q,
M:8FB/!,"<Q2'WLFRZZ=YYXU#GH(NKQMW4$H7Y2PE25?B3<B_+31."U?)0B5#
MLK[Q0\\(Z7*E-;E)O@P.VX-V"5V-OR<#)Q.4OUN')?WL:J569ZP[S=G6'6.Y
M7I#R-@1X$T;,XI2YO'@N!8G/Y2-L]C.FH.H 5T]V2;(8S3 L;BQP;=HV$T..
M6ED:BIKE\LM"\]KS*! OHD\LV,:!,,Q5<Q#X@""5C.RDY7(L#4@)F6P";_'"
M%AR5NDEJMC%E15'FJU> =!,1.!2\'G!<5%7IF/&/,G6CL]3&^1MBC59E0[>4
M[5:3=F)=I SPK=IZ":$:-<^(NC#+)'%*2((@Y;:B-%5N'V$P(1MEH)ZL!@M7
M:J/%9+%%>H26ZQJZJ^23RC&7WO##<8>6_D"^OJ!N)X3$/<C..=62[:B.[)+'
MX\QRN7[ETJ(.NM>[!6)YBL2$1S5L@:DL! ZB"!1!V>MA6!0FFFIX_W)'JXBC
M++=&2BPBVV8KMU]*,:=^#/SZSW<Z1D]U.IH%H"U?1#V!S'! P.P&X\>U4A82
M0:L?93(4&8#Y4I6X2 @!M%ZPU,E(;>C$C9B)(%.&RT6%BJ$I\WMT+^2C1OHJ
M-<77"0T_LA:RC(SS,JU00[A\GTN!@0B00** +(C@&\FSPHE'GED *B%FV>&@
MF#%;&7@I"U)JG'5V@V3'RG+.HX#] 6DX+TR0CN,X-%I@=7A5U\J4=>.JZ+R(
M6LZP6]SAXP.CGI)S!0PA$T6_2YN<9VD@8!1,.D0;W$\S"ZV#<OW:2#5UAZ;!
M,>AN=OQQ_L:CB&@ >PE]X01BLG@1BEOA@\6NJK)<OF%?:CL=0>]0")"&&L]#
M*G;U_'2<!".[Y'F_?H@!$UE4429<A$Z.G>D\FQ/B/5RR("?.6448%>9T 9D_
MD1L&_Y(V1;DR2#%(/ \%JFKN8K$JPV2!_]0:A*H<*$.E,4 >E9S2ISN*D\@W
M6Y25'R[11O@39%%CZ!Y-?2[6#*UJ&7WN;(]H><[U8M:Q']EXLG*+>OX,UY[8
M%/F?Y<J7)7$JFV^7*EH5OU]TR!;X2:YW7MZI2(]AFD><M%$5($%71#VK_!W/
MG\8RO<:Y=.%S6S4TN+J1XNMY;EK/ MC*Y2)7%3FJI> &[4*4T!TQ7J\K7):L
MY&Y<#4..WM3$I\J1L?UL#H=@W7HNF$ Y1B/4-B8JI#Q,% FR(.E-V\K5%LJG
M+_*D0(H@*HAK!_HX%41B%1:K8,10C"# 0Q@1+@<5BN @:'3PMD0VTP63-@RX
M5!YGG-QOF[64*! $ (>SM?_+MFIDB'?&7!0AY*2([:29*D];(S_M\XF^:8E-
MXQ_X]IN:DT.S[32=,Q&G=)J-1L/9:KQ_=^RT67-M RE& JDYE=,7D3'+S]8@
M[)*D:)GM45\DW(IH49J=29-=2PPJM*3@F@B:FG%+7K@EO#8HQD*@OC(=)(>0
M:?=0"UW1$F(.&%A 75:,"JN9,?8J<_AB<8I[:A*^6Y0@YG'(4]E2.W8I;.IB
MYW0-&YDQ$&'4&*@/BD*C&M=\@))\2Y,$(II'%2(&W'0>R0&A8%K%LK3=PQ9>
MC"\+8T?V1H?^[ :NHL8?$"Z8\0S#K+),F<=9,CG9TQ&3M4J-XHAGHX56]$*@
MOQ0+"53]]4K83&GZ&G;RDF4I:S=W!;+J@A/C A*YQ(=Y70GK=U7">H,2UD>O
M*V$M9M,UN]V+WYN]5OM$OG)QVNU\XAF=PPOGXU7O3+RC4MN#S\U^&[L*VG]O
MM0>#\MRWT[H8_)B1IS]= S\] 5Z"ZS69Y]R&Q>X511RDDR: @+!&'U3SG_</
MCVN-W</Z[NXC8S+#CM/$ "PZ $5/VK 8M@P;0:V/:OYE!]MVH91/JJ-B($=Z
M6E:"&)20:%<%W8K]/>0=RF+HT@>HE7P2AJ9\ZQ&H\?E'%)0PIP],1]:;^\;Z
M"FL@"U^4?!KGO,T>@?!^V&]910%XX:GZF/FTQU[\X]S\8@JB(PH@X\P-"TYP
M;A_8@T/=QJ(.Q-S'RNI63!2,5>W>/*)BT%RDPSH8JF"D-CV,L20^>"!J(I%N
M?N-;51D/;+[A4,*CJW2%-;2<6P1 GDC325O:#\@4Q;X/='*0_G6(C3\=+F6H
MK;N;V(#+CJ[=:SODL4T@8]3@(7_!3).KZ*]I9PIW@V06DJYURO@JBK0[,-O3
M<C[@(Z9KHX2.*(/6@R96DHW5=YBC?O<;]U\@B8S')"7-NFO:(D*ST<ZH?" 5
MKJ@K(:E 2I%5+[*R,Y]]+>/#,IZ^W&WEIXGPJ'%S=OVJKO8P,ETC=_QM/A/(
M251&8X0L&%R= "D]$*X24"U)%Q0[B+CS@MB6)ZN[[V041@=O$ LRE'!_/BZ7
M2FI+9CH2-6!X$@,T11&'2DI^70XWMF7$8CZ2:Q2A9G$%3,<J:FB$GHU*&@,@
MS6HXQ<YB=*'1M\0P!VK]5(U(-I=G4V5JP3TO7K*, BJJP\QV/,?&1#PH/[?>
M)P1:<SZ=\/<>';;=PHL*1&GZ2B6]K=PZH,&MQNZV+I>GY#S\H)REH&2;W;@X
M2CDK<<\QFXF+T3DO2&?SK%C H\_,I&XQCIKE2=DZ9)?UEJX=EXC0KN N-;O2
MK#/!-6P3?JA+,L2<Q4 -)NQSEZW<327:G:0 C-NA[(WO<'I (.]+M8?<6U)*
M]NCK@["R=^7,7-.SSJC:$<?RL.ZR^\)U,VA.T(F?\]0R#$! <PQ'*1'IXIJ5
M-&%4:KA<FB8+0)1JXWW+,:AW5!WIX:AV4?$H9C4":25FH0+F1CC(';#,CM68
M7FY36 RS2%<0%9I)UN:<B8W6OI02EY(]:>2RU7'-B;B:E8=,:0,ZCP(JP)*[
MTX2K: ]CA[B<N4(Q,#I.R*("%L*F/ $HD1^CH6:#R,RIA1QIH'[D82Y1]H*5
MYA=!NCF5$-P*;($LAHOEBR:H'UWA\B0#U*YNHIAF,!U1;S6M$8229" YV5?7
M/CV6C%;>:Z'26?&2"+%BM0]?-;4L6>DSLRL>U;!2>#PV5(:*=4V$4-HF9$FI
M$EK.5\LTTG+;.0QMLJ>V.<Q%,Z?QZ/3Q.)G[RLZF-%P'XX=H=?4ICTHIX$"^
M9HLW^76:%,+&1*[#&Q\[C^B=5;NP#N4"K1T3X%8VZWJ6SV\9L(;%4J8D%BEE
MY0P43DPU5)E55OBH";4VJA;(A5>Q90VW$UD";X=L6S$9DYZK>\[=-(W'G-UB
MH\DN**:A/&)/K'5+$H^%M13<"/K8 IM6F6AT%&C8;IMI?BP(G"<B=2?[^DIM
M'<YF/LX:WU86:\+0V&6_P-(2(^GE&U2%I"\[:G9%VXS@9H)D/)^FA#HN.="R
M;811I?U\61]!4UX->M-%Q8N=,97.(<)3CY+30=8,N7';HVCKQV6H[P?18V6;
MM %T(9JTE%&[^OD"C)R"6UI(XMK')(4?+SE=;\]B8I@.'0CG31TV5</ PE&\
M2@^J6#.G\5AX=19)%V[BL3H3S, D !DCHXRT] ([T9[5[Q4C&V+\FBFB2Z8^
M<(6WDK@+"0\+>F)/%K&K O E+B,)0%A">/^R$0J.GQH>SR<0FBKIX'1ZG6&G
MV:6<PHESUNXVOPY>N&1\>CYA8.MGP8!GU"5OYONM*2)H2(F!'-PD;?;,2/7I
M+:%7JQSV FA^A)-N1"O,(^+M%Z*Z$"M*"V%EWO""=ABS95QEL.$@7E5Z^?VK
M32]7^>3?K!H] \:*HT#HT\58$W>_JB;OF:65<XTJSV59U/U&A^S%$N1B)CKI
M<BA6&(M!B @R5LE?\BB*%'&,C>HN"8Q$C'.Q>E(3!=Q0H_P4YBR>V5&D8S<9
M V$]LV5Q09C"I%/=P%Q'&AMX9C7Q&EA:$RS%QBA?#2\'#IL'/'(U%VDW:[*P
M0#LM*#>JH(M#"Z E!/^/JT\C+Q68+*:^,NQDB9.LX'(XXF= 6 &YO!(H@"=W
MY71L@YB'B$HK'C%DER'8B-"N=0\C7Y@Q5HN"$*7I?(1^)]:O496]"!$(UK7,
M)JH^(""93 !@<^"1 YBB1E80PJ*F&'0:S,5M+Z 2WT6ZH(",C"#C8RGE96?:
MQO$\% ZRD>@SM[K%"Y3S6THWO,2HVZ9(C21=\T1R,W]*2G -QTF'>G48L!3N
M<$4I/>;(.5\Q0Z]*B.48/RN;&ZE[Q4P=T&I)0G,4+!(>LXJ<ROU81U\@)!/R
M'-_\B-XK%0A<"H1[U3UR$R?P05DF0/3RR/(+7EI^_AC_TA0'"(O0.'<$"&+A
M!)726A\HKIOSI&7X/A>572NK9&2Q?@AH&86;%Z_/I!,-EZ'JRSE3;[CMM3(B
MHIE26%HP25R4@2KL;>8>F:-K1G6R&0MEH%515[ZTV6;E+,3%F]7":F$+^D($
M ]B*A3YP(@HY JXG8I@[.IN;P,^+@[4"OQI@S6[>R.W'B@'79+D#IU+M^+!$
MK,";":+;.+SEL+3HS^8>N3D<8,+]3:)N <]4P%ZL>'JJRFE@4[J*@>^2H$ \
M[@ZYN_%9N\=RYJ0@'.N9)XP$JH_3FD;-1"5QXLQ>=@H1<BVZM0BV*!;%&/E\
MJ0C#M'!@$;<*4=!/$D0A#$3)O'&+ CU<4BJS#AZ)S3GJ&CEOA@\'@EF)J*?R
M@UL@;+ A+4#9+ N*1!'1K:0],7YB;0K,_ZZ$^O#A$_$]]0&5HC%N:5@"MN=E
MHJZ4WQ7E;I\8!2+QG7\KYN?E4-K!],AFL->I$8RU= 1QA3>W@!4*>D)7"6J%
M#H>7W<7.UEX^O6<,$LT/H1=;M?KA1&O&<EVH9DM25KKD9X6)*F,LG4@EC-5
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MC(H,QSGY B12UH"6J0U1K\N=*]+\!EIAEU\BE-SZV^M45R9FS(.K&:F0N>P
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M-6ZM$+DQFU!&>BQ;.7BT6-REZ.!IBH'?$@5:A!T9 CVUD6NY/L:82*REBRU
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MK $O70L))\^Y=4$Y^U-#0.B$)*,E\#-D)#274WUN92?/;#WY1B@@C;I#"L0
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MFX@HU0D:VC!%]0_KD0,&#G2^'YFJSL^;'?,1P@:B8@*M^R3?43A;]@3C)I*
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ME0V*MPCXA 23+'\W<MI1>)\OADU-'Y\=]TNJ*$9+Y"K5O? @&A1(?'TO#XJ
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MJ2C6X8M!:86U9,6(P(%?50N2FG=&? &]HS7;'>'#)5V-*"F;"I$3U&98+X%
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M8._E.,VX"Z7#MGYW#%.2TS![V@B)_NV13SCW8/6QINF"-)(,QEA4>J6W7N-
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MQ$JWW85U3B^1)1*7E]8R^%*!]4:1<][(OLL\;YK<2T4QC,=K!3:(2QSA;%>
MYZCJ=)P:<?P_3IGSB4'L5)IS^D_5YIR>GE^,3TZP\?D\&XU/+K@+&OYQ^F8T
M?O-FBO]\%N;#0Y]#NG[,(6XE6O6Z*!MVB[<P*N42<&%:]LN &;/O*/\44HZC
M44%.S1"#$1!)-*#9PX0#;J,^.#-NM#<&X+4!G2*[!4GM8&>&QM1"!>M7<UP>
M"1]S? 2 >#)EL6X+3&6 "'<C0E!X'1!\>/)9@LU7PN=.8@2&3/E@\Y\N"SI:
M:R0MRX'RBC(]I*!E3:E7ZN-+ 5=5#=ZL[^9J3$=I9@@\H!VD7UURR611:%5$
MG$6UUX2Z4Y"8M>/R1@YMKRS,[<%+XM82IQW+PQ%DCGC78SJ,#63G"YMP!19(
M(MOUS&-ILM>8Z]7]291<9\&U!SO.+5/R=NA51A)>#[CE:.5B4SKJJ4E8&]#"
M6GZ1NZU0)&KZA56/'22:<18\$QL<>M'0QW:8UEG0V"?!=FK">WVWYKVVFF[C
M24SJ @Q)WRKH)5G5RS)*]YDNC80@%<W<*);HX:9T>"0L5DK&T.MI<17A4MUQ
MRHVR6,W1Z!R>0*=+W7D1N,<WA?U*)D\_U^#37;)L/.T>:PVTV&V%?//XDF\H
M(VVE8A=YN<17T_:8OK5, 0AT:&\)1LD,>H/^TPT3A/2$.Z[*1ZU"HM(VKR+*
M"/FII#T+4@930[5-?QZVQYN*"D;HT%<"@;&]5=S?@]65L@.RT3P 9M=5T)?N
MQ7:QG$9>KZ4@3RDEW@<LO;=4O8$1_\TX(0S 8;(OU<O^]-YKZ=/^36I+,-VE
M!&?"*V2%13++>NE>=/X[I @2])>)4ABR/<V*P4N(Z3NIV$&*R&Y#T-U C V.
M;6%(#K@4F4E=S8KP=E+5^,@]9'A*1KHENM[P\X1?0((?N';9_,M)'*;;-GXO
MT,NY#$C!S?N-%44X&9 4-+J3Q"9:QDN(SXV'(1O'$FER?LA[*P$X933OW>]$
MW "K.9ZC)9J.C6*$*5A)!"M#1A+4381_X:O^:H;\)K"QG*N,;:5<IZ0Z>>6\
M:%\<0B+554')6LR.,0\*'%C0:9;HWM1?9TJ&0?6[@E^7\X"=.]-XH2D-*W>1
M[O$N=<#B;YA-@U,TAOXCZO,@$@/<).9UR.5J7DM6!7FXSGTSGY70S(VQI6Y[
M8WK1QPM2F13KWK>T9%E%;MH&\M.HY.X,V5?UXJMU/?M4=(+%Z"AOT1*[$*CU
MB&%B_1VITP(S6S8**>P'MBW<\L8JEII+9.9R0VL"NA)!>PZN>O=)P.6O9YK)
MA2@\S)\@1AK3G*5P-3].V?)1E[YO[\>G]"%#BLI)^U$C;T\!F$J&+F2^*M^$
MM'36N ;9E4!@BJ?X>95)7S[;,NF7HJC)$5@[0)C0KFP*:Y#$]=F^6;?;D*)#
M@R/RPO%AZ:RU'AO6BQZXCNG^@!VV=^O>/B&)P&4EQQ],J#\,?$-4E /QWKH7
MFEF3_P?U!N:!HWQQC9%9]96T5H$SB^ISG3P;4FUIU41/"+#?EW>F*DNF%-(B
MQFYJ=3A9#<8C/!N>WV%[6EJ#92.OMCDW&.!>+AG?)?>D#DV]J9)B!+6NY&FQ
MRUVS![6*9+X^XF,9J?I9V+:)/OFE:AN_  6ZLEW<03W3/=22(5<S]PJNB-<+
M%S.Y3:H/SD=6,'SR&3BL7!6^: FH0F@\0RS:G0N/Y>S$BYI,4))DW12]/A7M
M)L[U 8)*=<&^/WKUDN,B>K&&T- 7!=--%F8B?=2VI2A)N.(\B"&]8:$;<["$
M,X7$_'8.A^T;&QLVAIY?2C,])F81#VW%M(%8=SK@6$Q'39B0UC@)_&(U<P)^
MB!U9$]FS "&>R+D&$8-_<0S?$!NT\1:F![3%PHM[1X26S*,J/2=^%\-B=>\"
MH25K*B/A+:1#X=9/#3?QQ,9CB;87(T@,<O<&5@ *XT""*?$(#5H-J-$V%*&$
M/2*Y],0K,7S54:B!RY+6<MGPJ1Z7"'=<J0/9[=K;"H]!8JCP4 (,HA#4^0:[
MQYE.2IL:>B/?=[[E*.#]%]$D_H%]!&QKI<4:U\RTF8GC/Y"GV. 0\?-030?O
M05D!--%/;(%>EDB(_<1&96/7<8=+J<-;(CPI#EU-*-[@^G:O^0K8GC*N.9O\
M5<E8WVS#OK+  )O+6Q6%MOX'.4<JP4M-[.7+1$K'YB"8AYRO6D!.G[#Q'" #
MG\^5&3&SBY/;O"GL-!5*NP3!RP18?0BD0/@2+'E-M*CPJ)N 50%4$%:9="-5
M@^23,T\_RA>\)_N+&4DZ?]49CL]>3'[)T>^K*918W]JF2?..M=M-%4RR8.DZ
M]W/!%OQSP07C<V "!/D-Q!*<?WQ],KFXF)[^M/^R9-\?O7PD2>*'L_<_3U\C
MN&*_014)3-9]V#;8QR9S&T'H<M,7<<&]U"E%$3KC26 #JH?TKXS+@9F28D#9
MO9A?18"^3J]\4R][=P TI5S*?)!%@$!J9^-V.W;^@2RG=\=]!WV Z'Z!F4E1
M*TL!&7P9X-Z!E@Z*D)$K!L&GG@+)M)%">A]5Q8@T: OS$3B-",'%W]U>UTL=
M-[KU@S0\CS-+Z*ZPC#A5EI0:A],3<)3N@NOX')+LOR;FLMQ\R2* %UC@"(,(
MI.:I+#^T9"1916^S([[9HBGNI1ZNUV4%Q@\;Y-FEI"HJ7JIMBX+;'D'JLT %
M3L&[&7[:''ZGG5C\^0%W_M/0.]^3A=6K]AH9*==,=JR?<TE6&GCX3YC.SV$[
M,F$O :CIYP9.LLQ;" "AZ+-RF_ZZ/1P@47+*)%'C>E!IAQMI#V'P&UB;>&=\
M%.,6Y$U*PI4U:>&CE+0A]V2F9_@ BMZ Z.FOK@.#\A%HJ2C?A X%R2;:KDC<
MEHG(0??<4HS!;=TOY\:D$-^R77>$4P[26Y@5',"P\RJZ-D90N" 1"1,@I$H)
MTN]\9[UIUM.=2@XAI;]^9"7>\#7U++. 2ZGW<'A=OSJAM"W\6KT.J''Q F@X
MN<:5NR>Y(EDE4(H*@JTM5X91WARFO^CS1>8'^J$JSV*]'N'2D-"[[)LYY!W%
MD230JA5%_H0F3A5]$*]UDU,[3TA(;K\$,-LN$ $J?2^>LVGN[>6=K4SR0&A@
M<YM+WY'6W$V-FQG/9X?M@=JC8-CU4AA_R1U(@O2^Y&@K>6C<W[SS%'9T<,/;
M,KTZ<'!V*?AW(R<"0N1-)!#L3Y\TQ%MMOQ?T=LXQT]"W$2<RY+(@+"AF/1K4
MMB\[9M=P6_*>Z[98<#<0@AI+YFWY5? IG[IXPG)'.*C9P^:4TZ3$^A]]GW6]
M=KHT]Y<S'I$1D6S7P5.A4QY-8,K:!N@? Q"C0U-"8WSXR,=A9V8G_X%0$)LV
M-1MF>NV;5Q3,MEOFV!^'='ZS98Z0C[SZU/1KF45843!F#-[X/$%6CKH9M*G>
M>TMX7?[0UW,33TC@'!!XNV1UJ(./D#TH>5*S)-C.=WY>1=]77XJ^S[?HJYM$
M? EG-Z[ZW.VZO&)NDP;/2&UC164_#9SN=.L204;K_'90(>*>6;_=W$%4EQ77
M?SO,-E'9C+%&M<@L(Y44<JE8*W2?CT#VQS &^)X5P(/T#2/U5NL"D6C \]+.
M2\;L_2&SX@[0CE F^I"+$J4T,&]E9:+5];L;@+^<&?<3>%S/X9S&YC,X&BEE
M7$ [(:0LP3@N[AG3=OL,(Z5!FN$OZD9RUG;0>#\L%T)3SU60[WS<DS""#)*&
M&& @8(ENY8Z$RXYRF\2=DTG1E:H1X /XQQ>3;?"-\'M6>;:AWB)Y\DE,OML!
M:"%HP[Q%&Y95$9-_&"F5)?.H$F&'X3/&$RYR+><92KE3)F4!Y[R[ <6 !38M
M0*6VQ"6/(DW80TAYAS8M^Q2&P9F9"Z-\J=1V)$]!\8]S1!K$>Z\-P10>S*O"
M[>6&+$;M!LVWBE=4/OM[[]8,_</G9?2NT$MQ9; 0)C<O?/PU9IM<P%.@^3'-
M&2WI]ZD'Y$DL$E4?&_]"5.IBP?7UH ?U^Z.7M)9L-X.\J$1;+20+N2XM=\K(
M?^]R5#+35 BM:D05!I R0MRPPH4R=VPP@L'F]CDDB4Z$7*8R/?[1-1*)D%*
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MV]+R(#+0!P_V!72-<4:7B^MT)C 6@^GL+'&-#/YAO\UE2#0G.F(=E%A-PLW
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MT;H)CX)48XBWXGZE<PL&01!)CP%-?@+:%JD?<#\(L$U7VO; L/:R^NN>OY@
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MFMI9OJ:B<.JN&-]K==OMB28G=4B3/\0\XS"GQA=<(IC;S36I*9C'\*4KN+:
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M]C=J5D+BE(N?IV=OGDE_TI!E\R'&RK@Y-<O#;K)'V= @?2Y3E[CT9ENGG*;
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MJ^;>K2F1"\%]@XV8VH+M_7L0=<.CT>-:Q6O3@LT(_F#>#GW/O[@A0YSYN<<
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M"@<BQ_L1N 7??RGE^N+)@QG^."0!_YNVV1]&1#P-)(/!&L70(84=21UO\(V
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M\.^2"TR5K^A4N$35/HYG^K:0U"'(_\@_V[_WX$8OZKI#4-.S\GP?B[)^1I#
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M$I%(\3OP\'4QQSM7R]'I*3W&7^,4B$Z0X6D&C2)YQ7"<W/=_Y1T75=EC/-"
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MMZY;%JHF^Z(5AWJ&_,8MP4' 3I!IQ=X+"L"H\0%@E>[V55'W;=C-$#P)A"6
M'6-8F7<9<X2*#]5M-F3N.WS0"'YFB)3! ?817ZN%M81]!X"[C6HPW\V"O&K\
M52T5:>C+N=;=X0C!^![_V+BKFYC4V#RL8 3OV82>;OY<E%E)*&,:DQH4-@V
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M6[=(W38Y6!20/EAJ!_8APOX@+ WN+]MU7K9K+()B*I QZ$P>$^?_"&G'9;5
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M/F -XE#8G.&4N$9](POR8[EIIMIYH?(##4_:W81ITO0W+)M@])):Y5013-K
M'"<N%F(N.R7&I+VM8SB3-)E>DON6.=[H(G"U!%;Q.6LT41D]K.3P 88*8"U^
MH$:VRE).J3<*D1XV*;6^I:_.'EJ=NFC1=*J4VH5A889"IE6LU.6TY!ME.6K?
M9&+O_<W*RN8&264-3?Y5-+=SVO6.6[U)'='(%[EWE]!\F6(?=D&6LG7TNUM!
MK/T7HENE8D1336!D[RBP6_5A,X<_.CP"W'+C5:5-M+A]N?_Z:@-OEX=R.($2
MRN[DV%MJ\NB7HXW.I3SD9KHMY8*M$)2WI+8F^\*Y\W1GJ?=<>;G8L2FQ3-!4
MY.0Z2I$G$2?\0GG:N9:#?12J+"NM^MOEED^3U+&GY0ZF=)9@$W[28\KV_-B'
MM$W>57O;E0^*MJ<JX+,U'J1;._,.VF]IA%')4\VWL;M/K7T]/;OL=^O.O*:4
M!UM*GW*)HDE+;0)YW&+!"P=(408S5JYB.ZR>6&0]LCZJ= D.D"NY,!/P'@J+
M266(FT2.6U%9UQ#+RJXQ:)2RG2!9G 2FQ(>X>"8P0:_)#4LDI;R#RY)7N%3#
M43*H+_=7,I9/YWI;3!N:><<R7;=G-F%7[4';.\=K1S 34LIW53]_1DZ9W^H]
M!/ICHTTS3NPML"E!A;?Y&:T&?%T=*OR4EIL\I%Q;98?!9*T^E424,B\>>+ZD
M2-H*7\)B#,^?>5]@6?9AX)&)\P] YU[VGW;+._*C',[Y'W\Z^^ =AYB[%<%:
M>'+>\O;VX9A,?/,&.5AK,"([\8CK?DHYW][VSKN=;;8DMT*XX0D:D5%L2G:[
M+([5\F [NNU]#OX9QLBAVX'6H/[6  Q?0;]1<R(_0S_)-VCSVX/=[1U59F0Y
M[%4/4WT:SJK%% .3?4&S SE\_"J?)C)QAS?*65-SGK+J>-2ER?9H5%N35:-(
M!GW!A,ZP]/!Z>3&AKTMU).,4A8A,767%4," 4B8 :?[1]CXFR>@.QNHA2RKS
M&/R<I-=@T9^(.[@1C\3#)+@)BXP'XL[VCG?NIS=ZQ& O_I&D-^83'O/VW>JA
M(I4@GS!J5&[']X^9M0M8=HC%0Z\R5MV!29\D.UQ%"%J6NI3YCG:#XR+#G1CM
M;L@V(Z,[XZ'4JHZXTMN0VQ4]>L%^"V<A^V[MP4E\,W4WGYY:\OZYU_W4.>UW
M-7'^2;]W6G-KJNPPL2N=D2THS)A1SMN2)M/0XF-/E0$VY@"R'$N&('V8Q".S
M[\>BYY?2TX!4"V&@]G:XOX=Y#QL$N+#Q5RM_003CD?SD<5!,A^PVMV/S56[\
MU=O 7#%QLR, +\QHA$%XH8J4;-)Y$JE,4JY)3'-=Z$C?JXU/!+,#?1)L:67F
M<9#EKV#-'7J _Q3AC"4IP;J[MI1VB*IO7*1QF$WX:[G_UZ2>DKP2[SA419$F
M(YND^?0^;[RL$[X@4I=S.$OE5Y6R'BR#EOEW9A3(\/?BZY"!&$Q8 IMC:V^;
MN32Q-U7.X%@-$_2X<;F_)=EGR0E2/";12I<ECXY=S<WR"8MY9K)PO&6W&U/_
M5@[A^X;OPNCEK%7)+; @+*!&A+R6CVX@)G3AFE:9/,^9A'DA4PY@+)2(W+6&
M0.G93=6[/%6N[93:0!VJ!P<Z#DT$RO2#RA'!5X@$IK8(0EG; ,XALG:FYREG
M0N2J1$%Z,)=K*:A</;GZ4 QZN<F\V]XSV1V*14$K#%C9<ZJ[C2R Z1TU HG*
MU1I^&,_6,MRD+AE&IK211H&QS=C/FJ3LA W'2N)*;AYSF=.)H?1RI-.4]=_O
M9%,*WK;(P#61^.!K-=G"NA<3XO2$A3_2O)<J16<Q"U/1;"I.'&Z1S$!=W0"J
M3LSRDBX'3?)[J81K'M';=1&])D7T=G<W*Z)WT4/Y\DTIO2L;H:2(Q"K9*0?(
M)+C+?3 L^U2PK*G^AZ7T#TS;IL50EFH *N88E:B 93789QE3"TR?W+"6VJ(K
M,G [,=/F T<DURZ\J9@B<]VH("DS71>835"6F4K2^3OB?J:$;>E3GYH$&4KK
MYE6Z_)REK,>YT3!/TN713IT62?7V%>\^"S;IDCZ]5JL0I;'(%<VT*IDP:_)B
MD8HRF2I7YZB8(0TDSCS%G&JSEY39J4L9[*O66EJ\LP4)ZULT;,J91;9 \@:1
M9.X^E:/CDK+=]#[WN ]_=E$%LGMV>M1'YHZ- )Q[&7Q9D(%)8*@0UMZ>W1NT
MLJD8;U=)@97$UY$11 Y($CJ5Y""VH"EOM)%$+"3;WS)KE;N1[3_26AI'%(A5
M94\J[TQM3+$H"$DZ->>AKUU!9(!+9BCORHX$6\]'^*>VT8K2$1/M%5-=,LXI
MPQSKC^*8&',J"7BR.\M6O+\ TT1;ARG>G&K'.R.9P$[)W&C%ZF[11KU=Q[8%
M:X4/.R=$$^L L_'&%/,X9W(WP'VBHH1?H)ECNWOMK: 5R?$SF66Q\!*E>R28
MA&)L-5)F-9A+OV3E.GNPZ5BF/=;T5F@B(GR4- RPU3 6QDS7Y$>+@5_:AZ+W
MKB*@S>GVLS"G;DN"&ZO'0ID7 Y-IQ+WA>Z>^W._TOO&@*56$,NZK4)3<QZ#;
M U:IEU:QFWZOTX2*YHA_;V?[U3_A:I*'A)D.Z1=T/[_ZUTOJ>F)J0L(5W8]Z
M,=&=117Q6/U'=\:XVTBMV9T"^LO'5%,O5D_"CRV^J4D0DJ[**,0D&:R*L"5%
M9\40%EZ9?G,; C))[>+;T-<N5%A:\Y<+HGC)$%<IGHBTX6(EAJ1( TE[5UX;
M[W"'JB3-E+T1IF9<6T5G@/0;M7#M/W'A^M+I_]Z[P-0V2>O6/>GT/]?<1]LO
M)?&H:C\VJJ93M&HLQB4B)%I=Y#ST,SFC8U/-J<)(QHZS:H565DSJS&EFL2(5
M8.292\B'N_W^ ]JN192A,6KKH' F%N PABI@,E+M*9849T$:SC1YNK(9S;-]
MT#/=$E"RQ<56I78/4^5?4?3KDAM?>I'M@F,N,\\U)3^AO8_B?TM%Q3*N.#=E
MYIIU0X9KM(]7R7SBC9$M28PJ*PI8H4D4LJ0Y&0E+LJ*JK[ON\_VI=!A()M<[
MK3MQXU(2<CMGTTYM*BMNS@V'<(J[0SB0Z6YULHOMGUX8O])VP^%&1@7-PYC,
MFE4<PK2A&\)'W.G:<D4AS%]!97&>RM&I;,QD?ME"<^TLQ=!H^+$?D_>#R[O#
MDO!<<ME0^Q*0&B&V-LKJ>5L82O7G,CE'V=1X9Y)FQD> -I,*1F51IZBKQ"VX
M0NG\E2VJF, R:F'S%6C58T+*$J5?&8"M8YC/%[,Z5'K=U@(M@JR_E.FCYDA9
M+P*;?;!*6Q683I6BU4NY;% (2M^9G@P6FE05KV@ONJU%MK3?=;\M]#R+W2UV
MW8=E1B2-1QDG4A6H99UZ;3+C1B10C,:5Y=+H89MZ6K26OQ8Q!^))_&K,C89'
MAR4$US23K#N+BLQ;4GUJ2(5%[6OH=I]:WX[$89_KC]5Z8#-E%E<92*Y;;72T
M%O-;R$%(L1[)L>W+Z%K++A0'4-,:C^5YA#R[F16A8XLI3'' J4"<3(_E/0/Y
M$I6+ .R> &-(_DPY.WC[R)(@BC?'SU:TK64WK+7\,F#Y$**5)KQR.$0RIH59
MOX:-0I:'EPU4A2,5MAC,!UJ(K6(C&3:,ELC22" G%JWR9"S#%HL'?$1A\"4,
M^0MV,Z??)T.D,0W*[AE]8=P\P@L+F<,[8M5I"<-T&MY5I"Q!+;?LMV$0QA@8
MU+VE(GVJ0J.22,W4(5I'2<F+HG_F#O,=*,>H4O\;3K4-;_1'2[4 &Q8#W',Q
MP$;% -]N5@P0D]$^]@;>Y9EW?G%VWKNX_&,CHH$52[N\G5^ULI+AS(X\K2B'
MS2?LFPE4F0AD19HDPF=_<FX5L0, @JTI_6SHO)#4+#;B>EN<3\$+"NP"!!&*
MD)I%%''B)OH/,Y6[7[::J!M&N#938WZC#1D25,-S=[GUREY2S'TF\4?N2E"_
M&&4?9)I3J5*1%MDP,4^'?R@*9R3OQG"#SXLW[&NF,MPAR]/AFUNT;3$(FL%6
M2WZF53Y)IO#QT^^=+AT7X+J//M1YEHLIZ8Y-IT4L;03S]1@)W60(UG ?JK_T
M86!!3X=4+J>^T;DPYA@_O5$I-FEBW7J40J<C1K=P+T49:=;AV<PO_6TZ /.@
MX3%GN-O%+S\LVUCR6[%V;%O^R[*-,\)J? QE+$28KRGAEOJ:/U*FV\AD.RU4
MF)HH]-9PU6W46[+XZV3F(64-^@&NW.@!U[>!$T1DXN6E[79<<6=I:10]*N"B
M6\%+%3**M/50>=QEQIPJ83PG&1,<L5>9R!39>R4B)F1?9]4\/W^*QJD2R$3%
MNA8;2!Z\O?%8R:*HWC VLK:G,I6&9@PG5D[!@ %^BMDK&,B7)"6=LD5[RV3A
M58^QYQ?GC$J-[#O,O*R4%*O8&?U&5':46P8#+$2_SJC@W*]((/B-Q# -L^HE
MJEQVJN:Y,G)7%%CZTFA?17*D3JY:CB7[5Q+V\R99W(85D]=3X9A(6#E[E#\Y
M5,EWG**7+RU8Y/RU2EVB%?57V;PH1Y 4UY.JCZ;(^*V(-. MB+5%%V-,;J"7
MC=-J"DL%NT=4A%1O5Y8S<TKG#_& L+ 3^0?,$"K/YF5K&@D&2A%2-K9ETJ\E
M1V:J+$V6HA%>H#E =<CR,_HL./6#OK6>@-YLY1F&!2QOA%!RH=. H=Y^$9/O
MB[:5I4Q7?8WK-,EP6WJ-#(^2T 0#6.,"=IMAAIZ=(G@ 4:>47\7PKA:>4DZJ
M4EF[56X*%[]%9Z6\K1_'R9Q)58+ SWA?J)B^U!,M+3)]X%SX4;W!06*\2F;-
M"_)1JE>MCD1OF'E-++VK].:6@:V1C\@GR$B^M?>2O6E(/8Q00JLD!7<K@^%"
M$UO:5*04@%EQ/XI3TDPV V>,$B(3;VME'.\=F=CY1%DYM#^'!\\QW9S2#^:E
MD YBH[4(XMH$EE^I6Y3G;T4[Z^YW^U'<537WNRV3U;'$='#A*ZT!5@F<(D.H
MKAQ2VW8D9H(>4J5->^5O5@9 AR(6XU#7C&!"7F6QXL2.E?Q5/.N3(3D21Y;-
M4"I[PU82';YYDG+N6MU'^/LGCO .BTG5?8!70T.EM5,* 2J9-?H%XU2RJ.4V
MB0!#X9K1G)=^ZPL.$_K2(:DE&%:I_+(/4XL-CDMG+SFWM*^$274;)E&98; L
M<;C4@VH(.NH]EO>>2M'0N;K\=(8"#[6N;NV7Y:1*A$#*=V%\S(M\0;1_ @M*
MZ9"I<TID0[8 -.5L&UHB);904A(K9_5QH ,MT+DEDL[0JO-"S6;*NC8*GQ2X
M#68AF/^R :MSOXVXP^I[8U&1NC??PWRSZOIHS:--;\NF*0XIO^3+Q_1I9B7F
M:*1BW;7OL4@/CC8594;;Q8"+KT^2*:7+WL4]LA4$.RK<8J0?Y7LPFCJK4MCK
MC@M/K3V^Z)UT:)'[U#_']#:4*^W7G<KE845S1F14\@FQR2>S:V6,2Y5J& Y,
M$P*;2R4(+C$09:T&#(ZFL)<,9[(&DRB'*KQFK&Z'Z7)%RHQCM"AF61*$BNUZ
MI<!#W8?N4P5V+_H?/UUBE(*TP^H]8I=$_RF_6J5#J8Q#)G&PR3!8 #PT6AHZ
MHN!G)7<LXC EMIB$*HVKS-\L2GE!,LL)!O5<\<B3_\C4()#1)IT'.M<EURXZ
M(PPLR6%Y9\\4MV73<+/BO_LN_MND^._>WH;%?\].C_M'O=/+?N>DOR&QWTMK
M1;>4CN3"3!J+2O)H">T;N4K*Y3!' *)1HO2-S'E2:3!(BFBT&-IB4)=.^7$I
M/UPI+"HA"JK>S!8\IPO1/71DAM.9'RY-0[(,$KI2B:Q;M7PA\F.'?$)9-)9G
MVG31!*H8(Y4,J1@Z4RH!+6^8)C?T,_6O*@ZE,APB#3/.B!'WHWA@ 669TT.R
MK:IPT+PB[8[Q:F36PY0MG?II]7JIS(R3FI/4Y)):CGBJ<5J>MFQ64YLS4L=$
MT7ENE1;I49,QF9^N9V*RD$R2_E;#!5B!EY &6X;Y:K)B!]GOASQ.8/M+ @M9
MRQQ;-B[EI<&TX+>U_$85YWTDKJ%Y&+LR;G'VFF=+C#<Y7X=)-+)G*Y:"A0%,
MPK:RW/ID79!?!EJ3C,PT')6S$Q<S<LFDH%"-Y(+5X\/PCQH!Z02Z6-PL3<1=
M<IY,=J13%K-TJ>2;2ULH3"#O3EN'/(QIZT#?U=TN?VJMU-6@ ]O(RXO^V:77
MZ5YZW1YL*8_[W4[]ZWLQ1^-IG?/PK!TN!.6\%W5VVSNWRM9[WU3X[8Q("7;V
M=G?W6Y31ROO8<\ 96K*\CR)!HIXO;0#[C#@!!X!4/)OPG-UM)&54\^E$:"&-
M<I!"5:?J2+1*GO#SQU-_RK\C,59O=KW>]<Y3WW7?R"4&.25G\&JI?.GJ+RZU
MP/_9SCQ#)]XB@O=92[OVDE06F\(_,J:#1U?'@W3 7\7DXQQ@B7+F7:8DRT@R
M@K">,VV8U/!)DS1$)ZG2?&6ZY0B/U;2)NEX71\=AE 0W\.4YMU,1R>J4F:$?
MRWJTH3Q2/9%ZE-C2 </7(HLI;'8&&0-K,?5&RTN+2$B&PNLBLO:AQC_)"I0C
M2FS*%84N]L49&2[8O<=)*C#UNY-E N"\FU#R%Y6#/-9%ONX#>??'#601(U64
M\:=9[VS5Z"Z-:FEW9*QTQME5,K/,-VYU>R0\Z**FJ/,O)DS-"6$Q>>\7K3]]
M^#R-EZQ /;5(+'HDJREC"1=ZD?G,5YO3T1@$]"9^.J6\%[..2#KVD0XMD#=4
M$MM1;1CN.#A[!S-O,[)\ ;-N\$\9]PEE:IIFN]LRN75_J>3'>X\LSUZ6DY<(
M;2)) <A\;Y;U65(\LM?MNIN"3RVC-67S_[BZ^,,#F[!S4N\9J%1M//A7TMEX
MGWH7O<,_^&%1^J9_X5WT!N>][B5^H=W4]/0>'$A] 7W2.?W#ZW:N!CWZ@W(-
M6AX1"[1*- />V877O3@;#%YUSSZ?PS=PS_XIG:[..K\XZ_9Z2-R%#7L-)WSJ
M=2[PS\.+LRML -RWUX?&77CF$3["I0:7ZC'@)/E)_:"//..[?>Y<0IN\+Y\Z
MEX.S'KY9N,< [W)VA1IV+;R&;-F7SA_H23J%7N@=>5_@UBWHF_Z O?4MD@BJ
M!I^6=&ZKRAE$W05#JMN].N^<=K7<T/E%[W-_T!M0&ZAGN>N.H4'<X1?>4>=S
MYV./CL!3>J?'9Q==*AY4KP,NTCOZP[M"%4CZXJ3SI>4-+CN75Y=\XD7OXQ6W
MNN7!P1<?>]0(:!%V[I<^/MOIV1>/7L%%KW.,/09]TCL^AJYXL*?[D1#Q)*7/
M1S;BI\@"_Z V/)-W$<?UX+S3[<'H/H:Y!@/YGV1%[X U/.A_/(7Q<P%C%$8?
M(L'QV<G)V9<U? M.:/8OH@X^[;C^_J+W[T_]P_[ESO;^GY\N/_\Y.-Y^NWOP
M]N"X=[#?W3W:VS_>@?_O[;V!4S 6-$R]UU4/>LV#7 >;&.1:@[#:LULX>HP?
M]P=_7IUR).BXWSOZ\[)S>-+[<V]?#NH''@=K'ZS^I[W!  P'6!'13%B28$&E
M"YJ=D;:!(:5DD(>""48RE,^N4,JMDDMI?8>VP(_$U%%X"__-F<>2/!=_?[']
M K8'48258[!5T'_/D/59_DV \/<7C @O5*OY J^P%-"?9>(W]>&#5YE8>8K_
M&7FW\CKP5"\\=14^=F^G_6[WL=/0=G'@W^5NPB_6P";'CO_;ZWS$70!]!!T-
M?;#_XK[N>/.NO?.NTAT6-.,3K^B,Q=Y:S^ZY.#[W3OJGW;.34V_W_5[+.SGI
M6EWUFL?,\PZ<!W0%A97NFW,_Y-77>R;X%1FG93FQI-NTV>__OH=H;S_',SQX
MQ.[=/V(/?MZ(_>[FNP%4:\PXG/^V=F/QF>P(*7)WD6#.Y>ZVM_6Y\Q+L2.](
M1/X=Y@ MX*F;!FL$1$T>NX'28\3<%"U0^9DB_&Z0ND'J%OL-&D#WM'B_O;-1
MN+;:.MF]?_+LM+<W"^%/D_@5XSGC.Z;"]..@C0;*)4GKENKI]#K@\'_=IN\#
MA_!!^V =6W]?B]^WW[Q9MR:[(?_<;^ Y39[]]L$SX_:#,ZY>9Z^]CYA&E,Z]
M0=OK(N7-'57^624X;E"OX:!^-AQ_V(B.1)Z+])4,._WV:KN]?:!.^9$&BC\5
MOZW%6O$\$WW5W'63UDW:YQ^=ETB)U^3I^3LF_NN*F(5I^9I"]? =!^Y=PH"9
MR+OMO8T:"9Q1^GT&ZMOVVU^4++!83?GPSOKN.=(YZ5WT+SN#EM<_[;:_:^WZ
M>:/E)R4)//J-UWOT6^$LRV&TT:_ZGF?8;>_7V$J!_?)NC4,$;ORX\>/&CQL_
M:[0Z/LI;UTO#X,8[*0*1^D_QT;EQ_!S!BO;.OG/++<SH[>?NEA_]_.5)ZF:G
MFYUU\+]MWCSL'I^MG]-MHXH0][:[[W;WWQSM='9VWK_OOC\\WC_8["+$-ZX(
M\;X[ZI'R9Z?7/[LZ\;/\@JB=Q.@<^N@0NXA^D:5ZFU*/_6 C7LX@K_-J9SG-
MY8^JSW^>?CB/?&3#2^Z4VJ#X%F9$LW-))-;'49*DW@"%[-:P&+W>0S"<7GM9
M&OS]Q?7>K+C[S_Y!=%U,M_'_=MI?9]<O/-*H^OL+C.#D^$]I^7^[_W;V[<.$
MVW/P]CW\\>*)8[/QR^8&KG]OW?KW0]:_@Z:N?]\FX3#,8?W;_2'KW^[^6O5#
M:?T[2>Y0JITD2]V2]VN7O-T'+'EOMO?,DO?VW;9;\MR2MV3)>^>6O!^RY+UI
M^))WN(D;OGZ,NO/$STNLO9'(Q:/I;-?G<1[\4A70/>J-U@/OWCN\>^ =&X)?
MTF75_0Y=%F>S+G C79WT!D0W:G@]J^)WM7[ W?=[WF&2Y4GLG<,_<!>_NB#4
M^OD^^VDT3%*4:&Z5R8^>Q,*WL]M^9J53%G-CO1%4 R#]H2@,<BT)6!$K$DJK
MB)0[A7=11)+0^D+SY+-&^[*SM(8NLN"O)4OMXBT1$5_)#:.]D&]69GXY&8%S
M$4P(N?3K^S><JWQOBL,T'(TB\<)[>-\^;W) +=I[3S;)YD3P=]K+W]"&/>8G
MX;-:2X275#IKLZB8#C%/BV3,M?A!-B&EMZ% >0R4QD&],R^1 E.D%PN+$R('
MZ6M-%JZ-BL?RTMXX_(9:79D28LN\*8HBH_!&)) ?E5A/DR35X*T%TXM8"JS
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M3<KL(6__3<D6-+^1QB/S</HX8-DB'"5,\Y^%LE8)RX2<5>C@S\%?[7"A(60
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MI9^9_.#WN9-[2F$,7M%A$48(P\ZI[-:-=6]O(]:-ACB5F=Q7*"2"D[*)EXI
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MC+\'8.&7$8"84*P03@TQ9  ;5DJ.DE@?LN;%IC-AI2/$1 G?4"RP< Y&2YH
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MK3?G(P%*^7)7I<B*!V$K'TRI*Z1 F/P!C".IJIFTH8!$(S3ZJCH/FLP$>%5
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M4^#"GJ.@H'[SH\,JZ3R"GK-0Y:-J,B>)@29S(5&V?>S8T PW]7"2S@T-1Q$
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M?G_H.W,<P-D?1Q,7?OE_4$L#!!0    ( '.!5U87#O9S'P,  )<)   0
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MU&0S[4$"F7)954#,8#J+)Y0M9@ L\Q7]6<]?2">;1<B 0GF--*+,E"U4F,%
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M2P".T8V!J[&W([J5[R()WC8&E14*/(] 4/;*T F(J$ L&J;2("EIX =/9$G
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MBU<&[+6W>E(H[J:EM4$(YN-Q$#&5%0JP;V<0]'U88/#R1=!I]JXA]G7X; !
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MCL"KC@FZ&[Z?[";RFT/Z:/;=_]%8@N8,1G"6'QH>P3*2<_)&J2E$ZCF'H(1
M4.0(E).@Z;Y%GBQ").-&:$9*?CO@,9]$$-.MH$'"9A@6D01G,4Y!&()H6,99
M7$8X=%!K:9S"5(KTN?)1WC3ZUTS=A -(,I42& #@D4@ <V'3ZU^&'$G@BDZW
M:?$]6':TM]GR<[!*V24-+X\// P^D"3@#?SQFT5^>18)?RT6$0I7+,,W!@$*
MN2/#= G/_CI=)%08"*S,\!Q#J(%25$H"LX$S0 X&,@@A&,')R3(Q@'5941 5
MX0-24UE&H :R*53G=;15I.;=$V0_9:9ZK,A'817/<_(1TQ2=E$!-,9W*X?0
M\"G0)F:MR*TIHH6"0+ETB5#8,HPPNL#V$8_,E)I%P<TM[WKALVDM]VU%S2,B
MM5J4/ :?/I!.=ZZQZ3J!%H-5P/NER&VL6\^J]+NC"NNZO7_EC36BJ(RKG'6A
MI6"DZ>VV,TMJC]1+W'3HW2ZNF@A=T5[W.78\H9_]W+]15ZS0ZG= ^>?&ZS=6
M&]R5W%Z=WH#LKB_+]XW'XK*MN[OGM7>W'DK#G9^<A7^ K/;V%.&'^>Y]H<QY
M2JL>Y:+Q:[/F![OL:7+H+U:F(TSCXK42F<9QD>*65U/74^RUBGQ9:4,);;C$
M:[P&EMA*6\(XU+$,<FP)SV6%NW)UB;GCLG2%K'HB\KS.P*LU8/T("X"XNJ.#
ME:(%:$H@Y50QCF#BJ1:H!6+XSGN](G^]KO_JQK2U>F/:(/J&Z/VWK/.4PQP#
ME0;#.SSP'\=U:&(KQ0RLKQ/DAR!J;SJF0O@50&RJ0D;,BD41@C%74*K(%;1P
MC@2SIQ0L7ZN<\BEH*#'#E'S]V/\ZY<Q+%>59K]Q8]8^EOE_] ^M_4$L! A0#
M%     @ <X%75FROTLC-V   : 8! !8              ( !     &<Q;W<S
M,3%D>6=I<C P,# P,2YJ<&=02P$"% ,4    " !S@5=6KSL.QTRQ!  ]GT\
M%0              @ $!V0  ;6YK9"TQ,&M?,C R,C$R,S$N:'1M4$L! A0#
M%     @ <X%75HNR68#7+   A#T" !$              ( !@(H% &UN:V0M
M,C R,C$R,S$N>'-D4$L! A0#%     @ <X%75HL/HB33'   5>X! !4
M         ( !AK<% &UN:V0M,C R,C$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M '.!5U;K\8UBEW<  ,7K"  5              "  8S4!0!M;FMD+3(P,C(Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    " !S@5=6\K5M_@C_  !9=@\ %0
M        @ %63 8 ;6YK9"TR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @
M<X%75FSPK6L8IP  ,G8- !4              ( !D4L' &UN:V0M,C R,C$R
M,S%?<')E+GAM;%!+ 0(4 Q0    ( '.!5U9F#9^6BS$  &CX @ 3
M      "  =SR!P!M;FMD+65X,3 T,E\V,34N:'1M4$L! A0#%     @ <X%7
M5CZNLMMP.@  -U\# !,              ( !F"0( &UN:V0M97@Q,#0S7S8Q
M-BYH=&U02P$"% ,4    " !S@5=664XOJYT1  #ZFP  $P
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M+65X,3 U,U\T-30N:'1M4$L! A0#%     @ <X%75A<.]G,? P  EPD  !
M             ( !K]T) &UN:V0M97@R,S%?.2YH=&U02P$"% ,4    " !S
M@5=6KL$,8U '  "Y(   $               @ '\X D ;6YK9"UE>#,Q,5\W
M+FAT;5!+ 0(4 Q0    ( '.!5U92HC(@1P<  *,@   0              "
M 7KH"0!M;FMD+65X,S$R7S@N:'1M4$L! A0#%     @ <X%75N"$OLRQ!0
M.QL  !$              ( ![^\) &UN:V0M97@S,C%?,3 N:'1M4$L! A0#
M%     @ <X%75NA"S3"L!0  ,1L  !               ( !S_4) &UN:V0M
A97@S,C)?-BYH=&U02P4&     !, $P#0!   J?L)

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
